data_1rck_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1rck _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 N--CA 1.456 -0.159 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 77.29 66.77 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.31 140.28 29.76 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 125.502 1.521 . . . . 0.0 109.136 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.02 121.95 35.86 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.5 m -102.14 78.8 1.8 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.154 1.381 . . . . 0.0 107.864 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.38 -97.45 0.68 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 t -100.35 -39.56 7.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.933 1.293 . . . . 0.0 110.034 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.5 m -72.25 96.49 1.84 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.347 1.059 . . . . 0.0 109.767 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -79.92 155.67 27.63 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.257 1.023 . . . . 0.0 110.867 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -143.35 119.76 10.96 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.218 1.007 . . . . 0.0 110.744 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.5 t -60.24 159.09 10.37 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.147 1.779 . . . . 0.0 110.663 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.02 -17.34 51.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 t -76.86 -43.93 34.18 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.601 1.16 . . . . 0.0 108.743 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.81 -45.89 80.66 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.665 1.186 . . . . 0.0 111.305 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.6 t -58.2 -52.6 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.739 1.216 . . . . 0.0 108.345 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -68.18 -31.6 71.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.3 1.44 . . . . 0.0 113.484 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.14 -60.05 2.93 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.933 0.788 . . . . 0.0 109.417 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 -30.25 71.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.462 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.07 -51.51 15.54 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 119.507 -0.283 . . . . 0.0 111.494 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -60.36 -19.7 56.66 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.32 -72.16 0.27 Allowed 'General case' 0 C--N 1.347 0.49 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.03 -29.47 60.46 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.224 0.92 . . . . 0.0 111.788 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.6 t -56.86 -44.13 81.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.485 1.039 . . . . 0.0 109.005 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -96.58 4.01 52.24 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -126.54 -12.43 6.12 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -74.65 -53.09 9.98 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 119.186 0.903 . . . . 0.0 113.089 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.326 0.0 OUTLIER -137.47 33.56 2.51 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.949 0.881 . . . . 0.0 112.275 -177.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.414 ' CG ' ' H ' ' A' ' 30' ' ' ASP . 21.0 p-10 -74.0 -64.93 0.91 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.414 ' H ' ' CG ' ' A' ' 29' ' ' ASN . 4.6 p-10 176.7 37.68 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 129.024 2.93 . . . . 0.0 109.284 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -176.14 -171.13 0.41 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.134 1.774 . . . . 0.0 109.246 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.5 p -122.63 -51.65 1.93 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.929 2.092 . . . . 0.0 109.195 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 43.62 55.03 5.2 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 126.666 1.986 . . . . 0.0 112.081 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.33 179.68 25.93 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 112.251 -2.25 . . . . 0.0 111.625 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.8 p -61.44 -66.99 0.45 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.048 0.939 . . . . 0.0 110.215 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.0 t -163.7 -66.33 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.594 1.158 . . . . 0.0 108.541 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.1 p -106.48 31.27 5.32 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.364 1.066 . . . . 0.0 110.999 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -164.95 104.75 0.8 Allowed Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.538 1.535 . . . . 0.0 107.723 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -64.17 156.42 72.75 Favored 'Cis proline' 0 N--CA 1.456 -0.731 0 CA-C-N 120.289 1.139 . . . . 0.0 113.555 -0.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.63 168.54 6.27 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.884 1.673 . . . . 0.0 108.985 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 t -68.25 151.62 46.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -79.84 110.34 15.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -10.69 -91.14 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.951 3.301 . . . . 0.0 115.488 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 143.78 -54.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 130.269 3.428 . . . . 0.0 106.929 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -56.94 124.32 18.21 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.062 1.345 . . . . 0.0 109.888 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 62.28 58.59 1.74 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.954 1.302 . . . . 0.0 108.536 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.41 111.34 4.1 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.712 1.149 . . . . 0.0 110.624 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.24 169.2 16.84 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.572 0.749 . . . . 0.0 110.626 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -71.2 130.2 40.83 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.121 1.369 . . . . 0.0 113.682 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -163.6 120.98 1.2 Allowed Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 126.152 1.781 . . . . 0.0 108.706 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -65.29 -165.64 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.987 2.458 . . . . 0.0 111.111 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.7 t 76.96 -101.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.178 1.391 . . . . 0.0 110.045 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -167.8 -67.09 0.03 OUTLIER 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.178 0.899 . . . . 0.0 111.609 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.68 -172.7 14.75 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.256 1.408 . . . . 0.0 109.584 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.55 163.59 52.05 Favored 'Cis proline' 0 N--CA 1.456 -0.715 0 CA-C-N 119.118 1.459 . . . . 0.0 111.707 -1.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -110.71 172.9 6.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.343 1.057 . . . . 0.0 111.363 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -140.25 131.15 26.03 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.158 1.383 . . . . 0.0 108.606 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -94.58 161.82 14.05 Favored 'General case' 0 C--O 1.227 -0.09 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.03 105.99 1.41 Allowed Pre-proline 0 N--CA 1.455 -0.176 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.22 120.45 6.57 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 121.101 1.2 . . . . 0.0 109.866 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.666 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.6 tt -83.62 -175.43 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 123.665 1.698 . . . . 0.0 112.423 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.666 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 13.7 mmtt -160.31 163.02 33.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 109.82 -3.354 . . . . 0.0 110.816 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.0 t -78.82 56.86 1.98 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.998 1.719 . . . . 0.0 112.135 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.32 60.9 0.21 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 125.088 1.328 . . . . 0.0 112.474 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.18 140.3 3.05 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 117.695 0.747 . . . . 0.0 113.86 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.5 p -100.17 157.61 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 126.785 2.034 . . . . 0.0 107.239 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 64.91 74.21 0.4 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.134 0.974 . . . . 0.0 108.675 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.0 p -134.65 -169.39 2.33 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.409 1.483 . . . . 0.0 109.714 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.41 124.13 24.71 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.084 1.326 . . . . 0.0 113.695 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.37 101.0 0.87 Allowed Glycine 0 C--N 1.339 0.741 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.0 t 64.63 86.07 0.15 Allowed Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 125.363 1.465 . . . . 0.0 109.302 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.1 164.03 88.72 Favored 'Cis proline' 0 N--CA 1.458 -0.597 0 CA-C-N 119.571 0.882 . . . . 0.0 112.503 5.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.89 -58.07 0.17 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 87.11 -67.71 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 129.128 2.971 . . . . 0.0 108.321 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -70.48 119.93 15.37 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.484 1.914 . . . . 0.0 113.149 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.1 mtt-85 -141.48 147.8 38.44 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.121 1.369 . . . . 0.0 112.301 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -112.61 144.05 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.4 t -139.92 127.04 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.88 0.372 . . . . 0.0 110.647 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.39 174.15 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.358 0 C-N-CA 126.922 2.089 . . . . 0.0 111.202 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -93.56 169.08 10.61 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.952 2.101 . . . . 0.0 105.589 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.367 14.5 t -76.29 53.35 0.82 Allowed 'General case' 0 C--N 1.341 0.223 0 N-CA-C 117.775 2.509 . . . . 0.0 117.775 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -160.05 -83.31 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.82 -0.29 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.654 1.581 . . . . 0.0 114.27 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.57 110.56 16.16 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.016 1.28 . . . . 0.0 113.842 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -60.04 111.64 1.58 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.712 0.805 . . . . 0.0 109.707 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.25 -40.13 31.38 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.629 1.171 . . . . 0.0 111.349 -178.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.4 168.81 17.02 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.75 154.31 23.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.679 0.792 . . . . 0.0 110.353 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.8 pt -131.51 157.7 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 125.78 1.632 . . . . 0.0 107.99 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.0 t -159.53 139.28 11.58 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -84.36 46.77 1.26 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.7 t -65.65 -38.6 89.81 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.3 56.72 0.54 Allowed Glycine 0 C--N 1.335 0.486 0 N-CA-C 106.119 -2.792 . . . . 0.0 106.119 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -106.92 -17.56 14.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.3 m 64.39 35.54 9.6 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.6 21.93 78.72 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.704 2.097 . . . . 0.0 113.899 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -146.76 -70.58 0.24 Allowed 'General case' 0 C--N 1.347 0.484 0 CA-C-N 119.44 1.62 . . . . 0.0 114.216 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -58.9 100.36 0.07 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.054 1.742 . . . . 0.0 114.042 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.281 0.5 OUTLIER -78.14 140.98 39.02 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.439 0.695 . . . . 0.0 109.613 -178.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.17 160.86 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.74 160.65 29.0 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.31 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.8 m -117.93 159.55 22.94 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.638 1.175 . . . . 0.0 110.583 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.3 t 44.19 69.11 0.45 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.046 1.738 . . . . 0.0 115.429 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.43 -4.13 74.39 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.094 -0.837 . . . . 0.0 114.334 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.8 m -84.29 104.63 14.48 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 116.622 -1.656 . . . . 0.0 111.231 179.417 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.322 0.106 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.5 136.4 0.03 OUTLIER 'General case' 0 C--N 1.341 0.208 0 C-N-CA 126.664 1.985 . . . . 0.0 111.592 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.1 p -116.82 109.88 17.67 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.79 98.23 7.92 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 100.636 -3.838 . . . . 0.0 100.636 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.1 m -94.35 79.37 3.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.141 0.976 . . . . 0.0 109.102 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.09 -86.06 1.0 Allowed Glycine 0 C--N 1.34 0.777 0 C-N-CA 125.061 1.315 . . . . 0.0 110.013 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.4 p -119.58 -38.87 2.93 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 125.598 1.559 . . . . 0.0 110.156 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 m -74.14 100.78 3.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -95.04 149.43 21.26 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.85 0.86 . . . . 0.0 113.223 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -144.22 152.73 41.24 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.321 1.449 . . . . 0.0 110.043 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.9 m -74.55 159.6 31.98 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 125.556 1.542 . . . . 0.0 111.449 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.26 -22.67 67.02 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.5 t -70.49 -37.08 74.15 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 125.076 1.35 . . . . 0.0 109.062 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -65.69 -42.57 91.04 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.116 0.966 . . . . 0.0 109.731 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.1 t -61.27 -47.86 91.58 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.2 mtp85 -66.64 -26.55 67.12 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.214 1.406 . . . . 0.0 112.383 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.15 -60.58 2.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.71 -28.25 69.46 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.858 -0.592 . . . . 0.0 111.279 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.69 -37.1 50.34 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 118.941 -0.552 . . . . 0.0 112.38 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -70.5 -22.03 62.69 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.53 -59.74 2.61 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.96 -47.89 16.51 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.697 1.199 . . . . 0.0 110.33 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 m -51.1 -54.57 23.83 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.227 1.011 . . . . 0.0 110.961 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -77.09 -27.51 54.21 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -113.34 -6.0 13.55 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.289 0.0 OUTLIER -95.23 -38.96 10.32 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -179.077 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -147.29 33.53 0.88 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.326 0.966 . . . . 0.0 112.043 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -132.78 -70.71 0.54 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -136.49 85.49 2.15 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -56.77 118.76 5.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.022 1.329 . . . . 0.0 113.678 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.8 p -143.65 49.53 1.4 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.124 1.769 . . . . 0.0 108.681 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -163.26 153.05 15.4 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.116 0.966 . . . . 0.0 110.014 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.98 155.64 52.99 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.1 t -133.45 77.92 1.75 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.163 0.985 . . . . 0.0 108.87 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 p -107.09 -59.19 1.84 Allowed 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.87 -11.5 7.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.559 1.944 . . . . 0.0 110.733 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.66 129.95 3.53 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.93 139.71 55.04 Favored 'Cis proline' 0 N--CA 1.452 -0.959 0 CA-C-N 120.153 1.09 . . . . 0.0 110.536 -0.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -155.09 148.14 24.7 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 t -56.08 144.73 28.07 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -79.41 112.66 16.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -71.33 81.6 0.75 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.98 1.312 . . . . 0.0 109.215 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -156.76 76.04 0.86 Allowed 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.21 -37.97 73.02 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.862 1.265 . . . . 0.0 110.699 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -64.43 -35.59 81.42 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.29 114.76 0.24 Allowed Glycine 0 C--N 1.342 0.881 0 C-N-CA 125.875 1.702 . . . . 0.0 114.301 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -78.94 106.22 10.82 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.0 p-10 -28.98 111.03 0.06 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.484 1.914 . . . . 0.0 115.842 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -147.88 151.0 37.46 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 126.895 2.078 . . . . 0.0 108.076 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.02 78.04 3.72 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.327 2.685 . . . . 0.0 107.391 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.17 171.25 12.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 C-N-CA 124.841 1.256 . . . . 0.0 113.569 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -125.93 -49.61 1.6 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 128.034 2.534 . . . . 0.0 105.997 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.69 170.73 46.5 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.862 1.696 . . . . 0.0 113.914 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.55 134.74 32.26 Favored 'Cis proline' 0 N--CA 1.46 -0.498 0 O-C-N 122.419 0.694 . . . . 0.0 112.18 -0.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -107.49 136.5 47.17 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.602 1.561 . . . . 0.0 109.541 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -125.49 161.83 26.24 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 123.641 0.777 . . . . 0.0 111.24 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -83.88 153.34 24.05 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.597 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -155.44 103.21 2.2 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 102.791 -3.04 . . . . 0.0 102.791 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -76.46 136.59 17.69 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.027 1.818 . . . . 0.0 115.832 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.2 tp -89.87 171.24 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 126.086 1.754 . . . . 0.0 112.787 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.06 170.31 22.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 110.62 -2.991 . . . . 0.0 113.067 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -82.0 57.92 3.71 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.86 2.064 . . . . 0.0 112.029 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.28 73.43 0.77 Allowed Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.34 -177.58 40.63 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-O 121.631 0.573 . . . . 0.0 112.808 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.71 148.4 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 127.374 2.269 . . . . 0.0 106.39 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.312 51.4 p90 58.4 -170.11 0.12 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.78 1.632 . . . . 0.0 111.924 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.2 t -79.61 166.36 21.96 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.696 0.799 . . . . 0.0 112.577 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.08 140.24 3.1 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.29 -114.12 4.85 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 124.689 1.137 . . . . 0.0 111.103 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -155.31 -68.52 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.441 1.096 . . . . 0.0 109.972 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.55 160.46 46.56 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.292 1.995 . . . . 0.0 110.547 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.53 -83.4 0.06 OUTLIER Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 81.77 -39.89 0.13 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.186 1.794 . . . . 0.0 111.041 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -71.3 125.41 26.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.061 1.744 . . . . 0.0 115.064 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -139.5 131.33 27.57 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 123.723 0.809 . . . . 0.0 112.254 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.7 m -94.64 148.15 5.2 Favored 'Isoleucine or valine' 0 C--N 1.345 0.406 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -134.35 139.71 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 pt -135.16 165.75 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.256 0.622 . . . . 0.0 112.497 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -93.55 155.41 17.33 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 127.9 2.48 . . . . 0.0 108.621 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.37 15.0 t -79.55 65.64 4.78 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -156.86 -94.58 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.172 1 N-CA-C 98.856 -4.498 . . . . 0.0 98.856 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.4 m -162.98 9.4 0.06 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.698 2.399 . . . . 0.0 113.035 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -82.84 132.46 35.16 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.548 1.067 . . . . 0.0 112.609 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -73.12 122.72 22.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.54 -57.96 3.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.69 153.21 11.56 Favored Glycine 0 C--N 1.339 0.717 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.465 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.03 112.03 24.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.58 162.34 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.709 0.804 . . . . 0.0 109.181 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.6 t -160.3 150.13 17.92 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 63.97 6.55 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 175.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.1 t -63.75 -38.87 92.74 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.021 -1.049 . . . . 0.0 112.739 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.79 54.32 0.04 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.21 -78.78 0.4 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.77 0.828 . . . . 0.0 108.813 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.6 m -159.42 73.96 0.6 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.658 1.583 . . . . 0.0 108.72 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.83 -102.75 0.94 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.032 0.825 . . . . 0.0 111.719 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -79.77 -25.85 40.84 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.756 0.822 . . . . 0.0 111.83 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -49.15 129.69 18.2 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 124.52 1.128 . . . . 0.0 111.4 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -97.39 153.0 18.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.341 1.456 . . . . 0.0 113.405 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.0 m -135.21 167.26 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 126.957 2.103 . . . . 0.0 107.032 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.1 151.34 30.01 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 116.542 1.377 . . . . 0.0 116.542 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 38.7 m -106.53 -173.67 2.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.859 1.664 . . . . 0.0 106.641 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.0 t -69.32 140.98 54.37 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.454 -0.779 . . . . 0.0 108.984 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.31 32.54 59.97 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.936 0.779 . . . . 0.0 111.332 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.9 m -137.85 108.38 6.56 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 117.192 -1.385 . . . . 0.0 109.474 -178.984 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.0 m . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -40.24 132.22 1.98 Allowed 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.485 1.914 . . . . 0.0 112.664 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.8 p -102.65 89.06 3.38 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.272 1.029 . . . . 0.0 111.372 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -94.87 98.3 10.62 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.02 -165.14 0.92 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.118 1.367 . . . . 0.0 108.049 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -31.09 -57.87 0.27 Allowed Glycine 0 C--N 1.343 0.971 0 C-N-CA 125.993 1.758 . . . . 0.0 112.159 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.9 p -160.31 38.1 0.17 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.225 1.01 . . . . 0.0 109.687 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 m -129.49 94.15 3.71 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.7 110.47 15.06 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.697 1.199 . . . . 0.0 111.459 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -110.26 128.92 55.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.3 m -65.89 158.13 28.78 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 124.713 1.205 . . . . 0.0 110.726 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.64 -17.32 54.89 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.1 p -77.55 -37.98 49.56 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 124.0 0.92 . . . . 0.0 108.719 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -68.77 -36.04 77.82 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.027 0.931 . . . . 0.0 109.974 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.44 -47.82 89.96 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -64.49 -37.45 87.57 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.014 0.926 . . . . 0.0 111.374 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 -55.16 15.49 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.541 0.61 . . . . 0.0 110.225 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.44 -37.13 82.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.136 0.975 . . . . 0.0 111.172 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.32 -34.34 42.35 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -70.87 -22.02 62.34 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.1 -51.62 9.99 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.4 ' HB1' ' CD2' ' A' ' 59' ' ' PHE . . . -47.32 -67.07 0.31 Allowed 'General case' 0 C--N 1.345 0.375 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 176.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.2 t -39.09 -46.31 1.39 Allowed 'General case' 0 C--N 1.343 0.287 0 C-N-CA 127.892 2.477 . . . . 0.0 112.475 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -65.14 -58.34 6.27 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -71.73 -8.62 55.28 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.44 ' CE2' ' HB2' ' A' ' 57' ' ' GLN . 6.4 t80 -79.38 -47.94 14.88 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.957 1.303 . . . . 0.0 111.376 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -135.51 -26.66 1.23 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -72.89 -56.44 5.19 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.43 1.014 . . . . 0.0 112.861 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -128.13 73.02 1.44 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.472 1.509 . . . . 0.0 108.775 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -55.06 153.4 6.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.704 1.202 . . . . 0.0 113.058 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 59.6 p 56.17 70.85 0.6 Allowed 'General case' 0 C--N 1.34 0.164 0 C-N-CA 127.153 2.181 . . . . 0.0 112.437 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -158.17 91.15 1.08 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.65 -78.23 0.2 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.8 m -145.55 -116.39 0.08 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.159 0.983 . . . . 0.0 108.675 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.9 m -158.26 -50.51 0.06 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.597 1.559 . . . . 0.0 109.35 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.0 p -79.73 6.26 11.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.293 1.037 . . . . 0.0 112.868 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -151.94 95.29 3.23 Favored Pre-proline 0 N--CA 1.455 -0.208 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -84.22 142.75 40.07 Favored 'Cis proline' 0 N--CA 1.455 -0.746 0 N-CA-C 116.263 1.601 . . . . 0.0 116.263 2.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.15 158.83 25.19 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.703 2.401 . . . . 0.0 107.377 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 m -42.38 120.0 1.54 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.022 2.129 . . . . 0.0 113.555 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -138.13 86.47 2.17 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -167.63 -49.67 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.676 1.19 . . . . 0.0 109.039 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.96 59.7 5.79 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.156 1.382 . . . . 0.0 110.141 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.36 14.98 1.46 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.817 0.847 . . . . 0.0 112.117 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 56.9 83.62 0.1 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 125.222 1.409 . . . . 0.0 111.267 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.24 167.09 36.04 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.67 100.5 0.28 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.147 0.979 . . . . 0.0 112.989 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.97 164.86 26.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.537 0.735 . . . . 0.0 109.976 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -106.08 151.07 40.01 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -58.13 -95.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 124.524 3.482 . . . . 0.0 114.152 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m 24.92 -106.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 127.062 2.145 . . . . 0.0 113.521 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -163.01 -44.78 0.03 OUTLIER 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.076 0.853 . . . . 0.0 112.214 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.16 -167.54 29.19 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -60.94 165.65 30.04 Favored 'Cis proline' 0 CA--C 1.535 0.547 0 CA-C-N 119.572 1.686 . . . . 0.0 114.123 -0.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -132.15 143.15 49.78 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.541 1.136 . . . . 0.0 111.502 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.44 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -139.99 153.32 46.83 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.325 1.05 . . . . 0.0 108.231 177.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.75 154.28 23.68 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.4 ' CD2' ' HB1' ' A' ' 23' ' ' ALA . 26.9 t80 -160.74 106.68 1.3 Allowed Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.399 1.08 . . . . 0.0 109.006 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.92 155.75 15.25 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 N-CA-C 119.008 2.657 . . . . 0.0 119.008 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.604 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 6.5 tt -105.63 175.37 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 C-N-CA 126.984 2.114 . . . . 0.0 110.035 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.604 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 6.9 tptp -160.9 166.59 28.17 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 109.352 -3.567 . . . . 0.0 112.454 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.1 t -88.83 62.15 6.27 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.542 1.537 . . . . 0.0 108.764 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.06 64.19 0.66 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 167.5 145.0 4.34 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.1 t -123.56 66.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.0 t80 64.08 103.26 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.086 2.155 . . . . 0.0 112.863 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.8 p -138.96 64.23 1.49 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.3 -68.95 2.38 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.06 -135.38 22.74 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.8 p 54.16 102.08 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 127.39 2.276 . . . . 0.0 113.282 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.84 176.49 40.37 Favored 'Cis proline' 0 N--CA 1.457 -0.663 0 CA-C-N 119.707 0.931 . . . . 0.0 112.177 4.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.38 163.54 31.6 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.45 -43.64 0.15 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 118.375 -0.821 . . . . 0.0 111.655 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -69.36 107.08 3.16 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -119.24 129.23 54.83 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.434 1.094 . . . . 0.0 111.451 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.65 151.43 6.04 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -135.12 135.74 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -123.08 164.14 20.97 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -80.98 173.25 12.79 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.674 1.99 . . . . 0.0 108.598 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.406 ' HA ' ' CE1' ' A' ' 27' ' ' TYR 0.43 1.5 m -73.59 -15.04 61.28 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -177.534 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -81.02 -83.88 0.11 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 101.327 -3.583 . . . . 0.0 101.327 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.1 m -164.05 0.12 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.639 2.775 . . . . 0.0 113.895 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -79.39 132.19 36.33 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.37 117.27 14.93 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.996 2.118 . . . . 0.0 108.222 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.01 -66.1 1.11 Allowed 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.265 1.426 . . . . 0.0 111.952 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.49 146.71 20.99 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 115.976 1.15 . . . . 0.0 115.976 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.65 99.62 3.38 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 103.746 -2.686 . . . . 0.0 103.746 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.5 pt -136.77 165.49 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.073 0.949 . . . . 0.0 111.428 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.0 t -160.27 145.74 15.05 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -79.87 29.44 0.26 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.21 0.604 . . . . 0.0 111.791 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.8 t -65.19 -30.28 71.17 Favored 'General case' 0 C--N 1.343 0.307 0 O-C-N 120.797 -1.19 . . . . 0.0 113.405 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -138.39 49.32 0.84 Allowed Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.29 151.86 21.74 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.114 1.366 . . . . 0.0 110.86 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.1 t -66.39 -45.37 80.25 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.35 1.06 . . . . 0.0 109.495 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.7 -79.43 0.03 OUTLIER Glycine 0 C--N 1.339 0.741 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -97.4 7.52 46.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.352 1.061 . . . . 0.0 111.027 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -74.0 -174.21 1.81 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.4 1.08 . . . . 0.0 110.426 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -153.45 159.9 42.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.174 0.989 . . . . 0.0 110.976 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.6 157.99 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.954 1.702 . . . . 0.0 106.783 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.39 153.25 49.12 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 116.106 1.202 . . . . 0.0 116.106 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.4 t -107.28 -175.3 2.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.335 2.254 . . . . 0.0 106.752 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.6 t -64.94 117.72 8.02 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.4 -0.813 . . . . 0.0 109.95 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.42 -36.97 3.65 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.121 1.343 . . . . 0.0 109.812 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.5 m -93.74 132.78 37.78 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.245 1.418 . . . . 0.0 108.932 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.225 -1.369 . . . . 0.0 109.254 -179.546 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.7 p . . . . . 0 N--CA 1.456 -0.168 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.97 133.86 55.2 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.882 1.273 . . . . 0.0 110.873 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 p -97.35 121.03 38.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.579 1.152 . . . . 0.0 109.117 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -115.33 99.31 7.3 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 100.595 -3.854 . . . . 0.0 100.595 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -103.49 90.28 3.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.157 1.383 . . . . 0.0 109.563 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.46 -76.23 0.96 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.012 1.291 . . . . 0.0 110.862 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.5 t -132.48 -43.17 0.93 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.819 1.648 . . . . 0.0 109.921 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.6 m -68.74 112.54 5.54 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -102.21 152.63 20.8 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.471 1.108 . . . . 0.0 110.812 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -144.23 143.54 31.1 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.363 1.065 . . . . 0.0 108.21 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.9 t -68.27 154.74 41.13 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.765 1.226 . . . . 0.0 110.549 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.93 -19.89 54.39 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.6 t -73.52 -41.15 63.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.652 1.581 . . . . 0.0 109.339 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -68.35 -43.17 78.02 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.256 0.622 . . . . 0.0 110.963 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.8 t -59.8 -47.18 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -41.5 86.72 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.278 1.031 . . . . 0.0 111.686 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.48 -49.47 68.93 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.333 0.515 . . . . 0.0 109.87 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.56 -37.36 78.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.799 0.839 . . . . 0.0 109.938 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.44 -32.28 60.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -66.38 -27.33 67.78 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.03 -56.98 3.98 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -44.99 -58.35 3.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.528 1.531 . . . . 0.0 110.147 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.5 t -54.11 -50.71 66.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.366 1.467 . . . . 0.0 112.296 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -58.08 -34.57 70.3 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -92.13 -3.26 55.91 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -124.38 37.16 4.46 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.473 1.109 . . . . 0.0 111.132 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -89.84 -72.51 0.56 Allowed 'General case' 0 C--N 1.343 0.283 0 O-C-N 121.364 -0.835 . . . . 0.0 110.031 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -148.91 -61.17 0.23 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.933 1.293 . . . . 0.0 108.713 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -90.44 63.83 5.71 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.112 1.365 . . . . 0.0 107.95 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -51.83 138.28 24.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.711 1.604 . . . . 0.0 112.396 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.0 t -106.16 -33.5 7.82 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.367 1.067 . . . . 0.0 112.198 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.63 159.86 31.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.763 0.825 . . . . 0.0 110.97 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.94 166.48 47.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.399 0.999 . . . . 0.0 114.232 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -120.49 65.09 0.84 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.833 1.653 . . . . 0.0 107.977 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.7 m -167.32 -46.02 0.02 OUTLIER 'General case' 0 C--N 1.339 0.124 0 C-N-CA 127.192 2.197 . . . . 0.0 107.374 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.7 p -105.12 29.18 6.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.145 1.378 . . . . 0.0 111.131 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 73.32 157.39 0.16 Allowed Pre-proline 0 C--N 1.351 0.651 0 C-N-CA 125.144 1.378 . . . . 0.0 107.728 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.1 118.72 4.26 Favored 'Cis proline' 0 N--CA 1.452 -0.969 0 N-CA-C 115.404 1.271 . . . . 0.0 115.404 3.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -103.86 -170.24 1.75 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 126.518 1.927 . . . . 0.0 106.686 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.3 t -155.87 159.0 38.95 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.514 0.326 . . . . 0.0 111.267 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -153.43 167.09 30.61 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 122.774 0.43 . . . . 0.0 111.68 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -141.56 -51.76 0.43 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.609 1.563 . . . . 0.0 109.998 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -67.47 -78.81 0.06 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.966 0.906 . . . . 0.0 110.731 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 67.9 179.97 0.23 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.767 1.227 . . . . 0.0 111.345 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -74.63 -62.62 1.47 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.98 57.67 0.14 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -154.19 103.04 2.51 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.489 1.116 . . . . 0.0 108.346 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -141.57 176.43 8.9 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.307 1.443 . . . . 0.0 109.05 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -127.87 138.11 32.21 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 124.361 1.065 . . . . 0.0 109.043 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.66 66.17 8.81 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.713 2.942 . . . . 0.0 110.043 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.3 t -120.31 -95.06 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -153.35 -71.02 0.14 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.174 0.99 . . . . 0.0 109.695 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.11 -175.37 54.96 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.074 0.845 . . . . 0.0 111.225 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.97 126.85 1.93 Allowed 'Cis proline' 0 N--CA 1.459 -0.519 0 CA-C-N 118.982 1.391 . . . . 0.0 111.989 -0.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.69 130.69 35.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.446 0.641 . . . . 0.0 111.008 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -75.03 139.02 42.58 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 127.852 2.461 . . . . 0.0 111.235 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -98.16 146.57 25.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.574 1.15 . . . . 0.0 108.66 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -160.1 110.33 1.41 Allowed Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -81.15 131.93 8.03 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 122.006 1.804 . . . . 0.0 114.302 -176.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.631 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.7 tt -100.01 178.0 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 124.282 1.992 . . . . 0.0 110.875 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.631 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 4.8 tmtt? -160.46 153.71 21.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 109.063 -3.698 . . . . 0.0 110.721 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.2 p -80.81 56.5 2.72 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.566 1.546 . . . . 0.0 109.706 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.9 -61.99 0.04 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.32 -172.62 32.97 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 117.165 0.483 . . . . 0.0 112.705 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.95 143.57 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.568 1.547 . . . . 0.0 111.353 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.292 0.0 OUTLIER 25.45 55.68 0.04 OUTLIER 'General case' 0 C--N 1.345 0.37 0 C-N-CA 129.367 3.067 . . . . 0.0 116.41 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.8 p -79.77 85.36 5.46 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.98 173.6 39.24 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.89 -69.01 1.47 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.0 m -80.3 127.5 76.09 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.7 -88.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.225 2.617 . . . . 0.0 110.057 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.97 -51.32 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 106.019 -2.832 . . . . 0.0 106.019 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -169.72 -50.43 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.667 0.787 . . . . 0.0 112.02 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -73.9 130.07 39.16 Favored 'General case' 0 C--N 1.344 0.362 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -138.54 122.21 17.48 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.029 1.331 . . . . 0.0 110.43 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -83.64 148.77 4.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.3 t -136.91 114.9 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -177.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 pt -101.56 177.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.371 0 C-N-CA 124.585 1.154 . . . . 0.0 111.855 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -90.46 171.82 9.16 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 125.255 1.422 . . . . 0.0 108.024 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.7 -33.24 69.94 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 119.048 2.981 . . . . 0.0 119.048 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -87.75 -65.81 0.98 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.857 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.5 -7.58 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -175.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -78.9 108.82 12.63 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -56.33 118.52 4.83 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.51 -59.56 2.2 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.258 0.623 . . . . 0.0 110.655 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.35 164.74 34.15 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.28 153.22 27.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.1 0.96 . . . . 0.0 110.453 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.6 pt -138.89 155.57 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.746 1.618 . . . . 0.0 107.881 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.6 t -153.45 153.25 32.13 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -79.34 -22.62 44.25 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.354 0.662 . . . . 0.0 111.988 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 t -65.68 139.84 58.43 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 119.585 1.084 . . . . 0.0 109.905 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.08 -24.97 28.93 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.98 -159.02 0.66 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.262 1.425 . . . . 0.0 109.397 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.2 m -152.37 88.9 1.39 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.417 0.687 . . . . 0.0 111.06 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.06 -131.07 9.24 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.288 0.947 . . . . 0.0 112.53 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -79.38 -34.95 41.52 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 125.099 1.36 . . . . 0.0 110.619 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -44.12 134.05 4.95 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.863 1.665 . . . . 0.0 112.473 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.54 160.8 14.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.203 1.801 . . . . 0.0 111.203 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 m -139.32 166.04 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 126.531 1.932 . . . . 0.0 106.916 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.64 151.61 20.66 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.365 0.507 . . . . 0.0 113.726 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.81 -166.43 1.6 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.194 1.398 . . . . 0.0 109.198 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.5 t -62.55 129.58 41.23 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.908 0.483 . . . . 0.0 109.767 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.31 28.5 69.79 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.004 0.811 . . . . 0.0 112.095 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.8 m -151.52 116.49 5.22 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.168 -179.51 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 N--CA 1.455 -0.225 0 N-CA-C 101.342 -3.577 . . . . 0.0 101.342 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 70.21 73.59 0.22 Allowed 'General case' 0 C--N 1.343 0.32 0 N-CA-C 102.389 -3.189 . . . . 0.0 102.389 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.5 t -116.03 152.87 32.72 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -118.88 116.39 26.39 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 102.259 -3.237 . . . . 0.0 102.259 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -91.91 58.9 3.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.31 -78.53 0.82 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.556 1.074 . . . . 0.0 111.178 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 m -118.29 39.99 3.3 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.947 1.299 . . . . 0.0 110.274 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.33 152.88 38.96 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -150.51 113.94 4.92 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.621 0.646 . . . . 0.0 111.745 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.81 137.55 52.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.514 1.126 . . . . 0.0 111.251 178.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.9 t -70.11 160.31 32.27 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 126.368 1.867 . . . . 0.0 108.264 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.25 -19.05 30.95 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 t -72.57 -47.29 49.34 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -72.22 -28.22 63.04 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.638 1.175 . . . . 0.0 113.46 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.4 t -70.21 -51.79 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -58.83 -35.63 73.22 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 125.987 1.715 . . . . 0.0 111.277 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.67 -52.61 56.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.9 82.47 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.031 0.932 . . . . 0.0 112.033 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.43 -45.55 30.97 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -62.29 -22.43 66.02 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.9 -55.08 5.22 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.68 -42.9 12.14 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.209 1.004 . . . . 0.0 111.261 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 85.2 m -61.61 -52.77 63.02 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.178 0.991 . . . . 0.0 110.366 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -59.57 -41.45 90.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.364 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -69.32 -40.1 77.81 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.42 -0.8 . . . . 0.0 112.067 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -78.52 -32.63 48.14 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -136.49 -43.8 0.61 Allowed 'General case' 0 C--N 1.348 0.533 0 N-CA-C 118.216 2.672 . . . . 0.0 118.216 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -70.69 -22.95 62.4 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -165.48 102.41 0.71 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 77.27 -166.32 0.05 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.552 1.941 . . . . 0.0 111.169 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.4 p -123.79 -63.96 1.18 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.86 1.664 . . . . 0.0 109.07 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 52.07 90.84 0.02 OUTLIER 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.519 1.928 . . . . 0.0 112.062 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.02 -166.98 14.22 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.23 0.919 . . . . 0.0 110.821 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m 71.63 -11.43 0.73 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.987 1.715 . . . . 0.0 113.71 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.7 m -149.47 -43.35 0.14 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.806 0.842 . . . . 0.0 111.74 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.9 p -104.25 -22.96 13.29 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 77.41 152.43 0.13 Allowed Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.3 150.99 96.51 Favored 'Cis proline' 0 N--CA 1.45 -1.05 0 CA-C-N 121.088 1.424 . . . . 0.0 115.065 2.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -159.79 157.82 30.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 128.551 2.74 . . . . 0.0 105.713 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 t -53.28 149.49 7.25 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -89.09 161.92 16.26 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.692 1.597 . . . . 0.0 109.1 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -63.53 137.77 58.26 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.953 0.901 . . . . 0.0 111.706 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.69 -49.96 75.4 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.761 0.824 . . . . 0.0 108.908 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -59.1 137.38 57.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -71.96 88.92 1.08 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.986 0.515 . . . . 0.0 111.228 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.08 -29.53 66.64 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.88 164.09 36.32 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.212 1.405 . . . . 0.0 110.695 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -116.91 122.12 43.4 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.612 1.565 . . . . 0.0 107.835 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -119.42 157.69 50.86 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 124.821 1.248 . . . . 0.0 109.536 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -52.81 -35.36 69.43 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.825 3.017 . . . . 0.0 114.239 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.1 m -110.05 164.69 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.528 1.531 . . . . 0.0 112.044 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -95.75 159.53 14.93 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.573 1.549 . . . . 0.0 110.243 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.75 -154.54 30.87 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.4 1.0 . . . . 0.0 111.452 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.53 153.25 18.93 Favored 'Cis proline' 0 C--N 1.346 0.441 0 CA-C-N 118.722 1.261 . . . . 0.0 114.132 -0.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.67 167.07 17.74 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.165 0.986 . . . . 0.0 111.462 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -138.43 156.3 47.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.411 1.485 . . . . 0.0 109.253 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -90.17 157.84 17.53 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -160.15 108.9 1.4 Allowed Pre-proline 0 N--CA 1.454 -0.255 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -89.23 113.56 0.61 Allowed 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 122.65 2.233 . . . . 0.0 111.797 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.596 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 7.4 tt -86.22 174.67 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-O 123.632 1.682 . . . . 0.0 110.909 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.596 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 11.7 mmtp -155.48 150.73 26.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 109.851 -3.34 . . . . 0.0 110.912 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.5 p -88.68 61.03 5.85 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.311 1.444 . . . . 0.0 108.865 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.75 -61.58 0.02 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.05 166.12 36.18 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.0 p -77.6 138.0 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.505 1.122 . . . . 0.0 110.931 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.1 t80 53.57 86.92 0.04 OUTLIER 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.894 1.678 . . . . 0.0 112.111 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.4 t -151.41 158.97 44.41 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.21 1.004 . . . . 0.0 110.373 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.79 -133.11 2.65 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.501 1.048 . . . . 0.0 111.266 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.14 54.94 4.22 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 94.6 p 45.52 60.17 13.88 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.063 1.745 . . . . 0.0 112.64 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.1 141.24 18.48 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.749 2.966 . . . . 0.0 110.847 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 158.0 35.19 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.519 -0.601 . . . . 0.0 114.246 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -169.03 35.07 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.034 0.934 . . . . 0.0 110.764 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.25 93.85 0.29 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -145.96 153.48 40.85 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 m -119.86 146.6 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 102.474 -3.158 . . . . 0.0 102.474 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.255 81.2 t -125.55 113.14 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.1 pt -86.31 168.03 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.381 0 C-N-CA 125.704 1.602 . . . . 0.0 114.577 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -90.69 170.95 9.71 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.965 2.106 . . . . 0.0 107.374 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.367 11.6 t -85.35 52.93 2.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 118.048 2.611 . . . . 0.0 118.048 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -156.04 -89.81 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 101.245 -3.613 . . . . 0.0 101.245 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 36.3 t -163.94 66.43 0.17 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.198 1.399 . . . . 0.0 112.508 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -150.26 127.58 11.38 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 120.016 1.28 . . . . 0.0 113.051 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -64.46 117.29 7.1 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 177.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.39 -59.23 2.34 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 124.322 1.049 . . . . 0.0 110.631 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.57 -172.46 15.98 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.761 1.172 . . . . 0.0 111.472 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.31 144.05 13.94 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 122.802 0.441 . . . . 0.0 111.438 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.0 pt -131.06 159.34 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 125.487 1.515 . . . . 0.0 110.068 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.0 t -160.12 150.31 18.39 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.462 1.505 . . . . 0.0 109.418 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . 0.265 49.3 m170 -78.98 -51.87 9.03 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.409 1.004 . . . . 0.0 108.951 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.379 11.8 t 48.96 -69.82 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.706 2.802 . . . . 0.0 116.773 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.42 51.17 0.56 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 126.032 1.777 . . . . 0.0 108.879 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.79 158.02 36.24 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.913 1.285 . . . . 0.0 110.949 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.5 t -62.06 -40.51 96.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.214 0.606 . . . . 0.0 110.183 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -150.5 -109.64 0.47 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -94.38 -4.93 47.57 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.508 1.123 . . . . 0.0 112.083 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -65.17 174.5 2.0 Allowed 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.114 0.966 . . . . 0.0 112.113 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -125.64 150.99 47.11 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.735 1.614 . . . . 0.0 111.911 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.5 m -124.31 166.33 19.82 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 126.308 1.843 . . . . 0.0 107.009 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.04 160.21 24.87 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.3 m -100.66 174.22 6.17 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.136 0.975 . . . . 0.0 111.694 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.2 m 46.77 46.13 15.02 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.709 0.804 . . . . 0.0 112.069 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.67 22.95 73.81 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 119.311 -0.716 . . . . 0.0 114.052 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 55.0 m -86.57 146.77 26.22 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.974 0.909 . . . . 0.0 108.785 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 t30 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.055 -1.45 . . . . 0.0 109.437 -179.246 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 t . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.41 138.34 56.64 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.437 0.695 . . . . 0.0 109.134 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 t -141.81 119.99 12.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.487 0.315 . . . . 0.0 111.038 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.41 108.3 19.59 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.6 m -97.46 78.99 2.71 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.122 0.969 . . . . 0.0 109.177 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.83 -95.56 0.82 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.8 m -108.42 -31.78 7.69 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.851 1.26 . . . . 0.0 110.51 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 m -81.69 101.12 9.87 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -85.02 152.14 23.66 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 123.194 0.598 . . . . 0.0 111.322 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -142.06 133.73 26.93 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.645 1.178 . . . . 0.0 109.096 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.7 m -72.25 158.04 36.59 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 125.007 1.323 . . . . 0.0 111.314 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.08 -21.41 64.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.0 m -72.54 -39.35 67.58 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.076 0.95 . . . . 0.0 108.535 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -69.6 -50.22 46.6 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.547 1.139 . . . . 0.0 112.023 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.8 t -57.45 -48.23 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 123.608 0.763 . . . . 0.0 109.212 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -64.53 -43.31 94.41 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.545 1.138 . . . . 0.0 112.065 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.0 -54.24 14.1 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.972 0.509 . . . . 0.0 111.228 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.92 -26.76 67.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.421 0.689 . . . . 0.0 110.543 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.75 -38.09 29.28 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.481 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -65.79 -25.19 67.13 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.79 -60.0 2.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -44.97 -51.0 10.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.672 1.189 . . . . 0.0 110.196 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.01 -48.33 32.79 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.257 2.223 . . . . 0.0 111.796 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -81.75 -40.89 22.01 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.264 0.0 OUTLIER -67.75 -37.54 82.28 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 116.799 2.148 . . . . 0.0 116.799 -177.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.299 0.0 OUTLIER -82.14 6.27 17.02 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -179.09 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -77.49 -3.43 40.46 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.131 0.572 . . . . 0.0 110.786 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 64.02 48.11 3.16 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.442 1.897 . . . . 0.0 111.707 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -159.35 30.47 0.2 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.842 1.257 . . . . 0.0 110.658 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 176.88 165.69 0.51 Allowed 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 128.798 2.839 . . . . 0.0 108.86 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.263 0.0 OUTLIER -12.65 100.09 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.825 2.85 . . . . 0.0 115.233 -179.33 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 74.77 163.3 0.26 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 127.608 2.363 . . . . 0.0 115.792 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.98 82.57 0.06 OUTLIER Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.137 -0.813 . . . . 0.0 113.047 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.8 m 69.85 104.69 0.06 Allowed 'General case' 0 C--N 1.344 0.367 0 C-N-CA 126.384 1.873 . . . . 0.0 113.621 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -152.93 -55.89 0.12 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 100.988 -3.708 . . . . 0.0 100.988 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.575 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 40.7 p -130.64 -62.58 0.91 Allowed 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 101.006 -3.701 . . . . 0.0 101.006 175.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.575 ' CD1' ' C ' ' A' ' 37' ' ' THR . 23.9 m-85 -144.06 143.62 23.33 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 129.242 3.017 . . . . 0.0 106.072 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.67 144.73 62.24 Favored 'Cis proline' 0 N--CA 1.458 -0.567 0 CA-C-N 118.581 0.529 . . . . 0.0 112.596 1.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -156.54 151.76 26.48 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.537 0.608 . . . . 0.0 112.32 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.6 m -53.27 142.34 21.36 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.049 2.54 . . . . 0.0 113.121 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -91.9 136.76 32.91 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.705 1.202 . . . . 0.0 110.028 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -70.32 129.54 39.59 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.22 1.008 . . . . 0.0 111.864 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -86.17 61.04 6.59 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.936 1.294 . . . . 0.0 109.13 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -121.56 167.83 12.43 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.066 1.746 . . . . 0.0 109.076 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.49 154.16 41.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.382 0.673 . . . . 0.0 110.333 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.1 -88.27 0.32 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -121.51 152.91 38.64 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.241 1.417 . . . . 0.0 109.809 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 166.89 130.4 0.01 OUTLIER 'General case' 0 C--N 1.34 0.183 0 C-N-CA 128.109 2.564 . . . . 0.0 107.62 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -88.67 169.34 13.59 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.333 1.053 . . . . 0.0 108.96 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.19 -52.44 8.75 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.915 3.076 . . . . 0.0 113.024 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.9 m -65.05 156.62 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.11 1.364 . . . . 0.0 109.854 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -134.36 -168.66 2.18 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -46.32 138.55 7.52 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 127.608 2.527 . . . . 0.0 114.205 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.37 133.87 12.23 Favored 'Cis proline' 0 C--N 1.35 0.655 0 CA-C-N 119.933 1.866 . . . . 0.0 111.2 -2.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.53 108.99 1.64 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -177.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -123.35 157.7 32.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.994 1.718 . . . . 0.0 109.27 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -89.34 158.8 17.65 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.688 1.595 . . . . 0.0 112.633 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -159.18 117.96 1.68 Allowed Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.242 1.017 . . . . 0.0 108.917 177.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -81.44 137.83 10.6 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 N-CA-C 117.705 2.156 . . . . 0.0 117.705 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.256 3.3 mm -109.81 -0.32 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 1 C-N-CA 134.408 5.083 . . . . 0.0 115.207 179.116 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -75.41 104.62 6.05 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 126.704 2.002 . . . . 0.0 114.165 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.6 m 24.06 34.18 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.201 1 C-N-CA 131.884 4.074 . . . . 0.0 115.712 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.84 40.38 1.49 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.957 1.265 . . . . 0.0 111.534 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.13 -115.33 1.01 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.127 1.346 . . . . 0.0 113.211 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.16 48.58 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.983 1.313 . . . . 0.0 109.594 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 27.0 t80 61.21 71.42 0.56 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.472 1.909 . . . . 0.0 111.327 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 49.5 p -121.18 61.11 0.91 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.75 -153.62 24.06 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.5 -169.54 32.25 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 m -158.86 -68.34 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 125.111 1.364 . . . . 0.0 110.172 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.58 104.33 1.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.456 2.104 . . . . 0.0 109.799 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.15 79.85 1.15 Allowed Glycine 0 C--N 1.339 0.712 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.13 -70.84 0.25 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.05 123.06 18.05 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.619 1.1 . . . . 0.0 113.597 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -160.6 134.81 7.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.8 m -93.14 142.88 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.272 72.6 t -125.32 124.45 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.2 pt -130.99 175.09 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 123.934 0.771 . . . . 0.0 112.255 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -99.18 139.23 35.13 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 125.447 1.499 . . . . 0.0 109.199 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.548 0.5 OUTLIER -47.52 -12.72 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.401 1 N-CA-C 121.898 4.036 . . . . 0.0 121.898 -176.615 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -80.01 -81.85 0.12 Allowed 'General case' 0 N--CA 1.441 -0.884 1 N-CA-C 99.618 -4.216 . . . . 0.0 99.618 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.75 0.47 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.632 1.573 . . . . 0.0 114.472 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -82.27 127.73 33.49 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.33 135.34 55.19 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.641 1.577 . . . . 0.0 109.489 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.43 -50.83 3.49 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 122.982 0.513 . . . . 0.0 110.678 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.29 140.23 3.59 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.503 -0.379 . . . . 0.0 112.769 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.07 131.12 36.84 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.056 1.342 . . . . 0.0 108.034 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.8 pt -141.77 165.8 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.668 1.187 . . . . 0.0 110.391 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.8 t -158.57 146.54 18.21 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -83.58 15.13 3.29 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 122.665 0.386 . . . . 0.0 110.917 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 t -40.98 -45.29 2.56 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 116.92 2.192 . . . . 0.0 116.92 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -150.54 57.26 0.45 Allowed Glycine 0 C--N 1.331 0.301 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.02 175.89 5.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.891 1.276 . . . . 0.0 109.77 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.8 t -83.0 58.91 4.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.803 1.241 . . . . 0.0 111.028 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.37 -87.5 0.81 Allowed Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.228 1.394 . . . . 0.0 112.71 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -79.52 -24.75 42.01 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.114 0.966 . . . . 0.0 111.294 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -63.04 170.23 2.89 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.517 1.127 . . . . 0.0 110.178 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -130.31 168.19 17.3 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.617 1.567 . . . . 0.0 111.811 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.1 m -139.51 161.13 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 126.886 2.074 . . . . 0.0 105.748 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.25 131.7 10.58 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 114.775 0.67 . . . . 0.0 114.775 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.8 t -98.19 172.33 7.65 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.2 t 53.95 -153.63 0.28 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.904 1.229 . . . . 0.0 109.198 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.76 0.66 76.55 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.593 1.092 . . . . 0.0 110.401 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 m -79.69 149.15 31.31 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 125.495 1.518 . . . . 0.0 108.727 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.004 -1.474 . . . . 0.0 108.914 -179.186 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.6 m . . . . . 0 CA--C 1.528 0.133 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.44 122.7 11.02 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.8 0.84 . . . . 0.0 109.904 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 p -91.69 87.98 6.52 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -92.2 96.93 10.59 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 102.447 -3.168 . . . . 0.0 102.447 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.1 m -98.3 81.73 2.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.472 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.4 -86.98 0.91 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.9 p -122.12 -23.22 5.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.333 1.453 . . . . 0.0 110.929 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.55 91.6 3.98 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -84.15 127.99 34.27 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.933 1.293 . . . . 0.0 112.772 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -127.57 134.5 49.72 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.5 p -69.24 152.76 44.66 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 124.689 1.196 . . . . 0.0 110.194 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.38 -22.94 55.59 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.3 p -77.4 -35.51 54.19 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 123.284 0.634 . . . . 0.0 109.519 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -69.11 -33.87 74.17 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.423 0.689 . . . . 0.0 110.986 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.1 t -66.77 -50.56 64.52 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.0 tmt_? -61.49 -38.92 89.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.212 1.405 . . . . 0.0 110.99 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.44 -51.77 53.42 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.636 0.774 . . . . 0.0 109.58 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.83 -23.93 66.79 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 118.809 -0.615 . . . . 0.0 111.115 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.13 -41.77 33.96 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 118.468 0.577 . . . . 0.0 110.835 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -68.63 -20.89 64.5 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.09 -64.45 1.16 Allowed 'General case' 0 C--N 1.35 0.591 0 N-CA-C 103.292 -2.855 . . . . 0.0 103.292 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -39.88 -45.01 1.75 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.187 1.395 . . . . 0.0 111.473 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.5 m -55.26 -58.77 6.36 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.882 1.273 . . . . 0.0 109.753 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.2 tp-100 -65.84 -36.84 84.59 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -86.22 -10.13 55.23 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 128.772 2.829 . . . . 0.0 115.512 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -90.74 -61.48 1.66 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-N 120.07 1.304 . . . . 0.0 113.21 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -137.56 -10.0 1.64 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -66.46 -48.7 69.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.357 0.98 . . . . 0.0 111.276 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -172.38 108.61 0.21 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.045 1.338 . . . . 0.0 107.47 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.251 0.1 OUTLIER 89.26 163.61 0.05 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 128.724 2.81 . . . . 0.0 112.648 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.9 p -138.02 -45.45 0.52 Allowed 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 126.691 1.996 . . . . 0.0 109.026 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 85.62 165.35 0.09 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 127.844 2.458 . . . . 0.0 111.558 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.97 85.77 1.09 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.535 1.064 . . . . 0.0 111.781 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.9 p -132.47 -124.29 0.19 Allowed 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 m -177.69 -75.88 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.14 1.376 . . . . 0.0 109.711 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.02 0.5 57.53 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.776 1.63 . . . . 0.0 113.35 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -152.32 104.89 2.76 Favored Pre-proline 0 C--N 1.343 0.284 0 O-C-N 120.924 -1.11 . . . . 0.0 108.728 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -72.14 155.47 98.37 Favored 'Cis proline' 0 N--CA 1.459 -0.501 0 CA-C-N 119.942 1.015 . . . . 0.0 113.608 0.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.15 162.62 4.54 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.573 1.549 . . . . 0.0 109.945 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.6 m -70.27 136.63 50.04 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.869 1.668 . . . . 0.0 109.775 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -96.12 150.24 20.73 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.401 1.08 . . . . 0.0 109.96 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -78.88 165.75 23.17 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.108 0.963 . . . . 0.0 111.475 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -159.0 93.21 1.14 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.469 0.708 . . . . 0.0 110.337 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -164.23 -56.57 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.22 1.008 . . . . 0.0 109.894 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -166.07 134.05 2.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.801 1.24 . . . . 0.0 108.36 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.83 -83.68 0.15 Allowed Glycine 0 C--N 1.338 0.674 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -159.36 46.69 0.28 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.572 1.149 . . . . 0.0 107.992 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -74.95 164.23 26.78 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -127.95 94.67 36.29 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 125.481 1.512 . . . . 0.0 108.329 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.34 84.15 1.4 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.389 2.726 . . . . 0.0 110.982 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.7 t -113.17 -49.51 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.282 1.433 . . . . 0.0 109.198 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -154.15 -73.97 0.12 Allowed 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.854 0.861 . . . . 0.0 109.243 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.96 140.23 8.04 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.81 175.25 45.47 Favored 'Cis proline' 0 N--CA 1.459 -0.557 0 CA-C-N 118.845 1.322 . . . . 0.0 112.036 -0.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.59 -174.15 3.43 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.297 1.439 . . . . 0.0 108.75 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -157.12 146.14 20.03 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 122.968 0.507 . . . . 0.0 111.981 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -89.74 144.37 26.03 Favored 'General case' 0 C--N 1.343 0.295 0 O-C-N 123.687 0.617 . . . . 0.0 110.677 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -153.87 110.95 2.51 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -82.66 148.88 14.22 Favored 'Trans proline' 0 N--CA 1.439 -1.727 0 C-N-CA 121.824 1.683 . . . . 0.0 113.48 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.653 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.5 tt -106.73 -177.57 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-O 123.87 1.795 . . . . 0.0 111.7 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.653 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 18.5 tptt -160.29 159.35 31.23 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 109.622 -3.445 . . . . 0.0 113.041 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.5 p -90.11 60.41 4.82 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 126.515 1.926 . . . . 0.0 110.887 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.36 -53.94 0.05 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.66 -151.93 6.32 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.5 p -72.24 165.26 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.79 1.236 . . . . 0.0 109.083 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.44 141.91 14.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.9 m -118.09 -56.03 2.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.908 2.083 . . . . 0.0 107.427 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.61 -157.58 16.17 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.828 1.204 . . . . 0.0 111.42 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.39 36.34 59.44 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.375 0.988 . . . . 0.0 112.318 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.7 m -160.86 157.87 23.62 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 125.7 1.6 . . . . 0.0 108.274 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -45.36 -58.44 1.6 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.783 2.989 . . . . 0.0 111.884 169.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.4 141.47 12.24 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.438 ' HB3' ' CB ' ' A' ' 91' ' ' HIS . . . -148.3 -40.96 0.16 Allowed 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 117.428 -1.272 . . . . 0.0 112.273 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -88.14 120.45 29.5 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.032 0.933 . . . . 0.0 109.351 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.4 138.89 16.81 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -90.82 151.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.1 t -135.98 117.82 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.7 pt -109.68 164.12 6.29 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 C-N-CA 124.091 0.957 . . . . 0.0 112.18 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -79.41 157.87 27.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.312 1.845 . . . . 0.0 106.76 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.291 5.6 t -63.01 -10.14 12.8 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 -177.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -85.95 -80.54 0.22 Allowed 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.93 -5.45 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.666 2.386 . . . . 0.0 115.485 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.16 143.81 35.08 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 119.867 1.212 . . . . 0.0 114.021 -175.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -70.83 124.54 24.55 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.75 -48.08 6.75 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.028 0.531 . . . . 0.0 109.684 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.79 -170.08 41.22 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.12 141.07 22.01 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.508 1.123 . . . . 0.0 108.481 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.7 pt -137.71 166.34 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 124.598 1.159 . . . . 0.0 109.911 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.4 t -154.57 156.04 35.87 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.438 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 64.5 m170 -77.27 -40.85 43.18 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.763 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.6 t -54.67 142.97 26.41 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 123.127 0.571 . . . . 0.0 111.801 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.1 -24.01 33.22 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.71 -141.94 0.23 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.012 1.325 . . . . 0.0 109.087 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.2 t -155.23 80.63 1.05 Allowed 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.431 0.56 . . . . 0.0 111.114 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.94 -133.2 11.02 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.033 1.301 . . . . 0.0 111.963 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -79.77 -30.06 40.6 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.983 0.913 . . . . 0.0 111.376 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -52.58 140.02 24.11 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.032 0.933 . . . . 0.0 109.78 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.64 167.03 10.59 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.3 m -145.01 166.56 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 128.944 2.897 . . . . 0.0 106.064 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.6 164.59 39.73 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 123.64 0.638 . . . . 0.0 114.539 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 49.6 t -139.36 163.71 31.76 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.986 1.714 . . . . 0.0 108.304 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.6 p 54.92 43.81 29.33 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.51 1.924 . . . . 0.0 111.773 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.64 15.87 81.21 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.006 -0.885 . . . . 0.0 113.664 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.3 m -82.7 140.9 32.83 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.596 1.198 . . . . 0.0 108.59 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.107 -1.425 . . . . 0.0 108.986 179.652 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.3 p . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.54 164.56 0.14 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.485 1.914 . . . . 0.0 112.027 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.07 151.84 25.72 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.261 -0.274 . . . . 0.0 110.97 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.2 115.82 21.02 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.7 m -103.37 97.17 7.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.47 0.708 . . . . 0.0 109.819 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.9 -78.4 0.91 Allowed Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.768 1.175 . . . . 0.0 111.297 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 t -135.71 -8.42 2.15 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.547 1.139 . . . . 0.0 112.778 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.64 134.94 42.86 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 119.194 0.907 . . . . 0.0 109.502 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -94.4 154.69 17.34 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.809 0.844 . . . . 0.0 110.879 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -145.28 126.38 14.65 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.267 1.427 . . . . 0.0 108.836 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t -69.94 155.51 40.47 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.16 -16.65 34.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.6 t -76.28 -37.9 56.91 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.079 0.952 . . . . 0.0 109.459 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -74.6 -51.04 15.63 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.957 1.703 . . . . 0.0 111.152 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.84 -47.72 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.934 1.294 . . . . 0.0 107.524 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -69.67 -36.79 76.33 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.037 0.935 . . . . 0.0 111.94 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.13 -51.17 68.96 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.687 1.131 . . . . 0.0 109.859 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -34.72 74.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.775 0.83 . . . . 0.0 111.055 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.18 -33.35 33.08 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -69.94 -23.42 63.19 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.64 -53.15 6.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.19 -38.45 39.98 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.282 1.033 . . . . 0.0 110.41 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -55.3 35.31 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 126.171 1.789 . . . . 0.0 109.608 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.29 -30.97 68.11 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -90.55 -26.72 19.58 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -62.15 -32.75 73.39 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 119.202 0.91 . . . . 0.0 109.922 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -59.41 -19.03 44.13 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.024 0.929 . . . . 0.0 110.875 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 76.08 59.06 0.05 OUTLIER 'General case' 0 C--N 1.344 0.359 0 C-N-CA 127.294 2.237 . . . . 0.0 110.588 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -145.21 34.95 1.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.999 1.32 . . . . 0.0 109.529 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -175.27 130.99 0.29 Allowed 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 128.677 2.791 . . . . 0.0 106.455 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.7 p -84.35 85.79 7.34 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.26 0.552 . . . . 0.0 111.83 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.71 -160.23 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.044 1.737 . . . . 0.0 109.795 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -44.54 -49.8 8.47 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.233 1.397 . . . . 0.0 110.947 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.3 t 67.09 2.52 2.78 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.09 1.756 . . . . 0.0 115.735 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.9 m -67.77 -63.21 1.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -160.47 42.67 0.18 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.968 2.107 . . . . 0.0 107.076 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.438 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 9.8 m-85 -156.44 115.7 2.11 Favored Pre-proline 0 C--N 1.34 0.186 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.26 150.56 91.62 Favored 'Cis proline' 0 N--CA 1.456 -0.722 0 N-CA-C 114.239 0.823 . . . . 0.0 114.239 1.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.19 145.1 8.38 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.628 1.571 . . . . 0.0 108.577 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -60.44 145.47 48.1 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.849 1.66 . . . . 0.0 112.13 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -145.37 84.38 1.69 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -153.38 -158.47 0.88 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.934 1.294 . . . . 0.0 108.31 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.0 m120 67.83 2.52 3.1 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.629 1.572 . . . . 0.0 113.662 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -165.37 105.84 0.76 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -80.93 69.9 7.62 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.68 0.792 . . . . 0.0 110.659 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.28 11.91 56.6 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.945 0.783 . . . . 0.0 112.248 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -157.53 162.92 38.85 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 118.186 0.993 . . . . 0.0 111.809 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -116.03 119.72 36.78 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.131 1.373 . . . . 0.0 108.299 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -135.94 156.72 76.96 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 125.993 1.717 . . . . 0.0 107.722 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.74 163.36 18.92 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.095 2.53 . . . . 0.0 109.341 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.284 8.6 m 60.21 -165.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.176 1.39 . . . . 0.0 110.686 -178.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -112.79 -16.97 12.65 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.571 1.148 . . . . 0.0 113.392 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.07 -156.65 22.41 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.34 -177.05 5.33 Favored 'Cis proline' 0 CA--C 1.535 0.545 0 CA-C-N 119.037 1.418 . . . . 0.0 113.211 -0.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -148.25 155.27 41.14 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.615 0.366 . . . . 0.0 111.478 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -132.43 146.74 52.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.257 1.423 . . . . 0.0 107.777 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -86.6 156.8 19.89 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -152.5 109.7 2.76 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 13.0 Cg_endo -85.21 128.8 3.69 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.34 2.694 . . . . 0.0 116.965 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.548 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 10.1 tt -97.4 170.13 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 123.969 1.842 . . . . 0.0 112.193 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.548 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 8.3 mtpm? -160.74 113.51 1.99 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 109.394 -3.548 . . . . 0.0 111.623 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.9 p 10.76 50.14 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 129.806 3.242 . . . . 0.0 116.471 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.34 70.82 1.33 Allowed Glycine 0 C--N 1.337 0.639 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.08 113.89 0.54 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.9 t -84.08 137.77 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.103 1.361 . . . . 0.0 109.416 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.322 9.6 p90 46.17 53.38 9.41 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.027 2.131 . . . . 0.0 113.979 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.8 p -129.63 -33.44 1.85 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.963 1.705 . . . . 0.0 109.726 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.11 149.57 44.85 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 123.588 0.613 . . . . 0.0 112.815 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 172.07 -74.82 0.1 OUTLIER Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.8 t -153.0 105.22 2.64 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 124.121 0.968 . . . . 0.0 109.343 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -58.41 157.47 35.39 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 CA-C-N 119.735 0.941 . . . . 0.0 113.23 -5.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.81 -104.49 0.21 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 79.06 -60.18 0.37 Allowed 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 127.683 2.393 . . . . 0.0 109.052 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.92 121.9 18.25 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.445 1.498 . . . . 0.0 109.923 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -152.76 141.66 21.15 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.9 m -97.63 150.14 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.9 t -131.82 119.13 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.2 pt -100.62 167.75 2.01 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 C-N-CA 124.783 1.233 . . . . 0.0 113.17 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -82.46 168.26 17.62 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.875 2.07 . . . . 0.0 107.887 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.51 46.18 0.42 Allowed 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -160.36 -83.43 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.4 m -163.44 63.12 0.17 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.96 2.104 . . . . 0.0 112.034 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -148.83 114.74 5.72 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.445 1.93 . . . . 0.0 113.88 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -60.47 107.35 0.66 Allowed 'General case' 0 C--N 1.344 0.357 0 C-N-CA 123.56 0.744 . . . . 0.0 109.808 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.96 -68.22 0.72 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.34 169.35 35.46 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.87 146.64 48.26 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.25 1.02 . . . . 0.0 111.439 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.6 pt -139.28 166.04 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.577 1.551 . . . . 0.0 109.631 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.5 t -156.01 148.67 23.92 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -79.05 4.68 13.81 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 118.666 -0.683 . . . . 0.0 112.092 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.1 m -47.79 -49.94 27.24 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.73 32.68 6.4 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.577 1.084 . . . . 0.0 110.986 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -111.52 166.45 11.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.596 1.159 . . . . 0.0 112.641 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.2 t -103.49 67.61 0.92 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.707 1.603 . . . . 0.0 108.625 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.97 -109.8 3.79 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.763 1.173 . . . . 0.0 112.207 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -79.61 -9.18 59.59 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.175 0.99 . . . . 0.0 113.1 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -66.87 -179.65 0.94 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.062 0.945 . . . . 0.0 108.77 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -147.53 167.94 23.2 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.3 m -139.23 160.49 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 128.038 2.535 . . . . 0.0 105.381 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.67 149.6 20.17 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 115.527 0.971 . . . . 0.0 115.527 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.1 m -99.38 154.37 18.26 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.1 p 33.02 38.63 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 62.71 52.41 48.77 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.165 0.888 . . . . 0.0 111.853 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.1 t -81.65 28.95 0.39 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.517 1.127 . . . . 0.0 113.996 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 . . . . . 0 C--O 1.25 1.103 0 C-N-CA 125.974 1.709 . . . . 0.0 109.369 -179.243 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 110.53 98.35 0.0 OUTLIER 'General case' 0 C--N 1.345 0.393 0 C-N-CA 131.157 3.783 . . . . 0.0 107.096 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -107.28 94.61 5.18 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.84 1.256 . . . . 0.0 111.563 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.04 99.6 9.49 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 102.105 -3.294 . . . . 0.0 102.105 177.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -92.13 80.81 5.05 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.755 1.622 . . . . 0.0 109.211 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.41 -82.49 0.91 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.4 t -117.89 -45.81 2.66 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.49 1.516 . . . . 0.0 109.67 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.8 m -63.42 103.91 0.57 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.725 1.21 . . . . 0.0 109.885 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.82 131.42 34.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.097 1.359 . . . . 0.0 110.847 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -131.21 138.54 49.42 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.6 p -77.68 160.68 28.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 124.113 0.965 . . . . 0.0 111.773 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.87 -13.21 43.22 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.9 t -81.42 -41.38 21.96 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.92 -37.2 86.52 Favored 'General case' 0 C--N 1.345 0.402 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 t -59.86 -51.23 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 126.28 1.832 . . . . 0.0 108.538 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.79 -39.16 93.36 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.139 0.976 . . . . 0.0 111.805 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.94 -51.71 36.85 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.055 0.542 . . . . 0.0 110.419 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.41 -38.77 81.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.669 1.188 . . . . 0.0 110.884 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.89 -41.03 45.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -64.3 -21.5 66.63 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.64 -59.22 2.5 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.07 -47.4 11.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.906 1.283 . . . . 0.0 110.239 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.9 t -61.18 -53.95 50.51 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.474 1.509 . . . . 0.0 111.595 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -57.37 -46.69 83.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.943 0.497 . . . . 0.0 110.907 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -67.46 -48.96 65.66 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.685 1.194 . . . . 0.0 113.137 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -65.05 -34.33 78.18 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.694 0.798 . . . . 0.0 112.146 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -82.78 -47.16 12.23 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 123.033 0.533 . . . . 0.0 111.52 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -70.98 -3.56 20.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.533 1.133 . . . . 0.0 112.539 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.8 t70 69.16 76.69 0.23 Allowed 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.662 1.585 . . . . 0.0 110.812 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -144.88 122.79 11.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.0 1.72 . . . . 0.0 107.172 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.9 p -103.22 82.43 2.07 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.02 111.98 2.15 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.236 1.015 . . . . 0.0 110.35 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.63 112.53 3.14 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.414 1.006 . . . . 0.0 111.867 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.2 m -135.88 -56.97 0.77 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.993 1.317 . . . . 0.0 108.064 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -157.67 -68.18 0.09 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.089 1.755 . . . . 0.0 106.507 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.3 t -159.95 30.67 0.18 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.351 1.86 . . . . 0.0 108.639 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -124.43 155.04 69.4 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.569 1.947 . . . . 0.0 108.825 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -80.51 133.72 27.36 Favored 'Cis proline' 0 N--CA 1.452 -0.935 0 CA-C-N 119.519 0.864 . . . . 0.0 112.438 -0.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.97 166.17 33.23 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.997 1.319 . . . . 0.0 108.652 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.6 m -51.81 140.47 19.32 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 126.051 1.741 . . . . 0.0 112.107 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -129.71 119.7 23.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.738 1.215 . . . . 0.0 109.204 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -165.08 92.36 0.57 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -159.32 159.65 34.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.314 0.646 . . . . 0.0 111.149 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.8 t80 67.79 165.59 0.23 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.875 1.67 . . . . 0.0 112.615 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -109.62 -45.17 3.72 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 124.778 1.231 . . . . 0.0 110.788 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.13 38.21 2.2 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.006 0.812 . . . . 0.0 113.85 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -157.82 128.22 6.29 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.012 1.325 . . . . 0.0 108.653 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -165.27 -175.32 3.57 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.165 1.386 . . . . 0.0 108.954 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -143.06 157.11 61.31 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 125.459 1.504 . . . . 0.0 107.903 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -81.85 48.99 3.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.668 2.912 . . . . 0.0 111.506 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 m -153.45 171.88 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 127.547 2.339 . . . . 0.0 107.441 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -109.32 143.65 38.54 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.265 1.026 . . . . 0.0 110.33 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.71 -160.66 35.84 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.65 151.38 23.55 Favored 'Cis proline' 0 N--CA 1.46 -0.467 0 CA-C-N 118.793 1.297 . . . . 0.0 113.634 -0.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -111.74 174.09 6.04 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.669 1.188 . . . . 0.0 109.848 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -155.57 144.0 20.25 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.11 0.564 . . . . 0.0 110.508 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -87.81 149.93 23.85 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.877 0.871 . . . . 0.0 111.092 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -158.34 109.24 1.69 Allowed Pre-proline 0 N--CA 1.45 -0.444 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -79.92 136.1 11.63 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 121.344 1.363 . . . . 0.0 113.454 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.623 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.3 tt -98.51 177.25 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 124.089 1.899 . . . . 0.0 110.801 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.623 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.7 tptm -156.52 -169.63 3.08 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 109.295 -3.593 . . . . 0.0 110.835 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t -76.64 52.44 0.81 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.574 1.549 . . . . 0.0 112.464 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.35 68.45 1.46 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.34 103.14 0.2 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 51.7 t -66.21 120.32 13.09 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 124.43 1.092 . . . . 0.0 108.661 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 64.47 115.67 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.543 1.537 . . . . 0.0 111.308 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.2 p -97.34 -72.74 0.63 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.495 1.118 . . . . 0.0 111.867 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.71 -10.88 73.59 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.897 0.76 . . . . 0.0 111.854 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.52 -90.68 1.04 Allowed Glycine 0 C--N 1.343 0.96 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.9 m -141.39 72.81 25.82 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 123.339 0.656 . . . . 0.0 112.229 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.55 111.33 3.2 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 N-CA-C 105.761 -2.438 . . . . 0.0 105.761 163.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.08 -8.28 8.02 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-O 117.243 -1.865 . . . . 0.0 117.081 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.05 -60.19 0.2 Allowed 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 120.84 2.32 . . . . 0.0 114.315 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.52 118.33 13.18 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -147.2 137.22 23.19 Favored 'General case' 0 C--N 1.347 0.483 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.9 m -94.69 149.33 4.48 Favored 'Isoleucine or valine' 0 C--N 1.343 0.318 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.5 t -134.72 117.68 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 pt -103.53 -177.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.372 0 C-N-CA 124.407 1.083 . . . . 0.0 112.145 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -99.79 151.91 20.72 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 127.312 2.245 . . . . 0.0 105.308 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.326 5.3 t -63.07 -7.22 5.07 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 119.2 3.037 . . . . 0.0 119.2 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -89.29 -78.03 0.36 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.54 -9.96 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -79.21 151.49 31.19 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 118.868 0.758 . . . . 0.0 110.509 -176.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -93.53 137.55 32.69 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.514 1.125 . . . . 0.0 109.763 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.86 -57.59 2.32 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 123.258 0.623 . . . . 0.0 110.767 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.86 168.86 30.6 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.29 155.72 20.19 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 122.203 1.002 . . . . 0.0 112.794 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.2 pt -139.55 155.77 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 126.699 1.999 . . . . 0.0 106.575 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.5 t -154.69 156.47 36.46 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -77.96 -50.06 12.9 Favored 'General case' 0 C--N 1.346 0.442 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.673 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t 45.4 15.1 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.621 2.768 . . . . 0.0 116.248 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.76 49.79 3.28 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.174 1.369 . . . . 0.0 110.791 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.24 -87.13 0.11 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 124.293 1.037 . . . . 0.0 109.721 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.7 m -147.64 63.19 1.14 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.729 1.211 . . . . 0.0 108.756 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.04 -102.21 1.13 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.282 0.944 . . . . 0.0 111.737 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -79.53 -26.93 41.36 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.91 0.884 . . . . 0.0 112.006 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -50.31 129.96 22.4 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.989 0.916 . . . . 0.0 111.374 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -103.62 133.93 47.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.28 1.432 . . . . 0.0 110.266 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.6 m -111.15 164.81 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.33 137.76 17.45 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.872 -0.604 . . . . 0.0 114.105 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.8 t -83.29 -172.5 4.18 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.3 m -67.65 138.97 56.77 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.217 -0.927 . . . . 0.0 108.643 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.63 33.11 35.34 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.2 m -155.24 119.3 4.61 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.533 1.533 . . . . 0.0 110.574 -179.088 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -49.32 136.81 15.22 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.808 1.243 . . . . 0.0 110.485 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.7 p -112.45 117.58 32.78 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -117.41 94.59 4.61 Favored 'General case' 0 N--CA 1.422 -1.872 1 N-CA-C 100.176 -4.009 . . . . 0.0 100.176 177.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 54.2 m -95.02 71.87 3.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.29 -79.22 1.51 Allowed Glycine 0 C--N 1.34 0.799 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.3 t -123.29 -35.32 2.98 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.99 1.316 . . . . 0.0 111.344 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 m -72.86 99.25 2.62 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -95.58 148.36 22.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.264 1.026 . . . . 0.0 110.803 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.61 143.62 31.56 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.691 1.196 . . . . 0.0 108.003 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -68.71 150.73 47.57 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.86 -21.27 10.84 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.8 t -71.14 -44.51 65.41 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.387 1.075 . . . . 0.0 109.574 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.1 -39.01 92.53 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 118.682 0.673 . . . . 0.0 112.628 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.422 HG13 ' CE2' ' A' ' 85' ' ' TYR . 2.1 t -62.88 -53.31 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -57.13 -44.49 83.41 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.811 1.245 . . . . 0.0 110.291 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.03 -45.11 95.0 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.647 0.779 . . . . 0.0 110.077 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.13 -33.95 69.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.511 0.725 . . . . 0.0 110.372 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.08 -39.55 25.54 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -62.4 -25.93 68.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.934 1.243 . . . . 0.0 108.312 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.55 -64.51 1.13 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.57 -33.54 15.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.962 0.905 . . . . 0.0 111.346 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 t -61.89 -61.4 2.52 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.308 1.443 . . . . 0.0 110.05 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -65.7 -42.3 91.32 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -71.52 -48.7 47.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.329 1.451 . . . . 0.0 113.722 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.41 ' CE2' ' HG2' ' A' ' 57' ' ' GLN . 39.6 t80 -62.08 -34.68 76.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.48 0.582 . . . . 0.0 110.177 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -58.02 -34.81 70.45 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 118.432 -0.794 . . . . 0.0 112.447 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 122.08 73.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 129.577 3.151 . . . . 0.0 110.604 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -162.08 58.82 0.24 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.1 t70 124.18 154.52 0.0 OUTLIER 'General case' 0 C--N 1.344 0.343 0 C-N-CA 130.027 3.331 . . . . 0.0 109.257 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.6 p -110.78 67.65 0.65 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 126.044 1.738 . . . . 0.0 108.653 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.06 93.79 1.83 Allowed 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.047 0.539 . . . . 0.0 109.751 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.21 135.33 3.41 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.1 t -136.4 67.03 1.47 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.642 0.777 . . . . 0.0 110.589 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.1 m -122.24 -76.77 0.59 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -160.29 30.97 0.17 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.835 1.654 . . . . 0.0 109.105 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -149.05 134.3 9.47 Favored Pre-proline 0 C--N 1.342 0.278 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.68 145.9 85.35 Favored 'Cis proline' 0 N--CA 1.455 -0.776 0 CA-C-N 119.373 0.812 . . . . 0.0 112.483 -0.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -159.89 162.47 34.58 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 126.079 1.752 . . . . 0.0 108.459 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 t -59.91 150.23 29.32 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -106.56 88.44 2.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.11 1.364 . . . . 0.0 107.707 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -68.31 100.4 1.05 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.687 1.195 . . . . 0.0 109.943 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -66.17 -65.48 0.67 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.679 0.791 . . . . 0.0 111.105 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 58.41 56.03 4.61 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 68.06 -17.0 0.17 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.731 2.012 . . . . 0.0 114.593 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.75 -99.32 0.01 OUTLIER Glycine 0 CA--C 1.532 1.136 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.62 133.94 38.31 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -109.81 162.83 14.1 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.948 1.299 . . . . 0.0 110.88 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -153.95 153.21 28.26 Favored Pre-proline 0 N--CA 1.454 -0.257 0 C-N-CA 126.149 1.78 . . . . 0.0 107.231 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.99 -30.02 76.17 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.92 2.413 . . . . 0.0 112.026 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 t -91.06 -74.39 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.069 0.947 . . . . 0.0 108.462 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 t70 54.87 105.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.967 2.507 . . . . 0.0 115.405 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.81 117.68 2.0 Allowed Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.839 -0.978 . . . . 0.0 112.082 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -68.8 157.33 89.34 Favored 'Cis proline' 0 C--N 1.348 0.515 0 CA-C-N 119.521 1.661 . . . . 0.0 108.543 -1.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.56 134.75 15.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 119.85 3.278 . . . . 0.0 119.85 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.41 ' HG2' ' CE2' ' A' ' 27' ' ' TYR . 20.0 mp0 -145.07 144.97 31.24 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.476 1.11 . . . . 0.0 112.78 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -81.86 156.15 24.98 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.674 0.749 . . . . 0.0 110.346 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -160.63 107.53 1.32 Allowed Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.39 134.88 21.46 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 CA-C-N 120.913 1.362 . . . . 0.0 112.336 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.528 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 6.9 tp -82.27 176.14 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-O 123.863 1.792 . . . . 0.0 111.114 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.528 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 55.9 tptt -155.56 154.57 31.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 109.703 -3.408 . . . . 0.0 112.813 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.4 m -83.83 51.0 1.93 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 127.467 2.307 . . . . 0.0 108.367 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.62 65.03 0.07 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.48 -102.9 1.66 Allowed Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.2 p -110.6 -176.93 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.823 2.049 . . . . 0.0 109.886 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -41.27 166.72 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.291 2.636 . . . . 0.0 117.258 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.3 p -96.37 -64.17 1.07 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.375 1.47 . . . . 0.0 110.057 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.12 62.88 0.77 Allowed Glycine 0 C--N 1.338 0.679 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -170.76 -61.8 0.04 OUTLIER Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.2 t -154.13 147.4 18.2 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.288 1.035 . . . . 0.0 109.924 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.31 -158.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.193 3.262 . . . . 0.0 110.419 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.39 41.95 0.13 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 107.391 -2.284 . . . . 0.0 107.391 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.426 ' HB3' ' CB ' ' A' ' 91' ' ' HIS . . . 71.12 -27.07 0.17 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.824 2.049 . . . . 0.0 116.305 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.9 111.43 19.66 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 120.332 1.424 . . . . 0.0 110.438 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -120.1 154.09 35.2 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.101 0.96 . . . . 0.0 113.146 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.3 m -128.02 143.21 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -134.89 126.67 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pt -110.29 -165.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.371 0 C-N-CA 125.016 1.326 . . . . 0.0 114.447 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -122.97 136.87 55.02 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 128.48 2.712 . . . . 0.0 106.849 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.29 1.7 t -56.65 -15.55 4.67 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 118.746 2.869 . . . . 0.0 118.746 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -79.55 -77.15 0.19 Allowed 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 102.693 -3.077 . . . . 0.0 102.693 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.11 -2.16 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.012 2.125 . . . . 0.0 114.902 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -79.17 170.25 16.93 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 119.646 1.112 . . . . 0.0 112.155 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.422 ' CE2' HG13 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -112.65 126.95 55.93 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.767 1.227 . . . . 0.0 111.565 -178.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.5 -51.82 7.44 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.63 -158.26 31.07 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 112.28 -0.328 . . . . 0.0 112.28 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.54 145.22 29.0 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.357 1.063 . . . . 0.0 110.174 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 pt -138.32 166.81 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.705 1.202 . . . . 0.0 110.95 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.3 t -156.18 156.69 34.63 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.426 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 44.7 m170 -78.5 -30.67 47.33 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.117 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.5 m -29.48 -70.14 0.05 Allowed 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.987 2.115 . . . . 0.0 116.504 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.97 -12.84 79.25 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.111 0.862 . . . . 0.0 114.769 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.96 -142.21 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.345 1.073 . . . . 0.0 111.064 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.7 t -151.17 92.27 1.78 Allowed 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.033 0.933 . . . . 0.0 109.941 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.98 -105.97 2.21 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.97 1.272 . . . . 0.0 112.632 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -79.47 -32.03 42.52 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.871 0.868 . . . . 0.0 111.312 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -54.79 160.62 1.83 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.318 1.047 . . . . 0.0 111.685 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -125.09 163.37 22.54 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.239 1.416 . . . . 0.0 112.859 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.5 m -144.53 165.68 12.78 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 128.123 2.569 . . . . 0.0 106.473 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.68 157.34 23.63 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.232 0.444 . . . . 0.0 113.477 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.5 m -116.24 167.63 10.84 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.2 m 61.7 -157.31 0.34 Allowed 'General case' 0 C--N 1.342 0.243 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.37 -19.62 57.77 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.489 1.042 . . . . 0.0 111.359 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.8 m -79.46 144.69 33.81 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 125.011 1.324 . . . . 0.0 109.122 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 C--O 1.253 1.285 0 CA-C-O 117.066 -1.445 . . . . 0.0 109.193 179.039 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 CA--C 1.529 0.167 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 73.41 146.34 0.08 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 126.874 2.07 . . . . 0.0 109.974 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 t -151.15 135.45 16.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.506 0.193 . . . . 0.0 110.525 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.88 107.91 18.02 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -98.69 85.89 3.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.47 -115.06 4.93 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.0 m -91.15 -27.79 18.29 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.404 1.082 . . . . 0.0 110.23 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -76.33 94.53 3.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.202 1.001 . . . . 0.0 109.351 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -85.82 113.15 21.75 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.723 1.209 . . . . 0.0 109.977 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -103.99 133.02 49.65 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.124 0.97 . . . . 0.0 111.218 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.7 m -72.46 154.31 40.93 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.3 1.44 . . . . 0.0 108.951 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.08 -20.84 60.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.0 m -74.5 -37.91 62.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.774 0.829 . . . . 0.0 109.449 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -73.66 -47.72 37.7 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.751 1.22 . . . . 0.0 111.596 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.0 t -54.39 -50.29 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -71.81 -34.64 69.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.226 1.411 . . . . 0.0 113.272 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.76 -52.76 55.26 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.279 0.945 . . . . 0.0 109.396 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.59 87.75 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.91 -37.54 81.82 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.63 -22.51 61.68 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.33 -59.44 2.77 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.44 -41.72 73.25 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.365 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.74 -50.47 33.61 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.853 1.206 . . . . 0.0 110.577 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -68.52 -43.87 75.84 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.353 0.0 OUTLIER -75.08 -43.05 55.32 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -177.394 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -39.24 62.98 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.59 1.956 . . . . 0.0 107.928 177.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -76.81 -37.51 55.62 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.884 1.274 . . . . 0.0 112.867 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -63.16 -32.18 73.51 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 t0 67.92 32.0 5.38 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.439 1.495 . . . . 0.0 110.87 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -163.5 -165.18 1.01 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 129.283 3.033 . . . . 0.0 105.065 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.284 3.7 t 47.27 57.96 5.31 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.804 1.242 . . . . 0.0 110.518 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.52 172.16 13.35 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.663 1.585 . . . . 0.0 109.67 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.8 58.25 0.07 OUTLIER Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.3 t -118.95 -94.49 0.5 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.716 1.206 . . . . 0.0 108.207 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.9 m -158.1 -59.34 0.08 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.804 1.242 . . . . 0.0 108.223 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 82.7 p -130.56 -52.27 1.08 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.697 1.599 . . . . 0.0 108.439 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -45.24 124.57 5.58 Favored Pre-proline 0 C--N 1.342 0.271 0 C-N-CA 127.821 2.448 . . . . 0.0 108.531 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.52 119.22 5.08 Favored 'Cis proline' 0 N--CA 1.453 -0.857 0 CA-C-N 118.583 0.53 . . . . 0.0 111.613 1.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -135.85 146.35 47.37 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 124.643 1.177 . . . . 0.0 111.129 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -43.0 151.3 0.14 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.257 2.223 . . . . 0.0 114.743 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -126.4 127.23 45.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.742 2.017 . . . . 0.0 105.853 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -74.32 -103.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 122.79 0.436 . . . . 0.0 111.3 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -178.46 -46.08 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.212 1.405 . . . . 0.0 109.06 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -41.48 128.76 3.14 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 128.002 2.521 . . . . 0.0 115.106 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 43.87 82.5 0.03 OUTLIER 'General case' 0 C--N 1.342 0.267 0 C-N-CA 127.325 2.25 . . . . 0.0 113.361 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.46 -156.94 28.4 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.52 154.35 20.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.66 1.584 . . . . 0.0 108.339 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -132.29 129.65 39.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -72.32 151.57 92.1 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.722 1.209 . . . . 0.0 111.397 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -63.6 -12.52 31.58 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 124.05 3.167 . . . . 0.0 115.618 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.94 -64.18 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.063 0.847 . . . . 0.0 110.281 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 143.17 -52.03 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 129.601 3.16 . . . . 0.0 108.457 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.5 -162.96 28.38 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.436 1.017 . . . . 0.0 110.952 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.6 170.59 9.27 Favored 'Cis proline' 0 CA--C 1.535 0.542 0 CA-C-N 119.208 1.504 . . . . 0.0 114.999 -0.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.29 -179.17 6.36 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 125.061 1.344 . . . . 0.0 109.229 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.19 147.77 25.18 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.24 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -79.41 148.8 31.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.832 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -144.13 104.91 4.78 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -77.54 128.09 9.3 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 121.024 1.149 . . . . 0.0 113.319 -175.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.657 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.1 tt -90.83 179.33 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 124.281 1.991 . . . . 0.0 110.275 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.657 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 10.4 tptp -160.2 147.55 16.26 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 109.26 -3.609 . . . . 0.0 110.58 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.0 p -93.35 56.89 2.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.604 1.162 . . . . 0.0 108.531 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 178.78 57.3 0.07 OUTLIER Glycine 0 C--N 1.339 0.713 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.95 153.16 19.1 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.023 0.821 . . . . 0.0 111.951 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.57 147.61 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.489 1.116 . . . . 0.0 109.091 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.399 0.0 OUTLIER 28.97 44.5 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 128.794 2.837 . . . . 0.0 116.486 -178.567 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.8 p -141.72 108.41 5.37 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.459 1.504 . . . . 0.0 107.395 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -179.71 -177.53 47.94 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.06 160.42 33.97 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.2 t 72.18 145.85 0.11 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.056 1.742 . . . . 0.0 110.219 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -42.15 110.46 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.91 3.074 . . . . 0.0 113.715 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.62 -39.03 2.64 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 71.74 -12.08 0.68 Allowed 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 126.769 2.028 . . . . 0.0 115.814 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -88.78 126.41 35.33 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 120.568 1.531 . . . . 0.0 112.427 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.0 mtt-85 -136.91 145.82 44.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.34 150.04 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 102.389 -3.189 . . . . 0.0 102.389 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.33 127.03 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 O-C-N 121.543 -0.723 . . . . 0.0 109.284 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.9 pt -113.61 158.18 14.04 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 124.924 1.29 . . . . 0.0 108.424 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -79.28 172.98 13.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.869 0.868 . . . . 0.0 109.273 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.299 3.0 t -76.66 30.02 0.13 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -128.33 -80.19 0.58 Allowed 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 101.66 -3.459 . . . . 0.0 101.66 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.5 -19.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -84.65 139.42 32.06 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -55.67 129.68 40.14 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 125.117 1.367 . . . . 0.0 109.01 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.38 -45.0 5.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.205 1.402 . . . . 0.0 108.947 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.72 -160.98 24.25 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.42 148.55 23.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.347 1.459 . . . . 0.0 108.707 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.3 pt -142.97 164.56 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.929 1.292 . . . . 0.0 110.227 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -159.47 162.84 35.66 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.895 0.478 . . . . 0.0 111.728 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -78.89 -56.62 4.26 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.272 5.8 t 49.26 11.01 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.352 2.661 . . . . 0.0 115.606 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.36 -55.85 0.62 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 106.98 -2.448 . . . . 0.0 106.98 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 52.28 -169.33 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.483 1.913 . . . . 0.0 112.133 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.8 t -83.27 -42.24 17.4 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -147.54 -79.87 0.03 OUTLIER Glycine 0 C--N 1.342 0.891 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -130.47 3.2 4.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.182 1.393 . . . . 0.0 111.55 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -73.07 -169.84 0.66 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.962 1.305 . . . . 0.0 111.725 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -127.37 154.42 45.0 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.933 1.293 . . . . 0.0 112.224 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.81 162.75 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 126.215 1.806 . . . . 0.0 107.144 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.84 147.26 39.66 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.68 -178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.0 t -79.83 178.89 7.87 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.1 m -93.21 100.48 12.85 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.944 0.793 . . . . 0.0 108.869 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.65 75.49 1.27 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.1 t -135.13 29.82 3.35 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.54 1.536 . . . . 0.0 111.459 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.962 1.705 . . . . 0.0 110.519 -179.228 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 CA--C 1.53 0.205 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.58 156.6 0.14 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.639 1.976 . . . . 0.0 111.929 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 t -154.51 137.8 15.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.86 122.02 45.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.03 80.2 1.49 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.436 1.495 . . . . 0.0 108.058 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.74 -86.41 0.75 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.5 t -114.82 -41.86 3.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.108 1.363 . . . . 0.0 110.053 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.4 m -68.91 100.19 1.16 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.559 0.744 . . . . 0.0 109.45 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -80.03 151.97 29.67 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.895 0.878 . . . . 0.0 110.506 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -139.0 131.11 28.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.988 0.915 . . . . 0.0 110.225 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.9 m -72.21 156.43 39.16 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.42 1.488 . . . . 0.0 109.057 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.47 -21.35 62.27 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.6 m -70.88 -40.72 72.08 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.748 1.219 . . . . 0.0 109.373 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -49.07 67.8 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.53 1.132 . . . . 0.0 111.004 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.93 -49.34 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.241 1.416 . . . . 0.0 109.626 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -67.79 -40.26 83.97 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.765 0.826 . . . . 0.0 112.393 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.27 -49.97 71.96 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.54 -38.7 81.72 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.001 0.92 . . . . 0.0 110.098 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.88 -46.27 62.89 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -64.31 -20.35 66.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.14 -55.27 4.86 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.406 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . . . -55.21 -43.12 74.18 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 t -50.31 -53.24 30.18 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.044 0.938 . . . . 0.0 110.812 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -66.37 -44.4 83.25 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.07 -59.54 4.01 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.843 2.457 . . . . 0.0 112.204 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -64.92 -24.97 67.69 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.939 2.095 . . . . 0.0 113.758 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -76.11 -62.86 1.46 Allowed 'General case' 0 C--N 1.338 0.095 0 CA-C-N 118.763 0.71 . . . . 0.0 111.964 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -164.89 -37.61 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -81.3 61.76 4.94 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.576 1.151 . . . . 0.0 108.785 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -50.05 117.9 2.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.464 1.906 . . . . 0.0 111.935 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 t -90.48 -20.71 22.41 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.369 1.068 . . . . 0.0 108.983 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -155.4 -168.65 2.9 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.773 2.429 . . . . 0.0 107.888 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -176.62 150.11 10.19 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 121.589 -0.695 . . . . 0.0 113.213 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 m -153.55 -111.14 0.04 OUTLIER 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.696 1.199 . . . . 0.0 109.405 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.9 m -155.89 -55.67 0.09 Allowed 'General case' 0 C--N 1.347 0.476 0 CA-C-N 118.813 0.733 . . . . 0.0 112.36 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.2 p -87.87 -57.42 2.95 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.141 0.976 . . . . 0.0 110.351 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -92.19 153.37 43.09 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.522 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -98.31 56.04 1.0 Allowed 'Cis proline' 0 N--CA 1.442 -1.517 0 N-CA-C 105.139 -2.677 . . . . 0.0 105.139 -5.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -107.08 -168.39 1.4 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.555 1.142 . . . . 0.0 112.417 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.0 p -33.02 139.92 0.05 OUTLIER 'General case' 0 C--N 1.34 0.185 0 C-N-CA 128.56 2.744 . . . . 0.0 115.784 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -152.13 127.17 9.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.054 2.142 . . . . 0.0 105.515 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -149.24 -51.63 0.15 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.813 0.845 . . . . 0.0 110.171 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -58.02 158.13 7.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.842 1.257 . . . . 0.0 111.686 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 66.62 102.29 0.04 OUTLIER 'General case' 0 C--N 1.343 0.291 0 C-N-CA 125.927 1.691 . . . . 0.0 109.694 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -82.61 -142.44 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.147 0.979 . . . . 0.0 110.097 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.0 12.81 65.76 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -159.17 139.57 12.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.321 1.849 . . . . 0.0 108.584 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.06 166.22 17.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.671 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -134.97 162.19 59.19 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 124.772 1.229 . . . . 0.0 109.117 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -51.38 -41.12 60.86 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.852 3.035 . . . . 0.0 112.774 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.93 167.34 2.33 Favored 'Isoleucine or valine' 0 C--N 1.343 0.32 0 C-N-CA 123.585 0.754 . . . . 0.0 110.152 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -101.53 -177.22 3.37 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.981 1.313 . . . . 0.0 109.7 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -132.09 -156.76 8.41 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.471 1.034 . . . . 0.0 110.724 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.33 125.56 1.56 Allowed 'Cis proline' 0 N--CA 1.456 -0.712 0 CA-C-N 118.274 1.037 . . . . 0.0 113.436 -0.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -98.49 169.34 9.6 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.82 1.648 . . . . 0.0 109.261 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -138.83 156.18 47.53 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.45 159.8 17.1 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.406 ' CD2' ' HB3' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -161.18 102.32 1.25 Allowed Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -66.87 121.74 8.99 Favored 'Trans proline' 0 N--CA 1.425 -2.546 0 CA-C-N 121.353 1.519 . . . . 0.0 114.098 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.416 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 3.2 tp -84.24 167.3 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-O 124.573 2.13 . . . . 0.0 112.127 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.416 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -160.25 151.62 19.5 Favored 'General case' 0 C--N 1.317 -0.843 1 CA-C-N 108.394 -4.003 . . . . 0.0 111.882 -178.887 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.6 p -86.49 57.36 4.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.998 1.719 . . . . 0.0 110.635 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.58 -73.39 0.03 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.27 137.64 5.48 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.45 131.6 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 117.32 0.56 . . . . 0.0 111.405 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.273 0.7 OUTLIER 64.65 131.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.717 2.807 . . . . 0.0 113.359 -178.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.6 p -136.59 -50.28 0.67 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.913 1.685 . . . . 0.0 108.435 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.9 61.66 1.49 Allowed Glycine 0 C--N 1.341 0.807 0 C-N-CA 124.374 0.988 . . . . 0.0 111.324 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 168.76 34.27 0.02 OUTLIER Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.271 -0.738 . . . . 0.0 113.206 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.8 p -170.38 139.76 1.47 Allowed Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.812 0.845 . . . . 0.0 110.094 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.73 -72.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.848 2.365 . . . . 0.0 108.5 170.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.74 -25.28 27.13 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 118.406 -1.219 . . . . 0.0 112.886 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 76.03 -43.54 0.48 Allowed 'General case' 0 C--N 1.346 0.448 0 C-N-CA 126.31 1.844 . . . . 0.0 111.081 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.92 121.76 28.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.88 0.872 . . . . 0.0 110.598 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.03 121.38 26.36 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.89 0.876 . . . . 0.0 112.896 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.7 m -85.01 145.33 8.13 Favored 'Isoleucine or valine' 0 C--N 1.346 0.439 0 N-CA-C 102.692 -3.077 . . . . 0.0 102.692 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.8 t -131.47 115.89 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 pt -93.78 -177.97 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.454 0 C-N-CA 124.987 1.315 . . . . 0.0 110.663 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -123.23 166.9 14.47 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.356 14.9 t -75.99 62.83 1.68 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -149.57 -94.33 0.07 Allowed 'General case' 0 N--CA 1.432 -1.333 1 N-CA-C 99.55 -4.241 . . . . 0.0 99.55 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.5 t -164.12 8.92 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.771 1.228 . . . . 0.0 113.818 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -112.81 156.51 22.76 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -175.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -75.14 116.45 15.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.892 2.477 . . . . 0.0 108.456 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.23 -49.57 9.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.88 172.66 42.57 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.65 150.78 43.79 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.154 0.982 . . . . 0.0 111.087 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.4 pt -131.82 161.48 41.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.163 1.785 . . . . 0.0 108.15 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.66 139.21 14.96 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -86.26 15.98 4.8 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.0 m -69.74 -51.73 31.55 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 120.703 -1.248 . . . . 0.0 111.0 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.88 9.5 65.65 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.556 1.074 . . . . 0.0 112.385 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.18 158.66 16.49 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.004 1.322 . . . . 0.0 111.086 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.8 t -104.62 69.32 0.89 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.326 1.45 . . . . 0.0 108.436 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.06 -115.21 3.29 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.463 1.506 . . . . 0.0 109.548 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -102.68 22.06 14.32 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.558 1.143 . . . . 0.0 111.778 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.71 -164.73 0.45 Allowed 'General case' 0 C--N 1.342 0.266 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -146.94 155.18 42.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.5 m -140.95 165.03 20.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 126.856 2.062 . . . . 0.0 106.622 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.87 141.91 16.29 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 116.637 -0.256 . . . . 0.0 113.538 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.3 t -83.07 -174.82 5.51 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.6 m -68.82 127.64 33.82 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.101 -0.999 . . . . 0.0 109.023 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.36 42.1 12.41 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.4 m -149.98 124.86 9.88 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.806 1.242 . . . . 0.0 108.144 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t30 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 117.038 -1.458 . . . . 0.0 109.173 179.171 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 CA--C 1.529 0.169 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.46 123.41 14.65 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.8 t -130.8 124.39 31.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 123.73 0.644 . . . . 0.0 111.075 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -107.55 129.69 54.95 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.68 1.992 . . . . 0.0 106.507 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -119.81 93.39 4.05 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.879 0.371 . . . . 0.0 110.353 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.6 -84.01 0.66 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.9 m -115.53 -27.4 7.15 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.888 1.275 . . . . 0.0 110.802 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -66.71 155.12 38.9 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.733 0.697 . . . . 0.0 109.884 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -142.15 86.24 1.96 Allowed 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 123.788 0.68 . . . . 0.0 110.855 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.58 136.98 32.72 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.7 t -76.7 158.45 30.98 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.69 -19.55 50.45 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.7 m -71.54 -39.43 70.71 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.21 1.004 . . . . 0.0 109.214 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.99 -50.12 37.8 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.35 1.06 . . . . 0.0 112.459 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.7 t -54.79 -48.08 73.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.332 1.053 . . . . 0.0 108.917 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -71.11 -41.84 70.03 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.178 1.391 . . . . 0.0 113.363 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.72 -52.17 53.38 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.702 0.683 . . . . 0.0 110.651 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.95 80.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.448 0.699 . . . . 0.0 110.703 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.52 -39.02 67.91 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.802 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -67.12 -21.86 65.83 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.84 -63.53 1.39 Allowed 'General case' 0 C--N 1.347 0.48 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.33 -37.35 10.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.332 1.453 . . . . 0.0 111.535 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -61.7 2.44 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.473 1.909 . . . . 0.0 108.884 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -63.23 -36.7 84.51 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -66.87 -43.06 84.54 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.673 1.189 . . . . 0.0 111.987 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -74.36 -27.59 60.74 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.074 0.397 . . . . 0.0 111.798 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -89.07 9.39 25.53 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.338 1.055 . . . . 0.0 113.146 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.7 p30 -130.84 45.83 2.76 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.085 0.857 . . . . 0.0 110.54 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 70.66 37.28 1.44 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.849 2.06 . . . . 0.0 113.274 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.45 176.36 0.08 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.565 1.946 . . . . 0.0 114.905 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.1 t 21.35 79.38 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 129.351 3.061 . . . . 0.0 115.857 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.89 98.3 7.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.16 53.61 41.12 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.498 1.047 . . . . 0.0 111.034 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.3 m -140.38 -114.89 0.13 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.2 t -157.9 -82.33 0.06 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.3 p -115.44 -44.09 3.0 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.842 1.657 . . . . 0.0 107.528 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.484 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 15.2 m-85 -69.49 131.99 89.67 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 126.664 1.986 . . . . 0.0 106.514 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.91 137.18 48.42 Favored 'Cis proline' 0 N--CA 1.453 -0.896 0 CA-C-N 120.823 1.33 . . . . 0.0 113.314 0.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -159.91 150.16 18.63 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.895 1.678 . . . . 0.0 109.963 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -47.72 141.39 5.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.094 2.157 . . . . 0.0 113.451 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -113.89 97.18 6.24 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.784 1.634 . . . . 0.0 108.383 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -157.94 33.55 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -66.11 -50.53 63.7 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.06 0.544 . . . . 0.0 111.347 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -161.6 91.57 0.84 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 72.13 171.45 0.31 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.233 1.813 . . . . 0.0 110.741 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.22 8.2 7.99 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 118.315 -1.27 . . . . 0.0 114.559 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.3 t80 62.61 -158.98 0.32 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.016 1.408 . . . . 0.0 110.016 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -61.82 -172.73 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.828 1.651 . . . . 0.0 112.325 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.0 p90 51.7 63.39 9.43 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 125.748 1.619 . . . . 0.0 110.741 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.64 111.44 3.13 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.687 2.924 . . . . 0.0 110.075 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.76 170.68 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.199 1.399 . . . . 0.0 109.72 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.7 -57.97 6.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.23 -149.35 49.93 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 119.521 -0.6 . . . . 0.0 112.267 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.98 148.64 19.9 Favored 'Cis proline' 0 N--CA 1.459 -0.512 0 CA-C-N 118.604 1.202 . . . . 0.0 112.999 -0.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -111.18 140.69 45.52 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 125.742 1.617 . . . . 0.0 108.645 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -113.88 149.65 34.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.77 1.228 . . . . 0.0 113.42 -177.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -84.83 155.12 21.91 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.095 0.958 . . . . 0.0 110.553 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -153.53 108.71 2.57 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.484 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 11.2 Cg_endo -82.04 133.44 7.75 Favored 'Trans proline' 0 N--CA 1.432 -2.131 0 C-N-CA 121.931 1.754 . . . . 0.0 113.287 -175.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.549 ' CG2' ' H ' ' A' ' 62' ' ' LYS . 0.7 OUTLIER -106.21 -171.58 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 127.247 2.219 . . . . 0.0 106.298 178.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.549 ' H ' ' CG2' ' A' ' 61' ' ' ILE . 10.5 mmtt -162.74 -174.99 4.19 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 129.374 3.069 . . . . 0.0 108.396 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.2 m -88.74 53.46 2.71 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.96 -51.25 0.01 OUTLIER Glycine 0 C--N 1.344 1.025 0 C-N-CA 124.666 1.127 . . . . 0.0 111.87 -178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.87 -139.12 7.33 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 118.289 1.045 . . . . 0.0 112.966 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.0 p -52.96 142.4 5.81 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 125.716 1.606 . . . . 0.0 110.436 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.03 164.0 27.98 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.297 0.639 . . . . 0.0 112.124 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 t -134.18 63.97 1.61 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.538 1.535 . . . . 0.0 109.419 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 151.53 -177.32 29.52 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.54 -98.21 0.15 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.414 ' CB ' ' CD ' ' A' ' 72' ' ' PRO 0.327 67.3 m 56.19 -105.88 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.952 1.701 . . . . 0.0 111.08 -179.084 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 71' ' ' SER . 83.0 Cg_endo -75.64 131.07 13.2 Favored 'Trans proline' 0 C--N 1.352 0.711 0 CA-C-N 123.584 2.316 . . . . 0.0 109.07 175.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.47 162.86 25.34 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -157.51 48.86 0.42 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.919 0.888 . . . . 0.0 109.303 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.18 116.89 3.42 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.975 2.11 . . . . 0.0 105.881 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.22 165.53 30.67 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 m -135.58 142.62 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 102.259 -3.237 . . . . 0.0 102.259 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.0 t -133.08 120.38 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.0 pt -97.99 179.33 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.407 0 C-N-CA 126.395 1.878 . . . . 0.0 112.028 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -113.59 177.1 4.75 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.416 1.486 . . . . 0.0 109.681 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.332 11.5 t -77.88 55.29 1.39 Allowed 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 118.047 2.61 . . . . 0.0 118.047 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -160.71 -95.23 0.02 OUTLIER 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 101.626 -3.472 . . . . 0.0 101.626 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 90.8 m -163.92 47.9 0.12 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 129.209 3.004 . . . . 0.0 109.863 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -121.7 108.28 13.35 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.625 1.557 . . . . 0.0 114.202 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -65.35 104.68 0.99 Allowed 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.381 1.472 . . . . 0.0 107.718 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.93 -54.27 5.97 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.569 0.748 . . . . 0.0 111.994 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.35 149.01 12.12 Favored Glycine 0 C--N 1.34 0.799 0 C-N-CA 119.25 -1.452 . . . . 0.0 113.963 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.99 140.36 29.56 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.947 1.299 . . . . 0.0 109.162 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.7 pt -135.74 161.7 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.017 1.327 . . . . 0.0 109.812 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.0 t -159.92 148.67 17.42 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.523 0.729 . . . . 0.0 112.169 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -85.65 -25.81 26.38 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.8 m -49.26 109.4 0.26 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 126.282 1.833 . . . . 0.0 110.337 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.27 52.31 4.06 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.183 0.897 . . . . 0.0 111.041 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.49 -128.38 0.09 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.615 1.166 . . . . 0.0 108.721 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.8 m -145.85 71.39 1.27 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.016 0.926 . . . . 0.0 110.12 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.87 -91.28 0.27 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.758 1.171 . . . . 0.0 112.851 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -79.89 -34.74 38.86 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.651 1.18 . . . . 0.0 111.579 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -53.39 138.48 32.98 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.943 0.897 . . . . 0.0 111.016 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -106.27 147.82 28.7 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.529 1.532 . . . . 0.0 110.318 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.5 m -128.99 160.79 39.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 124.546 1.138 . . . . 0.0 108.288 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.06 142.39 21.42 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.994 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 8.7 t -85.26 -174.66 5.35 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.302 1.441 . . . . 0.0 108.332 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.3 m -65.11 131.06 45.57 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 121.344 -0.848 . . . . 0.0 109.101 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.61 43.85 51.09 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 16.3 m -146.78 144.41 29.35 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 57.5 t30 . . . . . 0 C--O 1.251 1.137 0 C-N-CA 125.344 1.458 . . . . 0.0 110.345 -179.116 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.68 155.86 0.16 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.501 1.921 . . . . 0.0 110.495 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.5 p -135.53 93.6 2.98 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.87 95.91 10.04 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 102.067 -3.309 . . . . 0.0 102.067 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.7 m -95.08 83.12 3.86 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.008 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.14 -87.74 0.58 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.0 p -120.01 -23.29 6.4 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.076 1.751 . . . . 0.0 110.657 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.6 m -75.65 91.25 2.86 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -84.22 106.52 15.91 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.882 1.273 . . . . 0.0 110.911 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -98.32 138.84 34.97 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.108 0.963 . . . . 0.0 110.057 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.2 t -72.5 152.72 41.73 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 124.69 1.196 . . . . 0.0 108.839 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.4 -18.09 48.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 t -76.34 -38.52 55.8 Favored 'General case' 0 C--N 1.345 0.391 0 C-N-CA 124.382 1.073 . . . . 0.0 108.334 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -67.81 -36.37 80.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.298 1.039 . . . . 0.0 111.514 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.4 t -67.56 -48.27 77.37 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -62.77 -38.01 88.9 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.734 1.214 . . . . 0.0 111.3 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.32 -51.97 26.25 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.9 0.88 . . . . 0.0 110.541 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.69 -41.96 74.48 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.476 1.11 . . . . 0.0 110.116 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.7 -25.38 38.19 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -69.44 -24.64 63.85 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.41 -55.7 4.87 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.36 -51.68 25.21 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 124.266 0.979 . . . . 0.0 111.711 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 t -61.98 -47.21 85.87 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.111 1.764 . . . . 0.0 112.515 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -63.22 -51.02 67.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.307 0.643 . . . . 0.0 111.939 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -68.95 -48.16 63.89 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -63.54 -22.09 66.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -110.14 9.86 23.95 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -157.98 61.22 0.46 Allowed 'General case' 0 C--N 1.339 0.143 0 CA-C-N 119.361 0.982 . . . . 0.0 109.123 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t70 64.22 99.01 0.04 OUTLIER 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.954 1.702 . . . . 0.0 109.27 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -61.42 114.57 3.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.6 p -105.99 -76.82 0.6 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.14 -179.9 0.09 Allowed 'General case' 0 C--N 1.342 0.242 0 C-N-CA 125.758 1.623 . . . . 0.0 113.876 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.38 -62.59 3.03 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.406 ' HG ' ' H ' ' A' ' 36' ' ' SER . 45.2 p -82.05 -108.87 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.909 0.884 . . . . 0.0 109.636 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.406 ' H ' ' HG ' ' A' ' 35' ' ' SER . 36.8 p -170.06 -51.35 0.02 OUTLIER 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.538 1.135 . . . . 0.0 110.045 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.4 t -80.24 31.38 0.27 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.029 1.332 . . . . 0.0 112.833 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.491 ' CD1' ' HD3' ' A' ' 60' ' ' PRO . 96.8 m-85 -170.01 113.96 0.48 Allowed Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 128.339 2.656 . . . . 0.0 104.334 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.54 134.48 35.79 Favored 'Cis proline' 0 N--CA 1.448 -1.157 0 CA-C-N 120.763 1.308 . . . . 0.0 111.333 1.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.23 161.44 41.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.987 1.315 . . . . 0.0 108.216 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 t -60.87 143.24 55.26 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-O 120.748 0.308 . . . . 0.0 110.881 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.34 122.72 27.82 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -64.44 161.98 16.06 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.276 1.03 . . . . 0.0 111.189 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -105.06 73.0 1.03 Allowed 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.158 0.983 . . . . 0.0 110.068 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -81.6 -89.01 0.08 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -155.46 -56.38 0.09 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.003 1.321 . . . . 0.0 109.304 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.69 135.18 44.28 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.044 1.307 . . . . 0.0 114.496 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 53.6 162.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 129.121 2.969 . . . . 0.0 117.816 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -161.68 160.98 29.27 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.09 2.156 . . . . 0.0 107.241 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -137.31 78.62 38.66 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.28 71.24 5.87 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.014 3.142 . . . . 0.0 110.09 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.4 t -119.73 -67.22 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 125.754 1.622 . . . . 0.0 107.919 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -165.87 78.76 0.27 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.05 162.22 54.68 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.2 152.9 97.64 Favored 'Cis proline' 0 N--CA 1.459 -0.54 0 CA-C-N 118.302 1.051 . . . . 0.0 112.902 0.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -121.75 156.92 32.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.931 2.093 . . . . 0.0 110.493 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -127.87 152.45 47.82 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.295 1.438 . . . . 0.0 112.462 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -94.04 156.17 16.74 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.242 1.017 . . . . 0.0 111.772 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -159.35 112.7 1.54 Allowed Pre-proline 0 N--CA 1.455 -0.188 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.491 ' HD3' ' CD1' ' A' ' 38' ' ' TYR . 31.2 Cg_endo -81.7 127.24 5.55 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 121.389 1.393 . . . . 0.0 112.506 -175.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.534 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 6.5 tt -84.47 167.2 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-O 123.816 1.769 . . . . 0.0 112.709 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.534 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 48.0 mmtm -142.71 145.36 33.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 109.098 -3.683 . . . . 0.0 112.71 -178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.5 t -91.61 58.24 3.47 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 125.585 1.554 . . . . 0.0 108.833 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.06 -64.8 0.03 OUTLIER Glycine 0 C--N 1.337 0.6 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.31 159.49 32.69 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.0 p -74.53 156.47 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.515 1.126 . . . . 0.0 109.603 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.3 t80 66.44 56.65 0.76 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.501 1.12 . . . . 0.0 111.099 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.9 p -149.96 166.29 30.09 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.303 1.041 . . . . 0.0 109.509 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -144.83 148.03 19.56 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.614 1.102 . . . . 0.0 110.824 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.19 170.18 33.82 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.1 t -52.5 -66.02 0.89 Allowed Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.941 1.297 . . . . 0.0 112.96 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.87 146.7 48.36 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.243 1.962 . . . . 0.0 111.51 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.83 139.57 6.58 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.421 ' HB2' ' CB ' ' A' ' 91' ' ' HIS . . . -173.39 -33.3 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.355 1.462 . . . . 0.0 111.833 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.07 120.06 29.05 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.658 1.583 . . . . 0.0 111.551 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -139.03 130.56 27.22 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.9 m -96.44 148.1 5.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.276 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.8 t -136.7 137.24 47.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.7 pt -117.3 176.3 2.81 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 C-N-CA 125.188 1.395 . . . . 0.0 112.904 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -97.28 163.58 12.84 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 128.08 2.552 . . . . 0.0 107.19 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.302 12.8 t -72.41 3.72 4.51 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -93.43 -86.87 0.25 Allowed 'General case' 0 N--CA 1.434 -1.267 1 N-CA-C 98.711 -4.551 . . . . 0.0 98.711 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.5 m -164.49 -5.63 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 128.253 2.621 . . . . 0.0 114.105 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -79.48 148.87 31.7 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.31 129.85 39.91 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.071 1.349 . . . . 0.0 107.754 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.91 -51.72 4.94 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.941 1.296 . . . . 0.0 108.958 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.35 -166.57 32.57 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.75 116.97 3.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.034 0.934 . . . . 0.0 108.802 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 45.4 pt -107.96 160.26 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.796 1.238 . . . . 0.0 110.649 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t -159.86 149.08 17.8 Favored 'General case' 0 C--N 1.343 0.284 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.421 ' CB ' ' HB2' ' A' ' 74' ' ' ALA . 27.2 m170 -79.75 -36.29 37.47 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.162 175.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.8 m -34.02 -58.99 0.44 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 128.478 2.711 . . . . 0.0 115.131 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.83 -36.33 92.61 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.521 1.057 . . . . 0.0 112.556 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.44 -159.66 0.29 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.933 1.293 . . . . 0.0 111.383 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.7 t -80.91 -81.46 0.13 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.626 0.77 . . . . 0.0 111.694 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -135.02 -78.45 0.1 Allowed Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.04 0.829 . . . . 0.0 111.805 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -79.82 -27.12 40.29 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.511 0.655 . . . . 0.0 111.519 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -59.48 151.85 23.14 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.976 1.31 . . . . 0.0 110.407 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -120.08 151.04 39.62 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.535 1.534 . . . . 0.0 110.069 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.1 m -147.69 166.14 5.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 125.942 1.697 . . . . 0.0 108.238 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.8 156.29 25.39 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.501 0.572 . . . . 0.0 112.69 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.3 m -104.84 -169.07 1.56 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.126 1.37 . . . . 0.0 108.244 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.4 t -61.33 113.99 2.94 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.83 60.51 1.96 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.3 m -154.78 121.14 5.33 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.98 0.912 . . . . 0.0 108.542 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.157 -1.402 . . . . 0.0 108.746 179.353 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 CA--C 1.529 0.169 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.27 136.0 57.73 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.815 0.846 . . . . 0.0 109.463 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 48.4 p -111.37 146.14 37.65 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.47 0.708 . . . . 0.0 109.68 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.83 117.92 8.88 Favored 'General case' 0 N--CA 1.44 -0.928 1 N-CA-C 99.675 -4.194 . . . . 0.0 99.675 177.445 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.26 103.55 5.8 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.896 0.379 . . . . 0.0 111.012 -177.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.91 -63.63 4.35 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 125.109 1.338 . . . . 0.0 109.807 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.4 p -155.65 -44.69 0.08 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.932 1.693 . . . . 0.0 109.275 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -54.65 115.83 2.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.612 1.965 . . . . 0.0 109.409 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -104.55 150.3 24.75 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.982 1.313 . . . . 0.0 111.068 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.88 141.03 26.15 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.018 1.327 . . . . 0.0 109.14 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.6 m -72.59 152.54 41.74 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 124.726 1.211 . . . . 0.0 110.142 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.61 -21.34 53.16 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.8 m -71.94 -41.22 68.06 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.873 1.269 . . . . 0.0 109.86 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -72.34 -41.11 66.85 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.022 0.929 . . . . 0.0 112.082 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.6 t -63.25 -47.73 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -67.07 -36.05 81.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.678 1.191 . . . . 0.0 110.999 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.08 -51.2 65.2 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 118.894 0.77 . . . . 0.0 109.391 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.45 -37.3 87.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.63 -41.71 87.87 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.349 -0.844 . . . . 0.0 111.967 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -69.46 -18.81 63.75 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.61 -62.54 1.64 Allowed 'General case' 0 C--N 1.347 0.464 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.436 ' HB3' ' CG ' ' A' ' 59' ' ' PHE . . . -46.41 -44.43 17.19 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.923 0.889 . . . . 0.0 111.19 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.9 t -61.37 -49.73 75.73 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 118.938 0.79 . . . . 0.0 110.293 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -68.84 -9.58 52.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.659 0.784 . . . . 0.0 112.65 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -115.12 -16.23 11.61 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.815 0.846 . . . . 0.0 112.915 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -65.57 -51.8 57.06 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.006 0.923 . . . . 0.0 110.427 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -90.98 -27.11 18.89 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -63.66 -25.0 68.02 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.901 0.773 . . . . 0.0 112.989 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 t70 65.15 45.56 2.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.626 1.17 . . . . 0.0 111.571 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -168.03 151.04 5.72 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.005 1.322 . . . . 0.0 108.909 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.0 p 47.5 39.52 9.63 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.727 1.611 . . . . 0.0 112.344 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.07 89.07 6.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.895 1.278 . . . . 0.0 110.979 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 52.78 -141.32 28.59 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.959 1.742 . . . . 0.0 112.578 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.1 p -154.27 -33.98 0.1 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.332 1.053 . . . . 0.0 112.637 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.7 t -82.14 -102.67 0.04 OUTLIER 'General case' 0 C--N 1.343 0.311 0 C-N-CA 123.627 0.771 . . . . 0.0 109.358 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.0 p -137.82 35.27 2.4 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.629 1.172 . . . . 0.0 109.209 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -133.24 148.2 68.12 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 124.0 0.92 . . . . 0.0 109.118 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.29 125.08 10.27 Favored 'Cis proline' 0 N--CA 1.452 -0.938 0 CA-C-N 118.733 0.583 . . . . 0.0 112.564 0.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.3 163.01 33.6 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.018 0.927 . . . . 0.0 110.881 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 m -48.19 124.18 7.41 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 127.952 2.501 . . . . 0.0 113.012 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -115.89 68.47 0.72 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.71 85.4 0.47 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.099 1.36 . . . . 0.0 112.778 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -131.19 137.16 48.83 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.852 1.661 . . . . 0.0 106.962 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -116.62 132.94 56.55 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.473 1.109 . . . . 0.0 110.847 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 40.72 45.89 2.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.175 2.19 . . . . 0.0 114.09 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.57 -79.26 1.42 Allowed Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -80.27 173.48 12.55 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.328 1.051 . . . . 0.0 112.097 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -79.52 6.18 11.06 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -127.13 67.2 70.01 Favored Pre-proline 0 C--N 1.318 -0.772 0 C-N-CA 127.93 2.492 . . . . 0.0 110.146 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.73 -41.84 3.95 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.82 2.346 . . . . 0.0 110.291 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.7 t 62.54 -97.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.885 1.674 . . . . 0.0 108.816 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -165.88 -58.16 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 126.319 1.848 . . . . 0.0 107.883 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.95 -175.79 51.79 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -58.21 151.67 36.73 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 CA-C-N 119.043 1.422 . . . . 0.0 113.5 -0.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -146.03 159.3 43.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.573 1.149 . . . . 0.0 109.778 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.2 161.69 29.55 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -175.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -88.1 157.24 18.91 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 113.699 -1.591 . . . . 0.0 108.89 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.436 ' CG ' ' HB3' ' A' ' 23' ' ' ALA . 15.2 t80 -160.24 112.6 1.4 Allowed Pre-proline 0 C--O 1.224 -0.259 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -82.15 137.16 9.42 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 121.387 1.391 . . . . 0.0 115.211 -175.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.663 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 3.0 tt -110.37 -175.85 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 124.034 1.873 . . . . 0.0 112.188 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.663 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -160.8 152.01 19.01 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 108.724 -3.853 . . . . 0.0 111.004 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.7 t -84.44 59.87 5.69 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.969 1.307 . . . . 0.0 108.878 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.05 -50.37 0.03 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.04 172.27 45.18 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.75 119.13 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.364 1.065 . . . . 0.0 109.587 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.3 t80 62.47 118.44 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.255 1.822 . . . . 0.0 112.665 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 79.6 p -126.84 154.12 44.77 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.94 1.296 . . . . 0.0 109.79 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.86 72.24 2.83 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.98 -48.39 0.02 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.8 m 60.7 80.12 0.27 Allowed Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 125.339 1.456 . . . . 0.0 110.694 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.49 -56.16 3.37 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.385 3.39 . . . . 0.0 112.026 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.41 39.24 3.51 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.967 1.27 . . . . 0.0 110.478 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.41 -73.2 0.12 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 117.959 -1.019 . . . . 0.0 112.567 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -67.38 117.16 8.99 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.8 mtt85 -146.73 129.46 16.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.74 155.37 3.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 103.601 -2.74 . . . . 0.0 103.601 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.0 t -136.14 123.35 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 O-C-N 120.587 -1.32 . . . . 0.0 108.146 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.7 pt -105.46 175.44 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.417 0 C-N-CA 125.775 1.63 . . . . 0.0 112.756 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -101.83 165.03 11.41 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 127.47 2.308 . . . . 0.0 108.364 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.251 11.4 t -67.26 -29.78 69.49 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 118.302 2.705 . . . . 0.0 118.302 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -79.14 -73.16 0.35 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.8 t -164.72 3.52 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -78.65 164.03 24.97 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 119.723 1.147 . . . . 0.0 113.953 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -104.68 117.53 34.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.59 -45.96 12.02 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.099 0.559 . . . . 0.0 110.188 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.66 -160.48 33.9 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.6 145.09 31.61 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.823 0.849 . . . . 0.0 109.652 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.5 pt -143.14 164.93 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.923 1.289 . . . . 0.0 111.571 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.407 ' HG1' ' H ' ' A' ' 92' ' ' THR . 3.2 t -155.79 146.5 22.08 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -79.1 -15.45 58.14 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.809 174.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.407 ' H ' ' HG1' ' A' ' 90' ' ' THR . 29.0 m -39.8 -55.36 1.97 Allowed 'General case' 0 C--N 1.345 0.409 0 C-N-CA 126.859 2.063 . . . . 0.0 114.576 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.83 28.14 11.04 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.519 1.057 . . . . 0.0 112.816 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.76 177.02 5.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.078 0.951 . . . . 0.0 111.325 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 84.2 p -68.0 -48.42 65.79 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.097 0.959 . . . . 0.0 111.378 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.8 -69.68 0.08 OUTLIER Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -102.23 29.17 5.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.722 1.209 . . . . 0.0 109.654 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -131.83 176.94 7.92 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.769 1.228 . . . . 0.0 109.618 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -127.42 164.52 21.67 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.164 1.786 . . . . 0.0 110.824 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.87 156.23 40.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 C-N-CA 124.875 1.27 . . . . 0.0 107.581 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.8 142.33 25.43 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.298 0.952 . . . . 0.0 112.762 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.7 m -96.27 179.03 5.18 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.797 0.839 . . . . 0.0 110.517 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 27.0 t -69.24 140.69 54.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.89 47.05 62.72 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.5 m -131.49 96.31 3.95 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.371 1.468 . . . . 0.0 107.085 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.7 t30 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 117.028 -1.463 . . . . 0.0 109.229 -179.1 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 CA--C 1.529 0.17 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 73.03 160.93 0.24 Allowed 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.353 1.461 . . . . 0.0 109.808 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 t -157.7 148.68 21.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.28 120.12 29.15 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 104.794 -2.298 . . . . 0.0 104.794 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.6 m -112.95 111.4 22.12 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.65 -95.17 0.18 Allowed Glycine 0 CA--C 1.529 0.923 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.8 p -118.54 -39.19 3.03 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.109 1.763 . . . . 0.0 109.7 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.4 m -61.28 126.06 26.0 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.024 1.33 . . . . 0.0 109.721 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -99.02 153.6 18.74 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.565 1.146 . . . . 0.0 110.289 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -142.77 121.3 12.47 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.678 1.191 . . . . 0.0 108.52 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.5 t -67.34 154.32 41.61 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 125.06 1.344 . . . . 0.0 110.473 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.85 -22.01 61.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.401 -1.704 . . . . 0.0 106.401 176.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.4 t -72.47 -39.76 67.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.324 1.049 . . . . 0.0 109.209 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -73.43 -44.08 59.05 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.342 0.657 . . . . 0.0 112.116 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.5 t -59.03 -51.47 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 124.993 1.317 . . . . 0.0 109.086 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -68.42 -41.05 80.93 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.921 0.888 . . . . 0.0 112.925 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.58 -47.16 87.4 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 123.753 0.658 . . . . 0.0 109.427 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.0 -39.54 78.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.314 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.36 -30.33 61.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -69.8 -25.48 63.8 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.19 -61.07 2.11 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 104.167 -2.531 . . . . 0.0 104.167 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -43.77 -43.65 6.22 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 124.763 1.289 . . . . 0.0 111.614 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.57 -64.03 0.98 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 126.385 1.874 . . . . 0.0 111.667 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.5 -36.67 83.3 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -88.65 -22.51 23.41 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.306 0.0 OUTLIER -92.65 16.76 11.44 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.779 1.627 . . . . 0.0 114.966 -178.352 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.6 -38.96 70.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.57 1.148 . . . . 0.0 110.368 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -145.6 -67.87 0.29 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.659 1.184 . . . . 0.0 109.003 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -177.37 91.73 0.03 OUTLIER 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.518 1.527 . . . . 0.0 108.104 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -119.17 -170.51 1.94 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.737 1.215 . . . . 0.0 109.897 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.9 p -70.88 83.89 0.66 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.254 1.422 . . . . 0.0 111.236 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.91 156.91 39.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.272 1.029 . . . . 0.0 110.784 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.15 -141.5 45.47 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.474 1.035 . . . . 0.0 112.438 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.0 t -90.32 -74.34 0.49 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.64 1.176 . . . . 0.0 109.935 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 t -151.54 -56.09 0.15 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.055 1.342 . . . . 0.0 108.32 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.3 p -79.36 -53.75 6.62 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -59.62 135.3 89.29 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -71.77 131.09 20.4 Favored 'Cis proline' 0 N--CA 1.454 -0.801 0 CA-C-N 119.123 0.723 . . . . 0.0 112.489 2.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.02 156.6 41.48 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 123.469 0.707 . . . . 0.0 111.555 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.9 p -34.45 137.24 0.12 Allowed 'General case' 0 C--N 1.34 0.166 0 C-N-CA 127.764 2.426 . . . . 0.0 115.096 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -135.52 88.01 2.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.081 1.352 . . . . 0.0 108.286 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -167.93 -39.61 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.867 1.667 . . . . 0.0 108.462 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -61.69 -35.77 78.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.888 1.275 . . . . 0.0 110.348 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -61.77 -77.28 0.05 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.243 1.017 . . . . 0.0 109.56 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -171.22 138.33 1.22 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.177 1.391 . . . . 0.0 108.254 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.4 132.79 23.26 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -144.2 108.21 4.74 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.279 0.632 . . . . 0.0 110.264 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 t70 51.17 -168.64 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.572 1.549 . . . . 0.0 113.517 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.0 p90 38.03 79.04 0.33 Allowed Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 127.159 2.184 . . . . 0.0 114.265 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.82 64.67 8.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.829 3.019 . . . . 0.0 107.833 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.34 -154.62 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 126.078 1.751 . . . . 0.0 110.112 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -100.99 118.58 37.28 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.509 1.123 . . . . 0.0 110.197 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.21 -176.46 30.32 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.218 0.914 . . . . 0.0 111.581 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.73 127.85 15.12 Favored 'Cis proline' 0 N--CA 1.453 -0.884 0 CA-C-N 117.527 0.664 . . . . 0.0 111.414 -0.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -102.47 140.26 36.99 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -115.66 162.17 17.63 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 123.878 0.736 . . . . 0.0 110.876 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -79.38 144.67 33.94 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.578 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -138.89 103.03 7.54 Favored Pre-proline 0 N--CA 1.443 -0.804 0 N-CA-C 102.086 -3.301 . . . . 0.0 102.086 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -77.99 137.25 15.45 Favored 'Trans proline' 0 N--CA 1.439 -1.691 0 C-N-CA 121.224 1.283 . . . . 0.0 111.964 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.647 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.5 tt -116.96 -177.98 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 124.581 2.134 . . . . 0.0 113.366 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.647 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -161.32 153.93 20.46 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 108.428 -3.987 . . . . 0.0 111.613 178.164 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.0 t -88.62 58.5 4.69 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.874 1.27 . . . . 0.0 108.165 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.48 -74.79 0.01 OUTLIER Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.29 86.77 0.1 OUTLIER Glycine 0 CA--C 1.527 0.793 0 CA-C-N 117.385 0.593 . . . . 0.0 111.973 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.266 12.9 p 41.12 60.43 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.958 2.103 . . . . 0.0 113.407 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 21.5 t80 58.2 93.97 0.03 OUTLIER 'General case' 0 C--N 1.344 0.339 0 C-N-CA 126.69 1.996 . . . . 0.0 114.047 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.0 t -155.99 124.41 5.85 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.901 1.28 . . . . 0.0 108.771 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.18 66.45 2.49 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.73 1.157 . . . . 0.0 111.492 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -164.97 77.8 0.14 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.5 t -146.02 108.74 4.31 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -61.37 160.11 48.73 Favored 'Cis proline' 0 N--CA 1.459 -0.537 0 CA-C-N 119.969 1.025 . . . . 0.0 113.987 0.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.68 -42.59 0.05 OUTLIER Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.167 1.365 . . . . 0.0 110.907 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 78.7 -48.29 0.44 Allowed 'General case' 0 C--N 1.342 0.281 0 C-N-CA 127.364 2.266 . . . . 0.0 112.538 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -75.93 124.9 28.1 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -136.99 118.0 14.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.366 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.4 m -84.2 164.55 2.58 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.3 t -140.26 137.19 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 pt -131.06 159.73 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.761 0.825 . . . . 0.0 112.513 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -89.16 146.04 25.04 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 127.464 2.306 . . . . 0.0 108.205 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.37 15.3 t -73.78 66.17 1.08 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -177.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -157.32 -94.45 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.184 1 N-CA-C 97.458 -5.016 . . . . 0.0 97.458 176.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -162.84 10.69 0.06 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.996 1.718 . . . . 0.0 113.774 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.3 140.93 29.04 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.993 0.815 . . . . 0.0 112.178 -177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -73.52 131.49 41.82 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.95 -56.79 2.86 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.89 -177.29 40.72 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 112.25 -0.34 . . . . 0.0 112.25 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.98 117.6 13.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.837 1.655 . . . . 0.0 107.056 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 41.0 pt -128.27 153.52 37.8 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 C-N-CA 124.075 0.95 . . . . 0.0 109.814 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -152.18 150.85 30.29 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.34 75.85 5.91 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.3 m -70.57 -84.54 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.086 -1.634 . . . . 0.0 110.24 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.7 34.57 5.56 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.85 153.17 42.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.224 1.81 . . . . 0.0 110.957 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -74.37 -11.55 60.28 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.588 0.755 . . . . 0.0 112.227 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.73 -94.86 0.1 OUTLIER Glycine 0 C--N 1.341 0.841 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -103.22 22.62 13.76 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.156 0.982 . . . . 0.0 110.54 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -72.26 178.78 3.71 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -151.82 133.98 15.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 m -115.12 166.53 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.56 145.21 19.41 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.105 0.802 . . . . 0.0 115.105 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.8 m -97.54 177.5 5.49 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 124.53 1.132 . . . . 0.0 110.559 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.3 t 44.06 41.76 4.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.667 0.787 . . . . 0.0 112.094 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.5 30.06 75.86 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.384 0.992 . . . . 0.0 113.922 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.4 m -86.54 151.14 23.73 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.654 1.182 . . . . 0.0 109.083 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 116.346 -1.788 . . . . 0.0 108.677 179.842 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.5 p . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.32 61.75 0.71 Allowed 'General case' 0 C--N 1.342 0.244 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 t -107.48 135.95 48.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.874 1.269 . . . . 0.0 110.67 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -110.57 108.41 18.35 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 103.393 -2.818 . . . . 0.0 103.393 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.34 85.42 4.6 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.02 -104.63 1.44 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.2 p -94.49 -44.52 7.84 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.494 1.118 . . . . 0.0 110.188 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.6 m -70.0 110.37 5.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.856 0.862 . . . . 0.0 110.24 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -84.72 148.52 26.34 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.684 1.193 . . . . 0.0 111.061 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -142.03 112.91 7.37 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.101 0.96 . . . . 0.0 111.098 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.7 t -65.37 157.49 29.13 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 125.84 1.656 . . . . 0.0 110.429 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.0 -19.27 29.66 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.5 m -73.43 -44.54 58.02 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.521 1.128 . . . . 0.0 109.184 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -71.91 -44.15 64.16 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 124.718 1.207 . . . . 0.0 112.34 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.25 -51.2 75.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -41.92 96.57 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.633 1.973 . . . . 0.0 112.517 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.34 -54.44 28.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.004 0.365 . . . . 0.0 110.191 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.73 72.37 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.207 0.603 . . . . 0.0 111.679 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.85 -44.97 30.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.06 -22.11 65.49 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.51 -65.83 0.88 Allowed 'General case' 0 C--N 1.345 0.409 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -44.22 -48.59 9.35 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 124.577 1.173 . . . . 0.0 111.83 177.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.8 t -54.13 -51.89 62.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.366 1.866 . . . . 0.0 111.924 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -58.34 -40.73 82.92 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.176 0.59 . . . . 0.0 111.253 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -70.9 -38.37 72.99 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -90.6 22.8 3.31 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-N 118.91 0.777 . . . . 0.0 112.468 -177.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -110.2 -48.96 3.12 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 124.361 1.064 . . . . 0.0 109.209 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -74.11 -38.69 63.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.383 0.673 . . . . 0.0 112.154 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 108.19 72.52 0.0 OUTLIER 'General case' 0 C--N 1.345 0.397 0 C-N-CA 129.674 3.189 . . . . 0.0 110.932 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -151.89 136.37 16.88 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.692 1.597 . . . . 0.0 107.57 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.6 p -80.31 -56.89 3.88 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.446 0.698 . . . . 0.0 111.786 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.87 82.71 0.16 Allowed 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.55 -48.59 0.96 Allowed Glycine 0 CA--C 1.528 0.886 0 N-CA-C 107.093 -2.403 . . . . 0.0 107.093 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.8 t 57.52 67.38 0.98 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.26 1.824 . . . . 0.0 113.713 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.2 m -143.86 -75.96 0.24 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.165 0.986 . . . . 0.0 108.771 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.3 t -160.35 41.22 0.18 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.497 0.59 . . . . 0.0 112.224 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.411 ' CA ' ' H ' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -172.25 127.62 0.57 Allowed Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 125.649 1.58 . . . . 0.0 107.479 -179.249 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -86.06 63.32 0.16 OUTLIER 'Cis proline' 0 N--CA 1.439 -1.702 0 CA-C-N 121.409 1.539 . . . . 0.0 110.1 -2.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.411 ' H ' ' CA ' ' A' ' 38' ' ' TYR . 6.7 m170 -84.27 173.09 11.26 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 t -69.3 145.54 52.95 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 111.426 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -95.82 55.09 1.58 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.481 1.512 . . . . 0.0 109.291 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.403 HD21 ' H ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -79.01 51.56 1.16 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.639 1.576 . . . . 0.0 112.347 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -160.84 53.44 0.29 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.381 1.472 . . . . 0.0 107.426 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.12 -55.99 8.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.499 1.519 . . . . 0.0 110.906 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 68.62 -72.41 0.1 Allowed 'General case' 0 C--N 1.343 0.292 0 C-N-CA 127.079 2.152 . . . . 0.0 111.168 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.24 -121.36 2.16 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.42 -169.3 0.17 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.356 1.062 . . . . 0.0 112.315 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -127.67 -164.06 1.33 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.998 0.919 . . . . 0.0 110.925 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.328 40.3 p90 61.63 47.33 1.13 Allowed Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 128.788 2.835 . . . . 0.0 115.855 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.7 125.94 8.54 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.175 1.916 . . . . 0.0 107.702 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.51 -125.0 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -153.72 127.57 8.86 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 125.711 1.605 . . . . 0.0 107.237 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.17 -85.04 0.05 OUTLIER Glycine 0 CA--C 1.531 1.063 0 CA-C-O 117.49 -1.728 . . . . 0.0 111.737 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.4 168.76 7.45 Favored 'Cis proline' 0 C--N 1.35 0.642 0 CA-C-N 121.676 2.738 . . . . 0.0 116.427 0.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.51 159.34 28.24 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.036 1.335 . . . . 0.0 113.188 -177.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -152.72 150.65 29.65 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.464 1.506 . . . . 0.0 111.948 -178.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -102.41 166.55 10.49 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -158.44 114.69 1.72 Allowed Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -86.79 108.06 0.77 Allowed 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 122.706 2.271 . . . . 0.0 112.342 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.643 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 9.3 tt -81.5 173.88 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 124.329 2.014 . . . . 0.0 110.966 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.643 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 14.2 mmtt -160.27 159.43 31.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 109.183 -3.644 . . . . 0.0 109.49 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 57.2 m -81.81 57.44 3.43 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.458 1.103 . . . . 0.0 109.539 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.46 62.71 0.24 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.95 -106.63 1.64 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 123.76 0.695 . . . . 0.0 112.376 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.1 95.05 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.32 1.048 . . . . 0.0 111.099 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 t80 44.98 80.74 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.879 1.672 . . . . 0.0 112.971 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.1 p -125.22 -29.94 3.23 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.744 1.218 . . . . 0.0 111.44 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.42 -69.2 1.25 Allowed Glycine 0 C--N 1.342 0.886 0 C-N-CA 124.838 1.209 . . . . 0.0 112.426 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.09 113.98 1.27 Allowed Glycine 0 C--N 1.34 0.76 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.9 m 54.17 69.89 1.96 Allowed Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 125.348 1.459 . . . . 0.0 112.715 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.11 149.65 82.19 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.369 2.713 . . . . 0.0 109.96 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -159.11 35.58 0.49 Allowed Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.109 -0.829 . . . . 0.0 115.152 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -153.87 -67.94 0.14 Allowed 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 118.452 1.126 . . . . 0.0 110.25 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.43 118.24 16.15 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.926 1.239 . . . . 0.0 108.384 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -140.14 117.44 11.32 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 m -85.1 146.67 6.29 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 176.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.2 t -132.84 135.81 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -177.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.43 HG21 ' H ' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -126.86 -176.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 C-N-CA 126.74 2.016 . . . . 0.0 110.186 -177.737 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.43 ' H ' HG21 ' A' ' 79' ' ' ILE . 63.5 m-80 -99.26 159.72 14.79 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 102.977 -2.972 . . . . 0.0 102.977 175.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.301 7.2 t -66.92 2.57 1.38 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 -178.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -95.58 -83.69 0.36 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 102.301 -3.222 . . . . 0.0 102.301 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.81 -5.07 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.721 2.408 . . . . 0.0 114.791 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -79.46 121.1 24.76 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -52.98 123.25 11.08 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 126.051 1.74 . . . . 0.0 108.497 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.56 -55.75 2.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.4 -164.43 23.06 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.45 137.02 8.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.482 1.113 . . . . 0.0 108.355 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 pt -133.89 174.25 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.438 1.095 . . . . 0.0 113.092 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.6 t -158.16 137.03 11.37 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.527 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -77.31 -24.11 50.92 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 118.211 0.46 . . . . 0.0 112.034 175.003 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.1 t -45.33 -25.52 0.41 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -145.03 51.57 0.61 Allowed Glycine 0 C--N 1.339 0.731 0 CA-C-N 119.165 0.893 . . . . 0.0 111.534 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.73 -177.37 3.11 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.817 1.247 . . . . 0.0 111.487 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.3 t -58.27 -53.33 59.47 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.554 1.541 . . . . 0.0 111.547 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.38 -70.06 0.05 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -112.54 35.03 4.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.854 1.262 . . . . 0.0 109.133 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -125.1 176.21 6.85 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.18 1.392 . . . . 0.0 109.955 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.446 ' CZ ' ' CD2' ' A' ' 91' ' ' HIS . 64.1 m-85 -125.17 159.3 31.86 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.11 1.364 . . . . 0.0 111.093 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.8 m -135.33 161.48 39.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 125.449 1.499 . . . . 0.0 107.864 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.26 156.65 34.08 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 123.862 0.744 . . . . 0.0 113.707 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.6 m -85.75 -170.67 3.22 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 123.607 0.763 . . . . 0.0 110.094 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.1 p -73.65 127.53 33.01 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.47 -1.0 88.64 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.815 -0.992 . . . . 0.0 113.361 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.7 m -79.38 91.22 5.05 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.4 t30 . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.953 -1.499 . . . . 0.0 109.439 -178.729 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.457 -0.103 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.31 89.74 0.09 Allowed 'General case' 0 C--N 1.344 0.357 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.81 132.22 36.41 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.91 114.76 23.69 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.5 m -105.49 88.82 2.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.03 -114.64 4.62 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.8 p -93.25 -29.23 15.79 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.282 1.033 . . . . 0.0 109.972 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -71.99 95.13 1.55 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.273 1.429 . . . . 0.0 108.776 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -89.95 147.19 23.86 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.527 1.131 . . . . 0.0 112.508 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -142.13 129.46 21.14 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -72.79 155.13 40.26 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 126.531 1.932 . . . . 0.0 107.315 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.47 -16.79 16.63 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.4 m -76.15 -35.2 59.3 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -51.9 15.84 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.755 1.222 . . . . 0.0 113.601 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . 0.273 17.9 m -60.99 -41.58 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.647 0 C-N-CA 127.239 2.216 . . . . 0.0 109.242 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -71.02 -44.58 65.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.886 0.874 . . . . 0.0 111.69 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.15 -54.64 26.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.096 0.407 . . . . 0.0 112.077 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.05 -37.56 85.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.481 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.33 -40.39 70.75 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -65.86 -19.74 65.99 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.46 -53.96 7.01 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.0 -51.38 17.29 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.229 1.412 . . . . 0.0 110.776 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 t -57.92 -46.19 85.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.748 0.819 . . . . 0.0 110.559 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -57.09 -38.0 72.72 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.529 0.731 . . . . 0.0 111.394 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -89.08 -9.04 52.63 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.71 -27.38 67.59 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.725 0.693 . . . . 0.0 112.208 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -80.54 -75.69 0.26 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 p30 171.94 68.62 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.696 1.998 . . . . 0.0 109.809 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -117.5 58.72 0.79 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.93 0.892 . . . . 0.0 109.438 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.84 162.72 0.08 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.86 2.464 . . . . 0.0 114.429 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 t -88.37 76.66 8.29 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.458 1.103 . . . . 0.0 110.182 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.52 102.37 4.48 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.314 1.045 . . . . 0.0 110.319 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.99 -114.26 4.48 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.5 t -75.8 -95.99 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 m 88.05 23.18 0.04 OUTLIER 'General case' 0 C--N 1.341 0.212 0 C-N-CA 125.018 1.327 . . . . 0.0 113.327 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t -78.95 -38.72 36.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 102.743 -3.058 . . . . 0.0 102.743 176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -89.18 151.82 47.17 Favored Pre-proline 0 N--CA 1.451 -0.405 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.14 142.52 57.81 Favored 'Cis proline' 0 N--CA 1.455 -0.791 0 N-CA-C 116.78 1.8 . . . . 0.0 116.78 0.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.65 147.54 39.43 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 127.912 2.485 . . . . 0.0 109.579 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.25 123.47 14.68 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 178.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -83.78 118.91 24.23 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -59.0 159.84 6.69 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.308 1.443 . . . . 0.0 111.013 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -134.42 59.95 1.72 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.037 0.935 . . . . 0.0 109.964 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -154.36 -22.32 0.13 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 112.068 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.74 -46.34 88.55 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.127 0.571 . . . . 0.0 111.386 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.31 -61.88 0.41 Allowed Glycine 0 C--N 1.339 0.723 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.06 148.19 52.2 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 123.81 0.844 . . . . 0.0 113.099 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -166.26 -178.49 4.59 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.094 1.758 . . . . 0.0 109.231 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -145.37 118.58 5.37 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.74 1.216 . . . . 0.0 108.555 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.32 84.99 1.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.08 2.52 . . . . 0.0 110.448 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -129.62 -97.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.245 0 C-N-CA 124.227 1.011 . . . . 0.0 108.379 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -153.17 117.47 4.9 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.156 0.982 . . . . 0.0 109.618 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.48 146.39 22.54 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -68.72 157.58 88.76 Favored 'Cis proline' 0 N--CA 1.457 -0.633 0 CA-C-N 119.983 1.891 . . . . 0.0 113.447 0.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.21 141.93 26.72 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.1 2.16 . . . . 0.0 108.235 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -134.39 166.56 22.55 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.59 164.56 23.74 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 126.481 1.912 . . . . 0.0 115.541 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -161.87 104.13 1.16 Allowed Pre-proline 0 N--CA 1.454 -0.246 0 O-C-N 121.43 -0.794 . . . . 0.0 110.571 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -74.69 137.35 22.36 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 121.088 1.424 . . . . 0.0 113.892 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.657 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.2 tt -109.27 178.97 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-O 124.444 2.069 . . . . 0.0 113.058 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.657 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 7.8 mmtt -153.12 153.77 33.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 108.647 -3.888 . . . . 0.0 109.869 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.8 p -76.08 51.94 0.7 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.63 1.972 . . . . 0.0 113.014 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.81 50.63 0.08 OUTLIER Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.405 1.002 . . . . 0.0 112.791 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.31 174.22 17.32 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 117.686 0.743 . . . . 0.0 112.783 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.8 t -80.86 131.79 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.834 1.253 . . . . 0.0 108.542 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -70.15 135.02 48.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.206 1.003 . . . . 0.0 110.907 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.9 p -139.27 75.61 1.52 Allowed 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.88 1.272 . . . . 0.0 107.583 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.47 -143.21 3.6 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.3 -50.73 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.9 p -153.35 150.1 22.89 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 124.218 1.007 . . . . 0.0 109.792 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -66.16 145.33 69.31 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 CA-C-N 119.393 0.819 . . . . 0.0 112.001 -8.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.28 -113.16 2.27 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.423 ' HB3' ' CB ' ' A' ' 91' ' ' HIS . . . 62.92 28.99 16.54 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.047 1.339 . . . . 0.0 113.866 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -155.02 84.15 1.08 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.16 132.64 47.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.522 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.72 159.79 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 103.311 -2.848 . . . . 0.0 103.311 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.2 t -139.17 131.39 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 120.479 -1.388 . . . . 0.0 108.089 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.7 pt -114.14 -179.46 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.311 1.444 . . . . 0.0 113.35 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -104.71 -174.38 2.52 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.099 2.159 . . . . 0.0 109.631 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.318 12.4 t -79.58 -30.17 41.49 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 120.402 3.482 . . . . 0.0 120.402 -177.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -79.32 -73.56 0.33 Allowed 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.7 t -164.75 1.22 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.849 2.06 . . . . 0.0 114.169 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -78.64 150.69 32.6 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 119.846 1.203 . . . . 0.0 113.813 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -95.85 117.98 31.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.34 1.856 . . . . 0.0 108.651 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.94 -52.69 7.54 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.35 0.66 . . . . 0.0 110.658 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.38 -169.21 38.38 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.9 162.37 31.77 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.827 0.813 . . . . 0.0 113.022 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.8 pt -142.21 163.67 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.59 1.556 . . . . 0.0 110.263 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.6 t -158.84 159.04 34.6 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.867 1.267 . . . . 0.0 111.016 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.423 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 49.9 m170 -79.6 -51.08 9.74 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.6 m -32.72 106.51 0.04 OUTLIER 'General case' 0 C--N 1.345 0.382 0 C-N-CA 127.852 2.461 . . . . 0.0 111.998 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.56 32.29 5.2 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.201 1.381 . . . . 0.0 111.079 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -134.5 -142.82 0.2 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.759 1.224 . . . . 0.0 109.248 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.6 t -151.46 62.86 0.88 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.26 0.624 . . . . 0.0 111.141 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.71 -125.29 6.73 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.534 1.064 . . . . 0.0 113.367 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -79.28 -26.2 42.37 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.643 1.177 . . . . 0.0 113.046 -178.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -56.3 118.05 4.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.984 0.914 . . . . 0.0 110.621 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -83.75 153.95 23.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.044 0.938 . . . . 0.0 111.145 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.6 m -126.76 166.54 23.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 C-N-CA 125.635 1.574 . . . . 0.0 107.556 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.38 148.03 23.74 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 123.891 0.758 . . . . 0.0 114.26 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.0 t -96.59 -175.09 3.21 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.716 2.006 . . . . 0.0 107.418 178.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.2 p -59.76 136.73 58.09 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.439 1.018 . . . . 0.0 109.851 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.06 26.56 74.6 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.566 0.603 . . . . 0.0 111.81 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.7 m -150.3 114.81 5.21 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.144 1.378 . . . . 0.0 107.497 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 . . . . . 0 C--O 1.251 1.154 0 CA-C-O 116.83 -1.557 . . . . 0.0 109.458 -179.82 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.1 m . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 72.91 139.74 0.06 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 127.184 2.194 . . . . 0.0 109.682 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 t -146.67 124.15 11.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.281 0.562 . . . . 0.0 111.641 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -100.66 101.16 11.98 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 32.8 m -85.72 74.96 10.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.615 1.166 . . . . 0.0 108.249 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.82 -98.71 1.08 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.8 m -88.14 -44.71 10.71 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.387 1.075 . . . . 0.0 110.433 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.0 107.15 1.42 Allowed 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.039 1.336 . . . . 0.0 112.493 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -91.41 103.69 16.3 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.572 1.149 . . . . 0.0 109.027 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -102.39 148.69 25.18 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.277 0.631 . . . . 0.0 110.713 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.4 m -83.13 157.6 22.72 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 125.476 1.51 . . . . 0.0 108.858 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.66 -19.55 63.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.2 m -71.95 -35.22 69.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.109 0.964 . . . . 0.0 109.026 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.64 -53.81 10.78 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 123.953 0.901 . . . . 0.0 112.679 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.95 -41.31 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -67.61 -44.75 77.32 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.663 0.785 . . . . 0.0 111.007 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.25 -48.45 78.17 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.498 0.59 . . . . 0.0 110.253 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.05 -32.1 73.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.157 0.983 . . . . 0.0 111.166 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.43 -36.84 52.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.776 0.262 . . . . 0.0 110.666 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -69.29 -20.33 63.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.72 -53.59 5.79 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.59 -40.31 59.57 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.54 1.136 . . . . 0.0 109.228 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.41 -53.94 52.61 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.366 1.466 . . . . 0.0 109.374 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -63.58 -49.49 73.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -70.79 -46.15 63.39 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.478 ' CD1' ' HG2' ' A' ' 57' ' ' GLN . 63.6 t80 -70.23 -19.55 63.13 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.465 -177.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -90.14 -77.68 0.39 Allowed 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.534 1.061 . . . . 0.0 110.207 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.8 p30 174.49 56.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.1 1.36 . . . . 0.0 111.616 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -146.01 92.7 2.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 86.19 117.59 0.04 OUTLIER 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 127.326 2.25 . . . . 0.0 105.819 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -92.05 85.17 5.43 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.045 0.938 . . . . 0.0 109.916 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.15 150.21 8.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.253 1.421 . . . . 0.0 112.722 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.61 -38.37 95.59 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.4 t 65.49 97.13 0.05 OUTLIER 'General case' 0 C--N 1.343 0.297 0 C-N-CA 126.773 2.029 . . . . 0.0 113.242 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.5 m -68.95 -55.65 10.29 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 t -159.81 16.89 0.15 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.171 1.388 . . . . 0.0 111.495 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -142.02 149.76 53.61 Favored Pre-proline 0 CA--C 1.511 -0.553 0 C-N-CA 126.067 1.747 . . . . 0.0 107.327 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.4 122.76 7.96 Favored 'Cis proline' 0 CA--C 1.557 1.651 0 N-CA-C 115.425 1.279 . . . . 0.0 115.425 0.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . 0.318 29.3 m-70 -82.84 138.33 33.98 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 127.358 2.263 . . . . 0.0 114.457 -178.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -70.77 133.17 46.33 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 102.829 -3.026 . . . . 0.0 102.829 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.28 63.1 3.82 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.211 0.914 . . . . 0.0 113.278 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.1 m120 30.98 -138.0 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 130.87 3.668 . . . . 0.0 114.912 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -111.73 140.25 46.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.854 2.061 . . . . 0.0 107.701 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 71.93 179.46 0.23 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.514 1.526 . . . . 0.0 109.998 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -84.76 98.08 10.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.35 -42.48 83.1 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.171 0.891 . . . . 0.0 111.694 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -145.25 162.71 36.51 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.127 0.971 . . . . 0.0 109.458 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -76.69 132.9 39.61 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.777 1.231 . . . . 0.0 112.612 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -149.28 154.01 38.3 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.428 1.491 . . . . 0.0 108.385 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.96 -47.63 23.92 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.023 2.482 . . . . 0.0 111.351 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.4 m -81.0 168.0 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.544 1.538 . . . . 0.0 109.755 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -98.53 -16.68 19.06 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.633 1.173 . . . . 0.0 112.406 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.66 -159.69 22.41 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.35 160.77 72.05 Favored 'Cis proline' 0 N--CA 1.459 -0.549 0 CA-C-N 118.783 1.291 . . . . 0.0 112.422 1.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.91 159.94 35.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.742 1.217 . . . . 0.0 111.465 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.478 ' HG2' ' CD1' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -132.96 135.95 45.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.9 178.058 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -80.68 162.43 24.16 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -160.77 117.91 1.45 Allowed Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -82.9 146.03 12.83 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 121.405 1.404 . . . . 0.0 113.103 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.514 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 0.5 OUTLIER -112.84 -165.48 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-O 123.81 1.767 . . . . 0.0 113.731 -178.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.514 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -161.65 176.09 11.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 109.678 -3.419 . . . . 0.0 111.586 -177.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.0 t -99.81 63.57 1.22 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.342 1.457 . . . . 0.0 110.673 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.68 -63.43 0.09 OUTLIER Glycine 0 C--N 1.337 0.593 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.85 -164.88 11.57 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.6 p -83.98 160.6 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.03 0.932 . . . . 0.0 111.643 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -37.93 126.68 1.24 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 128.097 2.559 . . . . 0.0 113.754 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.0 t -160.02 -40.98 0.05 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.496 1.518 . . . . 0.0 110.383 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.87 -80.3 0.75 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.93 95.08 2.29 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.8 p -157.13 153.04 22.9 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 125.024 1.33 . . . . 0.0 108.417 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.23 154.17 74.79 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.958 2.439 . . . . 0.0 110.642 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.05 -25.73 0.02 OUTLIER Glycine 0 CA--C 1.53 1.022 0 CA-C-O 117.956 -1.469 . . . . 0.0 114.655 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.415 ' HB3' ' CB ' ' A' ' 91' ' ' HIS . . . 88.95 -31.28 0.03 OUTLIER 'General case' 0 C--N 1.346 0.418 0 C-N-CA 126.205 1.802 . . . . 0.0 111.167 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -79.37 124.52 28.5 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.234 1.813 . . . . 0.0 113.391 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.84 128.08 7.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.804 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.7 m -85.9 146.03 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.7 t -133.96 122.87 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.3 pt -106.23 171.59 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 125.169 1.388 . . . . 0.0 111.566 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -79.68 165.47 22.82 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.285 2.1 m -67.98 -5.78 18.93 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -178.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -102.29 -73.3 0.66 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -165.17 -12.01 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 117.935 2.568 . . . . 0.0 117.935 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -78.77 126.96 31.43 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -57.33 111.21 1.02 Allowed 'General case' 0 C--N 1.344 0.346 0 C-N-CA 125.353 1.461 . . . . 0.0 107.454 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.99 -48.76 11.81 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.53 151.33 8.31 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.56 125.88 38.41 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.5 pt -127.13 155.74 38.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 C-N-CA 122.727 0.411 . . . . 0.0 110.11 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.8 t -156.73 154.06 29.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.415 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 2.5 m170 -79.04 -15.38 58.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.821 175.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.7 m -58.51 103.72 0.17 Allowed 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.668 1.187 . . . . 0.0 109.385 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.76 55.0 1.96 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.23 -174.95 4.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.729 1.212 . . . . 0.0 109.915 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -57.15 -47.56 80.86 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.249 1.019 . . . . 0.0 111.082 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.96 -70.37 0.12 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -86.63 -28.55 23.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.76 1.224 . . . . 0.0 109.305 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -57.06 160.61 3.54 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 126.304 1.842 . . . . 0.0 111.285 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -114.85 161.46 18.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.882 1.673 . . . . 0.0 112.029 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 m -146.28 164.08 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 126.615 1.966 . . . . 0.0 107.434 177.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.54 156.55 26.9 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 123.972 0.796 . . . . 0.0 112.414 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.0 m -103.39 -171.16 1.89 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.151 0.98 . . . . 0.0 110.897 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -82.87 79.32 9.28 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 121.599 0.714 . . . . 0.0 109.624 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.94 -26.22 0.2 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.259 1.409 . . . . 0.0 109.674 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.0 m -79.36 123.35 27.41 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.015 1.726 . . . . 0.0 107.412 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 126.199 1.8 . . . . 0.0 109.865 -179.056 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 119.919 -0.086 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.53 91.53 0.03 OUTLIER 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.807 1.643 . . . . 0.0 111.666 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 p -83.41 92.5 7.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.087 0.955 . . . . 0.0 112.068 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -99.71 96.25 7.49 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 101.481 -3.526 . . . . 0.0 101.481 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.9 m -89.12 73.04 8.23 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.94 -98.65 1.21 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 108.611 -1.795 . . . . 0.0 108.611 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.5 p -95.53 -42.13 8.59 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.41 1.084 . . . . 0.0 109.182 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.21 137.32 58.24 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -140.17 126.75 20.31 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.79 136.78 50.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.522 1.529 . . . . 0.0 108.338 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.7 p -64.73 161.57 17.67 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 125.152 1.381 . . . . 0.0 110.807 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.21 -16.78 36.39 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -78.28 -37.16 45.58 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 123.785 0.834 . . . . 0.0 109.986 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -66.64 -39.94 88.49 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.726 0.81 . . . . 0.0 109.992 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.5 t -60.2 -50.69 79.25 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -64.87 -23.29 67.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.138 1.375 . . . . 0.0 111.378 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.64 -61.11 1.89 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 119.202 0.91 . . . . 0.0 108.668 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.86 -24.93 66.19 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.679 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.2 -38.59 30.87 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 118.501 0.592 . . . . 0.0 112.012 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -69.5 -22.55 63.6 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.3 -65.22 0.95 Allowed 'General case' 0 C--N 1.347 0.487 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.38 -43.68 11.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.783 1.233 . . . . 0.0 111.941 177.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 t -61.81 -48.33 81.09 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 121.335 -0.853 . . . . 0.0 111.682 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -80.21 -24.33 40.32 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -112.6 -28.72 7.72 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -3.06 28.21 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -66.75 -46.64 74.73 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.175 0.99 . . . . 0.0 112.979 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -133.69 -80.69 0.47 Allowed 'General case' 0 C--N 1.34 0.183 0 O-C-N 123.354 0.409 . . . . 0.0 111.328 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -170.66 101.67 0.24 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -141.2 -169.38 2.83 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.963 0.905 . . . . 0.0 110.35 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.3 p -71.08 84.9 0.72 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.455 1.502 . . . . 0.0 112.152 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 137.94 162.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 129.464 3.106 . . . . 0.0 111.895 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 152.65 -87.88 0.13 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 126.169 1.842 . . . . 0.0 108.647 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.1 t 158.31 -94.75 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 129.21 3.004 . . . . 0.0 105.91 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.6 p -160.22 -55.05 0.06 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 p -81.36 -69.15 0.63 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.24 141.07 98.07 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 124.075 0.95 . . . . 0.0 109.129 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.18 133.33 27.46 Favored 'Cis proline' 0 N--CA 1.459 -0.504 0 N-CA-C 116.061 1.523 . . . . 0.0 116.061 3.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -132.49 136.97 47.03 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.963 2.105 . . . . 0.0 108.423 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.5 m -49.58 125.66 11.87 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.819 2.048 . . . . 0.0 110.195 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -80.03 70.61 6.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.703 1.201 . . . . 0.0 110.407 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -164.31 147.59 9.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.592 0.757 . . . . 0.0 110.027 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -162.29 -72.83 0.05 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.618 1.567 . . . . 0.0 107.03 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -152.76 -40.7 0.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.711 2.004 . . . . 0.0 108.31 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -118.28 161.96 19.06 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 125.392 1.477 . . . . 0.0 110.103 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.84 156.65 14.52 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.634 1.112 . . . . 0.0 110.459 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.55 156.78 37.77 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.655 0.782 . . . . 0.0 111.302 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -88.55 119.49 29.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.868 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -130.77 101.03 17.16 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.57 75.81 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.759 2.972 . . . . 0.0 111.286 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.9 t -140.04 -38.56 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.023 1.729 . . . . 0.0 109.238 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 80.57 108.88 0.07 Allowed 'General case' 0 C--N 1.345 0.387 0 C-N-CA 127.132 2.173 . . . . 0.0 109.251 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.84 -143.17 0.7 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.865 1.697 . . . . 0.0 113.533 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -65.99 139.06 40.76 Favored 'Cis proline' 0 N--CA 1.456 -0.717 0 CA-C-N 118.299 1.049 . . . . 0.0 112.652 1.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.37 163.72 12.61 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 126.351 1.86 . . . . 0.0 108.24 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -139.75 156.25 46.88 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -79.63 157.3 27.31 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.227 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -160.21 89.22 1.82 Allowed Pre-proline 0 N--CA 1.449 -0.511 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 178.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . 0.253 6.3 Cg_exo -63.84 137.46 58.33 Favored 'Trans proline' 0 N--CA 1.44 -1.657 0 C-N-CA 122.474 2.116 . . . . 0.0 116.757 -176.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.597 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.0 tt -108.14 176.96 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 124.278 1.99 . . . . 0.0 111.904 178.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.597 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -162.05 179.78 7.72 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 108.58 -3.918 . . . . 0.0 111.31 179.082 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.9 p -87.42 52.85 2.61 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.32 -65.57 0.02 OUTLIER Glycine 0 C--N 1.342 0.879 0 C-N-CA 125.187 1.375 . . . . 0.0 110.136 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.85 -127.13 1.62 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -68.27 164.94 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.89 1.276 . . . . 0.0 109.225 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -51.42 140.44 17.57 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.4 p -141.56 -55.79 0.47 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.566 1.946 . . . . 0.0 108.422 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.01 170.52 20.79 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.024 1.297 . . . . 0.0 111.248 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.38 151.15 25.33 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.506 1.05 . . . . 0.0 111.924 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.5 p 63.82 171.99 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.014 2.126 . . . . 0.0 112.657 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.55 159.89 30.24 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.012 2.475 . . . . 0.0 111.097 172.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.08 71.83 0.19 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.415 ' HB2' ' CB ' ' A' ' 91' ' ' HIS . . . -69.36 -16.52 63.55 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 118.142 -0.933 . . . . 0.0 112.575 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.54 125.12 38.99 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.322 1.849 . . . . 0.0 112.297 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.0 mtt85 -135.18 137.47 42.72 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.893 0.877 . . . . 0.0 113.115 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.9 m -103.07 145.3 12.56 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 176.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.262 91.7 t -134.73 133.99 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -176.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.7 pt -126.72 165.84 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -87.9 157.16 19.04 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 126.16 1.784 . . . . 0.0 109.79 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.377 8.2 t -79.73 56.06 2.18 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 -177.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -157.47 -87.07 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 100.785 -3.783 . . . . 0.0 100.785 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.45 1.85 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -83.91 127.1 33.61 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -64.35 127.87 33.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.325 1.05 . . . . 0.0 108.537 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.36 -44.89 8.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.563 0.745 . . . . 0.0 109.99 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.67 175.32 42.09 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.173 -0.537 . . . . 0.0 114.108 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.54 121.85 21.56 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 127.123 2.169 . . . . 0.0 106.166 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.3 pt -128.16 161.19 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.478 1.111 . . . . 0.0 110.243 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 t -157.91 159.81 36.95 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 74' ' ' ALA . 21.8 m170 -78.45 -24.09 46.22 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.4 m -61.56 108.07 0.91 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.793 0.837 . . . . 0.0 110.863 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.54 -15.71 19.67 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.818 1.199 . . . . 0.0 112.323 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.93 163.73 26.89 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.409 1.083 . . . . 0.0 111.8 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.8 t -104.05 52.03 0.77 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.957 1.303 . . . . 0.0 109.6 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 143.24 -147.67 19.14 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.796 1.189 . . . . 0.0 110.752 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -79.61 -14.84 58.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.496 1.119 . . . . 0.0 111.367 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -60.09 167.64 2.25 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 123.779 0.832 . . . . 0.0 110.919 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -106.71 159.66 16.05 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.437 1.095 . . . . 0.0 112.85 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 m -134.85 165.46 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 127.046 2.138 . . . . 0.0 106.399 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.14 138.01 13.91 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 122.984 0.326 . . . . 0.0 113.39 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.3 m -85.13 -174.37 5.21 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -77.44 121.33 23.67 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.745 -0.597 . . . . 0.0 110.648 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.03 66.2 1.59 Allowed Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.387 0.994 . . . . 0.0 110.789 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.4 t -139.31 29.37 2.21 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.984 1.314 . . . . 0.0 112.198 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 C--O 1.251 1.168 0 C-N-CA 127.68 2.392 . . . . 0.0 110.268 -179.13 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.5 p . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.08 147.29 35.41 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.473 1.109 . . . . 0.0 109.76 178.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.1 p -121.57 119.22 31.28 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 123.137 0.575 . . . . 0.0 110.239 -178.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.18 108.29 13.14 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 100.313 -3.958 . . . . 0.0 100.313 177.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.9 110.16 13.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.724 0.409 . . . . 0.0 110.242 -178.053 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.12 -82.71 0.75 Allowed Glycine 0 C--N 1.339 0.746 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.2 t -156.99 45.77 0.4 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.642 1.177 . . . . 0.0 108.874 179.057 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 m -141.39 96.92 3.06 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -85.68 139.05 31.69 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.71 1.604 . . . . 0.0 110.932 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -137.89 137.15 37.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.079 1.352 . . . . 0.0 108.271 178.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.5 m -70.58 149.18 47.35 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.29 -21.55 5.69 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.2 m -71.0 -47.66 57.54 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.153 0.981 . . . . 0.0 109.267 179.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.79 -38.04 85.74 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.81 -51.06 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.8 ttt-85 -64.19 -36.09 82.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.726 1.61 . . . . 0.0 111.785 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.29 -50.5 46.16 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.051 0.541 . . . . 0.0 109.908 179.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.58 -41.72 81.71 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.325 1.05 . . . . 0.0 110.213 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.91 -46.19 54.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -61.21 -21.81 64.19 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.64 -59.64 2.54 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -177.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.88 -32.54 53.61 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.817 0.698 . . . . 0.0 110.945 178.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.25 -53.84 42.7 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -56.44 -38.85 72.18 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.787 0.435 . . . . 0.0 110.549 178.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -74.38 -3.31 29.67 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 126.589 1.956 . . . . 0.0 113.147 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -134.41 17.84 3.67 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -99.3 -80.55 0.47 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.957 1.253 . . . . 0.0 108.823 179.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -157.97 17.2 0.24 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.245 1.018 . . . . 0.0 112.846 -179.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -122.3 67.7 0.94 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 77.1 116.53 0.06 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 127.406 2.283 . . . . 0.0 105.294 -177.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -96.03 -58.08 2.18 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 124.157 0.983 . . . . 0.0 112.159 -177.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 50.83 82.41 0.06 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.831 1.252 . . . . 0.0 112.534 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -112.75 33.09 5.81 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.768 1.651 . . . . 0.0 110.805 -179.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.7 m -149.24 65.08 1.02 Allowed 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.297 1.439 . . . . 0.0 107.212 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.6 p -161.33 -167.77 1.85 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.316 1.046 . . . . 0.0 108.765 -178.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.4 p -85.93 58.04 4.82 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 74.35 147.53 0.12 Allowed Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 126.885 2.074 . . . . 0.0 110.443 179.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.66 137.57 46.7 Favored 'Cis proline' 0 C--N 1.349 0.558 0 CA-C-N 119.73 0.939 . . . . 0.0 113.725 2.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -134.98 168.58 18.85 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.801 2.04 . . . . 0.0 110.216 -179.128 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.4 m -74.08 140.06 45.06 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.596 1.958 . . . . 0.0 109.489 178.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.49 81.78 5.92 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.86 146.49 49.6 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 71.77 126.23 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.054 2.142 . . . . 0.0 111.174 -178.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -98.67 53.19 1.01 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.91 0.884 . . . . 0.0 109.476 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -153.6 56.81 0.75 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.708 1.203 . . . . 0.0 108.102 179.123 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.8 -55.58 0.23 Allowed Glycine 0 C--N 1.341 0.855 0 C-N-CA 125.725 1.631 . . . . 0.0 109.042 179.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.61 175.65 13.65 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.313 1.045 . . . . 0.0 109.52 178.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -90.52 136.63 32.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.873 1.269 . . . . 0.0 110.871 -178.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -150.87 103.51 3.02 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 178.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.63 58.03 6.23 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.125 3.217 . . . . 0.0 114.074 -177.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -145.37 -134.22 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 178.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -146.5 143.23 28.8 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.183 0.901 . . . . 0.0 109.225 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.74 -176.19 50.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.214 0.911 . . . . 0.0 111.892 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.23 160.89 93.41 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 CA-C-N 118.174 0.987 . . . . 0.0 110.693 -1.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -112.4 171.82 7.29 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.267 1.027 . . . . 0.0 110.289 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -132.56 137.31 47.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.169 1.388 . . . . 0.0 109.055 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -93.7 155.29 17.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.603 0.761 . . . . 0.0 110.323 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -160.21 102.55 1.39 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.12 119.94 4.81 Favored 'Trans proline' 0 N--CA 1.442 -1.532 0 C-N-CA 122.226 1.951 . . . . 0.0 109.789 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.547 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 6.2 tt -79.38 170.63 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 124.109 1.909 . . . . 0.0 111.349 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.547 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 14.1 tptm -140.49 149.11 42.1 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 109.468 -3.515 . . . . 0.0 111.641 -178.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.4 m -89.48 60.28 5.12 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.129 1.771 . . . . 0.0 109.267 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.03 -55.79 0.03 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.29 -167.82 36.75 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.6 158.83 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.679 1.192 . . . . 0.0 110.899 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.18 -173.37 4.17 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.352 1.461 . . . . 0.0 108.341 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.2 t -160.36 33.11 0.17 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.752 1.221 . . . . 0.0 110.069 178.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -141.9 -24.38 0.21 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.824 1.202 . . . . 0.0 113.024 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.96 -143.86 49.01 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.643 1.222 . . . . 0.0 111.827 179.377 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.1 t 63.11 102.33 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.421 1.888 . . . . 0.0 111.975 179.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.85 161.7 29.68 Favored 'Cis proline' 0 C--N 1.349 0.567 0 CA-C-N 119.981 1.029 . . . . 0.0 113.619 -3.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.78 41.35 1.88 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.864 -0.964 . . . . 0.0 113.546 -179.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.406 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -88.54 -73.28 0.5 Allowed 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -60.99 112.92 2.26 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.603 1.161 . . . . 0.0 111.147 179.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -132.22 161.01 34.48 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -178.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 m -132.88 142.11 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 101.16 -3.644 . . . . 0.0 101.16 175.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.9 t -138.24 120.13 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -176.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -102.54 173.12 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.115 0 C-N-CA 125.85 1.66 . . . . 0.0 110.15 -178.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -88.56 161.06 17.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 103.184 -2.895 . . . . 0.0 103.184 176.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.366 13.4 t -57.09 -22.54 40.29 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 -177.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -85.97 -75.46 0.38 Allowed 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.62 -1.84 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -176.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -78.94 109.03 12.85 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -175.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -56.51 108.6 0.5 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.929 1.292 . . . . 0.0 109.228 -179.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.08 -60.05 2.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.604 1.162 . . . . 0.0 112.461 -177.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.8 175.57 46.39 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.62 146.12 52.04 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.424 1.089 . . . . 0.0 110.58 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.2 pt -143.61 171.37 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.292 1.037 . . . . 0.0 110.781 -178.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t -159.71 143.23 14.36 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 116.426 2.009 . . . . 0.0 116.426 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.406 ' HB2' ' CB ' ' A' ' 74' ' ' ALA 0.265 32.2 m170 -79.51 -29.36 41.53 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.094 174.542 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.2 -45.33 68.54 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.607 1.163 . . . . 0.0 113.666 -177.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -78.62 -21.9 68.14 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 124.047 0.832 . . . . 0.0 111.565 179.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.26 166.5 23.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.897 0.879 . . . . 0.0 112.003 -179.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.7 t -65.9 -36.02 82.23 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.158 0.983 . . . . 0.0 111.64 -179.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.53 -101.51 0.15 Allowed Glycine 0 C--N 1.341 0.808 0 CA-C-N 118.206 0.457 . . . . 0.0 112.26 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -79.58 -22.12 44.18 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.046 0.938 . . . . 0.0 113.017 -178.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -74.68 179.01 5.0 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.656 0.662 . . . . 0.0 110.584 179.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -119.41 159.03 24.99 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.563 1.545 . . . . 0.0 109.905 179.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.7 m -134.96 162.4 38.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 125.209 1.404 . . . . 0.0 107.542 177.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.44 147.94 30.41 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 116.311 -0.404 . . . . 0.0 113.51 -178.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 34.0 m -85.75 -173.91 4.87 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.309 1.444 . . . . 0.0 107.946 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.3 t -57.23 110.27 0.81 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.263 1.025 . . . . 0.0 111.841 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.95 34.2 76.38 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.939 1.256 . . . . 0.0 114.322 178.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 93.6 m -83.43 130.8 35.05 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 118.091 0.945 . . . . 0.0 109.169 179.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 117.238 -1.363 . . . . 0.0 108.927 179.438 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.4 t . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 120.722 0.296 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.53 147.02 0.06 Allowed 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 127.007 2.123 . . . . 0.0 112.227 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 t -159.66 156.3 27.61 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.87 121.23 18.11 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -178.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.4 m -103.28 91.04 3.91 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.28 -106.93 1.87 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.7 m -92.84 -33.32 14.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.527 1.131 . . . . 0.0 111.173 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 m -74.65 103.15 4.83 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.352 0.661 . . . . 0.0 110.275 -178.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -87.92 151.94 22.44 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.961 1.304 . . . . 0.0 111.684 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -142.54 134.23 26.77 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 123.481 0.713 . . . . 0.0 112.354 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.7 m -77.07 155.11 32.71 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.241 1.417 . . . . 0.0 107.465 177.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.82 -16.89 13.01 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 177.087 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -70.88 -43.29 68.71 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.871 0.868 . . . . 0.0 109.587 179.054 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -71.15 -47.3 58.65 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 123.932 0.893 . . . . 0.0 113.138 -179.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.4 t -60.1 -46.12 94.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -68.18 -40.84 82.15 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.84 1.256 . . . . 0.0 111.901 -179.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.98 -49.6 71.87 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.588 0.631 . . . . 0.0 110.021 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.33 -35.2 79.61 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.893 0.877 . . . . 0.0 111.563 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.21 -40.85 58.82 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 117.76 0.255 . . . . 0.0 111.661 179.12 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -65.38 -22.07 66.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.34 -61.73 1.91 Allowed 'General case' 0 C--N 1.348 0.505 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 -178.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -42.34 -47.54 4.9 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.097 1.359 . . . . 0.0 110.486 178.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.7 t -57.88 -66.61 0.45 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.767 1.627 . . . . 0.0 112.687 179.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -23.18 66.36 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.181 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -94.9 4.95 53.22 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.556 1.942 . . . . 0.0 113.413 -178.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -144.82 51.81 1.24 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.268 1.427 . . . . 0.0 110.63 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -95.13 -77.15 0.47 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 119.36 -0.352 . . . . 0.0 110.19 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 169.63 -65.4 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.683 1.593 . . . . 0.0 108.828 -178.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.25 69.79 7.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 111.22 116.19 0.0 OUTLIER 'General case' 0 C--O 1.231 0.102 0 C-N-CA 131.033 3.733 . . . . 0.0 106.743 -179.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.48 -63.95 0.3 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.483 1.113 . . . . 0.0 109.982 -178.741 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 66.52 163.35 0.18 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.562 1.545 . . . . 0.0 112.453 -179.186 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.93 106.7 0.15 Allowed Glycine 0 C--N 1.341 0.811 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -178.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m -139.1 57.21 1.67 Allowed 'General case' 0 C--N 1.34 0.173 0 CA-C-N 117.696 0.748 . . . . 0.0 112.149 -178.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -100.02 -75.93 0.56 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 177.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.261 3.6 t -160.23 26.56 0.17 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.682 1.593 . . . . 0.0 109.823 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.41 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -171.3 129.78 0.73 Allowed Pre-proline 0 C--N 1.349 0.548 0 C-N-CA 128.307 2.643 . . . . 0.0 106.872 178.329 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.6 132.3 25.84 Favored 'Cis proline' 0 N--CA 1.45 -1.083 0 N-CA-C 108.354 -1.441 . . . . 0.0 108.354 -2.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.3 158.17 43.88 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.874 0.47 . . . . 0.0 109.76 -179.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.4 m -55.64 130.97 45.24 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 125.97 1.708 . . . . 0.0 110.584 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -79.8 121.24 25.13 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.347 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -146.63 177.87 8.74 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.26 1.024 . . . . 0.0 110.514 -179.139 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 t30 59.13 73.27 0.49 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.259 1.424 . . . . 0.0 108.565 -178.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -82.01 91.23 6.58 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.051 0.94 . . . . 0.0 110.853 -178.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -62.08 -50.51 71.66 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -169.74 42.4 0.21 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 178.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -150.73 143.48 24.54 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 123.557 0.743 . . . . 0.0 112.159 -179.283 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -161.6 179.63 8.03 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.836 2.054 . . . . 0.0 107.677 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -137.93 119.33 10.58 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.84 74.37 5.26 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.981 3.121 . . . . 0.0 112.45 -178.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.26 -90.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.405 1.082 . . . . 0.0 108.714 178.517 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -145.93 -78.72 0.18 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-N 119.215 0.916 . . . . 0.0 110.228 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.22 -175.06 35.97 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.632 1.11 . . . . 0.0 111.045 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.25 140.33 32.48 Favored 'Cis proline' 0 N--CA 1.458 -0.59 0 CA-C-N 118.796 1.298 . . . . 0.0 110.422 1.031 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.38 172.27 11.91 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.954 0.902 . . . . 0.0 110.351 -178.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -153.9 137.82 16.29 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.064 0.459 . . . . 0.0 111.834 -178.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.55 143.81 30.8 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.697 1.599 . . . . 0.0 112.626 -178.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -154.48 113.85 2.44 Favored Pre-proline 0 C--N 1.342 0.251 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 178.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.41 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 17.6 Cg_endo -81.12 144.54 14.87 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 121.79 1.66 . . . . 0.0 114.389 -175.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.543 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -117.12 -171.64 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-O 124.671 2.176 . . . . 0.0 113.125 179.419 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.543 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -162.41 -175.47 4.54 Favored 'General case' 0 C--N 1.318 -0.796 2 CA-C-N 108.05 -4.159 . . . . 0.0 107.443 -178.656 . . . . . . . . 4 4 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.3 m -92.81 61.27 3.54 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.54 58.88 0.99 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -178.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.27 61.13 0.17 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.02 116.86 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.426 0.691 . . . . 0.0 111.206 -179.35 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.6 t80 53.64 65.64 1.46 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.248 1.419 . . . . 0.0 111.248 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.6 p -138.12 77.57 1.64 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.246 1.018 . . . . 0.0 110.825 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.95 99.92 0.07 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.738 0.685 . . . . 0.0 113.262 178.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.74 -174.35 49.31 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.2 m 56.8 86.63 0.16 Allowed Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 125.318 1.447 . . . . 0.0 111.602 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -62.72 142.6 42.14 Favored 'Cis proline' 0 N--CA 1.459 -0.505 0 CA-C-N 119.322 0.794 . . . . 0.0 112.76 -0.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.85 48.09 0.49 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.29 -55.6 8.82 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.693 0.797 . . . . 0.0 109.455 179.267 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -61.93 118.61 7.47 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.436 1.894 . . . . 0.0 112.843 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -143.37 126.91 16.89 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.0 m -92.9 148.05 4.98 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 177.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.6 t -137.06 131.81 46.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 pt -119.92 -175.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.394 0 C-N-CA 124.365 1.066 . . . . 0.0 112.301 -178.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -96.74 153.64 17.75 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 127.009 2.123 . . . . 0.0 106.071 177.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.6 t -67.31 -1.4 4.55 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 -178.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -93.29 -75.31 0.5 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 178.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -164.39 -12.04 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -179.094 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.72 132.82 36.28 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 -174.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -62.24 125.24 23.21 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.8 -42.41 8.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.2 1.0 . . . . 0.0 109.463 -178.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.18 -165.07 38.16 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.86 140.61 25.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.698 1.599 . . . . 0.0 107.678 179.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.8 pt -142.56 165.87 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.091 1.356 . . . . 0.0 109.129 -178.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.3 t -159.33 150.83 20.23 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.19 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -79.13 -9.8 59.65 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 175.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 54.1 m -66.16 112.0 3.7 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.477 1.111 . . . . 0.0 109.12 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.91 34.38 42.86 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.952 0.787 . . . . 0.0 111.669 -179.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.43 -21.2 11.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.21 1.404 . . . . 0.0 111.386 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.6 m 70.05 85.12 0.14 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 126.185 1.794 . . . . 0.0 110.639 179.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.91 -146.77 17.95 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.702 1.144 . . . . 0.0 111.359 179.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -80.0 3.61 19.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.681 1.192 . . . . 0.0 112.913 -179.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -68.28 -174.85 0.55 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.876 1.27 . . . . 0.0 111.594 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -140.7 157.56 45.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.81 0.844 . . . . 0.0 112.503 -178.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 m -143.94 163.29 15.18 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 127.095 2.158 . . . . 0.0 106.955 177.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.27 153.35 26.41 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 123.53 0.586 . . . . 0.0 113.302 -178.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -84.13 -179.85 7.32 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.27 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.9 t -79.53 122.69 26.79 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.351 -0.843 . . . . 0.0 112.219 -178.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.64 36.39 92.59 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.726 1.155 . . . . 0.0 112.361 179.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.5 t -80.05 146.69 31.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.0 p30 . . . . . 0 C--O 1.252 1.191 0 C-N-CA 125.397 1.479 . . . . 0.0 109.741 -179.031 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 CA--C 1.529 0.154 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -44.46 117.97 1.42 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.984 1.313 . . . . 0.0 110.764 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.51 121.87 41.78 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 124.964 1.306 . . . . 0.0 110.41 -178.124 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -119.07 92.14 3.73 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 100.285 -3.968 . . . . 0.0 100.285 177.126 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.8 m -98.93 91.13 4.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.982 0.913 . . . . 0.0 111.455 -177.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.72 -81.68 0.63 Allowed Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.979 1.276 . . . . 0.0 110.759 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.3 t -145.07 23.92 1.49 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.813 1.245 . . . . 0.0 110.339 179.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 m -129.29 102.01 6.25 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 179.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -95.18 151.72 18.98 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.347 0.659 . . . . 0.0 111.967 -178.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.26 155.69 41.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.01 1.324 . . . . 0.0 109.543 178.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.0 p -75.77 154.2 36.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.509 1.523 . . . . 0.0 110.352 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.5 -21.19 59.81 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 176.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.7 t -71.09 -41.22 70.91 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 124.648 1.179 . . . . 0.0 109.892 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -66.78 -39.83 87.94 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 118.65 0.659 . . . . 0.0 111.09 178.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.42 -50.68 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 123.741 0.816 . . . . 0.0 109.13 178.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -62.76 -39.14 93.24 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 123.71 0.804 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.6 -47.13 76.75 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.41 -31.24 72.34 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.56 0.744 . . . . 0.0 111.211 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.87 -42.52 24.06 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 178.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -68.4 -20.39 64.67 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.96 -65.42 1.01 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 104.33 -2.471 . . . . 0.0 104.33 -178.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -41.23 -53.68 3.12 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 124.708 1.255 . . . . 0.0 110.125 176.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 t -49.96 -61.87 1.9 Allowed 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.853 1.661 . . . . 0.0 113.319 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -61.55 -51.43 68.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.118 0.567 . . . . 0.0 111.458 -178.054 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -63.07 -28.6 70.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.722 1.209 . . . . 0.0 112.041 -177.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -71.92 -56.02 6.44 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.102 0.961 . . . . 0.0 109.557 179.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -60.25 -36.86 78.74 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.031 0.932 . . . . 0.0 110.994 -179.079 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -73.69 -35.88 65.23 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.311 0.645 . . . . 0.0 110.683 178.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 68.48 51.05 0.67 Allowed 'General case' 0 C--N 1.344 0.362 0 C-N-CA 126.09 1.756 . . . . 0.0 109.813 -178.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -172.56 -165.55 0.33 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.818 2.047 . . . . 0.0 107.823 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.36 8.8 t 49.65 51.79 15.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.871 2.069 . . . . 0.0 113.682 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.94 99.65 0.08 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.827 2.051 . . . . 0.0 107.081 178.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.91 33.31 3.1 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.033 0.825 . . . . 0.0 113.567 -178.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -78.49 -73.09 0.34 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -167.27 -72.71 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.79 2.036 . . . . 0.0 105.925 179.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.3 t -152.21 14.78 0.61 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.298 1.039 . . . . 0.0 111.557 178.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -76.95 130.79 74.69 Favored Pre-proline 0 C--N 1.346 0.421 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.54 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -69.89 121.25 5.32 Favored 'Cis proline' 0 N--CA 1.455 -0.738 0 N-CA-C 115.938 1.476 . . . . 0.0 115.938 -0.002 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -115.19 161.12 18.87 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.497 1.919 . . . . 0.0 106.053 178.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 t -52.31 143.04 15.66 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -118.31 152.64 35.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.198 1.399 . . . . 0.0 107.75 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 177.46 -65.04 0.01 OUTLIER 'General case' 0 C--O 1.231 0.082 0 C-N-CA 124.912 1.285 . . . . 0.0 108.848 -178.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 m120 53.05 44.59 30.2 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.811 1.644 . . . . 0.0 110.026 -179.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 59.38 -98.98 0.09 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.206 1.802 . . . . 0.0 109.287 -178.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -134.34 68.76 1.47 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.013 1.325 . . . . 0.0 107.792 178.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.05 -73.53 0.91 Allowed Glycine 0 C--N 1.341 0.859 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.209 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.29 116.73 12.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -141.19 121.31 13.78 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.851 0.86 . . . . 0.0 108.881 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -88.31 178.6 2.02 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 125.428 1.491 . . . . 0.0 107.985 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.66 -72.04 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.011 2.474 . . . . 0.0 111.113 178.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.416 ' CG1' ' ND2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER 41.77 -150.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 127.319 2.247 . . . . 0.0 114.197 178.546 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -124.23 -57.03 1.61 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.958 2.103 . . . . 0.0 107.797 178.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.84 129.93 6.7 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.648 -1.084 . . . . 0.0 111.153 179.217 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.17 -177.89 9.67 Favored 'Cis proline' 0 C--N 1.35 0.651 0 CA-C-N 119.813 1.807 . . . . 0.0 114.635 -0.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.86 163.36 38.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 128.716 2.807 . . . . 0.0 106.315 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -132.33 152.26 51.49 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.9 161.8 15.05 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -161.12 95.51 1.39 Allowed Pre-proline 0 N--CA 1.455 -0.203 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -67.69 132.26 26.43 Favored 'Trans proline' 0 N--CA 1.438 -1.744 0 CA-C-N 120.82 1.328 . . . . 0.0 112.727 -178.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.62 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.3 tt -101.81 179.33 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 123.93 1.824 . . . . 0.0 111.707 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.62 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 10.4 mttm -160.99 157.73 26.79 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 109.08 -3.691 . . . . 0.0 111.51 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.9 p -88.41 59.89 5.41 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.813 1.245 . . . . 0.0 111.234 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.11 31.0 0.13 Allowed Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.302 -0.721 . . . . 0.0 111.621 178.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.01 179.97 28.82 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.922 0.772 . . . . 0.0 112.056 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.8 p -73.64 131.15 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.094 1.358 . . . . 0.0 111.545 -179.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 41.8 t80 39.04 82.48 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.359 2.263 . . . . 0.0 114.09 178.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.2 t -160.59 125.3 3.72 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.104 0.961 . . . . 0.0 109.422 178.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 162.46 -83.16 0.12 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 154.16 -58.4 0.4 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.3 m -138.29 93.15 11.63 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.181 0.992 . . . . 0.0 110.518 -178.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -49.45 139.0 30.23 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 124.11 3.207 . . . . 0.0 111.565 169.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.14 -21.02 2.38 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 118.259 -1.301 . . . . 0.0 115.162 -178.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -151.94 -60.14 0.16 Allowed 'General case' 0 C--N 1.345 0.374 0 CA-C-N 119.657 1.729 . . . . 0.0 114.454 -178.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.42 117.52 12.06 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -177.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -146.0 125.67 13.38 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.422 0.689 . . . . 0.0 112.036 178.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.6 148.49 4.53 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.09 137.71 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.3 pt -117.42 -177.62 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.803 1.641 . . . . 0.0 112.143 -178.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.416 ' ND2' ' CG1' ' A' ' 52' ' ' VAL . 4.6 m120 -83.65 178.55 7.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 129.397 3.079 . . . . 0.0 107.118 178.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.1 t -90.71 24.76 2.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -140.57 -65.21 0.45 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 177.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -163.27 -21.03 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 118.741 2.867 . . . . 0.0 118.741 -177.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -79.82 150.2 30.77 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -175.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -75.44 134.52 40.85 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.149 1.78 . . . . 0.0 108.296 178.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.22 -53.7 2.86 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.942 0.897 . . . . 0.0 110.248 -179.357 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.91 152.11 10.95 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.15 127.67 53.02 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.377 1.471 . . . . 0.0 107.551 178.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.0 pt -132.19 157.59 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.457 1.103 . . . . 0.0 109.969 -178.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.4 t -158.07 151.8 23.75 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -179.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -80.21 -20.57 44.37 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.562 0.539 . . . . 0.0 110.509 174.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.0 m -49.01 -59.64 3.44 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 126.182 1.793 . . . . 0.0 112.714 -178.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.02 -27.45 70.37 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 123.846 0.736 . . . . 0.0 111.96 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.02 172.35 5.72 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.211 1.004 . . . . 0.0 112.27 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.3 t -60.79 -54.8 40.7 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.448 1.099 . . . . 0.0 111.564 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.68 -88.39 0.07 OUTLIER Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.428 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -80.23 -24.1 40.41 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.978 0.911 . . . . 0.0 112.001 -179.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -68.71 -178.18 1.12 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.518 1.127 . . . . 0.0 112.268 -178.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -128.17 160.46 31.97 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.524 1.529 . . . . 0.0 112.031 -179.007 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 m -148.27 161.25 6.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 126.747 2.019 . . . . 0.0 106.917 177.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.1 161.39 27.85 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 p -147.63 160.68 42.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.2 1.8 . . . . 0.0 109.4 178.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.2 t 70.51 58.76 0.23 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.046 1.738 . . . . 0.0 110.684 -178.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.59 28.74 70.26 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.306 -179.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.2 m -113.79 106.24 14.24 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.215 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.3 t30 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 116.851 -1.547 . . . . 0.0 109.822 179.704 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.6 p . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.83 152.05 45.28 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.706 0.802 . . . . 0.0 109.406 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 t -146.53 136.97 23.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.73 0.3 . . . . 0.0 111.705 -179.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.06 113.08 25.5 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.224 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.1 m -98.54 75.27 2.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.8 -84.11 1.59 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.0 m -123.44 -29.49 3.79 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.352 1.461 . . . . 0.0 110.816 179.112 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -71.73 98.04 1.87 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -79.56 141.58 36.49 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.138 1.375 . . . . 0.0 110.578 -178.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -137.14 129.01 29.04 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.325 1.05 . . . . 0.0 109.547 178.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.1 m -68.98 155.1 40.92 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.88 1.272 . . . . 0.0 108.652 178.209 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.71 -22.62 57.93 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 176.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.8 t -71.13 -37.74 72.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.034 0.934 . . . . 0.0 109.683 179.228 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -75.32 -44.89 42.88 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.102 1.361 . . . . 0.0 113.57 -178.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.2 t -60.48 -48.02 90.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -43.26 74.37 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 123.765 0.826 . . . . 0.0 112.258 -179.187 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.18 -47.24 85.37 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.301 0.376 . . . . 0.0 110.69 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.6 94.57 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.712 0.805 . . . . 0.0 109.566 -179.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.91 -27.86 60.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -71.51 -23.47 61.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.03 -58.03 3.26 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -179.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -44.28 -44.6 8.15 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.48 1.512 . . . . 0.0 111.002 176.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -62.9 -52.56 62.61 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.163 0.985 . . . . 0.0 109.862 178.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -61.14 -22.22 64.48 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.445 0.698 . . . . 0.0 112.182 179.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -99.74 7.4 45.1 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.898 1.679 . . . . 0.0 110.735 179.328 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -151.31 63.89 0.89 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.587 1.184 . . . . 0.0 108.51 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -100.59 -39.88 7.68 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 113.532 -1.667 . . . . 0.0 112.16 178.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -139.05 48.41 1.88 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.876 0.871 . . . . 0.0 111.062 -179.048 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 p30 46.46 41.75 9.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.584 1.954 . . . . 0.0 114.61 178.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -138.94 123.74 18.69 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 103.347 -2.834 . . . . 0.0 103.347 178.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 p -109.54 -84.09 0.55 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -176.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 163.24 97.57 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 128.394 2.677 . . . . 0.0 104.184 -178.139 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.5 -48.22 3.09 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -178.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m 59.17 71.64 0.57 Allowed 'General case' 0 C--N 1.345 0.402 0 C-N-CA 125.344 1.458 . . . . 0.0 110.267 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.3 t 179.68 -42.3 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.992 2.117 . . . . 0.0 107.238 -178.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.3 t -79.91 12.32 2.79 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.96 1.704 . . . . 0.0 112.667 179.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 71.94 136.57 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.792 1.637 . . . . 0.0 108.717 179.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.35 163.41 89.95 Favored 'Cis proline' 0 N--CA 1.449 -1.143 0 CA-C-N 119.616 0.899 . . . . 0.0 113.979 2.476 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -166.46 151.75 8.16 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 127.06 2.144 . . . . 0.0 107.131 178.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 t -52.0 155.66 1.78 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -178.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -138.36 99.01 3.73 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.345 2.258 . . . . 0.0 106.738 -179.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -131.04 153.65 49.05 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.28 1.032 . . . . 0.0 111.747 -178.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 54.47 32.22 16.3 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.873 2.069 . . . . 0.0 113.612 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -123.62 75.96 1.38 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -77.85 -1.46 31.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.413 1.085 . . . . 0.0 112.722 179.353 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.83 -43.34 96.64 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 124.346 0.975 . . . . 0.0 111.964 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.47 66.8 1.32 Allowed 'General case' 0 C--N 1.341 0.221 0 CA-C-O 121.658 0.742 . . . . 0.0 109.403 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -87.57 -175.16 5.1 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.632 1.173 . . . . 0.0 112.968 -178.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -141.3 143.58 31.02 Favored Pre-proline 0 N--CA 1.454 -0.226 0 C-N-CA 126.699 1.999 . . . . 0.0 106.73 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.14 -87.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.837 2.358 . . . . 0.0 110.272 179.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.1 t 31.23 -102.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 128.046 2.538 . . . . 0.0 113.358 178.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -167.76 115.43 0.75 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.246 1.019 . . . . 0.0 109.57 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.06 170.98 50.14 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.69 170.71 64.7 Favored 'Cis proline' 0 N--CA 1.459 -0.533 0 CA-C-N 118.645 1.223 . . . . 0.0 112.423 -0.147 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -130.5 170.84 13.7 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.92 1.288 . . . . 0.0 109.868 -178.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -149.99 148.5 29.13 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.172 0.989 . . . . 0.0 109.731 179.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -79.54 155.08 28.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.044 2.537 . . . . 0.0 112.369 -177.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -160.51 102.1 1.35 Allowed Pre-proline 0 N--CA 1.454 -0.258 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -78.79 126.36 7.25 Favored 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 121.786 1.658 . . . . 0.0 111.632 -176.422 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 tp -79.2 164.41 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 123.845 1.783 . . . . 0.0 113.186 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -142.93 145.55 33.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 109.316 -3.584 . . . . 0.0 110.752 -178.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.8 p -85.34 57.65 4.58 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.068 1.347 . . . . 0.0 108.421 179.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.59 -44.23 0.03 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -178.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.62 -132.59 2.18 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 117.788 0.794 . . . . 0.0 111.822 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -77.77 167.29 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.961 1.704 . . . . 0.0 110.3 -179.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -65.01 141.96 58.59 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 118.406 0.548 . . . . 0.0 110.965 -179.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -130.78 120.72 24.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.229 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.69 -66.17 3.58 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.271 0.939 . . . . 0.0 111.74 179.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.32 -115.56 1.76 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 -179.261 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.15 -178.76 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.61 1.164 . . . . 0.0 111.067 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.71 159.55 4.77 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.411 2.741 . . . . 0.0 113.34 172.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.59 82.49 0.05 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 -178.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.95 -35.87 35.79 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.477 1.111 . . . . 0.0 113.487 -178.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -74.96 118.48 17.97 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.564 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -144.57 133.65 22.77 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -178.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.8 m -100.12 145.83 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 176.133 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -130.81 136.49 58.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -177.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.0 pt -116.08 174.07 3.53 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 C-N-CA 125.066 1.346 . . . . 0.0 113.512 -178.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -99.99 162.67 12.84 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.885 2.074 . . . . 0.0 107.735 178.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.379 5.7 t -79.09 32.69 0.22 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 118.993 2.961 . . . . 0.0 118.993 -177.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.31 -85.62 0.63 Allowed 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 176.377 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.7 t -162.98 -6.31 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.12 1.768 . . . . 0.0 114.848 179.281 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -79.0 139.14 38.26 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.466 1.03 . . . . 0.0 112.984 -176.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -81.78 121.21 26.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.444 1.898 . . . . 0.0 106.522 178.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.72 -59.27 2.8 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 123.548 0.739 . . . . 0.0 111.691 -178.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.52 154.28 13.01 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.703 -0.76 . . . . 0.0 114.098 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.96 124.77 37.17 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.491 1.516 . . . . 0.0 109.399 179.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.5 pt -131.09 159.7 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 125.296 1.438 . . . . 0.0 108.414 -179.334 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.8 t -154.07 154.22 33.26 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.273 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -79.42 11.34 3.05 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 176.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.4 m -56.38 -69.66 0.14 Allowed 'General case' 0 C--N 1.343 0.316 0 CA-C-N 120.135 1.334 . . . . 0.0 112.449 -178.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.26 3.42 72.29 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.369 0.985 . . . . 0.0 112.965 -179.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.34 159.45 33.32 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.993 0.917 . . . . 0.0 111.365 179.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.5 t -69.45 -46.48 66.62 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.64 0.776 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -161.94 -86.73 0.06 OUTLIER Glycine 0 C--N 1.34 0.761 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -91.67 15.27 13.03 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.216 1.006 . . . . 0.0 111.296 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -91.17 -168.17 1.99 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.892 1.277 . . . . 0.0 109.727 -179.401 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -147.24 159.44 43.65 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.903 0.881 . . . . 0.0 112.201 -178.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.4 m -138.52 165.62 24.52 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 126.959 2.104 . . . . 0.0 107.21 177.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.71 138.58 14.33 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 123.566 0.603 . . . . 0.0 113.492 -178.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.7 m -84.81 -169.54 2.69 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.269 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -69.97 134.36 48.26 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.954 -0.466 . . . . 0.0 110.791 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.66 34.57 72.97 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.4 m -149.08 104.61 3.44 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.5 t30 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 116.873 -1.537 . . . . 0.0 109.454 179.446 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.2 p . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 67.13 163.97 0.2 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.8 2.04 . . . . 0.0 111.687 -179.202 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 t -156.32 128.52 7.51 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.98 115.37 29.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 178.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 23.1 m -101.06 72.82 1.49 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.777 1.631 . . . . 0.0 107.511 -179.048 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.02 -90.82 0.8 Allowed Glycine 0 C--N 1.34 0.754 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.3 t -106.53 -36.86 6.64 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.078 1.351 . . . . 0.0 110.416 179.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.7 m -71.39 112.96 7.94 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.616 0.766 . . . . 0.0 110.003 -179.15 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -92.29 147.39 22.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.093 0.957 . . . . 0.0 110.782 -179.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -142.08 122.23 13.81 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.778 1.231 . . . . 0.0 108.345 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.2 m -69.45 155.84 39.81 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 125.443 1.497 . . . . 0.0 110.163 178.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.9 -18.78 47.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.069 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.4 p -77.81 -39.48 43.61 Favored 'General case' 0 C--N 1.345 0.382 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -68.72 -45.97 70.15 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.278 1.031 . . . . 0.0 111.457 179.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 51.5 t -60.08 -49.78 82.71 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.095 0 C-N-CA 124.22 1.008 . . . . 0.0 109.242 179.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -63.6 -46.81 84.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.92 0.888 . . . . 0.0 111.434 -178.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.13 -52.57 58.48 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.589 0.756 . . . . 0.0 111.048 -177.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.04 -41.57 83.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.75 -29.29 66.61 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 179.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -68.41 -26.11 65.37 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.9 -59.5 2.69 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -43.93 -44.52 7.17 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.138 1.375 . . . . 0.0 112.145 177.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.9 t -60.08 -53.83 53.17 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.15 1.38 . . . . 0.0 111.06 -179.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -66.91 -43.15 84.08 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -81.37 -2.57 49.8 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 127.103 2.161 . . . . 0.0 114.03 -178.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -60.29 -45.73 92.33 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 120.288 1.404 . . . . 0.0 110.611 179.051 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -57.59 -46.28 84.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.974 1.31 . . . . 0.0 110.886 -178.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -84.45 -16.55 42.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.185 1.394 . . . . 0.0 113.277 -178.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.7 t0 65.26 79.18 0.26 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.533 1.933 . . . . 0.0 107.867 -178.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 83.94 -163.09 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.467 2.307 . . . . 0.0 107.198 -178.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.7 p -36.97 -41.2 0.33 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.087 1.355 . . . . 0.0 108.954 177.069 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 156.6 90.09 0.0 OUTLIER 'General case' 0 C--N 1.345 0.373 0 C-N-CA 129.971 3.308 . . . . 0.0 108.819 177.143 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -141.14 -136.0 3.24 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.278 1.894 . . . . 0.0 110.983 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.5 p 177.52 111.79 0.03 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 125.293 1.437 . . . . 0.0 109.407 -178.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 m 89.68 -8.72 0.39 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 128.74 2.816 . . . . 0.0 114.233 178.047 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 t -82.52 3.8 27.01 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.602 0.637 . . . . 0.0 112.225 179.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 81.21 141.21 0.07 OUTLIER Pre-proline 0 C--N 1.347 0.462 0 C-N-CA 127.818 2.447 . . . . 0.0 109.734 178.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.06 144.11 74.3 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 N-CA-C 117.258 1.984 . . . . 0.0 117.258 2.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.78 161.52 34.64 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 127.583 2.353 . . . . 0.0 106.324 178.406 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.2 t -59.13 149.04 29.15 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.631 0.65 . . . . 0.0 111.52 -179.281 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -90.69 143.53 26.65 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.209 1.004 . . . . 0.0 109.325 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -65.15 -49.24 70.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.817 1.647 . . . . 0.0 112.959 -178.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 71.22 -168.02 0.15 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.125 1.37 . . . . 0.0 109.851 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 68.5 168.71 0.28 Allowed 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.76 1.624 . . . . 0.0 112.471 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 55.65 50.91 13.42 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -178.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.81 -159.08 34.15 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 108.154 -1.978 . . . . 0.0 108.154 -177.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 35.58 96.94 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 127.403 2.281 . . . . 0.0 116.853 179.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -158.83 143.03 15.55 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.0 0.92 . . . . 0.0 109.427 178.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -102.24 153.53 38.01 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.036 1.335 . . . . 0.0 108.728 -179.306 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -78.17 42.18 1.16 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 124.102 3.201 . . . . 0.0 112.518 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.5 m -149.11 152.59 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 126.683 1.993 . . . . 0.0 107.161 178.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -144.87 113.58 6.75 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.18 -57.02 3.08 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.18 -1.344 . . . . 0.0 112.689 -178.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -53.8 149.16 16.64 Favored 'Cis proline' 0 C--N 1.351 0.68 0 CA-C-N 120.586 2.193 . . . . 0.0 113.944 0.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -92.94 156.69 16.76 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.649 1.179 . . . . 0.0 111.286 -178.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.78 154.29 45.57 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.373 1.869 . . . . 0.0 115.378 -176.203 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -80.46 150.45 29.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.654 1.982 . . . . 0.0 110.002 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -160.02 99.38 1.46 Allowed Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.609 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -79.38 120.11 4.36 Favored 'Trans proline' 0 N--CA 1.442 -1.531 0 C-N-CA 122.114 1.876 . . . . 0.0 113.768 -176.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.677 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.9 tt -85.8 -178.81 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-O 123.845 1.783 . . . . 0.0 108.841 178.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.677 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 7.6 mmtt -160.43 139.91 10.92 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 109.788 -3.369 . . . . 0.0 111.466 -178.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.5 p -90.22 63.17 5.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.231 1.412 . . . . 0.0 107.309 178.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.87 -51.16 0.04 OUTLIER Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.222 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.18 177.98 35.52 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.27 104.93 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 39.6 p90 47.86 71.31 0.35 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.597 1.959 . . . . 0.0 112.343 -178.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.9 p -110.24 138.36 46.73 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.061 1.344 . . . . 0.0 109.273 179.306 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.36 -80.09 1.86 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.82 111.29 0.09 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.04 0.828 . . . . 0.0 111.615 179.262 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.9 m 64.93 90.66 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.719 1.607 . . . . 0.0 110.723 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.29 165.86 84.69 Favored 'Cis proline' 0 N--CA 1.457 -0.63 0 CA-C-N 119.323 0.794 . . . . 0.0 112.055 4.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.35 -67.48 0.02 OUTLIER Glycine 0 CA--C 1.525 0.716 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 80.1 -59.72 0.32 Allowed 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 127.928 2.491 . . . . 0.0 109.478 179.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -65.52 115.6 5.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -135.52 159.69 40.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 122.148 0.975 . . . . 0.0 112.481 178.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.0 m -130.42 147.64 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 102.326 -3.212 . . . . 0.0 102.326 176.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.4 t -127.83 108.85 18.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -177.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -98.75 175.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.413 1.085 . . . . 0.0 111.498 -177.227 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -96.42 146.7 24.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.069 1.748 . . . . 0.0 107.108 179.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.9 t -61.11 -10.01 5.58 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 117.563 2.431 . . . . 0.0 117.563 -178.129 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -86.32 -76.51 0.34 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 178.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.48 -7.89 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 -178.473 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -79.07 169.53 18.05 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 119.339 0.972 . . . . 0.0 111.653 -176.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -113.46 125.81 54.64 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.513 1.925 . . . . 0.0 108.848 179.238 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.62 -62.99 1.35 Allowed 'General case' 0 C--N 1.346 0.431 0 C-N-CA 123.463 0.705 . . . . 0.0 111.241 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.26 170.04 43.09 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.66 153.82 38.86 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 123.931 0.892 . . . . 0.0 113.395 -178.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.5 pt -142.7 161.24 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 127.04 2.136 . . . . 0.0 109.392 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.4 t -160.57 142.76 12.74 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -177.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -78.35 64.35 3.43 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-N 120.89 1.677 . . . . 0.0 108.679 173.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.7 t -95.94 -34.45 11.8 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.227 -0.921 . . . . 0.0 109.652 178.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.68 -59.32 0.27 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 178.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 64.82 177.61 0.19 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.152 1.781 . . . . 0.0 113.591 178.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.4 t -150.64 56.98 0.92 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.553 1.541 . . . . 0.0 107.158 179.129 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.47 -77.28 0.23 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 107.503 -2.239 . . . . 0.0 107.503 -178.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -144.5 45.91 1.4 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.556 1.143 . . . . 0.0 108.985 178.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -114.17 160.59 18.8 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.613 1.165 . . . . 0.0 111.092 -179.059 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -109.49 109.84 20.78 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.743 1.617 . . . . 0.0 107.467 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.2 m -79.41 161.14 4.2 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.15 143.56 29.76 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 116.439 1.336 . . . . 0.0 116.439 -177.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.9 t -121.86 163.62 18.91 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 177.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.2 t 61.8 37.01 15.85 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.025 0.93 . . . . 0.0 109.865 -176.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.13 33.69 85.17 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.473 1.035 . . . . 0.0 111.892 -178.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.4 m -81.42 137.31 35.68 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.211 1.004 . . . . 0.0 109.387 179.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 116.921 -1.514 . . . . 0.0 108.535 179.219 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 CA--C 1.532 0.282 0 CA-C-O 121.336 0.589 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 145.26 109.36 0.0 OUTLIER 'General case' 0 C--O 1.231 0.102 1 C-N-CA 132.274 4.23 . . . . 0.0 103.403 179.765 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -122.57 125.56 45.95 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.594 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.34 99.92 5.84 Favored 'General case' 0 N--CA 1.444 -0.774 1 N-CA-C 100.04 -4.059 . . . . 0.0 100.04 176.355 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -102.94 85.66 2.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.601 1.56 . . . . 0.0 109.23 -177.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.21 -77.48 1.36 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.7 p -130.6 -33.63 1.62 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.303 1.441 . . . . 0.0 111.633 179.402 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -74.15 101.9 4.09 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -92.67 152.37 19.58 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.933 1.293 . . . . 0.0 111.379 -178.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -150.09 137.5 19.75 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.693 1.597 . . . . 0.0 108.677 178.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.1 p -71.56 154.0 41.76 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.216 1.407 . . . . 0.0 109.554 179.189 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.33 -22.59 12.51 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.1 t -72.1 -45.08 62.03 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 124.13 0.972 . . . . 0.0 109.279 179.391 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -69.69 -34.48 74.0 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.816 0.847 . . . . 0.0 113.159 179.524 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 85' ' ' TYR . 33.0 t -64.63 -50.69 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.075 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -60.83 -44.24 97.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.791 1.636 . . . . 0.0 110.67 -178.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.03 -52.29 56.79 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.896 0.478 . . . . 0.0 110.439 -179.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.38 73.53 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.222 1.009 . . . . 0.0 111.053 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.91 -39.69 42.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.258 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -66.73 -22.3 66.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.76 -64.19 1.21 Allowed 'General case' 0 C--N 1.348 0.519 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 -178.158 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.3 -34.88 16.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.664 0.786 . . . . 0.0 112.322 177.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -59.9 4.68 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.877 1.271 . . . . 0.0 109.547 178.622 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -64.63 -21.08 66.63 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.119 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -94.19 -20.68 19.64 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.602 1.161 . . . . 0.0 112.532 -178.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.413 ' CD1' ' HG3' ' A' ' 57' ' ' GLN . 9.7 t80 -74.31 -33.29 63.16 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.309 0.959 . . . . 0.0 112.841 -179.173 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -62.27 -14.68 41.32 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -178.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 t30 72.93 69.99 0.13 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.665 1.586 . . . . 0.0 111.025 177.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -136.12 58.24 1.75 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 178.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.8 t70 74.56 163.17 0.26 Allowed 'General case' 0 C--N 1.345 0.386 0 C-N-CA 126.91 2.084 . . . . 0.0 107.69 -177.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.3 p 54.45 56.5 6.78 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -151.07 158.12 43.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.262 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.37 73.72 0.44 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.698 1.618 . . . . 0.0 112.489 -179.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.1 p -72.45 -65.37 0.79 Allowed 'General case' 0 C--N 1.341 0.234 0 CA-C-N 117.876 0.838 . . . . 0.0 109.806 179.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.3 m -137.07 -58.16 0.71 Allowed 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 125.235 1.414 . . . . 0.0 107.771 178.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.0 t -157.35 40.94 0.31 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.72 1.208 . . . . 0.0 109.671 178.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -170.55 124.43 0.62 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 127.539 2.336 . . . . 0.0 106.666 179.355 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.36 140.52 66.73 Favored 'Cis proline' 0 N--CA 1.449 -1.106 0 CA-C-N 121.453 1.555 . . . . 0.0 109.657 -2.753 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -155.47 155.62 33.81 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.972 0.909 . . . . 0.0 109.355 179.602 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.9 p -66.39 152.99 43.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.55 0.74 . . . . 0.0 110.741 179.226 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.44 121.22 6.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.909 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -95.64 177.93 5.63 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.162 0.985 . . . . 0.0 111.223 -178.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -78.89 96.05 5.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.497 1.119 . . . . 0.0 109.166 -179.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -80.93 -98.23 0.04 OUTLIER 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.379 0.672 . . . . 0.0 110.111 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -158.55 35.7 0.23 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.333 0.653 . . . . 0.0 111.342 -179.369 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.75 -153.7 9.15 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.077 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.99 69.38 6.35 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 123.463 0.705 . . . . 0.0 109.953 178.818 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -75.65 118.63 18.68 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 178.629 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.03 117.74 39.14 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 125.448 1.499 . . . . 0.0 111.048 -177.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -78.5 89.55 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.125 2.55 . . . . 0.0 109.834 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 t -135.16 -63.52 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.328 0 C-N-CA 123.871 0.868 . . . . 0.0 110.621 -178.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 p30 -148.32 -122.48 0.06 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.35 1.06 . . . . 0.0 110.344 -179.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.28 132.55 2.29 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 118.35 -1.25 . . . . 0.0 110.738 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -68.04 -166.25 2.65 Favored 'Cis proline' 0 CA--C 1.538 0.689 0 CA-C-N 120.108 1.954 . . . . 0.0 114.369 -1.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -145.45 173.52 11.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.52 1.928 . . . . 0.0 108.255 179.386 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.413 ' HG3' ' CD1' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -148.01 143.05 26.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.059 0.544 . . . . 0.0 110.825 179.31 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -100.31 148.78 24.3 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.941 1.296 . . . . 0.0 111.263 179.34 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -158.39 127.46 3.1 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -75.54 147.26 31.74 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 CA-C-N 120.522 1.222 . . . . 0.0 112.27 -176.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.683 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 3.8 tp -79.4 -161.76 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 123.438 1.59 . . . . 0.0 110.869 -178.455 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.683 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 12.2 tttm -78.62 -163.84 0.51 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 111.321 -2.672 . . . . 0.0 111.64 -178.376 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.2 p 91.48 39.78 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 130.456 3.503 . . . . 0.0 107.277 -177.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.07 -54.56 0.24 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 108.386 -1.886 . . . . 0.0 108.386 -178.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.25 157.72 10.43 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.222 0.439 . . . . 0.0 112.169 179.123 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.1 t -127.26 120.94 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.29 47.3 p90 58.17 43.36 20.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.581 2.352 . . . . 0.0 112.713 -177.935 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.4 t -148.83 -41.09 0.15 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.348 0.659 . . . . 0.0 111.194 -179.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.3 55.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.94 87.13 1.35 Allowed Glycine 0 C--N 1.339 0.749 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.0 m -59.28 142.55 86.24 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 123.929 0.892 . . . . 0.0 110.394 179.436 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.3 140.28 30.31 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.803 2.335 . . . . 0.0 108.482 176.501 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.64 -61.28 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 105.451 -3.06 . . . . 0.0 105.451 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -168.94 -55.82 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -178.656 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -62.95 109.84 1.59 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 117.959 2.577 . . . . 0.0 117.959 -177.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -129.41 153.87 47.49 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.764 0.825 . . . . 0.0 112.056 178.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.6 143.31 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 176.429 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 83.8 t -137.05 136.24 47.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -175.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.3 pt -121.69 -177.71 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.376 0 C-N-CA 124.537 1.135 . . . . 0.0 113.606 -177.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -80.93 -175.2 5.25 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.133 2.173 . . . . 0.0 109.375 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.281 8.3 t -85.41 27.68 0.8 Allowed 'General case' 0 C--N 1.342 0.24 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 -178.328 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -150.62 -67.3 0.19 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.109 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.25 -14.61 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -176.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -78.91 128.65 33.59 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -175.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.489 ' CE2' ' CG1' ' A' ' 16' ' ' VAL . 16.3 t80 -60.11 136.41 58.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.631 1.173 . . . . 0.0 111.093 -179.186 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.24 -61.84 1.5 Allowed 'General case' 0 C--N 1.345 0.397 0 C-N-CA 124.422 1.089 . . . . 0.0 111.972 -178.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.14 170.05 42.82 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.67 145.89 46.98 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 125.039 1.336 . . . . 0.0 110.021 178.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.28 162.63 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.352 1.061 . . . . 0.0 108.895 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 t -159.34 143.29 14.96 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -178.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -82.11 40.63 0.63 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -55.49 -31.32 61.92 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.946 -1.096 . . . . 0.0 113.224 -178.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.09 -69.61 0.02 OUTLIER Glycine 0 C--N 1.337 0.591 0 N-CA-C 106.614 -2.594 . . . . 0.0 106.614 178.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 50.67 -111.48 0.53 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.537 1.535 . . . . 0.0 111.546 178.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.1 m -157.13 77.3 0.87 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.456 1.502 . . . . 0.0 107.162 179.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.63 -105.34 2.39 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -101.61 22.93 11.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.333 1.053 . . . . 0.0 111.506 -179.351 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -89.86 177.46 6.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.502 0.721 . . . . 0.0 109.979 179.527 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -121.76 158.87 27.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.961 1.705 . . . . 0.0 110.899 -179.137 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.3 m -141.59 158.14 21.48 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.79 146.98 36.07 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.747 -178.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.2 t -89.5 -167.32 1.83 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.587 1.555 . . . . 0.0 107.274 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.8 m -63.66 121.27 13.52 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.749 0.419 . . . . 0.0 110.804 178.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.99 9.01 85.88 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.379 0.99 . . . . 0.0 113.917 179.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.5 m -91.93 137.57 32.26 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.434 1.117 . . . . 0.0 108.983 179.179 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 t30 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 116.458 -1.734 . . . . 0.0 110.915 179.333 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.56 141.71 0.05 Allowed 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 127.155 2.182 . . . . 0.0 111.163 -179.356 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -129.15 96.06 4.22 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.046 0.938 . . . . 0.0 111.48 -179.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -98.97 94.52 6.6 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 101.42 -3.548 . . . . 0.0 101.42 177.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 59.7 m -90.98 73.67 6.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.241 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.34 -99.67 1.73 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 -178.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.6 m -101.54 -39.43 7.52 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.29 1.436 . . . . 0.0 109.249 178.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.71 105.54 4.34 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.047 1.339 . . . . 0.0 108.555 -179.344 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -111.36 134.37 52.99 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.152 0.981 . . . . 0.0 112.481 -178.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.49 149.87 44.61 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.718 1.607 . . . . 0.0 107.186 178.514 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.0 m -72.72 155.24 40.18 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.317 1.047 . . . . 0.0 110.507 -179.018 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.1 -19.3 43.25 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 176.71 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.6 t -72.54 -40.79 66.45 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 124.954 1.302 . . . . 0.0 109.461 178.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -70.93 -35.23 72.15 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.029 0.532 . . . . 0.0 111.153 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.1 t -59.6 -48.31 87.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.643 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -65.74 -38.03 88.01 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.203 1.401 . . . . 0.0 111.431 179.51 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 -55.19 15.34 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 118.489 0.586 . . . . 0.0 110.168 -179.285 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.45 -31.3 70.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.073 0.949 . . . . 0.0 110.852 179.451 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.98 -44.78 46.34 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 118.905 -0.569 . . . . 0.0 111.558 179.032 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -60.62 -24.53 65.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.37 -51.53 10.67 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -178.451 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.81 -32.38 31.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.89 1.276 . . . . 0.0 110.886 177.125 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 64.3 m -70.8 -54.07 13.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.772 0.715 . . . . 0.0 110.536 178.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -58.56 -42.28 87.55 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.753 0.421 . . . . 0.0 111.162 -178.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -74.47 -44.2 52.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.485 1.114 . . . . 0.0 110.96 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 27' ' ' TYR . 2.1 t80 -55.23 -36.39 65.96 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.568 1.076 . . . . 0.0 108.789 179.034 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -71.33 -67.23 0.53 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 155.51 -6.34 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.904 2.481 . . . . 0.0 113.57 -179.068 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.01 56.02 1.9 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.738 1.153 . . . . 0.0 113.153 -178.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 138.36 115.77 0.0 OUTLIER 'General case' 0 C--N 1.344 0.349 1 C-N-CA 131.97 4.108 . . . . 0.0 108.525 178.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.3 p -95.95 63.9 2.36 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.687 0.795 . . . . 0.0 109.243 -179.462 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.39 -161.03 0.42 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.848 1.259 . . . . 0.0 110.53 -179.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 45.79 -120.47 4.43 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.394 1.949 . . . . 0.0 113.868 178.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.1 t -139.68 -92.01 0.17 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.04 0.936 . . . . 0.0 110.874 -179.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 m -161.93 -41.71 0.04 OUTLIER 'General case' 0 C--N 1.344 0.337 0 C-N-CA 124.174 0.99 . . . . 0.0 111.102 -178.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 64.2 p -79.78 37.33 0.35 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.511 1.124 . . . . 0.0 112.932 -178.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 163.4 117.62 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 131.237 3.815 . . . . 0.0 104.453 179.114 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.97 126.23 11.99 Favored 'Cis proline' 0 N--CA 1.447 -1.236 0 N-CA-C 110.273 -0.703 . . . . 0.0 110.273 0.046 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.91 147.29 27.02 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 125.342 1.457 . . . . 0.0 110.28 179.425 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.19 139.42 58.66 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.969 1.308 . . . . 0.0 112.082 179.256 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -140.2 158.48 43.98 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 123.362 0.414 . . . . 0.0 111.028 178.083 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -154.01 -179.71 8.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.724 1.21 . . . . 0.0 109.617 -178.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.2 m120 73.52 165.96 0.29 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 126.79 2.036 . . . . 0.0 112.476 178.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 61.71 72.23 0.52 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.51 1.524 . . . . 0.0 110.775 179.337 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -74.36 162.25 29.05 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.073 0.949 . . . . 0.0 110.897 -179.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -178.35 -65.58 0.07 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 179.414 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.6 164.53 11.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.165 1.786 . . . . 0.0 108.74 179.009 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -131.56 124.22 29.57 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.834 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -89.95 154.49 47.54 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.711 1.204 . . . . 0.0 110.195 -178.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -45.8 -60.16 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 124.41 3.406 . . . . 0.0 114.125 179.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.1 m -76.81 152.92 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.663 0.785 . . . . 0.0 109.884 179.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -81.6 -80.1 0.16 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.756 0.822 . . . . 0.0 110.399 -179.179 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -175.12 171.26 44.43 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 118.853 -0.971 . . . . 0.0 111.147 179.545 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.11 157.95 27.13 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 119.799 1.8 . . . . 0.0 112.847 -1.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -150.41 129.38 12.57 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.208 0.603 . . . . 0.0 109.698 -177.082 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -117.68 152.82 34.45 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -176.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -90.53 144.87 25.36 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.763 2.825 . . . . 0.0 111.041 -177.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -147.75 109.69 3.82 Favored Pre-proline 0 C--N 1.346 0.447 0 C-N-CA 123.409 0.683 . . . . 0.0 109.157 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -78.14 142.82 19.63 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.189 1.926 . . . . 0.0 115.996 -175.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.581 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 1.2 tt -122.04 -165.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-O 124.177 1.942 . . . . 0.0 111.943 179.206 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.581 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 79.6 tttt -161.55 -179.73 7.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 109.233 -3.622 . . . . 0.0 109.191 -179.319 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.5 t -87.33 62.03 6.98 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.19 67.66 0.91 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.126 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.39 101.63 0.16 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.456 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.97 133.68 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.993 0.917 . . . . 0.0 109.174 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 p90 43.8 46.09 6.39 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.152 1.781 . . . . 0.0 113.402 -178.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.8 t -150.01 163.74 37.33 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.725 0.81 . . . . 0.0 110.451 -179.499 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.87 155.63 32.14 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -178.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -179.7 86.27 0.07 OUTLIER Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -179.322 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 m -148.39 -68.95 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.458 1.103 . . . . 0.0 109.178 179.304 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.06 -45.86 0.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.082 1.854 . . . . 0.0 110.925 173.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.47 58.5 12.97 Favored Glycine 0 C--N 1.342 0.892 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.77 -58.57 1.09 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.317 1.047 . . . . 0.0 112.058 -178.381 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -56.91 109.44 0.64 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.184 2.594 . . . . 0.0 117.154 -178.031 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -147.95 122.13 9.55 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -179.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.0 m -81.13 160.67 3.92 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.662 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.4 t -141.04 126.87 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 120.789 -1.195 . . . . 0.0 108.688 -178.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.2 pt -117.28 173.93 4.06 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 C-N-CA 125.176 1.39 . . . . 0.0 113.233 -177.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -79.54 -164.94 0.71 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 124.464 1.106 . . . . 0.0 111.182 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.427 0.6 OUTLIER -96.62 37.89 1.25 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 117.193 2.294 . . . . 0.0 117.193 -178.145 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -160.52 -78.4 0.05 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.694 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.2 t -163.32 63.92 0.18 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 113.619 -1.628 . . . . 0.0 114.125 -177.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -147.07 120.17 8.83 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.394 1.452 . . . . 0.0 113.744 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -65.84 122.45 17.35 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 177.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.77 -39.37 6.68 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.69 -172.89 39.47 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.019 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.33 139.0 28.26 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.936 0.894 . . . . 0.0 109.912 179.252 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.0 pt -132.45 166.57 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.728 1.211 . . . . 0.0 110.439 -178.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.3 t -160.46 150.06 17.57 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.974 0.91 . . . . 0.0 111.664 179.357 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -79.35 55.26 1.86 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 118.453 0.57 . . . . 0.0 109.73 175.113 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.9 m -80.34 -85.39 0.09 Allowed 'General case' 0 C--N 1.342 0.259 0 O-C-N 120.766 -1.209 . . . . 0.0 109.318 179.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.31 7.03 58.55 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.688 1.137 . . . . 0.0 112.006 179.011 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.92 162.87 23.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.17 1.388 . . . . 0.0 111.203 179.234 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.6 t -66.99 -48.8 67.35 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.567 0.747 . . . . 0.0 109.833 179.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.29 -51.08 0.2 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.298 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -87.52 -46.03 9.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.23 1.012 . . . . 0.0 110.597 -179.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -70.79 -171.23 0.5 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.626 0.77 . . . . 0.0 112.379 -179.109 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -137.07 172.05 13.59 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.014 1.325 . . . . 0.0 113.553 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.8 m -140.02 161.44 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 127.659 2.384 . . . . 0.0 106.019 176.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.4 164.91 38.56 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 116.515 1.366 . . . . 0.0 116.515 -177.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.8 m -113.56 -175.08 2.59 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.76 2.024 . . . . 0.0 107.442 177.78 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.9 p -69.56 110.99 5.08 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.67 36.1 2.12 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.648 1.594 . . . . 0.0 110.078 -178.73 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.0 m -153.54 100.02 2.38 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.129 1.771 . . . . 0.0 107.129 179.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 116.782 -1.58 . . . . 0.0 108.257 -179.298 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 CA--C 1.532 0.28 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.18 149.56 6.9 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.718 1.207 . . . . 0.0 113.181 -178.661 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 t -148.92 156.41 42.25 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.812 0.845 . . . . 0.0 109.31 179.287 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.99 110.95 9.42 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.254 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 93.0 m -90.62 72.97 6.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.46 -93.06 0.89 Allowed Glycine 0 C--N 1.34 0.792 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.0 p -98.99 -36.38 9.75 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.884 1.274 . . . . 0.0 110.612 179.102 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -71.24 97.59 1.58 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.668 0.787 . . . . 0.0 110.116 -178.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -82.31 151.6 26.67 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.553 1.141 . . . . 0.0 110.617 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -144.53 129.89 18.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.899 0.88 . . . . 0.0 111.015 179.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.2 p -69.67 155.97 39.69 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 125.11 1.364 . . . . 0.0 108.047 177.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.63 -22.61 62.1 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 176.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.5 t -69.2 -40.85 77.79 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -68.83 -48.45 63.49 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.095 0.958 . . . . 0.0 112.915 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.2 t -61.25 -46.99 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.195 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -64.42 -39.16 93.3 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.775 0.83 . . . . 0.0 110.719 179.169 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.42 -52.03 56.18 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.63 0.65 . . . . 0.0 110.423 -179.052 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.14 -34.14 74.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.26 0.624 . . . . 0.0 111.554 -179.468 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.81 -43.82 24.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -179.368 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -69.98 -14.81 62.88 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.72 -61.08 1.87 Allowed 'General case' 0 C--N 1.346 0.42 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.3 -36.35 14.01 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.687 1.195 . . . . 0.0 110.752 177.232 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -66.01 -63.47 1.08 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.958 1.303 . . . . 0.0 109.908 178.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -56.03 -28.88 59.25 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.537 0.735 . . . . 0.0 111.848 -178.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -79.61 -40.89 28.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.061 0.945 . . . . 0.0 111.486 179.148 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.402 ' CD2' ' CG ' ' A' ' 57' ' ' GLN . 23.9 t80 -101.25 23.88 10.3 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.799 0.84 . . . . 0.0 112.425 -178.298 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -86.0 14.6 5.95 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.942 -1.099 . . . . 0.0 112.076 179.176 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.3 m120 60.07 46.17 11.06 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.282 1.433 . . . . 0.0 111.527 178.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -154.72 73.03 0.88 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 80.62 110.67 0.07 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 127.617 2.367 . . . . 0.0 107.272 -178.128 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.6 t -87.66 -42.34 12.74 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.306 1.442 . . . . 0.0 113.332 -177.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 61.56 -171.46 0.15 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.628 1.171 . . . . 0.0 110.811 -178.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.35 167.07 39.3 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 121.96 -0.463 . . . . 0.0 112.326 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.9 t -148.99 -60.32 0.22 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.399 1.48 . . . . 0.0 107.685 179.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.4 p -124.55 -79.87 0.62 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.481 1.113 . . . . 0.0 108.125 178.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.488 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -160.39 41.65 0.18 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.233 1.013 . . . . 0.0 109.74 -179.0 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.488 ' CD1' ' C ' ' A' ' 37' ' ' THR . 43.0 m-85 -151.0 147.58 21.0 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 126.053 1.741 . . . . 0.0 107.993 -178.822 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.88 125.39 11.79 Favored 'Cis proline' 0 CA--C 1.539 0.75 0 CA-C-N 119.083 0.708 . . . . 0.0 111.726 0.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -119.14 165.61 13.96 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 125.994 1.717 . . . . 0.0 111.066 -179.269 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.8 p -67.8 145.83 54.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.443 0.697 . . . . 0.0 110.935 178.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -87.03 50.67 2.06 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.309 178.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -58.71 120.58 9.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.935 1.694 . . . . 0.0 108.052 179.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.7 m120 78.43 129.06 0.05 OUTLIER 'General case' 0 C--N 1.341 0.216 0 C-N-CA 126.42 1.888 . . . . 0.0 107.516 -178.223 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -82.41 20.43 1.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.346 -0.835 . . . . 0.0 112.691 -179.036 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 33.04 -99.13 0.02 OUTLIER 'General case' 0 C--N 1.347 0.485 0 C-N-CA 127.156 2.183 . . . . 0.0 112.025 179.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.45 23.16 2.84 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.572 1.082 . . . . 0.0 110.49 178.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.66 149.55 25.37 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 118.188 0.994 . . . . 0.0 111.271 -179.301 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -153.03 179.9 8.28 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.628 0.771 . . . . 0.0 111.701 -178.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -139.94 165.19 32.62 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 127.425 2.29 . . . . 0.0 106.552 -179.262 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.3 -51.86 10.14 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.435 2.756 . . . . 0.0 111.843 178.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 m -82.24 151.17 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.803 1.241 . . . . 0.0 109.338 178.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -172.36 127.22 0.54 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.742 0.817 . . . . 0.0 112.613 -178.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.99 114.84 0.02 OUTLIER Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.008 1.766 . . . . 0.0 115.798 177.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -62.8 149.72 64.31 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.084 1.942 . . . . 0.0 109.85 -2.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.13 150.18 28.82 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.538 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.402 ' CG ' ' CD2' ' A' ' 27' ' ' TYR . 63.0 mm-40 -133.4 157.82 44.57 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -178.115 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -112.01 151.04 29.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.715 2.406 . . . . 0.0 109.741 179.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -160.54 112.14 1.35 Allowed Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 177.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 24.3 Cg_endo -81.06 135.72 9.95 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.063 1.175 . . . . 0.0 111.08 -176.924 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.64 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.2 tt -109.32 178.13 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-O 124.22 1.962 . . . . 0.0 113.119 -179.419 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.64 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 19.9 ptmt -161.59 151.9 17.38 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 108.486 -3.961 . . . . 0.0 111.255 178.411 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.6 p -86.22 59.05 5.4 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.501 1.12 . . . . 0.0 108.656 179.462 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.92 71.82 0.06 OUTLIER Glycine 0 C--N 1.338 0.644 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.48 -178.83 47.64 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 123.942 0.782 . . . . 0.0 112.184 178.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.5 t -86.71 62.48 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.622 1.169 . . . . 0.0 109.924 -179.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 62.35 158.97 0.06 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.053 1.341 . . . . 0.0 114.287 178.646 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.9 p -138.53 -62.09 0.57 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.378 1.471 . . . . 0.0 108.435 178.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.38 -137.6 3.53 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.121 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.38 168.72 44.57 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.056 0.836 . . . . 0.0 113.145 178.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 m -74.11 174.5 4.89 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 125.815 1.646 . . . . 0.0 110.177 179.385 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -58.31 170.43 2.35 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.541 2.828 . . . . 0.0 112.804 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.62 -69.54 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 103.953 -3.659 . . . . 0.0 103.953 -179.331 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 170.75 -50.03 0.01 OUTLIER 'General case' 0 C--N 1.346 0.434 0 O-C-N 124.981 1.048 . . . . 0.0 113.296 -179.294 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -74.44 113.63 11.9 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 119.842 3.275 . . . . 0.0 119.842 -176.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 ptt180 -143.02 133.05 24.26 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.009 0.924 . . . . 0.0 110.552 177.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -90.48 147.04 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 178.308 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.254 78.0 t -133.61 123.83 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -176.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pt -105.75 -175.48 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.586 0 C-N-CA 126.455 1.902 . . . . 0.0 114.973 -177.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -112.82 145.21 41.02 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 128.903 2.881 . . . . 0.0 105.084 177.39 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.277 1.4 t -59.67 -16.84 29.34 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 120.783 3.623 . . . . 0.0 120.783 -177.072 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -79.61 -77.5 0.18 Allowed 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 103.625 -2.732 . . . . 0.0 103.625 178.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.53 -3.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.678 1.591 . . . . 0.0 114.598 -178.883 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.11 156.36 28.33 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 119.049 0.84 . . . . 0.0 111.151 -176.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -109.26 133.57 52.87 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.124 0.97 . . . . 0.0 110.709 -179.213 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.48 -64.84 1.08 Allowed 'General case' 0 C--N 1.342 0.268 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.042 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.25 168.4 37.0 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.183 -179.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.54 127.4 46.92 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.377 1.471 . . . . 0.0 109.638 -179.305 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 35.0 pt -120.52 154.61 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.656 1.182 . . . . 0.0 108.024 179.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.1 t -158.73 135.53 9.6 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -178.373 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -105.9 52.88 0.72 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.018 0.372 . . . . 0.0 110.685 174.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.7 t -60.12 -48.01 83.51 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.134 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.01 42.65 0.2 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.91 -40.23 11.27 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.533 1.133 . . . . 0.0 109.673 179.094 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.9 t -152.64 -51.8 0.11 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.193 1.397 . . . . 0.0 109.834 -179.512 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.82 -37.48 1.02 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -178.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -126.0 -40.9 1.98 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.753 1.621 . . . . 0.0 110.031 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -64.45 124.01 20.7 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.053 0.541 . . . . 0.0 109.553 179.457 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -79.48 162.43 25.45 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.026 1.73 . . . . 0.0 112.06 -178.594 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.2 m -137.41 164.2 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 127.922 2.489 . . . . 0.0 105.979 176.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.74 137.88 15.19 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 123.134 0.397 . . . . 0.0 112.948 -177.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.4 m -81.58 -171.18 3.17 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.33 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.0 p -72.21 123.02 22.06 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.692 -0.63 . . . . 0.0 111.271 -177.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.77 38.15 28.22 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -178.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -148.75 127.78 12.76 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.054 1.342 . . . . 0.0 108.395 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.3 t30 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 116.524 -1.703 . . . . 0.0 109.041 179.336 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 CA--C 1.53 0.177 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.15 160.03 31.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.509 0.724 . . . . 0.0 110.645 -179.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 t -152.21 139.51 19.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.08 103.96 11.08 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 179.204 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.5 m -90.3 82.14 6.0 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.453 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.25 -111.0 3.47 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.165 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.4 t -88.31 -43.24 11.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.129 0.972 . . . . 0.0 109.64 178.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 m -69.98 106.29 3.15 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.463 1.105 . . . . 0.0 109.741 -179.294 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -86.38 157.99 19.73 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.089 0.956 . . . . 0.0 111.979 -179.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -144.3 136.8 26.71 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.624 1.17 . . . . 0.0 110.582 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.5 t -79.91 154.27 28.43 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 125.215 1.406 . . . . 0.0 109.78 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.25 -18.93 64.09 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 176.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.6 m -78.78 -38.84 37.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.014 0.925 . . . . 0.0 108.731 178.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -71.48 -48.57 48.3 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.613 1.565 . . . . 0.0 110.811 -179.201 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.4 t -58.96 -46.71 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.948 1.699 . . . . 0.0 107.571 177.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -64.89 -39.49 93.61 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 124.204 1.002 . . . . 0.0 111.412 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.26 -52.42 62.13 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.061 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.29 74.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.73 1.212 . . . . 0.0 110.921 179.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.22 -51.82 16.32 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.226 -179.205 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -60.68 -18.08 51.71 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.87 -64.71 1.12 Allowed 'General case' 0 C--N 1.347 0.5 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -178.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -43.93 -48.91 8.59 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.638 1.575 . . . . 0.0 110.495 177.494 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -55.51 -49.77 71.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 128.251 2.62 . . . . 0.0 111.268 178.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -68.11 -22.11 64.91 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.238 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -108.52 -19.47 13.43 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -179.117 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -71.87 -40.37 69.0 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -177.539 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -115.7 -28.18 6.83 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.04 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -67.57 -59.04 3.67 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.73 0.695 . . . . 0.0 110.228 -178.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 168.87 115.5 0.01 OUTLIER 'General case' 0 C--N 1.341 0.208 0 C-N-CA 128.192 2.597 . . . . 0.0 106.238 -178.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -54.85 127.25 27.7 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.341 1.057 . . . . 0.0 110.191 178.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.0 t -134.2 -51.4 0.82 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.684 0.794 . . . . 0.0 112.657 -178.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.56 172.82 8.91 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.917 0.487 . . . . 0.0 110.659 -179.426 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.87 82.27 0.52 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 107.908 -2.077 . . . . 0.0 107.908 179.056 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 p -168.14 101.35 0.45 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -176.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.5 p -128.63 -50.88 1.26 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.903 0.881 . . . . 0.0 109.678 -178.454 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 p -79.5 -6.34 56.75 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.572 0.749 . . . . 0.0 109.183 178.337 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -157.5 121.84 2.27 Favored Pre-proline 0 C--N 1.343 0.319 0 C-N-CA 128.147 2.579 . . . . 0.0 104.375 177.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.22 147.66 49.28 Favored 'Cis proline' 0 N--CA 1.453 -0.886 0 N-CA-C 117.468 2.065 . . . . 0.0 117.468 -0.091 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.98 136.7 37.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 128.162 2.585 . . . . 0.0 105.386 178.691 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.7 m -56.63 127.87 33.55 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.753 1.221 . . . . 0.0 110.067 179.078 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -79.85 78.24 6.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.561 1.144 . . . . 0.0 110.242 -178.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -80.66 -17.69 50.39 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.19 0.996 . . . . 0.0 112.535 179.46 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -79.33 149.89 31.61 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.683 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -168.43 89.68 0.25 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.681 1.992 . . . . 0.0 107.468 178.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -150.37 55.26 0.92 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.168 0.987 . . . . 0.0 108.689 179.818 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.07 -64.88 0.58 Allowed Glycine 0 C--N 1.338 0.651 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -179.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -99.92 132.92 44.98 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.401 1.08 . . . . 0.0 110.767 179.312 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -178.7 154.3 0.74 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 126.438 1.895 . . . . 0.0 109.428 178.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -123.26 105.37 34.05 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.503 1.121 . . . . 0.0 109.738 -178.087 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.23 84.83 1.93 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.519 2.812 . . . . 0.0 110.49 179.169 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.49 -72.64 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.226 0 C-N-CA 124.476 1.11 . . . . 0.0 110.908 179.191 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -133.71 -90.01 0.38 Allowed 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.516 0.598 . . . . 0.0 111.562 -179.114 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.81 131.97 4.28 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -178.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -71.98 -177.89 18.8 Favored 'Cis proline' 0 N--CA 1.456 -0.7 0 CA-C-N 119.686 1.743 . . . . 0.0 111.699 1.238 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.05 173.25 11.66 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.182 1.793 . . . . 0.0 106.231 179.184 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.4 146.32 22.43 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -178.666 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -81.25 156.14 25.75 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 126.575 1.95 . . . . 0.0 112.397 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -160.87 102.1 1.29 Allowed Pre-proline 0 N--CA 1.452 -0.333 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -77.82 115.2 3.78 Favored 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 122.674 2.25 . . . . 0.0 111.802 -177.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.537 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 6.4 tt -89.64 173.76 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-O 123.767 1.746 . . . . 0.0 111.747 -179.095 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.537 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 63.2 pttt -160.45 151.86 19.44 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 109.849 -3.341 . . . . 0.0 112.213 179.114 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 t -88.68 58.95 4.88 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.932 1.293 . . . . 0.0 110.126 -179.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 169.05 34.37 0.02 OUTLIER Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.177 -0.791 . . . . 0.0 112.858 179.182 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.97 176.63 17.2 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 118.014 0.907 . . . . 0.0 112.807 179.111 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.6 t -95.35 144.9 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.345 1.858 . . . . 0.0 107.932 179.333 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.6 p90 56.92 -172.95 0.08 Allowed 'General case' 0 C--N 1.345 0.401 0 C-N-CA 126.76 2.024 . . . . 0.0 113.118 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.8 t -137.34 166.79 22.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.707 1.203 . . . . 0.0 110.696 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.89 133.71 8.93 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.048 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.2 -64.52 4.18 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.36 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.5 p -164.6 168.26 9.19 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.618 1.167 . . . . 0.0 109.489 -179.18 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -58.57 -170.52 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.131 3.221 . . . . 0.0 112.521 167.251 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.0 -55.37 0.07 OUTLIER Glycine 0 C--N 1.341 0.856 0 N-CA-C 105.276 -3.129 . . . . 0.0 105.276 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.03 -63.52 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.637 0.775 . . . . 0.0 110.472 179.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -70.72 126.01 28.42 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.038 1.735 . . . . 0.0 113.961 -178.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -145.28 126.35 14.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.18 0.992 . . . . 0.0 111.747 -179.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.9 m -91.69 147.69 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 176.672 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.3 t -136.08 115.9 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -177.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.5 pt -89.92 -178.89 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.652 0 C-N-CA 124.506 1.123 . . . . 0.0 112.892 -178.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -124.49 58.34 1.22 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 124.678 2.18 . . . . 0.0 112.549 -177.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.258 5.9 t 46.58 -21.31 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.245 1 C-N-CA 134.571 5.148 . . . . 0.0 121.707 177.499 . . . . . . . . 3 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -79.47 -74.16 0.31 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 178.786 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.47 -13.74 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.627 1.971 . . . . 0.0 114.078 -179.207 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -79.47 125.53 29.67 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.777 1.231 . . . . 0.0 113.795 -176.385 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -68.46 115.9 8.39 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.643 2.377 . . . . 0.0 109.453 178.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.26 -60.68 2.23 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 124.741 1.216 . . . . 0.0 111.239 -178.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.57 156.77 28.93 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.375 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.99 137.27 52.26 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.1 0.96 . . . . 0.0 109.273 -179.252 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.3 pt -125.43 156.77 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.3 1.44 . . . . 0.0 107.824 -179.455 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.439 ' HG1' ' H ' ' A' ' 92' ' ' THR . 14.8 t -158.85 150.05 20.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.752 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -79.03 -21.57 46.69 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 123.423 0.452 . . . . 0.0 111.251 176.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.439 ' H ' ' HG1' ' A' ' 90' ' ' THR . 24.3 m -59.65 109.03 0.82 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.032 1.333 . . . . 0.0 109.91 179.287 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.78 -29.49 8.9 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.762 1.172 . . . . 0.0 111.329 -179.236 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.4 -176.45 2.69 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.667 1.187 . . . . 0.0 111.95 -179.294 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -83.65 54.98 3.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.686 1.194 . . . . 0.0 111.614 -179.416 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.69 -74.47 1.55 Allowed Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.606 1.098 . . . . 0.0 113.055 178.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -80.05 -44.77 19.51 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.863 1.265 . . . . 0.0 111.03 -179.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -51.52 166.58 0.12 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.835 1.654 . . . . 0.0 113.459 -178.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -121.3 156.65 32.08 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.339 1.456 . . . . 0.0 112.308 -178.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.5 m -144.56 164.67 13.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 126.844 2.058 . . . . 0.0 107.139 177.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.75 138.76 14.54 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 123.679 0.657 . . . . 0.0 112.082 -178.261 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 34.0 m -82.24 -171.39 3.4 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.498 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.1 t -75.83 123.08 25.06 Favored 'General case' 0 C--N 1.341 0.197 0 O-C-N 121.833 -0.542 . . . . 0.0 109.611 -179.026 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.62 52.15 3.25 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -178.755 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.8 m -147.41 121.39 9.4 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.614 1.566 . . . . 0.0 106.833 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.7 t30 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 125.307 1.443 . . . . 0.0 110.685 -179.247 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.81 148.17 25.99 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.228 1.011 . . . . 0.0 109.857 179.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 t -150.18 156.27 41.29 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.66 128.5 42.72 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.249 1.82 . . . . 0.0 106.186 178.754 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -116.72 90.08 3.25 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.46 -86.4 1.03 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -178.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.1 m -127.77 -16.05 4.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.642 1.577 . . . . 0.0 111.364 178.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -81.55 98.55 8.36 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.182 0.993 . . . . 0.0 109.627 -179.164 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -80.08 155.8 27.37 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.112 0.965 . . . . 0.0 110.685 179.449 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -147.06 141.45 26.37 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.924 1.29 . . . . 0.0 110.782 179.294 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 p -78.21 148.38 34.02 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 177.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.61 -23.37 16.75 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.182 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.0 t -67.63 -44.52 77.77 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.54 0.736 . . . . 0.0 109.603 179.451 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -69.6 -41.03 76.27 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -178.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.402 HG13 ' CE2' ' A' ' 85' ' ' TYR . 2.2 t -61.75 -54.59 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -179.449 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.8 mtp85 -66.78 -34.92 78.88 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.795 1.238 . . . . 0.0 112.225 -178.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.79 -44.34 86.03 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 118.768 0.713 . . . . 0.0 109.737 179.366 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.19 80.48 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.08 0.552 . . . . 0.0 110.155 178.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.26 -40.46 62.33 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 119.109 -0.472 . . . . 0.0 112.252 178.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -66.01 -21.05 66.37 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.39 1.68 Allowed 'General case' 0 C--N 1.344 0.363 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -46.4 -44.22 16.97 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 124.376 1.047 . . . . 0.0 110.83 176.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.7 t -55.02 -51.17 67.1 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.045 1.738 . . . . 0.0 111.361 179.243 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -63.99 -48.41 76.49 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.629 0.65 . . . . 0.0 112.012 -178.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -68.84 -32.58 72.37 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -63.75 -39.05 93.33 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.443 0.565 . . . . 0.0 111.626 -178.061 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -99.82 -49.18 4.44 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -178.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -75.46 -45.58 37.69 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -176.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -158.36 94.05 1.26 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.593 0.633 . . . . 0.0 110.609 -178.014 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.37 104.95 2.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.43 179.352 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.257 5.0 t 165.0 83.26 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.691 2.796 . . . . 0.0 110.812 -179.218 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -177.69 103.6 0.05 OUTLIER 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.493 1.517 . . . . 0.0 107.423 179.12 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 153.19 -179.24 29.75 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.1 m -50.41 -52.04 41.15 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.954 1.301 . . . . 0.0 112.117 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.3 t -165.22 -61.56 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.856 0.862 . . . . 0.0 108.742 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -126.94 75.97 1.61 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.024 1.33 . . . . 0.0 108.309 -179.514 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.455 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 86.3 m-85 -157.68 111.15 1.81 Allowed Pre-proline 0 C--O 1.23 0.053 0 N-CA-C 102.524 -3.139 . . . . 0.0 102.524 179.073 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.98 142.18 63.64 Favored 'Cis proline' 0 CA--C 1.536 0.611 0 N-CA-C 116.37 1.642 . . . . 0.0 116.37 2.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -157.77 152.92 25.73 Favored 'General case' 0 C--N 1.345 0.37 0 C-N-CA 127.238 2.215 . . . . 0.0 109.895 178.238 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 p -41.73 138.89 1.32 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 126.307 1.843 . . . . 0.0 114.233 -178.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -138.97 59.04 1.63 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.332 1.453 . . . . 0.0 108.399 179.308 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -154.62 2.02 0.21 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.919 0.888 . . . . 0.0 112.882 -179.158 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -63.99 -52.43 59.67 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.543 0.737 . . . . 0.0 110.188 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -109.83 127.55 54.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.041 1.337 . . . . 0.0 108.317 178.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -85.89 164.34 17.53 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.834 0.854 . . . . 0.0 109.704 179.408 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.38 -77.88 0.36 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 107.052 -2.419 . . . . 0.0 107.052 -179.231 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.99 89.46 8.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.751 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -147.39 143.08 27.7 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.482 1.513 . . . . 0.0 108.26 179.501 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -95.44 154.16 39.4 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 125.073 1.349 . . . . 0.0 109.989 -178.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.83 81.81 2.09 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.37 3.38 . . . . 0.0 111.425 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.4 169.7 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 125.927 1.691 . . . . 0.0 108.559 179.459 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -92.34 121.17 33.57 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.42 -177.45 51.91 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.651 0.643 . . . . 0.0 112.961 -179.041 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.99 161.35 87.03 Favored 'Cis proline' 0 CA--C 1.534 0.502 0 CA-C-N 117.536 0.668 . . . . 0.0 113.789 0.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.47 153.86 50.93 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 126.332 1.853 . . . . 0.0 106.746 178.788 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.74 153.35 47.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 123.703 0.627 . . . . 0.0 111.536 -178.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -84.48 163.81 19.2 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -160.4 110.1 1.36 Allowed Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 178.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.455 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 23.0 Cg_endo -80.35 125.95 5.96 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.906 1.737 . . . . 0.0 114.989 -175.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.469 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 9.3 tt -87.79 159.1 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-O 124.45 2.071 . . . . 0.0 112.668 179.014 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.469 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.1 mptp? -135.62 135.88 40.56 Favored 'General case' 0 C--N 1.316 -0.868 1 CA-C-N 107.974 -4.194 . . . . 0.0 109.486 -177.991 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t -87.52 59.82 5.68 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.094 1.358 . . . . 0.0 109.993 -179.179 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.36 50.41 0.03 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.251 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.0 153.32 26.32 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.621 1.105 . . . . 0.0 110.378 -179.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.5 p -74.3 115.47 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.276 1.03 . . . . 0.0 110.868 -179.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.0 t80 53.15 76.95 0.18 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 125.535 1.534 . . . . 0.0 110.677 -179.26 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.0 p -138.73 64.02 1.5 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.468 1.107 . . . . 0.0 110.515 -178.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.11 -86.91 0.89 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.96 0.79 . . . . 0.0 111.97 178.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.83 -93.58 0.4 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.458 1.028 . . . . 0.0 110.613 -179.072 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.8 t 74.48 133.1 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 127.066 2.146 . . . . 0.0 111.593 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -67.72 -51.71 0.16 OUTLIER 'Cis proline' 0 C--N 1.348 0.532 0 CA-C-N 119.731 0.94 . . . . 0.0 112.042 -5.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.96 61.27 0.19 Allowed Glycine 0 C--N 1.341 0.856 0 C-N-CA 124.517 1.056 . . . . 0.0 111.594 179.379 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.06 -41.86 27.79 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.559 0.743 . . . . 0.0 109.05 178.441 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -70.3 111.49 5.93 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.085 1.754 . . . . 0.0 112.426 -178.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.05 128.88 46.99 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.959 0.903 . . . . 0.0 113.048 -178.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.0 m -100.34 148.36 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 102.595 -3.113 . . . . 0.0 102.595 176.04 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.5 t -140.13 135.96 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 O-C-N 121.873 -0.517 . . . . 0.0 109.651 -176.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.5 pt -126.46 165.55 24.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.308 0 C-N-CA 124.107 0.963 . . . . 0.0 111.865 -178.683 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -81.35 165.97 20.88 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 127.268 2.227 . . . . 0.0 108.186 178.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.356 12.2 t -64.77 -19.71 65.96 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 118.634 2.827 . . . . 0.0 118.634 -178.128 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -79.59 -85.54 0.08 Allowed 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 101.067 -3.679 . . . . 0.0 101.067 176.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 98.3 m -164.57 8.14 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 130.438 3.495 . . . . 0.0 112.832 -178.703 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -78.86 134.65 36.92 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 120.171 1.351 . . . . 0.0 111.798 -176.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.402 ' CE2' HG13 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -70.84 120.18 16.05 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.873 0.469 . . . . 0.0 110.09 -178.952 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.64 -48.95 7.86 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.178 0.991 . . . . 0.0 110.175 -179.082 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.12 -179.48 46.36 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-O 121.16 0.311 . . . . 0.0 112.686 179.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.0 135.24 45.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.842 2.057 . . . . 0.0 107.771 179.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.4 pt -146.61 171.67 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.785 1.234 . . . . 0.0 110.553 -178.392 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.5 t -160.06 151.77 20.03 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 179.349 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -79.28 -13.12 59.86 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 175.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.4 m -60.92 109.17 0.99 Allowed 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.003 1.321 . . . . 0.0 110.295 -179.333 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.5 59.46 5.27 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.407 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.52 -124.65 0.22 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.709 1.204 . . . . 0.0 108.558 179.467 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.5 m -149.16 73.17 1.19 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.793 1.237 . . . . 0.0 107.95 179.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.72 -104.86 1.61 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 179.587 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -79.8 -22.72 42.75 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.114 0.966 . . . . 0.0 111.18 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -56.16 159.07 3.62 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.577 1.151 . . . . 0.0 111.35 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -114.74 163.51 15.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.96 1.704 . . . . 0.0 111.854 -178.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.4 m -141.07 160.85 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 C-N-CA 126.228 1.811 . . . . 0.0 107.092 176.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.02 141.2 20.65 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 123.838 0.732 . . . . 0.0 114.158 -178.092 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -83.35 179.73 7.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 177.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.9 m -70.31 131.04 43.54 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.205 -0.935 . . . . 0.0 110.598 179.566 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.17 15.72 80.98 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.032 0.825 . . . . 0.0 113.712 179.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.3 m -80.01 131.71 35.85 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.323 1.061 . . . . 0.0 108.695 179.306 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 p30 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.816 -1.088 . . . . 0.0 110.558 -179.309 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.31 154.35 0.13 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 126.831 2.052 . . . . 0.0 112.52 179.015 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.4 t -152.81 123.43 7.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.573 179.066 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -96.79 109.74 22.36 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 178.901 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.8 m -87.7 63.21 7.41 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.468 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.55 -91.54 0.4 Allowed Glycine 0 C--N 1.342 0.886 0 C-N-CA 126.03 1.776 . . . . 0.0 109.08 -178.761 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.3 p -92.82 -47.98 6.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.396 1.079 . . . . 0.0 109.817 179.13 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.2 m -66.83 100.01 0.67 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.488 1.515 . . . . 0.0 108.168 179.388 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -88.4 148.2 24.35 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.12 0.568 . . . . 0.0 111.978 -178.783 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -136.44 135.74 38.93 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 123.996 0.918 . . . . 0.0 111.249 178.606 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.7 m -82.46 150.34 27.1 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 126.571 1.948 . . . . 0.0 108.647 178.62 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.61 -21.86 29.95 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.137 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 84.2 p -72.96 -46.71 50.82 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.565 0.746 . . . . 0.0 109.529 179.455 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -69.08 -38.72 79.17 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.761 1.224 . . . . 0.0 111.418 -179.307 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.3 t -57.98 -53.19 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.836 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -33.37 75.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.67 1.588 . . . . 0.0 112.032 -179.336 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.11 -57.63 8.11 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.018 0.527 . . . . 0.0 109.725 -178.678 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.84 -26.75 67.8 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 123.538 0.523 . . . . 0.0 110.953 -179.295 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.01 -54.03 12.67 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.867 0.758 . . . . 0.0 111.035 179.248 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -61.2 -19.91 62.16 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.191 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.73 -67.95 0.62 Allowed 'General case' 0 C--N 1.349 0.574 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 -178.085 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.448 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . . . -39.54 -46.07 1.68 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.625 1.17 . . . . 0.0 112.19 176.532 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 74.4 m -55.28 -68.49 0.19 Allowed 'General case' 0 C--N 1.346 0.417 0 C-N-CA 123.379 0.672 . . . . 0.0 110.342 179.366 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -53.81 -31.09 47.79 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.833 1.253 . . . . 0.0 112.928 -176.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -79.49 -48.0 14.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -179.066 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.37 0.1 OUTLIER -91.85 -2.58 56.79 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 119.381 3.104 . . . . 0.0 119.381 -176.539 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -57.04 -52.48 65.12 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.011 1.278 . . . . 0.0 109.382 178.975 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 152.03 66.14 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 130.438 3.495 . . . . 0.0 105.561 179.553 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -165.32 98.38 0.71 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.551 1.14 . . . . 0.0 107.984 -178.915 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.266 4.4 p30 52.27 -165.92 0.06 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.236 1.815 . . . . 0.0 111.982 -179.203 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.1 t -152.57 -49.12 0.1 Allowed 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.646 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 55.82 84.07 0.08 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 125.063 1.345 . . . . 0.0 109.396 -178.238 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.23 162.48 6.03 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.24 1.4 . . . . 0.0 111.849 -178.856 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.1 p -176.98 102.84 0.05 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.979 1.311 . . . . 0.0 108.915 -179.231 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.8 m -68.64 -67.46 0.47 Allowed 'General case' 0 C--N 1.34 0.167 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.895 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.6 p -147.45 18.91 1.19 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.468 1.907 . . . . 0.0 108.502 178.008 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -144.34 154.95 57.73 Favored Pre-proline 0 C--N 1.348 0.528 0 C-N-CA 129.798 3.239 . . . . 0.0 105.95 -178.297 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -80.38 111.41 2.24 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 CA-C-N 120.932 1.369 . . . . 0.0 113.58 3.855 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -122.27 158.86 28.58 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.426 1.491 . . . . 0.0 108.441 179.114 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -63.26 154.84 30.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.701 1.6 . . . . 0.0 108.617 178.755 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -77.97 119.78 21.9 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.296 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.27 145.91 10.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.937 2.095 . . . . 0.0 114.2 -178.152 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -73.44 148.17 43.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.381 1.472 . . . . 0.0 110.1 179.495 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.7 t80 74.22 146.15 0.08 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.764 2.025 . . . . 0.0 110.972 179.411 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 58.35 53.0 6.7 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.568 1.147 . . . . 0.0 108.933 -178.599 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.23 106.84 2.03 Favored Glycine 0 C--N 1.339 0.729 0 C-N-CA 124.751 1.167 . . . . 0.0 112.324 -178.698 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -73.31 106.99 5.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 178.494 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -53.88 120.99 7.05 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.069 1.347 . . . . 0.0 113.109 -178.4 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -132.75 151.96 79.03 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.351 1.861 . . . . 0.0 108.217 179.081 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.57 166.98 28.3 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.505 2.803 . . . . 0.0 112.464 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.273 22.9 m 55.03 171.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 129.03 2.932 . . . . 0.0 115.445 179.321 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -81.2 153.59 27.11 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.971 1.308 . . . . 0.0 111.999 -178.847 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.77 -147.73 23.1 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.527 1.537 . . . . 0.0 110.251 179.202 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.39 133.21 17.27 Favored 'Cis proline' 0 N--CA 1.458 -0.605 0 CA-C-N 118.847 1.324 . . . . 0.0 110.031 -1.782 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -108.62 140.53 41.87 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.935 0.894 . . . . 0.0 111.847 179.343 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -122.91 159.17 28.79 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.051 1.741 . . . . 0.0 109.613 -179.027 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -87.7 159.59 18.44 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.561 1.544 . . . . 0.0 111.928 -178.553 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 23' ' ' ALA . 18.4 t80 -160.41 109.74 1.36 Allowed Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.267 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -79.11 129.65 8.93 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 121.88 1.72 . . . . 0.0 111.151 -177.178 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.676 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.2 tt -87.71 -176.83 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-O 123.796 1.76 . . . . 0.0 110.237 179.096 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.676 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -152.52 141.24 20.94 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 110.07 -3.241 . . . . 0.0 111.623 -179.095 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 t -81.41 57.73 3.38 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.948 1.699 . . . . 0.0 109.942 179.647 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.21 45.54 0.08 OUTLIER Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.282 1.42 . . . . 0.0 112.008 179.059 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.76 176.36 26.08 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 117.884 0.842 . . . . 0.0 112.782 179.052 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 t -132.15 139.06 51.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.322 1.449 . . . . 0.0 108.278 178.961 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.263 26.4 p90 46.42 52.51 10.68 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.351 2.261 . . . . 0.0 114.487 179.473 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.9 p -80.49 -44.34 19.34 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.837 -0.539 . . . . 0.0 110.184 179.06 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.2 56.77 1.44 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.09 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -117.33 73.44 0.28 Allowed Glycine 0 C--N 1.34 0.793 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.485 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 92.0 p -71.17 152.16 94.6 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 124.082 0.953 . . . . 0.0 110.717 -179.938 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.98 -43.17 0.69 Allowed 'Cis proline' 0 N--CA 1.457 -0.672 0 CA-C-N 119.196 0.748 . . . . 0.0 110.904 -4.129 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.87 -54.61 3.7 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 179.187 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.427 ' HB3' ' CB ' ' A' ' 91' ' ' HIS . . . 64.3 43.97 4.52 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.632 1.173 . . . . 0.0 110.312 -178.678 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.83 101.19 1.29 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.641 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.28 148.56 50.82 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.251 0.621 . . . . 0.0 111.398 -179.032 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.1 m -111.26 144.32 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 176.909 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.17 121.83 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 -177.673 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 pt -127.12 167.84 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.615 -176.517 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -94.31 166.99 11.82 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 123.996 0.918 . . . . 0.0 110.809 -179.641 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.432 1.9 t -73.29 8.51 1.67 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 121.396 3.851 . . . . 0.0 121.396 -177.07 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -91.05 -94.88 0.12 Allowed 'General case' 0 N--CA 1.437 -1.101 1 N-CA-C 93.486 -6.487 . . . . 0.0 93.486 174.859 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . 0.353 9.8 t -165.93 54.29 0.1 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 127.634 2.374 . . . . 0.0 111.44 176.955 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -136.06 127.64 28.82 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 120.186 1.357 . . . . 0.0 112.957 -178.063 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.2 121.61 17.14 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 127.264 2.226 . . . . 0.0 108.138 179.055 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.63 -54.55 2.6 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 123.552 0.741 . . . . 0.0 111.774 -178.605 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -119.15 155.32 16.11 Favored Glycine 0 C--N 1.341 0.853 0 C-N-CA 124.428 1.014 . . . . 0.0 113.907 -178.72 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.91 102.07 3.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 178.539 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.9 pt -112.75 157.05 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.903 0.881 . . . . 0.0 111.633 -178.293 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.2 t -155.89 155.32 32.67 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.083 1.353 . . . . 0.0 112.197 -178.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.427 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 38.6 m170 -80.34 3.78 20.01 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 119.156 -0.45 . . . . 0.0 110.954 177.208 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -43.64 -39.59 3.65 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -177.671 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.46 44.44 1.22 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.573 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -110.83 155.16 22.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.315 1.446 . . . . 0.0 110.924 -179.769 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.8 t -89.84 61.29 5.3 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.536 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.9 -86.93 0.96 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.659 1.123 . . . . 0.0 112.381 179.028 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -96.91 -6.17 36.35 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -178.073 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -69.26 -173.44 0.54 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.191 0.905 . . . . 0.0 110.592 -179.401 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -147.0 153.89 40.59 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.182 0.593 . . . . 0.0 111.379 -178.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.1 m -142.55 163.66 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 126.483 1.913 . . . . 0.0 107.57 178.129 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.85 152.35 28.54 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.701 0.667 . . . . 0.0 114.056 -177.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 51.8 m -87.71 -168.27 2.17 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.92 1.288 . . . . 0.0 108.331 178.191 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.2 t -68.35 112.92 5.51 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.036 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.58 50.21 4.31 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.258 0.932 . . . . 0.0 110.802 -179.201 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.4 m -147.9 97.75 2.85 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.06 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 116.585 -1.674 . . . . 0.0 108.833 -179.385 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 54.69 81.13 0.11 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 125.533 1.533 . . . . 0.0 109.29 -179.405 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.5 t -105.35 138.12 42.05 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.362 0.665 . . . . 0.0 111.977 -177.37 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.94 125.34 52.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.292 1.837 . . . . 0.0 109.773 179.405 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -105.87 71.27 0.89 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 178.841 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.17 -80.73 1.49 Allowed Glycine 0 C--N 1.342 0.889 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 -178.868 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.1 t -123.64 -30.49 3.6 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.975 1.71 . . . . 0.0 110.757 178.943 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 m -70.36 92.0 0.78 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.126 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -89.15 145.06 25.68 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.477 1.511 . . . . 0.0 114.074 -177.819 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -141.48 134.93 29.71 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.243 1.417 . . . . 0.0 111.682 178.376 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.6 m -72.32 156.57 38.96 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 126.057 1.743 . . . . 0.0 108.618 177.677 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.21 -22.88 44.01 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.029 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 98.3 p -76.45 -34.45 58.72 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.916 -179.143 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -75.55 -38.21 59.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.418 1.487 . . . . 0.0 111.617 -179.526 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.1 t -63.42 -47.99 89.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.264 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -64.15 -32.1 73.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.7 1.6 . . . . 0.0 111.532 179.094 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.34 -56.65 7.8 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.078 0.551 . . . . 0.0 109.888 -179.081 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.5 -27.86 68.11 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 123.105 0.253 . . . . 0.0 110.551 179.656 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.34 -44.68 67.7 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.299 -0.876 . . . . 0.0 110.088 178.586 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -68.83 -17.51 64.02 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.338 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.32 -69.24 0.57 Allowed 'General case' 0 C--N 1.346 0.424 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 -178.387 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.487 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . . . -38.1 -58.13 0.99 Allowed 'General case' 0 CA--C 1.537 0.463 0 O-C-N 124.527 1.142 . . . . 0.0 112.438 175.93 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.5 t -56.23 -40.9 74.81 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 123.835 0.854 . . . . 0.0 112.668 -178.952 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -87.24 -2.96 59.0 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 179.442 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -117.26 -63.15 1.48 Allowed 'General case' 0 C--N 1.347 0.5 0 CA-C-N 120.163 1.347 . . . . 0.0 114.097 -178.616 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -49.98 -42.2 48.41 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.894 1.278 . . . . 0.0 111.99 -177.036 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -103.85 14.11 31.51 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -177.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -154.51 62.95 0.68 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.176 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 63.24 91.03 0.07 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.174 1.79 . . . . 0.0 109.206 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -57.06 112.69 1.42 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.556 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.9 t -97.65 -34.63 10.87 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.348 1.459 . . . . 0.0 107.593 178.284 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.53 97.9 7.36 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.512 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -142.49 52.07 0.66 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.359 0.98 . . . . 0.0 111.155 -179.088 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 m -71.95 -53.06 14.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.501 0.72 . . . . 0.0 109.789 178.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.5 m -111.38 -162.07 0.78 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.037 1.335 . . . . 0.0 107.98 -179.063 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.4 t -83.08 49.9 1.63 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.98 0.912 . . . . 0.0 109.747 179.145 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -140.79 142.82 29.68 Favored Pre-proline 0 C--N 1.342 0.257 0 C-N-CA 126.311 1.845 . . . . 0.0 106.638 -179.026 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -69.6 145.68 79.73 Favored 'Cis proline' 0 CA--C 1.535 0.56 0 N-CA-C 115.053 1.136 . . . . 0.0 115.053 2.917 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.57 140.2 49.39 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -177.514 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.3 m -57.12 120.07 7.41 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 127.359 2.263 . . . . 0.0 110.564 178.983 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -79.43 99.56 7.25 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.656 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -140.53 61.83 1.5 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.215 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -105.63 -178.67 3.72 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.231 1.412 . . . . 0.0 109.183 -179.584 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -67.78 102.92 1.31 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.954 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.3 144.21 42.07 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.575 0.75 . . . . 0.0 111.501 -179.102 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.68 68.28 0.16 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 107.849 -2.101 . . . . 0.0 107.849 -178.938 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -162.65 173.01 14.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.51 1.124 . . . . 0.0 109.331 -179.627 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -59.93 162.85 5.11 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.591 1.156 . . . . 0.0 111.171 178.904 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 49.4 p90 44.65 53.7 11.63 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 126.239 1.816 . . . . 0.0 113.134 -179.345 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.75 -47.74 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.606 2.204 . . . . 0.0 110.834 -179.239 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.4 t 57.58 -100.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.768 1.627 . . . . 0.0 109.995 -179.577 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 p30 178.8 -45.61 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.437 1.895 . . . . 0.0 108.952 -179.382 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.89 -158.83 41.2 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.781 0.705 . . . . 0.0 112.362 179.199 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.01 130.35 1.67 Allowed 'Cis proline' 0 N--CA 1.46 -0.472 0 CA-C-N 118.372 1.086 . . . . 0.0 113.423 1.549 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -134.25 141.93 47.16 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.834 0.854 . . . . 0.0 109.412 179.391 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -132.07 164.94 25.13 Favored 'General case' 0 C--N 1.344 0.359 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -177.372 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -79.86 153.25 29.19 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.934 2.093 . . . . 0.0 112.059 -178.942 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.487 ' CD2' ' HB3' ' A' ' 23' ' ' ALA . 52.5 t80 -160.39 106.43 1.36 Allowed Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 178.731 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -67.71 141.96 56.46 Favored 'Trans proline' 0 N--CA 1.441 -1.584 0 CA-C-N 120.302 1.144 . . . . 0.0 110.676 -176.81 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.472 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -90.03 -145.21 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-O 122.972 1.368 . . . . 0.0 111.972 -177.607 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.472 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 36.0 ttpt -79.77 149.51 31.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.381 -179.022 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.0 t 170.09 48.28 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.455 1 C-N-CA 132.088 4.155 . . . . 0.0 103.641 178.482 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.58 -46.26 1.07 Allowed Glycine 0 CA--C 1.534 1.229 0 N-CA-C 105.984 -2.846 . . . . 0.0 105.984 -177.45 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.4 165.22 25.43 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.433 1.016 . . . . 0.0 111.742 178.68 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.59 131.31 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.514 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.9 t80 57.2 83.34 0.11 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.703 1.201 . . . . 0.0 110.845 -179.381 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.5 p -131.54 -48.61 0.98 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.465 1.106 . . . . 0.0 111.753 -179.076 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.56 51.78 3.18 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -178.782 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.16 47.69 0.07 OUTLIER Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.533 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.5 t -69.52 -59.58 4.68 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.376 1.07 . . . . 0.0 111.252 179.567 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -82.32 -26.18 9.15 Favored 'Cis proline' 0 C--N 1.347 0.483 0 CA-C-N 121.573 1.597 . . . . 0.0 112.246 -6.2 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.29 -160.49 22.56 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.562 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.568 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . 69.21 21.71 7.03 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 126.349 1.86 . . . . 0.0 112.331 -178.912 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.4 91.69 0.61 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.986 1.314 . . . . 0.0 107.926 179.099 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.8 mtt85 -138.3 134.05 33.83 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.334 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 m -93.74 153.05 3.43 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 177.065 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.96 120.11 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -178.867 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -110.48 174.04 2.05 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 C-N-CA 125.015 1.326 . . . . 0.0 114.073 -177.645 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -100.55 154.62 18.41 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.755 2.422 . . . . 0.0 108.544 179.054 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.283 3.3 t -71.92 0.93 8.0 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -178.599 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -86.0 -83.22 0.18 Allowed 'General case' 0 N--CA 1.441 -0.888 1 N-CA-C 100.115 -4.031 . . . . 0.0 100.115 177.07 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.7 t -165.08 -4.29 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.295 2.238 . . . . 0.0 114.157 177.619 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -79.35 130.59 35.59 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -175.098 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -78.64 117.89 20.23 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.82 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.59 -59.73 2.63 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.344 0.658 . . . . 0.0 111.862 -177.557 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.45 156.83 17.82 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 179.61 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.49 155.27 18.38 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.588 1.155 . . . . 0.0 111.748 -179.249 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.5 pt -136.62 165.3 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 125.241 1.416 . . . . 0.0 110.802 179.28 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.1 t -159.32 144.84 16.0 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.666 0.786 . . . . 0.0 112.787 -178.774 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.568 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -82.42 -37.24 25.78 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.618 0.767 . . . . 0.0 111.073 177.892 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 m -49.97 -55.97 12.5 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.479 1.512 . . . . 0.0 112.367 -178.756 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -63.47 -27.0 70.15 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.108 0.861 . . . . 0.0 112.637 -179.58 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.39 178.76 6.91 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.288 1.035 . . . . 0.0 112.579 -178.925 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.9 m -65.59 -45.89 81.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.512 1.125 . . . . 0.0 110.54 179.07 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.05 -80.62 0.06 OUTLIER Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.466 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -79.53 -17.83 53.19 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.182 0.993 . . . . 0.0 112.039 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -79.74 163.85 24.16 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.326 0.65 . . . . 0.0 110.263 179.298 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.05 113.35 19.42 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.63 1.572 . . . . 0.0 107.671 179.209 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.4 m -97.47 161.55 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.436 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.88 155.65 51.07 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.395 -179.063 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.25 -173.31 4.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.342 1.457 . . . . 0.0 109.008 178.924 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.2 t -68.02 133.67 49.41 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.825 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.66 23.2 73.42 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -178.775 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.3 m -144.05 93.87 2.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.065 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 116.747 -1.597 . . . . 0.0 109.688 -178.658 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.37 152.86 0.57 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 126.612 1.965 . . . . 0.0 113.028 179.296 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.66 94.37 3.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.076 1.35 . . . . 0.0 110.571 -178.517 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -99.58 94.53 6.44 Favored 'General case' 0 N--CA 1.437 -1.099 1 N-CA-C 100.179 -4.008 . . . . 0.0 100.179 177.808 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.0 m -96.19 75.48 3.0 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.246 -177.696 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.0 -97.42 1.64 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 -178.804 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.3 t -114.76 -31.71 6.06 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.442 1.497 . . . . 0.0 109.253 178.479 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.1 m -77.06 95.53 4.22 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 102.059 -3.312 . . . . 0.0 102.059 178.051 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -114.28 152.24 31.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.552 1.141 . . . . 0.0 113.098 -176.425 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -143.76 165.78 26.71 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 125.041 1.336 . . . . 0.0 111.229 -179.214 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.3 m -85.97 156.94 20.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.334 1.453 . . . . 0.0 110.652 178.88 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.95 -20.78 40.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.915 -1.493 . . . . 0.0 107.164 176.875 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -68.77 -46.01 69.88 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.538 1.135 . . . . 0.0 109.939 179.379 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -43.38 93.21 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 123.135 0.574 . . . . 0.0 111.4 179.195 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.0 t -61.25 -46.07 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 123.013 0.525 . . . . 0.0 109.754 178.776 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 ttp-105 -62.76 -43.8 97.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.587 0.755 . . . . 0.0 110.177 -179.217 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.55 -45.41 87.25 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.546 0.738 . . . . 0.0 110.772 179.122 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.98 -33.22 75.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.46 1.104 . . . . 0.0 110.753 179.329 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.84 -37.71 47.8 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.964 0.505 . . . . 0.0 110.456 178.881 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -68.22 -20.64 64.84 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.229 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.25 -61.38 1.97 Allowed 'General case' 0 C--N 1.346 0.449 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 -178.807 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -41.13 -52.05 3.33 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.336 1.054 . . . . 0.0 111.46 176.663 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 46.4 t -61.97 -39.77 93.31 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.693 1.597 . . . . 0.0 111.04 179.017 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -88.01 7.08 32.95 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.768 1.227 . . . . 0.0 113.527 179.015 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -129.73 -10.87 4.43 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.455 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.457 ' HH ' ' HG1' ' A' ' 41' ' ' THR . 90.5 t80 -115.18 -27.28 7.34 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -179.059 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.95 -14.86 11.25 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.828 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -78.86 17.82 0.68 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.503 1.047 . . . . 0.0 113.616 -176.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.5 t70 86.51 40.22 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 127.941 2.496 . . . . 0.0 109.166 178.9 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -151.7 148.99 28.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.827 2.051 . . . . 0.0 106.232 179.269 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 t -166.24 77.99 0.24 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.127 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.19 96.04 0.1 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.182 0.993 . . . . 0.0 110.552 -179.228 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.94 58.87 4.58 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 125.226 1.393 . . . . 0.0 110.197 -179.265 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.4 t -72.78 -73.27 0.21 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.706 0.802 . . . . 0.0 110.147 -179.011 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 m -176.49 -49.63 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 127.441 2.297 . . . . 0.0 106.671 -178.584 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.0 t -79.95 25.04 0.38 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.485 1.914 . . . . 0.0 113.939 -178.844 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 74.49 163.69 0.14 Allowed Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 119.279 0.945 . . . . 0.0 109.839 178.414 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.25 117.94 3.5 Favored 'Cis proline' 0 N--CA 1.454 -0.838 0 N-CA-C 115.166 1.179 . . . . 0.0 115.166 2.65 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -125.71 150.86 47.32 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 127.223 2.209 . . . . 0.0 106.937 178.912 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.457 ' HG1' ' HH ' ' A' ' 27' ' ' TYR . 3.7 m -80.99 132.19 35.36 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.564 1.146 . . . . 0.0 109.777 -179.972 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -88.53 149.55 23.56 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.48 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -153.03 134.3 14.24 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.024 0.53 . . . . 0.0 110.494 -179.273 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 64.43 121.61 0.02 OUTLIER 'General case' 0 C--N 1.343 0.293 0 C-N-CA 127.378 2.271 . . . . 0.0 112.053 179.367 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -77.16 135.38 38.53 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.268 0.627 . . . . 0.0 109.699 179.433 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -126.91 75.3 1.56 Allowed 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.188 0.995 . . . . 0.0 109.407 -178.691 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.16 50.49 51.06 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.221 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -164.83 121.76 1.55 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.857 1.263 . . . . 0.0 108.69 -178.648 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -142.68 110.43 5.85 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.373 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -144.42 49.87 1.11 Allowed Pre-proline 0 N--CA 1.439 -1.014 0 C-N-CA 129.91 3.284 . . . . 0.0 108.879 177.635 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.56 150.3 27.87 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.006 2.471 . . . . 0.0 112.031 -178.998 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.7 t -142.03 -53.19 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.862 1.665 . . . . 0.0 106.892 178.757 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -160.19 126.38 4.19 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.136 1.375 . . . . 0.0 109.002 178.727 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.85 150.95 18.43 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.881 1.229 . . . . 0.0 112.238 -178.875 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.65 173.04 29.17 Favored 'Cis proline' 0 C--N 1.35 0.655 0 CA-C-N 119.375 1.588 . . . . 0.0 113.27 -2.251 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -126.17 174.71 8.3 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.292 1.437 . . . . 0.0 108.174 -179.256 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.63 154.01 37.96 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.879 0.371 . . . . 0.0 111.658 -179.491 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.18 153.17 19.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.594 1.558 . . . . 0.0 111.683 -178.889 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -157.33 117.17 1.99 Allowed Pre-proline 0 C--N 1.342 0.273 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.288 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.7 152.14 13.16 Favored 'Trans proline' 0 N--CA 1.438 -1.769 0 C-N-CA 121.187 1.258 . . . . 0.0 114.675 -176.382 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.52 178.32 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 127.77 2.428 . . . . 0.0 105.868 178.803 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -164.77 -168.92 1.58 Allowed 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 109.586 -3.461 . . . . 0.0 108.462 -178.879 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.2 m -84.65 60.71 6.28 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 177.136 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.54 71.53 1.16 Allowed Glycine 0 CA--C 1.53 0.999 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 -178.222 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.18 89.68 0.09 OUTLIER Glycine 0 CA--C 1.53 1.01 0 CA-C-N 117.295 0.547 . . . . 0.0 111.8 -179.329 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.1 t -94.68 97.49 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.317 1.447 . . . . 0.0 108.003 179.339 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 t80 48.82 66.21 1.15 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.394 1.478 . . . . 0.0 110.693 -179.586 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.2 p -104.53 -68.82 0.83 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.792 1.237 . . . . 0.0 109.43 179.853 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.33 177.23 47.3 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 179.47 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.54 -19.59 10.82 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 118.887 -0.952 . . . . 0.0 113.378 -179.787 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 92.0 p 50.35 71.69 1.48 Allowed Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.201 1.8 . . . . 0.0 111.6 -179.604 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.89 143.28 54.55 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.181 2.587 . . . . 0.0 109.403 -178.382 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.43 48.74 0.95 Allowed Glycine 0 C--N 1.338 0.691 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.252 -178.518 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.15 21.75 0.13 Allowed 'General case' 0 C--N 1.342 0.27 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 177.784 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.26 112.64 0.13 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.708 2.803 . . . . 0.0 105.85 176.18 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.91 134.31 9.58 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.387 1.875 . . . . 0.0 109.53 -176.298 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.9 m -90.8 152.8 3.29 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 177.615 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.1 t -135.62 119.21 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -178.694 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -102.54 176.54 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.4 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -99.28 168.42 10.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 127.258 2.223 . . . . 0.0 109.16 178.847 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.306 14.7 t -82.01 50.24 1.52 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -178.414 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -147.54 -90.1 0.09 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 102.545 -3.132 . . . . 0.0 102.545 177.477 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.16 0.44 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.657 1.983 . . . . 0.0 113.007 -178.939 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -82.7 133.68 35.16 Favored 'General case' 0 C--N 1.346 0.44 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -176.773 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -78.05 112.88 15.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.592 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.0 -49.65 11.52 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.322 1.049 . . . . 0.0 111.363 -178.171 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.07 151.29 7.95 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.108 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.56 158.18 17.12 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.855 0.862 . . . . 0.0 110.159 178.97 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.0 pt -138.71 151.84 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.602 -178.918 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.1 t -147.67 165.43 30.49 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 125.301 1.441 . . . . 0.0 112.749 -178.756 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -79.01 -50.86 10.42 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.457 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 m -39.9 107.8 0.08 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 127.026 2.13 . . . . 0.0 112.631 -178.763 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.8 -43.42 1.35 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.74 1.638 . . . . 0.0 109.259 -179.153 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.95 -175.89 0.62 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.799 1.639 . . . . 0.0 112.131 179.654 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.3 p -70.88 -50.76 31.53 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.171 0.988 . . . . 0.0 111.453 -179.894 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.54 -78.9 0.04 OUTLIER Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.372 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -79.35 -34.1 42.39 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.046 0.939 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -55.82 158.63 3.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.366 1.066 . . . . 0.0 111.046 179.205 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -118.5 157.98 26.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.67 1.188 . . . . 0.0 113.175 -178.298 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.6 160.94 41.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 C-N-CA 126.428 1.891 . . . . 0.0 107.192 177.712 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.52 161.11 46.21 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.068 0.842 . . . . 0.0 114.197 -177.928 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.6 t -143.06 163.75 31.98 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 126.002 1.721 . . . . 0.0 109.147 178.825 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.0 t 53.43 51.59 15.04 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.079 1.752 . . . . 0.0 111.468 -178.577 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.66 -10.79 70.73 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.087 -0.84 . . . . 0.0 113.285 179.2 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.9 m -79.55 143.95 34.36 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.604 1.202 . . . . 0.0 108.746 -179.351 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 p30 . . . . . 0 C--O 1.251 1.182 0 CA-C-O 117.528 -1.225 . . . . 0.0 110.045 -179.271 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.46 75.1 0.37 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.311 1.444 . . . . 0.0 109.393 179.72 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.5 m -79.35 101.06 7.89 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.104 1.762 . . . . 0.0 109.668 -178.001 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -115.96 115.85 26.9 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.553 1.541 . . . . 0.0 106.863 -179.154 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.4 m -113.39 93.82 4.58 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.58 0.752 . . . . 0.0 109.797 -179.223 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.07 -93.8 0.43 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.438 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.3 m -133.77 41.58 3.02 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.607 1.163 . . . . 0.0 109.233 179.184 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.4 m -141.16 89.2 2.22 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 179.075 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -85.67 141.57 29.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.656 1.182 . . . . 0.0 113.657 -177.594 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -141.81 136.72 30.91 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.69 1.596 . . . . 0.0 109.816 178.74 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.5 m -65.94 158.2 28.72 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.979 1.312 . . . . 0.0 110.266 178.231 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.05 -23.17 66.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.1 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.2 t -76.73 -33.25 58.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.145 1.378 . . . . 0.0 109.966 179.259 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -74.74 -39.55 61.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.867 0.867 . . . . 0.0 109.841 -179.028 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.47 -44.6 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.499 0.72 . . . . 0.0 110.43 178.342 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.48 -38.55 90.1 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 123.304 0.642 . . . . 0.0 110.46 179.47 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.08 -46.33 74.63 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.868 0.867 . . . . 0.0 109.259 179.029 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.58 -42.14 82.55 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.961 0.904 . . . . 0.0 108.953 178.775 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.91 -20.03 50.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 179.324 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -74.52 -26.21 59.84 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.315 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.74 -49.81 10.68 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -179.445 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.14 -48.83 23.19 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 124.612 1.195 . . . . 0.0 109.661 176.233 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.5 t -68.73 -29.79 68.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.82 2.048 . . . . 0.0 113.189 -179.922 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -73.35 -63.78 1.12 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.45 1.023 . . . . 0.0 112.206 -178.611 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.351 0.1 OUTLIER -66.79 -47.01 73.45 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 -176.035 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -60.02 -28.2 67.54 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.552 1.141 . . . . 0.0 112.32 -178.722 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -82.7 -71.5 0.49 Allowed 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -178.435 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -171.19 23.28 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -178.718 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -121.28 76.72 1.26 Allowed 'General case' 0 C--N 1.339 0.128 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.803 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 111.19 133.79 0.0 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 131.355 3.862 . . . . 0.0 108.294 -178.713 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -90.96 81.58 5.66 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.004 1.321 . . . . 0.0 108.845 179.688 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.44 162.43 12.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.879 0.872 . . . . 0.0 112.387 -179.263 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -42.37 96.67 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.592 1.091 . . . . 0.0 114.947 -178.706 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.4 m 61.08 75.81 0.39 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -178.288 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 p 175.39 -43.85 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 103.471 -2.789 . . . . 0.0 103.471 -176.361 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.7 p -115.69 51.25 0.95 Allowed 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.856 2.062 . . . . 0.0 110.437 178.432 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 23.4 m-85 64.08 133.21 0.03 OUTLIER Pre-proline 0 C--N 1.355 0.83 0 C-N-CA 126.093 1.757 . . . . 0.0 110.76 176.504 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -76.39 161.58 93.57 Favored 'Cis proline' 0 N--CA 1.45 -1.035 0 CA-C-N 120.18 1.1 . . . . 0.0 109.931 3.555 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.74 147.25 37.08 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.026 1.331 . . . . 0.0 109.919 -177.788 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 t -76.31 132.1 39.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 103.46 -2.793 . . . . 0.0 103.46 177.12 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -95.6 106.1 18.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 -178.115 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -162.31 -58.07 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.567 1.147 . . . . 0.0 108.771 -179.241 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -81.39 70.65 8.3 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.559 1.144 . . . . 0.0 109.618 -179.367 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.55 -72.9 0.09 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.11 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -176.39 147.82 0.71 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.493 1.117 . . . . 0.0 109.275 179.18 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.75 150.82 49.83 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 178.93 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.17 170.56 18.16 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.104 0.562 . . . . 0.0 110.415 -179.209 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -71.6 -163.94 0.11 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.293 0.637 . . . . 0.0 111.63 -179.352 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.0 p90 54.28 58.73 12.11 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 125.889 1.676 . . . . 0.0 111.088 -178.178 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.28 66.83 8.74 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 124.016 3.144 . . . . 0.0 110.445 -179.429 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.37 -65.31 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.135 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -166.32 -165.09 0.74 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.048 1.339 . . . . 0.0 107.987 179.294 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.99 -174.88 45.98 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 121.91 -0.494 . . . . 0.0 112.879 179.103 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.2 128.37 6.42 Favored 'Cis proline' 0 N--CA 1.458 -0.568 0 O-C-N 122.526 0.75 . . . . 0.0 112.364 -0.292 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.72 150.57 25.01 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.114 0.966 . . . . 0.0 110.536 179.343 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -103.22 162.95 12.55 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.547 1.539 . . . . 0.0 112.82 -178.709 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.278 14.9 tp10 -101.3 151.82 21.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.646 2.379 . . . . 0.0 110.496 -178.783 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -160.16 107.43 1.39 Allowed Pre-proline 0 C--N 1.342 0.244 0 C-N-CA 124.567 1.147 . . . . 0.0 108.494 177.546 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -83.3 132.43 6.02 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 121.653 1.569 . . . . 0.0 112.607 -177.532 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.575 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.7 tt -107.81 172.41 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 124.466 2.079 . . . . 0.0 113.234 -179.289 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.575 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 16.5 ptpt -161.65 164.51 29.2 Favored 'General case' 0 C--N 1.316 -0.871 1 CA-C-N 108.191 -4.095 . . . . 0.0 112.379 179.974 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.1 m -92.33 60.33 3.63 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.536 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.5 -62.75 0.03 OUTLIER Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -179.271 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.31 -172.27 13.13 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.647 0.642 . . . . 0.0 113.939 -178.663 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.3 t -124.33 103.99 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 127.889 2.476 . . . . 0.0 105.678 -179.418 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.9 t80 60.56 92.78 0.04 OUTLIER 'General case' 0 C--N 1.345 0.38 0 C-N-CA 126.09 1.756 . . . . 0.0 110.871 -178.519 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.3 p -142.85 39.68 1.5 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.844 0.858 . . . . 0.0 110.336 179.302 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.11 98.38 0.06 OUTLIER Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.979 0.8 . . . . 0.0 112.25 179.178 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.92 -178.54 48.96 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 123.718 0.675 . . . . 0.0 111.512 179.13 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.0 t 63.12 91.81 0.07 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.684 1.593 . . . . 0.0 110.5 -179.124 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -59.87 132.31 8.07 Favored 'Cis proline' 0 C--N 1.348 0.534 0 CA-C-N 119.355 0.805 . . . . 0.0 113.338 1.901 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.79 71.57 0.03 OUTLIER Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.507 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.422 ' HB2' ' CB ' ' A' ' 91' ' ' HIS . . . -62.93 -20.64 65.4 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.861 178.863 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.72 137.4 33.86 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.289 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -157.66 147.28 20.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.522 -179.069 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.9 m -110.04 145.98 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 177.237 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.5 t -127.66 121.24 56.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -177.328 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -107.84 173.17 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.38 0 C-N-CA 125.189 1.396 . . . . 0.0 112.45 -177.58 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -91.56 161.89 14.75 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.248 1.419 . . . . 0.0 109.293 179.363 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.32 15.3 t -79.16 54.08 1.58 Allowed 'General case' 0 C--N 1.341 0.223 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -179.076 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -151.81 -88.45 0.06 Allowed 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 101.982 -3.34 . . . . 0.0 101.982 177.209 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.24 5.51 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.181 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -91.3 129.75 37.25 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 -175.48 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.56 124.14 20.61 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 177.447 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.8 -51.73 5.08 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.166 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.24 153.45 10.93 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.075 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.84 141.28 31.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.569 1.148 . . . . 0.0 110.062 179.3 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.0 pt -135.14 156.76 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 125.267 1.427 . . . . 0.0 108.081 179.157 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.58 159.67 37.33 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 119.113 -0.47 . . . . 0.0 111.308 -178.731 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.422 ' CB ' ' HB2' ' A' ' 74' ' ' ALA . 21.4 m170 -78.88 -58.76 3.08 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.015 177.412 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.288 4.8 t 48.06 9.35 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 129.228 3.011 . . . . 0.0 117.168 -178.053 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.68 44.98 0.21 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.142 1.353 . . . . 0.0 110.505 179.399 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.88 -168.6 2.29 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.985 0.914 . . . . 0.0 109.073 179.086 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.8 m -59.84 -46.57 88.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.321 0.648 . . . . 0.0 110.426 179.167 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.28 -91.48 0.08 OUTLIER Glycine 0 C--N 1.337 0.619 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 179.157 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -85.37 -2.5 58.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.022 0.929 . . . . 0.0 110.234 178.458 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -63.51 168.21 4.86 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.629 1.172 . . . . 0.0 110.708 179.114 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -138.85 156.21 47.49 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -177.608 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 m -132.61 165.54 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 127.331 2.253 . . . . 0.0 106.692 177.093 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -75.2 162.07 53.42 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 114.668 0.627 . . . . 0.0 114.668 -178.185 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 6.6 t -148.26 159.15 44.27 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 126.096 1.758 . . . . 0.0 108.953 178.289 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t 61.38 38.11 16.4 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.726 2.01 . . . . 0.0 111.819 -178.328 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.72 42.98 99.59 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.154 1.359 . . . . 0.0 112.239 179.041 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.6 t -88.21 26.03 1.49 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 179.871 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 116.618 -1.658 . . . . 0.0 110.615 -179.31 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.5 p . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.8 0.333 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.13 152.66 39.96 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.791 1.236 . . . . 0.0 110.777 179.359 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.4 t -140.4 134.21 30.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.155 0.582 . . . . 0.0 110.508 179.043 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -109.92 103.33 12.09 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 178.854 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 20.6 m -88.24 70.21 9.19 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.184 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.08 -82.24 0.88 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.416 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.5 p -106.1 -48.14 3.67 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.161 1.384 . . . . 0.0 112.058 -178.887 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.5 m -72.79 105.59 4.41 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.984 0.513 . . . . 0.0 111.694 -178.436 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -81.8 148.51 28.84 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.219 1.408 . . . . 0.0 110.531 179.869 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -148.08 127.68 13.29 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.383 1.073 . . . . 0.0 109.495 179.156 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.9 p -71.15 160.12 33.45 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 125.133 1.373 . . . . 0.0 110.504 178.323 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.36 -19.73 37.96 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.164 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.4 t -77.74 -36.72 50.45 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 123.604 0.762 . . . . 0.0 109.385 -179.986 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -42.5 64.86 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.67 1.188 . . . . 0.0 111.069 179.205 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.411 HG12 ' CE2' ' A' ' 85' ' ' TYR . 22.3 t -61.87 -45.93 97.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.297 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -66.91 -41.48 87.04 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 124.883 1.273 . . . . 0.0 112.967 179.821 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.88 -53.61 53.42 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.749 0.42 . . . . 0.0 110.294 -178.122 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.16 -32.38 72.1 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.086 179.439 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.36 -49.32 43.39 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 179.874 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -61.87 -22.94 65.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.693 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.23 -71.98 0.28 Allowed 'General case' 0 C--N 1.348 0.52 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 -177.698 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -38.53 -44.44 0.95 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.912 0.885 . . . . 0.0 112.261 178.096 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.3 m -55.82 -52.71 63.05 Favored 'General case' 0 C--N 1.346 0.447 0 O-C-N 123.288 0.367 . . . . 0.0 111.784 179.184 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -56.16 -40.15 73.42 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.755 0.822 . . . . 0.0 112.421 -178.124 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -89.38 -16.48 30.88 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -178.875 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -80.45 -24.04 39.82 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.791 1.236 . . . . 0.0 113.826 179.367 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -60.64 -33.54 72.95 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.297 0.639 . . . . 0.0 112.692 -177.921 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -126.17 -86.27 0.61 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.147 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t0 168.13 59.05 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 128.354 2.662 . . . . 0.0 105.701 -178.379 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -81.66 -178.5 6.99 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.597 179.441 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.338 11.3 t -69.07 86.68 0.37 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -177.838 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.03 -161.66 1.07 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 127.242 2.217 . . . . 0.0 107.07 177.363 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -45.55 -49.21 11.82 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.478 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.1 m 47.62 50.04 15.57 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.181 1.792 . . . . 0.0 113.606 178.051 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.1 p -143.48 -54.3 0.38 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.776 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 t -154.3 19.44 0.49 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.387 1.475 . . . . 0.0 110.543 178.984 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.466 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 12.8 m-85 -166.03 129.39 1.58 Allowed Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 126.403 1.881 . . . . 0.0 106.32 178.879 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.64 135.8 34.03 Favored 'Cis proline' 0 N--CA 1.449 -1.118 0 CA-C-N 120.355 1.163 . . . . 0.0 110.402 -1.53 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.88 155.97 36.7 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.932 0.493 . . . . 0.0 110.214 178.762 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -64.02 157.73 24.42 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.845 1.258 . . . . 0.0 112.297 -179.332 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.92 45.14 1.13 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.956 0.903 . . . . 0.0 110.212 179.263 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 48.0 -121.56 1.38 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.84 2.056 . . . . 0.0 112.103 179.895 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -137.64 -179.27 5.65 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.858 1.663 . . . . 0.0 108.813 -179.367 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 66.91 -142.53 0.14 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.066 1.346 . . . . 0.0 110.965 178.933 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -126.29 106.53 9.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.188 1.395 . . . . 0.0 109.252 -178.571 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.98 93.0 0.31 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.295 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.4 t80 51.26 65.32 1.52 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.438 1.495 . . . . 0.0 109.666 -179.138 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.36 153.31 42.43 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.792 0.806 . . . . 0.0 112.684 -178.499 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -109.31 163.88 16.01 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 127.53 2.332 . . . . 0.0 108.522 -179.124 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.98 53.66 4.27 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.848 3.032 . . . . 0.0 111.837 178.865 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.2 m -155.04 171.09 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 127.842 2.457 . . . . 0.0 108.058 -179.333 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -92.46 -133.94 0.14 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.949 0.9 . . . . 0.0 109.52 179.983 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 166.32 -156.48 28.4 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.386 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.45 151.79 12.9 Favored 'Cis proline' 0 C--N 1.349 0.587 0 CA-C-N 119.205 1.503 . . . . 0.0 113.097 -1.5 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -134.26 148.38 50.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.205 1.002 . . . . 0.0 111.877 -178.635 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.57 152.31 22.57 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -177.659 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -104.81 146.59 28.77 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 127.471 2.308 . . . . 0.0 108.459 179.276 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -160.05 121.92 1.81 Allowed Pre-proline 0 C--O 1.224 -0.238 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 179.347 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.466 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 22.8 Cg_endo -75.97 145.28 28.07 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 CA-C-N 120.624 1.259 . . . . 0.0 112.753 -176.031 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.271 5.0 tp -78.99 159.83 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 124.483 2.087 . . . . 0.0 114.094 -178.07 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.94 118.74 37.4 Favored 'General case' 0 C--N 1.321 -0.672 1 CA-C-N 108.004 -4.18 . . . . 0.0 118.222 -176.372 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.1 m -105.86 43.99 1.08 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.743 1.617 . . . . 0.0 107.075 177.997 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.41 -6.28 5.94 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 118.279 -1.29 . . . . 0.0 115.366 -179.388 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.71 134.27 2.92 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 120.15 1.975 . . . . 0.0 113.064 179.462 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.94 141.83 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.194 1.398 . . . . 0.0 110.357 -179.005 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.8 p90 39.94 54.47 2.63 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.407 2.283 . . . . 0.0 114.527 179.311 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.2 p -134.09 34.32 3.34 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.833 1.253 . . . . 0.0 108.887 178.717 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.41 -154.6 11.45 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 124.294 0.95 . . . . 0.0 111.251 -179.257 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 47.71 74.93 0.21 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.856 1.217 . . . . 0.0 112.834 178.992 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.1 m -55.53 143.41 57.97 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.178 179.314 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -45.85 -50.72 9.28 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.554 2.836 . . . . 0.0 110.993 172.829 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.41 -39.85 0.22 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 178.526 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -171.11 29.21 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 116.429 -1.748 . . . . 0.0 113.629 -177.92 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -108.57 130.39 55.3 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 122.453 2.388 . . . . 0.0 113.749 -178.464 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -134.27 155.41 50.25 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 124.372 1.069 . . . . 0.0 113.112 179.884 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 m -124.97 142.04 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 103.404 -2.813 . . . . 0.0 103.404 176.115 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.9 t -136.45 127.9 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -176.955 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.63 172.5 5.21 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 C-N-CA 127.065 2.146 . . . . 0.0 110.71 -177.901 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -100.49 -178.24 3.74 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 126.066 1.746 . . . . 0.0 110.138 179.044 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.371 13.8 t -80.33 52.48 1.61 Allowed 'General case' 0 C--N 1.344 0.34 0 N-CA-C 118.524 2.787 . . . . 0.0 118.524 -178.068 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -160.5 -93.37 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 100.394 -3.928 . . . . 0.0 100.394 176.752 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 58.2 m -163.68 16.19 0.06 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 130.101 3.36 . . . . 0.0 112.353 179.398 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -79.21 97.65 6.31 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.778 1.172 . . . . 0.0 110.256 -177.69 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.411 ' CE2' HG12 ' A' ' 16' ' ' VAL . 9.1 t80 -55.64 112.72 1.21 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.667 1.587 . . . . 0.0 108.699 178.998 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.05 -51.52 9.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.449 0.7 . . . . 0.0 110.822 -178.641 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 166.66 162.27 17.8 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.275 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.84 147.06 24.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.059 0.944 . . . . 0.0 109.104 179.028 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.2 pt -134.52 160.59 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.966 1.306 . . . . 0.0 109.241 -178.969 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.9 t -158.43 167.43 29.69 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.453 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -78.45 -65.3 1.0 Allowed 'General case' 0 C--N 1.348 0.511 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.343 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.1 t 42.78 14.28 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 129.249 3.02 . . . . 0.0 116.778 -179.364 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.99 -32.71 0.15 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.466 1.507 . . . . 0.0 110.44 -179.038 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.18 127.57 17.27 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.829 1.652 . . . . 0.0 112.09 179.233 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.9 t -105.89 69.19 0.81 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.986 1.315 . . . . 0.0 109.114 179.718 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.67 -161.01 30.35 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.452 1.025 . . . . 0.0 110.921 179.373 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -79.5 8.55 6.14 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.071 0.948 . . . . 0.0 111.388 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -80.24 156.83 26.69 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.233 1.413 . . . . 0.0 110.286 178.852 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -137.78 159.96 40.56 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.279 1.432 . . . . 0.0 111.195 -178.192 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.9 m -128.38 176.15 8.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 C-N-CA 127.877 2.471 . . . . 0.0 106.969 178.05 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.31 171.07 43.6 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 117.054 1.581 . . . . 0.0 117.054 -177.647 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.3 m -129.26 -176.49 3.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.917 2.487 . . . . 0.0 107.206 177.963 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.6 t 28.5 38.84 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -177.099 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 53.32 48.94 58.49 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.324 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.6 t -79.23 150.54 31.58 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.596 0.759 . . . . 0.0 111.801 -178.615 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.1 t30 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.245 -1.36 . . . . 0.0 108.717 -179.386 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 76.82 63.08 0.04 OUTLIER 'General case' 0 C--N 1.34 0.167 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 -177.433 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 t -106.02 156.43 18.41 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.893 0.877 . . . . 0.0 111.354 -177.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.08 112.28 12.2 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 178.723 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.6 m -96.55 74.93 2.82 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.242 1.017 . . . . 0.0 110.012 -178.825 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.3 -70.81 2.1 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 125.097 1.332 . . . . 0.0 111.524 179.121 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.2 t -126.49 -44.58 1.69 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.896 1.678 . . . . 0.0 109.919 -179.222 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 m -68.5 111.06 4.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.644 0.778 . . . . 0.0 109.514 -179.349 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -81.41 151.94 27.66 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.083 0.953 . . . . 0.0 110.532 179.911 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -143.27 110.14 5.58 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.427 1.091 . . . . 0.0 110.326 -179.551 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.8 m -63.1 154.15 31.88 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 125.275 1.43 . . . . 0.0 109.171 178.77 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -20.9 57.81 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.865 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.4 m -74.35 -43.22 57.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.042 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -67.82 -47.29 69.46 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.189 0.995 . . . . 0.0 112.343 -179.174 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -60.19 -52.65 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 124.194 0.998 . . . . 0.0 109.215 -179.342 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -66.38 -38.8 88.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.141 1.377 . . . . 0.0 113.002 -177.841 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.51 -52.6 60.54 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.355 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.96 -32.55 73.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.431 179.237 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.92 -32.29 61.75 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 178.896 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -69.74 -24.66 63.57 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 176.959 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.06 -63.67 1.26 Allowed 'General case' 0 C--N 1.349 0.57 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 -179.222 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -41.58 -40.1 1.79 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.273 1.429 . . . . 0.0 112.447 176.852 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -60.89 -63.54 1.26 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.282 1.433 . . . . 0.0 110.247 179.219 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -66.43 -24.17 66.41 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -179.065 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -82.25 -45.31 15.18 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.211 1.404 . . . . 0.0 113.531 -177.798 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -66.23 -28.26 68.6 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.374 1.069 . . . . 0.0 112.589 -178.525 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -74.84 -64.73 0.98 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.407 0.548 . . . . 0.0 110.904 -177.738 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -172.49 -29.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.546 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -75.49 39.02 0.15 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -177.502 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.05 169.7 0.06 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.224 2.21 . . . . 0.0 110.689 178.608 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.0 t -158.28 37.19 0.24 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.388 1.475 . . . . 0.0 110.337 179.322 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.04 158.98 27.78 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.754 0.822 . . . . 0.0 111.835 -179.149 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.64 -137.59 7.33 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.573 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.7 t -145.32 -68.53 0.29 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.625 1.17 . . . . 0.0 108.452 179.091 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.2 m -83.33 -94.1 0.06 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.908 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.3 p -140.63 40.57 1.86 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.389 0.675 . . . . 0.0 110.677 178.571 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -82.17 132.06 54.49 Favored Pre-proline 0 C--N 1.345 0.389 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 177.66 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.49 123.75 5.73 Favored 'Cis proline' 0 CA--C 1.544 1.015 0 N-CA-C 114.044 0.748 . . . . 0.0 114.044 3.005 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.85 148.4 22.52 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 128.452 2.701 . . . . 0.0 113.758 -177.319 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.97 113.76 2.99 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.933 0.893 . . . . 0.0 109.264 179.047 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -95.03 90.38 5.92 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 120.838 0.352 . . . . 0.0 110.072 -178.821 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -156.12 119.21 4.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.162 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -128.58 -79.82 0.57 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.295 1.038 . . . . 0.0 109.336 -179.089 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -143.61 11.26 1.66 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.904 1.281 . . . . 0.0 110.884 179.467 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 55.45 47.64 20.66 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.225 1.41 . . . . 0.0 110.682 -178.852 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.67 -31.53 6.67 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.292 1.425 . . . . 0.0 111.303 179.413 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -127.44 94.02 3.87 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.041 1.336 . . . . 0.0 108.391 -179.195 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -118.88 -177.95 3.44 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.582 1.153 . . . . 0.0 111.487 -178.837 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.21 175.53 3.21 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.989 1.716 . . . . 0.0 108.553 -178.714 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.63 68.07 7.11 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.352 2.701 . . . . 0.0 111.573 -179.403 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.5 m -143.18 157.28 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 125.668 1.587 . . . . 0.0 109.78 179.695 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -85.5 -44.97 12.24 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.797 1.239 . . . . 0.0 111.235 -179.326 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.79 177.82 43.81 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.72 1.152 . . . . 0.0 111.865 -179.423 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.29 152.96 85.19 Favored 'Cis proline' 0 N--CA 1.458 -0.594 0 CA-C-N 117.973 0.886 . . . . 0.0 112.409 0.763 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.1 154.96 47.74 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 127.185 2.194 . . . . 0.0 109.981 179.325 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -135.85 160.81 37.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.049 -178.743 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.98 162.26 26.08 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.719 1.608 . . . . 0.0 112.14 -177.552 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -160.61 104.38 1.32 Allowed Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 177.388 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -80.84 135.46 10.09 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 121.899 1.733 . . . . 0.0 112.774 -175.778 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.667 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 3.7 tt -105.35 -176.34 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-O 124.249 1.976 . . . . 0.0 112.401 -179.223 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.667 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.3 mmtm -160.51 142.84 12.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 108.945 -3.752 . . . . 0.0 110.229 179.72 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.7 t -85.83 60.83 6.47 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.71 1.204 . . . . 0.0 109.138 -179.134 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.51 49.81 0.1 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.93 1.729 . . . . 0.0 109.003 -179.214 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.6 154.39 7.57 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.328 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.8 t -135.61 150.94 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.168 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 16.6 p90 48.33 48.47 18.93 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.818 1.647 . . . . 0.0 111.963 -179.051 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.1 m -79.29 138.31 37.7 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 125.027 1.331 . . . . 0.0 108.964 -178.896 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.91 -84.15 0.23 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.871 0.748 . . . . 0.0 112.791 -178.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.56 76.56 1.32 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.165 0.888 . . . . 0.0 112.096 -178.825 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.3 m -98.65 157.78 33.65 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.229 1.412 . . . . 0.0 110.177 179.338 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.9 -44.28 49.74 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.731 2.954 . . . . 0.0 111.495 164.61 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.57 24.23 26.49 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.773 1.178 . . . . 0.0 112.11 179.18 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.468 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -94.16 -68.92 0.77 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.158 -0.925 . . . . 0.0 109.548 179.203 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -70.4 107.1 3.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.096 0.958 . . . . 0.0 112.622 -178.621 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -140.03 131.65 27.2 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.338 0.655 . . . . 0.0 111.719 -179.074 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -94.19 153.16 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 176.882 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.7 t -132.95 130.42 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -178.348 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.5 pt -116.79 176.22 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.6 1.16 . . . . 0.0 112.634 -177.997 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -90.49 177.34 6.4 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 126.442 1.897 . . . . 0.0 110.022 179.763 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.322 12.9 t -81.2 47.71 1.05 Allowed 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 118.58 2.807 . . . . 0.0 118.58 -178.651 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -160.41 -87.04 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 177.05 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 76.7 m -162.97 62.6 0.19 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.198 2.599 . . . . 0.0 110.082 -176.793 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -144.02 117.74 9.27 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.202 1.819 . . . . 0.0 114.391 -179.416 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -55.74 128.83 36.73 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.365 1.066 . . . . 0.0 108.449 178.622 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.61 -59.6 1.68 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.931 0.892 . . . . 0.0 108.833 178.805 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.91 173.57 41.51 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.369 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.47 115.95 22.42 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.681 1.593 . . . . 0.0 109.231 179.267 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.9 pt -108.83 158.01 8.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 125.06 1.344 . . . . 0.0 110.017 -179.235 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 t -159.61 137.11 9.84 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 -179.529 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.468 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 6.5 m170 -78.1 -11.22 59.9 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 117.881 -1.057 . . . . 0.0 112.034 174.997 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.7 m -26.53 -65.63 0.06 Allowed 'General case' 0 C--N 1.349 0.549 0 C-N-CA 126.447 1.899 . . . . 0.0 114.937 -178.469 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.04 -75.51 1.25 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -179.348 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 50.81 -150.23 0.26 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.064 1.346 . . . . 0.0 112.27 -179.306 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 60.1 p -153.97 -51.41 0.1 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.163 1.385 . . . . 0.0 108.651 179.118 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -121.55 -86.38 0.86 Allowed Glycine 0 C--N 1.34 0.791 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 178.817 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -134.13 28.13 3.8 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.547 1.539 . . . . 0.0 110.734 179.23 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -85.96 164.96 17.1 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.906 1.282 . . . . 0.0 111.628 -178.885 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.454 ' CE2' ' NE2' ' A' ' 91' ' ' HIS . 13.5 m-85 -118.65 116.05 25.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.122 1.769 . . . . 0.0 107.781 179.098 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.4 m -90.89 164.44 2.12 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.255 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.15 133.83 11.99 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.071 -178.32 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 26.2 m -81.32 -172.99 4.09 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.526 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.9 t -75.8 93.06 3.1 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.993 -0.442 . . . . 0.0 110.12 -179.03 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.49 51.27 0.24 Allowed Glycine 0 CA--C 1.527 0.834 0 C-N-CA 126.105 1.812 . . . . 0.0 109.397 -179.37 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.0 m -154.66 110.82 3.22 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 125.2 1.4 . . . . 0.0 108.853 -179.14 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.5 m120 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.217 -1.373 . . . . 0.0 109.414 179.111 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -50.29 136.55 19.8 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.541 1.536 . . . . 0.0 111.436 -179.784 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.3 p -104.0 150.13 24.53 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.976 1.31 . . . . 0.0 111.379 -179.034 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -133.46 97.03 3.84 Favored 'General case' 0 N--CA 1.424 -1.772 1 N-CA-C 97.38 -5.044 . . . . 0.0 97.38 176.591 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -97.31 85.57 3.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.471 0.653 . . . . 0.0 110.668 -177.185 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.12 -96.2 1.58 Allowed Glycine 0 C--N 1.34 0.762 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 -178.879 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.7 m -104.91 -36.61 7.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.353 1.061 . . . . 0.0 110.307 179.23 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.38 168.03 19.27 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.346 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -156.75 132.45 9.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.091 0.156 . . . . 0.0 110.86 179.323 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -123.74 158.35 31.89 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.876 1.27 . . . . 0.0 109.947 -179.683 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.1 m -78.05 156.26 30.17 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.224 1.41 . . . . 0.0 110.479 -179.667 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.38 -18.9 42.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.83 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.7 p -72.66 -38.05 67.75 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 123.637 0.775 . . . . 0.0 109.966 179.248 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.93 -47.93 67.34 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.807 0.731 . . . . 0.0 110.236 178.654 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.2 t -53.14 -49.89 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 125.077 1.351 . . . . 0.0 108.496 179.09 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -69.51 -38.32 77.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.372 1.469 . . . . 0.0 113.083 -178.819 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.59 -54.18 31.43 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.817 0.735 . . . . 0.0 110.79 -178.507 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.25 -34.1 75.88 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.584 0.754 . . . . 0.0 111.118 179.43 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.11 -36.89 61.63 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 119.477 -0.297 . . . . 0.0 111.506 178.957 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -69.32 -20.78 63.87 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.449 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.5 -57.41 3.36 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -178.224 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.8 -38.26 47.38 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.088 1.355 . . . . 0.0 109.822 177.269 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.2 t -60.69 -54.57 43.68 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.358 1.463 . . . . 0.0 109.158 178.506 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -56.79 -36.85 70.35 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.687 0.395 . . . . 0.0 110.837 179.532 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.25 -6.52 59.28 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.714 1.206 . . . . 0.0 114.098 -179.863 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.42 ' CD2' ' HG3' ' A' ' 57' ' ' GLN . 8.7 t80 -128.23 43.96 3.04 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.154 0.888 . . . . 0.0 111.402 178.926 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -130.78 -84.46 0.52 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.338 1.455 . . . . 0.0 107.598 177.483 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -162.93 -14.75 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.274 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -84.17 65.21 8.66 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.586 1.554 . . . . 0.0 107.576 179.89 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 78.04 111.35 0.07 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 128.138 2.575 . . . . 0.0 108.475 -178.971 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.4 p -87.49 77.63 8.78 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.544 1.138 . . . . 0.0 109.295 -178.68 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.59 91.93 2.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.516 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.48 108.34 2.77 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 126.113 1.816 . . . . 0.0 108.57 -179.519 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 m -71.18 -66.9 0.56 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.834 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.0 p 156.49 -47.87 0.0 OUTLIER 'General case' 0 C--N 1.34 0.184 0 N-CA-C 100.537 -3.875 . . . . 0.0 100.537 -177.664 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.442 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 7.5 t -93.11 53.2 1.92 Allowed 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 125.838 1.655 . . . . 0.0 107.308 176.951 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER 79.69 155.15 0.13 Allowed Pre-proline 0 C--N 1.348 0.53 0 C-N-CA 127.376 2.27 . . . . 0.0 115.086 175.737 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.93 127.66 13.1 Favored 'Cis proline' 0 C--N 1.349 0.582 0 N-CA-C 114.93 1.089 . . . . 0.0 114.93 1.899 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.04 169.56 20.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.748 1.219 . . . . 0.0 110.212 178.913 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 m -37.52 131.66 0.9 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 128.737 2.815 . . . . 0.0 115.828 -178.911 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -109.07 109.21 20.17 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.975 1.71 . . . . 0.0 106.708 178.418 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -70.91 -36.34 72.67 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.616 1.166 . . . . 0.0 113.636 -178.788 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 70.86 77.26 0.18 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.198 1.399 . . . . 0.0 108.134 -178.465 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -72.76 91.53 1.49 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.111 1.364 . . . . 0.0 111.747 -178.641 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 54.75 152.83 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 129.305 3.042 . . . . 0.0 115.821 179.191 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.61 -145.25 24.26 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.774 1.178 . . . . 0.0 112.583 179.236 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.04 172.27 0.09 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.05 1.74 . . . . 0.0 113.46 -179.36 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -158.45 121.93 3.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 179.395 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -132.81 105.34 12.78 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 178.448 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.64 80.86 1.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.699 2.933 . . . . 0.0 113.397 -178.223 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.04 160.5 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.472 1.909 . . . . 0.0 107.81 178.822 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.57 -50.51 8.71 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.726 0.81 . . . . 0.0 110.623 179.557 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.54 -159.76 35.3 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.059 0.837 . . . . 0.0 111.257 -179.389 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.82 153.67 13.38 Favored 'Cis proline' 0 C--N 1.347 0.478 0 CA-C-N 119.092 1.446 . . . . 0.0 113.802 -0.172 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.87 158.25 20.41 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 123.877 0.871 . . . . 0.0 110.933 -178.994 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.42 ' HG3' ' CD2' ' A' ' 27' ' ' TYR . 6.2 mm100 -130.98 150.89 51.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.51 1.124 . . . . 0.0 111.687 -178.601 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -88.04 156.28 19.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.556 1.142 . . . . 0.0 110.653 179.216 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -159.74 109.22 1.46 Allowed Pre-proline 0 N--CA 1.457 -0.121 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.24 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -81.28 136.63 10.15 Favored 'Trans proline' 0 N--CA 1.436 -1.897 0 C-N-CA 121.043 1.162 . . . . 0.0 113.088 -177.827 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.482 ' CG2' ' H ' ' A' ' 62' ' ' LYS . 0.6 OUTLIER -103.26 -173.78 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 128.868 2.867 . . . . 0.0 103.891 178.896 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.482 ' H ' ' CG2' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -163.36 -179.38 6.52 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 112.308 -2.224 . . . . 0.0 113.022 -177.989 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.3 t -89.42 51.05 2.03 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.075 1.35 . . . . 0.0 107.647 178.013 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.33 -66.78 0.03 OUTLIER Glycine 0 C--N 1.344 0.975 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.097 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.22 -149.41 7.28 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 117.75 0.775 . . . . 0.0 113.14 -179.774 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 t -61.86 130.72 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 126.509 1.923 . . . . 0.0 108.941 -179.165 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.1 133.14 45.36 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.879 0.872 . . . . 0.0 112.752 -178.732 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 m -132.34 -33.85 1.26 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.544 1.938 . . . . 0.0 110.352 179.394 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.26 -141.21 0.36 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.307 1.432 . . . . 0.0 114.851 -178.636 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.77 -151.69 1.55 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.364 1.459 . . . . 0.0 113.957 -178.777 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 m 72.88 151.33 0.14 Allowed Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 126.545 1.938 . . . . 0.0 110.664 -179.246 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -57.95 -72.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.042 2.495 . . . . 0.0 110.537 179.146 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.24 64.69 1.45 Allowed Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 178.304 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.69 -49.0 78.24 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.434 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.01 132.48 48.68 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.742 1.617 . . . . 0.0 108.218 178.725 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -157.96 132.73 8.47 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -178.512 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.6 m -95.95 147.66 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 176.309 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -128.65 117.32 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -178.635 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 35.4 pt -99.96 174.1 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.412 0 C-N-CA 126.345 1.858 . . . . 0.0 112.684 -178.287 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -94.85 -175.36 3.54 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.135 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.295 13.8 t -84.51 42.85 0.92 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 -179.9 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.8 -72.49 0.1 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.054 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.68 -9.04 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 -177.227 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -79.3 118.59 21.36 Favored 'General case' 0 N--CA 1.458 -0.061 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -175.921 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -71.29 115.03 9.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.249 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.76 -57.97 3.41 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.945 0.898 . . . . 0.0 112.126 -178.548 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.77 151.6 12.03 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.769 179.716 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.07 131.11 44.76 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.291 1.436 . . . . 0.0 110.847 -179.052 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.6 pt -130.99 162.56 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 125.45 1.5 . . . . 0.0 109.638 -179.019 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 t -156.56 146.83 21.34 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -179.606 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -79.26 -26.64 42.36 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.237 175.177 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.0 m -31.05 -59.94 0.21 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 127.946 2.498 . . . . 0.0 115.347 -178.13 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.39 34.06 4.57 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.297 0.951 . . . . 0.0 112.231 -178.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.81 -87.51 0.16 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 117.604 0.702 . . . . 0.0 110.981 179.511 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.2 t -162.29 -51.94 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.083 1.353 . . . . 0.0 108.723 -179.188 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.46 -88.96 0.07 OUTLIER Glycine 0 C--N 1.339 0.71 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 179.24 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -79.94 -28.61 39.65 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.115 0.966 . . . . 0.0 110.325 178.725 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -63.19 169.3 3.6 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.287 1.435 . . . . 0.0 111.538 -179.541 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -128.64 156.71 42.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.899 2.08 . . . . 0.0 109.743 -179.711 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.7 m -141.88 155.84 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 C-N-CA 124.432 1.093 . . . . 0.0 108.17 177.094 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.47 129.05 9.05 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.122 -177.775 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 37.4 m -79.93 179.75 7.41 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.298 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.2 p -61.19 124.7 21.3 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.872 -1.143 . . . . 0.0 109.683 179.152 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.04 37.61 5.65 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -178.752 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 60.5 m -152.52 145.68 24.64 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.759 1.624 . . . . 0.0 107.965 -179.732 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 125.948 1.699 . . . . 0.0 110.952 179.47 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.1 t . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.59 177.29 0.21 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.47 1.508 . . . . 0.0 110.274 -178.877 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.6 p -143.95 94.13 2.54 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.08 0.552 . . . . 0.0 110.273 178.869 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.0 m -87.76 89.61 8.06 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 102.51 -3.144 . . . . 0.0 102.51 177.792 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.3 m -86.92 63.76 8.12 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.308 1.843 . . . . 0.0 108.852 -178.952 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.13 -79.29 1.88 Allowed Glycine 0 C--N 1.34 0.779 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.085 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.7 p -115.07 -42.45 3.2 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.429 1.491 . . . . 0.0 109.68 179.256 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.35 114.3 3.11 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 124.514 1.125 . . . . 0.0 108.568 178.925 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.65 99.75 7.96 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.709 0.804 . . . . 0.0 110.368 -178.176 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -94.67 146.24 24.29 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.559 0.743 . . . . 0.0 109.08 179.048 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.4 m -72.15 153.12 41.84 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 124.094 0.958 . . . . 0.0 109.979 -179.555 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.44 -18.87 43.09 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 176.822 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 63.3 m -75.28 -39.75 59.37 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 125.002 1.321 . . . . 0.0 109.176 178.705 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -68.92 -40.84 78.83 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 123.946 0.899 . . . . 0.0 110.85 179.188 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.1 t -61.53 -48.32 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.888 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 ttt85 -65.83 -39.82 91.2 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.58 1.552 . . . . 0.0 112.125 -179.715 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.19 -51.83 66.23 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.178 0.591 . . . . 0.0 109.65 -179.074 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.51 -30.67 71.44 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.272 0.629 . . . . 0.0 111.477 179.256 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.65 -46.71 45.01 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.302 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -65.71 -20.24 66.2 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.76 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.96 -61.49 2.0 Allowed 'General case' 0 C--N 1.346 0.456 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -177.643 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -43.83 -51.64 7.27 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 124.849 1.343 . . . . 0.0 109.313 176.732 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 m -48.19 -54.25 14.09 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 126.479 1.912 . . . . 0.0 111.155 178.775 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -70.99 -25.92 62.91 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -178.729 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -106.08 -2.21 22.94 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 -176.93 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.48 -5.66 15.09 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.076 1.307 . . . . 0.0 114.275 178.683 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -78.3 -62.95 1.52 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.062 0.846 . . . . 0.0 112.134 -178.102 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -159.68 -41.32 0.05 Allowed 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.124 0.57 . . . . 0.0 110.916 -178.785 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.68 60.71 5.4 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.222 1.409 . . . . 0.0 107.643 178.814 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -69.99 123.24 21.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.611 1.564 . . . . 0.0 111.408 -178.423 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.8 t -149.41 39.56 0.82 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.871 0.869 . . . . 0.0 110.906 179.032 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.69 105.01 0.1 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.47 1.908 . . . . 0.0 106.025 179.122 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.32 114.59 0.63 Allowed Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.242 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 78.8 p -70.59 -67.84 0.47 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.411 1.084 . . . . 0.0 111.038 -179.031 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.1 m -143.09 -69.44 0.33 Allowed 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.156 0.983 . . . . 0.0 108.69 179.421 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.0 p -104.62 -58.44 1.88 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.494 1.118 . . . . 0.0 108.091 179.338 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.95 123.62 82.5 Favored Pre-proline 0 N--CA 1.468 0.457 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 178.316 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.31 123.59 8.67 Favored 'Cis proline' 0 N--CA 1.456 -0.699 0 N-CA-C 116.662 1.755 . . . . 0.0 116.662 3.892 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.64 173.23 2.02 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 128.207 2.603 . . . . 0.0 108.031 178.051 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 52.4 p -72.15 160.14 32.95 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.68 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -117.86 119.47 34.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.131 2.172 . . . . 0.0 108.658 179.554 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -166.68 44.95 0.06 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.288 1.435 . . . . 0.0 108.703 179.138 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -95.2 77.47 3.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.257 1.023 . . . . 0.0 110.384 -179.013 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 63.28 -177.21 0.15 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.614 1.566 . . . . 0.0 113.685 178.505 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -74.25 -173.0 1.55 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.722 1.609 . . . . 0.0 111.295 179.127 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.09 -52.56 0.63 Allowed Glycine 0 C--N 1.34 0.782 0 C-N-CA 124.603 1.097 . . . . 0.0 110.46 179.452 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -138.36 131.52 30.09 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.103 0.961 . . . . 0.0 110.312 179.274 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -161.04 137.29 8.36 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.223 1.809 . . . . 0.0 107.278 179.302 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -94.47 151.71 39.52 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.943 0.897 . . . . 0.0 110.339 -178.86 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.88 67.29 6.67 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 124.244 3.296 . . . . 0.0 112.044 -179.368 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.0 m -147.65 163.94 6.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 125.866 1.666 . . . . 0.0 108.066 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -66.27 -44.42 83.65 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.749 0.819 . . . . 0.0 111.725 -179.652 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.3 -171.29 49.18 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.182 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.53 167.11 24.25 Favored 'Cis proline' 0 C--N 1.348 0.526 0 CA-C-N 119.529 1.665 . . . . 0.0 113.766 -1.5 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -128.69 146.97 50.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.178 1.391 . . . . 0.0 110.832 -179.338 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -91.69 138.2 31.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 128.086 2.554 . . . . 0.0 113.43 -178.342 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.1 141.52 30.94 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.285 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -149.75 114.46 3.47 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.862 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -80.59 133.36 9.37 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.141 1.894 . . . . 0.0 112.516 -176.882 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.687 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 2.3 tt -106.05 -170.23 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-O 123.481 1.61 . . . . 0.0 111.984 -179.262 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.687 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.2 mmtp -160.76 -170.06 2.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 109.962 -3.29 . . . . 0.0 112.493 179.37 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.1 t -85.77 63.05 7.83 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 126.705 2.002 . . . . 0.0 108.108 -179.667 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.47 59.99 2.06 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -179.261 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.13 98.24 0.18 Allowed Glycine 0 C--N 1.338 0.668 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.076 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.3 t -64.42 147.26 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 178.207 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.5 t80 69.85 -167.43 0.17 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.093 0.957 . . . . 0.0 108.693 -179.041 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.2 p -78.73 114.91 18.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.256 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.56 -130.31 5.58 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.826 1.203 . . . . 0.0 110.816 -179.285 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.65 73.18 2.7 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.195 0.903 . . . . 0.0 112.981 -178.94 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.3 m 56.55 69.82 1.64 Allowed Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.153 1.381 . . . . 0.0 112.401 178.885 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.99 85.03 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.212 3.274 . . . . 0.0 111.463 179.39 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.77 31.54 8.56 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.01 -0.883 . . . . 0.0 113.717 -179.203 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -157.08 -71.5 0.1 Allowed 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.75 1.275 . . . . 0.0 111.251 178.932 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -68.93 108.63 3.57 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.356 1.862 . . . . 0.0 114.926 -178.728 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -128.35 126.2 40.23 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 125.253 1.421 . . . . 0.0 111.846 179.693 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 m -93.74 144.2 10.03 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 176.699 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.7 t -137.63 127.18 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.042 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.7 pt -113.81 171.36 4.07 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 C-N-CA 125.188 1.395 . . . . 0.0 111.655 -178.352 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -85.22 165.95 16.94 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.881 1.672 . . . . 0.0 107.897 178.833 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.389 5.9 t -80.04 48.16 0.96 Allowed 'General case' 0 C--N 1.343 0.309 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -178.204 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -143.64 -85.59 0.14 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 102.071 -3.307 . . . . 0.0 102.071 176.754 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -163.61 -3.57 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.579 1.951 . . . . 0.0 114.616 178.687 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -79.67 122.4 26.5 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -176.084 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -63.32 117.15 6.22 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.507 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.65 -53.41 4.65 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 123.515 0.726 . . . . 0.0 110.761 -177.647 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.66 150.94 9.97 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.356 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.97 130.37 54.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.648 1.179 . . . . 0.0 108.145 179.565 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.8 pt -122.27 157.43 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.938 1.295 . . . . 0.0 108.579 -179.27 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.3 t -156.97 146.08 20.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -178.661 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -84.33 65.0 8.64 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 174.571 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.5 m -51.07 -46.61 61.81 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.927 0.785 . . . . 0.0 110.387 179.236 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.57 -51.48 0.03 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 179.401 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 30.25 -99.35 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 128.071 2.548 . . . . 0.0 112.669 -179.13 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.4 m -159.58 79.46 0.72 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.854 1.662 . . . . 0.0 107.251 179.141 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.49 -108.05 2.31 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.462 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -79.77 -5.9 56.23 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.736 0.814 . . . . 0.0 113.0 -179.325 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -64.64 160.86 18.86 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.002 0.819 . . . . 0.0 110.339 179.288 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -121.82 167.55 12.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.572 1.549 . . . . 0.0 113.656 -177.832 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.8 m -146.19 165.99 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 128.953 2.901 . . . . 0.0 105.928 176.737 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.2 144.96 17.09 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.369 0.509 . . . . 0.0 113.946 -178.238 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 13.9 m -94.3 165.24 12.68 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 124.092 0.957 . . . . 0.0 109.049 178.43 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 88.1 p 21.81 43.47 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 129.11 2.964 . . . . 0.0 118.091 -177.887 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.77 59.38 9.8 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.587 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.3 t -78.99 151.31 31.64 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.983 0.42 . . . . 0.0 110.689 -179.397 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 . . . . . 0 C--O 1.251 1.132 0 CA-C-O 116.468 -1.73 . . . . 0.0 110.779 -178.956 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.51 132.61 45.14 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.14 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.4 t -132.93 143.34 49.42 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -177.76 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.82 117.34 29.93 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.952 1.701 . . . . 0.0 108.212 178.885 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.8 m -103.76 78.18 1.54 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.896 1.278 . . . . 0.0 108.506 -178.814 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.51 -57.75 4.89 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.415 1.007 . . . . 0.0 111.723 179.392 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.1 t -150.79 -42.1 0.12 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.963 1.305 . . . . 0.0 110.56 -179.369 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.71 113.31 5.39 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.382 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -82.29 155.11 25.0 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.564 1.546 . . . . 0.0 111.394 -178.876 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -149.74 139.96 22.2 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.077 1.351 . . . . 0.0 109.092 178.956 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 m -81.52 160.19 23.98 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 124.862 1.265 . . . . 0.0 108.502 177.7 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.33 -23.42 48.71 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.863 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.2 p -77.85 -31.12 51.3 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.678 0.611 . . . . 0.0 110.286 -178.955 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.63 -39.43 70.42 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.939 0.896 . . . . 0.0 111.525 179.162 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.03 -38.66 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -179.141 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -72.0 -24.71 61.62 Favored 'General case' 0 C--N 1.347 0.461 0 C-N-CA 124.576 1.15 . . . . 0.0 112.384 179.124 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.47 -58.32 4.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.381 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.18 -23.34 63.92 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.076 179.33 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.73 -43.48 54.78 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 120.693 1.588 . . . . 0.0 111.292 178.944 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -66.93 -21.62 65.98 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.982 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.18 -64.3 1.17 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 -178.733 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.447 ' HB1' ' CD2' ' A' ' 59' ' ' PHE . . . -34.7 -53.05 0.54 Allowed 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.35 1.86 . . . . 0.0 111.226 175.952 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.3 t -56.75 -53.63 55.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.316 1.446 . . . . 0.0 110.919 179.446 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -73.87 -12.51 60.69 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -179.169 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -108.88 -19.24 13.47 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -178.832 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -80.84 -59.32 2.72 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.516 1.507 . . . . 0.0 112.785 -177.735 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -143.81 51.9 1.32 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.927 0.785 . . . . 0.0 111.713 -178.784 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -134.99 -53.58 0.8 Allowed 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.665 1.186 . . . . 0.0 108.835 178.764 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -138.4 86.21 2.14 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -178.977 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 68.23 -167.92 0.19 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.81 1.244 . . . . 0.0 110.215 -179.507 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.5 p -107.41 -41.02 5.2 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.17 1.388 . . . . 0.0 110.024 178.748 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 52.08 95.63 0.01 OUTLIER 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.505 1.922 . . . . 0.0 113.329 178.888 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.72 -95.64 0.99 Allowed Glycine 0 C--N 1.336 0.563 0 C-N-CA 124.816 1.198 . . . . 0.0 110.363 179.936 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m 54.8 67.48 1.01 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.413 1.085 . . . . 0.0 110.095 -179.09 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.4 t -113.08 -56.03 2.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 102.311 -3.218 . . . . 0.0 102.311 179.436 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.49 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 22.3 p -119.9 -31.54 4.46 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 127.645 2.378 . . . . 0.0 107.464 177.047 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' A' ' 37' ' ' THR . 1.8 m-85 -149.19 154.51 39.18 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 127.377 2.271 . . . . 0.0 110.044 -178.786 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.17 119.71 6.59 Favored 'Cis proline' 0 CA--C 1.542 0.907 0 N-CA-C 114.082 0.762 . . . . 0.0 114.082 1.93 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -127.85 158.83 36.67 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 125.966 1.706 . . . . 0.0 110.71 -179.343 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.9 m -59.64 135.7 57.76 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.996 2.118 . . . . 0.0 110.104 178.708 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -135.94 60.58 1.67 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.019 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -161.79 58.31 0.26 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.874 1.27 . . . . 0.0 109.076 -179.033 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -70.98 -62.69 1.3 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.968 0.907 . . . . 0.0 110.196 179.802 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -141.14 -80.66 0.25 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.949 1.3 . . . . 0.0 108.152 179.458 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -166.04 121.7 1.26 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -179.373 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.69 -73.59 0.05 OUTLIER Glycine 0 C--N 1.336 0.565 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 178.941 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.21 171.71 8.43 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.012 0.925 . . . . 0.0 109.446 179.068 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -128.46 146.37 50.83 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.142 0.977 . . . . 0.0 111.168 -179.201 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -153.1 155.17 31.76 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 125.866 1.667 . . . . 0.0 108.201 -179.707 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.28 -32.63 61.58 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.945 2.43 . . . . 0.0 111.137 178.874 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.9 m -74.78 164.93 3.38 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 C-N-CA 123.576 0.75 . . . . 0.0 111.094 179.276 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -100.43 -61.3 1.39 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.024 1.33 . . . . 0.0 109.203 179.431 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 135.77 -165.72 24.75 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.71 1.148 . . . . 0.0 110.998 179.441 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.61 138.21 23.31 Favored 'Cis proline' 0 C--N 1.345 0.392 0 CA-C-N 118.247 1.024 . . . . 0.0 111.533 -0.632 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -135.25 138.95 44.04 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 179.989 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -125.3 157.81 35.73 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.626 1.57 . . . . 0.0 112.116 -178.748 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.33 157.26 25.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 127.631 2.373 . . . . 0.0 114.151 -177.934 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CD2' ' HB1' ' A' ' 23' ' ' ALA . 60.7 t80 -160.8 113.36 1.32 Allowed Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.248 1.019 . . . . 0.0 110.157 177.915 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . 0.269 24.8 Cg_endo -70.52 138.64 35.86 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 CA-C-N 120.17 1.097 . . . . 0.0 112.731 -177.243 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.567 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -80.96 -149.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -176.969 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.567 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 27.0 mmmt -83.35 -171.04 3.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 131.156 3.783 . . . . 0.0 111.945 -178.15 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.3 t 91.56 54.97 0.0 OUTLIER 'General case' 0 C--N 1.343 0.295 0 C-N-CA 129.56 3.144 . . . . 0.0 105.383 -178.008 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.21 -46.02 0.84 Allowed Glycine 0 CA--C 1.53 0.997 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -178.377 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.29 172.09 24.09 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.364 1.459 . . . . 0.0 109.989 179.41 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.35 114.46 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 178.939 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 75.1 t80 61.63 75.81 0.39 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.163 1.385 . . . . 0.0 111.462 -179.181 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 t -160.26 -178.34 6.89 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.341 1.057 . . . . 0.0 110.128 178.724 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.16 -150.54 1.94 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.665 1.126 . . . . 0.0 112.316 179.508 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.4 -55.3 4.72 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -178.997 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.4 t -137.8 79.52 33.54 Favored Pre-proline 0 N--CA 1.451 -0.386 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.647 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -35.09 -54.63 0.63 Allowed 'Trans proline' 0 C--N 1.349 0.595 1 C-N-CA 126.242 4.628 . . . . 0.0 116.362 -175.824 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.72 99.26 0.16 Allowed Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.59 -0.815 . . . . 0.0 113.559 -179.231 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.11 -76.52 0.1 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 177.244 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.59 110.53 1.15 Allowed 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.761 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -136.29 119.66 16.84 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.821 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.4 m -89.15 152.0 3.4 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 176.622 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -137.75 141.77 38.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -176.982 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.59 179.56 4.17 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 123.72 0.808 . . . . 0.0 112.531 -178.485 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -96.38 169.84 9.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.461 1.905 . . . . 0.0 110.015 -178.62 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.278 6.5 t -76.56 28.03 0.13 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 118.051 2.611 . . . . 0.0 118.051 -177.967 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -129.5 -78.0 0.55 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 102.648 -3.093 . . . . 0.0 102.648 177.167 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.09 -19.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -178.686 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -79.28 145.57 33.45 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -175.4 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . 0.267 31.7 m-85 -63.61 157.16 24.55 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 127.498 2.319 . . . . 0.0 115.497 -179.042 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -113.84 -44.53 3.16 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 175.556 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.01 -148.45 20.22 Favored Glycine 0 C--N 1.349 1.262 0 C-N-CA 126.222 1.867 . . . . 0.0 111.752 177.576 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.84 147.77 35.96 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-O 121.554 0.693 . . . . 0.0 112.283 -178.79 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 pt -147.0 167.39 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 127.017 2.127 . . . . 0.0 108.376 -179.108 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.6 t -158.88 148.13 18.82 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 179.548 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -83.67 36.1 0.53 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.196 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.3 t -58.72 -35.51 72.79 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.46 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -173.25 60.35 0.14 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.568 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -97.17 -71.06 0.69 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.279 1.032 . . . . 0.0 108.999 179.323 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.3 t -170.66 -62.86 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.758 1.623 . . . . 0.0 109.041 179.219 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.46 -87.11 0.06 OUTLIER Glycine 0 C--N 1.338 0.671 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 179.407 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -79.87 -18.25 51.16 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.531 0.732 . . . . 0.0 110.215 178.743 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -65.03 168.36 6.64 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.369 1.468 . . . . 0.0 110.727 179.327 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -136.27 169.79 17.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.914 1.285 . . . . 0.0 113.056 -177.972 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.3 m -141.38 164.82 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.94 2.096 . . . . 0.0 106.424 176.65 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.47 142.65 27.26 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 115.029 0.772 . . . . 0.0 115.029 -177.493 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 24.6 t -109.37 169.99 8.35 Favored 'General case' 0 C--N 1.341 0.202 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 177.671 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.36 -157.57 0.33 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.684 -0.635 . . . . 0.0 109.425 -178.3 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.53 -9.34 58.25 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 124.183 0.897 . . . . 0.0 111.396 177.346 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.7 m -79.41 143.42 35.06 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 125.17 1.388 . . . . 0.0 108.982 179.213 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.189 1.396 . . . . 0.0 109.956 -179.217 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 81.6 p . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.33 127.43 8.96 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.061 1.345 . . . . 0.0 111.084 179.104 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -111.61 123.48 50.32 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.814 1.246 . . . . 0.0 109.713 -178.802 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -129.71 93.66 3.57 Favored 'General case' 0 N--CA 1.428 -1.53 1 N-CA-C 98.558 -4.608 . . . . 0.0 98.558 176.839 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.5 m -102.91 88.3 3.15 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.195 0.598 . . . . 0.0 110.295 -177.655 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.07 -79.38 1.02 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -178.946 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.2 p -132.83 -31.69 1.3 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.304 1.842 . . . . 0.0 110.464 178.521 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 m -67.41 106.7 2.19 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.024 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -108.07 141.66 39.42 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.546 1.138 . . . . 0.0 111.738 -178.352 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -144.45 144.33 31.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.779 1.632 . . . . 0.0 108.155 179.356 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.8 t -70.11 155.43 40.63 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 124.448 1.099 . . . . 0.0 109.912 178.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.71 -21.94 56.23 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 176.388 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -73.2 -35.85 66.43 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 125.157 1.383 . . . . 0.0 109.959 179.215 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.2 tp-100 -73.75 -35.56 65.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.173 0.589 . . . . 0.0 112.384 179.185 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 t -69.02 -47.13 77.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.377 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.3 ptt85 -65.26 -43.26 91.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.02 0.528 . . . . 0.0 110.554 179.551 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.72 89.5 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.543 0.737 . . . . 0.0 109.398 179.023 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.81 -38.98 79.81 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.369 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.92 -29.73 62.2 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 178.506 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -70.81 -24.1 62.49 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.494 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.36 -64.3 1.17 Allowed 'General case' 0 C--N 1.346 0.441 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 -178.76 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -39.25 -50.59 1.98 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.078 1.351 . . . . 0.0 112.211 176.445 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -51.99 -62.88 1.35 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 128.029 2.531 . . . . 0.0 111.586 179.324 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -66.03 -42.12 90.03 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.543 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -67.54 -30.85 70.6 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.418 1.087 . . . . 0.0 113.149 -177.728 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -84.48 -44.64 13.43 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 118.957 0.799 . . . . 0.0 112.12 -179.739 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -69.56 -51.13 38.25 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.233 0.613 . . . . 0.0 111.648 -179.007 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -78.03 -20.61 52.11 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.789 -179.458 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 63.74 65.21 0.73 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 124.935 1.294 . . . . 0.0 110.362 179.815 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -150.55 167.38 27.38 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 126.032 1.733 . . . . 0.0 108.049 179.099 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.287 0.0 OUTLIER 49.53 71.58 0.38 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.263 1.025 . . . . 0.0 113.46 -179.459 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.63 144.91 25.54 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.06 1.344 . . . . 0.0 108.549 179.179 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.72 -165.85 23.0 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.804 -0.519 . . . . 0.0 111.804 -179.42 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.1 m -83.86 46.66 1.2 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.904 0.882 . . . . 0.0 111.139 -179.384 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 87.7 p -146.75 161.54 40.4 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 178.733 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.7 p -80.11 33.31 0.28 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.885 -179.556 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -92.65 127.23 48.99 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 119.922 1.237 . . . . 0.0 109.504 -178.462 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -60.95 120.67 1.21 Allowed 'Cis proline' 0 C--N 1.348 0.506 0 N-CA-C 116.144 1.556 . . . . 0.0 116.144 -1.426 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -103.65 157.3 17.16 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.488 1.115 . . . . 0.0 108.84 178.933 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.92 118.86 8.36 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 122.706 0.403 . . . . 0.0 110.956 179.871 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.92 105.4 13.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 178.771 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -153.59 143.16 21.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.93 0.892 . . . . 0.0 110.296 -178.664 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 56.0 -134.0 1.44 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.07 1.348 . . . . 0.0 110.999 178.998 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 73.92 -73.7 0.09 Allowed 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.139 1.776 . . . . 0.0 109.065 -179.302 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -127.82 -37.09 1.96 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.787 1.635 . . . . 0.0 109.176 178.949 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.09 70.65 1.3 Allowed Glycine 0 C--N 1.342 0.874 0 C-N-CA 124.243 0.925 . . . . 0.0 112.027 178.92 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.33 -169.05 2.42 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.689 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -154.64 156.94 37.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.487 0.715 . . . . 0.0 110.689 179.449 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -148.92 144.51 18.24 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 125.739 1.616 . . . . 0.0 107.616 178.681 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -45.19 -45.47 14.74 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.49 3.46 . . . . 0.0 113.371 178.649 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -83.31 149.11 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 124.158 0.983 . . . . 0.0 110.482 179.323 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -91.61 168.7 11.32 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.855 1.262 . . . . 0.0 111.162 -178.854 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.08 -158.16 27.3 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.386 0.993 . . . . 0.0 111.797 -179.244 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.91 128.09 2.94 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 CA-C-N 118.215 1.007 . . . . 0.0 112.202 -0.362 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.44 158.33 21.71 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.907 2.083 . . . . 0.0 109.025 178.793 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -137.08 164.28 28.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.558 -177.954 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.98 157.54 26.8 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 126.709 2.004 . . . . 0.0 110.698 -178.078 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -160.12 96.77 1.51 Allowed Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 176.246 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.58 145.76 47.78 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 C-N-CA 120.379 0.719 . . . . 0.0 110.935 -176.119 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.69 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 2.9 tt -109.33 -172.77 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 124.253 1.978 . . . . 0.0 111.589 178.639 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.69 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 2.9 tttm -160.02 152.13 20.55 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 109.12 -3.673 . . . . 0.0 109.84 -179.397 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.1 t -76.58 52.27 0.79 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.628 1.571 . . . . 0.0 113.748 -178.165 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.0 43.05 0.24 Allowed Glycine 0 CA--C 1.526 0.759 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.402 178.016 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.58 76.48 0.03 OUTLIER Glycine 0 C--N 1.345 1.049 0 CA-C-N 119.53 1.665 . . . . 0.0 116.247 178.767 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.333 8.6 p 37.06 -139.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.43 0 C-N-CA 126.167 1.787 . . . . 0.0 113.385 177.683 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -58.12 -175.9 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.604 2.362 . . . . 0.0 114.173 178.548 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.1 p -78.92 158.74 27.98 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.398 1.079 . . . . 0.0 113.854 -177.373 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 178.77 47.98 0.07 OUTLIER Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.247 1.88 . . . . 0.0 108.686 179.247 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 170.25 -160.19 32.91 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.139 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 76.9 p -158.84 156.71 27.36 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 124.752 1.221 . . . . 0.0 109.437 -179.329 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -79.74 166.07 78.22 Favored 'Cis proline' 0 N--CA 1.458 -0.56 0 CA-C-N 119.427 0.831 . . . . 0.0 111.36 -2.505 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.64 -109.45 1.1 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 124.224 0.916 . . . . 0.0 112.406 -178.935 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 58.68 35.39 24.41 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 125.362 1.465 . . . . 0.0 111.541 -178.753 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -152.51 107.77 3.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.324 1.05 . . . . 0.0 110.529 178.377 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.44 130.56 19.54 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.51 -179.314 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.4 m -98.52 157.29 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 176.361 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.6 t -135.44 133.15 52.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -178.479 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -116.61 -179.95 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.781 1.232 . . . . 0.0 112.444 -178.307 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -101.45 174.82 5.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.952 2.101 . . . . 0.0 109.548 179.128 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.31 13.7 t -82.19 49.08 1.34 Allowed 'General case' 0 C--N 1.345 0.386 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -178.576 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -152.46 -87.99 0.06 Allowed 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 177.429 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 94.9 m -161.83 -0.22 0.05 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.874 2.469 . . . . 0.0 113.879 -176.898 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -80.06 138.85 37.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.364 0.984 . . . . 0.0 113.063 -176.866 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -80.0 128.39 33.42 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.405 1.482 . . . . 0.0 108.042 178.829 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.28 -47.89 6.42 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 123.556 0.743 . . . . 0.0 110.505 179.605 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.15 -174.24 46.25 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 179.339 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.97 141.88 44.48 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.39 1.476 . . . . 0.0 109.915 179.329 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.5 pt -141.07 157.26 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.795 1.238 . . . . 0.0 109.621 -179.079 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.0 t -150.81 149.81 30.19 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.126 0.97 . . . . 0.0 113.402 -178.48 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . 0.266 37.8 m170 -79.51 -24.1 42.49 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.972 0.805 . . . . 0.0 109.118 175.999 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.1 m -50.75 102.55 0.04 OUTLIER 'General case' 0 C--N 1.343 0.299 0 C-N-CA 126.339 1.855 . . . . 0.0 109.255 178.994 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.13 63.23 1.75 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -178.646 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.47 179.57 8.05 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.385 1.074 . . . . 0.0 110.609 179.571 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.7 t -86.18 62.07 7.21 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.507 1.523 . . . . 0.0 110.527 -179.353 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.21 -90.03 0.43 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.824 1.678 . . . . 0.0 113.199 178.418 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.35 -23.12 43.62 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.148 0.979 . . . . 0.0 111.344 -179.064 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -59.75 158.38 10.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.472 1.109 . . . . 0.0 112.129 -179.086 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -121.15 135.0 55.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.084 1.754 . . . . 0.0 108.991 -179.459 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 m -110.06 163.5 6.97 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.697 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.65 149.34 31.62 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.894 0.759 . . . . 0.0 112.935 -178.439 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.7 t -137.26 164.67 27.97 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 125.725 1.61 . . . . 0.0 108.849 178.76 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 96.4 p 46.47 50.65 12.47 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.366 2.267 . . . . 0.0 112.631 -179.649 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.12 64.04 2.28 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.241 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -146.01 132.99 20.22 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.863 1.265 . . . . 0.0 108.132 179.083 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 116.756 -1.592 . . . . 0.0 109.036 179.352 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.84 97.52 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.416 1.886 . . . . 0.0 110.878 179.34 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.5 m -99.69 121.73 41.67 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.46 1.904 . . . . 0.0 107.504 -178.733 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -122.59 111.29 16.6 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -179.683 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.3 m -100.04 81.91 2.48 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.484 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.89 -95.36 0.72 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.317 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.6 p -104.23 -36.33 7.68 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.116 1.366 . . . . 0.0 110.977 179.375 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -73.83 103.77 4.48 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.113 0.565 . . . . 0.0 110.099 -178.876 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -83.06 152.91 25.16 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.43 1.092 . . . . 0.0 110.622 -179.243 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -148.11 137.71 22.33 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.964 0.906 . . . . 0.0 111.281 -179.815 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.5 m -78.17 150.44 33.56 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.475 1.51 . . . . 0.0 107.757 178.295 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.96 -17.5 25.3 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.087 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.2 t -74.55 -44.99 48.43 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 124.506 1.122 . . . . 0.0 109.513 178.956 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -68.7 -43.73 75.42 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.051 0.94 . . . . 0.0 110.917 -179.894 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.9 t -56.72 -54.4 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 C-N-CA 126.988 2.115 . . . . 0.0 109.135 178.954 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -67.93 -43.05 80.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.071 -178.128 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.8 -49.48 77.33 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.694 0.679 . . . . 0.0 109.674 179.297 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.82 -31.75 68.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.313 1.045 . . . . 0.0 110.478 178.837 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.47 -38.47 29.87 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 179.769 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -66.7 -22.12 66.08 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.419 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.09 -54.91 5.53 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -179.182 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -46.77 -43.71 18.43 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.431 1.492 . . . . 0.0 112.499 177.853 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.0 p -73.28 -43.42 61.04 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.996 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -60.99 -31.02 70.63 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.137 0.426 . . . . 0.0 110.685 178.737 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -97.14 -3.88 40.26 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.341 1.457 . . . . 0.0 113.135 -179.177 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -57.45 -24.82 57.92 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.358 -0.839 . . . . 0.0 111.663 178.722 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.467 0.0 OUTLIER 127.73 59.44 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.634 1 C-N-CA 135.15 5.38 . . . . 0.0 112.837 -178.221 . . . . . . . . 4 3 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -129.16 -35.11 1.83 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.696 1.198 . . . . 0.0 112.188 -179.109 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -153.96 64.72 0.71 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.22 0.918 . . . . 0.0 113.127 179.505 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 t70 57.89 -170.32 0.11 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.315 1.446 . . . . 0.0 113.285 178.154 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.3 p 47.68 43.67 16.79 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.924 1.69 . . . . 0.0 112.94 179.049 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.85 -175.59 3.54 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.279 1.431 . . . . 0.0 114.426 -178.532 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -32.35 138.02 0.1 Allowed Glycine 0 C--N 1.341 0.846 0 C-N-CA 128.118 2.771 . . . . 0.0 117.558 -178.217 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.9 m -101.88 -55.94 2.39 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.311 1.444 . . . . 0.0 110.629 -179.519 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.6 p -97.65 -63.57 1.12 Allowed 'General case' 0 C--N 1.346 0.454 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -179.256 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.8 p -146.41 -42.03 0.2 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.598 1.959 . . . . 0.0 110.376 -179.532 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -91.59 151.6 42.62 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 124.692 1.197 . . . . 0.0 109.746 -178.088 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -84.38 134.2 20.57 Favored 'Cis proline' 0 N--CA 1.45 -1.048 0 CA-C-N 119.655 0.913 . . . . 0.0 111.127 -1.72 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.05 172.9 15.15 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 126.033 1.733 . . . . 0.0 108.207 179.412 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 t -60.4 147.77 39.66 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.715 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -80.01 116.61 20.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.998 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -68.48 -52.75 28.9 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.654 1.181 . . . . 0.0 112.301 -179.345 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -88.38 -170.04 2.8 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.482 1.113 . . . . 0.0 111.173 -179.061 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -129.07 -50.78 1.21 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.635 1.974 . . . . 0.0 108.638 179.505 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 53.99 70.61 0.59 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.326 1.85 . . . . 0.0 113.763 178.455 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.45 -98.38 0.24 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.684 1.135 . . . . 0.0 113.217 178.579 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.05 154.15 16.27 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.689 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -121.21 -170.11 1.96 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 126.23 1.812 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -131.25 158.38 75.41 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 125.328 1.451 . . . . 0.0 108.233 -178.63 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.5 66.57 4.58 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 124.006 3.137 . . . . 0.0 113.226 -178.766 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 m -163.1 164.94 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 126.86 2.064 . . . . 0.0 108.873 179.315 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -84.77 -58.99 2.49 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.478 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.95 177.63 15.02 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.11 1.338 . . . . 0.0 110.516 -179.321 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.57 139.17 58.46 Favored 'Cis proline' 0 N--CA 1.457 -0.629 0 CA-C-N 117.916 0.858 . . . . 0.0 111.442 0.127 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -114.8 150.79 34.89 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.891 1.277 . . . . 0.0 109.511 178.698 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -113.7 159.32 19.84 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -177.002 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -98.7 152.48 19.61 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.133 1.773 . . . . 0.0 109.529 179.132 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -160.84 119.83 1.53 Allowed Pre-proline 0 C--O 1.223 -0.301 0 C-N-CA 124.008 0.923 . . . . 0.0 108.707 177.272 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.91 122.97 3.09 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 121.229 1.286 . . . . 0.0 113.795 -177.572 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.417 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.4 tp -86.17 168.25 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 CA-C-O 123.678 1.704 . . . . 0.0 111.998 179.293 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.417 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 25.9 mmtt -158.64 158.11 33.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 109.233 -3.621 . . . . 0.0 111.604 -178.851 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.1 m -84.92 60.04 5.97 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.813 1.645 . . . . 0.0 110.36 -178.946 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.85 -61.69 0.01 OUTLIER Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 179.083 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.85 -104.47 0.19 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.207 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.24 163.97 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.429 1.092 . . . . 0.0 108.438 -179.455 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.93 152.63 12.52 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -178.37 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.8 p -139.21 -65.68 0.48 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.649 1.58 . . . . 0.0 108.575 179.378 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.02 105.11 0.27 Allowed Glycine 0 C--N 1.341 0.837 0 C-N-CA 124.417 1.008 . . . . 0.0 110.783 179.301 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -150.1 19.97 1.09 Allowed Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.808 -0.996 . . . . 0.0 113.069 179.313 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.1 m 67.42 119.97 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 126.375 1.87 . . . . 0.0 112.069 179.204 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.71 -176.24 17.91 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 CA-C-N 119.785 0.959 . . . . 0.0 112.499 0.131 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.07 66.99 0.32 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 108.19 -1.964 . . . . 0.0 108.19 179.287 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.95 -58.85 2.27 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.474 0.71 . . . . 0.0 112.097 -178.831 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -61.14 117.83 6.05 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.434 1.494 . . . . 0.0 113.398 -178.116 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -138.56 118.15 13.02 Favored 'General case' 0 C--N 1.344 0.368 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.159 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.5 m -81.64 148.39 5.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 176.879 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.27 53.6 t -130.97 111.51 20.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -178.071 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -101.12 -179.67 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 125.861 1.664 . . . . 0.0 113.936 -176.382 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -101.86 155.16 18.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 127.957 2.503 . . . . 0.0 108.62 179.875 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.282 11.4 t -64.11 -8.45 12.1 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -178.323 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -84.27 -80.74 0.19 Allowed 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 102.485 -3.154 . . . . 0.0 102.485 177.645 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 23.4 m -164.34 -7.39 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 129.589 3.155 . . . . 0.0 114.951 -179.17 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -79.68 132.76 36.29 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 116.501 2.038 . . . . 0.0 116.501 -175.314 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -75.34 123.16 24.87 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.152 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.51 -59.55 2.28 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.825 0.85 . . . . 0.0 111.258 -178.184 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.11 164.28 33.54 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -179.899 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.29 158.81 19.29 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.814 0.816 . . . . 0.0 112.25 -178.858 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.8 pt -140.46 160.3 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.329 2.252 . . . . 0.0 106.859 179.288 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.3 t -156.65 152.15 26.78 Favored 'General case' 0 C--N 1.343 0.326 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -179.046 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -83.57 38.34 0.62 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.337 0.655 . . . . 0.0 111.07 176.571 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.2 m -77.7 -73.3 0.31 Allowed 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.369 0.986 . . . . 0.0 109.624 -179.334 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.35 -9.21 60.63 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.489 1.043 . . . . 0.0 112.116 178.939 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.81 155.07 27.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.555 1.542 . . . . 0.0 111.748 178.993 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.8 m -68.89 -50.09 52.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.659 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.93 -84.29 0.05 OUTLIER Glycine 0 CA--C 1.527 0.787 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.193 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -89.01 0.32 56.77 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.127 0.971 . . . . 0.0 111.891 179.828 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -71.34 -170.57 0.51 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.863 0.865 . . . . 0.0 110.56 179.516 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -147.78 160.88 42.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.644 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.1 m -142.41 162.7 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 127.585 2.354 . . . . 0.0 106.334 177.012 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.98 121.53 5.55 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.074 0.845 . . . . 0.0 114.401 -178.808 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.44 159.6 15.03 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.65 1.18 . . . . 0.0 109.404 178.502 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.7 p 60.27 45.22 11.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.472 1.909 . . . . 0.0 111.042 -178.781 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.01 44.17 96.3 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.299 0.952 . . . . 0.0 111.928 179.448 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.9 m -104.84 149.53 25.59 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.625 1.17 . . . . 0.0 109.362 179.316 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.106 0 C-N-CA 124.445 1.098 . . . . 0.0 108.146 179.083 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.03 124.58 19.18 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.427 1.091 . . . . 0.0 109.817 179.274 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 p -89.46 81.39 6.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -178.309 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.27 92.09 6.88 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 175.877 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -100.51 79.06 2.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.535 1.534 . . . . 0.0 109.324 -177.643 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.76 -70.62 1.98 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.345 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.2 p -137.98 -34.11 0.68 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.632 1.573 . . . . 0.0 111.877 179.453 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 m -72.67 93.55 1.65 Allowed 'General case' 0 C--N 1.345 0.389 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.148 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -96.6 113.74 25.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.777 1.631 . . . . 0.0 112.869 -178.43 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.435 ' HH ' ' HG ' ' A' ' 63' ' ' SER . 3.2 m-85 -109.78 144.75 37.77 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.885 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.0 m -66.37 152.3 45.33 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 124.229 1.011 . . . . 0.0 109.527 179.148 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.94 -24.73 25.16 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.705 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.4 t -71.33 -43.79 66.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.146 1.378 . . . . 0.0 109.594 179.31 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -71.86 -29.47 64.41 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -179.263 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.29 -45.26 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.28 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -67.86 -32.94 73.79 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.37 1.068 . . . . 0.0 111.857 179.393 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.04 -58.17 5.43 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.444 1.02 . . . . 0.0 110.135 -179.265 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.53 -37.09 80.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.787 -178.843 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.78 58.63 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 179.413 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -68.78 -19.89 64.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.785 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.54 -60.86 2.17 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 179.525 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.71 -41.34 31.55 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.371 1.068 . . . . 0.0 112.4 177.219 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -55.74 30.86 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.002 1.321 . . . . 0.0 109.906 179.014 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -56.55 -31.47 64.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.675 1.19 . . . . 0.0 110.893 -178.379 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 -89.07 -32.05 17.74 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -178.832 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -63.94 -36.53 84.26 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.636 1.107 . . . . 0.0 113.927 -177.7 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -105.33 27.0 8.72 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.975 0.91 . . . . 0.0 111.98 -178.513 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.99 -36.83 8.46 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.076 0.95 . . . . 0.0 111.992 179.338 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.7 t70 83.49 96.19 0.04 OUTLIER 'General case' 0 C--N 1.344 0.345 0 C-N-CA 127.354 2.262 . . . . 0.0 108.789 -178.597 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 70.99 109.0 0.06 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 127.192 2.197 . . . . 0.0 109.65 -178.755 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -175.97 -47.98 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.25 1.42 . . . . 0.0 111.422 -177.622 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.88 96.92 3.21 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.986 0.514 . . . . 0.0 109.845 -179.288 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.16 49.62 3.78 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.564 1.078 . . . . 0.0 110.461 179.705 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.0 m -89.14 -76.49 0.41 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.799 1.239 . . . . 0.0 108.374 -179.463 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.8 t -173.72 -64.98 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.114 1.765 . . . . 0.0 106.48 179.235 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.08 8.67 0.65 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.388 1.475 . . . . 0.0 111.857 178.84 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -94.95 129.8 34.7 Favored Pre-proline 0 C--N 1.345 0.382 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.294 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -70.15 129.0 13.94 Favored 'Cis proline' 0 N--CA 1.456 -0.726 0 N-CA-C 115.444 1.286 . . . . 0.0 115.444 0.115 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . 0.252 21.3 m-70 -96.87 143.65 27.57 Favored 'General case' 0 C--N 1.343 0.298 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 178.059 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 t -63.14 142.15 58.49 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.584 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -107.35 119.26 38.92 Favored 'General case' 0 C--O 1.23 0.048 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.04 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -149.64 -63.57 0.22 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.279 1.832 . . . . 0.0 107.085 178.921 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.4 t30 50.91 -115.56 0.88 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.03 1.732 . . . . 0.0 112.044 178.798 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -169.37 -174.96 2.08 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.02 2.128 . . . . 0.0 107.627 -179.165 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 76.93 157.42 0.18 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.801 1.641 . . . . 0.0 110.869 179.319 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.45 70.14 2.47 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.077 0.846 . . . . 0.0 111.292 179.19 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.5 111.74 6.55 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.167 1.387 . . . . 0.0 107.809 179.042 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -148.31 -175.49 4.93 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.847 1.259 . . . . 0.0 108.355 179.721 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -132.01 144.97 55.42 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.662 1.185 . . . . 0.0 108.647 -179.076 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.23 67.3 6.95 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 124.36 3.373 . . . . 0.0 112.293 -179.226 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.05 -170.65 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 127.496 2.318 . . . . 0.0 107.573 179.246 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -118.57 131.33 56.21 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.765 1.226 . . . . 0.0 109.606 179.18 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.02 -172.23 45.92 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.324 0.964 . . . . 0.0 112.341 -179.353 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.95 151.93 97.61 Favored 'Cis proline' 0 N--CA 1.458 -0.594 0 CA-C-N 118.041 0.92 . . . . 0.0 111.809 0.078 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -118.14 176.28 5.29 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.861 1.265 . . . . 0.0 109.942 179.324 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.12 153.51 31.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.972 178.992 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.274 8.0 tp10 -79.92 150.05 30.67 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.099 2.56 . . . . 0.0 111.579 -177.7 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -155.27 106.0 2.23 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.004 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.71 135.06 23.11 Favored 'Trans proline' 0 N--CA 1.442 -1.542 0 N-CA-C 107.674 -1.702 . . . . 0.0 107.674 -177.311 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.505 ' CG1' ' H ' ' A' ' 62' ' ' LYS 0.266 0.1 OUTLIER -85.76 -147.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.34 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -176.1 . . . . . . . . 4 4 . 1 . 042 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.505 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.9 mmmm -79.25 166.28 22.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 110.936 -2.847 . . . . 0.0 111.401 -178.287 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.435 ' HG ' ' HH ' ' A' ' 11' ' ' TYR . 36.2 m 132.31 51.73 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.493 1 C-N-CA 133.199 4.599 . . . . 0.0 104.723 -177.987 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.54 -52.09 0.59 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.665 1.602 . . . . 0.0 109.243 -178.545 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 177.53 -164.72 34.02 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.483 1.04 . . . . 0.0 110.562 179.728 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.6 p -75.25 71.33 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.92 1.288 . . . . 0.0 107.975 178.888 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.7 t80 65.81 80.07 0.23 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 128.484 2.713 . . . . 0.0 111.251 -178.269 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 t -157.78 105.59 2.01 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.782 1.233 . . . . 0.0 108.909 179.083 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 179.13 -118.71 0.61 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.4 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 174.29 -99.4 0.14 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.159 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.0 m -60.84 -58.2 21.0 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.241 1.016 . . . . 0.0 112.138 179.534 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.17 134.31 36.17 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.064 1.843 . . . . 0.0 110.497 177.788 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.99 -103.64 0.17 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 179.522 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 72.66 -46.42 0.65 Allowed 'General case' 0 C--N 1.344 0.366 0 C-N-CA 127.257 2.223 . . . . 0.0 113.502 -179.645 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.24 125.17 28.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.848 1.659 . . . . 0.0 112.744 -178.488 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -146.28 124.18 12.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.686 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.5 m -86.76 156.17 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 103.317 -2.846 . . . . 0.0 103.317 177.098 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 73.3 t -134.89 115.49 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 -178.08 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -95.52 165.92 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.428 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -176.313 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -99.75 163.03 12.65 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 124.677 1.191 . . . . 0.0 108.185 178.949 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.327 5.2 t -74.11 27.84 0.08 Allowed 'General case' 0 C--N 1.339 0.144 0 N-CA-C 119.698 3.221 . . . . 0.0 119.698 -177.232 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -123.35 -79.32 0.61 Allowed 'General case' 0 N--CA 1.441 -0.917 1 N-CA-C 100.058 -4.053 . . . . 0.0 100.058 176.61 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.0 t -164.13 -24.03 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.14 1.776 . . . . 0.0 114.409 179.008 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -79.68 127.42 32.17 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -176.442 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . 0.344 4.5 p90 -82.24 147.67 28.82 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 123.665 0.603 . . . . 0.0 111.343 -178.922 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.81 -46.26 19.13 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.655 1.182 . . . . 0.0 111.335 -177.338 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.79 -153.69 16.6 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.116 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.82 150.36 32.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.393 0.616 . . . . 0.0 111.402 -179.308 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 44.2 pt -138.47 157.86 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.031 1.733 . . . . 0.0 108.043 -179.337 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.8 t -157.7 154.89 29.01 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.063 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -79.34 -14.89 58.69 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 123.344 0.403 . . . . 0.0 110.297 175.517 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.3 m -62.0 115.3 3.96 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 123.873 0.869 . . . . 0.0 109.832 -179.304 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.27 -15.3 63.52 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.959 0.79 . . . . 0.0 112.382 -179.11 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.97 -177.45 5.57 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.446 1.098 . . . . 0.0 111.4 -179.564 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.8 t -87.36 59.46 5.54 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.836 1.255 . . . . 0.0 111.141 -179.396 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.34 -89.31 1.01 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.971 1.272 . . . . 0.0 112.865 178.486 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -79.8 -31.6 40.74 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.405 1.082 . . . . 0.0 111.22 -179.35 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -55.21 165.65 0.69 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.685 1.594 . . . . 0.0 111.709 179.627 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -120.18 155.25 33.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.48 1.512 . . . . 0.0 111.956 -179.178 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.3 m -139.17 163.05 27.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 C-N-CA 125.949 1.7 . . . . 0.0 107.96 177.794 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.81 140.15 19.94 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.892 0.758 . . . . 0.0 112.183 -178.717 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 t -83.22 -177.41 6.74 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.658 1.183 . . . . 0.0 109.73 178.949 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.8 t -70.51 112.35 6.72 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.822 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.86 -41.24 2.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -178.95 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.1 m -86.49 94.19 9.35 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.988 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 t30 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.225 -1.369 . . . . 0.0 109.445 -178.918 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.2 m -77.29 123.5 26.56 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 77.29 66.77 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.31 140.28 29.76 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 125.502 1.521 . . . . 0.0 109.136 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.02 121.95 35.86 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.5 m -102.14 78.8 1.8 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.154 1.381 . . . . 0.0 107.864 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.38 -97.45 0.68 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 t -100.35 -39.56 7.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.933 1.293 . . . . 0.0 110.034 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.5 m -72.25 96.49 1.84 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.347 1.059 . . . . 0.0 109.767 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -79.92 155.67 27.63 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.257 1.023 . . . . 0.0 110.867 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -143.35 119.76 10.96 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.218 1.007 . . . . 0.0 110.744 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.5 t -60.24 159.09 10.37 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.147 1.779 . . . . 0.0 110.663 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.02 -17.34 51.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 t -76.86 -43.93 34.18 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.601 1.16 . . . . 0.0 108.743 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.81 -45.89 80.66 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.665 1.186 . . . . 0.0 111.305 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.6 t -58.2 -52.6 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.739 1.216 . . . . 0.0 108.345 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -68.18 -31.6 71.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.3 1.44 . . . . 0.0 113.484 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.14 -60.05 2.93 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.933 0.788 . . . . 0.0 109.417 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 -30.25 71.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.462 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.07 -51.51 15.54 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 119.507 -0.283 . . . . 0.0 111.494 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -60.36 -19.7 56.66 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.32 -72.16 0.27 Allowed 'General case' 0 C--N 1.347 0.49 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.03 -29.47 60.46 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.224 0.92 . . . . 0.0 111.788 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.6 t -56.86 -44.13 81.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.485 1.039 . . . . 0.0 109.005 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -96.58 4.01 52.24 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -126.54 -12.43 6.12 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -74.65 -53.09 9.98 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 119.186 0.903 . . . . 0.0 113.089 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.326 0.0 OUTLIER -137.47 33.56 2.51 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.949 0.881 . . . . 0.0 112.275 -177.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.414 ' CG ' ' H ' ' A' ' 30' ' ' ASP . 21.0 p-10 -74.0 -64.93 0.91 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.414 ' H ' ' CG ' ' A' ' 29' ' ' ASN . 4.6 p-10 176.7 37.68 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 129.024 2.93 . . . . 0.0 109.284 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -176.14 -171.13 0.41 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.134 1.774 . . . . 0.0 109.246 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.5 p -122.63 -51.65 1.93 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.929 2.092 . . . . 0.0 109.195 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 43.62 55.03 5.2 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 126.666 1.986 . . . . 0.0 112.081 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.33 179.68 25.93 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 112.251 -2.25 . . . . 0.0 111.625 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.8 p -61.44 -66.99 0.45 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.048 0.939 . . . . 0.0 110.215 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.0 t -163.7 -66.33 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.594 1.158 . . . . 0.0 108.541 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.1 p -106.48 31.27 5.32 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.364 1.066 . . . . 0.0 110.999 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -164.95 104.75 0.8 Allowed Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.538 1.535 . . . . 0.0 107.723 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -64.17 156.42 72.75 Favored 'Cis proline' 0 N--CA 1.456 -0.731 0 CA-C-N 120.289 1.139 . . . . 0.0 113.555 -0.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.63 168.54 6.27 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.884 1.673 . . . . 0.0 108.985 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 t -68.25 151.62 46.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -79.84 110.34 15.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -10.69 -91.14 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.951 3.301 . . . . 0.0 115.488 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 143.78 -54.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 130.269 3.428 . . . . 0.0 106.929 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -56.94 124.32 18.21 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.062 1.345 . . . . 0.0 109.888 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 62.28 58.59 1.74 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.954 1.302 . . . . 0.0 108.536 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.41 111.34 4.1 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.712 1.149 . . . . 0.0 110.624 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.24 169.2 16.84 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.572 0.749 . . . . 0.0 110.626 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -71.2 130.2 40.83 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.121 1.369 . . . . 0.0 113.682 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -163.6 120.98 1.2 Allowed Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 126.152 1.781 . . . . 0.0 108.706 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -65.29 -165.64 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.987 2.458 . . . . 0.0 111.111 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.7 t 76.96 -101.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.178 1.391 . . . . 0.0 110.045 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -167.8 -67.09 0.03 OUTLIER 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.178 0.899 . . . . 0.0 111.609 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.68 -172.7 14.75 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.256 1.408 . . . . 0.0 109.584 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.55 163.59 52.05 Favored 'Cis proline' 0 N--CA 1.456 -0.715 0 CA-C-N 119.118 1.459 . . . . 0.0 111.707 -1.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -110.71 172.9 6.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.343 1.057 . . . . 0.0 111.363 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -140.25 131.15 26.03 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.158 1.383 . . . . 0.0 108.606 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -94.58 161.82 14.05 Favored 'General case' 0 C--O 1.227 -0.09 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.03 105.99 1.41 Allowed Pre-proline 0 N--CA 1.455 -0.176 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.22 120.45 6.57 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 121.101 1.2 . . . . 0.0 109.866 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.666 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.6 tt -83.62 -175.43 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 123.665 1.698 . . . . 0.0 112.423 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.666 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 13.7 mmtt -160.31 163.02 33.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 109.82 -3.354 . . . . 0.0 110.816 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.0 t -78.82 56.86 1.98 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.998 1.719 . . . . 0.0 112.135 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.32 60.9 0.21 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 125.088 1.328 . . . . 0.0 112.474 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.18 140.3 3.05 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 117.695 0.747 . . . . 0.0 113.86 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.5 p -100.17 157.61 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 126.785 2.034 . . . . 0.0 107.239 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 64.91 74.21 0.4 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.134 0.974 . . . . 0.0 108.675 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.0 p -134.65 -169.39 2.33 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.409 1.483 . . . . 0.0 109.714 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.41 124.13 24.71 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.084 1.326 . . . . 0.0 113.695 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.37 101.0 0.87 Allowed Glycine 0 C--N 1.339 0.741 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.0 t 64.63 86.07 0.15 Allowed Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 125.363 1.465 . . . . 0.0 109.302 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.1 164.03 88.72 Favored 'Cis proline' 0 N--CA 1.458 -0.597 0 CA-C-N 119.571 0.882 . . . . 0.0 112.503 5.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.89 -58.07 0.17 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 87.11 -67.71 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 129.128 2.971 . . . . 0.0 108.321 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -70.48 119.93 15.37 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.484 1.914 . . . . 0.0 113.149 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.1 mtt-85 -141.48 147.8 38.44 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.121 1.369 . . . . 0.0 112.301 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -112.61 144.05 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.4 t -139.92 127.04 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.88 0.372 . . . . 0.0 110.647 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.39 174.15 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.358 0 C-N-CA 126.922 2.089 . . . . 0.0 111.202 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -93.56 169.08 10.61 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.952 2.101 . . . . 0.0 105.589 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.367 14.5 t -76.29 53.35 0.82 Allowed 'General case' 0 C--N 1.341 0.223 0 N-CA-C 117.775 2.509 . . . . 0.0 117.775 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -160.05 -83.31 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.82 -0.29 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.654 1.581 . . . . 0.0 114.27 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.57 110.56 16.16 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.016 1.28 . . . . 0.0 113.842 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -60.04 111.64 1.58 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.712 0.805 . . . . 0.0 109.707 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.25 -40.13 31.38 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.629 1.171 . . . . 0.0 111.349 -178.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.4 168.81 17.02 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.75 154.31 23.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.679 0.792 . . . . 0.0 110.353 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.8 pt -131.51 157.7 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 125.78 1.632 . . . . 0.0 107.99 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.0 t -159.53 139.28 11.58 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -84.36 46.77 1.26 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.7 t -65.65 -38.6 89.81 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.3 56.72 0.54 Allowed Glycine 0 C--N 1.335 0.486 0 N-CA-C 106.119 -2.792 . . . . 0.0 106.119 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -106.92 -17.56 14.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.3 m 64.39 35.54 9.6 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.6 21.93 78.72 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.704 2.097 . . . . 0.0 113.899 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -146.76 -70.58 0.24 Allowed 'General case' 0 C--N 1.347 0.484 0 CA-C-N 119.44 1.62 . . . . 0.0 114.216 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -58.9 100.36 0.07 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.054 1.742 . . . . 0.0 114.042 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.281 0.5 OUTLIER -78.14 140.98 39.02 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.439 0.695 . . . . 0.0 109.613 -178.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.17 160.86 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.74 160.65 29.0 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.31 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.8 m -117.93 159.55 22.94 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.638 1.175 . . . . 0.0 110.583 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.3 t 44.19 69.11 0.45 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.046 1.738 . . . . 0.0 115.429 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.43 -4.13 74.39 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.094 -0.837 . . . . 0.0 114.334 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.8 m -84.29 104.63 14.48 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 116.622 -1.656 . . . . 0.0 111.231 179.417 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 120.597 0.237 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.9 p -127.8 58.75 1.49 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.23 1.412 . . . . 0.0 111.234 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.5 136.4 0.03 OUTLIER 'General case' 0 C--N 1.341 0.208 0 C-N-CA 126.664 1.985 . . . . 0.0 111.592 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.1 p -116.82 109.88 17.67 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.79 98.23 7.92 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 100.636 -3.838 . . . . 0.0 100.636 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.1 m -94.35 79.37 3.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.141 0.976 . . . . 0.0 109.102 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.09 -86.06 1.0 Allowed Glycine 0 C--N 1.34 0.777 0 C-N-CA 125.061 1.315 . . . . 0.0 110.013 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.4 p -119.58 -38.87 2.93 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 125.598 1.559 . . . . 0.0 110.156 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 m -74.14 100.78 3.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -95.04 149.43 21.26 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.85 0.86 . . . . 0.0 113.223 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -144.22 152.73 41.24 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.321 1.449 . . . . 0.0 110.043 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.9 m -74.55 159.6 31.98 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 125.556 1.542 . . . . 0.0 111.449 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.26 -22.67 67.02 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.5 t -70.49 -37.08 74.15 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 125.076 1.35 . . . . 0.0 109.062 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -65.69 -42.57 91.04 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.116 0.966 . . . . 0.0 109.731 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.1 t -61.27 -47.86 91.58 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.2 mtp85 -66.64 -26.55 67.12 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.214 1.406 . . . . 0.0 112.383 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.15 -60.58 2.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.71 -28.25 69.46 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.858 -0.592 . . . . 0.0 111.279 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.69 -37.1 50.34 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 118.941 -0.552 . . . . 0.0 112.38 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -70.5 -22.03 62.69 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.53 -59.74 2.61 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.96 -47.89 16.51 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.697 1.199 . . . . 0.0 110.33 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 m -51.1 -54.57 23.83 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.227 1.011 . . . . 0.0 110.961 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -77.09 -27.51 54.21 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -113.34 -6.0 13.55 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.289 0.0 OUTLIER -95.23 -38.96 10.32 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -179.077 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -147.29 33.53 0.88 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.326 0.966 . . . . 0.0 112.043 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -132.78 -70.71 0.54 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -136.49 85.49 2.15 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -56.77 118.76 5.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.022 1.329 . . . . 0.0 113.678 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.8 p -143.65 49.53 1.4 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.124 1.769 . . . . 0.0 108.681 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -163.26 153.05 15.4 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.116 0.966 . . . . 0.0 110.014 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.98 155.64 52.99 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.1 t -133.45 77.92 1.75 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.163 0.985 . . . . 0.0 108.87 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 p -107.09 -59.19 1.84 Allowed 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.87 -11.5 7.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.559 1.944 . . . . 0.0 110.733 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.66 129.95 3.53 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.93 139.71 55.04 Favored 'Cis proline' 0 N--CA 1.452 -0.959 0 CA-C-N 120.153 1.09 . . . . 0.0 110.536 -0.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -155.09 148.14 24.7 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 t -56.08 144.73 28.07 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -79.41 112.66 16.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -71.33 81.6 0.75 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.98 1.312 . . . . 0.0 109.215 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -156.76 76.04 0.86 Allowed 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.21 -37.97 73.02 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.862 1.265 . . . . 0.0 110.699 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -64.43 -35.59 81.42 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.29 114.76 0.24 Allowed Glycine 0 C--N 1.342 0.881 0 C-N-CA 125.875 1.702 . . . . 0.0 114.301 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -78.94 106.22 10.82 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.0 p-10 -28.98 111.03 0.06 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.484 1.914 . . . . 0.0 115.842 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -147.88 151.0 37.46 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 126.895 2.078 . . . . 0.0 108.076 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.02 78.04 3.72 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.327 2.685 . . . . 0.0 107.391 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.17 171.25 12.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 C-N-CA 124.841 1.256 . . . . 0.0 113.569 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -125.93 -49.61 1.6 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 128.034 2.534 . . . . 0.0 105.997 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.69 170.73 46.5 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.862 1.696 . . . . 0.0 113.914 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.55 134.74 32.26 Favored 'Cis proline' 0 N--CA 1.46 -0.498 0 O-C-N 122.419 0.694 . . . . 0.0 112.18 -0.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -107.49 136.5 47.17 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.602 1.561 . . . . 0.0 109.541 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -125.49 161.83 26.24 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 123.641 0.777 . . . . 0.0 111.24 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -83.88 153.34 24.05 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.597 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -155.44 103.21 2.2 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 102.791 -3.04 . . . . 0.0 102.791 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -76.46 136.59 17.69 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.027 1.818 . . . . 0.0 115.832 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.2 tp -89.87 171.24 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 126.086 1.754 . . . . 0.0 112.787 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.06 170.31 22.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 110.62 -2.991 . . . . 0.0 113.067 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -82.0 57.92 3.71 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.86 2.064 . . . . 0.0 112.029 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.28 73.43 0.77 Allowed Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.34 -177.58 40.63 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-O 121.631 0.573 . . . . 0.0 112.808 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.71 148.4 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 127.374 2.269 . . . . 0.0 106.39 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.312 51.4 p90 58.4 -170.11 0.12 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.78 1.632 . . . . 0.0 111.924 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.2 t -79.61 166.36 21.96 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.696 0.799 . . . . 0.0 112.577 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.08 140.24 3.1 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.29 -114.12 4.85 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 124.689 1.137 . . . . 0.0 111.103 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -155.31 -68.52 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.441 1.096 . . . . 0.0 109.972 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.55 160.46 46.56 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.292 1.995 . . . . 0.0 110.547 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.53 -83.4 0.06 OUTLIER Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 81.77 -39.89 0.13 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.186 1.794 . . . . 0.0 111.041 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -71.3 125.41 26.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.061 1.744 . . . . 0.0 115.064 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -139.5 131.33 27.57 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 123.723 0.809 . . . . 0.0 112.254 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.7 m -94.64 148.15 5.2 Favored 'Isoleucine or valine' 0 C--N 1.345 0.406 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -134.35 139.71 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 pt -135.16 165.75 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.256 0.622 . . . . 0.0 112.497 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -93.55 155.41 17.33 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 127.9 2.48 . . . . 0.0 108.621 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.37 15.0 t -79.55 65.64 4.78 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -156.86 -94.58 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.172 1 N-CA-C 98.856 -4.498 . . . . 0.0 98.856 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.4 m -162.98 9.4 0.06 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.698 2.399 . . . . 0.0 113.035 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -82.84 132.46 35.16 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.548 1.067 . . . . 0.0 112.609 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -73.12 122.72 22.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.54 -57.96 3.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.69 153.21 11.56 Favored Glycine 0 C--N 1.339 0.717 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.465 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.03 112.03 24.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.58 162.34 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.709 0.804 . . . . 0.0 109.181 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.6 t -160.3 150.13 17.92 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 63.97 6.55 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 175.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.1 t -63.75 -38.87 92.74 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.021 -1.049 . . . . 0.0 112.739 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.79 54.32 0.04 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.21 -78.78 0.4 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.77 0.828 . . . . 0.0 108.813 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.6 m -159.42 73.96 0.6 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.658 1.583 . . . . 0.0 108.72 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.83 -102.75 0.94 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.032 0.825 . . . . 0.0 111.719 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -79.77 -25.85 40.84 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.756 0.822 . . . . 0.0 111.83 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -49.15 129.69 18.2 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 124.52 1.128 . . . . 0.0 111.4 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -97.39 153.0 18.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.341 1.456 . . . . 0.0 113.405 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.0 m -135.21 167.26 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 126.957 2.103 . . . . 0.0 107.032 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.1 151.34 30.01 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 116.542 1.377 . . . . 0.0 116.542 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 38.7 m -106.53 -173.67 2.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.859 1.664 . . . . 0.0 106.641 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.0 t -69.32 140.98 54.37 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.454 -0.779 . . . . 0.0 108.984 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.31 32.54 59.97 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.936 0.779 . . . . 0.0 111.332 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.9 m -137.85 108.38 6.56 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 117.192 -1.385 . . . . 0.0 109.474 -178.984 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.491 0 CA-C-O 120.511 0.196 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.0 m -152.93 129.5 10.74 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.496 1.518 . . . . 0.0 107.613 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -40.24 132.22 1.98 Allowed 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.485 1.914 . . . . 0.0 112.664 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.8 p -102.65 89.06 3.38 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.272 1.029 . . . . 0.0 111.372 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -94.87 98.3 10.62 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.02 -165.14 0.92 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.118 1.367 . . . . 0.0 108.049 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -31.09 -57.87 0.27 Allowed Glycine 0 C--N 1.343 0.971 0 C-N-CA 125.993 1.758 . . . . 0.0 112.159 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.9 p -160.31 38.1 0.17 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.225 1.01 . . . . 0.0 109.687 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 m -129.49 94.15 3.71 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.7 110.47 15.06 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.697 1.199 . . . . 0.0 111.459 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -110.26 128.92 55.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.3 m -65.89 158.13 28.78 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 124.713 1.205 . . . . 0.0 110.726 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.64 -17.32 54.89 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.1 p -77.55 -37.98 49.56 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 124.0 0.92 . . . . 0.0 108.719 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -68.77 -36.04 77.82 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.027 0.931 . . . . 0.0 109.974 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.44 -47.82 89.96 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -64.49 -37.45 87.57 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.014 0.926 . . . . 0.0 111.374 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 -55.16 15.49 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.541 0.61 . . . . 0.0 110.225 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.44 -37.13 82.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.136 0.975 . . . . 0.0 111.172 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.32 -34.34 42.35 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -70.87 -22.02 62.34 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.1 -51.62 9.99 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.4 ' HB1' ' CD2' ' A' ' 59' ' ' PHE . . . -47.32 -67.07 0.31 Allowed 'General case' 0 C--N 1.345 0.375 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 176.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.2 t -39.09 -46.31 1.39 Allowed 'General case' 0 C--N 1.343 0.287 0 C-N-CA 127.892 2.477 . . . . 0.0 112.475 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -65.14 -58.34 6.27 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -71.73 -8.62 55.28 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.44 ' CE2' ' HB2' ' A' ' 57' ' ' GLN . 6.4 t80 -79.38 -47.94 14.88 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.957 1.303 . . . . 0.0 111.376 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -135.51 -26.66 1.23 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -72.89 -56.44 5.19 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.43 1.014 . . . . 0.0 112.861 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -128.13 73.02 1.44 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.472 1.509 . . . . 0.0 108.775 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -55.06 153.4 6.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.704 1.202 . . . . 0.0 113.058 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 59.6 p 56.17 70.85 0.6 Allowed 'General case' 0 C--N 1.34 0.164 0 C-N-CA 127.153 2.181 . . . . 0.0 112.437 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -158.17 91.15 1.08 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.65 -78.23 0.2 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.8 m -145.55 -116.39 0.08 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.159 0.983 . . . . 0.0 108.675 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.9 m -158.26 -50.51 0.06 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.597 1.559 . . . . 0.0 109.35 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.0 p -79.73 6.26 11.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.293 1.037 . . . . 0.0 112.868 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -151.94 95.29 3.23 Favored Pre-proline 0 N--CA 1.455 -0.208 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -84.22 142.75 40.07 Favored 'Cis proline' 0 N--CA 1.455 -0.746 0 N-CA-C 116.263 1.601 . . . . 0.0 116.263 2.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.15 158.83 25.19 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.703 2.401 . . . . 0.0 107.377 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 m -42.38 120.0 1.54 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.022 2.129 . . . . 0.0 113.555 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -138.13 86.47 2.17 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -167.63 -49.67 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.676 1.19 . . . . 0.0 109.039 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.96 59.7 5.79 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.156 1.382 . . . . 0.0 110.141 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.36 14.98 1.46 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.817 0.847 . . . . 0.0 112.117 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 56.9 83.62 0.1 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 125.222 1.409 . . . . 0.0 111.267 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.24 167.09 36.04 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.67 100.5 0.28 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.147 0.979 . . . . 0.0 112.989 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.97 164.86 26.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.537 0.735 . . . . 0.0 109.976 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -106.08 151.07 40.01 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -58.13 -95.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 124.524 3.482 . . . . 0.0 114.152 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m 24.92 -106.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 127.062 2.145 . . . . 0.0 113.521 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -163.01 -44.78 0.03 OUTLIER 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.076 0.853 . . . . 0.0 112.214 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.16 -167.54 29.19 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -60.94 165.65 30.04 Favored 'Cis proline' 0 CA--C 1.535 0.547 0 CA-C-N 119.572 1.686 . . . . 0.0 114.123 -0.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -132.15 143.15 49.78 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.541 1.136 . . . . 0.0 111.502 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.44 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -139.99 153.32 46.83 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.325 1.05 . . . . 0.0 108.231 177.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.75 154.28 23.68 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.4 ' CD2' ' HB1' ' A' ' 23' ' ' ALA . 26.9 t80 -160.74 106.68 1.3 Allowed Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.399 1.08 . . . . 0.0 109.006 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.92 155.75 15.25 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 N-CA-C 119.008 2.657 . . . . 0.0 119.008 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.604 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 6.5 tt -105.63 175.37 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 C-N-CA 126.984 2.114 . . . . 0.0 110.035 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.604 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 6.9 tptp -160.9 166.59 28.17 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 109.352 -3.567 . . . . 0.0 112.454 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.1 t -88.83 62.15 6.27 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.542 1.537 . . . . 0.0 108.764 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.06 64.19 0.66 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 167.5 145.0 4.34 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.1 t -123.56 66.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.0 t80 64.08 103.26 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.086 2.155 . . . . 0.0 112.863 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.8 p -138.96 64.23 1.49 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.3 -68.95 2.38 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.06 -135.38 22.74 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.8 p 54.16 102.08 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 127.39 2.276 . . . . 0.0 113.282 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.84 176.49 40.37 Favored 'Cis proline' 0 N--CA 1.457 -0.663 0 CA-C-N 119.707 0.931 . . . . 0.0 112.177 4.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.38 163.54 31.6 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.45 -43.64 0.15 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 118.375 -0.821 . . . . 0.0 111.655 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -69.36 107.08 3.16 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -119.24 129.23 54.83 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.434 1.094 . . . . 0.0 111.451 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.65 151.43 6.04 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -135.12 135.74 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -123.08 164.14 20.97 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -80.98 173.25 12.79 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.674 1.99 . . . . 0.0 108.598 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.406 ' HA ' ' CE1' ' A' ' 27' ' ' TYR 0.43 1.5 m -73.59 -15.04 61.28 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -177.534 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -81.02 -83.88 0.11 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 101.327 -3.583 . . . . 0.0 101.327 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.1 m -164.05 0.12 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.639 2.775 . . . . 0.0 113.895 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -79.39 132.19 36.33 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.37 117.27 14.93 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.996 2.118 . . . . 0.0 108.222 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.01 -66.1 1.11 Allowed 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.265 1.426 . . . . 0.0 111.952 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.49 146.71 20.99 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 115.976 1.15 . . . . 0.0 115.976 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.65 99.62 3.38 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 103.746 -2.686 . . . . 0.0 103.746 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.5 pt -136.77 165.49 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.073 0.949 . . . . 0.0 111.428 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.0 t -160.27 145.74 15.05 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -79.87 29.44 0.26 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.21 0.604 . . . . 0.0 111.791 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.8 t -65.19 -30.28 71.17 Favored 'General case' 0 C--N 1.343 0.307 0 O-C-N 120.797 -1.19 . . . . 0.0 113.405 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -138.39 49.32 0.84 Allowed Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.29 151.86 21.74 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.114 1.366 . . . . 0.0 110.86 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.1 t -66.39 -45.37 80.25 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.35 1.06 . . . . 0.0 109.495 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.7 -79.43 0.03 OUTLIER Glycine 0 C--N 1.339 0.741 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -97.4 7.52 46.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.352 1.061 . . . . 0.0 111.027 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -74.0 -174.21 1.81 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.4 1.08 . . . . 0.0 110.426 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -153.45 159.9 42.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.174 0.989 . . . . 0.0 110.976 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.6 157.99 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.954 1.702 . . . . 0.0 106.783 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.39 153.25 49.12 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 116.106 1.202 . . . . 0.0 116.106 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.4 t -107.28 -175.3 2.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.335 2.254 . . . . 0.0 106.752 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.6 t -64.94 117.72 8.02 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.4 -0.813 . . . . 0.0 109.95 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.42 -36.97 3.65 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.121 1.343 . . . . 0.0 109.812 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.5 m -93.74 132.78 37.78 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.245 1.418 . . . . 0.0 108.932 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.225 -1.369 . . . . 0.0 109.254 -179.546 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.7 p -127.35 154.23 45.22 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.926 1.29 . . . . 0.0 110.141 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.97 133.86 55.2 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.882 1.273 . . . . 0.0 110.873 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 p -97.35 121.03 38.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.579 1.152 . . . . 0.0 109.117 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -115.33 99.31 7.3 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 100.595 -3.854 . . . . 0.0 100.595 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -103.49 90.28 3.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.157 1.383 . . . . 0.0 109.563 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.46 -76.23 0.96 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.012 1.291 . . . . 0.0 110.862 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.5 t -132.48 -43.17 0.93 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.819 1.648 . . . . 0.0 109.921 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.6 m -68.74 112.54 5.54 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -102.21 152.63 20.8 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.471 1.108 . . . . 0.0 110.812 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -144.23 143.54 31.1 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.363 1.065 . . . . 0.0 108.21 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.9 t -68.27 154.74 41.13 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.765 1.226 . . . . 0.0 110.549 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.93 -19.89 54.39 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.6 t -73.52 -41.15 63.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.652 1.581 . . . . 0.0 109.339 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -68.35 -43.17 78.02 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.256 0.622 . . . . 0.0 110.963 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.8 t -59.8 -47.18 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -41.5 86.72 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.278 1.031 . . . . 0.0 111.686 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.48 -49.47 68.93 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.333 0.515 . . . . 0.0 109.87 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.56 -37.36 78.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.799 0.839 . . . . 0.0 109.938 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.44 -32.28 60.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -66.38 -27.33 67.78 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.03 -56.98 3.98 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -44.99 -58.35 3.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.528 1.531 . . . . 0.0 110.147 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.5 t -54.11 -50.71 66.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.366 1.467 . . . . 0.0 112.296 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -58.08 -34.57 70.3 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -92.13 -3.26 55.91 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -124.38 37.16 4.46 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.473 1.109 . . . . 0.0 111.132 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -89.84 -72.51 0.56 Allowed 'General case' 0 C--N 1.343 0.283 0 O-C-N 121.364 -0.835 . . . . 0.0 110.031 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -148.91 -61.17 0.23 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.933 1.293 . . . . 0.0 108.713 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -90.44 63.83 5.71 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.112 1.365 . . . . 0.0 107.95 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -51.83 138.28 24.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.711 1.604 . . . . 0.0 112.396 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.0 t -106.16 -33.5 7.82 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.367 1.067 . . . . 0.0 112.198 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.63 159.86 31.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.763 0.825 . . . . 0.0 110.97 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.94 166.48 47.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.399 0.999 . . . . 0.0 114.232 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -120.49 65.09 0.84 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.833 1.653 . . . . 0.0 107.977 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.7 m -167.32 -46.02 0.02 OUTLIER 'General case' 0 C--N 1.339 0.124 0 C-N-CA 127.192 2.197 . . . . 0.0 107.374 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.7 p -105.12 29.18 6.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.145 1.378 . . . . 0.0 111.131 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 73.32 157.39 0.16 Allowed Pre-proline 0 C--N 1.351 0.651 0 C-N-CA 125.144 1.378 . . . . 0.0 107.728 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.1 118.72 4.26 Favored 'Cis proline' 0 N--CA 1.452 -0.969 0 N-CA-C 115.404 1.271 . . . . 0.0 115.404 3.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -103.86 -170.24 1.75 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 126.518 1.927 . . . . 0.0 106.686 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.3 t -155.87 159.0 38.95 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.514 0.326 . . . . 0.0 111.267 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -153.43 167.09 30.61 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 122.774 0.43 . . . . 0.0 111.68 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -141.56 -51.76 0.43 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.609 1.563 . . . . 0.0 109.998 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -67.47 -78.81 0.06 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.966 0.906 . . . . 0.0 110.731 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 67.9 179.97 0.23 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.767 1.227 . . . . 0.0 111.345 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -74.63 -62.62 1.47 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.98 57.67 0.14 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -154.19 103.04 2.51 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.489 1.116 . . . . 0.0 108.346 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -141.57 176.43 8.9 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.307 1.443 . . . . 0.0 109.05 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -127.87 138.11 32.21 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 124.361 1.065 . . . . 0.0 109.043 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.66 66.17 8.81 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.713 2.942 . . . . 0.0 110.043 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.3 t -120.31 -95.06 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -153.35 -71.02 0.14 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.174 0.99 . . . . 0.0 109.695 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.11 -175.37 54.96 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.074 0.845 . . . . 0.0 111.225 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.97 126.85 1.93 Allowed 'Cis proline' 0 N--CA 1.459 -0.519 0 CA-C-N 118.982 1.391 . . . . 0.0 111.989 -0.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.69 130.69 35.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.446 0.641 . . . . 0.0 111.008 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -75.03 139.02 42.58 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 127.852 2.461 . . . . 0.0 111.235 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -98.16 146.57 25.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.574 1.15 . . . . 0.0 108.66 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -160.1 110.33 1.41 Allowed Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -81.15 131.93 8.03 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 122.006 1.804 . . . . 0.0 114.302 -176.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.631 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.7 tt -100.01 178.0 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 124.282 1.992 . . . . 0.0 110.875 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.631 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 4.8 tmtt? -160.46 153.71 21.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 109.063 -3.698 . . . . 0.0 110.721 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.2 p -80.81 56.5 2.72 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.566 1.546 . . . . 0.0 109.706 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.9 -61.99 0.04 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.32 -172.62 32.97 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 117.165 0.483 . . . . 0.0 112.705 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.95 143.57 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.568 1.547 . . . . 0.0 111.353 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.292 0.0 OUTLIER 25.45 55.68 0.04 OUTLIER 'General case' 0 C--N 1.345 0.37 0 C-N-CA 129.367 3.067 . . . . 0.0 116.41 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.8 p -79.77 85.36 5.46 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.98 173.6 39.24 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.89 -69.01 1.47 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.0 m -80.3 127.5 76.09 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.7 -88.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.225 2.617 . . . . 0.0 110.057 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.97 -51.32 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 106.019 -2.832 . . . . 0.0 106.019 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -169.72 -50.43 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.667 0.787 . . . . 0.0 112.02 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -73.9 130.07 39.16 Favored 'General case' 0 C--N 1.344 0.362 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -138.54 122.21 17.48 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.029 1.331 . . . . 0.0 110.43 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -83.64 148.77 4.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.3 t -136.91 114.9 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -177.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 pt -101.56 177.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.371 0 C-N-CA 124.585 1.154 . . . . 0.0 111.855 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -90.46 171.82 9.16 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 125.255 1.422 . . . . 0.0 108.024 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.7 -33.24 69.94 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 119.048 2.981 . . . . 0.0 119.048 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -87.75 -65.81 0.98 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.857 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.5 -7.58 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -175.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -78.9 108.82 12.63 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -56.33 118.52 4.83 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.51 -59.56 2.2 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.258 0.623 . . . . 0.0 110.655 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.35 164.74 34.15 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.28 153.22 27.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.1 0.96 . . . . 0.0 110.453 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.6 pt -138.89 155.57 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.746 1.618 . . . . 0.0 107.881 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.6 t -153.45 153.25 32.13 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -79.34 -22.62 44.25 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.354 0.662 . . . . 0.0 111.988 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 t -65.68 139.84 58.43 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 119.585 1.084 . . . . 0.0 109.905 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.08 -24.97 28.93 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.98 -159.02 0.66 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.262 1.425 . . . . 0.0 109.397 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.2 m -152.37 88.9 1.39 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.417 0.687 . . . . 0.0 111.06 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.06 -131.07 9.24 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.288 0.947 . . . . 0.0 112.53 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -79.38 -34.95 41.52 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 125.099 1.36 . . . . 0.0 110.619 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -44.12 134.05 4.95 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.863 1.665 . . . . 0.0 112.473 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.54 160.8 14.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.203 1.801 . . . . 0.0 111.203 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 m -139.32 166.04 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 126.531 1.932 . . . . 0.0 106.916 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.64 151.61 20.66 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.365 0.507 . . . . 0.0 113.726 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.81 -166.43 1.6 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.194 1.398 . . . . 0.0 109.198 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.5 t -62.55 129.58 41.23 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.908 0.483 . . . . 0.0 109.767 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.31 28.5 69.79 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.004 0.811 . . . . 0.0 112.095 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.8 m -151.52 116.49 5.22 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.168 -179.51 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.518 . . . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 123.605 1.669 . . . . 0.0 115.355 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.8 m -160.42 74.29 0.54 Allowed 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 101.342 -3.577 . . . . 0.0 101.342 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 70.21 73.59 0.22 Allowed 'General case' 0 C--N 1.343 0.32 0 N-CA-C 102.389 -3.189 . . . . 0.0 102.389 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.5 t -116.03 152.87 32.72 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -118.88 116.39 26.39 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 102.259 -3.237 . . . . 0.0 102.259 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -91.91 58.9 3.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.31 -78.53 0.82 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.556 1.074 . . . . 0.0 111.178 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 m -118.29 39.99 3.3 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.947 1.299 . . . . 0.0 110.274 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.33 152.88 38.96 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -150.51 113.94 4.92 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.621 0.646 . . . . 0.0 111.745 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.81 137.55 52.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.514 1.126 . . . . 0.0 111.251 178.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.9 t -70.11 160.31 32.27 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 126.368 1.867 . . . . 0.0 108.264 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.25 -19.05 30.95 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 t -72.57 -47.29 49.34 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -72.22 -28.22 63.04 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.638 1.175 . . . . 0.0 113.46 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.4 t -70.21 -51.79 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -58.83 -35.63 73.22 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 125.987 1.715 . . . . 0.0 111.277 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.67 -52.61 56.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.9 82.47 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.031 0.932 . . . . 0.0 112.033 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.43 -45.55 30.97 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -62.29 -22.43 66.02 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.9 -55.08 5.22 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.68 -42.9 12.14 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.209 1.004 . . . . 0.0 111.261 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 85.2 m -61.61 -52.77 63.02 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.178 0.991 . . . . 0.0 110.366 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -59.57 -41.45 90.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.364 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -69.32 -40.1 77.81 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.42 -0.8 . . . . 0.0 112.067 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -78.52 -32.63 48.14 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -136.49 -43.8 0.61 Allowed 'General case' 0 C--N 1.348 0.533 0 N-CA-C 118.216 2.672 . . . . 0.0 118.216 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -70.69 -22.95 62.4 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -165.48 102.41 0.71 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 77.27 -166.32 0.05 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.552 1.941 . . . . 0.0 111.169 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.4 p -123.79 -63.96 1.18 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.86 1.664 . . . . 0.0 109.07 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 52.07 90.84 0.02 OUTLIER 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.519 1.928 . . . . 0.0 112.062 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.02 -166.98 14.22 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.23 0.919 . . . . 0.0 110.821 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m 71.63 -11.43 0.73 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.987 1.715 . . . . 0.0 113.71 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.7 m -149.47 -43.35 0.14 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.806 0.842 . . . . 0.0 111.74 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.9 p -104.25 -22.96 13.29 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 77.41 152.43 0.13 Allowed Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.3 150.99 96.51 Favored 'Cis proline' 0 N--CA 1.45 -1.05 0 CA-C-N 121.088 1.424 . . . . 0.0 115.065 2.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -159.79 157.82 30.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 128.551 2.74 . . . . 0.0 105.713 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 t -53.28 149.49 7.25 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -89.09 161.92 16.26 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.692 1.597 . . . . 0.0 109.1 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -63.53 137.77 58.26 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.953 0.901 . . . . 0.0 111.706 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.69 -49.96 75.4 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.761 0.824 . . . . 0.0 108.908 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -59.1 137.38 57.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -71.96 88.92 1.08 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.986 0.515 . . . . 0.0 111.228 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.08 -29.53 66.64 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.88 164.09 36.32 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.212 1.405 . . . . 0.0 110.695 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -116.91 122.12 43.4 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.612 1.565 . . . . 0.0 107.835 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -119.42 157.69 50.86 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 124.821 1.248 . . . . 0.0 109.536 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -52.81 -35.36 69.43 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.825 3.017 . . . . 0.0 114.239 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.1 m -110.05 164.69 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.528 1.531 . . . . 0.0 112.044 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -95.75 159.53 14.93 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.573 1.549 . . . . 0.0 110.243 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.75 -154.54 30.87 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.4 1.0 . . . . 0.0 111.452 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.53 153.25 18.93 Favored 'Cis proline' 0 C--N 1.346 0.441 0 CA-C-N 118.722 1.261 . . . . 0.0 114.132 -0.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.67 167.07 17.74 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.165 0.986 . . . . 0.0 111.462 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -138.43 156.3 47.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.411 1.485 . . . . 0.0 109.253 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -90.17 157.84 17.53 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -160.15 108.9 1.4 Allowed Pre-proline 0 N--CA 1.454 -0.255 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -89.23 113.56 0.61 Allowed 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 122.65 2.233 . . . . 0.0 111.797 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.596 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 7.4 tt -86.22 174.67 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-O 123.632 1.682 . . . . 0.0 110.909 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.596 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 11.7 mmtp -155.48 150.73 26.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 109.851 -3.34 . . . . 0.0 110.912 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.5 p -88.68 61.03 5.85 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.311 1.444 . . . . 0.0 108.865 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.75 -61.58 0.02 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.05 166.12 36.18 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.0 p -77.6 138.0 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.505 1.122 . . . . 0.0 110.931 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.1 t80 53.57 86.92 0.04 OUTLIER 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.894 1.678 . . . . 0.0 112.111 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.4 t -151.41 158.97 44.41 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.21 1.004 . . . . 0.0 110.373 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.79 -133.11 2.65 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.501 1.048 . . . . 0.0 111.266 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.14 54.94 4.22 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 94.6 p 45.52 60.17 13.88 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.063 1.745 . . . . 0.0 112.64 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.1 141.24 18.48 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.749 2.966 . . . . 0.0 110.847 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 158.0 35.19 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.519 -0.601 . . . . 0.0 114.246 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -169.03 35.07 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.034 0.934 . . . . 0.0 110.764 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.25 93.85 0.29 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -145.96 153.48 40.85 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 m -119.86 146.6 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 102.474 -3.158 . . . . 0.0 102.474 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.255 81.2 t -125.55 113.14 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.1 pt -86.31 168.03 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.381 0 C-N-CA 125.704 1.602 . . . . 0.0 114.577 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -90.69 170.95 9.71 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.965 2.106 . . . . 0.0 107.374 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.367 11.6 t -85.35 52.93 2.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 118.048 2.611 . . . . 0.0 118.048 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -156.04 -89.81 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 101.245 -3.613 . . . . 0.0 101.245 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 36.3 t -163.94 66.43 0.17 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.198 1.399 . . . . 0.0 112.508 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -150.26 127.58 11.38 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 120.016 1.28 . . . . 0.0 113.051 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -64.46 117.29 7.1 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 177.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.39 -59.23 2.34 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 124.322 1.049 . . . . 0.0 110.631 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.57 -172.46 15.98 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.761 1.172 . . . . 0.0 111.472 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.31 144.05 13.94 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 122.802 0.441 . . . . 0.0 111.438 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.0 pt -131.06 159.34 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 125.487 1.515 . . . . 0.0 110.068 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.0 t -160.12 150.31 18.39 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.462 1.505 . . . . 0.0 109.418 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . 0.265 49.3 m170 -78.98 -51.87 9.03 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.409 1.004 . . . . 0.0 108.951 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.379 11.8 t 48.96 -69.82 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.706 2.802 . . . . 0.0 116.773 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.42 51.17 0.56 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 126.032 1.777 . . . . 0.0 108.879 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.79 158.02 36.24 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.913 1.285 . . . . 0.0 110.949 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.5 t -62.06 -40.51 96.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.214 0.606 . . . . 0.0 110.183 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -150.5 -109.64 0.47 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -94.38 -4.93 47.57 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.508 1.123 . . . . 0.0 112.083 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -65.17 174.5 2.0 Allowed 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.114 0.966 . . . . 0.0 112.113 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -125.64 150.99 47.11 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.735 1.614 . . . . 0.0 111.911 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.5 m -124.31 166.33 19.82 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 126.308 1.843 . . . . 0.0 107.009 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.04 160.21 24.87 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.3 m -100.66 174.22 6.17 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.136 0.975 . . . . 0.0 111.694 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.2 m 46.77 46.13 15.02 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.709 0.804 . . . . 0.0 112.069 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.67 22.95 73.81 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 119.311 -0.716 . . . . 0.0 114.052 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 55.0 m -86.57 146.77 26.22 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.974 0.909 . . . . 0.0 108.785 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 t30 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.055 -1.45 . . . . 0.0 109.437 -179.246 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 120.596 0.236 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 t -158.14 -175.24 5.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.126 1.37 . . . . 0.0 108.595 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.41 138.34 56.64 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.437 0.695 . . . . 0.0 109.134 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 t -141.81 119.99 12.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.487 0.315 . . . . 0.0 111.038 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.41 108.3 19.59 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.6 m -97.46 78.99 2.71 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.122 0.969 . . . . 0.0 109.177 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.83 -95.56 0.82 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.8 m -108.42 -31.78 7.69 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.851 1.26 . . . . 0.0 110.51 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 m -81.69 101.12 9.87 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -85.02 152.14 23.66 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 123.194 0.598 . . . . 0.0 111.322 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -142.06 133.73 26.93 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.645 1.178 . . . . 0.0 109.096 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.7 m -72.25 158.04 36.59 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 125.007 1.323 . . . . 0.0 111.314 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.08 -21.41 64.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.0 m -72.54 -39.35 67.58 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.076 0.95 . . . . 0.0 108.535 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -69.6 -50.22 46.6 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.547 1.139 . . . . 0.0 112.023 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.8 t -57.45 -48.23 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 123.608 0.763 . . . . 0.0 109.212 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -64.53 -43.31 94.41 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.545 1.138 . . . . 0.0 112.065 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.0 -54.24 14.1 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.972 0.509 . . . . 0.0 111.228 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.92 -26.76 67.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.421 0.689 . . . . 0.0 110.543 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.75 -38.09 29.28 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.481 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -65.79 -25.19 67.13 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.79 -60.0 2.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -44.97 -51.0 10.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.672 1.189 . . . . 0.0 110.196 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.01 -48.33 32.79 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.257 2.223 . . . . 0.0 111.796 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -81.75 -40.89 22.01 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.264 0.0 OUTLIER -67.75 -37.54 82.28 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 116.799 2.148 . . . . 0.0 116.799 -177.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.299 0.0 OUTLIER -82.14 6.27 17.02 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -179.09 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -77.49 -3.43 40.46 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.131 0.572 . . . . 0.0 110.786 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 64.02 48.11 3.16 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.442 1.897 . . . . 0.0 111.707 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -159.35 30.47 0.2 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.842 1.257 . . . . 0.0 110.658 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 176.88 165.69 0.51 Allowed 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 128.798 2.839 . . . . 0.0 108.86 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.263 0.0 OUTLIER -12.65 100.09 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.825 2.85 . . . . 0.0 115.233 -179.33 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 74.77 163.3 0.26 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 127.608 2.363 . . . . 0.0 115.792 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.98 82.57 0.06 OUTLIER Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.137 -0.813 . . . . 0.0 113.047 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.8 m 69.85 104.69 0.06 Allowed 'General case' 0 C--N 1.344 0.367 0 C-N-CA 126.384 1.873 . . . . 0.0 113.621 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -152.93 -55.89 0.12 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 100.988 -3.708 . . . . 0.0 100.988 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.575 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 40.7 p -130.64 -62.58 0.91 Allowed 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 101.006 -3.701 . . . . 0.0 101.006 175.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.575 ' CD1' ' C ' ' A' ' 37' ' ' THR . 23.9 m-85 -144.06 143.62 23.33 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 129.242 3.017 . . . . 0.0 106.072 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.67 144.73 62.24 Favored 'Cis proline' 0 N--CA 1.458 -0.567 0 CA-C-N 118.581 0.529 . . . . 0.0 112.596 1.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -156.54 151.76 26.48 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.537 0.608 . . . . 0.0 112.32 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.6 m -53.27 142.34 21.36 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.049 2.54 . . . . 0.0 113.121 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -91.9 136.76 32.91 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.705 1.202 . . . . 0.0 110.028 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -70.32 129.54 39.59 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.22 1.008 . . . . 0.0 111.864 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -86.17 61.04 6.59 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.936 1.294 . . . . 0.0 109.13 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -121.56 167.83 12.43 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.066 1.746 . . . . 0.0 109.076 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.49 154.16 41.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.382 0.673 . . . . 0.0 110.333 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.1 -88.27 0.32 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -121.51 152.91 38.64 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.241 1.417 . . . . 0.0 109.809 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 166.89 130.4 0.01 OUTLIER 'General case' 0 C--N 1.34 0.183 0 C-N-CA 128.109 2.564 . . . . 0.0 107.62 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -88.67 169.34 13.59 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.333 1.053 . . . . 0.0 108.96 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.19 -52.44 8.75 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.915 3.076 . . . . 0.0 113.024 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.9 m -65.05 156.62 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.11 1.364 . . . . 0.0 109.854 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -134.36 -168.66 2.18 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -46.32 138.55 7.52 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 127.608 2.527 . . . . 0.0 114.205 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.37 133.87 12.23 Favored 'Cis proline' 0 C--N 1.35 0.655 0 CA-C-N 119.933 1.866 . . . . 0.0 111.2 -2.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.53 108.99 1.64 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -177.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -123.35 157.7 32.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.994 1.718 . . . . 0.0 109.27 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -89.34 158.8 17.65 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.688 1.595 . . . . 0.0 112.633 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -159.18 117.96 1.68 Allowed Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.242 1.017 . . . . 0.0 108.917 177.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -81.44 137.83 10.6 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 N-CA-C 117.705 2.156 . . . . 0.0 117.705 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.256 3.3 mm -109.81 -0.32 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 1 C-N-CA 134.408 5.083 . . . . 0.0 115.207 179.116 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -75.41 104.62 6.05 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 126.704 2.002 . . . . 0.0 114.165 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.6 m 24.06 34.18 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.201 1 C-N-CA 131.884 4.074 . . . . 0.0 115.712 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.84 40.38 1.49 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.957 1.265 . . . . 0.0 111.534 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.13 -115.33 1.01 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.127 1.346 . . . . 0.0 113.211 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.16 48.58 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.983 1.313 . . . . 0.0 109.594 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 27.0 t80 61.21 71.42 0.56 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.472 1.909 . . . . 0.0 111.327 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 49.5 p -121.18 61.11 0.91 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.75 -153.62 24.06 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.5 -169.54 32.25 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 m -158.86 -68.34 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 125.111 1.364 . . . . 0.0 110.172 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.58 104.33 1.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.456 2.104 . . . . 0.0 109.799 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.15 79.85 1.15 Allowed Glycine 0 C--N 1.339 0.712 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.13 -70.84 0.25 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.05 123.06 18.05 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.619 1.1 . . . . 0.0 113.597 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -160.6 134.81 7.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.8 m -93.14 142.88 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.272 72.6 t -125.32 124.45 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.2 pt -130.99 175.09 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 123.934 0.771 . . . . 0.0 112.255 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -99.18 139.23 35.13 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 125.447 1.499 . . . . 0.0 109.199 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.548 0.5 OUTLIER -47.52 -12.72 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.401 1 N-CA-C 121.898 4.036 . . . . 0.0 121.898 -176.615 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -80.01 -81.85 0.12 Allowed 'General case' 0 N--CA 1.441 -0.884 1 N-CA-C 99.618 -4.216 . . . . 0.0 99.618 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.75 0.47 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.632 1.573 . . . . 0.0 114.472 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -82.27 127.73 33.49 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.33 135.34 55.19 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.641 1.577 . . . . 0.0 109.489 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.43 -50.83 3.49 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 122.982 0.513 . . . . 0.0 110.678 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.29 140.23 3.59 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.503 -0.379 . . . . 0.0 112.769 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.07 131.12 36.84 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.056 1.342 . . . . 0.0 108.034 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.8 pt -141.77 165.8 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.668 1.187 . . . . 0.0 110.391 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.8 t -158.57 146.54 18.21 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -83.58 15.13 3.29 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 122.665 0.386 . . . . 0.0 110.917 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 t -40.98 -45.29 2.56 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 116.92 2.192 . . . . 0.0 116.92 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -150.54 57.26 0.45 Allowed Glycine 0 C--N 1.331 0.301 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.02 175.89 5.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.891 1.276 . . . . 0.0 109.77 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.8 t -83.0 58.91 4.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.803 1.241 . . . . 0.0 111.028 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.37 -87.5 0.81 Allowed Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.228 1.394 . . . . 0.0 112.71 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -79.52 -24.75 42.01 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.114 0.966 . . . . 0.0 111.294 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -63.04 170.23 2.89 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.517 1.127 . . . . 0.0 110.178 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -130.31 168.19 17.3 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.617 1.567 . . . . 0.0 111.811 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.1 m -139.51 161.13 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 126.886 2.074 . . . . 0.0 105.748 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.25 131.7 10.58 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 114.775 0.67 . . . . 0.0 114.775 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.8 t -98.19 172.33 7.65 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.2 t 53.95 -153.63 0.28 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.904 1.229 . . . . 0.0 109.198 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.76 0.66 76.55 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.593 1.092 . . . . 0.0 110.401 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 m -79.69 149.15 31.31 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 125.495 1.518 . . . . 0.0 108.727 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.004 -1.474 . . . . 0.0 108.914 -179.186 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 121.143 0.497 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.6 m -136.5 -170.19 2.62 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.44 1.496 . . . . 0.0 108.117 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.44 122.7 11.02 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.8 0.84 . . . . 0.0 109.904 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 p -91.69 87.98 6.52 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -92.2 96.93 10.59 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 102.447 -3.168 . . . . 0.0 102.447 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.1 m -98.3 81.73 2.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.472 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.4 -86.98 0.91 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.9 p -122.12 -23.22 5.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.333 1.453 . . . . 0.0 110.929 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.55 91.6 3.98 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -84.15 127.99 34.27 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.933 1.293 . . . . 0.0 112.772 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -127.57 134.5 49.72 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.5 p -69.24 152.76 44.66 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 124.689 1.196 . . . . 0.0 110.194 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.38 -22.94 55.59 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.3 p -77.4 -35.51 54.19 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 123.284 0.634 . . . . 0.0 109.519 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -69.11 -33.87 74.17 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.423 0.689 . . . . 0.0 110.986 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.1 t -66.77 -50.56 64.52 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.0 tmt_? -61.49 -38.92 89.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.212 1.405 . . . . 0.0 110.99 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.44 -51.77 53.42 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.636 0.774 . . . . 0.0 109.58 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.83 -23.93 66.79 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 118.809 -0.615 . . . . 0.0 111.115 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.13 -41.77 33.96 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 118.468 0.577 . . . . 0.0 110.835 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -68.63 -20.89 64.5 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.09 -64.45 1.16 Allowed 'General case' 0 C--N 1.35 0.591 0 N-CA-C 103.292 -2.855 . . . . 0.0 103.292 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -39.88 -45.01 1.75 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.187 1.395 . . . . 0.0 111.473 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.5 m -55.26 -58.77 6.36 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.882 1.273 . . . . 0.0 109.753 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.2 tp-100 -65.84 -36.84 84.59 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -86.22 -10.13 55.23 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 128.772 2.829 . . . . 0.0 115.512 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -90.74 -61.48 1.66 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-N 120.07 1.304 . . . . 0.0 113.21 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -137.56 -10.0 1.64 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -66.46 -48.7 69.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.357 0.98 . . . . 0.0 111.276 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -172.38 108.61 0.21 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.045 1.338 . . . . 0.0 107.47 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.251 0.1 OUTLIER 89.26 163.61 0.05 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 128.724 2.81 . . . . 0.0 112.648 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.9 p -138.02 -45.45 0.52 Allowed 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 126.691 1.996 . . . . 0.0 109.026 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 85.62 165.35 0.09 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 127.844 2.458 . . . . 0.0 111.558 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.97 85.77 1.09 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.535 1.064 . . . . 0.0 111.781 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.9 p -132.47 -124.29 0.19 Allowed 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 m -177.69 -75.88 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.14 1.376 . . . . 0.0 109.711 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.02 0.5 57.53 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.776 1.63 . . . . 0.0 113.35 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -152.32 104.89 2.76 Favored Pre-proline 0 C--N 1.343 0.284 0 O-C-N 120.924 -1.11 . . . . 0.0 108.728 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -72.14 155.47 98.37 Favored 'Cis proline' 0 N--CA 1.459 -0.501 0 CA-C-N 119.942 1.015 . . . . 0.0 113.608 0.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.15 162.62 4.54 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.573 1.549 . . . . 0.0 109.945 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.6 m -70.27 136.63 50.04 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.869 1.668 . . . . 0.0 109.775 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -96.12 150.24 20.73 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.401 1.08 . . . . 0.0 109.96 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -78.88 165.75 23.17 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.108 0.963 . . . . 0.0 111.475 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -159.0 93.21 1.14 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.469 0.708 . . . . 0.0 110.337 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -164.23 -56.57 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.22 1.008 . . . . 0.0 109.894 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -166.07 134.05 2.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.801 1.24 . . . . 0.0 108.36 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.83 -83.68 0.15 Allowed Glycine 0 C--N 1.338 0.674 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -159.36 46.69 0.28 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.572 1.149 . . . . 0.0 107.992 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -74.95 164.23 26.78 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -127.95 94.67 36.29 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 125.481 1.512 . . . . 0.0 108.329 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.34 84.15 1.4 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.389 2.726 . . . . 0.0 110.982 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.7 t -113.17 -49.51 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.282 1.433 . . . . 0.0 109.198 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -154.15 -73.97 0.12 Allowed 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.854 0.861 . . . . 0.0 109.243 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.96 140.23 8.04 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.81 175.25 45.47 Favored 'Cis proline' 0 N--CA 1.459 -0.557 0 CA-C-N 118.845 1.322 . . . . 0.0 112.036 -0.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.59 -174.15 3.43 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.297 1.439 . . . . 0.0 108.75 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -157.12 146.14 20.03 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 122.968 0.507 . . . . 0.0 111.981 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -89.74 144.37 26.03 Favored 'General case' 0 C--N 1.343 0.295 0 O-C-N 123.687 0.617 . . . . 0.0 110.677 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -153.87 110.95 2.51 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -82.66 148.88 14.22 Favored 'Trans proline' 0 N--CA 1.439 -1.727 0 C-N-CA 121.824 1.683 . . . . 0.0 113.48 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.653 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.5 tt -106.73 -177.57 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-O 123.87 1.795 . . . . 0.0 111.7 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.653 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 18.5 tptt -160.29 159.35 31.23 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 109.622 -3.445 . . . . 0.0 113.041 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.5 p -90.11 60.41 4.82 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 126.515 1.926 . . . . 0.0 110.887 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.36 -53.94 0.05 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.66 -151.93 6.32 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.5 p -72.24 165.26 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.79 1.236 . . . . 0.0 109.083 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.44 141.91 14.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.9 m -118.09 -56.03 2.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.908 2.083 . . . . 0.0 107.427 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.61 -157.58 16.17 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.828 1.204 . . . . 0.0 111.42 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.39 36.34 59.44 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.375 0.988 . . . . 0.0 112.318 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.7 m -160.86 157.87 23.62 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 125.7 1.6 . . . . 0.0 108.274 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -45.36 -58.44 1.6 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.783 2.989 . . . . 0.0 111.884 169.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.4 141.47 12.24 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.438 ' HB3' ' CB ' ' A' ' 91' ' ' HIS . . . -148.3 -40.96 0.16 Allowed 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 117.428 -1.272 . . . . 0.0 112.273 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -88.14 120.45 29.5 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.032 0.933 . . . . 0.0 109.351 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.4 138.89 16.81 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -90.82 151.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.1 t -135.98 117.82 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.7 pt -109.68 164.12 6.29 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 C-N-CA 124.091 0.957 . . . . 0.0 112.18 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -79.41 157.87 27.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.312 1.845 . . . . 0.0 106.76 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.291 5.6 t -63.01 -10.14 12.8 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 -177.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -85.95 -80.54 0.22 Allowed 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.93 -5.45 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.666 2.386 . . . . 0.0 115.485 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.16 143.81 35.08 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 119.867 1.212 . . . . 0.0 114.021 -175.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -70.83 124.54 24.55 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.75 -48.08 6.75 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.028 0.531 . . . . 0.0 109.684 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.79 -170.08 41.22 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.12 141.07 22.01 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.508 1.123 . . . . 0.0 108.481 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.7 pt -137.71 166.34 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 124.598 1.159 . . . . 0.0 109.911 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.4 t -154.57 156.04 35.87 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.438 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 64.5 m170 -77.27 -40.85 43.18 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.763 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.6 t -54.67 142.97 26.41 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 123.127 0.571 . . . . 0.0 111.801 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.1 -24.01 33.22 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.71 -141.94 0.23 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.012 1.325 . . . . 0.0 109.087 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.2 t -155.23 80.63 1.05 Allowed 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.431 0.56 . . . . 0.0 111.114 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.94 -133.2 11.02 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.033 1.301 . . . . 0.0 111.963 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -79.77 -30.06 40.6 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.983 0.913 . . . . 0.0 111.376 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -52.58 140.02 24.11 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.032 0.933 . . . . 0.0 109.78 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.64 167.03 10.59 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.3 m -145.01 166.56 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 128.944 2.897 . . . . 0.0 106.064 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.6 164.59 39.73 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 123.64 0.638 . . . . 0.0 114.539 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 49.6 t -139.36 163.71 31.76 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.986 1.714 . . . . 0.0 108.304 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.6 p 54.92 43.81 29.33 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.51 1.924 . . . . 0.0 111.773 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.64 15.87 81.21 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.006 -0.885 . . . . 0.0 113.664 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.3 m -82.7 140.9 32.83 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.596 1.198 . . . . 0.0 108.59 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.107 -1.425 . . . . 0.0 108.986 179.652 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.3 p -127.9 44.05 3.01 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.129 1.372 . . . . 0.0 110.411 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.54 164.56 0.14 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.485 1.914 . . . . 0.0 112.027 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.07 151.84 25.72 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.261 -0.274 . . . . 0.0 110.97 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.2 115.82 21.02 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.7 m -103.37 97.17 7.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.47 0.708 . . . . 0.0 109.819 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.9 -78.4 0.91 Allowed Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.768 1.175 . . . . 0.0 111.297 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 t -135.71 -8.42 2.15 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.547 1.139 . . . . 0.0 112.778 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.64 134.94 42.86 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 119.194 0.907 . . . . 0.0 109.502 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -94.4 154.69 17.34 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.809 0.844 . . . . 0.0 110.879 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -145.28 126.38 14.65 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.267 1.427 . . . . 0.0 108.836 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t -69.94 155.51 40.47 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.16 -16.65 34.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.6 t -76.28 -37.9 56.91 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.079 0.952 . . . . 0.0 109.459 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -74.6 -51.04 15.63 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.957 1.703 . . . . 0.0 111.152 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.84 -47.72 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.934 1.294 . . . . 0.0 107.524 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -69.67 -36.79 76.33 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.037 0.935 . . . . 0.0 111.94 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.13 -51.17 68.96 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.687 1.131 . . . . 0.0 109.859 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -34.72 74.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.775 0.83 . . . . 0.0 111.055 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.18 -33.35 33.08 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -69.94 -23.42 63.19 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.64 -53.15 6.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.19 -38.45 39.98 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.282 1.033 . . . . 0.0 110.41 176.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -55.3 35.31 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 126.171 1.789 . . . . 0.0 109.608 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.29 -30.97 68.11 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -90.55 -26.72 19.58 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -62.15 -32.75 73.39 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 119.202 0.91 . . . . 0.0 109.922 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -59.41 -19.03 44.13 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.024 0.929 . . . . 0.0 110.875 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 76.08 59.06 0.05 OUTLIER 'General case' 0 C--N 1.344 0.359 0 C-N-CA 127.294 2.237 . . . . 0.0 110.588 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -145.21 34.95 1.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.999 1.32 . . . . 0.0 109.529 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -175.27 130.99 0.29 Allowed 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 128.677 2.791 . . . . 0.0 106.455 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.7 p -84.35 85.79 7.34 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.26 0.552 . . . . 0.0 111.83 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.71 -160.23 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.044 1.737 . . . . 0.0 109.795 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -44.54 -49.8 8.47 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.233 1.397 . . . . 0.0 110.947 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.3 t 67.09 2.52 2.78 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.09 1.756 . . . . 0.0 115.735 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.9 m -67.77 -63.21 1.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -160.47 42.67 0.18 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.968 2.107 . . . . 0.0 107.076 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.438 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 9.8 m-85 -156.44 115.7 2.11 Favored Pre-proline 0 C--N 1.34 0.186 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.26 150.56 91.62 Favored 'Cis proline' 0 N--CA 1.456 -0.722 0 N-CA-C 114.239 0.823 . . . . 0.0 114.239 1.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.19 145.1 8.38 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.628 1.571 . . . . 0.0 108.577 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -60.44 145.47 48.1 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.849 1.66 . . . . 0.0 112.13 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -145.37 84.38 1.69 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -153.38 -158.47 0.88 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.934 1.294 . . . . 0.0 108.31 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.0 m120 67.83 2.52 3.1 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.629 1.572 . . . . 0.0 113.662 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -165.37 105.84 0.76 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -80.93 69.9 7.62 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.68 0.792 . . . . 0.0 110.659 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.28 11.91 56.6 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.945 0.783 . . . . 0.0 112.248 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -157.53 162.92 38.85 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 118.186 0.993 . . . . 0.0 111.809 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -116.03 119.72 36.78 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.131 1.373 . . . . 0.0 108.299 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -135.94 156.72 76.96 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 125.993 1.717 . . . . 0.0 107.722 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.74 163.36 18.92 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.095 2.53 . . . . 0.0 109.341 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.284 8.6 m 60.21 -165.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.176 1.39 . . . . 0.0 110.686 -178.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -112.79 -16.97 12.65 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.571 1.148 . . . . 0.0 113.392 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.07 -156.65 22.41 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.34 -177.05 5.33 Favored 'Cis proline' 0 CA--C 1.535 0.545 0 CA-C-N 119.037 1.418 . . . . 0.0 113.211 -0.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -148.25 155.27 41.14 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.615 0.366 . . . . 0.0 111.478 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -132.43 146.74 52.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.257 1.423 . . . . 0.0 107.777 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -86.6 156.8 19.89 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -152.5 109.7 2.76 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 13.0 Cg_endo -85.21 128.8 3.69 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.34 2.694 . . . . 0.0 116.965 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.548 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 10.1 tt -97.4 170.13 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 123.969 1.842 . . . . 0.0 112.193 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.548 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 8.3 mtpm? -160.74 113.51 1.99 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 109.394 -3.548 . . . . 0.0 111.623 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.9 p 10.76 50.14 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 129.806 3.242 . . . . 0.0 116.471 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.34 70.82 1.33 Allowed Glycine 0 C--N 1.337 0.639 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.08 113.89 0.54 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.9 t -84.08 137.77 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.103 1.361 . . . . 0.0 109.416 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.322 9.6 p90 46.17 53.38 9.41 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.027 2.131 . . . . 0.0 113.979 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.8 p -129.63 -33.44 1.85 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.963 1.705 . . . . 0.0 109.726 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.11 149.57 44.85 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 123.588 0.613 . . . . 0.0 112.815 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 172.07 -74.82 0.1 OUTLIER Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.8 t -153.0 105.22 2.64 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 124.121 0.968 . . . . 0.0 109.343 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -58.41 157.47 35.39 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 CA-C-N 119.735 0.941 . . . . 0.0 113.23 -5.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.81 -104.49 0.21 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 79.06 -60.18 0.37 Allowed 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 127.683 2.393 . . . . 0.0 109.052 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.92 121.9 18.25 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.445 1.498 . . . . 0.0 109.923 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -152.76 141.66 21.15 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.9 m -97.63 150.14 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.9 t -131.82 119.13 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.2 pt -100.62 167.75 2.01 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 C-N-CA 124.783 1.233 . . . . 0.0 113.17 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -82.46 168.26 17.62 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.875 2.07 . . . . 0.0 107.887 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.51 46.18 0.42 Allowed 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -160.36 -83.43 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.4 m -163.44 63.12 0.17 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.96 2.104 . . . . 0.0 112.034 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -148.83 114.74 5.72 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.445 1.93 . . . . 0.0 113.88 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -60.47 107.35 0.66 Allowed 'General case' 0 C--N 1.344 0.357 0 C-N-CA 123.56 0.744 . . . . 0.0 109.808 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.96 -68.22 0.72 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.34 169.35 35.46 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.87 146.64 48.26 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.25 1.02 . . . . 0.0 111.439 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.6 pt -139.28 166.04 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.577 1.551 . . . . 0.0 109.631 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.5 t -156.01 148.67 23.92 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -79.05 4.68 13.81 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 118.666 -0.683 . . . . 0.0 112.092 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.1 m -47.79 -49.94 27.24 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.73 32.68 6.4 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.577 1.084 . . . . 0.0 110.986 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -111.52 166.45 11.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.596 1.159 . . . . 0.0 112.641 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.2 t -103.49 67.61 0.92 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.707 1.603 . . . . 0.0 108.625 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.97 -109.8 3.79 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.763 1.173 . . . . 0.0 112.207 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -79.61 -9.18 59.59 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.175 0.99 . . . . 0.0 113.1 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -66.87 -179.65 0.94 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.062 0.945 . . . . 0.0 108.77 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -147.53 167.94 23.2 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.3 m -139.23 160.49 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 128.038 2.535 . . . . 0.0 105.381 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.67 149.6 20.17 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 115.527 0.971 . . . . 0.0 115.527 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.1 m -99.38 154.37 18.26 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.1 p 33.02 38.63 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 62.71 52.41 48.77 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.165 0.888 . . . . 0.0 111.853 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.1 t -81.65 28.95 0.39 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.517 1.127 . . . . 0.0 113.996 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 . . . . . 0 C--O 1.25 1.103 0 C-N-CA 125.974 1.709 . . . . 0.0 109.369 -179.243 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 t -77.96 92.5 4.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.722 1.209 . . . . 0.0 107.828 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 110.53 98.35 0.0 OUTLIER 'General case' 0 C--N 1.345 0.393 0 C-N-CA 131.157 3.783 . . . . 0.0 107.096 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -107.28 94.61 5.18 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.84 1.256 . . . . 0.0 111.563 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.04 99.6 9.49 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 102.105 -3.294 . . . . 0.0 102.105 177.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -92.13 80.81 5.05 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.755 1.622 . . . . 0.0 109.211 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.41 -82.49 0.91 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.4 t -117.89 -45.81 2.66 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.49 1.516 . . . . 0.0 109.67 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.8 m -63.42 103.91 0.57 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.725 1.21 . . . . 0.0 109.885 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.82 131.42 34.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.097 1.359 . . . . 0.0 110.847 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -131.21 138.54 49.42 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.6 p -77.68 160.68 28.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 124.113 0.965 . . . . 0.0 111.773 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.87 -13.21 43.22 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.9 t -81.42 -41.38 21.96 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.92 -37.2 86.52 Favored 'General case' 0 C--N 1.345 0.402 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 t -59.86 -51.23 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 126.28 1.832 . . . . 0.0 108.538 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.79 -39.16 93.36 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.139 0.976 . . . . 0.0 111.805 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.94 -51.71 36.85 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.055 0.542 . . . . 0.0 110.419 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.41 -38.77 81.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.669 1.188 . . . . 0.0 110.884 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.89 -41.03 45.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -64.3 -21.5 66.63 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.64 -59.22 2.5 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.07 -47.4 11.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.906 1.283 . . . . 0.0 110.239 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.9 t -61.18 -53.95 50.51 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.474 1.509 . . . . 0.0 111.595 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -57.37 -46.69 83.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.943 0.497 . . . . 0.0 110.907 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -67.46 -48.96 65.66 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.685 1.194 . . . . 0.0 113.137 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -65.05 -34.33 78.18 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.694 0.798 . . . . 0.0 112.146 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -82.78 -47.16 12.23 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 123.033 0.533 . . . . 0.0 111.52 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -70.98 -3.56 20.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.533 1.133 . . . . 0.0 112.539 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.8 t70 69.16 76.69 0.23 Allowed 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.662 1.585 . . . . 0.0 110.812 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -144.88 122.79 11.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.0 1.72 . . . . 0.0 107.172 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.9 p -103.22 82.43 2.07 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.02 111.98 2.15 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.236 1.015 . . . . 0.0 110.35 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.63 112.53 3.14 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.414 1.006 . . . . 0.0 111.867 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.2 m -135.88 -56.97 0.77 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.993 1.317 . . . . 0.0 108.064 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -157.67 -68.18 0.09 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.089 1.755 . . . . 0.0 106.507 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.3 t -159.95 30.67 0.18 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.351 1.86 . . . . 0.0 108.639 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -124.43 155.04 69.4 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.569 1.947 . . . . 0.0 108.825 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -80.51 133.72 27.36 Favored 'Cis proline' 0 N--CA 1.452 -0.935 0 CA-C-N 119.519 0.864 . . . . 0.0 112.438 -0.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.97 166.17 33.23 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.997 1.319 . . . . 0.0 108.652 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.6 m -51.81 140.47 19.32 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 126.051 1.741 . . . . 0.0 112.107 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -129.71 119.7 23.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.738 1.215 . . . . 0.0 109.204 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -165.08 92.36 0.57 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -159.32 159.65 34.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.314 0.646 . . . . 0.0 111.149 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.8 t80 67.79 165.59 0.23 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.875 1.67 . . . . 0.0 112.615 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -109.62 -45.17 3.72 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 124.778 1.231 . . . . 0.0 110.788 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.13 38.21 2.2 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.006 0.812 . . . . 0.0 113.85 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -157.82 128.22 6.29 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.012 1.325 . . . . 0.0 108.653 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -165.27 -175.32 3.57 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.165 1.386 . . . . 0.0 108.954 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -143.06 157.11 61.31 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 125.459 1.504 . . . . 0.0 107.903 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -81.85 48.99 3.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.668 2.912 . . . . 0.0 111.506 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 m -153.45 171.88 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 127.547 2.339 . . . . 0.0 107.441 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -109.32 143.65 38.54 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.265 1.026 . . . . 0.0 110.33 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.71 -160.66 35.84 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.65 151.38 23.55 Favored 'Cis proline' 0 N--CA 1.46 -0.467 0 CA-C-N 118.793 1.297 . . . . 0.0 113.634 -0.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -111.74 174.09 6.04 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.669 1.188 . . . . 0.0 109.848 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -155.57 144.0 20.25 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.11 0.564 . . . . 0.0 110.508 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -87.81 149.93 23.85 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.877 0.871 . . . . 0.0 111.092 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -158.34 109.24 1.69 Allowed Pre-proline 0 N--CA 1.45 -0.444 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -79.92 136.1 11.63 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 121.344 1.363 . . . . 0.0 113.454 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.623 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.3 tt -98.51 177.25 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 124.089 1.899 . . . . 0.0 110.801 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.623 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.7 tptm -156.52 -169.63 3.08 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 109.295 -3.593 . . . . 0.0 110.835 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t -76.64 52.44 0.81 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.574 1.549 . . . . 0.0 112.464 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.35 68.45 1.46 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.34 103.14 0.2 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 51.7 t -66.21 120.32 13.09 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 124.43 1.092 . . . . 0.0 108.661 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 64.47 115.67 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.543 1.537 . . . . 0.0 111.308 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.2 p -97.34 -72.74 0.63 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.495 1.118 . . . . 0.0 111.867 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.71 -10.88 73.59 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.897 0.76 . . . . 0.0 111.854 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.52 -90.68 1.04 Allowed Glycine 0 C--N 1.343 0.96 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.9 m -141.39 72.81 25.82 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 123.339 0.656 . . . . 0.0 112.229 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.55 111.33 3.2 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 N-CA-C 105.761 -2.438 . . . . 0.0 105.761 163.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.08 -8.28 8.02 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-O 117.243 -1.865 . . . . 0.0 117.081 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.05 -60.19 0.2 Allowed 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 120.84 2.32 . . . . 0.0 114.315 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.52 118.33 13.18 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -147.2 137.22 23.19 Favored 'General case' 0 C--N 1.347 0.483 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.9 m -94.69 149.33 4.48 Favored 'Isoleucine or valine' 0 C--N 1.343 0.318 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.5 t -134.72 117.68 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 pt -103.53 -177.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.372 0 C-N-CA 124.407 1.083 . . . . 0.0 112.145 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -99.79 151.91 20.72 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 127.312 2.245 . . . . 0.0 105.308 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.326 5.3 t -63.07 -7.22 5.07 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 119.2 3.037 . . . . 0.0 119.2 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -89.29 -78.03 0.36 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.54 -9.96 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -79.21 151.49 31.19 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 118.868 0.758 . . . . 0.0 110.509 -176.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -93.53 137.55 32.69 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.514 1.125 . . . . 0.0 109.763 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.86 -57.59 2.32 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 123.258 0.623 . . . . 0.0 110.767 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.86 168.86 30.6 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.29 155.72 20.19 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 122.203 1.002 . . . . 0.0 112.794 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.2 pt -139.55 155.77 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 126.699 1.999 . . . . 0.0 106.575 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.5 t -154.69 156.47 36.46 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -77.96 -50.06 12.9 Favored 'General case' 0 C--N 1.346 0.442 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.673 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t 45.4 15.1 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.621 2.768 . . . . 0.0 116.248 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.76 49.79 3.28 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.174 1.369 . . . . 0.0 110.791 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.24 -87.13 0.11 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 124.293 1.037 . . . . 0.0 109.721 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.7 m -147.64 63.19 1.14 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.729 1.211 . . . . 0.0 108.756 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.04 -102.21 1.13 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.282 0.944 . . . . 0.0 111.737 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -79.53 -26.93 41.36 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.91 0.884 . . . . 0.0 112.006 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -50.31 129.96 22.4 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.989 0.916 . . . . 0.0 111.374 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -103.62 133.93 47.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.28 1.432 . . . . 0.0 110.266 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.6 m -111.15 164.81 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.33 137.76 17.45 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.872 -0.604 . . . . 0.0 114.105 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.8 t -83.29 -172.5 4.18 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.3 m -67.65 138.97 56.77 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.217 -0.927 . . . . 0.0 108.643 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.63 33.11 35.34 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.2 m -155.24 119.3 4.61 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.533 1.533 . . . . 0.0 110.574 -179.088 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t -160.02 148.5 17.15 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.417 1.087 . . . . 0.0 108.318 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -49.32 136.81 15.22 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.808 1.243 . . . . 0.0 110.485 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.7 p -112.45 117.58 32.78 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -117.41 94.59 4.61 Favored 'General case' 0 N--CA 1.422 -1.872 1 N-CA-C 100.176 -4.009 . . . . 0.0 100.176 177.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 54.2 m -95.02 71.87 3.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.29 -79.22 1.51 Allowed Glycine 0 C--N 1.34 0.799 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.3 t -123.29 -35.32 2.98 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.99 1.316 . . . . 0.0 111.344 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 m -72.86 99.25 2.62 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -95.58 148.36 22.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.264 1.026 . . . . 0.0 110.803 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.61 143.62 31.56 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.691 1.196 . . . . 0.0 108.003 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -68.71 150.73 47.57 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.86 -21.27 10.84 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.8 t -71.14 -44.51 65.41 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.387 1.075 . . . . 0.0 109.574 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.1 -39.01 92.53 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 118.682 0.673 . . . . 0.0 112.628 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.422 HG13 ' CE2' ' A' ' 85' ' ' TYR . 2.1 t -62.88 -53.31 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -57.13 -44.49 83.41 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.811 1.245 . . . . 0.0 110.291 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.03 -45.11 95.0 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.647 0.779 . . . . 0.0 110.077 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.13 -33.95 69.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.511 0.725 . . . . 0.0 110.372 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.08 -39.55 25.54 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -62.4 -25.93 68.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.934 1.243 . . . . 0.0 108.312 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.55 -64.51 1.13 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.57 -33.54 15.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.962 0.905 . . . . 0.0 111.346 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 t -61.89 -61.4 2.52 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.308 1.443 . . . . 0.0 110.05 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -65.7 -42.3 91.32 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -71.52 -48.7 47.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.329 1.451 . . . . 0.0 113.722 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.41 ' CE2' ' HG2' ' A' ' 57' ' ' GLN . 39.6 t80 -62.08 -34.68 76.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.48 0.582 . . . . 0.0 110.177 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -58.02 -34.81 70.45 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 118.432 -0.794 . . . . 0.0 112.447 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 122.08 73.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 129.577 3.151 . . . . 0.0 110.604 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -162.08 58.82 0.24 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.1 t70 124.18 154.52 0.0 OUTLIER 'General case' 0 C--N 1.344 0.343 0 C-N-CA 130.027 3.331 . . . . 0.0 109.257 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.6 p -110.78 67.65 0.65 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 126.044 1.738 . . . . 0.0 108.653 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.06 93.79 1.83 Allowed 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.047 0.539 . . . . 0.0 109.751 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.21 135.33 3.41 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.1 t -136.4 67.03 1.47 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.642 0.777 . . . . 0.0 110.589 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.1 m -122.24 -76.77 0.59 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -160.29 30.97 0.17 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.835 1.654 . . . . 0.0 109.105 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -149.05 134.3 9.47 Favored Pre-proline 0 C--N 1.342 0.278 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.68 145.9 85.35 Favored 'Cis proline' 0 N--CA 1.455 -0.776 0 CA-C-N 119.373 0.812 . . . . 0.0 112.483 -0.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -159.89 162.47 34.58 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 126.079 1.752 . . . . 0.0 108.459 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 t -59.91 150.23 29.32 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -106.56 88.44 2.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.11 1.364 . . . . 0.0 107.707 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -68.31 100.4 1.05 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.687 1.195 . . . . 0.0 109.943 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -66.17 -65.48 0.67 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.679 0.791 . . . . 0.0 111.105 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 58.41 56.03 4.61 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 68.06 -17.0 0.17 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.731 2.012 . . . . 0.0 114.593 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.75 -99.32 0.01 OUTLIER Glycine 0 CA--C 1.532 1.136 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.62 133.94 38.31 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -109.81 162.83 14.1 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.948 1.299 . . . . 0.0 110.88 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -153.95 153.21 28.26 Favored Pre-proline 0 N--CA 1.454 -0.257 0 C-N-CA 126.149 1.78 . . . . 0.0 107.231 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.99 -30.02 76.17 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.92 2.413 . . . . 0.0 112.026 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 t -91.06 -74.39 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.069 0.947 . . . . 0.0 108.462 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 t70 54.87 105.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.967 2.507 . . . . 0.0 115.405 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.81 117.68 2.0 Allowed Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.839 -0.978 . . . . 0.0 112.082 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -68.8 157.33 89.34 Favored 'Cis proline' 0 C--N 1.348 0.515 0 CA-C-N 119.521 1.661 . . . . 0.0 108.543 -1.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.56 134.75 15.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 119.85 3.278 . . . . 0.0 119.85 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.41 ' HG2' ' CE2' ' A' ' 27' ' ' TYR . 20.0 mp0 -145.07 144.97 31.24 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.476 1.11 . . . . 0.0 112.78 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -81.86 156.15 24.98 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.674 0.749 . . . . 0.0 110.346 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -160.63 107.53 1.32 Allowed Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.39 134.88 21.46 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 CA-C-N 120.913 1.362 . . . . 0.0 112.336 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.528 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 6.9 tp -82.27 176.14 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-O 123.863 1.792 . . . . 0.0 111.114 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.528 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 55.9 tptt -155.56 154.57 31.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 109.703 -3.408 . . . . 0.0 112.813 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.4 m -83.83 51.0 1.93 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 127.467 2.307 . . . . 0.0 108.367 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.62 65.03 0.07 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.48 -102.9 1.66 Allowed Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.2 p -110.6 -176.93 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.823 2.049 . . . . 0.0 109.886 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -41.27 166.72 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.291 2.636 . . . . 0.0 117.258 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.3 p -96.37 -64.17 1.07 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.375 1.47 . . . . 0.0 110.057 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.12 62.88 0.77 Allowed Glycine 0 C--N 1.338 0.679 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -170.76 -61.8 0.04 OUTLIER Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.2 t -154.13 147.4 18.2 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.288 1.035 . . . . 0.0 109.924 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.31 -158.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.193 3.262 . . . . 0.0 110.419 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.39 41.95 0.13 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 107.391 -2.284 . . . . 0.0 107.391 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.426 ' HB3' ' CB ' ' A' ' 91' ' ' HIS . . . 71.12 -27.07 0.17 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.824 2.049 . . . . 0.0 116.305 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.9 111.43 19.66 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 120.332 1.424 . . . . 0.0 110.438 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -120.1 154.09 35.2 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.101 0.96 . . . . 0.0 113.146 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.3 m -128.02 143.21 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -134.89 126.67 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pt -110.29 -165.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.371 0 C-N-CA 125.016 1.326 . . . . 0.0 114.447 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -122.97 136.87 55.02 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 128.48 2.712 . . . . 0.0 106.849 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.29 1.7 t -56.65 -15.55 4.67 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 118.746 2.869 . . . . 0.0 118.746 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -79.55 -77.15 0.19 Allowed 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 102.693 -3.077 . . . . 0.0 102.693 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.11 -2.16 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.012 2.125 . . . . 0.0 114.902 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -79.17 170.25 16.93 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 119.646 1.112 . . . . 0.0 112.155 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.422 ' CE2' HG13 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -112.65 126.95 55.93 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.767 1.227 . . . . 0.0 111.565 -178.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.5 -51.82 7.44 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.63 -158.26 31.07 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 112.28 -0.328 . . . . 0.0 112.28 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.54 145.22 29.0 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.357 1.063 . . . . 0.0 110.174 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 pt -138.32 166.81 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.705 1.202 . . . . 0.0 110.95 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.3 t -156.18 156.69 34.63 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.426 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 44.7 m170 -78.5 -30.67 47.33 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.117 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.5 m -29.48 -70.14 0.05 Allowed 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.987 2.115 . . . . 0.0 116.504 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.97 -12.84 79.25 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.111 0.862 . . . . 0.0 114.769 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.96 -142.21 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.345 1.073 . . . . 0.0 111.064 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.7 t -151.17 92.27 1.78 Allowed 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.033 0.933 . . . . 0.0 109.941 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.98 -105.97 2.21 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.97 1.272 . . . . 0.0 112.632 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -79.47 -32.03 42.52 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.871 0.868 . . . . 0.0 111.312 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -54.79 160.62 1.83 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.318 1.047 . . . . 0.0 111.685 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -125.09 163.37 22.54 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.239 1.416 . . . . 0.0 112.859 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.5 m -144.53 165.68 12.78 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 128.123 2.569 . . . . 0.0 106.473 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.68 157.34 23.63 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.232 0.444 . . . . 0.0 113.477 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.5 m -116.24 167.63 10.84 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.2 m 61.7 -157.31 0.34 Allowed 'General case' 0 C--N 1.342 0.243 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.37 -19.62 57.77 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.489 1.042 . . . . 0.0 111.359 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.8 m -79.46 144.69 33.81 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 125.011 1.324 . . . . 0.0 109.122 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 C--O 1.253 1.285 0 CA-C-O 117.066 -1.445 . . . . 0.0 109.193 179.039 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 121.261 0.553 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -148.69 54.24 1.0 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.921 1.288 . . . . 0.0 107.937 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 73.41 146.34 0.08 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 126.874 2.07 . . . . 0.0 109.974 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 t -151.15 135.45 16.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.506 0.193 . . . . 0.0 110.525 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.88 107.91 18.02 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -98.69 85.89 3.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.47 -115.06 4.93 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.0 m -91.15 -27.79 18.29 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.404 1.082 . . . . 0.0 110.23 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -76.33 94.53 3.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.202 1.001 . . . . 0.0 109.351 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -85.82 113.15 21.75 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.723 1.209 . . . . 0.0 109.977 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -103.99 133.02 49.65 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.124 0.97 . . . . 0.0 111.218 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.7 m -72.46 154.31 40.93 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.3 1.44 . . . . 0.0 108.951 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.08 -20.84 60.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.0 m -74.5 -37.91 62.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.774 0.829 . . . . 0.0 109.449 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -73.66 -47.72 37.7 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.751 1.22 . . . . 0.0 111.596 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.0 t -54.39 -50.29 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -71.81 -34.64 69.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.226 1.411 . . . . 0.0 113.272 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.76 -52.76 55.26 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.279 0.945 . . . . 0.0 109.396 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.59 87.75 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.91 -37.54 81.82 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.63 -22.51 61.68 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.33 -59.44 2.77 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.44 -41.72 73.25 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.365 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.74 -50.47 33.61 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.853 1.206 . . . . 0.0 110.577 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -68.52 -43.87 75.84 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.353 0.0 OUTLIER -75.08 -43.05 55.32 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -177.394 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -39.24 62.98 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.59 1.956 . . . . 0.0 107.928 177.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -76.81 -37.51 55.62 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.884 1.274 . . . . 0.0 112.867 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -63.16 -32.18 73.51 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 t0 67.92 32.0 5.38 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.439 1.495 . . . . 0.0 110.87 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -163.5 -165.18 1.01 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 129.283 3.033 . . . . 0.0 105.065 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.284 3.7 t 47.27 57.96 5.31 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.804 1.242 . . . . 0.0 110.518 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.52 172.16 13.35 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.663 1.585 . . . . 0.0 109.67 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.8 58.25 0.07 OUTLIER Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.3 t -118.95 -94.49 0.5 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.716 1.206 . . . . 0.0 108.207 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.9 m -158.1 -59.34 0.08 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.804 1.242 . . . . 0.0 108.223 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 82.7 p -130.56 -52.27 1.08 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.697 1.599 . . . . 0.0 108.439 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -45.24 124.57 5.58 Favored Pre-proline 0 C--N 1.342 0.271 0 C-N-CA 127.821 2.448 . . . . 0.0 108.531 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.52 119.22 5.08 Favored 'Cis proline' 0 N--CA 1.453 -0.857 0 CA-C-N 118.583 0.53 . . . . 0.0 111.613 1.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -135.85 146.35 47.37 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 124.643 1.177 . . . . 0.0 111.129 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -43.0 151.3 0.14 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.257 2.223 . . . . 0.0 114.743 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -126.4 127.23 45.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.742 2.017 . . . . 0.0 105.853 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -74.32 -103.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 122.79 0.436 . . . . 0.0 111.3 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -178.46 -46.08 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.212 1.405 . . . . 0.0 109.06 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -41.48 128.76 3.14 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 128.002 2.521 . . . . 0.0 115.106 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 43.87 82.5 0.03 OUTLIER 'General case' 0 C--N 1.342 0.267 0 C-N-CA 127.325 2.25 . . . . 0.0 113.361 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.46 -156.94 28.4 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.52 154.35 20.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.66 1.584 . . . . 0.0 108.339 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -132.29 129.65 39.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -72.32 151.57 92.1 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.722 1.209 . . . . 0.0 111.397 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -63.6 -12.52 31.58 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 124.05 3.167 . . . . 0.0 115.618 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.94 -64.18 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.063 0.847 . . . . 0.0 110.281 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 143.17 -52.03 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 129.601 3.16 . . . . 0.0 108.457 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.5 -162.96 28.38 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.436 1.017 . . . . 0.0 110.952 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.6 170.59 9.27 Favored 'Cis proline' 0 CA--C 1.535 0.542 0 CA-C-N 119.208 1.504 . . . . 0.0 114.999 -0.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.29 -179.17 6.36 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 125.061 1.344 . . . . 0.0 109.229 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.19 147.77 25.18 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.24 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -79.41 148.8 31.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.832 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -144.13 104.91 4.78 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -77.54 128.09 9.3 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 121.024 1.149 . . . . 0.0 113.319 -175.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.657 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.1 tt -90.83 179.33 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 124.281 1.991 . . . . 0.0 110.275 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.657 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 10.4 tptp -160.2 147.55 16.26 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 109.26 -3.609 . . . . 0.0 110.58 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.0 p -93.35 56.89 2.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.604 1.162 . . . . 0.0 108.531 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 178.78 57.3 0.07 OUTLIER Glycine 0 C--N 1.339 0.713 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.95 153.16 19.1 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.023 0.821 . . . . 0.0 111.951 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.57 147.61 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.489 1.116 . . . . 0.0 109.091 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.399 0.0 OUTLIER 28.97 44.5 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 128.794 2.837 . . . . 0.0 116.486 -178.567 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.8 p -141.72 108.41 5.37 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.459 1.504 . . . . 0.0 107.395 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -179.71 -177.53 47.94 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.06 160.42 33.97 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.2 t 72.18 145.85 0.11 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.056 1.742 . . . . 0.0 110.219 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -42.15 110.46 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.91 3.074 . . . . 0.0 113.715 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.62 -39.03 2.64 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 71.74 -12.08 0.68 Allowed 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 126.769 2.028 . . . . 0.0 115.814 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -88.78 126.41 35.33 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 120.568 1.531 . . . . 0.0 112.427 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.0 mtt-85 -136.91 145.82 44.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.34 150.04 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 102.389 -3.189 . . . . 0.0 102.389 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.33 127.03 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 O-C-N 121.543 -0.723 . . . . 0.0 109.284 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.9 pt -113.61 158.18 14.04 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 124.924 1.29 . . . . 0.0 108.424 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -79.28 172.98 13.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.869 0.868 . . . . 0.0 109.273 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.299 3.0 t -76.66 30.02 0.13 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -128.33 -80.19 0.58 Allowed 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 101.66 -3.459 . . . . 0.0 101.66 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.5 -19.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -84.65 139.42 32.06 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -55.67 129.68 40.14 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 125.117 1.367 . . . . 0.0 109.01 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.38 -45.0 5.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.205 1.402 . . . . 0.0 108.947 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.72 -160.98 24.25 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.42 148.55 23.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.347 1.459 . . . . 0.0 108.707 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.3 pt -142.97 164.56 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.929 1.292 . . . . 0.0 110.227 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -159.47 162.84 35.66 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.895 0.478 . . . . 0.0 111.728 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -78.89 -56.62 4.26 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.272 5.8 t 49.26 11.01 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.352 2.661 . . . . 0.0 115.606 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.36 -55.85 0.62 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 106.98 -2.448 . . . . 0.0 106.98 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 52.28 -169.33 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.483 1.913 . . . . 0.0 112.133 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.8 t -83.27 -42.24 17.4 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -147.54 -79.87 0.03 OUTLIER Glycine 0 C--N 1.342 0.891 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -130.47 3.2 4.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.182 1.393 . . . . 0.0 111.55 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -73.07 -169.84 0.66 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.962 1.305 . . . . 0.0 111.725 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -127.37 154.42 45.0 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.933 1.293 . . . . 0.0 112.224 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.81 162.75 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 126.215 1.806 . . . . 0.0 107.144 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.84 147.26 39.66 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.68 -178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.0 t -79.83 178.89 7.87 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.1 m -93.21 100.48 12.85 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.944 0.793 . . . . 0.0 108.869 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.65 75.49 1.27 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.1 t -135.13 29.82 3.35 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.54 1.536 . . . . 0.0 111.459 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.962 1.705 . . . . 0.0 110.519 -179.228 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.526 0 CA-C-O 119.982 -0.056 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -157.88 55.9 0.48 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.58 156.6 0.14 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.639 1.976 . . . . 0.0 111.929 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 t -154.51 137.8 15.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.86 122.02 45.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.03 80.2 1.49 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.436 1.495 . . . . 0.0 108.058 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.74 -86.41 0.75 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.5 t -114.82 -41.86 3.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.108 1.363 . . . . 0.0 110.053 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.4 m -68.91 100.19 1.16 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.559 0.744 . . . . 0.0 109.45 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -80.03 151.97 29.67 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.895 0.878 . . . . 0.0 110.506 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -139.0 131.11 28.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.988 0.915 . . . . 0.0 110.225 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.9 m -72.21 156.43 39.16 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.42 1.488 . . . . 0.0 109.057 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.47 -21.35 62.27 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.6 m -70.88 -40.72 72.08 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.748 1.219 . . . . 0.0 109.373 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -49.07 67.8 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.53 1.132 . . . . 0.0 111.004 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.93 -49.34 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.241 1.416 . . . . 0.0 109.626 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -67.79 -40.26 83.97 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.765 0.826 . . . . 0.0 112.393 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.27 -49.97 71.96 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.54 -38.7 81.72 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.001 0.92 . . . . 0.0 110.098 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.88 -46.27 62.89 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -64.31 -20.35 66.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.14 -55.27 4.86 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.406 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . . . -55.21 -43.12 74.18 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 t -50.31 -53.24 30.18 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.044 0.938 . . . . 0.0 110.812 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -66.37 -44.4 83.25 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.07 -59.54 4.01 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.843 2.457 . . . . 0.0 112.204 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -64.92 -24.97 67.69 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.939 2.095 . . . . 0.0 113.758 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -76.11 -62.86 1.46 Allowed 'General case' 0 C--N 1.338 0.095 0 CA-C-N 118.763 0.71 . . . . 0.0 111.964 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -164.89 -37.61 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -81.3 61.76 4.94 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.576 1.151 . . . . 0.0 108.785 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -50.05 117.9 2.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.464 1.906 . . . . 0.0 111.935 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 t -90.48 -20.71 22.41 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.369 1.068 . . . . 0.0 108.983 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -155.4 -168.65 2.9 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.773 2.429 . . . . 0.0 107.888 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -176.62 150.11 10.19 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 121.589 -0.695 . . . . 0.0 113.213 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 m -153.55 -111.14 0.04 OUTLIER 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.696 1.199 . . . . 0.0 109.405 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.9 m -155.89 -55.67 0.09 Allowed 'General case' 0 C--N 1.347 0.476 0 CA-C-N 118.813 0.733 . . . . 0.0 112.36 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.2 p -87.87 -57.42 2.95 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.141 0.976 . . . . 0.0 110.351 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -92.19 153.37 43.09 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.522 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -98.31 56.04 1.0 Allowed 'Cis proline' 0 N--CA 1.442 -1.517 0 N-CA-C 105.139 -2.677 . . . . 0.0 105.139 -5.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -107.08 -168.39 1.4 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.555 1.142 . . . . 0.0 112.417 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.0 p -33.02 139.92 0.05 OUTLIER 'General case' 0 C--N 1.34 0.185 0 C-N-CA 128.56 2.744 . . . . 0.0 115.784 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -152.13 127.17 9.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.054 2.142 . . . . 0.0 105.515 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -149.24 -51.63 0.15 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.813 0.845 . . . . 0.0 110.171 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -58.02 158.13 7.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.842 1.257 . . . . 0.0 111.686 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 66.62 102.29 0.04 OUTLIER 'General case' 0 C--N 1.343 0.291 0 C-N-CA 125.927 1.691 . . . . 0.0 109.694 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -82.61 -142.44 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.147 0.979 . . . . 0.0 110.097 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.0 12.81 65.76 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -159.17 139.57 12.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.321 1.849 . . . . 0.0 108.584 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.06 166.22 17.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.671 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -134.97 162.19 59.19 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 124.772 1.229 . . . . 0.0 109.117 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -51.38 -41.12 60.86 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.852 3.035 . . . . 0.0 112.774 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.93 167.34 2.33 Favored 'Isoleucine or valine' 0 C--N 1.343 0.32 0 C-N-CA 123.585 0.754 . . . . 0.0 110.152 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -101.53 -177.22 3.37 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.981 1.313 . . . . 0.0 109.7 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -132.09 -156.76 8.41 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.471 1.034 . . . . 0.0 110.724 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.33 125.56 1.56 Allowed 'Cis proline' 0 N--CA 1.456 -0.712 0 CA-C-N 118.274 1.037 . . . . 0.0 113.436 -0.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -98.49 169.34 9.6 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.82 1.648 . . . . 0.0 109.261 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -138.83 156.18 47.53 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.45 159.8 17.1 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.406 ' CD2' ' HB3' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -161.18 102.32 1.25 Allowed Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -66.87 121.74 8.99 Favored 'Trans proline' 0 N--CA 1.425 -2.546 0 CA-C-N 121.353 1.519 . . . . 0.0 114.098 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.416 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 3.2 tp -84.24 167.3 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-O 124.573 2.13 . . . . 0.0 112.127 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.416 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -160.25 151.62 19.5 Favored 'General case' 0 C--N 1.317 -0.843 1 CA-C-N 108.394 -4.003 . . . . 0.0 111.882 -178.887 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.6 p -86.49 57.36 4.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.998 1.719 . . . . 0.0 110.635 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.58 -73.39 0.03 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.27 137.64 5.48 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.45 131.6 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 117.32 0.56 . . . . 0.0 111.405 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.273 0.7 OUTLIER 64.65 131.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.717 2.807 . . . . 0.0 113.359 -178.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.6 p -136.59 -50.28 0.67 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.913 1.685 . . . . 0.0 108.435 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.9 61.66 1.49 Allowed Glycine 0 C--N 1.341 0.807 0 C-N-CA 124.374 0.988 . . . . 0.0 111.324 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 168.76 34.27 0.02 OUTLIER Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.271 -0.738 . . . . 0.0 113.206 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.8 p -170.38 139.76 1.47 Allowed Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.812 0.845 . . . . 0.0 110.094 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.73 -72.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.848 2.365 . . . . 0.0 108.5 170.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.74 -25.28 27.13 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 118.406 -1.219 . . . . 0.0 112.886 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 76.03 -43.54 0.48 Allowed 'General case' 0 C--N 1.346 0.448 0 C-N-CA 126.31 1.844 . . . . 0.0 111.081 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.92 121.76 28.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.88 0.872 . . . . 0.0 110.598 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.03 121.38 26.36 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.89 0.876 . . . . 0.0 112.896 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.7 m -85.01 145.33 8.13 Favored 'Isoleucine or valine' 0 C--N 1.346 0.439 0 N-CA-C 102.692 -3.077 . . . . 0.0 102.692 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.8 t -131.47 115.89 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 pt -93.78 -177.97 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.454 0 C-N-CA 124.987 1.315 . . . . 0.0 110.663 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -123.23 166.9 14.47 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.356 14.9 t -75.99 62.83 1.68 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -149.57 -94.33 0.07 Allowed 'General case' 0 N--CA 1.432 -1.333 1 N-CA-C 99.55 -4.241 . . . . 0.0 99.55 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.5 t -164.12 8.92 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.771 1.228 . . . . 0.0 113.818 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -112.81 156.51 22.76 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -175.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -75.14 116.45 15.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.892 2.477 . . . . 0.0 108.456 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.23 -49.57 9.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.88 172.66 42.57 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.65 150.78 43.79 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.154 0.982 . . . . 0.0 111.087 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.4 pt -131.82 161.48 41.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.163 1.785 . . . . 0.0 108.15 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -156.66 139.21 14.96 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -86.26 15.98 4.8 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.0 m -69.74 -51.73 31.55 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 120.703 -1.248 . . . . 0.0 111.0 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.88 9.5 65.65 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.556 1.074 . . . . 0.0 112.385 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.18 158.66 16.49 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.004 1.322 . . . . 0.0 111.086 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.8 t -104.62 69.32 0.89 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.326 1.45 . . . . 0.0 108.436 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.06 -115.21 3.29 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.463 1.506 . . . . 0.0 109.548 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -102.68 22.06 14.32 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.558 1.143 . . . . 0.0 111.778 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.71 -164.73 0.45 Allowed 'General case' 0 C--N 1.342 0.266 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -146.94 155.18 42.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.5 m -140.95 165.03 20.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 126.856 2.062 . . . . 0.0 106.622 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.87 141.91 16.29 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 116.637 -0.256 . . . . 0.0 113.538 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.3 t -83.07 -174.82 5.51 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.6 m -68.82 127.64 33.82 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.101 -0.999 . . . . 0.0 109.023 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.36 42.1 12.41 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.4 m -149.98 124.86 9.88 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.806 1.242 . . . . 0.0 108.144 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t30 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 117.038 -1.458 . . . . 0.0 109.173 179.171 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 121.155 0.502 . . . . 0.0 111.992 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 t -127.05 164.51 21.38 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.943 1.697 . . . . 0.0 108.682 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.46 123.41 14.65 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.8 t -130.8 124.39 31.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 123.73 0.644 . . . . 0.0 111.075 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -107.55 129.69 54.95 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.68 1.992 . . . . 0.0 106.507 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -119.81 93.39 4.05 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.879 0.371 . . . . 0.0 110.353 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.6 -84.01 0.66 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.9 m -115.53 -27.4 7.15 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.888 1.275 . . . . 0.0 110.802 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -66.71 155.12 38.9 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.733 0.697 . . . . 0.0 109.884 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -142.15 86.24 1.96 Allowed 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 123.788 0.68 . . . . 0.0 110.855 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.58 136.98 32.72 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.7 t -76.7 158.45 30.98 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.69 -19.55 50.45 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.7 m -71.54 -39.43 70.71 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.21 1.004 . . . . 0.0 109.214 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.99 -50.12 37.8 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.35 1.06 . . . . 0.0 112.459 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.7 t -54.79 -48.08 73.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.332 1.053 . . . . 0.0 108.917 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -71.11 -41.84 70.03 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.178 1.391 . . . . 0.0 113.363 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.72 -52.17 53.38 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.702 0.683 . . . . 0.0 110.651 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.95 80.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.448 0.699 . . . . 0.0 110.703 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.52 -39.02 67.91 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.802 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -67.12 -21.86 65.83 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.84 -63.53 1.39 Allowed 'General case' 0 C--N 1.347 0.48 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.33 -37.35 10.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.332 1.453 . . . . 0.0 111.535 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -61.7 2.44 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.473 1.909 . . . . 0.0 108.884 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -63.23 -36.7 84.51 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -66.87 -43.06 84.54 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.673 1.189 . . . . 0.0 111.987 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -74.36 -27.59 60.74 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.074 0.397 . . . . 0.0 111.798 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -89.07 9.39 25.53 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.338 1.055 . . . . 0.0 113.146 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.7 p30 -130.84 45.83 2.76 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.085 0.857 . . . . 0.0 110.54 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 70.66 37.28 1.44 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.849 2.06 . . . . 0.0 113.274 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.45 176.36 0.08 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.565 1.946 . . . . 0.0 114.905 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.1 t 21.35 79.38 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 129.351 3.061 . . . . 0.0 115.857 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.89 98.3 7.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.16 53.61 41.12 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.498 1.047 . . . . 0.0 111.034 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.3 m -140.38 -114.89 0.13 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.2 t -157.9 -82.33 0.06 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.3 p -115.44 -44.09 3.0 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.842 1.657 . . . . 0.0 107.528 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.484 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 15.2 m-85 -69.49 131.99 89.67 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 126.664 1.986 . . . . 0.0 106.514 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.91 137.18 48.42 Favored 'Cis proline' 0 N--CA 1.453 -0.896 0 CA-C-N 120.823 1.33 . . . . 0.0 113.314 0.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -159.91 150.16 18.63 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.895 1.678 . . . . 0.0 109.963 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -47.72 141.39 5.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.094 2.157 . . . . 0.0 113.451 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -113.89 97.18 6.24 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.784 1.634 . . . . 0.0 108.383 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -157.94 33.55 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -66.11 -50.53 63.7 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.06 0.544 . . . . 0.0 111.347 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -161.6 91.57 0.84 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 72.13 171.45 0.31 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.233 1.813 . . . . 0.0 110.741 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.22 8.2 7.99 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 118.315 -1.27 . . . . 0.0 114.559 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.3 t80 62.61 -158.98 0.32 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.016 1.408 . . . . 0.0 110.016 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -61.82 -172.73 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.828 1.651 . . . . 0.0 112.325 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.0 p90 51.7 63.39 9.43 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 125.748 1.619 . . . . 0.0 110.741 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.64 111.44 3.13 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.687 2.924 . . . . 0.0 110.075 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.76 170.68 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.199 1.399 . . . . 0.0 109.72 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.7 -57.97 6.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.23 -149.35 49.93 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 119.521 -0.6 . . . . 0.0 112.267 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.98 148.64 19.9 Favored 'Cis proline' 0 N--CA 1.459 -0.512 0 CA-C-N 118.604 1.202 . . . . 0.0 112.999 -0.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -111.18 140.69 45.52 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 125.742 1.617 . . . . 0.0 108.645 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -113.88 149.65 34.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.77 1.228 . . . . 0.0 113.42 -177.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -84.83 155.12 21.91 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.095 0.958 . . . . 0.0 110.553 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -153.53 108.71 2.57 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.484 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 11.2 Cg_endo -82.04 133.44 7.75 Favored 'Trans proline' 0 N--CA 1.432 -2.131 0 C-N-CA 121.931 1.754 . . . . 0.0 113.287 -175.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.549 ' CG2' ' H ' ' A' ' 62' ' ' LYS . 0.7 OUTLIER -106.21 -171.58 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 127.247 2.219 . . . . 0.0 106.298 178.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.549 ' H ' ' CG2' ' A' ' 61' ' ' ILE . 10.5 mmtt -162.74 -174.99 4.19 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 129.374 3.069 . . . . 0.0 108.396 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.2 m -88.74 53.46 2.71 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.96 -51.25 0.01 OUTLIER Glycine 0 C--N 1.344 1.025 0 C-N-CA 124.666 1.127 . . . . 0.0 111.87 -178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.87 -139.12 7.33 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 118.289 1.045 . . . . 0.0 112.966 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.0 p -52.96 142.4 5.81 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 125.716 1.606 . . . . 0.0 110.436 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.03 164.0 27.98 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.297 0.639 . . . . 0.0 112.124 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 t -134.18 63.97 1.61 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.538 1.535 . . . . 0.0 109.419 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 151.53 -177.32 29.52 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.54 -98.21 0.15 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.414 ' CB ' ' CD ' ' A' ' 72' ' ' PRO 0.327 67.3 m 56.19 -105.88 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.952 1.701 . . . . 0.0 111.08 -179.084 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 71' ' ' SER . 83.0 Cg_endo -75.64 131.07 13.2 Favored 'Trans proline' 0 C--N 1.352 0.711 0 CA-C-N 123.584 2.316 . . . . 0.0 109.07 175.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.47 162.86 25.34 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -157.51 48.86 0.42 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.919 0.888 . . . . 0.0 109.303 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.18 116.89 3.42 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.975 2.11 . . . . 0.0 105.881 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.22 165.53 30.67 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 m -135.58 142.62 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 102.259 -3.237 . . . . 0.0 102.259 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.0 t -133.08 120.38 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.0 pt -97.99 179.33 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.407 0 C-N-CA 126.395 1.878 . . . . 0.0 112.028 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -113.59 177.1 4.75 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.416 1.486 . . . . 0.0 109.681 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.332 11.5 t -77.88 55.29 1.39 Allowed 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 118.047 2.61 . . . . 0.0 118.047 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -160.71 -95.23 0.02 OUTLIER 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 101.626 -3.472 . . . . 0.0 101.626 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 90.8 m -163.92 47.9 0.12 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 129.209 3.004 . . . . 0.0 109.863 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -121.7 108.28 13.35 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.625 1.557 . . . . 0.0 114.202 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -65.35 104.68 0.99 Allowed 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.381 1.472 . . . . 0.0 107.718 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.93 -54.27 5.97 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.569 0.748 . . . . 0.0 111.994 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.35 149.01 12.12 Favored Glycine 0 C--N 1.34 0.799 0 C-N-CA 119.25 -1.452 . . . . 0.0 113.963 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.99 140.36 29.56 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.947 1.299 . . . . 0.0 109.162 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.7 pt -135.74 161.7 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.017 1.327 . . . . 0.0 109.812 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.0 t -159.92 148.67 17.42 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.523 0.729 . . . . 0.0 112.169 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -85.65 -25.81 26.38 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.8 m -49.26 109.4 0.26 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 126.282 1.833 . . . . 0.0 110.337 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.27 52.31 4.06 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.183 0.897 . . . . 0.0 111.041 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.49 -128.38 0.09 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.615 1.166 . . . . 0.0 108.721 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.8 m -145.85 71.39 1.27 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.016 0.926 . . . . 0.0 110.12 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.87 -91.28 0.27 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.758 1.171 . . . . 0.0 112.851 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -79.89 -34.74 38.86 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.651 1.18 . . . . 0.0 111.579 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -53.39 138.48 32.98 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.943 0.897 . . . . 0.0 111.016 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -106.27 147.82 28.7 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.529 1.532 . . . . 0.0 110.318 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.5 m -128.99 160.79 39.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 124.546 1.138 . . . . 0.0 108.288 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.06 142.39 21.42 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.994 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 8.7 t -85.26 -174.66 5.35 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.302 1.441 . . . . 0.0 108.332 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.3 m -65.11 131.06 45.57 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 121.344 -0.848 . . . . 0.0 109.101 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.61 43.85 51.09 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 16.3 m -146.78 144.41 29.35 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 57.5 t30 . . . . . 0 C--O 1.251 1.137 0 C-N-CA 125.344 1.458 . . . . 0.0 110.345 -179.116 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 120.844 0.354 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.5 t -158.07 68.69 0.5 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.68 155.86 0.16 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.501 1.921 . . . . 0.0 110.495 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.5 p -135.53 93.6 2.98 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.87 95.91 10.04 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 102.067 -3.309 . . . . 0.0 102.067 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.7 m -95.08 83.12 3.86 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.008 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.14 -87.74 0.58 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.0 p -120.01 -23.29 6.4 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.076 1.751 . . . . 0.0 110.657 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.6 m -75.65 91.25 2.86 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -84.22 106.52 15.91 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.882 1.273 . . . . 0.0 110.911 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -98.32 138.84 34.97 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.108 0.963 . . . . 0.0 110.057 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.2 t -72.5 152.72 41.73 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 124.69 1.196 . . . . 0.0 108.839 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.4 -18.09 48.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 t -76.34 -38.52 55.8 Favored 'General case' 0 C--N 1.345 0.391 0 C-N-CA 124.382 1.073 . . . . 0.0 108.334 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -67.81 -36.37 80.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.298 1.039 . . . . 0.0 111.514 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.4 t -67.56 -48.27 77.37 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -62.77 -38.01 88.9 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.734 1.214 . . . . 0.0 111.3 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.32 -51.97 26.25 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.9 0.88 . . . . 0.0 110.541 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.69 -41.96 74.48 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.476 1.11 . . . . 0.0 110.116 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.7 -25.38 38.19 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -69.44 -24.64 63.85 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.41 -55.7 4.87 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.36 -51.68 25.21 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 124.266 0.979 . . . . 0.0 111.711 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 t -61.98 -47.21 85.87 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.111 1.764 . . . . 0.0 112.515 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -63.22 -51.02 67.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.307 0.643 . . . . 0.0 111.939 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -68.95 -48.16 63.89 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -63.54 -22.09 66.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -110.14 9.86 23.95 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -157.98 61.22 0.46 Allowed 'General case' 0 C--N 1.339 0.143 0 CA-C-N 119.361 0.982 . . . . 0.0 109.123 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t70 64.22 99.01 0.04 OUTLIER 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.954 1.702 . . . . 0.0 109.27 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -61.42 114.57 3.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.6 p -105.99 -76.82 0.6 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.14 -179.9 0.09 Allowed 'General case' 0 C--N 1.342 0.242 0 C-N-CA 125.758 1.623 . . . . 0.0 113.876 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.38 -62.59 3.03 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.406 ' HG ' ' H ' ' A' ' 36' ' ' SER . 45.2 p -82.05 -108.87 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.909 0.884 . . . . 0.0 109.636 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.406 ' H ' ' HG ' ' A' ' 35' ' ' SER . 36.8 p -170.06 -51.35 0.02 OUTLIER 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.538 1.135 . . . . 0.0 110.045 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.4 t -80.24 31.38 0.27 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.029 1.332 . . . . 0.0 112.833 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.491 ' CD1' ' HD3' ' A' ' 60' ' ' PRO . 96.8 m-85 -170.01 113.96 0.48 Allowed Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 128.339 2.656 . . . . 0.0 104.334 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.54 134.48 35.79 Favored 'Cis proline' 0 N--CA 1.448 -1.157 0 CA-C-N 120.763 1.308 . . . . 0.0 111.333 1.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.23 161.44 41.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.987 1.315 . . . . 0.0 108.216 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 t -60.87 143.24 55.26 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-O 120.748 0.308 . . . . 0.0 110.881 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.34 122.72 27.82 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -64.44 161.98 16.06 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.276 1.03 . . . . 0.0 111.189 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -105.06 73.0 1.03 Allowed 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.158 0.983 . . . . 0.0 110.068 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -81.6 -89.01 0.08 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -155.46 -56.38 0.09 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.003 1.321 . . . . 0.0 109.304 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.69 135.18 44.28 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.044 1.307 . . . . 0.0 114.496 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 53.6 162.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 129.121 2.969 . . . . 0.0 117.816 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -161.68 160.98 29.27 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.09 2.156 . . . . 0.0 107.241 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -137.31 78.62 38.66 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.28 71.24 5.87 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.014 3.142 . . . . 0.0 110.09 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.4 t -119.73 -67.22 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 125.754 1.622 . . . . 0.0 107.919 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -165.87 78.76 0.27 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.05 162.22 54.68 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.2 152.9 97.64 Favored 'Cis proline' 0 N--CA 1.459 -0.54 0 CA-C-N 118.302 1.051 . . . . 0.0 112.902 0.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -121.75 156.92 32.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.931 2.093 . . . . 0.0 110.493 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -127.87 152.45 47.82 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.295 1.438 . . . . 0.0 112.462 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -94.04 156.17 16.74 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.242 1.017 . . . . 0.0 111.772 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -159.35 112.7 1.54 Allowed Pre-proline 0 N--CA 1.455 -0.188 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.491 ' HD3' ' CD1' ' A' ' 38' ' ' TYR . 31.2 Cg_endo -81.7 127.24 5.55 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 121.389 1.393 . . . . 0.0 112.506 -175.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.534 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 6.5 tt -84.47 167.2 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-O 123.816 1.769 . . . . 0.0 112.709 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.534 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 48.0 mmtm -142.71 145.36 33.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 109.098 -3.683 . . . . 0.0 112.71 -178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.5 t -91.61 58.24 3.47 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 125.585 1.554 . . . . 0.0 108.833 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.06 -64.8 0.03 OUTLIER Glycine 0 C--N 1.337 0.6 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.31 159.49 32.69 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.0 p -74.53 156.47 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.515 1.126 . . . . 0.0 109.603 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.3 t80 66.44 56.65 0.76 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.501 1.12 . . . . 0.0 111.099 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.9 p -149.96 166.29 30.09 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.303 1.041 . . . . 0.0 109.509 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -144.83 148.03 19.56 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.614 1.102 . . . . 0.0 110.824 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.19 170.18 33.82 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.1 t -52.5 -66.02 0.89 Allowed Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.941 1.297 . . . . 0.0 112.96 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.87 146.7 48.36 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.243 1.962 . . . . 0.0 111.51 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.83 139.57 6.58 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.421 ' HB2' ' CB ' ' A' ' 91' ' ' HIS . . . -173.39 -33.3 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.355 1.462 . . . . 0.0 111.833 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.07 120.06 29.05 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.658 1.583 . . . . 0.0 111.551 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -139.03 130.56 27.22 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.9 m -96.44 148.1 5.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.276 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.8 t -136.7 137.24 47.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.7 pt -117.3 176.3 2.81 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 C-N-CA 125.188 1.395 . . . . 0.0 112.904 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -97.28 163.58 12.84 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 128.08 2.552 . . . . 0.0 107.19 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.302 12.8 t -72.41 3.72 4.51 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -93.43 -86.87 0.25 Allowed 'General case' 0 N--CA 1.434 -1.267 1 N-CA-C 98.711 -4.551 . . . . 0.0 98.711 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.5 m -164.49 -5.63 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 128.253 2.621 . . . . 0.0 114.105 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -79.48 148.87 31.7 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.31 129.85 39.91 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.071 1.349 . . . . 0.0 107.754 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.91 -51.72 4.94 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.941 1.296 . . . . 0.0 108.958 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.35 -166.57 32.57 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.75 116.97 3.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.034 0.934 . . . . 0.0 108.802 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 45.4 pt -107.96 160.26 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.796 1.238 . . . . 0.0 110.649 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t -159.86 149.08 17.8 Favored 'General case' 0 C--N 1.343 0.284 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.421 ' CB ' ' HB2' ' A' ' 74' ' ' ALA . 27.2 m170 -79.75 -36.29 37.47 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.162 175.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.8 m -34.02 -58.99 0.44 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 128.478 2.711 . . . . 0.0 115.131 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.83 -36.33 92.61 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.521 1.057 . . . . 0.0 112.556 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.44 -159.66 0.29 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.933 1.293 . . . . 0.0 111.383 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.7 t -80.91 -81.46 0.13 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.626 0.77 . . . . 0.0 111.694 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -135.02 -78.45 0.1 Allowed Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.04 0.829 . . . . 0.0 111.805 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -79.82 -27.12 40.29 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.511 0.655 . . . . 0.0 111.519 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -59.48 151.85 23.14 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.976 1.31 . . . . 0.0 110.407 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -120.08 151.04 39.62 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.535 1.534 . . . . 0.0 110.069 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.1 m -147.69 166.14 5.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 125.942 1.697 . . . . 0.0 108.238 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.8 156.29 25.39 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.501 0.572 . . . . 0.0 112.69 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.3 m -104.84 -169.07 1.56 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.126 1.37 . . . . 0.0 108.244 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.4 t -61.33 113.99 2.94 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.83 60.51 1.96 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.3 m -154.78 121.14 5.33 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.98 0.912 . . . . 0.0 108.542 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.157 -1.402 . . . . 0.0 108.746 179.353 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 120.326 0.108 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -145.25 159.9 42.31 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.819 1.248 . . . . 0.0 109.391 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.27 136.0 57.73 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.815 0.846 . . . . 0.0 109.463 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 48.4 p -111.37 146.14 37.65 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.47 0.708 . . . . 0.0 109.68 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.83 117.92 8.88 Favored 'General case' 0 N--CA 1.44 -0.928 1 N-CA-C 99.675 -4.194 . . . . 0.0 99.675 177.445 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.26 103.55 5.8 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.896 0.379 . . . . 0.0 111.012 -177.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.91 -63.63 4.35 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 125.109 1.338 . . . . 0.0 109.807 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.4 p -155.65 -44.69 0.08 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.932 1.693 . . . . 0.0 109.275 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -54.65 115.83 2.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.612 1.965 . . . . 0.0 109.409 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -104.55 150.3 24.75 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.982 1.313 . . . . 0.0 111.068 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.88 141.03 26.15 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.018 1.327 . . . . 0.0 109.14 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.6 m -72.59 152.54 41.74 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 124.726 1.211 . . . . 0.0 110.142 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.61 -21.34 53.16 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.8 m -71.94 -41.22 68.06 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.873 1.269 . . . . 0.0 109.86 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -72.34 -41.11 66.85 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.022 0.929 . . . . 0.0 112.082 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.6 t -63.25 -47.73 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -67.07 -36.05 81.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.678 1.191 . . . . 0.0 110.999 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.08 -51.2 65.2 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 118.894 0.77 . . . . 0.0 109.391 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.45 -37.3 87.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.63 -41.71 87.87 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.349 -0.844 . . . . 0.0 111.967 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -69.46 -18.81 63.75 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.61 -62.54 1.64 Allowed 'General case' 0 C--N 1.347 0.464 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.436 ' HB3' ' CG ' ' A' ' 59' ' ' PHE . . . -46.41 -44.43 17.19 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.923 0.889 . . . . 0.0 111.19 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.9 t -61.37 -49.73 75.73 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 118.938 0.79 . . . . 0.0 110.293 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -68.84 -9.58 52.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.659 0.784 . . . . 0.0 112.65 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -115.12 -16.23 11.61 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.815 0.846 . . . . 0.0 112.915 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -65.57 -51.8 57.06 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.006 0.923 . . . . 0.0 110.427 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -90.98 -27.11 18.89 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -63.66 -25.0 68.02 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.901 0.773 . . . . 0.0 112.989 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 t70 65.15 45.56 2.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.626 1.17 . . . . 0.0 111.571 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -168.03 151.04 5.72 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.005 1.322 . . . . 0.0 108.909 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.0 p 47.5 39.52 9.63 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.727 1.611 . . . . 0.0 112.344 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.07 89.07 6.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.895 1.278 . . . . 0.0 110.979 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 52.78 -141.32 28.59 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.959 1.742 . . . . 0.0 112.578 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.1 p -154.27 -33.98 0.1 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.332 1.053 . . . . 0.0 112.637 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.7 t -82.14 -102.67 0.04 OUTLIER 'General case' 0 C--N 1.343 0.311 0 C-N-CA 123.627 0.771 . . . . 0.0 109.358 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.0 p -137.82 35.27 2.4 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.629 1.172 . . . . 0.0 109.209 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -133.24 148.2 68.12 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 124.0 0.92 . . . . 0.0 109.118 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.29 125.08 10.27 Favored 'Cis proline' 0 N--CA 1.452 -0.938 0 CA-C-N 118.733 0.583 . . . . 0.0 112.564 0.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.3 163.01 33.6 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.018 0.927 . . . . 0.0 110.881 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 m -48.19 124.18 7.41 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 127.952 2.501 . . . . 0.0 113.012 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -115.89 68.47 0.72 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.71 85.4 0.47 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.099 1.36 . . . . 0.0 112.778 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -131.19 137.16 48.83 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.852 1.661 . . . . 0.0 106.962 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -116.62 132.94 56.55 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.473 1.109 . . . . 0.0 110.847 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 40.72 45.89 2.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.175 2.19 . . . . 0.0 114.09 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.57 -79.26 1.42 Allowed Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -80.27 173.48 12.55 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.328 1.051 . . . . 0.0 112.097 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -79.52 6.18 11.06 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -127.13 67.2 70.01 Favored Pre-proline 0 C--N 1.318 -0.772 0 C-N-CA 127.93 2.492 . . . . 0.0 110.146 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.73 -41.84 3.95 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.82 2.346 . . . . 0.0 110.291 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.7 t 62.54 -97.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.885 1.674 . . . . 0.0 108.816 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -165.88 -58.16 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 126.319 1.848 . . . . 0.0 107.883 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.95 -175.79 51.79 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -58.21 151.67 36.73 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 CA-C-N 119.043 1.422 . . . . 0.0 113.5 -0.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -146.03 159.3 43.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.573 1.149 . . . . 0.0 109.778 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.2 161.69 29.55 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -175.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -88.1 157.24 18.91 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 113.699 -1.591 . . . . 0.0 108.89 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.436 ' CG ' ' HB3' ' A' ' 23' ' ' ALA . 15.2 t80 -160.24 112.6 1.4 Allowed Pre-proline 0 C--O 1.224 -0.259 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -82.15 137.16 9.42 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 121.387 1.391 . . . . 0.0 115.211 -175.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.663 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 3.0 tt -110.37 -175.85 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 124.034 1.873 . . . . 0.0 112.188 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.663 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -160.8 152.01 19.01 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 108.724 -3.853 . . . . 0.0 111.004 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.7 t -84.44 59.87 5.69 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.969 1.307 . . . . 0.0 108.878 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.05 -50.37 0.03 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.04 172.27 45.18 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.75 119.13 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.364 1.065 . . . . 0.0 109.587 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.3 t80 62.47 118.44 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.255 1.822 . . . . 0.0 112.665 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 79.6 p -126.84 154.12 44.77 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.94 1.296 . . . . 0.0 109.79 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.86 72.24 2.83 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.98 -48.39 0.02 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.8 m 60.7 80.12 0.27 Allowed Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 125.339 1.456 . . . . 0.0 110.694 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.49 -56.16 3.37 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.385 3.39 . . . . 0.0 112.026 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.41 39.24 3.51 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.967 1.27 . . . . 0.0 110.478 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.41 -73.2 0.12 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 117.959 -1.019 . . . . 0.0 112.567 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -67.38 117.16 8.99 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.8 mtt85 -146.73 129.46 16.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.74 155.37 3.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 103.601 -2.74 . . . . 0.0 103.601 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.0 t -136.14 123.35 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 O-C-N 120.587 -1.32 . . . . 0.0 108.146 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.7 pt -105.46 175.44 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.417 0 C-N-CA 125.775 1.63 . . . . 0.0 112.756 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -101.83 165.03 11.41 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 127.47 2.308 . . . . 0.0 108.364 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.251 11.4 t -67.26 -29.78 69.49 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 118.302 2.705 . . . . 0.0 118.302 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -79.14 -73.16 0.35 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.8 t -164.72 3.52 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -78.65 164.03 24.97 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 119.723 1.147 . . . . 0.0 113.953 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -104.68 117.53 34.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.59 -45.96 12.02 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.099 0.559 . . . . 0.0 110.188 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.66 -160.48 33.9 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.6 145.09 31.61 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.823 0.849 . . . . 0.0 109.652 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.5 pt -143.14 164.93 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.923 1.289 . . . . 0.0 111.571 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.407 ' HG1' ' H ' ' A' ' 92' ' ' THR . 3.2 t -155.79 146.5 22.08 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -79.1 -15.45 58.14 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.809 174.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.407 ' H ' ' HG1' ' A' ' 90' ' ' THR . 29.0 m -39.8 -55.36 1.97 Allowed 'General case' 0 C--N 1.345 0.409 0 C-N-CA 126.859 2.063 . . . . 0.0 114.576 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.83 28.14 11.04 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.519 1.057 . . . . 0.0 112.816 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.76 177.02 5.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.078 0.951 . . . . 0.0 111.325 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 84.2 p -68.0 -48.42 65.79 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.097 0.959 . . . . 0.0 111.378 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.8 -69.68 0.08 OUTLIER Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -102.23 29.17 5.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.722 1.209 . . . . 0.0 109.654 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -131.83 176.94 7.92 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.769 1.228 . . . . 0.0 109.618 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -127.42 164.52 21.67 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.164 1.786 . . . . 0.0 110.824 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.87 156.23 40.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 C-N-CA 124.875 1.27 . . . . 0.0 107.581 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.8 142.33 25.43 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.298 0.952 . . . . 0.0 112.762 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.7 m -96.27 179.03 5.18 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.797 0.839 . . . . 0.0 110.517 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 27.0 t -69.24 140.69 54.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.89 47.05 62.72 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.5 m -131.49 96.31 3.95 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.371 1.468 . . . . 0.0 107.085 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.7 t30 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 117.028 -1.463 . . . . 0.0 109.229 -179.1 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 121.234 0.54 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.5 m -160.85 80.24 0.63 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 126.208 1.803 . . . . 0.0 106.849 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 73.03 160.93 0.24 Allowed 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.353 1.461 . . . . 0.0 109.808 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 t -157.7 148.68 21.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.28 120.12 29.15 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 104.794 -2.298 . . . . 0.0 104.794 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.6 m -112.95 111.4 22.12 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.65 -95.17 0.18 Allowed Glycine 0 CA--C 1.529 0.923 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.8 p -118.54 -39.19 3.03 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.109 1.763 . . . . 0.0 109.7 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.4 m -61.28 126.06 26.0 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.024 1.33 . . . . 0.0 109.721 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -99.02 153.6 18.74 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.565 1.146 . . . . 0.0 110.289 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -142.77 121.3 12.47 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.678 1.191 . . . . 0.0 108.52 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.5 t -67.34 154.32 41.61 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 125.06 1.344 . . . . 0.0 110.473 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.85 -22.01 61.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.401 -1.704 . . . . 0.0 106.401 176.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.4 t -72.47 -39.76 67.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.324 1.049 . . . . 0.0 109.209 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -73.43 -44.08 59.05 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.342 0.657 . . . . 0.0 112.116 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.5 t -59.03 -51.47 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 124.993 1.317 . . . . 0.0 109.086 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -68.42 -41.05 80.93 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.921 0.888 . . . . 0.0 112.925 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.58 -47.16 87.4 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 123.753 0.658 . . . . 0.0 109.427 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.0 -39.54 78.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.314 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.36 -30.33 61.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -69.8 -25.48 63.8 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.19 -61.07 2.11 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 104.167 -2.531 . . . . 0.0 104.167 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -43.77 -43.65 6.22 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 124.763 1.289 . . . . 0.0 111.614 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.57 -64.03 0.98 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 126.385 1.874 . . . . 0.0 111.667 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.5 -36.67 83.3 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -88.65 -22.51 23.41 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.306 0.0 OUTLIER -92.65 16.76 11.44 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.779 1.627 . . . . 0.0 114.966 -178.352 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.6 -38.96 70.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.57 1.148 . . . . 0.0 110.368 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -145.6 -67.87 0.29 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.659 1.184 . . . . 0.0 109.003 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -177.37 91.73 0.03 OUTLIER 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.518 1.527 . . . . 0.0 108.104 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -119.17 -170.51 1.94 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.737 1.215 . . . . 0.0 109.897 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.9 p -70.88 83.89 0.66 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.254 1.422 . . . . 0.0 111.236 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.91 156.91 39.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.272 1.029 . . . . 0.0 110.784 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.15 -141.5 45.47 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.474 1.035 . . . . 0.0 112.438 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.0 t -90.32 -74.34 0.49 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.64 1.176 . . . . 0.0 109.935 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 t -151.54 -56.09 0.15 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.055 1.342 . . . . 0.0 108.32 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.3 p -79.36 -53.75 6.62 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -59.62 135.3 89.29 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -71.77 131.09 20.4 Favored 'Cis proline' 0 N--CA 1.454 -0.801 0 CA-C-N 119.123 0.723 . . . . 0.0 112.489 2.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.02 156.6 41.48 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 123.469 0.707 . . . . 0.0 111.555 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.9 p -34.45 137.24 0.12 Allowed 'General case' 0 C--N 1.34 0.166 0 C-N-CA 127.764 2.426 . . . . 0.0 115.096 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -135.52 88.01 2.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.081 1.352 . . . . 0.0 108.286 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -167.93 -39.61 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.867 1.667 . . . . 0.0 108.462 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -61.69 -35.77 78.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.888 1.275 . . . . 0.0 110.348 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -61.77 -77.28 0.05 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.243 1.017 . . . . 0.0 109.56 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -171.22 138.33 1.22 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.177 1.391 . . . . 0.0 108.254 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.4 132.79 23.26 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -144.2 108.21 4.74 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.279 0.632 . . . . 0.0 110.264 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 t70 51.17 -168.64 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.572 1.549 . . . . 0.0 113.517 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.0 p90 38.03 79.04 0.33 Allowed Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 127.159 2.184 . . . . 0.0 114.265 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.82 64.67 8.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.829 3.019 . . . . 0.0 107.833 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.34 -154.62 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 126.078 1.751 . . . . 0.0 110.112 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -100.99 118.58 37.28 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.509 1.123 . . . . 0.0 110.197 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.21 -176.46 30.32 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.218 0.914 . . . . 0.0 111.581 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.73 127.85 15.12 Favored 'Cis proline' 0 N--CA 1.453 -0.884 0 CA-C-N 117.527 0.664 . . . . 0.0 111.414 -0.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -102.47 140.26 36.99 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -115.66 162.17 17.63 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 123.878 0.736 . . . . 0.0 110.876 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -79.38 144.67 33.94 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.578 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -138.89 103.03 7.54 Favored Pre-proline 0 N--CA 1.443 -0.804 0 N-CA-C 102.086 -3.301 . . . . 0.0 102.086 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -77.99 137.25 15.45 Favored 'Trans proline' 0 N--CA 1.439 -1.691 0 C-N-CA 121.224 1.283 . . . . 0.0 111.964 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.647 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.5 tt -116.96 -177.98 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 124.581 2.134 . . . . 0.0 113.366 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.647 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -161.32 153.93 20.46 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 108.428 -3.987 . . . . 0.0 111.613 178.164 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.0 t -88.62 58.5 4.69 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.874 1.27 . . . . 0.0 108.165 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.48 -74.79 0.01 OUTLIER Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.29 86.77 0.1 OUTLIER Glycine 0 CA--C 1.527 0.793 0 CA-C-N 117.385 0.593 . . . . 0.0 111.973 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.266 12.9 p 41.12 60.43 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.958 2.103 . . . . 0.0 113.407 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 21.5 t80 58.2 93.97 0.03 OUTLIER 'General case' 0 C--N 1.344 0.339 0 C-N-CA 126.69 1.996 . . . . 0.0 114.047 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.0 t -155.99 124.41 5.85 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.901 1.28 . . . . 0.0 108.771 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.18 66.45 2.49 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.73 1.157 . . . . 0.0 111.492 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -164.97 77.8 0.14 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.5 t -146.02 108.74 4.31 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -61.37 160.11 48.73 Favored 'Cis proline' 0 N--CA 1.459 -0.537 0 CA-C-N 119.969 1.025 . . . . 0.0 113.987 0.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.68 -42.59 0.05 OUTLIER Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.167 1.365 . . . . 0.0 110.907 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 78.7 -48.29 0.44 Allowed 'General case' 0 C--N 1.342 0.281 0 C-N-CA 127.364 2.266 . . . . 0.0 112.538 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -75.93 124.9 28.1 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -136.99 118.0 14.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.366 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.4 m -84.2 164.55 2.58 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.3 t -140.26 137.19 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 pt -131.06 159.73 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.761 0.825 . . . . 0.0 112.513 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -89.16 146.04 25.04 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 127.464 2.306 . . . . 0.0 108.205 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.37 15.3 t -73.78 66.17 1.08 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -177.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -157.32 -94.45 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.184 1 N-CA-C 97.458 -5.016 . . . . 0.0 97.458 176.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -162.84 10.69 0.06 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.996 1.718 . . . . 0.0 113.774 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.3 140.93 29.04 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.993 0.815 . . . . 0.0 112.178 -177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -73.52 131.49 41.82 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.95 -56.79 2.86 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.89 -177.29 40.72 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 112.25 -0.34 . . . . 0.0 112.25 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.98 117.6 13.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.837 1.655 . . . . 0.0 107.056 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 41.0 pt -128.27 153.52 37.8 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 C-N-CA 124.075 0.95 . . . . 0.0 109.814 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -152.18 150.85 30.29 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.34 75.85 5.91 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.3 m -70.57 -84.54 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.086 -1.634 . . . . 0.0 110.24 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.7 34.57 5.56 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.85 153.17 42.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.224 1.81 . . . . 0.0 110.957 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -74.37 -11.55 60.28 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.588 0.755 . . . . 0.0 112.227 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.73 -94.86 0.1 OUTLIER Glycine 0 C--N 1.341 0.841 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -103.22 22.62 13.76 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.156 0.982 . . . . 0.0 110.54 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -72.26 178.78 3.71 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -151.82 133.98 15.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 m -115.12 166.53 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.56 145.21 19.41 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.105 0.802 . . . . 0.0 115.105 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.8 m -97.54 177.5 5.49 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 124.53 1.132 . . . . 0.0 110.559 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.3 t 44.06 41.76 4.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.667 0.787 . . . . 0.0 112.094 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.5 30.06 75.86 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.384 0.992 . . . . 0.0 113.922 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.4 m -86.54 151.14 23.73 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.654 1.182 . . . . 0.0 109.083 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 116.346 -1.788 . . . . 0.0 108.677 179.842 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 121.025 0.44 . . . . 0.0 111.529 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.5 p -78.39 152.03 32.47 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.012 1.325 . . . . 0.0 108.365 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.32 61.75 0.71 Allowed 'General case' 0 C--N 1.342 0.244 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 t -107.48 135.95 48.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.874 1.269 . . . . 0.0 110.67 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -110.57 108.41 18.35 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 103.393 -2.818 . . . . 0.0 103.393 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.34 85.42 4.6 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.02 -104.63 1.44 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.2 p -94.49 -44.52 7.84 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.494 1.118 . . . . 0.0 110.188 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.6 m -70.0 110.37 5.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.856 0.862 . . . . 0.0 110.24 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -84.72 148.52 26.34 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.684 1.193 . . . . 0.0 111.061 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -142.03 112.91 7.37 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.101 0.96 . . . . 0.0 111.098 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.7 t -65.37 157.49 29.13 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 125.84 1.656 . . . . 0.0 110.429 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.0 -19.27 29.66 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.5 m -73.43 -44.54 58.02 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.521 1.128 . . . . 0.0 109.184 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -71.91 -44.15 64.16 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 124.718 1.207 . . . . 0.0 112.34 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.25 -51.2 75.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -41.92 96.57 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.633 1.973 . . . . 0.0 112.517 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.34 -54.44 28.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.004 0.365 . . . . 0.0 110.191 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.73 72.37 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.207 0.603 . . . . 0.0 111.679 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.85 -44.97 30.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.06 -22.11 65.49 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.51 -65.83 0.88 Allowed 'General case' 0 C--N 1.345 0.409 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -44.22 -48.59 9.35 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 124.577 1.173 . . . . 0.0 111.83 177.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.8 t -54.13 -51.89 62.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.366 1.866 . . . . 0.0 111.924 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -58.34 -40.73 82.92 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.176 0.59 . . . . 0.0 111.253 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -70.9 -38.37 72.99 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -90.6 22.8 3.31 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-N 118.91 0.777 . . . . 0.0 112.468 -177.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -110.2 -48.96 3.12 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 124.361 1.064 . . . . 0.0 109.209 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -74.11 -38.69 63.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.383 0.673 . . . . 0.0 112.154 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 108.19 72.52 0.0 OUTLIER 'General case' 0 C--N 1.345 0.397 0 C-N-CA 129.674 3.189 . . . . 0.0 110.932 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -151.89 136.37 16.88 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.692 1.597 . . . . 0.0 107.57 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.6 p -80.31 -56.89 3.88 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.446 0.698 . . . . 0.0 111.786 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.87 82.71 0.16 Allowed 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.55 -48.59 0.96 Allowed Glycine 0 CA--C 1.528 0.886 0 N-CA-C 107.093 -2.403 . . . . 0.0 107.093 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.8 t 57.52 67.38 0.98 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.26 1.824 . . . . 0.0 113.713 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.2 m -143.86 -75.96 0.24 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.165 0.986 . . . . 0.0 108.771 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.3 t -160.35 41.22 0.18 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.497 0.59 . . . . 0.0 112.224 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.411 ' CA ' ' H ' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -172.25 127.62 0.57 Allowed Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 125.649 1.58 . . . . 0.0 107.479 -179.249 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -86.06 63.32 0.16 OUTLIER 'Cis proline' 0 N--CA 1.439 -1.702 0 CA-C-N 121.409 1.539 . . . . 0.0 110.1 -2.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.411 ' H ' ' CA ' ' A' ' 38' ' ' TYR . 6.7 m170 -84.27 173.09 11.26 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 t -69.3 145.54 52.95 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 111.426 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -95.82 55.09 1.58 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.481 1.512 . . . . 0.0 109.291 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.403 HD21 ' H ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -79.01 51.56 1.16 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.639 1.576 . . . . 0.0 112.347 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -160.84 53.44 0.29 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.381 1.472 . . . . 0.0 107.426 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.12 -55.99 8.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.499 1.519 . . . . 0.0 110.906 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 68.62 -72.41 0.1 Allowed 'General case' 0 C--N 1.343 0.292 0 C-N-CA 127.079 2.152 . . . . 0.0 111.168 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.24 -121.36 2.16 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.42 -169.3 0.17 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.356 1.062 . . . . 0.0 112.315 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -127.67 -164.06 1.33 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.998 0.919 . . . . 0.0 110.925 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.328 40.3 p90 61.63 47.33 1.13 Allowed Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 128.788 2.835 . . . . 0.0 115.855 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.7 125.94 8.54 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.175 1.916 . . . . 0.0 107.702 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.51 -125.0 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -153.72 127.57 8.86 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 125.711 1.605 . . . . 0.0 107.237 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.17 -85.04 0.05 OUTLIER Glycine 0 CA--C 1.531 1.063 0 CA-C-O 117.49 -1.728 . . . . 0.0 111.737 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.4 168.76 7.45 Favored 'Cis proline' 0 C--N 1.35 0.642 0 CA-C-N 121.676 2.738 . . . . 0.0 116.427 0.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.51 159.34 28.24 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.036 1.335 . . . . 0.0 113.188 -177.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -152.72 150.65 29.65 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.464 1.506 . . . . 0.0 111.948 -178.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -102.41 166.55 10.49 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -158.44 114.69 1.72 Allowed Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -86.79 108.06 0.77 Allowed 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 122.706 2.271 . . . . 0.0 112.342 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.643 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 9.3 tt -81.5 173.88 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 124.329 2.014 . . . . 0.0 110.966 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.643 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 14.2 mmtt -160.27 159.43 31.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 109.183 -3.644 . . . . 0.0 109.49 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 57.2 m -81.81 57.44 3.43 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.458 1.103 . . . . 0.0 109.539 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.46 62.71 0.24 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.95 -106.63 1.64 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 123.76 0.695 . . . . 0.0 112.376 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.1 95.05 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.32 1.048 . . . . 0.0 111.099 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 t80 44.98 80.74 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.879 1.672 . . . . 0.0 112.971 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.1 p -125.22 -29.94 3.23 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.744 1.218 . . . . 0.0 111.44 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.42 -69.2 1.25 Allowed Glycine 0 C--N 1.342 0.886 0 C-N-CA 124.838 1.209 . . . . 0.0 112.426 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.09 113.98 1.27 Allowed Glycine 0 C--N 1.34 0.76 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.9 m 54.17 69.89 1.96 Allowed Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 125.348 1.459 . . . . 0.0 112.715 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.11 149.65 82.19 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.369 2.713 . . . . 0.0 109.96 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -159.11 35.58 0.49 Allowed Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.109 -0.829 . . . . 0.0 115.152 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -153.87 -67.94 0.14 Allowed 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 118.452 1.126 . . . . 0.0 110.25 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.43 118.24 16.15 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.926 1.239 . . . . 0.0 108.384 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -140.14 117.44 11.32 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 m -85.1 146.67 6.29 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 176.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.2 t -132.84 135.81 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -177.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.43 HG21 ' H ' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -126.86 -176.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 C-N-CA 126.74 2.016 . . . . 0.0 110.186 -177.737 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.43 ' H ' HG21 ' A' ' 79' ' ' ILE . 63.5 m-80 -99.26 159.72 14.79 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 102.977 -2.972 . . . . 0.0 102.977 175.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.301 7.2 t -66.92 2.57 1.38 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 -178.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -95.58 -83.69 0.36 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 102.301 -3.222 . . . . 0.0 102.301 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.81 -5.07 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.721 2.408 . . . . 0.0 114.791 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -79.46 121.1 24.76 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -52.98 123.25 11.08 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 126.051 1.74 . . . . 0.0 108.497 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.56 -55.75 2.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.4 -164.43 23.06 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.45 137.02 8.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.482 1.113 . . . . 0.0 108.355 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 pt -133.89 174.25 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.438 1.095 . . . . 0.0 113.092 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.6 t -158.16 137.03 11.37 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.527 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -77.31 -24.11 50.92 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 118.211 0.46 . . . . 0.0 112.034 175.003 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.1 t -45.33 -25.52 0.41 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -145.03 51.57 0.61 Allowed Glycine 0 C--N 1.339 0.731 0 CA-C-N 119.165 0.893 . . . . 0.0 111.534 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.73 -177.37 3.11 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.817 1.247 . . . . 0.0 111.487 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.3 t -58.27 -53.33 59.47 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.554 1.541 . . . . 0.0 111.547 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.38 -70.06 0.05 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -112.54 35.03 4.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.854 1.262 . . . . 0.0 109.133 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -125.1 176.21 6.85 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.18 1.392 . . . . 0.0 109.955 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.446 ' CZ ' ' CD2' ' A' ' 91' ' ' HIS . 64.1 m-85 -125.17 159.3 31.86 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.11 1.364 . . . . 0.0 111.093 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.8 m -135.33 161.48 39.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 125.449 1.499 . . . . 0.0 107.864 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.26 156.65 34.08 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 123.862 0.744 . . . . 0.0 113.707 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.6 m -85.75 -170.67 3.22 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 123.607 0.763 . . . . 0.0 110.094 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.1 p -73.65 127.53 33.01 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.47 -1.0 88.64 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.815 -0.992 . . . . 0.0 113.361 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.7 m -79.38 91.22 5.05 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.4 t30 . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.953 -1.499 . . . . 0.0 109.439 -178.729 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 111.287 0.106 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.0 t -77.83 119.4 21.26 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.441 1.097 . . . . 0.0 108.316 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.31 89.74 0.09 Allowed 'General case' 0 C--N 1.344 0.357 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.81 132.22 36.41 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.91 114.76 23.69 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.5 m -105.49 88.82 2.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.03 -114.64 4.62 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.8 p -93.25 -29.23 15.79 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.282 1.033 . . . . 0.0 109.972 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -71.99 95.13 1.55 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.273 1.429 . . . . 0.0 108.776 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -89.95 147.19 23.86 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.527 1.131 . . . . 0.0 112.508 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -142.13 129.46 21.14 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -72.79 155.13 40.26 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 126.531 1.932 . . . . 0.0 107.315 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.47 -16.79 16.63 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.4 m -76.15 -35.2 59.3 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -51.9 15.84 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.755 1.222 . . . . 0.0 113.601 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . 0.273 17.9 m -60.99 -41.58 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.647 0 C-N-CA 127.239 2.216 . . . . 0.0 109.242 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -71.02 -44.58 65.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.886 0.874 . . . . 0.0 111.69 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.15 -54.64 26.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.096 0.407 . . . . 0.0 112.077 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.05 -37.56 85.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.481 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.33 -40.39 70.75 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -65.86 -19.74 65.99 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.46 -53.96 7.01 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.0 -51.38 17.29 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.229 1.412 . . . . 0.0 110.776 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 t -57.92 -46.19 85.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.748 0.819 . . . . 0.0 110.559 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -57.09 -38.0 72.72 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.529 0.731 . . . . 0.0 111.394 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -89.08 -9.04 52.63 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.71 -27.38 67.59 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.725 0.693 . . . . 0.0 112.208 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -80.54 -75.69 0.26 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 p30 171.94 68.62 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.696 1.998 . . . . 0.0 109.809 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -117.5 58.72 0.79 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.93 0.892 . . . . 0.0 109.438 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.84 162.72 0.08 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.86 2.464 . . . . 0.0 114.429 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 t -88.37 76.66 8.29 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.458 1.103 . . . . 0.0 110.182 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.52 102.37 4.48 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.314 1.045 . . . . 0.0 110.319 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.99 -114.26 4.48 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.5 t -75.8 -95.99 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 m 88.05 23.18 0.04 OUTLIER 'General case' 0 C--N 1.341 0.212 0 C-N-CA 125.018 1.327 . . . . 0.0 113.327 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t -78.95 -38.72 36.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 102.743 -3.058 . . . . 0.0 102.743 176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -89.18 151.82 47.17 Favored Pre-proline 0 N--CA 1.451 -0.405 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.14 142.52 57.81 Favored 'Cis proline' 0 N--CA 1.455 -0.791 0 N-CA-C 116.78 1.8 . . . . 0.0 116.78 0.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.65 147.54 39.43 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 127.912 2.485 . . . . 0.0 109.579 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.25 123.47 14.68 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 178.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -83.78 118.91 24.23 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -59.0 159.84 6.69 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.308 1.443 . . . . 0.0 111.013 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -134.42 59.95 1.72 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.037 0.935 . . . . 0.0 109.964 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -154.36 -22.32 0.13 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 112.068 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.74 -46.34 88.55 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.127 0.571 . . . . 0.0 111.386 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.31 -61.88 0.41 Allowed Glycine 0 C--N 1.339 0.723 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.06 148.19 52.2 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 123.81 0.844 . . . . 0.0 113.099 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -166.26 -178.49 4.59 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.094 1.758 . . . . 0.0 109.231 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -145.37 118.58 5.37 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.74 1.216 . . . . 0.0 108.555 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.32 84.99 1.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.08 2.52 . . . . 0.0 110.448 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -129.62 -97.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.245 0 C-N-CA 124.227 1.011 . . . . 0.0 108.379 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -153.17 117.47 4.9 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.156 0.982 . . . . 0.0 109.618 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.48 146.39 22.54 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -68.72 157.58 88.76 Favored 'Cis proline' 0 N--CA 1.457 -0.633 0 CA-C-N 119.983 1.891 . . . . 0.0 113.447 0.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.21 141.93 26.72 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.1 2.16 . . . . 0.0 108.235 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -134.39 166.56 22.55 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.59 164.56 23.74 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 126.481 1.912 . . . . 0.0 115.541 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -161.87 104.13 1.16 Allowed Pre-proline 0 N--CA 1.454 -0.246 0 O-C-N 121.43 -0.794 . . . . 0.0 110.571 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -74.69 137.35 22.36 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 121.088 1.424 . . . . 0.0 113.892 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.657 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.2 tt -109.27 178.97 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-O 124.444 2.069 . . . . 0.0 113.058 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.657 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 7.8 mmtt -153.12 153.77 33.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 108.647 -3.888 . . . . 0.0 109.869 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.8 p -76.08 51.94 0.7 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.63 1.972 . . . . 0.0 113.014 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.81 50.63 0.08 OUTLIER Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.405 1.002 . . . . 0.0 112.791 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.31 174.22 17.32 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 117.686 0.743 . . . . 0.0 112.783 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.8 t -80.86 131.79 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.834 1.253 . . . . 0.0 108.542 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -70.15 135.02 48.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.206 1.003 . . . . 0.0 110.907 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.9 p -139.27 75.61 1.52 Allowed 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.88 1.272 . . . . 0.0 107.583 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.47 -143.21 3.6 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.3 -50.73 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.9 p -153.35 150.1 22.89 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 124.218 1.007 . . . . 0.0 109.792 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -66.16 145.33 69.31 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 CA-C-N 119.393 0.819 . . . . 0.0 112.001 -8.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.28 -113.16 2.27 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.423 ' HB3' ' CB ' ' A' ' 91' ' ' HIS . . . 62.92 28.99 16.54 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.047 1.339 . . . . 0.0 113.866 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -155.02 84.15 1.08 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.16 132.64 47.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.522 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.72 159.79 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 103.311 -2.848 . . . . 0.0 103.311 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.2 t -139.17 131.39 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 120.479 -1.388 . . . . 0.0 108.089 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.7 pt -114.14 -179.46 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.311 1.444 . . . . 0.0 113.35 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -104.71 -174.38 2.52 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.099 2.159 . . . . 0.0 109.631 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.318 12.4 t -79.58 -30.17 41.49 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 120.402 3.482 . . . . 0.0 120.402 -177.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -79.32 -73.56 0.33 Allowed 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.7 t -164.75 1.22 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.849 2.06 . . . . 0.0 114.169 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -78.64 150.69 32.6 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 119.846 1.203 . . . . 0.0 113.813 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -95.85 117.98 31.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.34 1.856 . . . . 0.0 108.651 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.94 -52.69 7.54 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.35 0.66 . . . . 0.0 110.658 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.38 -169.21 38.38 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.9 162.37 31.77 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.827 0.813 . . . . 0.0 113.022 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.8 pt -142.21 163.67 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.59 1.556 . . . . 0.0 110.263 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.6 t -158.84 159.04 34.6 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.867 1.267 . . . . 0.0 111.016 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.423 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 49.9 m170 -79.6 -51.08 9.74 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.6 m -32.72 106.51 0.04 OUTLIER 'General case' 0 C--N 1.345 0.382 0 C-N-CA 127.852 2.461 . . . . 0.0 111.998 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.56 32.29 5.2 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.201 1.381 . . . . 0.0 111.079 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -134.5 -142.82 0.2 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.759 1.224 . . . . 0.0 109.248 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.6 t -151.46 62.86 0.88 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.26 0.624 . . . . 0.0 111.141 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.71 -125.29 6.73 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.534 1.064 . . . . 0.0 113.367 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -79.28 -26.2 42.37 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.643 1.177 . . . . 0.0 113.046 -178.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -56.3 118.05 4.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.984 0.914 . . . . 0.0 110.621 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -83.75 153.95 23.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.044 0.938 . . . . 0.0 111.145 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.6 m -126.76 166.54 23.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 C-N-CA 125.635 1.574 . . . . 0.0 107.556 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.38 148.03 23.74 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 123.891 0.758 . . . . 0.0 114.26 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.0 t -96.59 -175.09 3.21 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.716 2.006 . . . . 0.0 107.418 178.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.2 p -59.76 136.73 58.09 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.439 1.018 . . . . 0.0 109.851 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.06 26.56 74.6 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.566 0.603 . . . . 0.0 111.81 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.7 m -150.3 114.81 5.21 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.144 1.378 . . . . 0.0 107.497 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 . . . . . 0 C--O 1.251 1.154 0 CA-C-O 116.83 -1.557 . . . . 0.0 109.458 -179.82 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 120.592 0.234 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.1 m -147.92 52.93 1.03 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.601 1.16 . . . . 0.0 108.981 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 72.91 139.74 0.06 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 127.184 2.194 . . . . 0.0 109.682 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 t -146.67 124.15 11.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.281 0.562 . . . . 0.0 111.641 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -100.66 101.16 11.98 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 32.8 m -85.72 74.96 10.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.615 1.166 . . . . 0.0 108.249 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.82 -98.71 1.08 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.8 m -88.14 -44.71 10.71 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.387 1.075 . . . . 0.0 110.433 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.0 107.15 1.42 Allowed 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.039 1.336 . . . . 0.0 112.493 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -91.41 103.69 16.3 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.572 1.149 . . . . 0.0 109.027 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -102.39 148.69 25.18 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.277 0.631 . . . . 0.0 110.713 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.4 m -83.13 157.6 22.72 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 125.476 1.51 . . . . 0.0 108.858 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.66 -19.55 63.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.2 m -71.95 -35.22 69.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.109 0.964 . . . . 0.0 109.026 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.64 -53.81 10.78 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 123.953 0.901 . . . . 0.0 112.679 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.95 -41.31 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -67.61 -44.75 77.32 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.663 0.785 . . . . 0.0 111.007 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.25 -48.45 78.17 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.498 0.59 . . . . 0.0 110.253 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.05 -32.1 73.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.157 0.983 . . . . 0.0 111.166 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.43 -36.84 52.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.776 0.262 . . . . 0.0 110.666 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -69.29 -20.33 63.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.72 -53.59 5.79 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.59 -40.31 59.57 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.54 1.136 . . . . 0.0 109.228 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.41 -53.94 52.61 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.366 1.466 . . . . 0.0 109.374 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -63.58 -49.49 73.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -70.79 -46.15 63.39 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.478 ' CD1' ' HG2' ' A' ' 57' ' ' GLN . 63.6 t80 -70.23 -19.55 63.13 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.465 -177.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -90.14 -77.68 0.39 Allowed 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.534 1.061 . . . . 0.0 110.207 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.8 p30 174.49 56.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.1 1.36 . . . . 0.0 111.616 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -146.01 92.7 2.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 86.19 117.59 0.04 OUTLIER 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 127.326 2.25 . . . . 0.0 105.819 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -92.05 85.17 5.43 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.045 0.938 . . . . 0.0 109.916 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.15 150.21 8.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.253 1.421 . . . . 0.0 112.722 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.61 -38.37 95.59 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.4 t 65.49 97.13 0.05 OUTLIER 'General case' 0 C--N 1.343 0.297 0 C-N-CA 126.773 2.029 . . . . 0.0 113.242 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.5 m -68.95 -55.65 10.29 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 t -159.81 16.89 0.15 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.171 1.388 . . . . 0.0 111.495 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -142.02 149.76 53.61 Favored Pre-proline 0 CA--C 1.511 -0.553 0 C-N-CA 126.067 1.747 . . . . 0.0 107.327 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.4 122.76 7.96 Favored 'Cis proline' 0 CA--C 1.557 1.651 0 N-CA-C 115.425 1.279 . . . . 0.0 115.425 0.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . 0.318 29.3 m-70 -82.84 138.33 33.98 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 127.358 2.263 . . . . 0.0 114.457 -178.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -70.77 133.17 46.33 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 102.829 -3.026 . . . . 0.0 102.829 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.28 63.1 3.82 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.211 0.914 . . . . 0.0 113.278 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.1 m120 30.98 -138.0 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 130.87 3.668 . . . . 0.0 114.912 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -111.73 140.25 46.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.854 2.061 . . . . 0.0 107.701 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 71.93 179.46 0.23 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.514 1.526 . . . . 0.0 109.998 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -84.76 98.08 10.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.35 -42.48 83.1 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.171 0.891 . . . . 0.0 111.694 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -145.25 162.71 36.51 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.127 0.971 . . . . 0.0 109.458 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -76.69 132.9 39.61 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.777 1.231 . . . . 0.0 112.612 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -149.28 154.01 38.3 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.428 1.491 . . . . 0.0 108.385 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.96 -47.63 23.92 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.023 2.482 . . . . 0.0 111.351 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.4 m -81.0 168.0 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.544 1.538 . . . . 0.0 109.755 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -98.53 -16.68 19.06 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.633 1.173 . . . . 0.0 112.406 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.66 -159.69 22.41 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.35 160.77 72.05 Favored 'Cis proline' 0 N--CA 1.459 -0.549 0 CA-C-N 118.783 1.291 . . . . 0.0 112.422 1.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.91 159.94 35.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.742 1.217 . . . . 0.0 111.465 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.478 ' HG2' ' CD1' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -132.96 135.95 45.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.9 178.058 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -80.68 162.43 24.16 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -160.77 117.91 1.45 Allowed Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -82.9 146.03 12.83 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 121.405 1.404 . . . . 0.0 113.103 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.514 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 0.5 OUTLIER -112.84 -165.48 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-O 123.81 1.767 . . . . 0.0 113.731 -178.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.514 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -161.65 176.09 11.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 109.678 -3.419 . . . . 0.0 111.586 -177.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.0 t -99.81 63.57 1.22 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.342 1.457 . . . . 0.0 110.673 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.68 -63.43 0.09 OUTLIER Glycine 0 C--N 1.337 0.593 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.85 -164.88 11.57 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.6 p -83.98 160.6 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.03 0.932 . . . . 0.0 111.643 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -37.93 126.68 1.24 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 128.097 2.559 . . . . 0.0 113.754 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.0 t -160.02 -40.98 0.05 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.496 1.518 . . . . 0.0 110.383 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.87 -80.3 0.75 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.93 95.08 2.29 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.8 p -157.13 153.04 22.9 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 125.024 1.33 . . . . 0.0 108.417 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.23 154.17 74.79 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.958 2.439 . . . . 0.0 110.642 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.05 -25.73 0.02 OUTLIER Glycine 0 CA--C 1.53 1.022 0 CA-C-O 117.956 -1.469 . . . . 0.0 114.655 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.415 ' HB3' ' CB ' ' A' ' 91' ' ' HIS . . . 88.95 -31.28 0.03 OUTLIER 'General case' 0 C--N 1.346 0.418 0 C-N-CA 126.205 1.802 . . . . 0.0 111.167 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -79.37 124.52 28.5 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.234 1.813 . . . . 0.0 113.391 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.84 128.08 7.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.804 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.7 m -85.9 146.03 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.7 t -133.96 122.87 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.3 pt -106.23 171.59 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 125.169 1.388 . . . . 0.0 111.566 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -79.68 165.47 22.82 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.285 2.1 m -67.98 -5.78 18.93 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -178.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -102.29 -73.3 0.66 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -165.17 -12.01 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 117.935 2.568 . . . . 0.0 117.935 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -78.77 126.96 31.43 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -57.33 111.21 1.02 Allowed 'General case' 0 C--N 1.344 0.346 0 C-N-CA 125.353 1.461 . . . . 0.0 107.454 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.99 -48.76 11.81 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.53 151.33 8.31 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.56 125.88 38.41 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.5 pt -127.13 155.74 38.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 C-N-CA 122.727 0.411 . . . . 0.0 110.11 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.8 t -156.73 154.06 29.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.415 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 2.5 m170 -79.04 -15.38 58.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.821 175.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.7 m -58.51 103.72 0.17 Allowed 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.668 1.187 . . . . 0.0 109.385 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.76 55.0 1.96 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.23 -174.95 4.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.729 1.212 . . . . 0.0 109.915 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -57.15 -47.56 80.86 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.249 1.019 . . . . 0.0 111.082 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.96 -70.37 0.12 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -86.63 -28.55 23.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.76 1.224 . . . . 0.0 109.305 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -57.06 160.61 3.54 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 126.304 1.842 . . . . 0.0 111.285 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -114.85 161.46 18.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.882 1.673 . . . . 0.0 112.029 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 m -146.28 164.08 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 126.615 1.966 . . . . 0.0 107.434 177.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.54 156.55 26.9 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 123.972 0.796 . . . . 0.0 112.414 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.0 m -103.39 -171.16 1.89 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.151 0.98 . . . . 0.0 110.897 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -82.87 79.32 9.28 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 121.599 0.714 . . . . 0.0 109.624 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.94 -26.22 0.2 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.259 1.409 . . . . 0.0 109.674 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.0 m -79.36 123.35 27.41 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.015 1.726 . . . . 0.0 107.412 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 126.199 1.8 . . . . 0.0 109.865 -179.056 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.1 m -143.39 80.49 1.67 Allowed 'General case' 0 C--N 1.342 0.242 0 C-N-CA 123.585 0.754 . . . . 0.0 110.819 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.53 91.53 0.03 OUTLIER 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.807 1.643 . . . . 0.0 111.666 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 p -83.41 92.5 7.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.087 0.955 . . . . 0.0 112.068 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -99.71 96.25 7.49 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 101.481 -3.526 . . . . 0.0 101.481 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.9 m -89.12 73.04 8.23 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.94 -98.65 1.21 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 108.611 -1.795 . . . . 0.0 108.611 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.5 p -95.53 -42.13 8.59 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.41 1.084 . . . . 0.0 109.182 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.21 137.32 58.24 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -140.17 126.75 20.31 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.79 136.78 50.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.522 1.529 . . . . 0.0 108.338 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.7 p -64.73 161.57 17.67 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 125.152 1.381 . . . . 0.0 110.807 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.21 -16.78 36.39 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -78.28 -37.16 45.58 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 123.785 0.834 . . . . 0.0 109.986 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -66.64 -39.94 88.49 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.726 0.81 . . . . 0.0 109.992 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.5 t -60.2 -50.69 79.25 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -64.87 -23.29 67.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.138 1.375 . . . . 0.0 111.378 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.64 -61.11 1.89 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 119.202 0.91 . . . . 0.0 108.668 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.86 -24.93 66.19 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.679 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.2 -38.59 30.87 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 118.501 0.592 . . . . 0.0 112.012 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -69.5 -22.55 63.6 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.3 -65.22 0.95 Allowed 'General case' 0 C--N 1.347 0.487 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.38 -43.68 11.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.783 1.233 . . . . 0.0 111.941 177.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 t -61.81 -48.33 81.09 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 121.335 -0.853 . . . . 0.0 111.682 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -80.21 -24.33 40.32 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -112.6 -28.72 7.72 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -3.06 28.21 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -66.75 -46.64 74.73 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.175 0.99 . . . . 0.0 112.979 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -133.69 -80.69 0.47 Allowed 'General case' 0 C--N 1.34 0.183 0 O-C-N 123.354 0.409 . . . . 0.0 111.328 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -170.66 101.67 0.24 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -141.2 -169.38 2.83 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.963 0.905 . . . . 0.0 110.35 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.3 p -71.08 84.9 0.72 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.455 1.502 . . . . 0.0 112.152 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 137.94 162.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 129.464 3.106 . . . . 0.0 111.895 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 152.65 -87.88 0.13 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 126.169 1.842 . . . . 0.0 108.647 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.1 t 158.31 -94.75 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 129.21 3.004 . . . . 0.0 105.91 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.6 p -160.22 -55.05 0.06 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 p -81.36 -69.15 0.63 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.24 141.07 98.07 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 124.075 0.95 . . . . 0.0 109.129 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.18 133.33 27.46 Favored 'Cis proline' 0 N--CA 1.459 -0.504 0 N-CA-C 116.061 1.523 . . . . 0.0 116.061 3.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -132.49 136.97 47.03 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.963 2.105 . . . . 0.0 108.423 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.5 m -49.58 125.66 11.87 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.819 2.048 . . . . 0.0 110.195 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -80.03 70.61 6.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.703 1.201 . . . . 0.0 110.407 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -164.31 147.59 9.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.592 0.757 . . . . 0.0 110.027 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -162.29 -72.83 0.05 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.618 1.567 . . . . 0.0 107.03 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -152.76 -40.7 0.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.711 2.004 . . . . 0.0 108.31 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -118.28 161.96 19.06 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 125.392 1.477 . . . . 0.0 110.103 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.84 156.65 14.52 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.634 1.112 . . . . 0.0 110.459 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.55 156.78 37.77 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.655 0.782 . . . . 0.0 111.302 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -88.55 119.49 29.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.868 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -130.77 101.03 17.16 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.57 75.81 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.759 2.972 . . . . 0.0 111.286 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.9 t -140.04 -38.56 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.023 1.729 . . . . 0.0 109.238 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 80.57 108.88 0.07 Allowed 'General case' 0 C--N 1.345 0.387 0 C-N-CA 127.132 2.173 . . . . 0.0 109.251 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.84 -143.17 0.7 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.865 1.697 . . . . 0.0 113.533 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -65.99 139.06 40.76 Favored 'Cis proline' 0 N--CA 1.456 -0.717 0 CA-C-N 118.299 1.049 . . . . 0.0 112.652 1.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.37 163.72 12.61 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 126.351 1.86 . . . . 0.0 108.24 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -139.75 156.25 46.88 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -79.63 157.3 27.31 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.227 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -160.21 89.22 1.82 Allowed Pre-proline 0 N--CA 1.449 -0.511 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 178.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . 0.253 6.3 Cg_exo -63.84 137.46 58.33 Favored 'Trans proline' 0 N--CA 1.44 -1.657 0 C-N-CA 122.474 2.116 . . . . 0.0 116.757 -176.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.597 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.0 tt -108.14 176.96 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 124.278 1.99 . . . . 0.0 111.904 178.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.597 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -162.05 179.78 7.72 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 108.58 -3.918 . . . . 0.0 111.31 179.082 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.9 p -87.42 52.85 2.61 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.32 -65.57 0.02 OUTLIER Glycine 0 C--N 1.342 0.879 0 C-N-CA 125.187 1.375 . . . . 0.0 110.136 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.85 -127.13 1.62 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -68.27 164.94 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.89 1.276 . . . . 0.0 109.225 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -51.42 140.44 17.57 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.4 p -141.56 -55.79 0.47 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.566 1.946 . . . . 0.0 108.422 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.01 170.52 20.79 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.024 1.297 . . . . 0.0 111.248 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.38 151.15 25.33 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.506 1.05 . . . . 0.0 111.924 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.5 p 63.82 171.99 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.014 2.126 . . . . 0.0 112.657 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.55 159.89 30.24 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.012 2.475 . . . . 0.0 111.097 172.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.08 71.83 0.19 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.415 ' HB2' ' CB ' ' A' ' 91' ' ' HIS . . . -69.36 -16.52 63.55 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 118.142 -0.933 . . . . 0.0 112.575 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.54 125.12 38.99 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.322 1.849 . . . . 0.0 112.297 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.0 mtt85 -135.18 137.47 42.72 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.893 0.877 . . . . 0.0 113.115 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.9 m -103.07 145.3 12.56 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 176.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.262 91.7 t -134.73 133.99 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -176.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.7 pt -126.72 165.84 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -87.9 157.16 19.04 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 126.16 1.784 . . . . 0.0 109.79 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.377 8.2 t -79.73 56.06 2.18 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 -177.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -157.47 -87.07 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 100.785 -3.783 . . . . 0.0 100.785 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.45 1.85 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -83.91 127.1 33.61 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -64.35 127.87 33.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.325 1.05 . . . . 0.0 108.537 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.36 -44.89 8.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.563 0.745 . . . . 0.0 109.99 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.67 175.32 42.09 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.173 -0.537 . . . . 0.0 114.108 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.54 121.85 21.56 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 127.123 2.169 . . . . 0.0 106.166 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.3 pt -128.16 161.19 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.478 1.111 . . . . 0.0 110.243 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 t -157.91 159.81 36.95 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 74' ' ' ALA . 21.8 m170 -78.45 -24.09 46.22 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.4 m -61.56 108.07 0.91 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.793 0.837 . . . . 0.0 110.863 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.54 -15.71 19.67 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.818 1.199 . . . . 0.0 112.323 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.93 163.73 26.89 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.409 1.083 . . . . 0.0 111.8 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.8 t -104.05 52.03 0.77 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.957 1.303 . . . . 0.0 109.6 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 143.24 -147.67 19.14 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.796 1.189 . . . . 0.0 110.752 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -79.61 -14.84 58.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.496 1.119 . . . . 0.0 111.367 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -60.09 167.64 2.25 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 123.779 0.832 . . . . 0.0 110.919 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -106.71 159.66 16.05 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.437 1.095 . . . . 0.0 112.85 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 m -134.85 165.46 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 127.046 2.138 . . . . 0.0 106.399 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.14 138.01 13.91 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 122.984 0.326 . . . . 0.0 113.39 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.3 m -85.13 -174.37 5.21 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -77.44 121.33 23.67 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.745 -0.597 . . . . 0.0 110.648 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.03 66.2 1.59 Allowed Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.387 0.994 . . . . 0.0 110.789 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.4 t -139.31 29.37 2.21 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.984 1.314 . . . . 0.0 112.198 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 C--O 1.251 1.168 0 C-N-CA 127.68 2.392 . . . . 0.0 110.268 -179.13 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 121.1 0.476 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.5 p -139.37 -166.5 2.06 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.305 1.442 . . . . 0.0 110.009 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.08 147.29 35.41 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.473 1.109 . . . . 0.0 109.76 178.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.1 p -121.57 119.22 31.28 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 123.137 0.575 . . . . 0.0 110.239 -178.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.18 108.29 13.14 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 100.313 -3.958 . . . . 0.0 100.313 177.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.9 110.16 13.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.724 0.409 . . . . 0.0 110.242 -178.053 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.12 -82.71 0.75 Allowed Glycine 0 C--N 1.339 0.746 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.2 t -156.99 45.77 0.4 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.642 1.177 . . . . 0.0 108.874 179.057 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 m -141.39 96.92 3.06 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -85.68 139.05 31.69 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.71 1.604 . . . . 0.0 110.932 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -137.89 137.15 37.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.079 1.352 . . . . 0.0 108.271 178.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.5 m -70.58 149.18 47.35 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.29 -21.55 5.69 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.2 m -71.0 -47.66 57.54 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.153 0.981 . . . . 0.0 109.267 179.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.79 -38.04 85.74 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.81 -51.06 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.8 ttt-85 -64.19 -36.09 82.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.726 1.61 . . . . 0.0 111.785 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.29 -50.5 46.16 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.051 0.541 . . . . 0.0 109.908 179.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.58 -41.72 81.71 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.325 1.05 . . . . 0.0 110.213 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.91 -46.19 54.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -61.21 -21.81 64.19 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.64 -59.64 2.54 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -177.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.88 -32.54 53.61 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.817 0.698 . . . . 0.0 110.945 178.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.25 -53.84 42.7 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -56.44 -38.85 72.18 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.787 0.435 . . . . 0.0 110.549 178.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -74.38 -3.31 29.67 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 126.589 1.956 . . . . 0.0 113.147 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -134.41 17.84 3.67 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -99.3 -80.55 0.47 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.957 1.253 . . . . 0.0 108.823 179.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -157.97 17.2 0.24 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.245 1.018 . . . . 0.0 112.846 -179.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -122.3 67.7 0.94 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 77.1 116.53 0.06 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 127.406 2.283 . . . . 0.0 105.294 -177.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -96.03 -58.08 2.18 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 124.157 0.983 . . . . 0.0 112.159 -177.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 50.83 82.41 0.06 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.831 1.252 . . . . 0.0 112.534 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -112.75 33.09 5.81 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.768 1.651 . . . . 0.0 110.805 -179.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.7 m -149.24 65.08 1.02 Allowed 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.297 1.439 . . . . 0.0 107.212 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.6 p -161.33 -167.77 1.85 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.316 1.046 . . . . 0.0 108.765 -178.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.4 p -85.93 58.04 4.82 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 74.35 147.53 0.12 Allowed Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 126.885 2.074 . . . . 0.0 110.443 179.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.66 137.57 46.7 Favored 'Cis proline' 0 C--N 1.349 0.558 0 CA-C-N 119.73 0.939 . . . . 0.0 113.725 2.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -134.98 168.58 18.85 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.801 2.04 . . . . 0.0 110.216 -179.128 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.4 m -74.08 140.06 45.06 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.596 1.958 . . . . 0.0 109.489 178.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.49 81.78 5.92 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.86 146.49 49.6 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 71.77 126.23 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.054 2.142 . . . . 0.0 111.174 -178.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -98.67 53.19 1.01 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.91 0.884 . . . . 0.0 109.476 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -153.6 56.81 0.75 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.708 1.203 . . . . 0.0 108.102 179.123 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.8 -55.58 0.23 Allowed Glycine 0 C--N 1.341 0.855 0 C-N-CA 125.725 1.631 . . . . 0.0 109.042 179.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.61 175.65 13.65 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.313 1.045 . . . . 0.0 109.52 178.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -90.52 136.63 32.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.873 1.269 . . . . 0.0 110.871 -178.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -150.87 103.51 3.02 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 178.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.63 58.03 6.23 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.125 3.217 . . . . 0.0 114.074 -177.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -145.37 -134.22 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 178.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -146.5 143.23 28.8 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.183 0.901 . . . . 0.0 109.225 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.74 -176.19 50.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.214 0.911 . . . . 0.0 111.892 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.23 160.89 93.41 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 CA-C-N 118.174 0.987 . . . . 0.0 110.693 -1.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -112.4 171.82 7.29 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.267 1.027 . . . . 0.0 110.289 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -132.56 137.31 47.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.169 1.388 . . . . 0.0 109.055 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -93.7 155.29 17.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.603 0.761 . . . . 0.0 110.323 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -160.21 102.55 1.39 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.12 119.94 4.81 Favored 'Trans proline' 0 N--CA 1.442 -1.532 0 C-N-CA 122.226 1.951 . . . . 0.0 109.789 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.547 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 6.2 tt -79.38 170.63 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 124.109 1.909 . . . . 0.0 111.349 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.547 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 14.1 tptm -140.49 149.11 42.1 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 109.468 -3.515 . . . . 0.0 111.641 -178.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.4 m -89.48 60.28 5.12 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.129 1.771 . . . . 0.0 109.267 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.03 -55.79 0.03 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.29 -167.82 36.75 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.6 158.83 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.679 1.192 . . . . 0.0 110.899 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.18 -173.37 4.17 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.352 1.461 . . . . 0.0 108.341 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.2 t -160.36 33.11 0.17 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.752 1.221 . . . . 0.0 110.069 178.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -141.9 -24.38 0.21 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.824 1.202 . . . . 0.0 113.024 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.96 -143.86 49.01 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.643 1.222 . . . . 0.0 111.827 179.377 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.1 t 63.11 102.33 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.421 1.888 . . . . 0.0 111.975 179.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.85 161.7 29.68 Favored 'Cis proline' 0 C--N 1.349 0.567 0 CA-C-N 119.981 1.029 . . . . 0.0 113.619 -3.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.78 41.35 1.88 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.864 -0.964 . . . . 0.0 113.546 -179.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.406 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -88.54 -73.28 0.5 Allowed 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -60.99 112.92 2.26 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.603 1.161 . . . . 0.0 111.147 179.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -132.22 161.01 34.48 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -178.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 m -132.88 142.11 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 101.16 -3.644 . . . . 0.0 101.16 175.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.9 t -138.24 120.13 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -176.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -102.54 173.12 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.115 0 C-N-CA 125.85 1.66 . . . . 0.0 110.15 -178.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -88.56 161.06 17.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 103.184 -2.895 . . . . 0.0 103.184 176.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.366 13.4 t -57.09 -22.54 40.29 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 -177.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -85.97 -75.46 0.38 Allowed 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.62 -1.84 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -176.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -78.94 109.03 12.85 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -175.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -56.51 108.6 0.5 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.929 1.292 . . . . 0.0 109.228 -179.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.08 -60.05 2.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.604 1.162 . . . . 0.0 112.461 -177.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.8 175.57 46.39 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.62 146.12 52.04 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.424 1.089 . . . . 0.0 110.58 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.2 pt -143.61 171.37 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.292 1.037 . . . . 0.0 110.781 -178.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t -159.71 143.23 14.36 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 116.426 2.009 . . . . 0.0 116.426 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.406 ' HB2' ' CB ' ' A' ' 74' ' ' ALA 0.265 32.2 m170 -79.51 -29.36 41.53 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.094 174.542 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.2 -45.33 68.54 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.607 1.163 . . . . 0.0 113.666 -177.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -78.62 -21.9 68.14 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 124.047 0.832 . . . . 0.0 111.565 179.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.26 166.5 23.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.897 0.879 . . . . 0.0 112.003 -179.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.7 t -65.9 -36.02 82.23 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.158 0.983 . . . . 0.0 111.64 -179.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.53 -101.51 0.15 Allowed Glycine 0 C--N 1.341 0.808 0 CA-C-N 118.206 0.457 . . . . 0.0 112.26 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -79.58 -22.12 44.18 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.046 0.938 . . . . 0.0 113.017 -178.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -74.68 179.01 5.0 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.656 0.662 . . . . 0.0 110.584 179.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -119.41 159.03 24.99 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.563 1.545 . . . . 0.0 109.905 179.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.7 m -134.96 162.4 38.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 125.209 1.404 . . . . 0.0 107.542 177.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.44 147.94 30.41 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 116.311 -0.404 . . . . 0.0 113.51 -178.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 34.0 m -85.75 -173.91 4.87 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.309 1.444 . . . . 0.0 107.946 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.3 t -57.23 110.27 0.81 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.263 1.025 . . . . 0.0 111.841 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.95 34.2 76.38 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.939 1.256 . . . . 0.0 114.322 178.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 93.6 m -83.43 130.8 35.05 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 118.091 0.945 . . . . 0.0 109.169 179.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 117.238 -1.363 . . . . 0.0 108.927 179.438 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.574 0 CA-C-O 120.727 0.299 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.4 t -106.01 60.17 0.65 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.934 1.294 . . . . 0.0 110.269 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.53 147.02 0.06 Allowed 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 127.007 2.123 . . . . 0.0 112.227 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 t -159.66 156.3 27.61 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.87 121.23 18.11 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -178.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.4 m -103.28 91.04 3.91 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.28 -106.93 1.87 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.7 m -92.84 -33.32 14.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.527 1.131 . . . . 0.0 111.173 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 m -74.65 103.15 4.83 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.352 0.661 . . . . 0.0 110.275 -178.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -87.92 151.94 22.44 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.961 1.304 . . . . 0.0 111.684 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -142.54 134.23 26.77 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 123.481 0.713 . . . . 0.0 112.354 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.7 m -77.07 155.11 32.71 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.241 1.417 . . . . 0.0 107.465 177.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.82 -16.89 13.01 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 177.087 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -70.88 -43.29 68.71 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.871 0.868 . . . . 0.0 109.587 179.054 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -71.15 -47.3 58.65 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 123.932 0.893 . . . . 0.0 113.138 -179.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.4 t -60.1 -46.12 94.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -68.18 -40.84 82.15 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.84 1.256 . . . . 0.0 111.901 -179.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.98 -49.6 71.87 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.588 0.631 . . . . 0.0 110.021 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.33 -35.2 79.61 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.893 0.877 . . . . 0.0 111.563 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.21 -40.85 58.82 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 117.76 0.255 . . . . 0.0 111.661 179.12 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -65.38 -22.07 66.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.34 -61.73 1.91 Allowed 'General case' 0 C--N 1.348 0.505 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 -178.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -42.34 -47.54 4.9 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.097 1.359 . . . . 0.0 110.486 178.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.7 t -57.88 -66.61 0.45 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.767 1.627 . . . . 0.0 112.687 179.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -23.18 66.36 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.181 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -94.9 4.95 53.22 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.556 1.942 . . . . 0.0 113.413 -178.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -144.82 51.81 1.24 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.268 1.427 . . . . 0.0 110.63 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -95.13 -77.15 0.47 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 119.36 -0.352 . . . . 0.0 110.19 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 169.63 -65.4 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.683 1.593 . . . . 0.0 108.828 -178.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.25 69.79 7.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 111.22 116.19 0.0 OUTLIER 'General case' 0 C--O 1.231 0.102 0 C-N-CA 131.033 3.733 . . . . 0.0 106.743 -179.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.48 -63.95 0.3 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.483 1.113 . . . . 0.0 109.982 -178.741 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 66.52 163.35 0.18 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.562 1.545 . . . . 0.0 112.453 -179.186 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.93 106.7 0.15 Allowed Glycine 0 C--N 1.341 0.811 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -178.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m -139.1 57.21 1.67 Allowed 'General case' 0 C--N 1.34 0.173 0 CA-C-N 117.696 0.748 . . . . 0.0 112.149 -178.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -100.02 -75.93 0.56 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 177.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.261 3.6 t -160.23 26.56 0.17 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.682 1.593 . . . . 0.0 109.823 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.41 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -171.3 129.78 0.73 Allowed Pre-proline 0 C--N 1.349 0.548 0 C-N-CA 128.307 2.643 . . . . 0.0 106.872 178.329 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.6 132.3 25.84 Favored 'Cis proline' 0 N--CA 1.45 -1.083 0 N-CA-C 108.354 -1.441 . . . . 0.0 108.354 -2.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.3 158.17 43.88 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.874 0.47 . . . . 0.0 109.76 -179.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.4 m -55.64 130.97 45.24 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 125.97 1.708 . . . . 0.0 110.584 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -79.8 121.24 25.13 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.347 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -146.63 177.87 8.74 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.26 1.024 . . . . 0.0 110.514 -179.139 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 t30 59.13 73.27 0.49 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.259 1.424 . . . . 0.0 108.565 -178.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -82.01 91.23 6.58 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.051 0.94 . . . . 0.0 110.853 -178.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -62.08 -50.51 71.66 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -169.74 42.4 0.21 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 178.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -150.73 143.48 24.54 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 123.557 0.743 . . . . 0.0 112.159 -179.283 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -161.6 179.63 8.03 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.836 2.054 . . . . 0.0 107.677 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -137.93 119.33 10.58 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.84 74.37 5.26 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.981 3.121 . . . . 0.0 112.45 -178.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.26 -90.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.405 1.082 . . . . 0.0 108.714 178.517 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -145.93 -78.72 0.18 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-N 119.215 0.916 . . . . 0.0 110.228 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.22 -175.06 35.97 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.632 1.11 . . . . 0.0 111.045 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.25 140.33 32.48 Favored 'Cis proline' 0 N--CA 1.458 -0.59 0 CA-C-N 118.796 1.298 . . . . 0.0 110.422 1.031 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.38 172.27 11.91 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.954 0.902 . . . . 0.0 110.351 -178.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -153.9 137.82 16.29 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.064 0.459 . . . . 0.0 111.834 -178.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.55 143.81 30.8 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.697 1.599 . . . . 0.0 112.626 -178.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -154.48 113.85 2.44 Favored Pre-proline 0 C--N 1.342 0.251 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 178.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.41 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 17.6 Cg_endo -81.12 144.54 14.87 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 121.79 1.66 . . . . 0.0 114.389 -175.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.543 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -117.12 -171.64 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-O 124.671 2.176 . . . . 0.0 113.125 179.419 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.543 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -162.41 -175.47 4.54 Favored 'General case' 0 C--N 1.318 -0.796 2 CA-C-N 108.05 -4.159 . . . . 0.0 107.443 -178.656 . . . . . . . . 4 4 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.3 m -92.81 61.27 3.54 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.54 58.88 0.99 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -178.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.27 61.13 0.17 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.02 116.86 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.426 0.691 . . . . 0.0 111.206 -179.35 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.6 t80 53.64 65.64 1.46 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.248 1.419 . . . . 0.0 111.248 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.6 p -138.12 77.57 1.64 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.246 1.018 . . . . 0.0 110.825 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.95 99.92 0.07 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.738 0.685 . . . . 0.0 113.262 178.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.74 -174.35 49.31 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.2 m 56.8 86.63 0.16 Allowed Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 125.318 1.447 . . . . 0.0 111.602 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -62.72 142.6 42.14 Favored 'Cis proline' 0 N--CA 1.459 -0.505 0 CA-C-N 119.322 0.794 . . . . 0.0 112.76 -0.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.85 48.09 0.49 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.29 -55.6 8.82 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.693 0.797 . . . . 0.0 109.455 179.267 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -61.93 118.61 7.47 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.436 1.894 . . . . 0.0 112.843 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -143.37 126.91 16.89 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.0 m -92.9 148.05 4.98 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 177.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.6 t -137.06 131.81 46.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 pt -119.92 -175.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.394 0 C-N-CA 124.365 1.066 . . . . 0.0 112.301 -178.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -96.74 153.64 17.75 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 127.009 2.123 . . . . 0.0 106.071 177.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.6 t -67.31 -1.4 4.55 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 -178.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -93.29 -75.31 0.5 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 178.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -164.39 -12.04 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -179.094 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.72 132.82 36.28 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 -174.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -62.24 125.24 23.21 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.8 -42.41 8.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.2 1.0 . . . . 0.0 109.463 -178.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.18 -165.07 38.16 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.86 140.61 25.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.698 1.599 . . . . 0.0 107.678 179.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.8 pt -142.56 165.87 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.091 1.356 . . . . 0.0 109.129 -178.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.3 t -159.33 150.83 20.23 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.19 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -79.13 -9.8 59.65 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 175.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 54.1 m -66.16 112.0 3.7 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.477 1.111 . . . . 0.0 109.12 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.91 34.38 42.86 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.952 0.787 . . . . 0.0 111.669 -179.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.43 -21.2 11.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.21 1.404 . . . . 0.0 111.386 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.6 m 70.05 85.12 0.14 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 126.185 1.794 . . . . 0.0 110.639 179.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.91 -146.77 17.95 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.702 1.144 . . . . 0.0 111.359 179.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -80.0 3.61 19.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.681 1.192 . . . . 0.0 112.913 -179.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -68.28 -174.85 0.55 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.876 1.27 . . . . 0.0 111.594 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -140.7 157.56 45.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.81 0.844 . . . . 0.0 112.503 -178.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 m -143.94 163.29 15.18 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 127.095 2.158 . . . . 0.0 106.955 177.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.27 153.35 26.41 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 123.53 0.586 . . . . 0.0 113.302 -178.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -84.13 -179.85 7.32 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.27 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.9 t -79.53 122.69 26.79 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.351 -0.843 . . . . 0.0 112.219 -178.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.64 36.39 92.59 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.726 1.155 . . . . 0.0 112.361 179.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.5 t -80.05 146.69 31.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.0 p30 . . . . . 0 C--O 1.252 1.191 0 C-N-CA 125.397 1.479 . . . . 0.0 109.741 -179.031 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m -133.29 176.95 8.06 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.14 1.376 . . . . 0.0 108.994 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -44.46 117.97 1.42 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.984 1.313 . . . . 0.0 110.764 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.51 121.87 41.78 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 124.964 1.306 . . . . 0.0 110.41 -178.124 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -119.07 92.14 3.73 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 100.285 -3.968 . . . . 0.0 100.285 177.126 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.8 m -98.93 91.13 4.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.982 0.913 . . . . 0.0 111.455 -177.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.72 -81.68 0.63 Allowed Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.979 1.276 . . . . 0.0 110.759 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.3 t -145.07 23.92 1.49 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.813 1.245 . . . . 0.0 110.339 179.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 m -129.29 102.01 6.25 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 179.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -95.18 151.72 18.98 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.347 0.659 . . . . 0.0 111.967 -178.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.26 155.69 41.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.01 1.324 . . . . 0.0 109.543 178.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.0 p -75.77 154.2 36.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.509 1.523 . . . . 0.0 110.352 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.5 -21.19 59.81 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 176.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.7 t -71.09 -41.22 70.91 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 124.648 1.179 . . . . 0.0 109.892 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -66.78 -39.83 87.94 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 118.65 0.659 . . . . 0.0 111.09 178.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.42 -50.68 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 123.741 0.816 . . . . 0.0 109.13 178.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -62.76 -39.14 93.24 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 123.71 0.804 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.6 -47.13 76.75 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.41 -31.24 72.34 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.56 0.744 . . . . 0.0 111.211 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.87 -42.52 24.06 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 178.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -68.4 -20.39 64.67 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.96 -65.42 1.01 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 104.33 -2.471 . . . . 0.0 104.33 -178.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -41.23 -53.68 3.12 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 124.708 1.255 . . . . 0.0 110.125 176.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 t -49.96 -61.87 1.9 Allowed 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.853 1.661 . . . . 0.0 113.319 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -61.55 -51.43 68.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.118 0.567 . . . . 0.0 111.458 -178.054 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -63.07 -28.6 70.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.722 1.209 . . . . 0.0 112.041 -177.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -71.92 -56.02 6.44 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.102 0.961 . . . . 0.0 109.557 179.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -60.25 -36.86 78.74 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.031 0.932 . . . . 0.0 110.994 -179.079 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -73.69 -35.88 65.23 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.311 0.645 . . . . 0.0 110.683 178.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 68.48 51.05 0.67 Allowed 'General case' 0 C--N 1.344 0.362 0 C-N-CA 126.09 1.756 . . . . 0.0 109.813 -178.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -172.56 -165.55 0.33 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.818 2.047 . . . . 0.0 107.823 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.36 8.8 t 49.65 51.79 15.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.871 2.069 . . . . 0.0 113.682 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.94 99.65 0.08 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.827 2.051 . . . . 0.0 107.081 178.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.91 33.31 3.1 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.033 0.825 . . . . 0.0 113.567 -178.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -78.49 -73.09 0.34 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -167.27 -72.71 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.79 2.036 . . . . 0.0 105.925 179.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.3 t -152.21 14.78 0.61 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.298 1.039 . . . . 0.0 111.557 178.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -76.95 130.79 74.69 Favored Pre-proline 0 C--N 1.346 0.421 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.54 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -69.89 121.25 5.32 Favored 'Cis proline' 0 N--CA 1.455 -0.738 0 N-CA-C 115.938 1.476 . . . . 0.0 115.938 -0.002 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -115.19 161.12 18.87 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.497 1.919 . . . . 0.0 106.053 178.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 t -52.31 143.04 15.66 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -118.31 152.64 35.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.198 1.399 . . . . 0.0 107.75 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 177.46 -65.04 0.01 OUTLIER 'General case' 0 C--O 1.231 0.082 0 C-N-CA 124.912 1.285 . . . . 0.0 108.848 -178.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 m120 53.05 44.59 30.2 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.811 1.644 . . . . 0.0 110.026 -179.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 59.38 -98.98 0.09 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.206 1.802 . . . . 0.0 109.287 -178.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -134.34 68.76 1.47 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.013 1.325 . . . . 0.0 107.792 178.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.05 -73.53 0.91 Allowed Glycine 0 C--N 1.341 0.859 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.209 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.29 116.73 12.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -141.19 121.31 13.78 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.851 0.86 . . . . 0.0 108.881 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -88.31 178.6 2.02 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 125.428 1.491 . . . . 0.0 107.985 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.66 -72.04 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.011 2.474 . . . . 0.0 111.113 178.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.416 ' CG1' ' ND2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER 41.77 -150.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 127.319 2.247 . . . . 0.0 114.197 178.546 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -124.23 -57.03 1.61 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.958 2.103 . . . . 0.0 107.797 178.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.84 129.93 6.7 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.648 -1.084 . . . . 0.0 111.153 179.217 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.17 -177.89 9.67 Favored 'Cis proline' 0 C--N 1.35 0.651 0 CA-C-N 119.813 1.807 . . . . 0.0 114.635 -0.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.86 163.36 38.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 128.716 2.807 . . . . 0.0 106.315 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -132.33 152.26 51.49 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.9 161.8 15.05 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -161.12 95.51 1.39 Allowed Pre-proline 0 N--CA 1.455 -0.203 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -67.69 132.26 26.43 Favored 'Trans proline' 0 N--CA 1.438 -1.744 0 CA-C-N 120.82 1.328 . . . . 0.0 112.727 -178.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.62 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.3 tt -101.81 179.33 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 123.93 1.824 . . . . 0.0 111.707 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.62 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 10.4 mttm -160.99 157.73 26.79 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 109.08 -3.691 . . . . 0.0 111.51 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.9 p -88.41 59.89 5.41 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.813 1.245 . . . . 0.0 111.234 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.11 31.0 0.13 Allowed Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.302 -0.721 . . . . 0.0 111.621 178.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.01 179.97 28.82 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.922 0.772 . . . . 0.0 112.056 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.8 p -73.64 131.15 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.094 1.358 . . . . 0.0 111.545 -179.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 41.8 t80 39.04 82.48 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.359 2.263 . . . . 0.0 114.09 178.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.2 t -160.59 125.3 3.72 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.104 0.961 . . . . 0.0 109.422 178.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 162.46 -83.16 0.12 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 154.16 -58.4 0.4 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.3 m -138.29 93.15 11.63 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.181 0.992 . . . . 0.0 110.518 -178.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -49.45 139.0 30.23 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 124.11 3.207 . . . . 0.0 111.565 169.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.14 -21.02 2.38 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 118.259 -1.301 . . . . 0.0 115.162 -178.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -151.94 -60.14 0.16 Allowed 'General case' 0 C--N 1.345 0.374 0 CA-C-N 119.657 1.729 . . . . 0.0 114.454 -178.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.42 117.52 12.06 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -177.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -146.0 125.67 13.38 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.422 0.689 . . . . 0.0 112.036 178.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.6 148.49 4.53 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.09 137.71 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.3 pt -117.42 -177.62 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.803 1.641 . . . . 0.0 112.143 -178.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.416 ' ND2' ' CG1' ' A' ' 52' ' ' VAL . 4.6 m120 -83.65 178.55 7.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 129.397 3.079 . . . . 0.0 107.118 178.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.1 t -90.71 24.76 2.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -140.57 -65.21 0.45 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 177.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -163.27 -21.03 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 118.741 2.867 . . . . 0.0 118.741 -177.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -79.82 150.2 30.77 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -175.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -75.44 134.52 40.85 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.149 1.78 . . . . 0.0 108.296 178.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.22 -53.7 2.86 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.942 0.897 . . . . 0.0 110.248 -179.357 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.91 152.11 10.95 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.15 127.67 53.02 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.377 1.471 . . . . 0.0 107.551 178.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.0 pt -132.19 157.59 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.457 1.103 . . . . 0.0 109.969 -178.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.4 t -158.07 151.8 23.75 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -179.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -80.21 -20.57 44.37 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.562 0.539 . . . . 0.0 110.509 174.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.0 m -49.01 -59.64 3.44 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 126.182 1.793 . . . . 0.0 112.714 -178.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.02 -27.45 70.37 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 123.846 0.736 . . . . 0.0 111.96 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.02 172.35 5.72 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.211 1.004 . . . . 0.0 112.27 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.3 t -60.79 -54.8 40.7 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.448 1.099 . . . . 0.0 111.564 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.68 -88.39 0.07 OUTLIER Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.428 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -80.23 -24.1 40.41 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.978 0.911 . . . . 0.0 112.001 -179.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -68.71 -178.18 1.12 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.518 1.127 . . . . 0.0 112.268 -178.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -128.17 160.46 31.97 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.524 1.529 . . . . 0.0 112.031 -179.007 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 m -148.27 161.25 6.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 126.747 2.019 . . . . 0.0 106.917 177.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.1 161.39 27.85 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 p -147.63 160.68 42.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.2 1.8 . . . . 0.0 109.4 178.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.2 t 70.51 58.76 0.23 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.046 1.738 . . . . 0.0 110.684 -178.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.59 28.74 70.26 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.306 -179.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.2 m -113.79 106.24 14.24 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.215 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.3 t30 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 116.851 -1.547 . . . . 0.0 109.822 179.704 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.493 0 CA-C-O 121.142 0.496 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.6 p -136.42 -174.34 3.67 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.255 1.422 . . . . 0.0 109.945 179.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.83 152.05 45.28 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.706 0.802 . . . . 0.0 109.406 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 t -146.53 136.97 23.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.73 0.3 . . . . 0.0 111.705 -179.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.06 113.08 25.5 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.224 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.1 m -98.54 75.27 2.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.8 -84.11 1.59 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.0 m -123.44 -29.49 3.79 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.352 1.461 . . . . 0.0 110.816 179.112 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -71.73 98.04 1.87 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -79.56 141.58 36.49 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.138 1.375 . . . . 0.0 110.578 -178.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -137.14 129.01 29.04 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.325 1.05 . . . . 0.0 109.547 178.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.1 m -68.98 155.1 40.92 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.88 1.272 . . . . 0.0 108.652 178.209 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.71 -22.62 57.93 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 176.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.8 t -71.13 -37.74 72.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.034 0.934 . . . . 0.0 109.683 179.228 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -75.32 -44.89 42.88 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.102 1.361 . . . . 0.0 113.57 -178.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.2 t -60.48 -48.02 90.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -43.26 74.37 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 123.765 0.826 . . . . 0.0 112.258 -179.187 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.18 -47.24 85.37 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.301 0.376 . . . . 0.0 110.69 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.6 94.57 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.712 0.805 . . . . 0.0 109.566 -179.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.91 -27.86 60.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -71.51 -23.47 61.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.03 -58.03 3.26 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -179.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -44.28 -44.6 8.15 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.48 1.512 . . . . 0.0 111.002 176.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -62.9 -52.56 62.61 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.163 0.985 . . . . 0.0 109.862 178.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -61.14 -22.22 64.48 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.445 0.698 . . . . 0.0 112.182 179.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -99.74 7.4 45.1 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.898 1.679 . . . . 0.0 110.735 179.328 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -151.31 63.89 0.89 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.587 1.184 . . . . 0.0 108.51 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -100.59 -39.88 7.68 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 113.532 -1.667 . . . . 0.0 112.16 178.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -139.05 48.41 1.88 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.876 0.871 . . . . 0.0 111.062 -179.048 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 p30 46.46 41.75 9.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.584 1.954 . . . . 0.0 114.61 178.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -138.94 123.74 18.69 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 103.347 -2.834 . . . . 0.0 103.347 178.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 p -109.54 -84.09 0.55 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -176.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 163.24 97.57 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 128.394 2.677 . . . . 0.0 104.184 -178.139 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.5 -48.22 3.09 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -178.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m 59.17 71.64 0.57 Allowed 'General case' 0 C--N 1.345 0.402 0 C-N-CA 125.344 1.458 . . . . 0.0 110.267 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.3 t 179.68 -42.3 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.992 2.117 . . . . 0.0 107.238 -178.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.3 t -79.91 12.32 2.79 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.96 1.704 . . . . 0.0 112.667 179.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 71.94 136.57 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.792 1.637 . . . . 0.0 108.717 179.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.35 163.41 89.95 Favored 'Cis proline' 0 N--CA 1.449 -1.143 0 CA-C-N 119.616 0.899 . . . . 0.0 113.979 2.476 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -166.46 151.75 8.16 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 127.06 2.144 . . . . 0.0 107.131 178.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 t -52.0 155.66 1.78 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -178.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -138.36 99.01 3.73 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.345 2.258 . . . . 0.0 106.738 -179.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -131.04 153.65 49.05 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.28 1.032 . . . . 0.0 111.747 -178.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 54.47 32.22 16.3 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.873 2.069 . . . . 0.0 113.612 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -123.62 75.96 1.38 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -77.85 -1.46 31.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.413 1.085 . . . . 0.0 112.722 179.353 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.83 -43.34 96.64 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 124.346 0.975 . . . . 0.0 111.964 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.47 66.8 1.32 Allowed 'General case' 0 C--N 1.341 0.221 0 CA-C-O 121.658 0.742 . . . . 0.0 109.403 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -87.57 -175.16 5.1 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.632 1.173 . . . . 0.0 112.968 -178.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -141.3 143.58 31.02 Favored Pre-proline 0 N--CA 1.454 -0.226 0 C-N-CA 126.699 1.999 . . . . 0.0 106.73 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.14 -87.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.837 2.358 . . . . 0.0 110.272 179.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.1 t 31.23 -102.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 128.046 2.538 . . . . 0.0 113.358 178.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -167.76 115.43 0.75 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.246 1.019 . . . . 0.0 109.57 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.06 170.98 50.14 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.69 170.71 64.7 Favored 'Cis proline' 0 N--CA 1.459 -0.533 0 CA-C-N 118.645 1.223 . . . . 0.0 112.423 -0.147 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -130.5 170.84 13.7 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.92 1.288 . . . . 0.0 109.868 -178.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -149.99 148.5 29.13 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.172 0.989 . . . . 0.0 109.731 179.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -79.54 155.08 28.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.044 2.537 . . . . 0.0 112.369 -177.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -160.51 102.1 1.35 Allowed Pre-proline 0 N--CA 1.454 -0.258 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -78.79 126.36 7.25 Favored 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 121.786 1.658 . . . . 0.0 111.632 -176.422 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.3 tp -79.2 164.41 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 123.845 1.783 . . . . 0.0 113.186 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -142.93 145.55 33.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 109.316 -3.584 . . . . 0.0 110.752 -178.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.8 p -85.34 57.65 4.58 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.068 1.347 . . . . 0.0 108.421 179.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.59 -44.23 0.03 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -178.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.62 -132.59 2.18 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 117.788 0.794 . . . . 0.0 111.822 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -77.77 167.29 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.961 1.704 . . . . 0.0 110.3 -179.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -65.01 141.96 58.59 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 118.406 0.548 . . . . 0.0 110.965 -179.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -130.78 120.72 24.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.229 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.69 -66.17 3.58 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.271 0.939 . . . . 0.0 111.74 179.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.32 -115.56 1.76 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 -179.261 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.15 -178.76 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.61 1.164 . . . . 0.0 111.067 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.71 159.55 4.77 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.411 2.741 . . . . 0.0 113.34 172.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.59 82.49 0.05 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 -178.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.95 -35.87 35.79 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.477 1.111 . . . . 0.0 113.487 -178.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -74.96 118.48 17.97 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.564 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -144.57 133.65 22.77 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -178.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.8 m -100.12 145.83 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 176.133 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -130.81 136.49 58.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -177.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.0 pt -116.08 174.07 3.53 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 C-N-CA 125.066 1.346 . . . . 0.0 113.512 -178.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -99.99 162.67 12.84 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.885 2.074 . . . . 0.0 107.735 178.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.379 5.7 t -79.09 32.69 0.22 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 118.993 2.961 . . . . 0.0 118.993 -177.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.31 -85.62 0.63 Allowed 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 176.377 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.7 t -162.98 -6.31 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.12 1.768 . . . . 0.0 114.848 179.281 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -79.0 139.14 38.26 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.466 1.03 . . . . 0.0 112.984 -176.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -81.78 121.21 26.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.444 1.898 . . . . 0.0 106.522 178.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.72 -59.27 2.8 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 123.548 0.739 . . . . 0.0 111.691 -178.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.52 154.28 13.01 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.703 -0.76 . . . . 0.0 114.098 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.96 124.77 37.17 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.491 1.516 . . . . 0.0 109.399 179.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.5 pt -131.09 159.7 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 125.296 1.438 . . . . 0.0 108.414 -179.334 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.8 t -154.07 154.22 33.26 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.273 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -79.42 11.34 3.05 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 176.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.4 m -56.38 -69.66 0.14 Allowed 'General case' 0 C--N 1.343 0.316 0 CA-C-N 120.135 1.334 . . . . 0.0 112.449 -178.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.26 3.42 72.29 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.369 0.985 . . . . 0.0 112.965 -179.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.34 159.45 33.32 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.993 0.917 . . . . 0.0 111.365 179.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.5 t -69.45 -46.48 66.62 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.64 0.776 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -161.94 -86.73 0.06 OUTLIER Glycine 0 C--N 1.34 0.761 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -91.67 15.27 13.03 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.216 1.006 . . . . 0.0 111.296 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -91.17 -168.17 1.99 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.892 1.277 . . . . 0.0 109.727 -179.401 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -147.24 159.44 43.65 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.903 0.881 . . . . 0.0 112.201 -178.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.4 m -138.52 165.62 24.52 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 126.959 2.104 . . . . 0.0 107.21 177.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.71 138.58 14.33 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 123.566 0.603 . . . . 0.0 113.492 -178.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.7 m -84.81 -169.54 2.69 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.269 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -69.97 134.36 48.26 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.954 -0.466 . . . . 0.0 110.791 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.66 34.57 72.97 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.4 m -149.08 104.61 3.44 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.5 t30 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 116.873 -1.537 . . . . 0.0 109.454 179.446 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.2 p -130.07 46.93 2.57 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.231 1.413 . . . . 0.0 109.593 179.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 67.13 163.97 0.2 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.8 2.04 . . . . 0.0 111.687 -179.202 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 t -156.32 128.52 7.51 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.98 115.37 29.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 178.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 23.1 m -101.06 72.82 1.49 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.777 1.631 . . . . 0.0 107.511 -179.048 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.02 -90.82 0.8 Allowed Glycine 0 C--N 1.34 0.754 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.3 t -106.53 -36.86 6.64 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.078 1.351 . . . . 0.0 110.416 179.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.7 m -71.39 112.96 7.94 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.616 0.766 . . . . 0.0 110.003 -179.15 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -92.29 147.39 22.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.093 0.957 . . . . 0.0 110.782 -179.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -142.08 122.23 13.81 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.778 1.231 . . . . 0.0 108.345 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.2 m -69.45 155.84 39.81 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 125.443 1.497 . . . . 0.0 110.163 178.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.9 -18.78 47.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.069 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.4 p -77.81 -39.48 43.61 Favored 'General case' 0 C--N 1.345 0.382 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -68.72 -45.97 70.15 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.278 1.031 . . . . 0.0 111.457 179.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 51.5 t -60.08 -49.78 82.71 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.095 0 C-N-CA 124.22 1.008 . . . . 0.0 109.242 179.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -63.6 -46.81 84.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.92 0.888 . . . . 0.0 111.434 -178.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.13 -52.57 58.48 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.589 0.756 . . . . 0.0 111.048 -177.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.04 -41.57 83.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.75 -29.29 66.61 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 179.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -68.41 -26.11 65.37 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.9 -59.5 2.69 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -43.93 -44.52 7.17 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.138 1.375 . . . . 0.0 112.145 177.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.9 t -60.08 -53.83 53.17 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.15 1.38 . . . . 0.0 111.06 -179.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -66.91 -43.15 84.08 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -81.37 -2.57 49.8 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 127.103 2.161 . . . . 0.0 114.03 -178.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -60.29 -45.73 92.33 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 120.288 1.404 . . . . 0.0 110.611 179.051 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -57.59 -46.28 84.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.974 1.31 . . . . 0.0 110.886 -178.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -84.45 -16.55 42.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.185 1.394 . . . . 0.0 113.277 -178.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.7 t0 65.26 79.18 0.26 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.533 1.933 . . . . 0.0 107.867 -178.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 83.94 -163.09 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.467 2.307 . . . . 0.0 107.198 -178.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.7 p -36.97 -41.2 0.33 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.087 1.355 . . . . 0.0 108.954 177.069 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 156.6 90.09 0.0 OUTLIER 'General case' 0 C--N 1.345 0.373 0 C-N-CA 129.971 3.308 . . . . 0.0 108.819 177.143 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -141.14 -136.0 3.24 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.278 1.894 . . . . 0.0 110.983 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.5 p 177.52 111.79 0.03 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 125.293 1.437 . . . . 0.0 109.407 -178.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 m 89.68 -8.72 0.39 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 128.74 2.816 . . . . 0.0 114.233 178.047 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 t -82.52 3.8 27.01 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.602 0.637 . . . . 0.0 112.225 179.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 81.21 141.21 0.07 OUTLIER Pre-proline 0 C--N 1.347 0.462 0 C-N-CA 127.818 2.447 . . . . 0.0 109.734 178.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.06 144.11 74.3 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 N-CA-C 117.258 1.984 . . . . 0.0 117.258 2.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.78 161.52 34.64 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 127.583 2.353 . . . . 0.0 106.324 178.406 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.2 t -59.13 149.04 29.15 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.631 0.65 . . . . 0.0 111.52 -179.281 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -90.69 143.53 26.65 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.209 1.004 . . . . 0.0 109.325 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -65.15 -49.24 70.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.817 1.647 . . . . 0.0 112.959 -178.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 71.22 -168.02 0.15 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.125 1.37 . . . . 0.0 109.851 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 68.5 168.71 0.28 Allowed 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.76 1.624 . . . . 0.0 112.471 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 55.65 50.91 13.42 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -178.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.81 -159.08 34.15 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 108.154 -1.978 . . . . 0.0 108.154 -177.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 35.58 96.94 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 127.403 2.281 . . . . 0.0 116.853 179.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -158.83 143.03 15.55 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.0 0.92 . . . . 0.0 109.427 178.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -102.24 153.53 38.01 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.036 1.335 . . . . 0.0 108.728 -179.306 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -78.17 42.18 1.16 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 124.102 3.201 . . . . 0.0 112.518 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.5 m -149.11 152.59 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 126.683 1.993 . . . . 0.0 107.161 178.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -144.87 113.58 6.75 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.18 -57.02 3.08 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.18 -1.344 . . . . 0.0 112.689 -178.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -53.8 149.16 16.64 Favored 'Cis proline' 0 C--N 1.351 0.68 0 CA-C-N 120.586 2.193 . . . . 0.0 113.944 0.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -92.94 156.69 16.76 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.649 1.179 . . . . 0.0 111.286 -178.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.78 154.29 45.57 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.373 1.869 . . . . 0.0 115.378 -176.203 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -80.46 150.45 29.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.654 1.982 . . . . 0.0 110.002 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -160.02 99.38 1.46 Allowed Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.609 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -79.38 120.11 4.36 Favored 'Trans proline' 0 N--CA 1.442 -1.531 0 C-N-CA 122.114 1.876 . . . . 0.0 113.768 -176.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.677 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.9 tt -85.8 -178.81 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-O 123.845 1.783 . . . . 0.0 108.841 178.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.677 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 7.6 mmtt -160.43 139.91 10.92 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 109.788 -3.369 . . . . 0.0 111.466 -178.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.5 p -90.22 63.17 5.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.231 1.412 . . . . 0.0 107.309 178.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.87 -51.16 0.04 OUTLIER Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.222 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.18 177.98 35.52 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.27 104.93 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 39.6 p90 47.86 71.31 0.35 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.597 1.959 . . . . 0.0 112.343 -178.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.9 p -110.24 138.36 46.73 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.061 1.344 . . . . 0.0 109.273 179.306 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.36 -80.09 1.86 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.82 111.29 0.09 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.04 0.828 . . . . 0.0 111.615 179.262 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.9 m 64.93 90.66 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.719 1.607 . . . . 0.0 110.723 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.29 165.86 84.69 Favored 'Cis proline' 0 N--CA 1.457 -0.63 0 CA-C-N 119.323 0.794 . . . . 0.0 112.055 4.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.35 -67.48 0.02 OUTLIER Glycine 0 CA--C 1.525 0.716 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 80.1 -59.72 0.32 Allowed 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 127.928 2.491 . . . . 0.0 109.478 179.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -65.52 115.6 5.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -135.52 159.69 40.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 122.148 0.975 . . . . 0.0 112.481 178.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.0 m -130.42 147.64 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 102.326 -3.212 . . . . 0.0 102.326 176.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.4 t -127.83 108.85 18.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -177.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -98.75 175.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.413 1.085 . . . . 0.0 111.498 -177.227 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -96.42 146.7 24.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.069 1.748 . . . . 0.0 107.108 179.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.9 t -61.11 -10.01 5.58 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 117.563 2.431 . . . . 0.0 117.563 -178.129 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -86.32 -76.51 0.34 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 178.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.48 -7.89 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 -178.473 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -79.07 169.53 18.05 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 119.339 0.972 . . . . 0.0 111.653 -176.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -113.46 125.81 54.64 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.513 1.925 . . . . 0.0 108.848 179.238 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.62 -62.99 1.35 Allowed 'General case' 0 C--N 1.346 0.431 0 C-N-CA 123.463 0.705 . . . . 0.0 111.241 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.26 170.04 43.09 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.66 153.82 38.86 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 123.931 0.892 . . . . 0.0 113.395 -178.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.5 pt -142.7 161.24 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 127.04 2.136 . . . . 0.0 109.392 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.4 t -160.57 142.76 12.74 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -177.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -78.35 64.35 3.43 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-N 120.89 1.677 . . . . 0.0 108.679 173.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.7 t -95.94 -34.45 11.8 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.227 -0.921 . . . . 0.0 109.652 178.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.68 -59.32 0.27 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 178.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 64.82 177.61 0.19 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.152 1.781 . . . . 0.0 113.591 178.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.4 t -150.64 56.98 0.92 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.553 1.541 . . . . 0.0 107.158 179.129 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.47 -77.28 0.23 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 107.503 -2.239 . . . . 0.0 107.503 -178.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -144.5 45.91 1.4 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.556 1.143 . . . . 0.0 108.985 178.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -114.17 160.59 18.8 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.613 1.165 . . . . 0.0 111.092 -179.059 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -109.49 109.84 20.78 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.743 1.617 . . . . 0.0 107.467 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.2 m -79.41 161.14 4.2 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.15 143.56 29.76 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 116.439 1.336 . . . . 0.0 116.439 -177.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.9 t -121.86 163.62 18.91 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 177.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.2 t 61.8 37.01 15.85 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.025 0.93 . . . . 0.0 109.865 -176.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.13 33.69 85.17 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.473 1.035 . . . . 0.0 111.892 -178.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.4 m -81.42 137.31 35.68 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.211 1.004 . . . . 0.0 109.387 179.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 116.921 -1.514 . . . . 0.0 108.535 179.219 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.2 t -79.19 75.36 5.75 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.056 1.342 . . . . 0.0 110.374 -178.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 145.26 109.36 0.0 OUTLIER 'General case' 0 C--O 1.231 0.102 1 C-N-CA 132.274 4.23 . . . . 0.0 103.403 179.765 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -122.57 125.56 45.95 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.594 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.34 99.92 5.84 Favored 'General case' 0 N--CA 1.444 -0.774 1 N-CA-C 100.04 -4.059 . . . . 0.0 100.04 176.355 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -102.94 85.66 2.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.601 1.56 . . . . 0.0 109.23 -177.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.21 -77.48 1.36 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.7 p -130.6 -33.63 1.62 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.303 1.441 . . . . 0.0 111.633 179.402 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -74.15 101.9 4.09 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -92.67 152.37 19.58 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.933 1.293 . . . . 0.0 111.379 -178.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -150.09 137.5 19.75 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.693 1.597 . . . . 0.0 108.677 178.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.1 p -71.56 154.0 41.76 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.216 1.407 . . . . 0.0 109.554 179.189 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.33 -22.59 12.51 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.1 t -72.1 -45.08 62.03 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 124.13 0.972 . . . . 0.0 109.279 179.391 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -69.69 -34.48 74.0 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.816 0.847 . . . . 0.0 113.159 179.524 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 85' ' ' TYR . 33.0 t -64.63 -50.69 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.075 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -60.83 -44.24 97.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.791 1.636 . . . . 0.0 110.67 -178.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.03 -52.29 56.79 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.896 0.478 . . . . 0.0 110.439 -179.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.38 73.53 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.222 1.009 . . . . 0.0 111.053 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.91 -39.69 42.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.258 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -66.73 -22.3 66.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.76 -64.19 1.21 Allowed 'General case' 0 C--N 1.348 0.519 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 -178.158 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.3 -34.88 16.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.664 0.786 . . . . 0.0 112.322 177.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -59.9 4.68 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.877 1.271 . . . . 0.0 109.547 178.622 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -64.63 -21.08 66.63 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.119 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -94.19 -20.68 19.64 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.602 1.161 . . . . 0.0 112.532 -178.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.413 ' CD1' ' HG3' ' A' ' 57' ' ' GLN . 9.7 t80 -74.31 -33.29 63.16 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.309 0.959 . . . . 0.0 112.841 -179.173 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -62.27 -14.68 41.32 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -178.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 t30 72.93 69.99 0.13 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.665 1.586 . . . . 0.0 111.025 177.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -136.12 58.24 1.75 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 178.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.8 t70 74.56 163.17 0.26 Allowed 'General case' 0 C--N 1.345 0.386 0 C-N-CA 126.91 2.084 . . . . 0.0 107.69 -177.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.3 p 54.45 56.5 6.78 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -151.07 158.12 43.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.262 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.37 73.72 0.44 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.698 1.618 . . . . 0.0 112.489 -179.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.1 p -72.45 -65.37 0.79 Allowed 'General case' 0 C--N 1.341 0.234 0 CA-C-N 117.876 0.838 . . . . 0.0 109.806 179.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.3 m -137.07 -58.16 0.71 Allowed 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 125.235 1.414 . . . . 0.0 107.771 178.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.0 t -157.35 40.94 0.31 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.72 1.208 . . . . 0.0 109.671 178.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -170.55 124.43 0.62 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 127.539 2.336 . . . . 0.0 106.666 179.355 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.36 140.52 66.73 Favored 'Cis proline' 0 N--CA 1.449 -1.106 0 CA-C-N 121.453 1.555 . . . . 0.0 109.657 -2.753 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -155.47 155.62 33.81 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.972 0.909 . . . . 0.0 109.355 179.602 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.9 p -66.39 152.99 43.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.55 0.74 . . . . 0.0 110.741 179.226 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.44 121.22 6.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.909 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -95.64 177.93 5.63 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.162 0.985 . . . . 0.0 111.223 -178.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -78.89 96.05 5.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.497 1.119 . . . . 0.0 109.166 -179.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -80.93 -98.23 0.04 OUTLIER 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.379 0.672 . . . . 0.0 110.111 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -158.55 35.7 0.23 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.333 0.653 . . . . 0.0 111.342 -179.369 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.75 -153.7 9.15 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.077 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.99 69.38 6.35 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 123.463 0.705 . . . . 0.0 109.953 178.818 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -75.65 118.63 18.68 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 178.629 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.03 117.74 39.14 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 125.448 1.499 . . . . 0.0 111.048 -177.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -78.5 89.55 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.125 2.55 . . . . 0.0 109.834 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 t -135.16 -63.52 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.328 0 C-N-CA 123.871 0.868 . . . . 0.0 110.621 -178.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 p30 -148.32 -122.48 0.06 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.35 1.06 . . . . 0.0 110.344 -179.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.28 132.55 2.29 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 118.35 -1.25 . . . . 0.0 110.738 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -68.04 -166.25 2.65 Favored 'Cis proline' 0 CA--C 1.538 0.689 0 CA-C-N 120.108 1.954 . . . . 0.0 114.369 -1.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -145.45 173.52 11.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.52 1.928 . . . . 0.0 108.255 179.386 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.413 ' HG3' ' CD1' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -148.01 143.05 26.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.059 0.544 . . . . 0.0 110.825 179.31 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -100.31 148.78 24.3 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.941 1.296 . . . . 0.0 111.263 179.34 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -158.39 127.46 3.1 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -75.54 147.26 31.74 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 CA-C-N 120.522 1.222 . . . . 0.0 112.27 -176.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.683 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 3.8 tp -79.4 -161.76 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 123.438 1.59 . . . . 0.0 110.869 -178.455 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.683 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 12.2 tttm -78.62 -163.84 0.51 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 111.321 -2.672 . . . . 0.0 111.64 -178.376 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.2 p 91.48 39.78 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 130.456 3.503 . . . . 0.0 107.277 -177.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.07 -54.56 0.24 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 108.386 -1.886 . . . . 0.0 108.386 -178.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.25 157.72 10.43 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.222 0.439 . . . . 0.0 112.169 179.123 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.1 t -127.26 120.94 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.29 47.3 p90 58.17 43.36 20.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.581 2.352 . . . . 0.0 112.713 -177.935 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.4 t -148.83 -41.09 0.15 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.348 0.659 . . . . 0.0 111.194 -179.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.3 55.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.94 87.13 1.35 Allowed Glycine 0 C--N 1.339 0.749 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.0 m -59.28 142.55 86.24 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 123.929 0.892 . . . . 0.0 110.394 179.436 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.3 140.28 30.31 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.803 2.335 . . . . 0.0 108.482 176.501 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.64 -61.28 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 105.451 -3.06 . . . . 0.0 105.451 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -168.94 -55.82 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -178.656 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -62.95 109.84 1.59 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 117.959 2.577 . . . . 0.0 117.959 -177.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -129.41 153.87 47.49 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.764 0.825 . . . . 0.0 112.056 178.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.6 143.31 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 176.429 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 83.8 t -137.05 136.24 47.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -175.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.3 pt -121.69 -177.71 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.376 0 C-N-CA 124.537 1.135 . . . . 0.0 113.606 -177.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -80.93 -175.2 5.25 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.133 2.173 . . . . 0.0 109.375 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.281 8.3 t -85.41 27.68 0.8 Allowed 'General case' 0 C--N 1.342 0.24 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 -178.328 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -150.62 -67.3 0.19 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.109 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.25 -14.61 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -176.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -78.91 128.65 33.59 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -175.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.489 ' CE2' ' CG1' ' A' ' 16' ' ' VAL . 16.3 t80 -60.11 136.41 58.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.631 1.173 . . . . 0.0 111.093 -179.186 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.24 -61.84 1.5 Allowed 'General case' 0 C--N 1.345 0.397 0 C-N-CA 124.422 1.089 . . . . 0.0 111.972 -178.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.14 170.05 42.82 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.67 145.89 46.98 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 125.039 1.336 . . . . 0.0 110.021 178.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.28 162.63 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.352 1.061 . . . . 0.0 108.895 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 t -159.34 143.29 14.96 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -178.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -82.11 40.63 0.63 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -55.49 -31.32 61.92 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.946 -1.096 . . . . 0.0 113.224 -178.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.09 -69.61 0.02 OUTLIER Glycine 0 C--N 1.337 0.591 0 N-CA-C 106.614 -2.594 . . . . 0.0 106.614 178.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 50.67 -111.48 0.53 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.537 1.535 . . . . 0.0 111.546 178.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.1 m -157.13 77.3 0.87 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.456 1.502 . . . . 0.0 107.162 179.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.63 -105.34 2.39 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -101.61 22.93 11.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.333 1.053 . . . . 0.0 111.506 -179.351 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -89.86 177.46 6.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.502 0.721 . . . . 0.0 109.979 179.527 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -121.76 158.87 27.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.961 1.705 . . . . 0.0 110.899 -179.137 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.3 m -141.59 158.14 21.48 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.79 146.98 36.07 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.747 -178.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.2 t -89.5 -167.32 1.83 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.587 1.555 . . . . 0.0 107.274 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.8 m -63.66 121.27 13.52 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.749 0.419 . . . . 0.0 110.804 178.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.99 9.01 85.88 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.379 0.99 . . . . 0.0 113.917 179.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.5 m -91.93 137.57 32.26 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.434 1.117 . . . . 0.0 108.983 179.179 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 t30 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 116.458 -1.734 . . . . 0.0 110.915 179.333 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.4 t -149.68 72.02 1.12 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.447 1.099 . . . . 0.0 108.581 -179.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.56 141.71 0.05 Allowed 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 127.155 2.182 . . . . 0.0 111.163 -179.356 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -129.15 96.06 4.22 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.046 0.938 . . . . 0.0 111.48 -179.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -98.97 94.52 6.6 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 101.42 -3.548 . . . . 0.0 101.42 177.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 59.7 m -90.98 73.67 6.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.241 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.34 -99.67 1.73 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 -178.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.6 m -101.54 -39.43 7.52 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.29 1.436 . . . . 0.0 109.249 178.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.71 105.54 4.34 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.047 1.339 . . . . 0.0 108.555 -179.344 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -111.36 134.37 52.99 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.152 0.981 . . . . 0.0 112.481 -178.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.49 149.87 44.61 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.718 1.607 . . . . 0.0 107.186 178.514 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.0 m -72.72 155.24 40.18 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.317 1.047 . . . . 0.0 110.507 -179.018 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.1 -19.3 43.25 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 176.71 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.6 t -72.54 -40.79 66.45 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 124.954 1.302 . . . . 0.0 109.461 178.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -70.93 -35.23 72.15 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.029 0.532 . . . . 0.0 111.153 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.1 t -59.6 -48.31 87.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.643 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -65.74 -38.03 88.01 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.203 1.401 . . . . 0.0 111.431 179.51 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 -55.19 15.34 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 118.489 0.586 . . . . 0.0 110.168 -179.285 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.45 -31.3 70.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.073 0.949 . . . . 0.0 110.852 179.451 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.98 -44.78 46.34 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 118.905 -0.569 . . . . 0.0 111.558 179.032 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -60.62 -24.53 65.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.37 -51.53 10.67 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -178.451 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.81 -32.38 31.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.89 1.276 . . . . 0.0 110.886 177.125 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 64.3 m -70.8 -54.07 13.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.772 0.715 . . . . 0.0 110.536 178.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -58.56 -42.28 87.55 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.753 0.421 . . . . 0.0 111.162 -178.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -74.47 -44.2 52.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.485 1.114 . . . . 0.0 110.96 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 27' ' ' TYR . 2.1 t80 -55.23 -36.39 65.96 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.568 1.076 . . . . 0.0 108.789 179.034 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -71.33 -67.23 0.53 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 155.51 -6.34 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.904 2.481 . . . . 0.0 113.57 -179.068 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.01 56.02 1.9 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.738 1.153 . . . . 0.0 113.153 -178.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 138.36 115.77 0.0 OUTLIER 'General case' 0 C--N 1.344 0.349 1 C-N-CA 131.97 4.108 . . . . 0.0 108.525 178.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.3 p -95.95 63.9 2.36 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.687 0.795 . . . . 0.0 109.243 -179.462 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.39 -161.03 0.42 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.848 1.259 . . . . 0.0 110.53 -179.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 45.79 -120.47 4.43 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.394 1.949 . . . . 0.0 113.868 178.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.1 t -139.68 -92.01 0.17 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.04 0.936 . . . . 0.0 110.874 -179.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 m -161.93 -41.71 0.04 OUTLIER 'General case' 0 C--N 1.344 0.337 0 C-N-CA 124.174 0.99 . . . . 0.0 111.102 -178.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 64.2 p -79.78 37.33 0.35 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.511 1.124 . . . . 0.0 112.932 -178.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 163.4 117.62 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 131.237 3.815 . . . . 0.0 104.453 179.114 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.97 126.23 11.99 Favored 'Cis proline' 0 N--CA 1.447 -1.236 0 N-CA-C 110.273 -0.703 . . . . 0.0 110.273 0.046 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.91 147.29 27.02 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 125.342 1.457 . . . . 0.0 110.28 179.425 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.19 139.42 58.66 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.969 1.308 . . . . 0.0 112.082 179.256 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -140.2 158.48 43.98 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 123.362 0.414 . . . . 0.0 111.028 178.083 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -154.01 -179.71 8.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.724 1.21 . . . . 0.0 109.617 -178.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.2 m120 73.52 165.96 0.29 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 126.79 2.036 . . . . 0.0 112.476 178.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 61.71 72.23 0.52 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.51 1.524 . . . . 0.0 110.775 179.337 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -74.36 162.25 29.05 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.073 0.949 . . . . 0.0 110.897 -179.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -178.35 -65.58 0.07 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 179.414 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.6 164.53 11.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.165 1.786 . . . . 0.0 108.74 179.009 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -131.56 124.22 29.57 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.834 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -89.95 154.49 47.54 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.711 1.204 . . . . 0.0 110.195 -178.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -45.8 -60.16 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 124.41 3.406 . . . . 0.0 114.125 179.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.1 m -76.81 152.92 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.663 0.785 . . . . 0.0 109.884 179.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -81.6 -80.1 0.16 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.756 0.822 . . . . 0.0 110.399 -179.179 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -175.12 171.26 44.43 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 118.853 -0.971 . . . . 0.0 111.147 179.545 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.11 157.95 27.13 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 119.799 1.8 . . . . 0.0 112.847 -1.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -150.41 129.38 12.57 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.208 0.603 . . . . 0.0 109.698 -177.082 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -117.68 152.82 34.45 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -176.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -90.53 144.87 25.36 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.763 2.825 . . . . 0.0 111.041 -177.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -147.75 109.69 3.82 Favored Pre-proline 0 C--N 1.346 0.447 0 C-N-CA 123.409 0.683 . . . . 0.0 109.157 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -78.14 142.82 19.63 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.189 1.926 . . . . 0.0 115.996 -175.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.581 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 1.2 tt -122.04 -165.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-O 124.177 1.942 . . . . 0.0 111.943 179.206 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.581 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 79.6 tttt -161.55 -179.73 7.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 109.233 -3.622 . . . . 0.0 109.191 -179.319 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.5 t -87.33 62.03 6.98 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.19 67.66 0.91 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.126 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.39 101.63 0.16 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.456 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.97 133.68 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.993 0.917 . . . . 0.0 109.174 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 p90 43.8 46.09 6.39 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.152 1.781 . . . . 0.0 113.402 -178.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.8 t -150.01 163.74 37.33 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.725 0.81 . . . . 0.0 110.451 -179.499 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.87 155.63 32.14 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -178.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -179.7 86.27 0.07 OUTLIER Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -179.322 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 m -148.39 -68.95 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.458 1.103 . . . . 0.0 109.178 179.304 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.06 -45.86 0.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.082 1.854 . . . . 0.0 110.925 173.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.47 58.5 12.97 Favored Glycine 0 C--N 1.342 0.892 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.77 -58.57 1.09 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.317 1.047 . . . . 0.0 112.058 -178.381 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -56.91 109.44 0.64 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.184 2.594 . . . . 0.0 117.154 -178.031 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -147.95 122.13 9.55 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -179.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.0 m -81.13 160.67 3.92 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.662 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.4 t -141.04 126.87 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 120.789 -1.195 . . . . 0.0 108.688 -178.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.2 pt -117.28 173.93 4.06 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 C-N-CA 125.176 1.39 . . . . 0.0 113.233 -177.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -79.54 -164.94 0.71 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 124.464 1.106 . . . . 0.0 111.182 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.427 0.6 OUTLIER -96.62 37.89 1.25 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 117.193 2.294 . . . . 0.0 117.193 -178.145 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -160.52 -78.4 0.05 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.694 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.2 t -163.32 63.92 0.18 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 113.619 -1.628 . . . . 0.0 114.125 -177.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -147.07 120.17 8.83 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.394 1.452 . . . . 0.0 113.744 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -65.84 122.45 17.35 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 177.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.77 -39.37 6.68 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.69 -172.89 39.47 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.019 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.33 139.0 28.26 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.936 0.894 . . . . 0.0 109.912 179.252 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.0 pt -132.45 166.57 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.728 1.211 . . . . 0.0 110.439 -178.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.3 t -160.46 150.06 17.57 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.974 0.91 . . . . 0.0 111.664 179.357 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -79.35 55.26 1.86 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 118.453 0.57 . . . . 0.0 109.73 175.113 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.9 m -80.34 -85.39 0.09 Allowed 'General case' 0 C--N 1.342 0.259 0 O-C-N 120.766 -1.209 . . . . 0.0 109.318 179.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.31 7.03 58.55 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.688 1.137 . . . . 0.0 112.006 179.011 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.92 162.87 23.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.17 1.388 . . . . 0.0 111.203 179.234 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.6 t -66.99 -48.8 67.35 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.567 0.747 . . . . 0.0 109.833 179.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.29 -51.08 0.2 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.298 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -87.52 -46.03 9.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.23 1.012 . . . . 0.0 110.597 -179.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -70.79 -171.23 0.5 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.626 0.77 . . . . 0.0 112.379 -179.109 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -137.07 172.05 13.59 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.014 1.325 . . . . 0.0 113.553 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.8 m -140.02 161.44 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 127.659 2.384 . . . . 0.0 106.019 176.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.4 164.91 38.56 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 116.515 1.366 . . . . 0.0 116.515 -177.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.8 m -113.56 -175.08 2.59 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.76 2.024 . . . . 0.0 107.442 177.78 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.9 p -69.56 110.99 5.08 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.67 36.1 2.12 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.648 1.594 . . . . 0.0 110.078 -178.73 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.0 m -153.54 100.02 2.38 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.129 1.771 . . . . 0.0 107.129 179.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 116.782 -1.58 . . . . 0.0 108.257 -179.298 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 t -148.92 174.67 12.01 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.866 1.266 . . . . 0.0 109.654 -179.775 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.18 149.56 6.9 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.718 1.207 . . . . 0.0 113.181 -178.661 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 t -148.92 156.41 42.25 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.812 0.845 . . . . 0.0 109.31 179.287 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.99 110.95 9.42 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.254 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 93.0 m -90.62 72.97 6.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.46 -93.06 0.89 Allowed Glycine 0 C--N 1.34 0.792 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.0 p -98.99 -36.38 9.75 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.884 1.274 . . . . 0.0 110.612 179.102 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -71.24 97.59 1.58 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.668 0.787 . . . . 0.0 110.116 -178.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -82.31 151.6 26.67 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.553 1.141 . . . . 0.0 110.617 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -144.53 129.89 18.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.899 0.88 . . . . 0.0 111.015 179.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.2 p -69.67 155.97 39.69 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 125.11 1.364 . . . . 0.0 108.047 177.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.63 -22.61 62.1 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 176.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.5 t -69.2 -40.85 77.79 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -68.83 -48.45 63.49 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.095 0.958 . . . . 0.0 112.915 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.2 t -61.25 -46.99 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.195 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -64.42 -39.16 93.3 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.775 0.83 . . . . 0.0 110.719 179.169 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.42 -52.03 56.18 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.63 0.65 . . . . 0.0 110.423 -179.052 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.14 -34.14 74.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.26 0.624 . . . . 0.0 111.554 -179.468 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.81 -43.82 24.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -179.368 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -69.98 -14.81 62.88 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.72 -61.08 1.87 Allowed 'General case' 0 C--N 1.346 0.42 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.3 -36.35 14.01 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.687 1.195 . . . . 0.0 110.752 177.232 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -66.01 -63.47 1.08 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.958 1.303 . . . . 0.0 109.908 178.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -56.03 -28.88 59.25 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.537 0.735 . . . . 0.0 111.848 -178.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -79.61 -40.89 28.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.061 0.945 . . . . 0.0 111.486 179.148 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.402 ' CD2' ' CG ' ' A' ' 57' ' ' GLN . 23.9 t80 -101.25 23.88 10.3 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.799 0.84 . . . . 0.0 112.425 -178.298 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -86.0 14.6 5.95 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.942 -1.099 . . . . 0.0 112.076 179.176 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.3 m120 60.07 46.17 11.06 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.282 1.433 . . . . 0.0 111.527 178.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -154.72 73.03 0.88 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 80.62 110.67 0.07 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 127.617 2.367 . . . . 0.0 107.272 -178.128 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.6 t -87.66 -42.34 12.74 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.306 1.442 . . . . 0.0 113.332 -177.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 61.56 -171.46 0.15 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.628 1.171 . . . . 0.0 110.811 -178.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.35 167.07 39.3 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 121.96 -0.463 . . . . 0.0 112.326 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.9 t -148.99 -60.32 0.22 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.399 1.48 . . . . 0.0 107.685 179.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.4 p -124.55 -79.87 0.62 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.481 1.113 . . . . 0.0 108.125 178.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.488 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -160.39 41.65 0.18 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.233 1.013 . . . . 0.0 109.74 -179.0 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.488 ' CD1' ' C ' ' A' ' 37' ' ' THR . 43.0 m-85 -151.0 147.58 21.0 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 126.053 1.741 . . . . 0.0 107.993 -178.822 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.88 125.39 11.79 Favored 'Cis proline' 0 CA--C 1.539 0.75 0 CA-C-N 119.083 0.708 . . . . 0.0 111.726 0.219 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -119.14 165.61 13.96 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 125.994 1.717 . . . . 0.0 111.066 -179.269 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.8 p -67.8 145.83 54.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.443 0.697 . . . . 0.0 110.935 178.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -87.03 50.67 2.06 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.309 178.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -58.71 120.58 9.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.935 1.694 . . . . 0.0 108.052 179.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.7 m120 78.43 129.06 0.05 OUTLIER 'General case' 0 C--N 1.341 0.216 0 C-N-CA 126.42 1.888 . . . . 0.0 107.516 -178.223 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -82.41 20.43 1.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.346 -0.835 . . . . 0.0 112.691 -179.036 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 33.04 -99.13 0.02 OUTLIER 'General case' 0 C--N 1.347 0.485 0 C-N-CA 127.156 2.183 . . . . 0.0 112.025 179.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.45 23.16 2.84 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.572 1.082 . . . . 0.0 110.49 178.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.66 149.55 25.37 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 118.188 0.994 . . . . 0.0 111.271 -179.301 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -153.03 179.9 8.28 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.628 0.771 . . . . 0.0 111.701 -178.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -139.94 165.19 32.62 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 127.425 2.29 . . . . 0.0 106.552 -179.262 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.3 -51.86 10.14 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.435 2.756 . . . . 0.0 111.843 178.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 m -82.24 151.17 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.803 1.241 . . . . 0.0 109.338 178.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -172.36 127.22 0.54 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.742 0.817 . . . . 0.0 112.613 -178.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.99 114.84 0.02 OUTLIER Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.008 1.766 . . . . 0.0 115.798 177.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -62.8 149.72 64.31 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.084 1.942 . . . . 0.0 109.85 -2.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.13 150.18 28.82 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.538 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.402 ' CG ' ' CD2' ' A' ' 27' ' ' TYR . 63.0 mm-40 -133.4 157.82 44.57 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -178.115 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -112.01 151.04 29.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.715 2.406 . . . . 0.0 109.741 179.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -160.54 112.14 1.35 Allowed Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 177.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 24.3 Cg_endo -81.06 135.72 9.95 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.063 1.175 . . . . 0.0 111.08 -176.924 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.64 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.2 tt -109.32 178.13 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-O 124.22 1.962 . . . . 0.0 113.119 -179.419 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.64 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 19.9 ptmt -161.59 151.9 17.38 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 108.486 -3.961 . . . . 0.0 111.255 178.411 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.6 p -86.22 59.05 5.4 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.501 1.12 . . . . 0.0 108.656 179.462 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.92 71.82 0.06 OUTLIER Glycine 0 C--N 1.338 0.644 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.48 -178.83 47.64 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 123.942 0.782 . . . . 0.0 112.184 178.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.5 t -86.71 62.48 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.622 1.169 . . . . 0.0 109.924 -179.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 62.35 158.97 0.06 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.053 1.341 . . . . 0.0 114.287 178.646 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.9 p -138.53 -62.09 0.57 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.378 1.471 . . . . 0.0 108.435 178.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.38 -137.6 3.53 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.121 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.38 168.72 44.57 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.056 0.836 . . . . 0.0 113.145 178.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 m -74.11 174.5 4.89 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 125.815 1.646 . . . . 0.0 110.177 179.385 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -58.31 170.43 2.35 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.541 2.828 . . . . 0.0 112.804 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.62 -69.54 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 103.953 -3.659 . . . . 0.0 103.953 -179.331 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 170.75 -50.03 0.01 OUTLIER 'General case' 0 C--N 1.346 0.434 0 O-C-N 124.981 1.048 . . . . 0.0 113.296 -179.294 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -74.44 113.63 11.9 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 119.842 3.275 . . . . 0.0 119.842 -176.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 ptt180 -143.02 133.05 24.26 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.009 0.924 . . . . 0.0 110.552 177.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -90.48 147.04 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 178.308 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.254 78.0 t -133.61 123.83 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -176.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pt -105.75 -175.48 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.586 0 C-N-CA 126.455 1.902 . . . . 0.0 114.973 -177.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -112.82 145.21 41.02 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 128.903 2.881 . . . . 0.0 105.084 177.39 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.277 1.4 t -59.67 -16.84 29.34 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 120.783 3.623 . . . . 0.0 120.783 -177.072 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -79.61 -77.5 0.18 Allowed 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 103.625 -2.732 . . . . 0.0 103.625 178.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.53 -3.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.678 1.591 . . . . 0.0 114.598 -178.883 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.11 156.36 28.33 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 119.049 0.84 . . . . 0.0 111.151 -176.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -109.26 133.57 52.87 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.124 0.97 . . . . 0.0 110.709 -179.213 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.48 -64.84 1.08 Allowed 'General case' 0 C--N 1.342 0.268 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.042 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.25 168.4 37.0 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.183 -179.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.54 127.4 46.92 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.377 1.471 . . . . 0.0 109.638 -179.305 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 35.0 pt -120.52 154.61 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.656 1.182 . . . . 0.0 108.024 179.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.1 t -158.73 135.53 9.6 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -178.373 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -105.9 52.88 0.72 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.018 0.372 . . . . 0.0 110.685 174.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.7 t -60.12 -48.01 83.51 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.134 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.01 42.65 0.2 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.91 -40.23 11.27 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.533 1.133 . . . . 0.0 109.673 179.094 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.9 t -152.64 -51.8 0.11 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.193 1.397 . . . . 0.0 109.834 -179.512 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.82 -37.48 1.02 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -178.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -126.0 -40.9 1.98 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.753 1.621 . . . . 0.0 110.031 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -64.45 124.01 20.7 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.053 0.541 . . . . 0.0 109.553 179.457 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -79.48 162.43 25.45 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.026 1.73 . . . . 0.0 112.06 -178.594 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.2 m -137.41 164.2 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 127.922 2.489 . . . . 0.0 105.979 176.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.74 137.88 15.19 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 123.134 0.397 . . . . 0.0 112.948 -177.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.4 m -81.58 -171.18 3.17 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.33 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.0 p -72.21 123.02 22.06 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.692 -0.63 . . . . 0.0 111.271 -177.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.77 38.15 28.22 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -178.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -148.75 127.78 12.76 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.054 1.342 . . . . 0.0 108.395 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.3 t30 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 116.524 -1.703 . . . . 0.0 109.041 179.336 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.5 m -136.98 172.94 12.26 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.322 1.849 . . . . 0.0 109.202 -179.46 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.15 160.03 31.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.509 0.724 . . . . 0.0 110.645 -179.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 t -152.21 139.51 19.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.08 103.96 11.08 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 179.204 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.5 m -90.3 82.14 6.0 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.453 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.25 -111.0 3.47 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.165 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.4 t -88.31 -43.24 11.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.129 0.972 . . . . 0.0 109.64 178.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 m -69.98 106.29 3.15 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.463 1.105 . . . . 0.0 109.741 -179.294 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -86.38 157.99 19.73 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.089 0.956 . . . . 0.0 111.979 -179.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -144.3 136.8 26.71 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.624 1.17 . . . . 0.0 110.582 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.5 t -79.91 154.27 28.43 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 125.215 1.406 . . . . 0.0 109.78 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.25 -18.93 64.09 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 176.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.6 m -78.78 -38.84 37.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.014 0.925 . . . . 0.0 108.731 178.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -71.48 -48.57 48.3 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.613 1.565 . . . . 0.0 110.811 -179.201 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.4 t -58.96 -46.71 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.948 1.699 . . . . 0.0 107.571 177.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -64.89 -39.49 93.61 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 124.204 1.002 . . . . 0.0 111.412 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.26 -52.42 62.13 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.061 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.29 74.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.73 1.212 . . . . 0.0 110.921 179.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.22 -51.82 16.32 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.226 -179.205 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -60.68 -18.08 51.71 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.87 -64.71 1.12 Allowed 'General case' 0 C--N 1.347 0.5 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -178.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -43.93 -48.91 8.59 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.638 1.575 . . . . 0.0 110.495 177.494 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -55.51 -49.77 71.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 128.251 2.62 . . . . 0.0 111.268 178.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -68.11 -22.11 64.91 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.238 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -108.52 -19.47 13.43 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -179.117 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -71.87 -40.37 69.0 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -177.539 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -115.7 -28.18 6.83 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.04 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -67.57 -59.04 3.67 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.73 0.695 . . . . 0.0 110.228 -178.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 168.87 115.5 0.01 OUTLIER 'General case' 0 C--N 1.341 0.208 0 C-N-CA 128.192 2.597 . . . . 0.0 106.238 -178.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -54.85 127.25 27.7 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.341 1.057 . . . . 0.0 110.191 178.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.0 t -134.2 -51.4 0.82 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.684 0.794 . . . . 0.0 112.657 -178.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.56 172.82 8.91 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.917 0.487 . . . . 0.0 110.659 -179.426 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.87 82.27 0.52 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 107.908 -2.077 . . . . 0.0 107.908 179.056 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 p -168.14 101.35 0.45 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -176.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.5 p -128.63 -50.88 1.26 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.903 0.881 . . . . 0.0 109.678 -178.454 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 p -79.5 -6.34 56.75 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.572 0.749 . . . . 0.0 109.183 178.337 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -157.5 121.84 2.27 Favored Pre-proline 0 C--N 1.343 0.319 0 C-N-CA 128.147 2.579 . . . . 0.0 104.375 177.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.22 147.66 49.28 Favored 'Cis proline' 0 N--CA 1.453 -0.886 0 N-CA-C 117.468 2.065 . . . . 0.0 117.468 -0.091 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.98 136.7 37.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 128.162 2.585 . . . . 0.0 105.386 178.691 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.7 m -56.63 127.87 33.55 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.753 1.221 . . . . 0.0 110.067 179.078 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -79.85 78.24 6.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.561 1.144 . . . . 0.0 110.242 -178.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -80.66 -17.69 50.39 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.19 0.996 . . . . 0.0 112.535 179.46 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -79.33 149.89 31.61 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.683 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -168.43 89.68 0.25 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.681 1.992 . . . . 0.0 107.468 178.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -150.37 55.26 0.92 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.168 0.987 . . . . 0.0 108.689 179.818 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.07 -64.88 0.58 Allowed Glycine 0 C--N 1.338 0.651 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -179.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -99.92 132.92 44.98 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.401 1.08 . . . . 0.0 110.767 179.312 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -178.7 154.3 0.74 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 126.438 1.895 . . . . 0.0 109.428 178.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -123.26 105.37 34.05 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.503 1.121 . . . . 0.0 109.738 -178.087 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.23 84.83 1.93 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.519 2.812 . . . . 0.0 110.49 179.169 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.49 -72.64 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.226 0 C-N-CA 124.476 1.11 . . . . 0.0 110.908 179.191 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -133.71 -90.01 0.38 Allowed 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.516 0.598 . . . . 0.0 111.562 -179.114 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.81 131.97 4.28 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -178.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -71.98 -177.89 18.8 Favored 'Cis proline' 0 N--CA 1.456 -0.7 0 CA-C-N 119.686 1.743 . . . . 0.0 111.699 1.238 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.05 173.25 11.66 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.182 1.793 . . . . 0.0 106.231 179.184 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.4 146.32 22.43 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -178.666 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -81.25 156.14 25.75 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 126.575 1.95 . . . . 0.0 112.397 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -160.87 102.1 1.29 Allowed Pre-proline 0 N--CA 1.452 -0.333 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -77.82 115.2 3.78 Favored 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 122.674 2.25 . . . . 0.0 111.802 -177.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.537 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 6.4 tt -89.64 173.76 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-O 123.767 1.746 . . . . 0.0 111.747 -179.095 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.537 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 63.2 pttt -160.45 151.86 19.44 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 109.849 -3.341 . . . . 0.0 112.213 179.114 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 t -88.68 58.95 4.88 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.932 1.293 . . . . 0.0 110.126 -179.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 169.05 34.37 0.02 OUTLIER Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.177 -0.791 . . . . 0.0 112.858 179.182 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.97 176.63 17.2 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 118.014 0.907 . . . . 0.0 112.807 179.111 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.6 t -95.35 144.9 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.345 1.858 . . . . 0.0 107.932 179.333 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.6 p90 56.92 -172.95 0.08 Allowed 'General case' 0 C--N 1.345 0.401 0 C-N-CA 126.76 2.024 . . . . 0.0 113.118 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.8 t -137.34 166.79 22.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.707 1.203 . . . . 0.0 110.696 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.89 133.71 8.93 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.048 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.2 -64.52 4.18 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.36 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.5 p -164.6 168.26 9.19 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.618 1.167 . . . . 0.0 109.489 -179.18 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -58.57 -170.52 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.131 3.221 . . . . 0.0 112.521 167.251 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.0 -55.37 0.07 OUTLIER Glycine 0 C--N 1.341 0.856 0 N-CA-C 105.276 -3.129 . . . . 0.0 105.276 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.03 -63.52 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.637 0.775 . . . . 0.0 110.472 179.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -70.72 126.01 28.42 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.038 1.735 . . . . 0.0 113.961 -178.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -145.28 126.35 14.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.18 0.992 . . . . 0.0 111.747 -179.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.9 m -91.69 147.69 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 176.672 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.3 t -136.08 115.9 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -177.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.5 pt -89.92 -178.89 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.652 0 C-N-CA 124.506 1.123 . . . . 0.0 112.892 -178.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -124.49 58.34 1.22 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 124.678 2.18 . . . . 0.0 112.549 -177.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.258 5.9 t 46.58 -21.31 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.245 1 C-N-CA 134.571 5.148 . . . . 0.0 121.707 177.499 . . . . . . . . 3 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -79.47 -74.16 0.31 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 178.786 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.47 -13.74 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.627 1.971 . . . . 0.0 114.078 -179.207 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -79.47 125.53 29.67 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.777 1.231 . . . . 0.0 113.795 -176.385 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -68.46 115.9 8.39 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.643 2.377 . . . . 0.0 109.453 178.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.26 -60.68 2.23 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 124.741 1.216 . . . . 0.0 111.239 -178.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.57 156.77 28.93 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.375 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.99 137.27 52.26 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.1 0.96 . . . . 0.0 109.273 -179.252 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.3 pt -125.43 156.77 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.3 1.44 . . . . 0.0 107.824 -179.455 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.439 ' HG1' ' H ' ' A' ' 92' ' ' THR . 14.8 t -158.85 150.05 20.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.752 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -79.03 -21.57 46.69 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 123.423 0.452 . . . . 0.0 111.251 176.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.439 ' H ' ' HG1' ' A' ' 90' ' ' THR . 24.3 m -59.65 109.03 0.82 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.032 1.333 . . . . 0.0 109.91 179.287 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.78 -29.49 8.9 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.762 1.172 . . . . 0.0 111.329 -179.236 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.4 -176.45 2.69 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.667 1.187 . . . . 0.0 111.95 -179.294 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -83.65 54.98 3.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.686 1.194 . . . . 0.0 111.614 -179.416 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.69 -74.47 1.55 Allowed Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.606 1.098 . . . . 0.0 113.055 178.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -80.05 -44.77 19.51 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.863 1.265 . . . . 0.0 111.03 -179.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -51.52 166.58 0.12 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.835 1.654 . . . . 0.0 113.459 -178.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -121.3 156.65 32.08 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.339 1.456 . . . . 0.0 112.308 -178.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.5 m -144.56 164.67 13.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 126.844 2.058 . . . . 0.0 107.139 177.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.75 138.76 14.54 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 123.679 0.657 . . . . 0.0 112.082 -178.261 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 34.0 m -82.24 -171.39 3.4 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.498 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.1 t -75.83 123.08 25.06 Favored 'General case' 0 C--N 1.341 0.197 0 O-C-N 121.833 -0.542 . . . . 0.0 109.611 -179.026 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.62 52.15 3.25 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -178.755 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.8 m -147.41 121.39 9.4 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.614 1.566 . . . . 0.0 106.833 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.7 t30 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 125.307 1.443 . . . . 0.0 110.685 -179.247 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 121.066 0.46 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -153.85 176.05 12.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.049 1.34 . . . . 0.0 109.057 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.81 148.17 25.99 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.228 1.011 . . . . 0.0 109.857 179.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 t -150.18 156.27 41.29 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.66 128.5 42.72 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.249 1.82 . . . . 0.0 106.186 178.754 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -116.72 90.08 3.25 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.46 -86.4 1.03 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -178.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.1 m -127.77 -16.05 4.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.642 1.577 . . . . 0.0 111.364 178.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -81.55 98.55 8.36 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.182 0.993 . . . . 0.0 109.627 -179.164 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -80.08 155.8 27.37 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.112 0.965 . . . . 0.0 110.685 179.449 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -147.06 141.45 26.37 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.924 1.29 . . . . 0.0 110.782 179.294 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 p -78.21 148.38 34.02 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 177.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.61 -23.37 16.75 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.182 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.0 t -67.63 -44.52 77.77 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.54 0.736 . . . . 0.0 109.603 179.451 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -69.6 -41.03 76.27 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -178.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.402 HG13 ' CE2' ' A' ' 85' ' ' TYR . 2.2 t -61.75 -54.59 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -179.449 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.8 mtp85 -66.78 -34.92 78.88 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.795 1.238 . . . . 0.0 112.225 -178.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.79 -44.34 86.03 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 118.768 0.713 . . . . 0.0 109.737 179.366 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.19 80.48 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.08 0.552 . . . . 0.0 110.155 178.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.26 -40.46 62.33 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 119.109 -0.472 . . . . 0.0 112.252 178.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -66.01 -21.05 66.37 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.39 1.68 Allowed 'General case' 0 C--N 1.344 0.363 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -46.4 -44.22 16.97 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 124.376 1.047 . . . . 0.0 110.83 176.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.7 t -55.02 -51.17 67.1 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.045 1.738 . . . . 0.0 111.361 179.243 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -63.99 -48.41 76.49 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.629 0.65 . . . . 0.0 112.012 -178.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -68.84 -32.58 72.37 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -63.75 -39.05 93.33 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.443 0.565 . . . . 0.0 111.626 -178.061 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -99.82 -49.18 4.44 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -178.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -75.46 -45.58 37.69 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -176.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -158.36 94.05 1.26 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.593 0.633 . . . . 0.0 110.609 -178.014 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.37 104.95 2.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.43 179.352 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.257 5.0 t 165.0 83.26 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.691 2.796 . . . . 0.0 110.812 -179.218 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -177.69 103.6 0.05 OUTLIER 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.493 1.517 . . . . 0.0 107.423 179.12 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 153.19 -179.24 29.75 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.1 m -50.41 -52.04 41.15 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.954 1.301 . . . . 0.0 112.117 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.3 t -165.22 -61.56 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.856 0.862 . . . . 0.0 108.742 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -126.94 75.97 1.61 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.024 1.33 . . . . 0.0 108.309 -179.514 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.455 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 86.3 m-85 -157.68 111.15 1.81 Allowed Pre-proline 0 C--O 1.23 0.053 0 N-CA-C 102.524 -3.139 . . . . 0.0 102.524 179.073 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.98 142.18 63.64 Favored 'Cis proline' 0 CA--C 1.536 0.611 0 N-CA-C 116.37 1.642 . . . . 0.0 116.37 2.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -157.77 152.92 25.73 Favored 'General case' 0 C--N 1.345 0.37 0 C-N-CA 127.238 2.215 . . . . 0.0 109.895 178.238 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 p -41.73 138.89 1.32 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 126.307 1.843 . . . . 0.0 114.233 -178.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -138.97 59.04 1.63 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.332 1.453 . . . . 0.0 108.399 179.308 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -154.62 2.02 0.21 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.919 0.888 . . . . 0.0 112.882 -179.158 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -63.99 -52.43 59.67 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.543 0.737 . . . . 0.0 110.188 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -109.83 127.55 54.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.041 1.337 . . . . 0.0 108.317 178.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -85.89 164.34 17.53 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.834 0.854 . . . . 0.0 109.704 179.408 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.38 -77.88 0.36 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 107.052 -2.419 . . . . 0.0 107.052 -179.231 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.99 89.46 8.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.751 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -147.39 143.08 27.7 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.482 1.513 . . . . 0.0 108.26 179.501 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -95.44 154.16 39.4 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 125.073 1.349 . . . . 0.0 109.989 -178.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.83 81.81 2.09 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.37 3.38 . . . . 0.0 111.425 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.4 169.7 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 125.927 1.691 . . . . 0.0 108.559 179.459 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -92.34 121.17 33.57 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.42 -177.45 51.91 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.651 0.643 . . . . 0.0 112.961 -179.041 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.99 161.35 87.03 Favored 'Cis proline' 0 CA--C 1.534 0.502 0 CA-C-N 117.536 0.668 . . . . 0.0 113.789 0.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.47 153.86 50.93 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 126.332 1.853 . . . . 0.0 106.746 178.788 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.74 153.35 47.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 123.703 0.627 . . . . 0.0 111.536 -178.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -84.48 163.81 19.2 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -160.4 110.1 1.36 Allowed Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 178.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.455 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 23.0 Cg_endo -80.35 125.95 5.96 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.906 1.737 . . . . 0.0 114.989 -175.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.469 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 9.3 tt -87.79 159.1 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-O 124.45 2.071 . . . . 0.0 112.668 179.014 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.469 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.1 mptp? -135.62 135.88 40.56 Favored 'General case' 0 C--N 1.316 -0.868 1 CA-C-N 107.974 -4.194 . . . . 0.0 109.486 -177.991 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t -87.52 59.82 5.68 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.094 1.358 . . . . 0.0 109.993 -179.179 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.36 50.41 0.03 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.251 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.0 153.32 26.32 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.621 1.105 . . . . 0.0 110.378 -179.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.5 p -74.3 115.47 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.276 1.03 . . . . 0.0 110.868 -179.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.0 t80 53.15 76.95 0.18 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 125.535 1.534 . . . . 0.0 110.677 -179.26 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.0 p -138.73 64.02 1.5 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.468 1.107 . . . . 0.0 110.515 -178.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.11 -86.91 0.89 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.96 0.79 . . . . 0.0 111.97 178.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.83 -93.58 0.4 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.458 1.028 . . . . 0.0 110.613 -179.072 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.8 t 74.48 133.1 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 127.066 2.146 . . . . 0.0 111.593 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -67.72 -51.71 0.16 OUTLIER 'Cis proline' 0 C--N 1.348 0.532 0 CA-C-N 119.731 0.94 . . . . 0.0 112.042 -5.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.96 61.27 0.19 Allowed Glycine 0 C--N 1.341 0.856 0 C-N-CA 124.517 1.056 . . . . 0.0 111.594 179.379 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.06 -41.86 27.79 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.559 0.743 . . . . 0.0 109.05 178.441 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -70.3 111.49 5.93 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.085 1.754 . . . . 0.0 112.426 -178.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.05 128.88 46.99 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.959 0.903 . . . . 0.0 113.048 -178.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.0 m -100.34 148.36 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 102.595 -3.113 . . . . 0.0 102.595 176.04 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.5 t -140.13 135.96 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 O-C-N 121.873 -0.517 . . . . 0.0 109.651 -176.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.5 pt -126.46 165.55 24.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.308 0 C-N-CA 124.107 0.963 . . . . 0.0 111.865 -178.683 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -81.35 165.97 20.88 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 127.268 2.227 . . . . 0.0 108.186 178.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.356 12.2 t -64.77 -19.71 65.96 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 118.634 2.827 . . . . 0.0 118.634 -178.128 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -79.59 -85.54 0.08 Allowed 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 101.067 -3.679 . . . . 0.0 101.067 176.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 98.3 m -164.57 8.14 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 130.438 3.495 . . . . 0.0 112.832 -178.703 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -78.86 134.65 36.92 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 120.171 1.351 . . . . 0.0 111.798 -176.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.402 ' CE2' HG13 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -70.84 120.18 16.05 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.873 0.469 . . . . 0.0 110.09 -178.952 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.64 -48.95 7.86 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.178 0.991 . . . . 0.0 110.175 -179.082 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.12 -179.48 46.36 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-O 121.16 0.311 . . . . 0.0 112.686 179.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.0 135.24 45.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.842 2.057 . . . . 0.0 107.771 179.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.4 pt -146.61 171.67 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.785 1.234 . . . . 0.0 110.553 -178.392 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.5 t -160.06 151.77 20.03 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 179.349 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -79.28 -13.12 59.86 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 175.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.4 m -60.92 109.17 0.99 Allowed 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.003 1.321 . . . . 0.0 110.295 -179.333 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.5 59.46 5.27 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.407 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.52 -124.65 0.22 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.709 1.204 . . . . 0.0 108.558 179.467 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.5 m -149.16 73.17 1.19 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.793 1.237 . . . . 0.0 107.95 179.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.72 -104.86 1.61 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 179.587 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -79.8 -22.72 42.75 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.114 0.966 . . . . 0.0 111.18 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -56.16 159.07 3.62 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.577 1.151 . . . . 0.0 111.35 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -114.74 163.51 15.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.96 1.704 . . . . 0.0 111.854 -178.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.4 m -141.07 160.85 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 C-N-CA 126.228 1.811 . . . . 0.0 107.092 176.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.02 141.2 20.65 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 123.838 0.732 . . . . 0.0 114.158 -178.092 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -83.35 179.73 7.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 177.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.9 m -70.31 131.04 43.54 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.205 -0.935 . . . . 0.0 110.598 179.566 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.17 15.72 80.98 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.032 0.825 . . . . 0.0 113.712 179.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.3 m -80.01 131.71 35.85 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.323 1.061 . . . . 0.0 108.695 179.306 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 p30 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.816 -1.088 . . . . 0.0 110.558 -179.309 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.9 m -135.37 62.87 1.62 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.32 1.048 . . . . 0.0 109.446 -179.346 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.31 154.35 0.13 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 126.831 2.052 . . . . 0.0 112.52 179.015 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.4 t -152.81 123.43 7.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.573 179.066 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -96.79 109.74 22.36 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 178.901 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.8 m -87.7 63.21 7.41 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.468 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.55 -91.54 0.4 Allowed Glycine 0 C--N 1.342 0.886 0 C-N-CA 126.03 1.776 . . . . 0.0 109.08 -178.761 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.3 p -92.82 -47.98 6.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.396 1.079 . . . . 0.0 109.817 179.13 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.2 m -66.83 100.01 0.67 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.488 1.515 . . . . 0.0 108.168 179.388 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -88.4 148.2 24.35 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.12 0.568 . . . . 0.0 111.978 -178.783 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -136.44 135.74 38.93 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 123.996 0.918 . . . . 0.0 111.249 178.606 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.7 m -82.46 150.34 27.1 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 126.571 1.948 . . . . 0.0 108.647 178.62 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.61 -21.86 29.95 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.137 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 84.2 p -72.96 -46.71 50.82 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.565 0.746 . . . . 0.0 109.529 179.455 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -69.08 -38.72 79.17 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.761 1.224 . . . . 0.0 111.418 -179.307 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.3 t -57.98 -53.19 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.836 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -33.37 75.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.67 1.588 . . . . 0.0 112.032 -179.336 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.11 -57.63 8.11 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.018 0.527 . . . . 0.0 109.725 -178.678 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.84 -26.75 67.8 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 123.538 0.523 . . . . 0.0 110.953 -179.295 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.01 -54.03 12.67 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.867 0.758 . . . . 0.0 111.035 179.248 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -61.2 -19.91 62.16 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.191 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.73 -67.95 0.62 Allowed 'General case' 0 C--N 1.349 0.574 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 -178.085 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.448 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . . . -39.54 -46.07 1.68 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.625 1.17 . . . . 0.0 112.19 176.532 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 74.4 m -55.28 -68.49 0.19 Allowed 'General case' 0 C--N 1.346 0.417 0 C-N-CA 123.379 0.672 . . . . 0.0 110.342 179.366 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -53.81 -31.09 47.79 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.833 1.253 . . . . 0.0 112.928 -176.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -79.49 -48.0 14.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -179.066 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.37 0.1 OUTLIER -91.85 -2.58 56.79 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 119.381 3.104 . . . . 0.0 119.381 -176.539 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -57.04 -52.48 65.12 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.011 1.278 . . . . 0.0 109.382 178.975 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 152.03 66.14 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 130.438 3.495 . . . . 0.0 105.561 179.553 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -165.32 98.38 0.71 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.551 1.14 . . . . 0.0 107.984 -178.915 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.266 4.4 p30 52.27 -165.92 0.06 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.236 1.815 . . . . 0.0 111.982 -179.203 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.1 t -152.57 -49.12 0.1 Allowed 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.646 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 55.82 84.07 0.08 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 125.063 1.345 . . . . 0.0 109.396 -178.238 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.23 162.48 6.03 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.24 1.4 . . . . 0.0 111.849 -178.856 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.1 p -176.98 102.84 0.05 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.979 1.311 . . . . 0.0 108.915 -179.231 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.8 m -68.64 -67.46 0.47 Allowed 'General case' 0 C--N 1.34 0.167 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.895 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.6 p -147.45 18.91 1.19 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.468 1.907 . . . . 0.0 108.502 178.008 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -144.34 154.95 57.73 Favored Pre-proline 0 C--N 1.348 0.528 0 C-N-CA 129.798 3.239 . . . . 0.0 105.95 -178.297 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -80.38 111.41 2.24 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 CA-C-N 120.932 1.369 . . . . 0.0 113.58 3.855 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -122.27 158.86 28.58 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.426 1.491 . . . . 0.0 108.441 179.114 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -63.26 154.84 30.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.701 1.6 . . . . 0.0 108.617 178.755 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -77.97 119.78 21.9 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.296 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.27 145.91 10.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.937 2.095 . . . . 0.0 114.2 -178.152 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -73.44 148.17 43.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.381 1.472 . . . . 0.0 110.1 179.495 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.7 t80 74.22 146.15 0.08 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.764 2.025 . . . . 0.0 110.972 179.411 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 58.35 53.0 6.7 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.568 1.147 . . . . 0.0 108.933 -178.599 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.23 106.84 2.03 Favored Glycine 0 C--N 1.339 0.729 0 C-N-CA 124.751 1.167 . . . . 0.0 112.324 -178.698 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -73.31 106.99 5.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 178.494 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -53.88 120.99 7.05 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.069 1.347 . . . . 0.0 113.109 -178.4 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -132.75 151.96 79.03 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.351 1.861 . . . . 0.0 108.217 179.081 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.57 166.98 28.3 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.505 2.803 . . . . 0.0 112.464 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.273 22.9 m 55.03 171.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 129.03 2.932 . . . . 0.0 115.445 179.321 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -81.2 153.59 27.11 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.971 1.308 . . . . 0.0 111.999 -178.847 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.77 -147.73 23.1 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.527 1.537 . . . . 0.0 110.251 179.202 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.39 133.21 17.27 Favored 'Cis proline' 0 N--CA 1.458 -0.605 0 CA-C-N 118.847 1.324 . . . . 0.0 110.031 -1.782 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -108.62 140.53 41.87 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.935 0.894 . . . . 0.0 111.847 179.343 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -122.91 159.17 28.79 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.051 1.741 . . . . 0.0 109.613 -179.027 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -87.7 159.59 18.44 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.561 1.544 . . . . 0.0 111.928 -178.553 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 23' ' ' ALA . 18.4 t80 -160.41 109.74 1.36 Allowed Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.267 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -79.11 129.65 8.93 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 121.88 1.72 . . . . 0.0 111.151 -177.178 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.676 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.2 tt -87.71 -176.83 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-O 123.796 1.76 . . . . 0.0 110.237 179.096 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.676 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -152.52 141.24 20.94 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 110.07 -3.241 . . . . 0.0 111.623 -179.095 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 t -81.41 57.73 3.38 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.948 1.699 . . . . 0.0 109.942 179.647 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.21 45.54 0.08 OUTLIER Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.282 1.42 . . . . 0.0 112.008 179.059 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.76 176.36 26.08 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 117.884 0.842 . . . . 0.0 112.782 179.052 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 t -132.15 139.06 51.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.322 1.449 . . . . 0.0 108.278 178.961 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.263 26.4 p90 46.42 52.51 10.68 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.351 2.261 . . . . 0.0 114.487 179.473 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.9 p -80.49 -44.34 19.34 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.837 -0.539 . . . . 0.0 110.184 179.06 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.2 56.77 1.44 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.09 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -117.33 73.44 0.28 Allowed Glycine 0 C--N 1.34 0.793 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.485 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 92.0 p -71.17 152.16 94.6 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 124.082 0.953 . . . . 0.0 110.717 -179.938 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.98 -43.17 0.69 Allowed 'Cis proline' 0 N--CA 1.457 -0.672 0 CA-C-N 119.196 0.748 . . . . 0.0 110.904 -4.129 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.87 -54.61 3.7 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 179.187 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.427 ' HB3' ' CB ' ' A' ' 91' ' ' HIS . . . 64.3 43.97 4.52 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.632 1.173 . . . . 0.0 110.312 -178.678 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.83 101.19 1.29 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.641 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.28 148.56 50.82 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.251 0.621 . . . . 0.0 111.398 -179.032 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.1 m -111.26 144.32 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 176.909 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.17 121.83 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 -177.673 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 pt -127.12 167.84 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.615 -176.517 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -94.31 166.99 11.82 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 123.996 0.918 . . . . 0.0 110.809 -179.641 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.432 1.9 t -73.29 8.51 1.67 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 121.396 3.851 . . . . 0.0 121.396 -177.07 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -91.05 -94.88 0.12 Allowed 'General case' 0 N--CA 1.437 -1.101 1 N-CA-C 93.486 -6.487 . . . . 0.0 93.486 174.859 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . 0.353 9.8 t -165.93 54.29 0.1 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 127.634 2.374 . . . . 0.0 111.44 176.955 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -136.06 127.64 28.82 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 120.186 1.357 . . . . 0.0 112.957 -178.063 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.2 121.61 17.14 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 127.264 2.226 . . . . 0.0 108.138 179.055 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.63 -54.55 2.6 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 123.552 0.741 . . . . 0.0 111.774 -178.605 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -119.15 155.32 16.11 Favored Glycine 0 C--N 1.341 0.853 0 C-N-CA 124.428 1.014 . . . . 0.0 113.907 -178.72 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.91 102.07 3.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 178.539 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.9 pt -112.75 157.05 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.903 0.881 . . . . 0.0 111.633 -178.293 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.2 t -155.89 155.32 32.67 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.083 1.353 . . . . 0.0 112.197 -178.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.427 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 38.6 m170 -80.34 3.78 20.01 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 119.156 -0.45 . . . . 0.0 110.954 177.208 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -43.64 -39.59 3.65 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -177.671 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.46 44.44 1.22 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.573 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -110.83 155.16 22.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.315 1.446 . . . . 0.0 110.924 -179.769 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.8 t -89.84 61.29 5.3 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.536 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.9 -86.93 0.96 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.659 1.123 . . . . 0.0 112.381 179.028 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -96.91 -6.17 36.35 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -178.073 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -69.26 -173.44 0.54 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.191 0.905 . . . . 0.0 110.592 -179.401 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -147.0 153.89 40.59 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.182 0.593 . . . . 0.0 111.379 -178.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.1 m -142.55 163.66 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 126.483 1.913 . . . . 0.0 107.57 178.129 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.85 152.35 28.54 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.701 0.667 . . . . 0.0 114.056 -177.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 51.8 m -87.71 -168.27 2.17 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.92 1.288 . . . . 0.0 108.331 178.191 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.2 t -68.35 112.92 5.51 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.036 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.58 50.21 4.31 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.258 0.932 . . . . 0.0 110.802 -179.201 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.4 m -147.9 97.75 2.85 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.06 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 116.585 -1.674 . . . . 0.0 108.833 -179.385 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.1 t -160.45 98.23 1.25 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.134 0.974 . . . . 0.0 109.705 -179.015 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 54.69 81.13 0.11 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 125.533 1.533 . . . . 0.0 109.29 -179.405 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.5 t -105.35 138.12 42.05 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.362 0.665 . . . . 0.0 111.977 -177.37 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.94 125.34 52.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.292 1.837 . . . . 0.0 109.773 179.405 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -105.87 71.27 0.89 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 178.841 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.17 -80.73 1.49 Allowed Glycine 0 C--N 1.342 0.889 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 -178.868 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.1 t -123.64 -30.49 3.6 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.975 1.71 . . . . 0.0 110.757 178.943 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 m -70.36 92.0 0.78 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.126 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -89.15 145.06 25.68 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.477 1.511 . . . . 0.0 114.074 -177.819 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -141.48 134.93 29.71 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.243 1.417 . . . . 0.0 111.682 178.376 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.6 m -72.32 156.57 38.96 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 126.057 1.743 . . . . 0.0 108.618 177.677 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.21 -22.88 44.01 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.029 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 98.3 p -76.45 -34.45 58.72 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.916 -179.143 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -75.55 -38.21 59.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.418 1.487 . . . . 0.0 111.617 -179.526 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.1 t -63.42 -47.99 89.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.264 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -64.15 -32.1 73.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.7 1.6 . . . . 0.0 111.532 179.094 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.34 -56.65 7.8 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.078 0.551 . . . . 0.0 109.888 -179.081 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.5 -27.86 68.11 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 123.105 0.253 . . . . 0.0 110.551 179.656 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.34 -44.68 67.7 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.299 -0.876 . . . . 0.0 110.088 178.586 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -68.83 -17.51 64.02 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.338 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.32 -69.24 0.57 Allowed 'General case' 0 C--N 1.346 0.424 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 -178.387 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.487 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . . . -38.1 -58.13 0.99 Allowed 'General case' 0 CA--C 1.537 0.463 0 O-C-N 124.527 1.142 . . . . 0.0 112.438 175.93 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.5 t -56.23 -40.9 74.81 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 123.835 0.854 . . . . 0.0 112.668 -178.952 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -87.24 -2.96 59.0 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 179.442 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -117.26 -63.15 1.48 Allowed 'General case' 0 C--N 1.347 0.5 0 CA-C-N 120.163 1.347 . . . . 0.0 114.097 -178.616 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -49.98 -42.2 48.41 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.894 1.278 . . . . 0.0 111.99 -177.036 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -103.85 14.11 31.51 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -177.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -154.51 62.95 0.68 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.176 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 63.24 91.03 0.07 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.174 1.79 . . . . 0.0 109.206 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -57.06 112.69 1.42 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.556 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.9 t -97.65 -34.63 10.87 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.348 1.459 . . . . 0.0 107.593 178.284 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.53 97.9 7.36 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.512 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -142.49 52.07 0.66 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.359 0.98 . . . . 0.0 111.155 -179.088 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 m -71.95 -53.06 14.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.501 0.72 . . . . 0.0 109.789 178.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.5 m -111.38 -162.07 0.78 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.037 1.335 . . . . 0.0 107.98 -179.063 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.4 t -83.08 49.9 1.63 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.98 0.912 . . . . 0.0 109.747 179.145 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -140.79 142.82 29.68 Favored Pre-proline 0 C--N 1.342 0.257 0 C-N-CA 126.311 1.845 . . . . 0.0 106.638 -179.026 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -69.6 145.68 79.73 Favored 'Cis proline' 0 CA--C 1.535 0.56 0 N-CA-C 115.053 1.136 . . . . 0.0 115.053 2.917 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.57 140.2 49.39 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -177.514 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.3 m -57.12 120.07 7.41 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 127.359 2.263 . . . . 0.0 110.564 178.983 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -79.43 99.56 7.25 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.656 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -140.53 61.83 1.5 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.215 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -105.63 -178.67 3.72 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.231 1.412 . . . . 0.0 109.183 -179.584 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -67.78 102.92 1.31 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.954 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.3 144.21 42.07 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.575 0.75 . . . . 0.0 111.501 -179.102 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.68 68.28 0.16 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 107.849 -2.101 . . . . 0.0 107.849 -178.938 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -162.65 173.01 14.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.51 1.124 . . . . 0.0 109.331 -179.627 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -59.93 162.85 5.11 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.591 1.156 . . . . 0.0 111.171 178.904 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 49.4 p90 44.65 53.7 11.63 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 126.239 1.816 . . . . 0.0 113.134 -179.345 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.75 -47.74 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.606 2.204 . . . . 0.0 110.834 -179.239 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.4 t 57.58 -100.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.768 1.627 . . . . 0.0 109.995 -179.577 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 p30 178.8 -45.61 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.437 1.895 . . . . 0.0 108.952 -179.382 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.89 -158.83 41.2 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.781 0.705 . . . . 0.0 112.362 179.199 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.01 130.35 1.67 Allowed 'Cis proline' 0 N--CA 1.46 -0.472 0 CA-C-N 118.372 1.086 . . . . 0.0 113.423 1.549 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -134.25 141.93 47.16 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.834 0.854 . . . . 0.0 109.412 179.391 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -132.07 164.94 25.13 Favored 'General case' 0 C--N 1.344 0.359 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -177.372 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -79.86 153.25 29.19 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.934 2.093 . . . . 0.0 112.059 -178.942 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.487 ' CD2' ' HB3' ' A' ' 23' ' ' ALA . 52.5 t80 -160.39 106.43 1.36 Allowed Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 178.731 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -67.71 141.96 56.46 Favored 'Trans proline' 0 N--CA 1.441 -1.584 0 CA-C-N 120.302 1.144 . . . . 0.0 110.676 -176.81 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.472 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -90.03 -145.21 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-O 122.972 1.368 . . . . 0.0 111.972 -177.607 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.472 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 36.0 ttpt -79.77 149.51 31.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.381 -179.022 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.0 t 170.09 48.28 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.455 1 C-N-CA 132.088 4.155 . . . . 0.0 103.641 178.482 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.58 -46.26 1.07 Allowed Glycine 0 CA--C 1.534 1.229 0 N-CA-C 105.984 -2.846 . . . . 0.0 105.984 -177.45 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.4 165.22 25.43 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.433 1.016 . . . . 0.0 111.742 178.68 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.59 131.31 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.514 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.9 t80 57.2 83.34 0.11 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.703 1.201 . . . . 0.0 110.845 -179.381 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.5 p -131.54 -48.61 0.98 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.465 1.106 . . . . 0.0 111.753 -179.076 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.56 51.78 3.18 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -178.782 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.16 47.69 0.07 OUTLIER Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.533 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.5 t -69.52 -59.58 4.68 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.376 1.07 . . . . 0.0 111.252 179.567 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -82.32 -26.18 9.15 Favored 'Cis proline' 0 C--N 1.347 0.483 0 CA-C-N 121.573 1.597 . . . . 0.0 112.246 -6.2 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.29 -160.49 22.56 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.562 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.568 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . 69.21 21.71 7.03 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 126.349 1.86 . . . . 0.0 112.331 -178.912 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.4 91.69 0.61 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.986 1.314 . . . . 0.0 107.926 179.099 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.8 mtt85 -138.3 134.05 33.83 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.334 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 m -93.74 153.05 3.43 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 177.065 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.96 120.11 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -178.867 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -110.48 174.04 2.05 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 C-N-CA 125.015 1.326 . . . . 0.0 114.073 -177.645 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -100.55 154.62 18.41 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.755 2.422 . . . . 0.0 108.544 179.054 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.283 3.3 t -71.92 0.93 8.0 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -178.599 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -86.0 -83.22 0.18 Allowed 'General case' 0 N--CA 1.441 -0.888 1 N-CA-C 100.115 -4.031 . . . . 0.0 100.115 177.07 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.7 t -165.08 -4.29 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.295 2.238 . . . . 0.0 114.157 177.619 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -79.35 130.59 35.59 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -175.098 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -78.64 117.89 20.23 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.82 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.59 -59.73 2.63 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.344 0.658 . . . . 0.0 111.862 -177.557 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.45 156.83 17.82 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 179.61 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.49 155.27 18.38 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.588 1.155 . . . . 0.0 111.748 -179.249 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.5 pt -136.62 165.3 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 125.241 1.416 . . . . 0.0 110.802 179.28 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.1 t -159.32 144.84 16.0 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.666 0.786 . . . . 0.0 112.787 -178.774 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.568 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -82.42 -37.24 25.78 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.618 0.767 . . . . 0.0 111.073 177.892 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 m -49.97 -55.97 12.5 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.479 1.512 . . . . 0.0 112.367 -178.756 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -63.47 -27.0 70.15 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.108 0.861 . . . . 0.0 112.637 -179.58 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.39 178.76 6.91 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.288 1.035 . . . . 0.0 112.579 -178.925 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.9 m -65.59 -45.89 81.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.512 1.125 . . . . 0.0 110.54 179.07 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.05 -80.62 0.06 OUTLIER Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.466 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -79.53 -17.83 53.19 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.182 0.993 . . . . 0.0 112.039 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -79.74 163.85 24.16 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.326 0.65 . . . . 0.0 110.263 179.298 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.05 113.35 19.42 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.63 1.572 . . . . 0.0 107.671 179.209 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.4 m -97.47 161.55 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.436 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.88 155.65 51.07 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.395 -179.063 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.25 -173.31 4.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.342 1.457 . . . . 0.0 109.008 178.924 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.2 t -68.02 133.67 49.41 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.825 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.66 23.2 73.42 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -178.775 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.3 m -144.05 93.87 2.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.065 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 116.747 -1.597 . . . . 0.0 109.688 -178.658 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.408 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -79.84 169.94 17.2 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.804 1.242 . . . . 0.0 111.858 -178.839 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.37 152.86 0.57 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 126.612 1.965 . . . . 0.0 113.028 179.296 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.66 94.37 3.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.076 1.35 . . . . 0.0 110.571 -178.517 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -99.58 94.53 6.44 Favored 'General case' 0 N--CA 1.437 -1.099 1 N-CA-C 100.179 -4.008 . . . . 0.0 100.179 177.808 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.0 m -96.19 75.48 3.0 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.246 -177.696 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.0 -97.42 1.64 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 -178.804 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.3 t -114.76 -31.71 6.06 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.442 1.497 . . . . 0.0 109.253 178.479 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.1 m -77.06 95.53 4.22 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 102.059 -3.312 . . . . 0.0 102.059 178.051 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -114.28 152.24 31.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.552 1.141 . . . . 0.0 113.098 -176.425 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -143.76 165.78 26.71 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 125.041 1.336 . . . . 0.0 111.229 -179.214 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.3 m -85.97 156.94 20.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.334 1.453 . . . . 0.0 110.652 178.88 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.95 -20.78 40.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.915 -1.493 . . . . 0.0 107.164 176.875 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -68.77 -46.01 69.88 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.538 1.135 . . . . 0.0 109.939 179.379 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -43.38 93.21 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 123.135 0.574 . . . . 0.0 111.4 179.195 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.0 t -61.25 -46.07 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 123.013 0.525 . . . . 0.0 109.754 178.776 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 ttp-105 -62.76 -43.8 97.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.587 0.755 . . . . 0.0 110.177 -179.217 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.55 -45.41 87.25 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.546 0.738 . . . . 0.0 110.772 179.122 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.98 -33.22 75.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.46 1.104 . . . . 0.0 110.753 179.329 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.84 -37.71 47.8 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.964 0.505 . . . . 0.0 110.456 178.881 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -68.22 -20.64 64.84 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.229 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.25 -61.38 1.97 Allowed 'General case' 0 C--N 1.346 0.449 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 -178.807 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -41.13 -52.05 3.33 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.336 1.054 . . . . 0.0 111.46 176.663 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 46.4 t -61.97 -39.77 93.31 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.693 1.597 . . . . 0.0 111.04 179.017 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -88.01 7.08 32.95 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.768 1.227 . . . . 0.0 113.527 179.015 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -129.73 -10.87 4.43 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.455 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.457 ' HH ' ' HG1' ' A' ' 41' ' ' THR . 90.5 t80 -115.18 -27.28 7.34 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -179.059 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.95 -14.86 11.25 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.828 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -78.86 17.82 0.68 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.503 1.047 . . . . 0.0 113.616 -176.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.5 t70 86.51 40.22 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 127.941 2.496 . . . . 0.0 109.166 178.9 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -151.7 148.99 28.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.827 2.051 . . . . 0.0 106.232 179.269 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 t -166.24 77.99 0.24 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.127 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.19 96.04 0.1 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.182 0.993 . . . . 0.0 110.552 -179.228 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.94 58.87 4.58 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 125.226 1.393 . . . . 0.0 110.197 -179.265 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.4 t -72.78 -73.27 0.21 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.706 0.802 . . . . 0.0 110.147 -179.011 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 m -176.49 -49.63 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 127.441 2.297 . . . . 0.0 106.671 -178.584 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.0 t -79.95 25.04 0.38 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.485 1.914 . . . . 0.0 113.939 -178.844 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 74.49 163.69 0.14 Allowed Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 119.279 0.945 . . . . 0.0 109.839 178.414 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.25 117.94 3.5 Favored 'Cis proline' 0 N--CA 1.454 -0.838 0 N-CA-C 115.166 1.179 . . . . 0.0 115.166 2.65 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -125.71 150.86 47.32 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 127.223 2.209 . . . . 0.0 106.937 178.912 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.457 ' HG1' ' HH ' ' A' ' 27' ' ' TYR . 3.7 m -80.99 132.19 35.36 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.564 1.146 . . . . 0.0 109.777 -179.972 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -88.53 149.55 23.56 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.48 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -153.03 134.3 14.24 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.024 0.53 . . . . 0.0 110.494 -179.273 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 64.43 121.61 0.02 OUTLIER 'General case' 0 C--N 1.343 0.293 0 C-N-CA 127.378 2.271 . . . . 0.0 112.053 179.367 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -77.16 135.38 38.53 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.268 0.627 . . . . 0.0 109.699 179.433 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -126.91 75.3 1.56 Allowed 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.188 0.995 . . . . 0.0 109.407 -178.691 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.16 50.49 51.06 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.221 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -164.83 121.76 1.55 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.857 1.263 . . . . 0.0 108.69 -178.648 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -142.68 110.43 5.85 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.373 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -144.42 49.87 1.11 Allowed Pre-proline 0 N--CA 1.439 -1.014 0 C-N-CA 129.91 3.284 . . . . 0.0 108.879 177.635 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.56 150.3 27.87 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.006 2.471 . . . . 0.0 112.031 -178.998 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.7 t -142.03 -53.19 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.862 1.665 . . . . 0.0 106.892 178.757 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -160.19 126.38 4.19 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.136 1.375 . . . . 0.0 109.002 178.727 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.85 150.95 18.43 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.881 1.229 . . . . 0.0 112.238 -178.875 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.65 173.04 29.17 Favored 'Cis proline' 0 C--N 1.35 0.655 0 CA-C-N 119.375 1.588 . . . . 0.0 113.27 -2.251 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -126.17 174.71 8.3 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.292 1.437 . . . . 0.0 108.174 -179.256 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.63 154.01 37.96 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.879 0.371 . . . . 0.0 111.658 -179.491 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.18 153.17 19.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.594 1.558 . . . . 0.0 111.683 -178.889 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -157.33 117.17 1.99 Allowed Pre-proline 0 C--N 1.342 0.273 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.288 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.7 152.14 13.16 Favored 'Trans proline' 0 N--CA 1.438 -1.769 0 C-N-CA 121.187 1.258 . . . . 0.0 114.675 -176.382 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.52 178.32 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 127.77 2.428 . . . . 0.0 105.868 178.803 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -164.77 -168.92 1.58 Allowed 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 109.586 -3.461 . . . . 0.0 108.462 -178.879 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.2 m -84.65 60.71 6.28 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 177.136 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.54 71.53 1.16 Allowed Glycine 0 CA--C 1.53 0.999 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 -178.222 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.18 89.68 0.09 OUTLIER Glycine 0 CA--C 1.53 1.01 0 CA-C-N 117.295 0.547 . . . . 0.0 111.8 -179.329 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.1 t -94.68 97.49 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.317 1.447 . . . . 0.0 108.003 179.339 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 t80 48.82 66.21 1.15 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.394 1.478 . . . . 0.0 110.693 -179.586 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.2 p -104.53 -68.82 0.83 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.792 1.237 . . . . 0.0 109.43 179.853 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.33 177.23 47.3 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 179.47 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.54 -19.59 10.82 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 118.887 -0.952 . . . . 0.0 113.378 -179.787 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 92.0 p 50.35 71.69 1.48 Allowed Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.201 1.8 . . . . 0.0 111.6 -179.604 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.89 143.28 54.55 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.181 2.587 . . . . 0.0 109.403 -178.382 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.43 48.74 0.95 Allowed Glycine 0 C--N 1.338 0.691 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.252 -178.518 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.15 21.75 0.13 Allowed 'General case' 0 C--N 1.342 0.27 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 177.784 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.26 112.64 0.13 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.708 2.803 . . . . 0.0 105.85 176.18 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.91 134.31 9.58 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.387 1.875 . . . . 0.0 109.53 -176.298 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.9 m -90.8 152.8 3.29 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 177.615 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.1 t -135.62 119.21 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -178.694 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -102.54 176.54 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.4 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -99.28 168.42 10.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 127.258 2.223 . . . . 0.0 109.16 178.847 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.306 14.7 t -82.01 50.24 1.52 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -178.414 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -147.54 -90.1 0.09 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 102.545 -3.132 . . . . 0.0 102.545 177.477 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.16 0.44 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.657 1.983 . . . . 0.0 113.007 -178.939 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -82.7 133.68 35.16 Favored 'General case' 0 C--N 1.346 0.44 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -176.773 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -78.05 112.88 15.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.592 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.0 -49.65 11.52 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.322 1.049 . . . . 0.0 111.363 -178.171 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.07 151.29 7.95 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.108 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.56 158.18 17.12 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.855 0.862 . . . . 0.0 110.159 178.97 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.0 pt -138.71 151.84 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.602 -178.918 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.1 t -147.67 165.43 30.49 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 125.301 1.441 . . . . 0.0 112.749 -178.756 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -79.01 -50.86 10.42 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.457 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 m -39.9 107.8 0.08 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 127.026 2.13 . . . . 0.0 112.631 -178.763 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.8 -43.42 1.35 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.74 1.638 . . . . 0.0 109.259 -179.153 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.95 -175.89 0.62 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.799 1.639 . . . . 0.0 112.131 179.654 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.3 p -70.88 -50.76 31.53 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.171 0.988 . . . . 0.0 111.453 -179.894 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.54 -78.9 0.04 OUTLIER Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.372 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -79.35 -34.1 42.39 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.046 0.939 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -55.82 158.63 3.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.366 1.066 . . . . 0.0 111.046 179.205 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -118.5 157.98 26.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.67 1.188 . . . . 0.0 113.175 -178.298 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.6 160.94 41.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 C-N-CA 126.428 1.891 . . . . 0.0 107.192 177.712 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.52 161.11 46.21 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.068 0.842 . . . . 0.0 114.197 -177.928 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.6 t -143.06 163.75 31.98 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 126.002 1.721 . . . . 0.0 109.147 178.825 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.0 t 53.43 51.59 15.04 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.079 1.752 . . . . 0.0 111.468 -178.577 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.66 -10.79 70.73 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.087 -0.84 . . . . 0.0 113.285 179.2 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.9 m -79.55 143.95 34.36 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.604 1.202 . . . . 0.0 108.746 -179.351 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 p30 . . . . . 0 C--O 1.251 1.182 0 CA-C-O 117.528 -1.225 . . . . 0.0 110.045 -179.271 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 120.521 0.201 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t -160.08 102.77 1.45 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.292 0.637 . . . . 0.0 109.54 179.435 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.46 75.1 0.37 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.311 1.444 . . . . 0.0 109.393 179.72 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.5 m -79.35 101.06 7.89 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.104 1.762 . . . . 0.0 109.668 -178.001 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -115.96 115.85 26.9 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.553 1.541 . . . . 0.0 106.863 -179.154 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.4 m -113.39 93.82 4.58 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.58 0.752 . . . . 0.0 109.797 -179.223 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.07 -93.8 0.43 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.438 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.3 m -133.77 41.58 3.02 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.607 1.163 . . . . 0.0 109.233 179.184 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.4 m -141.16 89.2 2.22 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 179.075 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -85.67 141.57 29.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.656 1.182 . . . . 0.0 113.657 -177.594 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -141.81 136.72 30.91 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.69 1.596 . . . . 0.0 109.816 178.74 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.5 m -65.94 158.2 28.72 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.979 1.312 . . . . 0.0 110.266 178.231 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.05 -23.17 66.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.1 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.2 t -76.73 -33.25 58.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.145 1.378 . . . . 0.0 109.966 179.259 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -74.74 -39.55 61.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.867 0.867 . . . . 0.0 109.841 -179.028 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.47 -44.6 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.499 0.72 . . . . 0.0 110.43 178.342 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.48 -38.55 90.1 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 123.304 0.642 . . . . 0.0 110.46 179.47 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.08 -46.33 74.63 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.868 0.867 . . . . 0.0 109.259 179.029 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.58 -42.14 82.55 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.961 0.904 . . . . 0.0 108.953 178.775 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.91 -20.03 50.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 179.324 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -74.52 -26.21 59.84 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.315 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.74 -49.81 10.68 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -179.445 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.14 -48.83 23.19 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 124.612 1.195 . . . . 0.0 109.661 176.233 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.5 t -68.73 -29.79 68.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.82 2.048 . . . . 0.0 113.189 -179.922 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -73.35 -63.78 1.12 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.45 1.023 . . . . 0.0 112.206 -178.611 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.351 0.1 OUTLIER -66.79 -47.01 73.45 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 -176.035 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -60.02 -28.2 67.54 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.552 1.141 . . . . 0.0 112.32 -178.722 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -82.7 -71.5 0.49 Allowed 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -178.435 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -171.19 23.28 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -178.718 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -121.28 76.72 1.26 Allowed 'General case' 0 C--N 1.339 0.128 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.803 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 111.19 133.79 0.0 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 131.355 3.862 . . . . 0.0 108.294 -178.713 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -90.96 81.58 5.66 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.004 1.321 . . . . 0.0 108.845 179.688 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.44 162.43 12.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.879 0.872 . . . . 0.0 112.387 -179.263 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -42.37 96.67 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.592 1.091 . . . . 0.0 114.947 -178.706 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.4 m 61.08 75.81 0.39 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -178.288 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 p 175.39 -43.85 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 103.471 -2.789 . . . . 0.0 103.471 -176.361 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.7 p -115.69 51.25 0.95 Allowed 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.856 2.062 . . . . 0.0 110.437 178.432 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 23.4 m-85 64.08 133.21 0.03 OUTLIER Pre-proline 0 C--N 1.355 0.83 0 C-N-CA 126.093 1.757 . . . . 0.0 110.76 176.504 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -76.39 161.58 93.57 Favored 'Cis proline' 0 N--CA 1.45 -1.035 0 CA-C-N 120.18 1.1 . . . . 0.0 109.931 3.555 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.74 147.25 37.08 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.026 1.331 . . . . 0.0 109.919 -177.788 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 t -76.31 132.1 39.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 103.46 -2.793 . . . . 0.0 103.46 177.12 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -95.6 106.1 18.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 -178.115 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -162.31 -58.07 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.567 1.147 . . . . 0.0 108.771 -179.241 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -81.39 70.65 8.3 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.559 1.144 . . . . 0.0 109.618 -179.367 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.55 -72.9 0.09 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.11 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -176.39 147.82 0.71 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.493 1.117 . . . . 0.0 109.275 179.18 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.75 150.82 49.83 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 178.93 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.17 170.56 18.16 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.104 0.562 . . . . 0.0 110.415 -179.209 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -71.6 -163.94 0.11 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.293 0.637 . . . . 0.0 111.63 -179.352 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.0 p90 54.28 58.73 12.11 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 125.889 1.676 . . . . 0.0 111.088 -178.178 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.28 66.83 8.74 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 124.016 3.144 . . . . 0.0 110.445 -179.429 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.37 -65.31 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.135 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -166.32 -165.09 0.74 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.048 1.339 . . . . 0.0 107.987 179.294 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.99 -174.88 45.98 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 121.91 -0.494 . . . . 0.0 112.879 179.103 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.2 128.37 6.42 Favored 'Cis proline' 0 N--CA 1.458 -0.568 0 O-C-N 122.526 0.75 . . . . 0.0 112.364 -0.292 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.72 150.57 25.01 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.114 0.966 . . . . 0.0 110.536 179.343 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -103.22 162.95 12.55 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.547 1.539 . . . . 0.0 112.82 -178.709 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.278 14.9 tp10 -101.3 151.82 21.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.646 2.379 . . . . 0.0 110.496 -178.783 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -160.16 107.43 1.39 Allowed Pre-proline 0 C--N 1.342 0.244 0 C-N-CA 124.567 1.147 . . . . 0.0 108.494 177.546 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -83.3 132.43 6.02 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 121.653 1.569 . . . . 0.0 112.607 -177.532 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.575 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.7 tt -107.81 172.41 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 124.466 2.079 . . . . 0.0 113.234 -179.289 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.575 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 16.5 ptpt -161.65 164.51 29.2 Favored 'General case' 0 C--N 1.316 -0.871 1 CA-C-N 108.191 -4.095 . . . . 0.0 112.379 179.974 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.1 m -92.33 60.33 3.63 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.536 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.5 -62.75 0.03 OUTLIER Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -179.271 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.31 -172.27 13.13 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.647 0.642 . . . . 0.0 113.939 -178.663 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.3 t -124.33 103.99 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 127.889 2.476 . . . . 0.0 105.678 -179.418 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.9 t80 60.56 92.78 0.04 OUTLIER 'General case' 0 C--N 1.345 0.38 0 C-N-CA 126.09 1.756 . . . . 0.0 110.871 -178.519 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.3 p -142.85 39.68 1.5 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.844 0.858 . . . . 0.0 110.336 179.302 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.11 98.38 0.06 OUTLIER Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.979 0.8 . . . . 0.0 112.25 179.178 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.92 -178.54 48.96 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 123.718 0.675 . . . . 0.0 111.512 179.13 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.0 t 63.12 91.81 0.07 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.684 1.593 . . . . 0.0 110.5 -179.124 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -59.87 132.31 8.07 Favored 'Cis proline' 0 C--N 1.348 0.534 0 CA-C-N 119.355 0.805 . . . . 0.0 113.338 1.901 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.79 71.57 0.03 OUTLIER Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.507 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.422 ' HB2' ' CB ' ' A' ' 91' ' ' HIS . . . -62.93 -20.64 65.4 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.861 178.863 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.72 137.4 33.86 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.289 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -157.66 147.28 20.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.522 -179.069 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.9 m -110.04 145.98 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 177.237 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.5 t -127.66 121.24 56.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -177.328 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -107.84 173.17 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.38 0 C-N-CA 125.189 1.396 . . . . 0.0 112.45 -177.58 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -91.56 161.89 14.75 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.248 1.419 . . . . 0.0 109.293 179.363 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.32 15.3 t -79.16 54.08 1.58 Allowed 'General case' 0 C--N 1.341 0.223 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -179.076 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -151.81 -88.45 0.06 Allowed 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 101.982 -3.34 . . . . 0.0 101.982 177.209 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.24 5.51 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.181 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -91.3 129.75 37.25 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 -175.48 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.56 124.14 20.61 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 177.447 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.8 -51.73 5.08 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.166 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.24 153.45 10.93 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.075 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.84 141.28 31.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.569 1.148 . . . . 0.0 110.062 179.3 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.0 pt -135.14 156.76 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 125.267 1.427 . . . . 0.0 108.081 179.157 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.58 159.67 37.33 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 119.113 -0.47 . . . . 0.0 111.308 -178.731 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.422 ' CB ' ' HB2' ' A' ' 74' ' ' ALA . 21.4 m170 -78.88 -58.76 3.08 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.015 177.412 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.288 4.8 t 48.06 9.35 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 129.228 3.011 . . . . 0.0 117.168 -178.053 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.68 44.98 0.21 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.142 1.353 . . . . 0.0 110.505 179.399 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.88 -168.6 2.29 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.985 0.914 . . . . 0.0 109.073 179.086 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.8 m -59.84 -46.57 88.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.321 0.648 . . . . 0.0 110.426 179.167 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.28 -91.48 0.08 OUTLIER Glycine 0 C--N 1.337 0.619 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 179.157 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -85.37 -2.5 58.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.022 0.929 . . . . 0.0 110.234 178.458 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -63.51 168.21 4.86 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.629 1.172 . . . . 0.0 110.708 179.114 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -138.85 156.21 47.49 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -177.608 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 m -132.61 165.54 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 127.331 2.253 . . . . 0.0 106.692 177.093 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -75.2 162.07 53.42 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 114.668 0.627 . . . . 0.0 114.668 -178.185 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 6.6 t -148.26 159.15 44.27 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 126.096 1.758 . . . . 0.0 108.953 178.289 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t 61.38 38.11 16.4 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.726 2.01 . . . . 0.0 111.819 -178.328 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.72 42.98 99.59 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.154 1.359 . . . . 0.0 112.239 179.041 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.6 t -88.21 26.03 1.49 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 179.871 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 116.618 -1.658 . . . . 0.0 110.615 -179.31 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.488 0.185 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.5 p -125.85 177.09 6.5 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.936 1.294 . . . . 0.0 110.843 -178.98 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.13 152.66 39.96 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.791 1.236 . . . . 0.0 110.777 179.359 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.4 t -140.4 134.21 30.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.155 0.582 . . . . 0.0 110.508 179.043 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -109.92 103.33 12.09 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 178.854 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 20.6 m -88.24 70.21 9.19 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.184 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.08 -82.24 0.88 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.416 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.5 p -106.1 -48.14 3.67 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.161 1.384 . . . . 0.0 112.058 -178.887 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.5 m -72.79 105.59 4.41 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.984 0.513 . . . . 0.0 111.694 -178.436 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -81.8 148.51 28.84 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.219 1.408 . . . . 0.0 110.531 179.869 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -148.08 127.68 13.29 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.383 1.073 . . . . 0.0 109.495 179.156 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.9 p -71.15 160.12 33.45 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 125.133 1.373 . . . . 0.0 110.504 178.323 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.36 -19.73 37.96 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.164 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.4 t -77.74 -36.72 50.45 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 123.604 0.762 . . . . 0.0 109.385 -179.986 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -42.5 64.86 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.67 1.188 . . . . 0.0 111.069 179.205 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.411 HG12 ' CE2' ' A' ' 85' ' ' TYR . 22.3 t -61.87 -45.93 97.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.297 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -66.91 -41.48 87.04 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 124.883 1.273 . . . . 0.0 112.967 179.821 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.88 -53.61 53.42 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.749 0.42 . . . . 0.0 110.294 -178.122 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.16 -32.38 72.1 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.086 179.439 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.36 -49.32 43.39 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 179.874 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -61.87 -22.94 65.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.693 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.23 -71.98 0.28 Allowed 'General case' 0 C--N 1.348 0.52 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 -177.698 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -38.53 -44.44 0.95 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.912 0.885 . . . . 0.0 112.261 178.096 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.3 m -55.82 -52.71 63.05 Favored 'General case' 0 C--N 1.346 0.447 0 O-C-N 123.288 0.367 . . . . 0.0 111.784 179.184 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -56.16 -40.15 73.42 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.755 0.822 . . . . 0.0 112.421 -178.124 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -89.38 -16.48 30.88 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -178.875 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -80.45 -24.04 39.82 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.791 1.236 . . . . 0.0 113.826 179.367 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -60.64 -33.54 72.95 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.297 0.639 . . . . 0.0 112.692 -177.921 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -126.17 -86.27 0.61 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.147 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t0 168.13 59.05 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 128.354 2.662 . . . . 0.0 105.701 -178.379 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -81.66 -178.5 6.99 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.597 179.441 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.338 11.3 t -69.07 86.68 0.37 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -177.838 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.03 -161.66 1.07 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 127.242 2.217 . . . . 0.0 107.07 177.363 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -45.55 -49.21 11.82 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.478 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.1 m 47.62 50.04 15.57 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.181 1.792 . . . . 0.0 113.606 178.051 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.1 p -143.48 -54.3 0.38 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.776 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 t -154.3 19.44 0.49 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.387 1.475 . . . . 0.0 110.543 178.984 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.466 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 12.8 m-85 -166.03 129.39 1.58 Allowed Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 126.403 1.881 . . . . 0.0 106.32 178.879 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.64 135.8 34.03 Favored 'Cis proline' 0 N--CA 1.449 -1.118 0 CA-C-N 120.355 1.163 . . . . 0.0 110.402 -1.53 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.88 155.97 36.7 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.932 0.493 . . . . 0.0 110.214 178.762 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -64.02 157.73 24.42 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.845 1.258 . . . . 0.0 112.297 -179.332 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.92 45.14 1.13 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.956 0.903 . . . . 0.0 110.212 179.263 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 48.0 -121.56 1.38 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.84 2.056 . . . . 0.0 112.103 179.895 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -137.64 -179.27 5.65 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.858 1.663 . . . . 0.0 108.813 -179.367 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 66.91 -142.53 0.14 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.066 1.346 . . . . 0.0 110.965 178.933 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -126.29 106.53 9.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.188 1.395 . . . . 0.0 109.252 -178.571 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.98 93.0 0.31 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.295 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.4 t80 51.26 65.32 1.52 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.438 1.495 . . . . 0.0 109.666 -179.138 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.36 153.31 42.43 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.792 0.806 . . . . 0.0 112.684 -178.499 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -109.31 163.88 16.01 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 127.53 2.332 . . . . 0.0 108.522 -179.124 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.98 53.66 4.27 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.848 3.032 . . . . 0.0 111.837 178.865 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.2 m -155.04 171.09 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 127.842 2.457 . . . . 0.0 108.058 -179.333 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -92.46 -133.94 0.14 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.949 0.9 . . . . 0.0 109.52 179.983 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 166.32 -156.48 28.4 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.386 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.45 151.79 12.9 Favored 'Cis proline' 0 C--N 1.349 0.587 0 CA-C-N 119.205 1.503 . . . . 0.0 113.097 -1.5 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -134.26 148.38 50.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.205 1.002 . . . . 0.0 111.877 -178.635 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.57 152.31 22.57 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -177.659 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -104.81 146.59 28.77 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 127.471 2.308 . . . . 0.0 108.459 179.276 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -160.05 121.92 1.81 Allowed Pre-proline 0 C--O 1.224 -0.238 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 179.347 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.466 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 22.8 Cg_endo -75.97 145.28 28.07 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 CA-C-N 120.624 1.259 . . . . 0.0 112.753 -176.031 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.271 5.0 tp -78.99 159.83 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 124.483 2.087 . . . . 0.0 114.094 -178.07 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.94 118.74 37.4 Favored 'General case' 0 C--N 1.321 -0.672 1 CA-C-N 108.004 -4.18 . . . . 0.0 118.222 -176.372 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.1 m -105.86 43.99 1.08 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.743 1.617 . . . . 0.0 107.075 177.997 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.41 -6.28 5.94 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 118.279 -1.29 . . . . 0.0 115.366 -179.388 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.71 134.27 2.92 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 120.15 1.975 . . . . 0.0 113.064 179.462 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.94 141.83 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.194 1.398 . . . . 0.0 110.357 -179.005 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.8 p90 39.94 54.47 2.63 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.407 2.283 . . . . 0.0 114.527 179.311 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.2 p -134.09 34.32 3.34 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.833 1.253 . . . . 0.0 108.887 178.717 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.41 -154.6 11.45 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 124.294 0.95 . . . . 0.0 111.251 -179.257 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 47.71 74.93 0.21 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.856 1.217 . . . . 0.0 112.834 178.992 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.1 m -55.53 143.41 57.97 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.178 179.314 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -45.85 -50.72 9.28 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.554 2.836 . . . . 0.0 110.993 172.829 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.41 -39.85 0.22 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 178.526 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -171.11 29.21 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 116.429 -1.748 . . . . 0.0 113.629 -177.92 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -108.57 130.39 55.3 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 122.453 2.388 . . . . 0.0 113.749 -178.464 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -134.27 155.41 50.25 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 124.372 1.069 . . . . 0.0 113.112 179.884 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 m -124.97 142.04 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 103.404 -2.813 . . . . 0.0 103.404 176.115 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.9 t -136.45 127.9 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -176.955 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.63 172.5 5.21 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 C-N-CA 127.065 2.146 . . . . 0.0 110.71 -177.901 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -100.49 -178.24 3.74 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 126.066 1.746 . . . . 0.0 110.138 179.044 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.371 13.8 t -80.33 52.48 1.61 Allowed 'General case' 0 C--N 1.344 0.34 0 N-CA-C 118.524 2.787 . . . . 0.0 118.524 -178.068 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -160.5 -93.37 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 100.394 -3.928 . . . . 0.0 100.394 176.752 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 58.2 m -163.68 16.19 0.06 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 130.101 3.36 . . . . 0.0 112.353 179.398 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -79.21 97.65 6.31 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.778 1.172 . . . . 0.0 110.256 -177.69 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.411 ' CE2' HG12 ' A' ' 16' ' ' VAL . 9.1 t80 -55.64 112.72 1.21 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.667 1.587 . . . . 0.0 108.699 178.998 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.05 -51.52 9.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.449 0.7 . . . . 0.0 110.822 -178.641 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 166.66 162.27 17.8 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.275 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.84 147.06 24.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.059 0.944 . . . . 0.0 109.104 179.028 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.2 pt -134.52 160.59 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.966 1.306 . . . . 0.0 109.241 -178.969 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.9 t -158.43 167.43 29.69 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.453 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -78.45 -65.3 1.0 Allowed 'General case' 0 C--N 1.348 0.511 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.343 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.1 t 42.78 14.28 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 129.249 3.02 . . . . 0.0 116.778 -179.364 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.99 -32.71 0.15 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.466 1.507 . . . . 0.0 110.44 -179.038 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.18 127.57 17.27 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.829 1.652 . . . . 0.0 112.09 179.233 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.9 t -105.89 69.19 0.81 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.986 1.315 . . . . 0.0 109.114 179.718 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.67 -161.01 30.35 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.452 1.025 . . . . 0.0 110.921 179.373 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -79.5 8.55 6.14 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.071 0.948 . . . . 0.0 111.388 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -80.24 156.83 26.69 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.233 1.413 . . . . 0.0 110.286 178.852 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -137.78 159.96 40.56 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.279 1.432 . . . . 0.0 111.195 -178.192 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.9 m -128.38 176.15 8.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 C-N-CA 127.877 2.471 . . . . 0.0 106.969 178.05 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.31 171.07 43.6 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 117.054 1.581 . . . . 0.0 117.054 -177.647 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.3 m -129.26 -176.49 3.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.917 2.487 . . . . 0.0 107.206 177.963 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.6 t 28.5 38.84 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -177.099 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 53.32 48.94 58.49 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.324 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.6 t -79.23 150.54 31.58 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.596 0.759 . . . . 0.0 111.801 -178.615 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.1 t30 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.245 -1.36 . . . . 0.0 108.717 -179.386 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 m -78.25 150.84 33.33 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.75 1.62 . . . . 0.0 108.299 179.082 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 76.82 63.08 0.04 OUTLIER 'General case' 0 C--N 1.34 0.167 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 -177.433 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 t -106.02 156.43 18.41 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.893 0.877 . . . . 0.0 111.354 -177.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.08 112.28 12.2 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 178.723 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.6 m -96.55 74.93 2.82 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.242 1.017 . . . . 0.0 110.012 -178.825 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.3 -70.81 2.1 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 125.097 1.332 . . . . 0.0 111.524 179.121 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.2 t -126.49 -44.58 1.69 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.896 1.678 . . . . 0.0 109.919 -179.222 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 m -68.5 111.06 4.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.644 0.778 . . . . 0.0 109.514 -179.349 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -81.41 151.94 27.66 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.083 0.953 . . . . 0.0 110.532 179.911 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -143.27 110.14 5.58 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.427 1.091 . . . . 0.0 110.326 -179.551 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.8 m -63.1 154.15 31.88 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 125.275 1.43 . . . . 0.0 109.171 178.77 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -20.9 57.81 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.865 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.4 m -74.35 -43.22 57.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.042 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -67.82 -47.29 69.46 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.189 0.995 . . . . 0.0 112.343 -179.174 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -60.19 -52.65 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 124.194 0.998 . . . . 0.0 109.215 -179.342 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -66.38 -38.8 88.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.141 1.377 . . . . 0.0 113.002 -177.841 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.51 -52.6 60.54 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.355 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.96 -32.55 73.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.431 179.237 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.92 -32.29 61.75 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 178.896 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -69.74 -24.66 63.57 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 176.959 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.06 -63.67 1.26 Allowed 'General case' 0 C--N 1.349 0.57 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 -179.222 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -41.58 -40.1 1.79 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.273 1.429 . . . . 0.0 112.447 176.852 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -60.89 -63.54 1.26 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.282 1.433 . . . . 0.0 110.247 179.219 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -66.43 -24.17 66.41 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -179.065 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -82.25 -45.31 15.18 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.211 1.404 . . . . 0.0 113.531 -177.798 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -66.23 -28.26 68.6 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.374 1.069 . . . . 0.0 112.589 -178.525 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -74.84 -64.73 0.98 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.407 0.548 . . . . 0.0 110.904 -177.738 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -172.49 -29.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.546 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -75.49 39.02 0.15 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -177.502 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.05 169.7 0.06 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.224 2.21 . . . . 0.0 110.689 178.608 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.0 t -158.28 37.19 0.24 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.388 1.475 . . . . 0.0 110.337 179.322 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.04 158.98 27.78 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.754 0.822 . . . . 0.0 111.835 -179.149 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.64 -137.59 7.33 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.573 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.7 t -145.32 -68.53 0.29 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.625 1.17 . . . . 0.0 108.452 179.091 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.2 m -83.33 -94.1 0.06 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.908 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.3 p -140.63 40.57 1.86 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.389 0.675 . . . . 0.0 110.677 178.571 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -82.17 132.06 54.49 Favored Pre-proline 0 C--N 1.345 0.389 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 177.66 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.49 123.75 5.73 Favored 'Cis proline' 0 CA--C 1.544 1.015 0 N-CA-C 114.044 0.748 . . . . 0.0 114.044 3.005 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.85 148.4 22.52 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 128.452 2.701 . . . . 0.0 113.758 -177.319 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.97 113.76 2.99 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.933 0.893 . . . . 0.0 109.264 179.047 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -95.03 90.38 5.92 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 120.838 0.352 . . . . 0.0 110.072 -178.821 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -156.12 119.21 4.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.162 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -128.58 -79.82 0.57 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.295 1.038 . . . . 0.0 109.336 -179.089 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -143.61 11.26 1.66 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.904 1.281 . . . . 0.0 110.884 179.467 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 55.45 47.64 20.66 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.225 1.41 . . . . 0.0 110.682 -178.852 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.67 -31.53 6.67 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.292 1.425 . . . . 0.0 111.303 179.413 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -127.44 94.02 3.87 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.041 1.336 . . . . 0.0 108.391 -179.195 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -118.88 -177.95 3.44 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.582 1.153 . . . . 0.0 111.487 -178.837 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.21 175.53 3.21 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.989 1.716 . . . . 0.0 108.553 -178.714 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.63 68.07 7.11 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.352 2.701 . . . . 0.0 111.573 -179.403 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.5 m -143.18 157.28 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 125.668 1.587 . . . . 0.0 109.78 179.695 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -85.5 -44.97 12.24 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.797 1.239 . . . . 0.0 111.235 -179.326 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.79 177.82 43.81 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.72 1.152 . . . . 0.0 111.865 -179.423 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.29 152.96 85.19 Favored 'Cis proline' 0 N--CA 1.458 -0.594 0 CA-C-N 117.973 0.886 . . . . 0.0 112.409 0.763 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.1 154.96 47.74 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 127.185 2.194 . . . . 0.0 109.981 179.325 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -135.85 160.81 37.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.049 -178.743 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.98 162.26 26.08 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.719 1.608 . . . . 0.0 112.14 -177.552 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -160.61 104.38 1.32 Allowed Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 177.388 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -80.84 135.46 10.09 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 121.899 1.733 . . . . 0.0 112.774 -175.778 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.667 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 3.7 tt -105.35 -176.34 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-O 124.249 1.976 . . . . 0.0 112.401 -179.223 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.667 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.3 mmtm -160.51 142.84 12.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 108.945 -3.752 . . . . 0.0 110.229 179.72 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.7 t -85.83 60.83 6.47 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.71 1.204 . . . . 0.0 109.138 -179.134 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.51 49.81 0.1 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.93 1.729 . . . . 0.0 109.003 -179.214 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.6 154.39 7.57 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.328 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.8 t -135.61 150.94 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.168 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 16.6 p90 48.33 48.47 18.93 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.818 1.647 . . . . 0.0 111.963 -179.051 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.1 m -79.29 138.31 37.7 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 125.027 1.331 . . . . 0.0 108.964 -178.896 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.91 -84.15 0.23 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.871 0.748 . . . . 0.0 112.791 -178.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.56 76.56 1.32 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.165 0.888 . . . . 0.0 112.096 -178.825 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.3 m -98.65 157.78 33.65 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.229 1.412 . . . . 0.0 110.177 179.338 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.9 -44.28 49.74 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.731 2.954 . . . . 0.0 111.495 164.61 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.57 24.23 26.49 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.773 1.178 . . . . 0.0 112.11 179.18 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.468 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -94.16 -68.92 0.77 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.158 -0.925 . . . . 0.0 109.548 179.203 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -70.4 107.1 3.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.096 0.958 . . . . 0.0 112.622 -178.621 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -140.03 131.65 27.2 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.338 0.655 . . . . 0.0 111.719 -179.074 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -94.19 153.16 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 176.882 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.7 t -132.95 130.42 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -178.348 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.5 pt -116.79 176.22 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.6 1.16 . . . . 0.0 112.634 -177.997 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -90.49 177.34 6.4 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 126.442 1.897 . . . . 0.0 110.022 179.763 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.322 12.9 t -81.2 47.71 1.05 Allowed 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 118.58 2.807 . . . . 0.0 118.58 -178.651 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -160.41 -87.04 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 177.05 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 76.7 m -162.97 62.6 0.19 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.198 2.599 . . . . 0.0 110.082 -176.793 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -144.02 117.74 9.27 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.202 1.819 . . . . 0.0 114.391 -179.416 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -55.74 128.83 36.73 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.365 1.066 . . . . 0.0 108.449 178.622 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.61 -59.6 1.68 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.931 0.892 . . . . 0.0 108.833 178.805 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.91 173.57 41.51 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.369 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.47 115.95 22.42 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.681 1.593 . . . . 0.0 109.231 179.267 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.9 pt -108.83 158.01 8.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 125.06 1.344 . . . . 0.0 110.017 -179.235 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 t -159.61 137.11 9.84 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 -179.529 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.468 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 6.5 m170 -78.1 -11.22 59.9 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 117.881 -1.057 . . . . 0.0 112.034 174.997 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.7 m -26.53 -65.63 0.06 Allowed 'General case' 0 C--N 1.349 0.549 0 C-N-CA 126.447 1.899 . . . . 0.0 114.937 -178.469 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.04 -75.51 1.25 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -179.348 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 50.81 -150.23 0.26 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.064 1.346 . . . . 0.0 112.27 -179.306 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 60.1 p -153.97 -51.41 0.1 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.163 1.385 . . . . 0.0 108.651 179.118 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -121.55 -86.38 0.86 Allowed Glycine 0 C--N 1.34 0.791 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 178.817 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -134.13 28.13 3.8 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.547 1.539 . . . . 0.0 110.734 179.23 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -85.96 164.96 17.1 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.906 1.282 . . . . 0.0 111.628 -178.885 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.454 ' CE2' ' NE2' ' A' ' 91' ' ' HIS . 13.5 m-85 -118.65 116.05 25.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.122 1.769 . . . . 0.0 107.781 179.098 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.4 m -90.89 164.44 2.12 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.255 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.15 133.83 11.99 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.071 -178.32 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 26.2 m -81.32 -172.99 4.09 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.526 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.9 t -75.8 93.06 3.1 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.993 -0.442 . . . . 0.0 110.12 -179.03 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.49 51.27 0.24 Allowed Glycine 0 CA--C 1.527 0.834 0 C-N-CA 126.105 1.812 . . . . 0.0 109.397 -179.37 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.0 m -154.66 110.82 3.22 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 125.2 1.4 . . . . 0.0 108.853 -179.14 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.5 m120 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.217 -1.373 . . . . 0.0 109.414 179.111 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.2 m -145.36 139.18 26.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.964 0.905 . . . . 0.0 109.497 -179.287 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -50.29 136.55 19.8 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.541 1.536 . . . . 0.0 111.436 -179.784 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.3 p -104.0 150.13 24.53 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.976 1.31 . . . . 0.0 111.379 -179.034 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -133.46 97.03 3.84 Favored 'General case' 0 N--CA 1.424 -1.772 1 N-CA-C 97.38 -5.044 . . . . 0.0 97.38 176.591 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -97.31 85.57 3.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.471 0.653 . . . . 0.0 110.668 -177.185 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.12 -96.2 1.58 Allowed Glycine 0 C--N 1.34 0.762 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 -178.879 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.7 m -104.91 -36.61 7.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.353 1.061 . . . . 0.0 110.307 179.23 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.38 168.03 19.27 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.346 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -156.75 132.45 9.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.091 0.156 . . . . 0.0 110.86 179.323 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -123.74 158.35 31.89 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.876 1.27 . . . . 0.0 109.947 -179.683 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.1 m -78.05 156.26 30.17 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.224 1.41 . . . . 0.0 110.479 -179.667 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.38 -18.9 42.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.83 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.7 p -72.66 -38.05 67.75 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 123.637 0.775 . . . . 0.0 109.966 179.248 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.93 -47.93 67.34 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.807 0.731 . . . . 0.0 110.236 178.654 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.2 t -53.14 -49.89 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 125.077 1.351 . . . . 0.0 108.496 179.09 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -69.51 -38.32 77.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.372 1.469 . . . . 0.0 113.083 -178.819 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.59 -54.18 31.43 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.817 0.735 . . . . 0.0 110.79 -178.507 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.25 -34.1 75.88 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.584 0.754 . . . . 0.0 111.118 179.43 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.11 -36.89 61.63 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 119.477 -0.297 . . . . 0.0 111.506 178.957 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -69.32 -20.78 63.87 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.449 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.5 -57.41 3.36 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -178.224 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.8 -38.26 47.38 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.088 1.355 . . . . 0.0 109.822 177.269 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.2 t -60.69 -54.57 43.68 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.358 1.463 . . . . 0.0 109.158 178.506 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -56.79 -36.85 70.35 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.687 0.395 . . . . 0.0 110.837 179.532 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.25 -6.52 59.28 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.714 1.206 . . . . 0.0 114.098 -179.863 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.42 ' CD2' ' HG3' ' A' ' 57' ' ' GLN . 8.7 t80 -128.23 43.96 3.04 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.154 0.888 . . . . 0.0 111.402 178.926 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -130.78 -84.46 0.52 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.338 1.455 . . . . 0.0 107.598 177.483 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -162.93 -14.75 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.274 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -84.17 65.21 8.66 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.586 1.554 . . . . 0.0 107.576 179.89 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 78.04 111.35 0.07 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 128.138 2.575 . . . . 0.0 108.475 -178.971 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.4 p -87.49 77.63 8.78 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.544 1.138 . . . . 0.0 109.295 -178.68 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.59 91.93 2.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.516 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.48 108.34 2.77 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 126.113 1.816 . . . . 0.0 108.57 -179.519 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 m -71.18 -66.9 0.56 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.834 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.0 p 156.49 -47.87 0.0 OUTLIER 'General case' 0 C--N 1.34 0.184 0 N-CA-C 100.537 -3.875 . . . . 0.0 100.537 -177.664 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.442 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 7.5 t -93.11 53.2 1.92 Allowed 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 125.838 1.655 . . . . 0.0 107.308 176.951 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER 79.69 155.15 0.13 Allowed Pre-proline 0 C--N 1.348 0.53 0 C-N-CA 127.376 2.27 . . . . 0.0 115.086 175.737 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.93 127.66 13.1 Favored 'Cis proline' 0 C--N 1.349 0.582 0 N-CA-C 114.93 1.089 . . . . 0.0 114.93 1.899 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.04 169.56 20.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.748 1.219 . . . . 0.0 110.212 178.913 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 m -37.52 131.66 0.9 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 128.737 2.815 . . . . 0.0 115.828 -178.911 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -109.07 109.21 20.17 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.975 1.71 . . . . 0.0 106.708 178.418 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -70.91 -36.34 72.67 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.616 1.166 . . . . 0.0 113.636 -178.788 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 70.86 77.26 0.18 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.198 1.399 . . . . 0.0 108.134 -178.465 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -72.76 91.53 1.49 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.111 1.364 . . . . 0.0 111.747 -178.641 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 54.75 152.83 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 129.305 3.042 . . . . 0.0 115.821 179.191 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.61 -145.25 24.26 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.774 1.178 . . . . 0.0 112.583 179.236 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.04 172.27 0.09 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.05 1.74 . . . . 0.0 113.46 -179.36 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -158.45 121.93 3.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 179.395 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -132.81 105.34 12.78 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 178.448 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.64 80.86 1.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.699 2.933 . . . . 0.0 113.397 -178.223 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.04 160.5 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.472 1.909 . . . . 0.0 107.81 178.822 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.57 -50.51 8.71 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.726 0.81 . . . . 0.0 110.623 179.557 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.54 -159.76 35.3 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.059 0.837 . . . . 0.0 111.257 -179.389 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.82 153.67 13.38 Favored 'Cis proline' 0 C--N 1.347 0.478 0 CA-C-N 119.092 1.446 . . . . 0.0 113.802 -0.172 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.87 158.25 20.41 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 123.877 0.871 . . . . 0.0 110.933 -178.994 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.42 ' HG3' ' CD2' ' A' ' 27' ' ' TYR . 6.2 mm100 -130.98 150.89 51.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.51 1.124 . . . . 0.0 111.687 -178.601 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -88.04 156.28 19.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.556 1.142 . . . . 0.0 110.653 179.216 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -159.74 109.22 1.46 Allowed Pre-proline 0 N--CA 1.457 -0.121 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.24 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -81.28 136.63 10.15 Favored 'Trans proline' 0 N--CA 1.436 -1.897 0 C-N-CA 121.043 1.162 . . . . 0.0 113.088 -177.827 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.482 ' CG2' ' H ' ' A' ' 62' ' ' LYS . 0.6 OUTLIER -103.26 -173.78 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 128.868 2.867 . . . . 0.0 103.891 178.896 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.482 ' H ' ' CG2' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -163.36 -179.38 6.52 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 112.308 -2.224 . . . . 0.0 113.022 -177.989 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.3 t -89.42 51.05 2.03 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.075 1.35 . . . . 0.0 107.647 178.013 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.33 -66.78 0.03 OUTLIER Glycine 0 C--N 1.344 0.975 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.097 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.22 -149.41 7.28 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 117.75 0.775 . . . . 0.0 113.14 -179.774 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 t -61.86 130.72 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 126.509 1.923 . . . . 0.0 108.941 -179.165 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.1 133.14 45.36 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.879 0.872 . . . . 0.0 112.752 -178.732 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 m -132.34 -33.85 1.26 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.544 1.938 . . . . 0.0 110.352 179.394 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.26 -141.21 0.36 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.307 1.432 . . . . 0.0 114.851 -178.636 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.77 -151.69 1.55 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.364 1.459 . . . . 0.0 113.957 -178.777 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 m 72.88 151.33 0.14 Allowed Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 126.545 1.938 . . . . 0.0 110.664 -179.246 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -57.95 -72.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.042 2.495 . . . . 0.0 110.537 179.146 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.24 64.69 1.45 Allowed Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 178.304 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.69 -49.0 78.24 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.434 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.01 132.48 48.68 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.742 1.617 . . . . 0.0 108.218 178.725 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -157.96 132.73 8.47 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -178.512 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.6 m -95.95 147.66 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 176.309 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -128.65 117.32 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -178.635 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 35.4 pt -99.96 174.1 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.412 0 C-N-CA 126.345 1.858 . . . . 0.0 112.684 -178.287 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -94.85 -175.36 3.54 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.135 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.295 13.8 t -84.51 42.85 0.92 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 -179.9 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.8 -72.49 0.1 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.054 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.68 -9.04 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 -177.227 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -79.3 118.59 21.36 Favored 'General case' 0 N--CA 1.458 -0.061 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -175.921 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -71.29 115.03 9.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.249 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.76 -57.97 3.41 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.945 0.898 . . . . 0.0 112.126 -178.548 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.77 151.6 12.03 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.769 179.716 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.07 131.11 44.76 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.291 1.436 . . . . 0.0 110.847 -179.052 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.6 pt -130.99 162.56 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 125.45 1.5 . . . . 0.0 109.638 -179.019 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 t -156.56 146.83 21.34 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -179.606 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -79.26 -26.64 42.36 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.237 175.177 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.0 m -31.05 -59.94 0.21 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 127.946 2.498 . . . . 0.0 115.347 -178.13 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.39 34.06 4.57 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.297 0.951 . . . . 0.0 112.231 -178.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.81 -87.51 0.16 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 117.604 0.702 . . . . 0.0 110.981 179.511 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.2 t -162.29 -51.94 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.083 1.353 . . . . 0.0 108.723 -179.188 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.46 -88.96 0.07 OUTLIER Glycine 0 C--N 1.339 0.71 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 179.24 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -79.94 -28.61 39.65 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.115 0.966 . . . . 0.0 110.325 178.725 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -63.19 169.3 3.6 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.287 1.435 . . . . 0.0 111.538 -179.541 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -128.64 156.71 42.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.899 2.08 . . . . 0.0 109.743 -179.711 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.7 m -141.88 155.84 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 C-N-CA 124.432 1.093 . . . . 0.0 108.17 177.094 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.47 129.05 9.05 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.122 -177.775 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 37.4 m -79.93 179.75 7.41 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.298 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.2 p -61.19 124.7 21.3 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.872 -1.143 . . . . 0.0 109.683 179.152 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.04 37.61 5.65 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -178.752 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 60.5 m -152.52 145.68 24.64 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.759 1.624 . . . . 0.0 107.965 -179.732 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 125.948 1.699 . . . . 0.0 110.952 179.47 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 121.027 0.442 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.1 t -160.14 69.86 0.41 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.896 1.279 . . . . 0.0 107.966 -179.04 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.59 177.29 0.21 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.47 1.508 . . . . 0.0 110.274 -178.877 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.6 p -143.95 94.13 2.54 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.08 0.552 . . . . 0.0 110.273 178.869 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.0 m -87.76 89.61 8.06 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 102.51 -3.144 . . . . 0.0 102.51 177.792 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.3 m -86.92 63.76 8.12 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.308 1.843 . . . . 0.0 108.852 -178.952 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.13 -79.29 1.88 Allowed Glycine 0 C--N 1.34 0.779 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.085 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.7 p -115.07 -42.45 3.2 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.429 1.491 . . . . 0.0 109.68 179.256 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.35 114.3 3.11 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 124.514 1.125 . . . . 0.0 108.568 178.925 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.65 99.75 7.96 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.709 0.804 . . . . 0.0 110.368 -178.176 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -94.67 146.24 24.29 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.559 0.743 . . . . 0.0 109.08 179.048 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.4 m -72.15 153.12 41.84 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 124.094 0.958 . . . . 0.0 109.979 -179.555 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.44 -18.87 43.09 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 176.822 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 63.3 m -75.28 -39.75 59.37 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 125.002 1.321 . . . . 0.0 109.176 178.705 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -68.92 -40.84 78.83 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 123.946 0.899 . . . . 0.0 110.85 179.188 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.1 t -61.53 -48.32 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.888 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 ttt85 -65.83 -39.82 91.2 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.58 1.552 . . . . 0.0 112.125 -179.715 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.19 -51.83 66.23 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.178 0.591 . . . . 0.0 109.65 -179.074 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.51 -30.67 71.44 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.272 0.629 . . . . 0.0 111.477 179.256 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.65 -46.71 45.01 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.302 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -65.71 -20.24 66.2 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.76 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.96 -61.49 2.0 Allowed 'General case' 0 C--N 1.346 0.456 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -177.643 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -43.83 -51.64 7.27 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 124.849 1.343 . . . . 0.0 109.313 176.732 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 m -48.19 -54.25 14.09 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 126.479 1.912 . . . . 0.0 111.155 178.775 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -70.99 -25.92 62.91 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -178.729 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -106.08 -2.21 22.94 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 -176.93 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.48 -5.66 15.09 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.076 1.307 . . . . 0.0 114.275 178.683 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -78.3 -62.95 1.52 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.062 0.846 . . . . 0.0 112.134 -178.102 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -159.68 -41.32 0.05 Allowed 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.124 0.57 . . . . 0.0 110.916 -178.785 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.68 60.71 5.4 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.222 1.409 . . . . 0.0 107.643 178.814 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -69.99 123.24 21.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.611 1.564 . . . . 0.0 111.408 -178.423 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.8 t -149.41 39.56 0.82 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.871 0.869 . . . . 0.0 110.906 179.032 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.69 105.01 0.1 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.47 1.908 . . . . 0.0 106.025 179.122 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.32 114.59 0.63 Allowed Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.242 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 78.8 p -70.59 -67.84 0.47 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.411 1.084 . . . . 0.0 111.038 -179.031 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.1 m -143.09 -69.44 0.33 Allowed 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.156 0.983 . . . . 0.0 108.69 179.421 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.0 p -104.62 -58.44 1.88 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.494 1.118 . . . . 0.0 108.091 179.338 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.95 123.62 82.5 Favored Pre-proline 0 N--CA 1.468 0.457 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 178.316 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.31 123.59 8.67 Favored 'Cis proline' 0 N--CA 1.456 -0.699 0 N-CA-C 116.662 1.755 . . . . 0.0 116.662 3.892 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.64 173.23 2.02 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 128.207 2.603 . . . . 0.0 108.031 178.051 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 52.4 p -72.15 160.14 32.95 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.68 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -117.86 119.47 34.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.131 2.172 . . . . 0.0 108.658 179.554 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -166.68 44.95 0.06 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.288 1.435 . . . . 0.0 108.703 179.138 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -95.2 77.47 3.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.257 1.023 . . . . 0.0 110.384 -179.013 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 63.28 -177.21 0.15 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.614 1.566 . . . . 0.0 113.685 178.505 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -74.25 -173.0 1.55 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.722 1.609 . . . . 0.0 111.295 179.127 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.09 -52.56 0.63 Allowed Glycine 0 C--N 1.34 0.782 0 C-N-CA 124.603 1.097 . . . . 0.0 110.46 179.452 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -138.36 131.52 30.09 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.103 0.961 . . . . 0.0 110.312 179.274 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -161.04 137.29 8.36 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.223 1.809 . . . . 0.0 107.278 179.302 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -94.47 151.71 39.52 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.943 0.897 . . . . 0.0 110.339 -178.86 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.88 67.29 6.67 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 124.244 3.296 . . . . 0.0 112.044 -179.368 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.0 m -147.65 163.94 6.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 125.866 1.666 . . . . 0.0 108.066 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -66.27 -44.42 83.65 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.749 0.819 . . . . 0.0 111.725 -179.652 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.3 -171.29 49.18 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.182 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.53 167.11 24.25 Favored 'Cis proline' 0 C--N 1.348 0.526 0 CA-C-N 119.529 1.665 . . . . 0.0 113.766 -1.5 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -128.69 146.97 50.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.178 1.391 . . . . 0.0 110.832 -179.338 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -91.69 138.2 31.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 128.086 2.554 . . . . 0.0 113.43 -178.342 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.1 141.52 30.94 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.285 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -149.75 114.46 3.47 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.862 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -80.59 133.36 9.37 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.141 1.894 . . . . 0.0 112.516 -176.882 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.687 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 2.3 tt -106.05 -170.23 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-O 123.481 1.61 . . . . 0.0 111.984 -179.262 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.687 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.2 mmtp -160.76 -170.06 2.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 109.962 -3.29 . . . . 0.0 112.493 179.37 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.1 t -85.77 63.05 7.83 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 126.705 2.002 . . . . 0.0 108.108 -179.667 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.47 59.99 2.06 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -179.261 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.13 98.24 0.18 Allowed Glycine 0 C--N 1.338 0.668 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.076 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.3 t -64.42 147.26 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 178.207 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.5 t80 69.85 -167.43 0.17 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.093 0.957 . . . . 0.0 108.693 -179.041 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.2 p -78.73 114.91 18.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.256 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.56 -130.31 5.58 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.826 1.203 . . . . 0.0 110.816 -179.285 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.65 73.18 2.7 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.195 0.903 . . . . 0.0 112.981 -178.94 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.3 m 56.55 69.82 1.64 Allowed Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.153 1.381 . . . . 0.0 112.401 178.885 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.99 85.03 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.212 3.274 . . . . 0.0 111.463 179.39 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.77 31.54 8.56 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.01 -0.883 . . . . 0.0 113.717 -179.203 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -157.08 -71.5 0.1 Allowed 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.75 1.275 . . . . 0.0 111.251 178.932 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -68.93 108.63 3.57 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.356 1.862 . . . . 0.0 114.926 -178.728 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -128.35 126.2 40.23 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 125.253 1.421 . . . . 0.0 111.846 179.693 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 m -93.74 144.2 10.03 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 176.699 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.7 t -137.63 127.18 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.042 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.7 pt -113.81 171.36 4.07 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 C-N-CA 125.188 1.395 . . . . 0.0 111.655 -178.352 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -85.22 165.95 16.94 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.881 1.672 . . . . 0.0 107.897 178.833 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.389 5.9 t -80.04 48.16 0.96 Allowed 'General case' 0 C--N 1.343 0.309 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -178.204 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -143.64 -85.59 0.14 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 102.071 -3.307 . . . . 0.0 102.071 176.754 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -163.61 -3.57 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.579 1.951 . . . . 0.0 114.616 178.687 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -79.67 122.4 26.5 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -176.084 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -63.32 117.15 6.22 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.507 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.65 -53.41 4.65 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 123.515 0.726 . . . . 0.0 110.761 -177.647 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.66 150.94 9.97 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.356 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.97 130.37 54.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.648 1.179 . . . . 0.0 108.145 179.565 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.8 pt -122.27 157.43 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.938 1.295 . . . . 0.0 108.579 -179.27 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.3 t -156.97 146.08 20.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -178.661 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -84.33 65.0 8.64 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 174.571 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.5 m -51.07 -46.61 61.81 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.927 0.785 . . . . 0.0 110.387 179.236 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.57 -51.48 0.03 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 179.401 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 30.25 -99.35 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 128.071 2.548 . . . . 0.0 112.669 -179.13 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.4 m -159.58 79.46 0.72 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.854 1.662 . . . . 0.0 107.251 179.141 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.49 -108.05 2.31 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.462 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -79.77 -5.9 56.23 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.736 0.814 . . . . 0.0 113.0 -179.325 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -64.64 160.86 18.86 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.002 0.819 . . . . 0.0 110.339 179.288 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -121.82 167.55 12.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.572 1.549 . . . . 0.0 113.656 -177.832 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.8 m -146.19 165.99 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 128.953 2.901 . . . . 0.0 105.928 176.737 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.2 144.96 17.09 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.369 0.509 . . . . 0.0 113.946 -178.238 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 13.9 m -94.3 165.24 12.68 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 124.092 0.957 . . . . 0.0 109.049 178.43 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 88.1 p 21.81 43.47 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 129.11 2.964 . . . . 0.0 118.091 -177.887 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.77 59.38 9.8 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.587 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.3 t -78.99 151.31 31.64 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.983 0.42 . . . . 0.0 110.689 -179.397 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 . . . . . 0 C--O 1.251 1.132 0 CA-C-O 116.468 -1.73 . . . . 0.0 110.779 -178.956 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 121.05 0.452 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t -152.44 143.94 23.41 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.865 1.266 . . . . 0.0 108.231 179.937 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.51 132.61 45.14 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.14 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.4 t -132.93 143.34 49.42 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -177.76 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.82 117.34 29.93 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.952 1.701 . . . . 0.0 108.212 178.885 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.8 m -103.76 78.18 1.54 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.896 1.278 . . . . 0.0 108.506 -178.814 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.51 -57.75 4.89 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.415 1.007 . . . . 0.0 111.723 179.392 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.1 t -150.79 -42.1 0.12 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.963 1.305 . . . . 0.0 110.56 -179.369 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.71 113.31 5.39 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.382 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -82.29 155.11 25.0 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.564 1.546 . . . . 0.0 111.394 -178.876 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -149.74 139.96 22.2 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.077 1.351 . . . . 0.0 109.092 178.956 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 m -81.52 160.19 23.98 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 124.862 1.265 . . . . 0.0 108.502 177.7 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.33 -23.42 48.71 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.863 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.2 p -77.85 -31.12 51.3 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.678 0.611 . . . . 0.0 110.286 -178.955 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.63 -39.43 70.42 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.939 0.896 . . . . 0.0 111.525 179.162 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.03 -38.66 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -179.141 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -72.0 -24.71 61.62 Favored 'General case' 0 C--N 1.347 0.461 0 C-N-CA 124.576 1.15 . . . . 0.0 112.384 179.124 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.47 -58.32 4.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.381 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.18 -23.34 63.92 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.076 179.33 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.73 -43.48 54.78 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 120.693 1.588 . . . . 0.0 111.292 178.944 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -66.93 -21.62 65.98 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.982 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.18 -64.3 1.17 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 -178.733 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.447 ' HB1' ' CD2' ' A' ' 59' ' ' PHE . . . -34.7 -53.05 0.54 Allowed 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.35 1.86 . . . . 0.0 111.226 175.952 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.3 t -56.75 -53.63 55.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.316 1.446 . . . . 0.0 110.919 179.446 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -73.87 -12.51 60.69 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -179.169 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -108.88 -19.24 13.47 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -178.832 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -80.84 -59.32 2.72 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.516 1.507 . . . . 0.0 112.785 -177.735 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -143.81 51.9 1.32 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.927 0.785 . . . . 0.0 111.713 -178.784 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -134.99 -53.58 0.8 Allowed 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.665 1.186 . . . . 0.0 108.835 178.764 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -138.4 86.21 2.14 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -178.977 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 68.23 -167.92 0.19 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.81 1.244 . . . . 0.0 110.215 -179.507 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.5 p -107.41 -41.02 5.2 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.17 1.388 . . . . 0.0 110.024 178.748 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 52.08 95.63 0.01 OUTLIER 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.505 1.922 . . . . 0.0 113.329 178.888 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.72 -95.64 0.99 Allowed Glycine 0 C--N 1.336 0.563 0 C-N-CA 124.816 1.198 . . . . 0.0 110.363 179.936 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m 54.8 67.48 1.01 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.413 1.085 . . . . 0.0 110.095 -179.09 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.4 t -113.08 -56.03 2.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 102.311 -3.218 . . . . 0.0 102.311 179.436 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.49 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 22.3 p -119.9 -31.54 4.46 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 127.645 2.378 . . . . 0.0 107.464 177.047 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' A' ' 37' ' ' THR . 1.8 m-85 -149.19 154.51 39.18 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 127.377 2.271 . . . . 0.0 110.044 -178.786 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.17 119.71 6.59 Favored 'Cis proline' 0 CA--C 1.542 0.907 0 N-CA-C 114.082 0.762 . . . . 0.0 114.082 1.93 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -127.85 158.83 36.67 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 125.966 1.706 . . . . 0.0 110.71 -179.343 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.9 m -59.64 135.7 57.76 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.996 2.118 . . . . 0.0 110.104 178.708 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -135.94 60.58 1.67 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.019 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -161.79 58.31 0.26 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.874 1.27 . . . . 0.0 109.076 -179.033 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -70.98 -62.69 1.3 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.968 0.907 . . . . 0.0 110.196 179.802 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -141.14 -80.66 0.25 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.949 1.3 . . . . 0.0 108.152 179.458 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -166.04 121.7 1.26 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -179.373 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.69 -73.59 0.05 OUTLIER Glycine 0 C--N 1.336 0.565 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 178.941 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.21 171.71 8.43 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.012 0.925 . . . . 0.0 109.446 179.068 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -128.46 146.37 50.83 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.142 0.977 . . . . 0.0 111.168 -179.201 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -153.1 155.17 31.76 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 125.866 1.667 . . . . 0.0 108.201 -179.707 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.28 -32.63 61.58 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.945 2.43 . . . . 0.0 111.137 178.874 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.9 m -74.78 164.93 3.38 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 C-N-CA 123.576 0.75 . . . . 0.0 111.094 179.276 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -100.43 -61.3 1.39 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.024 1.33 . . . . 0.0 109.203 179.431 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 135.77 -165.72 24.75 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.71 1.148 . . . . 0.0 110.998 179.441 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.61 138.21 23.31 Favored 'Cis proline' 0 C--N 1.345 0.392 0 CA-C-N 118.247 1.024 . . . . 0.0 111.533 -0.632 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -135.25 138.95 44.04 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 179.989 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -125.3 157.81 35.73 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.626 1.57 . . . . 0.0 112.116 -178.748 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.33 157.26 25.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 127.631 2.373 . . . . 0.0 114.151 -177.934 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CD2' ' HB1' ' A' ' 23' ' ' ALA . 60.7 t80 -160.8 113.36 1.32 Allowed Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.248 1.019 . . . . 0.0 110.157 177.915 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . 0.269 24.8 Cg_endo -70.52 138.64 35.86 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 CA-C-N 120.17 1.097 . . . . 0.0 112.731 -177.243 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.567 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -80.96 -149.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -176.969 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.567 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 27.0 mmmt -83.35 -171.04 3.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 131.156 3.783 . . . . 0.0 111.945 -178.15 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.3 t 91.56 54.97 0.0 OUTLIER 'General case' 0 C--N 1.343 0.295 0 C-N-CA 129.56 3.144 . . . . 0.0 105.383 -178.008 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.21 -46.02 0.84 Allowed Glycine 0 CA--C 1.53 0.997 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -178.377 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.29 172.09 24.09 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.364 1.459 . . . . 0.0 109.989 179.41 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.35 114.46 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 178.939 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 75.1 t80 61.63 75.81 0.39 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.163 1.385 . . . . 0.0 111.462 -179.181 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 t -160.26 -178.34 6.89 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.341 1.057 . . . . 0.0 110.128 178.724 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.16 -150.54 1.94 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.665 1.126 . . . . 0.0 112.316 179.508 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.4 -55.3 4.72 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -178.997 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.4 t -137.8 79.52 33.54 Favored Pre-proline 0 N--CA 1.451 -0.386 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.647 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -35.09 -54.63 0.63 Allowed 'Trans proline' 0 C--N 1.349 0.595 1 C-N-CA 126.242 4.628 . . . . 0.0 116.362 -175.824 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.72 99.26 0.16 Allowed Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.59 -0.815 . . . . 0.0 113.559 -179.231 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.11 -76.52 0.1 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 177.244 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.59 110.53 1.15 Allowed 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.761 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -136.29 119.66 16.84 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.821 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.4 m -89.15 152.0 3.4 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 176.622 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -137.75 141.77 38.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -176.982 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.59 179.56 4.17 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 123.72 0.808 . . . . 0.0 112.531 -178.485 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -96.38 169.84 9.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.461 1.905 . . . . 0.0 110.015 -178.62 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.278 6.5 t -76.56 28.03 0.13 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 118.051 2.611 . . . . 0.0 118.051 -177.967 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -129.5 -78.0 0.55 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 102.648 -3.093 . . . . 0.0 102.648 177.167 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.09 -19.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -178.686 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -79.28 145.57 33.45 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -175.4 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . 0.267 31.7 m-85 -63.61 157.16 24.55 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 127.498 2.319 . . . . 0.0 115.497 -179.042 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -113.84 -44.53 3.16 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 175.556 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.01 -148.45 20.22 Favored Glycine 0 C--N 1.349 1.262 0 C-N-CA 126.222 1.867 . . . . 0.0 111.752 177.576 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.84 147.77 35.96 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-O 121.554 0.693 . . . . 0.0 112.283 -178.79 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 pt -147.0 167.39 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 127.017 2.127 . . . . 0.0 108.376 -179.108 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.6 t -158.88 148.13 18.82 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 179.548 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -83.67 36.1 0.53 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.196 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.3 t -58.72 -35.51 72.79 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.46 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -173.25 60.35 0.14 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.568 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -97.17 -71.06 0.69 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.279 1.032 . . . . 0.0 108.999 179.323 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.3 t -170.66 -62.86 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.758 1.623 . . . . 0.0 109.041 179.219 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.46 -87.11 0.06 OUTLIER Glycine 0 C--N 1.338 0.671 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 179.407 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -79.87 -18.25 51.16 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.531 0.732 . . . . 0.0 110.215 178.743 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -65.03 168.36 6.64 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.369 1.468 . . . . 0.0 110.727 179.327 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -136.27 169.79 17.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.914 1.285 . . . . 0.0 113.056 -177.972 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.3 m -141.38 164.82 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.94 2.096 . . . . 0.0 106.424 176.65 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.47 142.65 27.26 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 115.029 0.772 . . . . 0.0 115.029 -177.493 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 24.6 t -109.37 169.99 8.35 Favored 'General case' 0 C--N 1.341 0.202 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 177.671 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.36 -157.57 0.33 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.684 -0.635 . . . . 0.0 109.425 -178.3 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.53 -9.34 58.25 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 124.183 0.897 . . . . 0.0 111.396 177.346 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.7 m -79.41 143.42 35.06 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 125.17 1.388 . . . . 0.0 108.982 179.213 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.189 1.396 . . . . 0.0 109.956 -179.217 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 121.215 0.531 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 81.6 p -85.93 176.86 7.83 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.419 1.087 . . . . 0.0 109.762 179.117 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.33 127.43 8.96 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.061 1.345 . . . . 0.0 111.084 179.104 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -111.61 123.48 50.32 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.814 1.246 . . . . 0.0 109.713 -178.802 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -129.71 93.66 3.57 Favored 'General case' 0 N--CA 1.428 -1.53 1 N-CA-C 98.558 -4.608 . . . . 0.0 98.558 176.839 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.5 m -102.91 88.3 3.15 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.195 0.598 . . . . 0.0 110.295 -177.655 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.07 -79.38 1.02 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -178.946 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.2 p -132.83 -31.69 1.3 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.304 1.842 . . . . 0.0 110.464 178.521 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 m -67.41 106.7 2.19 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.024 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -108.07 141.66 39.42 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.546 1.138 . . . . 0.0 111.738 -178.352 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -144.45 144.33 31.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.779 1.632 . . . . 0.0 108.155 179.356 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.8 t -70.11 155.43 40.63 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 124.448 1.099 . . . . 0.0 109.912 178.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.71 -21.94 56.23 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 176.388 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -73.2 -35.85 66.43 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 125.157 1.383 . . . . 0.0 109.959 179.215 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.2 tp-100 -73.75 -35.56 65.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.173 0.589 . . . . 0.0 112.384 179.185 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 t -69.02 -47.13 77.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.377 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.3 ptt85 -65.26 -43.26 91.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.02 0.528 . . . . 0.0 110.554 179.551 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.72 89.5 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.543 0.737 . . . . 0.0 109.398 179.023 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.81 -38.98 79.81 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.369 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.92 -29.73 62.2 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 178.506 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -70.81 -24.1 62.49 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.494 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.36 -64.3 1.17 Allowed 'General case' 0 C--N 1.346 0.441 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 -178.76 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -39.25 -50.59 1.98 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.078 1.351 . . . . 0.0 112.211 176.445 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -51.99 -62.88 1.35 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 128.029 2.531 . . . . 0.0 111.586 179.324 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -66.03 -42.12 90.03 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.543 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -67.54 -30.85 70.6 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.418 1.087 . . . . 0.0 113.149 -177.728 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -84.48 -44.64 13.43 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 118.957 0.799 . . . . 0.0 112.12 -179.739 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -69.56 -51.13 38.25 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.233 0.613 . . . . 0.0 111.648 -179.007 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -78.03 -20.61 52.11 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.789 -179.458 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 63.74 65.21 0.73 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 124.935 1.294 . . . . 0.0 110.362 179.815 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -150.55 167.38 27.38 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 126.032 1.733 . . . . 0.0 108.049 179.099 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.287 0.0 OUTLIER 49.53 71.58 0.38 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.263 1.025 . . . . 0.0 113.46 -179.459 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.63 144.91 25.54 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.06 1.344 . . . . 0.0 108.549 179.179 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.72 -165.85 23.0 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.804 -0.519 . . . . 0.0 111.804 -179.42 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.1 m -83.86 46.66 1.2 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.904 0.882 . . . . 0.0 111.139 -179.384 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 87.7 p -146.75 161.54 40.4 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 178.733 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.7 p -80.11 33.31 0.28 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.885 -179.556 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -92.65 127.23 48.99 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 119.922 1.237 . . . . 0.0 109.504 -178.462 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -60.95 120.67 1.21 Allowed 'Cis proline' 0 C--N 1.348 0.506 0 N-CA-C 116.144 1.556 . . . . 0.0 116.144 -1.426 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -103.65 157.3 17.16 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.488 1.115 . . . . 0.0 108.84 178.933 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.92 118.86 8.36 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 122.706 0.403 . . . . 0.0 110.956 179.871 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.92 105.4 13.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 178.771 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -153.59 143.16 21.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.93 0.892 . . . . 0.0 110.296 -178.664 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 56.0 -134.0 1.44 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.07 1.348 . . . . 0.0 110.999 178.998 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 73.92 -73.7 0.09 Allowed 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.139 1.776 . . . . 0.0 109.065 -179.302 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -127.82 -37.09 1.96 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.787 1.635 . . . . 0.0 109.176 178.949 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.09 70.65 1.3 Allowed Glycine 0 C--N 1.342 0.874 0 C-N-CA 124.243 0.925 . . . . 0.0 112.027 178.92 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.33 -169.05 2.42 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.689 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -154.64 156.94 37.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.487 0.715 . . . . 0.0 110.689 179.449 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -148.92 144.51 18.24 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 125.739 1.616 . . . . 0.0 107.616 178.681 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -45.19 -45.47 14.74 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.49 3.46 . . . . 0.0 113.371 178.649 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -83.31 149.11 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 124.158 0.983 . . . . 0.0 110.482 179.323 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -91.61 168.7 11.32 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.855 1.262 . . . . 0.0 111.162 -178.854 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.08 -158.16 27.3 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.386 0.993 . . . . 0.0 111.797 -179.244 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.91 128.09 2.94 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 CA-C-N 118.215 1.007 . . . . 0.0 112.202 -0.362 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.44 158.33 21.71 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.907 2.083 . . . . 0.0 109.025 178.793 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -137.08 164.28 28.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.558 -177.954 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.98 157.54 26.8 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 126.709 2.004 . . . . 0.0 110.698 -178.078 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -160.12 96.77 1.51 Allowed Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 176.246 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.58 145.76 47.78 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 C-N-CA 120.379 0.719 . . . . 0.0 110.935 -176.119 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.69 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 2.9 tt -109.33 -172.77 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 124.253 1.978 . . . . 0.0 111.589 178.639 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.69 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 2.9 tttm -160.02 152.13 20.55 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 109.12 -3.673 . . . . 0.0 109.84 -179.397 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.1 t -76.58 52.27 0.79 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.628 1.571 . . . . 0.0 113.748 -178.165 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.0 43.05 0.24 Allowed Glycine 0 CA--C 1.526 0.759 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.402 178.016 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.58 76.48 0.03 OUTLIER Glycine 0 C--N 1.345 1.049 0 CA-C-N 119.53 1.665 . . . . 0.0 116.247 178.767 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.333 8.6 p 37.06 -139.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.43 0 C-N-CA 126.167 1.787 . . . . 0.0 113.385 177.683 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -58.12 -175.9 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.604 2.362 . . . . 0.0 114.173 178.548 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.1 p -78.92 158.74 27.98 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.398 1.079 . . . . 0.0 113.854 -177.373 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 178.77 47.98 0.07 OUTLIER Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.247 1.88 . . . . 0.0 108.686 179.247 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 170.25 -160.19 32.91 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.139 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 76.9 p -158.84 156.71 27.36 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 124.752 1.221 . . . . 0.0 109.437 -179.329 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -79.74 166.07 78.22 Favored 'Cis proline' 0 N--CA 1.458 -0.56 0 CA-C-N 119.427 0.831 . . . . 0.0 111.36 -2.505 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.64 -109.45 1.1 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 124.224 0.916 . . . . 0.0 112.406 -178.935 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 58.68 35.39 24.41 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 125.362 1.465 . . . . 0.0 111.541 -178.753 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -152.51 107.77 3.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.324 1.05 . . . . 0.0 110.529 178.377 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.44 130.56 19.54 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.51 -179.314 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.4 m -98.52 157.29 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 176.361 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.6 t -135.44 133.15 52.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -178.479 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -116.61 -179.95 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.781 1.232 . . . . 0.0 112.444 -178.307 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -101.45 174.82 5.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.952 2.101 . . . . 0.0 109.548 179.128 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.31 13.7 t -82.19 49.08 1.34 Allowed 'General case' 0 C--N 1.345 0.386 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -178.576 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -152.46 -87.99 0.06 Allowed 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 177.429 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 94.9 m -161.83 -0.22 0.05 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.874 2.469 . . . . 0.0 113.879 -176.898 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -80.06 138.85 37.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.364 0.984 . . . . 0.0 113.063 -176.866 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -80.0 128.39 33.42 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.405 1.482 . . . . 0.0 108.042 178.829 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.28 -47.89 6.42 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 123.556 0.743 . . . . 0.0 110.505 179.605 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.15 -174.24 46.25 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 179.339 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.97 141.88 44.48 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.39 1.476 . . . . 0.0 109.915 179.329 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.5 pt -141.07 157.26 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.795 1.238 . . . . 0.0 109.621 -179.079 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.0 t -150.81 149.81 30.19 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.126 0.97 . . . . 0.0 113.402 -178.48 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . 0.266 37.8 m170 -79.51 -24.1 42.49 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.972 0.805 . . . . 0.0 109.118 175.999 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.1 m -50.75 102.55 0.04 OUTLIER 'General case' 0 C--N 1.343 0.299 0 C-N-CA 126.339 1.855 . . . . 0.0 109.255 178.994 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.13 63.23 1.75 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -178.646 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.47 179.57 8.05 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.385 1.074 . . . . 0.0 110.609 179.571 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.7 t -86.18 62.07 7.21 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.507 1.523 . . . . 0.0 110.527 -179.353 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.21 -90.03 0.43 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.824 1.678 . . . . 0.0 113.199 178.418 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.35 -23.12 43.62 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.148 0.979 . . . . 0.0 111.344 -179.064 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -59.75 158.38 10.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.472 1.109 . . . . 0.0 112.129 -179.086 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -121.15 135.0 55.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.084 1.754 . . . . 0.0 108.991 -179.459 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 m -110.06 163.5 6.97 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.697 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.65 149.34 31.62 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.894 0.759 . . . . 0.0 112.935 -178.439 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.7 t -137.26 164.67 27.97 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 125.725 1.61 . . . . 0.0 108.849 178.76 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 96.4 p 46.47 50.65 12.47 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.366 2.267 . . . . 0.0 112.631 -179.649 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.12 64.04 2.28 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.241 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -146.01 132.99 20.22 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.863 1.265 . . . . 0.0 108.132 179.083 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 116.756 -1.592 . . . . 0.0 109.036 179.352 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 121.235 0.54 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t -159.88 71.86 0.49 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.272 1.029 . . . . 0.0 108.576 -179.338 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.84 97.52 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.416 1.886 . . . . 0.0 110.878 179.34 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.5 m -99.69 121.73 41.67 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.46 1.904 . . . . 0.0 107.504 -178.733 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -122.59 111.29 16.6 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -179.683 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.3 m -100.04 81.91 2.48 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.484 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.89 -95.36 0.72 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.317 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.6 p -104.23 -36.33 7.68 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.116 1.366 . . . . 0.0 110.977 179.375 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -73.83 103.77 4.48 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.113 0.565 . . . . 0.0 110.099 -178.876 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -83.06 152.91 25.16 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.43 1.092 . . . . 0.0 110.622 -179.243 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -148.11 137.71 22.33 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.964 0.906 . . . . 0.0 111.281 -179.815 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.5 m -78.17 150.44 33.56 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.475 1.51 . . . . 0.0 107.757 178.295 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.96 -17.5 25.3 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.087 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.2 t -74.55 -44.99 48.43 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 124.506 1.122 . . . . 0.0 109.513 178.956 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -68.7 -43.73 75.42 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.051 0.94 . . . . 0.0 110.917 -179.894 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.9 t -56.72 -54.4 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 C-N-CA 126.988 2.115 . . . . 0.0 109.135 178.954 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -67.93 -43.05 80.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.071 -178.128 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.8 -49.48 77.33 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.694 0.679 . . . . 0.0 109.674 179.297 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.82 -31.75 68.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.313 1.045 . . . . 0.0 110.478 178.837 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.47 -38.47 29.87 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 179.769 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -66.7 -22.12 66.08 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.419 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.09 -54.91 5.53 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -179.182 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -46.77 -43.71 18.43 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.431 1.492 . . . . 0.0 112.499 177.853 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.0 p -73.28 -43.42 61.04 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.996 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -60.99 -31.02 70.63 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.137 0.426 . . . . 0.0 110.685 178.737 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -97.14 -3.88 40.26 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.341 1.457 . . . . 0.0 113.135 -179.177 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -57.45 -24.82 57.92 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.358 -0.839 . . . . 0.0 111.663 178.722 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.467 0.0 OUTLIER 127.73 59.44 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.634 1 C-N-CA 135.15 5.38 . . . . 0.0 112.837 -178.221 . . . . . . . . 4 3 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -129.16 -35.11 1.83 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.696 1.198 . . . . 0.0 112.188 -179.109 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -153.96 64.72 0.71 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.22 0.918 . . . . 0.0 113.127 179.505 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 t70 57.89 -170.32 0.11 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.315 1.446 . . . . 0.0 113.285 178.154 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.3 p 47.68 43.67 16.79 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.924 1.69 . . . . 0.0 112.94 179.049 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.85 -175.59 3.54 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.279 1.431 . . . . 0.0 114.426 -178.532 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -32.35 138.02 0.1 Allowed Glycine 0 C--N 1.341 0.846 0 C-N-CA 128.118 2.771 . . . . 0.0 117.558 -178.217 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.9 m -101.88 -55.94 2.39 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.311 1.444 . . . . 0.0 110.629 -179.519 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.6 p -97.65 -63.57 1.12 Allowed 'General case' 0 C--N 1.346 0.454 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -179.256 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.8 p -146.41 -42.03 0.2 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.598 1.959 . . . . 0.0 110.376 -179.532 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -91.59 151.6 42.62 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 124.692 1.197 . . . . 0.0 109.746 -178.088 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -84.38 134.2 20.57 Favored 'Cis proline' 0 N--CA 1.45 -1.048 0 CA-C-N 119.655 0.913 . . . . 0.0 111.127 -1.72 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.05 172.9 15.15 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 126.033 1.733 . . . . 0.0 108.207 179.412 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 t -60.4 147.77 39.66 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.715 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -80.01 116.61 20.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.998 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -68.48 -52.75 28.9 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.654 1.181 . . . . 0.0 112.301 -179.345 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -88.38 -170.04 2.8 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.482 1.113 . . . . 0.0 111.173 -179.061 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -129.07 -50.78 1.21 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.635 1.974 . . . . 0.0 108.638 179.505 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 53.99 70.61 0.59 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.326 1.85 . . . . 0.0 113.763 178.455 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.45 -98.38 0.24 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.684 1.135 . . . . 0.0 113.217 178.579 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.05 154.15 16.27 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.689 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -121.21 -170.11 1.96 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 126.23 1.812 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -131.25 158.38 75.41 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 125.328 1.451 . . . . 0.0 108.233 -178.63 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.5 66.57 4.58 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 124.006 3.137 . . . . 0.0 113.226 -178.766 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 m -163.1 164.94 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 126.86 2.064 . . . . 0.0 108.873 179.315 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -84.77 -58.99 2.49 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.478 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.95 177.63 15.02 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.11 1.338 . . . . 0.0 110.516 -179.321 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.57 139.17 58.46 Favored 'Cis proline' 0 N--CA 1.457 -0.629 0 CA-C-N 117.916 0.858 . . . . 0.0 111.442 0.127 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -114.8 150.79 34.89 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.891 1.277 . . . . 0.0 109.511 178.698 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -113.7 159.32 19.84 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -177.002 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -98.7 152.48 19.61 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.133 1.773 . . . . 0.0 109.529 179.132 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -160.84 119.83 1.53 Allowed Pre-proline 0 C--O 1.223 -0.301 0 C-N-CA 124.008 0.923 . . . . 0.0 108.707 177.272 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.91 122.97 3.09 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 121.229 1.286 . . . . 0.0 113.795 -177.572 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.417 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.4 tp -86.17 168.25 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 CA-C-O 123.678 1.704 . . . . 0.0 111.998 179.293 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.417 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 25.9 mmtt -158.64 158.11 33.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 109.233 -3.621 . . . . 0.0 111.604 -178.851 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.1 m -84.92 60.04 5.97 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.813 1.645 . . . . 0.0 110.36 -178.946 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.85 -61.69 0.01 OUTLIER Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 179.083 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.85 -104.47 0.19 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.207 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.24 163.97 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.429 1.092 . . . . 0.0 108.438 -179.455 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.93 152.63 12.52 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -178.37 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.8 p -139.21 -65.68 0.48 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.649 1.58 . . . . 0.0 108.575 179.378 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.02 105.11 0.27 Allowed Glycine 0 C--N 1.341 0.837 0 C-N-CA 124.417 1.008 . . . . 0.0 110.783 179.301 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -150.1 19.97 1.09 Allowed Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.808 -0.996 . . . . 0.0 113.069 179.313 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.1 m 67.42 119.97 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 126.375 1.87 . . . . 0.0 112.069 179.204 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.71 -176.24 17.91 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 CA-C-N 119.785 0.959 . . . . 0.0 112.499 0.131 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.07 66.99 0.32 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 108.19 -1.964 . . . . 0.0 108.19 179.287 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.95 -58.85 2.27 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.474 0.71 . . . . 0.0 112.097 -178.831 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -61.14 117.83 6.05 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.434 1.494 . . . . 0.0 113.398 -178.116 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -138.56 118.15 13.02 Favored 'General case' 0 C--N 1.344 0.368 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.159 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.5 m -81.64 148.39 5.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 176.879 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.27 53.6 t -130.97 111.51 20.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -178.071 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -101.12 -179.67 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 125.861 1.664 . . . . 0.0 113.936 -176.382 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -101.86 155.16 18.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 127.957 2.503 . . . . 0.0 108.62 179.875 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.282 11.4 t -64.11 -8.45 12.1 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -178.323 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -84.27 -80.74 0.19 Allowed 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 102.485 -3.154 . . . . 0.0 102.485 177.645 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 23.4 m -164.34 -7.39 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 129.589 3.155 . . . . 0.0 114.951 -179.17 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -79.68 132.76 36.29 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 116.501 2.038 . . . . 0.0 116.501 -175.314 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -75.34 123.16 24.87 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.152 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.51 -59.55 2.28 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.825 0.85 . . . . 0.0 111.258 -178.184 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.11 164.28 33.54 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -179.899 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.29 158.81 19.29 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.814 0.816 . . . . 0.0 112.25 -178.858 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.8 pt -140.46 160.3 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.329 2.252 . . . . 0.0 106.859 179.288 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.3 t -156.65 152.15 26.78 Favored 'General case' 0 C--N 1.343 0.326 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -179.046 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -83.57 38.34 0.62 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.337 0.655 . . . . 0.0 111.07 176.571 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.2 m -77.7 -73.3 0.31 Allowed 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.369 0.986 . . . . 0.0 109.624 -179.334 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.35 -9.21 60.63 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.489 1.043 . . . . 0.0 112.116 178.939 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.81 155.07 27.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.555 1.542 . . . . 0.0 111.748 178.993 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.8 m -68.89 -50.09 52.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.659 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.93 -84.29 0.05 OUTLIER Glycine 0 CA--C 1.527 0.787 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.193 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -89.01 0.32 56.77 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.127 0.971 . . . . 0.0 111.891 179.828 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -71.34 -170.57 0.51 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.863 0.865 . . . . 0.0 110.56 179.516 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -147.78 160.88 42.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.644 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.1 m -142.41 162.7 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 127.585 2.354 . . . . 0.0 106.334 177.012 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.98 121.53 5.55 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.074 0.845 . . . . 0.0 114.401 -178.808 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.44 159.6 15.03 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.65 1.18 . . . . 0.0 109.404 178.502 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.7 p 60.27 45.22 11.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.472 1.909 . . . . 0.0 111.042 -178.781 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.01 44.17 96.3 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.299 0.952 . . . . 0.0 111.928 179.448 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.9 m -104.84 149.53 25.59 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.625 1.17 . . . . 0.0 109.362 179.316 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.106 0 C-N-CA 124.445 1.098 . . . . 0.0 108.146 179.083 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 110.727 -0.101 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.9 m -146.33 163.2 36.31 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.607 1.163 . . . . 0.0 109.684 -179.312 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.03 124.58 19.18 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.427 1.091 . . . . 0.0 109.817 179.274 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 p -89.46 81.39 6.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -178.309 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.27 92.09 6.88 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 175.877 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -100.51 79.06 2.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.535 1.534 . . . . 0.0 109.324 -177.643 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.76 -70.62 1.98 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.345 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.2 p -137.98 -34.11 0.68 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.632 1.573 . . . . 0.0 111.877 179.453 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 m -72.67 93.55 1.65 Allowed 'General case' 0 C--N 1.345 0.389 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.148 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -96.6 113.74 25.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.777 1.631 . . . . 0.0 112.869 -178.43 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.435 ' HH ' ' HG ' ' A' ' 63' ' ' SER . 3.2 m-85 -109.78 144.75 37.77 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.885 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.0 m -66.37 152.3 45.33 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 124.229 1.011 . . . . 0.0 109.527 179.148 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.94 -24.73 25.16 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.705 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.4 t -71.33 -43.79 66.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.146 1.378 . . . . 0.0 109.594 179.31 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -71.86 -29.47 64.41 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -179.263 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.29 -45.26 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.28 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -67.86 -32.94 73.79 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.37 1.068 . . . . 0.0 111.857 179.393 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.04 -58.17 5.43 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.444 1.02 . . . . 0.0 110.135 -179.265 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.53 -37.09 80.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.787 -178.843 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.78 58.63 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 179.413 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -68.78 -19.89 64.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.785 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.54 -60.86 2.17 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 179.525 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.71 -41.34 31.55 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.371 1.068 . . . . 0.0 112.4 177.219 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -55.74 30.86 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.002 1.321 . . . . 0.0 109.906 179.014 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -56.55 -31.47 64.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.675 1.19 . . . . 0.0 110.893 -178.379 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 -89.07 -32.05 17.74 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -178.832 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -63.94 -36.53 84.26 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.636 1.107 . . . . 0.0 113.927 -177.7 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -105.33 27.0 8.72 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.975 0.91 . . . . 0.0 111.98 -178.513 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.99 -36.83 8.46 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.076 0.95 . . . . 0.0 111.992 179.338 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.7 t70 83.49 96.19 0.04 OUTLIER 'General case' 0 C--N 1.344 0.345 0 C-N-CA 127.354 2.262 . . . . 0.0 108.789 -178.597 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 70.99 109.0 0.06 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 127.192 2.197 . . . . 0.0 109.65 -178.755 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -175.97 -47.98 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.25 1.42 . . . . 0.0 111.422 -177.622 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.88 96.92 3.21 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.986 0.514 . . . . 0.0 109.845 -179.288 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.16 49.62 3.78 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.564 1.078 . . . . 0.0 110.461 179.705 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.0 m -89.14 -76.49 0.41 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.799 1.239 . . . . 0.0 108.374 -179.463 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.8 t -173.72 -64.98 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.114 1.765 . . . . 0.0 106.48 179.235 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.08 8.67 0.65 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.388 1.475 . . . . 0.0 111.857 178.84 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -94.95 129.8 34.7 Favored Pre-proline 0 C--N 1.345 0.382 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.294 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -70.15 129.0 13.94 Favored 'Cis proline' 0 N--CA 1.456 -0.726 0 N-CA-C 115.444 1.286 . . . . 0.0 115.444 0.115 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . 0.252 21.3 m-70 -96.87 143.65 27.57 Favored 'General case' 0 C--N 1.343 0.298 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 178.059 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 t -63.14 142.15 58.49 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.584 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -107.35 119.26 38.92 Favored 'General case' 0 C--O 1.23 0.048 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.04 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -149.64 -63.57 0.22 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.279 1.832 . . . . 0.0 107.085 178.921 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.4 t30 50.91 -115.56 0.88 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.03 1.732 . . . . 0.0 112.044 178.798 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -169.37 -174.96 2.08 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.02 2.128 . . . . 0.0 107.627 -179.165 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 76.93 157.42 0.18 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.801 1.641 . . . . 0.0 110.869 179.319 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.45 70.14 2.47 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.077 0.846 . . . . 0.0 111.292 179.19 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.5 111.74 6.55 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.167 1.387 . . . . 0.0 107.809 179.042 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -148.31 -175.49 4.93 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.847 1.259 . . . . 0.0 108.355 179.721 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -132.01 144.97 55.42 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.662 1.185 . . . . 0.0 108.647 -179.076 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.23 67.3 6.95 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 124.36 3.373 . . . . 0.0 112.293 -179.226 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.05 -170.65 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 127.496 2.318 . . . . 0.0 107.573 179.246 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -118.57 131.33 56.21 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.765 1.226 . . . . 0.0 109.606 179.18 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.02 -172.23 45.92 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.324 0.964 . . . . 0.0 112.341 -179.353 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.95 151.93 97.61 Favored 'Cis proline' 0 N--CA 1.458 -0.594 0 CA-C-N 118.041 0.92 . . . . 0.0 111.809 0.078 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -118.14 176.28 5.29 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.861 1.265 . . . . 0.0 109.942 179.324 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.12 153.51 31.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.972 178.992 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.274 8.0 tp10 -79.92 150.05 30.67 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.099 2.56 . . . . 0.0 111.579 -177.7 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -155.27 106.0 2.23 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.004 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.71 135.06 23.11 Favored 'Trans proline' 0 N--CA 1.442 -1.542 0 N-CA-C 107.674 -1.702 . . . . 0.0 107.674 -177.311 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.505 ' CG1' ' H ' ' A' ' 62' ' ' LYS 0.266 0.1 OUTLIER -85.76 -147.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.34 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -176.1 . . . . . . . . 4 4 . 1 . 042 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.505 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.9 mmmm -79.25 166.28 22.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 110.936 -2.847 . . . . 0.0 111.401 -178.287 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.435 ' HG ' ' HH ' ' A' ' 11' ' ' TYR . 36.2 m 132.31 51.73 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.493 1 C-N-CA 133.199 4.599 . . . . 0.0 104.723 -177.987 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.54 -52.09 0.59 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.665 1.602 . . . . 0.0 109.243 -178.545 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 177.53 -164.72 34.02 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.483 1.04 . . . . 0.0 110.562 179.728 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.6 p -75.25 71.33 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.92 1.288 . . . . 0.0 107.975 178.888 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.7 t80 65.81 80.07 0.23 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 128.484 2.713 . . . . 0.0 111.251 -178.269 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 t -157.78 105.59 2.01 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.782 1.233 . . . . 0.0 108.909 179.083 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 179.13 -118.71 0.61 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.4 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 174.29 -99.4 0.14 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.159 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.0 m -60.84 -58.2 21.0 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.241 1.016 . . . . 0.0 112.138 179.534 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.17 134.31 36.17 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.064 1.843 . . . . 0.0 110.497 177.788 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.99 -103.64 0.17 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 179.522 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 72.66 -46.42 0.65 Allowed 'General case' 0 C--N 1.344 0.366 0 C-N-CA 127.257 2.223 . . . . 0.0 113.502 -179.645 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.24 125.17 28.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.848 1.659 . . . . 0.0 112.744 -178.488 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -146.28 124.18 12.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.686 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.5 m -86.76 156.17 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 103.317 -2.846 . . . . 0.0 103.317 177.098 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 73.3 t -134.89 115.49 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 -178.08 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -95.52 165.92 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.428 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -176.313 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -99.75 163.03 12.65 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 124.677 1.191 . . . . 0.0 108.185 178.949 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.327 5.2 t -74.11 27.84 0.08 Allowed 'General case' 0 C--N 1.339 0.144 0 N-CA-C 119.698 3.221 . . . . 0.0 119.698 -177.232 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -123.35 -79.32 0.61 Allowed 'General case' 0 N--CA 1.441 -0.917 1 N-CA-C 100.058 -4.053 . . . . 0.0 100.058 176.61 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.0 t -164.13 -24.03 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.14 1.776 . . . . 0.0 114.409 179.008 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -79.68 127.42 32.17 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -176.442 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . 0.344 4.5 p90 -82.24 147.67 28.82 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 123.665 0.603 . . . . 0.0 111.343 -178.922 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.81 -46.26 19.13 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.655 1.182 . . . . 0.0 111.335 -177.338 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.79 -153.69 16.6 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.116 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.82 150.36 32.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.393 0.616 . . . . 0.0 111.402 -179.308 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 44.2 pt -138.47 157.86 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.031 1.733 . . . . 0.0 108.043 -179.337 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.8 t -157.7 154.89 29.01 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.063 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -79.34 -14.89 58.69 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 123.344 0.403 . . . . 0.0 110.297 175.517 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.3 m -62.0 115.3 3.96 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 123.873 0.869 . . . . 0.0 109.832 -179.304 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.27 -15.3 63.52 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.959 0.79 . . . . 0.0 112.382 -179.11 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.97 -177.45 5.57 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.446 1.098 . . . . 0.0 111.4 -179.564 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.8 t -87.36 59.46 5.54 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.836 1.255 . . . . 0.0 111.141 -179.396 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.34 -89.31 1.01 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.971 1.272 . . . . 0.0 112.865 178.486 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -79.8 -31.6 40.74 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.405 1.082 . . . . 0.0 111.22 -179.35 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -55.21 165.65 0.69 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.685 1.594 . . . . 0.0 111.709 179.627 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -120.18 155.25 33.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.48 1.512 . . . . 0.0 111.956 -179.178 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.3 m -139.17 163.05 27.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 C-N-CA 125.949 1.7 . . . . 0.0 107.96 177.794 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.81 140.15 19.94 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.892 0.758 . . . . 0.0 112.183 -178.717 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 t -83.22 -177.41 6.74 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.658 1.183 . . . . 0.0 109.73 178.949 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.8 t -70.51 112.35 6.72 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.822 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.86 -41.24 2.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -178.95 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.1 m -86.49 94.19 9.35 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.988 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 t30 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.225 -1.369 . . . . 0.0 109.445 -178.918 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 N--CA 1.456 -0.159 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 77.29 66.77 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.31 140.28 29.76 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 125.502 1.521 . . . . 0.0 109.136 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.02 121.95 35.86 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.5 m -102.14 78.8 1.8 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.154 1.381 . . . . 0.0 107.864 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.38 -97.45 0.68 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 t -100.35 -39.56 7.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.933 1.293 . . . . 0.0 110.034 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.5 m -72.25 96.49 1.84 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.347 1.059 . . . . 0.0 109.767 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -79.92 155.67 27.63 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.257 1.023 . . . . 0.0 110.867 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -143.35 119.76 10.96 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.218 1.007 . . . . 0.0 110.744 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.5 t -60.24 159.09 10.37 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.147 1.779 . . . . 0.0 110.663 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.02 -17.34 51.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 t -76.86 -43.93 34.18 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.601 1.16 . . . . 0.0 108.743 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.81 -45.89 80.66 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.665 1.186 . . . . 0.0 111.305 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.433 HG13 ' CE2' ' A' ' 85' ' ' TYR . 73.6 t -58.2 -52.6 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.739 1.216 . . . . 0.0 108.345 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -68.18 -31.6 71.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.3 1.44 . . . . 0.0 113.484 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.14 -60.05 2.93 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.933 0.788 . . . . 0.0 109.417 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 -30.25 71.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.462 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.07 -51.51 15.54 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 119.507 -0.283 . . . . 0.0 111.494 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -60.36 -19.7 56.66 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.32 -72.16 0.27 Allowed 'General case' 0 C--N 1.347 0.49 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.599 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -56.03 -29.47 60.46 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.224 0.92 . . . . 0.0 111.788 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.6 t -56.86 -44.13 81.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.485 1.039 . . . . 0.0 109.005 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -96.58 4.01 52.24 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -126.54 -12.43 6.12 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -74.65 -53.09 9.98 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 119.186 0.903 . . . . 0.0 113.089 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.326 0.0 OUTLIER -137.47 33.56 2.51 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.949 0.881 . . . . 0.0 112.275 -177.529 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -74.0 -64.93 0.91 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 176.7 37.68 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 129.024 2.93 . . . . 0.0 109.284 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -176.14 -171.13 0.41 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.134 1.774 . . . . 0.0 109.246 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.5 p -122.63 -51.65 1.93 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.929 2.092 . . . . 0.0 109.195 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 43.62 55.03 5.2 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 126.666 1.986 . . . . 0.0 112.081 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.33 179.68 25.93 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 112.251 -2.25 . . . . 0.0 111.625 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.8 p -61.44 -66.99 0.45 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.048 0.939 . . . . 0.0 110.215 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.0 t -163.7 -66.33 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.594 1.158 . . . . 0.0 108.541 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.1 p -106.48 31.27 5.32 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.364 1.066 . . . . 0.0 110.999 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -164.95 104.75 0.8 Allowed Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.538 1.535 . . . . 0.0 107.723 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -64.17 156.42 72.75 Favored 'Cis proline' 0 N--CA 1.456 -0.731 0 CA-C-N 120.289 1.139 . . . . 0.0 113.555 -0.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.63 168.54 6.27 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.884 1.673 . . . . 0.0 108.985 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 t -68.25 151.62 46.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -79.84 110.34 15.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -10.69 -91.14 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.951 3.301 . . . . 0.0 115.488 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 143.78 -54.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 130.269 3.428 . . . . 0.0 106.929 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -56.94 124.32 18.21 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.062 1.345 . . . . 0.0 109.888 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 62.28 58.59 1.74 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.954 1.302 . . . . 0.0 108.536 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.41 111.34 4.1 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.712 1.149 . . . . 0.0 110.624 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.24 169.2 16.84 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.572 0.749 . . . . 0.0 110.626 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -71.2 130.2 40.83 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.121 1.369 . . . . 0.0 113.682 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -163.6 120.98 1.2 Allowed Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 126.152 1.781 . . . . 0.0 108.706 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -65.29 -165.64 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.987 2.458 . . . . 0.0 111.111 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.7 t 76.96 -101.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.178 1.391 . . . . 0.0 110.045 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -167.8 -67.09 0.03 OUTLIER 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.178 0.899 . . . . 0.0 111.609 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.68 -172.7 14.75 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.256 1.408 . . . . 0.0 109.584 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.55 163.59 52.05 Favored 'Cis proline' 0 N--CA 1.456 -0.715 0 CA-C-N 119.118 1.459 . . . . 0.0 111.707 -1.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -110.71 172.9 6.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.343 1.057 . . . . 0.0 111.363 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -140.25 131.15 26.03 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.158 1.383 . . . . 0.0 108.606 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -94.58 161.82 14.05 Favored 'General case' 0 C--O 1.227 -0.09 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.599 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -160.03 105.99 1.41 Allowed Pre-proline 0 N--CA 1.455 -0.176 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.025 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.22 120.45 6.57 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 121.101 1.2 . . . . 0.0 109.866 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.612 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.6 tt -83.62 -175.43 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 123.665 1.698 . . . . 0.0 112.423 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.612 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 13.7 mmtt -160.31 163.02 33.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 109.82 -3.354 . . . . 0.0 110.816 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.0 t -78.82 56.86 1.98 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.998 1.719 . . . . 0.0 112.135 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.32 60.9 0.21 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 125.088 1.328 . . . . 0.0 112.474 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.18 140.3 3.05 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 117.695 0.747 . . . . 0.0 113.86 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.5 p -100.17 157.61 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 126.785 2.034 . . . . 0.0 107.239 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 64.91 74.21 0.4 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.134 0.974 . . . . 0.0 108.675 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.0 p -134.65 -169.39 2.33 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.409 1.483 . . . . 0.0 109.714 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.41 124.13 24.71 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.084 1.326 . . . . 0.0 113.695 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.37 101.0 0.87 Allowed Glycine 0 C--N 1.339 0.741 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.0 t 64.63 86.07 0.15 Allowed Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 125.363 1.465 . . . . 0.0 109.302 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.1 164.03 88.72 Favored 'Cis proline' 0 N--CA 1.458 -0.597 0 CA-C-N 119.571 0.882 . . . . 0.0 112.503 5.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.89 -58.07 0.17 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.473 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . 87.11 -67.71 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 129.128 2.971 . . . . 0.0 108.321 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -70.48 119.93 15.37 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.484 1.914 . . . . 0.0 113.149 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.1 mtt-85 -141.48 147.8 38.44 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.121 1.369 . . . . 0.0 112.301 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -112.61 144.05 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.4 t -139.92 127.04 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.88 0.372 . . . . 0.0 110.647 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -106.39 174.15 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.358 0 C-N-CA 126.922 2.089 . . . . 0.0 111.202 -178.325 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -93.56 169.08 10.61 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.952 2.101 . . . . 0.0 105.589 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.367 14.5 t -76.29 53.35 0.82 Allowed 'General case' 0 C--N 1.341 0.223 0 N-CA-C 117.775 2.509 . . . . 0.0 117.775 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -160.05 -83.31 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.82 -0.29 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.654 1.581 . . . . 0.0 114.27 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.57 110.56 16.16 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.016 1.28 . . . . 0.0 113.842 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.433 ' CE2' HG13 ' A' ' 16' ' ' VAL . 8.2 t80 -60.04 111.64 1.58 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.712 0.805 . . . . 0.0 109.707 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.25 -40.13 31.38 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.629 1.171 . . . . 0.0 111.349 -178.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.4 168.81 17.02 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.422 ' HB2' ' OH ' ' A' ' 85' ' ' TYR . . . -109.75 154.31 23.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.679 0.792 . . . . 0.0 110.353 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.8 pt -131.51 157.7 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 125.78 1.632 . . . . 0.0 107.99 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.0 t -159.53 139.28 11.58 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.473 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 24.9 m170 -84.36 46.77 1.26 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.7 t -65.65 -38.6 89.81 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.3 56.72 0.54 Allowed Glycine 0 C--N 1.335 0.486 0 N-CA-C 106.119 -2.792 . . . . 0.0 106.119 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -106.92 -17.56 14.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.3 m 64.39 35.54 9.6 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.6 21.93 78.72 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.704 2.097 . . . . 0.0 113.899 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -146.76 -70.58 0.24 Allowed 'General case' 0 C--N 1.347 0.484 0 CA-C-N 119.44 1.62 . . . . 0.0 114.216 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -58.9 100.36 0.07 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.054 1.742 . . . . 0.0 114.042 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.281 0.5 OUTLIER -78.14 140.98 39.02 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.439 0.695 . . . . 0.0 109.613 -178.433 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.17 160.86 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.74 160.65 29.0 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.31 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.8 m -117.93 159.55 22.94 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.638 1.175 . . . . 0.0 110.583 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.3 t 44.19 69.11 0.45 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.046 1.738 . . . . 0.0 115.429 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.43 -4.13 74.39 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.094 -0.837 . . . . 0.0 114.334 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.8 m -84.29 104.63 14.48 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 116.622 -1.656 . . . . 0.0 111.231 179.417 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.322 0.106 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.5 136.4 0.03 OUTLIER 'General case' 0 C--N 1.341 0.208 0 C-N-CA 126.664 1.985 . . . . 0.0 111.592 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.1 p -116.82 109.88 17.67 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.79 98.23 7.92 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 100.636 -3.838 . . . . 0.0 100.636 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.1 m -94.35 79.37 3.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.141 0.976 . . . . 0.0 109.102 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.09 -86.06 1.0 Allowed Glycine 0 C--N 1.34 0.777 0 C-N-CA 125.061 1.315 . . . . 0.0 110.013 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.4 p -119.58 -38.87 2.93 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 125.598 1.559 . . . . 0.0 110.156 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 m -74.14 100.78 3.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -95.04 149.43 21.26 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.85 0.86 . . . . 0.0 113.223 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -144.22 152.73 41.24 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.321 1.449 . . . . 0.0 110.043 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.9 m -74.55 159.6 31.98 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 125.556 1.542 . . . . 0.0 111.449 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.26 -22.67 67.02 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.5 t -70.49 -37.08 74.15 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 125.076 1.35 . . . . 0.0 109.062 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -65.69 -42.57 91.04 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.116 0.966 . . . . 0.0 109.731 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.1 t -61.27 -47.86 91.58 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.2 mtp85 -66.64 -26.55 67.12 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.214 1.406 . . . . 0.0 112.383 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.15 -60.58 2.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.71 -28.25 69.46 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.858 -0.592 . . . . 0.0 111.279 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.69 -37.1 50.34 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 118.941 -0.552 . . . . 0.0 112.38 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -70.5 -22.03 62.69 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.53 -59.74 2.61 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.49 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -45.96 -47.89 16.51 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.697 1.199 . . . . 0.0 110.33 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 m -51.1 -54.57 23.83 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.227 1.011 . . . . 0.0 110.961 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -77.09 -27.51 54.21 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -113.34 -6.0 13.55 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.289 0.0 OUTLIER -95.23 -38.96 10.32 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -179.077 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -147.29 33.53 0.88 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.326 0.966 . . . . 0.0 112.043 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -132.78 -70.71 0.54 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -136.49 85.49 2.15 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -56.77 118.76 5.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.022 1.329 . . . . 0.0 113.678 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.8 p -143.65 49.53 1.4 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.124 1.769 . . . . 0.0 108.681 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -163.26 153.05 15.4 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.116 0.966 . . . . 0.0 110.014 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.98 155.64 52.99 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.1 t -133.45 77.92 1.75 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.163 0.985 . . . . 0.0 108.87 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 p -107.09 -59.19 1.84 Allowed 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.87 -11.5 7.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.559 1.944 . . . . 0.0 110.733 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.66 129.95 3.53 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.93 139.71 55.04 Favored 'Cis proline' 0 N--CA 1.452 -0.959 0 CA-C-N 120.153 1.09 . . . . 0.0 110.536 -0.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -155.09 148.14 24.7 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 t -56.08 144.73 28.07 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -79.41 112.66 16.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -71.33 81.6 0.75 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.98 1.312 . . . . 0.0 109.215 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -156.76 76.04 0.86 Allowed 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.21 -37.97 73.02 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.862 1.265 . . . . 0.0 110.699 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -64.43 -35.59 81.42 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.29 114.76 0.24 Allowed Glycine 0 C--N 1.342 0.881 0 C-N-CA 125.875 1.702 . . . . 0.0 114.301 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -78.94 106.22 10.82 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.0 p-10 -28.98 111.03 0.06 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.484 1.914 . . . . 0.0 115.842 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -147.88 151.0 37.46 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 126.895 2.078 . . . . 0.0 108.076 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.02 78.04 3.72 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.327 2.685 . . . . 0.0 107.391 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.17 171.25 12.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 C-N-CA 124.841 1.256 . . . . 0.0 113.569 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -125.93 -49.61 1.6 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 128.034 2.534 . . . . 0.0 105.997 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.69 170.73 46.5 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.862 1.696 . . . . 0.0 113.914 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.55 134.74 32.26 Favored 'Cis proline' 0 N--CA 1.46 -0.498 0 O-C-N 122.419 0.694 . . . . 0.0 112.18 -0.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -107.49 136.5 47.17 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.602 1.561 . . . . 0.0 109.541 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -125.49 161.83 26.24 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 123.641 0.777 . . . . 0.0 111.24 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -83.88 153.34 24.05 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.597 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.49 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 17.1 t80 -155.44 103.21 2.2 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 102.791 -3.04 . . . . 0.0 102.791 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -76.46 136.59 17.69 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.027 1.818 . . . . 0.0 115.832 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 62' ' ' LYS . 1.2 tp -89.87 171.24 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 126.086 1.754 . . . . 0.0 112.787 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -159.06 170.31 22.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 110.62 -2.991 . . . . 0.0 113.067 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -82.0 57.92 3.71 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.86 2.064 . . . . 0.0 112.029 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.28 73.43 0.77 Allowed Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.34 -177.58 40.63 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-O 121.631 0.573 . . . . 0.0 112.808 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.71 148.4 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 127.374 2.269 . . . . 0.0 106.39 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.312 51.4 p90 58.4 -170.11 0.12 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.78 1.632 . . . . 0.0 111.924 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.2 t -79.61 166.36 21.96 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.696 0.799 . . . . 0.0 112.577 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.08 140.24 3.1 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.29 -114.12 4.85 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 124.689 1.137 . . . . 0.0 111.103 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -155.31 -68.52 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.441 1.096 . . . . 0.0 109.972 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.55 160.46 46.56 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.292 1.995 . . . . 0.0 110.547 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.53 -83.4 0.06 OUTLIER Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.47 ' HB1' ' H ' ' A' ' 91' ' ' HIS . . . 81.77 -39.89 0.13 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.186 1.794 . . . . 0.0 111.041 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -71.3 125.41 26.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.061 1.744 . . . . 0.0 115.064 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -139.5 131.33 27.57 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 123.723 0.809 . . . . 0.0 112.254 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.7 m -94.64 148.15 5.2 Favored 'Isoleucine or valine' 0 C--N 1.345 0.406 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -134.35 139.71 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 pt -135.16 165.75 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.256 0.622 . . . . 0.0 112.497 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -93.55 155.41 17.33 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 127.9 2.48 . . . . 0.0 108.621 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.37 15.0 t -79.55 65.64 4.78 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -156.86 -94.58 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.172 1 N-CA-C 98.856 -4.498 . . . . 0.0 98.856 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.4 m -162.98 9.4 0.06 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.698 2.399 . . . . 0.0 113.035 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -82.84 132.46 35.16 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.548 1.067 . . . . 0.0 112.609 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -73.12 122.72 22.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.54 -57.96 3.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.69 153.21 11.56 Favored Glycine 0 C--N 1.339 0.717 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.465 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.03 112.03 24.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.58 162.34 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.709 0.804 . . . . 0.0 109.181 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.6 t -160.3 150.13 17.92 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.47 ' H ' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -89.47 63.97 6.55 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 175.27 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.1 t -63.75 -38.87 92.74 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.021 -1.049 . . . . 0.0 112.739 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.79 54.32 0.04 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.21 -78.78 0.4 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.77 0.828 . . . . 0.0 108.813 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.6 m -159.42 73.96 0.6 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.658 1.583 . . . . 0.0 108.72 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.83 -102.75 0.94 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.032 0.825 . . . . 0.0 111.719 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -79.77 -25.85 40.84 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.756 0.822 . . . . 0.0 111.83 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -49.15 129.69 18.2 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 124.52 1.128 . . . . 0.0 111.4 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -97.39 153.0 18.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.341 1.456 . . . . 0.0 113.405 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.0 m -135.21 167.26 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 126.957 2.103 . . . . 0.0 107.032 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.1 151.34 30.01 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 116.542 1.377 . . . . 0.0 116.542 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 38.7 m -106.53 -173.67 2.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.859 1.664 . . . . 0.0 106.641 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.0 t -69.32 140.98 54.37 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.454 -0.779 . . . . 0.0 108.984 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.31 32.54 59.97 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.936 0.779 . . . . 0.0 111.332 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.9 m -137.85 108.38 6.56 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 117.192 -1.385 . . . . 0.0 109.474 -178.984 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.0 m . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -40.24 132.22 1.98 Allowed 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.485 1.914 . . . . 0.0 112.664 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.8 p -102.65 89.06 3.38 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.272 1.029 . . . . 0.0 111.372 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -94.87 98.3 10.62 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.02 -165.14 0.92 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.118 1.367 . . . . 0.0 108.049 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -31.09 -57.87 0.27 Allowed Glycine 0 C--N 1.343 0.971 0 C-N-CA 125.993 1.758 . . . . 0.0 112.159 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.9 p -160.31 38.1 0.17 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.225 1.01 . . . . 0.0 109.687 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 m -129.49 94.15 3.71 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.7 110.47 15.06 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.697 1.199 . . . . 0.0 111.459 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -110.26 128.92 55.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.3 m -65.89 158.13 28.78 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 124.713 1.205 . . . . 0.0 110.726 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.64 -17.32 54.89 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.1 p -77.55 -37.98 49.56 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 124.0 0.92 . . . . 0.0 108.719 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -68.77 -36.04 77.82 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.027 0.931 . . . . 0.0 109.974 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.407 HG11 ' CE2' ' A' ' 85' ' ' TYR . 58.7 t -63.44 -47.82 89.96 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -64.49 -37.45 87.57 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.014 0.926 . . . . 0.0 111.374 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 -55.16 15.49 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.541 0.61 . . . . 0.0 110.225 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.44 -37.13 82.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.136 0.975 . . . . 0.0 111.172 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.32 -34.34 42.35 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -70.87 -22.02 62.34 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.1 -51.62 9.99 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.486 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -47.32 -67.07 0.31 Allowed 'General case' 0 C--N 1.345 0.375 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 176.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.2 t -39.09 -46.31 1.39 Allowed 'General case' 0 C--N 1.343 0.287 0 C-N-CA 127.892 2.477 . . . . 0.0 112.475 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -65.14 -58.34 6.27 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -71.73 -8.62 55.28 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 57' ' ' GLN . 6.4 t80 -79.38 -47.94 14.88 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.957 1.303 . . . . 0.0 111.376 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -135.51 -26.66 1.23 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -72.89 -56.44 5.19 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.43 1.014 . . . . 0.0 112.861 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -128.13 73.02 1.44 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.472 1.509 . . . . 0.0 108.775 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -55.06 153.4 6.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.704 1.202 . . . . 0.0 113.058 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 59.6 p 56.17 70.85 0.6 Allowed 'General case' 0 C--N 1.34 0.164 0 C-N-CA 127.153 2.181 . . . . 0.0 112.437 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -158.17 91.15 1.08 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.65 -78.23 0.2 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.8 m -145.55 -116.39 0.08 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.159 0.983 . . . . 0.0 108.675 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.9 m -158.26 -50.51 0.06 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.597 1.559 . . . . 0.0 109.35 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.0 p -79.73 6.26 11.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.293 1.037 . . . . 0.0 112.868 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -151.94 95.29 3.23 Favored Pre-proline 0 N--CA 1.455 -0.208 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -84.22 142.75 40.07 Favored 'Cis proline' 0 N--CA 1.455 -0.746 0 N-CA-C 116.263 1.601 . . . . 0.0 116.263 2.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.15 158.83 25.19 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.703 2.401 . . . . 0.0 107.377 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 m -42.38 120.0 1.54 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.022 2.129 . . . . 0.0 113.555 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -138.13 86.47 2.17 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -167.63 -49.67 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.676 1.19 . . . . 0.0 109.039 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -86.96 59.7 5.79 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.156 1.382 . . . . 0.0 110.141 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.36 14.98 1.46 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.817 0.847 . . . . 0.0 112.117 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 56.9 83.62 0.1 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 125.222 1.409 . . . . 0.0 111.267 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.24 167.09 36.04 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.67 100.5 0.28 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.147 0.979 . . . . 0.0 112.989 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.97 164.86 26.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.537 0.735 . . . . 0.0 109.976 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -106.08 151.07 40.01 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -58.13 -95.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 124.524 3.482 . . . . 0.0 114.152 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m 24.92 -106.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 127.062 2.145 . . . . 0.0 113.521 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -163.01 -44.78 0.03 OUTLIER 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.076 0.853 . . . . 0.0 112.214 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.16 -167.54 29.19 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -60.94 165.65 30.04 Favored 'Cis proline' 0 CA--C 1.535 0.547 0 CA-C-N 119.572 1.686 . . . . 0.0 114.123 -0.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -132.15 143.15 49.78 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.541 1.136 . . . . 0.0 111.502 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.466 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -139.99 153.32 46.83 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.325 1.05 . . . . 0.0 108.231 177.744 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.75 154.28 23.68 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.486 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 26.9 t80 -160.74 106.68 1.3 Allowed Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.399 1.08 . . . . 0.0 109.006 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.92 155.75 15.25 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 N-CA-C 119.008 2.657 . . . . 0.0 119.008 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.496 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 6.5 tt -105.63 175.37 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 C-N-CA 126.984 2.114 . . . . 0.0 110.035 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.496 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 6.9 tptp -160.9 166.59 28.17 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 109.352 -3.567 . . . . 0.0 112.454 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.1 t -88.83 62.15 6.27 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.542 1.537 . . . . 0.0 108.764 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.06 64.19 0.66 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 167.5 145.0 4.34 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.1 t -123.56 66.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.0 t80 64.08 103.26 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.086 2.155 . . . . 0.0 112.863 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.8 p -138.96 64.23 1.49 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.3 -68.95 2.38 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.06 -135.38 22.74 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.8 p 54.16 102.08 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 127.39 2.276 . . . . 0.0 113.282 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.84 176.49 40.37 Favored 'Cis proline' 0 N--CA 1.457 -0.663 0 CA-C-N 119.707 0.931 . . . . 0.0 112.177 4.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.38 163.54 31.6 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.45 -43.64 0.15 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 118.375 -0.821 . . . . 0.0 111.655 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -69.36 107.08 3.16 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -119.24 129.23 54.83 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.434 1.094 . . . . 0.0 111.451 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.65 151.43 6.04 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -135.12 135.74 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -123.08 164.14 20.97 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -80.98 173.25 12.79 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.674 1.99 . . . . 0.0 108.598 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.447 ' HA ' ' CE1' ' A' ' 27' ' ' TYR 0.43 1.5 m -73.59 -15.04 61.28 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -177.534 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -81.02 -83.88 0.11 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 101.327 -3.583 . . . . 0.0 101.327 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.1 m -164.05 0.12 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.639 2.775 . . . . 0.0 113.895 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -79.39 132.19 36.33 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.407 ' CE2' HG11 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -73.37 117.27 14.93 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.996 2.118 . . . . 0.0 108.222 178.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.01 -66.1 1.11 Allowed 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.265 1.426 . . . . 0.0 111.952 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.49 146.71 20.99 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 115.976 1.15 . . . . 0.0 115.976 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.65 99.62 3.38 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 103.746 -2.686 . . . . 0.0 103.746 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.5 pt -136.77 165.49 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.073 0.949 . . . . 0.0 111.428 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.0 t -160.27 145.74 15.05 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -79.87 29.44 0.26 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.21 0.604 . . . . 0.0 111.791 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.8 t -65.19 -30.28 71.17 Favored 'General case' 0 C--N 1.343 0.307 0 O-C-N 120.797 -1.19 . . . . 0.0 113.405 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -138.39 49.32 0.84 Allowed Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.29 151.86 21.74 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.114 1.366 . . . . 0.0 110.86 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.1 t -66.39 -45.37 80.25 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.35 1.06 . . . . 0.0 109.495 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.7 -79.43 0.03 OUTLIER Glycine 0 C--N 1.339 0.741 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -97.4 7.52 46.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.352 1.061 . . . . 0.0 111.027 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -74.0 -174.21 1.81 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.4 1.08 . . . . 0.0 110.426 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -153.45 159.9 42.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.174 0.989 . . . . 0.0 110.976 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.6 157.99 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.954 1.702 . . . . 0.0 106.783 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.39 153.25 49.12 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 116.106 1.202 . . . . 0.0 116.106 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.4 t -107.28 -175.3 2.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.335 2.254 . . . . 0.0 106.752 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.6 t -64.94 117.72 8.02 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.4 -0.813 . . . . 0.0 109.95 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.42 -36.97 3.65 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.121 1.343 . . . . 0.0 109.812 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.5 m -93.74 132.78 37.78 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.245 1.418 . . . . 0.0 108.932 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.225 -1.369 . . . . 0.0 109.254 -179.546 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.7 p . . . . . 0 N--CA 1.456 -0.168 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.97 133.86 55.2 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.882 1.273 . . . . 0.0 110.873 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 p -97.35 121.03 38.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.579 1.152 . . . . 0.0 109.117 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -115.33 99.31 7.3 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 100.595 -3.854 . . . . 0.0 100.595 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -103.49 90.28 3.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.157 1.383 . . . . 0.0 109.563 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.46 -76.23 0.96 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.012 1.291 . . . . 0.0 110.862 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.5 t -132.48 -43.17 0.93 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.819 1.648 . . . . 0.0 109.921 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.6 m -68.74 112.54 5.54 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -102.21 152.63 20.8 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.471 1.108 . . . . 0.0 110.812 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -144.23 143.54 31.1 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.363 1.065 . . . . 0.0 108.21 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.9 t -68.27 154.74 41.13 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.765 1.226 . . . . 0.0 110.549 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.93 -19.89 54.39 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.6 t -73.52 -41.15 63.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.652 1.581 . . . . 0.0 109.339 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -68.35 -43.17 78.02 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.256 0.622 . . . . 0.0 110.963 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.8 t -59.8 -47.18 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -41.5 86.72 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.278 1.031 . . . . 0.0 111.686 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.48 -49.47 68.93 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.333 0.515 . . . . 0.0 109.87 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.56 -37.36 78.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.799 0.839 . . . . 0.0 109.938 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.44 -32.28 60.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -66.38 -27.33 67.78 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.03 -56.98 3.98 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.458 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -44.99 -58.35 3.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.528 1.531 . . . . 0.0 110.147 177.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.5 t -54.11 -50.71 66.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.366 1.467 . . . . 0.0 112.296 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -58.08 -34.57 70.3 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -92.13 -3.26 55.91 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -124.38 37.16 4.46 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.473 1.109 . . . . 0.0 111.132 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -89.84 -72.51 0.56 Allowed 'General case' 0 C--N 1.343 0.283 0 O-C-N 121.364 -0.835 . . . . 0.0 110.031 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -148.91 -61.17 0.23 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.933 1.293 . . . . 0.0 108.713 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -90.44 63.83 5.71 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.112 1.365 . . . . 0.0 107.95 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -51.83 138.28 24.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.711 1.604 . . . . 0.0 112.396 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.0 t -106.16 -33.5 7.82 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.367 1.067 . . . . 0.0 112.198 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.63 159.86 31.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.763 0.825 . . . . 0.0 110.97 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.94 166.48 47.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.399 0.999 . . . . 0.0 114.232 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -120.49 65.09 0.84 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.833 1.653 . . . . 0.0 107.977 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.7 m -167.32 -46.02 0.02 OUTLIER 'General case' 0 C--N 1.339 0.124 0 C-N-CA 127.192 2.197 . . . . 0.0 107.374 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.7 p -105.12 29.18 6.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.145 1.378 . . . . 0.0 111.131 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 73.32 157.39 0.16 Allowed Pre-proline 0 C--N 1.351 0.651 0 C-N-CA 125.144 1.378 . . . . 0.0 107.728 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.401 ' HB3' HE21 ' A' ' 57' ' ' GLN . 86.0 Cg_endo -71.1 118.72 4.26 Favored 'Cis proline' 0 N--CA 1.452 -0.969 0 N-CA-C 115.404 1.271 . . . . 0.0 115.404 3.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -103.86 -170.24 1.75 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 126.518 1.927 . . . . 0.0 106.686 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.3 t -155.87 159.0 38.95 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.514 0.326 . . . . 0.0 111.267 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -153.43 167.09 30.61 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 122.774 0.43 . . . . 0.0 111.68 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -141.56 -51.76 0.43 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.609 1.563 . . . . 0.0 109.998 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -67.47 -78.81 0.06 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.966 0.906 . . . . 0.0 110.731 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 67.9 179.97 0.23 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.767 1.227 . . . . 0.0 111.345 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -74.63 -62.62 1.47 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.98 57.67 0.14 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -154.19 103.04 2.51 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.489 1.116 . . . . 0.0 108.346 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -141.57 176.43 8.9 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.307 1.443 . . . . 0.0 109.05 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -127.87 138.11 32.21 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 124.361 1.065 . . . . 0.0 109.043 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.66 66.17 8.81 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.713 2.942 . . . . 0.0 110.043 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.3 t -120.31 -95.06 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -153.35 -71.02 0.14 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.174 0.99 . . . . 0.0 109.695 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.11 -175.37 54.96 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.074 0.845 . . . . 0.0 111.225 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.97 126.85 1.93 Allowed 'Cis proline' 0 N--CA 1.459 -0.519 0 CA-C-N 118.982 1.391 . . . . 0.0 111.989 -0.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.69 130.69 35.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.446 0.641 . . . . 0.0 111.008 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' A' ' 39' ' ' PRO . 53.4 tt0 -75.03 139.02 42.58 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 127.852 2.461 . . . . 0.0 111.235 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -98.16 146.57 25.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.574 1.15 . . . . 0.0 108.66 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.458 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 8.0 t80 -160.1 110.33 1.41 Allowed Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -81.15 131.93 8.03 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 122.006 1.804 . . . . 0.0 114.302 -176.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.54 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.7 tt -100.01 178.0 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 124.282 1.992 . . . . 0.0 110.875 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.54 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 4.8 tmtt? -160.46 153.71 21.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 109.063 -3.698 . . . . 0.0 110.721 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.2 p -80.81 56.5 2.72 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.566 1.546 . . . . 0.0 109.706 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.9 -61.99 0.04 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.32 -172.62 32.97 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 117.165 0.483 . . . . 0.0 112.705 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.95 143.57 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.568 1.547 . . . . 0.0 111.353 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.292 0.0 OUTLIER 25.45 55.68 0.04 OUTLIER 'General case' 0 C--N 1.345 0.37 0 C-N-CA 129.367 3.067 . . . . 0.0 116.41 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.8 p -79.77 85.36 5.46 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.98 173.6 39.24 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.89 -69.01 1.47 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.0 m -80.3 127.5 76.09 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.7 -88.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.225 2.617 . . . . 0.0 110.057 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.97 -51.32 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 106.019 -2.832 . . . . 0.0 106.019 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -169.72 -50.43 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.667 0.787 . . . . 0.0 112.02 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -73.9 130.07 39.16 Favored 'General case' 0 C--N 1.344 0.362 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -138.54 122.21 17.48 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.029 1.331 . . . . 0.0 110.43 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -83.64 148.77 4.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.3 t -136.91 114.9 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -177.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 pt -101.56 177.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.371 0 C-N-CA 124.585 1.154 . . . . 0.0 111.855 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -90.46 171.82 9.16 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 125.255 1.422 . . . . 0.0 108.024 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.7 -33.24 69.94 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 119.048 2.981 . . . . 0.0 119.048 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -87.75 -65.81 0.98 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.857 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.5 -7.58 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -175.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -78.9 108.82 12.63 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -56.33 118.52 4.83 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.51 -59.56 2.2 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.258 0.623 . . . . 0.0 110.655 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.35 164.74 34.15 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.28 153.22 27.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.1 0.96 . . . . 0.0 110.453 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.6 pt -138.89 155.57 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.746 1.618 . . . . 0.0 107.881 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.6 t -153.45 153.25 32.13 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -79.34 -22.62 44.25 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.354 0.662 . . . . 0.0 111.988 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 t -65.68 139.84 58.43 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 119.585 1.084 . . . . 0.0 109.905 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.08 -24.97 28.93 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.98 -159.02 0.66 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.262 1.425 . . . . 0.0 109.397 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.2 m -152.37 88.9 1.39 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.417 0.687 . . . . 0.0 111.06 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.06 -131.07 9.24 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.288 0.947 . . . . 0.0 112.53 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -79.38 -34.95 41.52 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 125.099 1.36 . . . . 0.0 110.619 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -44.12 134.05 4.95 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.863 1.665 . . . . 0.0 112.473 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.54 160.8 14.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.203 1.801 . . . . 0.0 111.203 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 m -139.32 166.04 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 126.531 1.932 . . . . 0.0 106.916 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.64 151.61 20.66 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.365 0.507 . . . . 0.0 113.726 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.81 -166.43 1.6 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.194 1.398 . . . . 0.0 109.198 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.5 t -62.55 129.58 41.23 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.908 0.483 . . . . 0.0 109.767 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.31 28.5 69.79 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.004 0.811 . . . . 0.0 112.095 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.8 m -151.52 116.49 5.22 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.168 -179.51 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 N--CA 1.455 -0.225 0 N-CA-C 101.342 -3.577 . . . . 0.0 101.342 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 70.21 73.59 0.22 Allowed 'General case' 0 C--N 1.343 0.32 0 N-CA-C 102.389 -3.189 . . . . 0.0 102.389 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.5 t -116.03 152.87 32.72 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -118.88 116.39 26.39 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 102.259 -3.237 . . . . 0.0 102.259 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -91.91 58.9 3.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.31 -78.53 0.82 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.556 1.074 . . . . 0.0 111.178 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 m -118.29 39.99 3.3 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.947 1.299 . . . . 0.0 110.274 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.33 152.88 38.96 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -150.51 113.94 4.92 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.621 0.646 . . . . 0.0 111.745 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.81 137.55 52.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.514 1.126 . . . . 0.0 111.251 178.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.9 t -70.11 160.31 32.27 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 126.368 1.867 . . . . 0.0 108.264 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.25 -19.05 30.95 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 t -72.57 -47.29 49.34 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -72.22 -28.22 63.04 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.638 1.175 . . . . 0.0 113.46 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.4 t -70.21 -51.79 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -58.83 -35.63 73.22 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 125.987 1.715 . . . . 0.0 111.277 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.67 -52.61 56.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.9 82.47 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.031 0.932 . . . . 0.0 112.033 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.43 -45.55 30.97 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -62.29 -22.43 66.02 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.406 ' CB ' HG21 ' A' ' 66' ' ' VAL . . . -79.9 -55.08 5.22 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.68 -42.9 12.14 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.209 1.004 . . . . 0.0 111.261 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 85.2 m -61.61 -52.77 63.02 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.178 0.991 . . . . 0.0 110.366 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -59.57 -41.45 90.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.364 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -69.32 -40.1 77.81 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.42 -0.8 . . . . 0.0 112.067 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -78.52 -32.63 48.14 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -136.49 -43.8 0.61 Allowed 'General case' 0 C--N 1.348 0.533 0 N-CA-C 118.216 2.672 . . . . 0.0 118.216 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -70.69 -22.95 62.4 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -165.48 102.41 0.71 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 77.27 -166.32 0.05 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.552 1.941 . . . . 0.0 111.169 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.4 p -123.79 -63.96 1.18 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.86 1.664 . . . . 0.0 109.07 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 52.07 90.84 0.02 OUTLIER 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.519 1.928 . . . . 0.0 112.062 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.02 -166.98 14.22 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.23 0.919 . . . . 0.0 110.821 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m 71.63 -11.43 0.73 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.987 1.715 . . . . 0.0 113.71 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.7 m -149.47 -43.35 0.14 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.806 0.842 . . . . 0.0 111.74 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.9 p -104.25 -22.96 13.29 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 77.41 152.43 0.13 Allowed Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.3 150.99 96.51 Favored 'Cis proline' 0 N--CA 1.45 -1.05 0 CA-C-N 121.088 1.424 . . . . 0.0 115.065 2.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -159.79 157.82 30.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 128.551 2.74 . . . . 0.0 105.713 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 t -53.28 149.49 7.25 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -89.09 161.92 16.26 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.692 1.597 . . . . 0.0 109.1 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -63.53 137.77 58.26 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.953 0.901 . . . . 0.0 111.706 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.69 -49.96 75.4 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.761 0.824 . . . . 0.0 108.908 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -59.1 137.38 57.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -71.96 88.92 1.08 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.986 0.515 . . . . 0.0 111.228 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.08 -29.53 66.64 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.88 164.09 36.32 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.212 1.405 . . . . 0.0 110.695 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -116.91 122.12 43.4 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.612 1.565 . . . . 0.0 107.835 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.405 ' CD1' ' HA3' ' A' ' 87' ' ' GLY . 17.4 m-85 -119.42 157.69 50.86 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 124.821 1.248 . . . . 0.0 109.536 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -52.81 -35.36 69.43 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.825 3.017 . . . . 0.0 114.239 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.1 m -110.05 164.69 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.528 1.531 . . . . 0.0 112.044 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -95.75 159.53 14.93 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.573 1.549 . . . . 0.0 110.243 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.75 -154.54 30.87 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.4 1.0 . . . . 0.0 111.452 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.53 153.25 18.93 Favored 'Cis proline' 0 C--N 1.346 0.441 0 CA-C-N 118.722 1.261 . . . . 0.0 114.132 -0.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.67 167.07 17.74 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.165 0.986 . . . . 0.0 111.462 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -138.43 156.3 47.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.411 1.485 . . . . 0.0 109.253 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -90.17 157.84 17.53 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -160.15 108.9 1.4 Allowed Pre-proline 0 N--CA 1.454 -0.255 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -89.23 113.56 0.61 Allowed 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 122.65 2.233 . . . . 0.0 111.797 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.483 HG13 ' H ' ' A' ' 62' ' ' LYS . 7.4 tt -86.22 174.67 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-O 123.632 1.682 . . . . 0.0 110.909 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.483 ' H ' HG13 ' A' ' 61' ' ' ILE . 11.7 mmtp -155.48 150.73 26.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 109.851 -3.34 . . . . 0.0 110.912 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.5 p -88.68 61.03 5.85 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.311 1.444 . . . . 0.0 108.865 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.75 -61.58 0.02 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.05 166.12 36.18 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.406 HG21 ' CB ' ' A' ' 22' ' ' ALA . 10.0 p -77.6 138.0 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.505 1.122 . . . . 0.0 110.931 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.1 t80 53.57 86.92 0.04 OUTLIER 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.894 1.678 . . . . 0.0 112.111 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.4 t -151.41 158.97 44.41 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.21 1.004 . . . . 0.0 110.373 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.79 -133.11 2.65 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.501 1.048 . . . . 0.0 111.266 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.14 54.94 4.22 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 94.6 p 45.52 60.17 13.88 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.063 1.745 . . . . 0.0 112.64 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.1 141.24 18.48 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.749 2.966 . . . . 0.0 110.847 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 158.0 35.19 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.519 -0.601 . . . . 0.0 114.246 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -169.03 35.07 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.034 0.934 . . . . 0.0 110.764 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.25 93.85 0.29 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -145.96 153.48 40.85 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 m -119.86 146.6 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 102.474 -3.158 . . . . 0.0 102.474 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.255 81.2 t -125.55 113.14 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.1 pt -86.31 168.03 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.381 0 C-N-CA 125.704 1.602 . . . . 0.0 114.577 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -90.69 170.95 9.71 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.965 2.106 . . . . 0.0 107.374 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.367 11.6 t -85.35 52.93 2.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 118.048 2.611 . . . . 0.0 118.048 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -156.04 -89.81 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 101.245 -3.613 . . . . 0.0 101.245 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 36.3 t -163.94 66.43 0.17 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.198 1.399 . . . . 0.0 112.508 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -150.26 127.58 11.38 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 120.016 1.28 . . . . 0.0 113.051 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -64.46 117.29 7.1 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 177.752 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.39 -59.23 2.34 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 124.322 1.049 . . . . 0.0 110.631 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.405 ' HA3' ' CD1' ' A' ' 50' ' ' PHE . . . -145.57 -172.46 15.98 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.761 1.172 . . . . 0.0 111.472 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.31 144.05 13.94 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 122.802 0.441 . . . . 0.0 111.438 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.0 pt -131.06 159.34 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 125.487 1.515 . . . . 0.0 110.068 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.0 t -160.12 150.31 18.39 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.462 1.505 . . . . 0.0 109.418 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.539 ' HB2' ' HB1' ' A' ' 74' ' ' ALA 0.265 49.3 m170 -78.98 -51.87 9.03 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.409 1.004 . . . . 0.0 108.951 177.765 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.379 11.8 t 48.96 -69.82 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.706 2.802 . . . . 0.0 116.773 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.42 51.17 0.56 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 126.032 1.777 . . . . 0.0 108.879 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.79 158.02 36.24 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.913 1.285 . . . . 0.0 110.949 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.5 t -62.06 -40.51 96.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.214 0.606 . . . . 0.0 110.183 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -150.5 -109.64 0.47 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -94.38 -4.93 47.57 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.508 1.123 . . . . 0.0 112.083 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -65.17 174.5 2.0 Allowed 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.114 0.966 . . . . 0.0 112.113 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -125.64 150.99 47.11 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.735 1.614 . . . . 0.0 111.911 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.5 m -124.31 166.33 19.82 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 126.308 1.843 . . . . 0.0 107.009 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.04 160.21 24.87 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.3 m -100.66 174.22 6.17 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.136 0.975 . . . . 0.0 111.694 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.2 m 46.77 46.13 15.02 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.709 0.804 . . . . 0.0 112.069 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.67 22.95 73.81 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 119.311 -0.716 . . . . 0.0 114.052 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 55.0 m -86.57 146.77 26.22 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.974 0.909 . . . . 0.0 108.785 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 t30 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.055 -1.45 . . . . 0.0 109.437 -179.246 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 t . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.41 138.34 56.64 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.437 0.695 . . . . 0.0 109.134 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 t -141.81 119.99 12.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.487 0.315 . . . . 0.0 111.038 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.41 108.3 19.59 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.6 m -97.46 78.99 2.71 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.122 0.969 . . . . 0.0 109.177 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.83 -95.56 0.82 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.8 m -108.42 -31.78 7.69 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.851 1.26 . . . . 0.0 110.51 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 m -81.69 101.12 9.87 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -85.02 152.14 23.66 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 123.194 0.598 . . . . 0.0 111.322 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -142.06 133.73 26.93 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.645 1.178 . . . . 0.0 109.096 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.7 m -72.25 158.04 36.59 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 125.007 1.323 . . . . 0.0 111.314 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.08 -21.41 64.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.0 m -72.54 -39.35 67.58 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.076 0.95 . . . . 0.0 108.535 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -69.6 -50.22 46.6 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.547 1.139 . . . . 0.0 112.023 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.466 HG13 HG11 ' A' ' 77' ' ' VAL . 50.8 t -57.45 -48.23 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 123.608 0.763 . . . . 0.0 109.212 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -64.53 -43.31 94.41 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.545 1.138 . . . . 0.0 112.065 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.0 -54.24 14.1 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.972 0.509 . . . . 0.0 111.228 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.595 ' HB1' ' HE2' ' A' ' 59' ' ' PHE . . . -60.92 -26.76 67.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.421 0.689 . . . . 0.0 110.543 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.75 -38.09 29.28 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.481 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -65.79 -25.19 67.13 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.79 -60.0 2.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.402 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -44.97 -51.0 10.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.672 1.189 . . . . 0.0 110.196 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.01 -48.33 32.79 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.257 2.223 . . . . 0.0 111.796 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -81.75 -40.89 22.01 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.264 0.0 OUTLIER -67.75 -37.54 82.28 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 116.799 2.148 . . . . 0.0 116.799 -177.146 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.299 0.0 OUTLIER -82.14 6.27 17.02 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -179.09 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -77.49 -3.43 40.46 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.131 0.572 . . . . 0.0 110.786 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 64.02 48.11 3.16 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.442 1.897 . . . . 0.0 111.707 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -159.35 30.47 0.2 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.842 1.257 . . . . 0.0 110.658 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 176.88 165.69 0.51 Allowed 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 128.798 2.839 . . . . 0.0 108.86 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.263 0.0 OUTLIER -12.65 100.09 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.825 2.85 . . . . 0.0 115.233 -179.33 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 74.77 163.3 0.26 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 127.608 2.363 . . . . 0.0 115.792 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.98 82.57 0.06 OUTLIER Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.137 -0.813 . . . . 0.0 113.047 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.8 m 69.85 104.69 0.06 Allowed 'General case' 0 C--N 1.344 0.367 0 C-N-CA 126.384 1.873 . . . . 0.0 113.621 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -152.93 -55.89 0.12 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 100.988 -3.708 . . . . 0.0 100.988 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.575 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 40.7 p -130.64 -62.58 0.91 Allowed 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 101.006 -3.701 . . . . 0.0 101.006 175.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.575 ' CD1' ' C ' ' A' ' 37' ' ' THR . 23.9 m-85 -144.06 143.62 23.33 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 129.242 3.017 . . . . 0.0 106.072 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.67 144.73 62.24 Favored 'Cis proline' 0 N--CA 1.458 -0.567 0 CA-C-N 118.581 0.529 . . . . 0.0 112.596 1.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -156.54 151.76 26.48 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.537 0.608 . . . . 0.0 112.32 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.6 m -53.27 142.34 21.36 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.049 2.54 . . . . 0.0 113.121 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -91.9 136.76 32.91 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.705 1.202 . . . . 0.0 110.028 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -70.32 129.54 39.59 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.22 1.008 . . . . 0.0 111.864 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -86.17 61.04 6.59 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.936 1.294 . . . . 0.0 109.13 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -121.56 167.83 12.43 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.066 1.746 . . . . 0.0 109.076 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.49 154.16 41.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.382 0.673 . . . . 0.0 110.333 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.1 -88.27 0.32 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -121.51 152.91 38.64 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.241 1.417 . . . . 0.0 109.809 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 166.89 130.4 0.01 OUTLIER 'General case' 0 C--N 1.34 0.183 0 C-N-CA 128.109 2.564 . . . . 0.0 107.62 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -88.67 169.34 13.59 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.333 1.053 . . . . 0.0 108.96 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.19 -52.44 8.75 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.915 3.076 . . . . 0.0 113.024 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.9 m -65.05 156.62 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.11 1.364 . . . . 0.0 109.854 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -134.36 -168.66 2.18 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -46.32 138.55 7.52 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 127.608 2.527 . . . . 0.0 114.205 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.37 133.87 12.23 Favored 'Cis proline' 0 C--N 1.35 0.655 0 CA-C-N 119.933 1.866 . . . . 0.0 111.2 -2.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.53 108.99 1.64 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -177.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -123.35 157.7 32.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.994 1.718 . . . . 0.0 109.27 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -89.34 158.8 17.65 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.688 1.595 . . . . 0.0 112.633 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.595 ' HE2' ' HB1' ' A' ' 19' ' ' ALA . 89.1 t80 -159.18 117.96 1.68 Allowed Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.242 1.017 . . . . 0.0 108.917 177.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -81.44 137.83 10.6 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 N-CA-C 117.705 2.156 . . . . 0.0 117.705 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.625 HG13 HG13 ' A' ' 77' ' ' VAL 0.256 3.3 mm -109.81 -0.32 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 1 C-N-CA 134.408 5.083 . . . . 0.0 115.207 179.116 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -75.41 104.62 6.05 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 126.704 2.002 . . . . 0.0 114.165 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.6 m 24.06 34.18 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.201 1 C-N-CA 131.884 4.074 . . . . 0.0 115.712 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.84 40.38 1.49 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.957 1.265 . . . . 0.0 111.534 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.13 -115.33 1.01 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.127 1.346 . . . . 0.0 113.211 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.16 48.58 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.983 1.313 . . . . 0.0 109.594 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 27.0 t80 61.21 71.42 0.56 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.472 1.909 . . . . 0.0 111.327 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 49.5 p -121.18 61.11 0.91 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.75 -153.62 24.06 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.5 -169.54 32.25 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 m -158.86 -68.34 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 125.111 1.364 . . . . 0.0 110.172 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.58 104.33 1.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.456 2.104 . . . . 0.0 109.799 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.15 79.85 1.15 Allowed Glycine 0 C--N 1.339 0.712 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.13 -70.84 0.25 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.05 123.06 18.05 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.619 1.1 . . . . 0.0 113.597 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -160.6 134.81 7.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.625 HG13 HG13 ' A' ' 61' ' ' ILE . 11.8 m -93.14 142.88 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 177.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.272 72.6 t -125.32 124.45 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 85' ' ' TYR . 7.2 pt -130.99 175.09 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 123.934 0.771 . . . . 0.0 112.255 -175.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -99.18 139.23 35.13 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 125.447 1.499 . . . . 0.0 109.199 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.548 0.5 OUTLIER -47.52 -12.72 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.401 1 N-CA-C 121.898 4.036 . . . . 0.0 121.898 -176.615 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -80.01 -81.85 0.12 Allowed 'General case' 0 N--CA 1.441 -0.884 1 N-CA-C 99.618 -4.216 . . . . 0.0 99.618 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.75 0.47 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.632 1.573 . . . . 0.0 114.472 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -82.27 127.73 33.49 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.584 ' HA ' HG22 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -65.33 135.34 55.19 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.641 1.577 . . . . 0.0 109.489 178.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.43 -50.83 3.49 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 122.982 0.513 . . . . 0.0 110.678 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.29 140.23 3.59 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.503 -0.379 . . . . 0.0 112.769 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.07 131.12 36.84 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.056 1.342 . . . . 0.0 108.034 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.8 pt -141.77 165.8 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.668 1.187 . . . . 0.0 110.391 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.421 HG23 HG22 ' A' ' 92' ' ' THR . 9.8 t -158.57 146.54 18.21 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -83.58 15.13 3.29 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 122.665 0.386 . . . . 0.0 110.917 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.421 HG22 HG23 ' A' ' 90' ' ' THR . 6.2 t -40.98 -45.29 2.56 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 116.92 2.192 . . . . 0.0 116.92 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -150.54 57.26 0.45 Allowed Glycine 0 C--N 1.331 0.301 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.02 175.89 5.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.891 1.276 . . . . 0.0 109.77 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.8 t -83.0 58.91 4.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.803 1.241 . . . . 0.0 111.028 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.37 -87.5 0.81 Allowed Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.228 1.394 . . . . 0.0 112.71 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -79.52 -24.75 42.01 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.114 0.966 . . . . 0.0 111.294 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -63.04 170.23 2.89 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.517 1.127 . . . . 0.0 110.178 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -130.31 168.19 17.3 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.617 1.567 . . . . 0.0 111.811 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.1 m -139.51 161.13 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 126.886 2.074 . . . . 0.0 105.748 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.25 131.7 10.58 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 114.775 0.67 . . . . 0.0 114.775 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.8 t -98.19 172.33 7.65 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.2 t 53.95 -153.63 0.28 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.904 1.229 . . . . 0.0 109.198 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.76 0.66 76.55 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.593 1.092 . . . . 0.0 110.401 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 m -79.69 149.15 31.31 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 125.495 1.518 . . . . 0.0 108.727 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.004 -1.474 . . . . 0.0 108.914 -179.186 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.6 m . . . . . 0 CA--C 1.528 0.133 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.44 122.7 11.02 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.8 0.84 . . . . 0.0 109.904 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.517 HG22 ' HB3' ' A' ' 103' ' ' SER . 3.0 p -91.69 87.98 6.52 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -92.2 96.93 10.59 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 102.447 -3.168 . . . . 0.0 102.447 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.1 m -98.3 81.73 2.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.472 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.4 -86.98 0.91 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.9 p -122.12 -23.22 5.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.333 1.453 . . . . 0.0 110.929 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.55 91.6 3.98 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -84.15 127.99 34.27 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.933 1.293 . . . . 0.0 112.772 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -127.57 134.5 49.72 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.5 p -69.24 152.76 44.66 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 124.689 1.196 . . . . 0.0 110.194 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.38 -22.94 55.59 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.3 p -77.4 -35.51 54.19 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 123.284 0.634 . . . . 0.0 109.519 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -69.11 -33.87 74.17 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.423 0.689 . . . . 0.0 110.986 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.1 t -66.77 -50.56 64.52 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.0 tmt_? -61.49 -38.92 89.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.212 1.405 . . . . 0.0 110.99 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.44 -51.77 53.42 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.636 0.774 . . . . 0.0 109.58 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.83 -23.93 66.79 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 118.809 -0.615 . . . . 0.0 111.115 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.13 -41.77 33.96 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 118.468 0.577 . . . . 0.0 110.835 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -68.63 -20.89 64.5 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.09 -64.45 1.16 Allowed 'General case' 0 C--N 1.35 0.591 0 N-CA-C 103.292 -2.855 . . . . 0.0 103.292 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -39.88 -45.01 1.75 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.187 1.395 . . . . 0.0 111.473 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.5 m -55.26 -58.77 6.36 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.882 1.273 . . . . 0.0 109.753 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.2 tp-100 -65.84 -36.84 84.59 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -86.22 -10.13 55.23 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 128.772 2.829 . . . . 0.0 115.512 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -90.74 -61.48 1.66 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-N 120.07 1.304 . . . . 0.0 113.21 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -137.56 -10.0 1.64 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -66.46 -48.7 69.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.357 0.98 . . . . 0.0 111.276 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -172.38 108.61 0.21 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.045 1.338 . . . . 0.0 107.47 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.251 0.1 OUTLIER 89.26 163.61 0.05 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 128.724 2.81 . . . . 0.0 112.648 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.9 p -138.02 -45.45 0.52 Allowed 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 126.691 1.996 . . . . 0.0 109.026 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 85.62 165.35 0.09 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 127.844 2.458 . . . . 0.0 111.558 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.97 85.77 1.09 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.535 1.064 . . . . 0.0 111.781 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.9 p -132.47 -124.29 0.19 Allowed 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 m -177.69 -75.88 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.14 1.376 . . . . 0.0 109.711 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.02 0.5 57.53 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.776 1.63 . . . . 0.0 113.35 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -152.32 104.89 2.76 Favored Pre-proline 0 C--N 1.343 0.284 0 O-C-N 120.924 -1.11 . . . . 0.0 108.728 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -72.14 155.47 98.37 Favored 'Cis proline' 0 N--CA 1.459 -0.501 0 CA-C-N 119.942 1.015 . . . . 0.0 113.608 0.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.15 162.62 4.54 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.573 1.549 . . . . 0.0 109.945 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.6 m -70.27 136.63 50.04 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.869 1.668 . . . . 0.0 109.775 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -96.12 150.24 20.73 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.401 1.08 . . . . 0.0 109.96 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -78.88 165.75 23.17 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.108 0.963 . . . . 0.0 111.475 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -159.0 93.21 1.14 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.469 0.708 . . . . 0.0 110.337 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -164.23 -56.57 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.22 1.008 . . . . 0.0 109.894 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -166.07 134.05 2.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.801 1.24 . . . . 0.0 108.36 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.83 -83.68 0.15 Allowed Glycine 0 C--N 1.338 0.674 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -159.36 46.69 0.28 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.572 1.149 . . . . 0.0 107.992 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -74.95 164.23 26.78 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -127.95 94.67 36.29 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 125.481 1.512 . . . . 0.0 108.329 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.34 84.15 1.4 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.389 2.726 . . . . 0.0 110.982 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.7 t -113.17 -49.51 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.282 1.433 . . . . 0.0 109.198 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -154.15 -73.97 0.12 Allowed 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.854 0.861 . . . . 0.0 109.243 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.96 140.23 8.04 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.81 175.25 45.47 Favored 'Cis proline' 0 N--CA 1.459 -0.557 0 CA-C-N 118.845 1.322 . . . . 0.0 112.036 -0.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.59 -174.15 3.43 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.297 1.439 . . . . 0.0 108.75 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -157.12 146.14 20.03 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 122.968 0.507 . . . . 0.0 111.981 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -89.74 144.37 26.03 Favored 'General case' 0 C--N 1.343 0.295 0 O-C-N 123.687 0.617 . . . . 0.0 110.677 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -153.87 110.95 2.51 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -82.66 148.88 14.22 Favored 'Trans proline' 0 N--CA 1.439 -1.727 0 C-N-CA 121.824 1.683 . . . . 0.0 113.48 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.526 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.5 tt -106.73 -177.57 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-O 123.87 1.795 . . . . 0.0 111.7 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.526 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 18.5 tptt -160.29 159.35 31.23 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 109.622 -3.445 . . . . 0.0 113.041 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.5 p -90.11 60.41 4.82 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 126.515 1.926 . . . . 0.0 110.887 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.36 -53.94 0.05 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.66 -151.93 6.32 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.5 p -72.24 165.26 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.79 1.236 . . . . 0.0 109.083 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.44 141.91 14.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.9 m -118.09 -56.03 2.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.908 2.083 . . . . 0.0 107.427 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.61 -157.58 16.17 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.828 1.204 . . . . 0.0 111.42 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.39 36.34 59.44 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.375 0.988 . . . . 0.0 112.318 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.7 m -160.86 157.87 23.62 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 125.7 1.6 . . . . 0.0 108.274 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -45.36 -58.44 1.6 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.783 2.989 . . . . 0.0 111.884 169.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.4 141.47 12.24 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -148.3 -40.96 0.16 Allowed 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 117.428 -1.272 . . . . 0.0 112.273 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -88.14 120.45 29.5 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.032 0.933 . . . . 0.0 109.351 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.4 138.89 16.81 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -90.82 151.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.1 t -135.98 117.82 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.7 pt -109.68 164.12 6.29 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 C-N-CA 124.091 0.957 . . . . 0.0 112.18 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -79.41 157.87 27.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.312 1.845 . . . . 0.0 106.76 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.291 5.6 t -63.01 -10.14 12.8 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 -177.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -85.95 -80.54 0.22 Allowed 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.93 -5.45 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.666 2.386 . . . . 0.0 115.485 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.16 143.81 35.08 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 119.867 1.212 . . . . 0.0 114.021 -175.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -70.83 124.54 24.55 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.75 -48.08 6.75 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.028 0.531 . . . . 0.0 109.684 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.79 -170.08 41.22 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.12 141.07 22.01 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.508 1.123 . . . . 0.0 108.481 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.7 pt -137.71 166.34 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 124.598 1.159 . . . . 0.0 109.911 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.4 t -154.57 156.04 35.87 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.539 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 64.5 m170 -77.27 -40.85 43.18 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.763 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.6 t -54.67 142.97 26.41 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 123.127 0.571 . . . . 0.0 111.801 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.1 -24.01 33.22 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.71 -141.94 0.23 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.012 1.325 . . . . 0.0 109.087 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.2 t -155.23 80.63 1.05 Allowed 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.431 0.56 . . . . 0.0 111.114 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.94 -133.2 11.02 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.033 1.301 . . . . 0.0 111.963 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -79.77 -30.06 40.6 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.983 0.913 . . . . 0.0 111.376 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -52.58 140.02 24.11 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.032 0.933 . . . . 0.0 109.78 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.64 167.03 10.59 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.3 m -145.01 166.56 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 128.944 2.897 . . . . 0.0 106.064 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.6 164.59 39.73 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 123.64 0.638 . . . . 0.0 114.539 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 49.6 t -139.36 163.71 31.76 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.986 1.714 . . . . 0.0 108.304 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.517 ' HB3' HG22 ' A' ' 4' ' ' THR . 59.6 p 54.92 43.81 29.33 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.51 1.924 . . . . 0.0 111.773 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.64 15.87 81.21 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.006 -0.885 . . . . 0.0 113.664 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.3 m -82.7 140.9 32.83 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.596 1.198 . . . . 0.0 108.59 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.107 -1.425 . . . . 0.0 108.986 179.652 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.3 p . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.54 164.56 0.14 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.485 1.914 . . . . 0.0 112.027 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.07 151.84 25.72 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.261 -0.274 . . . . 0.0 110.97 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.2 115.82 21.02 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.7 m -103.37 97.17 7.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.47 0.708 . . . . 0.0 109.819 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.9 -78.4 0.91 Allowed Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.768 1.175 . . . . 0.0 111.297 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 t -135.71 -8.42 2.15 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.547 1.139 . . . . 0.0 112.778 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.64 134.94 42.86 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 119.194 0.907 . . . . 0.0 109.502 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -94.4 154.69 17.34 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.809 0.844 . . . . 0.0 110.879 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -145.28 126.38 14.65 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.267 1.427 . . . . 0.0 108.836 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t -69.94 155.51 40.47 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.16 -16.65 34.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.6 t -76.28 -37.9 56.91 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.079 0.952 . . . . 0.0 109.459 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -74.6 -51.04 15.63 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.957 1.703 . . . . 0.0 111.152 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.84 -47.72 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.934 1.294 . . . . 0.0 107.524 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -69.67 -36.79 76.33 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.037 0.935 . . . . 0.0 111.94 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.13 -51.17 68.96 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.687 1.131 . . . . 0.0 109.859 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -34.72 74.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.775 0.83 . . . . 0.0 111.055 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.18 -33.35 33.08 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -69.94 -23.42 63.19 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.441 ' CB ' HG11 ' A' ' 66' ' ' VAL . . . -80.64 -53.15 6.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.482 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -50.19 -38.45 39.98 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.282 1.033 . . . . 0.0 110.41 176.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -55.3 35.31 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 126.171 1.789 . . . . 0.0 109.608 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.29 -30.97 68.11 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -90.55 -26.72 19.58 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -62.15 -32.75 73.39 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 119.202 0.91 . . . . 0.0 109.922 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -59.41 -19.03 44.13 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.024 0.929 . . . . 0.0 110.875 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 76.08 59.06 0.05 OUTLIER 'General case' 0 C--N 1.344 0.359 0 C-N-CA 127.294 2.237 . . . . 0.0 110.588 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -145.21 34.95 1.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.999 1.32 . . . . 0.0 109.529 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -175.27 130.99 0.29 Allowed 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 128.677 2.791 . . . . 0.0 106.455 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.7 p -84.35 85.79 7.34 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.26 0.552 . . . . 0.0 111.83 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.71 -160.23 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.044 1.737 . . . . 0.0 109.795 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -44.54 -49.8 8.47 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.233 1.397 . . . . 0.0 110.947 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.3 t 67.09 2.52 2.78 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.09 1.756 . . . . 0.0 115.735 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.9 m -67.77 -63.21 1.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -160.47 42.67 0.18 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.968 2.107 . . . . 0.0 107.076 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.438 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 9.8 m-85 -156.44 115.7 2.11 Favored Pre-proline 0 C--N 1.34 0.186 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.26 150.56 91.62 Favored 'Cis proline' 0 N--CA 1.456 -0.722 0 N-CA-C 114.239 0.823 . . . . 0.0 114.239 1.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.19 145.1 8.38 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.628 1.571 . . . . 0.0 108.577 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -60.44 145.47 48.1 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.849 1.66 . . . . 0.0 112.13 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -145.37 84.38 1.69 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -153.38 -158.47 0.88 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.934 1.294 . . . . 0.0 108.31 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.0 m120 67.83 2.52 3.1 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.629 1.572 . . . . 0.0 113.662 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -165.37 105.84 0.76 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -80.93 69.9 7.62 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.68 0.792 . . . . 0.0 110.659 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.28 11.91 56.6 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.945 0.783 . . . . 0.0 112.248 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -157.53 162.92 38.85 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 118.186 0.993 . . . . 0.0 111.809 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -116.03 119.72 36.78 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.131 1.373 . . . . 0.0 108.299 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -135.94 156.72 76.96 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 125.993 1.717 . . . . 0.0 107.722 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.401 ' O ' HG22 ' A' ' 52' ' ' VAL . 37.3 Cg_endo -61.74 163.36 18.92 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.095 2.53 . . . . 0.0 109.341 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 51' ' ' PRO 0.284 8.6 m 60.21 -165.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.176 1.39 . . . . 0.0 110.686 -178.201 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -112.79 -16.97 12.65 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.571 1.148 . . . . 0.0 113.392 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.07 -156.65 22.41 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.34 -177.05 5.33 Favored 'Cis proline' 0 CA--C 1.535 0.545 0 CA-C-N 119.037 1.418 . . . . 0.0 113.211 -0.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -148.25 155.27 41.14 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.615 0.366 . . . . 0.0 111.478 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -132.43 146.74 52.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.257 1.423 . . . . 0.0 107.777 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -86.6 156.8 19.89 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.482 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 35.8 t80 -152.5 109.7 2.76 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 13.0 Cg_endo -85.21 128.8 3.69 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.34 2.694 . . . . 0.0 116.965 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.444 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 10.1 tt -97.4 170.13 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 123.969 1.842 . . . . 0.0 112.193 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.444 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 8.3 mtpm? -160.74 113.51 1.99 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 109.394 -3.548 . . . . 0.0 111.623 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.9 p 10.76 50.14 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 129.806 3.242 . . . . 0.0 116.471 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.34 70.82 1.33 Allowed Glycine 0 C--N 1.337 0.639 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.08 113.89 0.54 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.441 HG11 ' CB ' ' A' ' 22' ' ' ALA . 26.9 t -84.08 137.77 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.103 1.361 . . . . 0.0 109.416 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.322 9.6 p90 46.17 53.38 9.41 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.027 2.131 . . . . 0.0 113.979 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.8 p -129.63 -33.44 1.85 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.963 1.705 . . . . 0.0 109.726 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.11 149.57 44.85 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 123.588 0.613 . . . . 0.0 112.815 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 172.07 -74.82 0.1 OUTLIER Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.8 t -153.0 105.22 2.64 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 124.121 0.968 . . . . 0.0 109.343 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -58.41 157.47 35.39 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 CA-C-N 119.735 0.941 . . . . 0.0 113.23 -5.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.81 -104.49 0.21 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 79.06 -60.18 0.37 Allowed 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 127.683 2.393 . . . . 0.0 109.052 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.92 121.9 18.25 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.445 1.498 . . . . 0.0 109.923 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -152.76 141.66 21.15 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.9 m -97.63 150.14 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.9 t -131.82 119.13 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.2 pt -100.62 167.75 2.01 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 C-N-CA 124.783 1.233 . . . . 0.0 113.17 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -82.46 168.26 17.62 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.875 2.07 . . . . 0.0 107.887 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.51 46.18 0.42 Allowed 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -160.36 -83.43 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.4 m -163.44 63.12 0.17 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.96 2.104 . . . . 0.0 112.034 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -148.83 114.74 5.72 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.445 1.93 . . . . 0.0 113.88 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -60.47 107.35 0.66 Allowed 'General case' 0 C--N 1.344 0.357 0 C-N-CA 123.56 0.744 . . . . 0.0 109.808 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.96 -68.22 0.72 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.34 169.35 35.46 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.87 146.64 48.26 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.25 1.02 . . . . 0.0 111.439 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.6 pt -139.28 166.04 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.577 1.551 . . . . 0.0 109.631 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.5 t -156.01 148.67 23.92 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -79.05 4.68 13.81 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 118.666 -0.683 . . . . 0.0 112.092 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.1 m -47.79 -49.94 27.24 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.73 32.68 6.4 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.577 1.084 . . . . 0.0 110.986 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -111.52 166.45 11.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.596 1.159 . . . . 0.0 112.641 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.2 t -103.49 67.61 0.92 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.707 1.603 . . . . 0.0 108.625 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.97 -109.8 3.79 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.763 1.173 . . . . 0.0 112.207 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -79.61 -9.18 59.59 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.175 0.99 . . . . 0.0 113.1 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -66.87 -179.65 0.94 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.062 0.945 . . . . 0.0 108.77 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -147.53 167.94 23.2 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.3 m -139.23 160.49 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 128.038 2.535 . . . . 0.0 105.381 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.67 149.6 20.17 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 115.527 0.971 . . . . 0.0 115.527 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.1 m -99.38 154.37 18.26 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.1 p 33.02 38.63 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 62.71 52.41 48.77 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.165 0.888 . . . . 0.0 111.853 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.1 t -81.65 28.95 0.39 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.517 1.127 . . . . 0.0 113.996 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 . . . . . 0 C--O 1.25 1.103 0 C-N-CA 125.974 1.709 . . . . 0.0 109.369 -179.243 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 110.53 98.35 0.0 OUTLIER 'General case' 0 C--N 1.345 0.393 0 C-N-CA 131.157 3.783 . . . . 0.0 107.096 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -107.28 94.61 5.18 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.84 1.256 . . . . 0.0 111.563 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.04 99.6 9.49 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 102.105 -3.294 . . . . 0.0 102.105 177.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -92.13 80.81 5.05 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.755 1.622 . . . . 0.0 109.211 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.41 -82.49 0.91 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.4 t -117.89 -45.81 2.66 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.49 1.516 . . . . 0.0 109.67 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.8 m -63.42 103.91 0.57 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.725 1.21 . . . . 0.0 109.885 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.82 131.42 34.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.097 1.359 . . . . 0.0 110.847 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -131.21 138.54 49.42 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.6 p -77.68 160.68 28.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 124.113 0.965 . . . . 0.0 111.773 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.87 -13.21 43.22 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.9 t -81.42 -41.38 21.96 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.92 -37.2 86.52 Favored 'General case' 0 C--N 1.345 0.402 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.53 HG13 ' CE2' ' A' ' 85' ' ' TYR . 3.3 t -59.86 -51.23 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 126.28 1.832 . . . . 0.0 108.538 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.79 -39.16 93.36 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.139 0.976 . . . . 0.0 111.805 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.94 -51.71 36.85 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.055 0.542 . . . . 0.0 110.419 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.41 -38.77 81.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.669 1.188 . . . . 0.0 110.884 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.89 -41.03 45.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -64.3 -21.5 66.63 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.64 -59.22 2.5 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.07 -47.4 11.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.906 1.283 . . . . 0.0 110.239 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.9 t -61.18 -53.95 50.51 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.474 1.509 . . . . 0.0 111.595 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -57.37 -46.69 83.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.943 0.497 . . . . 0.0 110.907 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -67.46 -48.96 65.66 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.685 1.194 . . . . 0.0 113.137 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -65.05 -34.33 78.18 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.694 0.798 . . . . 0.0 112.146 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -82.78 -47.16 12.23 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 123.033 0.533 . . . . 0.0 111.52 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -70.98 -3.56 20.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.533 1.133 . . . . 0.0 112.539 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.8 t70 69.16 76.69 0.23 Allowed 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.662 1.585 . . . . 0.0 110.812 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -144.88 122.79 11.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.0 1.72 . . . . 0.0 107.172 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.9 p -103.22 82.43 2.07 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.02 111.98 2.15 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.236 1.015 . . . . 0.0 110.35 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.63 112.53 3.14 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.414 1.006 . . . . 0.0 111.867 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.2 m -135.88 -56.97 0.77 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.993 1.317 . . . . 0.0 108.064 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -157.67 -68.18 0.09 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.089 1.755 . . . . 0.0 106.507 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.3 t -159.95 30.67 0.18 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.351 1.86 . . . . 0.0 108.639 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -124.43 155.04 69.4 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.569 1.947 . . . . 0.0 108.825 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -80.51 133.72 27.36 Favored 'Cis proline' 0 N--CA 1.452 -0.935 0 CA-C-N 119.519 0.864 . . . . 0.0 112.438 -0.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.97 166.17 33.23 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.997 1.319 . . . . 0.0 108.652 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.6 m -51.81 140.47 19.32 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 126.051 1.741 . . . . 0.0 112.107 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -129.71 119.7 23.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.738 1.215 . . . . 0.0 109.204 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -165.08 92.36 0.57 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -159.32 159.65 34.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.314 0.646 . . . . 0.0 111.149 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.8 t80 67.79 165.59 0.23 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.875 1.67 . . . . 0.0 112.615 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -109.62 -45.17 3.72 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 124.778 1.231 . . . . 0.0 110.788 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.13 38.21 2.2 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.006 0.812 . . . . 0.0 113.85 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -157.82 128.22 6.29 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.012 1.325 . . . . 0.0 108.653 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -165.27 -175.32 3.57 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.165 1.386 . . . . 0.0 108.954 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -143.06 157.11 61.31 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 125.459 1.504 . . . . 0.0 107.903 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -81.85 48.99 3.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.668 2.912 . . . . 0.0 111.506 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 m -153.45 171.88 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 127.547 2.339 . . . . 0.0 107.441 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -109.32 143.65 38.54 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.265 1.026 . . . . 0.0 110.33 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.71 -160.66 35.84 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.65 151.38 23.55 Favored 'Cis proline' 0 N--CA 1.46 -0.467 0 CA-C-N 118.793 1.297 . . . . 0.0 113.634 -0.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -111.74 174.09 6.04 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.669 1.188 . . . . 0.0 109.848 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -155.57 144.0 20.25 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.11 0.564 . . . . 0.0 110.508 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -87.81 149.93 23.85 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.877 0.871 . . . . 0.0 111.092 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -158.34 109.24 1.69 Allowed Pre-proline 0 N--CA 1.45 -0.444 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -79.92 136.1 11.63 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 121.344 1.363 . . . . 0.0 113.454 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.503 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.3 tt -98.51 177.25 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 124.089 1.899 . . . . 0.0 110.801 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.503 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.7 tptm -156.52 -169.63 3.08 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 109.295 -3.593 . . . . 0.0 110.835 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t -76.64 52.44 0.81 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.574 1.549 . . . . 0.0 112.464 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.35 68.45 1.46 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.34 103.14 0.2 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 51.7 t -66.21 120.32 13.09 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 124.43 1.092 . . . . 0.0 108.661 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 64.47 115.67 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.543 1.537 . . . . 0.0 111.308 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.2 p -97.34 -72.74 0.63 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.495 1.118 . . . . 0.0 111.867 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.71 -10.88 73.59 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.897 0.76 . . . . 0.0 111.854 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.52 -90.68 1.04 Allowed Glycine 0 C--N 1.343 0.96 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.9 m -141.39 72.81 25.82 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 123.339 0.656 . . . . 0.0 112.229 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.55 111.33 3.2 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 N-CA-C 105.761 -2.438 . . . . 0.0 105.761 163.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.08 -8.28 8.02 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-O 117.243 -1.865 . . . . 0.0 117.081 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.452 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -150.05 -60.19 0.2 Allowed 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 120.84 2.32 . . . . 0.0 114.315 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.52 118.33 13.18 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -147.2 137.22 23.19 Favored 'General case' 0 C--N 1.347 0.483 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.9 m -94.69 149.33 4.48 Favored 'Isoleucine or valine' 0 C--N 1.343 0.318 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.5 t -134.72 117.68 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 pt -103.53 -177.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.372 0 C-N-CA 124.407 1.083 . . . . 0.0 112.145 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -99.79 151.91 20.72 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 127.312 2.245 . . . . 0.0 105.308 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.326 5.3 t -63.07 -7.22 5.07 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 119.2 3.037 . . . . 0.0 119.2 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -89.29 -78.03 0.36 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.54 -9.96 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -79.21 151.49 31.19 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 118.868 0.758 . . . . 0.0 110.509 -176.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.53 ' CE2' HG13 ' A' ' 16' ' ' VAL . 7.0 t80 -93.53 137.55 32.69 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.514 1.125 . . . . 0.0 109.763 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.86 -57.59 2.32 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 123.258 0.623 . . . . 0.0 110.767 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.86 168.86 30.6 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.29 155.72 20.19 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 122.203 1.002 . . . . 0.0 112.794 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.2 pt -139.55 155.77 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 126.699 1.999 . . . . 0.0 106.575 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.5 t -154.69 156.47 36.46 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.452 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 53.2 m170 -77.96 -50.06 12.9 Favored 'General case' 0 C--N 1.346 0.442 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.673 176.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t 45.4 15.1 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.621 2.768 . . . . 0.0 116.248 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.76 49.79 3.28 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.174 1.369 . . . . 0.0 110.791 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.24 -87.13 0.11 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 124.293 1.037 . . . . 0.0 109.721 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.7 m -147.64 63.19 1.14 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.729 1.211 . . . . 0.0 108.756 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.04 -102.21 1.13 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.282 0.944 . . . . 0.0 111.737 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -79.53 -26.93 41.36 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.91 0.884 . . . . 0.0 112.006 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -50.31 129.96 22.4 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.989 0.916 . . . . 0.0 111.374 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -103.62 133.93 47.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.28 1.432 . . . . 0.0 110.266 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.6 m -111.15 164.81 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.33 137.76 17.45 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.872 -0.604 . . . . 0.0 114.105 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.8 t -83.29 -172.5 4.18 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.3 m -67.65 138.97 56.77 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.217 -0.927 . . . . 0.0 108.643 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.63 33.11 35.34 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.2 m -155.24 119.3 4.61 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.533 1.533 . . . . 0.0 110.574 -179.088 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -49.32 136.81 15.22 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.808 1.243 . . . . 0.0 110.485 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.7 p -112.45 117.58 32.78 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -117.41 94.59 4.61 Favored 'General case' 0 N--CA 1.422 -1.872 1 N-CA-C 100.176 -4.009 . . . . 0.0 100.176 177.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 54.2 m -95.02 71.87 3.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.29 -79.22 1.51 Allowed Glycine 0 C--N 1.34 0.799 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.3 t -123.29 -35.32 2.98 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.99 1.316 . . . . 0.0 111.344 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 m -72.86 99.25 2.62 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -95.58 148.36 22.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.264 1.026 . . . . 0.0 110.803 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.61 143.62 31.56 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.691 1.196 . . . . 0.0 108.003 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -68.71 150.73 47.57 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.86 -21.27 10.84 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.8 t -71.14 -44.51 65.41 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.387 1.075 . . . . 0.0 109.574 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.1 -39.01 92.53 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 118.682 0.673 . . . . 0.0 112.628 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.447 HG12 ' CE2' ' A' ' 85' ' ' TYR . 2.1 t -62.88 -53.31 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -57.13 -44.49 83.41 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.811 1.245 . . . . 0.0 110.291 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.03 -45.11 95.0 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.647 0.779 . . . . 0.0 110.077 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.13 -33.95 69.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.511 0.725 . . . . 0.0 110.372 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.08 -39.55 25.54 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -62.4 -25.93 68.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.934 1.243 . . . . 0.0 108.312 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.55 -64.51 1.13 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.57 -33.54 15.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.962 0.905 . . . . 0.0 111.346 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 t -61.89 -61.4 2.52 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.308 1.443 . . . . 0.0 110.05 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -65.7 -42.3 91.32 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -71.52 -48.7 47.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.329 1.451 . . . . 0.0 113.722 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.457 ' CE2' ' HG2' ' A' ' 57' ' ' GLN . 39.6 t80 -62.08 -34.68 76.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.48 0.582 . . . . 0.0 110.177 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -58.02 -34.81 70.45 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 118.432 -0.794 . . . . 0.0 112.447 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 122.08 73.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 129.577 3.151 . . . . 0.0 110.604 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -162.08 58.82 0.24 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.1 t70 124.18 154.52 0.0 OUTLIER 'General case' 0 C--N 1.344 0.343 0 C-N-CA 130.027 3.331 . . . . 0.0 109.257 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.6 p -110.78 67.65 0.65 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 126.044 1.738 . . . . 0.0 108.653 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.06 93.79 1.83 Allowed 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.047 0.539 . . . . 0.0 109.751 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.21 135.33 3.41 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.1 t -136.4 67.03 1.47 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.642 0.777 . . . . 0.0 110.589 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.1 m -122.24 -76.77 0.59 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -160.29 30.97 0.17 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.835 1.654 . . . . 0.0 109.105 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -149.05 134.3 9.47 Favored Pre-proline 0 C--N 1.342 0.278 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.68 145.9 85.35 Favored 'Cis proline' 0 N--CA 1.455 -0.776 0 CA-C-N 119.373 0.812 . . . . 0.0 112.483 -0.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -159.89 162.47 34.58 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 126.079 1.752 . . . . 0.0 108.459 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 t -59.91 150.23 29.32 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -106.56 88.44 2.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.11 1.364 . . . . 0.0 107.707 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -68.31 100.4 1.05 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.687 1.195 . . . . 0.0 109.943 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -66.17 -65.48 0.67 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.679 0.791 . . . . 0.0 111.105 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 58.41 56.03 4.61 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 68.06 -17.0 0.17 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.731 2.012 . . . . 0.0 114.593 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.75 -99.32 0.01 OUTLIER Glycine 0 CA--C 1.532 1.136 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.62 133.94 38.31 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -109.81 162.83 14.1 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.948 1.299 . . . . 0.0 110.88 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -153.95 153.21 28.26 Favored Pre-proline 0 N--CA 1.454 -0.257 0 C-N-CA 126.149 1.78 . . . . 0.0 107.231 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.99 -30.02 76.17 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.92 2.413 . . . . 0.0 112.026 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 t -91.06 -74.39 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.069 0.947 . . . . 0.0 108.462 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 t70 54.87 105.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.967 2.507 . . . . 0.0 115.405 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.81 117.68 2.0 Allowed Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.839 -0.978 . . . . 0.0 112.082 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -68.8 157.33 89.34 Favored 'Cis proline' 0 C--N 1.348 0.515 0 CA-C-N 119.521 1.661 . . . . 0.0 108.543 -1.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.56 134.75 15.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 119.85 3.278 . . . . 0.0 119.85 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.457 ' HG2' ' CE2' ' A' ' 27' ' ' TYR . 20.0 mp0 -145.07 144.97 31.24 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.476 1.11 . . . . 0.0 112.78 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -81.86 156.15 24.98 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.674 0.749 . . . . 0.0 110.346 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -160.63 107.53 1.32 Allowed Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.39 134.88 21.46 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 CA-C-N 120.913 1.362 . . . . 0.0 112.336 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.45 HG13 ' H ' ' A' ' 62' ' ' LYS . 6.9 tp -82.27 176.14 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-O 123.863 1.792 . . . . 0.0 111.114 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.45 ' H ' HG13 ' A' ' 61' ' ' ILE . 55.9 tptt -155.56 154.57 31.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 109.703 -3.408 . . . . 0.0 112.813 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.4 m -83.83 51.0 1.93 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 127.467 2.307 . . . . 0.0 108.367 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.62 65.03 0.07 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.48 -102.9 1.66 Allowed Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 67' ' ' TYR . 8.2 p -110.6 -176.93 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.823 2.049 . . . . 0.0 109.886 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.498 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -41.27 166.72 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.291 2.636 . . . . 0.0 117.258 -178.772 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.3 p -96.37 -64.17 1.07 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.375 1.47 . . . . 0.0 110.057 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.12 62.88 0.77 Allowed Glycine 0 C--N 1.338 0.679 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -170.76 -61.8 0.04 OUTLIER Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.2 t -154.13 147.4 18.2 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.288 1.035 . . . . 0.0 109.924 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.31 -158.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.193 3.262 . . . . 0.0 110.419 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.39 41.95 0.13 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 107.391 -2.284 . . . . 0.0 107.391 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.44 ' HB1' ' H ' ' A' ' 91' ' ' HIS . . . 71.12 -27.07 0.17 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.824 2.049 . . . . 0.0 116.305 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.9 111.43 19.66 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 120.332 1.424 . . . . 0.0 110.438 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -120.1 154.09 35.2 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.101 0.96 . . . . 0.0 113.146 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.3 m -128.02 143.21 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -134.89 126.67 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pt -110.29 -165.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.371 0 C-N-CA 125.016 1.326 . . . . 0.0 114.447 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -122.97 136.87 55.02 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 128.48 2.712 . . . . 0.0 106.849 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.29 1.7 t -56.65 -15.55 4.67 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 118.746 2.869 . . . . 0.0 118.746 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -79.55 -77.15 0.19 Allowed 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 102.693 -3.077 . . . . 0.0 102.693 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.11 -2.16 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.012 2.125 . . . . 0.0 114.902 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -79.17 170.25 16.93 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 119.646 1.112 . . . . 0.0 112.155 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.447 ' CE2' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -112.65 126.95 55.93 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.767 1.227 . . . . 0.0 111.565 -178.331 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.5 -51.82 7.44 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.63 -158.26 31.07 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 112.28 -0.328 . . . . 0.0 112.28 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.54 145.22 29.0 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.357 1.063 . . . . 0.0 110.174 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 pt -138.32 166.81 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.705 1.202 . . . . 0.0 110.95 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.3 t -156.18 156.69 34.63 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.44 ' H ' ' HB1' ' A' ' 74' ' ' ALA . 44.7 m170 -78.5 -30.67 47.33 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.117 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.5 m -29.48 -70.14 0.05 Allowed 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.987 2.115 . . . . 0.0 116.504 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.97 -12.84 79.25 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.111 0.862 . . . . 0.0 114.769 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.96 -142.21 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.345 1.073 . . . . 0.0 111.064 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.7 t -151.17 92.27 1.78 Allowed 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.033 0.933 . . . . 0.0 109.941 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.98 -105.97 2.21 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.97 1.272 . . . . 0.0 112.632 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -79.47 -32.03 42.52 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.871 0.868 . . . . 0.0 111.312 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -54.79 160.62 1.83 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.318 1.047 . . . . 0.0 111.685 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -125.09 163.37 22.54 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.239 1.416 . . . . 0.0 112.859 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.5 m -144.53 165.68 12.78 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 128.123 2.569 . . . . 0.0 106.473 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.68 157.34 23.63 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.232 0.444 . . . . 0.0 113.477 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.5 m -116.24 167.63 10.84 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.2 m 61.7 -157.31 0.34 Allowed 'General case' 0 C--N 1.342 0.243 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.37 -19.62 57.77 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.489 1.042 . . . . 0.0 111.359 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.8 m -79.46 144.69 33.81 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 125.011 1.324 . . . . 0.0 109.122 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 C--O 1.253 1.285 0 CA-C-O 117.066 -1.445 . . . . 0.0 109.193 179.039 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 CA--C 1.529 0.167 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 73.41 146.34 0.08 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 126.874 2.07 . . . . 0.0 109.974 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 t -151.15 135.45 16.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.506 0.193 . . . . 0.0 110.525 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.88 107.91 18.02 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -98.69 85.89 3.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.47 -115.06 4.93 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.0 m -91.15 -27.79 18.29 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.404 1.082 . . . . 0.0 110.23 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -76.33 94.53 3.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.202 1.001 . . . . 0.0 109.351 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -85.82 113.15 21.75 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.723 1.209 . . . . 0.0 109.977 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -103.99 133.02 49.65 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.124 0.97 . . . . 0.0 111.218 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.7 m -72.46 154.31 40.93 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.3 1.44 . . . . 0.0 108.951 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.08 -20.84 60.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.0 m -74.5 -37.91 62.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.774 0.829 . . . . 0.0 109.449 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -73.66 -47.72 37.7 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.751 1.22 . . . . 0.0 111.596 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.0 t -54.39 -50.29 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -71.81 -34.64 69.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.226 1.411 . . . . 0.0 113.272 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.76 -52.76 55.26 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.279 0.945 . . . . 0.0 109.396 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.59 87.75 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.91 -37.54 81.82 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.63 -22.51 61.68 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.33 -59.44 2.77 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -55.44 -41.72 73.25 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.365 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.74 -50.47 33.61 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.853 1.206 . . . . 0.0 110.577 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -68.52 -43.87 75.84 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.353 0.0 OUTLIER -75.08 -43.05 55.32 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -177.394 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -39.24 62.98 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.59 1.956 . . . . 0.0 107.928 177.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -76.81 -37.51 55.62 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.884 1.274 . . . . 0.0 112.867 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -63.16 -32.18 73.51 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 t0 67.92 32.0 5.38 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.439 1.495 . . . . 0.0 110.87 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -163.5 -165.18 1.01 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 129.283 3.033 . . . . 0.0 105.065 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.284 3.7 t 47.27 57.96 5.31 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.804 1.242 . . . . 0.0 110.518 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.52 172.16 13.35 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.663 1.585 . . . . 0.0 109.67 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.8 58.25 0.07 OUTLIER Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.3 t -118.95 -94.49 0.5 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.716 1.206 . . . . 0.0 108.207 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.9 m -158.1 -59.34 0.08 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.804 1.242 . . . . 0.0 108.223 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 82.7 p -130.56 -52.27 1.08 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.697 1.599 . . . . 0.0 108.439 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -45.24 124.57 5.58 Favored Pre-proline 0 C--N 1.342 0.271 0 C-N-CA 127.821 2.448 . . . . 0.0 108.531 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.52 119.22 5.08 Favored 'Cis proline' 0 N--CA 1.453 -0.857 0 CA-C-N 118.583 0.53 . . . . 0.0 111.613 1.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -135.85 146.35 47.37 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 124.643 1.177 . . . . 0.0 111.129 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -43.0 151.3 0.14 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.257 2.223 . . . . 0.0 114.743 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -126.4 127.23 45.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.742 2.017 . . . . 0.0 105.853 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -74.32 -103.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 122.79 0.436 . . . . 0.0 111.3 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -178.46 -46.08 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.212 1.405 . . . . 0.0 109.06 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -41.48 128.76 3.14 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 128.002 2.521 . . . . 0.0 115.106 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 43.87 82.5 0.03 OUTLIER 'General case' 0 C--N 1.342 0.267 0 C-N-CA 127.325 2.25 . . . . 0.0 113.361 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.46 -156.94 28.4 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.52 154.35 20.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.66 1.584 . . . . 0.0 108.339 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -132.29 129.65 39.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -72.32 151.57 92.1 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.722 1.209 . . . . 0.0 111.397 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -63.6 -12.52 31.58 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 124.05 3.167 . . . . 0.0 115.618 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.94 -64.18 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.063 0.847 . . . . 0.0 110.281 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 143.17 -52.03 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 129.601 3.16 . . . . 0.0 108.457 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.5 -162.96 28.38 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.436 1.017 . . . . 0.0 110.952 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.6 170.59 9.27 Favored 'Cis proline' 0 CA--C 1.535 0.542 0 CA-C-N 119.208 1.504 . . . . 0.0 114.999 -0.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.29 -179.17 6.36 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 125.061 1.344 . . . . 0.0 109.229 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.19 147.77 25.18 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.24 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -79.41 148.8 31.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.832 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.489 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 20.4 t80 -144.13 104.91 4.78 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.468 ' HB3' HH11 ' A' ' 76' ' ' ARG . 26.3 Cg_endo -77.54 128.09 9.3 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 121.024 1.149 . . . . 0.0 113.319 -175.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.557 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.1 tt -90.83 179.33 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 124.281 1.991 . . . . 0.0 110.275 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.557 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 10.4 tptp -160.2 147.55 16.26 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 109.26 -3.609 . . . . 0.0 110.58 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.0 p -93.35 56.89 2.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.604 1.162 . . . . 0.0 108.531 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 178.78 57.3 0.07 OUTLIER Glycine 0 C--N 1.339 0.713 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.95 153.16 19.1 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.023 0.821 . . . . 0.0 111.951 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.57 147.61 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.489 1.116 . . . . 0.0 109.091 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.399 0.0 OUTLIER 28.97 44.5 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 128.794 2.837 . . . . 0.0 116.486 -178.567 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.8 p -141.72 108.41 5.37 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.459 1.504 . . . . 0.0 107.395 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -179.71 -177.53 47.94 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.06 160.42 33.97 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.2 t 72.18 145.85 0.11 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.056 1.742 . . . . 0.0 110.219 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -42.15 110.46 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.91 3.074 . . . . 0.0 113.715 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.62 -39.03 2.64 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.455 ' HB1' ' H ' ' A' ' 91' ' ' HIS . . . 71.74 -12.08 0.68 Allowed 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 126.769 2.028 . . . . 0.0 115.814 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -88.78 126.41 35.33 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 120.568 1.531 . . . . 0.0 112.427 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.468 HH11 ' HB3' ' A' ' 60' ' ' PRO . 33.0 mtt-85 -136.91 145.82 44.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.34 150.04 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 102.389 -3.189 . . . . 0.0 102.389 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.33 127.03 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 O-C-N 121.543 -0.723 . . . . 0.0 109.284 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.9 pt -113.61 158.18 14.04 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 124.924 1.29 . . . . 0.0 108.424 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -79.28 172.98 13.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.869 0.868 . . . . 0.0 109.273 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.299 3.0 t -76.66 30.02 0.13 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -128.33 -80.19 0.58 Allowed 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 101.66 -3.459 . . . . 0.0 101.66 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.5 -19.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -84.65 139.42 32.06 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -55.67 129.68 40.14 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 125.117 1.367 . . . . 0.0 109.01 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.38 -45.0 5.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.205 1.402 . . . . 0.0 108.947 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.72 -160.98 24.25 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.42 148.55 23.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.347 1.459 . . . . 0.0 108.707 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.3 pt -142.97 164.56 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.929 1.292 . . . . 0.0 110.227 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -159.47 162.84 35.66 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.895 0.478 . . . . 0.0 111.728 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.455 ' H ' ' HB1' ' A' ' 74' ' ' ALA . 22.4 m170 -78.89 -56.62 4.26 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.272 5.8 t 49.26 11.01 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.352 2.661 . . . . 0.0 115.606 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.36 -55.85 0.62 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 106.98 -2.448 . . . . 0.0 106.98 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 52.28 -169.33 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.483 1.913 . . . . 0.0 112.133 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.8 t -83.27 -42.24 17.4 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -147.54 -79.87 0.03 OUTLIER Glycine 0 C--N 1.342 0.891 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -130.47 3.2 4.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.182 1.393 . . . . 0.0 111.55 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -73.07 -169.84 0.66 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.962 1.305 . . . . 0.0 111.725 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -127.37 154.42 45.0 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.933 1.293 . . . . 0.0 112.224 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.81 162.75 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 126.215 1.806 . . . . 0.0 107.144 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.84 147.26 39.66 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.68 -178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.0 t -79.83 178.89 7.87 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.1 m -93.21 100.48 12.85 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.944 0.793 . . . . 0.0 108.869 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.65 75.49 1.27 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.1 t -135.13 29.82 3.35 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.54 1.536 . . . . 0.0 111.459 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.962 1.705 . . . . 0.0 110.519 -179.228 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 CA--C 1.53 0.205 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.58 156.6 0.14 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.639 1.976 . . . . 0.0 111.929 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 t -154.51 137.8 15.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.86 122.02 45.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.03 80.2 1.49 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.436 1.495 . . . . 0.0 108.058 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.74 -86.41 0.75 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.5 t -114.82 -41.86 3.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.108 1.363 . . . . 0.0 110.053 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.4 m -68.91 100.19 1.16 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.559 0.744 . . . . 0.0 109.45 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -80.03 151.97 29.67 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.895 0.878 . . . . 0.0 110.506 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -139.0 131.11 28.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.988 0.915 . . . . 0.0 110.225 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.9 m -72.21 156.43 39.16 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.42 1.488 . . . . 0.0 109.057 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.47 -21.35 62.27 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.6 m -70.88 -40.72 72.08 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.748 1.219 . . . . 0.0 109.373 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -49.07 67.8 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.53 1.132 . . . . 0.0 111.004 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.93 -49.34 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.241 1.416 . . . . 0.0 109.626 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -67.79 -40.26 83.97 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.765 0.826 . . . . 0.0 112.393 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.27 -49.97 71.96 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.54 -38.7 81.72 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.001 0.92 . . . . 0.0 110.098 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.88 -46.27 62.89 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -64.31 -20.35 66.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.14 -55.27 4.86 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.705 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -55.21 -43.12 74.18 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 t -50.31 -53.24 30.18 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.044 0.938 . . . . 0.0 110.812 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -66.37 -44.4 83.25 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -65.07 -59.54 4.01 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.843 2.457 . . . . 0.0 112.204 -177.713 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -64.92 -24.97 67.69 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.939 2.095 . . . . 0.0 113.758 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -76.11 -62.86 1.46 Allowed 'General case' 0 C--N 1.338 0.095 0 CA-C-N 118.763 0.71 . . . . 0.0 111.964 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -164.89 -37.61 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -81.3 61.76 4.94 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.576 1.151 . . . . 0.0 108.785 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -50.05 117.9 2.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.464 1.906 . . . . 0.0 111.935 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 t -90.48 -20.71 22.41 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.369 1.068 . . . . 0.0 108.983 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 26' ' ' TYR . . . -155.4 -168.65 2.9 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.773 2.429 . . . . 0.0 107.888 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -176.62 150.11 10.19 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 121.589 -0.695 . . . . 0.0 113.213 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 m -153.55 -111.14 0.04 OUTLIER 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.696 1.199 . . . . 0.0 109.405 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.9 m -155.89 -55.67 0.09 Allowed 'General case' 0 C--N 1.347 0.476 0 CA-C-N 118.813 0.733 . . . . 0.0 112.36 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.2 p -87.87 -57.42 2.95 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.141 0.976 . . . . 0.0 110.351 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -92.19 153.37 43.09 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.522 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.434 ' HG3' ' CE2' ' A' ' 26' ' ' TYR . 26.8 Cg_endo -98.31 56.04 1.0 Allowed 'Cis proline' 0 N--CA 1.442 -1.517 0 N-CA-C 105.139 -2.677 . . . . 0.0 105.139 -5.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -107.08 -168.39 1.4 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.555 1.142 . . . . 0.0 112.417 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.0 p -33.02 139.92 0.05 OUTLIER 'General case' 0 C--N 1.34 0.185 0 C-N-CA 128.56 2.744 . . . . 0.0 115.784 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -152.13 127.17 9.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.054 2.142 . . . . 0.0 105.515 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -149.24 -51.63 0.15 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.813 0.845 . . . . 0.0 110.171 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -58.02 158.13 7.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.842 1.257 . . . . 0.0 111.686 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 66.62 102.29 0.04 OUTLIER 'General case' 0 C--N 1.343 0.291 0 C-N-CA 125.927 1.691 . . . . 0.0 109.694 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -82.61 -142.44 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.147 0.979 . . . . 0.0 110.097 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.0 12.81 65.76 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -159.17 139.57 12.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.321 1.849 . . . . 0.0 108.584 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.06 166.22 17.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.671 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -134.97 162.19 59.19 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 124.772 1.229 . . . . 0.0 109.117 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -51.38 -41.12 60.86 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.852 3.035 . . . . 0.0 112.774 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.93 167.34 2.33 Favored 'Isoleucine or valine' 0 C--N 1.343 0.32 0 C-N-CA 123.585 0.754 . . . . 0.0 110.152 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -101.53 -177.22 3.37 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.981 1.313 . . . . 0.0 109.7 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -132.09 -156.76 8.41 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.471 1.034 . . . . 0.0 110.724 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.33 125.56 1.56 Allowed 'Cis proline' 0 N--CA 1.456 -0.712 0 CA-C-N 118.274 1.037 . . . . 0.0 113.436 -0.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -98.49 169.34 9.6 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.82 1.648 . . . . 0.0 109.261 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -138.83 156.18 47.53 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.45 159.8 17.1 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.705 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -161.18 102.32 1.25 Allowed Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 66.0 Cg_endo -66.87 121.74 8.99 Favored 'Trans proline' 0 N--CA 1.425 -2.546 0 CA-C-N 121.353 1.519 . . . . 0.0 114.098 -177.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 62' ' ' LYS . 3.2 tp -84.24 167.3 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-O 124.573 2.13 . . . . 0.0 112.127 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.449 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -160.25 151.62 19.5 Favored 'General case' 0 C--N 1.317 -0.843 1 CA-C-N 108.394 -4.003 . . . . 0.0 111.882 -178.887 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.6 p -86.49 57.36 4.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.998 1.719 . . . . 0.0 110.635 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.58 -73.39 0.03 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.27 137.64 5.48 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.45 131.6 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 117.32 0.56 . . . . 0.0 111.405 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.273 0.7 OUTLIER 64.65 131.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.717 2.807 . . . . 0.0 113.359 -178.659 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.6 p -136.59 -50.28 0.67 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.913 1.685 . . . . 0.0 108.435 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.9 61.66 1.49 Allowed Glycine 0 C--N 1.341 0.807 0 C-N-CA 124.374 0.988 . . . . 0.0 111.324 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 168.76 34.27 0.02 OUTLIER Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.271 -0.738 . . . . 0.0 113.206 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.8 p -170.38 139.76 1.47 Allowed Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.812 0.845 . . . . 0.0 110.094 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.73 -72.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.848 2.365 . . . . 0.0 108.5 170.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.74 -25.28 27.13 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 118.406 -1.219 . . . . 0.0 112.886 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 76.03 -43.54 0.48 Allowed 'General case' 0 C--N 1.346 0.448 0 C-N-CA 126.31 1.844 . . . . 0.0 111.081 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.92 121.76 28.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.88 0.872 . . . . 0.0 110.598 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -130.03 121.38 26.36 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.89 0.876 . . . . 0.0 112.896 -178.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.7 m -85.01 145.33 8.13 Favored 'Isoleucine or valine' 0 C--N 1.346 0.439 0 N-CA-C 102.692 -3.077 . . . . 0.0 102.692 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.8 t -131.47 115.89 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 pt -93.78 -177.97 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.454 0 C-N-CA 124.987 1.315 . . . . 0.0 110.663 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -123.23 166.9 14.47 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.356 14.9 t -75.99 62.83 1.68 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -149.57 -94.33 0.07 Allowed 'General case' 0 N--CA 1.432 -1.333 1 N-CA-C 99.55 -4.241 . . . . 0.0 99.55 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.5 t -164.12 8.92 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.771 1.228 . . . . 0.0 113.818 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -112.81 156.51 22.76 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -175.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -75.14 116.45 15.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.892 2.477 . . . . 0.0 108.456 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.23 -49.57 9.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.88 172.66 42.57 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.65 150.78 43.79 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.154 0.982 . . . . 0.0 111.087 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.4 pt -131.82 161.48 41.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.163 1.785 . . . . 0.0 108.15 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 92' ' ' THR . 0.8 OUTLIER -156.66 139.21 14.96 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -177.621 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -86.26 15.98 4.8 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.513 ' H ' HG23 ' A' ' 90' ' ' THR . 98.0 m -69.74 -51.73 31.55 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 120.703 -1.248 . . . . 0.0 111.0 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.88 9.5 65.65 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.556 1.074 . . . . 0.0 112.385 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.18 158.66 16.49 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.004 1.322 . . . . 0.0 111.086 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.8 t -104.62 69.32 0.89 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.326 1.45 . . . . 0.0 108.436 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.06 -115.21 3.29 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.463 1.506 . . . . 0.0 109.548 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -102.68 22.06 14.32 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.558 1.143 . . . . 0.0 111.778 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.71 -164.73 0.45 Allowed 'General case' 0 C--N 1.342 0.266 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -146.94 155.18 42.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.5 m -140.95 165.03 20.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 126.856 2.062 . . . . 0.0 106.622 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.87 141.91 16.29 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 116.637 -0.256 . . . . 0.0 113.538 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.3 t -83.07 -174.82 5.51 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.6 m -68.82 127.64 33.82 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.101 -0.999 . . . . 0.0 109.023 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.36 42.1 12.41 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.4 m -149.98 124.86 9.88 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.806 1.242 . . . . 0.0 108.144 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t30 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 117.038 -1.458 . . . . 0.0 109.173 179.171 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 CA--C 1.529 0.169 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.46 123.41 14.65 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.412 HG22 ' CG2' ' A' ' 16' ' ' VAL . 3.8 t -130.8 124.39 31.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 123.73 0.644 . . . . 0.0 111.075 -178.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -107.55 129.69 54.95 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.68 1.992 . . . . 0.0 106.507 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -119.81 93.39 4.05 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.879 0.371 . . . . 0.0 110.353 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.6 -84.01 0.66 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.9 m -115.53 -27.4 7.15 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.888 1.275 . . . . 0.0 110.802 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -66.71 155.12 38.9 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.733 0.697 . . . . 0.0 109.884 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -142.15 86.24 1.96 Allowed 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 123.788 0.68 . . . . 0.0 110.855 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.58 136.98 32.72 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.7 t -76.7 158.45 30.98 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.69 -19.55 50.45 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.7 m -71.54 -39.43 70.71 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.21 1.004 . . . . 0.0 109.214 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.99 -50.12 37.8 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.35 1.06 . . . . 0.0 112.459 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.437 HG11 ' CE2' ' A' ' 85' ' ' TYR . 21.7 t -54.79 -48.08 73.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.332 1.053 . . . . 0.0 108.917 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -71.11 -41.84 70.03 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.178 1.391 . . . . 0.0 113.363 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.72 -52.17 53.38 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.702 0.683 . . . . 0.0 110.651 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.432 ' HB1' ' CE2' ' A' ' 59' ' ' PHE . . . -60.93 -36.95 80.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.448 0.699 . . . . 0.0 110.703 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.52 -39.02 67.91 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.802 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -67.12 -21.86 65.83 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.84 -63.53 1.39 Allowed 'General case' 0 C--N 1.347 0.48 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.435 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -47.33 -37.35 10.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.332 1.453 . . . . 0.0 111.535 177.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -61.7 2.44 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.473 1.909 . . . . 0.0 108.884 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -63.23 -36.7 84.51 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -66.87 -43.06 84.54 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.673 1.189 . . . . 0.0 111.987 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -74.36 -27.59 60.74 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.074 0.397 . . . . 0.0 111.798 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -89.07 9.39 25.53 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.338 1.055 . . . . 0.0 113.146 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.7 p30 -130.84 45.83 2.76 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.085 0.857 . . . . 0.0 110.54 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 70.66 37.28 1.44 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.849 2.06 . . . . 0.0 113.274 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.45 176.36 0.08 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.565 1.946 . . . . 0.0 114.905 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.1 t 21.35 79.38 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 129.351 3.061 . . . . 0.0 115.857 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.89 98.3 7.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.16 53.61 41.12 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.498 1.047 . . . . 0.0 111.034 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.3 m -140.38 -114.89 0.13 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.2 t -157.9 -82.33 0.06 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.3 p -115.44 -44.09 3.0 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.842 1.657 . . . . 0.0 107.528 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.49 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 15.2 m-85 -69.49 131.99 89.67 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 126.664 1.986 . . . . 0.0 106.514 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.91 137.18 48.42 Favored 'Cis proline' 0 N--CA 1.453 -0.896 0 CA-C-N 120.823 1.33 . . . . 0.0 113.314 0.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -159.91 150.16 18.63 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.895 1.678 . . . . 0.0 109.963 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -47.72 141.39 5.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.094 2.157 . . . . 0.0 113.451 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -113.89 97.18 6.24 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.784 1.634 . . . . 0.0 108.383 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -157.94 33.55 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -66.11 -50.53 63.7 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.06 0.544 . . . . 0.0 111.347 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -161.6 91.57 0.84 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 72.13 171.45 0.31 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.233 1.813 . . . . 0.0 110.741 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.22 8.2 7.99 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 118.315 -1.27 . . . . 0.0 114.559 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.3 t80 62.61 -158.98 0.32 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.016 1.408 . . . . 0.0 110.016 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -61.82 -172.73 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.828 1.651 . . . . 0.0 112.325 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.0 p90 51.7 63.39 9.43 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 125.748 1.619 . . . . 0.0 110.741 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.64 111.44 3.13 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.687 2.924 . . . . 0.0 110.075 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.76 170.68 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.199 1.399 . . . . 0.0 109.72 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.7 -57.97 6.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.23 -149.35 49.93 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 119.521 -0.6 . . . . 0.0 112.267 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.98 148.64 19.9 Favored 'Cis proline' 0 N--CA 1.459 -0.512 0 CA-C-N 118.604 1.202 . . . . 0.0 112.999 -0.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -111.18 140.69 45.52 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 125.742 1.617 . . . . 0.0 108.645 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -113.88 149.65 34.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.77 1.228 . . . . 0.0 113.42 -177.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -84.83 155.12 21.91 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.095 0.958 . . . . 0.0 110.553 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.435 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 62.7 t80 -153.53 108.71 2.57 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 176.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.49 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 11.2 Cg_endo -82.04 133.44 7.75 Favored 'Trans proline' 0 N--CA 1.432 -2.131 0 C-N-CA 121.931 1.754 . . . . 0.0 113.287 -175.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.45 ' CG2' ' H ' ' A' ' 62' ' ' LYS . 0.7 OUTLIER -106.21 -171.58 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 127.247 2.219 . . . . 0.0 106.298 178.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.45 ' H ' ' CG2' ' A' ' 61' ' ' ILE . 10.5 mmtt -162.74 -174.99 4.19 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 129.374 3.069 . . . . 0.0 108.396 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.2 m -88.74 53.46 2.71 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.96 -51.25 0.01 OUTLIER Glycine 0 C--N 1.344 1.025 0 C-N-CA 124.666 1.127 . . . . 0.0 111.87 -178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.87 -139.12 7.33 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 118.289 1.045 . . . . 0.0 112.966 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.0 p -52.96 142.4 5.81 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 125.716 1.606 . . . . 0.0 110.436 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.03 164.0 27.98 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.297 0.639 . . . . 0.0 112.124 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 t -134.18 63.97 1.61 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.538 1.535 . . . . 0.0 109.419 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 151.53 -177.32 29.52 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.54 -98.21 0.15 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.414 ' CB ' ' CD ' ' A' ' 72' ' ' PRO 0.327 67.3 m 56.19 -105.88 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.952 1.701 . . . . 0.0 111.08 -179.084 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 71' ' ' SER . 83.0 Cg_endo -75.64 131.07 13.2 Favored 'Trans proline' 0 C--N 1.352 0.711 0 CA-C-N 123.584 2.316 . . . . 0.0 109.07 175.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.47 162.86 25.34 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -157.51 48.86 0.42 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.919 0.888 . . . . 0.0 109.303 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.18 116.89 3.42 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.975 2.11 . . . . 0.0 105.881 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.22 165.53 30.67 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 m -135.58 142.62 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 102.259 -3.237 . . . . 0.0 102.259 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.0 t -133.08 120.38 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.0 pt -97.99 179.33 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.407 0 C-N-CA 126.395 1.878 . . . . 0.0 112.028 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -113.59 177.1 4.75 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.416 1.486 . . . . 0.0 109.681 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.332 11.5 t -77.88 55.29 1.39 Allowed 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 118.047 2.61 . . . . 0.0 118.047 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -160.71 -95.23 0.02 OUTLIER 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 101.626 -3.472 . . . . 0.0 101.626 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 90.8 m -163.92 47.9 0.12 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 129.209 3.004 . . . . 0.0 109.863 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -121.7 108.28 13.35 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.625 1.557 . . . . 0.0 114.202 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.437 ' CE2' HG11 ' A' ' 16' ' ' VAL . 3.3 t80 -65.35 104.68 0.99 Allowed 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.381 1.472 . . . . 0.0 107.718 178.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.93 -54.27 5.97 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.569 0.748 . . . . 0.0 111.994 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.35 149.01 12.12 Favored Glycine 0 C--N 1.34 0.799 0 C-N-CA 119.25 -1.452 . . . . 0.0 113.963 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.99 140.36 29.56 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.947 1.299 . . . . 0.0 109.162 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.7 pt -135.74 161.7 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.017 1.327 . . . . 0.0 109.812 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.0 t -159.92 148.67 17.42 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.523 0.729 . . . . 0.0 112.169 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.47 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 5.0 m170 -85.65 -25.81 26.38 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.8 m -49.26 109.4 0.26 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 126.282 1.833 . . . . 0.0 110.337 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.27 52.31 4.06 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.183 0.897 . . . . 0.0 111.041 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.49 -128.38 0.09 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.615 1.166 . . . . 0.0 108.721 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.8 m -145.85 71.39 1.27 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.016 0.926 . . . . 0.0 110.12 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.87 -91.28 0.27 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.758 1.171 . . . . 0.0 112.851 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -79.89 -34.74 38.86 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.651 1.18 . . . . 0.0 111.579 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -53.39 138.48 32.98 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.943 0.897 . . . . 0.0 111.016 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -106.27 147.82 28.7 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.529 1.532 . . . . 0.0 110.318 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.5 m -128.99 160.79 39.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 124.546 1.138 . . . . 0.0 108.288 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.06 142.39 21.42 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.994 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 8.7 t -85.26 -174.66 5.35 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.302 1.441 . . . . 0.0 108.332 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.3 m -65.11 131.06 45.57 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 121.344 -0.848 . . . . 0.0 109.101 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.61 43.85 51.09 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 16.3 m -146.78 144.41 29.35 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 57.5 t30 . . . . . 0 C--O 1.251 1.137 0 C-N-CA 125.344 1.458 . . . . 0.0 110.345 -179.116 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.68 155.86 0.16 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.501 1.921 . . . . 0.0 110.495 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.5 p -135.53 93.6 2.98 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.87 95.91 10.04 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 102.067 -3.309 . . . . 0.0 102.067 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.7 m -95.08 83.12 3.86 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.008 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.14 -87.74 0.58 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.0 p -120.01 -23.29 6.4 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.076 1.751 . . . . 0.0 110.657 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.6 m -75.65 91.25 2.86 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -84.22 106.52 15.91 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.882 1.273 . . . . 0.0 110.911 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -98.32 138.84 34.97 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.108 0.963 . . . . 0.0 110.057 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.2 t -72.5 152.72 41.73 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 124.69 1.196 . . . . 0.0 108.839 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.4 -18.09 48.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 t -76.34 -38.52 55.8 Favored 'General case' 0 C--N 1.345 0.391 0 C-N-CA 124.382 1.073 . . . . 0.0 108.334 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -67.81 -36.37 80.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.298 1.039 . . . . 0.0 111.514 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.4 t -67.56 -48.27 77.37 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -62.77 -38.01 88.9 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.734 1.214 . . . . 0.0 111.3 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.32 -51.97 26.25 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.9 0.88 . . . . 0.0 110.541 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.69 -41.96 74.48 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.476 1.11 . . . . 0.0 110.116 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.7 -25.38 38.19 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -69.44 -24.64 63.85 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.41 -55.7 4.87 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.36 -51.68 25.21 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 124.266 0.979 . . . . 0.0 111.711 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 t -61.98 -47.21 85.87 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.111 1.764 . . . . 0.0 112.515 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -63.22 -51.02 67.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.307 0.643 . . . . 0.0 111.939 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -68.95 -48.16 63.89 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -63.54 -22.09 66.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -110.14 9.86 23.95 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -157.98 61.22 0.46 Allowed 'General case' 0 C--N 1.339 0.143 0 CA-C-N 119.361 0.982 . . . . 0.0 109.123 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t70 64.22 99.01 0.04 OUTLIER 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.954 1.702 . . . . 0.0 109.27 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -61.42 114.57 3.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.6 p -105.99 -76.82 0.6 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.14 -179.9 0.09 Allowed 'General case' 0 C--N 1.342 0.242 0 C-N-CA 125.758 1.623 . . . . 0.0 113.876 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.38 -62.59 3.03 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 p -82.05 -108.87 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.909 0.884 . . . . 0.0 109.636 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.8 p -170.06 -51.35 0.02 OUTLIER 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.538 1.135 . . . . 0.0 110.045 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.4 t -80.24 31.38 0.27 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.029 1.332 . . . . 0.0 112.833 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.497 ' CD1' ' HD3' ' A' ' 60' ' ' PRO . 96.8 m-85 -170.01 113.96 0.48 Allowed Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 128.339 2.656 . . . . 0.0 104.334 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.54 134.48 35.79 Favored 'Cis proline' 0 N--CA 1.448 -1.157 0 CA-C-N 120.763 1.308 . . . . 0.0 111.333 1.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -155.23 161.44 41.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.987 1.315 . . . . 0.0 108.216 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 t -60.87 143.24 55.26 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-O 120.748 0.308 . . . . 0.0 110.881 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.34 122.72 27.82 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -64.44 161.98 16.06 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.276 1.03 . . . . 0.0 111.189 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -105.06 73.0 1.03 Allowed 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.158 0.983 . . . . 0.0 110.068 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -81.6 -89.01 0.08 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -155.46 -56.38 0.09 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.003 1.321 . . . . 0.0 109.304 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.69 135.18 44.28 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.044 1.307 . . . . 0.0 114.496 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 53.6 162.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 129.121 2.969 . . . . 0.0 117.816 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -161.68 160.98 29.27 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.09 2.156 . . . . 0.0 107.241 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -137.31 78.62 38.66 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.28 71.24 5.87 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.014 3.142 . . . . 0.0 110.09 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.4 t -119.73 -67.22 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 125.754 1.622 . . . . 0.0 107.919 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -165.87 78.76 0.27 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.05 162.22 54.68 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.2 152.9 97.64 Favored 'Cis proline' 0 N--CA 1.459 -0.54 0 CA-C-N 118.302 1.051 . . . . 0.0 112.902 0.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -121.75 156.92 32.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.931 2.093 . . . . 0.0 110.493 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -127.87 152.45 47.82 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.295 1.438 . . . . 0.0 112.462 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -94.04 156.17 16.74 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.242 1.017 . . . . 0.0 111.772 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -159.35 112.7 1.54 Allowed Pre-proline 0 N--CA 1.455 -0.188 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.497 ' HD3' ' CD1' ' A' ' 38' ' ' TYR . 31.2 Cg_endo -81.7 127.24 5.55 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 121.389 1.393 . . . . 0.0 112.506 -175.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.502 HG13 ' H ' ' A' ' 62' ' ' LYS . 6.5 tt -84.47 167.2 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-O 123.816 1.769 . . . . 0.0 112.709 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.502 ' H ' HG13 ' A' ' 61' ' ' ILE . 48.0 mmtm -142.71 145.36 33.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 109.098 -3.683 . . . . 0.0 112.71 -178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.5 t -91.61 58.24 3.47 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 125.585 1.554 . . . . 0.0 108.833 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.06 -64.8 0.03 OUTLIER Glycine 0 C--N 1.337 0.6 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.31 159.49 32.69 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.0 p -74.53 156.47 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.515 1.126 . . . . 0.0 109.603 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.3 t80 66.44 56.65 0.76 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.501 1.12 . . . . 0.0 111.099 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.9 p -149.96 166.29 30.09 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.303 1.041 . . . . 0.0 109.509 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -144.83 148.03 19.56 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.614 1.102 . . . . 0.0 110.824 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.19 170.18 33.82 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.1 t -52.5 -66.02 0.89 Allowed Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.941 1.297 . . . . 0.0 112.96 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.87 146.7 48.36 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.243 1.962 . . . . 0.0 111.51 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.83 139.57 6.58 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -173.39 -33.3 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.355 1.462 . . . . 0.0 111.833 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.07 120.06 29.05 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.658 1.583 . . . . 0.0 111.551 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -139.03 130.56 27.22 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.9 m -96.44 148.1 5.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.276 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.8 t -136.7 137.24 47.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.7 pt -117.3 176.3 2.81 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 C-N-CA 125.188 1.395 . . . . 0.0 112.904 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -97.28 163.58 12.84 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 128.08 2.552 . . . . 0.0 107.19 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.302 12.8 t -72.41 3.72 4.51 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -93.43 -86.87 0.25 Allowed 'General case' 0 N--CA 1.434 -1.267 1 N-CA-C 98.711 -4.551 . . . . 0.0 98.711 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.5 m -164.49 -5.63 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 128.253 2.621 . . . . 0.0 114.105 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -79.48 148.87 31.7 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.31 129.85 39.91 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.071 1.349 . . . . 0.0 107.754 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.91 -51.72 4.94 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.941 1.296 . . . . 0.0 108.958 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.35 -166.57 32.57 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.75 116.97 3.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.034 0.934 . . . . 0.0 108.802 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 45.4 pt -107.96 160.26 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.796 1.238 . . . . 0.0 110.649 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t -159.86 149.08 17.8 Favored 'General case' 0 C--N 1.343 0.284 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.541 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 27.2 m170 -79.75 -36.29 37.47 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.162 175.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.8 m -34.02 -58.99 0.44 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 128.478 2.711 . . . . 0.0 115.131 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.83 -36.33 92.61 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.521 1.057 . . . . 0.0 112.556 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.44 -159.66 0.29 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.933 1.293 . . . . 0.0 111.383 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.7 t -80.91 -81.46 0.13 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.626 0.77 . . . . 0.0 111.694 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -135.02 -78.45 0.1 Allowed Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.04 0.829 . . . . 0.0 111.805 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -79.82 -27.12 40.29 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.511 0.655 . . . . 0.0 111.519 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -59.48 151.85 23.14 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.976 1.31 . . . . 0.0 110.407 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -120.08 151.04 39.62 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.535 1.534 . . . . 0.0 110.069 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.1 m -147.69 166.14 5.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 125.942 1.697 . . . . 0.0 108.238 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.8 156.29 25.39 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.501 0.572 . . . . 0.0 112.69 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.3 m -104.84 -169.07 1.56 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.126 1.37 . . . . 0.0 108.244 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.4 t -61.33 113.99 2.94 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.83 60.51 1.96 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.3 m -154.78 121.14 5.33 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.98 0.912 . . . . 0.0 108.542 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.157 -1.402 . . . . 0.0 108.746 179.353 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 CA--C 1.529 0.169 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.27 136.0 57.73 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.815 0.846 . . . . 0.0 109.463 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.56 HG23 HG21 ' A' ' 16' ' ' VAL . 48.4 p -111.37 146.14 37.65 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.47 0.708 . . . . 0.0 109.68 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.83 117.92 8.88 Favored 'General case' 0 N--CA 1.44 -0.928 1 N-CA-C 99.675 -4.194 . . . . 0.0 99.675 177.445 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.26 103.55 5.8 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.896 0.379 . . . . 0.0 111.012 -177.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.91 -63.63 4.35 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 125.109 1.338 . . . . 0.0 109.807 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.4 p -155.65 -44.69 0.08 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.932 1.693 . . . . 0.0 109.275 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -54.65 115.83 2.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.612 1.965 . . . . 0.0 109.409 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -104.55 150.3 24.75 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.982 1.313 . . . . 0.0 111.068 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.88 141.03 26.15 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.018 1.327 . . . . 0.0 109.14 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.6 m -72.59 152.54 41.74 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 124.726 1.211 . . . . 0.0 110.142 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.61 -21.34 53.16 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.8 m -71.94 -41.22 68.06 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.873 1.269 . . . . 0.0 109.86 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -72.34 -41.11 66.85 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.022 0.929 . . . . 0.0 112.082 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.56 HG21 HG23 ' A' ' 4' ' ' THR . 23.6 t -63.25 -47.73 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -67.07 -36.05 81.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.678 1.191 . . . . 0.0 110.999 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.08 -51.2 65.2 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 118.894 0.77 . . . . 0.0 109.391 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.45 -37.3 87.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.63 -41.71 87.87 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.349 -0.844 . . . . 0.0 111.967 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -69.46 -18.81 63.75 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.61 -62.54 1.64 Allowed 'General case' 0 C--N 1.347 0.464 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.461 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -46.41 -44.43 17.19 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.923 0.889 . . . . 0.0 111.19 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.9 t -61.37 -49.73 75.73 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 118.938 0.79 . . . . 0.0 110.293 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -68.84 -9.58 52.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.659 0.784 . . . . 0.0 112.65 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -115.12 -16.23 11.61 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.815 0.846 . . . . 0.0 112.915 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.42 ' CD2' ' HG3' ' A' ' 57' ' ' GLN . 48.2 t80 -65.57 -51.8 57.06 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.006 0.923 . . . . 0.0 110.427 -178.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -90.98 -27.11 18.89 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -63.66 -25.0 68.02 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.901 0.773 . . . . 0.0 112.989 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 t70 65.15 45.56 2.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.626 1.17 . . . . 0.0 111.571 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -168.03 151.04 5.72 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.005 1.322 . . . . 0.0 108.909 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.0 p 47.5 39.52 9.63 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.727 1.611 . . . . 0.0 112.344 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.07 89.07 6.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.895 1.278 . . . . 0.0 110.979 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 52.78 -141.32 28.59 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.959 1.742 . . . . 0.0 112.578 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.1 p -154.27 -33.98 0.1 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.332 1.053 . . . . 0.0 112.637 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.7 t -82.14 -102.67 0.04 OUTLIER 'General case' 0 C--N 1.343 0.311 0 C-N-CA 123.627 0.771 . . . . 0.0 109.358 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.0 p -137.82 35.27 2.4 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.629 1.172 . . . . 0.0 109.209 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -133.24 148.2 68.12 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 124.0 0.92 . . . . 0.0 109.118 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.29 125.08 10.27 Favored 'Cis proline' 0 N--CA 1.452 -0.938 0 CA-C-N 118.733 0.583 . . . . 0.0 112.564 0.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.3 163.01 33.6 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.018 0.927 . . . . 0.0 110.881 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 m -48.19 124.18 7.41 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 127.952 2.501 . . . . 0.0 113.012 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -115.89 68.47 0.72 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.71 85.4 0.47 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.099 1.36 . . . . 0.0 112.778 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -131.19 137.16 48.83 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.852 1.661 . . . . 0.0 106.962 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -116.62 132.94 56.55 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.473 1.109 . . . . 0.0 110.847 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 40.72 45.89 2.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.175 2.19 . . . . 0.0 114.09 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.57 -79.26 1.42 Allowed Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -80.27 173.48 12.55 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.328 1.051 . . . . 0.0 112.097 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -79.52 6.18 11.06 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -127.13 67.2 70.01 Favored Pre-proline 0 C--N 1.318 -0.772 0 C-N-CA 127.93 2.492 . . . . 0.0 110.146 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.73 -41.84 3.95 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.82 2.346 . . . . 0.0 110.291 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.7 t 62.54 -97.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.885 1.674 . . . . 0.0 108.816 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -165.88 -58.16 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 126.319 1.848 . . . . 0.0 107.883 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.95 -175.79 51.79 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -58.21 151.67 36.73 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 CA-C-N 119.043 1.422 . . . . 0.0 113.5 -0.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -146.03 159.3 43.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.573 1.149 . . . . 0.0 109.778 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.42 ' HG3' ' CD2' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -129.2 161.69 29.55 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -175.528 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -88.1 157.24 18.91 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 113.699 -1.591 . . . . 0.0 108.89 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.461 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 15.2 t80 -160.24 112.6 1.4 Allowed Pre-proline 0 C--O 1.224 -0.259 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -82.15 137.16 9.42 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 121.387 1.391 . . . . 0.0 115.211 -175.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.606 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 3.0 tt -110.37 -175.85 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 124.034 1.873 . . . . 0.0 112.188 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.606 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -160.8 152.01 19.01 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 108.724 -3.853 . . . . 0.0 111.004 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.7 t -84.44 59.87 5.69 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.969 1.307 . . . . 0.0 108.878 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.05 -50.37 0.03 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.04 172.27 45.18 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.75 119.13 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.364 1.065 . . . . 0.0 109.587 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.3 t80 62.47 118.44 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.255 1.822 . . . . 0.0 112.665 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 79.6 p -126.84 154.12 44.77 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.94 1.296 . . . . 0.0 109.79 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.86 72.24 2.83 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.98 -48.39 0.02 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.8 m 60.7 80.12 0.27 Allowed Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 125.339 1.456 . . . . 0.0 110.694 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.49 -56.16 3.37 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.385 3.39 . . . . 0.0 112.026 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.41 39.24 3.51 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.967 1.27 . . . . 0.0 110.478 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -154.41 -73.2 0.12 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 117.959 -1.019 . . . . 0.0 112.567 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -67.38 117.16 8.99 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.8 mtt85 -146.73 129.46 16.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.74 155.37 3.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 103.601 -2.74 . . . . 0.0 103.601 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.0 t -136.14 123.35 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 O-C-N 120.587 -1.32 . . . . 0.0 108.146 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.7 pt -105.46 175.44 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.417 0 C-N-CA 125.775 1.63 . . . . 0.0 112.756 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -101.83 165.03 11.41 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 127.47 2.308 . . . . 0.0 108.364 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.251 11.4 t -67.26 -29.78 69.49 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 118.302 2.705 . . . . 0.0 118.302 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -79.14 -73.16 0.35 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.8 t -164.72 3.52 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -78.65 164.03 24.97 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 119.723 1.147 . . . . 0.0 113.953 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -104.68 117.53 34.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.59 -45.96 12.02 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.099 0.559 . . . . 0.0 110.188 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.66 -160.48 33.9 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.6 145.09 31.61 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.823 0.849 . . . . 0.0 109.652 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.5 pt -143.14 164.93 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.923 1.289 . . . . 0.0 111.571 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.2 t -155.79 146.5 22.08 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.46 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 24.0 m170 -79.1 -15.45 58.14 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.809 174.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.0 m -39.8 -55.36 1.97 Allowed 'General case' 0 C--N 1.345 0.409 0 C-N-CA 126.859 2.063 . . . . 0.0 114.576 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.83 28.14 11.04 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.519 1.057 . . . . 0.0 112.816 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.76 177.02 5.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.078 0.951 . . . . 0.0 111.325 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 84.2 p -68.0 -48.42 65.79 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.097 0.959 . . . . 0.0 111.378 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.8 -69.68 0.08 OUTLIER Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -102.23 29.17 5.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.722 1.209 . . . . 0.0 109.654 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -131.83 176.94 7.92 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.769 1.228 . . . . 0.0 109.618 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -127.42 164.52 21.67 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.164 1.786 . . . . 0.0 110.824 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.87 156.23 40.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 C-N-CA 124.875 1.27 . . . . 0.0 107.581 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.8 142.33 25.43 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.298 0.952 . . . . 0.0 112.762 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.7 m -96.27 179.03 5.18 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.797 0.839 . . . . 0.0 110.517 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 27.0 t -69.24 140.69 54.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.89 47.05 62.72 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.5 m -131.49 96.31 3.95 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.371 1.468 . . . . 0.0 107.085 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.7 t30 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 117.028 -1.463 . . . . 0.0 109.229 -179.1 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 CA--C 1.529 0.17 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 73.03 160.93 0.24 Allowed 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.353 1.461 . . . . 0.0 109.808 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 t -157.7 148.68 21.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.28 120.12 29.15 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 104.794 -2.298 . . . . 0.0 104.794 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.6 m -112.95 111.4 22.12 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.65 -95.17 0.18 Allowed Glycine 0 CA--C 1.529 0.923 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.8 p -118.54 -39.19 3.03 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.109 1.763 . . . . 0.0 109.7 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.4 m -61.28 126.06 26.0 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.024 1.33 . . . . 0.0 109.721 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -99.02 153.6 18.74 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.565 1.146 . . . . 0.0 110.289 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -142.77 121.3 12.47 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.678 1.191 . . . . 0.0 108.52 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.5 t -67.34 154.32 41.61 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 125.06 1.344 . . . . 0.0 110.473 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.85 -22.01 61.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.401 -1.704 . . . . 0.0 106.401 176.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.4 t -72.47 -39.76 67.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.324 1.049 . . . . 0.0 109.209 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -73.43 -44.08 59.05 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.342 0.657 . . . . 0.0 112.116 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.5 t -59.03 -51.47 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 124.993 1.317 . . . . 0.0 109.086 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -68.42 -41.05 80.93 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.921 0.888 . . . . 0.0 112.925 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.58 -47.16 87.4 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 123.753 0.658 . . . . 0.0 109.427 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.44 ' HA ' HG23 ' A' ' 66' ' ' VAL . . . -58.0 -39.54 78.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.314 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.36 -30.33 61.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -69.8 -25.48 63.8 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.19 -61.07 2.11 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 104.167 -2.531 . . . . 0.0 104.167 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.532 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . . . -43.77 -43.65 6.22 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 124.763 1.289 . . . . 0.0 111.614 176.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.57 -64.03 0.98 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 126.385 1.874 . . . . 0.0 111.667 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.5 -36.67 83.3 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -88.65 -22.51 23.41 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.306 0.0 OUTLIER -92.65 16.76 11.44 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.779 1.627 . . . . 0.0 114.966 -178.352 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.6 -38.96 70.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.57 1.148 . . . . 0.0 110.368 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -145.6 -67.87 0.29 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.659 1.184 . . . . 0.0 109.003 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -177.37 91.73 0.03 OUTLIER 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.518 1.527 . . . . 0.0 108.104 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -119.17 -170.51 1.94 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.737 1.215 . . . . 0.0 109.897 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.9 p -70.88 83.89 0.66 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.254 1.422 . . . . 0.0 111.236 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.91 156.91 39.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.272 1.029 . . . . 0.0 110.784 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.15 -141.5 45.47 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.474 1.035 . . . . 0.0 112.438 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.0 t -90.32 -74.34 0.49 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.64 1.176 . . . . 0.0 109.935 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 t -151.54 -56.09 0.15 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.055 1.342 . . . . 0.0 108.32 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.3 p -79.36 -53.75 6.62 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -59.62 135.3 89.29 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -71.77 131.09 20.4 Favored 'Cis proline' 0 N--CA 1.454 -0.801 0 CA-C-N 119.123 0.723 . . . . 0.0 112.489 2.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.02 156.6 41.48 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 123.469 0.707 . . . . 0.0 111.555 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.9 p -34.45 137.24 0.12 Allowed 'General case' 0 C--N 1.34 0.166 0 C-N-CA 127.764 2.426 . . . . 0.0 115.096 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -135.52 88.01 2.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.081 1.352 . . . . 0.0 108.286 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -167.93 -39.61 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.867 1.667 . . . . 0.0 108.462 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -61.69 -35.77 78.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.888 1.275 . . . . 0.0 110.348 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -61.77 -77.28 0.05 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.243 1.017 . . . . 0.0 109.56 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -171.22 138.33 1.22 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.177 1.391 . . . . 0.0 108.254 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.4 132.79 23.26 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -144.2 108.21 4.74 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.279 0.632 . . . . 0.0 110.264 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 t70 51.17 -168.64 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.572 1.549 . . . . 0.0 113.517 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.0 p90 38.03 79.04 0.33 Allowed Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 127.159 2.184 . . . . 0.0 114.265 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.82 64.67 8.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.829 3.019 . . . . 0.0 107.833 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.34 -154.62 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 126.078 1.751 . . . . 0.0 110.112 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -100.99 118.58 37.28 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.509 1.123 . . . . 0.0 110.197 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.21 -176.46 30.32 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.218 0.914 . . . . 0.0 111.581 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.73 127.85 15.12 Favored 'Cis proline' 0 N--CA 1.453 -0.884 0 CA-C-N 117.527 0.664 . . . . 0.0 111.414 -0.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -102.47 140.26 36.99 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -115.66 162.17 17.63 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 123.878 0.736 . . . . 0.0 110.876 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -79.38 144.67 33.94 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.578 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.532 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 69.2 t80 -138.89 103.03 7.54 Favored Pre-proline 0 N--CA 1.443 -0.804 0 N-CA-C 102.086 -3.301 . . . . 0.0 102.086 176.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HB3' ' HD2' ' A' ' 76' ' ' ARG . 11.5 Cg_endo -77.99 137.25 15.45 Favored 'Trans proline' 0 N--CA 1.439 -1.691 0 C-N-CA 121.224 1.283 . . . . 0.0 111.964 -176.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.574 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.5 tt -116.96 -177.98 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 124.581 2.134 . . . . 0.0 113.366 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.574 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -161.32 153.93 20.46 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 108.428 -3.987 . . . . 0.0 111.613 178.164 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.0 t -88.62 58.5 4.69 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.874 1.27 . . . . 0.0 108.165 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.48 -74.79 0.01 OUTLIER Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.29 86.77 0.1 OUTLIER Glycine 0 CA--C 1.527 0.793 0 CA-C-N 117.385 0.593 . . . . 0.0 111.973 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.44 HG23 ' HA ' ' A' ' 19' ' ' ALA 0.266 12.9 p 41.12 60.43 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.958 2.103 . . . . 0.0 113.407 178.898 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 21.5 t80 58.2 93.97 0.03 OUTLIER 'General case' 0 C--N 1.344 0.339 0 C-N-CA 126.69 1.996 . . . . 0.0 114.047 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.0 t -155.99 124.41 5.85 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.901 1.28 . . . . 0.0 108.771 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.18 66.45 2.49 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.73 1.157 . . . . 0.0 111.492 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -164.97 77.8 0.14 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.5 t -146.02 108.74 4.31 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -61.37 160.11 48.73 Favored 'Cis proline' 0 N--CA 1.459 -0.537 0 CA-C-N 119.969 1.025 . . . . 0.0 113.987 0.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.68 -42.59 0.05 OUTLIER Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.167 1.365 . . . . 0.0 110.907 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 78.7 -48.29 0.44 Allowed 'General case' 0 C--N 1.342 0.281 0 C-N-CA 127.364 2.266 . . . . 0.0 112.538 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -75.93 124.9 28.1 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.437 ' HD2' ' HB3' ' A' ' 60' ' ' PRO . 14.5 mmt180 -136.99 118.0 14.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.366 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.4 m -84.2 164.55 2.58 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.3 t -140.26 137.19 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 pt -131.06 159.73 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.761 0.825 . . . . 0.0 112.513 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -89.16 146.04 25.04 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 127.464 2.306 . . . . 0.0 108.205 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.37 15.3 t -73.78 66.17 1.08 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -177.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -157.32 -94.45 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.184 1 N-CA-C 97.458 -5.016 . . . . 0.0 97.458 176.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -162.84 10.69 0.06 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.996 1.718 . . . . 0.0 113.774 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.3 140.93 29.04 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.993 0.815 . . . . 0.0 112.178 -177.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -73.52 131.49 41.82 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.95 -56.79 2.86 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.89 -177.29 40.72 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 112.25 -0.34 . . . . 0.0 112.25 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.98 117.6 13.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.837 1.655 . . . . 0.0 107.056 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 41.0 pt -128.27 153.52 37.8 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 C-N-CA 124.075 0.95 . . . . 0.0 109.814 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -152.18 150.85 30.29 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.34 75.85 5.91 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.3 m -70.57 -84.54 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.086 -1.634 . . . . 0.0 110.24 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.7 34.57 5.56 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.85 153.17 42.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.224 1.81 . . . . 0.0 110.957 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -74.37 -11.55 60.28 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.588 0.755 . . . . 0.0 112.227 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.73 -94.86 0.1 OUTLIER Glycine 0 C--N 1.341 0.841 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -103.22 22.62 13.76 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.156 0.982 . . . . 0.0 110.54 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -72.26 178.78 3.71 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -151.82 133.98 15.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 m -115.12 166.53 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.56 145.21 19.41 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.105 0.802 . . . . 0.0 115.105 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.8 m -97.54 177.5 5.49 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 124.53 1.132 . . . . 0.0 110.559 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.3 t 44.06 41.76 4.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.667 0.787 . . . . 0.0 112.094 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.5 30.06 75.86 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.384 0.992 . . . . 0.0 113.922 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.4 m -86.54 151.14 23.73 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.654 1.182 . . . . 0.0 109.083 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 116.346 -1.788 . . . . 0.0 108.677 179.842 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.5 p . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.32 61.75 0.71 Allowed 'General case' 0 C--N 1.342 0.244 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 t -107.48 135.95 48.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.874 1.269 . . . . 0.0 110.67 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -110.57 108.41 18.35 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 103.393 -2.818 . . . . 0.0 103.393 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.34 85.42 4.6 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.02 -104.63 1.44 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.2 p -94.49 -44.52 7.84 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.494 1.118 . . . . 0.0 110.188 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.6 m -70.0 110.37 5.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.856 0.862 . . . . 0.0 110.24 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -84.72 148.52 26.34 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.684 1.193 . . . . 0.0 111.061 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -142.03 112.91 7.37 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.101 0.96 . . . . 0.0 111.098 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.7 t -65.37 157.49 29.13 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 125.84 1.656 . . . . 0.0 110.429 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.0 -19.27 29.66 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.5 m -73.43 -44.54 58.02 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.521 1.128 . . . . 0.0 109.184 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -71.91 -44.15 64.16 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 124.718 1.207 . . . . 0.0 112.34 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.25 -51.2 75.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -41.92 96.57 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.633 1.973 . . . . 0.0 112.517 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.34 -54.44 28.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.004 0.365 . . . . 0.0 110.191 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.73 72.37 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.207 0.603 . . . . 0.0 111.679 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.85 -44.97 30.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.06 -22.11 65.49 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.51 -65.83 0.88 Allowed 'General case' 0 C--N 1.345 0.409 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.513 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . . . -44.22 -48.59 9.35 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 124.577 1.173 . . . . 0.0 111.83 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.8 t -54.13 -51.89 62.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.366 1.866 . . . . 0.0 111.924 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -58.34 -40.73 82.92 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.176 0.59 . . . . 0.0 111.253 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -70.9 -38.37 72.99 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -90.6 22.8 3.31 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-N 118.91 0.777 . . . . 0.0 112.468 -177.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -110.2 -48.96 3.12 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 124.361 1.064 . . . . 0.0 109.209 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -74.11 -38.69 63.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.383 0.673 . . . . 0.0 112.154 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 108.19 72.52 0.0 OUTLIER 'General case' 0 C--N 1.345 0.397 0 C-N-CA 129.674 3.189 . . . . 0.0 110.932 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -151.89 136.37 16.88 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.692 1.597 . . . . 0.0 107.57 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.6 p -80.31 -56.89 3.88 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.446 0.698 . . . . 0.0 111.786 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.87 82.71 0.16 Allowed 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.55 -48.59 0.96 Allowed Glycine 0 CA--C 1.528 0.886 0 N-CA-C 107.093 -2.403 . . . . 0.0 107.093 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.8 t 57.52 67.38 0.98 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.26 1.824 . . . . 0.0 113.713 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.2 m -143.86 -75.96 0.24 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.165 0.986 . . . . 0.0 108.771 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.3 t -160.35 41.22 0.18 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.497 0.59 . . . . 0.0 112.224 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -172.25 127.62 0.57 Allowed Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 125.649 1.58 . . . . 0.0 107.479 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -86.06 63.32 0.16 OUTLIER 'Cis proline' 0 N--CA 1.439 -1.702 0 CA-C-N 121.409 1.539 . . . . 0.0 110.1 -2.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -84.27 173.09 11.26 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 t -69.3 145.54 52.95 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 111.426 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -95.82 55.09 1.58 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.481 1.512 . . . . 0.0 109.291 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -79.01 51.56 1.16 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.639 1.576 . . . . 0.0 112.347 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -160.84 53.44 0.29 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.381 1.472 . . . . 0.0 107.426 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.12 -55.99 8.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.499 1.519 . . . . 0.0 110.906 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 68.62 -72.41 0.1 Allowed 'General case' 0 C--N 1.343 0.292 0 C-N-CA 127.079 2.152 . . . . 0.0 111.168 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.24 -121.36 2.16 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.42 -169.3 0.17 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.356 1.062 . . . . 0.0 112.315 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -127.67 -164.06 1.33 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.998 0.919 . . . . 0.0 110.925 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.328 40.3 p90 61.63 47.33 1.13 Allowed Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 128.788 2.835 . . . . 0.0 115.855 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.7 125.94 8.54 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.175 1.916 . . . . 0.0 107.702 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.51 -125.0 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -153.72 127.57 8.86 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 125.711 1.605 . . . . 0.0 107.237 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.17 -85.04 0.05 OUTLIER Glycine 0 CA--C 1.531 1.063 0 CA-C-O 117.49 -1.728 . . . . 0.0 111.737 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.4 168.76 7.45 Favored 'Cis proline' 0 C--N 1.35 0.642 0 CA-C-N 121.676 2.738 . . . . 0.0 116.427 0.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.51 159.34 28.24 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.036 1.335 . . . . 0.0 113.188 -177.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -152.72 150.65 29.65 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.464 1.506 . . . . 0.0 111.948 -178.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -102.41 166.55 10.49 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 48.0 t80 -158.44 114.69 1.72 Allowed Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -86.79 108.06 0.77 Allowed 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 122.706 2.271 . . . . 0.0 112.342 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.534 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 9.3 tt -81.5 173.88 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 124.329 2.014 . . . . 0.0 110.966 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.534 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 14.2 mmtt -160.27 159.43 31.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 109.183 -3.644 . . . . 0.0 109.49 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 57.2 m -81.81 57.44 3.43 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.458 1.103 . . . . 0.0 109.539 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.46 62.71 0.24 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.95 -106.63 1.64 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 123.76 0.695 . . . . 0.0 112.376 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.1 95.05 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.32 1.048 . . . . 0.0 111.099 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 t80 44.98 80.74 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.879 1.672 . . . . 0.0 112.971 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.1 p -125.22 -29.94 3.23 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.744 1.218 . . . . 0.0 111.44 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.42 -69.2 1.25 Allowed Glycine 0 C--N 1.342 0.886 0 C-N-CA 124.838 1.209 . . . . 0.0 112.426 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.09 113.98 1.27 Allowed Glycine 0 C--N 1.34 0.76 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.9 m 54.17 69.89 1.96 Allowed Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 125.348 1.459 . . . . 0.0 112.715 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.11 149.65 82.19 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.369 2.713 . . . . 0.0 109.96 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -159.11 35.58 0.49 Allowed Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.109 -0.829 . . . . 0.0 115.152 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.741 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -153.87 -67.94 0.14 Allowed 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 118.452 1.126 . . . . 0.0 110.25 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.43 118.24 16.15 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.926 1.239 . . . . 0.0 108.384 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -140.14 117.44 11.32 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 m -85.1 146.67 6.29 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 176.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.2 t -132.84 135.81 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -177.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.482 HG22 ' H ' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -126.86 -176.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 C-N-CA 126.74 2.016 . . . . 0.0 110.186 -177.737 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.482 ' H ' HG22 ' A' ' 79' ' ' ILE . 63.5 m-80 -99.26 159.72 14.79 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 102.977 -2.972 . . . . 0.0 102.977 175.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.301 7.2 t -66.92 2.57 1.38 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 -178.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -95.58 -83.69 0.36 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 102.301 -3.222 . . . . 0.0 102.301 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.81 -5.07 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.721 2.408 . . . . 0.0 114.791 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -79.46 121.1 24.76 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -52.98 123.25 11.08 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 126.051 1.74 . . . . 0.0 108.497 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.56 -55.75 2.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.4 -164.43 23.06 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.45 137.02 8.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.482 1.113 . . . . 0.0 108.355 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 pt -133.89 174.25 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.438 1.095 . . . . 0.0 113.092 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 74' ' ' ALA . 12.6 t -158.16 137.03 11.37 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.741 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -77.31 -24.11 50.92 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 118.211 0.46 . . . . 0.0 112.034 175.003 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.1 t -45.33 -25.52 0.41 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -145.03 51.57 0.61 Allowed Glycine 0 C--N 1.339 0.731 0 CA-C-N 119.165 0.893 . . . . 0.0 111.534 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.73 -177.37 3.11 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.817 1.247 . . . . 0.0 111.487 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.3 t -58.27 -53.33 59.47 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.554 1.541 . . . . 0.0 111.547 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.38 -70.06 0.05 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -112.54 35.03 4.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.854 1.262 . . . . 0.0 109.133 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -125.1 176.21 6.85 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.18 1.392 . . . . 0.0 109.955 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.447 ' CE1' ' CE1' ' A' ' 91' ' ' HIS . 64.1 m-85 -125.17 159.3 31.86 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.11 1.364 . . . . 0.0 111.093 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.8 m -135.33 161.48 39.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 125.449 1.499 . . . . 0.0 107.864 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.26 156.65 34.08 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 123.862 0.744 . . . . 0.0 113.707 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.6 m -85.75 -170.67 3.22 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 123.607 0.763 . . . . 0.0 110.094 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.1 p -73.65 127.53 33.01 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.47 -1.0 88.64 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.815 -0.992 . . . . 0.0 113.361 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.7 m -79.38 91.22 5.05 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.4 t30 . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.953 -1.499 . . . . 0.0 109.439 -178.729 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.457 -0.103 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.31 89.74 0.09 Allowed 'General case' 0 C--N 1.344 0.357 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.81 132.22 36.41 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.91 114.76 23.69 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.5 m -105.49 88.82 2.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.03 -114.64 4.62 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.8 p -93.25 -29.23 15.79 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.282 1.033 . . . . 0.0 109.972 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -71.99 95.13 1.55 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.273 1.429 . . . . 0.0 108.776 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -89.95 147.19 23.86 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.527 1.131 . . . . 0.0 112.508 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -142.13 129.46 21.14 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -72.79 155.13 40.26 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 126.531 1.932 . . . . 0.0 107.315 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.47 -16.79 16.63 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.4 m -76.15 -35.2 59.3 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -51.9 15.84 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.755 1.222 . . . . 0.0 113.601 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . 0.273 17.9 m -60.99 -41.58 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.647 0 C-N-CA 127.239 2.216 . . . . 0.0 109.242 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -71.02 -44.58 65.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.886 0.874 . . . . 0.0 111.69 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.15 -54.64 26.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.096 0.407 . . . . 0.0 112.077 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.45 ' HB1' ' HE2' ' A' ' 59' ' ' PHE . . . -62.05 -37.56 85.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.481 -178.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.33 -40.39 70.75 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -65.86 -19.74 65.99 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.46 -53.96 7.01 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.559 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -47.0 -51.38 17.29 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.229 1.412 . . . . 0.0 110.776 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 t -57.92 -46.19 85.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.748 0.819 . . . . 0.0 110.559 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -57.09 -38.0 72.72 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.529 0.731 . . . . 0.0 111.394 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -89.08 -9.04 52.63 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.71 -27.38 67.59 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.725 0.693 . . . . 0.0 112.208 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -80.54 -75.69 0.26 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 p30 171.94 68.62 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.696 1.998 . . . . 0.0 109.809 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -117.5 58.72 0.79 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.93 0.892 . . . . 0.0 109.438 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.84 162.72 0.08 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.86 2.464 . . . . 0.0 114.429 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 t -88.37 76.66 8.29 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.458 1.103 . . . . 0.0 110.182 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.52 102.37 4.48 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.314 1.045 . . . . 0.0 110.319 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.99 -114.26 4.48 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.5 t -75.8 -95.99 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 m 88.05 23.18 0.04 OUTLIER 'General case' 0 C--N 1.341 0.212 0 C-N-CA 125.018 1.327 . . . . 0.0 113.327 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t -78.95 -38.72 36.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 102.743 -3.058 . . . . 0.0 102.743 176.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.488 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 17.0 m-85 -89.18 151.82 47.17 Favored Pre-proline 0 N--CA 1.451 -0.405 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.14 142.52 57.81 Favored 'Cis proline' 0 N--CA 1.455 -0.791 0 N-CA-C 116.78 1.8 . . . . 0.0 116.78 0.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.65 147.54 39.43 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 127.912 2.485 . . . . 0.0 109.579 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.25 123.47 14.68 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 178.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -83.78 118.91 24.23 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -59.0 159.84 6.69 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.308 1.443 . . . . 0.0 111.013 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -134.42 59.95 1.72 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.037 0.935 . . . . 0.0 109.964 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -154.36 -22.32 0.13 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 112.068 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.74 -46.34 88.55 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.127 0.571 . . . . 0.0 111.386 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.31 -61.88 0.41 Allowed Glycine 0 C--N 1.339 0.723 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.06 148.19 52.2 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 123.81 0.844 . . . . 0.0 113.099 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -166.26 -178.49 4.59 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.094 1.758 . . . . 0.0 109.231 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -145.37 118.58 5.37 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.74 1.216 . . . . 0.0 108.555 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.32 84.99 1.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.08 2.52 . . . . 0.0 110.448 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -129.62 -97.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.245 0 C-N-CA 124.227 1.011 . . . . 0.0 108.379 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -153.17 117.47 4.9 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.156 0.982 . . . . 0.0 109.618 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.48 146.39 22.54 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -68.72 157.58 88.76 Favored 'Cis proline' 0 N--CA 1.457 -0.633 0 CA-C-N 119.983 1.891 . . . . 0.0 113.447 0.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.21 141.93 26.72 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.1 2.16 . . . . 0.0 108.235 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -134.39 166.56 22.55 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.59 164.56 23.74 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 126.481 1.912 . . . . 0.0 115.541 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.559 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 75.4 t80 -161.87 104.13 1.16 Allowed Pre-proline 0 N--CA 1.454 -0.246 0 O-C-N 121.43 -0.794 . . . . 0.0 110.571 175.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.488 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 12.8 Cg_endo -74.69 137.35 22.36 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 121.088 1.424 . . . . 0.0 113.892 -177.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.55 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.2 tt -109.27 178.97 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-O 124.444 2.069 . . . . 0.0 113.058 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.55 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 7.8 mmtt -153.12 153.77 33.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 108.647 -3.888 . . . . 0.0 109.869 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.8 p -76.08 51.94 0.7 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.63 1.972 . . . . 0.0 113.014 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.81 50.63 0.08 OUTLIER Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.405 1.002 . . . . 0.0 112.791 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.31 174.22 17.32 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 117.686 0.743 . . . . 0.0 112.783 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.8 t -80.86 131.79 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.834 1.253 . . . . 0.0 108.542 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -70.15 135.02 48.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.206 1.003 . . . . 0.0 110.907 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.9 p -139.27 75.61 1.52 Allowed 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.88 1.272 . . . . 0.0 107.583 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.47 -143.21 3.6 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.3 -50.73 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.9 p -153.35 150.1 22.89 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 124.218 1.007 . . . . 0.0 109.792 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -66.16 145.33 69.31 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 CA-C-N 119.393 0.819 . . . . 0.0 112.001 -8.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.28 -113.16 2.27 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . 62.92 28.99 16.54 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.047 1.339 . . . . 0.0 113.866 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -155.02 84.15 1.08 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.16 132.64 47.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.522 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.72 159.79 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 103.311 -2.848 . . . . 0.0 103.311 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.2 t -139.17 131.39 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 120.479 -1.388 . . . . 0.0 108.089 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.7 pt -114.14 -179.46 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.311 1.444 . . . . 0.0 113.35 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -104.71 -174.38 2.52 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.099 2.159 . . . . 0.0 109.631 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.318 12.4 t -79.58 -30.17 41.49 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 120.402 3.482 . . . . 0.0 120.402 -177.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -79.32 -73.56 0.33 Allowed 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.7 t -164.75 1.22 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.849 2.06 . . . . 0.0 114.169 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -78.64 150.69 32.6 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 119.846 1.203 . . . . 0.0 113.813 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -95.85 117.98 31.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.34 1.856 . . . . 0.0 108.651 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.94 -52.69 7.54 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.35 0.66 . . . . 0.0 110.658 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.38 -169.21 38.38 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.9 162.37 31.77 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.827 0.813 . . . . 0.0 113.022 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.8 pt -142.21 163.67 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.59 1.556 . . . . 0.0 110.263 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.6 t -158.84 159.04 34.6 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.867 1.267 . . . . 0.0 111.016 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.449 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 49.9 m170 -79.6 -51.08 9.74 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.6 m -32.72 106.51 0.04 OUTLIER 'General case' 0 C--N 1.345 0.382 0 C-N-CA 127.852 2.461 . . . . 0.0 111.998 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.56 32.29 5.2 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.201 1.381 . . . . 0.0 111.079 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -134.5 -142.82 0.2 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.759 1.224 . . . . 0.0 109.248 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.6 t -151.46 62.86 0.88 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.26 0.624 . . . . 0.0 111.141 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.71 -125.29 6.73 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.534 1.064 . . . . 0.0 113.367 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -79.28 -26.2 42.37 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.643 1.177 . . . . 0.0 113.046 -178.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -56.3 118.05 4.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.984 0.914 . . . . 0.0 110.621 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -83.75 153.95 23.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.044 0.938 . . . . 0.0 111.145 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.6 m -126.76 166.54 23.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 C-N-CA 125.635 1.574 . . . . 0.0 107.556 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.38 148.03 23.74 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 123.891 0.758 . . . . 0.0 114.26 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.0 t -96.59 -175.09 3.21 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.716 2.006 . . . . 0.0 107.418 178.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.2 p -59.76 136.73 58.09 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.439 1.018 . . . . 0.0 109.851 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.06 26.56 74.6 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.566 0.603 . . . . 0.0 111.81 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.7 m -150.3 114.81 5.21 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.144 1.378 . . . . 0.0 107.497 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 . . . . . 0 C--O 1.251 1.154 0 CA-C-O 116.83 -1.557 . . . . 0.0 109.458 -179.82 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.1 m . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 72.91 139.74 0.06 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 127.184 2.194 . . . . 0.0 109.682 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 t -146.67 124.15 11.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.281 0.562 . . . . 0.0 111.641 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -100.66 101.16 11.98 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 32.8 m -85.72 74.96 10.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.615 1.166 . . . . 0.0 108.249 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.82 -98.71 1.08 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.8 m -88.14 -44.71 10.71 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.387 1.075 . . . . 0.0 110.433 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.0 107.15 1.42 Allowed 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.039 1.336 . . . . 0.0 112.493 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -91.41 103.69 16.3 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.572 1.149 . . . . 0.0 109.027 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -102.39 148.69 25.18 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.277 0.631 . . . . 0.0 110.713 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.4 m -83.13 157.6 22.72 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 125.476 1.51 . . . . 0.0 108.858 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.66 -19.55 63.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.2 m -71.95 -35.22 69.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.109 0.964 . . . . 0.0 109.026 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.64 -53.81 10.78 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 123.953 0.901 . . . . 0.0 112.679 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.95 -41.31 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -67.61 -44.75 77.32 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.663 0.785 . . . . 0.0 111.007 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.25 -48.45 78.17 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.498 0.59 . . . . 0.0 110.253 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.05 -32.1 73.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.157 0.983 . . . . 0.0 111.166 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.43 -36.84 52.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.776 0.262 . . . . 0.0 110.666 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -69.29 -20.33 63.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.72 -53.59 5.79 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.59 -40.31 59.57 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.54 1.136 . . . . 0.0 109.228 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.41 -53.94 52.61 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.366 1.466 . . . . 0.0 109.374 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -63.58 -49.49 73.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -70.79 -46.15 63.39 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.474 ' CD1' ' HG2' ' A' ' 57' ' ' GLN . 63.6 t80 -70.23 -19.55 63.13 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.465 -177.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -90.14 -77.68 0.39 Allowed 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.534 1.061 . . . . 0.0 110.207 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.8 p30 174.49 56.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.1 1.36 . . . . 0.0 111.616 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -146.01 92.7 2.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 86.19 117.59 0.04 OUTLIER 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 127.326 2.25 . . . . 0.0 105.819 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -92.05 85.17 5.43 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.045 0.938 . . . . 0.0 109.916 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.15 150.21 8.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.253 1.421 . . . . 0.0 112.722 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.61 -38.37 95.59 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.4 t 65.49 97.13 0.05 OUTLIER 'General case' 0 C--N 1.343 0.297 0 C-N-CA 126.773 2.029 . . . . 0.0 113.242 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.5 m -68.95 -55.65 10.29 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 t -159.81 16.89 0.15 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.171 1.388 . . . . 0.0 111.495 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -142.02 149.76 53.61 Favored Pre-proline 0 CA--C 1.511 -0.553 0 C-N-CA 126.067 1.747 . . . . 0.0 107.327 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.4 122.76 7.96 Favored 'Cis proline' 0 CA--C 1.557 1.651 0 N-CA-C 115.425 1.279 . . . . 0.0 115.425 0.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . 0.318 9.6 m80 -82.84 138.33 33.98 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 127.358 2.263 . . . . 0.0 114.457 -178.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -70.77 133.17 46.33 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 102.829 -3.026 . . . . 0.0 102.829 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.28 63.1 3.82 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.211 0.914 . . . . 0.0 113.278 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.1 m120 30.98 -138.0 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 130.87 3.668 . . . . 0.0 114.912 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -111.73 140.25 46.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.854 2.061 . . . . 0.0 107.701 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 71.93 179.46 0.23 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.514 1.526 . . . . 0.0 109.998 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -84.76 98.08 10.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.35 -42.48 83.1 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.171 0.891 . . . . 0.0 111.694 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -145.25 162.71 36.51 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.127 0.971 . . . . 0.0 109.458 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -76.69 132.9 39.61 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.777 1.231 . . . . 0.0 112.612 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -149.28 154.01 38.3 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.428 1.491 . . . . 0.0 108.385 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.96 -47.63 23.92 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.023 2.482 . . . . 0.0 111.351 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.42 HG21 HD21 ' A' ' 80' ' ' ASN . 22.4 m -81.0 168.0 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.544 1.538 . . . . 0.0 109.755 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -98.53 -16.68 19.06 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.633 1.173 . . . . 0.0 112.406 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.66 -159.69 22.41 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.35 160.77 72.05 Favored 'Cis proline' 0 N--CA 1.459 -0.549 0 CA-C-N 118.783 1.291 . . . . 0.0 112.422 1.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.91 159.94 35.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.742 1.217 . . . . 0.0 111.465 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.474 ' HG2' ' CD1' ' A' ' 27' ' ' TYR . 1.6 tp60 -132.96 135.95 45.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.9 178.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -80.68 162.43 24.16 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -160.77 117.91 1.45 Allowed Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -82.9 146.03 12.83 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 121.405 1.404 . . . . 0.0 113.103 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 62' ' ' LYS . 0.5 OUTLIER -112.84 -165.48 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-O 123.81 1.767 . . . . 0.0 113.731 -178.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.467 ' N ' HG23 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -161.65 176.09 11.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 109.678 -3.419 . . . . 0.0 111.586 -177.638 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.0 t -99.81 63.57 1.22 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.342 1.457 . . . . 0.0 110.673 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.68 -63.43 0.09 OUTLIER Glycine 0 C--N 1.337 0.593 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.85 -164.88 11.57 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.6 p -83.98 160.6 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.03 0.932 . . . . 0.0 111.643 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -37.93 126.68 1.24 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 128.097 2.559 . . . . 0.0 113.754 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.0 t -160.02 -40.98 0.05 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.496 1.518 . . . . 0.0 110.383 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.87 -80.3 0.75 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.93 95.08 2.29 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.8 p -157.13 153.04 22.9 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 125.024 1.33 . . . . 0.0 108.417 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.23 154.17 74.79 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.958 2.439 . . . . 0.0 110.642 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 74' ' ' ALA . . . -165.05 -25.73 0.02 OUTLIER Glycine 0 CA--C 1.53 1.022 0 CA-C-O 117.956 -1.469 . . . . 0.0 114.655 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.602 ' HB1' ' H ' ' A' ' 91' ' ' HIS . . . 88.95 -31.28 0.03 OUTLIER 'General case' 0 C--N 1.346 0.418 0 C-N-CA 126.205 1.802 . . . . 0.0 111.167 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -79.37 124.52 28.5 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.234 1.813 . . . . 0.0 113.391 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.84 128.08 7.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.804 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.7 m -85.9 146.03 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.7 t -133.96 122.87 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.3 pt -106.23 171.59 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 125.169 1.388 . . . . 0.0 111.566 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.42 HD21 HG21 ' A' ' 52' ' ' VAL . 8.8 m120 -79.68 165.47 22.82 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 178.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.285 2.1 m -67.98 -5.78 18.93 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -178.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -102.29 -73.3 0.66 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -165.17 -12.01 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 117.935 2.568 . . . . 0.0 117.935 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -78.77 126.96 31.43 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -57.33 111.21 1.02 Allowed 'General case' 0 C--N 1.344 0.346 0 C-N-CA 125.353 1.461 . . . . 0.0 107.454 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.99 -48.76 11.81 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.53 151.33 8.31 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.56 125.88 38.41 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.5 pt -127.13 155.74 38.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 C-N-CA 122.727 0.411 . . . . 0.0 110.11 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.8 t -156.73 154.06 29.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.602 ' H ' ' HB1' ' A' ' 74' ' ' ALA . 2.5 m170 -79.04 -15.38 58.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.821 175.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.7 m -58.51 103.72 0.17 Allowed 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.668 1.187 . . . . 0.0 109.385 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.76 55.0 1.96 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.23 -174.95 4.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.729 1.212 . . . . 0.0 109.915 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -57.15 -47.56 80.86 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.249 1.019 . . . . 0.0 111.082 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.96 -70.37 0.12 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -86.63 -28.55 23.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.76 1.224 . . . . 0.0 109.305 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -57.06 160.61 3.54 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 126.304 1.842 . . . . 0.0 111.285 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -114.85 161.46 18.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.882 1.673 . . . . 0.0 112.029 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 m -146.28 164.08 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 126.615 1.966 . . . . 0.0 107.434 177.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.54 156.55 26.9 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 123.972 0.796 . . . . 0.0 112.414 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.0 m -103.39 -171.16 1.89 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.151 0.98 . . . . 0.0 110.897 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -82.87 79.32 9.28 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 121.599 0.714 . . . . 0.0 109.624 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.94 -26.22 0.2 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.259 1.409 . . . . 0.0 109.674 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.0 m -79.36 123.35 27.41 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.015 1.726 . . . . 0.0 107.412 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 126.199 1.8 . . . . 0.0 109.865 -179.056 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 119.919 -0.086 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.53 91.53 0.03 OUTLIER 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.807 1.643 . . . . 0.0 111.666 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 p -83.41 92.5 7.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.087 0.955 . . . . 0.0 112.068 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -99.71 96.25 7.49 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 101.481 -3.526 . . . . 0.0 101.481 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.9 m -89.12 73.04 8.23 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.94 -98.65 1.21 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 108.611 -1.795 . . . . 0.0 108.611 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.5 p -95.53 -42.13 8.59 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.41 1.084 . . . . 0.0 109.182 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.21 137.32 58.24 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -140.17 126.75 20.31 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.79 136.78 50.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.522 1.529 . . . . 0.0 108.338 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.7 p -64.73 161.57 17.67 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 125.152 1.381 . . . . 0.0 110.807 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.21 -16.78 36.39 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -78.28 -37.16 45.58 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 123.785 0.834 . . . . 0.0 109.986 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -66.64 -39.94 88.49 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.726 0.81 . . . . 0.0 109.992 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.5 t -60.2 -50.69 79.25 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -64.87 -23.29 67.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.138 1.375 . . . . 0.0 111.378 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.64 -61.11 1.89 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 119.202 0.91 . . . . 0.0 108.668 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.86 -24.93 66.19 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.679 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.2 -38.59 30.87 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 118.501 0.592 . . . . 0.0 112.012 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -69.5 -22.55 63.6 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.3 -65.22 0.95 Allowed 'General case' 0 C--N 1.347 0.487 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.431 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -45.38 -43.68 11.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.783 1.233 . . . . 0.0 111.941 177.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 t -61.81 -48.33 81.09 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 121.335 -0.853 . . . . 0.0 111.682 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -80.21 -24.33 40.32 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -112.6 -28.72 7.72 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -3.06 28.21 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -66.75 -46.64 74.73 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.175 0.99 . . . . 0.0 112.979 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -133.69 -80.69 0.47 Allowed 'General case' 0 C--N 1.34 0.183 0 O-C-N 123.354 0.409 . . . . 0.0 111.328 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -170.66 101.67 0.24 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -141.2 -169.38 2.83 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.963 0.905 . . . . 0.0 110.35 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.3 p -71.08 84.9 0.72 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.455 1.502 . . . . 0.0 112.152 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 137.94 162.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 129.464 3.106 . . . . 0.0 111.895 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 152.65 -87.88 0.13 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 126.169 1.842 . . . . 0.0 108.647 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.1 t 158.31 -94.75 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 129.21 3.004 . . . . 0.0 105.91 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.6 p -160.22 -55.05 0.06 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 p -81.36 -69.15 0.63 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.24 141.07 98.07 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 124.075 0.95 . . . . 0.0 109.129 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.18 133.33 27.46 Favored 'Cis proline' 0 N--CA 1.459 -0.504 0 N-CA-C 116.061 1.523 . . . . 0.0 116.061 3.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -132.49 136.97 47.03 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.963 2.105 . . . . 0.0 108.423 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.5 m -49.58 125.66 11.87 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.819 2.048 . . . . 0.0 110.195 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -80.03 70.61 6.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.703 1.201 . . . . 0.0 110.407 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -164.31 147.59 9.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.592 0.757 . . . . 0.0 110.027 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -162.29 -72.83 0.05 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.618 1.567 . . . . 0.0 107.03 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -152.76 -40.7 0.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.711 2.004 . . . . 0.0 108.31 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -118.28 161.96 19.06 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 125.392 1.477 . . . . 0.0 110.103 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.84 156.65 14.52 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.634 1.112 . . . . 0.0 110.459 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.55 156.78 37.77 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.655 0.782 . . . . 0.0 111.302 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -88.55 119.49 29.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.868 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -130.77 101.03 17.16 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.57 75.81 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.759 2.972 . . . . 0.0 111.286 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.9 t -140.04 -38.56 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.023 1.729 . . . . 0.0 109.238 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 80.57 108.88 0.07 Allowed 'General case' 0 C--N 1.345 0.387 0 C-N-CA 127.132 2.173 . . . . 0.0 109.251 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.84 -143.17 0.7 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.865 1.697 . . . . 0.0 113.533 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -65.99 139.06 40.76 Favored 'Cis proline' 0 N--CA 1.456 -0.717 0 CA-C-N 118.299 1.049 . . . . 0.0 112.652 1.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.37 163.72 12.61 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 126.351 1.86 . . . . 0.0 108.24 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -139.75 156.25 46.88 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -79.63 157.3 27.31 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.227 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.431 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 7.3 t80 -160.21 89.22 1.82 Allowed Pre-proline 0 N--CA 1.449 -0.511 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . 0.253 6.3 Cg_exo -63.84 137.46 58.33 Favored 'Trans proline' 0 N--CA 1.44 -1.657 0 C-N-CA 122.474 2.116 . . . . 0.0 116.757 -176.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.531 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.0 tt -108.14 176.96 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 124.278 1.99 . . . . 0.0 111.904 178.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.531 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -162.05 179.78 7.72 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 108.58 -3.918 . . . . 0.0 111.31 179.082 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.9 p -87.42 52.85 2.61 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.32 -65.57 0.02 OUTLIER Glycine 0 C--N 1.342 0.879 0 C-N-CA 125.187 1.375 . . . . 0.0 110.136 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.85 -127.13 1.62 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -68.27 164.94 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.89 1.276 . . . . 0.0 109.225 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -51.42 140.44 17.57 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.4 p -141.56 -55.79 0.47 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.566 1.946 . . . . 0.0 108.422 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.01 170.52 20.79 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.024 1.297 . . . . 0.0 111.248 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.38 151.15 25.33 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.506 1.05 . . . . 0.0 111.924 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.5 p 63.82 171.99 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.014 2.126 . . . . 0.0 112.657 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.55 159.89 30.24 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.012 2.475 . . . . 0.0 111.097 172.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.08 71.83 0.19 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.487 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -69.36 -16.52 63.55 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 118.142 -0.933 . . . . 0.0 112.575 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.54 125.12 38.99 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.322 1.849 . . . . 0.0 112.297 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.0 mtt85 -135.18 137.47 42.72 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.893 0.877 . . . . 0.0 113.115 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.9 m -103.07 145.3 12.56 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 176.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.262 91.7 t -134.73 133.99 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -176.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.7 pt -126.72 165.84 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -87.9 157.16 19.04 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 126.16 1.784 . . . . 0.0 109.79 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.377 8.2 t -79.73 56.06 2.18 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 -177.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -157.47 -87.07 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 100.785 -3.783 . . . . 0.0 100.785 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.45 1.85 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -83.91 127.1 33.61 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -64.35 127.87 33.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.325 1.05 . . . . 0.0 108.537 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.36 -44.89 8.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.563 0.745 . . . . 0.0 109.99 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.67 175.32 42.09 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.173 -0.537 . . . . 0.0 114.108 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.54 121.85 21.56 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 127.123 2.169 . . . . 0.0 106.166 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.3 pt -128.16 161.19 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.478 1.111 . . . . 0.0 110.243 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 t -157.91 159.81 36.95 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.487 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 21.8 m170 -78.45 -24.09 46.22 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.4 m -61.56 108.07 0.91 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.793 0.837 . . . . 0.0 110.863 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.54 -15.71 19.67 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.818 1.199 . . . . 0.0 112.323 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.93 163.73 26.89 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.409 1.083 . . . . 0.0 111.8 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.8 t -104.05 52.03 0.77 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.957 1.303 . . . . 0.0 109.6 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 143.24 -147.67 19.14 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.796 1.189 . . . . 0.0 110.752 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -79.61 -14.84 58.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.496 1.119 . . . . 0.0 111.367 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -60.09 167.64 2.25 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 123.779 0.832 . . . . 0.0 110.919 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -106.71 159.66 16.05 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.437 1.095 . . . . 0.0 112.85 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 m -134.85 165.46 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 127.046 2.138 . . . . 0.0 106.399 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.14 138.01 13.91 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 122.984 0.326 . . . . 0.0 113.39 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.3 m -85.13 -174.37 5.21 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -77.44 121.33 23.67 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.745 -0.597 . . . . 0.0 110.648 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.03 66.2 1.59 Allowed Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.387 0.994 . . . . 0.0 110.789 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.4 t -139.31 29.37 2.21 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.984 1.314 . . . . 0.0 112.198 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 C--O 1.251 1.168 0 C-N-CA 127.68 2.392 . . . . 0.0 110.268 -179.13 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.5 p . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.08 147.29 35.41 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.473 1.109 . . . . 0.0 109.76 178.551 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.1 p -121.57 119.22 31.28 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 123.137 0.575 . . . . 0.0 110.239 -178.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.18 108.29 13.14 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 100.313 -3.958 . . . . 0.0 100.313 177.522 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.9 110.16 13.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.724 0.409 . . . . 0.0 110.242 -178.053 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.12 -82.71 0.75 Allowed Glycine 0 C--N 1.339 0.746 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.34 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.2 t -156.99 45.77 0.4 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.642 1.177 . . . . 0.0 108.874 179.057 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 m -141.39 96.92 3.06 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -85.68 139.05 31.69 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.71 1.604 . . . . 0.0 110.932 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -137.89 137.15 37.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.079 1.352 . . . . 0.0 108.271 178.364 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.447 ' O ' HG23 ' A' ' 16' ' ' VAL . 44.5 m -70.58 149.18 47.35 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.831 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.29 -21.55 5.69 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.129 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.2 m -71.0 -47.66 57.54 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.153 0.981 . . . . 0.0 109.267 179.048 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.79 -38.04 85.74 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 12' ' ' SER . 2.6 t -63.81 -51.06 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.315 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.8 ttt-85 -64.19 -36.09 82.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.726 1.61 . . . . 0.0 111.785 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.29 -50.5 46.16 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.051 0.541 . . . . 0.0 109.908 179.07 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.517 ' HB1' ' HE2' ' A' ' 59' ' ' PHE . . . -57.58 -41.72 81.71 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.325 1.05 . . . . 0.0 110.213 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.91 -46.19 54.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.04 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -61.21 -21.81 64.19 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.145 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.64 -59.64 2.54 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -177.657 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.88 -32.54 53.61 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.817 0.698 . . . . 0.0 110.945 178.028 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.25 -53.84 42.7 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -56.44 -38.85 72.18 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.787 0.435 . . . . 0.0 110.549 178.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -74.38 -3.31 29.67 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 126.589 1.956 . . . . 0.0 113.147 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -134.41 17.84 3.67 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -99.3 -80.55 0.47 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.957 1.253 . . . . 0.0 108.823 179.085 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -157.97 17.2 0.24 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.245 1.018 . . . . 0.0 112.846 -179.102 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -122.3 67.7 0.94 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.5 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 77.1 116.53 0.06 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 127.406 2.283 . . . . 0.0 105.294 -177.358 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -96.03 -58.08 2.18 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 124.157 0.983 . . . . 0.0 112.159 -177.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 50.83 82.41 0.06 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.831 1.252 . . . . 0.0 112.534 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -112.75 33.09 5.81 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.768 1.651 . . . . 0.0 110.805 -179.371 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.7 m -149.24 65.08 1.02 Allowed 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.297 1.439 . . . . 0.0 107.212 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.6 p -161.33 -167.77 1.85 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.316 1.046 . . . . 0.0 108.765 -178.796 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.4 p -85.93 58.04 4.82 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.732 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 74.35 147.53 0.12 Allowed Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 126.885 2.074 . . . . 0.0 110.443 179.246 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.66 137.57 46.7 Favored 'Cis proline' 0 C--N 1.349 0.558 0 CA-C-N 119.73 0.939 . . . . 0.0 113.725 2.601 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -134.98 168.58 18.85 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.801 2.04 . . . . 0.0 110.216 -179.128 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.4 m -74.08 140.06 45.06 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.596 1.958 . . . . 0.0 109.489 178.379 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.49 81.78 5.92 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.86 146.49 49.6 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 71.77 126.23 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.054 2.142 . . . . 0.0 111.174 -178.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -98.67 53.19 1.01 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.91 0.884 . . . . 0.0 109.476 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -153.6 56.81 0.75 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.708 1.203 . . . . 0.0 108.102 179.123 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.8 -55.58 0.23 Allowed Glycine 0 C--N 1.341 0.855 0 C-N-CA 125.725 1.631 . . . . 0.0 109.042 179.362 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.61 175.65 13.65 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.313 1.045 . . . . 0.0 109.52 178.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -90.52 136.63 32.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.873 1.269 . . . . 0.0 110.871 -178.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -150.87 103.51 3.02 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 178.894 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.63 58.03 6.23 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.125 3.217 . . . . 0.0 114.074 -177.849 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -145.37 -134.22 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 178.52 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -146.5 143.23 28.8 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.183 0.901 . . . . 0.0 109.225 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.74 -176.19 50.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.214 0.911 . . . . 0.0 111.892 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.23 160.89 93.41 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 CA-C-N 118.174 0.987 . . . . 0.0 110.693 -1.348 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -112.4 171.82 7.29 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.267 1.027 . . . . 0.0 110.289 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -132.56 137.31 47.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.169 1.388 . . . . 0.0 109.055 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -93.7 155.29 17.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.603 0.761 . . . . 0.0 110.323 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.517 ' HE2' ' HB1' ' A' ' 19' ' ' ALA . 22.4 t80 -160.21 102.55 1.39 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.695 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.12 119.94 4.81 Favored 'Trans proline' 0 N--CA 1.442 -1.532 0 C-N-CA 122.226 1.951 . . . . 0.0 109.789 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.52 HG13 ' H ' ' A' ' 62' ' ' LYS . 6.2 tt -79.38 170.63 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 124.109 1.909 . . . . 0.0 111.349 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.52 ' H ' HG13 ' A' ' 61' ' ' ILE . 14.1 tptm -140.49 149.11 42.1 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 109.468 -3.515 . . . . 0.0 111.641 -178.832 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.4 m -89.48 60.28 5.12 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.129 1.771 . . . . 0.0 109.267 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.03 -55.79 0.03 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.29 -167.82 36.75 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.6 158.83 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.679 1.192 . . . . 0.0 110.899 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.18 -173.37 4.17 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.352 1.461 . . . . 0.0 108.341 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.2 t -160.36 33.11 0.17 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.752 1.221 . . . . 0.0 110.069 178.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -141.9 -24.38 0.21 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.824 1.202 . . . . 0.0 113.024 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.96 -143.86 49.01 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.643 1.222 . . . . 0.0 111.827 179.377 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.1 t 63.11 102.33 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.421 1.888 . . . . 0.0 111.975 179.211 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.85 161.7 29.68 Favored 'Cis proline' 0 C--N 1.349 0.567 0 CA-C-N 119.981 1.029 . . . . 0.0 113.619 -3.426 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.78 41.35 1.88 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.864 -0.964 . . . . 0.0 113.546 -179.058 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.54 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -88.54 -73.28 0.5 Allowed 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.55 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -60.99 112.92 2.26 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.603 1.161 . . . . 0.0 111.147 179.515 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -132.22 161.01 34.48 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -178.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 m -132.88 142.11 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 101.16 -3.644 . . . . 0.0 101.16 175.412 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.9 t -138.24 120.13 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -176.343 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -102.54 173.12 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.115 0 C-N-CA 125.85 1.66 . . . . 0.0 110.15 -178.979 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -88.56 161.06 17.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 103.184 -2.895 . . . . 0.0 103.184 176.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.366 13.4 t -57.09 -22.54 40.29 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 -177.223 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -85.97 -75.46 0.38 Allowed 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.239 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.62 -1.84 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -176.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -78.94 109.03 12.85 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -175.31 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -56.51 108.6 0.5 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.929 1.292 . . . . 0.0 109.228 -179.555 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.08 -60.05 2.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.604 1.162 . . . . 0.0 112.461 -177.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.8 175.57 46.39 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.62 146.12 52.04 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.424 1.089 . . . . 0.0 110.58 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.2 pt -143.61 171.37 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.292 1.037 . . . . 0.0 110.781 -178.218 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t -159.71 143.23 14.36 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 116.426 2.009 . . . . 0.0 116.426 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.54 ' HB2' ' CB ' ' A' ' 74' ' ' ALA 0.265 32.2 m170 -79.51 -29.36 41.53 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.094 174.542 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.2 -45.33 68.54 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.607 1.163 . . . . 0.0 113.666 -177.89 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -78.62 -21.9 68.14 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 124.047 0.832 . . . . 0.0 111.565 179.226 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.26 166.5 23.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.897 0.879 . . . . 0.0 112.003 -179.058 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.7 t -65.9 -36.02 82.23 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.158 0.983 . . . . 0.0 111.64 -179.435 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.53 -101.51 0.15 Allowed Glycine 0 C--N 1.341 0.808 0 CA-C-N 118.206 0.457 . . . . 0.0 112.26 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -79.58 -22.12 44.18 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.046 0.938 . . . . 0.0 113.017 -178.364 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -74.68 179.01 5.0 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.656 0.662 . . . . 0.0 110.584 179.072 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -119.41 159.03 24.99 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.563 1.545 . . . . 0.0 109.905 179.319 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.7 m -134.96 162.4 38.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 125.209 1.404 . . . . 0.0 107.542 177.326 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.44 147.94 30.41 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 116.311 -0.404 . . . . 0.0 113.51 -178.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 34.0 m -85.75 -173.91 4.87 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.309 1.444 . . . . 0.0 107.946 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.3 t -57.23 110.27 0.81 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.263 1.025 . . . . 0.0 111.841 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.95 34.2 76.38 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.939 1.256 . . . . 0.0 114.322 178.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 93.6 m -83.43 130.8 35.05 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 118.091 0.945 . . . . 0.0 109.169 179.092 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 117.238 -1.363 . . . . 0.0 108.927 179.438 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.4 t . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 120.722 0.296 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.53 147.02 0.06 Allowed 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 127.007 2.123 . . . . 0.0 112.227 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 t -159.66 156.3 27.61 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.533 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.87 121.23 18.11 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -178.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.4 m -103.28 91.04 3.91 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.285 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.28 -106.93 1.87 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.217 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.7 m -92.84 -33.32 14.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.527 1.131 . . . . 0.0 111.173 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 m -74.65 103.15 4.83 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.352 0.661 . . . . 0.0 110.275 -178.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -87.92 151.94 22.44 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.961 1.304 . . . . 0.0 111.684 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -142.54 134.23 26.77 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 123.481 0.713 . . . . 0.0 112.354 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.7 m -77.07 155.11 32.71 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.241 1.417 . . . . 0.0 107.465 177.595 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.82 -16.89 13.01 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 177.087 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -70.88 -43.29 68.71 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.871 0.868 . . . . 0.0 109.587 179.054 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -71.15 -47.3 58.65 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 123.932 0.893 . . . . 0.0 113.138 -179.208 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.4 t -60.1 -46.12 94.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.038 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -68.18 -40.84 82.15 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.84 1.256 . . . . 0.0 111.901 -179.21 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.98 -49.6 71.87 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.588 0.631 . . . . 0.0 110.021 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.33 -35.2 79.61 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.893 0.877 . . . . 0.0 111.563 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.21 -40.85 58.82 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 117.76 0.255 . . . . 0.0 111.661 179.12 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -65.38 -22.07 66.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.399 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.34 -61.73 1.91 Allowed 'General case' 0 C--N 1.348 0.505 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 -178.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -42.34 -47.54 4.9 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.097 1.359 . . . . 0.0 110.486 178.361 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.7 t -57.88 -66.61 0.45 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.767 1.627 . . . . 0.0 112.687 179.399 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -23.18 66.36 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.181 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -94.9 4.95 53.22 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.556 1.942 . . . . 0.0 113.413 -178.436 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -144.82 51.81 1.24 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.268 1.427 . . . . 0.0 110.63 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -95.13 -77.15 0.47 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 119.36 -0.352 . . . . 0.0 110.19 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 169.63 -65.4 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.683 1.593 . . . . 0.0 108.828 -178.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.25 69.79 7.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 111.22 116.19 0.0 OUTLIER 'General case' 0 C--O 1.231 0.102 0 C-N-CA 131.033 3.733 . . . . 0.0 106.743 -179.166 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.48 -63.95 0.3 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.483 1.113 . . . . 0.0 109.982 -178.741 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 66.52 163.35 0.18 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.562 1.545 . . . . 0.0 112.453 -179.186 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.93 106.7 0.15 Allowed Glycine 0 C--N 1.341 0.811 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -178.733 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m -139.1 57.21 1.67 Allowed 'General case' 0 C--N 1.34 0.173 0 CA-C-N 117.696 0.748 . . . . 0.0 112.149 -178.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -100.02 -75.93 0.56 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 177.924 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.261 3.6 t -160.23 26.56 0.17 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.682 1.593 . . . . 0.0 109.823 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.409 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -171.3 129.78 0.73 Allowed Pre-proline 0 C--N 1.349 0.548 0 C-N-CA 128.307 2.643 . . . . 0.0 106.872 178.329 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.6 132.3 25.84 Favored 'Cis proline' 0 N--CA 1.45 -1.083 0 N-CA-C 108.354 -1.441 . . . . 0.0 108.354 -2.407 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.3 158.17 43.88 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.874 0.47 . . . . 0.0 109.76 -179.357 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.4 m -55.64 130.97 45.24 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 125.97 1.708 . . . . 0.0 110.584 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -79.8 121.24 25.13 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.347 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -146.63 177.87 8.74 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.26 1.024 . . . . 0.0 110.514 -179.139 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 t30 59.13 73.27 0.49 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.259 1.424 . . . . 0.0 108.565 -178.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -82.01 91.23 6.58 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.051 0.94 . . . . 0.0 110.853 -178.732 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -62.08 -50.51 71.66 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.491 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -169.74 42.4 0.21 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 178.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -150.73 143.48 24.54 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 123.557 0.743 . . . . 0.0 112.159 -179.283 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -161.6 179.63 8.03 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.836 2.054 . . . . 0.0 107.677 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -137.93 119.33 10.58 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.84 74.37 5.26 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.981 3.121 . . . . 0.0 112.45 -178.556 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.26 -90.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.405 1.082 . . . . 0.0 108.714 178.517 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -145.93 -78.72 0.18 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-N 119.215 0.916 . . . . 0.0 110.228 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.22 -175.06 35.97 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.632 1.11 . . . . 0.0 111.045 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.25 140.33 32.48 Favored 'Cis proline' 0 N--CA 1.458 -0.59 0 CA-C-N 118.796 1.298 . . . . 0.0 110.422 1.031 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.38 172.27 11.91 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.954 0.902 . . . . 0.0 110.351 -178.58 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -153.9 137.82 16.29 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.064 0.459 . . . . 0.0 111.834 -178.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.55 143.81 30.8 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.697 1.599 . . . . 0.0 112.626 -178.748 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -154.48 113.85 2.44 Favored Pre-proline 0 C--N 1.342 0.251 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 178.286 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.409 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 17.6 Cg_endo -81.12 144.54 14.87 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 121.79 1.66 . . . . 0.0 114.389 -175.526 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.544 HG12 ' H ' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -117.12 -171.64 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-O 124.671 2.176 . . . . 0.0 113.125 179.419 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.544 ' H ' HG12 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -162.41 -175.47 4.54 Favored 'General case' 0 C--N 1.318 -0.796 2 CA-C-N 108.05 -4.159 . . . . 0.0 107.443 -178.656 . . . . . . . . 4 4 . 1 . 022 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.3 m -92.81 61.27 3.54 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.329 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.54 58.88 0.99 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -178.628 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.27 61.13 0.17 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.02 116.86 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.426 0.691 . . . . 0.0 111.206 -179.35 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.6 t80 53.64 65.64 1.46 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.248 1.419 . . . . 0.0 111.248 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.6 p -138.12 77.57 1.64 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.246 1.018 . . . . 0.0 110.825 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.95 99.92 0.07 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.738 0.685 . . . . 0.0 113.262 178.62 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.74 -174.35 49.31 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.2 m 56.8 86.63 0.16 Allowed Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 125.318 1.447 . . . . 0.0 111.602 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -62.72 142.6 42.14 Favored 'Cis proline' 0 N--CA 1.459 -0.505 0 CA-C-N 119.322 0.794 . . . . 0.0 112.76 -0.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.85 48.09 0.49 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.29 -55.6 8.82 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.693 0.797 . . . . 0.0 109.455 179.267 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -61.93 118.61 7.47 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.436 1.894 . . . . 0.0 112.843 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -143.37 126.91 16.89 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.187 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.0 m -92.9 148.05 4.98 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 177.024 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.6 t -137.06 131.81 46.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.603 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 pt -119.92 -175.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.394 0 C-N-CA 124.365 1.066 . . . . 0.0 112.301 -178.392 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -96.74 153.64 17.75 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 127.009 2.123 . . . . 0.0 106.071 177.869 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.6 t -67.31 -1.4 4.55 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 -178.536 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -93.29 -75.31 0.5 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 178.397 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -164.39 -12.04 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -179.094 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.72 132.82 36.28 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 -174.398 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -62.24 125.24 23.21 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.8 -42.41 8.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.2 1.0 . . . . 0.0 109.463 -178.897 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.18 -165.07 38.16 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.86 140.61 25.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.698 1.599 . . . . 0.0 107.678 179.421 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.8 pt -142.56 165.87 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.091 1.356 . . . . 0.0 109.129 -178.885 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.3 t -159.33 150.83 20.23 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.19 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -79.13 -9.8 59.65 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 175.343 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 54.1 m -66.16 112.0 3.7 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.477 1.111 . . . . 0.0 109.12 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.91 34.38 42.86 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.952 0.787 . . . . 0.0 111.669 -179.301 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.43 -21.2 11.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.21 1.404 . . . . 0.0 111.386 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.6 m 70.05 85.12 0.14 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 126.185 1.794 . . . . 0.0 110.639 179.37 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.91 -146.77 17.95 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.702 1.144 . . . . 0.0 111.359 179.192 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -80.0 3.61 19.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.681 1.192 . . . . 0.0 112.913 -179.239 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -68.28 -174.85 0.55 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.876 1.27 . . . . 0.0 111.594 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -140.7 157.56 45.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.81 0.844 . . . . 0.0 112.503 -178.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 m -143.94 163.29 15.18 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 127.095 2.158 . . . . 0.0 106.955 177.426 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.27 153.35 26.41 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 123.53 0.586 . . . . 0.0 113.302 -178.143 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -84.13 -179.85 7.32 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.27 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.9 t -79.53 122.69 26.79 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.351 -0.843 . . . . 0.0 112.219 -178.395 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.64 36.39 92.59 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.726 1.155 . . . . 0.0 112.361 179.067 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.5 t -80.05 146.69 31.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.0 p30 . . . . . 0 C--O 1.252 1.191 0 C-N-CA 125.397 1.479 . . . . 0.0 109.741 -179.031 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 CA--C 1.529 0.154 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -44.46 117.97 1.42 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.984 1.313 . . . . 0.0 110.764 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.51 121.87 41.78 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 124.964 1.306 . . . . 0.0 110.41 -178.124 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -119.07 92.14 3.73 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 100.285 -3.968 . . . . 0.0 100.285 177.126 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.8 m -98.93 91.13 4.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.982 0.913 . . . . 0.0 111.455 -177.546 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.72 -81.68 0.63 Allowed Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.979 1.276 . . . . 0.0 110.759 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.3 t -145.07 23.92 1.49 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.813 1.245 . . . . 0.0 110.339 179.11 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 m -129.29 102.01 6.25 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 179.043 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -95.18 151.72 18.98 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.347 0.659 . . . . 0.0 111.967 -178.561 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.26 155.69 41.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.01 1.324 . . . . 0.0 109.543 178.75 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.0 p -75.77 154.2 36.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.509 1.523 . . . . 0.0 110.352 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.5 -21.19 59.81 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 176.597 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.7 t -71.09 -41.22 70.91 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 124.648 1.179 . . . . 0.0 109.892 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -66.78 -39.83 87.94 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 118.65 0.659 . . . . 0.0 111.09 178.769 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.42 -50.68 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 123.741 0.816 . . . . 0.0 109.13 178.586 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -62.76 -39.14 93.24 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 123.71 0.804 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.6 -47.13 76.75 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.41 -31.24 72.34 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.56 0.744 . . . . 0.0 111.211 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.87 -42.52 24.06 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 178.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -68.4 -20.39 64.67 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.349 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.406 ' HB1' ' CE2' ' A' ' 26' ' ' TYR . . . -79.96 -65.42 1.01 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 104.33 -2.471 . . . . 0.0 104.33 -178.105 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -41.23 -53.68 3.12 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 124.708 1.255 . . . . 0.0 110.125 176.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 t -49.96 -61.87 1.9 Allowed 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.853 1.661 . . . . 0.0 113.319 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -61.55 -51.43 68.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.118 0.567 . . . . 0.0 111.458 -178.054 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.406 ' CE2' ' HB1' ' A' ' 22' ' ' ALA . 1.6 m-30 -63.07 -28.6 70.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.722 1.209 . . . . 0.0 112.041 -177.702 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.407 ' CE2' ' HG3' ' A' ' 57' ' ' GLN . 6.3 t80 -71.92 -56.02 6.44 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.102 0.961 . . . . 0.0 109.557 179.043 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -60.25 -36.86 78.74 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.031 0.932 . . . . 0.0 110.994 -179.079 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -73.69 -35.88 65.23 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.311 0.645 . . . . 0.0 110.683 178.836 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 68.48 51.05 0.67 Allowed 'General case' 0 C--N 1.344 0.362 0 C-N-CA 126.09 1.756 . . . . 0.0 109.813 -178.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -172.56 -165.55 0.33 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.818 2.047 . . . . 0.0 107.823 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.36 8.8 t 49.65 51.79 15.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.871 2.069 . . . . 0.0 113.682 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.94 99.65 0.08 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.827 2.051 . . . . 0.0 107.081 178.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.91 33.31 3.1 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.033 0.825 . . . . 0.0 113.567 -178.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -78.49 -73.09 0.34 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.275 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -167.27 -72.71 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.79 2.036 . . . . 0.0 105.925 179.295 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.3 t -152.21 14.78 0.61 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.298 1.039 . . . . 0.0 111.557 178.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.43 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 8.8 m-85 -76.95 130.79 74.69 Favored Pre-proline 0 C--N 1.346 0.421 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.54 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -69.89 121.25 5.32 Favored 'Cis proline' 0 N--CA 1.455 -0.738 0 N-CA-C 115.938 1.476 . . . . 0.0 115.938 -0.002 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -115.19 161.12 18.87 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.497 1.919 . . . . 0.0 106.053 178.651 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 t -52.31 143.04 15.66 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.715 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -118.31 152.64 35.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.198 1.399 . . . . 0.0 107.75 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 177.46 -65.04 0.01 OUTLIER 'General case' 0 C--O 1.231 0.082 0 C-N-CA 124.912 1.285 . . . . 0.0 108.848 -178.622 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 m120 53.05 44.59 30.2 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.811 1.644 . . . . 0.0 110.026 -179.247 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 59.38 -98.98 0.09 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.206 1.802 . . . . 0.0 109.287 -178.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -134.34 68.76 1.47 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.013 1.325 . . . . 0.0 107.792 178.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.05 -73.53 0.91 Allowed Glycine 0 C--N 1.341 0.859 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.209 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.29 116.73 12.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -141.19 121.31 13.78 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.851 0.86 . . . . 0.0 108.881 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -88.31 178.6 2.02 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 125.428 1.491 . . . . 0.0 107.985 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.66 -72.04 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.011 2.474 . . . . 0.0 111.113 178.674 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER 41.77 -150.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 127.319 2.247 . . . . 0.0 114.197 178.546 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -124.23 -57.03 1.61 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.958 2.103 . . . . 0.0 107.797 178.767 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.84 129.93 6.7 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.648 -1.084 . . . . 0.0 111.153 179.217 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.17 -177.89 9.67 Favored 'Cis proline' 0 C--N 1.35 0.651 0 CA-C-N 119.813 1.807 . . . . 0.0 114.635 -0.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.86 163.36 38.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 128.716 2.807 . . . . 0.0 106.315 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.407 ' HG3' ' CE2' ' A' ' 27' ' ' TYR . 10.0 mm100 -132.33 152.26 51.49 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.4 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.9 161.8 15.05 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -161.12 95.51 1.39 Allowed Pre-proline 0 N--CA 1.455 -0.203 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.892 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.43 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 95.9 Cg_endo -67.69 132.26 26.43 Favored 'Trans proline' 0 N--CA 1.438 -1.744 0 CA-C-N 120.82 1.328 . . . . 0.0 112.727 -178.574 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.547 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.3 tt -101.81 179.33 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 123.93 1.824 . . . . 0.0 111.707 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.547 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 10.4 mttm -160.99 157.73 26.79 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 109.08 -3.691 . . . . 0.0 111.51 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.9 p -88.41 59.89 5.41 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.813 1.245 . . . . 0.0 111.234 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.11 31.0 0.13 Allowed Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.302 -0.721 . . . . 0.0 111.621 178.575 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.01 179.97 28.82 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.922 0.772 . . . . 0.0 112.056 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.8 p -73.64 131.15 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.094 1.358 . . . . 0.0 111.545 -179.095 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 41.8 t80 39.04 82.48 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.359 2.263 . . . . 0.0 114.09 178.948 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.2 t -160.59 125.3 3.72 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.104 0.961 . . . . 0.0 109.422 178.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 162.46 -83.16 0.12 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 154.16 -58.4 0.4 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.218 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.3 m -138.29 93.15 11.63 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.181 0.992 . . . . 0.0 110.518 -178.98 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -49.45 139.0 30.23 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 124.11 3.207 . . . . 0.0 111.565 169.116 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.14 -21.02 2.38 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 118.259 -1.301 . . . . 0.0 115.162 -178.45 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.476 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -151.94 -60.14 0.16 Allowed 'General case' 0 C--N 1.345 0.374 0 CA-C-N 119.657 1.729 . . . . 0.0 114.454 -178.667 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.42 117.52 12.06 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -177.4 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -146.0 125.67 13.38 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.422 0.689 . . . . 0.0 112.036 178.77 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.6 148.49 4.53 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.681 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.09 137.71 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.86 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.3 pt -117.42 -177.62 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.803 1.641 . . . . 0.0 112.143 -178.442 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -83.65 178.55 7.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 129.397 3.079 . . . . 0.0 107.118 178.682 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.1 t -90.71 24.76 2.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -140.57 -65.21 0.45 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 177.824 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -163.27 -21.03 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 118.741 2.867 . . . . 0.0 118.741 -177.553 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -79.82 150.2 30.77 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -175.276 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -75.44 134.52 40.85 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.149 1.78 . . . . 0.0 108.296 178.549 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.22 -53.7 2.86 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.942 0.897 . . . . 0.0 110.248 -179.357 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.91 152.11 10.95 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.15 127.67 53.02 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.377 1.471 . . . . 0.0 107.551 178.718 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.0 pt -132.19 157.59 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.457 1.103 . . . . 0.0 109.969 -178.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.4 t -158.07 151.8 23.75 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -179.122 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.476 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 27.8 m170 -80.21 -20.57 44.37 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.562 0.539 . . . . 0.0 110.509 174.847 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.0 m -49.01 -59.64 3.44 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 126.182 1.793 . . . . 0.0 112.714 -178.106 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.02 -27.45 70.37 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 123.846 0.736 . . . . 0.0 111.96 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.02 172.35 5.72 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.211 1.004 . . . . 0.0 112.27 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.3 t -60.79 -54.8 40.7 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.448 1.099 . . . . 0.0 111.564 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.68 -88.39 0.07 OUTLIER Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.428 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -80.23 -24.1 40.41 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.978 0.911 . . . . 0.0 112.001 -179.616 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -68.71 -178.18 1.12 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.518 1.127 . . . . 0.0 112.268 -178.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -128.17 160.46 31.97 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.524 1.529 . . . . 0.0 112.031 -179.007 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 m -148.27 161.25 6.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 126.747 2.019 . . . . 0.0 106.917 177.145 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.1 161.39 27.85 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 p -147.63 160.68 42.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.2 1.8 . . . . 0.0 109.4 178.528 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.2 t 70.51 58.76 0.23 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.046 1.738 . . . . 0.0 110.684 -178.519 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.59 28.74 70.26 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.306 -179.371 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.2 m -113.79 106.24 14.24 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.215 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.3 t30 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 116.851 -1.547 . . . . 0.0 109.822 179.704 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.6 p . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.83 152.05 45.28 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.706 0.802 . . . . 0.0 109.406 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 t -146.53 136.97 23.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.73 0.3 . . . . 0.0 111.705 -179.379 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.06 113.08 25.5 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.224 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.1 m -98.54 75.27 2.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.377 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.8 -84.11 1.59 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.022 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.0 m -123.44 -29.49 3.79 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.352 1.461 . . . . 0.0 110.816 179.112 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -71.73 98.04 1.87 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -79.56 141.58 36.49 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.138 1.375 . . . . 0.0 110.578 -178.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -137.14 129.01 29.04 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.325 1.05 . . . . 0.0 109.547 178.885 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.1 m -68.98 155.1 40.92 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.88 1.272 . . . . 0.0 108.652 178.209 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.71 -22.62 57.93 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 176.735 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.8 t -71.13 -37.74 72.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.034 0.934 . . . . 0.0 109.683 179.228 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -75.32 -44.89 42.88 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.102 1.361 . . . . 0.0 113.57 -178.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.2 t -60.48 -48.02 90.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -43.26 74.37 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 123.765 0.826 . . . . 0.0 112.258 -179.187 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.18 -47.24 85.37 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.301 0.376 . . . . 0.0 110.69 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.6 94.57 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.712 0.805 . . . . 0.0 109.566 -179.629 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.91 -27.86 60.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -71.51 -23.47 61.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.557 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.03 -58.03 3.26 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -179.083 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.482 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -44.28 -44.6 8.15 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.48 1.512 . . . . 0.0 111.002 176.586 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -62.9 -52.56 62.61 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.163 0.985 . . . . 0.0 109.862 178.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -61.14 -22.22 64.48 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.445 0.698 . . . . 0.0 112.182 179.309 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -99.74 7.4 45.1 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.898 1.679 . . . . 0.0 110.735 179.328 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -151.31 63.89 0.89 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.587 1.184 . . . . 0.0 108.51 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -100.59 -39.88 7.68 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 113.532 -1.667 . . . . 0.0 112.16 178.286 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -139.05 48.41 1.88 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.876 0.871 . . . . 0.0 111.062 -179.048 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 p30 46.46 41.75 9.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.584 1.954 . . . . 0.0 114.61 178.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -138.94 123.74 18.69 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 103.347 -2.834 . . . . 0.0 103.347 178.107 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 p -109.54 -84.09 0.55 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -176.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 163.24 97.57 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 128.394 2.677 . . . . 0.0 104.184 -178.139 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.5 -48.22 3.09 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -178.362 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m 59.17 71.64 0.57 Allowed 'General case' 0 C--N 1.345 0.402 0 C-N-CA 125.344 1.458 . . . . 0.0 110.267 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.3 t 179.68 -42.3 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.992 2.117 . . . . 0.0 107.238 -178.499 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.3 t -79.91 12.32 2.79 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.96 1.704 . . . . 0.0 112.667 179.223 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 71.94 136.57 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.792 1.637 . . . . 0.0 108.717 179.023 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.35 163.41 89.95 Favored 'Cis proline' 0 N--CA 1.449 -1.143 0 CA-C-N 119.616 0.899 . . . . 0.0 113.979 2.476 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -166.46 151.75 8.16 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 127.06 2.144 . . . . 0.0 107.131 178.767 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 t -52.0 155.66 1.78 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -178.191 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -138.36 99.01 3.73 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.345 2.258 . . . . 0.0 106.738 -179.439 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -131.04 153.65 49.05 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.28 1.032 . . . . 0.0 111.747 -178.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 54.47 32.22 16.3 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.873 2.069 . . . . 0.0 113.612 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -123.62 75.96 1.38 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.827 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -77.85 -1.46 31.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.413 1.085 . . . . 0.0 112.722 179.353 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.83 -43.34 96.64 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 124.346 0.975 . . . . 0.0 111.964 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.47 66.8 1.32 Allowed 'General case' 0 C--N 1.341 0.221 0 CA-C-O 121.658 0.742 . . . . 0.0 109.403 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -87.57 -175.16 5.1 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.632 1.173 . . . . 0.0 112.968 -178.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -141.3 143.58 31.02 Favored Pre-proline 0 N--CA 1.454 -0.226 0 C-N-CA 126.699 1.999 . . . . 0.0 106.73 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.14 -87.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.837 2.358 . . . . 0.0 110.272 179.111 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.1 t 31.23 -102.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 128.046 2.538 . . . . 0.0 113.358 178.795 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -167.76 115.43 0.75 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.246 1.019 . . . . 0.0 109.57 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.06 170.98 50.14 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.224 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.69 170.71 64.7 Favored 'Cis proline' 0 N--CA 1.459 -0.533 0 CA-C-N 118.645 1.223 . . . . 0.0 112.423 -0.147 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -130.5 170.84 13.7 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.92 1.288 . . . . 0.0 109.868 -178.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -149.99 148.5 29.13 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.172 0.989 . . . . 0.0 109.731 179.252 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -79.54 155.08 28.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.044 2.537 . . . . 0.0 112.369 -177.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.482 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 28.0 t80 -160.51 102.1 1.35 Allowed Pre-proline 0 N--CA 1.454 -0.258 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.937 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -78.79 126.36 7.25 Favored 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 121.786 1.658 . . . . 0.0 111.632 -176.422 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 62' ' ' LYS . 2.3 tp -79.2 164.41 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 123.845 1.783 . . . . 0.0 113.186 -178.506 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.414 ' N ' HG13 ' A' ' 61' ' ' ILE . 33.3 mmtp -142.93 145.55 33.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 109.316 -3.584 . . . . 0.0 110.752 -178.458 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.8 p -85.34 57.65 4.58 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.068 1.347 . . . . 0.0 108.421 179.046 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.59 -44.23 0.03 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -178.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.62 -132.59 2.18 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 117.788 0.794 . . . . 0.0 111.822 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -77.77 167.29 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.961 1.704 . . . . 0.0 110.3 -179.252 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -65.01 141.96 58.59 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 118.406 0.548 . . . . 0.0 110.965 -179.424 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -130.78 120.72 24.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.229 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.69 -66.17 3.58 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.271 0.939 . . . . 0.0 111.74 179.188 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.32 -115.56 1.76 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 -179.261 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.15 -178.76 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.61 1.164 . . . . 0.0 111.067 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.71 159.55 4.77 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.411 2.741 . . . . 0.0 113.34 172.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.59 82.49 0.05 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 -178.753 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.461 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -50.95 -35.87 35.79 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.477 1.111 . . . . 0.0 113.487 -178.937 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -74.96 118.48 17.97 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.564 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -144.57 133.65 22.77 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -178.041 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.8 m -100.12 145.83 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 176.133 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -130.81 136.49 58.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -177.436 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.0 pt -116.08 174.07 3.53 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 C-N-CA 125.066 1.346 . . . . 0.0 113.512 -178.003 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -99.99 162.67 12.84 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.885 2.074 . . . . 0.0 107.735 178.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.379 5.7 t -79.09 32.69 0.22 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 118.993 2.961 . . . . 0.0 118.993 -177.7 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.31 -85.62 0.63 Allowed 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 176.377 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.7 t -162.98 -6.31 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.12 1.768 . . . . 0.0 114.848 179.281 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -79.0 139.14 38.26 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.466 1.03 . . . . 0.0 112.984 -176.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -81.78 121.21 26.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.444 1.898 . . . . 0.0 106.522 178.712 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.72 -59.27 2.8 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 123.548 0.739 . . . . 0.0 111.691 -178.363 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.52 154.28 13.01 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.703 -0.76 . . . . 0.0 114.098 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.96 124.77 37.17 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.491 1.516 . . . . 0.0 109.399 179.219 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.5 pt -131.09 159.7 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 125.296 1.438 . . . . 0.0 108.414 -179.334 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.8 t -154.07 154.22 33.26 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.273 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.461 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 13.4 m170 -79.42 11.34 3.05 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 176.825 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.4 m -56.38 -69.66 0.14 Allowed 'General case' 0 C--N 1.343 0.316 0 CA-C-N 120.135 1.334 . . . . 0.0 112.449 -178.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.26 3.42 72.29 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.369 0.985 . . . . 0.0 112.965 -179.371 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.34 159.45 33.32 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.993 0.917 . . . . 0.0 111.365 179.439 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.5 t -69.45 -46.48 66.62 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.64 0.776 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -161.94 -86.73 0.06 OUTLIER Glycine 0 C--N 1.34 0.761 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.214 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -91.67 15.27 13.03 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.216 1.006 . . . . 0.0 111.296 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -91.17 -168.17 1.99 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.892 1.277 . . . . 0.0 109.727 -179.401 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -147.24 159.44 43.65 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.903 0.881 . . . . 0.0 112.201 -178.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.4 m -138.52 165.62 24.52 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 126.959 2.104 . . . . 0.0 107.21 177.604 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.71 138.58 14.33 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 123.566 0.603 . . . . 0.0 113.492 -178.433 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.7 m -84.81 -169.54 2.69 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.269 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -69.97 134.36 48.26 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.954 -0.466 . . . . 0.0 110.791 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.66 34.57 72.97 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.4 m -149.08 104.61 3.44 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.5 t30 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 116.873 -1.537 . . . . 0.0 109.454 179.446 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.2 p . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 67.13 163.97 0.2 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.8 2.04 . . . . 0.0 111.687 -179.202 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 t -156.32 128.52 7.51 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.98 115.37 29.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 178.927 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 23.1 m -101.06 72.82 1.49 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.777 1.631 . . . . 0.0 107.511 -179.048 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.02 -90.82 0.8 Allowed Glycine 0 C--N 1.34 0.754 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.23 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.3 t -106.53 -36.86 6.64 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.078 1.351 . . . . 0.0 110.416 179.34 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.7 m -71.39 112.96 7.94 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.616 0.766 . . . . 0.0 110.003 -179.15 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -92.29 147.39 22.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.093 0.957 . . . . 0.0 110.782 -179.298 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -142.08 122.23 13.81 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.778 1.231 . . . . 0.0 108.345 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.2 m -69.45 155.84 39.81 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 125.443 1.497 . . . . 0.0 110.163 178.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.9 -18.78 47.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.069 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.4 p -77.81 -39.48 43.61 Favored 'General case' 0 C--N 1.345 0.382 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -68.72 -45.97 70.15 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.278 1.031 . . . . 0.0 111.457 179.397 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 51.5 t -60.08 -49.78 82.71 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.095 0 C-N-CA 124.22 1.008 . . . . 0.0 109.242 179.056 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -63.6 -46.81 84.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.92 0.888 . . . . 0.0 111.434 -178.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.13 -52.57 58.48 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.589 0.756 . . . . 0.0 111.048 -177.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.04 -41.57 83.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.75 -29.29 66.61 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 179.165 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -68.41 -26.11 65.37 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.9 -59.5 2.69 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -43.93 -44.52 7.17 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.138 1.375 . . . . 0.0 112.145 177.346 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.9 t -60.08 -53.83 53.17 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.15 1.38 . . . . 0.0 111.06 -179.317 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -66.91 -43.15 84.08 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -81.37 -2.57 49.8 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 127.103 2.161 . . . . 0.0 114.03 -178.747 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -60.29 -45.73 92.33 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 120.288 1.404 . . . . 0.0 110.611 179.051 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -57.59 -46.28 84.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.974 1.31 . . . . 0.0 110.886 -178.762 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -84.45 -16.55 42.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.185 1.394 . . . . 0.0 113.277 -178.781 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.7 t0 65.26 79.18 0.26 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.533 1.933 . . . . 0.0 107.867 -178.234 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 83.94 -163.09 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.467 2.307 . . . . 0.0 107.198 -178.697 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.7 p -36.97 -41.2 0.33 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.087 1.355 . . . . 0.0 108.954 177.069 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 156.6 90.09 0.0 OUTLIER 'General case' 0 C--N 1.345 0.373 0 C-N-CA 129.971 3.308 . . . . 0.0 108.819 177.143 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -141.14 -136.0 3.24 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.278 1.894 . . . . 0.0 110.983 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.5 p 177.52 111.79 0.03 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 125.293 1.437 . . . . 0.0 109.407 -178.524 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 m 89.68 -8.72 0.39 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 128.74 2.816 . . . . 0.0 114.233 178.047 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 t -82.52 3.8 27.01 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.602 0.637 . . . . 0.0 112.225 179.099 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 81.21 141.21 0.07 OUTLIER Pre-proline 0 C--N 1.347 0.462 0 C-N-CA 127.818 2.447 . . . . 0.0 109.734 178.736 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.06 144.11 74.3 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 N-CA-C 117.258 1.984 . . . . 0.0 117.258 2.307 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.78 161.52 34.64 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 127.583 2.353 . . . . 0.0 106.324 178.406 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.2 t -59.13 149.04 29.15 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.631 0.65 . . . . 0.0 111.52 -179.281 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -90.69 143.53 26.65 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.209 1.004 . . . . 0.0 109.325 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -65.15 -49.24 70.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.817 1.647 . . . . 0.0 112.959 -178.861 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 71.22 -168.02 0.15 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.125 1.37 . . . . 0.0 109.851 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 68.5 168.71 0.28 Allowed 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.76 1.624 . . . . 0.0 112.471 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 55.65 50.91 13.42 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -178.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.81 -159.08 34.15 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 108.154 -1.978 . . . . 0.0 108.154 -177.849 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 35.58 96.94 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 127.403 2.281 . . . . 0.0 116.853 179.07 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -158.83 143.03 15.55 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.0 0.92 . . . . 0.0 109.427 178.548 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -102.24 153.53 38.01 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.036 1.335 . . . . 0.0 108.728 -179.306 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -78.17 42.18 1.16 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 124.102 3.201 . . . . 0.0 112.518 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.5 m -149.11 152.59 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 126.683 1.993 . . . . 0.0 107.161 178.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -144.87 113.58 6.75 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.18 -57.02 3.08 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.18 -1.344 . . . . 0.0 112.689 -178.944 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -53.8 149.16 16.64 Favored 'Cis proline' 0 C--N 1.351 0.68 0 CA-C-N 120.586 2.193 . . . . 0.0 113.944 0.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -92.94 156.69 16.76 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.649 1.179 . . . . 0.0 111.286 -178.68 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.78 154.29 45.57 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.373 1.869 . . . . 0.0 115.378 -176.203 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -80.46 150.45 29.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.654 1.982 . . . . 0.0 110.002 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.524 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 65.7 t80 -160.02 99.38 1.46 Allowed Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.609 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -79.38 120.11 4.36 Favored 'Trans proline' 0 N--CA 1.442 -1.531 0 C-N-CA 122.114 1.876 . . . . 0.0 113.768 -176.865 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.561 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.9 tt -85.8 -178.81 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-O 123.845 1.783 . . . . 0.0 108.841 178.718 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.561 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 7.6 mmtt -160.43 139.91 10.92 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 109.788 -3.369 . . . . 0.0 111.466 -178.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.5 p -90.22 63.17 5.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.231 1.412 . . . . 0.0 107.309 178.899 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.87 -51.16 0.04 OUTLIER Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.222 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.18 177.98 35.52 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.27 104.93 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 39.6 p90 47.86 71.31 0.35 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.597 1.959 . . . . 0.0 112.343 -178.576 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.9 p -110.24 138.36 46.73 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.061 1.344 . . . . 0.0 109.273 179.306 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.36 -80.09 1.86 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.2 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.82 111.29 0.09 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.04 0.828 . . . . 0.0 111.615 179.262 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.9 m 64.93 90.66 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.719 1.607 . . . . 0.0 110.723 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.29 165.86 84.69 Favored 'Cis proline' 0 N--CA 1.457 -0.63 0 CA-C-N 119.323 0.794 . . . . 0.0 112.055 4.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.35 -67.48 0.02 OUTLIER Glycine 0 CA--C 1.525 0.716 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.413 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . 80.1 -59.72 0.32 Allowed 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 127.928 2.491 . . . . 0.0 109.478 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -65.52 115.6 5.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.223 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -135.52 159.69 40.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 122.148 0.975 . . . . 0.0 112.481 178.894 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.0 m -130.42 147.64 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 102.326 -3.212 . . . . 0.0 102.326 176.357 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.4 t -127.83 108.85 18.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -177.876 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -98.75 175.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.413 1.085 . . . . 0.0 111.498 -177.227 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -96.42 146.7 24.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.069 1.748 . . . . 0.0 107.108 179.258 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.9 t -61.11 -10.01 5.58 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 117.563 2.431 . . . . 0.0 117.563 -178.129 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -86.32 -76.51 0.34 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 178.414 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.48 -7.89 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 -178.473 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -79.07 169.53 18.05 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 119.339 0.972 . . . . 0.0 111.653 -176.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -113.46 125.81 54.64 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.513 1.925 . . . . 0.0 108.848 179.238 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.62 -62.99 1.35 Allowed 'General case' 0 C--N 1.346 0.431 0 C-N-CA 123.463 0.705 . . . . 0.0 111.241 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.26 170.04 43.09 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.66 153.82 38.86 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 123.931 0.892 . . . . 0.0 113.395 -178.27 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.5 pt -142.7 161.24 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 127.04 2.136 . . . . 0.0 109.392 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.4 t -160.57 142.76 12.74 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -177.95 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.413 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 9.6 m170 -78.35 64.35 3.43 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-N 120.89 1.677 . . . . 0.0 108.679 173.782 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.7 t -95.94 -34.45 11.8 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.227 -0.921 . . . . 0.0 109.652 178.708 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.68 -59.32 0.27 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 178.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 64.82 177.61 0.19 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.152 1.781 . . . . 0.0 113.591 178.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.4 t -150.64 56.98 0.92 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.553 1.541 . . . . 0.0 107.158 179.129 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.47 -77.28 0.23 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 107.503 -2.239 . . . . 0.0 107.503 -178.75 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -144.5 45.91 1.4 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.556 1.143 . . . . 0.0 108.985 178.971 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -114.17 160.59 18.8 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.613 1.165 . . . . 0.0 111.092 -179.059 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -109.49 109.84 20.78 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.743 1.617 . . . . 0.0 107.467 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.2 m -79.41 161.14 4.2 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.332 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.15 143.56 29.76 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 116.439 1.336 . . . . 0.0 116.439 -177.382 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.9 t -121.86 163.62 18.91 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 177.519 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.2 t 61.8 37.01 15.85 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.025 0.93 . . . . 0.0 109.865 -176.077 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.13 33.69 85.17 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.473 1.035 . . . . 0.0 111.892 -178.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.4 m -81.42 137.31 35.68 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.211 1.004 . . . . 0.0 109.387 179.547 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 116.921 -1.514 . . . . 0.0 108.535 179.219 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 CA--C 1.532 0.282 0 CA-C-O 121.336 0.589 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 145.26 109.36 0.0 OUTLIER 'General case' 0 C--O 1.231 0.102 1 C-N-CA 132.274 4.23 . . . . 0.0 103.403 179.765 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -122.57 125.56 45.95 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.594 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.34 99.92 5.84 Favored 'General case' 0 N--CA 1.444 -0.774 1 N-CA-C 100.04 -4.059 . . . . 0.0 100.04 176.355 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -102.94 85.66 2.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.601 1.56 . . . . 0.0 109.23 -177.979 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.21 -77.48 1.36 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.7 p -130.6 -33.63 1.62 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.303 1.441 . . . . 0.0 111.633 179.402 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -74.15 101.9 4.09 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.038 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -92.67 152.37 19.58 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.933 1.293 . . . . 0.0 111.379 -178.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -150.09 137.5 19.75 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.693 1.597 . . . . 0.0 108.677 178.558 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.1 p -71.56 154.0 41.76 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.216 1.407 . . . . 0.0 109.554 179.189 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.33 -22.59 12.51 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.035 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.1 t -72.1 -45.08 62.03 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 124.13 0.972 . . . . 0.0 109.279 179.391 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -69.69 -34.48 74.0 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.816 0.847 . . . . 0.0 113.159 179.524 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 85' ' ' TYR . 33.0 t -64.63 -50.69 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.075 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -60.83 -44.24 97.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.791 1.636 . . . . 0.0 110.67 -178.949 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.03 -52.29 56.79 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.896 0.478 . . . . 0.0 110.439 -179.115 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.38 73.53 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.222 1.009 . . . . 0.0 111.053 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.91 -39.69 42.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.258 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -66.73 -22.3 66.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.491 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.76 -64.19 1.21 Allowed 'General case' 0 C--N 1.348 0.519 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 -178.158 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.3 -34.88 16.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.664 0.786 . . . . 0.0 112.322 177.664 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -59.9 4.68 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.877 1.271 . . . . 0.0 109.547 178.622 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -64.63 -21.08 66.63 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.119 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -94.19 -20.68 19.64 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.602 1.161 . . . . 0.0 112.532 -178.356 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.411 ' CD1' ' HG3' ' A' ' 57' ' ' GLN . 9.7 t80 -74.31 -33.29 63.16 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.309 0.959 . . . . 0.0 112.841 -179.173 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -62.27 -14.68 41.32 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -178.444 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 t30 72.93 69.99 0.13 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.665 1.586 . . . . 0.0 111.025 177.924 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -136.12 58.24 1.75 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 178.359 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.8 t70 74.56 163.17 0.26 Allowed 'General case' 0 C--N 1.345 0.386 0 C-N-CA 126.91 2.084 . . . . 0.0 107.69 -177.588 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.3 p 54.45 56.5 6.78 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.92 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -151.07 158.12 43.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.262 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.37 73.72 0.44 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.698 1.618 . . . . 0.0 112.489 -179.428 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.1 p -72.45 -65.37 0.79 Allowed 'General case' 0 C--N 1.341 0.234 0 CA-C-N 117.876 0.838 . . . . 0.0 109.806 179.257 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.3 m -137.07 -58.16 0.71 Allowed 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 125.235 1.414 . . . . 0.0 107.771 178.853 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.0 t -157.35 40.94 0.31 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.72 1.208 . . . . 0.0 109.671 178.759 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -170.55 124.43 0.62 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 127.539 2.336 . . . . 0.0 106.666 179.355 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.36 140.52 66.73 Favored 'Cis proline' 0 N--CA 1.449 -1.106 0 CA-C-N 121.453 1.555 . . . . 0.0 109.657 -2.753 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -155.47 155.62 33.81 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.972 0.909 . . . . 0.0 109.355 179.602 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.9 p -66.39 152.99 43.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.55 0.74 . . . . 0.0 110.741 179.226 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.44 121.22 6.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.909 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -95.64 177.93 5.63 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.162 0.985 . . . . 0.0 111.223 -178.772 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -78.89 96.05 5.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.497 1.119 . . . . 0.0 109.166 -179.441 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -80.93 -98.23 0.04 OUTLIER 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.379 0.672 . . . . 0.0 110.111 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -158.55 35.7 0.23 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.333 0.653 . . . . 0.0 111.342 -179.369 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.75 -153.7 9.15 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.077 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.99 69.38 6.35 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 123.463 0.705 . . . . 0.0 109.953 178.818 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -75.65 118.63 18.68 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 178.629 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.03 117.74 39.14 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 125.448 1.499 . . . . 0.0 111.048 -177.488 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -78.5 89.55 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.125 2.55 . . . . 0.0 109.834 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 t -135.16 -63.52 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.328 0 C-N-CA 123.871 0.868 . . . . 0.0 110.621 -178.986 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 p30 -148.32 -122.48 0.06 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.35 1.06 . . . . 0.0 110.344 -179.699 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.28 132.55 2.29 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 118.35 -1.25 . . . . 0.0 110.738 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -68.04 -166.25 2.65 Favored 'Cis proline' 0 CA--C 1.538 0.689 0 CA-C-N 120.108 1.954 . . . . 0.0 114.369 -1.105 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -145.45 173.52 11.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.52 1.928 . . . . 0.0 108.255 179.386 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.411 ' HG3' ' CD1' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -148.01 143.05 26.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.059 0.544 . . . . 0.0 110.825 179.31 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -100.31 148.78 24.3 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.941 1.296 . . . . 0.0 111.263 179.34 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -158.39 127.46 3.1 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.568 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -75.54 147.26 31.74 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 CA-C-N 120.522 1.222 . . . . 0.0 112.27 -176.883 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.611 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 3.8 tp -79.4 -161.76 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 123.438 1.59 . . . . 0.0 110.869 -178.455 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.611 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 12.2 tttm -78.62 -163.84 0.51 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 111.321 -2.672 . . . . 0.0 111.64 -178.376 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.2 p 91.48 39.78 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 130.456 3.503 . . . . 0.0 107.277 -177.824 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.07 -54.56 0.24 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 108.386 -1.886 . . . . 0.0 108.386 -178.589 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.25 157.72 10.43 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.222 0.439 . . . . 0.0 112.169 179.123 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.486 HG12 ' CD2' ' A' ' 67' ' ' TYR . 24.1 t -127.26 120.94 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 179.061 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.486 ' CD2' HG12 ' A' ' 66' ' ' VAL 0.29 47.3 p90 58.17 43.36 20.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.581 2.352 . . . . 0.0 112.713 -177.935 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.4 t -148.83 -41.09 0.15 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.348 0.659 . . . . 0.0 111.194 -179.68 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.3 55.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.307 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.94 87.13 1.35 Allowed Glycine 0 C--N 1.339 0.749 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.0 m -59.28 142.55 86.24 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 123.929 0.892 . . . . 0.0 110.394 179.436 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.3 140.28 30.31 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.803 2.335 . . . . 0.0 108.482 176.501 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.64 -61.28 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 105.451 -3.06 . . . . 0.0 105.451 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -168.94 -55.82 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -178.656 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -62.95 109.84 1.59 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 117.959 2.577 . . . . 0.0 117.959 -177.357 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -129.41 153.87 47.49 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.764 0.825 . . . . 0.0 112.056 178.93 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.6 143.31 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 176.429 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 89' ' ' ILE . 83.8 t -137.05 136.24 47.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -175.659 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.3 pt -121.69 -177.71 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.376 0 C-N-CA 124.537 1.135 . . . . 0.0 113.606 -177.545 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -80.93 -175.2 5.25 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.133 2.173 . . . . 0.0 109.375 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.281 8.3 t -85.41 27.68 0.8 Allowed 'General case' 0 C--N 1.342 0.24 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 -178.328 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -150.62 -67.3 0.19 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.109 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.25 -14.61 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -176.956 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -78.91 128.65 33.59 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -175.657 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.489 ' CE2' ' CG1' ' A' ' 16' ' ' VAL . 16.3 t80 -60.11 136.41 58.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.631 1.173 . . . . 0.0 111.093 -179.186 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.24 -61.84 1.5 Allowed 'General case' 0 C--N 1.345 0.397 0 C-N-CA 124.422 1.089 . . . . 0.0 111.972 -178.892 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.14 170.05 42.82 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.115 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.67 145.89 46.98 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 125.039 1.336 . . . . 0.0 110.021 178.947 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.412 HD11 HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -144.28 162.63 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.352 1.061 . . . . 0.0 108.895 179.426 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 t -159.34 143.29 14.96 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -178.919 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -82.11 40.63 0.63 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.733 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -55.49 -31.32 61.92 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.946 -1.096 . . . . 0.0 113.224 -178.554 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.09 -69.61 0.02 OUTLIER Glycine 0 C--N 1.337 0.591 0 N-CA-C 106.614 -2.594 . . . . 0.0 106.614 178.955 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 50.67 -111.48 0.53 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.537 1.535 . . . . 0.0 111.546 178.809 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.1 m -157.13 77.3 0.87 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.456 1.502 . . . . 0.0 107.162 179.307 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.63 -105.34 2.39 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -101.61 22.93 11.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.333 1.053 . . . . 0.0 111.506 -179.351 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -89.86 177.46 6.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.502 0.721 . . . . 0.0 109.979 179.527 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -121.76 158.87 27.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.961 1.705 . . . . 0.0 110.899 -179.137 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.3 m -141.59 158.14 21.48 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.702 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.79 146.98 36.07 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.747 -178.42 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.2 t -89.5 -167.32 1.83 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.587 1.555 . . . . 0.0 107.274 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.8 m -63.66 121.27 13.52 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.749 0.419 . . . . 0.0 110.804 178.886 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.99 9.01 85.88 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.379 0.99 . . . . 0.0 113.917 179.22 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.5 m -91.93 137.57 32.26 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.434 1.117 . . . . 0.0 108.983 179.179 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 t30 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 116.458 -1.734 . . . . 0.0 110.915 179.333 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.56 141.71 0.05 Allowed 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 127.155 2.182 . . . . 0.0 111.163 -179.356 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -129.15 96.06 4.22 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.046 0.938 . . . . 0.0 111.48 -179.504 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -98.97 94.52 6.6 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 101.42 -3.548 . . . . 0.0 101.42 177.693 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 59.7 m -90.98 73.67 6.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.241 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.34 -99.67 1.73 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 -178.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.6 m -101.54 -39.43 7.52 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.29 1.436 . . . . 0.0 109.249 178.97 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.71 105.54 4.34 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.047 1.339 . . . . 0.0 108.555 -179.344 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -111.36 134.37 52.99 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.152 0.981 . . . . 0.0 112.481 -178.578 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.49 149.87 44.61 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.718 1.607 . . . . 0.0 107.186 178.514 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.0 m -72.72 155.24 40.18 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.317 1.047 . . . . 0.0 110.507 -179.018 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.1 -19.3 43.25 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 176.71 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.6 t -72.54 -40.79 66.45 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 124.954 1.302 . . . . 0.0 109.461 178.943 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -70.93 -35.23 72.15 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.029 0.532 . . . . 0.0 111.153 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.1 t -59.6 -48.31 87.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.643 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -65.74 -38.03 88.01 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.203 1.401 . . . . 0.0 111.431 179.51 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 -55.19 15.34 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 118.489 0.586 . . . . 0.0 110.168 -179.285 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.45 -31.3 70.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.073 0.949 . . . . 0.0 110.852 179.451 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.98 -44.78 46.34 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 118.905 -0.569 . . . . 0.0 111.558 179.032 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -60.62 -24.53 65.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.479 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.37 -51.53 10.67 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -178.451 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.81 -32.38 31.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.89 1.276 . . . . 0.0 110.886 177.125 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 64.3 m -70.8 -54.07 13.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.772 0.715 . . . . 0.0 110.536 178.921 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -58.56 -42.28 87.55 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.753 0.421 . . . . 0.0 111.162 -178.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -74.47 -44.2 52.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.485 1.114 . . . . 0.0 110.96 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 27' ' ' TYR . 2.1 t80 -55.23 -36.39 65.96 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.568 1.076 . . . . 0.0 108.789 179.034 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -71.33 -67.23 0.53 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.3 p30 155.51 -6.34 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.904 2.481 . . . . 0.0 113.57 -179.068 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.01 56.02 1.9 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.738 1.153 . . . . 0.0 113.153 -178.469 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 138.36 115.77 0.0 OUTLIER 'General case' 0 C--N 1.344 0.349 1 C-N-CA 131.97 4.108 . . . . 0.0 108.525 178.807 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.3 p -95.95 63.9 2.36 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.687 0.795 . . . . 0.0 109.243 -179.462 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.39 -161.03 0.42 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.848 1.259 . . . . 0.0 110.53 -179.503 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 45.79 -120.47 4.43 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.394 1.949 . . . . 0.0 113.868 178.686 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.1 t -139.68 -92.01 0.17 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.04 0.936 . . . . 0.0 110.874 -179.278 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 m -161.93 -41.71 0.04 OUTLIER 'General case' 0 C--N 1.344 0.337 0 C-N-CA 124.174 0.99 . . . . 0.0 111.102 -178.364 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 64.2 p -79.78 37.33 0.35 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.511 1.124 . . . . 0.0 112.932 -178.703 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 163.4 117.62 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 131.237 3.815 . . . . 0.0 104.453 179.114 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.97 126.23 11.99 Favored 'Cis proline' 0 N--CA 1.447 -1.236 0 N-CA-C 110.273 -0.703 . . . . 0.0 110.273 0.046 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -150.91 147.29 27.02 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 125.342 1.457 . . . . 0.0 110.28 179.425 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.19 139.42 58.66 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.969 1.308 . . . . 0.0 112.082 179.256 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -140.2 158.48 43.98 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 123.362 0.414 . . . . 0.0 111.028 178.083 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -154.01 -179.71 8.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.724 1.21 . . . . 0.0 109.617 -178.895 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.2 m120 73.52 165.96 0.29 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 126.79 2.036 . . . . 0.0 112.476 178.832 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 61.71 72.23 0.52 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.51 1.524 . . . . 0.0 110.775 179.337 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -74.36 162.25 29.05 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.073 0.949 . . . . 0.0 110.897 -179.385 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -178.35 -65.58 0.07 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 179.414 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.6 164.53 11.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.165 1.786 . . . . 0.0 108.74 179.009 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -131.56 124.22 29.57 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.834 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.417 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 58.0 m-85 -89.95 154.49 47.54 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.711 1.204 . . . . 0.0 110.195 -178.799 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -45.8 -60.16 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 124.41 3.406 . . . . 0.0 114.125 179.394 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.1 m -76.81 152.92 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.663 0.785 . . . . 0.0 109.884 179.283 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -81.6 -80.1 0.16 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.756 0.822 . . . . 0.0 110.399 -179.179 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -175.12 171.26 44.43 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 118.853 -0.971 . . . . 0.0 111.147 179.545 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.11 157.95 27.13 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 119.799 1.8 . . . . 0.0 112.847 -1.805 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.637 ' CZ ' HG12 ' A' ' 78' ' ' VAL . 32.4 t80 -150.41 129.38 12.57 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.208 0.603 . . . . 0.0 109.698 -177.082 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -117.68 152.82 34.45 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -176.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -90.53 144.87 25.36 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.763 2.825 . . . . 0.0 111.041 -177.89 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -147.75 109.69 3.82 Favored Pre-proline 0 C--N 1.346 0.447 0 C-N-CA 123.409 0.683 . . . . 0.0 109.157 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -78.14 142.82 19.63 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.189 1.926 . . . . 0.0 115.996 -175.724 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.512 HG12 ' H ' ' A' ' 62' ' ' LYS . 1.2 tt -122.04 -165.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-O 124.177 1.942 . . . . 0.0 111.943 179.206 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.512 ' H ' HG12 ' A' ' 61' ' ' ILE . 79.6 tttt -161.55 -179.73 7.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 109.233 -3.622 . . . . 0.0 109.191 -179.319 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.5 t -87.33 62.03 6.98 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.678 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.19 67.66 0.91 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.126 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.39 101.63 0.16 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.456 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.97 133.68 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.993 0.917 . . . . 0.0 109.174 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 p90 43.8 46.09 6.39 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.152 1.781 . . . . 0.0 113.402 -178.619 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.8 t -150.01 163.74 37.33 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.725 0.81 . . . . 0.0 110.451 -179.499 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.87 155.63 32.14 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -178.986 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -179.7 86.27 0.07 OUTLIER Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -179.322 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 m -148.39 -68.95 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.458 1.103 . . . . 0.0 109.178 179.304 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.06 -45.86 0.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.082 1.854 . . . . 0.0 110.925 173.684 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.47 58.5 12.97 Favored Glycine 0 C--N 1.342 0.892 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.432 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -129.77 -58.57 1.09 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.317 1.047 . . . . 0.0 112.058 -178.381 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -56.91 109.44 0.64 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.184 2.594 . . . . 0.0 117.154 -178.031 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -147.95 122.13 9.55 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -179.427 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.0 m -81.13 160.67 3.92 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.662 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.637 HG12 ' CZ ' ' A' ' 56' ' ' TYR . 45.4 t -141.04 126.87 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 120.789 -1.195 . . . . 0.0 108.688 -178.822 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.2 pt -117.28 173.93 4.06 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 C-N-CA 125.176 1.39 . . . . 0.0 113.233 -177.343 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -79.54 -164.94 0.71 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 124.464 1.106 . . . . 0.0 111.182 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.427 0.6 OUTLIER -96.62 37.89 1.25 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 117.193 2.294 . . . . 0.0 117.193 -178.145 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -160.52 -78.4 0.05 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.694 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.2 t -163.32 63.92 0.18 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 113.619 -1.628 . . . . 0.0 114.125 -177.48 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -147.07 120.17 8.83 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.394 1.452 . . . . 0.0 113.744 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -65.84 122.45 17.35 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 177.732 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 50' ' ' PHE . . . -103.77 -39.37 6.68 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.908 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.69 -172.89 39.47 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.019 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.33 139.0 28.26 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.936 0.894 . . . . 0.0 109.912 179.252 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.0 pt -132.45 166.57 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.728 1.211 . . . . 0.0 110.439 -178.563 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.3 t -160.46 150.06 17.57 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.974 0.91 . . . . 0.0 111.664 179.357 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.432 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 34.0 m170 -79.35 55.26 1.86 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 118.453 0.57 . . . . 0.0 109.73 175.113 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.9 m -80.34 -85.39 0.09 Allowed 'General case' 0 C--N 1.342 0.259 0 O-C-N 120.766 -1.209 . . . . 0.0 109.318 179.459 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.412 ' H ' HG21 ' A' ' 100' ' ' VAL . . . -80.31 7.03 58.55 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.688 1.137 . . . . 0.0 112.006 179.011 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.92 162.87 23.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.17 1.388 . . . . 0.0 111.203 179.234 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.6 t -66.99 -48.8 67.35 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.567 0.747 . . . . 0.0 109.833 179.075 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.29 -51.08 0.2 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.298 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -87.52 -46.03 9.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.23 1.012 . . . . 0.0 110.597 -179.619 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -70.79 -171.23 0.5 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.626 0.77 . . . . 0.0 112.379 -179.109 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -137.07 172.05 13.59 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.014 1.325 . . . . 0.0 113.553 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.412 HG21 ' H ' ' A' ' 93' ' ' GLY . 12.8 m -140.02 161.44 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 127.659 2.384 . . . . 0.0 106.019 176.725 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.4 164.91 38.56 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 116.515 1.366 . . . . 0.0 116.515 -177.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.8 m -113.56 -175.08 2.59 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.76 2.024 . . . . 0.0 107.442 177.78 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.9 p -69.56 110.99 5.08 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.713 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.67 36.1 2.12 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.648 1.594 . . . . 0.0 110.078 -178.73 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.0 m -153.54 100.02 2.38 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.129 1.771 . . . . 0.0 107.129 179.361 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 116.782 -1.58 . . . . 0.0 108.257 -179.298 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 CA--C 1.532 0.28 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.18 149.56 6.9 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.718 1.207 . . . . 0.0 113.181 -178.661 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 t -148.92 156.41 42.25 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.812 0.845 . . . . 0.0 109.31 179.287 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.99 110.95 9.42 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.254 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 93.0 m -90.62 72.97 6.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.46 -93.06 0.89 Allowed Glycine 0 C--N 1.34 0.792 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.0 p -98.99 -36.38 9.75 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.884 1.274 . . . . 0.0 110.612 179.102 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -71.24 97.59 1.58 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.668 0.787 . . . . 0.0 110.116 -178.832 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -82.31 151.6 26.67 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.553 1.141 . . . . 0.0 110.617 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -144.53 129.89 18.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.899 0.88 . . . . 0.0 111.015 179.044 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.2 p -69.67 155.97 39.69 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 125.11 1.364 . . . . 0.0 108.047 177.578 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.63 -22.61 62.1 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 176.498 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.5 t -69.2 -40.85 77.79 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.351 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -68.83 -48.45 63.49 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.095 0.958 . . . . 0.0 112.915 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.2 t -61.25 -46.99 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.195 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -64.42 -39.16 93.3 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.775 0.83 . . . . 0.0 110.719 179.169 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.42 -52.03 56.18 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.63 0.65 . . . . 0.0 110.423 -179.052 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.573 ' HA ' HG13 ' A' ' 66' ' ' VAL . . . -61.14 -34.14 74.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.26 0.624 . . . . 0.0 111.554 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.81 -43.82 24.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -179.368 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -69.98 -14.81 62.88 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.846 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.72 -61.08 1.87 Allowed 'General case' 0 C--N 1.346 0.42 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.3 -36.35 14.01 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.687 1.195 . . . . 0.0 110.752 177.232 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -66.01 -63.47 1.08 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.958 1.303 . . . . 0.0 109.908 178.728 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -56.03 -28.88 59.25 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.537 0.735 . . . . 0.0 111.848 -178.789 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -79.61 -40.89 28.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.061 0.945 . . . . 0.0 111.486 179.148 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.462 ' CD2' ' HG3' ' A' ' 57' ' ' GLN . 23.9 t80 -101.25 23.88 10.3 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.799 0.84 . . . . 0.0 112.425 -178.298 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -86.0 14.6 5.95 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.942 -1.099 . . . . 0.0 112.076 179.176 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.3 m120 60.07 46.17 11.06 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.282 1.433 . . . . 0.0 111.527 178.857 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -154.72 73.03 0.88 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 80.62 110.67 0.07 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 127.617 2.367 . . . . 0.0 107.272 -178.128 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.6 t -87.66 -42.34 12.74 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.306 1.442 . . . . 0.0 113.332 -177.905 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 61.56 -171.46 0.15 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.628 1.171 . . . . 0.0 110.811 -178.733 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.35 167.07 39.3 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 121.96 -0.463 . . . . 0.0 112.326 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.9 t -148.99 -60.32 0.22 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.399 1.48 . . . . 0.0 107.685 179.256 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.4 p -124.55 -79.87 0.62 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.481 1.113 . . . . 0.0 108.125 178.767 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.488 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -160.39 41.65 0.18 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.233 1.013 . . . . 0.0 109.74 -179.0 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.488 ' CD1' ' C ' ' A' ' 37' ' ' THR . 43.0 m-85 -151.0 147.58 21.0 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 126.053 1.741 . . . . 0.0 107.993 -178.822 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.88 125.39 11.79 Favored 'Cis proline' 0 CA--C 1.539 0.75 0 CA-C-N 119.083 0.708 . . . . 0.0 111.726 0.219 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -119.14 165.61 13.96 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 125.994 1.717 . . . . 0.0 111.066 -179.269 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.8 p -67.8 145.83 54.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.443 0.697 . . . . 0.0 110.935 178.697 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -87.03 50.67 2.06 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.309 178.899 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -58.71 120.58 9.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.935 1.694 . . . . 0.0 108.052 179.751 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.7 m120 78.43 129.06 0.05 OUTLIER 'General case' 0 C--N 1.341 0.216 0 C-N-CA 126.42 1.888 . . . . 0.0 107.516 -178.223 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -82.41 20.43 1.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.346 -0.835 . . . . 0.0 112.691 -179.036 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 33.04 -99.13 0.02 OUTLIER 'General case' 0 C--N 1.347 0.485 0 C-N-CA 127.156 2.183 . . . . 0.0 112.025 179.437 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.45 23.16 2.84 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.572 1.082 . . . . 0.0 110.49 178.336 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.66 149.55 25.37 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 118.188 0.994 . . . . 0.0 111.271 -179.301 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -153.03 179.9 8.28 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.628 0.771 . . . . 0.0 111.701 -178.886 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -139.94 165.19 32.62 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 127.425 2.29 . . . . 0.0 106.552 -179.262 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.3 -51.86 10.14 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.435 2.756 . . . . 0.0 111.843 178.734 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 52' ' ' VAL . 3.7 m -82.24 151.17 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.803 1.241 . . . . 0.0 109.338 178.842 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -172.36 127.22 0.54 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.742 0.817 . . . . 0.0 112.613 -178.904 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.99 114.84 0.02 OUTLIER Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.008 1.766 . . . . 0.0 115.798 177.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -62.8 149.72 64.31 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.084 1.942 . . . . 0.0 109.85 -2.793 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.13 150.18 28.82 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.538 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.542 ' O ' HG13 ' A' ' 78' ' ' VAL . 63.0 mm-40 -133.4 157.82 44.57 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -178.115 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -112.01 151.04 29.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.715 2.406 . . . . 0.0 109.741 179.147 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -160.54 112.14 1.35 Allowed Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 177.618 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.434 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 24.3 Cg_endo -81.06 135.72 9.95 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.063 1.175 . . . . 0.0 111.08 -176.924 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.549 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.2 tt -109.32 178.13 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-O 124.22 1.962 . . . . 0.0 113.119 -179.419 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.549 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 19.9 ptmt -161.59 151.9 17.38 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 108.486 -3.961 . . . . 0.0 111.255 178.411 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.6 p -86.22 59.05 5.4 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.501 1.12 . . . . 0.0 108.656 179.462 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.92 71.82 0.06 OUTLIER Glycine 0 C--N 1.338 0.644 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.123 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.48 -178.83 47.64 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 123.942 0.782 . . . . 0.0 112.184 178.926 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.573 HG13 ' HA ' ' A' ' 19' ' ' ALA . 67.5 t -86.71 62.48 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.622 1.169 . . . . 0.0 109.924 -179.024 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 62.35 158.97 0.06 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.053 1.341 . . . . 0.0 114.287 178.646 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.9 p -138.53 -62.09 0.57 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.378 1.471 . . . . 0.0 108.435 178.639 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.38 -137.6 3.53 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.121 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.38 168.72 44.57 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.056 0.836 . . . . 0.0 113.145 178.99 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 m -74.11 174.5 4.89 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 125.815 1.646 . . . . 0.0 110.177 179.385 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -58.31 170.43 2.35 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.541 2.828 . . . . 0.0 112.804 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 74' ' ' ALA . . . -152.62 -69.54 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 103.953 -3.659 . . . . 0.0 103.953 -179.331 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . 170.75 -50.03 0.01 OUTLIER 'General case' 0 C--N 1.346 0.434 0 O-C-N 124.981 1.048 . . . . 0.0 113.296 -179.294 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -74.44 113.63 11.9 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 119.842 3.275 . . . . 0.0 119.842 -176.832 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 ptt180 -143.02 133.05 24.26 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.009 0.924 . . . . 0.0 110.552 177.772 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -90.48 147.04 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 178.308 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 57' ' ' GLN 0.254 78.0 t -133.61 123.83 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -176.791 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pt -105.75 -175.48 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.586 0 C-N-CA 126.455 1.902 . . . . 0.0 114.973 -177.096 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -112.82 145.21 41.02 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 128.903 2.881 . . . . 0.0 105.084 177.39 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.277 1.4 t -59.67 -16.84 29.34 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 120.783 3.623 . . . . 0.0 120.783 -177.072 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -79.61 -77.5 0.18 Allowed 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 103.625 -2.732 . . . . 0.0 103.625 178.755 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.53 -3.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.678 1.591 . . . . 0.0 114.598 -178.883 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.11 156.36 28.33 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 119.049 0.84 . . . . 0.0 111.151 -176.901 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -109.26 133.57 52.87 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.124 0.97 . . . . 0.0 110.709 -179.213 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.48 -64.84 1.08 Allowed 'General case' 0 C--N 1.342 0.268 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.042 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.25 168.4 37.0 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.183 -179.436 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.54 127.4 46.92 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.377 1.471 . . . . 0.0 109.638 -179.305 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 35.0 pt -120.52 154.61 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.656 1.182 . . . . 0.0 108.024 179.363 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.1 t -158.73 135.53 9.6 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -178.373 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.401 ' N ' ' HB1' ' A' ' 74' ' ' ALA . 4.0 p80 -105.9 52.88 0.72 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.018 0.372 . . . . 0.0 110.685 174.851 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.7 t -60.12 -48.01 83.51 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.134 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.01 42.65 0.2 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.91 -40.23 11.27 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.533 1.133 . . . . 0.0 109.673 179.094 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.9 t -152.64 -51.8 0.11 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.193 1.397 . . . . 0.0 109.834 -179.512 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.82 -37.48 1.02 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -178.99 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -126.0 -40.9 1.98 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.753 1.621 . . . . 0.0 110.031 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -64.45 124.01 20.7 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.053 0.541 . . . . 0.0 109.553 179.457 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -79.48 162.43 25.45 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.026 1.73 . . . . 0.0 112.06 -178.594 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.2 m -137.41 164.2 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 127.922 2.489 . . . . 0.0 105.979 176.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.74 137.88 15.19 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 123.134 0.397 . . . . 0.0 112.948 -177.751 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.4 m -81.58 -171.18 3.17 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.33 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.0 p -72.21 123.02 22.06 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.692 -0.63 . . . . 0.0 111.271 -177.948 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.77 38.15 28.22 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -178.964 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -148.75 127.78 12.76 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.054 1.342 . . . . 0.0 108.395 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.3 t30 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 116.524 -1.703 . . . . 0.0 109.041 179.336 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 CA--C 1.53 0.177 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.15 160.03 31.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.509 0.724 . . . . 0.0 110.645 -179.793 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 t -152.21 139.51 19.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.497 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.08 103.96 11.08 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 179.204 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.5 m -90.3 82.14 6.0 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.453 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.25 -111.0 3.47 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.165 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.4 t -88.31 -43.24 11.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.129 0.972 . . . . 0.0 109.64 178.953 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 m -69.98 106.29 3.15 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.463 1.105 . . . . 0.0 109.741 -179.294 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -86.38 157.99 19.73 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.089 0.956 . . . . 0.0 111.979 -179.178 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -144.3 136.8 26.71 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.624 1.17 . . . . 0.0 110.582 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.5 t -79.91 154.27 28.43 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 125.215 1.406 . . . . 0.0 109.78 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.25 -18.93 64.09 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 176.852 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.6 m -78.78 -38.84 37.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.014 0.925 . . . . 0.0 108.731 178.972 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -71.48 -48.57 48.3 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.613 1.565 . . . . 0.0 110.811 -179.201 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.4 t -58.96 -46.71 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.948 1.699 . . . . 0.0 107.571 177.432 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -64.89 -39.49 93.61 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 124.204 1.002 . . . . 0.0 111.412 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.26 -52.42 62.13 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.061 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.29 74.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.73 1.212 . . . . 0.0 110.921 179.564 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.22 -51.82 16.32 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.226 -179.205 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -60.68 -18.08 51.71 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.859 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.87 -64.71 1.12 Allowed 'General case' 0 C--N 1.347 0.5 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -178.781 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.478 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -43.93 -48.91 8.59 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.638 1.575 . . . . 0.0 110.495 177.494 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -55.51 -49.77 71.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 128.251 2.62 . . . . 0.0 111.268 178.96 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -68.11 -22.11 64.91 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.238 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -108.52 -19.47 13.43 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -179.117 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -71.87 -40.37 69.0 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -177.539 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -115.7 -28.18 6.83 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.04 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -67.57 -59.04 3.67 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.73 0.695 . . . . 0.0 110.228 -178.99 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 168.87 115.5 0.01 OUTLIER 'General case' 0 C--N 1.341 0.208 0 C-N-CA 128.192 2.597 . . . . 0.0 106.238 -178.892 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -54.85 127.25 27.7 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.341 1.057 . . . . 0.0 110.191 178.634 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.0 t -134.2 -51.4 0.82 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.684 0.794 . . . . 0.0 112.657 -178.836 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.56 172.82 8.91 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.917 0.487 . . . . 0.0 110.659 -179.426 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.87 82.27 0.52 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 107.908 -2.077 . . . . 0.0 107.908 179.056 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 p -168.14 101.35 0.45 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -176.973 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.5 p -128.63 -50.88 1.26 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.903 0.881 . . . . 0.0 109.678 -178.454 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 p -79.5 -6.34 56.75 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.572 0.749 . . . . 0.0 109.183 178.337 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -157.5 121.84 2.27 Favored Pre-proline 0 C--N 1.343 0.319 0 C-N-CA 128.147 2.579 . . . . 0.0 104.375 177.791 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.22 147.66 49.28 Favored 'Cis proline' 0 N--CA 1.453 -0.886 0 N-CA-C 117.468 2.065 . . . . 0.0 117.468 -0.091 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.98 136.7 37.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 128.162 2.585 . . . . 0.0 105.386 178.691 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.7 m -56.63 127.87 33.55 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.753 1.221 . . . . 0.0 110.067 179.078 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -79.85 78.24 6.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.561 1.144 . . . . 0.0 110.242 -178.911 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -80.66 -17.69 50.39 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.19 0.996 . . . . 0.0 112.535 179.46 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -79.33 149.89 31.61 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.683 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -168.43 89.68 0.25 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.681 1.992 . . . . 0.0 107.468 178.429 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -150.37 55.26 0.92 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.168 0.987 . . . . 0.0 108.689 179.818 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.07 -64.88 0.58 Allowed Glycine 0 C--N 1.338 0.651 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -179.178 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -99.92 132.92 44.98 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.401 1.08 . . . . 0.0 110.767 179.312 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -178.7 154.3 0.74 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 126.438 1.895 . . . . 0.0 109.428 178.877 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -123.26 105.37 34.05 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.503 1.121 . . . . 0.0 109.738 -178.087 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.23 84.83 1.93 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.519 2.812 . . . . 0.0 110.49 179.169 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.49 -72.64 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.226 0 C-N-CA 124.476 1.11 . . . . 0.0 110.908 179.191 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -133.71 -90.01 0.38 Allowed 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.516 0.598 . . . . 0.0 111.562 -179.114 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.81 131.97 4.28 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -178.515 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -71.98 -177.89 18.8 Favored 'Cis proline' 0 N--CA 1.456 -0.7 0 CA-C-N 119.686 1.743 . . . . 0.0 111.699 1.238 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.05 173.25 11.66 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.182 1.793 . . . . 0.0 106.231 179.184 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.4 146.32 22.43 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -178.666 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -81.25 156.14 25.75 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 126.575 1.95 . . . . 0.0 112.397 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.478 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 14.5 t80 -160.87 102.1 1.29 Allowed Pre-proline 0 N--CA 1.452 -0.333 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.441 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -77.82 115.2 3.78 Favored 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 122.674 2.25 . . . . 0.0 111.802 -177.572 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.44 HG13 ' H ' ' A' ' 62' ' ' LYS . 6.4 tt -89.64 173.76 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-O 123.767 1.746 . . . . 0.0 111.747 -179.095 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.44 ' H ' HG13 ' A' ' 61' ' ' ILE . 63.2 pttt -160.45 151.86 19.44 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 109.849 -3.341 . . . . 0.0 112.213 179.114 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 t -88.68 58.95 4.88 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.932 1.293 . . . . 0.0 110.126 -179.348 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 169.05 34.37 0.02 OUTLIER Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.177 -0.791 . . . . 0.0 112.858 179.182 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.97 176.63 17.2 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 118.014 0.907 . . . . 0.0 112.807 179.111 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.6 t -95.35 144.9 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.345 1.858 . . . . 0.0 107.932 179.333 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.6 p90 56.92 -172.95 0.08 Allowed 'General case' 0 C--N 1.345 0.401 0 C-N-CA 126.76 2.024 . . . . 0.0 113.118 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.8 t -137.34 166.79 22.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.707 1.203 . . . . 0.0 110.696 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.89 133.71 8.93 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.048 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.2 -64.52 4.18 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.36 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.5 p -164.6 168.26 9.19 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.618 1.167 . . . . 0.0 109.489 -179.18 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -58.57 -170.52 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.131 3.221 . . . . 0.0 112.521 167.251 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.0 -55.37 0.07 OUTLIER Glycine 0 C--N 1.341 0.856 0 N-CA-C 105.276 -3.129 . . . . 0.0 105.276 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.447 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -165.03 -63.52 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.637 0.775 . . . . 0.0 110.472 179.348 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -70.72 126.01 28.42 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.038 1.735 . . . . 0.0 113.961 -178.593 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -145.28 126.35 14.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.18 0.992 . . . . 0.0 111.747 -179.714 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.9 m -91.69 147.69 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 176.672 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.3 t -136.08 115.9 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -177.674 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.5 pt -89.92 -178.89 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.652 0 C-N-CA 124.506 1.123 . . . . 0.0 112.892 -178.497 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -124.49 58.34 1.22 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 124.678 2.18 . . . . 0.0 112.549 -177.805 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.258 5.9 t 46.58 -21.31 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.245 1 C-N-CA 134.571 5.148 . . . . 0.0 121.707 177.499 . . . . . . . . 3 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -79.47 -74.16 0.31 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 178.786 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.47 -13.74 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.627 1.971 . . . . 0.0 114.078 -179.207 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -79.47 125.53 29.67 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.777 1.231 . . . . 0.0 113.795 -176.385 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -68.46 115.9 8.39 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.643 2.377 . . . . 0.0 109.453 178.932 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.26 -60.68 2.23 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 124.741 1.216 . . . . 0.0 111.239 -178.682 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.57 156.77 28.93 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.375 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.99 137.27 52.26 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.1 0.96 . . . . 0.0 109.273 -179.252 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.3 pt -125.43 156.77 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.3 1.44 . . . . 0.0 107.824 -179.455 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -158.85 150.05 20.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.752 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 33.2 m170 -79.03 -21.57 46.69 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 123.423 0.452 . . . . 0.0 111.251 176.093 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.3 m -59.65 109.03 0.82 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.032 1.333 . . . . 0.0 109.91 179.287 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.78 -29.49 8.9 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.762 1.172 . . . . 0.0 111.329 -179.236 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.4 -176.45 2.69 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.667 1.187 . . . . 0.0 111.95 -179.294 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -83.65 54.98 3.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.686 1.194 . . . . 0.0 111.614 -179.416 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.69 -74.47 1.55 Allowed Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.606 1.098 . . . . 0.0 113.055 178.634 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -80.05 -44.77 19.51 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.863 1.265 . . . . 0.0 111.03 -179.313 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -51.52 166.58 0.12 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.835 1.654 . . . . 0.0 113.459 -178.652 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -121.3 156.65 32.08 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.339 1.456 . . . . 0.0 112.308 -178.728 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.5 m -144.56 164.67 13.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 126.844 2.058 . . . . 0.0 107.139 177.671 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.75 138.76 14.54 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 123.679 0.657 . . . . 0.0 112.082 -178.261 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 34.0 m -82.24 -171.39 3.4 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.498 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.1 t -75.83 123.08 25.06 Favored 'General case' 0 C--N 1.341 0.197 0 O-C-N 121.833 -0.542 . . . . 0.0 109.611 -179.026 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.62 52.15 3.25 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -178.755 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.8 m -147.41 121.39 9.4 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.614 1.566 . . . . 0.0 106.833 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.7 t30 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 125.307 1.443 . . . . 0.0 110.685 -179.247 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.81 148.17 25.99 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.228 1.011 . . . . 0.0 109.857 179.188 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 t -150.18 156.27 41.29 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.793 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.66 128.5 42.72 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.249 1.82 . . . . 0.0 106.186 178.754 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -116.72 90.08 3.25 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.46 -86.4 1.03 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -178.969 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.1 m -127.77 -16.05 4.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.642 1.577 . . . . 0.0 111.364 178.759 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -81.55 98.55 8.36 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.182 0.993 . . . . 0.0 109.627 -179.164 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -80.08 155.8 27.37 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.112 0.965 . . . . 0.0 110.685 179.449 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -147.06 141.45 26.37 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.924 1.29 . . . . 0.0 110.782 179.294 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 p -78.21 148.38 34.02 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 177.815 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.61 -23.37 16.75 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.182 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.0 t -67.63 -44.52 77.77 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.54 0.736 . . . . 0.0 109.603 179.451 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -69.6 -41.03 76.27 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -178.925 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.431 HG23 ' H ' ' A' ' 16' ' ' VAL . 2.2 t -61.75 -54.59 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -179.449 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.8 mtp85 -66.78 -34.92 78.88 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.795 1.238 . . . . 0.0 112.225 -178.953 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.79 -44.34 86.03 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 118.768 0.713 . . . . 0.0 109.737 179.366 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.19 80.48 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.08 0.552 . . . . 0.0 110.155 178.927 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.26 -40.46 62.33 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 119.109 -0.472 . . . . 0.0 112.252 178.86 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -66.01 -21.05 66.37 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.653 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.39 1.68 Allowed 'General case' 0 C--N 1.344 0.363 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.908 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -46.4 -44.22 16.97 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 124.376 1.047 . . . . 0.0 110.83 176.884 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.7 t -55.02 -51.17 67.1 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.045 1.738 . . . . 0.0 111.361 179.243 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -63.99 -48.41 76.49 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.629 0.65 . . . . 0.0 112.012 -178.848 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -68.84 -32.58 72.37 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -63.75 -39.05 93.33 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.443 0.565 . . . . 0.0 111.626 -178.061 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.82 -49.18 4.44 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -178.992 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -75.46 -45.58 37.69 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -176.444 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -158.36 94.05 1.26 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.593 0.633 . . . . 0.0 110.609 -178.014 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.37 104.95 2.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.43 179.352 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.257 5.0 t 165.0 83.26 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.691 2.796 . . . . 0.0 110.812 -179.218 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -177.69 103.6 0.05 OUTLIER 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.493 1.517 . . . . 0.0 107.423 179.12 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 153.19 -179.24 29.75 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.1 m -50.41 -52.04 41.15 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.954 1.301 . . . . 0.0 112.117 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.3 t -165.22 -61.56 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.856 0.862 . . . . 0.0 108.742 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -126.94 75.97 1.61 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.024 1.33 . . . . 0.0 108.309 -179.514 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 86.3 m-85 -157.68 111.15 1.81 Allowed Pre-proline 0 C--O 1.23 0.053 0 N-CA-C 102.524 -3.139 . . . . 0.0 102.524 179.073 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.98 142.18 63.64 Favored 'Cis proline' 0 CA--C 1.536 0.611 0 N-CA-C 116.37 1.642 . . . . 0.0 116.37 2.867 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -157.77 152.92 25.73 Favored 'General case' 0 C--N 1.345 0.37 0 C-N-CA 127.238 2.215 . . . . 0.0 109.895 178.238 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 p -41.73 138.89 1.32 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 126.307 1.843 . . . . 0.0 114.233 -178.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -138.97 59.04 1.63 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.332 1.453 . . . . 0.0 108.399 179.308 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -154.62 2.02 0.21 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.919 0.888 . . . . 0.0 112.882 -179.158 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -63.99 -52.43 59.67 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.543 0.737 . . . . 0.0 110.188 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -109.83 127.55 54.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.041 1.337 . . . . 0.0 108.317 178.871 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -85.89 164.34 17.53 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.834 0.854 . . . . 0.0 109.704 179.408 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.38 -77.88 0.36 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 107.052 -2.419 . . . . 0.0 107.052 -179.231 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.99 89.46 8.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.751 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -147.39 143.08 27.7 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.482 1.513 . . . . 0.0 108.26 179.501 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -95.44 154.16 39.4 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 125.073 1.349 . . . . 0.0 109.989 -178.63 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.83 81.81 2.09 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.37 3.38 . . . . 0.0 111.425 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.4 169.7 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 125.927 1.691 . . . . 0.0 108.559 179.459 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -92.34 121.17 33.57 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.966 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.42 -177.45 51.91 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.651 0.643 . . . . 0.0 112.961 -179.041 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.99 161.35 87.03 Favored 'Cis proline' 0 CA--C 1.534 0.502 0 CA-C-N 117.536 0.668 . . . . 0.0 113.789 0.139 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.47 153.86 50.93 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 126.332 1.853 . . . . 0.0 106.746 178.788 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.74 153.35 47.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 123.703 0.627 . . . . 0.0 111.536 -178.754 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -84.48 163.81 19.2 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.125 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -160.4 110.1 1.36 Allowed Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 178.396 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 23.0 Cg_endo -80.35 125.95 5.96 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.906 1.737 . . . . 0.0 114.989 -175.831 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.425 HG13 ' H ' ' A' ' 62' ' ' LYS . 9.3 tt -87.79 159.1 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-O 124.45 2.071 . . . . 0.0 112.668 179.014 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.425 ' H ' HG13 ' A' ' 61' ' ' ILE . 3.1 mptp? -135.62 135.88 40.56 Favored 'General case' 0 C--N 1.316 -0.868 1 CA-C-N 107.974 -4.194 . . . . 0.0 109.486 -177.991 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t -87.52 59.82 5.68 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.094 1.358 . . . . 0.0 109.993 -179.179 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.36 50.41 0.03 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.251 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.0 153.32 26.32 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.621 1.105 . . . . 0.0 110.378 -179.173 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.5 p -74.3 115.47 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.276 1.03 . . . . 0.0 110.868 -179.104 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.0 t80 53.15 76.95 0.18 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 125.535 1.534 . . . . 0.0 110.677 -179.26 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.0 p -138.73 64.02 1.5 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.468 1.107 . . . . 0.0 110.515 -178.937 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.11 -86.91 0.89 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.96 0.79 . . . . 0.0 111.97 178.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.83 -93.58 0.4 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.458 1.028 . . . . 0.0 110.613 -179.072 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.8 t 74.48 133.1 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 127.066 2.146 . . . . 0.0 111.593 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -67.72 -51.71 0.16 OUTLIER 'Cis proline' 0 C--N 1.348 0.532 0 CA-C-N 119.731 0.94 . . . . 0.0 112.042 -5.198 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.96 61.27 0.19 Allowed Glycine 0 C--N 1.341 0.856 0 C-N-CA 124.517 1.056 . . . . 0.0 111.594 179.379 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -79.06 -41.86 27.79 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.559 0.743 . . . . 0.0 109.05 178.441 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -70.3 111.49 5.93 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.085 1.754 . . . . 0.0 112.426 -178.776 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.05 128.88 46.99 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.959 0.903 . . . . 0.0 113.048 -178.662 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.0 m -100.34 148.36 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 102.595 -3.113 . . . . 0.0 102.595 176.04 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.5 t -140.13 135.96 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 O-C-N 121.873 -0.517 . . . . 0.0 109.651 -176.83 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.5 pt -126.46 165.55 24.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.308 0 C-N-CA 124.107 0.963 . . . . 0.0 111.865 -178.683 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -81.35 165.97 20.88 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 127.268 2.227 . . . . 0.0 108.186 178.924 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.356 12.2 t -64.77 -19.71 65.96 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 118.634 2.827 . . . . 0.0 118.634 -178.128 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -79.59 -85.54 0.08 Allowed 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 101.067 -3.679 . . . . 0.0 101.067 176.924 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 98.3 m -164.57 8.14 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 130.438 3.495 . . . . 0.0 112.832 -178.703 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -78.86 134.65 36.92 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 120.171 1.351 . . . . 0.0 111.798 -176.261 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.422 ' CE2' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -70.84 120.18 16.05 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.873 0.469 . . . . 0.0 110.09 -178.952 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.64 -48.95 7.86 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.178 0.991 . . . . 0.0 110.175 -179.082 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.12 -179.48 46.36 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-O 121.16 0.311 . . . . 0.0 112.686 179.031 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.0 135.24 45.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.842 2.057 . . . . 0.0 107.771 179.84 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.4 pt -146.61 171.67 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.785 1.234 . . . . 0.0 110.553 -178.392 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.5 t -160.06 151.77 20.03 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 179.349 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.445 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 9.0 m170 -79.28 -13.12 59.86 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 175.188 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.4 m -60.92 109.17 0.99 Allowed 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.003 1.321 . . . . 0.0 110.295 -179.333 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.5 59.46 5.27 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.407 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.52 -124.65 0.22 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.709 1.204 . . . . 0.0 108.558 179.467 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.5 m -149.16 73.17 1.19 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.793 1.237 . . . . 0.0 107.95 179.285 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.72 -104.86 1.61 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 179.587 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -79.8 -22.72 42.75 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.114 0.966 . . . . 0.0 111.18 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -56.16 159.07 3.62 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.577 1.151 . . . . 0.0 111.35 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -114.74 163.51 15.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.96 1.704 . . . . 0.0 111.854 -178.777 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.4 m -141.07 160.85 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 C-N-CA 126.228 1.811 . . . . 0.0 107.092 176.992 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.02 141.2 20.65 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 123.838 0.732 . . . . 0.0 114.158 -178.092 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -83.35 179.73 7.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 177.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.9 m -70.31 131.04 43.54 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.205 -0.935 . . . . 0.0 110.598 179.566 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.17 15.72 80.98 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.032 0.825 . . . . 0.0 113.712 179.322 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.3 m -80.01 131.71 35.85 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.323 1.061 . . . . 0.0 108.695 179.306 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 p30 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.816 -1.088 . . . . 0.0 110.558 -179.309 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.31 154.35 0.13 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 126.831 2.052 . . . . 0.0 112.52 179.015 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.4 t -152.81 123.43 7.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.573 179.066 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -96.79 109.74 22.36 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 178.901 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.8 m -87.7 63.21 7.41 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.468 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.55 -91.54 0.4 Allowed Glycine 0 C--N 1.342 0.886 0 C-N-CA 126.03 1.776 . . . . 0.0 109.08 -178.761 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.3 p -92.82 -47.98 6.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.396 1.079 . . . . 0.0 109.817 179.13 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.2 m -66.83 100.01 0.67 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.488 1.515 . . . . 0.0 108.168 179.388 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -88.4 148.2 24.35 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.12 0.568 . . . . 0.0 111.978 -178.783 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -136.44 135.74 38.93 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 123.996 0.918 . . . . 0.0 111.249 178.606 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.7 m -82.46 150.34 27.1 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 126.571 1.948 . . . . 0.0 108.647 178.62 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.61 -21.86 29.95 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.137 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 84.2 p -72.96 -46.71 50.82 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.565 0.746 . . . . 0.0 109.529 179.455 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -69.08 -38.72 79.17 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.761 1.224 . . . . 0.0 111.418 -179.307 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.3 t -57.98 -53.19 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.836 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -33.37 75.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.67 1.588 . . . . 0.0 112.032 -179.336 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.11 -57.63 8.11 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.018 0.527 . . . . 0.0 109.725 -178.678 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.84 -26.75 67.8 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 123.538 0.523 . . . . 0.0 110.953 -179.295 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.01 -54.03 12.67 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.867 0.758 . . . . 0.0 111.035 179.248 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -61.2 -19.91 62.16 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.191 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.73 -67.95 0.62 Allowed 'General case' 0 C--N 1.349 0.574 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 -178.085 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.48 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -39.54 -46.07 1.68 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.625 1.17 . . . . 0.0 112.19 176.532 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 74.4 m -55.28 -68.49 0.19 Allowed 'General case' 0 C--N 1.346 0.417 0 C-N-CA 123.379 0.672 . . . . 0.0 110.342 179.366 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -53.81 -31.09 47.79 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.833 1.253 . . . . 0.0 112.928 -176.934 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -79.49 -48.0 14.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -179.066 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.37 0.1 OUTLIER -91.85 -2.58 56.79 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 119.381 3.104 . . . . 0.0 119.381 -176.539 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -57.04 -52.48 65.12 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.011 1.278 . . . . 0.0 109.382 178.975 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 152.03 66.14 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 130.438 3.495 . . . . 0.0 105.561 179.553 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -165.32 98.38 0.71 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.551 1.14 . . . . 0.0 107.984 -178.915 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.266 4.4 p30 52.27 -165.92 0.06 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.236 1.815 . . . . 0.0 111.982 -179.203 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.1 t -152.57 -49.12 0.1 Allowed 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.646 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 55.82 84.07 0.08 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 125.063 1.345 . . . . 0.0 109.396 -178.238 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.23 162.48 6.03 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.24 1.4 . . . . 0.0 111.849 -178.856 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.1 p -176.98 102.84 0.05 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.979 1.311 . . . . 0.0 108.915 -179.231 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.8 m -68.64 -67.46 0.47 Allowed 'General case' 0 C--N 1.34 0.167 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.895 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.6 p -147.45 18.91 1.19 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.468 1.907 . . . . 0.0 108.502 178.008 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -144.34 154.95 57.73 Favored Pre-proline 0 C--N 1.348 0.528 0 C-N-CA 129.798 3.239 . . . . 0.0 105.95 -178.297 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -80.38 111.41 2.24 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 CA-C-N 120.932 1.369 . . . . 0.0 113.58 3.855 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -122.27 158.86 28.58 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.426 1.491 . . . . 0.0 108.441 179.114 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -63.26 154.84 30.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.701 1.6 . . . . 0.0 108.617 178.755 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -77.97 119.78 21.9 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.296 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.27 145.91 10.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.937 2.095 . . . . 0.0 114.2 -178.152 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -73.44 148.17 43.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.381 1.472 . . . . 0.0 110.1 179.495 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.7 t80 74.22 146.15 0.08 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.764 2.025 . . . . 0.0 110.972 179.411 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 58.35 53.0 6.7 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.568 1.147 . . . . 0.0 108.933 -178.599 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.23 106.84 2.03 Favored Glycine 0 C--N 1.339 0.729 0 C-N-CA 124.751 1.167 . . . . 0.0 112.324 -178.698 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -73.31 106.99 5.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 178.494 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -53.88 120.99 7.05 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.069 1.347 . . . . 0.0 113.109 -178.4 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -132.75 151.96 79.03 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.351 1.861 . . . . 0.0 108.217 179.081 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.57 166.98 28.3 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.505 2.803 . . . . 0.0 112.464 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.273 22.9 m 55.03 171.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 129.03 2.932 . . . . 0.0 115.445 179.321 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -81.2 153.59 27.11 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.971 1.308 . . . . 0.0 111.999 -178.847 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.77 -147.73 23.1 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.527 1.537 . . . . 0.0 110.251 179.202 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.39 133.21 17.27 Favored 'Cis proline' 0 N--CA 1.458 -0.605 0 CA-C-N 118.847 1.324 . . . . 0.0 110.031 -1.782 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -108.62 140.53 41.87 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.935 0.894 . . . . 0.0 111.847 179.343 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -122.91 159.17 28.79 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.051 1.741 . . . . 0.0 109.613 -179.027 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -87.7 159.59 18.44 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.561 1.544 . . . . 0.0 111.928 -178.553 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.48 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 18.4 t80 -160.41 109.74 1.36 Allowed Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.267 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -79.11 129.65 8.93 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 121.88 1.72 . . . . 0.0 111.151 -177.178 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.549 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.2 tt -87.71 -176.83 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-O 123.796 1.76 . . . . 0.0 110.237 179.096 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.549 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -152.52 141.24 20.94 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 110.07 -3.241 . . . . 0.0 111.623 -179.095 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 t -81.41 57.73 3.38 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.948 1.699 . . . . 0.0 109.942 179.647 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.21 45.54 0.08 OUTLIER Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.282 1.42 . . . . 0.0 112.008 179.059 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.76 176.36 26.08 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 117.884 0.842 . . . . 0.0 112.782 179.052 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 t -132.15 139.06 51.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.322 1.449 . . . . 0.0 108.278 178.961 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.263 26.4 p90 46.42 52.51 10.68 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.351 2.261 . . . . 0.0 114.487 179.473 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.9 p -80.49 -44.34 19.34 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.837 -0.539 . . . . 0.0 110.184 179.06 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.2 56.77 1.44 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.09 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -117.33 73.44 0.28 Allowed Glycine 0 C--N 1.34 0.793 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.485 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 92.0 p -71.17 152.16 94.6 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 124.082 0.953 . . . . 0.0 110.717 -179.938 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.98 -43.17 0.69 Allowed 'Cis proline' 0 N--CA 1.457 -0.672 0 CA-C-N 119.196 0.748 . . . . 0.0 110.904 -4.129 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.87 -54.61 3.7 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 179.187 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . 64.3 43.97 4.52 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.632 1.173 . . . . 0.0 110.312 -178.678 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.83 101.19 1.29 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.641 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.28 148.56 50.82 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.251 0.621 . . . . 0.0 111.398 -179.032 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.1 m -111.26 144.32 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 176.909 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.17 121.83 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 -177.673 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.478 HG22 ' HA ' ' A' ' 85' ' ' TYR . 3.2 pt -127.12 167.84 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.615 -176.517 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -94.31 166.99 11.82 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 123.996 0.918 . . . . 0.0 110.809 -179.641 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.432 1.9 t -73.29 8.51 1.67 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 121.396 3.851 . . . . 0.0 121.396 -177.07 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -91.05 -94.88 0.12 Allowed 'General case' 0 N--CA 1.437 -1.101 1 N-CA-C 93.486 -6.487 . . . . 0.0 93.486 174.859 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . 0.353 9.8 t -165.93 54.29 0.1 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 127.634 2.374 . . . . 0.0 111.44 176.955 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -136.06 127.64 28.82 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 120.186 1.357 . . . . 0.0 112.957 -178.063 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.478 ' HA ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -69.2 121.61 17.14 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 127.264 2.226 . . . . 0.0 108.138 179.055 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.63 -54.55 2.6 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 123.552 0.741 . . . . 0.0 111.774 -178.605 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -119.15 155.32 16.11 Favored Glycine 0 C--N 1.341 0.853 0 C-N-CA 124.428 1.014 . . . . 0.0 113.907 -178.72 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.91 102.07 3.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 178.539 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.9 pt -112.75 157.05 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.903 0.881 . . . . 0.0 111.633 -178.293 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.2 t -155.89 155.32 32.67 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.083 1.353 . . . . 0.0 112.197 -178.368 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.501 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 38.6 m170 -80.34 3.78 20.01 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 119.156 -0.45 . . . . 0.0 110.954 177.208 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -43.64 -39.59 3.65 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -177.671 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.46 44.44 1.22 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.573 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -110.83 155.16 22.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.315 1.446 . . . . 0.0 110.924 -179.769 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.8 t -89.84 61.29 5.3 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.536 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.9 -86.93 0.96 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.659 1.123 . . . . 0.0 112.381 179.028 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -96.91 -6.17 36.35 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -178.073 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -69.26 -173.44 0.54 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.191 0.905 . . . . 0.0 110.592 -179.401 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -147.0 153.89 40.59 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.182 0.593 . . . . 0.0 111.379 -178.911 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.1 m -142.55 163.66 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 126.483 1.913 . . . . 0.0 107.57 178.129 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.85 152.35 28.54 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.701 0.667 . . . . 0.0 114.056 -177.928 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 51.8 m -87.71 -168.27 2.17 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.92 1.288 . . . . 0.0 108.331 178.191 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.2 t -68.35 112.92 5.51 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.036 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.58 50.21 4.31 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.258 0.932 . . . . 0.0 110.802 -179.201 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.4 m -147.9 97.75 2.85 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.06 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 116.585 -1.674 . . . . 0.0 108.833 -179.385 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 54.69 81.13 0.11 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 125.533 1.533 . . . . 0.0 109.29 -179.405 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.405 HG22 ' CG2' ' A' ' 16' ' ' VAL . 7.5 t -105.35 138.12 42.05 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.362 0.665 . . . . 0.0 111.977 -177.37 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.94 125.34 52.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.292 1.837 . . . . 0.0 109.773 179.405 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -105.87 71.27 0.89 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 178.841 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.17 -80.73 1.49 Allowed Glycine 0 C--N 1.342 0.889 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 -178.868 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.1 t -123.64 -30.49 3.6 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.975 1.71 . . . . 0.0 110.757 178.943 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 m -70.36 92.0 0.78 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.126 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -89.15 145.06 25.68 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.477 1.511 . . . . 0.0 114.074 -177.819 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -141.48 134.93 29.71 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.243 1.417 . . . . 0.0 111.682 178.376 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.6 m -72.32 156.57 38.96 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 126.057 1.743 . . . . 0.0 108.618 177.677 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.21 -22.88 44.01 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.029 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 98.3 p -76.45 -34.45 58.72 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.916 -179.143 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -75.55 -38.21 59.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.418 1.487 . . . . 0.0 111.617 -179.526 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.405 ' CG2' HG22 ' A' ' 4' ' ' THR . 43.1 t -63.42 -47.99 89.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.264 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -64.15 -32.1 73.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.7 1.6 . . . . 0.0 111.532 179.094 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.34 -56.65 7.8 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.078 0.551 . . . . 0.0 109.888 -179.081 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.5 -27.86 68.11 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 123.105 0.253 . . . . 0.0 110.551 179.656 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.34 -44.68 67.7 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.299 -0.876 . . . . 0.0 110.088 178.586 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -68.83 -17.51 64.02 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.338 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.32 -69.24 0.57 Allowed 'General case' 0 C--N 1.346 0.424 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 -178.387 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.511 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -38.1 -58.13 0.99 Allowed 'General case' 0 CA--C 1.537 0.463 0 O-C-N 124.527 1.142 . . . . 0.0 112.438 175.93 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.5 t -56.23 -40.9 74.81 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 123.835 0.854 . . . . 0.0 112.668 -178.952 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -87.24 -2.96 59.0 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 179.442 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -117.26 -63.15 1.48 Allowed 'General case' 0 C--N 1.347 0.5 0 CA-C-N 120.163 1.347 . . . . 0.0 114.097 -178.616 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -49.98 -42.2 48.41 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.894 1.278 . . . . 0.0 111.99 -177.036 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -103.85 14.11 31.51 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -177.997 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -154.51 62.95 0.68 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.176 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 63.24 91.03 0.07 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.174 1.79 . . . . 0.0 109.206 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -57.06 112.69 1.42 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.556 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.9 t -97.65 -34.63 10.87 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.348 1.459 . . . . 0.0 107.593 178.284 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.53 97.9 7.36 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.512 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -142.49 52.07 0.66 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.359 0.98 . . . . 0.0 111.155 -179.088 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 m -71.95 -53.06 14.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.501 0.72 . . . . 0.0 109.789 178.882 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.5 m -111.38 -162.07 0.78 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.037 1.335 . . . . 0.0 107.98 -179.063 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.4 t -83.08 49.9 1.63 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.98 0.912 . . . . 0.0 109.747 179.145 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -140.79 142.82 29.68 Favored Pre-proline 0 C--N 1.342 0.257 0 C-N-CA 126.311 1.845 . . . . 0.0 106.638 -179.026 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -69.6 145.68 79.73 Favored 'Cis proline' 0 CA--C 1.535 0.56 0 N-CA-C 115.053 1.136 . . . . 0.0 115.053 2.917 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.57 140.2 49.39 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -177.514 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.3 m -57.12 120.07 7.41 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 127.359 2.263 . . . . 0.0 110.564 178.983 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -79.43 99.56 7.25 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.656 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -140.53 61.83 1.5 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.215 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -105.63 -178.67 3.72 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.231 1.412 . . . . 0.0 109.183 -179.584 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -67.78 102.92 1.31 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.954 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.3 144.21 42.07 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.575 0.75 . . . . 0.0 111.501 -179.102 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.68 68.28 0.16 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 107.849 -2.101 . . . . 0.0 107.849 -178.938 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -162.65 173.01 14.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.51 1.124 . . . . 0.0 109.331 -179.627 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -59.93 162.85 5.11 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.591 1.156 . . . . 0.0 111.171 178.904 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 49.4 p90 44.65 53.7 11.63 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 126.239 1.816 . . . . 0.0 113.134 -179.345 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.75 -47.74 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.606 2.204 . . . . 0.0 110.834 -179.239 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.4 t 57.58 -100.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.768 1.627 . . . . 0.0 109.995 -179.577 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 p30 178.8 -45.61 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.437 1.895 . . . . 0.0 108.952 -179.382 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.89 -158.83 41.2 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.781 0.705 . . . . 0.0 112.362 179.199 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.01 130.35 1.67 Allowed 'Cis proline' 0 N--CA 1.46 -0.472 0 CA-C-N 118.372 1.086 . . . . 0.0 113.423 1.549 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -134.25 141.93 47.16 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.834 0.854 . . . . 0.0 109.412 179.391 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -132.07 164.94 25.13 Favored 'General case' 0 C--N 1.344 0.359 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -177.372 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -79.86 153.25 29.19 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.934 2.093 . . . . 0.0 112.059 -178.942 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.511 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 52.5 t80 -160.39 106.43 1.36 Allowed Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 178.731 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -67.71 141.96 56.46 Favored 'Trans proline' 0 N--CA 1.441 -1.584 0 CA-C-N 120.302 1.144 . . . . 0.0 110.676 -176.81 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.42 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -90.03 -145.21 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-O 122.972 1.368 . . . . 0.0 111.972 -177.607 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.42 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 36.0 ttpt -79.77 149.51 31.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.381 -179.022 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.0 t 170.09 48.28 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.455 1 C-N-CA 132.088 4.155 . . . . 0.0 103.641 178.482 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.58 -46.26 1.07 Allowed Glycine 0 CA--C 1.534 1.229 0 N-CA-C 105.984 -2.846 . . . . 0.0 105.984 -177.45 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.4 165.22 25.43 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.433 1.016 . . . . 0.0 111.742 178.68 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.59 131.31 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.514 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.9 t80 57.2 83.34 0.11 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.703 1.201 . . . . 0.0 110.845 -179.381 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.5 p -131.54 -48.61 0.98 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.465 1.106 . . . . 0.0 111.753 -179.076 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.56 51.78 3.18 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -178.782 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.16 47.69 0.07 OUTLIER Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.533 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.5 t -69.52 -59.58 4.68 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.376 1.07 . . . . 0.0 111.252 179.567 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -82.32 -26.18 9.15 Favored 'Cis proline' 0 C--N 1.347 0.483 0 CA-C-N 121.573 1.597 . . . . 0.0 112.246 -6.2 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.29 -160.49 22.56 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.562 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.758 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . 69.21 21.71 7.03 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 126.349 1.86 . . . . 0.0 112.331 -178.912 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.4 91.69 0.61 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.986 1.314 . . . . 0.0 107.926 179.099 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.8 mtt85 -138.3 134.05 33.83 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.334 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 m -93.74 153.05 3.43 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 177.065 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.96 120.11 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -178.867 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -110.48 174.04 2.05 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 C-N-CA 125.015 1.326 . . . . 0.0 114.073 -177.645 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -100.55 154.62 18.41 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.755 2.422 . . . . 0.0 108.544 179.054 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.283 3.3 t -71.92 0.93 8.0 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -178.599 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -86.0 -83.22 0.18 Allowed 'General case' 0 N--CA 1.441 -0.888 1 N-CA-C 100.115 -4.031 . . . . 0.0 100.115 177.07 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.7 t -165.08 -4.29 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.295 2.238 . . . . 0.0 114.157 177.619 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -79.35 130.59 35.59 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -175.098 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -78.64 117.89 20.23 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.82 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.59 -59.73 2.63 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.344 0.658 . . . . 0.0 111.862 -177.557 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.45 156.83 17.82 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 179.61 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.49 155.27 18.38 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.588 1.155 . . . . 0.0 111.748 -179.249 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.5 pt -136.62 165.3 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 125.241 1.416 . . . . 0.0 110.802 179.28 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.1 t -159.32 144.84 16.0 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.666 0.786 . . . . 0.0 112.787 -178.774 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.758 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -82.42 -37.24 25.78 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.618 0.767 . . . . 0.0 111.073 177.892 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 m -49.97 -55.97 12.5 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.479 1.512 . . . . 0.0 112.367 -178.756 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -63.47 -27.0 70.15 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.108 0.861 . . . . 0.0 112.637 -179.58 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.39 178.76 6.91 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.288 1.035 . . . . 0.0 112.579 -178.925 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.9 m -65.59 -45.89 81.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.512 1.125 . . . . 0.0 110.54 179.07 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.05 -80.62 0.06 OUTLIER Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.466 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -79.53 -17.83 53.19 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.182 0.993 . . . . 0.0 112.039 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -79.74 163.85 24.16 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.326 0.65 . . . . 0.0 110.263 179.298 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.05 113.35 19.42 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.63 1.572 . . . . 0.0 107.671 179.209 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.4 m -97.47 161.55 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.436 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.88 155.65 51.07 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.395 -179.063 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.25 -173.31 4.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.342 1.457 . . . . 0.0 109.008 178.924 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.2 t -68.02 133.67 49.41 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.825 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.66 23.2 73.42 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -178.775 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.3 m -144.05 93.87 2.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.065 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 116.747 -1.597 . . . . 0.0 109.688 -178.658 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.37 152.86 0.57 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 126.612 1.965 . . . . 0.0 113.028 179.296 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.66 94.37 3.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.076 1.35 . . . . 0.0 110.571 -178.517 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 5' ' ' THR . 1.1 m -99.58 94.53 6.44 Favored 'General case' 0 N--CA 1.437 -1.099 1 N-CA-C 100.179 -4.008 . . . . 0.0 100.179 177.808 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.0 m -96.19 75.48 3.0 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.246 -177.696 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.0 -97.42 1.64 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 -178.804 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.3 t -114.76 -31.71 6.06 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.442 1.497 . . . . 0.0 109.253 178.479 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.1 m -77.06 95.53 4.22 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 102.059 -3.312 . . . . 0.0 102.059 178.051 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -114.28 152.24 31.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.552 1.141 . . . . 0.0 113.098 -176.425 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -143.76 165.78 26.71 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 125.041 1.336 . . . . 0.0 111.229 -179.214 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.3 m -85.97 156.94 20.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.334 1.453 . . . . 0.0 110.652 178.88 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.95 -20.78 40.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.915 -1.493 . . . . 0.0 107.164 176.875 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -68.77 -46.01 69.88 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.538 1.135 . . . . 0.0 109.939 179.379 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -43.38 93.21 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 123.135 0.574 . . . . 0.0 111.4 179.195 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.0 t -61.25 -46.07 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 123.013 0.525 . . . . 0.0 109.754 178.776 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 ttp-105 -62.76 -43.8 97.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.587 0.755 . . . . 0.0 110.177 -179.217 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.55 -45.41 87.25 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.546 0.738 . . . . 0.0 110.772 179.122 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.98 -33.22 75.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.46 1.104 . . . . 0.0 110.753 179.329 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.84 -37.71 47.8 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.964 0.505 . . . . 0.0 110.456 178.881 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -68.22 -20.64 64.84 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.229 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.25 -61.38 1.97 Allowed 'General case' 0 C--N 1.346 0.449 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 -178.807 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -41.13 -52.05 3.33 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.336 1.054 . . . . 0.0 111.46 176.663 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 46.4 t -61.97 -39.77 93.31 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.693 1.597 . . . . 0.0 111.04 179.017 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -88.01 7.08 32.95 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.768 1.227 . . . . 0.0 113.527 179.015 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -129.73 -10.87 4.43 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.455 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -115.18 -27.28 7.34 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -179.059 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.95 -14.86 11.25 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.828 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -78.86 17.82 0.68 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.503 1.047 . . . . 0.0 113.616 -176.952 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.5 t70 86.51 40.22 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 127.941 2.496 . . . . 0.0 109.166 178.9 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -151.7 148.99 28.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.827 2.051 . . . . 0.0 106.232 179.269 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 t -166.24 77.99 0.24 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.127 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.19 96.04 0.1 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.182 0.993 . . . . 0.0 110.552 -179.228 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.94 58.87 4.58 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 125.226 1.393 . . . . 0.0 110.197 -179.265 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.4 t -72.78 -73.27 0.21 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.706 0.802 . . . . 0.0 110.147 -179.011 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 m -176.49 -49.63 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 127.441 2.297 . . . . 0.0 106.671 -178.584 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.0 t -79.95 25.04 0.38 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.485 1.914 . . . . 0.0 113.939 -178.844 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 74.49 163.69 0.14 Allowed Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 119.279 0.945 . . . . 0.0 109.839 178.414 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.25 117.94 3.5 Favored 'Cis proline' 0 N--CA 1.454 -0.838 0 N-CA-C 115.166 1.179 . . . . 0.0 115.166 2.65 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -125.71 150.86 47.32 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 127.223 2.209 . . . . 0.0 106.937 178.912 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 m -80.99 132.19 35.36 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.564 1.146 . . . . 0.0 109.777 -179.972 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -88.53 149.55 23.56 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.48 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -153.03 134.3 14.24 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.024 0.53 . . . . 0.0 110.494 -179.273 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 64.43 121.61 0.02 OUTLIER 'General case' 0 C--N 1.343 0.293 0 C-N-CA 127.378 2.271 . . . . 0.0 112.053 179.367 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -77.16 135.38 38.53 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.268 0.627 . . . . 0.0 109.699 179.433 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -126.91 75.3 1.56 Allowed 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.188 0.995 . . . . 0.0 109.407 -178.691 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.16 50.49 51.06 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.221 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -164.83 121.76 1.55 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.857 1.263 . . . . 0.0 108.69 -178.648 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -142.68 110.43 5.85 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.373 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -144.42 49.87 1.11 Allowed Pre-proline 0 N--CA 1.439 -1.014 0 C-N-CA 129.91 3.284 . . . . 0.0 108.879 177.635 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.56 150.3 27.87 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.006 2.471 . . . . 0.0 112.031 -178.998 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.7 t -142.03 -53.19 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.862 1.665 . . . . 0.0 106.892 178.757 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -160.19 126.38 4.19 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.136 1.375 . . . . 0.0 109.002 178.727 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.85 150.95 18.43 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.881 1.229 . . . . 0.0 112.238 -178.875 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.65 173.04 29.17 Favored 'Cis proline' 0 C--N 1.35 0.655 0 CA-C-N 119.375 1.588 . . . . 0.0 113.27 -2.251 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -126.17 174.71 8.3 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.292 1.437 . . . . 0.0 108.174 -179.256 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.63 154.01 37.96 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.879 0.371 . . . . 0.0 111.658 -179.491 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.18 153.17 19.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.594 1.558 . . . . 0.0 111.683 -178.889 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -157.33 117.17 1.99 Allowed Pre-proline 0 C--N 1.342 0.273 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.288 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.7 152.14 13.16 Favored 'Trans proline' 0 N--CA 1.438 -1.769 0 C-N-CA 121.187 1.258 . . . . 0.0 114.675 -176.382 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.52 178.32 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 127.77 2.428 . . . . 0.0 105.868 178.803 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -164.77 -168.92 1.58 Allowed 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 109.586 -3.461 . . . . 0.0 108.462 -178.879 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.2 m -84.65 60.71 6.28 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 177.136 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.54 71.53 1.16 Allowed Glycine 0 CA--C 1.53 0.999 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 -178.222 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.18 89.68 0.09 OUTLIER Glycine 0 CA--C 1.53 1.01 0 CA-C-N 117.295 0.547 . . . . 0.0 111.8 -179.329 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.1 t -94.68 97.49 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.317 1.447 . . . . 0.0 108.003 179.339 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 t80 48.82 66.21 1.15 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.394 1.478 . . . . 0.0 110.693 -179.586 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.2 p -104.53 -68.82 0.83 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.792 1.237 . . . . 0.0 109.43 179.853 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.33 177.23 47.3 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 179.47 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.54 -19.59 10.82 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 118.887 -0.952 . . . . 0.0 113.378 -179.787 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 92.0 p 50.35 71.69 1.48 Allowed Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.201 1.8 . . . . 0.0 111.6 -179.604 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.89 143.28 54.55 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.181 2.587 . . . . 0.0 109.403 -178.382 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.43 48.74 0.95 Allowed Glycine 0 C--N 1.338 0.691 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.252 -178.518 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.15 21.75 0.13 Allowed 'General case' 0 C--N 1.342 0.27 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 177.784 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.26 112.64 0.13 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.708 2.803 . . . . 0.0 105.85 176.18 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.91 134.31 9.58 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.387 1.875 . . . . 0.0 109.53 -176.298 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.9 m -90.8 152.8 3.29 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 177.615 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.1 t -135.62 119.21 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -178.694 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -102.54 176.54 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.4 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -99.28 168.42 10.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 127.258 2.223 . . . . 0.0 109.16 178.847 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.306 14.7 t -82.01 50.24 1.52 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -178.414 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -147.54 -90.1 0.09 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 102.545 -3.132 . . . . 0.0 102.545 177.477 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.16 0.44 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.657 1.983 . . . . 0.0 113.007 -178.939 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -82.7 133.68 35.16 Favored 'General case' 0 C--N 1.346 0.44 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -176.773 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -78.05 112.88 15.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.592 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.0 -49.65 11.52 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.322 1.049 . . . . 0.0 111.363 -178.171 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.07 151.29 7.95 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.108 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.56 158.18 17.12 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.855 0.862 . . . . 0.0 110.159 178.97 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.0 pt -138.71 151.84 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.602 -178.918 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.1 t -147.67 165.43 30.49 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 125.301 1.441 . . . . 0.0 112.749 -178.756 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -79.01 -50.86 10.42 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.457 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 m -39.9 107.8 0.08 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 127.026 2.13 . . . . 0.0 112.631 -178.763 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.8 -43.42 1.35 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.74 1.638 . . . . 0.0 109.259 -179.153 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.95 -175.89 0.62 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.799 1.639 . . . . 0.0 112.131 179.654 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.3 p -70.88 -50.76 31.53 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.171 0.988 . . . . 0.0 111.453 -179.894 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.54 -78.9 0.04 OUTLIER Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.372 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -79.35 -34.1 42.39 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.046 0.939 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -55.82 158.63 3.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.366 1.066 . . . . 0.0 111.046 179.205 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -118.5 157.98 26.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.67 1.188 . . . . 0.0 113.175 -178.298 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.6 160.94 41.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 C-N-CA 126.428 1.891 . . . . 0.0 107.192 177.712 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.52 161.11 46.21 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.068 0.842 . . . . 0.0 114.197 -177.928 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.6 t -143.06 163.75 31.98 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 126.002 1.721 . . . . 0.0 109.147 178.825 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.0 t 53.43 51.59 15.04 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.079 1.752 . . . . 0.0 111.468 -178.577 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.66 -10.79 70.73 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.087 -0.84 . . . . 0.0 113.285 179.2 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.9 m -79.55 143.95 34.36 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.604 1.202 . . . . 0.0 108.746 -179.351 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 p30 . . . . . 0 C--O 1.251 1.182 0 CA-C-O 117.528 -1.225 . . . . 0.0 110.045 -179.271 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.46 75.1 0.37 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.311 1.444 . . . . 0.0 109.393 179.72 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.5 m -79.35 101.06 7.89 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.104 1.762 . . . . 0.0 109.668 -178.001 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -115.96 115.85 26.9 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.553 1.541 . . . . 0.0 106.863 -179.154 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.4 m -113.39 93.82 4.58 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.58 0.752 . . . . 0.0 109.797 -179.223 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.07 -93.8 0.43 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.438 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.3 m -133.77 41.58 3.02 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.607 1.163 . . . . 0.0 109.233 179.184 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.4 m -141.16 89.2 2.22 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 179.075 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -85.67 141.57 29.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.656 1.182 . . . . 0.0 113.657 -177.594 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -141.81 136.72 30.91 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.69 1.596 . . . . 0.0 109.816 178.74 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.5 m -65.94 158.2 28.72 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.979 1.312 . . . . 0.0 110.266 178.231 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.05 -23.17 66.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.1 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.2 t -76.73 -33.25 58.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.145 1.378 . . . . 0.0 109.966 179.259 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -74.74 -39.55 61.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.867 0.867 . . . . 0.0 109.841 -179.028 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.47 -44.6 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.499 0.72 . . . . 0.0 110.43 178.342 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.48 -38.55 90.1 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 123.304 0.642 . . . . 0.0 110.46 179.47 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.08 -46.33 74.63 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.868 0.867 . . . . 0.0 109.259 179.029 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.58 -42.14 82.55 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.961 0.904 . . . . 0.0 108.953 178.775 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.91 -20.03 50.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 179.324 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -74.52 -26.21 59.84 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.315 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.74 -49.81 10.68 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -179.445 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.14 -48.83 23.19 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 124.612 1.195 . . . . 0.0 109.661 176.233 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.5 t -68.73 -29.79 68.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.82 2.048 . . . . 0.0 113.189 -179.922 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -73.35 -63.78 1.12 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.45 1.023 . . . . 0.0 112.206 -178.611 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.351 0.1 OUTLIER -66.79 -47.01 73.45 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 -176.035 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -60.02 -28.2 67.54 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.552 1.141 . . . . 0.0 112.32 -178.722 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -82.7 -71.5 0.49 Allowed 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -178.435 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -171.19 23.28 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -178.718 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -121.28 76.72 1.26 Allowed 'General case' 0 C--N 1.339 0.128 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.803 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 111.19 133.79 0.0 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 131.355 3.862 . . . . 0.0 108.294 -178.713 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -90.96 81.58 5.66 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.004 1.321 . . . . 0.0 108.845 179.688 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.44 162.43 12.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.879 0.872 . . . . 0.0 112.387 -179.263 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -42.37 96.67 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.592 1.091 . . . . 0.0 114.947 -178.706 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.4 m 61.08 75.81 0.39 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -178.288 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 p 175.39 -43.85 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 103.471 -2.789 . . . . 0.0 103.471 -176.361 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.7 p -115.69 51.25 0.95 Allowed 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.856 2.062 . . . . 0.0 110.437 178.432 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 23.4 m-85 64.08 133.21 0.03 OUTLIER Pre-proline 0 C--N 1.355 0.83 0 C-N-CA 126.093 1.757 . . . . 0.0 110.76 176.504 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -76.39 161.58 93.57 Favored 'Cis proline' 0 N--CA 1.45 -1.035 0 CA-C-N 120.18 1.1 . . . . 0.0 109.931 3.555 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.74 147.25 37.08 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.026 1.331 . . . . 0.0 109.919 -177.788 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 t -76.31 132.1 39.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 103.46 -2.793 . . . . 0.0 103.46 177.12 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -95.6 106.1 18.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 -178.115 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -162.31 -58.07 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.567 1.147 . . . . 0.0 108.771 -179.241 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -81.39 70.65 8.3 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.559 1.144 . . . . 0.0 109.618 -179.367 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.55 -72.9 0.09 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.11 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -176.39 147.82 0.71 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.493 1.117 . . . . 0.0 109.275 179.18 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.75 150.82 49.83 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 178.93 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.17 170.56 18.16 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.104 0.562 . . . . 0.0 110.415 -179.209 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -71.6 -163.94 0.11 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.293 0.637 . . . . 0.0 111.63 -179.352 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.0 p90 54.28 58.73 12.11 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 125.889 1.676 . . . . 0.0 111.088 -178.178 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.28 66.83 8.74 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 124.016 3.144 . . . . 0.0 110.445 -179.429 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.37 -65.31 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.135 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -166.32 -165.09 0.74 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.048 1.339 . . . . 0.0 107.987 179.294 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.99 -174.88 45.98 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 121.91 -0.494 . . . . 0.0 112.879 179.103 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.2 128.37 6.42 Favored 'Cis proline' 0 N--CA 1.458 -0.568 0 O-C-N 122.526 0.75 . . . . 0.0 112.364 -0.292 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.72 150.57 25.01 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.114 0.966 . . . . 0.0 110.536 179.343 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -103.22 162.95 12.55 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.547 1.539 . . . . 0.0 112.82 -178.709 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.278 14.9 tp10 -101.3 151.82 21.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.646 2.379 . . . . 0.0 110.496 -178.783 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -160.16 107.43 1.39 Allowed Pre-proline 0 C--N 1.342 0.244 0 C-N-CA 124.567 1.147 . . . . 0.0 108.494 177.546 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -83.3 132.43 6.02 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 121.653 1.569 . . . . 0.0 112.607 -177.532 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.501 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.7 tt -107.81 172.41 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 124.466 2.079 . . . . 0.0 113.234 -179.289 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.501 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 16.5 ptpt -161.65 164.51 29.2 Favored 'General case' 0 C--N 1.316 -0.871 1 CA-C-N 108.191 -4.095 . . . . 0.0 112.379 179.974 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.1 m -92.33 60.33 3.63 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.536 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.5 -62.75 0.03 OUTLIER Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -179.271 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.31 -172.27 13.13 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.647 0.642 . . . . 0.0 113.939 -178.663 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.3 t -124.33 103.99 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 127.889 2.476 . . . . 0.0 105.678 -179.418 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.9 t80 60.56 92.78 0.04 OUTLIER 'General case' 0 C--N 1.345 0.38 0 C-N-CA 126.09 1.756 . . . . 0.0 110.871 -178.519 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.3 p -142.85 39.68 1.5 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.844 0.858 . . . . 0.0 110.336 179.302 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.11 98.38 0.06 OUTLIER Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.979 0.8 . . . . 0.0 112.25 179.178 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.92 -178.54 48.96 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 123.718 0.675 . . . . 0.0 111.512 179.13 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.0 t 63.12 91.81 0.07 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.684 1.593 . . . . 0.0 110.5 -179.124 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -59.87 132.31 8.07 Favored 'Cis proline' 0 C--N 1.348 0.534 0 CA-C-N 119.355 0.805 . . . . 0.0 113.338 1.901 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.79 71.57 0.03 OUTLIER Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.507 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.495 ' HB1' ' CB ' ' A' ' 91' ' ' HIS . . . -62.93 -20.64 65.4 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.861 178.863 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.72 137.4 33.86 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.289 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -157.66 147.28 20.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.522 -179.069 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.9 m -110.04 145.98 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 177.237 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.5 t -127.66 121.24 56.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -177.328 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -107.84 173.17 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.38 0 C-N-CA 125.189 1.396 . . . . 0.0 112.45 -177.58 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -91.56 161.89 14.75 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.248 1.419 . . . . 0.0 109.293 179.363 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.32 15.3 t -79.16 54.08 1.58 Allowed 'General case' 0 C--N 1.341 0.223 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -179.076 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -151.81 -88.45 0.06 Allowed 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 101.982 -3.34 . . . . 0.0 101.982 177.209 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.24 5.51 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.181 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -91.3 129.75 37.25 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 -175.48 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.56 124.14 20.61 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 177.447 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.8 -51.73 5.08 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.166 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.24 153.45 10.93 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.075 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.84 141.28 31.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.569 1.148 . . . . 0.0 110.062 179.3 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.0 pt -135.14 156.76 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 125.267 1.427 . . . . 0.0 108.081 179.157 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.58 159.67 37.33 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 119.113 -0.47 . . . . 0.0 111.308 -178.731 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.495 ' CB ' ' HB1' ' A' ' 74' ' ' ALA . 21.4 m170 -78.88 -58.76 3.08 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.015 177.412 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.288 4.8 t 48.06 9.35 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 129.228 3.011 . . . . 0.0 117.168 -178.053 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.68 44.98 0.21 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.142 1.353 . . . . 0.0 110.505 179.399 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.88 -168.6 2.29 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.985 0.914 . . . . 0.0 109.073 179.086 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.8 m -59.84 -46.57 88.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.321 0.648 . . . . 0.0 110.426 179.167 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.28 -91.48 0.08 OUTLIER Glycine 0 C--N 1.337 0.619 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 179.157 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -85.37 -2.5 58.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.022 0.929 . . . . 0.0 110.234 178.458 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -63.51 168.21 4.86 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.629 1.172 . . . . 0.0 110.708 179.114 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -138.85 156.21 47.49 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -177.608 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 m -132.61 165.54 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 127.331 2.253 . . . . 0.0 106.692 177.093 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -75.2 162.07 53.42 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 114.668 0.627 . . . . 0.0 114.668 -178.185 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 6.6 t -148.26 159.15 44.27 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 126.096 1.758 . . . . 0.0 108.953 178.289 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t 61.38 38.11 16.4 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.726 2.01 . . . . 0.0 111.819 -178.328 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.72 42.98 99.59 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.154 1.359 . . . . 0.0 112.239 179.041 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.6 t -88.21 26.03 1.49 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 179.871 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 116.618 -1.658 . . . . 0.0 110.615 -179.31 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.5 p . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.8 0.333 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.13 152.66 39.96 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.791 1.236 . . . . 0.0 110.777 179.359 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.4 t -140.4 134.21 30.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.155 0.582 . . . . 0.0 110.508 179.043 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -109.92 103.33 12.09 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 178.854 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 20.6 m -88.24 70.21 9.19 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.184 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.08 -82.24 0.88 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.416 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.5 p -106.1 -48.14 3.67 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.161 1.384 . . . . 0.0 112.058 -178.887 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.5 m -72.79 105.59 4.41 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.984 0.513 . . . . 0.0 111.694 -178.436 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -81.8 148.51 28.84 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.219 1.408 . . . . 0.0 110.531 179.869 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -148.08 127.68 13.29 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.383 1.073 . . . . 0.0 109.495 179.156 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.9 p -71.15 160.12 33.45 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 125.133 1.373 . . . . 0.0 110.504 178.323 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.36 -19.73 37.96 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.164 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.4 t -77.74 -36.72 50.45 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 123.604 0.762 . . . . 0.0 109.385 -179.986 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -42.5 64.86 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.67 1.188 . . . . 0.0 111.069 179.205 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.477 HG11 ' CE2' ' A' ' 85' ' ' TYR . 22.3 t -61.87 -45.93 97.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.297 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -66.91 -41.48 87.04 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 124.883 1.273 . . . . 0.0 112.967 179.821 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.88 -53.61 53.42 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.749 0.42 . . . . 0.0 110.294 -178.122 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.16 -32.38 72.1 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.086 179.439 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.36 -49.32 43.39 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 179.874 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -61.87 -22.94 65.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.693 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.23 -71.98 0.28 Allowed 'General case' 0 C--N 1.348 0.52 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 -177.698 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -38.53 -44.44 0.95 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.912 0.885 . . . . 0.0 112.261 178.096 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.3 m -55.82 -52.71 63.05 Favored 'General case' 0 C--N 1.346 0.447 0 O-C-N 123.288 0.367 . . . . 0.0 111.784 179.184 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -56.16 -40.15 73.42 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.755 0.822 . . . . 0.0 112.421 -178.124 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -89.38 -16.48 30.88 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -178.875 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -80.45 -24.04 39.82 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.791 1.236 . . . . 0.0 113.826 179.367 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -60.64 -33.54 72.95 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.297 0.639 . . . . 0.0 112.692 -177.921 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -126.17 -86.27 0.61 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.147 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t0 168.13 59.05 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 128.354 2.662 . . . . 0.0 105.701 -178.379 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -81.66 -178.5 6.99 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.597 179.441 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.338 11.3 t -69.07 86.68 0.37 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -177.838 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.03 -161.66 1.07 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 127.242 2.217 . . . . 0.0 107.07 177.363 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -45.55 -49.21 11.82 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.478 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.1 m 47.62 50.04 15.57 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.181 1.792 . . . . 0.0 113.606 178.051 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.1 p -143.48 -54.3 0.38 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.776 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.456 HG23 ' CE1' ' A' ' 38' ' ' TYR . 1.1 t -154.3 19.44 0.49 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.387 1.475 . . . . 0.0 110.543 178.984 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.474 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 12.8 m-85 -166.03 129.39 1.58 Allowed Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 126.403 1.881 . . . . 0.0 106.32 178.879 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.64 135.8 34.03 Favored 'Cis proline' 0 N--CA 1.449 -1.118 0 CA-C-N 120.355 1.163 . . . . 0.0 110.402 -1.53 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.88 155.97 36.7 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.932 0.493 . . . . 0.0 110.214 178.762 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -64.02 157.73 24.42 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.845 1.258 . . . . 0.0 112.297 -179.332 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.92 45.14 1.13 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.956 0.903 . . . . 0.0 110.212 179.263 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 48.0 -121.56 1.38 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.84 2.056 . . . . 0.0 112.103 179.895 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -137.64 -179.27 5.65 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.858 1.663 . . . . 0.0 108.813 -179.367 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 66.91 -142.53 0.14 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.066 1.346 . . . . 0.0 110.965 178.933 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -126.29 106.53 9.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.188 1.395 . . . . 0.0 109.252 -178.571 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.98 93.0 0.31 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.295 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.4 t80 51.26 65.32 1.52 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.438 1.495 . . . . 0.0 109.666 -179.138 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.36 153.31 42.43 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.792 0.806 . . . . 0.0 112.684 -178.499 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -109.31 163.88 16.01 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 127.53 2.332 . . . . 0.0 108.522 -179.124 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.98 53.66 4.27 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.848 3.032 . . . . 0.0 111.837 178.865 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.2 m -155.04 171.09 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 127.842 2.457 . . . . 0.0 108.058 -179.333 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -92.46 -133.94 0.14 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.949 0.9 . . . . 0.0 109.52 179.983 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 166.32 -156.48 28.4 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.386 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.45 151.79 12.9 Favored 'Cis proline' 0 C--N 1.349 0.587 0 CA-C-N 119.205 1.503 . . . . 0.0 113.097 -1.5 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -134.26 148.38 50.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.205 1.002 . . . . 0.0 111.877 -178.635 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.57 152.31 22.57 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -177.659 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -104.81 146.59 28.77 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 127.471 2.308 . . . . 0.0 108.459 179.276 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.631 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 52.8 t80 -160.05 121.92 1.81 Allowed Pre-proline 0 C--O 1.224 -0.238 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 179.347 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.474 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 22.8 Cg_endo -75.97 145.28 28.07 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 CA-C-N 120.624 1.259 . . . . 0.0 112.753 -176.031 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.271 5.0 tp -78.99 159.83 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 124.483 2.087 . . . . 0.0 114.094 -178.07 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.94 118.74 37.4 Favored 'General case' 0 C--N 1.321 -0.672 1 CA-C-N 108.004 -4.18 . . . . 0.0 118.222 -176.372 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.1 m -105.86 43.99 1.08 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.743 1.617 . . . . 0.0 107.075 177.997 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.41 -6.28 5.94 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 118.279 -1.29 . . . . 0.0 115.366 -179.388 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.71 134.27 2.92 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 120.15 1.975 . . . . 0.0 113.064 179.462 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.94 141.83 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.194 1.398 . . . . 0.0 110.357 -179.005 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.8 p90 39.94 54.47 2.63 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.407 2.283 . . . . 0.0 114.527 179.311 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.2 p -134.09 34.32 3.34 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.833 1.253 . . . . 0.0 108.887 178.717 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.41 -154.6 11.45 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 124.294 0.95 . . . . 0.0 111.251 -179.257 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 47.71 74.93 0.21 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.856 1.217 . . . . 0.0 112.834 178.992 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.1 m -55.53 143.41 57.97 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.178 179.314 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -45.85 -50.72 9.28 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.554 2.836 . . . . 0.0 110.993 172.829 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.41 -39.85 0.22 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 178.526 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -171.11 29.21 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 116.429 -1.748 . . . . 0.0 113.629 -177.92 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -108.57 130.39 55.3 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 122.453 2.388 . . . . 0.0 113.749 -178.464 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -134.27 155.41 50.25 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 124.372 1.069 . . . . 0.0 113.112 179.884 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 m -124.97 142.04 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 103.404 -2.813 . . . . 0.0 103.404 176.115 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.9 t -136.45 127.9 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -176.955 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.63 172.5 5.21 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 C-N-CA 127.065 2.146 . . . . 0.0 110.71 -177.901 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -100.49 -178.24 3.74 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 126.066 1.746 . . . . 0.0 110.138 179.044 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.371 13.8 t -80.33 52.48 1.61 Allowed 'General case' 0 C--N 1.344 0.34 0 N-CA-C 118.524 2.787 . . . . 0.0 118.524 -178.068 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -160.5 -93.37 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 100.394 -3.928 . . . . 0.0 100.394 176.752 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 58.2 m -163.68 16.19 0.06 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 130.101 3.36 . . . . 0.0 112.353 179.398 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -79.21 97.65 6.31 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.778 1.172 . . . . 0.0 110.256 -177.69 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.477 ' CE2' HG11 ' A' ' 16' ' ' VAL . 9.1 t80 -55.64 112.72 1.21 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.667 1.587 . . . . 0.0 108.699 178.998 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.05 -51.52 9.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.449 0.7 . . . . 0.0 110.822 -178.641 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 166.66 162.27 17.8 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.275 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.84 147.06 24.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.059 0.944 . . . . 0.0 109.104 179.028 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.2 pt -134.52 160.59 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.966 1.306 . . . . 0.0 109.241 -178.969 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 74' ' ' ALA . 11.9 t -158.43 167.43 29.69 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.453 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.431 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 17.1 m170 -78.45 -65.3 1.0 Allowed 'General case' 0 C--N 1.348 0.511 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.343 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.1 t 42.78 14.28 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 129.249 3.02 . . . . 0.0 116.778 -179.364 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.99 -32.71 0.15 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.466 1.507 . . . . 0.0 110.44 -179.038 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.18 127.57 17.27 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.829 1.652 . . . . 0.0 112.09 179.233 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.9 t -105.89 69.19 0.81 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.986 1.315 . . . . 0.0 109.114 179.718 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.67 -161.01 30.35 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.452 1.025 . . . . 0.0 110.921 179.373 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -79.5 8.55 6.14 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.071 0.948 . . . . 0.0 111.388 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -80.24 156.83 26.69 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.233 1.413 . . . . 0.0 110.286 178.852 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -137.78 159.96 40.56 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.279 1.432 . . . . 0.0 111.195 -178.192 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.9 m -128.38 176.15 8.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 C-N-CA 127.877 2.471 . . . . 0.0 106.969 178.05 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.31 171.07 43.6 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 117.054 1.581 . . . . 0.0 117.054 -177.647 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.3 m -129.26 -176.49 3.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.917 2.487 . . . . 0.0 107.206 177.963 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.6 t 28.5 38.84 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -177.099 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 53.32 48.94 58.49 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.324 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.6 t -79.23 150.54 31.58 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.596 0.759 . . . . 0.0 111.801 -178.615 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.1 t30 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.245 -1.36 . . . . 0.0 108.717 -179.386 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 76.82 63.08 0.04 OUTLIER 'General case' 0 C--N 1.34 0.167 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 -177.433 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 t -106.02 156.43 18.41 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.893 0.877 . . . . 0.0 111.354 -177.92 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.08 112.28 12.2 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 178.723 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.6 m -96.55 74.93 2.82 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.242 1.017 . . . . 0.0 110.012 -178.825 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.3 -70.81 2.1 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 125.097 1.332 . . . . 0.0 111.524 179.121 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.2 t -126.49 -44.58 1.69 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.896 1.678 . . . . 0.0 109.919 -179.222 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 m -68.5 111.06 4.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.644 0.778 . . . . 0.0 109.514 -179.349 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -81.41 151.94 27.66 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.083 0.953 . . . . 0.0 110.532 179.911 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -143.27 110.14 5.58 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.427 1.091 . . . . 0.0 110.326 -179.551 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.8 m -63.1 154.15 31.88 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 125.275 1.43 . . . . 0.0 109.171 178.77 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -20.9 57.81 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.865 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.4 m -74.35 -43.22 57.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.042 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -67.82 -47.29 69.46 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.189 0.995 . . . . 0.0 112.343 -179.174 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -60.19 -52.65 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 124.194 0.998 . . . . 0.0 109.215 -179.342 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -66.38 -38.8 88.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.141 1.377 . . . . 0.0 113.002 -177.841 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.51 -52.6 60.54 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.355 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.488 ' HB1' ' HE2' ' A' ' 59' ' ' PHE . . . -61.96 -32.55 73.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.431 179.237 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.92 -32.29 61.75 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 178.896 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -69.74 -24.66 63.57 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 176.959 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.06 -63.67 1.26 Allowed 'General case' 0 C--N 1.349 0.57 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 -179.222 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.497 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -41.58 -40.1 1.79 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.273 1.429 . . . . 0.0 112.447 176.852 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -60.89 -63.54 1.26 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.282 1.433 . . . . 0.0 110.247 179.219 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -66.43 -24.17 66.41 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -179.065 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -82.25 -45.31 15.18 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.211 1.404 . . . . 0.0 113.531 -177.798 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -66.23 -28.26 68.6 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.374 1.069 . . . . 0.0 112.589 -178.525 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -74.84 -64.73 0.98 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.407 0.548 . . . . 0.0 110.904 -177.738 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -172.49 -29.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.546 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -75.49 39.02 0.15 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -177.502 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.05 169.7 0.06 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.224 2.21 . . . . 0.0 110.689 178.608 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.0 t -158.28 37.19 0.24 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.388 1.475 . . . . 0.0 110.337 179.322 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.04 158.98 27.78 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.754 0.822 . . . . 0.0 111.835 -179.149 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.64 -137.59 7.33 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.573 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.7 t -145.32 -68.53 0.29 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.625 1.17 . . . . 0.0 108.452 179.091 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.2 m -83.33 -94.1 0.06 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.908 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.3 p -140.63 40.57 1.86 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.389 0.675 . . . . 0.0 110.677 178.571 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -82.17 132.06 54.49 Favored Pre-proline 0 C--N 1.345 0.389 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 177.66 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.49 123.75 5.73 Favored 'Cis proline' 0 CA--C 1.544 1.015 0 N-CA-C 114.044 0.748 . . . . 0.0 114.044 3.005 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.85 148.4 22.52 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 128.452 2.701 . . . . 0.0 113.758 -177.319 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.97 113.76 2.99 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.933 0.893 . . . . 0.0 109.264 179.047 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -95.03 90.38 5.92 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 120.838 0.352 . . . . 0.0 110.072 -178.821 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -156.12 119.21 4.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.162 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -128.58 -79.82 0.57 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.295 1.038 . . . . 0.0 109.336 -179.089 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -143.61 11.26 1.66 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.904 1.281 . . . . 0.0 110.884 179.467 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 55.45 47.64 20.66 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.225 1.41 . . . . 0.0 110.682 -178.852 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.67 -31.53 6.67 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.292 1.425 . . . . 0.0 111.303 179.413 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -127.44 94.02 3.87 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.041 1.336 . . . . 0.0 108.391 -179.195 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -118.88 -177.95 3.44 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.582 1.153 . . . . 0.0 111.487 -178.837 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.21 175.53 3.21 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.989 1.716 . . . . 0.0 108.553 -178.714 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.63 68.07 7.11 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.352 2.701 . . . . 0.0 111.573 -179.403 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.5 m -143.18 157.28 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 125.668 1.587 . . . . 0.0 109.78 179.695 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -85.5 -44.97 12.24 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.797 1.239 . . . . 0.0 111.235 -179.326 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.79 177.82 43.81 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.72 1.152 . . . . 0.0 111.865 -179.423 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.29 152.96 85.19 Favored 'Cis proline' 0 N--CA 1.458 -0.594 0 CA-C-N 117.973 0.886 . . . . 0.0 112.409 0.763 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.1 154.96 47.74 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 127.185 2.194 . . . . 0.0 109.981 179.325 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -135.85 160.81 37.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.049 -178.743 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.98 162.26 26.08 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.719 1.608 . . . . 0.0 112.14 -177.552 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.497 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 70.9 t80 -160.61 104.38 1.32 Allowed Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 177.388 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -80.84 135.46 10.09 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 121.899 1.733 . . . . 0.0 112.774 -175.778 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.58 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 3.7 tt -105.35 -176.34 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-O 124.249 1.976 . . . . 0.0 112.401 -179.223 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.58 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.3 mmtm -160.51 142.84 12.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 108.945 -3.752 . . . . 0.0 110.229 179.72 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.7 t -85.83 60.83 6.47 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.71 1.204 . . . . 0.0 109.138 -179.134 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.51 49.81 0.1 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.93 1.729 . . . . 0.0 109.003 -179.214 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.6 154.39 7.57 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.328 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.8 t -135.61 150.94 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.168 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 16.6 p90 48.33 48.47 18.93 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.818 1.647 . . . . 0.0 111.963 -179.051 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.1 m -79.29 138.31 37.7 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 125.027 1.331 . . . . 0.0 108.964 -178.896 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.91 -84.15 0.23 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.871 0.748 . . . . 0.0 112.791 -178.857 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.56 76.56 1.32 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.165 0.888 . . . . 0.0 112.096 -178.825 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.3 m -98.65 157.78 33.65 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.229 1.412 . . . . 0.0 110.177 179.338 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.9 -44.28 49.74 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.731 2.954 . . . . 0.0 111.495 164.61 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.57 24.23 26.49 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.773 1.178 . . . . 0.0 112.11 179.18 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.539 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -94.16 -68.92 0.77 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.158 -0.925 . . . . 0.0 109.548 179.203 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -70.4 107.1 3.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.096 0.958 . . . . 0.0 112.622 -178.621 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -140.03 131.65 27.2 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.338 0.655 . . . . 0.0 111.719 -179.074 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -94.19 153.16 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 176.882 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.7 t -132.95 130.42 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -178.348 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.5 pt -116.79 176.22 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.6 1.16 . . . . 0.0 112.634 -177.997 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -90.49 177.34 6.4 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 126.442 1.897 . . . . 0.0 110.022 179.763 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.322 12.9 t -81.2 47.71 1.05 Allowed 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 118.58 2.807 . . . . 0.0 118.58 -178.651 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -160.41 -87.04 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 177.05 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 76.7 m -162.97 62.6 0.19 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.198 2.599 . . . . 0.0 110.082 -176.793 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -144.02 117.74 9.27 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.202 1.819 . . . . 0.0 114.391 -179.416 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -55.74 128.83 36.73 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.365 1.066 . . . . 0.0 108.449 178.622 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.61 -59.6 1.68 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.931 0.892 . . . . 0.0 108.833 178.805 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.91 173.57 41.51 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.369 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.47 115.95 22.42 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.681 1.593 . . . . 0.0 109.231 179.267 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.9 pt -108.83 158.01 8.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 125.06 1.344 . . . . 0.0 110.017 -179.235 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 t -159.61 137.11 9.84 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 -179.529 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.539 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 6.5 m170 -78.1 -11.22 59.9 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 117.881 -1.057 . . . . 0.0 112.034 174.997 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.7 m -26.53 -65.63 0.06 Allowed 'General case' 0 C--N 1.349 0.549 0 C-N-CA 126.447 1.899 . . . . 0.0 114.937 -178.469 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.04 -75.51 1.25 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -179.348 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 50.81 -150.23 0.26 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.064 1.346 . . . . 0.0 112.27 -179.306 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 60.1 p -153.97 -51.41 0.1 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.163 1.385 . . . . 0.0 108.651 179.118 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -121.55 -86.38 0.86 Allowed Glycine 0 C--N 1.34 0.791 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 178.817 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -134.13 28.13 3.8 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.547 1.539 . . . . 0.0 110.734 179.23 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -85.96 164.96 17.1 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.906 1.282 . . . . 0.0 111.628 -178.885 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.454 ' CE2' ' NE2' ' A' ' 91' ' ' HIS . 13.5 m-85 -118.65 116.05 25.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.122 1.769 . . . . 0.0 107.781 179.098 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.4 m -90.89 164.44 2.12 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.255 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.15 133.83 11.99 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.071 -178.32 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 26.2 m -81.32 -172.99 4.09 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.526 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.9 t -75.8 93.06 3.1 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.993 -0.442 . . . . 0.0 110.12 -179.03 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.49 51.27 0.24 Allowed Glycine 0 CA--C 1.527 0.834 0 C-N-CA 126.105 1.812 . . . . 0.0 109.397 -179.37 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.0 m -154.66 110.82 3.22 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 125.2 1.4 . . . . 0.0 108.853 -179.14 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.5 m120 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.217 -1.373 . . . . 0.0 109.414 179.111 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -50.29 136.55 19.8 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.541 1.536 . . . . 0.0 111.436 -179.784 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.3 p -104.0 150.13 24.53 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.976 1.31 . . . . 0.0 111.379 -179.034 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -133.46 97.03 3.84 Favored 'General case' 0 N--CA 1.424 -1.772 1 N-CA-C 97.38 -5.044 . . . . 0.0 97.38 176.591 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -97.31 85.57 3.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.471 0.653 . . . . 0.0 110.668 -177.185 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.12 -96.2 1.58 Allowed Glycine 0 C--N 1.34 0.762 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 -178.879 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.7 m -104.91 -36.61 7.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.353 1.061 . . . . 0.0 110.307 179.23 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.38 168.03 19.27 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.346 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -156.75 132.45 9.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.091 0.156 . . . . 0.0 110.86 179.323 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -123.74 158.35 31.89 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.876 1.27 . . . . 0.0 109.947 -179.683 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.1 m -78.05 156.26 30.17 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.224 1.41 . . . . 0.0 110.479 -179.667 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.38 -18.9 42.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.83 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.7 p -72.66 -38.05 67.75 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 123.637 0.775 . . . . 0.0 109.966 179.248 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.93 -47.93 67.34 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.807 0.731 . . . . 0.0 110.236 178.654 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.2 t -53.14 -49.89 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 125.077 1.351 . . . . 0.0 108.496 179.09 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -69.51 -38.32 77.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.372 1.469 . . . . 0.0 113.083 -178.819 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.59 -54.18 31.43 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.817 0.735 . . . . 0.0 110.79 -178.507 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.25 -34.1 75.88 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.584 0.754 . . . . 0.0 111.118 179.43 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.11 -36.89 61.63 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 119.477 -0.297 . . . . 0.0 111.506 178.957 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -69.32 -20.78 63.87 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.449 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.5 -57.41 3.36 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -178.224 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.8 -38.26 47.38 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.088 1.355 . . . . 0.0 109.822 177.269 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.2 t -60.69 -54.57 43.68 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.358 1.463 . . . . 0.0 109.158 178.506 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -56.79 -36.85 70.35 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.687 0.395 . . . . 0.0 110.837 179.532 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.25 -6.52 59.28 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.714 1.206 . . . . 0.0 114.098 -179.863 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.46 ' CD2' ' HG3' ' A' ' 57' ' ' GLN . 8.7 t80 -128.23 43.96 3.04 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.154 0.888 . . . . 0.0 111.402 178.926 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -130.78 -84.46 0.52 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.338 1.455 . . . . 0.0 107.598 177.483 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -162.93 -14.75 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.274 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -84.17 65.21 8.66 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.586 1.554 . . . . 0.0 107.576 179.89 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 78.04 111.35 0.07 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 128.138 2.575 . . . . 0.0 108.475 -178.971 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.4 p -87.49 77.63 8.78 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.544 1.138 . . . . 0.0 109.295 -178.68 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.59 91.93 2.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.516 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.48 108.34 2.77 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 126.113 1.816 . . . . 0.0 108.57 -179.519 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 m -71.18 -66.9 0.56 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.834 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.0 p 156.49 -47.87 0.0 OUTLIER 'General case' 0 C--N 1.34 0.184 0 N-CA-C 100.537 -3.875 . . . . 0.0 100.537 -177.664 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.442 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 7.5 t -93.11 53.2 1.92 Allowed 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 125.838 1.655 . . . . 0.0 107.308 176.951 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER 79.69 155.15 0.13 Allowed Pre-proline 0 C--N 1.348 0.53 0 C-N-CA 127.376 2.27 . . . . 0.0 115.086 175.737 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.93 127.66 13.1 Favored 'Cis proline' 0 C--N 1.349 0.582 0 N-CA-C 114.93 1.089 . . . . 0.0 114.93 1.899 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.04 169.56 20.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.748 1.219 . . . . 0.0 110.212 178.913 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 m -37.52 131.66 0.9 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 128.737 2.815 . . . . 0.0 115.828 -178.911 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -109.07 109.21 20.17 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.975 1.71 . . . . 0.0 106.708 178.418 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -70.91 -36.34 72.67 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.616 1.166 . . . . 0.0 113.636 -178.788 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 70.86 77.26 0.18 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.198 1.399 . . . . 0.0 108.134 -178.465 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -72.76 91.53 1.49 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.111 1.364 . . . . 0.0 111.747 -178.641 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 54.75 152.83 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 129.305 3.042 . . . . 0.0 115.821 179.191 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.61 -145.25 24.26 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.774 1.178 . . . . 0.0 112.583 179.236 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.04 172.27 0.09 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.05 1.74 . . . . 0.0 113.46 -179.36 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -158.45 121.93 3.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 179.395 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -132.81 105.34 12.78 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 178.448 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.64 80.86 1.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.699 2.933 . . . . 0.0 113.397 -178.223 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.04 160.5 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.472 1.909 . . . . 0.0 107.81 178.822 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.57 -50.51 8.71 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.726 0.81 . . . . 0.0 110.623 179.557 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.54 -159.76 35.3 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.059 0.837 . . . . 0.0 111.257 -179.389 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.82 153.67 13.38 Favored 'Cis proline' 0 C--N 1.347 0.478 0 CA-C-N 119.092 1.446 . . . . 0.0 113.802 -0.172 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.87 158.25 20.41 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 123.877 0.871 . . . . 0.0 110.933 -178.994 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.46 ' HG3' ' CD2' ' A' ' 27' ' ' TYR . 6.2 mm100 -130.98 150.89 51.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.51 1.124 . . . . 0.0 111.687 -178.601 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -88.04 156.28 19.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.556 1.142 . . . . 0.0 110.653 179.216 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -159.74 109.22 1.46 Allowed Pre-proline 0 N--CA 1.457 -0.121 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.24 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -81.28 136.63 10.15 Favored 'Trans proline' 0 N--CA 1.436 -1.897 0 C-N-CA 121.043 1.162 . . . . 0.0 113.088 -177.827 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.26 -173.78 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 128.868 2.867 . . . . 0.0 103.891 178.896 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.36 -179.38 6.52 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 112.308 -2.224 . . . . 0.0 113.022 -177.989 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.3 t -89.42 51.05 2.03 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.075 1.35 . . . . 0.0 107.647 178.013 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.33 -66.78 0.03 OUTLIER Glycine 0 C--N 1.344 0.975 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.097 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.22 -149.41 7.28 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 117.75 0.775 . . . . 0.0 113.14 -179.774 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 t -61.86 130.72 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 126.509 1.923 . . . . 0.0 108.941 -179.165 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.1 133.14 45.36 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.879 0.872 . . . . 0.0 112.752 -178.732 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 m -132.34 -33.85 1.26 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.544 1.938 . . . . 0.0 110.352 179.394 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.26 -141.21 0.36 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.307 1.432 . . . . 0.0 114.851 -178.636 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.77 -151.69 1.55 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.364 1.459 . . . . 0.0 113.957 -178.777 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 m 72.88 151.33 0.14 Allowed Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 126.545 1.938 . . . . 0.0 110.664 -179.246 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -57.95 -72.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.042 2.495 . . . . 0.0 110.537 179.146 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.24 64.69 1.45 Allowed Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 178.304 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -61.69 -49.0 78.24 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.434 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.01 132.48 48.68 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.742 1.617 . . . . 0.0 108.218 178.725 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -157.96 132.73 8.47 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -178.512 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.6 m -95.95 147.66 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 176.309 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -128.65 117.32 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -178.635 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 35.4 pt -99.96 174.1 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.412 0 C-N-CA 126.345 1.858 . . . . 0.0 112.684 -178.287 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -94.85 -175.36 3.54 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.135 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.295 13.8 t -84.51 42.85 0.92 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 -179.9 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.8 -72.49 0.1 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.054 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.68 -9.04 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 -177.227 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -79.3 118.59 21.36 Favored 'General case' 0 N--CA 1.458 -0.061 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -175.921 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -71.29 115.03 9.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.249 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.76 -57.97 3.41 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.945 0.898 . . . . 0.0 112.126 -178.548 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.77 151.6 12.03 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.769 179.716 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.07 131.11 44.76 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.291 1.436 . . . . 0.0 110.847 -179.052 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.6 pt -130.99 162.56 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 125.45 1.5 . . . . 0.0 109.638 -179.019 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 t -156.56 146.83 21.34 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -179.606 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.459 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 19.8 m170 -79.26 -26.64 42.36 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.237 175.177 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.0 m -31.05 -59.94 0.21 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 127.946 2.498 . . . . 0.0 115.347 -178.13 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.39 34.06 4.57 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.297 0.951 . . . . 0.0 112.231 -178.908 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.81 -87.51 0.16 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 117.604 0.702 . . . . 0.0 110.981 179.511 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.2 t -162.29 -51.94 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.083 1.353 . . . . 0.0 108.723 -179.188 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.46 -88.96 0.07 OUTLIER Glycine 0 C--N 1.339 0.71 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 179.24 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -79.94 -28.61 39.65 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.115 0.966 . . . . 0.0 110.325 178.725 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -63.19 169.3 3.6 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.287 1.435 . . . . 0.0 111.538 -179.541 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -128.64 156.71 42.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.899 2.08 . . . . 0.0 109.743 -179.711 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.7 m -141.88 155.84 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 C-N-CA 124.432 1.093 . . . . 0.0 108.17 177.094 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.47 129.05 9.05 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.122 -177.775 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 37.4 m -79.93 179.75 7.41 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.298 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.2 p -61.19 124.7 21.3 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.872 -1.143 . . . . 0.0 109.683 179.152 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.04 37.61 5.65 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -178.752 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 60.5 m -152.52 145.68 24.64 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.759 1.624 . . . . 0.0 107.965 -179.732 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 125.948 1.699 . . . . 0.0 110.952 179.47 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.1 t . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.59 177.29 0.21 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.47 1.508 . . . . 0.0 110.274 -178.877 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.6 p -143.95 94.13 2.54 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.08 0.552 . . . . 0.0 110.273 178.869 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.0 m -87.76 89.61 8.06 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 102.51 -3.144 . . . . 0.0 102.51 177.792 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.3 m -86.92 63.76 8.12 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.308 1.843 . . . . 0.0 108.852 -178.952 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.13 -79.29 1.88 Allowed Glycine 0 C--N 1.34 0.779 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.085 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.7 p -115.07 -42.45 3.2 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.429 1.491 . . . . 0.0 109.68 179.256 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.35 114.3 3.11 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 124.514 1.125 . . . . 0.0 108.568 178.925 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.65 99.75 7.96 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.709 0.804 . . . . 0.0 110.368 -178.176 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -94.67 146.24 24.29 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.559 0.743 . . . . 0.0 109.08 179.048 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.4 m -72.15 153.12 41.84 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 124.094 0.958 . . . . 0.0 109.979 -179.555 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.44 -18.87 43.09 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 176.822 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 63.3 m -75.28 -39.75 59.37 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 125.002 1.321 . . . . 0.0 109.176 178.705 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -68.92 -40.84 78.83 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 123.946 0.899 . . . . 0.0 110.85 179.188 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.1 t -61.53 -48.32 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.888 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 ttt85 -65.83 -39.82 91.2 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.58 1.552 . . . . 0.0 112.125 -179.715 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.19 -51.83 66.23 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.178 0.591 . . . . 0.0 109.65 -179.074 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.51 -30.67 71.44 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.272 0.629 . . . . 0.0 111.477 179.256 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.65 -46.71 45.01 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.302 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -65.71 -20.24 66.2 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.76 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.96 -61.49 2.0 Allowed 'General case' 0 C--N 1.346 0.456 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -177.643 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -43.83 -51.64 7.27 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 124.849 1.343 . . . . 0.0 109.313 176.732 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 m -48.19 -54.25 14.09 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 126.479 1.912 . . . . 0.0 111.155 178.775 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -70.99 -25.92 62.91 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -178.729 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -106.08 -2.21 22.94 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 -176.93 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.416 ' CD2' ' HB2' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -110.48 -5.66 15.09 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.076 1.307 . . . . 0.0 114.275 178.683 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -78.3 -62.95 1.52 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.062 0.846 . . . . 0.0 112.134 -178.102 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -159.68 -41.32 0.05 Allowed 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.124 0.57 . . . . 0.0 110.916 -178.785 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.68 60.71 5.4 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.222 1.409 . . . . 0.0 107.643 178.814 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -69.99 123.24 21.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.611 1.564 . . . . 0.0 111.408 -178.423 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.8 t -149.41 39.56 0.82 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.871 0.869 . . . . 0.0 110.906 179.032 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.69 105.01 0.1 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.47 1.908 . . . . 0.0 106.025 179.122 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.32 114.59 0.63 Allowed Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.242 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 78.8 p -70.59 -67.84 0.47 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.411 1.084 . . . . 0.0 111.038 -179.031 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.1 m -143.09 -69.44 0.33 Allowed 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.156 0.983 . . . . 0.0 108.69 179.421 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.0 p -104.62 -58.44 1.88 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.494 1.118 . . . . 0.0 108.091 179.338 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.95 123.62 82.5 Favored Pre-proline 0 N--CA 1.468 0.457 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 178.316 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.31 123.59 8.67 Favored 'Cis proline' 0 N--CA 1.456 -0.699 0 N-CA-C 116.662 1.755 . . . . 0.0 116.662 3.892 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.64 173.23 2.02 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 128.207 2.603 . . . . 0.0 108.031 178.051 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 52.4 p -72.15 160.14 32.95 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.68 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -117.86 119.47 34.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.131 2.172 . . . . 0.0 108.658 179.554 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -166.68 44.95 0.06 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.288 1.435 . . . . 0.0 108.703 179.138 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -95.2 77.47 3.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.257 1.023 . . . . 0.0 110.384 -179.013 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 63.28 -177.21 0.15 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.614 1.566 . . . . 0.0 113.685 178.505 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -74.25 -173.0 1.55 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.722 1.609 . . . . 0.0 111.295 179.127 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.09 -52.56 0.63 Allowed Glycine 0 C--N 1.34 0.782 0 C-N-CA 124.603 1.097 . . . . 0.0 110.46 179.452 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -138.36 131.52 30.09 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.103 0.961 . . . . 0.0 110.312 179.274 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -161.04 137.29 8.36 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.223 1.809 . . . . 0.0 107.278 179.302 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -94.47 151.71 39.52 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.943 0.897 . . . . 0.0 110.339 -178.86 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.88 67.29 6.67 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 124.244 3.296 . . . . 0.0 112.044 -179.368 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.0 m -147.65 163.94 6.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 125.866 1.666 . . . . 0.0 108.066 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -66.27 -44.42 83.65 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.749 0.819 . . . . 0.0 111.725 -179.652 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.3 -171.29 49.18 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.182 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.53 167.11 24.25 Favored 'Cis proline' 0 C--N 1.348 0.526 0 CA-C-N 119.529 1.665 . . . . 0.0 113.766 -1.5 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -128.69 146.97 50.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.178 1.391 . . . . 0.0 110.832 -179.338 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.416 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 2.5 tp60 -91.69 138.2 31.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 128.086 2.554 . . . . 0.0 113.43 -178.342 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.1 141.52 30.94 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.285 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -149.75 114.46 3.47 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.862 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -80.59 133.36 9.37 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.141 1.894 . . . . 0.0 112.516 -176.882 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.58 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 2.3 tt -106.05 -170.23 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-O 123.481 1.61 . . . . 0.0 111.984 -179.262 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.58 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.2 mmtp -160.76 -170.06 2.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 109.962 -3.29 . . . . 0.0 112.493 179.37 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.1 t -85.77 63.05 7.83 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 126.705 2.002 . . . . 0.0 108.108 -179.667 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.47 59.99 2.06 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -179.261 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.13 98.24 0.18 Allowed Glycine 0 C--N 1.338 0.668 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.076 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.3 t -64.42 147.26 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 178.207 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.5 t80 69.85 -167.43 0.17 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.093 0.957 . . . . 0.0 108.693 -179.041 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.2 p -78.73 114.91 18.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.256 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.56 -130.31 5.58 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.826 1.203 . . . . 0.0 110.816 -179.285 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.65 73.18 2.7 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.195 0.903 . . . . 0.0 112.981 -178.94 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.3 m 56.55 69.82 1.64 Allowed Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.153 1.381 . . . . 0.0 112.401 178.885 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.99 85.03 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.212 3.274 . . . . 0.0 111.463 179.39 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.77 31.54 8.56 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.01 -0.883 . . . . 0.0 113.717 -179.203 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.4 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -157.08 -71.5 0.1 Allowed 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.75 1.275 . . . . 0.0 111.251 178.932 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -68.93 108.63 3.57 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.356 1.862 . . . . 0.0 114.926 -178.728 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -128.35 126.2 40.23 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 125.253 1.421 . . . . 0.0 111.846 179.693 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 m -93.74 144.2 10.03 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 176.699 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.7 t -137.63 127.18 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.042 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.7 pt -113.81 171.36 4.07 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 C-N-CA 125.188 1.395 . . . . 0.0 111.655 -178.352 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -85.22 165.95 16.94 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.881 1.672 . . . . 0.0 107.897 178.833 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.389 5.9 t -80.04 48.16 0.96 Allowed 'General case' 0 C--N 1.343 0.309 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -178.204 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -143.64 -85.59 0.14 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 102.071 -3.307 . . . . 0.0 102.071 176.754 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -163.61 -3.57 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.579 1.951 . . . . 0.0 114.616 178.687 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -79.67 122.4 26.5 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -176.084 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -63.32 117.15 6.22 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.507 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.65 -53.41 4.65 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 123.515 0.726 . . . . 0.0 110.761 -177.647 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.66 150.94 9.97 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.356 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.97 130.37 54.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.648 1.179 . . . . 0.0 108.145 179.565 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.8 pt -122.27 157.43 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.938 1.295 . . . . 0.0 108.579 -179.27 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.3 t -156.97 146.08 20.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -178.661 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.4 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 24.7 m170 -84.33 65.0 8.64 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 174.571 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.5 m -51.07 -46.61 61.81 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.927 0.785 . . . . 0.0 110.387 179.236 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.57 -51.48 0.03 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 179.401 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 30.25 -99.35 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 128.071 2.548 . . . . 0.0 112.669 -179.13 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.4 m -159.58 79.46 0.72 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.854 1.662 . . . . 0.0 107.251 179.141 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.49 -108.05 2.31 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.462 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -79.77 -5.9 56.23 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.736 0.814 . . . . 0.0 113.0 -179.325 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -64.64 160.86 18.86 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.002 0.819 . . . . 0.0 110.339 179.288 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -121.82 167.55 12.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.572 1.549 . . . . 0.0 113.656 -177.832 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.8 m -146.19 165.99 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 128.953 2.901 . . . . 0.0 105.928 176.737 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.2 144.96 17.09 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.369 0.509 . . . . 0.0 113.946 -178.238 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 13.9 m -94.3 165.24 12.68 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 124.092 0.957 . . . . 0.0 109.049 178.43 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 88.1 p 21.81 43.47 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 129.11 2.964 . . . . 0.0 118.091 -177.887 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.77 59.38 9.8 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.587 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.3 t -78.99 151.31 31.64 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.983 0.42 . . . . 0.0 110.689 -179.397 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 . . . . . 0 C--O 1.251 1.132 0 CA-C-O 116.468 -1.73 . . . . 0.0 110.779 -178.956 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.51 132.61 45.14 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.14 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.4 t -132.93 143.34 49.42 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -177.76 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.82 117.34 29.93 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.952 1.701 . . . . 0.0 108.212 178.885 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.8 m -103.76 78.18 1.54 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.896 1.278 . . . . 0.0 108.506 -178.814 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.51 -57.75 4.89 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.415 1.007 . . . . 0.0 111.723 179.392 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.1 t -150.79 -42.1 0.12 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.963 1.305 . . . . 0.0 110.56 -179.369 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.71 113.31 5.39 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.382 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -82.29 155.11 25.0 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.564 1.546 . . . . 0.0 111.394 -178.876 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -149.74 139.96 22.2 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.077 1.351 . . . . 0.0 109.092 178.956 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 m -81.52 160.19 23.98 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 124.862 1.265 . . . . 0.0 108.502 177.7 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.33 -23.42 48.71 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.863 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.2 p -77.85 -31.12 51.3 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.678 0.611 . . . . 0.0 110.286 -178.955 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -39.43 70.42 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.939 0.896 . . . . 0.0 111.525 179.162 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.03 -38.66 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -179.141 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -72.0 -24.71 61.62 Favored 'General case' 0 C--N 1.347 0.461 0 C-N-CA 124.576 1.15 . . . . 0.0 112.384 179.124 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.47 -58.32 4.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.381 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.18 -23.34 63.92 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.076 179.33 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.73 -43.48 54.78 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 120.693 1.588 . . . . 0.0 111.292 178.944 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -66.93 -21.62 65.98 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.982 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.18 -64.3 1.17 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 -178.733 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.553 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -34.7 -53.05 0.54 Allowed 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.35 1.86 . . . . 0.0 111.226 175.952 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.3 t -56.75 -53.63 55.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.316 1.446 . . . . 0.0 110.919 179.446 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -73.87 -12.51 60.69 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -179.169 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -108.88 -19.24 13.47 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -178.832 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -80.84 -59.32 2.72 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.516 1.507 . . . . 0.0 112.785 -177.735 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -143.81 51.9 1.32 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.927 0.785 . . . . 0.0 111.713 -178.784 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -134.99 -53.58 0.8 Allowed 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.665 1.186 . . . . 0.0 108.835 178.764 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -138.4 86.21 2.14 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -178.977 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 68.23 -167.92 0.19 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.81 1.244 . . . . 0.0 110.215 -179.507 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.5 p -107.41 -41.02 5.2 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.17 1.388 . . . . 0.0 110.024 178.748 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 52.08 95.63 0.01 OUTLIER 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.505 1.922 . . . . 0.0 113.329 178.888 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.72 -95.64 0.99 Allowed Glycine 0 C--N 1.336 0.563 0 C-N-CA 124.816 1.198 . . . . 0.0 110.363 179.936 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m 54.8 67.48 1.01 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.413 1.085 . . . . 0.0 110.095 -179.09 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.4 t -113.08 -56.03 2.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 102.311 -3.218 . . . . 0.0 102.311 179.436 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.49 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 22.3 p -119.9 -31.54 4.46 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 127.645 2.378 . . . . 0.0 107.464 177.047 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' A' ' 37' ' ' THR . 1.8 m-85 -149.19 154.51 39.18 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 127.377 2.271 . . . . 0.0 110.044 -178.786 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.17 119.71 6.59 Favored 'Cis proline' 0 CA--C 1.542 0.907 0 N-CA-C 114.082 0.762 . . . . 0.0 114.082 1.93 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -127.85 158.83 36.67 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 125.966 1.706 . . . . 0.0 110.71 -179.343 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.9 m -59.64 135.7 57.76 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.996 2.118 . . . . 0.0 110.104 178.708 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -135.94 60.58 1.67 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.019 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -161.79 58.31 0.26 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.874 1.27 . . . . 0.0 109.076 -179.033 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -70.98 -62.69 1.3 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.968 0.907 . . . . 0.0 110.196 179.802 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -141.14 -80.66 0.25 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.949 1.3 . . . . 0.0 108.152 179.458 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -166.04 121.7 1.26 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -179.373 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.69 -73.59 0.05 OUTLIER Glycine 0 C--N 1.336 0.565 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 178.941 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.21 171.71 8.43 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.012 0.925 . . . . 0.0 109.446 179.068 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -128.46 146.37 50.83 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.142 0.977 . . . . 0.0 111.168 -179.201 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -153.1 155.17 31.76 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 125.866 1.667 . . . . 0.0 108.201 -179.707 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.28 -32.63 61.58 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.945 2.43 . . . . 0.0 111.137 178.874 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.9 m -74.78 164.93 3.38 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 C-N-CA 123.576 0.75 . . . . 0.0 111.094 179.276 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -100.43 -61.3 1.39 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.024 1.33 . . . . 0.0 109.203 179.431 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 135.77 -165.72 24.75 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.71 1.148 . . . . 0.0 110.998 179.441 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.61 138.21 23.31 Favored 'Cis proline' 0 C--N 1.345 0.392 0 CA-C-N 118.247 1.024 . . . . 0.0 111.533 -0.632 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -135.25 138.95 44.04 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 179.989 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -125.3 157.81 35.73 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.626 1.57 . . . . 0.0 112.116 -178.748 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.33 157.26 25.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 127.631 2.373 . . . . 0.0 114.151 -177.934 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.553 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 60.7 t80 -160.8 113.36 1.32 Allowed Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.248 1.019 . . . . 0.0 110.157 177.915 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . 0.269 24.8 Cg_endo -70.52 138.64 35.86 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 CA-C-N 120.17 1.097 . . . . 0.0 112.731 -177.243 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.499 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -80.96 -149.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -176.969 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.499 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 27.0 mmmt -83.35 -171.04 3.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 131.156 3.783 . . . . 0.0 111.945 -178.15 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.3 t 91.56 54.97 0.0 OUTLIER 'General case' 0 C--N 1.343 0.295 0 C-N-CA 129.56 3.144 . . . . 0.0 105.383 -178.008 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.21 -46.02 0.84 Allowed Glycine 0 CA--C 1.53 0.997 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -178.377 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.29 172.09 24.09 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.364 1.459 . . . . 0.0 109.989 179.41 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.35 114.46 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 178.939 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 75.1 t80 61.63 75.81 0.39 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.163 1.385 . . . . 0.0 111.462 -179.181 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 t -160.26 -178.34 6.89 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.341 1.057 . . . . 0.0 110.128 178.724 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.16 -150.54 1.94 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.665 1.126 . . . . 0.0 112.316 179.508 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.4 -55.3 4.72 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -178.997 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.4 t -137.8 79.52 33.54 Favored Pre-proline 0 N--CA 1.451 -0.386 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.647 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -35.09 -54.63 0.63 Allowed 'Trans proline' 0 C--N 1.349 0.595 1 C-N-CA 126.242 4.628 . . . . 0.0 116.362 -175.824 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.72 99.26 0.16 Allowed Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.59 -0.815 . . . . 0.0 113.559 -179.231 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.442 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -155.11 -76.52 0.1 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 177.244 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.59 110.53 1.15 Allowed 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.761 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -136.29 119.66 16.84 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.821 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.4 m -89.15 152.0 3.4 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 176.622 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -137.75 141.77 38.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -176.982 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.59 179.56 4.17 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 123.72 0.808 . . . . 0.0 112.531 -178.485 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -96.38 169.84 9.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.461 1.905 . . . . 0.0 110.015 -178.62 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.278 6.5 t -76.56 28.03 0.13 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 118.051 2.611 . . . . 0.0 118.051 -177.967 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -129.5 -78.0 0.55 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 102.648 -3.093 . . . . 0.0 102.648 177.167 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.09 -19.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -178.686 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -79.28 145.57 33.45 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -175.4 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . 0.267 31.7 m-85 -63.61 157.16 24.55 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 127.498 2.319 . . . . 0.0 115.497 -179.042 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -113.84 -44.53 3.16 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 175.556 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.01 -148.45 20.22 Favored Glycine 0 C--N 1.349 1.262 0 C-N-CA 126.222 1.867 . . . . 0.0 111.752 177.576 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.84 147.77 35.96 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-O 121.554 0.693 . . . . 0.0 112.283 -178.79 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 pt -147.0 167.39 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 127.017 2.127 . . . . 0.0 108.376 -179.108 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.6 t -158.88 148.13 18.82 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 179.548 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.442 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 24.7 m170 -83.67 36.1 0.53 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.196 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.3 t -58.72 -35.51 72.79 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.46 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -173.25 60.35 0.14 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.568 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -97.17 -71.06 0.69 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.279 1.032 . . . . 0.0 108.999 179.323 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.3 t -170.66 -62.86 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.758 1.623 . . . . 0.0 109.041 179.219 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.46 -87.11 0.06 OUTLIER Glycine 0 C--N 1.338 0.671 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 179.407 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -79.87 -18.25 51.16 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.531 0.732 . . . . 0.0 110.215 178.743 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -65.03 168.36 6.64 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.369 1.468 . . . . 0.0 110.727 179.327 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -136.27 169.79 17.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.914 1.285 . . . . 0.0 113.056 -177.972 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.3 m -141.38 164.82 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.94 2.096 . . . . 0.0 106.424 176.65 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.47 142.65 27.26 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 115.029 0.772 . . . . 0.0 115.029 -177.493 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 24.6 t -109.37 169.99 8.35 Favored 'General case' 0 C--N 1.341 0.202 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 177.671 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.36 -157.57 0.33 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.684 -0.635 . . . . 0.0 109.425 -178.3 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.53 -9.34 58.25 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 124.183 0.897 . . . . 0.0 111.396 177.346 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.7 m -79.41 143.42 35.06 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 125.17 1.388 . . . . 0.0 108.982 179.213 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.189 1.396 . . . . 0.0 109.956 -179.217 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 81.6 p . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.33 127.43 8.96 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.061 1.345 . . . . 0.0 111.084 179.104 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -111.61 123.48 50.32 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.814 1.246 . . . . 0.0 109.713 -178.802 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -129.71 93.66 3.57 Favored 'General case' 0 N--CA 1.428 -1.53 1 N-CA-C 98.558 -4.608 . . . . 0.0 98.558 176.839 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.5 m -102.91 88.3 3.15 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.195 0.598 . . . . 0.0 110.295 -177.655 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.07 -79.38 1.02 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -178.946 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.2 p -132.83 -31.69 1.3 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.304 1.842 . . . . 0.0 110.464 178.521 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 m -67.41 106.7 2.19 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.024 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -108.07 141.66 39.42 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.546 1.138 . . . . 0.0 111.738 -178.352 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -144.45 144.33 31.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.779 1.632 . . . . 0.0 108.155 179.356 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.8 t -70.11 155.43 40.63 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 124.448 1.099 . . . . 0.0 109.912 178.957 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.71 -21.94 56.23 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 176.388 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -73.2 -35.85 66.43 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 125.157 1.383 . . . . 0.0 109.959 179.215 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.2 tp-100 -73.75 -35.56 65.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.173 0.589 . . . . 0.0 112.384 179.185 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 t -69.02 -47.13 77.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.377 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.3 ptt85 -65.26 -43.26 91.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.02 0.528 . . . . 0.0 110.554 179.551 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.72 89.5 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.543 0.737 . . . . 0.0 109.398 179.023 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.81 -38.98 79.81 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.369 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.92 -29.73 62.2 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 178.506 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -70.81 -24.1 62.49 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.494 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HB1' ' CE2' ' A' ' 26' ' ' TYR . . . -77.36 -64.3 1.17 Allowed 'General case' 0 C--N 1.346 0.441 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 -178.76 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.535 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -39.25 -50.59 1.98 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.078 1.351 . . . . 0.0 112.211 176.445 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -51.99 -62.88 1.35 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 128.029 2.531 . . . . 0.0 111.586 179.324 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -66.03 -42.12 90.03 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.543 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.422 ' CE2' ' HB1' ' A' ' 22' ' ' ALA . 6.4 m-30 -67.54 -30.85 70.6 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.418 1.087 . . . . 0.0 113.149 -177.728 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -84.48 -44.64 13.43 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 118.957 0.799 . . . . 0.0 112.12 -179.739 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -69.56 -51.13 38.25 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.233 0.613 . . . . 0.0 111.648 -179.007 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -78.03 -20.61 52.11 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.789 -179.458 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 63.74 65.21 0.73 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 124.935 1.294 . . . . 0.0 110.362 179.815 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -150.55 167.38 27.38 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 126.032 1.733 . . . . 0.0 108.049 179.099 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.287 0.0 OUTLIER 49.53 71.58 0.38 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.263 1.025 . . . . 0.0 113.46 -179.459 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.63 144.91 25.54 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.06 1.344 . . . . 0.0 108.549 179.179 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.72 -165.85 23.0 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.804 -0.519 . . . . 0.0 111.804 -179.42 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.1 m -83.86 46.66 1.2 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.904 0.882 . . . . 0.0 111.139 -179.384 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 87.7 p -146.75 161.54 40.4 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 178.733 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.7 p -80.11 33.31 0.28 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.885 -179.556 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -92.65 127.23 48.99 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 119.922 1.237 . . . . 0.0 109.504 -178.462 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -60.95 120.67 1.21 Allowed 'Cis proline' 0 C--N 1.348 0.506 0 N-CA-C 116.144 1.556 . . . . 0.0 116.144 -1.426 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -103.65 157.3 17.16 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.488 1.115 . . . . 0.0 108.84 178.933 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.92 118.86 8.36 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 122.706 0.403 . . . . 0.0 110.956 179.871 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.92 105.4 13.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 178.771 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -153.59 143.16 21.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.93 0.892 . . . . 0.0 110.296 -178.664 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 56.0 -134.0 1.44 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.07 1.348 . . . . 0.0 110.999 178.998 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 73.92 -73.7 0.09 Allowed 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.139 1.776 . . . . 0.0 109.065 -179.302 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -127.82 -37.09 1.96 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.787 1.635 . . . . 0.0 109.176 178.949 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.09 70.65 1.3 Allowed Glycine 0 C--N 1.342 0.874 0 C-N-CA 124.243 0.925 . . . . 0.0 112.027 178.92 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.33 -169.05 2.42 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.689 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -154.64 156.94 37.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.487 0.715 . . . . 0.0 110.689 179.449 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -148.92 144.51 18.24 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 125.739 1.616 . . . . 0.0 107.616 178.681 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -45.19 -45.47 14.74 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.49 3.46 . . . . 0.0 113.371 178.649 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -83.31 149.11 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 124.158 0.983 . . . . 0.0 110.482 179.323 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -91.61 168.7 11.32 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.855 1.262 . . . . 0.0 111.162 -178.854 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.08 -158.16 27.3 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.386 0.993 . . . . 0.0 111.797 -179.244 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.91 128.09 2.94 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 CA-C-N 118.215 1.007 . . . . 0.0 112.202 -0.362 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.44 158.33 21.71 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.907 2.083 . . . . 0.0 109.025 178.793 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -137.08 164.28 28.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.558 -177.954 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.98 157.54 26.8 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 126.709 2.004 . . . . 0.0 110.698 -178.078 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.535 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 56.9 t80 -160.12 96.77 1.51 Allowed Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 176.246 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.58 145.76 47.78 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 C-N-CA 120.379 0.719 . . . . 0.0 110.935 -176.119 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.589 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 2.9 tt -109.33 -172.77 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 124.253 1.978 . . . . 0.0 111.589 178.639 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.589 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 2.9 tttm -160.02 152.13 20.55 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 109.12 -3.673 . . . . 0.0 109.84 -179.397 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.1 t -76.58 52.27 0.79 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.628 1.571 . . . . 0.0 113.748 -178.165 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.0 43.05 0.24 Allowed Glycine 0 CA--C 1.526 0.759 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.402 178.016 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.58 76.48 0.03 OUTLIER Glycine 0 C--N 1.345 1.049 0 CA-C-N 119.53 1.665 . . . . 0.0 116.247 178.767 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 67' ' ' TYR 0.333 8.6 p 37.06 -139.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.43 0 C-N-CA 126.167 1.787 . . . . 0.0 113.385 177.683 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.422 ' H ' HG22 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -58.12 -175.9 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.604 2.362 . . . . 0.0 114.173 178.548 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.1 p -78.92 158.74 27.98 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.398 1.079 . . . . 0.0 113.854 -177.373 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 178.77 47.98 0.07 OUTLIER Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.247 1.88 . . . . 0.0 108.686 179.247 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 170.25 -160.19 32.91 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.139 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 76.9 p -158.84 156.71 27.36 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 124.752 1.221 . . . . 0.0 109.437 -179.329 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -79.74 166.07 78.22 Favored 'Cis proline' 0 N--CA 1.458 -0.56 0 CA-C-N 119.427 0.831 . . . . 0.0 111.36 -2.505 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.64 -109.45 1.1 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 124.224 0.916 . . . . 0.0 112.406 -178.935 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.484 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . 58.68 35.39 24.41 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 125.362 1.465 . . . . 0.0 111.541 -178.753 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -152.51 107.77 3.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.324 1.05 . . . . 0.0 110.529 178.377 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.44 130.56 19.54 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.51 -179.314 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.4 m -98.52 157.29 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 176.361 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.6 t -135.44 133.15 52.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -178.479 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -116.61 -179.95 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.781 1.232 . . . . 0.0 112.444 -178.307 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -101.45 174.82 5.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.952 2.101 . . . . 0.0 109.548 179.128 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.31 13.7 t -82.19 49.08 1.34 Allowed 'General case' 0 C--N 1.345 0.386 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -178.576 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -152.46 -87.99 0.06 Allowed 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 177.429 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 94.9 m -161.83 -0.22 0.05 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.874 2.469 . . . . 0.0 113.879 -176.898 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -80.06 138.85 37.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.364 0.984 . . . . 0.0 113.063 -176.866 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -80.0 128.39 33.42 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.405 1.482 . . . . 0.0 108.042 178.829 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.28 -47.89 6.42 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 123.556 0.743 . . . . 0.0 110.505 179.605 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.15 -174.24 46.25 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 179.339 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.97 141.88 44.48 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.39 1.476 . . . . 0.0 109.915 179.329 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.5 pt -141.07 157.26 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.795 1.238 . . . . 0.0 109.621 -179.079 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.0 t -150.81 149.81 30.19 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.126 0.97 . . . . 0.0 113.402 -178.48 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.484 ' HB2' ' CB ' ' A' ' 74' ' ' ALA 0.266 37.8 m170 -79.51 -24.1 42.49 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.972 0.805 . . . . 0.0 109.118 175.999 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.1 m -50.75 102.55 0.04 OUTLIER 'General case' 0 C--N 1.343 0.299 0 C-N-CA 126.339 1.855 . . . . 0.0 109.255 178.994 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.13 63.23 1.75 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -178.646 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.47 179.57 8.05 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.385 1.074 . . . . 0.0 110.609 179.571 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.7 t -86.18 62.07 7.21 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.507 1.523 . . . . 0.0 110.527 -179.353 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.21 -90.03 0.43 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.824 1.678 . . . . 0.0 113.199 178.418 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.35 -23.12 43.62 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.148 0.979 . . . . 0.0 111.344 -179.064 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -59.75 158.38 10.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.472 1.109 . . . . 0.0 112.129 -179.086 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -121.15 135.0 55.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.084 1.754 . . . . 0.0 108.991 -179.459 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 m -110.06 163.5 6.97 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.697 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.65 149.34 31.62 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.894 0.759 . . . . 0.0 112.935 -178.439 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.7 t -137.26 164.67 27.97 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 125.725 1.61 . . . . 0.0 108.849 178.76 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 96.4 p 46.47 50.65 12.47 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.366 2.267 . . . . 0.0 112.631 -179.649 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.12 64.04 2.28 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.241 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -146.01 132.99 20.22 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.863 1.265 . . . . 0.0 108.132 179.083 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 116.756 -1.592 . . . . 0.0 109.036 179.352 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.84 97.52 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.416 1.886 . . . . 0.0 110.878 179.34 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.5 m -99.69 121.73 41.67 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.46 1.904 . . . . 0.0 107.504 -178.733 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -122.59 111.29 16.6 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -179.683 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.3 m -100.04 81.91 2.48 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.484 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.89 -95.36 0.72 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.317 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.6 p -104.23 -36.33 7.68 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.116 1.366 . . . . 0.0 110.977 179.375 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -73.83 103.77 4.48 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.113 0.565 . . . . 0.0 110.099 -178.876 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -83.06 152.91 25.16 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.43 1.092 . . . . 0.0 110.622 -179.243 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -148.11 137.71 22.33 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.964 0.906 . . . . 0.0 111.281 -179.815 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.5 m -78.17 150.44 33.56 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.475 1.51 . . . . 0.0 107.757 178.295 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.96 -17.5 25.3 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.087 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.2 t -74.55 -44.99 48.43 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 124.506 1.122 . . . . 0.0 109.513 178.956 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -68.7 -43.73 75.42 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.051 0.94 . . . . 0.0 110.917 -179.894 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.9 t -56.72 -54.4 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 C-N-CA 126.988 2.115 . . . . 0.0 109.135 178.954 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -67.93 -43.05 80.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.071 -178.128 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.8 -49.48 77.33 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.694 0.679 . . . . 0.0 109.674 179.297 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.82 -31.75 68.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.313 1.045 . . . . 0.0 110.478 178.837 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.47 -38.47 29.87 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 179.769 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -66.7 -22.12 66.08 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.419 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.09 -54.91 5.53 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -179.182 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.439 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -46.77 -43.71 18.43 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.431 1.492 . . . . 0.0 112.499 177.853 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.0 p -73.28 -43.42 61.04 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.996 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -60.99 -31.02 70.63 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.137 0.426 . . . . 0.0 110.685 178.737 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -97.14 -3.88 40.26 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.341 1.457 . . . . 0.0 113.135 -179.177 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -57.45 -24.82 57.92 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.358 -0.839 . . . . 0.0 111.663 178.722 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.467 0.0 OUTLIER 127.73 59.44 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.634 1 C-N-CA 135.15 5.38 . . . . 0.0 112.837 -178.221 . . . . . . . . 4 3 . 1 . 041 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -129.16 -35.11 1.83 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.696 1.198 . . . . 0.0 112.188 -179.109 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -153.96 64.72 0.71 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.22 0.918 . . . . 0.0 113.127 179.505 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 t70 57.89 -170.32 0.11 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.315 1.446 . . . . 0.0 113.285 178.154 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.3 p 47.68 43.67 16.79 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.924 1.69 . . . . 0.0 112.94 179.049 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.85 -175.59 3.54 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.279 1.431 . . . . 0.0 114.426 -178.532 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -32.35 138.02 0.1 Allowed Glycine 0 C--N 1.341 0.846 0 C-N-CA 128.118 2.771 . . . . 0.0 117.558 -178.217 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.9 m -101.88 -55.94 2.39 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.311 1.444 . . . . 0.0 110.629 -179.519 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.6 p -97.65 -63.57 1.12 Allowed 'General case' 0 C--N 1.346 0.454 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -179.256 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.8 p -146.41 -42.03 0.2 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.598 1.959 . . . . 0.0 110.376 -179.532 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -91.59 151.6 42.62 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 124.692 1.197 . . . . 0.0 109.746 -178.088 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -84.38 134.2 20.57 Favored 'Cis proline' 0 N--CA 1.45 -1.048 0 CA-C-N 119.655 0.913 . . . . 0.0 111.127 -1.72 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.05 172.9 15.15 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 126.033 1.733 . . . . 0.0 108.207 179.412 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 t -60.4 147.77 39.66 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.715 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -80.01 116.61 20.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.998 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -68.48 -52.75 28.9 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.654 1.181 . . . . 0.0 112.301 -179.345 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -88.38 -170.04 2.8 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.482 1.113 . . . . 0.0 111.173 -179.061 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -129.07 -50.78 1.21 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.635 1.974 . . . . 0.0 108.638 179.505 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 53.99 70.61 0.59 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.326 1.85 . . . . 0.0 113.763 178.455 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.45 -98.38 0.24 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.684 1.135 . . . . 0.0 113.217 178.579 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.05 154.15 16.27 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.689 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -121.21 -170.11 1.96 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 126.23 1.812 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -131.25 158.38 75.41 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 125.328 1.451 . . . . 0.0 108.233 -178.63 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.409 ' O ' HG13 ' A' ' 52' ' ' VAL . 81.2 Cg_endo -73.5 66.57 4.58 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 124.006 3.137 . . . . 0.0 113.226 -178.766 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 51' ' ' PRO . 3.0 m -163.1 164.94 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 126.86 2.064 . . . . 0.0 108.873 179.315 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -84.77 -58.99 2.49 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.478 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.95 177.63 15.02 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.11 1.338 . . . . 0.0 110.516 -179.321 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.57 139.17 58.46 Favored 'Cis proline' 0 N--CA 1.457 -0.629 0 CA-C-N 117.916 0.858 . . . . 0.0 111.442 0.127 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -114.8 150.79 34.89 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.891 1.277 . . . . 0.0 109.511 178.698 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -113.7 159.32 19.84 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -177.002 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -98.7 152.48 19.61 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.133 1.773 . . . . 0.0 109.529 179.132 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 58.6 t80 -160.84 119.83 1.53 Allowed Pre-proline 0 C--O 1.223 -0.301 0 C-N-CA 124.008 0.923 . . . . 0.0 108.707 177.272 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.91 122.97 3.09 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 121.229 1.286 . . . . 0.0 113.795 -177.572 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 62' ' ' LYS . 4.4 tp -86.17 168.25 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 CA-C-O 123.678 1.704 . . . . 0.0 111.998 179.293 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.408 ' N ' HG13 ' A' ' 61' ' ' ILE . 25.9 mmtt -158.64 158.11 33.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 109.233 -3.621 . . . . 0.0 111.604 -178.851 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.1 m -84.92 60.04 5.97 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.813 1.645 . . . . 0.0 110.36 -178.946 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.85 -61.69 0.01 OUTLIER Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 179.083 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.85 -104.47 0.19 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.207 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.24 163.97 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.429 1.092 . . . . 0.0 108.438 -179.455 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.93 152.63 12.52 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -178.37 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.8 p -139.21 -65.68 0.48 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.649 1.58 . . . . 0.0 108.575 179.378 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.02 105.11 0.27 Allowed Glycine 0 C--N 1.341 0.837 0 C-N-CA 124.417 1.008 . . . . 0.0 110.783 179.301 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -150.1 19.97 1.09 Allowed Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.808 -0.996 . . . . 0.0 113.069 179.313 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.1 m 67.42 119.97 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 126.375 1.87 . . . . 0.0 112.069 179.204 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.71 -176.24 17.91 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 CA-C-N 119.785 0.959 . . . . 0.0 112.499 0.131 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.07 66.99 0.32 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 108.19 -1.964 . . . . 0.0 108.19 179.287 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.95 -58.85 2.27 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.474 0.71 . . . . 0.0 112.097 -178.831 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -61.14 117.83 6.05 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.434 1.494 . . . . 0.0 113.398 -178.116 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -138.56 118.15 13.02 Favored 'General case' 0 C--N 1.344 0.368 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.159 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.5 m -81.64 148.39 5.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 176.879 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.27 53.6 t -130.97 111.51 20.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -178.071 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -101.12 -179.67 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 125.861 1.664 . . . . 0.0 113.936 -176.382 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -101.86 155.16 18.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 127.957 2.503 . . . . 0.0 108.62 179.875 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.282 11.4 t -64.11 -8.45 12.1 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -178.323 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -84.27 -80.74 0.19 Allowed 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 102.485 -3.154 . . . . 0.0 102.485 177.645 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 23.4 m -164.34 -7.39 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 129.589 3.155 . . . . 0.0 114.951 -179.17 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -79.68 132.76 36.29 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 116.501 2.038 . . . . 0.0 116.501 -175.314 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -75.34 123.16 24.87 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.152 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.51 -59.55 2.28 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.825 0.85 . . . . 0.0 111.258 -178.184 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.11 164.28 33.54 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -179.899 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.29 158.81 19.29 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.814 0.816 . . . . 0.0 112.25 -178.858 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.8 pt -140.46 160.3 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.329 2.252 . . . . 0.0 106.859 179.288 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.3 t -156.65 152.15 26.78 Favored 'General case' 0 C--N 1.343 0.326 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -179.046 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -83.57 38.34 0.62 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.337 0.655 . . . . 0.0 111.07 176.571 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.2 m -77.7 -73.3 0.31 Allowed 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.369 0.986 . . . . 0.0 109.624 -179.334 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.35 -9.21 60.63 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.489 1.043 . . . . 0.0 112.116 178.939 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.81 155.07 27.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.555 1.542 . . . . 0.0 111.748 178.993 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.8 m -68.89 -50.09 52.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.659 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.93 -84.29 0.05 OUTLIER Glycine 0 CA--C 1.527 0.787 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.193 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -89.01 0.32 56.77 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.127 0.971 . . . . 0.0 111.891 179.828 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -71.34 -170.57 0.51 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.863 0.865 . . . . 0.0 110.56 179.516 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -147.78 160.88 42.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.644 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.1 m -142.41 162.7 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 127.585 2.354 . . . . 0.0 106.334 177.012 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.98 121.53 5.55 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.074 0.845 . . . . 0.0 114.401 -178.808 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.44 159.6 15.03 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.65 1.18 . . . . 0.0 109.404 178.502 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.7 p 60.27 45.22 11.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.472 1.909 . . . . 0.0 111.042 -178.781 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.01 44.17 96.3 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.299 0.952 . . . . 0.0 111.928 179.448 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.9 m -104.84 149.53 25.59 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.625 1.17 . . . . 0.0 109.362 179.316 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.106 0 C-N-CA 124.445 1.098 . . . . 0.0 108.146 179.083 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.03 124.58 19.18 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.427 1.091 . . . . 0.0 109.817 179.274 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 p -89.46 81.39 6.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -178.309 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.27 92.09 6.88 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 175.877 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -100.51 79.06 2.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.535 1.534 . . . . 0.0 109.324 -177.643 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.76 -70.62 1.98 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.345 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.2 p -137.98 -34.11 0.68 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.632 1.573 . . . . 0.0 111.877 179.453 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 m -72.67 93.55 1.65 Allowed 'General case' 0 C--N 1.345 0.389 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.148 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -96.6 113.74 25.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.777 1.631 . . . . 0.0 112.869 -178.43 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -109.78 144.75 37.77 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.885 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 16' ' ' VAL . 50.0 m -66.37 152.3 45.33 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 124.229 1.011 . . . . 0.0 109.527 179.148 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.94 -24.73 25.16 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.705 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.4 t -71.33 -43.79 66.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.146 1.378 . . . . 0.0 109.594 179.31 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -71.86 -29.47 64.41 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -179.263 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 12' ' ' SER . 1.9 t -72.29 -45.26 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.28 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -67.86 -32.94 73.79 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.37 1.068 . . . . 0.0 111.857 179.393 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.04 -58.17 5.43 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.444 1.02 . . . . 0.0 110.135 -179.265 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.4 ' HB1' ' HE2' ' A' ' 59' ' ' PHE . . . -60.53 -37.09 80.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.787 -178.843 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.78 58.63 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 179.413 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -68.78 -19.89 64.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.785 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.54 -60.86 2.17 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 179.525 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.463 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . . . -48.71 -41.34 31.55 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.371 1.068 . . . . 0.0 112.4 177.219 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -55.74 30.86 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.002 1.321 . . . . 0.0 109.906 179.014 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -56.55 -31.47 64.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.675 1.19 . . . . 0.0 110.893 -178.379 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 -89.07 -32.05 17.74 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -178.832 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -63.94 -36.53 84.26 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.636 1.107 . . . . 0.0 113.927 -177.7 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -105.33 27.0 8.72 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.975 0.91 . . . . 0.0 111.98 -178.513 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.99 -36.83 8.46 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.076 0.95 . . . . 0.0 111.992 179.338 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.7 t70 83.49 96.19 0.04 OUTLIER 'General case' 0 C--N 1.344 0.345 0 C-N-CA 127.354 2.262 . . . . 0.0 108.789 -178.597 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 70.99 109.0 0.06 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 127.192 2.197 . . . . 0.0 109.65 -178.755 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -175.97 -47.98 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.25 1.42 . . . . 0.0 111.422 -177.622 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.88 96.92 3.21 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.986 0.514 . . . . 0.0 109.845 -179.288 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.16 49.62 3.78 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.564 1.078 . . . . 0.0 110.461 179.705 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.0 m -89.14 -76.49 0.41 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.799 1.239 . . . . 0.0 108.374 -179.463 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.8 t -173.72 -64.98 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.114 1.765 . . . . 0.0 106.48 179.235 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.525 HG23 ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -150.08 8.67 0.65 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.388 1.475 . . . . 0.0 111.857 178.84 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -94.95 129.8 34.7 Favored Pre-proline 0 C--N 1.345 0.382 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.294 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -70.15 129.0 13.94 Favored 'Cis proline' 0 N--CA 1.456 -0.726 0 N-CA-C 115.444 1.286 . . . . 0.0 115.444 0.115 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.525 ' CE1' HG23 ' A' ' 37' ' ' THR 0.252 21.3 m-70 -96.87 143.65 27.57 Favored 'General case' 0 C--N 1.343 0.298 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 178.059 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 t -63.14 142.15 58.49 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.584 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -107.35 119.26 38.92 Favored 'General case' 0 C--O 1.23 0.048 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.04 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -149.64 -63.57 0.22 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.279 1.832 . . . . 0.0 107.085 178.921 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.4 t30 50.91 -115.56 0.88 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.03 1.732 . . . . 0.0 112.044 178.798 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -169.37 -174.96 2.08 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.02 2.128 . . . . 0.0 107.627 -179.165 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 76.93 157.42 0.18 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.801 1.641 . . . . 0.0 110.869 179.319 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.45 70.14 2.47 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.077 0.846 . . . . 0.0 111.292 179.19 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.5 111.74 6.55 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.167 1.387 . . . . 0.0 107.809 179.042 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -148.31 -175.49 4.93 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.847 1.259 . . . . 0.0 108.355 179.721 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -132.01 144.97 55.42 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.662 1.185 . . . . 0.0 108.647 -179.076 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.23 67.3 6.95 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 124.36 3.373 . . . . 0.0 112.293 -179.226 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.05 -170.65 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 127.496 2.318 . . . . 0.0 107.573 179.246 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -118.57 131.33 56.21 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.765 1.226 . . . . 0.0 109.606 179.18 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.02 -172.23 45.92 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.324 0.964 . . . . 0.0 112.341 -179.353 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.95 151.93 97.61 Favored 'Cis proline' 0 N--CA 1.458 -0.594 0 CA-C-N 118.041 0.92 . . . . 0.0 111.809 0.078 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -118.14 176.28 5.29 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.861 1.265 . . . . 0.0 109.942 179.324 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.12 153.51 31.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.972 178.992 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.274 8.0 tp10 -79.92 150.05 30.67 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.099 2.56 . . . . 0.0 111.579 -177.7 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 77.7 t80 -155.27 106.0 2.23 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.004 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.429 ' HG2' ' CD1' ' A' ' 67' ' ' TYR . 60.5 Cg_endo -72.71 135.06 23.11 Favored 'Trans proline' 0 N--CA 1.442 -1.542 0 N-CA-C 107.674 -1.702 . . . . 0.0 107.674 -177.311 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.466 ' CG1' ' H ' ' A' ' 62' ' ' LYS 0.266 0.1 OUTLIER -85.76 -147.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.34 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -176.1 . . . . . . . . 4 4 . 1 . 042 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.466 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.9 mmmm -79.25 166.28 22.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 110.936 -2.847 . . . . 0.0 111.401 -178.287 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.2 m 132.31 51.73 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.493 1 C-N-CA 133.199 4.599 . . . . 0.0 104.723 -177.987 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.54 -52.09 0.59 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.665 1.602 . . . . 0.0 109.243 -178.545 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 177.53 -164.72 34.02 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.483 1.04 . . . . 0.0 110.562 179.728 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.6 p -75.25 71.33 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.92 1.288 . . . . 0.0 107.975 178.888 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.429 ' CD1' ' HG2' ' A' ' 60' ' ' PRO . 34.7 t80 65.81 80.07 0.23 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 128.484 2.713 . . . . 0.0 111.251 -178.269 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 t -157.78 105.59 2.01 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.782 1.233 . . . . 0.0 108.909 179.083 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 179.13 -118.71 0.61 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.4 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 174.29 -99.4 0.14 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.159 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.0 m -60.84 -58.2 21.0 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.241 1.016 . . . . 0.0 112.138 179.534 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.17 134.31 36.17 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.064 1.843 . . . . 0.0 110.497 177.788 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.99 -103.64 0.17 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 179.522 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.441 ' HB1' ' H ' ' A' ' 91' ' ' HIS . . . 72.66 -46.42 0.65 Allowed 'General case' 0 C--N 1.344 0.366 0 C-N-CA 127.257 2.223 . . . . 0.0 113.502 -179.645 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.24 125.17 28.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.848 1.659 . . . . 0.0 112.744 -178.488 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -146.28 124.18 12.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.686 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.5 m -86.76 156.17 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 103.317 -2.846 . . . . 0.0 103.317 177.098 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 73.3 t -134.89 115.49 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 -178.08 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 85' ' ' TYR . 1.8 pt -95.52 165.92 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.428 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -176.313 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -99.75 163.03 12.65 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 124.677 1.191 . . . . 0.0 108.185 178.949 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.327 5.2 t -74.11 27.84 0.08 Allowed 'General case' 0 C--N 1.339 0.144 0 N-CA-C 119.698 3.221 . . . . 0.0 119.698 -177.232 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -123.35 -79.32 0.61 Allowed 'General case' 0 N--CA 1.441 -0.917 1 N-CA-C 100.058 -4.053 . . . . 0.0 100.058 176.61 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.0 t -164.13 -24.03 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.14 1.776 . . . . 0.0 114.409 179.008 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -79.68 127.42 32.17 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -176.442 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 79' ' ' ILE 0.344 4.5 p90 -82.24 147.67 28.82 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 123.665 0.603 . . . . 0.0 111.343 -178.922 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.81 -46.26 19.13 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.655 1.182 . . . . 0.0 111.335 -177.338 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.79 -153.69 16.6 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.116 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.82 150.36 32.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.393 0.616 . . . . 0.0 111.402 -179.308 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 44.2 pt -138.47 157.86 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.031 1.733 . . . . 0.0 108.043 -179.337 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.8 t -157.7 154.89 29.01 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.063 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.441 ' H ' ' HB1' ' A' ' 74' ' ' ALA . 11.3 m170 -79.34 -14.89 58.69 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 123.344 0.403 . . . . 0.0 110.297 175.517 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.3 m -62.0 115.3 3.96 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 123.873 0.869 . . . . 0.0 109.832 -179.304 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.27 -15.3 63.52 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.959 0.79 . . . . 0.0 112.382 -179.11 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.97 -177.45 5.57 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.446 1.098 . . . . 0.0 111.4 -179.564 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.8 t -87.36 59.46 5.54 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.836 1.255 . . . . 0.0 111.141 -179.396 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.34 -89.31 1.01 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.971 1.272 . . . . 0.0 112.865 178.486 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -79.8 -31.6 40.74 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.405 1.082 . . . . 0.0 111.22 -179.35 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -55.21 165.65 0.69 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.685 1.594 . . . . 0.0 111.709 179.627 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -120.18 155.25 33.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.48 1.512 . . . . 0.0 111.956 -179.178 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.3 m -139.17 163.05 27.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 C-N-CA 125.949 1.7 . . . . 0.0 107.96 177.794 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.81 140.15 19.94 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.892 0.758 . . . . 0.0 112.183 -178.717 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 t -83.22 -177.41 6.74 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.658 1.183 . . . . 0.0 109.73 178.949 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.8 t -70.51 112.35 6.72 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.822 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.86 -41.24 2.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -178.95 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.1 m -86.49 94.19 9.35 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.988 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 t30 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.225 -1.369 . . . . 0.0 109.445 -178.918 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.2 m -77.29 123.5 26.56 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 77.29 66.77 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.31 140.28 29.76 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 125.502 1.521 . . . . 0.0 109.136 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.02 121.95 35.86 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.5 m -102.14 78.8 1.8 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.154 1.381 . . . . 0.0 107.864 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.38 -97.45 0.68 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 t -100.35 -39.56 7.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.933 1.293 . . . . 0.0 110.034 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.5 m -72.25 96.49 1.84 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.347 1.059 . . . . 0.0 109.767 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -79.92 155.67 27.63 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.257 1.023 . . . . 0.0 110.867 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -143.35 119.76 10.96 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.218 1.007 . . . . 0.0 110.744 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.5 t -60.24 159.09 10.37 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.147 1.779 . . . . 0.0 110.663 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.02 -17.34 51.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 t -76.86 -43.93 34.18 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.601 1.16 . . . . 0.0 108.743 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.81 -45.89 80.66 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.665 1.186 . . . . 0.0 111.305 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.433 HG13 ' CE2' ' A' ' 85' ' ' TYR . 73.6 t -58.2 -52.6 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.739 1.216 . . . . 0.0 108.345 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -68.18 -31.6 71.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.3 1.44 . . . . 0.0 113.484 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.14 -60.05 2.93 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.933 0.788 . . . . 0.0 109.417 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 -30.25 71.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.462 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.07 -51.51 15.54 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 119.507 -0.283 . . . . 0.0 111.494 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -60.36 -19.7 56.66 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.32 -72.16 0.27 Allowed 'General case' 0 C--N 1.347 0.49 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.599 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -56.03 -29.47 60.46 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.224 0.92 . . . . 0.0 111.788 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.6 t -56.86 -44.13 81.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.485 1.039 . . . . 0.0 109.005 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -96.58 4.01 52.24 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -126.54 -12.43 6.12 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -74.65 -53.09 9.98 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 119.186 0.903 . . . . 0.0 113.089 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.326 0.0 OUTLIER -137.47 33.56 2.51 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.949 0.881 . . . . 0.0 112.275 -177.529 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -74.0 -64.93 0.91 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 176.7 37.68 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 129.024 2.93 . . . . 0.0 109.284 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -176.14 -171.13 0.41 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.134 1.774 . . . . 0.0 109.246 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.5 p -122.63 -51.65 1.93 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.929 2.092 . . . . 0.0 109.195 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 43.62 55.03 5.2 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 126.666 1.986 . . . . 0.0 112.081 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.33 179.68 25.93 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 112.251 -2.25 . . . . 0.0 111.625 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.8 p -61.44 -66.99 0.45 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.048 0.939 . . . . 0.0 110.215 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.0 t -163.7 -66.33 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.594 1.158 . . . . 0.0 108.541 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.1 p -106.48 31.27 5.32 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.364 1.066 . . . . 0.0 110.999 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -164.95 104.75 0.8 Allowed Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.538 1.535 . . . . 0.0 107.723 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -64.17 156.42 72.75 Favored 'Cis proline' 0 N--CA 1.456 -0.731 0 CA-C-N 120.289 1.139 . . . . 0.0 113.555 -0.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.63 168.54 6.27 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.884 1.673 . . . . 0.0 108.985 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 t -68.25 151.62 46.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -79.84 110.34 15.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -10.69 -91.14 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.951 3.301 . . . . 0.0 115.488 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 143.78 -54.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 130.269 3.428 . . . . 0.0 106.929 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -56.94 124.32 18.21 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.062 1.345 . . . . 0.0 109.888 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 62.28 58.59 1.74 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.954 1.302 . . . . 0.0 108.536 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.41 111.34 4.1 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.712 1.149 . . . . 0.0 110.624 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.24 169.2 16.84 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.572 0.749 . . . . 0.0 110.626 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -71.2 130.2 40.83 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.121 1.369 . . . . 0.0 113.682 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -163.6 120.98 1.2 Allowed Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 126.152 1.781 . . . . 0.0 108.706 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -65.29 -165.64 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.987 2.458 . . . . 0.0 111.111 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.7 t 76.96 -101.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.178 1.391 . . . . 0.0 110.045 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -167.8 -67.09 0.03 OUTLIER 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.178 0.899 . . . . 0.0 111.609 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.68 -172.7 14.75 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.256 1.408 . . . . 0.0 109.584 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.55 163.59 52.05 Favored 'Cis proline' 0 N--CA 1.456 -0.715 0 CA-C-N 119.118 1.459 . . . . 0.0 111.707 -1.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -110.71 172.9 6.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.343 1.057 . . . . 0.0 111.363 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -140.25 131.15 26.03 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.158 1.383 . . . . 0.0 108.606 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -94.58 161.82 14.05 Favored 'General case' 0 C--O 1.227 -0.09 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.599 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -160.03 105.99 1.41 Allowed Pre-proline 0 N--CA 1.455 -0.176 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.025 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.22 120.45 6.57 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 121.101 1.2 . . . . 0.0 109.866 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.612 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.6 tt -83.62 -175.43 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 123.665 1.698 . . . . 0.0 112.423 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.612 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 13.7 mmtt -160.31 163.02 33.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 109.82 -3.354 . . . . 0.0 110.816 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.0 t -78.82 56.86 1.98 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.998 1.719 . . . . 0.0 112.135 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.32 60.9 0.21 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 125.088 1.328 . . . . 0.0 112.474 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.18 140.3 3.05 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 117.695 0.747 . . . . 0.0 113.86 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.5 p -100.17 157.61 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 126.785 2.034 . . . . 0.0 107.239 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 64.91 74.21 0.4 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.134 0.974 . . . . 0.0 108.675 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.0 p -134.65 -169.39 2.33 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.409 1.483 . . . . 0.0 109.714 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.41 124.13 24.71 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.084 1.326 . . . . 0.0 113.695 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.37 101.0 0.87 Allowed Glycine 0 C--N 1.339 0.741 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.0 t 64.63 86.07 0.15 Allowed Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 125.363 1.465 . . . . 0.0 109.302 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.1 164.03 88.72 Favored 'Cis proline' 0 N--CA 1.458 -0.597 0 CA-C-N 119.571 0.882 . . . . 0.0 112.503 5.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.89 -58.07 0.17 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.473 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . 87.11 -67.71 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 129.128 2.971 . . . . 0.0 108.321 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -70.48 119.93 15.37 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.484 1.914 . . . . 0.0 113.149 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.1 mtt-85 -141.48 147.8 38.44 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.121 1.369 . . . . 0.0 112.301 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -112.61 144.05 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.4 t -139.92 127.04 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.88 0.372 . . . . 0.0 110.647 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -106.39 174.15 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.358 0 C-N-CA 126.922 2.089 . . . . 0.0 111.202 -178.325 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -93.56 169.08 10.61 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.952 2.101 . . . . 0.0 105.589 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.367 14.5 t -76.29 53.35 0.82 Allowed 'General case' 0 C--N 1.341 0.223 0 N-CA-C 117.775 2.509 . . . . 0.0 117.775 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -160.05 -83.31 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.82 -0.29 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.654 1.581 . . . . 0.0 114.27 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.57 110.56 16.16 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.016 1.28 . . . . 0.0 113.842 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.433 ' CE2' HG13 ' A' ' 16' ' ' VAL . 8.2 t80 -60.04 111.64 1.58 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.712 0.805 . . . . 0.0 109.707 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.25 -40.13 31.38 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.629 1.171 . . . . 0.0 111.349 -178.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.4 168.81 17.02 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' HB2' ' OH ' ' A' ' 85' ' ' TYR . . . -109.75 154.31 23.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.679 0.792 . . . . 0.0 110.353 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.8 pt -131.51 157.7 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 125.78 1.632 . . . . 0.0 107.99 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.0 t -159.53 139.28 11.58 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.473 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 24.9 m170 -84.36 46.77 1.26 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.7 t -65.65 -38.6 89.81 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.3 56.72 0.54 Allowed Glycine 0 C--N 1.335 0.486 0 N-CA-C 106.119 -2.792 . . . . 0.0 106.119 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -106.92 -17.56 14.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.3 m 64.39 35.54 9.6 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.6 21.93 78.72 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.704 2.097 . . . . 0.0 113.899 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -146.76 -70.58 0.24 Allowed 'General case' 0 C--N 1.347 0.484 0 CA-C-N 119.44 1.62 . . . . 0.0 114.216 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -58.9 100.36 0.07 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.054 1.742 . . . . 0.0 114.042 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.281 0.5 OUTLIER -78.14 140.98 39.02 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.439 0.695 . . . . 0.0 109.613 -178.433 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.17 160.86 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.74 160.65 29.0 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.31 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.8 m -117.93 159.55 22.94 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.638 1.175 . . . . 0.0 110.583 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.3 t 44.19 69.11 0.45 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.046 1.738 . . . . 0.0 115.429 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.43 -4.13 74.39 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.094 -0.837 . . . . 0.0 114.334 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.8 m -84.29 104.63 14.48 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 116.622 -1.656 . . . . 0.0 111.231 179.417 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 120.597 0.237 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.9 p -127.8 58.75 1.49 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.23 1.412 . . . . 0.0 111.234 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.5 136.4 0.03 OUTLIER 'General case' 0 C--N 1.341 0.208 0 C-N-CA 126.664 1.985 . . . . 0.0 111.592 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.1 p -116.82 109.88 17.67 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.79 98.23 7.92 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 100.636 -3.838 . . . . 0.0 100.636 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.1 m -94.35 79.37 3.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.141 0.976 . . . . 0.0 109.102 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.09 -86.06 1.0 Allowed Glycine 0 C--N 1.34 0.777 0 C-N-CA 125.061 1.315 . . . . 0.0 110.013 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.4 p -119.58 -38.87 2.93 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 125.598 1.559 . . . . 0.0 110.156 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 m -74.14 100.78 3.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -95.04 149.43 21.26 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.85 0.86 . . . . 0.0 113.223 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -144.22 152.73 41.24 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.321 1.449 . . . . 0.0 110.043 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.9 m -74.55 159.6 31.98 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 125.556 1.542 . . . . 0.0 111.449 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.26 -22.67 67.02 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.5 t -70.49 -37.08 74.15 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 125.076 1.35 . . . . 0.0 109.062 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -65.69 -42.57 91.04 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.116 0.966 . . . . 0.0 109.731 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.1 t -61.27 -47.86 91.58 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.2 mtp85 -66.64 -26.55 67.12 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.214 1.406 . . . . 0.0 112.383 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.15 -60.58 2.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.71 -28.25 69.46 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.858 -0.592 . . . . 0.0 111.279 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.69 -37.1 50.34 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 118.941 -0.552 . . . . 0.0 112.38 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -70.5 -22.03 62.69 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.53 -59.74 2.61 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.49 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -45.96 -47.89 16.51 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.697 1.199 . . . . 0.0 110.33 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 m -51.1 -54.57 23.83 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.227 1.011 . . . . 0.0 110.961 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -77.09 -27.51 54.21 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -113.34 -6.0 13.55 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.289 0.0 OUTLIER -95.23 -38.96 10.32 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -179.077 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -147.29 33.53 0.88 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.326 0.966 . . . . 0.0 112.043 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -132.78 -70.71 0.54 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -136.49 85.49 2.15 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -56.77 118.76 5.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.022 1.329 . . . . 0.0 113.678 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.8 p -143.65 49.53 1.4 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.124 1.769 . . . . 0.0 108.681 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -163.26 153.05 15.4 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.116 0.966 . . . . 0.0 110.014 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.98 155.64 52.99 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.1 t -133.45 77.92 1.75 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.163 0.985 . . . . 0.0 108.87 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 p -107.09 -59.19 1.84 Allowed 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.87 -11.5 7.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.559 1.944 . . . . 0.0 110.733 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.66 129.95 3.53 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.93 139.71 55.04 Favored 'Cis proline' 0 N--CA 1.452 -0.959 0 CA-C-N 120.153 1.09 . . . . 0.0 110.536 -0.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -155.09 148.14 24.7 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 t -56.08 144.73 28.07 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -79.41 112.66 16.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -71.33 81.6 0.75 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.98 1.312 . . . . 0.0 109.215 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -156.76 76.04 0.86 Allowed 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.21 -37.97 73.02 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.862 1.265 . . . . 0.0 110.699 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -64.43 -35.59 81.42 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.29 114.76 0.24 Allowed Glycine 0 C--N 1.342 0.881 0 C-N-CA 125.875 1.702 . . . . 0.0 114.301 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -78.94 106.22 10.82 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.0 p-10 -28.98 111.03 0.06 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.484 1.914 . . . . 0.0 115.842 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -147.88 151.0 37.46 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 126.895 2.078 . . . . 0.0 108.076 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.02 78.04 3.72 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.327 2.685 . . . . 0.0 107.391 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.17 171.25 12.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 C-N-CA 124.841 1.256 . . . . 0.0 113.569 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -125.93 -49.61 1.6 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 128.034 2.534 . . . . 0.0 105.997 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.69 170.73 46.5 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.862 1.696 . . . . 0.0 113.914 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.55 134.74 32.26 Favored 'Cis proline' 0 N--CA 1.46 -0.498 0 O-C-N 122.419 0.694 . . . . 0.0 112.18 -0.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -107.49 136.5 47.17 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.602 1.561 . . . . 0.0 109.541 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -125.49 161.83 26.24 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 123.641 0.777 . . . . 0.0 111.24 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -83.88 153.34 24.05 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.597 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.49 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 17.1 t80 -155.44 103.21 2.2 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 102.791 -3.04 . . . . 0.0 102.791 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -76.46 136.59 17.69 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.027 1.818 . . . . 0.0 115.832 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 62' ' ' LYS . 1.2 tp -89.87 171.24 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 126.086 1.754 . . . . 0.0 112.787 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -159.06 170.31 22.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 110.62 -2.991 . . . . 0.0 113.067 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -82.0 57.92 3.71 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.86 2.064 . . . . 0.0 112.029 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.28 73.43 0.77 Allowed Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.34 -177.58 40.63 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-O 121.631 0.573 . . . . 0.0 112.808 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.71 148.4 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 127.374 2.269 . . . . 0.0 106.39 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.312 51.4 p90 58.4 -170.11 0.12 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.78 1.632 . . . . 0.0 111.924 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.2 t -79.61 166.36 21.96 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.696 0.799 . . . . 0.0 112.577 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.08 140.24 3.1 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.29 -114.12 4.85 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 124.689 1.137 . . . . 0.0 111.103 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -155.31 -68.52 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.441 1.096 . . . . 0.0 109.972 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.55 160.46 46.56 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.292 1.995 . . . . 0.0 110.547 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.53 -83.4 0.06 OUTLIER Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.47 ' HB1' ' H ' ' A' ' 91' ' ' HIS . . . 81.77 -39.89 0.13 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.186 1.794 . . . . 0.0 111.041 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -71.3 125.41 26.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.061 1.744 . . . . 0.0 115.064 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -139.5 131.33 27.57 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 123.723 0.809 . . . . 0.0 112.254 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.7 m -94.64 148.15 5.2 Favored 'Isoleucine or valine' 0 C--N 1.345 0.406 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -134.35 139.71 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 pt -135.16 165.75 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.256 0.622 . . . . 0.0 112.497 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -93.55 155.41 17.33 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 127.9 2.48 . . . . 0.0 108.621 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.37 15.0 t -79.55 65.64 4.78 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -156.86 -94.58 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.172 1 N-CA-C 98.856 -4.498 . . . . 0.0 98.856 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.4 m -162.98 9.4 0.06 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.698 2.399 . . . . 0.0 113.035 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -82.84 132.46 35.16 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.548 1.067 . . . . 0.0 112.609 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -73.12 122.72 22.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.54 -57.96 3.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.69 153.21 11.56 Favored Glycine 0 C--N 1.339 0.717 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.465 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.03 112.03 24.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.58 162.34 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.709 0.804 . . . . 0.0 109.181 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.6 t -160.3 150.13 17.92 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.47 ' H ' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -89.47 63.97 6.55 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 175.27 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.1 t -63.75 -38.87 92.74 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.021 -1.049 . . . . 0.0 112.739 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.79 54.32 0.04 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.21 -78.78 0.4 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.77 0.828 . . . . 0.0 108.813 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.6 m -159.42 73.96 0.6 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.658 1.583 . . . . 0.0 108.72 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.83 -102.75 0.94 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.032 0.825 . . . . 0.0 111.719 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -79.77 -25.85 40.84 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.756 0.822 . . . . 0.0 111.83 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -49.15 129.69 18.2 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 124.52 1.128 . . . . 0.0 111.4 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -97.39 153.0 18.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.341 1.456 . . . . 0.0 113.405 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.0 m -135.21 167.26 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 126.957 2.103 . . . . 0.0 107.032 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.1 151.34 30.01 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 116.542 1.377 . . . . 0.0 116.542 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 38.7 m -106.53 -173.67 2.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.859 1.664 . . . . 0.0 106.641 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.0 t -69.32 140.98 54.37 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.454 -0.779 . . . . 0.0 108.984 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.31 32.54 59.97 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.936 0.779 . . . . 0.0 111.332 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.9 m -137.85 108.38 6.56 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 117.192 -1.385 . . . . 0.0 109.474 -178.984 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.491 0 CA-C-O 120.511 0.196 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.0 m -152.93 129.5 10.74 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.496 1.518 . . . . 0.0 107.613 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -40.24 132.22 1.98 Allowed 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.485 1.914 . . . . 0.0 112.664 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.8 p -102.65 89.06 3.38 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.272 1.029 . . . . 0.0 111.372 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -94.87 98.3 10.62 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.02 -165.14 0.92 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.118 1.367 . . . . 0.0 108.049 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -31.09 -57.87 0.27 Allowed Glycine 0 C--N 1.343 0.971 0 C-N-CA 125.993 1.758 . . . . 0.0 112.159 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.9 p -160.31 38.1 0.17 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.225 1.01 . . . . 0.0 109.687 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 m -129.49 94.15 3.71 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.7 110.47 15.06 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.697 1.199 . . . . 0.0 111.459 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -110.26 128.92 55.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.3 m -65.89 158.13 28.78 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 124.713 1.205 . . . . 0.0 110.726 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.64 -17.32 54.89 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.1 p -77.55 -37.98 49.56 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 124.0 0.92 . . . . 0.0 108.719 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -68.77 -36.04 77.82 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.027 0.931 . . . . 0.0 109.974 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.407 HG11 ' CE2' ' A' ' 85' ' ' TYR . 58.7 t -63.44 -47.82 89.96 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -64.49 -37.45 87.57 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.014 0.926 . . . . 0.0 111.374 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 -55.16 15.49 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.541 0.61 . . . . 0.0 110.225 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.44 -37.13 82.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.136 0.975 . . . . 0.0 111.172 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.32 -34.34 42.35 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -70.87 -22.02 62.34 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.1 -51.62 9.99 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.486 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -47.32 -67.07 0.31 Allowed 'General case' 0 C--N 1.345 0.375 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 176.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.2 t -39.09 -46.31 1.39 Allowed 'General case' 0 C--N 1.343 0.287 0 C-N-CA 127.892 2.477 . . . . 0.0 112.475 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -65.14 -58.34 6.27 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -71.73 -8.62 55.28 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 57' ' ' GLN . 6.4 t80 -79.38 -47.94 14.88 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.957 1.303 . . . . 0.0 111.376 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -135.51 -26.66 1.23 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -72.89 -56.44 5.19 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.43 1.014 . . . . 0.0 112.861 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -128.13 73.02 1.44 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.472 1.509 . . . . 0.0 108.775 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -55.06 153.4 6.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.704 1.202 . . . . 0.0 113.058 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 59.6 p 56.17 70.85 0.6 Allowed 'General case' 0 C--N 1.34 0.164 0 C-N-CA 127.153 2.181 . . . . 0.0 112.437 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -158.17 91.15 1.08 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.65 -78.23 0.2 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.8 m -145.55 -116.39 0.08 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.159 0.983 . . . . 0.0 108.675 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.9 m -158.26 -50.51 0.06 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.597 1.559 . . . . 0.0 109.35 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.0 p -79.73 6.26 11.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.293 1.037 . . . . 0.0 112.868 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -151.94 95.29 3.23 Favored Pre-proline 0 N--CA 1.455 -0.208 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -84.22 142.75 40.07 Favored 'Cis proline' 0 N--CA 1.455 -0.746 0 N-CA-C 116.263 1.601 . . . . 0.0 116.263 2.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.15 158.83 25.19 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.703 2.401 . . . . 0.0 107.377 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 m -42.38 120.0 1.54 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.022 2.129 . . . . 0.0 113.555 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -138.13 86.47 2.17 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -167.63 -49.67 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.676 1.19 . . . . 0.0 109.039 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -86.96 59.7 5.79 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.156 1.382 . . . . 0.0 110.141 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.36 14.98 1.46 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.817 0.847 . . . . 0.0 112.117 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 56.9 83.62 0.1 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 125.222 1.409 . . . . 0.0 111.267 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.24 167.09 36.04 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.67 100.5 0.28 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.147 0.979 . . . . 0.0 112.989 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.97 164.86 26.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.537 0.735 . . . . 0.0 109.976 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -106.08 151.07 40.01 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -58.13 -95.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 124.524 3.482 . . . . 0.0 114.152 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m 24.92 -106.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 127.062 2.145 . . . . 0.0 113.521 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -163.01 -44.78 0.03 OUTLIER 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.076 0.853 . . . . 0.0 112.214 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.16 -167.54 29.19 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -60.94 165.65 30.04 Favored 'Cis proline' 0 CA--C 1.535 0.547 0 CA-C-N 119.572 1.686 . . . . 0.0 114.123 -0.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -132.15 143.15 49.78 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.541 1.136 . . . . 0.0 111.502 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.466 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -139.99 153.32 46.83 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.325 1.05 . . . . 0.0 108.231 177.744 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.75 154.28 23.68 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.486 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 26.9 t80 -160.74 106.68 1.3 Allowed Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.399 1.08 . . . . 0.0 109.006 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.92 155.75 15.25 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 N-CA-C 119.008 2.657 . . . . 0.0 119.008 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.496 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 6.5 tt -105.63 175.37 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 C-N-CA 126.984 2.114 . . . . 0.0 110.035 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.496 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 6.9 tptp -160.9 166.59 28.17 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 109.352 -3.567 . . . . 0.0 112.454 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.1 t -88.83 62.15 6.27 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.542 1.537 . . . . 0.0 108.764 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.06 64.19 0.66 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 167.5 145.0 4.34 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.1 t -123.56 66.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.0 t80 64.08 103.26 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.086 2.155 . . . . 0.0 112.863 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.8 p -138.96 64.23 1.49 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.3 -68.95 2.38 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.06 -135.38 22.74 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.8 p 54.16 102.08 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 127.39 2.276 . . . . 0.0 113.282 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.84 176.49 40.37 Favored 'Cis proline' 0 N--CA 1.457 -0.663 0 CA-C-N 119.707 0.931 . . . . 0.0 112.177 4.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.38 163.54 31.6 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.45 -43.64 0.15 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 118.375 -0.821 . . . . 0.0 111.655 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -69.36 107.08 3.16 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -119.24 129.23 54.83 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.434 1.094 . . . . 0.0 111.451 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.65 151.43 6.04 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -135.12 135.74 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -123.08 164.14 20.97 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -80.98 173.25 12.79 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.674 1.99 . . . . 0.0 108.598 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.447 ' HA ' ' CE1' ' A' ' 27' ' ' TYR 0.43 1.5 m -73.59 -15.04 61.28 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -177.534 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -81.02 -83.88 0.11 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 101.327 -3.583 . . . . 0.0 101.327 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.1 m -164.05 0.12 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.639 2.775 . . . . 0.0 113.895 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -79.39 132.19 36.33 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.407 ' CE2' HG11 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -73.37 117.27 14.93 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.996 2.118 . . . . 0.0 108.222 178.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.01 -66.1 1.11 Allowed 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.265 1.426 . . . . 0.0 111.952 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.49 146.71 20.99 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 115.976 1.15 . . . . 0.0 115.976 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.65 99.62 3.38 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 103.746 -2.686 . . . . 0.0 103.746 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.5 pt -136.77 165.49 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.073 0.949 . . . . 0.0 111.428 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.0 t -160.27 145.74 15.05 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -79.87 29.44 0.26 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.21 0.604 . . . . 0.0 111.791 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.8 t -65.19 -30.28 71.17 Favored 'General case' 0 C--N 1.343 0.307 0 O-C-N 120.797 -1.19 . . . . 0.0 113.405 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -138.39 49.32 0.84 Allowed Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.29 151.86 21.74 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.114 1.366 . . . . 0.0 110.86 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.1 t -66.39 -45.37 80.25 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.35 1.06 . . . . 0.0 109.495 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.7 -79.43 0.03 OUTLIER Glycine 0 C--N 1.339 0.741 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -97.4 7.52 46.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.352 1.061 . . . . 0.0 111.027 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -74.0 -174.21 1.81 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.4 1.08 . . . . 0.0 110.426 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -153.45 159.9 42.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.174 0.989 . . . . 0.0 110.976 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.6 157.99 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.954 1.702 . . . . 0.0 106.783 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.39 153.25 49.12 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 116.106 1.202 . . . . 0.0 116.106 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.4 t -107.28 -175.3 2.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.335 2.254 . . . . 0.0 106.752 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.6 t -64.94 117.72 8.02 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.4 -0.813 . . . . 0.0 109.95 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.42 -36.97 3.65 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.121 1.343 . . . . 0.0 109.812 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.5 m -93.74 132.78 37.78 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.245 1.418 . . . . 0.0 108.932 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.225 -1.369 . . . . 0.0 109.254 -179.546 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.7 p -127.35 154.23 45.22 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.926 1.29 . . . . 0.0 110.141 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.97 133.86 55.2 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.882 1.273 . . . . 0.0 110.873 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 p -97.35 121.03 38.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.579 1.152 . . . . 0.0 109.117 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -115.33 99.31 7.3 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 100.595 -3.854 . . . . 0.0 100.595 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -103.49 90.28 3.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.157 1.383 . . . . 0.0 109.563 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.46 -76.23 0.96 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.012 1.291 . . . . 0.0 110.862 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.5 t -132.48 -43.17 0.93 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.819 1.648 . . . . 0.0 109.921 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.6 m -68.74 112.54 5.54 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -102.21 152.63 20.8 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.471 1.108 . . . . 0.0 110.812 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -144.23 143.54 31.1 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.363 1.065 . . . . 0.0 108.21 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.9 t -68.27 154.74 41.13 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.765 1.226 . . . . 0.0 110.549 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.93 -19.89 54.39 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.6 t -73.52 -41.15 63.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.652 1.581 . . . . 0.0 109.339 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -68.35 -43.17 78.02 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.256 0.622 . . . . 0.0 110.963 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.8 t -59.8 -47.18 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -41.5 86.72 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.278 1.031 . . . . 0.0 111.686 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.48 -49.47 68.93 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.333 0.515 . . . . 0.0 109.87 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.56 -37.36 78.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.799 0.839 . . . . 0.0 109.938 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.44 -32.28 60.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -66.38 -27.33 67.78 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.03 -56.98 3.98 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.458 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -44.99 -58.35 3.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.528 1.531 . . . . 0.0 110.147 177.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.5 t -54.11 -50.71 66.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.366 1.467 . . . . 0.0 112.296 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -58.08 -34.57 70.3 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -92.13 -3.26 55.91 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -124.38 37.16 4.46 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.473 1.109 . . . . 0.0 111.132 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -89.84 -72.51 0.56 Allowed 'General case' 0 C--N 1.343 0.283 0 O-C-N 121.364 -0.835 . . . . 0.0 110.031 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -148.91 -61.17 0.23 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.933 1.293 . . . . 0.0 108.713 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -90.44 63.83 5.71 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.112 1.365 . . . . 0.0 107.95 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -51.83 138.28 24.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.711 1.604 . . . . 0.0 112.396 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.0 t -106.16 -33.5 7.82 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.367 1.067 . . . . 0.0 112.198 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.63 159.86 31.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.763 0.825 . . . . 0.0 110.97 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.94 166.48 47.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.399 0.999 . . . . 0.0 114.232 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -120.49 65.09 0.84 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.833 1.653 . . . . 0.0 107.977 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.7 m -167.32 -46.02 0.02 OUTLIER 'General case' 0 C--N 1.339 0.124 0 C-N-CA 127.192 2.197 . . . . 0.0 107.374 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.7 p -105.12 29.18 6.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.145 1.378 . . . . 0.0 111.131 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 73.32 157.39 0.16 Allowed Pre-proline 0 C--N 1.351 0.651 0 C-N-CA 125.144 1.378 . . . . 0.0 107.728 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.401 ' HB3' HE21 ' A' ' 57' ' ' GLN . 86.0 Cg_endo -71.1 118.72 4.26 Favored 'Cis proline' 0 N--CA 1.452 -0.969 0 N-CA-C 115.404 1.271 . . . . 0.0 115.404 3.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -103.86 -170.24 1.75 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 126.518 1.927 . . . . 0.0 106.686 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.3 t -155.87 159.0 38.95 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.514 0.326 . . . . 0.0 111.267 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -153.43 167.09 30.61 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 122.774 0.43 . . . . 0.0 111.68 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -141.56 -51.76 0.43 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.609 1.563 . . . . 0.0 109.998 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -67.47 -78.81 0.06 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.966 0.906 . . . . 0.0 110.731 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 67.9 179.97 0.23 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.767 1.227 . . . . 0.0 111.345 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -74.63 -62.62 1.47 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.98 57.67 0.14 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -154.19 103.04 2.51 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.489 1.116 . . . . 0.0 108.346 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -141.57 176.43 8.9 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.307 1.443 . . . . 0.0 109.05 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -127.87 138.11 32.21 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 124.361 1.065 . . . . 0.0 109.043 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.66 66.17 8.81 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.713 2.942 . . . . 0.0 110.043 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.3 t -120.31 -95.06 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -153.35 -71.02 0.14 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.174 0.99 . . . . 0.0 109.695 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.11 -175.37 54.96 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.074 0.845 . . . . 0.0 111.225 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.97 126.85 1.93 Allowed 'Cis proline' 0 N--CA 1.459 -0.519 0 CA-C-N 118.982 1.391 . . . . 0.0 111.989 -0.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.69 130.69 35.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.446 0.641 . . . . 0.0 111.008 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' A' ' 39' ' ' PRO . 53.4 tt0 -75.03 139.02 42.58 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 127.852 2.461 . . . . 0.0 111.235 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -98.16 146.57 25.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.574 1.15 . . . . 0.0 108.66 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.458 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 8.0 t80 -160.1 110.33 1.41 Allowed Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -81.15 131.93 8.03 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 122.006 1.804 . . . . 0.0 114.302 -176.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.54 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.7 tt -100.01 178.0 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 124.282 1.992 . . . . 0.0 110.875 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.54 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 4.8 tmtt? -160.46 153.71 21.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 109.063 -3.698 . . . . 0.0 110.721 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.2 p -80.81 56.5 2.72 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.566 1.546 . . . . 0.0 109.706 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.9 -61.99 0.04 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.32 -172.62 32.97 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 117.165 0.483 . . . . 0.0 112.705 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.95 143.57 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.568 1.547 . . . . 0.0 111.353 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.292 0.0 OUTLIER 25.45 55.68 0.04 OUTLIER 'General case' 0 C--N 1.345 0.37 0 C-N-CA 129.367 3.067 . . . . 0.0 116.41 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.8 p -79.77 85.36 5.46 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.98 173.6 39.24 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.89 -69.01 1.47 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.0 m -80.3 127.5 76.09 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.7 -88.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.225 2.617 . . . . 0.0 110.057 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.97 -51.32 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 106.019 -2.832 . . . . 0.0 106.019 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -169.72 -50.43 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.667 0.787 . . . . 0.0 112.02 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -73.9 130.07 39.16 Favored 'General case' 0 C--N 1.344 0.362 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -138.54 122.21 17.48 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.029 1.331 . . . . 0.0 110.43 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -83.64 148.77 4.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.3 t -136.91 114.9 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -177.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 pt -101.56 177.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.371 0 C-N-CA 124.585 1.154 . . . . 0.0 111.855 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -90.46 171.82 9.16 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 125.255 1.422 . . . . 0.0 108.024 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.7 -33.24 69.94 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 119.048 2.981 . . . . 0.0 119.048 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -87.75 -65.81 0.98 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.857 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.5 -7.58 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -175.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -78.9 108.82 12.63 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -56.33 118.52 4.83 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.51 -59.56 2.2 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.258 0.623 . . . . 0.0 110.655 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.35 164.74 34.15 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.28 153.22 27.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.1 0.96 . . . . 0.0 110.453 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.6 pt -138.89 155.57 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.746 1.618 . . . . 0.0 107.881 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.6 t -153.45 153.25 32.13 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -79.34 -22.62 44.25 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.354 0.662 . . . . 0.0 111.988 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 t -65.68 139.84 58.43 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 119.585 1.084 . . . . 0.0 109.905 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.08 -24.97 28.93 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.98 -159.02 0.66 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.262 1.425 . . . . 0.0 109.397 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.2 m -152.37 88.9 1.39 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.417 0.687 . . . . 0.0 111.06 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.06 -131.07 9.24 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.288 0.947 . . . . 0.0 112.53 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -79.38 -34.95 41.52 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 125.099 1.36 . . . . 0.0 110.619 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -44.12 134.05 4.95 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.863 1.665 . . . . 0.0 112.473 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.54 160.8 14.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.203 1.801 . . . . 0.0 111.203 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 m -139.32 166.04 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 126.531 1.932 . . . . 0.0 106.916 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.64 151.61 20.66 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.365 0.507 . . . . 0.0 113.726 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.81 -166.43 1.6 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.194 1.398 . . . . 0.0 109.198 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.5 t -62.55 129.58 41.23 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.908 0.483 . . . . 0.0 109.767 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.31 28.5 69.79 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.004 0.811 . . . . 0.0 112.095 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.8 m -151.52 116.49 5.22 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.168 -179.51 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PCA . . . . . 0.415 ' H2 ' ' OH ' ' A' ' 85' ' ' TYR 0.518 . . . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 123.605 1.669 . . . . 0.0 115.355 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.8 m -160.42 74.29 0.54 Allowed 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 101.342 -3.577 . . . . 0.0 101.342 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 70.21 73.59 0.22 Allowed 'General case' 0 C--N 1.343 0.32 0 N-CA-C 102.389 -3.189 . . . . 0.0 102.389 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.5 t -116.03 152.87 32.72 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -118.88 116.39 26.39 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 102.259 -3.237 . . . . 0.0 102.259 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -91.91 58.9 3.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.31 -78.53 0.82 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.556 1.074 . . . . 0.0 111.178 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 m -118.29 39.99 3.3 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.947 1.299 . . . . 0.0 110.274 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.33 152.88 38.96 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -150.51 113.94 4.92 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.621 0.646 . . . . 0.0 111.745 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.81 137.55 52.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.514 1.126 . . . . 0.0 111.251 178.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.9 t -70.11 160.31 32.27 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 126.368 1.867 . . . . 0.0 108.264 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.25 -19.05 30.95 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 t -72.57 -47.29 49.34 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -72.22 -28.22 63.04 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.638 1.175 . . . . 0.0 113.46 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.4 t -70.21 -51.79 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -58.83 -35.63 73.22 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 125.987 1.715 . . . . 0.0 111.277 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.67 -52.61 56.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.9 82.47 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.031 0.932 . . . . 0.0 112.033 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.43 -45.55 30.97 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -62.29 -22.43 66.02 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.406 ' CB ' HG21 ' A' ' 66' ' ' VAL . . . -79.9 -55.08 5.22 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.68 -42.9 12.14 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.209 1.004 . . . . 0.0 111.261 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 85.2 m -61.61 -52.77 63.02 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.178 0.991 . . . . 0.0 110.366 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -59.57 -41.45 90.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.364 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -69.32 -40.1 77.81 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.42 -0.8 . . . . 0.0 112.067 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -78.52 -32.63 48.14 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -136.49 -43.8 0.61 Allowed 'General case' 0 C--N 1.348 0.533 0 N-CA-C 118.216 2.672 . . . . 0.0 118.216 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -70.69 -22.95 62.4 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -165.48 102.41 0.71 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 77.27 -166.32 0.05 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.552 1.941 . . . . 0.0 111.169 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.4 p -123.79 -63.96 1.18 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.86 1.664 . . . . 0.0 109.07 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 52.07 90.84 0.02 OUTLIER 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.519 1.928 . . . . 0.0 112.062 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.02 -166.98 14.22 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.23 0.919 . . . . 0.0 110.821 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m 71.63 -11.43 0.73 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.987 1.715 . . . . 0.0 113.71 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.7 m -149.47 -43.35 0.14 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.806 0.842 . . . . 0.0 111.74 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.9 p -104.25 -22.96 13.29 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 77.41 152.43 0.13 Allowed Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.3 150.99 96.51 Favored 'Cis proline' 0 N--CA 1.45 -1.05 0 CA-C-N 121.088 1.424 . . . . 0.0 115.065 2.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -159.79 157.82 30.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 128.551 2.74 . . . . 0.0 105.713 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 t -53.28 149.49 7.25 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -89.09 161.92 16.26 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.692 1.597 . . . . 0.0 109.1 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -63.53 137.77 58.26 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.953 0.901 . . . . 0.0 111.706 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.69 -49.96 75.4 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.761 0.824 . . . . 0.0 108.908 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -59.1 137.38 57.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -71.96 88.92 1.08 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.986 0.515 . . . . 0.0 111.228 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.08 -29.53 66.64 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.88 164.09 36.32 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.212 1.405 . . . . 0.0 110.695 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -116.91 122.12 43.4 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.612 1.565 . . . . 0.0 107.835 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.405 ' CD1' ' HA3' ' A' ' 87' ' ' GLY . 17.4 m-85 -119.42 157.69 50.86 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 124.821 1.248 . . . . 0.0 109.536 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -52.81 -35.36 69.43 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.825 3.017 . . . . 0.0 114.239 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.1 m -110.05 164.69 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.528 1.531 . . . . 0.0 112.044 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -95.75 159.53 14.93 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.573 1.549 . . . . 0.0 110.243 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.75 -154.54 30.87 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.4 1.0 . . . . 0.0 111.452 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.53 153.25 18.93 Favored 'Cis proline' 0 C--N 1.346 0.441 0 CA-C-N 118.722 1.261 . . . . 0.0 114.132 -0.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.67 167.07 17.74 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.165 0.986 . . . . 0.0 111.462 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -138.43 156.3 47.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.411 1.485 . . . . 0.0 109.253 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -90.17 157.84 17.53 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -160.15 108.9 1.4 Allowed Pre-proline 0 N--CA 1.454 -0.255 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -89.23 113.56 0.61 Allowed 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 122.65 2.233 . . . . 0.0 111.797 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.483 HG13 ' H ' ' A' ' 62' ' ' LYS . 7.4 tt -86.22 174.67 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-O 123.632 1.682 . . . . 0.0 110.909 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.483 ' H ' HG13 ' A' ' 61' ' ' ILE . 11.7 mmtp -155.48 150.73 26.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 109.851 -3.34 . . . . 0.0 110.912 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.5 p -88.68 61.03 5.85 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.311 1.444 . . . . 0.0 108.865 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.75 -61.58 0.02 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.05 166.12 36.18 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.406 HG21 ' CB ' ' A' ' 22' ' ' ALA . 10.0 p -77.6 138.0 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.505 1.122 . . . . 0.0 110.931 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.1 t80 53.57 86.92 0.04 OUTLIER 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.894 1.678 . . . . 0.0 112.111 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.4 t -151.41 158.97 44.41 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.21 1.004 . . . . 0.0 110.373 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.79 -133.11 2.65 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.501 1.048 . . . . 0.0 111.266 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.14 54.94 4.22 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 94.6 p 45.52 60.17 13.88 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.063 1.745 . . . . 0.0 112.64 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.1 141.24 18.48 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.749 2.966 . . . . 0.0 110.847 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 158.0 35.19 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.519 -0.601 . . . . 0.0 114.246 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -169.03 35.07 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.034 0.934 . . . . 0.0 110.764 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.25 93.85 0.29 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -145.96 153.48 40.85 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 m -119.86 146.6 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 102.474 -3.158 . . . . 0.0 102.474 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.255 81.2 t -125.55 113.14 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.1 pt -86.31 168.03 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.381 0 C-N-CA 125.704 1.602 . . . . 0.0 114.577 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -90.69 170.95 9.71 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.965 2.106 . . . . 0.0 107.374 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.367 11.6 t -85.35 52.93 2.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 118.048 2.611 . . . . 0.0 118.048 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -156.04 -89.81 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 101.245 -3.613 . . . . 0.0 101.245 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 36.3 t -163.94 66.43 0.17 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.198 1.399 . . . . 0.0 112.508 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -150.26 127.58 11.38 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 120.016 1.28 . . . . 0.0 113.051 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -64.46 117.29 7.1 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 177.752 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.39 -59.23 2.34 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 124.322 1.049 . . . . 0.0 110.631 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.405 ' HA3' ' CD1' ' A' ' 50' ' ' PHE . . . -145.57 -172.46 15.98 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.761 1.172 . . . . 0.0 111.472 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.31 144.05 13.94 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 122.802 0.441 . . . . 0.0 111.438 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.0 pt -131.06 159.34 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 125.487 1.515 . . . . 0.0 110.068 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.0 t -160.12 150.31 18.39 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.462 1.505 . . . . 0.0 109.418 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.539 ' HB2' ' HB1' ' A' ' 74' ' ' ALA 0.265 49.3 m170 -78.98 -51.87 9.03 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.409 1.004 . . . . 0.0 108.951 177.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.379 11.8 t 48.96 -69.82 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.706 2.802 . . . . 0.0 116.773 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.42 51.17 0.56 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 126.032 1.777 . . . . 0.0 108.879 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.79 158.02 36.24 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.913 1.285 . . . . 0.0 110.949 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.5 t -62.06 -40.51 96.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.214 0.606 . . . . 0.0 110.183 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -150.5 -109.64 0.47 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -94.38 -4.93 47.57 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.508 1.123 . . . . 0.0 112.083 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -65.17 174.5 2.0 Allowed 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.114 0.966 . . . . 0.0 112.113 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -125.64 150.99 47.11 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.735 1.614 . . . . 0.0 111.911 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.5 m -124.31 166.33 19.82 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 126.308 1.843 . . . . 0.0 107.009 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.04 160.21 24.87 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.3 m -100.66 174.22 6.17 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.136 0.975 . . . . 0.0 111.694 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.2 m 46.77 46.13 15.02 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.709 0.804 . . . . 0.0 112.069 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.67 22.95 73.81 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 119.311 -0.716 . . . . 0.0 114.052 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 55.0 m -86.57 146.77 26.22 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.974 0.909 . . . . 0.0 108.785 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 t30 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.055 -1.45 . . . . 0.0 109.437 -179.246 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 120.596 0.236 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 t -158.14 -175.24 5.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.126 1.37 . . . . 0.0 108.595 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.41 138.34 56.64 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.437 0.695 . . . . 0.0 109.134 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 t -141.81 119.99 12.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.487 0.315 . . . . 0.0 111.038 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.41 108.3 19.59 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.6 m -97.46 78.99 2.71 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.122 0.969 . . . . 0.0 109.177 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.83 -95.56 0.82 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.8 m -108.42 -31.78 7.69 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.851 1.26 . . . . 0.0 110.51 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 m -81.69 101.12 9.87 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -85.02 152.14 23.66 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 123.194 0.598 . . . . 0.0 111.322 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -142.06 133.73 26.93 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.645 1.178 . . . . 0.0 109.096 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.7 m -72.25 158.04 36.59 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 125.007 1.323 . . . . 0.0 111.314 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.08 -21.41 64.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.0 m -72.54 -39.35 67.58 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.076 0.95 . . . . 0.0 108.535 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -69.6 -50.22 46.6 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.547 1.139 . . . . 0.0 112.023 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.466 HG13 HG11 ' A' ' 77' ' ' VAL . 50.8 t -57.45 -48.23 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 123.608 0.763 . . . . 0.0 109.212 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -64.53 -43.31 94.41 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.545 1.138 . . . . 0.0 112.065 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.0 -54.24 14.1 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.972 0.509 . . . . 0.0 111.228 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.595 ' HB1' ' HE2' ' A' ' 59' ' ' PHE . . . -60.92 -26.76 67.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.421 0.689 . . . . 0.0 110.543 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.75 -38.09 29.28 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.481 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -65.79 -25.19 67.13 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.79 -60.0 2.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.402 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -44.97 -51.0 10.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.672 1.189 . . . . 0.0 110.196 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.01 -48.33 32.79 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.257 2.223 . . . . 0.0 111.796 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -81.75 -40.89 22.01 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.264 0.0 OUTLIER -67.75 -37.54 82.28 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 116.799 2.148 . . . . 0.0 116.799 -177.146 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.299 0.0 OUTLIER -82.14 6.27 17.02 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -179.09 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -77.49 -3.43 40.46 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.131 0.572 . . . . 0.0 110.786 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 64.02 48.11 3.16 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.442 1.897 . . . . 0.0 111.707 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -159.35 30.47 0.2 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.842 1.257 . . . . 0.0 110.658 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 176.88 165.69 0.51 Allowed 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 128.798 2.839 . . . . 0.0 108.86 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.263 0.0 OUTLIER -12.65 100.09 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.825 2.85 . . . . 0.0 115.233 -179.33 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 74.77 163.3 0.26 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 127.608 2.363 . . . . 0.0 115.792 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.98 82.57 0.06 OUTLIER Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.137 -0.813 . . . . 0.0 113.047 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.8 m 69.85 104.69 0.06 Allowed 'General case' 0 C--N 1.344 0.367 0 C-N-CA 126.384 1.873 . . . . 0.0 113.621 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -152.93 -55.89 0.12 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 100.988 -3.708 . . . . 0.0 100.988 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.575 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 40.7 p -130.64 -62.58 0.91 Allowed 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 101.006 -3.701 . . . . 0.0 101.006 175.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.575 ' CD1' ' C ' ' A' ' 37' ' ' THR . 23.9 m-85 -144.06 143.62 23.33 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 129.242 3.017 . . . . 0.0 106.072 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.67 144.73 62.24 Favored 'Cis proline' 0 N--CA 1.458 -0.567 0 CA-C-N 118.581 0.529 . . . . 0.0 112.596 1.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -156.54 151.76 26.48 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.537 0.608 . . . . 0.0 112.32 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.6 m -53.27 142.34 21.36 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.049 2.54 . . . . 0.0 113.121 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -91.9 136.76 32.91 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.705 1.202 . . . . 0.0 110.028 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -70.32 129.54 39.59 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.22 1.008 . . . . 0.0 111.864 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -86.17 61.04 6.59 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.936 1.294 . . . . 0.0 109.13 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -121.56 167.83 12.43 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.066 1.746 . . . . 0.0 109.076 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.49 154.16 41.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.382 0.673 . . . . 0.0 110.333 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.1 -88.27 0.32 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -121.51 152.91 38.64 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.241 1.417 . . . . 0.0 109.809 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 166.89 130.4 0.01 OUTLIER 'General case' 0 C--N 1.34 0.183 0 C-N-CA 128.109 2.564 . . . . 0.0 107.62 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -88.67 169.34 13.59 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.333 1.053 . . . . 0.0 108.96 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.19 -52.44 8.75 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.915 3.076 . . . . 0.0 113.024 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.9 m -65.05 156.62 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.11 1.364 . . . . 0.0 109.854 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -134.36 -168.66 2.18 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -46.32 138.55 7.52 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 127.608 2.527 . . . . 0.0 114.205 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.37 133.87 12.23 Favored 'Cis proline' 0 C--N 1.35 0.655 0 CA-C-N 119.933 1.866 . . . . 0.0 111.2 -2.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.53 108.99 1.64 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -177.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -123.35 157.7 32.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.994 1.718 . . . . 0.0 109.27 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -89.34 158.8 17.65 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.688 1.595 . . . . 0.0 112.633 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.595 ' HE2' ' HB1' ' A' ' 19' ' ' ALA . 89.1 t80 -159.18 117.96 1.68 Allowed Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.242 1.017 . . . . 0.0 108.917 177.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -81.44 137.83 10.6 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 N-CA-C 117.705 2.156 . . . . 0.0 117.705 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.625 HG13 HG13 ' A' ' 77' ' ' VAL 0.256 3.3 mm -109.81 -0.32 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 1 C-N-CA 134.408 5.083 . . . . 0.0 115.207 179.116 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -75.41 104.62 6.05 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 126.704 2.002 . . . . 0.0 114.165 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.6 m 24.06 34.18 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.201 1 C-N-CA 131.884 4.074 . . . . 0.0 115.712 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.84 40.38 1.49 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.957 1.265 . . . . 0.0 111.534 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.13 -115.33 1.01 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.127 1.346 . . . . 0.0 113.211 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.16 48.58 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.983 1.313 . . . . 0.0 109.594 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 27.0 t80 61.21 71.42 0.56 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.472 1.909 . . . . 0.0 111.327 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 49.5 p -121.18 61.11 0.91 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.75 -153.62 24.06 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.5 -169.54 32.25 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 m -158.86 -68.34 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 125.111 1.364 . . . . 0.0 110.172 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.58 104.33 1.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.456 2.104 . . . . 0.0 109.799 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.15 79.85 1.15 Allowed Glycine 0 C--N 1.339 0.712 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.13 -70.84 0.25 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.05 123.06 18.05 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.619 1.1 . . . . 0.0 113.597 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -160.6 134.81 7.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.625 HG13 HG13 ' A' ' 61' ' ' ILE . 11.8 m -93.14 142.88 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 177.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.272 72.6 t -125.32 124.45 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 85' ' ' TYR . 7.2 pt -130.99 175.09 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 123.934 0.771 . . . . 0.0 112.255 -175.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -99.18 139.23 35.13 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 125.447 1.499 . . . . 0.0 109.199 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.548 0.5 OUTLIER -47.52 -12.72 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.401 1 N-CA-C 121.898 4.036 . . . . 0.0 121.898 -176.615 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -80.01 -81.85 0.12 Allowed 'General case' 0 N--CA 1.441 -0.884 1 N-CA-C 99.618 -4.216 . . . . 0.0 99.618 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.75 0.47 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.632 1.573 . . . . 0.0 114.472 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -82.27 127.73 33.49 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.584 ' HA ' HG22 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -65.33 135.34 55.19 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.641 1.577 . . . . 0.0 109.489 178.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.43 -50.83 3.49 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 122.982 0.513 . . . . 0.0 110.678 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.29 140.23 3.59 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.503 -0.379 . . . . 0.0 112.769 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.07 131.12 36.84 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.056 1.342 . . . . 0.0 108.034 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.8 pt -141.77 165.8 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.668 1.187 . . . . 0.0 110.391 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.421 HG23 HG22 ' A' ' 92' ' ' THR . 9.8 t -158.57 146.54 18.21 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -83.58 15.13 3.29 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 122.665 0.386 . . . . 0.0 110.917 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.421 HG22 HG23 ' A' ' 90' ' ' THR . 6.2 t -40.98 -45.29 2.56 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 116.92 2.192 . . . . 0.0 116.92 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -150.54 57.26 0.45 Allowed Glycine 0 C--N 1.331 0.301 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.02 175.89 5.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.891 1.276 . . . . 0.0 109.77 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.8 t -83.0 58.91 4.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.803 1.241 . . . . 0.0 111.028 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.37 -87.5 0.81 Allowed Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.228 1.394 . . . . 0.0 112.71 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -79.52 -24.75 42.01 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.114 0.966 . . . . 0.0 111.294 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -63.04 170.23 2.89 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.517 1.127 . . . . 0.0 110.178 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -130.31 168.19 17.3 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.617 1.567 . . . . 0.0 111.811 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.1 m -139.51 161.13 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 126.886 2.074 . . . . 0.0 105.748 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.25 131.7 10.58 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 114.775 0.67 . . . . 0.0 114.775 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.8 t -98.19 172.33 7.65 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.2 t 53.95 -153.63 0.28 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.904 1.229 . . . . 0.0 109.198 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.76 0.66 76.55 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.593 1.092 . . . . 0.0 110.401 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 m -79.69 149.15 31.31 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 125.495 1.518 . . . . 0.0 108.727 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.004 -1.474 . . . . 0.0 108.914 -179.186 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 121.143 0.497 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.6 m -136.5 -170.19 2.62 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.44 1.496 . . . . 0.0 108.117 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.44 122.7 11.02 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.8 0.84 . . . . 0.0 109.904 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.517 HG22 ' HB3' ' A' ' 103' ' ' SER . 3.0 p -91.69 87.98 6.52 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -92.2 96.93 10.59 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 102.447 -3.168 . . . . 0.0 102.447 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.1 m -98.3 81.73 2.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.472 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.4 -86.98 0.91 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.9 p -122.12 -23.22 5.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.333 1.453 . . . . 0.0 110.929 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.55 91.6 3.98 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -84.15 127.99 34.27 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.933 1.293 . . . . 0.0 112.772 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -127.57 134.5 49.72 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.5 p -69.24 152.76 44.66 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 124.689 1.196 . . . . 0.0 110.194 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.38 -22.94 55.59 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.3 p -77.4 -35.51 54.19 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 123.284 0.634 . . . . 0.0 109.519 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -69.11 -33.87 74.17 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.423 0.689 . . . . 0.0 110.986 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.1 t -66.77 -50.56 64.52 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.0 tmt_? -61.49 -38.92 89.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.212 1.405 . . . . 0.0 110.99 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.44 -51.77 53.42 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.636 0.774 . . . . 0.0 109.58 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.83 -23.93 66.79 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 118.809 -0.615 . . . . 0.0 111.115 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.13 -41.77 33.96 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 118.468 0.577 . . . . 0.0 110.835 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -68.63 -20.89 64.5 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.09 -64.45 1.16 Allowed 'General case' 0 C--N 1.35 0.591 0 N-CA-C 103.292 -2.855 . . . . 0.0 103.292 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -39.88 -45.01 1.75 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.187 1.395 . . . . 0.0 111.473 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.5 m -55.26 -58.77 6.36 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.882 1.273 . . . . 0.0 109.753 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.2 tp-100 -65.84 -36.84 84.59 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -86.22 -10.13 55.23 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 128.772 2.829 . . . . 0.0 115.512 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -90.74 -61.48 1.66 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-N 120.07 1.304 . . . . 0.0 113.21 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -137.56 -10.0 1.64 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -66.46 -48.7 69.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.357 0.98 . . . . 0.0 111.276 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -172.38 108.61 0.21 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.045 1.338 . . . . 0.0 107.47 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.251 0.1 OUTLIER 89.26 163.61 0.05 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 128.724 2.81 . . . . 0.0 112.648 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.9 p -138.02 -45.45 0.52 Allowed 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 126.691 1.996 . . . . 0.0 109.026 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 85.62 165.35 0.09 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 127.844 2.458 . . . . 0.0 111.558 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.97 85.77 1.09 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.535 1.064 . . . . 0.0 111.781 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.9 p -132.47 -124.29 0.19 Allowed 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 m -177.69 -75.88 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.14 1.376 . . . . 0.0 109.711 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.02 0.5 57.53 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.776 1.63 . . . . 0.0 113.35 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -152.32 104.89 2.76 Favored Pre-proline 0 C--N 1.343 0.284 0 O-C-N 120.924 -1.11 . . . . 0.0 108.728 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -72.14 155.47 98.37 Favored 'Cis proline' 0 N--CA 1.459 -0.501 0 CA-C-N 119.942 1.015 . . . . 0.0 113.608 0.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.15 162.62 4.54 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.573 1.549 . . . . 0.0 109.945 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.6 m -70.27 136.63 50.04 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.869 1.668 . . . . 0.0 109.775 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -96.12 150.24 20.73 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.401 1.08 . . . . 0.0 109.96 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -78.88 165.75 23.17 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.108 0.963 . . . . 0.0 111.475 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -159.0 93.21 1.14 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.469 0.708 . . . . 0.0 110.337 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -164.23 -56.57 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.22 1.008 . . . . 0.0 109.894 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -166.07 134.05 2.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.801 1.24 . . . . 0.0 108.36 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.83 -83.68 0.15 Allowed Glycine 0 C--N 1.338 0.674 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -159.36 46.69 0.28 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.572 1.149 . . . . 0.0 107.992 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -74.95 164.23 26.78 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -127.95 94.67 36.29 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 125.481 1.512 . . . . 0.0 108.329 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.34 84.15 1.4 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.389 2.726 . . . . 0.0 110.982 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.7 t -113.17 -49.51 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.282 1.433 . . . . 0.0 109.198 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -154.15 -73.97 0.12 Allowed 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.854 0.861 . . . . 0.0 109.243 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.96 140.23 8.04 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.81 175.25 45.47 Favored 'Cis proline' 0 N--CA 1.459 -0.557 0 CA-C-N 118.845 1.322 . . . . 0.0 112.036 -0.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.59 -174.15 3.43 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.297 1.439 . . . . 0.0 108.75 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -157.12 146.14 20.03 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 122.968 0.507 . . . . 0.0 111.981 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -89.74 144.37 26.03 Favored 'General case' 0 C--N 1.343 0.295 0 O-C-N 123.687 0.617 . . . . 0.0 110.677 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -153.87 110.95 2.51 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -82.66 148.88 14.22 Favored 'Trans proline' 0 N--CA 1.439 -1.727 0 C-N-CA 121.824 1.683 . . . . 0.0 113.48 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.526 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.5 tt -106.73 -177.57 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-O 123.87 1.795 . . . . 0.0 111.7 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.526 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 18.5 tptt -160.29 159.35 31.23 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 109.622 -3.445 . . . . 0.0 113.041 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.5 p -90.11 60.41 4.82 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 126.515 1.926 . . . . 0.0 110.887 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.36 -53.94 0.05 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.66 -151.93 6.32 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.5 p -72.24 165.26 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.79 1.236 . . . . 0.0 109.083 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.44 141.91 14.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.9 m -118.09 -56.03 2.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.908 2.083 . . . . 0.0 107.427 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.61 -157.58 16.17 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.828 1.204 . . . . 0.0 111.42 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.39 36.34 59.44 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.375 0.988 . . . . 0.0 112.318 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.7 m -160.86 157.87 23.62 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 125.7 1.6 . . . . 0.0 108.274 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -45.36 -58.44 1.6 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.783 2.989 . . . . 0.0 111.884 169.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.4 141.47 12.24 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -148.3 -40.96 0.16 Allowed 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 117.428 -1.272 . . . . 0.0 112.273 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -88.14 120.45 29.5 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.032 0.933 . . . . 0.0 109.351 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.4 138.89 16.81 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -90.82 151.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.1 t -135.98 117.82 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.7 pt -109.68 164.12 6.29 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 C-N-CA 124.091 0.957 . . . . 0.0 112.18 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -79.41 157.87 27.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.312 1.845 . . . . 0.0 106.76 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.291 5.6 t -63.01 -10.14 12.8 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 -177.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -85.95 -80.54 0.22 Allowed 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.93 -5.45 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.666 2.386 . . . . 0.0 115.485 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.16 143.81 35.08 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 119.867 1.212 . . . . 0.0 114.021 -175.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -70.83 124.54 24.55 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.75 -48.08 6.75 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.028 0.531 . . . . 0.0 109.684 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.79 -170.08 41.22 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.12 141.07 22.01 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.508 1.123 . . . . 0.0 108.481 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.7 pt -137.71 166.34 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 124.598 1.159 . . . . 0.0 109.911 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.4 t -154.57 156.04 35.87 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.539 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 64.5 m170 -77.27 -40.85 43.18 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.763 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.6 t -54.67 142.97 26.41 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 123.127 0.571 . . . . 0.0 111.801 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.1 -24.01 33.22 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.71 -141.94 0.23 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.012 1.325 . . . . 0.0 109.087 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.2 t -155.23 80.63 1.05 Allowed 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.431 0.56 . . . . 0.0 111.114 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.94 -133.2 11.02 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.033 1.301 . . . . 0.0 111.963 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -79.77 -30.06 40.6 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.983 0.913 . . . . 0.0 111.376 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -52.58 140.02 24.11 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.032 0.933 . . . . 0.0 109.78 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.64 167.03 10.59 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.3 m -145.01 166.56 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 128.944 2.897 . . . . 0.0 106.064 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.6 164.59 39.73 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 123.64 0.638 . . . . 0.0 114.539 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 49.6 t -139.36 163.71 31.76 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.986 1.714 . . . . 0.0 108.304 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.517 ' HB3' HG22 ' A' ' 4' ' ' THR . 59.6 p 54.92 43.81 29.33 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.51 1.924 . . . . 0.0 111.773 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.64 15.87 81.21 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.006 -0.885 . . . . 0.0 113.664 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.3 m -82.7 140.9 32.83 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.596 1.198 . . . . 0.0 108.59 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.107 -1.425 . . . . 0.0 108.986 179.652 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.3 p -127.9 44.05 3.01 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.129 1.372 . . . . 0.0 110.411 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.54 164.56 0.14 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.485 1.914 . . . . 0.0 112.027 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.07 151.84 25.72 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.261 -0.274 . . . . 0.0 110.97 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.2 115.82 21.02 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.7 m -103.37 97.17 7.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.47 0.708 . . . . 0.0 109.819 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.9 -78.4 0.91 Allowed Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.768 1.175 . . . . 0.0 111.297 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 t -135.71 -8.42 2.15 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.547 1.139 . . . . 0.0 112.778 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.64 134.94 42.86 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 119.194 0.907 . . . . 0.0 109.502 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -94.4 154.69 17.34 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.809 0.844 . . . . 0.0 110.879 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -145.28 126.38 14.65 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.267 1.427 . . . . 0.0 108.836 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t -69.94 155.51 40.47 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.16 -16.65 34.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.6 t -76.28 -37.9 56.91 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.079 0.952 . . . . 0.0 109.459 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -74.6 -51.04 15.63 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.957 1.703 . . . . 0.0 111.152 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.84 -47.72 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.934 1.294 . . . . 0.0 107.524 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -69.67 -36.79 76.33 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.037 0.935 . . . . 0.0 111.94 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.13 -51.17 68.96 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.687 1.131 . . . . 0.0 109.859 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -34.72 74.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.775 0.83 . . . . 0.0 111.055 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.18 -33.35 33.08 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -69.94 -23.42 63.19 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.441 ' CB ' HG11 ' A' ' 66' ' ' VAL . . . -80.64 -53.15 6.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.482 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -50.19 -38.45 39.98 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.282 1.033 . . . . 0.0 110.41 176.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -55.3 35.31 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 126.171 1.789 . . . . 0.0 109.608 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.29 -30.97 68.11 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -90.55 -26.72 19.58 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -62.15 -32.75 73.39 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 119.202 0.91 . . . . 0.0 109.922 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -59.41 -19.03 44.13 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.024 0.929 . . . . 0.0 110.875 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 76.08 59.06 0.05 OUTLIER 'General case' 0 C--N 1.344 0.359 0 C-N-CA 127.294 2.237 . . . . 0.0 110.588 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -145.21 34.95 1.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.999 1.32 . . . . 0.0 109.529 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -175.27 130.99 0.29 Allowed 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 128.677 2.791 . . . . 0.0 106.455 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.7 p -84.35 85.79 7.34 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.26 0.552 . . . . 0.0 111.83 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.71 -160.23 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.044 1.737 . . . . 0.0 109.795 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -44.54 -49.8 8.47 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.233 1.397 . . . . 0.0 110.947 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.3 t 67.09 2.52 2.78 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.09 1.756 . . . . 0.0 115.735 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.9 m -67.77 -63.21 1.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -160.47 42.67 0.18 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.968 2.107 . . . . 0.0 107.076 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.438 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 9.8 m-85 -156.44 115.7 2.11 Favored Pre-proline 0 C--N 1.34 0.186 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.26 150.56 91.62 Favored 'Cis proline' 0 N--CA 1.456 -0.722 0 N-CA-C 114.239 0.823 . . . . 0.0 114.239 1.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.19 145.1 8.38 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.628 1.571 . . . . 0.0 108.577 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -60.44 145.47 48.1 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.849 1.66 . . . . 0.0 112.13 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -145.37 84.38 1.69 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -153.38 -158.47 0.88 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.934 1.294 . . . . 0.0 108.31 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.0 m120 67.83 2.52 3.1 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.629 1.572 . . . . 0.0 113.662 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -165.37 105.84 0.76 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -80.93 69.9 7.62 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.68 0.792 . . . . 0.0 110.659 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.28 11.91 56.6 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.945 0.783 . . . . 0.0 112.248 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -157.53 162.92 38.85 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 118.186 0.993 . . . . 0.0 111.809 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -116.03 119.72 36.78 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.131 1.373 . . . . 0.0 108.299 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -135.94 156.72 76.96 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 125.993 1.717 . . . . 0.0 107.722 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.401 ' O ' HG22 ' A' ' 52' ' ' VAL . 37.3 Cg_endo -61.74 163.36 18.92 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.095 2.53 . . . . 0.0 109.341 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 51' ' ' PRO 0.284 8.6 m 60.21 -165.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.176 1.39 . . . . 0.0 110.686 -178.201 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -112.79 -16.97 12.65 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.571 1.148 . . . . 0.0 113.392 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.07 -156.65 22.41 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.34 -177.05 5.33 Favored 'Cis proline' 0 CA--C 1.535 0.545 0 CA-C-N 119.037 1.418 . . . . 0.0 113.211 -0.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -148.25 155.27 41.14 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.615 0.366 . . . . 0.0 111.478 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -132.43 146.74 52.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.257 1.423 . . . . 0.0 107.777 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -86.6 156.8 19.89 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.482 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 35.8 t80 -152.5 109.7 2.76 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 13.0 Cg_endo -85.21 128.8 3.69 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.34 2.694 . . . . 0.0 116.965 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.444 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 10.1 tt -97.4 170.13 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 123.969 1.842 . . . . 0.0 112.193 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.444 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 8.3 mtpm? -160.74 113.51 1.99 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 109.394 -3.548 . . . . 0.0 111.623 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.9 p 10.76 50.14 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 129.806 3.242 . . . . 0.0 116.471 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.34 70.82 1.33 Allowed Glycine 0 C--N 1.337 0.639 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.08 113.89 0.54 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.441 HG11 ' CB ' ' A' ' 22' ' ' ALA . 26.9 t -84.08 137.77 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.103 1.361 . . . . 0.0 109.416 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.322 9.6 p90 46.17 53.38 9.41 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.027 2.131 . . . . 0.0 113.979 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.8 p -129.63 -33.44 1.85 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.963 1.705 . . . . 0.0 109.726 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.11 149.57 44.85 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 123.588 0.613 . . . . 0.0 112.815 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 172.07 -74.82 0.1 OUTLIER Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.8 t -153.0 105.22 2.64 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 124.121 0.968 . . . . 0.0 109.343 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -58.41 157.47 35.39 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 CA-C-N 119.735 0.941 . . . . 0.0 113.23 -5.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.81 -104.49 0.21 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 79.06 -60.18 0.37 Allowed 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 127.683 2.393 . . . . 0.0 109.052 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.92 121.9 18.25 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.445 1.498 . . . . 0.0 109.923 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -152.76 141.66 21.15 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.9 m -97.63 150.14 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.9 t -131.82 119.13 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.2 pt -100.62 167.75 2.01 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 C-N-CA 124.783 1.233 . . . . 0.0 113.17 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -82.46 168.26 17.62 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.875 2.07 . . . . 0.0 107.887 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.51 46.18 0.42 Allowed 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -160.36 -83.43 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.4 m -163.44 63.12 0.17 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.96 2.104 . . . . 0.0 112.034 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -148.83 114.74 5.72 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.445 1.93 . . . . 0.0 113.88 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -60.47 107.35 0.66 Allowed 'General case' 0 C--N 1.344 0.357 0 C-N-CA 123.56 0.744 . . . . 0.0 109.808 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.96 -68.22 0.72 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.34 169.35 35.46 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.87 146.64 48.26 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.25 1.02 . . . . 0.0 111.439 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.6 pt -139.28 166.04 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.577 1.551 . . . . 0.0 109.631 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.5 t -156.01 148.67 23.92 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -79.05 4.68 13.81 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 118.666 -0.683 . . . . 0.0 112.092 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.1 m -47.79 -49.94 27.24 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.73 32.68 6.4 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.577 1.084 . . . . 0.0 110.986 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -111.52 166.45 11.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.596 1.159 . . . . 0.0 112.641 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.2 t -103.49 67.61 0.92 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.707 1.603 . . . . 0.0 108.625 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.97 -109.8 3.79 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.763 1.173 . . . . 0.0 112.207 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -79.61 -9.18 59.59 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.175 0.99 . . . . 0.0 113.1 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -66.87 -179.65 0.94 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.062 0.945 . . . . 0.0 108.77 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -147.53 167.94 23.2 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.3 m -139.23 160.49 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 128.038 2.535 . . . . 0.0 105.381 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.67 149.6 20.17 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 115.527 0.971 . . . . 0.0 115.527 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.1 m -99.38 154.37 18.26 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.1 p 33.02 38.63 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 62.71 52.41 48.77 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.165 0.888 . . . . 0.0 111.853 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.1 t -81.65 28.95 0.39 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.517 1.127 . . . . 0.0 113.996 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 . . . . . 0 C--O 1.25 1.103 0 C-N-CA 125.974 1.709 . . . . 0.0 109.369 -179.243 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 t -77.96 92.5 4.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.722 1.209 . . . . 0.0 107.828 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 110.53 98.35 0.0 OUTLIER 'General case' 0 C--N 1.345 0.393 0 C-N-CA 131.157 3.783 . . . . 0.0 107.096 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -107.28 94.61 5.18 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.84 1.256 . . . . 0.0 111.563 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.04 99.6 9.49 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 102.105 -3.294 . . . . 0.0 102.105 177.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -92.13 80.81 5.05 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.755 1.622 . . . . 0.0 109.211 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.41 -82.49 0.91 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.4 t -117.89 -45.81 2.66 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.49 1.516 . . . . 0.0 109.67 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.8 m -63.42 103.91 0.57 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.725 1.21 . . . . 0.0 109.885 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.82 131.42 34.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.097 1.359 . . . . 0.0 110.847 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -131.21 138.54 49.42 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.6 p -77.68 160.68 28.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 124.113 0.965 . . . . 0.0 111.773 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.87 -13.21 43.22 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.9 t -81.42 -41.38 21.96 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.92 -37.2 86.52 Favored 'General case' 0 C--N 1.345 0.402 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.53 HG13 ' CE2' ' A' ' 85' ' ' TYR . 3.3 t -59.86 -51.23 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 126.28 1.832 . . . . 0.0 108.538 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.79 -39.16 93.36 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.139 0.976 . . . . 0.0 111.805 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.94 -51.71 36.85 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.055 0.542 . . . . 0.0 110.419 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.41 -38.77 81.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.669 1.188 . . . . 0.0 110.884 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.89 -41.03 45.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -64.3 -21.5 66.63 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.64 -59.22 2.5 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.07 -47.4 11.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.906 1.283 . . . . 0.0 110.239 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.9 t -61.18 -53.95 50.51 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.474 1.509 . . . . 0.0 111.595 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -57.37 -46.69 83.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.943 0.497 . . . . 0.0 110.907 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -67.46 -48.96 65.66 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.685 1.194 . . . . 0.0 113.137 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -65.05 -34.33 78.18 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.694 0.798 . . . . 0.0 112.146 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -82.78 -47.16 12.23 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 123.033 0.533 . . . . 0.0 111.52 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -70.98 -3.56 20.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.533 1.133 . . . . 0.0 112.539 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.8 t70 69.16 76.69 0.23 Allowed 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.662 1.585 . . . . 0.0 110.812 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -144.88 122.79 11.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.0 1.72 . . . . 0.0 107.172 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.9 p -103.22 82.43 2.07 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.02 111.98 2.15 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.236 1.015 . . . . 0.0 110.35 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.63 112.53 3.14 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.414 1.006 . . . . 0.0 111.867 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.2 m -135.88 -56.97 0.77 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.993 1.317 . . . . 0.0 108.064 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -157.67 -68.18 0.09 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.089 1.755 . . . . 0.0 106.507 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.3 t -159.95 30.67 0.18 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.351 1.86 . . . . 0.0 108.639 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -124.43 155.04 69.4 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.569 1.947 . . . . 0.0 108.825 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -80.51 133.72 27.36 Favored 'Cis proline' 0 N--CA 1.452 -0.935 0 CA-C-N 119.519 0.864 . . . . 0.0 112.438 -0.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.97 166.17 33.23 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.997 1.319 . . . . 0.0 108.652 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.6 m -51.81 140.47 19.32 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 126.051 1.741 . . . . 0.0 112.107 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -129.71 119.7 23.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.738 1.215 . . . . 0.0 109.204 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -165.08 92.36 0.57 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -159.32 159.65 34.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.314 0.646 . . . . 0.0 111.149 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.8 t80 67.79 165.59 0.23 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.875 1.67 . . . . 0.0 112.615 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -109.62 -45.17 3.72 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 124.778 1.231 . . . . 0.0 110.788 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.13 38.21 2.2 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.006 0.812 . . . . 0.0 113.85 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -157.82 128.22 6.29 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.012 1.325 . . . . 0.0 108.653 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -165.27 -175.32 3.57 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.165 1.386 . . . . 0.0 108.954 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -143.06 157.11 61.31 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 125.459 1.504 . . . . 0.0 107.903 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -81.85 48.99 3.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.668 2.912 . . . . 0.0 111.506 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 m -153.45 171.88 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 127.547 2.339 . . . . 0.0 107.441 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -109.32 143.65 38.54 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.265 1.026 . . . . 0.0 110.33 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.71 -160.66 35.84 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.65 151.38 23.55 Favored 'Cis proline' 0 N--CA 1.46 -0.467 0 CA-C-N 118.793 1.297 . . . . 0.0 113.634 -0.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -111.74 174.09 6.04 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.669 1.188 . . . . 0.0 109.848 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -155.57 144.0 20.25 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.11 0.564 . . . . 0.0 110.508 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -87.81 149.93 23.85 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.877 0.871 . . . . 0.0 111.092 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -158.34 109.24 1.69 Allowed Pre-proline 0 N--CA 1.45 -0.444 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -79.92 136.1 11.63 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 121.344 1.363 . . . . 0.0 113.454 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.503 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.3 tt -98.51 177.25 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 124.089 1.899 . . . . 0.0 110.801 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.503 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.7 tptm -156.52 -169.63 3.08 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 109.295 -3.593 . . . . 0.0 110.835 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t -76.64 52.44 0.81 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.574 1.549 . . . . 0.0 112.464 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.35 68.45 1.46 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.34 103.14 0.2 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 51.7 t -66.21 120.32 13.09 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 124.43 1.092 . . . . 0.0 108.661 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 64.47 115.67 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.543 1.537 . . . . 0.0 111.308 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.2 p -97.34 -72.74 0.63 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.495 1.118 . . . . 0.0 111.867 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.71 -10.88 73.59 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.897 0.76 . . . . 0.0 111.854 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.52 -90.68 1.04 Allowed Glycine 0 C--N 1.343 0.96 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.9 m -141.39 72.81 25.82 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 123.339 0.656 . . . . 0.0 112.229 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.55 111.33 3.2 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 N-CA-C 105.761 -2.438 . . . . 0.0 105.761 163.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.08 -8.28 8.02 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-O 117.243 -1.865 . . . . 0.0 117.081 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.452 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -150.05 -60.19 0.2 Allowed 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 120.84 2.32 . . . . 0.0 114.315 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.52 118.33 13.18 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -147.2 137.22 23.19 Favored 'General case' 0 C--N 1.347 0.483 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.9 m -94.69 149.33 4.48 Favored 'Isoleucine or valine' 0 C--N 1.343 0.318 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.5 t -134.72 117.68 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 pt -103.53 -177.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.372 0 C-N-CA 124.407 1.083 . . . . 0.0 112.145 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -99.79 151.91 20.72 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 127.312 2.245 . . . . 0.0 105.308 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.326 5.3 t -63.07 -7.22 5.07 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 119.2 3.037 . . . . 0.0 119.2 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -89.29 -78.03 0.36 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.54 -9.96 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -79.21 151.49 31.19 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 118.868 0.758 . . . . 0.0 110.509 -176.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.53 ' CE2' HG13 ' A' ' 16' ' ' VAL . 7.0 t80 -93.53 137.55 32.69 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.514 1.125 . . . . 0.0 109.763 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.86 -57.59 2.32 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 123.258 0.623 . . . . 0.0 110.767 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.86 168.86 30.6 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.29 155.72 20.19 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 122.203 1.002 . . . . 0.0 112.794 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.2 pt -139.55 155.77 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 126.699 1.999 . . . . 0.0 106.575 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.5 t -154.69 156.47 36.46 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.452 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 53.2 m170 -77.96 -50.06 12.9 Favored 'General case' 0 C--N 1.346 0.442 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.673 176.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t 45.4 15.1 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.621 2.768 . . . . 0.0 116.248 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.76 49.79 3.28 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.174 1.369 . . . . 0.0 110.791 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.24 -87.13 0.11 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 124.293 1.037 . . . . 0.0 109.721 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.7 m -147.64 63.19 1.14 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.729 1.211 . . . . 0.0 108.756 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.04 -102.21 1.13 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.282 0.944 . . . . 0.0 111.737 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -79.53 -26.93 41.36 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.91 0.884 . . . . 0.0 112.006 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -50.31 129.96 22.4 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.989 0.916 . . . . 0.0 111.374 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -103.62 133.93 47.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.28 1.432 . . . . 0.0 110.266 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.6 m -111.15 164.81 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.33 137.76 17.45 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.872 -0.604 . . . . 0.0 114.105 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.8 t -83.29 -172.5 4.18 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.3 m -67.65 138.97 56.77 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.217 -0.927 . . . . 0.0 108.643 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.63 33.11 35.34 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.2 m -155.24 119.3 4.61 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.533 1.533 . . . . 0.0 110.574 -179.088 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t -160.02 148.5 17.15 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.417 1.087 . . . . 0.0 108.318 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -49.32 136.81 15.22 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.808 1.243 . . . . 0.0 110.485 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.7 p -112.45 117.58 32.78 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -117.41 94.59 4.61 Favored 'General case' 0 N--CA 1.422 -1.872 1 N-CA-C 100.176 -4.009 . . . . 0.0 100.176 177.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 54.2 m -95.02 71.87 3.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.29 -79.22 1.51 Allowed Glycine 0 C--N 1.34 0.799 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.3 t -123.29 -35.32 2.98 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.99 1.316 . . . . 0.0 111.344 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 m -72.86 99.25 2.62 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -95.58 148.36 22.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.264 1.026 . . . . 0.0 110.803 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.61 143.62 31.56 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.691 1.196 . . . . 0.0 108.003 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -68.71 150.73 47.57 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.86 -21.27 10.84 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.8 t -71.14 -44.51 65.41 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.387 1.075 . . . . 0.0 109.574 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.1 -39.01 92.53 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 118.682 0.673 . . . . 0.0 112.628 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.447 HG12 ' CE2' ' A' ' 85' ' ' TYR . 2.1 t -62.88 -53.31 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -57.13 -44.49 83.41 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.811 1.245 . . . . 0.0 110.291 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.03 -45.11 95.0 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.647 0.779 . . . . 0.0 110.077 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.13 -33.95 69.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.511 0.725 . . . . 0.0 110.372 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.08 -39.55 25.54 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -62.4 -25.93 68.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.934 1.243 . . . . 0.0 108.312 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.55 -64.51 1.13 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.57 -33.54 15.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.962 0.905 . . . . 0.0 111.346 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 t -61.89 -61.4 2.52 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.308 1.443 . . . . 0.0 110.05 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -65.7 -42.3 91.32 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -71.52 -48.7 47.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.329 1.451 . . . . 0.0 113.722 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.457 ' CE2' ' HG2' ' A' ' 57' ' ' GLN . 39.6 t80 -62.08 -34.68 76.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.48 0.582 . . . . 0.0 110.177 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -58.02 -34.81 70.45 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 118.432 -0.794 . . . . 0.0 112.447 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 122.08 73.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 129.577 3.151 . . . . 0.0 110.604 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -162.08 58.82 0.24 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.1 t70 124.18 154.52 0.0 OUTLIER 'General case' 0 C--N 1.344 0.343 0 C-N-CA 130.027 3.331 . . . . 0.0 109.257 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.6 p -110.78 67.65 0.65 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 126.044 1.738 . . . . 0.0 108.653 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.06 93.79 1.83 Allowed 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.047 0.539 . . . . 0.0 109.751 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.21 135.33 3.41 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.1 t -136.4 67.03 1.47 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.642 0.777 . . . . 0.0 110.589 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.1 m -122.24 -76.77 0.59 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -160.29 30.97 0.17 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.835 1.654 . . . . 0.0 109.105 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -149.05 134.3 9.47 Favored Pre-proline 0 C--N 1.342 0.278 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.68 145.9 85.35 Favored 'Cis proline' 0 N--CA 1.455 -0.776 0 CA-C-N 119.373 0.812 . . . . 0.0 112.483 -0.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -159.89 162.47 34.58 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 126.079 1.752 . . . . 0.0 108.459 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 t -59.91 150.23 29.32 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -106.56 88.44 2.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.11 1.364 . . . . 0.0 107.707 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -68.31 100.4 1.05 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.687 1.195 . . . . 0.0 109.943 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -66.17 -65.48 0.67 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.679 0.791 . . . . 0.0 111.105 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 58.41 56.03 4.61 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 68.06 -17.0 0.17 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.731 2.012 . . . . 0.0 114.593 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.75 -99.32 0.01 OUTLIER Glycine 0 CA--C 1.532 1.136 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.62 133.94 38.31 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -109.81 162.83 14.1 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.948 1.299 . . . . 0.0 110.88 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -153.95 153.21 28.26 Favored Pre-proline 0 N--CA 1.454 -0.257 0 C-N-CA 126.149 1.78 . . . . 0.0 107.231 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.99 -30.02 76.17 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.92 2.413 . . . . 0.0 112.026 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 t -91.06 -74.39 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.069 0.947 . . . . 0.0 108.462 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 t70 54.87 105.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.967 2.507 . . . . 0.0 115.405 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.81 117.68 2.0 Allowed Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.839 -0.978 . . . . 0.0 112.082 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -68.8 157.33 89.34 Favored 'Cis proline' 0 C--N 1.348 0.515 0 CA-C-N 119.521 1.661 . . . . 0.0 108.543 -1.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.56 134.75 15.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 119.85 3.278 . . . . 0.0 119.85 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.457 ' HG2' ' CE2' ' A' ' 27' ' ' TYR . 20.0 mp0 -145.07 144.97 31.24 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.476 1.11 . . . . 0.0 112.78 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -81.86 156.15 24.98 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.674 0.749 . . . . 0.0 110.346 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -160.63 107.53 1.32 Allowed Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.39 134.88 21.46 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 CA-C-N 120.913 1.362 . . . . 0.0 112.336 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.45 HG13 ' H ' ' A' ' 62' ' ' LYS . 6.9 tp -82.27 176.14 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-O 123.863 1.792 . . . . 0.0 111.114 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.45 ' H ' HG13 ' A' ' 61' ' ' ILE . 55.9 tptt -155.56 154.57 31.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 109.703 -3.408 . . . . 0.0 112.813 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.4 m -83.83 51.0 1.93 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 127.467 2.307 . . . . 0.0 108.367 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.62 65.03 0.07 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.48 -102.9 1.66 Allowed Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 67' ' ' TYR . 8.2 p -110.6 -176.93 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.823 2.049 . . . . 0.0 109.886 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.498 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -41.27 166.72 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.291 2.636 . . . . 0.0 117.258 -178.772 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.3 p -96.37 -64.17 1.07 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.375 1.47 . . . . 0.0 110.057 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.12 62.88 0.77 Allowed Glycine 0 C--N 1.338 0.679 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -170.76 -61.8 0.04 OUTLIER Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.2 t -154.13 147.4 18.2 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.288 1.035 . . . . 0.0 109.924 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.31 -158.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.193 3.262 . . . . 0.0 110.419 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.39 41.95 0.13 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 107.391 -2.284 . . . . 0.0 107.391 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.44 ' HB1' ' H ' ' A' ' 91' ' ' HIS . . . 71.12 -27.07 0.17 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.824 2.049 . . . . 0.0 116.305 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.9 111.43 19.66 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 120.332 1.424 . . . . 0.0 110.438 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -120.1 154.09 35.2 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.101 0.96 . . . . 0.0 113.146 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.3 m -128.02 143.21 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -134.89 126.67 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pt -110.29 -165.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.371 0 C-N-CA 125.016 1.326 . . . . 0.0 114.447 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -122.97 136.87 55.02 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 128.48 2.712 . . . . 0.0 106.849 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.29 1.7 t -56.65 -15.55 4.67 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 118.746 2.869 . . . . 0.0 118.746 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -79.55 -77.15 0.19 Allowed 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 102.693 -3.077 . . . . 0.0 102.693 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.11 -2.16 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.012 2.125 . . . . 0.0 114.902 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -79.17 170.25 16.93 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 119.646 1.112 . . . . 0.0 112.155 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.447 ' CE2' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -112.65 126.95 55.93 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.767 1.227 . . . . 0.0 111.565 -178.331 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.5 -51.82 7.44 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.63 -158.26 31.07 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 112.28 -0.328 . . . . 0.0 112.28 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.54 145.22 29.0 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.357 1.063 . . . . 0.0 110.174 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 pt -138.32 166.81 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.705 1.202 . . . . 0.0 110.95 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.3 t -156.18 156.69 34.63 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.44 ' H ' ' HB1' ' A' ' 74' ' ' ALA . 44.7 m170 -78.5 -30.67 47.33 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.117 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.5 m -29.48 -70.14 0.05 Allowed 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.987 2.115 . . . . 0.0 116.504 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.97 -12.84 79.25 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.111 0.862 . . . . 0.0 114.769 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.96 -142.21 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.345 1.073 . . . . 0.0 111.064 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.7 t -151.17 92.27 1.78 Allowed 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.033 0.933 . . . . 0.0 109.941 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.98 -105.97 2.21 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.97 1.272 . . . . 0.0 112.632 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -79.47 -32.03 42.52 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.871 0.868 . . . . 0.0 111.312 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -54.79 160.62 1.83 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.318 1.047 . . . . 0.0 111.685 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -125.09 163.37 22.54 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.239 1.416 . . . . 0.0 112.859 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.5 m -144.53 165.68 12.78 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 128.123 2.569 . . . . 0.0 106.473 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.68 157.34 23.63 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.232 0.444 . . . . 0.0 113.477 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.5 m -116.24 167.63 10.84 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.2 m 61.7 -157.31 0.34 Allowed 'General case' 0 C--N 1.342 0.243 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.37 -19.62 57.77 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.489 1.042 . . . . 0.0 111.359 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.8 m -79.46 144.69 33.81 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 125.011 1.324 . . . . 0.0 109.122 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 C--O 1.253 1.285 0 CA-C-O 117.066 -1.445 . . . . 0.0 109.193 179.039 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 121.261 0.553 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -148.69 54.24 1.0 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.921 1.288 . . . . 0.0 107.937 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 73.41 146.34 0.08 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 126.874 2.07 . . . . 0.0 109.974 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 t -151.15 135.45 16.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.506 0.193 . . . . 0.0 110.525 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.88 107.91 18.02 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -98.69 85.89 3.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.47 -115.06 4.93 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.0 m -91.15 -27.79 18.29 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.404 1.082 . . . . 0.0 110.23 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -76.33 94.53 3.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.202 1.001 . . . . 0.0 109.351 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -85.82 113.15 21.75 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.723 1.209 . . . . 0.0 109.977 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -103.99 133.02 49.65 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.124 0.97 . . . . 0.0 111.218 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.7 m -72.46 154.31 40.93 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.3 1.44 . . . . 0.0 108.951 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.08 -20.84 60.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.0 m -74.5 -37.91 62.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.774 0.829 . . . . 0.0 109.449 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -73.66 -47.72 37.7 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.751 1.22 . . . . 0.0 111.596 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.0 t -54.39 -50.29 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -71.81 -34.64 69.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.226 1.411 . . . . 0.0 113.272 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.76 -52.76 55.26 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.279 0.945 . . . . 0.0 109.396 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.59 87.75 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.91 -37.54 81.82 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.63 -22.51 61.68 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.33 -59.44 2.77 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -55.44 -41.72 73.25 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.365 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.74 -50.47 33.61 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.853 1.206 . . . . 0.0 110.577 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -68.52 -43.87 75.84 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.353 0.0 OUTLIER -75.08 -43.05 55.32 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -177.394 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -39.24 62.98 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.59 1.956 . . . . 0.0 107.928 177.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -76.81 -37.51 55.62 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.884 1.274 . . . . 0.0 112.867 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -63.16 -32.18 73.51 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 t0 67.92 32.0 5.38 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.439 1.495 . . . . 0.0 110.87 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -163.5 -165.18 1.01 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 129.283 3.033 . . . . 0.0 105.065 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.284 3.7 t 47.27 57.96 5.31 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.804 1.242 . . . . 0.0 110.518 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.52 172.16 13.35 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.663 1.585 . . . . 0.0 109.67 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.8 58.25 0.07 OUTLIER Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.3 t -118.95 -94.49 0.5 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.716 1.206 . . . . 0.0 108.207 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.9 m -158.1 -59.34 0.08 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.804 1.242 . . . . 0.0 108.223 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 82.7 p -130.56 -52.27 1.08 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.697 1.599 . . . . 0.0 108.439 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -45.24 124.57 5.58 Favored Pre-proline 0 C--N 1.342 0.271 0 C-N-CA 127.821 2.448 . . . . 0.0 108.531 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.52 119.22 5.08 Favored 'Cis proline' 0 N--CA 1.453 -0.857 0 CA-C-N 118.583 0.53 . . . . 0.0 111.613 1.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -135.85 146.35 47.37 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 124.643 1.177 . . . . 0.0 111.129 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -43.0 151.3 0.14 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.257 2.223 . . . . 0.0 114.743 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -126.4 127.23 45.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.742 2.017 . . . . 0.0 105.853 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -74.32 -103.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 122.79 0.436 . . . . 0.0 111.3 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -178.46 -46.08 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.212 1.405 . . . . 0.0 109.06 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -41.48 128.76 3.14 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 128.002 2.521 . . . . 0.0 115.106 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 43.87 82.5 0.03 OUTLIER 'General case' 0 C--N 1.342 0.267 0 C-N-CA 127.325 2.25 . . . . 0.0 113.361 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.46 -156.94 28.4 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.52 154.35 20.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.66 1.584 . . . . 0.0 108.339 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -132.29 129.65 39.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -72.32 151.57 92.1 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.722 1.209 . . . . 0.0 111.397 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -63.6 -12.52 31.58 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 124.05 3.167 . . . . 0.0 115.618 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.94 -64.18 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.063 0.847 . . . . 0.0 110.281 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 143.17 -52.03 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 129.601 3.16 . . . . 0.0 108.457 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.5 -162.96 28.38 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.436 1.017 . . . . 0.0 110.952 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.6 170.59 9.27 Favored 'Cis proline' 0 CA--C 1.535 0.542 0 CA-C-N 119.208 1.504 . . . . 0.0 114.999 -0.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.29 -179.17 6.36 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 125.061 1.344 . . . . 0.0 109.229 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.19 147.77 25.18 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.24 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -79.41 148.8 31.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.832 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.489 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 20.4 t80 -144.13 104.91 4.78 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.468 ' HB3' HH11 ' A' ' 76' ' ' ARG . 26.3 Cg_endo -77.54 128.09 9.3 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 121.024 1.149 . . . . 0.0 113.319 -175.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.557 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.1 tt -90.83 179.33 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 124.281 1.991 . . . . 0.0 110.275 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.557 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 10.4 tptp -160.2 147.55 16.26 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 109.26 -3.609 . . . . 0.0 110.58 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.0 p -93.35 56.89 2.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.604 1.162 . . . . 0.0 108.531 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 178.78 57.3 0.07 OUTLIER Glycine 0 C--N 1.339 0.713 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.95 153.16 19.1 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.023 0.821 . . . . 0.0 111.951 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.57 147.61 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.489 1.116 . . . . 0.0 109.091 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.399 0.0 OUTLIER 28.97 44.5 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 128.794 2.837 . . . . 0.0 116.486 -178.567 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.8 p -141.72 108.41 5.37 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.459 1.504 . . . . 0.0 107.395 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -179.71 -177.53 47.94 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.06 160.42 33.97 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.2 t 72.18 145.85 0.11 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.056 1.742 . . . . 0.0 110.219 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -42.15 110.46 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.91 3.074 . . . . 0.0 113.715 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.62 -39.03 2.64 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.455 ' HB1' ' H ' ' A' ' 91' ' ' HIS . . . 71.74 -12.08 0.68 Allowed 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 126.769 2.028 . . . . 0.0 115.814 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -88.78 126.41 35.33 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 120.568 1.531 . . . . 0.0 112.427 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.468 HH11 ' HB3' ' A' ' 60' ' ' PRO . 33.0 mtt-85 -136.91 145.82 44.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.34 150.04 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 102.389 -3.189 . . . . 0.0 102.389 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.33 127.03 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 O-C-N 121.543 -0.723 . . . . 0.0 109.284 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.9 pt -113.61 158.18 14.04 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 124.924 1.29 . . . . 0.0 108.424 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -79.28 172.98 13.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.869 0.868 . . . . 0.0 109.273 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.299 3.0 t -76.66 30.02 0.13 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -128.33 -80.19 0.58 Allowed 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 101.66 -3.459 . . . . 0.0 101.66 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.5 -19.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -84.65 139.42 32.06 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -55.67 129.68 40.14 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 125.117 1.367 . . . . 0.0 109.01 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.38 -45.0 5.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.205 1.402 . . . . 0.0 108.947 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.72 -160.98 24.25 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.42 148.55 23.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.347 1.459 . . . . 0.0 108.707 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.3 pt -142.97 164.56 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.929 1.292 . . . . 0.0 110.227 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -159.47 162.84 35.66 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.895 0.478 . . . . 0.0 111.728 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.455 ' H ' ' HB1' ' A' ' 74' ' ' ALA . 22.4 m170 -78.89 -56.62 4.26 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.272 5.8 t 49.26 11.01 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.352 2.661 . . . . 0.0 115.606 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.36 -55.85 0.62 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 106.98 -2.448 . . . . 0.0 106.98 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 52.28 -169.33 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.483 1.913 . . . . 0.0 112.133 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.8 t -83.27 -42.24 17.4 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -147.54 -79.87 0.03 OUTLIER Glycine 0 C--N 1.342 0.891 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -130.47 3.2 4.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.182 1.393 . . . . 0.0 111.55 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -73.07 -169.84 0.66 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.962 1.305 . . . . 0.0 111.725 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -127.37 154.42 45.0 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.933 1.293 . . . . 0.0 112.224 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.81 162.75 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 126.215 1.806 . . . . 0.0 107.144 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.84 147.26 39.66 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.68 -178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.0 t -79.83 178.89 7.87 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.1 m -93.21 100.48 12.85 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.944 0.793 . . . . 0.0 108.869 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.65 75.49 1.27 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.1 t -135.13 29.82 3.35 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.54 1.536 . . . . 0.0 111.459 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.962 1.705 . . . . 0.0 110.519 -179.228 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.526 0 CA-C-O 119.982 -0.056 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -157.88 55.9 0.48 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.58 156.6 0.14 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.639 1.976 . . . . 0.0 111.929 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 t -154.51 137.8 15.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.86 122.02 45.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.03 80.2 1.49 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.436 1.495 . . . . 0.0 108.058 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.74 -86.41 0.75 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.5 t -114.82 -41.86 3.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.108 1.363 . . . . 0.0 110.053 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.4 m -68.91 100.19 1.16 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.559 0.744 . . . . 0.0 109.45 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -80.03 151.97 29.67 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.895 0.878 . . . . 0.0 110.506 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -139.0 131.11 28.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.988 0.915 . . . . 0.0 110.225 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.9 m -72.21 156.43 39.16 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.42 1.488 . . . . 0.0 109.057 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.47 -21.35 62.27 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.6 m -70.88 -40.72 72.08 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.748 1.219 . . . . 0.0 109.373 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -49.07 67.8 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.53 1.132 . . . . 0.0 111.004 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.93 -49.34 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.241 1.416 . . . . 0.0 109.626 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -67.79 -40.26 83.97 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.765 0.826 . . . . 0.0 112.393 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.27 -49.97 71.96 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.54 -38.7 81.72 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.001 0.92 . . . . 0.0 110.098 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.88 -46.27 62.89 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -64.31 -20.35 66.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.14 -55.27 4.86 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.705 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -55.21 -43.12 74.18 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 t -50.31 -53.24 30.18 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.044 0.938 . . . . 0.0 110.812 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -66.37 -44.4 83.25 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -65.07 -59.54 4.01 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.843 2.457 . . . . 0.0 112.204 -177.713 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -64.92 -24.97 67.69 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.939 2.095 . . . . 0.0 113.758 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -76.11 -62.86 1.46 Allowed 'General case' 0 C--N 1.338 0.095 0 CA-C-N 118.763 0.71 . . . . 0.0 111.964 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -164.89 -37.61 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -81.3 61.76 4.94 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.576 1.151 . . . . 0.0 108.785 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -50.05 117.9 2.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.464 1.906 . . . . 0.0 111.935 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 t -90.48 -20.71 22.41 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.369 1.068 . . . . 0.0 108.983 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 26' ' ' TYR . . . -155.4 -168.65 2.9 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.773 2.429 . . . . 0.0 107.888 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -176.62 150.11 10.19 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 121.589 -0.695 . . . . 0.0 113.213 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 m -153.55 -111.14 0.04 OUTLIER 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.696 1.199 . . . . 0.0 109.405 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.9 m -155.89 -55.67 0.09 Allowed 'General case' 0 C--N 1.347 0.476 0 CA-C-N 118.813 0.733 . . . . 0.0 112.36 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.2 p -87.87 -57.42 2.95 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.141 0.976 . . . . 0.0 110.351 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -92.19 153.37 43.09 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.522 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.434 ' HG3' ' CE2' ' A' ' 26' ' ' TYR . 26.8 Cg_endo -98.31 56.04 1.0 Allowed 'Cis proline' 0 N--CA 1.442 -1.517 0 N-CA-C 105.139 -2.677 . . . . 0.0 105.139 -5.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -107.08 -168.39 1.4 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.555 1.142 . . . . 0.0 112.417 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.0 p -33.02 139.92 0.05 OUTLIER 'General case' 0 C--N 1.34 0.185 0 C-N-CA 128.56 2.744 . . . . 0.0 115.784 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -152.13 127.17 9.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.054 2.142 . . . . 0.0 105.515 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -149.24 -51.63 0.15 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.813 0.845 . . . . 0.0 110.171 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -58.02 158.13 7.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.842 1.257 . . . . 0.0 111.686 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 66.62 102.29 0.04 OUTLIER 'General case' 0 C--N 1.343 0.291 0 C-N-CA 125.927 1.691 . . . . 0.0 109.694 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -82.61 -142.44 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.147 0.979 . . . . 0.0 110.097 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.0 12.81 65.76 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -159.17 139.57 12.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.321 1.849 . . . . 0.0 108.584 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.06 166.22 17.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.671 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -134.97 162.19 59.19 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 124.772 1.229 . . . . 0.0 109.117 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -51.38 -41.12 60.86 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.852 3.035 . . . . 0.0 112.774 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.93 167.34 2.33 Favored 'Isoleucine or valine' 0 C--N 1.343 0.32 0 C-N-CA 123.585 0.754 . . . . 0.0 110.152 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -101.53 -177.22 3.37 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.981 1.313 . . . . 0.0 109.7 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -132.09 -156.76 8.41 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.471 1.034 . . . . 0.0 110.724 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.33 125.56 1.56 Allowed 'Cis proline' 0 N--CA 1.456 -0.712 0 CA-C-N 118.274 1.037 . . . . 0.0 113.436 -0.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -98.49 169.34 9.6 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.82 1.648 . . . . 0.0 109.261 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -138.83 156.18 47.53 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.45 159.8 17.1 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.705 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -161.18 102.32 1.25 Allowed Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 66.0 Cg_endo -66.87 121.74 8.99 Favored 'Trans proline' 0 N--CA 1.425 -2.546 0 CA-C-N 121.353 1.519 . . . . 0.0 114.098 -177.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 62' ' ' LYS . 3.2 tp -84.24 167.3 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-O 124.573 2.13 . . . . 0.0 112.127 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.449 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -160.25 151.62 19.5 Favored 'General case' 0 C--N 1.317 -0.843 1 CA-C-N 108.394 -4.003 . . . . 0.0 111.882 -178.887 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.6 p -86.49 57.36 4.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.998 1.719 . . . . 0.0 110.635 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.58 -73.39 0.03 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.27 137.64 5.48 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.45 131.6 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 117.32 0.56 . . . . 0.0 111.405 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.273 0.7 OUTLIER 64.65 131.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.717 2.807 . . . . 0.0 113.359 -178.659 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.6 p -136.59 -50.28 0.67 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.913 1.685 . . . . 0.0 108.435 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.9 61.66 1.49 Allowed Glycine 0 C--N 1.341 0.807 0 C-N-CA 124.374 0.988 . . . . 0.0 111.324 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 168.76 34.27 0.02 OUTLIER Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.271 -0.738 . . . . 0.0 113.206 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.8 p -170.38 139.76 1.47 Allowed Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.812 0.845 . . . . 0.0 110.094 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.73 -72.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.848 2.365 . . . . 0.0 108.5 170.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.74 -25.28 27.13 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 118.406 -1.219 . . . . 0.0 112.886 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 76.03 -43.54 0.48 Allowed 'General case' 0 C--N 1.346 0.448 0 C-N-CA 126.31 1.844 . . . . 0.0 111.081 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.92 121.76 28.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.88 0.872 . . . . 0.0 110.598 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -130.03 121.38 26.36 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.89 0.876 . . . . 0.0 112.896 -178.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.7 m -85.01 145.33 8.13 Favored 'Isoleucine or valine' 0 C--N 1.346 0.439 0 N-CA-C 102.692 -3.077 . . . . 0.0 102.692 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.8 t -131.47 115.89 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 pt -93.78 -177.97 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.454 0 C-N-CA 124.987 1.315 . . . . 0.0 110.663 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -123.23 166.9 14.47 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.356 14.9 t -75.99 62.83 1.68 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -149.57 -94.33 0.07 Allowed 'General case' 0 N--CA 1.432 -1.333 1 N-CA-C 99.55 -4.241 . . . . 0.0 99.55 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.5 t -164.12 8.92 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.771 1.228 . . . . 0.0 113.818 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -112.81 156.51 22.76 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -175.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -75.14 116.45 15.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.892 2.477 . . . . 0.0 108.456 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.23 -49.57 9.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.88 172.66 42.57 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.65 150.78 43.79 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.154 0.982 . . . . 0.0 111.087 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.4 pt -131.82 161.48 41.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.163 1.785 . . . . 0.0 108.15 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 92' ' ' THR . 0.8 OUTLIER -156.66 139.21 14.96 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -177.621 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -86.26 15.98 4.8 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.513 ' H ' HG23 ' A' ' 90' ' ' THR . 98.0 m -69.74 -51.73 31.55 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 120.703 -1.248 . . . . 0.0 111.0 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.88 9.5 65.65 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.556 1.074 . . . . 0.0 112.385 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.18 158.66 16.49 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.004 1.322 . . . . 0.0 111.086 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.8 t -104.62 69.32 0.89 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.326 1.45 . . . . 0.0 108.436 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.06 -115.21 3.29 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.463 1.506 . . . . 0.0 109.548 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -102.68 22.06 14.32 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.558 1.143 . . . . 0.0 111.778 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.71 -164.73 0.45 Allowed 'General case' 0 C--N 1.342 0.266 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -146.94 155.18 42.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.5 m -140.95 165.03 20.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 126.856 2.062 . . . . 0.0 106.622 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.87 141.91 16.29 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 116.637 -0.256 . . . . 0.0 113.538 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.3 t -83.07 -174.82 5.51 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.6 m -68.82 127.64 33.82 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.101 -0.999 . . . . 0.0 109.023 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.36 42.1 12.41 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.4 m -149.98 124.86 9.88 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.806 1.242 . . . . 0.0 108.144 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t30 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 117.038 -1.458 . . . . 0.0 109.173 179.171 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 121.155 0.502 . . . . 0.0 111.992 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 t -127.05 164.51 21.38 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.943 1.697 . . . . 0.0 108.682 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.46 123.41 14.65 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.412 HG22 ' CG2' ' A' ' 16' ' ' VAL . 3.8 t -130.8 124.39 31.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 123.73 0.644 . . . . 0.0 111.075 -178.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -107.55 129.69 54.95 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.68 1.992 . . . . 0.0 106.507 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -119.81 93.39 4.05 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.879 0.371 . . . . 0.0 110.353 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.6 -84.01 0.66 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.9 m -115.53 -27.4 7.15 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.888 1.275 . . . . 0.0 110.802 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -66.71 155.12 38.9 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.733 0.697 . . . . 0.0 109.884 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -142.15 86.24 1.96 Allowed 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 123.788 0.68 . . . . 0.0 110.855 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.58 136.98 32.72 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.7 t -76.7 158.45 30.98 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.69 -19.55 50.45 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.7 m -71.54 -39.43 70.71 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.21 1.004 . . . . 0.0 109.214 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.99 -50.12 37.8 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.35 1.06 . . . . 0.0 112.459 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.437 HG11 ' CE2' ' A' ' 85' ' ' TYR . 21.7 t -54.79 -48.08 73.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.332 1.053 . . . . 0.0 108.917 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -71.11 -41.84 70.03 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.178 1.391 . . . . 0.0 113.363 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.72 -52.17 53.38 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.702 0.683 . . . . 0.0 110.651 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.432 ' HB1' ' CE2' ' A' ' 59' ' ' PHE . . . -60.93 -36.95 80.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.448 0.699 . . . . 0.0 110.703 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.52 -39.02 67.91 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.802 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -67.12 -21.86 65.83 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.84 -63.53 1.39 Allowed 'General case' 0 C--N 1.347 0.48 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.435 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -47.33 -37.35 10.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.332 1.453 . . . . 0.0 111.535 177.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -61.7 2.44 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.473 1.909 . . . . 0.0 108.884 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -63.23 -36.7 84.51 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -66.87 -43.06 84.54 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.673 1.189 . . . . 0.0 111.987 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -74.36 -27.59 60.74 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.074 0.397 . . . . 0.0 111.798 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -89.07 9.39 25.53 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.338 1.055 . . . . 0.0 113.146 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.7 p30 -130.84 45.83 2.76 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.085 0.857 . . . . 0.0 110.54 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 70.66 37.28 1.44 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.849 2.06 . . . . 0.0 113.274 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.45 176.36 0.08 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.565 1.946 . . . . 0.0 114.905 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.1 t 21.35 79.38 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 129.351 3.061 . . . . 0.0 115.857 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.89 98.3 7.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.16 53.61 41.12 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.498 1.047 . . . . 0.0 111.034 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.3 m -140.38 -114.89 0.13 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.2 t -157.9 -82.33 0.06 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.3 p -115.44 -44.09 3.0 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.842 1.657 . . . . 0.0 107.528 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.49 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 15.2 m-85 -69.49 131.99 89.67 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 126.664 1.986 . . . . 0.0 106.514 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.91 137.18 48.42 Favored 'Cis proline' 0 N--CA 1.453 -0.896 0 CA-C-N 120.823 1.33 . . . . 0.0 113.314 0.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -159.91 150.16 18.63 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.895 1.678 . . . . 0.0 109.963 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -47.72 141.39 5.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.094 2.157 . . . . 0.0 113.451 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -113.89 97.18 6.24 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.784 1.634 . . . . 0.0 108.383 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -157.94 33.55 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -66.11 -50.53 63.7 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.06 0.544 . . . . 0.0 111.347 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -161.6 91.57 0.84 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 72.13 171.45 0.31 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.233 1.813 . . . . 0.0 110.741 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.22 8.2 7.99 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 118.315 -1.27 . . . . 0.0 114.559 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.3 t80 62.61 -158.98 0.32 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.016 1.408 . . . . 0.0 110.016 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -61.82 -172.73 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.828 1.651 . . . . 0.0 112.325 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.0 p90 51.7 63.39 9.43 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 125.748 1.619 . . . . 0.0 110.741 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.64 111.44 3.13 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.687 2.924 . . . . 0.0 110.075 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.76 170.68 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.199 1.399 . . . . 0.0 109.72 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.7 -57.97 6.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.23 -149.35 49.93 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 119.521 -0.6 . . . . 0.0 112.267 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.98 148.64 19.9 Favored 'Cis proline' 0 N--CA 1.459 -0.512 0 CA-C-N 118.604 1.202 . . . . 0.0 112.999 -0.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -111.18 140.69 45.52 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 125.742 1.617 . . . . 0.0 108.645 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -113.88 149.65 34.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.77 1.228 . . . . 0.0 113.42 -177.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -84.83 155.12 21.91 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.095 0.958 . . . . 0.0 110.553 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.435 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 62.7 t80 -153.53 108.71 2.57 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 176.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.49 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 11.2 Cg_endo -82.04 133.44 7.75 Favored 'Trans proline' 0 N--CA 1.432 -2.131 0 C-N-CA 121.931 1.754 . . . . 0.0 113.287 -175.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.45 ' CG2' ' H ' ' A' ' 62' ' ' LYS . 0.7 OUTLIER -106.21 -171.58 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 127.247 2.219 . . . . 0.0 106.298 178.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.45 ' H ' ' CG2' ' A' ' 61' ' ' ILE . 10.5 mmtt -162.74 -174.99 4.19 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 129.374 3.069 . . . . 0.0 108.396 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.2 m -88.74 53.46 2.71 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.96 -51.25 0.01 OUTLIER Glycine 0 C--N 1.344 1.025 0 C-N-CA 124.666 1.127 . . . . 0.0 111.87 -178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.87 -139.12 7.33 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 118.289 1.045 . . . . 0.0 112.966 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.0 p -52.96 142.4 5.81 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 125.716 1.606 . . . . 0.0 110.436 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.03 164.0 27.98 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.297 0.639 . . . . 0.0 112.124 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 t -134.18 63.97 1.61 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.538 1.535 . . . . 0.0 109.419 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 151.53 -177.32 29.52 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.54 -98.21 0.15 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.414 ' CB ' ' CD ' ' A' ' 72' ' ' PRO 0.327 67.3 m 56.19 -105.88 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.952 1.701 . . . . 0.0 111.08 -179.084 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 71' ' ' SER . 83.0 Cg_endo -75.64 131.07 13.2 Favored 'Trans proline' 0 C--N 1.352 0.711 0 CA-C-N 123.584 2.316 . . . . 0.0 109.07 175.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.47 162.86 25.34 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -157.51 48.86 0.42 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.919 0.888 . . . . 0.0 109.303 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.18 116.89 3.42 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.975 2.11 . . . . 0.0 105.881 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.22 165.53 30.67 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 m -135.58 142.62 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 102.259 -3.237 . . . . 0.0 102.259 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.0 t -133.08 120.38 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.0 pt -97.99 179.33 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.407 0 C-N-CA 126.395 1.878 . . . . 0.0 112.028 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -113.59 177.1 4.75 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.416 1.486 . . . . 0.0 109.681 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.332 11.5 t -77.88 55.29 1.39 Allowed 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 118.047 2.61 . . . . 0.0 118.047 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -160.71 -95.23 0.02 OUTLIER 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 101.626 -3.472 . . . . 0.0 101.626 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 90.8 m -163.92 47.9 0.12 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 129.209 3.004 . . . . 0.0 109.863 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -121.7 108.28 13.35 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.625 1.557 . . . . 0.0 114.202 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.437 ' CE2' HG11 ' A' ' 16' ' ' VAL . 3.3 t80 -65.35 104.68 0.99 Allowed 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.381 1.472 . . . . 0.0 107.718 178.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.93 -54.27 5.97 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.569 0.748 . . . . 0.0 111.994 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.35 149.01 12.12 Favored Glycine 0 C--N 1.34 0.799 0 C-N-CA 119.25 -1.452 . . . . 0.0 113.963 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.99 140.36 29.56 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.947 1.299 . . . . 0.0 109.162 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.7 pt -135.74 161.7 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.017 1.327 . . . . 0.0 109.812 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.0 t -159.92 148.67 17.42 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.523 0.729 . . . . 0.0 112.169 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.47 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 5.0 m170 -85.65 -25.81 26.38 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.8 m -49.26 109.4 0.26 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 126.282 1.833 . . . . 0.0 110.337 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.27 52.31 4.06 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.183 0.897 . . . . 0.0 111.041 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.49 -128.38 0.09 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.615 1.166 . . . . 0.0 108.721 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.8 m -145.85 71.39 1.27 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.016 0.926 . . . . 0.0 110.12 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.87 -91.28 0.27 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.758 1.171 . . . . 0.0 112.851 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -79.89 -34.74 38.86 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.651 1.18 . . . . 0.0 111.579 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -53.39 138.48 32.98 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.943 0.897 . . . . 0.0 111.016 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -106.27 147.82 28.7 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.529 1.532 . . . . 0.0 110.318 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.5 m -128.99 160.79 39.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 124.546 1.138 . . . . 0.0 108.288 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.06 142.39 21.42 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.994 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 8.7 t -85.26 -174.66 5.35 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.302 1.441 . . . . 0.0 108.332 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.3 m -65.11 131.06 45.57 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 121.344 -0.848 . . . . 0.0 109.101 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.61 43.85 51.09 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 16.3 m -146.78 144.41 29.35 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 57.5 t30 . . . . . 0 C--O 1.251 1.137 0 C-N-CA 125.344 1.458 . . . . 0.0 110.345 -179.116 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 120.844 0.354 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.5 t -158.07 68.69 0.5 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.68 155.86 0.16 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.501 1.921 . . . . 0.0 110.495 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.5 p -135.53 93.6 2.98 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.87 95.91 10.04 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 102.067 -3.309 . . . . 0.0 102.067 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.7 m -95.08 83.12 3.86 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.008 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.14 -87.74 0.58 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.0 p -120.01 -23.29 6.4 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.076 1.751 . . . . 0.0 110.657 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.6 m -75.65 91.25 2.86 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -84.22 106.52 15.91 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.882 1.273 . . . . 0.0 110.911 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -98.32 138.84 34.97 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.108 0.963 . . . . 0.0 110.057 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.2 t -72.5 152.72 41.73 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 124.69 1.196 . . . . 0.0 108.839 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.4 -18.09 48.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 t -76.34 -38.52 55.8 Favored 'General case' 0 C--N 1.345 0.391 0 C-N-CA 124.382 1.073 . . . . 0.0 108.334 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -67.81 -36.37 80.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.298 1.039 . . . . 0.0 111.514 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.4 t -67.56 -48.27 77.37 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -62.77 -38.01 88.9 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.734 1.214 . . . . 0.0 111.3 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.32 -51.97 26.25 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.9 0.88 . . . . 0.0 110.541 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.69 -41.96 74.48 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.476 1.11 . . . . 0.0 110.116 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.7 -25.38 38.19 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -69.44 -24.64 63.85 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.41 -55.7 4.87 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.36 -51.68 25.21 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 124.266 0.979 . . . . 0.0 111.711 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 t -61.98 -47.21 85.87 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.111 1.764 . . . . 0.0 112.515 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -63.22 -51.02 67.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.307 0.643 . . . . 0.0 111.939 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -68.95 -48.16 63.89 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -63.54 -22.09 66.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -110.14 9.86 23.95 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -157.98 61.22 0.46 Allowed 'General case' 0 C--N 1.339 0.143 0 CA-C-N 119.361 0.982 . . . . 0.0 109.123 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t70 64.22 99.01 0.04 OUTLIER 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.954 1.702 . . . . 0.0 109.27 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -61.42 114.57 3.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.6 p -105.99 -76.82 0.6 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.14 -179.9 0.09 Allowed 'General case' 0 C--N 1.342 0.242 0 C-N-CA 125.758 1.623 . . . . 0.0 113.876 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.38 -62.59 3.03 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 p -82.05 -108.87 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.909 0.884 . . . . 0.0 109.636 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.8 p -170.06 -51.35 0.02 OUTLIER 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.538 1.135 . . . . 0.0 110.045 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.4 t -80.24 31.38 0.27 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.029 1.332 . . . . 0.0 112.833 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.497 ' CD1' ' HD3' ' A' ' 60' ' ' PRO . 96.8 m-85 -170.01 113.96 0.48 Allowed Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 128.339 2.656 . . . . 0.0 104.334 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.54 134.48 35.79 Favored 'Cis proline' 0 N--CA 1.448 -1.157 0 CA-C-N 120.763 1.308 . . . . 0.0 111.333 1.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -155.23 161.44 41.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.987 1.315 . . . . 0.0 108.216 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 t -60.87 143.24 55.26 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-O 120.748 0.308 . . . . 0.0 110.881 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.34 122.72 27.82 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -64.44 161.98 16.06 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.276 1.03 . . . . 0.0 111.189 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -105.06 73.0 1.03 Allowed 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.158 0.983 . . . . 0.0 110.068 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -81.6 -89.01 0.08 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -155.46 -56.38 0.09 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.003 1.321 . . . . 0.0 109.304 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.69 135.18 44.28 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.044 1.307 . . . . 0.0 114.496 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 53.6 162.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 129.121 2.969 . . . . 0.0 117.816 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -161.68 160.98 29.27 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.09 2.156 . . . . 0.0 107.241 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -137.31 78.62 38.66 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.28 71.24 5.87 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.014 3.142 . . . . 0.0 110.09 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.4 t -119.73 -67.22 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 125.754 1.622 . . . . 0.0 107.919 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -165.87 78.76 0.27 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.05 162.22 54.68 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.2 152.9 97.64 Favored 'Cis proline' 0 N--CA 1.459 -0.54 0 CA-C-N 118.302 1.051 . . . . 0.0 112.902 0.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -121.75 156.92 32.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.931 2.093 . . . . 0.0 110.493 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -127.87 152.45 47.82 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.295 1.438 . . . . 0.0 112.462 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -94.04 156.17 16.74 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.242 1.017 . . . . 0.0 111.772 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -159.35 112.7 1.54 Allowed Pre-proline 0 N--CA 1.455 -0.188 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.497 ' HD3' ' CD1' ' A' ' 38' ' ' TYR . 31.2 Cg_endo -81.7 127.24 5.55 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 121.389 1.393 . . . . 0.0 112.506 -175.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.502 HG13 ' H ' ' A' ' 62' ' ' LYS . 6.5 tt -84.47 167.2 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-O 123.816 1.769 . . . . 0.0 112.709 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.502 ' H ' HG13 ' A' ' 61' ' ' ILE . 48.0 mmtm -142.71 145.36 33.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 109.098 -3.683 . . . . 0.0 112.71 -178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.5 t -91.61 58.24 3.47 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 125.585 1.554 . . . . 0.0 108.833 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.06 -64.8 0.03 OUTLIER Glycine 0 C--N 1.337 0.6 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.31 159.49 32.69 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.0 p -74.53 156.47 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.515 1.126 . . . . 0.0 109.603 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.3 t80 66.44 56.65 0.76 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.501 1.12 . . . . 0.0 111.099 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.9 p -149.96 166.29 30.09 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.303 1.041 . . . . 0.0 109.509 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -144.83 148.03 19.56 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.614 1.102 . . . . 0.0 110.824 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.19 170.18 33.82 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.1 t -52.5 -66.02 0.89 Allowed Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.941 1.297 . . . . 0.0 112.96 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.87 146.7 48.36 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.243 1.962 . . . . 0.0 111.51 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.83 139.57 6.58 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -173.39 -33.3 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.355 1.462 . . . . 0.0 111.833 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.07 120.06 29.05 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.658 1.583 . . . . 0.0 111.551 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -139.03 130.56 27.22 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.9 m -96.44 148.1 5.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.276 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.8 t -136.7 137.24 47.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.7 pt -117.3 176.3 2.81 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 C-N-CA 125.188 1.395 . . . . 0.0 112.904 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -97.28 163.58 12.84 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 128.08 2.552 . . . . 0.0 107.19 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.302 12.8 t -72.41 3.72 4.51 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -93.43 -86.87 0.25 Allowed 'General case' 0 N--CA 1.434 -1.267 1 N-CA-C 98.711 -4.551 . . . . 0.0 98.711 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.5 m -164.49 -5.63 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 128.253 2.621 . . . . 0.0 114.105 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -79.48 148.87 31.7 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.31 129.85 39.91 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.071 1.349 . . . . 0.0 107.754 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.91 -51.72 4.94 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.941 1.296 . . . . 0.0 108.958 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.35 -166.57 32.57 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.75 116.97 3.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.034 0.934 . . . . 0.0 108.802 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 45.4 pt -107.96 160.26 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.796 1.238 . . . . 0.0 110.649 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t -159.86 149.08 17.8 Favored 'General case' 0 C--N 1.343 0.284 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.541 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 27.2 m170 -79.75 -36.29 37.47 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.162 175.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.8 m -34.02 -58.99 0.44 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 128.478 2.711 . . . . 0.0 115.131 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.83 -36.33 92.61 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.521 1.057 . . . . 0.0 112.556 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.44 -159.66 0.29 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.933 1.293 . . . . 0.0 111.383 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.7 t -80.91 -81.46 0.13 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.626 0.77 . . . . 0.0 111.694 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -135.02 -78.45 0.1 Allowed Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.04 0.829 . . . . 0.0 111.805 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -79.82 -27.12 40.29 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.511 0.655 . . . . 0.0 111.519 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -59.48 151.85 23.14 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.976 1.31 . . . . 0.0 110.407 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -120.08 151.04 39.62 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.535 1.534 . . . . 0.0 110.069 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.1 m -147.69 166.14 5.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 125.942 1.697 . . . . 0.0 108.238 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.8 156.29 25.39 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.501 0.572 . . . . 0.0 112.69 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.3 m -104.84 -169.07 1.56 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.126 1.37 . . . . 0.0 108.244 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.4 t -61.33 113.99 2.94 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.83 60.51 1.96 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.3 m -154.78 121.14 5.33 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.98 0.912 . . . . 0.0 108.542 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.157 -1.402 . . . . 0.0 108.746 179.353 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 120.326 0.108 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -145.25 159.9 42.31 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.819 1.248 . . . . 0.0 109.391 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.27 136.0 57.73 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.815 0.846 . . . . 0.0 109.463 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.56 HG23 HG21 ' A' ' 16' ' ' VAL . 48.4 p -111.37 146.14 37.65 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.47 0.708 . . . . 0.0 109.68 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.83 117.92 8.88 Favored 'General case' 0 N--CA 1.44 -0.928 1 N-CA-C 99.675 -4.194 . . . . 0.0 99.675 177.445 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.26 103.55 5.8 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.896 0.379 . . . . 0.0 111.012 -177.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.91 -63.63 4.35 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 125.109 1.338 . . . . 0.0 109.807 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.4 p -155.65 -44.69 0.08 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.932 1.693 . . . . 0.0 109.275 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -54.65 115.83 2.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.612 1.965 . . . . 0.0 109.409 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -104.55 150.3 24.75 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.982 1.313 . . . . 0.0 111.068 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.88 141.03 26.15 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.018 1.327 . . . . 0.0 109.14 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.6 m -72.59 152.54 41.74 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 124.726 1.211 . . . . 0.0 110.142 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.61 -21.34 53.16 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.8 m -71.94 -41.22 68.06 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.873 1.269 . . . . 0.0 109.86 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -72.34 -41.11 66.85 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.022 0.929 . . . . 0.0 112.082 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.56 HG21 HG23 ' A' ' 4' ' ' THR . 23.6 t -63.25 -47.73 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -67.07 -36.05 81.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.678 1.191 . . . . 0.0 110.999 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.08 -51.2 65.2 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 118.894 0.77 . . . . 0.0 109.391 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.45 -37.3 87.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.63 -41.71 87.87 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.349 -0.844 . . . . 0.0 111.967 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -69.46 -18.81 63.75 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.61 -62.54 1.64 Allowed 'General case' 0 C--N 1.347 0.464 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.461 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -46.41 -44.43 17.19 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.923 0.889 . . . . 0.0 111.19 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.9 t -61.37 -49.73 75.73 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 118.938 0.79 . . . . 0.0 110.293 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -68.84 -9.58 52.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.659 0.784 . . . . 0.0 112.65 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -115.12 -16.23 11.61 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.815 0.846 . . . . 0.0 112.915 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.42 ' CD2' ' HG3' ' A' ' 57' ' ' GLN . 48.2 t80 -65.57 -51.8 57.06 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.006 0.923 . . . . 0.0 110.427 -178.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -90.98 -27.11 18.89 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -63.66 -25.0 68.02 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.901 0.773 . . . . 0.0 112.989 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 t70 65.15 45.56 2.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.626 1.17 . . . . 0.0 111.571 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -168.03 151.04 5.72 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.005 1.322 . . . . 0.0 108.909 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.0 p 47.5 39.52 9.63 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.727 1.611 . . . . 0.0 112.344 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.07 89.07 6.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.895 1.278 . . . . 0.0 110.979 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 52.78 -141.32 28.59 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.959 1.742 . . . . 0.0 112.578 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.1 p -154.27 -33.98 0.1 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.332 1.053 . . . . 0.0 112.637 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.7 t -82.14 -102.67 0.04 OUTLIER 'General case' 0 C--N 1.343 0.311 0 C-N-CA 123.627 0.771 . . . . 0.0 109.358 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.0 p -137.82 35.27 2.4 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.629 1.172 . . . . 0.0 109.209 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -133.24 148.2 68.12 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 124.0 0.92 . . . . 0.0 109.118 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.29 125.08 10.27 Favored 'Cis proline' 0 N--CA 1.452 -0.938 0 CA-C-N 118.733 0.583 . . . . 0.0 112.564 0.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.3 163.01 33.6 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.018 0.927 . . . . 0.0 110.881 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 m -48.19 124.18 7.41 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 127.952 2.501 . . . . 0.0 113.012 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -115.89 68.47 0.72 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.71 85.4 0.47 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.099 1.36 . . . . 0.0 112.778 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -131.19 137.16 48.83 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.852 1.661 . . . . 0.0 106.962 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -116.62 132.94 56.55 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.473 1.109 . . . . 0.0 110.847 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 40.72 45.89 2.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.175 2.19 . . . . 0.0 114.09 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.57 -79.26 1.42 Allowed Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -80.27 173.48 12.55 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.328 1.051 . . . . 0.0 112.097 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -79.52 6.18 11.06 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -127.13 67.2 70.01 Favored Pre-proline 0 C--N 1.318 -0.772 0 C-N-CA 127.93 2.492 . . . . 0.0 110.146 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.73 -41.84 3.95 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.82 2.346 . . . . 0.0 110.291 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.7 t 62.54 -97.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.885 1.674 . . . . 0.0 108.816 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -165.88 -58.16 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 126.319 1.848 . . . . 0.0 107.883 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.95 -175.79 51.79 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -58.21 151.67 36.73 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 CA-C-N 119.043 1.422 . . . . 0.0 113.5 -0.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -146.03 159.3 43.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.573 1.149 . . . . 0.0 109.778 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.42 ' HG3' ' CD2' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -129.2 161.69 29.55 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -175.528 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -88.1 157.24 18.91 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 113.699 -1.591 . . . . 0.0 108.89 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.461 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 15.2 t80 -160.24 112.6 1.4 Allowed Pre-proline 0 C--O 1.224 -0.259 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -82.15 137.16 9.42 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 121.387 1.391 . . . . 0.0 115.211 -175.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.606 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 3.0 tt -110.37 -175.85 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 124.034 1.873 . . . . 0.0 112.188 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.606 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -160.8 152.01 19.01 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 108.724 -3.853 . . . . 0.0 111.004 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.7 t -84.44 59.87 5.69 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.969 1.307 . . . . 0.0 108.878 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.05 -50.37 0.03 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.04 172.27 45.18 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.75 119.13 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.364 1.065 . . . . 0.0 109.587 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.3 t80 62.47 118.44 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.255 1.822 . . . . 0.0 112.665 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 79.6 p -126.84 154.12 44.77 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.94 1.296 . . . . 0.0 109.79 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.86 72.24 2.83 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.98 -48.39 0.02 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.8 m 60.7 80.12 0.27 Allowed Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 125.339 1.456 . . . . 0.0 110.694 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.49 -56.16 3.37 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.385 3.39 . . . . 0.0 112.026 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.41 39.24 3.51 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.967 1.27 . . . . 0.0 110.478 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -154.41 -73.2 0.12 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 117.959 -1.019 . . . . 0.0 112.567 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -67.38 117.16 8.99 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.8 mtt85 -146.73 129.46 16.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.74 155.37 3.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 103.601 -2.74 . . . . 0.0 103.601 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.0 t -136.14 123.35 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 O-C-N 120.587 -1.32 . . . . 0.0 108.146 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.7 pt -105.46 175.44 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.417 0 C-N-CA 125.775 1.63 . . . . 0.0 112.756 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -101.83 165.03 11.41 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 127.47 2.308 . . . . 0.0 108.364 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.251 11.4 t -67.26 -29.78 69.49 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 118.302 2.705 . . . . 0.0 118.302 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -79.14 -73.16 0.35 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.8 t -164.72 3.52 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -78.65 164.03 24.97 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 119.723 1.147 . . . . 0.0 113.953 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -104.68 117.53 34.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.59 -45.96 12.02 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.099 0.559 . . . . 0.0 110.188 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.66 -160.48 33.9 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.6 145.09 31.61 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.823 0.849 . . . . 0.0 109.652 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.5 pt -143.14 164.93 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.923 1.289 . . . . 0.0 111.571 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.2 t -155.79 146.5 22.08 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.46 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 24.0 m170 -79.1 -15.45 58.14 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.809 174.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.0 m -39.8 -55.36 1.97 Allowed 'General case' 0 C--N 1.345 0.409 0 C-N-CA 126.859 2.063 . . . . 0.0 114.576 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.83 28.14 11.04 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.519 1.057 . . . . 0.0 112.816 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.76 177.02 5.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.078 0.951 . . . . 0.0 111.325 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 84.2 p -68.0 -48.42 65.79 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.097 0.959 . . . . 0.0 111.378 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.8 -69.68 0.08 OUTLIER Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -102.23 29.17 5.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.722 1.209 . . . . 0.0 109.654 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -131.83 176.94 7.92 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.769 1.228 . . . . 0.0 109.618 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -127.42 164.52 21.67 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.164 1.786 . . . . 0.0 110.824 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.87 156.23 40.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 C-N-CA 124.875 1.27 . . . . 0.0 107.581 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.8 142.33 25.43 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.298 0.952 . . . . 0.0 112.762 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.7 m -96.27 179.03 5.18 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.797 0.839 . . . . 0.0 110.517 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 27.0 t -69.24 140.69 54.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.89 47.05 62.72 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.5 m -131.49 96.31 3.95 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.371 1.468 . . . . 0.0 107.085 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.7 t30 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 117.028 -1.463 . . . . 0.0 109.229 -179.1 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 121.234 0.54 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.5 m -160.85 80.24 0.63 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 126.208 1.803 . . . . 0.0 106.849 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 73.03 160.93 0.24 Allowed 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.353 1.461 . . . . 0.0 109.808 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 t -157.7 148.68 21.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.28 120.12 29.15 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 104.794 -2.298 . . . . 0.0 104.794 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.6 m -112.95 111.4 22.12 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.65 -95.17 0.18 Allowed Glycine 0 CA--C 1.529 0.923 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.8 p -118.54 -39.19 3.03 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.109 1.763 . . . . 0.0 109.7 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.4 m -61.28 126.06 26.0 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.024 1.33 . . . . 0.0 109.721 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -99.02 153.6 18.74 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.565 1.146 . . . . 0.0 110.289 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -142.77 121.3 12.47 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.678 1.191 . . . . 0.0 108.52 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.5 t -67.34 154.32 41.61 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 125.06 1.344 . . . . 0.0 110.473 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.85 -22.01 61.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.401 -1.704 . . . . 0.0 106.401 176.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.4 t -72.47 -39.76 67.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.324 1.049 . . . . 0.0 109.209 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -73.43 -44.08 59.05 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.342 0.657 . . . . 0.0 112.116 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.5 t -59.03 -51.47 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 124.993 1.317 . . . . 0.0 109.086 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -68.42 -41.05 80.93 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.921 0.888 . . . . 0.0 112.925 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.58 -47.16 87.4 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 123.753 0.658 . . . . 0.0 109.427 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.44 ' HA ' HG23 ' A' ' 66' ' ' VAL . . . -58.0 -39.54 78.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.314 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.36 -30.33 61.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -69.8 -25.48 63.8 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.19 -61.07 2.11 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 104.167 -2.531 . . . . 0.0 104.167 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.532 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . . . -43.77 -43.65 6.22 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 124.763 1.289 . . . . 0.0 111.614 176.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.57 -64.03 0.98 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 126.385 1.874 . . . . 0.0 111.667 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.5 -36.67 83.3 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -88.65 -22.51 23.41 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.306 0.0 OUTLIER -92.65 16.76 11.44 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.779 1.627 . . . . 0.0 114.966 -178.352 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.6 -38.96 70.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.57 1.148 . . . . 0.0 110.368 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -145.6 -67.87 0.29 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.659 1.184 . . . . 0.0 109.003 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -177.37 91.73 0.03 OUTLIER 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.518 1.527 . . . . 0.0 108.104 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -119.17 -170.51 1.94 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.737 1.215 . . . . 0.0 109.897 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.9 p -70.88 83.89 0.66 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.254 1.422 . . . . 0.0 111.236 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.91 156.91 39.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.272 1.029 . . . . 0.0 110.784 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.15 -141.5 45.47 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.474 1.035 . . . . 0.0 112.438 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.0 t -90.32 -74.34 0.49 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.64 1.176 . . . . 0.0 109.935 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 t -151.54 -56.09 0.15 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.055 1.342 . . . . 0.0 108.32 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.3 p -79.36 -53.75 6.62 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -59.62 135.3 89.29 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -71.77 131.09 20.4 Favored 'Cis proline' 0 N--CA 1.454 -0.801 0 CA-C-N 119.123 0.723 . . . . 0.0 112.489 2.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.02 156.6 41.48 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 123.469 0.707 . . . . 0.0 111.555 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.9 p -34.45 137.24 0.12 Allowed 'General case' 0 C--N 1.34 0.166 0 C-N-CA 127.764 2.426 . . . . 0.0 115.096 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -135.52 88.01 2.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.081 1.352 . . . . 0.0 108.286 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -167.93 -39.61 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.867 1.667 . . . . 0.0 108.462 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -61.69 -35.77 78.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.888 1.275 . . . . 0.0 110.348 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -61.77 -77.28 0.05 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.243 1.017 . . . . 0.0 109.56 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -171.22 138.33 1.22 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.177 1.391 . . . . 0.0 108.254 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.4 132.79 23.26 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -144.2 108.21 4.74 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.279 0.632 . . . . 0.0 110.264 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 t70 51.17 -168.64 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.572 1.549 . . . . 0.0 113.517 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.0 p90 38.03 79.04 0.33 Allowed Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 127.159 2.184 . . . . 0.0 114.265 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.82 64.67 8.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.829 3.019 . . . . 0.0 107.833 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.34 -154.62 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 126.078 1.751 . . . . 0.0 110.112 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -100.99 118.58 37.28 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.509 1.123 . . . . 0.0 110.197 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.21 -176.46 30.32 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.218 0.914 . . . . 0.0 111.581 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.73 127.85 15.12 Favored 'Cis proline' 0 N--CA 1.453 -0.884 0 CA-C-N 117.527 0.664 . . . . 0.0 111.414 -0.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -102.47 140.26 36.99 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -115.66 162.17 17.63 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 123.878 0.736 . . . . 0.0 110.876 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -79.38 144.67 33.94 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.578 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.532 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 69.2 t80 -138.89 103.03 7.54 Favored Pre-proline 0 N--CA 1.443 -0.804 0 N-CA-C 102.086 -3.301 . . . . 0.0 102.086 176.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HB3' ' HD2' ' A' ' 76' ' ' ARG . 11.5 Cg_endo -77.99 137.25 15.45 Favored 'Trans proline' 0 N--CA 1.439 -1.691 0 C-N-CA 121.224 1.283 . . . . 0.0 111.964 -176.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.574 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.5 tt -116.96 -177.98 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 124.581 2.134 . . . . 0.0 113.366 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.574 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -161.32 153.93 20.46 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 108.428 -3.987 . . . . 0.0 111.613 178.164 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.0 t -88.62 58.5 4.69 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.874 1.27 . . . . 0.0 108.165 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.48 -74.79 0.01 OUTLIER Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.29 86.77 0.1 OUTLIER Glycine 0 CA--C 1.527 0.793 0 CA-C-N 117.385 0.593 . . . . 0.0 111.973 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.44 HG23 ' HA ' ' A' ' 19' ' ' ALA 0.266 12.9 p 41.12 60.43 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.958 2.103 . . . . 0.0 113.407 178.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 21.5 t80 58.2 93.97 0.03 OUTLIER 'General case' 0 C--N 1.344 0.339 0 C-N-CA 126.69 1.996 . . . . 0.0 114.047 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.0 t -155.99 124.41 5.85 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.901 1.28 . . . . 0.0 108.771 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.18 66.45 2.49 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.73 1.157 . . . . 0.0 111.492 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -164.97 77.8 0.14 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.5 t -146.02 108.74 4.31 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -61.37 160.11 48.73 Favored 'Cis proline' 0 N--CA 1.459 -0.537 0 CA-C-N 119.969 1.025 . . . . 0.0 113.987 0.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.68 -42.59 0.05 OUTLIER Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.167 1.365 . . . . 0.0 110.907 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 78.7 -48.29 0.44 Allowed 'General case' 0 C--N 1.342 0.281 0 C-N-CA 127.364 2.266 . . . . 0.0 112.538 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -75.93 124.9 28.1 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.437 ' HD2' ' HB3' ' A' ' 60' ' ' PRO . 14.5 mmt180 -136.99 118.0 14.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.366 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.4 m -84.2 164.55 2.58 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.3 t -140.26 137.19 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 pt -131.06 159.73 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.761 0.825 . . . . 0.0 112.513 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -89.16 146.04 25.04 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 127.464 2.306 . . . . 0.0 108.205 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.37 15.3 t -73.78 66.17 1.08 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -177.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -157.32 -94.45 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.184 1 N-CA-C 97.458 -5.016 . . . . 0.0 97.458 176.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -162.84 10.69 0.06 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.996 1.718 . . . . 0.0 113.774 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.3 140.93 29.04 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.993 0.815 . . . . 0.0 112.178 -177.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -73.52 131.49 41.82 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.95 -56.79 2.86 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.89 -177.29 40.72 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 112.25 -0.34 . . . . 0.0 112.25 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.98 117.6 13.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.837 1.655 . . . . 0.0 107.056 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 41.0 pt -128.27 153.52 37.8 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 C-N-CA 124.075 0.95 . . . . 0.0 109.814 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -152.18 150.85 30.29 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.34 75.85 5.91 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.3 m -70.57 -84.54 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.086 -1.634 . . . . 0.0 110.24 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.7 34.57 5.56 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.85 153.17 42.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.224 1.81 . . . . 0.0 110.957 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -74.37 -11.55 60.28 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.588 0.755 . . . . 0.0 112.227 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.73 -94.86 0.1 OUTLIER Glycine 0 C--N 1.341 0.841 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -103.22 22.62 13.76 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.156 0.982 . . . . 0.0 110.54 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -72.26 178.78 3.71 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -151.82 133.98 15.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 m -115.12 166.53 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.56 145.21 19.41 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.105 0.802 . . . . 0.0 115.105 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.8 m -97.54 177.5 5.49 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 124.53 1.132 . . . . 0.0 110.559 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.3 t 44.06 41.76 4.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.667 0.787 . . . . 0.0 112.094 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.5 30.06 75.86 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.384 0.992 . . . . 0.0 113.922 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.4 m -86.54 151.14 23.73 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.654 1.182 . . . . 0.0 109.083 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 116.346 -1.788 . . . . 0.0 108.677 179.842 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 121.025 0.44 . . . . 0.0 111.529 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.5 p -78.39 152.03 32.47 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.012 1.325 . . . . 0.0 108.365 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.32 61.75 0.71 Allowed 'General case' 0 C--N 1.342 0.244 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 t -107.48 135.95 48.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.874 1.269 . . . . 0.0 110.67 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -110.57 108.41 18.35 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 103.393 -2.818 . . . . 0.0 103.393 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.34 85.42 4.6 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.02 -104.63 1.44 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.2 p -94.49 -44.52 7.84 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.494 1.118 . . . . 0.0 110.188 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.6 m -70.0 110.37 5.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.856 0.862 . . . . 0.0 110.24 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -84.72 148.52 26.34 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.684 1.193 . . . . 0.0 111.061 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -142.03 112.91 7.37 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.101 0.96 . . . . 0.0 111.098 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.7 t -65.37 157.49 29.13 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 125.84 1.656 . . . . 0.0 110.429 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.0 -19.27 29.66 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.5 m -73.43 -44.54 58.02 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.521 1.128 . . . . 0.0 109.184 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -71.91 -44.15 64.16 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 124.718 1.207 . . . . 0.0 112.34 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.25 -51.2 75.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -41.92 96.57 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.633 1.973 . . . . 0.0 112.517 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.34 -54.44 28.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.004 0.365 . . . . 0.0 110.191 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.73 72.37 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.207 0.603 . . . . 0.0 111.679 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.85 -44.97 30.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.06 -22.11 65.49 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.51 -65.83 0.88 Allowed 'General case' 0 C--N 1.345 0.409 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.513 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . . . -44.22 -48.59 9.35 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 124.577 1.173 . . . . 0.0 111.83 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.8 t -54.13 -51.89 62.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.366 1.866 . . . . 0.0 111.924 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -58.34 -40.73 82.92 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.176 0.59 . . . . 0.0 111.253 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -70.9 -38.37 72.99 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -90.6 22.8 3.31 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-N 118.91 0.777 . . . . 0.0 112.468 -177.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -110.2 -48.96 3.12 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 124.361 1.064 . . . . 0.0 109.209 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -74.11 -38.69 63.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.383 0.673 . . . . 0.0 112.154 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 108.19 72.52 0.0 OUTLIER 'General case' 0 C--N 1.345 0.397 0 C-N-CA 129.674 3.189 . . . . 0.0 110.932 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -151.89 136.37 16.88 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.692 1.597 . . . . 0.0 107.57 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.6 p -80.31 -56.89 3.88 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.446 0.698 . . . . 0.0 111.786 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.87 82.71 0.16 Allowed 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.55 -48.59 0.96 Allowed Glycine 0 CA--C 1.528 0.886 0 N-CA-C 107.093 -2.403 . . . . 0.0 107.093 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.8 t 57.52 67.38 0.98 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.26 1.824 . . . . 0.0 113.713 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.2 m -143.86 -75.96 0.24 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.165 0.986 . . . . 0.0 108.771 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.3 t -160.35 41.22 0.18 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.497 0.59 . . . . 0.0 112.224 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -172.25 127.62 0.57 Allowed Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 125.649 1.58 . . . . 0.0 107.479 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -86.06 63.32 0.16 OUTLIER 'Cis proline' 0 N--CA 1.439 -1.702 0 CA-C-N 121.409 1.539 . . . . 0.0 110.1 -2.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -84.27 173.09 11.26 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 t -69.3 145.54 52.95 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 111.426 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -95.82 55.09 1.58 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.481 1.512 . . . . 0.0 109.291 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -79.01 51.56 1.16 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.639 1.576 . . . . 0.0 112.347 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -160.84 53.44 0.29 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.381 1.472 . . . . 0.0 107.426 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.12 -55.99 8.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.499 1.519 . . . . 0.0 110.906 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 68.62 -72.41 0.1 Allowed 'General case' 0 C--N 1.343 0.292 0 C-N-CA 127.079 2.152 . . . . 0.0 111.168 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.24 -121.36 2.16 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.42 -169.3 0.17 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.356 1.062 . . . . 0.0 112.315 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -127.67 -164.06 1.33 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.998 0.919 . . . . 0.0 110.925 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.328 40.3 p90 61.63 47.33 1.13 Allowed Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 128.788 2.835 . . . . 0.0 115.855 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.7 125.94 8.54 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.175 1.916 . . . . 0.0 107.702 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.51 -125.0 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -153.72 127.57 8.86 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 125.711 1.605 . . . . 0.0 107.237 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.17 -85.04 0.05 OUTLIER Glycine 0 CA--C 1.531 1.063 0 CA-C-O 117.49 -1.728 . . . . 0.0 111.737 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.4 168.76 7.45 Favored 'Cis proline' 0 C--N 1.35 0.642 0 CA-C-N 121.676 2.738 . . . . 0.0 116.427 0.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.51 159.34 28.24 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.036 1.335 . . . . 0.0 113.188 -177.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -152.72 150.65 29.65 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.464 1.506 . . . . 0.0 111.948 -178.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -102.41 166.55 10.49 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 48.0 t80 -158.44 114.69 1.72 Allowed Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -86.79 108.06 0.77 Allowed 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 122.706 2.271 . . . . 0.0 112.342 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.534 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 9.3 tt -81.5 173.88 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 124.329 2.014 . . . . 0.0 110.966 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.534 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 14.2 mmtt -160.27 159.43 31.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 109.183 -3.644 . . . . 0.0 109.49 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 57.2 m -81.81 57.44 3.43 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.458 1.103 . . . . 0.0 109.539 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.46 62.71 0.24 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.95 -106.63 1.64 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 123.76 0.695 . . . . 0.0 112.376 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.1 95.05 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.32 1.048 . . . . 0.0 111.099 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 t80 44.98 80.74 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.879 1.672 . . . . 0.0 112.971 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.1 p -125.22 -29.94 3.23 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.744 1.218 . . . . 0.0 111.44 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.42 -69.2 1.25 Allowed Glycine 0 C--N 1.342 0.886 0 C-N-CA 124.838 1.209 . . . . 0.0 112.426 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.09 113.98 1.27 Allowed Glycine 0 C--N 1.34 0.76 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.9 m 54.17 69.89 1.96 Allowed Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 125.348 1.459 . . . . 0.0 112.715 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.11 149.65 82.19 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.369 2.713 . . . . 0.0 109.96 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -159.11 35.58 0.49 Allowed Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.109 -0.829 . . . . 0.0 115.152 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.741 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -153.87 -67.94 0.14 Allowed 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 118.452 1.126 . . . . 0.0 110.25 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.43 118.24 16.15 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.926 1.239 . . . . 0.0 108.384 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -140.14 117.44 11.32 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 m -85.1 146.67 6.29 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 176.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.2 t -132.84 135.81 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -177.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.482 HG22 ' H ' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -126.86 -176.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 C-N-CA 126.74 2.016 . . . . 0.0 110.186 -177.737 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.482 ' H ' HG22 ' A' ' 79' ' ' ILE . 63.5 m-80 -99.26 159.72 14.79 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 102.977 -2.972 . . . . 0.0 102.977 175.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.301 7.2 t -66.92 2.57 1.38 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 -178.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -95.58 -83.69 0.36 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 102.301 -3.222 . . . . 0.0 102.301 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.81 -5.07 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.721 2.408 . . . . 0.0 114.791 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -79.46 121.1 24.76 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -52.98 123.25 11.08 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 126.051 1.74 . . . . 0.0 108.497 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.56 -55.75 2.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.4 -164.43 23.06 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.45 137.02 8.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.482 1.113 . . . . 0.0 108.355 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 pt -133.89 174.25 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.438 1.095 . . . . 0.0 113.092 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 74' ' ' ALA . 12.6 t -158.16 137.03 11.37 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.741 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -77.31 -24.11 50.92 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 118.211 0.46 . . . . 0.0 112.034 175.003 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.1 t -45.33 -25.52 0.41 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -145.03 51.57 0.61 Allowed Glycine 0 C--N 1.339 0.731 0 CA-C-N 119.165 0.893 . . . . 0.0 111.534 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.73 -177.37 3.11 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.817 1.247 . . . . 0.0 111.487 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.3 t -58.27 -53.33 59.47 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.554 1.541 . . . . 0.0 111.547 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.38 -70.06 0.05 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -112.54 35.03 4.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.854 1.262 . . . . 0.0 109.133 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -125.1 176.21 6.85 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.18 1.392 . . . . 0.0 109.955 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.447 ' CE1' ' CE1' ' A' ' 91' ' ' HIS . 64.1 m-85 -125.17 159.3 31.86 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.11 1.364 . . . . 0.0 111.093 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.8 m -135.33 161.48 39.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 125.449 1.499 . . . . 0.0 107.864 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.26 156.65 34.08 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 123.862 0.744 . . . . 0.0 113.707 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.6 m -85.75 -170.67 3.22 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 123.607 0.763 . . . . 0.0 110.094 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.1 p -73.65 127.53 33.01 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.47 -1.0 88.64 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.815 -0.992 . . . . 0.0 113.361 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.7 m -79.38 91.22 5.05 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.4 t30 . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.953 -1.499 . . . . 0.0 109.439 -178.729 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 111.287 0.106 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.0 t -77.83 119.4 21.26 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.441 1.097 . . . . 0.0 108.316 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.31 89.74 0.09 Allowed 'General case' 0 C--N 1.344 0.357 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.81 132.22 36.41 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.91 114.76 23.69 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.5 m -105.49 88.82 2.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.03 -114.64 4.62 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.8 p -93.25 -29.23 15.79 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.282 1.033 . . . . 0.0 109.972 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -71.99 95.13 1.55 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.273 1.429 . . . . 0.0 108.776 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -89.95 147.19 23.86 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.527 1.131 . . . . 0.0 112.508 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -142.13 129.46 21.14 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -72.79 155.13 40.26 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 126.531 1.932 . . . . 0.0 107.315 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.47 -16.79 16.63 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.4 m -76.15 -35.2 59.3 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -51.9 15.84 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.755 1.222 . . . . 0.0 113.601 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . 0.273 17.9 m -60.99 -41.58 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.647 0 C-N-CA 127.239 2.216 . . . . 0.0 109.242 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -71.02 -44.58 65.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.886 0.874 . . . . 0.0 111.69 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.15 -54.64 26.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.096 0.407 . . . . 0.0 112.077 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.45 ' HB1' ' HE2' ' A' ' 59' ' ' PHE . . . -62.05 -37.56 85.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.481 -178.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.33 -40.39 70.75 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -65.86 -19.74 65.99 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.46 -53.96 7.01 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.559 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -47.0 -51.38 17.29 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.229 1.412 . . . . 0.0 110.776 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 t -57.92 -46.19 85.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.748 0.819 . . . . 0.0 110.559 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -57.09 -38.0 72.72 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.529 0.731 . . . . 0.0 111.394 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -89.08 -9.04 52.63 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.71 -27.38 67.59 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.725 0.693 . . . . 0.0 112.208 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -80.54 -75.69 0.26 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 p30 171.94 68.62 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.696 1.998 . . . . 0.0 109.809 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -117.5 58.72 0.79 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.93 0.892 . . . . 0.0 109.438 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.84 162.72 0.08 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.86 2.464 . . . . 0.0 114.429 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 t -88.37 76.66 8.29 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.458 1.103 . . . . 0.0 110.182 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.52 102.37 4.48 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.314 1.045 . . . . 0.0 110.319 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.99 -114.26 4.48 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.5 t -75.8 -95.99 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 m 88.05 23.18 0.04 OUTLIER 'General case' 0 C--N 1.341 0.212 0 C-N-CA 125.018 1.327 . . . . 0.0 113.327 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t -78.95 -38.72 36.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 102.743 -3.058 . . . . 0.0 102.743 176.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.488 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 17.0 m-85 -89.18 151.82 47.17 Favored Pre-proline 0 N--CA 1.451 -0.405 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.14 142.52 57.81 Favored 'Cis proline' 0 N--CA 1.455 -0.791 0 N-CA-C 116.78 1.8 . . . . 0.0 116.78 0.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.65 147.54 39.43 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 127.912 2.485 . . . . 0.0 109.579 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.25 123.47 14.68 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 178.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -83.78 118.91 24.23 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -59.0 159.84 6.69 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.308 1.443 . . . . 0.0 111.013 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -134.42 59.95 1.72 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.037 0.935 . . . . 0.0 109.964 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -154.36 -22.32 0.13 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 112.068 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.74 -46.34 88.55 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.127 0.571 . . . . 0.0 111.386 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.31 -61.88 0.41 Allowed Glycine 0 C--N 1.339 0.723 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.06 148.19 52.2 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 123.81 0.844 . . . . 0.0 113.099 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -166.26 -178.49 4.59 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.094 1.758 . . . . 0.0 109.231 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -145.37 118.58 5.37 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.74 1.216 . . . . 0.0 108.555 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.32 84.99 1.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.08 2.52 . . . . 0.0 110.448 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -129.62 -97.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.245 0 C-N-CA 124.227 1.011 . . . . 0.0 108.379 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -153.17 117.47 4.9 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.156 0.982 . . . . 0.0 109.618 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.48 146.39 22.54 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -68.72 157.58 88.76 Favored 'Cis proline' 0 N--CA 1.457 -0.633 0 CA-C-N 119.983 1.891 . . . . 0.0 113.447 0.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.21 141.93 26.72 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.1 2.16 . . . . 0.0 108.235 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -134.39 166.56 22.55 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.59 164.56 23.74 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 126.481 1.912 . . . . 0.0 115.541 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.559 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 75.4 t80 -161.87 104.13 1.16 Allowed Pre-proline 0 N--CA 1.454 -0.246 0 O-C-N 121.43 -0.794 . . . . 0.0 110.571 175.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.488 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 12.8 Cg_endo -74.69 137.35 22.36 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 121.088 1.424 . . . . 0.0 113.892 -177.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.55 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.2 tt -109.27 178.97 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-O 124.444 2.069 . . . . 0.0 113.058 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.55 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 7.8 mmtt -153.12 153.77 33.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 108.647 -3.888 . . . . 0.0 109.869 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.8 p -76.08 51.94 0.7 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.63 1.972 . . . . 0.0 113.014 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.81 50.63 0.08 OUTLIER Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.405 1.002 . . . . 0.0 112.791 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.31 174.22 17.32 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 117.686 0.743 . . . . 0.0 112.783 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.8 t -80.86 131.79 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.834 1.253 . . . . 0.0 108.542 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -70.15 135.02 48.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.206 1.003 . . . . 0.0 110.907 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.9 p -139.27 75.61 1.52 Allowed 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.88 1.272 . . . . 0.0 107.583 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.47 -143.21 3.6 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.3 -50.73 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.9 p -153.35 150.1 22.89 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 124.218 1.007 . . . . 0.0 109.792 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -66.16 145.33 69.31 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 CA-C-N 119.393 0.819 . . . . 0.0 112.001 -8.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.28 -113.16 2.27 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . 62.92 28.99 16.54 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.047 1.339 . . . . 0.0 113.866 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -155.02 84.15 1.08 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.16 132.64 47.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.522 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.72 159.79 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 103.311 -2.848 . . . . 0.0 103.311 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.2 t -139.17 131.39 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 120.479 -1.388 . . . . 0.0 108.089 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.7 pt -114.14 -179.46 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.311 1.444 . . . . 0.0 113.35 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -104.71 -174.38 2.52 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.099 2.159 . . . . 0.0 109.631 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.318 12.4 t -79.58 -30.17 41.49 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 120.402 3.482 . . . . 0.0 120.402 -177.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -79.32 -73.56 0.33 Allowed 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.7 t -164.75 1.22 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.849 2.06 . . . . 0.0 114.169 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -78.64 150.69 32.6 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 119.846 1.203 . . . . 0.0 113.813 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -95.85 117.98 31.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.34 1.856 . . . . 0.0 108.651 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.94 -52.69 7.54 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.35 0.66 . . . . 0.0 110.658 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.38 -169.21 38.38 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.9 162.37 31.77 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.827 0.813 . . . . 0.0 113.022 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.8 pt -142.21 163.67 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.59 1.556 . . . . 0.0 110.263 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.6 t -158.84 159.04 34.6 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.867 1.267 . . . . 0.0 111.016 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.449 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 49.9 m170 -79.6 -51.08 9.74 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.6 m -32.72 106.51 0.04 OUTLIER 'General case' 0 C--N 1.345 0.382 0 C-N-CA 127.852 2.461 . . . . 0.0 111.998 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.56 32.29 5.2 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.201 1.381 . . . . 0.0 111.079 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -134.5 -142.82 0.2 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.759 1.224 . . . . 0.0 109.248 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.6 t -151.46 62.86 0.88 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.26 0.624 . . . . 0.0 111.141 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.71 -125.29 6.73 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.534 1.064 . . . . 0.0 113.367 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -79.28 -26.2 42.37 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.643 1.177 . . . . 0.0 113.046 -178.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -56.3 118.05 4.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.984 0.914 . . . . 0.0 110.621 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -83.75 153.95 23.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.044 0.938 . . . . 0.0 111.145 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.6 m -126.76 166.54 23.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 C-N-CA 125.635 1.574 . . . . 0.0 107.556 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.38 148.03 23.74 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 123.891 0.758 . . . . 0.0 114.26 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.0 t -96.59 -175.09 3.21 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.716 2.006 . . . . 0.0 107.418 178.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.2 p -59.76 136.73 58.09 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.439 1.018 . . . . 0.0 109.851 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.06 26.56 74.6 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.566 0.603 . . . . 0.0 111.81 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.7 m -150.3 114.81 5.21 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.144 1.378 . . . . 0.0 107.497 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 . . . . . 0 C--O 1.251 1.154 0 CA-C-O 116.83 -1.557 . . . . 0.0 109.458 -179.82 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 120.592 0.234 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.1 m -147.92 52.93 1.03 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.601 1.16 . . . . 0.0 108.981 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 72.91 139.74 0.06 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 127.184 2.194 . . . . 0.0 109.682 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 t -146.67 124.15 11.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.281 0.562 . . . . 0.0 111.641 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -100.66 101.16 11.98 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 32.8 m -85.72 74.96 10.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.615 1.166 . . . . 0.0 108.249 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.82 -98.71 1.08 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.8 m -88.14 -44.71 10.71 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.387 1.075 . . . . 0.0 110.433 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.0 107.15 1.42 Allowed 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.039 1.336 . . . . 0.0 112.493 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -91.41 103.69 16.3 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.572 1.149 . . . . 0.0 109.027 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -102.39 148.69 25.18 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.277 0.631 . . . . 0.0 110.713 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.4 m -83.13 157.6 22.72 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 125.476 1.51 . . . . 0.0 108.858 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.66 -19.55 63.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.2 m -71.95 -35.22 69.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.109 0.964 . . . . 0.0 109.026 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.64 -53.81 10.78 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 123.953 0.901 . . . . 0.0 112.679 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.95 -41.31 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -67.61 -44.75 77.32 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.663 0.785 . . . . 0.0 111.007 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.25 -48.45 78.17 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.498 0.59 . . . . 0.0 110.253 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.05 -32.1 73.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.157 0.983 . . . . 0.0 111.166 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.43 -36.84 52.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.776 0.262 . . . . 0.0 110.666 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -69.29 -20.33 63.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.72 -53.59 5.79 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.59 -40.31 59.57 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.54 1.136 . . . . 0.0 109.228 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.41 -53.94 52.61 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.366 1.466 . . . . 0.0 109.374 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -63.58 -49.49 73.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -70.79 -46.15 63.39 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.474 ' CD1' ' HG2' ' A' ' 57' ' ' GLN . 63.6 t80 -70.23 -19.55 63.13 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.465 -177.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -90.14 -77.68 0.39 Allowed 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.534 1.061 . . . . 0.0 110.207 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.8 p30 174.49 56.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.1 1.36 . . . . 0.0 111.616 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -146.01 92.7 2.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 86.19 117.59 0.04 OUTLIER 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 127.326 2.25 . . . . 0.0 105.819 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -92.05 85.17 5.43 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.045 0.938 . . . . 0.0 109.916 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.15 150.21 8.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.253 1.421 . . . . 0.0 112.722 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.61 -38.37 95.59 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.4 t 65.49 97.13 0.05 OUTLIER 'General case' 0 C--N 1.343 0.297 0 C-N-CA 126.773 2.029 . . . . 0.0 113.242 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.5 m -68.95 -55.65 10.29 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 t -159.81 16.89 0.15 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.171 1.388 . . . . 0.0 111.495 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -142.02 149.76 53.61 Favored Pre-proline 0 CA--C 1.511 -0.553 0 C-N-CA 126.067 1.747 . . . . 0.0 107.327 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.4 122.76 7.96 Favored 'Cis proline' 0 CA--C 1.557 1.651 0 N-CA-C 115.425 1.279 . . . . 0.0 115.425 0.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . 0.318 9.6 m80 -82.84 138.33 33.98 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 127.358 2.263 . . . . 0.0 114.457 -178.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -70.77 133.17 46.33 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 102.829 -3.026 . . . . 0.0 102.829 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.28 63.1 3.82 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.211 0.914 . . . . 0.0 113.278 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.1 m120 30.98 -138.0 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 130.87 3.668 . . . . 0.0 114.912 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -111.73 140.25 46.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.854 2.061 . . . . 0.0 107.701 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 71.93 179.46 0.23 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.514 1.526 . . . . 0.0 109.998 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -84.76 98.08 10.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.35 -42.48 83.1 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.171 0.891 . . . . 0.0 111.694 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -145.25 162.71 36.51 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.127 0.971 . . . . 0.0 109.458 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -76.69 132.9 39.61 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.777 1.231 . . . . 0.0 112.612 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -149.28 154.01 38.3 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.428 1.491 . . . . 0.0 108.385 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.96 -47.63 23.92 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.023 2.482 . . . . 0.0 111.351 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.42 HG21 HD21 ' A' ' 80' ' ' ASN . 22.4 m -81.0 168.0 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.544 1.538 . . . . 0.0 109.755 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -98.53 -16.68 19.06 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.633 1.173 . . . . 0.0 112.406 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.66 -159.69 22.41 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.35 160.77 72.05 Favored 'Cis proline' 0 N--CA 1.459 -0.549 0 CA-C-N 118.783 1.291 . . . . 0.0 112.422 1.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.91 159.94 35.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.742 1.217 . . . . 0.0 111.465 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.474 ' HG2' ' CD1' ' A' ' 27' ' ' TYR . 1.6 tp60 -132.96 135.95 45.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.9 178.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -80.68 162.43 24.16 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -160.77 117.91 1.45 Allowed Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -82.9 146.03 12.83 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 121.405 1.404 . . . . 0.0 113.103 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 62' ' ' LYS . 0.5 OUTLIER -112.84 -165.48 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-O 123.81 1.767 . . . . 0.0 113.731 -178.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.467 ' N ' HG23 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -161.65 176.09 11.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 109.678 -3.419 . . . . 0.0 111.586 -177.638 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.0 t -99.81 63.57 1.22 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.342 1.457 . . . . 0.0 110.673 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.68 -63.43 0.09 OUTLIER Glycine 0 C--N 1.337 0.593 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.85 -164.88 11.57 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.6 p -83.98 160.6 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.03 0.932 . . . . 0.0 111.643 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -37.93 126.68 1.24 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 128.097 2.559 . . . . 0.0 113.754 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.0 t -160.02 -40.98 0.05 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.496 1.518 . . . . 0.0 110.383 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.87 -80.3 0.75 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.93 95.08 2.29 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.8 p -157.13 153.04 22.9 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 125.024 1.33 . . . . 0.0 108.417 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.23 154.17 74.79 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.958 2.439 . . . . 0.0 110.642 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 74' ' ' ALA . . . -165.05 -25.73 0.02 OUTLIER Glycine 0 CA--C 1.53 1.022 0 CA-C-O 117.956 -1.469 . . . . 0.0 114.655 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.602 ' HB1' ' H ' ' A' ' 91' ' ' HIS . . . 88.95 -31.28 0.03 OUTLIER 'General case' 0 C--N 1.346 0.418 0 C-N-CA 126.205 1.802 . . . . 0.0 111.167 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -79.37 124.52 28.5 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.234 1.813 . . . . 0.0 113.391 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.84 128.08 7.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.804 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.7 m -85.9 146.03 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.7 t -133.96 122.87 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.3 pt -106.23 171.59 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 125.169 1.388 . . . . 0.0 111.566 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.42 HD21 HG21 ' A' ' 52' ' ' VAL . 8.8 m120 -79.68 165.47 22.82 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 178.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.285 2.1 m -67.98 -5.78 18.93 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -178.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -102.29 -73.3 0.66 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -165.17 -12.01 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 117.935 2.568 . . . . 0.0 117.935 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -78.77 126.96 31.43 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -57.33 111.21 1.02 Allowed 'General case' 0 C--N 1.344 0.346 0 C-N-CA 125.353 1.461 . . . . 0.0 107.454 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.99 -48.76 11.81 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.53 151.33 8.31 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.56 125.88 38.41 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.5 pt -127.13 155.74 38.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 C-N-CA 122.727 0.411 . . . . 0.0 110.11 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.8 t -156.73 154.06 29.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.602 ' H ' ' HB1' ' A' ' 74' ' ' ALA . 2.5 m170 -79.04 -15.38 58.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.821 175.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.7 m -58.51 103.72 0.17 Allowed 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.668 1.187 . . . . 0.0 109.385 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.76 55.0 1.96 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.23 -174.95 4.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.729 1.212 . . . . 0.0 109.915 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -57.15 -47.56 80.86 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.249 1.019 . . . . 0.0 111.082 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.96 -70.37 0.12 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -86.63 -28.55 23.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.76 1.224 . . . . 0.0 109.305 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -57.06 160.61 3.54 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 126.304 1.842 . . . . 0.0 111.285 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -114.85 161.46 18.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.882 1.673 . . . . 0.0 112.029 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 m -146.28 164.08 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 126.615 1.966 . . . . 0.0 107.434 177.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.54 156.55 26.9 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 123.972 0.796 . . . . 0.0 112.414 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.0 m -103.39 -171.16 1.89 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.151 0.98 . . . . 0.0 110.897 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -82.87 79.32 9.28 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 121.599 0.714 . . . . 0.0 109.624 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.94 -26.22 0.2 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.259 1.409 . . . . 0.0 109.674 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.0 m -79.36 123.35 27.41 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.015 1.726 . . . . 0.0 107.412 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 126.199 1.8 . . . . 0.0 109.865 -179.056 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.1 m -143.39 80.49 1.67 Allowed 'General case' 0 C--N 1.342 0.242 0 C-N-CA 123.585 0.754 . . . . 0.0 110.819 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.53 91.53 0.03 OUTLIER 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.807 1.643 . . . . 0.0 111.666 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 p -83.41 92.5 7.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.087 0.955 . . . . 0.0 112.068 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -99.71 96.25 7.49 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 101.481 -3.526 . . . . 0.0 101.481 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.9 m -89.12 73.04 8.23 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.94 -98.65 1.21 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 108.611 -1.795 . . . . 0.0 108.611 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.5 p -95.53 -42.13 8.59 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.41 1.084 . . . . 0.0 109.182 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.21 137.32 58.24 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -140.17 126.75 20.31 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.79 136.78 50.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.522 1.529 . . . . 0.0 108.338 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.7 p -64.73 161.57 17.67 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 125.152 1.381 . . . . 0.0 110.807 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.21 -16.78 36.39 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -78.28 -37.16 45.58 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 123.785 0.834 . . . . 0.0 109.986 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -66.64 -39.94 88.49 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.726 0.81 . . . . 0.0 109.992 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.5 t -60.2 -50.69 79.25 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -64.87 -23.29 67.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.138 1.375 . . . . 0.0 111.378 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.64 -61.11 1.89 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 119.202 0.91 . . . . 0.0 108.668 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.86 -24.93 66.19 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.679 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.2 -38.59 30.87 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 118.501 0.592 . . . . 0.0 112.012 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -69.5 -22.55 63.6 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.3 -65.22 0.95 Allowed 'General case' 0 C--N 1.347 0.487 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.431 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -45.38 -43.68 11.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.783 1.233 . . . . 0.0 111.941 177.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 t -61.81 -48.33 81.09 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 121.335 -0.853 . . . . 0.0 111.682 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -80.21 -24.33 40.32 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -112.6 -28.72 7.72 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -3.06 28.21 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -66.75 -46.64 74.73 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.175 0.99 . . . . 0.0 112.979 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -133.69 -80.69 0.47 Allowed 'General case' 0 C--N 1.34 0.183 0 O-C-N 123.354 0.409 . . . . 0.0 111.328 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -170.66 101.67 0.24 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -141.2 -169.38 2.83 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.963 0.905 . . . . 0.0 110.35 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.3 p -71.08 84.9 0.72 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.455 1.502 . . . . 0.0 112.152 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 137.94 162.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 129.464 3.106 . . . . 0.0 111.895 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 152.65 -87.88 0.13 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 126.169 1.842 . . . . 0.0 108.647 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.1 t 158.31 -94.75 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 129.21 3.004 . . . . 0.0 105.91 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.6 p -160.22 -55.05 0.06 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 p -81.36 -69.15 0.63 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.24 141.07 98.07 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 124.075 0.95 . . . . 0.0 109.129 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.18 133.33 27.46 Favored 'Cis proline' 0 N--CA 1.459 -0.504 0 N-CA-C 116.061 1.523 . . . . 0.0 116.061 3.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -132.49 136.97 47.03 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.963 2.105 . . . . 0.0 108.423 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.5 m -49.58 125.66 11.87 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.819 2.048 . . . . 0.0 110.195 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -80.03 70.61 6.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.703 1.201 . . . . 0.0 110.407 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -164.31 147.59 9.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.592 0.757 . . . . 0.0 110.027 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -162.29 -72.83 0.05 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.618 1.567 . . . . 0.0 107.03 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -152.76 -40.7 0.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.711 2.004 . . . . 0.0 108.31 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -118.28 161.96 19.06 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 125.392 1.477 . . . . 0.0 110.103 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.84 156.65 14.52 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.634 1.112 . . . . 0.0 110.459 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.55 156.78 37.77 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.655 0.782 . . . . 0.0 111.302 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -88.55 119.49 29.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.868 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -130.77 101.03 17.16 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.57 75.81 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.759 2.972 . . . . 0.0 111.286 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.9 t -140.04 -38.56 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.023 1.729 . . . . 0.0 109.238 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 80.57 108.88 0.07 Allowed 'General case' 0 C--N 1.345 0.387 0 C-N-CA 127.132 2.173 . . . . 0.0 109.251 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.84 -143.17 0.7 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.865 1.697 . . . . 0.0 113.533 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -65.99 139.06 40.76 Favored 'Cis proline' 0 N--CA 1.456 -0.717 0 CA-C-N 118.299 1.049 . . . . 0.0 112.652 1.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.37 163.72 12.61 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 126.351 1.86 . . . . 0.0 108.24 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -139.75 156.25 46.88 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -79.63 157.3 27.31 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.227 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.431 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 7.3 t80 -160.21 89.22 1.82 Allowed Pre-proline 0 N--CA 1.449 -0.511 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . 0.253 6.3 Cg_exo -63.84 137.46 58.33 Favored 'Trans proline' 0 N--CA 1.44 -1.657 0 C-N-CA 122.474 2.116 . . . . 0.0 116.757 -176.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.531 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.0 tt -108.14 176.96 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 124.278 1.99 . . . . 0.0 111.904 178.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.531 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -162.05 179.78 7.72 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 108.58 -3.918 . . . . 0.0 111.31 179.082 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.9 p -87.42 52.85 2.61 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.32 -65.57 0.02 OUTLIER Glycine 0 C--N 1.342 0.879 0 C-N-CA 125.187 1.375 . . . . 0.0 110.136 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.85 -127.13 1.62 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -68.27 164.94 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.89 1.276 . . . . 0.0 109.225 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -51.42 140.44 17.57 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.4 p -141.56 -55.79 0.47 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.566 1.946 . . . . 0.0 108.422 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.01 170.52 20.79 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.024 1.297 . . . . 0.0 111.248 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.38 151.15 25.33 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.506 1.05 . . . . 0.0 111.924 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.5 p 63.82 171.99 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.014 2.126 . . . . 0.0 112.657 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.55 159.89 30.24 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.012 2.475 . . . . 0.0 111.097 172.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.08 71.83 0.19 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.487 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -69.36 -16.52 63.55 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 118.142 -0.933 . . . . 0.0 112.575 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.54 125.12 38.99 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.322 1.849 . . . . 0.0 112.297 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.0 mtt85 -135.18 137.47 42.72 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.893 0.877 . . . . 0.0 113.115 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.9 m -103.07 145.3 12.56 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 176.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.262 91.7 t -134.73 133.99 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -176.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.7 pt -126.72 165.84 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -87.9 157.16 19.04 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 126.16 1.784 . . . . 0.0 109.79 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.377 8.2 t -79.73 56.06 2.18 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 -177.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -157.47 -87.07 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 100.785 -3.783 . . . . 0.0 100.785 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.45 1.85 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -83.91 127.1 33.61 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -64.35 127.87 33.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.325 1.05 . . . . 0.0 108.537 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.36 -44.89 8.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.563 0.745 . . . . 0.0 109.99 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.67 175.32 42.09 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.173 -0.537 . . . . 0.0 114.108 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.54 121.85 21.56 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 127.123 2.169 . . . . 0.0 106.166 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.3 pt -128.16 161.19 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.478 1.111 . . . . 0.0 110.243 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 t -157.91 159.81 36.95 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.487 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 21.8 m170 -78.45 -24.09 46.22 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.4 m -61.56 108.07 0.91 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.793 0.837 . . . . 0.0 110.863 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.54 -15.71 19.67 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.818 1.199 . . . . 0.0 112.323 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.93 163.73 26.89 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.409 1.083 . . . . 0.0 111.8 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.8 t -104.05 52.03 0.77 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.957 1.303 . . . . 0.0 109.6 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 143.24 -147.67 19.14 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.796 1.189 . . . . 0.0 110.752 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -79.61 -14.84 58.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.496 1.119 . . . . 0.0 111.367 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -60.09 167.64 2.25 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 123.779 0.832 . . . . 0.0 110.919 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -106.71 159.66 16.05 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.437 1.095 . . . . 0.0 112.85 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 m -134.85 165.46 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 127.046 2.138 . . . . 0.0 106.399 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.14 138.01 13.91 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 122.984 0.326 . . . . 0.0 113.39 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.3 m -85.13 -174.37 5.21 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -77.44 121.33 23.67 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.745 -0.597 . . . . 0.0 110.648 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.03 66.2 1.59 Allowed Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.387 0.994 . . . . 0.0 110.789 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.4 t -139.31 29.37 2.21 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.984 1.314 . . . . 0.0 112.198 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 C--O 1.251 1.168 0 C-N-CA 127.68 2.392 . . . . 0.0 110.268 -179.13 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 121.1 0.476 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.5 p -139.37 -166.5 2.06 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.305 1.442 . . . . 0.0 110.009 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.08 147.29 35.41 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.473 1.109 . . . . 0.0 109.76 178.551 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.1 p -121.57 119.22 31.28 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 123.137 0.575 . . . . 0.0 110.239 -178.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.18 108.29 13.14 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 100.313 -3.958 . . . . 0.0 100.313 177.522 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.9 110.16 13.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.724 0.409 . . . . 0.0 110.242 -178.053 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.12 -82.71 0.75 Allowed Glycine 0 C--N 1.339 0.746 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.34 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.2 t -156.99 45.77 0.4 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.642 1.177 . . . . 0.0 108.874 179.057 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 m -141.39 96.92 3.06 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -85.68 139.05 31.69 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.71 1.604 . . . . 0.0 110.932 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -137.89 137.15 37.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.079 1.352 . . . . 0.0 108.271 178.364 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.447 ' O ' HG23 ' A' ' 16' ' ' VAL . 44.5 m -70.58 149.18 47.35 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.29 -21.55 5.69 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.129 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.2 m -71.0 -47.66 57.54 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.153 0.981 . . . . 0.0 109.267 179.048 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.79 -38.04 85.74 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 12' ' ' SER . 2.6 t -63.81 -51.06 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.315 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.8 ttt-85 -64.19 -36.09 82.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.726 1.61 . . . . 0.0 111.785 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.29 -50.5 46.16 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.051 0.541 . . . . 0.0 109.908 179.07 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.517 ' HB1' ' HE2' ' A' ' 59' ' ' PHE . . . -57.58 -41.72 81.71 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.325 1.05 . . . . 0.0 110.213 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.91 -46.19 54.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.04 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -61.21 -21.81 64.19 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.145 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.64 -59.64 2.54 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -177.657 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.88 -32.54 53.61 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.817 0.698 . . . . 0.0 110.945 178.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.25 -53.84 42.7 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -56.44 -38.85 72.18 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.787 0.435 . . . . 0.0 110.549 178.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -74.38 -3.31 29.67 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 126.589 1.956 . . . . 0.0 113.147 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -134.41 17.84 3.67 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -99.3 -80.55 0.47 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.957 1.253 . . . . 0.0 108.823 179.085 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -157.97 17.2 0.24 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.245 1.018 . . . . 0.0 112.846 -179.102 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -122.3 67.7 0.94 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.5 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 77.1 116.53 0.06 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 127.406 2.283 . . . . 0.0 105.294 -177.358 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -96.03 -58.08 2.18 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 124.157 0.983 . . . . 0.0 112.159 -177.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 50.83 82.41 0.06 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.831 1.252 . . . . 0.0 112.534 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -112.75 33.09 5.81 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.768 1.651 . . . . 0.0 110.805 -179.371 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.7 m -149.24 65.08 1.02 Allowed 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.297 1.439 . . . . 0.0 107.212 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.6 p -161.33 -167.77 1.85 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.316 1.046 . . . . 0.0 108.765 -178.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.4 p -85.93 58.04 4.82 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 74.35 147.53 0.12 Allowed Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 126.885 2.074 . . . . 0.0 110.443 179.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.66 137.57 46.7 Favored 'Cis proline' 0 C--N 1.349 0.558 0 CA-C-N 119.73 0.939 . . . . 0.0 113.725 2.601 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -134.98 168.58 18.85 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.801 2.04 . . . . 0.0 110.216 -179.128 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.4 m -74.08 140.06 45.06 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.596 1.958 . . . . 0.0 109.489 178.379 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.49 81.78 5.92 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.86 146.49 49.6 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 71.77 126.23 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.054 2.142 . . . . 0.0 111.174 -178.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -98.67 53.19 1.01 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.91 0.884 . . . . 0.0 109.476 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -153.6 56.81 0.75 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.708 1.203 . . . . 0.0 108.102 179.123 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.8 -55.58 0.23 Allowed Glycine 0 C--N 1.341 0.855 0 C-N-CA 125.725 1.631 . . . . 0.0 109.042 179.362 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.61 175.65 13.65 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.313 1.045 . . . . 0.0 109.52 178.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -90.52 136.63 32.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.873 1.269 . . . . 0.0 110.871 -178.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -150.87 103.51 3.02 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 178.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.63 58.03 6.23 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.125 3.217 . . . . 0.0 114.074 -177.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -145.37 -134.22 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 178.52 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -146.5 143.23 28.8 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.183 0.901 . . . . 0.0 109.225 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.74 -176.19 50.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.214 0.911 . . . . 0.0 111.892 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.23 160.89 93.41 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 CA-C-N 118.174 0.987 . . . . 0.0 110.693 -1.348 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -112.4 171.82 7.29 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.267 1.027 . . . . 0.0 110.289 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -132.56 137.31 47.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.169 1.388 . . . . 0.0 109.055 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -93.7 155.29 17.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.603 0.761 . . . . 0.0 110.323 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.517 ' HE2' ' HB1' ' A' ' 19' ' ' ALA . 22.4 t80 -160.21 102.55 1.39 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.695 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.12 119.94 4.81 Favored 'Trans proline' 0 N--CA 1.442 -1.532 0 C-N-CA 122.226 1.951 . . . . 0.0 109.789 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.52 HG13 ' H ' ' A' ' 62' ' ' LYS . 6.2 tt -79.38 170.63 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 124.109 1.909 . . . . 0.0 111.349 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.52 ' H ' HG13 ' A' ' 61' ' ' ILE . 14.1 tptm -140.49 149.11 42.1 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 109.468 -3.515 . . . . 0.0 111.641 -178.832 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.4 m -89.48 60.28 5.12 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.129 1.771 . . . . 0.0 109.267 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.03 -55.79 0.03 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.29 -167.82 36.75 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.6 158.83 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.679 1.192 . . . . 0.0 110.899 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.18 -173.37 4.17 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.352 1.461 . . . . 0.0 108.341 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.2 t -160.36 33.11 0.17 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.752 1.221 . . . . 0.0 110.069 178.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -141.9 -24.38 0.21 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.824 1.202 . . . . 0.0 113.024 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.96 -143.86 49.01 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.643 1.222 . . . . 0.0 111.827 179.377 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.1 t 63.11 102.33 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.421 1.888 . . . . 0.0 111.975 179.211 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.85 161.7 29.68 Favored 'Cis proline' 0 C--N 1.349 0.567 0 CA-C-N 119.981 1.029 . . . . 0.0 113.619 -3.426 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.78 41.35 1.88 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.864 -0.964 . . . . 0.0 113.546 -179.058 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.54 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -88.54 -73.28 0.5 Allowed 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.55 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -60.99 112.92 2.26 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.603 1.161 . . . . 0.0 111.147 179.515 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -132.22 161.01 34.48 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -178.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 m -132.88 142.11 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 101.16 -3.644 . . . . 0.0 101.16 175.412 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.9 t -138.24 120.13 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -176.343 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -102.54 173.12 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.115 0 C-N-CA 125.85 1.66 . . . . 0.0 110.15 -178.979 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -88.56 161.06 17.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 103.184 -2.895 . . . . 0.0 103.184 176.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.366 13.4 t -57.09 -22.54 40.29 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 -177.223 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -85.97 -75.46 0.38 Allowed 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.239 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.62 -1.84 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -176.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -78.94 109.03 12.85 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -175.31 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -56.51 108.6 0.5 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.929 1.292 . . . . 0.0 109.228 -179.555 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.08 -60.05 2.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.604 1.162 . . . . 0.0 112.461 -177.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.8 175.57 46.39 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.62 146.12 52.04 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.424 1.089 . . . . 0.0 110.58 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.2 pt -143.61 171.37 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.292 1.037 . . . . 0.0 110.781 -178.218 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t -159.71 143.23 14.36 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 116.426 2.009 . . . . 0.0 116.426 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.54 ' HB2' ' CB ' ' A' ' 74' ' ' ALA 0.265 32.2 m170 -79.51 -29.36 41.53 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.094 174.542 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.2 -45.33 68.54 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.607 1.163 . . . . 0.0 113.666 -177.89 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -78.62 -21.9 68.14 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 124.047 0.832 . . . . 0.0 111.565 179.226 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.26 166.5 23.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.897 0.879 . . . . 0.0 112.003 -179.058 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.7 t -65.9 -36.02 82.23 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.158 0.983 . . . . 0.0 111.64 -179.435 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.53 -101.51 0.15 Allowed Glycine 0 C--N 1.341 0.808 0 CA-C-N 118.206 0.457 . . . . 0.0 112.26 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -79.58 -22.12 44.18 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.046 0.938 . . . . 0.0 113.017 -178.364 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -74.68 179.01 5.0 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.656 0.662 . . . . 0.0 110.584 179.072 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -119.41 159.03 24.99 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.563 1.545 . . . . 0.0 109.905 179.319 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.7 m -134.96 162.4 38.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 125.209 1.404 . . . . 0.0 107.542 177.326 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.44 147.94 30.41 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 116.311 -0.404 . . . . 0.0 113.51 -178.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 34.0 m -85.75 -173.91 4.87 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.309 1.444 . . . . 0.0 107.946 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.3 t -57.23 110.27 0.81 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.263 1.025 . . . . 0.0 111.841 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.95 34.2 76.38 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.939 1.256 . . . . 0.0 114.322 178.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 93.6 m -83.43 130.8 35.05 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 118.091 0.945 . . . . 0.0 109.169 179.092 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 117.238 -1.363 . . . . 0.0 108.927 179.438 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.574 0 CA-C-O 120.727 0.299 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.4 t -106.01 60.17 0.65 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.934 1.294 . . . . 0.0 110.269 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.53 147.02 0.06 Allowed 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 127.007 2.123 . . . . 0.0 112.227 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 t -159.66 156.3 27.61 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.533 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.87 121.23 18.11 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -178.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.4 m -103.28 91.04 3.91 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.285 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.28 -106.93 1.87 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.217 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.7 m -92.84 -33.32 14.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.527 1.131 . . . . 0.0 111.173 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 m -74.65 103.15 4.83 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.352 0.661 . . . . 0.0 110.275 -178.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -87.92 151.94 22.44 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.961 1.304 . . . . 0.0 111.684 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -142.54 134.23 26.77 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 123.481 0.713 . . . . 0.0 112.354 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.7 m -77.07 155.11 32.71 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.241 1.417 . . . . 0.0 107.465 177.595 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.82 -16.89 13.01 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 177.087 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -70.88 -43.29 68.71 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.871 0.868 . . . . 0.0 109.587 179.054 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -71.15 -47.3 58.65 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 123.932 0.893 . . . . 0.0 113.138 -179.208 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.4 t -60.1 -46.12 94.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.038 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -68.18 -40.84 82.15 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.84 1.256 . . . . 0.0 111.901 -179.21 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.98 -49.6 71.87 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.588 0.631 . . . . 0.0 110.021 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.33 -35.2 79.61 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.893 0.877 . . . . 0.0 111.563 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.21 -40.85 58.82 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 117.76 0.255 . . . . 0.0 111.661 179.12 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -65.38 -22.07 66.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.399 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.34 -61.73 1.91 Allowed 'General case' 0 C--N 1.348 0.505 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 -178.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -42.34 -47.54 4.9 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.097 1.359 . . . . 0.0 110.486 178.361 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.7 t -57.88 -66.61 0.45 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.767 1.627 . . . . 0.0 112.687 179.399 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -23.18 66.36 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.181 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -94.9 4.95 53.22 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.556 1.942 . . . . 0.0 113.413 -178.436 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -144.82 51.81 1.24 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.268 1.427 . . . . 0.0 110.63 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -95.13 -77.15 0.47 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 119.36 -0.352 . . . . 0.0 110.19 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 169.63 -65.4 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.683 1.593 . . . . 0.0 108.828 -178.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.25 69.79 7.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 111.22 116.19 0.0 OUTLIER 'General case' 0 C--O 1.231 0.102 0 C-N-CA 131.033 3.733 . . . . 0.0 106.743 -179.166 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.48 -63.95 0.3 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.483 1.113 . . . . 0.0 109.982 -178.741 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 66.52 163.35 0.18 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.562 1.545 . . . . 0.0 112.453 -179.186 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.93 106.7 0.15 Allowed Glycine 0 C--N 1.341 0.811 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -178.733 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m -139.1 57.21 1.67 Allowed 'General case' 0 C--N 1.34 0.173 0 CA-C-N 117.696 0.748 . . . . 0.0 112.149 -178.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -100.02 -75.93 0.56 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 177.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.261 3.6 t -160.23 26.56 0.17 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.682 1.593 . . . . 0.0 109.823 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.409 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -171.3 129.78 0.73 Allowed Pre-proline 0 C--N 1.349 0.548 0 C-N-CA 128.307 2.643 . . . . 0.0 106.872 178.329 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.6 132.3 25.84 Favored 'Cis proline' 0 N--CA 1.45 -1.083 0 N-CA-C 108.354 -1.441 . . . . 0.0 108.354 -2.407 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.3 158.17 43.88 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.874 0.47 . . . . 0.0 109.76 -179.357 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.4 m -55.64 130.97 45.24 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 125.97 1.708 . . . . 0.0 110.584 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -79.8 121.24 25.13 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.347 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -146.63 177.87 8.74 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.26 1.024 . . . . 0.0 110.514 -179.139 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 t30 59.13 73.27 0.49 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.259 1.424 . . . . 0.0 108.565 -178.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -82.01 91.23 6.58 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.051 0.94 . . . . 0.0 110.853 -178.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -62.08 -50.51 71.66 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -169.74 42.4 0.21 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 178.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -150.73 143.48 24.54 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 123.557 0.743 . . . . 0.0 112.159 -179.283 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -161.6 179.63 8.03 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.836 2.054 . . . . 0.0 107.677 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -137.93 119.33 10.58 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.84 74.37 5.26 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.981 3.121 . . . . 0.0 112.45 -178.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.26 -90.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.405 1.082 . . . . 0.0 108.714 178.517 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -145.93 -78.72 0.18 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-N 119.215 0.916 . . . . 0.0 110.228 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.22 -175.06 35.97 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.632 1.11 . . . . 0.0 111.045 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.25 140.33 32.48 Favored 'Cis proline' 0 N--CA 1.458 -0.59 0 CA-C-N 118.796 1.298 . . . . 0.0 110.422 1.031 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.38 172.27 11.91 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.954 0.902 . . . . 0.0 110.351 -178.58 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -153.9 137.82 16.29 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.064 0.459 . . . . 0.0 111.834 -178.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.55 143.81 30.8 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.697 1.599 . . . . 0.0 112.626 -178.748 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -154.48 113.85 2.44 Favored Pre-proline 0 C--N 1.342 0.251 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 178.286 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.409 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 17.6 Cg_endo -81.12 144.54 14.87 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 121.79 1.66 . . . . 0.0 114.389 -175.526 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.544 HG12 ' H ' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -117.12 -171.64 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-O 124.671 2.176 . . . . 0.0 113.125 179.419 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.544 ' H ' HG12 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -162.41 -175.47 4.54 Favored 'General case' 0 C--N 1.318 -0.796 2 CA-C-N 108.05 -4.159 . . . . 0.0 107.443 -178.656 . . . . . . . . 4 4 . 1 . 022 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.3 m -92.81 61.27 3.54 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.329 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.54 58.88 0.99 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -178.628 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.27 61.13 0.17 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.02 116.86 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.426 0.691 . . . . 0.0 111.206 -179.35 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.6 t80 53.64 65.64 1.46 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.248 1.419 . . . . 0.0 111.248 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.6 p -138.12 77.57 1.64 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.246 1.018 . . . . 0.0 110.825 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.95 99.92 0.07 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.738 0.685 . . . . 0.0 113.262 178.62 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.74 -174.35 49.31 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.2 m 56.8 86.63 0.16 Allowed Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 125.318 1.447 . . . . 0.0 111.602 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -62.72 142.6 42.14 Favored 'Cis proline' 0 N--CA 1.459 -0.505 0 CA-C-N 119.322 0.794 . . . . 0.0 112.76 -0.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.85 48.09 0.49 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.29 -55.6 8.82 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.693 0.797 . . . . 0.0 109.455 179.267 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -61.93 118.61 7.47 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.436 1.894 . . . . 0.0 112.843 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -143.37 126.91 16.89 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.187 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.0 m -92.9 148.05 4.98 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 177.024 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.6 t -137.06 131.81 46.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.603 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 pt -119.92 -175.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.394 0 C-N-CA 124.365 1.066 . . . . 0.0 112.301 -178.392 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -96.74 153.64 17.75 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 127.009 2.123 . . . . 0.0 106.071 177.869 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.6 t -67.31 -1.4 4.55 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 -178.536 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -93.29 -75.31 0.5 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 178.397 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -164.39 -12.04 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -179.094 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.72 132.82 36.28 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 -174.398 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -62.24 125.24 23.21 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.8 -42.41 8.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.2 1.0 . . . . 0.0 109.463 -178.897 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.18 -165.07 38.16 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.86 140.61 25.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.698 1.599 . . . . 0.0 107.678 179.421 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.8 pt -142.56 165.87 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.091 1.356 . . . . 0.0 109.129 -178.885 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.3 t -159.33 150.83 20.23 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.19 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -79.13 -9.8 59.65 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 175.343 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 54.1 m -66.16 112.0 3.7 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.477 1.111 . . . . 0.0 109.12 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.91 34.38 42.86 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.952 0.787 . . . . 0.0 111.669 -179.301 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.43 -21.2 11.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.21 1.404 . . . . 0.0 111.386 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.6 m 70.05 85.12 0.14 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 126.185 1.794 . . . . 0.0 110.639 179.37 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.91 -146.77 17.95 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.702 1.144 . . . . 0.0 111.359 179.192 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -80.0 3.61 19.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.681 1.192 . . . . 0.0 112.913 -179.239 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -68.28 -174.85 0.55 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.876 1.27 . . . . 0.0 111.594 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -140.7 157.56 45.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.81 0.844 . . . . 0.0 112.503 -178.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 m -143.94 163.29 15.18 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 127.095 2.158 . . . . 0.0 106.955 177.426 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.27 153.35 26.41 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 123.53 0.586 . . . . 0.0 113.302 -178.143 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -84.13 -179.85 7.32 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.27 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.9 t -79.53 122.69 26.79 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.351 -0.843 . . . . 0.0 112.219 -178.395 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.64 36.39 92.59 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.726 1.155 . . . . 0.0 112.361 179.067 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.5 t -80.05 146.69 31.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.0 p30 . . . . . 0 C--O 1.252 1.191 0 C-N-CA 125.397 1.479 . . . . 0.0 109.741 -179.031 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m -133.29 176.95 8.06 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.14 1.376 . . . . 0.0 108.994 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -44.46 117.97 1.42 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.984 1.313 . . . . 0.0 110.764 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.51 121.87 41.78 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 124.964 1.306 . . . . 0.0 110.41 -178.124 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -119.07 92.14 3.73 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 100.285 -3.968 . . . . 0.0 100.285 177.126 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.8 m -98.93 91.13 4.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.982 0.913 . . . . 0.0 111.455 -177.546 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.72 -81.68 0.63 Allowed Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.979 1.276 . . . . 0.0 110.759 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.3 t -145.07 23.92 1.49 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.813 1.245 . . . . 0.0 110.339 179.11 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 m -129.29 102.01 6.25 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 179.043 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -95.18 151.72 18.98 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.347 0.659 . . . . 0.0 111.967 -178.561 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.26 155.69 41.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.01 1.324 . . . . 0.0 109.543 178.75 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.0 p -75.77 154.2 36.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.509 1.523 . . . . 0.0 110.352 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.5 -21.19 59.81 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 176.597 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.7 t -71.09 -41.22 70.91 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 124.648 1.179 . . . . 0.0 109.892 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -66.78 -39.83 87.94 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 118.65 0.659 . . . . 0.0 111.09 178.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.42 -50.68 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 123.741 0.816 . . . . 0.0 109.13 178.586 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -62.76 -39.14 93.24 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 123.71 0.804 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.6 -47.13 76.75 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.41 -31.24 72.34 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.56 0.744 . . . . 0.0 111.211 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.87 -42.52 24.06 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 178.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -68.4 -20.39 64.67 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.349 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.406 ' HB1' ' CE2' ' A' ' 26' ' ' TYR . . . -79.96 -65.42 1.01 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 104.33 -2.471 . . . . 0.0 104.33 -178.105 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -41.23 -53.68 3.12 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 124.708 1.255 . . . . 0.0 110.125 176.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 t -49.96 -61.87 1.9 Allowed 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.853 1.661 . . . . 0.0 113.319 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -61.55 -51.43 68.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.118 0.567 . . . . 0.0 111.458 -178.054 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.406 ' CE2' ' HB1' ' A' ' 22' ' ' ALA . 1.6 m-30 -63.07 -28.6 70.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.722 1.209 . . . . 0.0 112.041 -177.702 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.407 ' CE2' ' HG3' ' A' ' 57' ' ' GLN . 6.3 t80 -71.92 -56.02 6.44 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.102 0.961 . . . . 0.0 109.557 179.043 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -60.25 -36.86 78.74 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.031 0.932 . . . . 0.0 110.994 -179.079 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -73.69 -35.88 65.23 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.311 0.645 . . . . 0.0 110.683 178.836 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 68.48 51.05 0.67 Allowed 'General case' 0 C--N 1.344 0.362 0 C-N-CA 126.09 1.756 . . . . 0.0 109.813 -178.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -172.56 -165.55 0.33 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.818 2.047 . . . . 0.0 107.823 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.36 8.8 t 49.65 51.79 15.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.871 2.069 . . . . 0.0 113.682 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.94 99.65 0.08 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.827 2.051 . . . . 0.0 107.081 178.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.91 33.31 3.1 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.033 0.825 . . . . 0.0 113.567 -178.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -78.49 -73.09 0.34 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.275 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -167.27 -72.71 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.79 2.036 . . . . 0.0 105.925 179.295 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.3 t -152.21 14.78 0.61 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.298 1.039 . . . . 0.0 111.557 178.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.43 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 8.8 m-85 -76.95 130.79 74.69 Favored Pre-proline 0 C--N 1.346 0.421 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.54 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -69.89 121.25 5.32 Favored 'Cis proline' 0 N--CA 1.455 -0.738 0 N-CA-C 115.938 1.476 . . . . 0.0 115.938 -0.002 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -115.19 161.12 18.87 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.497 1.919 . . . . 0.0 106.053 178.651 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 t -52.31 143.04 15.66 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.715 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -118.31 152.64 35.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.198 1.399 . . . . 0.0 107.75 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 177.46 -65.04 0.01 OUTLIER 'General case' 0 C--O 1.231 0.082 0 C-N-CA 124.912 1.285 . . . . 0.0 108.848 -178.622 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 m120 53.05 44.59 30.2 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.811 1.644 . . . . 0.0 110.026 -179.247 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 59.38 -98.98 0.09 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.206 1.802 . . . . 0.0 109.287 -178.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -134.34 68.76 1.47 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.013 1.325 . . . . 0.0 107.792 178.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.05 -73.53 0.91 Allowed Glycine 0 C--N 1.341 0.859 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.209 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.29 116.73 12.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -141.19 121.31 13.78 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.851 0.86 . . . . 0.0 108.881 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -88.31 178.6 2.02 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 125.428 1.491 . . . . 0.0 107.985 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.66 -72.04 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.011 2.474 . . . . 0.0 111.113 178.674 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER 41.77 -150.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 127.319 2.247 . . . . 0.0 114.197 178.546 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -124.23 -57.03 1.61 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.958 2.103 . . . . 0.0 107.797 178.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.84 129.93 6.7 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.648 -1.084 . . . . 0.0 111.153 179.217 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.17 -177.89 9.67 Favored 'Cis proline' 0 C--N 1.35 0.651 0 CA-C-N 119.813 1.807 . . . . 0.0 114.635 -0.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.86 163.36 38.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 128.716 2.807 . . . . 0.0 106.315 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.407 ' HG3' ' CE2' ' A' ' 27' ' ' TYR . 10.0 mm100 -132.33 152.26 51.49 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.4 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.9 161.8 15.05 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -161.12 95.51 1.39 Allowed Pre-proline 0 N--CA 1.455 -0.203 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.43 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 95.9 Cg_endo -67.69 132.26 26.43 Favored 'Trans proline' 0 N--CA 1.438 -1.744 0 CA-C-N 120.82 1.328 . . . . 0.0 112.727 -178.574 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.547 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.3 tt -101.81 179.33 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 123.93 1.824 . . . . 0.0 111.707 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.547 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 10.4 mttm -160.99 157.73 26.79 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 109.08 -3.691 . . . . 0.0 111.51 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.9 p -88.41 59.89 5.41 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.813 1.245 . . . . 0.0 111.234 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.11 31.0 0.13 Allowed Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.302 -0.721 . . . . 0.0 111.621 178.575 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.01 179.97 28.82 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.922 0.772 . . . . 0.0 112.056 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.8 p -73.64 131.15 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.094 1.358 . . . . 0.0 111.545 -179.095 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 41.8 t80 39.04 82.48 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.359 2.263 . . . . 0.0 114.09 178.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.2 t -160.59 125.3 3.72 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.104 0.961 . . . . 0.0 109.422 178.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 162.46 -83.16 0.12 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 154.16 -58.4 0.4 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.218 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.3 m -138.29 93.15 11.63 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.181 0.992 . . . . 0.0 110.518 -178.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -49.45 139.0 30.23 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 124.11 3.207 . . . . 0.0 111.565 169.116 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.14 -21.02 2.38 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 118.259 -1.301 . . . . 0.0 115.162 -178.45 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.476 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -151.94 -60.14 0.16 Allowed 'General case' 0 C--N 1.345 0.374 0 CA-C-N 119.657 1.729 . . . . 0.0 114.454 -178.667 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.42 117.52 12.06 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -177.4 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -146.0 125.67 13.38 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.422 0.689 . . . . 0.0 112.036 178.77 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.6 148.49 4.53 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.09 137.71 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.3 pt -117.42 -177.62 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.803 1.641 . . . . 0.0 112.143 -178.442 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -83.65 178.55 7.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 129.397 3.079 . . . . 0.0 107.118 178.682 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.1 t -90.71 24.76 2.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -140.57 -65.21 0.45 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 177.824 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -163.27 -21.03 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 118.741 2.867 . . . . 0.0 118.741 -177.553 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -79.82 150.2 30.77 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -175.276 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -75.44 134.52 40.85 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.149 1.78 . . . . 0.0 108.296 178.549 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.22 -53.7 2.86 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.942 0.897 . . . . 0.0 110.248 -179.357 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.91 152.11 10.95 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.15 127.67 53.02 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.377 1.471 . . . . 0.0 107.551 178.718 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.0 pt -132.19 157.59 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.457 1.103 . . . . 0.0 109.969 -178.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.4 t -158.07 151.8 23.75 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -179.122 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.476 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 27.8 m170 -80.21 -20.57 44.37 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.562 0.539 . . . . 0.0 110.509 174.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.0 m -49.01 -59.64 3.44 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 126.182 1.793 . . . . 0.0 112.714 -178.106 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.02 -27.45 70.37 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 123.846 0.736 . . . . 0.0 111.96 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.02 172.35 5.72 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.211 1.004 . . . . 0.0 112.27 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.3 t -60.79 -54.8 40.7 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.448 1.099 . . . . 0.0 111.564 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.68 -88.39 0.07 OUTLIER Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.428 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -80.23 -24.1 40.41 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.978 0.911 . . . . 0.0 112.001 -179.616 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -68.71 -178.18 1.12 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.518 1.127 . . . . 0.0 112.268 -178.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -128.17 160.46 31.97 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.524 1.529 . . . . 0.0 112.031 -179.007 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 m -148.27 161.25 6.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 126.747 2.019 . . . . 0.0 106.917 177.145 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.1 161.39 27.85 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 p -147.63 160.68 42.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.2 1.8 . . . . 0.0 109.4 178.528 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.2 t 70.51 58.76 0.23 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.046 1.738 . . . . 0.0 110.684 -178.519 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.59 28.74 70.26 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.306 -179.371 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.2 m -113.79 106.24 14.24 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.215 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.3 t30 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 116.851 -1.547 . . . . 0.0 109.822 179.704 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.493 0 CA-C-O 121.142 0.496 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.6 p -136.42 -174.34 3.67 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.255 1.422 . . . . 0.0 109.945 179.388 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.83 152.05 45.28 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.706 0.802 . . . . 0.0 109.406 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 t -146.53 136.97 23.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.73 0.3 . . . . 0.0 111.705 -179.379 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.06 113.08 25.5 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.224 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.1 m -98.54 75.27 2.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.377 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.8 -84.11 1.59 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.022 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.0 m -123.44 -29.49 3.79 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.352 1.461 . . . . 0.0 110.816 179.112 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -71.73 98.04 1.87 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -79.56 141.58 36.49 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.138 1.375 . . . . 0.0 110.578 -178.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -137.14 129.01 29.04 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.325 1.05 . . . . 0.0 109.547 178.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.1 m -68.98 155.1 40.92 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.88 1.272 . . . . 0.0 108.652 178.209 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.71 -22.62 57.93 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 176.735 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.8 t -71.13 -37.74 72.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.034 0.934 . . . . 0.0 109.683 179.228 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -75.32 -44.89 42.88 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.102 1.361 . . . . 0.0 113.57 -178.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.2 t -60.48 -48.02 90.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -43.26 74.37 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 123.765 0.826 . . . . 0.0 112.258 -179.187 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.18 -47.24 85.37 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.301 0.376 . . . . 0.0 110.69 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.6 94.57 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.712 0.805 . . . . 0.0 109.566 -179.629 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.91 -27.86 60.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -71.51 -23.47 61.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.557 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.03 -58.03 3.26 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -179.083 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.482 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -44.28 -44.6 8.15 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.48 1.512 . . . . 0.0 111.002 176.586 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -62.9 -52.56 62.61 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.163 0.985 . . . . 0.0 109.862 178.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -61.14 -22.22 64.48 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.445 0.698 . . . . 0.0 112.182 179.309 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -99.74 7.4 45.1 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.898 1.679 . . . . 0.0 110.735 179.328 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -151.31 63.89 0.89 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.587 1.184 . . . . 0.0 108.51 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -100.59 -39.88 7.68 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 113.532 -1.667 . . . . 0.0 112.16 178.286 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -139.05 48.41 1.88 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.876 0.871 . . . . 0.0 111.062 -179.048 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 p30 46.46 41.75 9.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.584 1.954 . . . . 0.0 114.61 178.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -138.94 123.74 18.69 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 103.347 -2.834 . . . . 0.0 103.347 178.107 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 p -109.54 -84.09 0.55 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -176.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 163.24 97.57 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 128.394 2.677 . . . . 0.0 104.184 -178.139 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.5 -48.22 3.09 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -178.362 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m 59.17 71.64 0.57 Allowed 'General case' 0 C--N 1.345 0.402 0 C-N-CA 125.344 1.458 . . . . 0.0 110.267 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.3 t 179.68 -42.3 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.992 2.117 . . . . 0.0 107.238 -178.499 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.3 t -79.91 12.32 2.79 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.96 1.704 . . . . 0.0 112.667 179.223 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 71.94 136.57 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.792 1.637 . . . . 0.0 108.717 179.023 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.35 163.41 89.95 Favored 'Cis proline' 0 N--CA 1.449 -1.143 0 CA-C-N 119.616 0.899 . . . . 0.0 113.979 2.476 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -166.46 151.75 8.16 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 127.06 2.144 . . . . 0.0 107.131 178.767 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 t -52.0 155.66 1.78 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -178.191 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -138.36 99.01 3.73 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.345 2.258 . . . . 0.0 106.738 -179.439 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -131.04 153.65 49.05 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.28 1.032 . . . . 0.0 111.747 -178.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 54.47 32.22 16.3 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.873 2.069 . . . . 0.0 113.612 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -123.62 75.96 1.38 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.827 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -77.85 -1.46 31.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.413 1.085 . . . . 0.0 112.722 179.353 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.83 -43.34 96.64 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 124.346 0.975 . . . . 0.0 111.964 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.47 66.8 1.32 Allowed 'General case' 0 C--N 1.341 0.221 0 CA-C-O 121.658 0.742 . . . . 0.0 109.403 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -87.57 -175.16 5.1 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.632 1.173 . . . . 0.0 112.968 -178.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -141.3 143.58 31.02 Favored Pre-proline 0 N--CA 1.454 -0.226 0 C-N-CA 126.699 1.999 . . . . 0.0 106.73 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.14 -87.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.837 2.358 . . . . 0.0 110.272 179.111 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.1 t 31.23 -102.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 128.046 2.538 . . . . 0.0 113.358 178.795 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -167.76 115.43 0.75 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.246 1.019 . . . . 0.0 109.57 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.06 170.98 50.14 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.224 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.69 170.71 64.7 Favored 'Cis proline' 0 N--CA 1.459 -0.533 0 CA-C-N 118.645 1.223 . . . . 0.0 112.423 -0.147 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -130.5 170.84 13.7 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.92 1.288 . . . . 0.0 109.868 -178.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -149.99 148.5 29.13 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.172 0.989 . . . . 0.0 109.731 179.252 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -79.54 155.08 28.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.044 2.537 . . . . 0.0 112.369 -177.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.482 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 28.0 t80 -160.51 102.1 1.35 Allowed Pre-proline 0 N--CA 1.454 -0.258 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -78.79 126.36 7.25 Favored 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 121.786 1.658 . . . . 0.0 111.632 -176.422 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 62' ' ' LYS . 2.3 tp -79.2 164.41 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 123.845 1.783 . . . . 0.0 113.186 -178.506 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.414 ' N ' HG13 ' A' ' 61' ' ' ILE . 33.3 mmtp -142.93 145.55 33.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 109.316 -3.584 . . . . 0.0 110.752 -178.458 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.8 p -85.34 57.65 4.58 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.068 1.347 . . . . 0.0 108.421 179.046 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.59 -44.23 0.03 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -178.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.62 -132.59 2.18 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 117.788 0.794 . . . . 0.0 111.822 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -77.77 167.29 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.961 1.704 . . . . 0.0 110.3 -179.252 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -65.01 141.96 58.59 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 118.406 0.548 . . . . 0.0 110.965 -179.424 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -130.78 120.72 24.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.229 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.69 -66.17 3.58 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.271 0.939 . . . . 0.0 111.74 179.188 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.32 -115.56 1.76 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 -179.261 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.15 -178.76 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.61 1.164 . . . . 0.0 111.067 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.71 159.55 4.77 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.411 2.741 . . . . 0.0 113.34 172.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.59 82.49 0.05 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 -178.753 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.461 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -50.95 -35.87 35.79 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.477 1.111 . . . . 0.0 113.487 -178.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -74.96 118.48 17.97 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.564 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -144.57 133.65 22.77 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -178.041 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.8 m -100.12 145.83 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 176.133 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -130.81 136.49 58.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -177.436 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.0 pt -116.08 174.07 3.53 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 C-N-CA 125.066 1.346 . . . . 0.0 113.512 -178.003 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -99.99 162.67 12.84 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.885 2.074 . . . . 0.0 107.735 178.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.379 5.7 t -79.09 32.69 0.22 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 118.993 2.961 . . . . 0.0 118.993 -177.7 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.31 -85.62 0.63 Allowed 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 176.377 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.7 t -162.98 -6.31 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.12 1.768 . . . . 0.0 114.848 179.281 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -79.0 139.14 38.26 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.466 1.03 . . . . 0.0 112.984 -176.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -81.78 121.21 26.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.444 1.898 . . . . 0.0 106.522 178.712 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.72 -59.27 2.8 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 123.548 0.739 . . . . 0.0 111.691 -178.363 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.52 154.28 13.01 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.703 -0.76 . . . . 0.0 114.098 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.96 124.77 37.17 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.491 1.516 . . . . 0.0 109.399 179.219 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.5 pt -131.09 159.7 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 125.296 1.438 . . . . 0.0 108.414 -179.334 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.8 t -154.07 154.22 33.26 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.273 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.461 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 13.4 m170 -79.42 11.34 3.05 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 176.825 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.4 m -56.38 -69.66 0.14 Allowed 'General case' 0 C--N 1.343 0.316 0 CA-C-N 120.135 1.334 . . . . 0.0 112.449 -178.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.26 3.42 72.29 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.369 0.985 . . . . 0.0 112.965 -179.371 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.34 159.45 33.32 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.993 0.917 . . . . 0.0 111.365 179.439 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.5 t -69.45 -46.48 66.62 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.64 0.776 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -161.94 -86.73 0.06 OUTLIER Glycine 0 C--N 1.34 0.761 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.214 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -91.67 15.27 13.03 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.216 1.006 . . . . 0.0 111.296 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -91.17 -168.17 1.99 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.892 1.277 . . . . 0.0 109.727 -179.401 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -147.24 159.44 43.65 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.903 0.881 . . . . 0.0 112.201 -178.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.4 m -138.52 165.62 24.52 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 126.959 2.104 . . . . 0.0 107.21 177.604 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.71 138.58 14.33 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 123.566 0.603 . . . . 0.0 113.492 -178.433 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.7 m -84.81 -169.54 2.69 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.269 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -69.97 134.36 48.26 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.954 -0.466 . . . . 0.0 110.791 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.66 34.57 72.97 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.4 m -149.08 104.61 3.44 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.5 t30 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 116.873 -1.537 . . . . 0.0 109.454 179.446 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.2 p -130.07 46.93 2.57 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.231 1.413 . . . . 0.0 109.593 179.235 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 67.13 163.97 0.2 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.8 2.04 . . . . 0.0 111.687 -179.202 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 t -156.32 128.52 7.51 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.98 115.37 29.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 178.927 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 23.1 m -101.06 72.82 1.49 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.777 1.631 . . . . 0.0 107.511 -179.048 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.02 -90.82 0.8 Allowed Glycine 0 C--N 1.34 0.754 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.23 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.3 t -106.53 -36.86 6.64 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.078 1.351 . . . . 0.0 110.416 179.34 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.7 m -71.39 112.96 7.94 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.616 0.766 . . . . 0.0 110.003 -179.15 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -92.29 147.39 22.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.093 0.957 . . . . 0.0 110.782 -179.298 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -142.08 122.23 13.81 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.778 1.231 . . . . 0.0 108.345 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.2 m -69.45 155.84 39.81 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 125.443 1.497 . . . . 0.0 110.163 178.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.9 -18.78 47.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.069 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.4 p -77.81 -39.48 43.61 Favored 'General case' 0 C--N 1.345 0.382 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -68.72 -45.97 70.15 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.278 1.031 . . . . 0.0 111.457 179.397 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 51.5 t -60.08 -49.78 82.71 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.095 0 C-N-CA 124.22 1.008 . . . . 0.0 109.242 179.056 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -63.6 -46.81 84.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.92 0.888 . . . . 0.0 111.434 -178.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.13 -52.57 58.48 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.589 0.756 . . . . 0.0 111.048 -177.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.04 -41.57 83.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.75 -29.29 66.61 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 179.165 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -68.41 -26.11 65.37 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.9 -59.5 2.69 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -43.93 -44.52 7.17 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.138 1.375 . . . . 0.0 112.145 177.346 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.9 t -60.08 -53.83 53.17 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.15 1.38 . . . . 0.0 111.06 -179.317 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -66.91 -43.15 84.08 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -81.37 -2.57 49.8 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 127.103 2.161 . . . . 0.0 114.03 -178.747 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -60.29 -45.73 92.33 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 120.288 1.404 . . . . 0.0 110.611 179.051 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -57.59 -46.28 84.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.974 1.31 . . . . 0.0 110.886 -178.762 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -84.45 -16.55 42.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.185 1.394 . . . . 0.0 113.277 -178.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.7 t0 65.26 79.18 0.26 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.533 1.933 . . . . 0.0 107.867 -178.234 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 83.94 -163.09 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.467 2.307 . . . . 0.0 107.198 -178.697 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.7 p -36.97 -41.2 0.33 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.087 1.355 . . . . 0.0 108.954 177.069 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 156.6 90.09 0.0 OUTLIER 'General case' 0 C--N 1.345 0.373 0 C-N-CA 129.971 3.308 . . . . 0.0 108.819 177.143 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -141.14 -136.0 3.24 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.278 1.894 . . . . 0.0 110.983 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.5 p 177.52 111.79 0.03 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 125.293 1.437 . . . . 0.0 109.407 -178.524 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 m 89.68 -8.72 0.39 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 128.74 2.816 . . . . 0.0 114.233 178.047 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 t -82.52 3.8 27.01 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.602 0.637 . . . . 0.0 112.225 179.099 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 81.21 141.21 0.07 OUTLIER Pre-proline 0 C--N 1.347 0.462 0 C-N-CA 127.818 2.447 . . . . 0.0 109.734 178.736 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.06 144.11 74.3 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 N-CA-C 117.258 1.984 . . . . 0.0 117.258 2.307 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.78 161.52 34.64 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 127.583 2.353 . . . . 0.0 106.324 178.406 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.2 t -59.13 149.04 29.15 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.631 0.65 . . . . 0.0 111.52 -179.281 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -90.69 143.53 26.65 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.209 1.004 . . . . 0.0 109.325 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -65.15 -49.24 70.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.817 1.647 . . . . 0.0 112.959 -178.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 71.22 -168.02 0.15 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.125 1.37 . . . . 0.0 109.851 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 68.5 168.71 0.28 Allowed 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.76 1.624 . . . . 0.0 112.471 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 55.65 50.91 13.42 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -178.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.81 -159.08 34.15 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 108.154 -1.978 . . . . 0.0 108.154 -177.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 35.58 96.94 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 127.403 2.281 . . . . 0.0 116.853 179.07 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -158.83 143.03 15.55 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.0 0.92 . . . . 0.0 109.427 178.548 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -102.24 153.53 38.01 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.036 1.335 . . . . 0.0 108.728 -179.306 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -78.17 42.18 1.16 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 124.102 3.201 . . . . 0.0 112.518 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.5 m -149.11 152.59 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 126.683 1.993 . . . . 0.0 107.161 178.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -144.87 113.58 6.75 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.18 -57.02 3.08 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.18 -1.344 . . . . 0.0 112.689 -178.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -53.8 149.16 16.64 Favored 'Cis proline' 0 C--N 1.351 0.68 0 CA-C-N 120.586 2.193 . . . . 0.0 113.944 0.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -92.94 156.69 16.76 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.649 1.179 . . . . 0.0 111.286 -178.68 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.78 154.29 45.57 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.373 1.869 . . . . 0.0 115.378 -176.203 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -80.46 150.45 29.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.654 1.982 . . . . 0.0 110.002 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.524 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 65.7 t80 -160.02 99.38 1.46 Allowed Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.609 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -79.38 120.11 4.36 Favored 'Trans proline' 0 N--CA 1.442 -1.531 0 C-N-CA 122.114 1.876 . . . . 0.0 113.768 -176.865 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.561 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.9 tt -85.8 -178.81 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-O 123.845 1.783 . . . . 0.0 108.841 178.718 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.561 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 7.6 mmtt -160.43 139.91 10.92 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 109.788 -3.369 . . . . 0.0 111.466 -178.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.5 p -90.22 63.17 5.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.231 1.412 . . . . 0.0 107.309 178.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.87 -51.16 0.04 OUTLIER Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.222 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.18 177.98 35.52 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.27 104.93 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 39.6 p90 47.86 71.31 0.35 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.597 1.959 . . . . 0.0 112.343 -178.576 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.9 p -110.24 138.36 46.73 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.061 1.344 . . . . 0.0 109.273 179.306 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.36 -80.09 1.86 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.2 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.82 111.29 0.09 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.04 0.828 . . . . 0.0 111.615 179.262 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.9 m 64.93 90.66 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.719 1.607 . . . . 0.0 110.723 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.29 165.86 84.69 Favored 'Cis proline' 0 N--CA 1.457 -0.63 0 CA-C-N 119.323 0.794 . . . . 0.0 112.055 4.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.35 -67.48 0.02 OUTLIER Glycine 0 CA--C 1.525 0.716 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.413 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . 80.1 -59.72 0.32 Allowed 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 127.928 2.491 . . . . 0.0 109.478 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -65.52 115.6 5.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.223 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -135.52 159.69 40.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 122.148 0.975 . . . . 0.0 112.481 178.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.0 m -130.42 147.64 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 102.326 -3.212 . . . . 0.0 102.326 176.357 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.4 t -127.83 108.85 18.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -177.876 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -98.75 175.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.413 1.085 . . . . 0.0 111.498 -177.227 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -96.42 146.7 24.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.069 1.748 . . . . 0.0 107.108 179.258 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.9 t -61.11 -10.01 5.58 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 117.563 2.431 . . . . 0.0 117.563 -178.129 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -86.32 -76.51 0.34 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 178.414 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.48 -7.89 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 -178.473 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -79.07 169.53 18.05 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 119.339 0.972 . . . . 0.0 111.653 -176.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -113.46 125.81 54.64 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.513 1.925 . . . . 0.0 108.848 179.238 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.62 -62.99 1.35 Allowed 'General case' 0 C--N 1.346 0.431 0 C-N-CA 123.463 0.705 . . . . 0.0 111.241 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.26 170.04 43.09 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.66 153.82 38.86 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 123.931 0.892 . . . . 0.0 113.395 -178.27 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.5 pt -142.7 161.24 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 127.04 2.136 . . . . 0.0 109.392 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.4 t -160.57 142.76 12.74 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -177.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.413 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 9.6 m170 -78.35 64.35 3.43 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-N 120.89 1.677 . . . . 0.0 108.679 173.782 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.7 t -95.94 -34.45 11.8 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.227 -0.921 . . . . 0.0 109.652 178.708 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.68 -59.32 0.27 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 178.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 64.82 177.61 0.19 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.152 1.781 . . . . 0.0 113.591 178.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.4 t -150.64 56.98 0.92 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.553 1.541 . . . . 0.0 107.158 179.129 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.47 -77.28 0.23 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 107.503 -2.239 . . . . 0.0 107.503 -178.75 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -144.5 45.91 1.4 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.556 1.143 . . . . 0.0 108.985 178.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -114.17 160.59 18.8 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.613 1.165 . . . . 0.0 111.092 -179.059 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -109.49 109.84 20.78 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.743 1.617 . . . . 0.0 107.467 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.2 m -79.41 161.14 4.2 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.332 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.15 143.56 29.76 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 116.439 1.336 . . . . 0.0 116.439 -177.382 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.9 t -121.86 163.62 18.91 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 177.519 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.2 t 61.8 37.01 15.85 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.025 0.93 . . . . 0.0 109.865 -176.077 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.13 33.69 85.17 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.473 1.035 . . . . 0.0 111.892 -178.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.4 m -81.42 137.31 35.68 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.211 1.004 . . . . 0.0 109.387 179.547 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 116.921 -1.514 . . . . 0.0 108.535 179.219 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.2 t -79.19 75.36 5.75 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.056 1.342 . . . . 0.0 110.374 -178.783 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 145.26 109.36 0.0 OUTLIER 'General case' 0 C--O 1.231 0.102 1 C-N-CA 132.274 4.23 . . . . 0.0 103.403 179.765 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -122.57 125.56 45.95 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.594 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.34 99.92 5.84 Favored 'General case' 0 N--CA 1.444 -0.774 1 N-CA-C 100.04 -4.059 . . . . 0.0 100.04 176.355 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -102.94 85.66 2.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.601 1.56 . . . . 0.0 109.23 -177.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.21 -77.48 1.36 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.7 p -130.6 -33.63 1.62 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.303 1.441 . . . . 0.0 111.633 179.402 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -74.15 101.9 4.09 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.038 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -92.67 152.37 19.58 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.933 1.293 . . . . 0.0 111.379 -178.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -150.09 137.5 19.75 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.693 1.597 . . . . 0.0 108.677 178.558 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.1 p -71.56 154.0 41.76 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.216 1.407 . . . . 0.0 109.554 179.189 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.33 -22.59 12.51 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.035 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.1 t -72.1 -45.08 62.03 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 124.13 0.972 . . . . 0.0 109.279 179.391 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -69.69 -34.48 74.0 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.816 0.847 . . . . 0.0 113.159 179.524 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 85' ' ' TYR . 33.0 t -64.63 -50.69 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.075 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -60.83 -44.24 97.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.791 1.636 . . . . 0.0 110.67 -178.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.03 -52.29 56.79 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.896 0.478 . . . . 0.0 110.439 -179.115 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.38 73.53 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.222 1.009 . . . . 0.0 111.053 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.91 -39.69 42.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.258 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -66.73 -22.3 66.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.491 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.76 -64.19 1.21 Allowed 'General case' 0 C--N 1.348 0.519 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 -178.158 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.3 -34.88 16.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.664 0.786 . . . . 0.0 112.322 177.664 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -59.9 4.68 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.877 1.271 . . . . 0.0 109.547 178.622 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -64.63 -21.08 66.63 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.119 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -94.19 -20.68 19.64 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.602 1.161 . . . . 0.0 112.532 -178.356 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.411 ' CD1' ' HG3' ' A' ' 57' ' ' GLN . 9.7 t80 -74.31 -33.29 63.16 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.309 0.959 . . . . 0.0 112.841 -179.173 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -62.27 -14.68 41.32 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -178.444 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 t30 72.93 69.99 0.13 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.665 1.586 . . . . 0.0 111.025 177.924 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -136.12 58.24 1.75 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 178.359 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.8 t70 74.56 163.17 0.26 Allowed 'General case' 0 C--N 1.345 0.386 0 C-N-CA 126.91 2.084 . . . . 0.0 107.69 -177.588 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.3 p 54.45 56.5 6.78 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -151.07 158.12 43.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.262 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.37 73.72 0.44 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.698 1.618 . . . . 0.0 112.489 -179.428 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.1 p -72.45 -65.37 0.79 Allowed 'General case' 0 C--N 1.341 0.234 0 CA-C-N 117.876 0.838 . . . . 0.0 109.806 179.257 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.3 m -137.07 -58.16 0.71 Allowed 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 125.235 1.414 . . . . 0.0 107.771 178.853 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.0 t -157.35 40.94 0.31 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.72 1.208 . . . . 0.0 109.671 178.759 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -170.55 124.43 0.62 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 127.539 2.336 . . . . 0.0 106.666 179.355 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.36 140.52 66.73 Favored 'Cis proline' 0 N--CA 1.449 -1.106 0 CA-C-N 121.453 1.555 . . . . 0.0 109.657 -2.753 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -155.47 155.62 33.81 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.972 0.909 . . . . 0.0 109.355 179.602 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.9 p -66.39 152.99 43.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.55 0.74 . . . . 0.0 110.741 179.226 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.44 121.22 6.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.909 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -95.64 177.93 5.63 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.162 0.985 . . . . 0.0 111.223 -178.772 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -78.89 96.05 5.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.497 1.119 . . . . 0.0 109.166 -179.441 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -80.93 -98.23 0.04 OUTLIER 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.379 0.672 . . . . 0.0 110.111 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -158.55 35.7 0.23 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.333 0.653 . . . . 0.0 111.342 -179.369 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.75 -153.7 9.15 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.077 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.99 69.38 6.35 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 123.463 0.705 . . . . 0.0 109.953 178.818 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -75.65 118.63 18.68 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 178.629 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.03 117.74 39.14 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 125.448 1.499 . . . . 0.0 111.048 -177.488 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -78.5 89.55 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.125 2.55 . . . . 0.0 109.834 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 t -135.16 -63.52 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.328 0 C-N-CA 123.871 0.868 . . . . 0.0 110.621 -178.986 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 p30 -148.32 -122.48 0.06 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.35 1.06 . . . . 0.0 110.344 -179.699 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.28 132.55 2.29 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 118.35 -1.25 . . . . 0.0 110.738 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -68.04 -166.25 2.65 Favored 'Cis proline' 0 CA--C 1.538 0.689 0 CA-C-N 120.108 1.954 . . . . 0.0 114.369 -1.105 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -145.45 173.52 11.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.52 1.928 . . . . 0.0 108.255 179.386 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.411 ' HG3' ' CD1' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -148.01 143.05 26.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.059 0.544 . . . . 0.0 110.825 179.31 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -100.31 148.78 24.3 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.941 1.296 . . . . 0.0 111.263 179.34 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -158.39 127.46 3.1 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.568 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -75.54 147.26 31.74 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 CA-C-N 120.522 1.222 . . . . 0.0 112.27 -176.883 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.611 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 3.8 tp -79.4 -161.76 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 123.438 1.59 . . . . 0.0 110.869 -178.455 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.611 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 12.2 tttm -78.62 -163.84 0.51 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 111.321 -2.672 . . . . 0.0 111.64 -178.376 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.2 p 91.48 39.78 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 130.456 3.503 . . . . 0.0 107.277 -177.824 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.07 -54.56 0.24 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 108.386 -1.886 . . . . 0.0 108.386 -178.589 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.25 157.72 10.43 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.222 0.439 . . . . 0.0 112.169 179.123 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.486 HG12 ' CD2' ' A' ' 67' ' ' TYR . 24.1 t -127.26 120.94 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 179.061 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.486 ' CD2' HG12 ' A' ' 66' ' ' VAL 0.29 47.3 p90 58.17 43.36 20.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.581 2.352 . . . . 0.0 112.713 -177.935 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.4 t -148.83 -41.09 0.15 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.348 0.659 . . . . 0.0 111.194 -179.68 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.3 55.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.307 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.94 87.13 1.35 Allowed Glycine 0 C--N 1.339 0.749 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.0 m -59.28 142.55 86.24 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 123.929 0.892 . . . . 0.0 110.394 179.436 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.3 140.28 30.31 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.803 2.335 . . . . 0.0 108.482 176.501 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.64 -61.28 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 105.451 -3.06 . . . . 0.0 105.451 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -168.94 -55.82 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -178.656 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -62.95 109.84 1.59 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 117.959 2.577 . . . . 0.0 117.959 -177.357 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -129.41 153.87 47.49 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.764 0.825 . . . . 0.0 112.056 178.93 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.6 143.31 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 176.429 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 89' ' ' ILE . 83.8 t -137.05 136.24 47.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -175.659 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.3 pt -121.69 -177.71 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.376 0 C-N-CA 124.537 1.135 . . . . 0.0 113.606 -177.545 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -80.93 -175.2 5.25 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.133 2.173 . . . . 0.0 109.375 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.281 8.3 t -85.41 27.68 0.8 Allowed 'General case' 0 C--N 1.342 0.24 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 -178.328 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -150.62 -67.3 0.19 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.109 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.25 -14.61 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -176.956 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -78.91 128.65 33.59 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -175.657 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.489 ' CE2' ' CG1' ' A' ' 16' ' ' VAL . 16.3 t80 -60.11 136.41 58.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.631 1.173 . . . . 0.0 111.093 -179.186 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.24 -61.84 1.5 Allowed 'General case' 0 C--N 1.345 0.397 0 C-N-CA 124.422 1.089 . . . . 0.0 111.972 -178.892 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.14 170.05 42.82 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.115 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.67 145.89 46.98 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 125.039 1.336 . . . . 0.0 110.021 178.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.412 HD11 HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -144.28 162.63 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.352 1.061 . . . . 0.0 108.895 179.426 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 t -159.34 143.29 14.96 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -178.919 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -82.11 40.63 0.63 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.733 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -55.49 -31.32 61.92 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.946 -1.096 . . . . 0.0 113.224 -178.554 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.09 -69.61 0.02 OUTLIER Glycine 0 C--N 1.337 0.591 0 N-CA-C 106.614 -2.594 . . . . 0.0 106.614 178.955 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 50.67 -111.48 0.53 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.537 1.535 . . . . 0.0 111.546 178.809 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.1 m -157.13 77.3 0.87 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.456 1.502 . . . . 0.0 107.162 179.307 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.63 -105.34 2.39 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -101.61 22.93 11.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.333 1.053 . . . . 0.0 111.506 -179.351 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -89.86 177.46 6.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.502 0.721 . . . . 0.0 109.979 179.527 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -121.76 158.87 27.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.961 1.705 . . . . 0.0 110.899 -179.137 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.3 m -141.59 158.14 21.48 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.702 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.79 146.98 36.07 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.747 -178.42 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.2 t -89.5 -167.32 1.83 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.587 1.555 . . . . 0.0 107.274 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.8 m -63.66 121.27 13.52 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.749 0.419 . . . . 0.0 110.804 178.886 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.99 9.01 85.88 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.379 0.99 . . . . 0.0 113.917 179.22 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.5 m -91.93 137.57 32.26 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.434 1.117 . . . . 0.0 108.983 179.179 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 t30 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 116.458 -1.734 . . . . 0.0 110.915 179.333 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.4 t -149.68 72.02 1.12 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.447 1.099 . . . . 0.0 108.581 -179.463 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.56 141.71 0.05 Allowed 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 127.155 2.182 . . . . 0.0 111.163 -179.356 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -129.15 96.06 4.22 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.046 0.938 . . . . 0.0 111.48 -179.504 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -98.97 94.52 6.6 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 101.42 -3.548 . . . . 0.0 101.42 177.693 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 59.7 m -90.98 73.67 6.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.241 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.34 -99.67 1.73 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 -178.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.6 m -101.54 -39.43 7.52 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.29 1.436 . . . . 0.0 109.249 178.97 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.71 105.54 4.34 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.047 1.339 . . . . 0.0 108.555 -179.344 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -111.36 134.37 52.99 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.152 0.981 . . . . 0.0 112.481 -178.578 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.49 149.87 44.61 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.718 1.607 . . . . 0.0 107.186 178.514 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.0 m -72.72 155.24 40.18 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.317 1.047 . . . . 0.0 110.507 -179.018 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.1 -19.3 43.25 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 176.71 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.6 t -72.54 -40.79 66.45 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 124.954 1.302 . . . . 0.0 109.461 178.943 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -70.93 -35.23 72.15 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.029 0.532 . . . . 0.0 111.153 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.1 t -59.6 -48.31 87.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.643 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -65.74 -38.03 88.01 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.203 1.401 . . . . 0.0 111.431 179.51 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 -55.19 15.34 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 118.489 0.586 . . . . 0.0 110.168 -179.285 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.45 -31.3 70.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.073 0.949 . . . . 0.0 110.852 179.451 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.98 -44.78 46.34 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 118.905 -0.569 . . . . 0.0 111.558 179.032 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -60.62 -24.53 65.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.479 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.37 -51.53 10.67 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -178.451 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.81 -32.38 31.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.89 1.276 . . . . 0.0 110.886 177.125 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 64.3 m -70.8 -54.07 13.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.772 0.715 . . . . 0.0 110.536 178.921 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -58.56 -42.28 87.55 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.753 0.421 . . . . 0.0 111.162 -178.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -74.47 -44.2 52.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.485 1.114 . . . . 0.0 110.96 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 27' ' ' TYR . 2.1 t80 -55.23 -36.39 65.96 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.568 1.076 . . . . 0.0 108.789 179.034 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -71.33 -67.23 0.53 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.3 p30 155.51 -6.34 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.904 2.481 . . . . 0.0 113.57 -179.068 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.01 56.02 1.9 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.738 1.153 . . . . 0.0 113.153 -178.469 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 138.36 115.77 0.0 OUTLIER 'General case' 0 C--N 1.344 0.349 1 C-N-CA 131.97 4.108 . . . . 0.0 108.525 178.807 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.3 p -95.95 63.9 2.36 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.687 0.795 . . . . 0.0 109.243 -179.462 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.39 -161.03 0.42 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.848 1.259 . . . . 0.0 110.53 -179.503 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 45.79 -120.47 4.43 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.394 1.949 . . . . 0.0 113.868 178.686 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.1 t -139.68 -92.01 0.17 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.04 0.936 . . . . 0.0 110.874 -179.278 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 m -161.93 -41.71 0.04 OUTLIER 'General case' 0 C--N 1.344 0.337 0 C-N-CA 124.174 0.99 . . . . 0.0 111.102 -178.364 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 64.2 p -79.78 37.33 0.35 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.511 1.124 . . . . 0.0 112.932 -178.703 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 163.4 117.62 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 131.237 3.815 . . . . 0.0 104.453 179.114 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.97 126.23 11.99 Favored 'Cis proline' 0 N--CA 1.447 -1.236 0 N-CA-C 110.273 -0.703 . . . . 0.0 110.273 0.046 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -150.91 147.29 27.02 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 125.342 1.457 . . . . 0.0 110.28 179.425 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.19 139.42 58.66 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.969 1.308 . . . . 0.0 112.082 179.256 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -140.2 158.48 43.98 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 123.362 0.414 . . . . 0.0 111.028 178.083 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -154.01 -179.71 8.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.724 1.21 . . . . 0.0 109.617 -178.895 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.2 m120 73.52 165.96 0.29 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 126.79 2.036 . . . . 0.0 112.476 178.832 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 61.71 72.23 0.52 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.51 1.524 . . . . 0.0 110.775 179.337 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -74.36 162.25 29.05 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.073 0.949 . . . . 0.0 110.897 -179.385 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -178.35 -65.58 0.07 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 179.414 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.6 164.53 11.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.165 1.786 . . . . 0.0 108.74 179.009 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -131.56 124.22 29.57 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.834 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.417 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 58.0 m-85 -89.95 154.49 47.54 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.711 1.204 . . . . 0.0 110.195 -178.799 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -45.8 -60.16 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 124.41 3.406 . . . . 0.0 114.125 179.394 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.1 m -76.81 152.92 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.663 0.785 . . . . 0.0 109.884 179.283 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -81.6 -80.1 0.16 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.756 0.822 . . . . 0.0 110.399 -179.179 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -175.12 171.26 44.43 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 118.853 -0.971 . . . . 0.0 111.147 179.545 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.11 157.95 27.13 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 119.799 1.8 . . . . 0.0 112.847 -1.805 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.637 ' CZ ' HG12 ' A' ' 78' ' ' VAL . 32.4 t80 -150.41 129.38 12.57 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.208 0.603 . . . . 0.0 109.698 -177.082 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -117.68 152.82 34.45 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -176.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -90.53 144.87 25.36 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.763 2.825 . . . . 0.0 111.041 -177.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -147.75 109.69 3.82 Favored Pre-proline 0 C--N 1.346 0.447 0 C-N-CA 123.409 0.683 . . . . 0.0 109.157 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -78.14 142.82 19.63 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.189 1.926 . . . . 0.0 115.996 -175.724 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.512 HG12 ' H ' ' A' ' 62' ' ' LYS . 1.2 tt -122.04 -165.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-O 124.177 1.942 . . . . 0.0 111.943 179.206 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.512 ' H ' HG12 ' A' ' 61' ' ' ILE . 79.6 tttt -161.55 -179.73 7.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 109.233 -3.622 . . . . 0.0 109.191 -179.319 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.5 t -87.33 62.03 6.98 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.678 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.19 67.66 0.91 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.126 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.39 101.63 0.16 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.456 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.97 133.68 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.993 0.917 . . . . 0.0 109.174 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 p90 43.8 46.09 6.39 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.152 1.781 . . . . 0.0 113.402 -178.619 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.8 t -150.01 163.74 37.33 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.725 0.81 . . . . 0.0 110.451 -179.499 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.87 155.63 32.14 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -178.986 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -179.7 86.27 0.07 OUTLIER Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -179.322 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 m -148.39 -68.95 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.458 1.103 . . . . 0.0 109.178 179.304 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.06 -45.86 0.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.082 1.854 . . . . 0.0 110.925 173.684 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.47 58.5 12.97 Favored Glycine 0 C--N 1.342 0.892 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.432 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -129.77 -58.57 1.09 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.317 1.047 . . . . 0.0 112.058 -178.381 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -56.91 109.44 0.64 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.184 2.594 . . . . 0.0 117.154 -178.031 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -147.95 122.13 9.55 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -179.427 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.0 m -81.13 160.67 3.92 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.662 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.637 HG12 ' CZ ' ' A' ' 56' ' ' TYR . 45.4 t -141.04 126.87 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 120.789 -1.195 . . . . 0.0 108.688 -178.822 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.2 pt -117.28 173.93 4.06 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 C-N-CA 125.176 1.39 . . . . 0.0 113.233 -177.343 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -79.54 -164.94 0.71 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 124.464 1.106 . . . . 0.0 111.182 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.427 0.6 OUTLIER -96.62 37.89 1.25 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 117.193 2.294 . . . . 0.0 117.193 -178.145 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -160.52 -78.4 0.05 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.694 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.2 t -163.32 63.92 0.18 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 113.619 -1.628 . . . . 0.0 114.125 -177.48 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -147.07 120.17 8.83 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.394 1.452 . . . . 0.0 113.744 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -65.84 122.45 17.35 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 177.732 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 50' ' ' PHE . . . -103.77 -39.37 6.68 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.908 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.69 -172.89 39.47 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.019 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.33 139.0 28.26 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.936 0.894 . . . . 0.0 109.912 179.252 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.0 pt -132.45 166.57 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.728 1.211 . . . . 0.0 110.439 -178.563 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.3 t -160.46 150.06 17.57 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.974 0.91 . . . . 0.0 111.664 179.357 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.432 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 34.0 m170 -79.35 55.26 1.86 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 118.453 0.57 . . . . 0.0 109.73 175.113 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.9 m -80.34 -85.39 0.09 Allowed 'General case' 0 C--N 1.342 0.259 0 O-C-N 120.766 -1.209 . . . . 0.0 109.318 179.459 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.412 ' H ' HG21 ' A' ' 100' ' ' VAL . . . -80.31 7.03 58.55 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.688 1.137 . . . . 0.0 112.006 179.011 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.92 162.87 23.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.17 1.388 . . . . 0.0 111.203 179.234 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.6 t -66.99 -48.8 67.35 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.567 0.747 . . . . 0.0 109.833 179.075 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.29 -51.08 0.2 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.298 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -87.52 -46.03 9.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.23 1.012 . . . . 0.0 110.597 -179.619 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -70.79 -171.23 0.5 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.626 0.77 . . . . 0.0 112.379 -179.109 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -137.07 172.05 13.59 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.014 1.325 . . . . 0.0 113.553 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.412 HG21 ' H ' ' A' ' 93' ' ' GLY . 12.8 m -140.02 161.44 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 127.659 2.384 . . . . 0.0 106.019 176.725 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.4 164.91 38.56 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 116.515 1.366 . . . . 0.0 116.515 -177.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.8 m -113.56 -175.08 2.59 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.76 2.024 . . . . 0.0 107.442 177.78 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.9 p -69.56 110.99 5.08 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.713 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.67 36.1 2.12 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.648 1.594 . . . . 0.0 110.078 -178.73 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.0 m -153.54 100.02 2.38 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.129 1.771 . . . . 0.0 107.129 179.361 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 116.782 -1.58 . . . . 0.0 108.257 -179.298 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 t -148.92 174.67 12.01 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.866 1.266 . . . . 0.0 109.654 -179.775 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.18 149.56 6.9 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.718 1.207 . . . . 0.0 113.181 -178.661 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 t -148.92 156.41 42.25 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.812 0.845 . . . . 0.0 109.31 179.287 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.99 110.95 9.42 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.254 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 93.0 m -90.62 72.97 6.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.46 -93.06 0.89 Allowed Glycine 0 C--N 1.34 0.792 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.0 p -98.99 -36.38 9.75 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.884 1.274 . . . . 0.0 110.612 179.102 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -71.24 97.59 1.58 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.668 0.787 . . . . 0.0 110.116 -178.832 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -82.31 151.6 26.67 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.553 1.141 . . . . 0.0 110.617 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -144.53 129.89 18.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.899 0.88 . . . . 0.0 111.015 179.044 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.2 p -69.67 155.97 39.69 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 125.11 1.364 . . . . 0.0 108.047 177.578 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.63 -22.61 62.1 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 176.498 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.5 t -69.2 -40.85 77.79 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.351 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -68.83 -48.45 63.49 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.095 0.958 . . . . 0.0 112.915 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.2 t -61.25 -46.99 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.195 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -64.42 -39.16 93.3 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.775 0.83 . . . . 0.0 110.719 179.169 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.42 -52.03 56.18 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.63 0.65 . . . . 0.0 110.423 -179.052 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.573 ' HA ' HG13 ' A' ' 66' ' ' VAL . . . -61.14 -34.14 74.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.26 0.624 . . . . 0.0 111.554 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.81 -43.82 24.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -179.368 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -69.98 -14.81 62.88 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.846 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.72 -61.08 1.87 Allowed 'General case' 0 C--N 1.346 0.42 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.3 -36.35 14.01 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.687 1.195 . . . . 0.0 110.752 177.232 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -66.01 -63.47 1.08 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.958 1.303 . . . . 0.0 109.908 178.728 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -56.03 -28.88 59.25 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.537 0.735 . . . . 0.0 111.848 -178.789 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -79.61 -40.89 28.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.061 0.945 . . . . 0.0 111.486 179.148 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.462 ' CD2' ' HG3' ' A' ' 57' ' ' GLN . 23.9 t80 -101.25 23.88 10.3 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.799 0.84 . . . . 0.0 112.425 -178.298 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -86.0 14.6 5.95 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.942 -1.099 . . . . 0.0 112.076 179.176 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.3 m120 60.07 46.17 11.06 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.282 1.433 . . . . 0.0 111.527 178.857 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -154.72 73.03 0.88 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 80.62 110.67 0.07 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 127.617 2.367 . . . . 0.0 107.272 -178.128 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.6 t -87.66 -42.34 12.74 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.306 1.442 . . . . 0.0 113.332 -177.905 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 61.56 -171.46 0.15 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.628 1.171 . . . . 0.0 110.811 -178.733 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.35 167.07 39.3 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 121.96 -0.463 . . . . 0.0 112.326 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.9 t -148.99 -60.32 0.22 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.399 1.48 . . . . 0.0 107.685 179.256 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.4 p -124.55 -79.87 0.62 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.481 1.113 . . . . 0.0 108.125 178.767 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.488 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -160.39 41.65 0.18 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.233 1.013 . . . . 0.0 109.74 -179.0 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.488 ' CD1' ' C ' ' A' ' 37' ' ' THR . 43.0 m-85 -151.0 147.58 21.0 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 126.053 1.741 . . . . 0.0 107.993 -178.822 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.88 125.39 11.79 Favored 'Cis proline' 0 CA--C 1.539 0.75 0 CA-C-N 119.083 0.708 . . . . 0.0 111.726 0.219 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -119.14 165.61 13.96 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 125.994 1.717 . . . . 0.0 111.066 -179.269 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.8 p -67.8 145.83 54.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.443 0.697 . . . . 0.0 110.935 178.697 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -87.03 50.67 2.06 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.309 178.899 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -58.71 120.58 9.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.935 1.694 . . . . 0.0 108.052 179.751 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.7 m120 78.43 129.06 0.05 OUTLIER 'General case' 0 C--N 1.341 0.216 0 C-N-CA 126.42 1.888 . . . . 0.0 107.516 -178.223 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -82.41 20.43 1.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.346 -0.835 . . . . 0.0 112.691 -179.036 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 33.04 -99.13 0.02 OUTLIER 'General case' 0 C--N 1.347 0.485 0 C-N-CA 127.156 2.183 . . . . 0.0 112.025 179.437 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.45 23.16 2.84 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.572 1.082 . . . . 0.0 110.49 178.336 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.66 149.55 25.37 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 118.188 0.994 . . . . 0.0 111.271 -179.301 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -153.03 179.9 8.28 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.628 0.771 . . . . 0.0 111.701 -178.886 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -139.94 165.19 32.62 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 127.425 2.29 . . . . 0.0 106.552 -179.262 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.3 -51.86 10.14 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.435 2.756 . . . . 0.0 111.843 178.734 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 52' ' ' VAL . 3.7 m -82.24 151.17 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.803 1.241 . . . . 0.0 109.338 178.842 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -172.36 127.22 0.54 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.742 0.817 . . . . 0.0 112.613 -178.904 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.99 114.84 0.02 OUTLIER Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.008 1.766 . . . . 0.0 115.798 177.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -62.8 149.72 64.31 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.084 1.942 . . . . 0.0 109.85 -2.793 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.13 150.18 28.82 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.538 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.542 ' O ' HG13 ' A' ' 78' ' ' VAL . 63.0 mm-40 -133.4 157.82 44.57 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -178.115 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -112.01 151.04 29.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.715 2.406 . . . . 0.0 109.741 179.147 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -160.54 112.14 1.35 Allowed Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 177.618 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.434 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 24.3 Cg_endo -81.06 135.72 9.95 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.063 1.175 . . . . 0.0 111.08 -176.924 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.549 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.2 tt -109.32 178.13 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-O 124.22 1.962 . . . . 0.0 113.119 -179.419 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.549 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 19.9 ptmt -161.59 151.9 17.38 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 108.486 -3.961 . . . . 0.0 111.255 178.411 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.6 p -86.22 59.05 5.4 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.501 1.12 . . . . 0.0 108.656 179.462 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.92 71.82 0.06 OUTLIER Glycine 0 C--N 1.338 0.644 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.123 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.48 -178.83 47.64 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 123.942 0.782 . . . . 0.0 112.184 178.926 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.573 HG13 ' HA ' ' A' ' 19' ' ' ALA . 67.5 t -86.71 62.48 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.622 1.169 . . . . 0.0 109.924 -179.024 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 62.35 158.97 0.06 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.053 1.341 . . . . 0.0 114.287 178.646 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.9 p -138.53 -62.09 0.57 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.378 1.471 . . . . 0.0 108.435 178.639 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.38 -137.6 3.53 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.121 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.38 168.72 44.57 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.056 0.836 . . . . 0.0 113.145 178.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 m -74.11 174.5 4.89 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 125.815 1.646 . . . . 0.0 110.177 179.385 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -58.31 170.43 2.35 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.541 2.828 . . . . 0.0 112.804 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 74' ' ' ALA . . . -152.62 -69.54 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 103.953 -3.659 . . . . 0.0 103.953 -179.331 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . 170.75 -50.03 0.01 OUTLIER 'General case' 0 C--N 1.346 0.434 0 O-C-N 124.981 1.048 . . . . 0.0 113.296 -179.294 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -74.44 113.63 11.9 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 119.842 3.275 . . . . 0.0 119.842 -176.832 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 ptt180 -143.02 133.05 24.26 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.009 0.924 . . . . 0.0 110.552 177.772 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -90.48 147.04 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 178.308 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 57' ' ' GLN 0.254 78.0 t -133.61 123.83 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -176.791 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pt -105.75 -175.48 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.586 0 C-N-CA 126.455 1.902 . . . . 0.0 114.973 -177.096 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -112.82 145.21 41.02 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 128.903 2.881 . . . . 0.0 105.084 177.39 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.277 1.4 t -59.67 -16.84 29.34 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 120.783 3.623 . . . . 0.0 120.783 -177.072 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -79.61 -77.5 0.18 Allowed 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 103.625 -2.732 . . . . 0.0 103.625 178.755 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.53 -3.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.678 1.591 . . . . 0.0 114.598 -178.883 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.11 156.36 28.33 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 119.049 0.84 . . . . 0.0 111.151 -176.901 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -109.26 133.57 52.87 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.124 0.97 . . . . 0.0 110.709 -179.213 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.48 -64.84 1.08 Allowed 'General case' 0 C--N 1.342 0.268 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.042 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.25 168.4 37.0 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.183 -179.436 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.54 127.4 46.92 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.377 1.471 . . . . 0.0 109.638 -179.305 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 35.0 pt -120.52 154.61 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.656 1.182 . . . . 0.0 108.024 179.363 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.1 t -158.73 135.53 9.6 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -178.373 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.401 ' N ' ' HB1' ' A' ' 74' ' ' ALA . 4.0 p80 -105.9 52.88 0.72 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.018 0.372 . . . . 0.0 110.685 174.851 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.7 t -60.12 -48.01 83.51 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.134 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.01 42.65 0.2 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.91 -40.23 11.27 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.533 1.133 . . . . 0.0 109.673 179.094 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.9 t -152.64 -51.8 0.11 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.193 1.397 . . . . 0.0 109.834 -179.512 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.82 -37.48 1.02 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -178.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -126.0 -40.9 1.98 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.753 1.621 . . . . 0.0 110.031 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -64.45 124.01 20.7 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.053 0.541 . . . . 0.0 109.553 179.457 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -79.48 162.43 25.45 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.026 1.73 . . . . 0.0 112.06 -178.594 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.2 m -137.41 164.2 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 127.922 2.489 . . . . 0.0 105.979 176.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.74 137.88 15.19 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 123.134 0.397 . . . . 0.0 112.948 -177.751 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.4 m -81.58 -171.18 3.17 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.33 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.0 p -72.21 123.02 22.06 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.692 -0.63 . . . . 0.0 111.271 -177.948 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.77 38.15 28.22 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -178.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -148.75 127.78 12.76 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.054 1.342 . . . . 0.0 108.395 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.3 t30 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 116.524 -1.703 . . . . 0.0 109.041 179.336 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.5 m -136.98 172.94 12.26 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.322 1.849 . . . . 0.0 109.202 -179.46 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.15 160.03 31.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.509 0.724 . . . . 0.0 110.645 -179.793 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 t -152.21 139.51 19.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.497 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.08 103.96 11.08 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 179.204 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.5 m -90.3 82.14 6.0 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.453 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.25 -111.0 3.47 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.165 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.4 t -88.31 -43.24 11.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.129 0.972 . . . . 0.0 109.64 178.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 m -69.98 106.29 3.15 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.463 1.105 . . . . 0.0 109.741 -179.294 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -86.38 157.99 19.73 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.089 0.956 . . . . 0.0 111.979 -179.178 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -144.3 136.8 26.71 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.624 1.17 . . . . 0.0 110.582 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.5 t -79.91 154.27 28.43 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 125.215 1.406 . . . . 0.0 109.78 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.25 -18.93 64.09 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 176.852 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.6 m -78.78 -38.84 37.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.014 0.925 . . . . 0.0 108.731 178.972 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -71.48 -48.57 48.3 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.613 1.565 . . . . 0.0 110.811 -179.201 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.4 t -58.96 -46.71 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.948 1.699 . . . . 0.0 107.571 177.432 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -64.89 -39.49 93.61 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 124.204 1.002 . . . . 0.0 111.412 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.26 -52.42 62.13 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.061 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.29 74.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.73 1.212 . . . . 0.0 110.921 179.564 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.22 -51.82 16.32 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.226 -179.205 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -60.68 -18.08 51.71 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.859 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.87 -64.71 1.12 Allowed 'General case' 0 C--N 1.347 0.5 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -178.781 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.478 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -43.93 -48.91 8.59 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.638 1.575 . . . . 0.0 110.495 177.494 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -55.51 -49.77 71.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 128.251 2.62 . . . . 0.0 111.268 178.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -68.11 -22.11 64.91 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.238 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -108.52 -19.47 13.43 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -179.117 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -71.87 -40.37 69.0 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -177.539 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -115.7 -28.18 6.83 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.04 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -67.57 -59.04 3.67 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.73 0.695 . . . . 0.0 110.228 -178.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 168.87 115.5 0.01 OUTLIER 'General case' 0 C--N 1.341 0.208 0 C-N-CA 128.192 2.597 . . . . 0.0 106.238 -178.892 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -54.85 127.25 27.7 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.341 1.057 . . . . 0.0 110.191 178.634 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.0 t -134.2 -51.4 0.82 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.684 0.794 . . . . 0.0 112.657 -178.836 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.56 172.82 8.91 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.917 0.487 . . . . 0.0 110.659 -179.426 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.87 82.27 0.52 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 107.908 -2.077 . . . . 0.0 107.908 179.056 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 p -168.14 101.35 0.45 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -176.973 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.5 p -128.63 -50.88 1.26 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.903 0.881 . . . . 0.0 109.678 -178.454 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 p -79.5 -6.34 56.75 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.572 0.749 . . . . 0.0 109.183 178.337 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -157.5 121.84 2.27 Favored Pre-proline 0 C--N 1.343 0.319 0 C-N-CA 128.147 2.579 . . . . 0.0 104.375 177.791 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.22 147.66 49.28 Favored 'Cis proline' 0 N--CA 1.453 -0.886 0 N-CA-C 117.468 2.065 . . . . 0.0 117.468 -0.091 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.98 136.7 37.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 128.162 2.585 . . . . 0.0 105.386 178.691 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.7 m -56.63 127.87 33.55 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.753 1.221 . . . . 0.0 110.067 179.078 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -79.85 78.24 6.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.561 1.144 . . . . 0.0 110.242 -178.911 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -80.66 -17.69 50.39 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.19 0.996 . . . . 0.0 112.535 179.46 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -79.33 149.89 31.61 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.683 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -168.43 89.68 0.25 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.681 1.992 . . . . 0.0 107.468 178.429 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -150.37 55.26 0.92 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.168 0.987 . . . . 0.0 108.689 179.818 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.07 -64.88 0.58 Allowed Glycine 0 C--N 1.338 0.651 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -179.178 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -99.92 132.92 44.98 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.401 1.08 . . . . 0.0 110.767 179.312 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -178.7 154.3 0.74 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 126.438 1.895 . . . . 0.0 109.428 178.877 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -123.26 105.37 34.05 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.503 1.121 . . . . 0.0 109.738 -178.087 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.23 84.83 1.93 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.519 2.812 . . . . 0.0 110.49 179.169 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.49 -72.64 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.226 0 C-N-CA 124.476 1.11 . . . . 0.0 110.908 179.191 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -133.71 -90.01 0.38 Allowed 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.516 0.598 . . . . 0.0 111.562 -179.114 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.81 131.97 4.28 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -178.515 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -71.98 -177.89 18.8 Favored 'Cis proline' 0 N--CA 1.456 -0.7 0 CA-C-N 119.686 1.743 . . . . 0.0 111.699 1.238 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.05 173.25 11.66 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.182 1.793 . . . . 0.0 106.231 179.184 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.4 146.32 22.43 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -178.666 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -81.25 156.14 25.75 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 126.575 1.95 . . . . 0.0 112.397 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.478 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 14.5 t80 -160.87 102.1 1.29 Allowed Pre-proline 0 N--CA 1.452 -0.333 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.441 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -77.82 115.2 3.78 Favored 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 122.674 2.25 . . . . 0.0 111.802 -177.572 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.44 HG13 ' H ' ' A' ' 62' ' ' LYS . 6.4 tt -89.64 173.76 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-O 123.767 1.746 . . . . 0.0 111.747 -179.095 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.44 ' H ' HG13 ' A' ' 61' ' ' ILE . 63.2 pttt -160.45 151.86 19.44 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 109.849 -3.341 . . . . 0.0 112.213 179.114 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 t -88.68 58.95 4.88 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.932 1.293 . . . . 0.0 110.126 -179.348 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 169.05 34.37 0.02 OUTLIER Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.177 -0.791 . . . . 0.0 112.858 179.182 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.97 176.63 17.2 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 118.014 0.907 . . . . 0.0 112.807 179.111 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.6 t -95.35 144.9 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.345 1.858 . . . . 0.0 107.932 179.333 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.6 p90 56.92 -172.95 0.08 Allowed 'General case' 0 C--N 1.345 0.401 0 C-N-CA 126.76 2.024 . . . . 0.0 113.118 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.8 t -137.34 166.79 22.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.707 1.203 . . . . 0.0 110.696 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.89 133.71 8.93 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.048 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.2 -64.52 4.18 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.36 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.5 p -164.6 168.26 9.19 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.618 1.167 . . . . 0.0 109.489 -179.18 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -58.57 -170.52 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.131 3.221 . . . . 0.0 112.521 167.251 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.0 -55.37 0.07 OUTLIER Glycine 0 C--N 1.341 0.856 0 N-CA-C 105.276 -3.129 . . . . 0.0 105.276 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.447 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -165.03 -63.52 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.637 0.775 . . . . 0.0 110.472 179.348 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -70.72 126.01 28.42 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.038 1.735 . . . . 0.0 113.961 -178.593 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -145.28 126.35 14.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.18 0.992 . . . . 0.0 111.747 -179.714 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.9 m -91.69 147.69 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 176.672 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.3 t -136.08 115.9 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -177.674 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.5 pt -89.92 -178.89 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.652 0 C-N-CA 124.506 1.123 . . . . 0.0 112.892 -178.497 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -124.49 58.34 1.22 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 124.678 2.18 . . . . 0.0 112.549 -177.805 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.258 5.9 t 46.58 -21.31 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.245 1 C-N-CA 134.571 5.148 . . . . 0.0 121.707 177.499 . . . . . . . . 3 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -79.47 -74.16 0.31 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 178.786 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.47 -13.74 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.627 1.971 . . . . 0.0 114.078 -179.207 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -79.47 125.53 29.67 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.777 1.231 . . . . 0.0 113.795 -176.385 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -68.46 115.9 8.39 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.643 2.377 . . . . 0.0 109.453 178.932 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.26 -60.68 2.23 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 124.741 1.216 . . . . 0.0 111.239 -178.682 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.57 156.77 28.93 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.375 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.99 137.27 52.26 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.1 0.96 . . . . 0.0 109.273 -179.252 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.3 pt -125.43 156.77 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.3 1.44 . . . . 0.0 107.824 -179.455 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -158.85 150.05 20.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.752 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 33.2 m170 -79.03 -21.57 46.69 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 123.423 0.452 . . . . 0.0 111.251 176.093 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.3 m -59.65 109.03 0.82 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.032 1.333 . . . . 0.0 109.91 179.287 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.78 -29.49 8.9 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.762 1.172 . . . . 0.0 111.329 -179.236 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.4 -176.45 2.69 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.667 1.187 . . . . 0.0 111.95 -179.294 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -83.65 54.98 3.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.686 1.194 . . . . 0.0 111.614 -179.416 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.69 -74.47 1.55 Allowed Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.606 1.098 . . . . 0.0 113.055 178.634 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -80.05 -44.77 19.51 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.863 1.265 . . . . 0.0 111.03 -179.313 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -51.52 166.58 0.12 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.835 1.654 . . . . 0.0 113.459 -178.652 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -121.3 156.65 32.08 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.339 1.456 . . . . 0.0 112.308 -178.728 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.5 m -144.56 164.67 13.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 126.844 2.058 . . . . 0.0 107.139 177.671 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.75 138.76 14.54 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 123.679 0.657 . . . . 0.0 112.082 -178.261 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 34.0 m -82.24 -171.39 3.4 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.498 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.1 t -75.83 123.08 25.06 Favored 'General case' 0 C--N 1.341 0.197 0 O-C-N 121.833 -0.542 . . . . 0.0 109.611 -179.026 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.62 52.15 3.25 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -178.755 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.8 m -147.41 121.39 9.4 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.614 1.566 . . . . 0.0 106.833 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.7 t30 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 125.307 1.443 . . . . 0.0 110.685 -179.247 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 121.066 0.46 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -153.85 176.05 12.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.049 1.34 . . . . 0.0 109.057 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.81 148.17 25.99 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.228 1.011 . . . . 0.0 109.857 179.188 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 t -150.18 156.27 41.29 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.793 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.66 128.5 42.72 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.249 1.82 . . . . 0.0 106.186 178.754 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -116.72 90.08 3.25 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.46 -86.4 1.03 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -178.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.1 m -127.77 -16.05 4.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.642 1.577 . . . . 0.0 111.364 178.759 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -81.55 98.55 8.36 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.182 0.993 . . . . 0.0 109.627 -179.164 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -80.08 155.8 27.37 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.112 0.965 . . . . 0.0 110.685 179.449 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -147.06 141.45 26.37 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.924 1.29 . . . . 0.0 110.782 179.294 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 p -78.21 148.38 34.02 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 177.815 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.61 -23.37 16.75 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.182 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.0 t -67.63 -44.52 77.77 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.54 0.736 . . . . 0.0 109.603 179.451 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -69.6 -41.03 76.27 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -178.925 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.431 HG23 ' H ' ' A' ' 16' ' ' VAL . 2.2 t -61.75 -54.59 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -179.449 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.8 mtp85 -66.78 -34.92 78.88 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.795 1.238 . . . . 0.0 112.225 -178.953 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.79 -44.34 86.03 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 118.768 0.713 . . . . 0.0 109.737 179.366 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.19 80.48 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.08 0.552 . . . . 0.0 110.155 178.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.26 -40.46 62.33 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 119.109 -0.472 . . . . 0.0 112.252 178.86 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -66.01 -21.05 66.37 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.653 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.39 1.68 Allowed 'General case' 0 C--N 1.344 0.363 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -46.4 -44.22 16.97 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 124.376 1.047 . . . . 0.0 110.83 176.884 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.7 t -55.02 -51.17 67.1 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.045 1.738 . . . . 0.0 111.361 179.243 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -63.99 -48.41 76.49 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.629 0.65 . . . . 0.0 112.012 -178.848 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -68.84 -32.58 72.37 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -63.75 -39.05 93.33 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.443 0.565 . . . . 0.0 111.626 -178.061 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.82 -49.18 4.44 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -178.992 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -75.46 -45.58 37.69 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -176.444 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -158.36 94.05 1.26 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.593 0.633 . . . . 0.0 110.609 -178.014 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.37 104.95 2.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.43 179.352 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.257 5.0 t 165.0 83.26 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.691 2.796 . . . . 0.0 110.812 -179.218 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -177.69 103.6 0.05 OUTLIER 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.493 1.517 . . . . 0.0 107.423 179.12 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 153.19 -179.24 29.75 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.1 m -50.41 -52.04 41.15 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.954 1.301 . . . . 0.0 112.117 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.3 t -165.22 -61.56 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.856 0.862 . . . . 0.0 108.742 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -126.94 75.97 1.61 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.024 1.33 . . . . 0.0 108.309 -179.514 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 86.3 m-85 -157.68 111.15 1.81 Allowed Pre-proline 0 C--O 1.23 0.053 0 N-CA-C 102.524 -3.139 . . . . 0.0 102.524 179.073 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.98 142.18 63.64 Favored 'Cis proline' 0 CA--C 1.536 0.611 0 N-CA-C 116.37 1.642 . . . . 0.0 116.37 2.867 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -157.77 152.92 25.73 Favored 'General case' 0 C--N 1.345 0.37 0 C-N-CA 127.238 2.215 . . . . 0.0 109.895 178.238 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 p -41.73 138.89 1.32 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 126.307 1.843 . . . . 0.0 114.233 -178.957 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -138.97 59.04 1.63 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.332 1.453 . . . . 0.0 108.399 179.308 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -154.62 2.02 0.21 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.919 0.888 . . . . 0.0 112.882 -179.158 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -63.99 -52.43 59.67 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.543 0.737 . . . . 0.0 110.188 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -109.83 127.55 54.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.041 1.337 . . . . 0.0 108.317 178.871 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -85.89 164.34 17.53 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.834 0.854 . . . . 0.0 109.704 179.408 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.38 -77.88 0.36 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 107.052 -2.419 . . . . 0.0 107.052 -179.231 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.99 89.46 8.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.751 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -147.39 143.08 27.7 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.482 1.513 . . . . 0.0 108.26 179.501 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -95.44 154.16 39.4 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 125.073 1.349 . . . . 0.0 109.989 -178.63 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.83 81.81 2.09 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.37 3.38 . . . . 0.0 111.425 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.4 169.7 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 125.927 1.691 . . . . 0.0 108.559 179.459 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -92.34 121.17 33.57 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.966 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.42 -177.45 51.91 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.651 0.643 . . . . 0.0 112.961 -179.041 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.99 161.35 87.03 Favored 'Cis proline' 0 CA--C 1.534 0.502 0 CA-C-N 117.536 0.668 . . . . 0.0 113.789 0.139 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.47 153.86 50.93 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 126.332 1.853 . . . . 0.0 106.746 178.788 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.74 153.35 47.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 123.703 0.627 . . . . 0.0 111.536 -178.754 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -84.48 163.81 19.2 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.125 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -160.4 110.1 1.36 Allowed Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 178.396 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 23.0 Cg_endo -80.35 125.95 5.96 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.906 1.737 . . . . 0.0 114.989 -175.831 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.425 HG13 ' H ' ' A' ' 62' ' ' LYS . 9.3 tt -87.79 159.1 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-O 124.45 2.071 . . . . 0.0 112.668 179.014 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.425 ' H ' HG13 ' A' ' 61' ' ' ILE . 3.1 mptp? -135.62 135.88 40.56 Favored 'General case' 0 C--N 1.316 -0.868 1 CA-C-N 107.974 -4.194 . . . . 0.0 109.486 -177.991 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t -87.52 59.82 5.68 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.094 1.358 . . . . 0.0 109.993 -179.179 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.36 50.41 0.03 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.251 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.0 153.32 26.32 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.621 1.105 . . . . 0.0 110.378 -179.173 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.5 p -74.3 115.47 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.276 1.03 . . . . 0.0 110.868 -179.104 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.0 t80 53.15 76.95 0.18 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 125.535 1.534 . . . . 0.0 110.677 -179.26 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.0 p -138.73 64.02 1.5 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.468 1.107 . . . . 0.0 110.515 -178.937 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.11 -86.91 0.89 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.96 0.79 . . . . 0.0 111.97 178.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.83 -93.58 0.4 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.458 1.028 . . . . 0.0 110.613 -179.072 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.8 t 74.48 133.1 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 127.066 2.146 . . . . 0.0 111.593 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -67.72 -51.71 0.16 OUTLIER 'Cis proline' 0 C--N 1.348 0.532 0 CA-C-N 119.731 0.94 . . . . 0.0 112.042 -5.198 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.96 61.27 0.19 Allowed Glycine 0 C--N 1.341 0.856 0 C-N-CA 124.517 1.056 . . . . 0.0 111.594 179.379 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -79.06 -41.86 27.79 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.559 0.743 . . . . 0.0 109.05 178.441 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -70.3 111.49 5.93 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.085 1.754 . . . . 0.0 112.426 -178.776 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.05 128.88 46.99 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.959 0.903 . . . . 0.0 113.048 -178.662 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.0 m -100.34 148.36 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 102.595 -3.113 . . . . 0.0 102.595 176.04 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.5 t -140.13 135.96 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 O-C-N 121.873 -0.517 . . . . 0.0 109.651 -176.83 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.5 pt -126.46 165.55 24.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.308 0 C-N-CA 124.107 0.963 . . . . 0.0 111.865 -178.683 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -81.35 165.97 20.88 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 127.268 2.227 . . . . 0.0 108.186 178.924 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.356 12.2 t -64.77 -19.71 65.96 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 118.634 2.827 . . . . 0.0 118.634 -178.128 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -79.59 -85.54 0.08 Allowed 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 101.067 -3.679 . . . . 0.0 101.067 176.924 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 98.3 m -164.57 8.14 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 130.438 3.495 . . . . 0.0 112.832 -178.703 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -78.86 134.65 36.92 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 120.171 1.351 . . . . 0.0 111.798 -176.261 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.422 ' CE2' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -70.84 120.18 16.05 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.873 0.469 . . . . 0.0 110.09 -178.952 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.64 -48.95 7.86 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.178 0.991 . . . . 0.0 110.175 -179.082 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.12 -179.48 46.36 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-O 121.16 0.311 . . . . 0.0 112.686 179.031 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.0 135.24 45.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.842 2.057 . . . . 0.0 107.771 179.84 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.4 pt -146.61 171.67 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.785 1.234 . . . . 0.0 110.553 -178.392 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.5 t -160.06 151.77 20.03 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 179.349 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.445 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 9.0 m170 -79.28 -13.12 59.86 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 175.188 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.4 m -60.92 109.17 0.99 Allowed 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.003 1.321 . . . . 0.0 110.295 -179.333 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.5 59.46 5.27 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.407 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.52 -124.65 0.22 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.709 1.204 . . . . 0.0 108.558 179.467 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.5 m -149.16 73.17 1.19 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.793 1.237 . . . . 0.0 107.95 179.285 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.72 -104.86 1.61 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 179.587 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -79.8 -22.72 42.75 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.114 0.966 . . . . 0.0 111.18 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -56.16 159.07 3.62 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.577 1.151 . . . . 0.0 111.35 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -114.74 163.51 15.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.96 1.704 . . . . 0.0 111.854 -178.777 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.4 m -141.07 160.85 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 C-N-CA 126.228 1.811 . . . . 0.0 107.092 176.992 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.02 141.2 20.65 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 123.838 0.732 . . . . 0.0 114.158 -178.092 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -83.35 179.73 7.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 177.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.9 m -70.31 131.04 43.54 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.205 -0.935 . . . . 0.0 110.598 179.566 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.17 15.72 80.98 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.032 0.825 . . . . 0.0 113.712 179.322 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.3 m -80.01 131.71 35.85 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.323 1.061 . . . . 0.0 108.695 179.306 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 p30 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.816 -1.088 . . . . 0.0 110.558 -179.309 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.9 m -135.37 62.87 1.62 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.32 1.048 . . . . 0.0 109.446 -179.346 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.31 154.35 0.13 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 126.831 2.052 . . . . 0.0 112.52 179.015 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.4 t -152.81 123.43 7.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.573 179.066 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -96.79 109.74 22.36 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 178.901 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.8 m -87.7 63.21 7.41 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.468 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.55 -91.54 0.4 Allowed Glycine 0 C--N 1.342 0.886 0 C-N-CA 126.03 1.776 . . . . 0.0 109.08 -178.761 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.3 p -92.82 -47.98 6.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.396 1.079 . . . . 0.0 109.817 179.13 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.2 m -66.83 100.01 0.67 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.488 1.515 . . . . 0.0 108.168 179.388 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -88.4 148.2 24.35 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.12 0.568 . . . . 0.0 111.978 -178.783 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -136.44 135.74 38.93 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 123.996 0.918 . . . . 0.0 111.249 178.606 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.7 m -82.46 150.34 27.1 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 126.571 1.948 . . . . 0.0 108.647 178.62 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.61 -21.86 29.95 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.137 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 84.2 p -72.96 -46.71 50.82 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.565 0.746 . . . . 0.0 109.529 179.455 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -69.08 -38.72 79.17 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.761 1.224 . . . . 0.0 111.418 -179.307 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.3 t -57.98 -53.19 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.836 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -33.37 75.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.67 1.588 . . . . 0.0 112.032 -179.336 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.11 -57.63 8.11 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.018 0.527 . . . . 0.0 109.725 -178.678 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.84 -26.75 67.8 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 123.538 0.523 . . . . 0.0 110.953 -179.295 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.01 -54.03 12.67 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.867 0.758 . . . . 0.0 111.035 179.248 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -61.2 -19.91 62.16 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.191 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.73 -67.95 0.62 Allowed 'General case' 0 C--N 1.349 0.574 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 -178.085 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.48 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -39.54 -46.07 1.68 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.625 1.17 . . . . 0.0 112.19 176.532 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 74.4 m -55.28 -68.49 0.19 Allowed 'General case' 0 C--N 1.346 0.417 0 C-N-CA 123.379 0.672 . . . . 0.0 110.342 179.366 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -53.81 -31.09 47.79 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.833 1.253 . . . . 0.0 112.928 -176.934 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -79.49 -48.0 14.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -179.066 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.37 0.1 OUTLIER -91.85 -2.58 56.79 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 119.381 3.104 . . . . 0.0 119.381 -176.539 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -57.04 -52.48 65.12 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.011 1.278 . . . . 0.0 109.382 178.975 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 152.03 66.14 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 130.438 3.495 . . . . 0.0 105.561 179.553 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -165.32 98.38 0.71 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.551 1.14 . . . . 0.0 107.984 -178.915 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.266 4.4 p30 52.27 -165.92 0.06 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.236 1.815 . . . . 0.0 111.982 -179.203 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.1 t -152.57 -49.12 0.1 Allowed 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.646 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 55.82 84.07 0.08 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 125.063 1.345 . . . . 0.0 109.396 -178.238 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.23 162.48 6.03 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.24 1.4 . . . . 0.0 111.849 -178.856 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.1 p -176.98 102.84 0.05 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.979 1.311 . . . . 0.0 108.915 -179.231 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.8 m -68.64 -67.46 0.47 Allowed 'General case' 0 C--N 1.34 0.167 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.895 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.6 p -147.45 18.91 1.19 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.468 1.907 . . . . 0.0 108.502 178.008 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -144.34 154.95 57.73 Favored Pre-proline 0 C--N 1.348 0.528 0 C-N-CA 129.798 3.239 . . . . 0.0 105.95 -178.297 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -80.38 111.41 2.24 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 CA-C-N 120.932 1.369 . . . . 0.0 113.58 3.855 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -122.27 158.86 28.58 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.426 1.491 . . . . 0.0 108.441 179.114 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -63.26 154.84 30.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.701 1.6 . . . . 0.0 108.617 178.755 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -77.97 119.78 21.9 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.296 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.27 145.91 10.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.937 2.095 . . . . 0.0 114.2 -178.152 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -73.44 148.17 43.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.381 1.472 . . . . 0.0 110.1 179.495 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.7 t80 74.22 146.15 0.08 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.764 2.025 . . . . 0.0 110.972 179.411 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 58.35 53.0 6.7 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.568 1.147 . . . . 0.0 108.933 -178.599 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.23 106.84 2.03 Favored Glycine 0 C--N 1.339 0.729 0 C-N-CA 124.751 1.167 . . . . 0.0 112.324 -178.698 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -73.31 106.99 5.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 178.494 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -53.88 120.99 7.05 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.069 1.347 . . . . 0.0 113.109 -178.4 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -132.75 151.96 79.03 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.351 1.861 . . . . 0.0 108.217 179.081 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.57 166.98 28.3 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.505 2.803 . . . . 0.0 112.464 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.273 22.9 m 55.03 171.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 129.03 2.932 . . . . 0.0 115.445 179.321 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -81.2 153.59 27.11 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.971 1.308 . . . . 0.0 111.999 -178.847 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.77 -147.73 23.1 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.527 1.537 . . . . 0.0 110.251 179.202 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.39 133.21 17.27 Favored 'Cis proline' 0 N--CA 1.458 -0.605 0 CA-C-N 118.847 1.324 . . . . 0.0 110.031 -1.782 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -108.62 140.53 41.87 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.935 0.894 . . . . 0.0 111.847 179.343 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -122.91 159.17 28.79 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.051 1.741 . . . . 0.0 109.613 -179.027 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -87.7 159.59 18.44 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.561 1.544 . . . . 0.0 111.928 -178.553 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.48 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 18.4 t80 -160.41 109.74 1.36 Allowed Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.267 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -79.11 129.65 8.93 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 121.88 1.72 . . . . 0.0 111.151 -177.178 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.549 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.2 tt -87.71 -176.83 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-O 123.796 1.76 . . . . 0.0 110.237 179.096 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.549 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -152.52 141.24 20.94 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 110.07 -3.241 . . . . 0.0 111.623 -179.095 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 t -81.41 57.73 3.38 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.948 1.699 . . . . 0.0 109.942 179.647 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.21 45.54 0.08 OUTLIER Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.282 1.42 . . . . 0.0 112.008 179.059 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.76 176.36 26.08 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 117.884 0.842 . . . . 0.0 112.782 179.052 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 t -132.15 139.06 51.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.322 1.449 . . . . 0.0 108.278 178.961 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.263 26.4 p90 46.42 52.51 10.68 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.351 2.261 . . . . 0.0 114.487 179.473 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.9 p -80.49 -44.34 19.34 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.837 -0.539 . . . . 0.0 110.184 179.06 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.2 56.77 1.44 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.09 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -117.33 73.44 0.28 Allowed Glycine 0 C--N 1.34 0.793 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.485 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 92.0 p -71.17 152.16 94.6 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 124.082 0.953 . . . . 0.0 110.717 -179.938 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.98 -43.17 0.69 Allowed 'Cis proline' 0 N--CA 1.457 -0.672 0 CA-C-N 119.196 0.748 . . . . 0.0 110.904 -4.129 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.87 -54.61 3.7 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 179.187 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . 64.3 43.97 4.52 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.632 1.173 . . . . 0.0 110.312 -178.678 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.83 101.19 1.29 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.641 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.28 148.56 50.82 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.251 0.621 . . . . 0.0 111.398 -179.032 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.1 m -111.26 144.32 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 176.909 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.17 121.83 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 -177.673 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.478 HG22 ' HA ' ' A' ' 85' ' ' TYR . 3.2 pt -127.12 167.84 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.615 -176.517 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -94.31 166.99 11.82 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 123.996 0.918 . . . . 0.0 110.809 -179.641 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.432 1.9 t -73.29 8.51 1.67 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 121.396 3.851 . . . . 0.0 121.396 -177.07 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -91.05 -94.88 0.12 Allowed 'General case' 0 N--CA 1.437 -1.101 1 N-CA-C 93.486 -6.487 . . . . 0.0 93.486 174.859 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . 0.353 9.8 t -165.93 54.29 0.1 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 127.634 2.374 . . . . 0.0 111.44 176.955 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -136.06 127.64 28.82 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 120.186 1.357 . . . . 0.0 112.957 -178.063 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.478 ' HA ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -69.2 121.61 17.14 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 127.264 2.226 . . . . 0.0 108.138 179.055 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.63 -54.55 2.6 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 123.552 0.741 . . . . 0.0 111.774 -178.605 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -119.15 155.32 16.11 Favored Glycine 0 C--N 1.341 0.853 0 C-N-CA 124.428 1.014 . . . . 0.0 113.907 -178.72 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.91 102.07 3.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 178.539 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.9 pt -112.75 157.05 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.903 0.881 . . . . 0.0 111.633 -178.293 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.2 t -155.89 155.32 32.67 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.083 1.353 . . . . 0.0 112.197 -178.368 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.501 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 38.6 m170 -80.34 3.78 20.01 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 119.156 -0.45 . . . . 0.0 110.954 177.208 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -43.64 -39.59 3.65 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -177.671 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.46 44.44 1.22 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.573 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -110.83 155.16 22.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.315 1.446 . . . . 0.0 110.924 -179.769 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.8 t -89.84 61.29 5.3 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.536 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.9 -86.93 0.96 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.659 1.123 . . . . 0.0 112.381 179.028 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -96.91 -6.17 36.35 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -178.073 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -69.26 -173.44 0.54 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.191 0.905 . . . . 0.0 110.592 -179.401 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -147.0 153.89 40.59 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.182 0.593 . . . . 0.0 111.379 -178.911 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.1 m -142.55 163.66 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 126.483 1.913 . . . . 0.0 107.57 178.129 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.85 152.35 28.54 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.701 0.667 . . . . 0.0 114.056 -177.928 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 51.8 m -87.71 -168.27 2.17 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.92 1.288 . . . . 0.0 108.331 178.191 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.2 t -68.35 112.92 5.51 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.036 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.58 50.21 4.31 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.258 0.932 . . . . 0.0 110.802 -179.201 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.4 m -147.9 97.75 2.85 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.06 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 116.585 -1.674 . . . . 0.0 108.833 -179.385 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.1 t -160.45 98.23 1.25 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.134 0.974 . . . . 0.0 109.705 -179.015 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 54.69 81.13 0.11 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 125.533 1.533 . . . . 0.0 109.29 -179.405 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.405 HG22 ' CG2' ' A' ' 16' ' ' VAL . 7.5 t -105.35 138.12 42.05 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.362 0.665 . . . . 0.0 111.977 -177.37 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.94 125.34 52.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.292 1.837 . . . . 0.0 109.773 179.405 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -105.87 71.27 0.89 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 178.841 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.17 -80.73 1.49 Allowed Glycine 0 C--N 1.342 0.889 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 -178.868 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.1 t -123.64 -30.49 3.6 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.975 1.71 . . . . 0.0 110.757 178.943 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 m -70.36 92.0 0.78 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.126 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -89.15 145.06 25.68 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.477 1.511 . . . . 0.0 114.074 -177.819 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -141.48 134.93 29.71 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.243 1.417 . . . . 0.0 111.682 178.376 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.6 m -72.32 156.57 38.96 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 126.057 1.743 . . . . 0.0 108.618 177.677 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.21 -22.88 44.01 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.029 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 98.3 p -76.45 -34.45 58.72 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.916 -179.143 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -75.55 -38.21 59.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.418 1.487 . . . . 0.0 111.617 -179.526 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.405 ' CG2' HG22 ' A' ' 4' ' ' THR . 43.1 t -63.42 -47.99 89.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.264 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -64.15 -32.1 73.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.7 1.6 . . . . 0.0 111.532 179.094 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.34 -56.65 7.8 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.078 0.551 . . . . 0.0 109.888 -179.081 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.5 -27.86 68.11 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 123.105 0.253 . . . . 0.0 110.551 179.656 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.34 -44.68 67.7 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.299 -0.876 . . . . 0.0 110.088 178.586 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -68.83 -17.51 64.02 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.338 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.32 -69.24 0.57 Allowed 'General case' 0 C--N 1.346 0.424 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 -178.387 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.511 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -38.1 -58.13 0.99 Allowed 'General case' 0 CA--C 1.537 0.463 0 O-C-N 124.527 1.142 . . . . 0.0 112.438 175.93 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.5 t -56.23 -40.9 74.81 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 123.835 0.854 . . . . 0.0 112.668 -178.952 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -87.24 -2.96 59.0 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 179.442 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -117.26 -63.15 1.48 Allowed 'General case' 0 C--N 1.347 0.5 0 CA-C-N 120.163 1.347 . . . . 0.0 114.097 -178.616 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -49.98 -42.2 48.41 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.894 1.278 . . . . 0.0 111.99 -177.036 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -103.85 14.11 31.51 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -177.997 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -154.51 62.95 0.68 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.176 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 63.24 91.03 0.07 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.174 1.79 . . . . 0.0 109.206 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -57.06 112.69 1.42 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.556 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.9 t -97.65 -34.63 10.87 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.348 1.459 . . . . 0.0 107.593 178.284 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.53 97.9 7.36 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.512 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -142.49 52.07 0.66 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.359 0.98 . . . . 0.0 111.155 -179.088 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 m -71.95 -53.06 14.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.501 0.72 . . . . 0.0 109.789 178.882 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.5 m -111.38 -162.07 0.78 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.037 1.335 . . . . 0.0 107.98 -179.063 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.4 t -83.08 49.9 1.63 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.98 0.912 . . . . 0.0 109.747 179.145 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -140.79 142.82 29.68 Favored Pre-proline 0 C--N 1.342 0.257 0 C-N-CA 126.311 1.845 . . . . 0.0 106.638 -179.026 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -69.6 145.68 79.73 Favored 'Cis proline' 0 CA--C 1.535 0.56 0 N-CA-C 115.053 1.136 . . . . 0.0 115.053 2.917 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.57 140.2 49.39 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -177.514 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.3 m -57.12 120.07 7.41 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 127.359 2.263 . . . . 0.0 110.564 178.983 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -79.43 99.56 7.25 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.656 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -140.53 61.83 1.5 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.215 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -105.63 -178.67 3.72 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.231 1.412 . . . . 0.0 109.183 -179.584 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -67.78 102.92 1.31 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.954 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.3 144.21 42.07 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.575 0.75 . . . . 0.0 111.501 -179.102 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.68 68.28 0.16 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 107.849 -2.101 . . . . 0.0 107.849 -178.938 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -162.65 173.01 14.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.51 1.124 . . . . 0.0 109.331 -179.627 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -59.93 162.85 5.11 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.591 1.156 . . . . 0.0 111.171 178.904 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 49.4 p90 44.65 53.7 11.63 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 126.239 1.816 . . . . 0.0 113.134 -179.345 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.75 -47.74 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.606 2.204 . . . . 0.0 110.834 -179.239 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.4 t 57.58 -100.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.768 1.627 . . . . 0.0 109.995 -179.577 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 p30 178.8 -45.61 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.437 1.895 . . . . 0.0 108.952 -179.382 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.89 -158.83 41.2 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.781 0.705 . . . . 0.0 112.362 179.199 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.01 130.35 1.67 Allowed 'Cis proline' 0 N--CA 1.46 -0.472 0 CA-C-N 118.372 1.086 . . . . 0.0 113.423 1.549 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -134.25 141.93 47.16 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.834 0.854 . . . . 0.0 109.412 179.391 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -132.07 164.94 25.13 Favored 'General case' 0 C--N 1.344 0.359 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -177.372 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -79.86 153.25 29.19 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.934 2.093 . . . . 0.0 112.059 -178.942 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.511 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 52.5 t80 -160.39 106.43 1.36 Allowed Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 178.731 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -67.71 141.96 56.46 Favored 'Trans proline' 0 N--CA 1.441 -1.584 0 CA-C-N 120.302 1.144 . . . . 0.0 110.676 -176.81 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.42 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -90.03 -145.21 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-O 122.972 1.368 . . . . 0.0 111.972 -177.607 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.42 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 36.0 ttpt -79.77 149.51 31.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.381 -179.022 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.0 t 170.09 48.28 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.455 1 C-N-CA 132.088 4.155 . . . . 0.0 103.641 178.482 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.58 -46.26 1.07 Allowed Glycine 0 CA--C 1.534 1.229 0 N-CA-C 105.984 -2.846 . . . . 0.0 105.984 -177.45 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.4 165.22 25.43 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.433 1.016 . . . . 0.0 111.742 178.68 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.59 131.31 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.514 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.9 t80 57.2 83.34 0.11 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.703 1.201 . . . . 0.0 110.845 -179.381 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.5 p -131.54 -48.61 0.98 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.465 1.106 . . . . 0.0 111.753 -179.076 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.56 51.78 3.18 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -178.782 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.16 47.69 0.07 OUTLIER Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.533 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.5 t -69.52 -59.58 4.68 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.376 1.07 . . . . 0.0 111.252 179.567 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -82.32 -26.18 9.15 Favored 'Cis proline' 0 C--N 1.347 0.483 0 CA-C-N 121.573 1.597 . . . . 0.0 112.246 -6.2 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.29 -160.49 22.56 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.562 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.758 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . 69.21 21.71 7.03 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 126.349 1.86 . . . . 0.0 112.331 -178.912 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.4 91.69 0.61 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.986 1.314 . . . . 0.0 107.926 179.099 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.8 mtt85 -138.3 134.05 33.83 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.334 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 m -93.74 153.05 3.43 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 177.065 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.96 120.11 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -178.867 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -110.48 174.04 2.05 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 C-N-CA 125.015 1.326 . . . . 0.0 114.073 -177.645 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -100.55 154.62 18.41 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.755 2.422 . . . . 0.0 108.544 179.054 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.283 3.3 t -71.92 0.93 8.0 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -178.599 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -86.0 -83.22 0.18 Allowed 'General case' 0 N--CA 1.441 -0.888 1 N-CA-C 100.115 -4.031 . . . . 0.0 100.115 177.07 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.7 t -165.08 -4.29 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.295 2.238 . . . . 0.0 114.157 177.619 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -79.35 130.59 35.59 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -175.098 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -78.64 117.89 20.23 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.82 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.59 -59.73 2.63 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.344 0.658 . . . . 0.0 111.862 -177.557 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.45 156.83 17.82 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 179.61 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.49 155.27 18.38 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.588 1.155 . . . . 0.0 111.748 -179.249 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.5 pt -136.62 165.3 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 125.241 1.416 . . . . 0.0 110.802 179.28 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.1 t -159.32 144.84 16.0 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.666 0.786 . . . . 0.0 112.787 -178.774 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.758 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -82.42 -37.24 25.78 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.618 0.767 . . . . 0.0 111.073 177.892 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 m -49.97 -55.97 12.5 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.479 1.512 . . . . 0.0 112.367 -178.756 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -63.47 -27.0 70.15 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.108 0.861 . . . . 0.0 112.637 -179.58 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.39 178.76 6.91 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.288 1.035 . . . . 0.0 112.579 -178.925 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.9 m -65.59 -45.89 81.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.512 1.125 . . . . 0.0 110.54 179.07 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.05 -80.62 0.06 OUTLIER Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.466 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -79.53 -17.83 53.19 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.182 0.993 . . . . 0.0 112.039 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -79.74 163.85 24.16 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.326 0.65 . . . . 0.0 110.263 179.298 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.05 113.35 19.42 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.63 1.572 . . . . 0.0 107.671 179.209 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.4 m -97.47 161.55 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.436 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.88 155.65 51.07 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.395 -179.063 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.25 -173.31 4.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.342 1.457 . . . . 0.0 109.008 178.924 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.2 t -68.02 133.67 49.41 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.825 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.66 23.2 73.42 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -178.775 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.3 m -144.05 93.87 2.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.065 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 116.747 -1.597 . . . . 0.0 109.688 -178.658 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.408 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -79.84 169.94 17.2 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.804 1.242 . . . . 0.0 111.858 -178.839 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.37 152.86 0.57 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 126.612 1.965 . . . . 0.0 113.028 179.296 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.66 94.37 3.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.076 1.35 . . . . 0.0 110.571 -178.517 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 5' ' ' THR . 1.1 m -99.58 94.53 6.44 Favored 'General case' 0 N--CA 1.437 -1.099 1 N-CA-C 100.179 -4.008 . . . . 0.0 100.179 177.808 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.0 m -96.19 75.48 3.0 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.246 -177.696 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.0 -97.42 1.64 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 -178.804 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.3 t -114.76 -31.71 6.06 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.442 1.497 . . . . 0.0 109.253 178.479 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.1 m -77.06 95.53 4.22 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 102.059 -3.312 . . . . 0.0 102.059 178.051 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -114.28 152.24 31.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.552 1.141 . . . . 0.0 113.098 -176.425 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -143.76 165.78 26.71 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 125.041 1.336 . . . . 0.0 111.229 -179.214 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.3 m -85.97 156.94 20.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.334 1.453 . . . . 0.0 110.652 178.88 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.95 -20.78 40.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.915 -1.493 . . . . 0.0 107.164 176.875 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -68.77 -46.01 69.88 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.538 1.135 . . . . 0.0 109.939 179.379 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -43.38 93.21 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 123.135 0.574 . . . . 0.0 111.4 179.195 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.0 t -61.25 -46.07 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 123.013 0.525 . . . . 0.0 109.754 178.776 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 ttp-105 -62.76 -43.8 97.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.587 0.755 . . . . 0.0 110.177 -179.217 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.55 -45.41 87.25 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.546 0.738 . . . . 0.0 110.772 179.122 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.98 -33.22 75.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.46 1.104 . . . . 0.0 110.753 179.329 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.84 -37.71 47.8 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.964 0.505 . . . . 0.0 110.456 178.881 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -68.22 -20.64 64.84 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.229 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.25 -61.38 1.97 Allowed 'General case' 0 C--N 1.346 0.449 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 -178.807 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -41.13 -52.05 3.33 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.336 1.054 . . . . 0.0 111.46 176.663 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 46.4 t -61.97 -39.77 93.31 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.693 1.597 . . . . 0.0 111.04 179.017 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -88.01 7.08 32.95 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.768 1.227 . . . . 0.0 113.527 179.015 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -129.73 -10.87 4.43 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.455 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -115.18 -27.28 7.34 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -179.059 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.95 -14.86 11.25 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.828 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -78.86 17.82 0.68 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.503 1.047 . . . . 0.0 113.616 -176.952 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.5 t70 86.51 40.22 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 127.941 2.496 . . . . 0.0 109.166 178.9 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -151.7 148.99 28.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.827 2.051 . . . . 0.0 106.232 179.269 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 t -166.24 77.99 0.24 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.127 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.19 96.04 0.1 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.182 0.993 . . . . 0.0 110.552 -179.228 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.94 58.87 4.58 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 125.226 1.393 . . . . 0.0 110.197 -179.265 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.4 t -72.78 -73.27 0.21 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.706 0.802 . . . . 0.0 110.147 -179.011 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 m -176.49 -49.63 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 127.441 2.297 . . . . 0.0 106.671 -178.584 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.0 t -79.95 25.04 0.38 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.485 1.914 . . . . 0.0 113.939 -178.844 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 74.49 163.69 0.14 Allowed Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 119.279 0.945 . . . . 0.0 109.839 178.414 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.25 117.94 3.5 Favored 'Cis proline' 0 N--CA 1.454 -0.838 0 N-CA-C 115.166 1.179 . . . . 0.0 115.166 2.65 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -125.71 150.86 47.32 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 127.223 2.209 . . . . 0.0 106.937 178.912 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 m -80.99 132.19 35.36 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.564 1.146 . . . . 0.0 109.777 -179.972 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -88.53 149.55 23.56 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.48 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -153.03 134.3 14.24 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.024 0.53 . . . . 0.0 110.494 -179.273 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 64.43 121.61 0.02 OUTLIER 'General case' 0 C--N 1.343 0.293 0 C-N-CA 127.378 2.271 . . . . 0.0 112.053 179.367 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -77.16 135.38 38.53 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.268 0.627 . . . . 0.0 109.699 179.433 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -126.91 75.3 1.56 Allowed 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.188 0.995 . . . . 0.0 109.407 -178.691 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.16 50.49 51.06 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.221 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -164.83 121.76 1.55 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.857 1.263 . . . . 0.0 108.69 -178.648 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -142.68 110.43 5.85 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.373 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -144.42 49.87 1.11 Allowed Pre-proline 0 N--CA 1.439 -1.014 0 C-N-CA 129.91 3.284 . . . . 0.0 108.879 177.635 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.56 150.3 27.87 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.006 2.471 . . . . 0.0 112.031 -178.998 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.7 t -142.03 -53.19 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.862 1.665 . . . . 0.0 106.892 178.757 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -160.19 126.38 4.19 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.136 1.375 . . . . 0.0 109.002 178.727 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.85 150.95 18.43 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.881 1.229 . . . . 0.0 112.238 -178.875 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.65 173.04 29.17 Favored 'Cis proline' 0 C--N 1.35 0.655 0 CA-C-N 119.375 1.588 . . . . 0.0 113.27 -2.251 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -126.17 174.71 8.3 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.292 1.437 . . . . 0.0 108.174 -179.256 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.63 154.01 37.96 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.879 0.371 . . . . 0.0 111.658 -179.491 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.18 153.17 19.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.594 1.558 . . . . 0.0 111.683 -178.889 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -157.33 117.17 1.99 Allowed Pre-proline 0 C--N 1.342 0.273 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.288 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.7 152.14 13.16 Favored 'Trans proline' 0 N--CA 1.438 -1.769 0 C-N-CA 121.187 1.258 . . . . 0.0 114.675 -176.382 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.52 178.32 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 127.77 2.428 . . . . 0.0 105.868 178.803 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -164.77 -168.92 1.58 Allowed 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 109.586 -3.461 . . . . 0.0 108.462 -178.879 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.2 m -84.65 60.71 6.28 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 177.136 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.54 71.53 1.16 Allowed Glycine 0 CA--C 1.53 0.999 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 -178.222 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.18 89.68 0.09 OUTLIER Glycine 0 CA--C 1.53 1.01 0 CA-C-N 117.295 0.547 . . . . 0.0 111.8 -179.329 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.1 t -94.68 97.49 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.317 1.447 . . . . 0.0 108.003 179.339 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 t80 48.82 66.21 1.15 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.394 1.478 . . . . 0.0 110.693 -179.586 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.2 p -104.53 -68.82 0.83 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.792 1.237 . . . . 0.0 109.43 179.853 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.33 177.23 47.3 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 179.47 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.54 -19.59 10.82 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 118.887 -0.952 . . . . 0.0 113.378 -179.787 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 92.0 p 50.35 71.69 1.48 Allowed Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.201 1.8 . . . . 0.0 111.6 -179.604 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.89 143.28 54.55 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.181 2.587 . . . . 0.0 109.403 -178.382 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.43 48.74 0.95 Allowed Glycine 0 C--N 1.338 0.691 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.252 -178.518 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.15 21.75 0.13 Allowed 'General case' 0 C--N 1.342 0.27 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 177.784 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.26 112.64 0.13 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.708 2.803 . . . . 0.0 105.85 176.18 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.91 134.31 9.58 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.387 1.875 . . . . 0.0 109.53 -176.298 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.9 m -90.8 152.8 3.29 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 177.615 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.1 t -135.62 119.21 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -178.694 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -102.54 176.54 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.4 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -99.28 168.42 10.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 127.258 2.223 . . . . 0.0 109.16 178.847 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.306 14.7 t -82.01 50.24 1.52 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -178.414 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -147.54 -90.1 0.09 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 102.545 -3.132 . . . . 0.0 102.545 177.477 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.16 0.44 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.657 1.983 . . . . 0.0 113.007 -178.939 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -82.7 133.68 35.16 Favored 'General case' 0 C--N 1.346 0.44 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -176.773 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -78.05 112.88 15.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.592 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.0 -49.65 11.52 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.322 1.049 . . . . 0.0 111.363 -178.171 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.07 151.29 7.95 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.108 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.56 158.18 17.12 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.855 0.862 . . . . 0.0 110.159 178.97 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.0 pt -138.71 151.84 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.602 -178.918 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.1 t -147.67 165.43 30.49 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 125.301 1.441 . . . . 0.0 112.749 -178.756 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -79.01 -50.86 10.42 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.457 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 m -39.9 107.8 0.08 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 127.026 2.13 . . . . 0.0 112.631 -178.763 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.8 -43.42 1.35 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.74 1.638 . . . . 0.0 109.259 -179.153 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.95 -175.89 0.62 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.799 1.639 . . . . 0.0 112.131 179.654 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.3 p -70.88 -50.76 31.53 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.171 0.988 . . . . 0.0 111.453 -179.894 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.54 -78.9 0.04 OUTLIER Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.372 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -79.35 -34.1 42.39 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.046 0.939 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -55.82 158.63 3.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.366 1.066 . . . . 0.0 111.046 179.205 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -118.5 157.98 26.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.67 1.188 . . . . 0.0 113.175 -178.298 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.6 160.94 41.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 C-N-CA 126.428 1.891 . . . . 0.0 107.192 177.712 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.52 161.11 46.21 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.068 0.842 . . . . 0.0 114.197 -177.928 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.6 t -143.06 163.75 31.98 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 126.002 1.721 . . . . 0.0 109.147 178.825 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.0 t 53.43 51.59 15.04 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.079 1.752 . . . . 0.0 111.468 -178.577 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.66 -10.79 70.73 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.087 -0.84 . . . . 0.0 113.285 179.2 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.9 m -79.55 143.95 34.36 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.604 1.202 . . . . 0.0 108.746 -179.351 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 p30 . . . . . 0 C--O 1.251 1.182 0 CA-C-O 117.528 -1.225 . . . . 0.0 110.045 -179.271 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 120.521 0.201 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t -160.08 102.77 1.45 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.292 0.637 . . . . 0.0 109.54 179.435 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.46 75.1 0.37 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.311 1.444 . . . . 0.0 109.393 179.72 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.5 m -79.35 101.06 7.89 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.104 1.762 . . . . 0.0 109.668 -178.001 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -115.96 115.85 26.9 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.553 1.541 . . . . 0.0 106.863 -179.154 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.4 m -113.39 93.82 4.58 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.58 0.752 . . . . 0.0 109.797 -179.223 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.07 -93.8 0.43 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.438 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.3 m -133.77 41.58 3.02 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.607 1.163 . . . . 0.0 109.233 179.184 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.4 m -141.16 89.2 2.22 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 179.075 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -85.67 141.57 29.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.656 1.182 . . . . 0.0 113.657 -177.594 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -141.81 136.72 30.91 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.69 1.596 . . . . 0.0 109.816 178.74 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.5 m -65.94 158.2 28.72 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.979 1.312 . . . . 0.0 110.266 178.231 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.05 -23.17 66.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.1 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.2 t -76.73 -33.25 58.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.145 1.378 . . . . 0.0 109.966 179.259 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -74.74 -39.55 61.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.867 0.867 . . . . 0.0 109.841 -179.028 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.47 -44.6 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.499 0.72 . . . . 0.0 110.43 178.342 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.48 -38.55 90.1 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 123.304 0.642 . . . . 0.0 110.46 179.47 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.08 -46.33 74.63 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.868 0.867 . . . . 0.0 109.259 179.029 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.58 -42.14 82.55 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.961 0.904 . . . . 0.0 108.953 178.775 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.91 -20.03 50.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 179.324 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -74.52 -26.21 59.84 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.315 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.74 -49.81 10.68 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -179.445 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.14 -48.83 23.19 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 124.612 1.195 . . . . 0.0 109.661 176.233 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.5 t -68.73 -29.79 68.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.82 2.048 . . . . 0.0 113.189 -179.922 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -73.35 -63.78 1.12 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.45 1.023 . . . . 0.0 112.206 -178.611 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.351 0.1 OUTLIER -66.79 -47.01 73.45 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 -176.035 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -60.02 -28.2 67.54 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.552 1.141 . . . . 0.0 112.32 -178.722 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -82.7 -71.5 0.49 Allowed 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -178.435 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -171.19 23.28 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -178.718 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -121.28 76.72 1.26 Allowed 'General case' 0 C--N 1.339 0.128 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.803 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 111.19 133.79 0.0 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 131.355 3.862 . . . . 0.0 108.294 -178.713 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -90.96 81.58 5.66 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.004 1.321 . . . . 0.0 108.845 179.688 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.44 162.43 12.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.879 0.872 . . . . 0.0 112.387 -179.263 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -42.37 96.67 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.592 1.091 . . . . 0.0 114.947 -178.706 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.4 m 61.08 75.81 0.39 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -178.288 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 p 175.39 -43.85 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 103.471 -2.789 . . . . 0.0 103.471 -176.361 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.7 p -115.69 51.25 0.95 Allowed 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.856 2.062 . . . . 0.0 110.437 178.432 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 23.4 m-85 64.08 133.21 0.03 OUTLIER Pre-proline 0 C--N 1.355 0.83 0 C-N-CA 126.093 1.757 . . . . 0.0 110.76 176.504 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -76.39 161.58 93.57 Favored 'Cis proline' 0 N--CA 1.45 -1.035 0 CA-C-N 120.18 1.1 . . . . 0.0 109.931 3.555 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.74 147.25 37.08 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.026 1.331 . . . . 0.0 109.919 -177.788 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 t -76.31 132.1 39.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 103.46 -2.793 . . . . 0.0 103.46 177.12 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -95.6 106.1 18.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 -178.115 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -162.31 -58.07 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.567 1.147 . . . . 0.0 108.771 -179.241 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -81.39 70.65 8.3 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.559 1.144 . . . . 0.0 109.618 -179.367 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.55 -72.9 0.09 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.11 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -176.39 147.82 0.71 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.493 1.117 . . . . 0.0 109.275 179.18 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.75 150.82 49.83 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 178.93 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.17 170.56 18.16 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.104 0.562 . . . . 0.0 110.415 -179.209 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -71.6 -163.94 0.11 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.293 0.637 . . . . 0.0 111.63 -179.352 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.0 p90 54.28 58.73 12.11 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 125.889 1.676 . . . . 0.0 111.088 -178.178 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.28 66.83 8.74 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 124.016 3.144 . . . . 0.0 110.445 -179.429 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.37 -65.31 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.135 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -166.32 -165.09 0.74 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.048 1.339 . . . . 0.0 107.987 179.294 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.99 -174.88 45.98 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 121.91 -0.494 . . . . 0.0 112.879 179.103 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.2 128.37 6.42 Favored 'Cis proline' 0 N--CA 1.458 -0.568 0 O-C-N 122.526 0.75 . . . . 0.0 112.364 -0.292 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.72 150.57 25.01 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.114 0.966 . . . . 0.0 110.536 179.343 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -103.22 162.95 12.55 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.547 1.539 . . . . 0.0 112.82 -178.709 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.278 14.9 tp10 -101.3 151.82 21.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.646 2.379 . . . . 0.0 110.496 -178.783 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -160.16 107.43 1.39 Allowed Pre-proline 0 C--N 1.342 0.244 0 C-N-CA 124.567 1.147 . . . . 0.0 108.494 177.546 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -83.3 132.43 6.02 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 121.653 1.569 . . . . 0.0 112.607 -177.532 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.501 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.7 tt -107.81 172.41 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 124.466 2.079 . . . . 0.0 113.234 -179.289 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.501 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 16.5 ptpt -161.65 164.51 29.2 Favored 'General case' 0 C--N 1.316 -0.871 1 CA-C-N 108.191 -4.095 . . . . 0.0 112.379 179.974 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.1 m -92.33 60.33 3.63 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.536 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.5 -62.75 0.03 OUTLIER Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -179.271 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.31 -172.27 13.13 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.647 0.642 . . . . 0.0 113.939 -178.663 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.3 t -124.33 103.99 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 127.889 2.476 . . . . 0.0 105.678 -179.418 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.9 t80 60.56 92.78 0.04 OUTLIER 'General case' 0 C--N 1.345 0.38 0 C-N-CA 126.09 1.756 . . . . 0.0 110.871 -178.519 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.3 p -142.85 39.68 1.5 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.844 0.858 . . . . 0.0 110.336 179.302 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.11 98.38 0.06 OUTLIER Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.979 0.8 . . . . 0.0 112.25 179.178 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.92 -178.54 48.96 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 123.718 0.675 . . . . 0.0 111.512 179.13 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.0 t 63.12 91.81 0.07 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.684 1.593 . . . . 0.0 110.5 -179.124 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -59.87 132.31 8.07 Favored 'Cis proline' 0 C--N 1.348 0.534 0 CA-C-N 119.355 0.805 . . . . 0.0 113.338 1.901 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.79 71.57 0.03 OUTLIER Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.507 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.495 ' HB1' ' CB ' ' A' ' 91' ' ' HIS . . . -62.93 -20.64 65.4 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.861 178.863 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.72 137.4 33.86 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.289 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -157.66 147.28 20.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.522 -179.069 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.9 m -110.04 145.98 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 177.237 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.5 t -127.66 121.24 56.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -177.328 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -107.84 173.17 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.38 0 C-N-CA 125.189 1.396 . . . . 0.0 112.45 -177.58 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -91.56 161.89 14.75 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.248 1.419 . . . . 0.0 109.293 179.363 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.32 15.3 t -79.16 54.08 1.58 Allowed 'General case' 0 C--N 1.341 0.223 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -179.076 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -151.81 -88.45 0.06 Allowed 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 101.982 -3.34 . . . . 0.0 101.982 177.209 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.24 5.51 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.181 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -91.3 129.75 37.25 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 -175.48 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.56 124.14 20.61 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 177.447 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.8 -51.73 5.08 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.166 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.24 153.45 10.93 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.075 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.84 141.28 31.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.569 1.148 . . . . 0.0 110.062 179.3 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.0 pt -135.14 156.76 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 125.267 1.427 . . . . 0.0 108.081 179.157 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.58 159.67 37.33 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 119.113 -0.47 . . . . 0.0 111.308 -178.731 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.495 ' CB ' ' HB1' ' A' ' 74' ' ' ALA . 21.4 m170 -78.88 -58.76 3.08 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.015 177.412 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.288 4.8 t 48.06 9.35 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 129.228 3.011 . . . . 0.0 117.168 -178.053 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.68 44.98 0.21 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.142 1.353 . . . . 0.0 110.505 179.399 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.88 -168.6 2.29 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.985 0.914 . . . . 0.0 109.073 179.086 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.8 m -59.84 -46.57 88.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.321 0.648 . . . . 0.0 110.426 179.167 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.28 -91.48 0.08 OUTLIER Glycine 0 C--N 1.337 0.619 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 179.157 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -85.37 -2.5 58.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.022 0.929 . . . . 0.0 110.234 178.458 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -63.51 168.21 4.86 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.629 1.172 . . . . 0.0 110.708 179.114 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -138.85 156.21 47.49 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -177.608 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 m -132.61 165.54 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 127.331 2.253 . . . . 0.0 106.692 177.093 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -75.2 162.07 53.42 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 114.668 0.627 . . . . 0.0 114.668 -178.185 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 6.6 t -148.26 159.15 44.27 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 126.096 1.758 . . . . 0.0 108.953 178.289 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t 61.38 38.11 16.4 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.726 2.01 . . . . 0.0 111.819 -178.328 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.72 42.98 99.59 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.154 1.359 . . . . 0.0 112.239 179.041 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.6 t -88.21 26.03 1.49 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 179.871 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 116.618 -1.658 . . . . 0.0 110.615 -179.31 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.488 0.185 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.5 p -125.85 177.09 6.5 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.936 1.294 . . . . 0.0 110.843 -178.98 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.13 152.66 39.96 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.791 1.236 . . . . 0.0 110.777 179.359 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.4 t -140.4 134.21 30.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.155 0.582 . . . . 0.0 110.508 179.043 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -109.92 103.33 12.09 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 178.854 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 20.6 m -88.24 70.21 9.19 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.184 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.08 -82.24 0.88 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.416 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.5 p -106.1 -48.14 3.67 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.161 1.384 . . . . 0.0 112.058 -178.887 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.5 m -72.79 105.59 4.41 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.984 0.513 . . . . 0.0 111.694 -178.436 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -81.8 148.51 28.84 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.219 1.408 . . . . 0.0 110.531 179.869 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -148.08 127.68 13.29 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.383 1.073 . . . . 0.0 109.495 179.156 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.9 p -71.15 160.12 33.45 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 125.133 1.373 . . . . 0.0 110.504 178.323 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.36 -19.73 37.96 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.164 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.4 t -77.74 -36.72 50.45 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 123.604 0.762 . . . . 0.0 109.385 -179.986 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -42.5 64.86 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.67 1.188 . . . . 0.0 111.069 179.205 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.477 HG11 ' CE2' ' A' ' 85' ' ' TYR . 22.3 t -61.87 -45.93 97.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.297 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -66.91 -41.48 87.04 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 124.883 1.273 . . . . 0.0 112.967 179.821 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.88 -53.61 53.42 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.749 0.42 . . . . 0.0 110.294 -178.122 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.16 -32.38 72.1 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.086 179.439 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.36 -49.32 43.39 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 179.874 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -61.87 -22.94 65.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.693 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.23 -71.98 0.28 Allowed 'General case' 0 C--N 1.348 0.52 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 -177.698 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -38.53 -44.44 0.95 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.912 0.885 . . . . 0.0 112.261 178.096 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.3 m -55.82 -52.71 63.05 Favored 'General case' 0 C--N 1.346 0.447 0 O-C-N 123.288 0.367 . . . . 0.0 111.784 179.184 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -56.16 -40.15 73.42 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.755 0.822 . . . . 0.0 112.421 -178.124 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -89.38 -16.48 30.88 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -178.875 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -80.45 -24.04 39.82 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.791 1.236 . . . . 0.0 113.826 179.367 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -60.64 -33.54 72.95 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.297 0.639 . . . . 0.0 112.692 -177.921 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -126.17 -86.27 0.61 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.147 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t0 168.13 59.05 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 128.354 2.662 . . . . 0.0 105.701 -178.379 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -81.66 -178.5 6.99 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.597 179.441 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.338 11.3 t -69.07 86.68 0.37 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -177.838 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.03 -161.66 1.07 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 127.242 2.217 . . . . 0.0 107.07 177.363 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -45.55 -49.21 11.82 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.478 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.1 m 47.62 50.04 15.57 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.181 1.792 . . . . 0.0 113.606 178.051 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.1 p -143.48 -54.3 0.38 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.776 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.456 HG23 ' CE1' ' A' ' 38' ' ' TYR . 1.1 t -154.3 19.44 0.49 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.387 1.475 . . . . 0.0 110.543 178.984 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.474 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 12.8 m-85 -166.03 129.39 1.58 Allowed Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 126.403 1.881 . . . . 0.0 106.32 178.879 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.64 135.8 34.03 Favored 'Cis proline' 0 N--CA 1.449 -1.118 0 CA-C-N 120.355 1.163 . . . . 0.0 110.402 -1.53 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.88 155.97 36.7 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.932 0.493 . . . . 0.0 110.214 178.762 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -64.02 157.73 24.42 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.845 1.258 . . . . 0.0 112.297 -179.332 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.92 45.14 1.13 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.956 0.903 . . . . 0.0 110.212 179.263 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 48.0 -121.56 1.38 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.84 2.056 . . . . 0.0 112.103 179.895 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -137.64 -179.27 5.65 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.858 1.663 . . . . 0.0 108.813 -179.367 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 66.91 -142.53 0.14 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.066 1.346 . . . . 0.0 110.965 178.933 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -126.29 106.53 9.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.188 1.395 . . . . 0.0 109.252 -178.571 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.98 93.0 0.31 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.295 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.4 t80 51.26 65.32 1.52 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.438 1.495 . . . . 0.0 109.666 -179.138 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.36 153.31 42.43 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.792 0.806 . . . . 0.0 112.684 -178.499 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -109.31 163.88 16.01 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 127.53 2.332 . . . . 0.0 108.522 -179.124 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.98 53.66 4.27 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.848 3.032 . . . . 0.0 111.837 178.865 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.2 m -155.04 171.09 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 127.842 2.457 . . . . 0.0 108.058 -179.333 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -92.46 -133.94 0.14 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.949 0.9 . . . . 0.0 109.52 179.983 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 166.32 -156.48 28.4 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.386 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.45 151.79 12.9 Favored 'Cis proline' 0 C--N 1.349 0.587 0 CA-C-N 119.205 1.503 . . . . 0.0 113.097 -1.5 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -134.26 148.38 50.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.205 1.002 . . . . 0.0 111.877 -178.635 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.57 152.31 22.57 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -177.659 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -104.81 146.59 28.77 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 127.471 2.308 . . . . 0.0 108.459 179.276 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.631 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 52.8 t80 -160.05 121.92 1.81 Allowed Pre-proline 0 C--O 1.224 -0.238 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 179.347 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.474 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 22.8 Cg_endo -75.97 145.28 28.07 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 CA-C-N 120.624 1.259 . . . . 0.0 112.753 -176.031 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.271 5.0 tp -78.99 159.83 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 124.483 2.087 . . . . 0.0 114.094 -178.07 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.94 118.74 37.4 Favored 'General case' 0 C--N 1.321 -0.672 1 CA-C-N 108.004 -4.18 . . . . 0.0 118.222 -176.372 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.1 m -105.86 43.99 1.08 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.743 1.617 . . . . 0.0 107.075 177.997 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.41 -6.28 5.94 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 118.279 -1.29 . . . . 0.0 115.366 -179.388 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.71 134.27 2.92 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 120.15 1.975 . . . . 0.0 113.064 179.462 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.94 141.83 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.194 1.398 . . . . 0.0 110.357 -179.005 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.8 p90 39.94 54.47 2.63 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.407 2.283 . . . . 0.0 114.527 179.311 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.2 p -134.09 34.32 3.34 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.833 1.253 . . . . 0.0 108.887 178.717 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.41 -154.6 11.45 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 124.294 0.95 . . . . 0.0 111.251 -179.257 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 47.71 74.93 0.21 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.856 1.217 . . . . 0.0 112.834 178.992 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.1 m -55.53 143.41 57.97 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.178 179.314 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -45.85 -50.72 9.28 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.554 2.836 . . . . 0.0 110.993 172.829 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.41 -39.85 0.22 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 178.526 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -171.11 29.21 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 116.429 -1.748 . . . . 0.0 113.629 -177.92 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -108.57 130.39 55.3 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 122.453 2.388 . . . . 0.0 113.749 -178.464 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -134.27 155.41 50.25 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 124.372 1.069 . . . . 0.0 113.112 179.884 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 m -124.97 142.04 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 103.404 -2.813 . . . . 0.0 103.404 176.115 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.9 t -136.45 127.9 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -176.955 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.63 172.5 5.21 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 C-N-CA 127.065 2.146 . . . . 0.0 110.71 -177.901 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -100.49 -178.24 3.74 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 126.066 1.746 . . . . 0.0 110.138 179.044 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.371 13.8 t -80.33 52.48 1.61 Allowed 'General case' 0 C--N 1.344 0.34 0 N-CA-C 118.524 2.787 . . . . 0.0 118.524 -178.068 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -160.5 -93.37 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 100.394 -3.928 . . . . 0.0 100.394 176.752 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 58.2 m -163.68 16.19 0.06 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 130.101 3.36 . . . . 0.0 112.353 179.398 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -79.21 97.65 6.31 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.778 1.172 . . . . 0.0 110.256 -177.69 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.477 ' CE2' HG11 ' A' ' 16' ' ' VAL . 9.1 t80 -55.64 112.72 1.21 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.667 1.587 . . . . 0.0 108.699 178.998 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.05 -51.52 9.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.449 0.7 . . . . 0.0 110.822 -178.641 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 166.66 162.27 17.8 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.275 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.84 147.06 24.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.059 0.944 . . . . 0.0 109.104 179.028 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.2 pt -134.52 160.59 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.966 1.306 . . . . 0.0 109.241 -178.969 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 74' ' ' ALA . 11.9 t -158.43 167.43 29.69 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.453 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.431 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 17.1 m170 -78.45 -65.3 1.0 Allowed 'General case' 0 C--N 1.348 0.511 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.343 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.1 t 42.78 14.28 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 129.249 3.02 . . . . 0.0 116.778 -179.364 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.99 -32.71 0.15 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.466 1.507 . . . . 0.0 110.44 -179.038 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.18 127.57 17.27 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.829 1.652 . . . . 0.0 112.09 179.233 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.9 t -105.89 69.19 0.81 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.986 1.315 . . . . 0.0 109.114 179.718 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.67 -161.01 30.35 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.452 1.025 . . . . 0.0 110.921 179.373 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -79.5 8.55 6.14 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.071 0.948 . . . . 0.0 111.388 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -80.24 156.83 26.69 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.233 1.413 . . . . 0.0 110.286 178.852 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -137.78 159.96 40.56 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.279 1.432 . . . . 0.0 111.195 -178.192 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.9 m -128.38 176.15 8.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 C-N-CA 127.877 2.471 . . . . 0.0 106.969 178.05 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.31 171.07 43.6 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 117.054 1.581 . . . . 0.0 117.054 -177.647 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.3 m -129.26 -176.49 3.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.917 2.487 . . . . 0.0 107.206 177.963 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.6 t 28.5 38.84 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -177.099 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 53.32 48.94 58.49 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.324 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.6 t -79.23 150.54 31.58 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.596 0.759 . . . . 0.0 111.801 -178.615 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.1 t30 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.245 -1.36 . . . . 0.0 108.717 -179.386 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 m -78.25 150.84 33.33 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.75 1.62 . . . . 0.0 108.299 179.082 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 76.82 63.08 0.04 OUTLIER 'General case' 0 C--N 1.34 0.167 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 -177.433 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 t -106.02 156.43 18.41 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.893 0.877 . . . . 0.0 111.354 -177.92 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.08 112.28 12.2 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 178.723 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.6 m -96.55 74.93 2.82 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.242 1.017 . . . . 0.0 110.012 -178.825 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.3 -70.81 2.1 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 125.097 1.332 . . . . 0.0 111.524 179.121 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.2 t -126.49 -44.58 1.69 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.896 1.678 . . . . 0.0 109.919 -179.222 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 m -68.5 111.06 4.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.644 0.778 . . . . 0.0 109.514 -179.349 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -81.41 151.94 27.66 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.083 0.953 . . . . 0.0 110.532 179.911 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -143.27 110.14 5.58 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.427 1.091 . . . . 0.0 110.326 -179.551 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.8 m -63.1 154.15 31.88 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 125.275 1.43 . . . . 0.0 109.171 178.77 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -20.9 57.81 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.865 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.4 m -74.35 -43.22 57.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.042 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -67.82 -47.29 69.46 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.189 0.995 . . . . 0.0 112.343 -179.174 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -60.19 -52.65 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 124.194 0.998 . . . . 0.0 109.215 -179.342 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -66.38 -38.8 88.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.141 1.377 . . . . 0.0 113.002 -177.841 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.51 -52.6 60.54 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.355 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.488 ' HB1' ' HE2' ' A' ' 59' ' ' PHE . . . -61.96 -32.55 73.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.431 179.237 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.92 -32.29 61.75 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 178.896 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -69.74 -24.66 63.57 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 176.959 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.06 -63.67 1.26 Allowed 'General case' 0 C--N 1.349 0.57 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 -179.222 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.497 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -41.58 -40.1 1.79 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.273 1.429 . . . . 0.0 112.447 176.852 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -60.89 -63.54 1.26 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.282 1.433 . . . . 0.0 110.247 179.219 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -66.43 -24.17 66.41 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -179.065 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -82.25 -45.31 15.18 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.211 1.404 . . . . 0.0 113.531 -177.798 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -66.23 -28.26 68.6 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.374 1.069 . . . . 0.0 112.589 -178.525 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -74.84 -64.73 0.98 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.407 0.548 . . . . 0.0 110.904 -177.738 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -172.49 -29.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.546 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -75.49 39.02 0.15 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -177.502 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.05 169.7 0.06 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.224 2.21 . . . . 0.0 110.689 178.608 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.0 t -158.28 37.19 0.24 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.388 1.475 . . . . 0.0 110.337 179.322 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.04 158.98 27.78 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.754 0.822 . . . . 0.0 111.835 -179.149 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.64 -137.59 7.33 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.573 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.7 t -145.32 -68.53 0.29 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.625 1.17 . . . . 0.0 108.452 179.091 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.2 m -83.33 -94.1 0.06 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.908 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.3 p -140.63 40.57 1.86 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.389 0.675 . . . . 0.0 110.677 178.571 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -82.17 132.06 54.49 Favored Pre-proline 0 C--N 1.345 0.389 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 177.66 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.49 123.75 5.73 Favored 'Cis proline' 0 CA--C 1.544 1.015 0 N-CA-C 114.044 0.748 . . . . 0.0 114.044 3.005 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.85 148.4 22.52 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 128.452 2.701 . . . . 0.0 113.758 -177.319 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.97 113.76 2.99 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.933 0.893 . . . . 0.0 109.264 179.047 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -95.03 90.38 5.92 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 120.838 0.352 . . . . 0.0 110.072 -178.821 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -156.12 119.21 4.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.162 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -128.58 -79.82 0.57 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.295 1.038 . . . . 0.0 109.336 -179.089 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -143.61 11.26 1.66 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.904 1.281 . . . . 0.0 110.884 179.467 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 55.45 47.64 20.66 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.225 1.41 . . . . 0.0 110.682 -178.852 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.67 -31.53 6.67 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.292 1.425 . . . . 0.0 111.303 179.413 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -127.44 94.02 3.87 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.041 1.336 . . . . 0.0 108.391 -179.195 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -118.88 -177.95 3.44 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.582 1.153 . . . . 0.0 111.487 -178.837 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.21 175.53 3.21 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.989 1.716 . . . . 0.0 108.553 -178.714 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.63 68.07 7.11 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.352 2.701 . . . . 0.0 111.573 -179.403 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.5 m -143.18 157.28 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 125.668 1.587 . . . . 0.0 109.78 179.695 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -85.5 -44.97 12.24 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.797 1.239 . . . . 0.0 111.235 -179.326 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.79 177.82 43.81 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.72 1.152 . . . . 0.0 111.865 -179.423 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.29 152.96 85.19 Favored 'Cis proline' 0 N--CA 1.458 -0.594 0 CA-C-N 117.973 0.886 . . . . 0.0 112.409 0.763 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.1 154.96 47.74 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 127.185 2.194 . . . . 0.0 109.981 179.325 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -135.85 160.81 37.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.049 -178.743 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.98 162.26 26.08 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.719 1.608 . . . . 0.0 112.14 -177.552 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.497 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 70.9 t80 -160.61 104.38 1.32 Allowed Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 177.388 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -80.84 135.46 10.09 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 121.899 1.733 . . . . 0.0 112.774 -175.778 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.58 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 3.7 tt -105.35 -176.34 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-O 124.249 1.976 . . . . 0.0 112.401 -179.223 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.58 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.3 mmtm -160.51 142.84 12.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 108.945 -3.752 . . . . 0.0 110.229 179.72 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.7 t -85.83 60.83 6.47 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.71 1.204 . . . . 0.0 109.138 -179.134 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.51 49.81 0.1 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.93 1.729 . . . . 0.0 109.003 -179.214 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.6 154.39 7.57 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.328 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.8 t -135.61 150.94 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.168 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 16.6 p90 48.33 48.47 18.93 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.818 1.647 . . . . 0.0 111.963 -179.051 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.1 m -79.29 138.31 37.7 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 125.027 1.331 . . . . 0.0 108.964 -178.896 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.91 -84.15 0.23 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.871 0.748 . . . . 0.0 112.791 -178.857 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.56 76.56 1.32 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.165 0.888 . . . . 0.0 112.096 -178.825 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.3 m -98.65 157.78 33.65 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.229 1.412 . . . . 0.0 110.177 179.338 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.9 -44.28 49.74 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.731 2.954 . . . . 0.0 111.495 164.61 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.57 24.23 26.49 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.773 1.178 . . . . 0.0 112.11 179.18 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.539 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -94.16 -68.92 0.77 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.158 -0.925 . . . . 0.0 109.548 179.203 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -70.4 107.1 3.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.096 0.958 . . . . 0.0 112.622 -178.621 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -140.03 131.65 27.2 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.338 0.655 . . . . 0.0 111.719 -179.074 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -94.19 153.16 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 176.882 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.7 t -132.95 130.42 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -178.348 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.5 pt -116.79 176.22 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.6 1.16 . . . . 0.0 112.634 -177.997 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -90.49 177.34 6.4 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 126.442 1.897 . . . . 0.0 110.022 179.763 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.322 12.9 t -81.2 47.71 1.05 Allowed 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 118.58 2.807 . . . . 0.0 118.58 -178.651 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -160.41 -87.04 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 177.05 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 76.7 m -162.97 62.6 0.19 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.198 2.599 . . . . 0.0 110.082 -176.793 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -144.02 117.74 9.27 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.202 1.819 . . . . 0.0 114.391 -179.416 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -55.74 128.83 36.73 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.365 1.066 . . . . 0.0 108.449 178.622 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.61 -59.6 1.68 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.931 0.892 . . . . 0.0 108.833 178.805 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.91 173.57 41.51 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.369 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.47 115.95 22.42 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.681 1.593 . . . . 0.0 109.231 179.267 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.9 pt -108.83 158.01 8.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 125.06 1.344 . . . . 0.0 110.017 -179.235 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 t -159.61 137.11 9.84 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 -179.529 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.539 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 6.5 m170 -78.1 -11.22 59.9 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 117.881 -1.057 . . . . 0.0 112.034 174.997 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.7 m -26.53 -65.63 0.06 Allowed 'General case' 0 C--N 1.349 0.549 0 C-N-CA 126.447 1.899 . . . . 0.0 114.937 -178.469 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.04 -75.51 1.25 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -179.348 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 50.81 -150.23 0.26 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.064 1.346 . . . . 0.0 112.27 -179.306 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 60.1 p -153.97 -51.41 0.1 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.163 1.385 . . . . 0.0 108.651 179.118 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -121.55 -86.38 0.86 Allowed Glycine 0 C--N 1.34 0.791 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 178.817 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -134.13 28.13 3.8 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.547 1.539 . . . . 0.0 110.734 179.23 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -85.96 164.96 17.1 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.906 1.282 . . . . 0.0 111.628 -178.885 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.454 ' CE2' ' NE2' ' A' ' 91' ' ' HIS . 13.5 m-85 -118.65 116.05 25.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.122 1.769 . . . . 0.0 107.781 179.098 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.4 m -90.89 164.44 2.12 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.255 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.15 133.83 11.99 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.071 -178.32 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 26.2 m -81.32 -172.99 4.09 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.526 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.9 t -75.8 93.06 3.1 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.993 -0.442 . . . . 0.0 110.12 -179.03 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.49 51.27 0.24 Allowed Glycine 0 CA--C 1.527 0.834 0 C-N-CA 126.105 1.812 . . . . 0.0 109.397 -179.37 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.0 m -154.66 110.82 3.22 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 125.2 1.4 . . . . 0.0 108.853 -179.14 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.5 m120 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.217 -1.373 . . . . 0.0 109.414 179.111 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.2 m -145.36 139.18 26.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.964 0.905 . . . . 0.0 109.497 -179.287 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -50.29 136.55 19.8 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.541 1.536 . . . . 0.0 111.436 -179.784 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.3 p -104.0 150.13 24.53 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.976 1.31 . . . . 0.0 111.379 -179.034 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -133.46 97.03 3.84 Favored 'General case' 0 N--CA 1.424 -1.772 1 N-CA-C 97.38 -5.044 . . . . 0.0 97.38 176.591 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -97.31 85.57 3.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.471 0.653 . . . . 0.0 110.668 -177.185 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.12 -96.2 1.58 Allowed Glycine 0 C--N 1.34 0.762 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 -178.879 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.7 m -104.91 -36.61 7.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.353 1.061 . . . . 0.0 110.307 179.23 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.38 168.03 19.27 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.346 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -156.75 132.45 9.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.091 0.156 . . . . 0.0 110.86 179.323 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -123.74 158.35 31.89 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.876 1.27 . . . . 0.0 109.947 -179.683 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.1 m -78.05 156.26 30.17 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.224 1.41 . . . . 0.0 110.479 -179.667 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.38 -18.9 42.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.83 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.7 p -72.66 -38.05 67.75 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 123.637 0.775 . . . . 0.0 109.966 179.248 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.93 -47.93 67.34 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.807 0.731 . . . . 0.0 110.236 178.654 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.2 t -53.14 -49.89 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 125.077 1.351 . . . . 0.0 108.496 179.09 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -69.51 -38.32 77.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.372 1.469 . . . . 0.0 113.083 -178.819 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.59 -54.18 31.43 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.817 0.735 . . . . 0.0 110.79 -178.507 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.25 -34.1 75.88 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.584 0.754 . . . . 0.0 111.118 179.43 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.11 -36.89 61.63 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 119.477 -0.297 . . . . 0.0 111.506 178.957 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -69.32 -20.78 63.87 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.449 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.5 -57.41 3.36 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -178.224 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.8 -38.26 47.38 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.088 1.355 . . . . 0.0 109.822 177.269 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.2 t -60.69 -54.57 43.68 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.358 1.463 . . . . 0.0 109.158 178.506 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -56.79 -36.85 70.35 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.687 0.395 . . . . 0.0 110.837 179.532 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.25 -6.52 59.28 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.714 1.206 . . . . 0.0 114.098 -179.863 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.46 ' CD2' ' HG3' ' A' ' 57' ' ' GLN . 8.7 t80 -128.23 43.96 3.04 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.154 0.888 . . . . 0.0 111.402 178.926 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -130.78 -84.46 0.52 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.338 1.455 . . . . 0.0 107.598 177.483 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -162.93 -14.75 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.274 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -84.17 65.21 8.66 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.586 1.554 . . . . 0.0 107.576 179.89 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 78.04 111.35 0.07 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 128.138 2.575 . . . . 0.0 108.475 -178.971 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.4 p -87.49 77.63 8.78 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.544 1.138 . . . . 0.0 109.295 -178.68 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.59 91.93 2.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.516 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.48 108.34 2.77 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 126.113 1.816 . . . . 0.0 108.57 -179.519 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 m -71.18 -66.9 0.56 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.834 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.0 p 156.49 -47.87 0.0 OUTLIER 'General case' 0 C--N 1.34 0.184 0 N-CA-C 100.537 -3.875 . . . . 0.0 100.537 -177.664 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.442 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 7.5 t -93.11 53.2 1.92 Allowed 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 125.838 1.655 . . . . 0.0 107.308 176.951 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER 79.69 155.15 0.13 Allowed Pre-proline 0 C--N 1.348 0.53 0 C-N-CA 127.376 2.27 . . . . 0.0 115.086 175.737 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.93 127.66 13.1 Favored 'Cis proline' 0 C--N 1.349 0.582 0 N-CA-C 114.93 1.089 . . . . 0.0 114.93 1.899 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.04 169.56 20.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.748 1.219 . . . . 0.0 110.212 178.913 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 m -37.52 131.66 0.9 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 128.737 2.815 . . . . 0.0 115.828 -178.911 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -109.07 109.21 20.17 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.975 1.71 . . . . 0.0 106.708 178.418 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -70.91 -36.34 72.67 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.616 1.166 . . . . 0.0 113.636 -178.788 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 70.86 77.26 0.18 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.198 1.399 . . . . 0.0 108.134 -178.465 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -72.76 91.53 1.49 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.111 1.364 . . . . 0.0 111.747 -178.641 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 54.75 152.83 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 129.305 3.042 . . . . 0.0 115.821 179.191 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.61 -145.25 24.26 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.774 1.178 . . . . 0.0 112.583 179.236 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.04 172.27 0.09 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.05 1.74 . . . . 0.0 113.46 -179.36 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -158.45 121.93 3.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 179.395 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -132.81 105.34 12.78 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 178.448 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.64 80.86 1.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.699 2.933 . . . . 0.0 113.397 -178.223 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.04 160.5 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.472 1.909 . . . . 0.0 107.81 178.822 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.57 -50.51 8.71 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.726 0.81 . . . . 0.0 110.623 179.557 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.54 -159.76 35.3 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.059 0.837 . . . . 0.0 111.257 -179.389 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.82 153.67 13.38 Favored 'Cis proline' 0 C--N 1.347 0.478 0 CA-C-N 119.092 1.446 . . . . 0.0 113.802 -0.172 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.87 158.25 20.41 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 123.877 0.871 . . . . 0.0 110.933 -178.994 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.46 ' HG3' ' CD2' ' A' ' 27' ' ' TYR . 6.2 mm100 -130.98 150.89 51.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.51 1.124 . . . . 0.0 111.687 -178.601 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -88.04 156.28 19.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.556 1.142 . . . . 0.0 110.653 179.216 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -159.74 109.22 1.46 Allowed Pre-proline 0 N--CA 1.457 -0.121 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.24 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -81.28 136.63 10.15 Favored 'Trans proline' 0 N--CA 1.436 -1.897 0 C-N-CA 121.043 1.162 . . . . 0.0 113.088 -177.827 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.26 -173.78 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 128.868 2.867 . . . . 0.0 103.891 178.896 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.36 -179.38 6.52 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 112.308 -2.224 . . . . 0.0 113.022 -177.989 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.3 t -89.42 51.05 2.03 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.075 1.35 . . . . 0.0 107.647 178.013 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.33 -66.78 0.03 OUTLIER Glycine 0 C--N 1.344 0.975 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.097 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.22 -149.41 7.28 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 117.75 0.775 . . . . 0.0 113.14 -179.774 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 t -61.86 130.72 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 126.509 1.923 . . . . 0.0 108.941 -179.165 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.1 133.14 45.36 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.879 0.872 . . . . 0.0 112.752 -178.732 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 m -132.34 -33.85 1.26 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.544 1.938 . . . . 0.0 110.352 179.394 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.26 -141.21 0.36 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.307 1.432 . . . . 0.0 114.851 -178.636 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.77 -151.69 1.55 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.364 1.459 . . . . 0.0 113.957 -178.777 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 m 72.88 151.33 0.14 Allowed Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 126.545 1.938 . . . . 0.0 110.664 -179.246 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -57.95 -72.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.042 2.495 . . . . 0.0 110.537 179.146 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.24 64.69 1.45 Allowed Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 178.304 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -61.69 -49.0 78.24 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.434 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.01 132.48 48.68 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.742 1.617 . . . . 0.0 108.218 178.725 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -157.96 132.73 8.47 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -178.512 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.6 m -95.95 147.66 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 176.309 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -128.65 117.32 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -178.635 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 35.4 pt -99.96 174.1 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.412 0 C-N-CA 126.345 1.858 . . . . 0.0 112.684 -178.287 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -94.85 -175.36 3.54 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.135 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.295 13.8 t -84.51 42.85 0.92 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 -179.9 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.8 -72.49 0.1 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.054 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.68 -9.04 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 -177.227 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -79.3 118.59 21.36 Favored 'General case' 0 N--CA 1.458 -0.061 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -175.921 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -71.29 115.03 9.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.249 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.76 -57.97 3.41 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.945 0.898 . . . . 0.0 112.126 -178.548 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.77 151.6 12.03 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.769 179.716 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.07 131.11 44.76 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.291 1.436 . . . . 0.0 110.847 -179.052 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.6 pt -130.99 162.56 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 125.45 1.5 . . . . 0.0 109.638 -179.019 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 t -156.56 146.83 21.34 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -179.606 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.459 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 19.8 m170 -79.26 -26.64 42.36 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.237 175.177 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.0 m -31.05 -59.94 0.21 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 127.946 2.498 . . . . 0.0 115.347 -178.13 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.39 34.06 4.57 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.297 0.951 . . . . 0.0 112.231 -178.908 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.81 -87.51 0.16 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 117.604 0.702 . . . . 0.0 110.981 179.511 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.2 t -162.29 -51.94 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.083 1.353 . . . . 0.0 108.723 -179.188 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.46 -88.96 0.07 OUTLIER Glycine 0 C--N 1.339 0.71 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 179.24 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -79.94 -28.61 39.65 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.115 0.966 . . . . 0.0 110.325 178.725 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -63.19 169.3 3.6 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.287 1.435 . . . . 0.0 111.538 -179.541 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -128.64 156.71 42.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.899 2.08 . . . . 0.0 109.743 -179.711 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.7 m -141.88 155.84 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 C-N-CA 124.432 1.093 . . . . 0.0 108.17 177.094 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.47 129.05 9.05 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.122 -177.775 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 37.4 m -79.93 179.75 7.41 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.298 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.2 p -61.19 124.7 21.3 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.872 -1.143 . . . . 0.0 109.683 179.152 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.04 37.61 5.65 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -178.752 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 60.5 m -152.52 145.68 24.64 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.759 1.624 . . . . 0.0 107.965 -179.732 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 125.948 1.699 . . . . 0.0 110.952 179.47 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 121.027 0.442 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.1 t -160.14 69.86 0.41 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.896 1.279 . . . . 0.0 107.966 -179.04 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.59 177.29 0.21 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.47 1.508 . . . . 0.0 110.274 -178.877 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.6 p -143.95 94.13 2.54 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.08 0.552 . . . . 0.0 110.273 178.869 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.0 m -87.76 89.61 8.06 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 102.51 -3.144 . . . . 0.0 102.51 177.792 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.3 m -86.92 63.76 8.12 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.308 1.843 . . . . 0.0 108.852 -178.952 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.13 -79.29 1.88 Allowed Glycine 0 C--N 1.34 0.779 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.085 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.7 p -115.07 -42.45 3.2 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.429 1.491 . . . . 0.0 109.68 179.256 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.35 114.3 3.11 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 124.514 1.125 . . . . 0.0 108.568 178.925 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.65 99.75 7.96 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.709 0.804 . . . . 0.0 110.368 -178.176 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -94.67 146.24 24.29 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.559 0.743 . . . . 0.0 109.08 179.048 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.4 m -72.15 153.12 41.84 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 124.094 0.958 . . . . 0.0 109.979 -179.555 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.44 -18.87 43.09 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 176.822 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 63.3 m -75.28 -39.75 59.37 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 125.002 1.321 . . . . 0.0 109.176 178.705 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -68.92 -40.84 78.83 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 123.946 0.899 . . . . 0.0 110.85 179.188 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.1 t -61.53 -48.32 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.888 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 ttt85 -65.83 -39.82 91.2 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.58 1.552 . . . . 0.0 112.125 -179.715 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.19 -51.83 66.23 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.178 0.591 . . . . 0.0 109.65 -179.074 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.51 -30.67 71.44 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.272 0.629 . . . . 0.0 111.477 179.256 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.65 -46.71 45.01 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.302 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -65.71 -20.24 66.2 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.76 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.96 -61.49 2.0 Allowed 'General case' 0 C--N 1.346 0.456 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -177.643 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -43.83 -51.64 7.27 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 124.849 1.343 . . . . 0.0 109.313 176.732 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 m -48.19 -54.25 14.09 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 126.479 1.912 . . . . 0.0 111.155 178.775 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -70.99 -25.92 62.91 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -178.729 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -106.08 -2.21 22.94 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 -176.93 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.416 ' CD2' ' HB2' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -110.48 -5.66 15.09 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.076 1.307 . . . . 0.0 114.275 178.683 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -78.3 -62.95 1.52 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.062 0.846 . . . . 0.0 112.134 -178.102 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -159.68 -41.32 0.05 Allowed 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.124 0.57 . . . . 0.0 110.916 -178.785 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.68 60.71 5.4 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.222 1.409 . . . . 0.0 107.643 178.814 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -69.99 123.24 21.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.611 1.564 . . . . 0.0 111.408 -178.423 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.8 t -149.41 39.56 0.82 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.871 0.869 . . . . 0.0 110.906 179.032 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.69 105.01 0.1 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.47 1.908 . . . . 0.0 106.025 179.122 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.32 114.59 0.63 Allowed Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.242 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 78.8 p -70.59 -67.84 0.47 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.411 1.084 . . . . 0.0 111.038 -179.031 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.1 m -143.09 -69.44 0.33 Allowed 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.156 0.983 . . . . 0.0 108.69 179.421 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.0 p -104.62 -58.44 1.88 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.494 1.118 . . . . 0.0 108.091 179.338 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.95 123.62 82.5 Favored Pre-proline 0 N--CA 1.468 0.457 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 178.316 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.31 123.59 8.67 Favored 'Cis proline' 0 N--CA 1.456 -0.699 0 N-CA-C 116.662 1.755 . . . . 0.0 116.662 3.892 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.64 173.23 2.02 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 128.207 2.603 . . . . 0.0 108.031 178.051 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 52.4 p -72.15 160.14 32.95 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.68 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -117.86 119.47 34.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.131 2.172 . . . . 0.0 108.658 179.554 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -166.68 44.95 0.06 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.288 1.435 . . . . 0.0 108.703 179.138 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -95.2 77.47 3.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.257 1.023 . . . . 0.0 110.384 -179.013 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 63.28 -177.21 0.15 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.614 1.566 . . . . 0.0 113.685 178.505 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -74.25 -173.0 1.55 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.722 1.609 . . . . 0.0 111.295 179.127 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.09 -52.56 0.63 Allowed Glycine 0 C--N 1.34 0.782 0 C-N-CA 124.603 1.097 . . . . 0.0 110.46 179.452 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -138.36 131.52 30.09 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.103 0.961 . . . . 0.0 110.312 179.274 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -161.04 137.29 8.36 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.223 1.809 . . . . 0.0 107.278 179.302 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -94.47 151.71 39.52 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.943 0.897 . . . . 0.0 110.339 -178.86 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.88 67.29 6.67 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 124.244 3.296 . . . . 0.0 112.044 -179.368 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.0 m -147.65 163.94 6.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 125.866 1.666 . . . . 0.0 108.066 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -66.27 -44.42 83.65 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.749 0.819 . . . . 0.0 111.725 -179.652 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.3 -171.29 49.18 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.182 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.53 167.11 24.25 Favored 'Cis proline' 0 C--N 1.348 0.526 0 CA-C-N 119.529 1.665 . . . . 0.0 113.766 -1.5 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -128.69 146.97 50.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.178 1.391 . . . . 0.0 110.832 -179.338 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.416 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 2.5 tp60 -91.69 138.2 31.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 128.086 2.554 . . . . 0.0 113.43 -178.342 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.1 141.52 30.94 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.285 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -149.75 114.46 3.47 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.862 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -80.59 133.36 9.37 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.141 1.894 . . . . 0.0 112.516 -176.882 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.58 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 2.3 tt -106.05 -170.23 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-O 123.481 1.61 . . . . 0.0 111.984 -179.262 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.58 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.2 mmtp -160.76 -170.06 2.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 109.962 -3.29 . . . . 0.0 112.493 179.37 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.1 t -85.77 63.05 7.83 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 126.705 2.002 . . . . 0.0 108.108 -179.667 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.47 59.99 2.06 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -179.261 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.13 98.24 0.18 Allowed Glycine 0 C--N 1.338 0.668 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.076 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.3 t -64.42 147.26 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 178.207 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.5 t80 69.85 -167.43 0.17 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.093 0.957 . . . . 0.0 108.693 -179.041 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.2 p -78.73 114.91 18.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.256 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.56 -130.31 5.58 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.826 1.203 . . . . 0.0 110.816 -179.285 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.65 73.18 2.7 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.195 0.903 . . . . 0.0 112.981 -178.94 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.3 m 56.55 69.82 1.64 Allowed Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.153 1.381 . . . . 0.0 112.401 178.885 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.99 85.03 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.212 3.274 . . . . 0.0 111.463 179.39 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.77 31.54 8.56 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.01 -0.883 . . . . 0.0 113.717 -179.203 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.4 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -157.08 -71.5 0.1 Allowed 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.75 1.275 . . . . 0.0 111.251 178.932 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -68.93 108.63 3.57 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.356 1.862 . . . . 0.0 114.926 -178.728 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -128.35 126.2 40.23 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 125.253 1.421 . . . . 0.0 111.846 179.693 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 m -93.74 144.2 10.03 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 176.699 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.7 t -137.63 127.18 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.042 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.7 pt -113.81 171.36 4.07 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 C-N-CA 125.188 1.395 . . . . 0.0 111.655 -178.352 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -85.22 165.95 16.94 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.881 1.672 . . . . 0.0 107.897 178.833 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.389 5.9 t -80.04 48.16 0.96 Allowed 'General case' 0 C--N 1.343 0.309 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -178.204 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -143.64 -85.59 0.14 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 102.071 -3.307 . . . . 0.0 102.071 176.754 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -163.61 -3.57 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.579 1.951 . . . . 0.0 114.616 178.687 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -79.67 122.4 26.5 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -176.084 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -63.32 117.15 6.22 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.507 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.65 -53.41 4.65 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 123.515 0.726 . . . . 0.0 110.761 -177.647 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.66 150.94 9.97 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.356 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.97 130.37 54.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.648 1.179 . . . . 0.0 108.145 179.565 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.8 pt -122.27 157.43 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.938 1.295 . . . . 0.0 108.579 -179.27 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.3 t -156.97 146.08 20.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -178.661 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.4 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 24.7 m170 -84.33 65.0 8.64 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 174.571 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.5 m -51.07 -46.61 61.81 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.927 0.785 . . . . 0.0 110.387 179.236 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.57 -51.48 0.03 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 179.401 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 30.25 -99.35 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 128.071 2.548 . . . . 0.0 112.669 -179.13 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.4 m -159.58 79.46 0.72 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.854 1.662 . . . . 0.0 107.251 179.141 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.49 -108.05 2.31 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.462 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -79.77 -5.9 56.23 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.736 0.814 . . . . 0.0 113.0 -179.325 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -64.64 160.86 18.86 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.002 0.819 . . . . 0.0 110.339 179.288 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -121.82 167.55 12.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.572 1.549 . . . . 0.0 113.656 -177.832 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.8 m -146.19 165.99 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 128.953 2.901 . . . . 0.0 105.928 176.737 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.2 144.96 17.09 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.369 0.509 . . . . 0.0 113.946 -178.238 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 13.9 m -94.3 165.24 12.68 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 124.092 0.957 . . . . 0.0 109.049 178.43 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 88.1 p 21.81 43.47 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 129.11 2.964 . . . . 0.0 118.091 -177.887 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.77 59.38 9.8 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.587 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.3 t -78.99 151.31 31.64 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.983 0.42 . . . . 0.0 110.689 -179.397 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 . . . . . 0 C--O 1.251 1.132 0 CA-C-O 116.468 -1.73 . . . . 0.0 110.779 -178.956 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 121.05 0.452 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t -152.44 143.94 23.41 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.865 1.266 . . . . 0.0 108.231 179.937 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.51 132.61 45.14 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.14 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.4 t -132.93 143.34 49.42 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -177.76 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.82 117.34 29.93 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.952 1.701 . . . . 0.0 108.212 178.885 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.8 m -103.76 78.18 1.54 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.896 1.278 . . . . 0.0 108.506 -178.814 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.51 -57.75 4.89 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.415 1.007 . . . . 0.0 111.723 179.392 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.1 t -150.79 -42.1 0.12 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.963 1.305 . . . . 0.0 110.56 -179.369 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.71 113.31 5.39 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.382 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -82.29 155.11 25.0 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.564 1.546 . . . . 0.0 111.394 -178.876 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -149.74 139.96 22.2 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.077 1.351 . . . . 0.0 109.092 178.956 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 m -81.52 160.19 23.98 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 124.862 1.265 . . . . 0.0 108.502 177.7 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.33 -23.42 48.71 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.863 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.2 p -77.85 -31.12 51.3 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.678 0.611 . . . . 0.0 110.286 -178.955 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -39.43 70.42 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.939 0.896 . . . . 0.0 111.525 179.162 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.03 -38.66 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -179.141 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -72.0 -24.71 61.62 Favored 'General case' 0 C--N 1.347 0.461 0 C-N-CA 124.576 1.15 . . . . 0.0 112.384 179.124 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.47 -58.32 4.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.381 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.18 -23.34 63.92 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.076 179.33 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.73 -43.48 54.78 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 120.693 1.588 . . . . 0.0 111.292 178.944 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -66.93 -21.62 65.98 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.982 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.18 -64.3 1.17 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 -178.733 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.553 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -34.7 -53.05 0.54 Allowed 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.35 1.86 . . . . 0.0 111.226 175.952 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.3 t -56.75 -53.63 55.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.316 1.446 . . . . 0.0 110.919 179.446 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -73.87 -12.51 60.69 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -179.169 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -108.88 -19.24 13.47 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -178.832 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -80.84 -59.32 2.72 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.516 1.507 . . . . 0.0 112.785 -177.735 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -143.81 51.9 1.32 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.927 0.785 . . . . 0.0 111.713 -178.784 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -134.99 -53.58 0.8 Allowed 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.665 1.186 . . . . 0.0 108.835 178.764 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -138.4 86.21 2.14 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -178.977 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 68.23 -167.92 0.19 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.81 1.244 . . . . 0.0 110.215 -179.507 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.5 p -107.41 -41.02 5.2 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.17 1.388 . . . . 0.0 110.024 178.748 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 52.08 95.63 0.01 OUTLIER 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.505 1.922 . . . . 0.0 113.329 178.888 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.72 -95.64 0.99 Allowed Glycine 0 C--N 1.336 0.563 0 C-N-CA 124.816 1.198 . . . . 0.0 110.363 179.936 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m 54.8 67.48 1.01 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.413 1.085 . . . . 0.0 110.095 -179.09 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.4 t -113.08 -56.03 2.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 102.311 -3.218 . . . . 0.0 102.311 179.436 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.49 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 22.3 p -119.9 -31.54 4.46 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 127.645 2.378 . . . . 0.0 107.464 177.047 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' A' ' 37' ' ' THR . 1.8 m-85 -149.19 154.51 39.18 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 127.377 2.271 . . . . 0.0 110.044 -178.786 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.17 119.71 6.59 Favored 'Cis proline' 0 CA--C 1.542 0.907 0 N-CA-C 114.082 0.762 . . . . 0.0 114.082 1.93 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -127.85 158.83 36.67 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 125.966 1.706 . . . . 0.0 110.71 -179.343 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.9 m -59.64 135.7 57.76 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.996 2.118 . . . . 0.0 110.104 178.708 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -135.94 60.58 1.67 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.019 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -161.79 58.31 0.26 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.874 1.27 . . . . 0.0 109.076 -179.033 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -70.98 -62.69 1.3 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.968 0.907 . . . . 0.0 110.196 179.802 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -141.14 -80.66 0.25 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.949 1.3 . . . . 0.0 108.152 179.458 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -166.04 121.7 1.26 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -179.373 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.69 -73.59 0.05 OUTLIER Glycine 0 C--N 1.336 0.565 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 178.941 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.21 171.71 8.43 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.012 0.925 . . . . 0.0 109.446 179.068 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -128.46 146.37 50.83 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.142 0.977 . . . . 0.0 111.168 -179.201 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -153.1 155.17 31.76 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 125.866 1.667 . . . . 0.0 108.201 -179.707 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.28 -32.63 61.58 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.945 2.43 . . . . 0.0 111.137 178.874 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.9 m -74.78 164.93 3.38 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 C-N-CA 123.576 0.75 . . . . 0.0 111.094 179.276 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -100.43 -61.3 1.39 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.024 1.33 . . . . 0.0 109.203 179.431 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 135.77 -165.72 24.75 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.71 1.148 . . . . 0.0 110.998 179.441 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.61 138.21 23.31 Favored 'Cis proline' 0 C--N 1.345 0.392 0 CA-C-N 118.247 1.024 . . . . 0.0 111.533 -0.632 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -135.25 138.95 44.04 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 179.989 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -125.3 157.81 35.73 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.626 1.57 . . . . 0.0 112.116 -178.748 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.33 157.26 25.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 127.631 2.373 . . . . 0.0 114.151 -177.934 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.553 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 60.7 t80 -160.8 113.36 1.32 Allowed Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.248 1.019 . . . . 0.0 110.157 177.915 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . 0.269 24.8 Cg_endo -70.52 138.64 35.86 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 CA-C-N 120.17 1.097 . . . . 0.0 112.731 -177.243 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.499 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -80.96 -149.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -176.969 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.499 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 27.0 mmmt -83.35 -171.04 3.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 131.156 3.783 . . . . 0.0 111.945 -178.15 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.3 t 91.56 54.97 0.0 OUTLIER 'General case' 0 C--N 1.343 0.295 0 C-N-CA 129.56 3.144 . . . . 0.0 105.383 -178.008 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.21 -46.02 0.84 Allowed Glycine 0 CA--C 1.53 0.997 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -178.377 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.29 172.09 24.09 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.364 1.459 . . . . 0.0 109.989 179.41 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.35 114.46 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 178.939 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 75.1 t80 61.63 75.81 0.39 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.163 1.385 . . . . 0.0 111.462 -179.181 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 t -160.26 -178.34 6.89 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.341 1.057 . . . . 0.0 110.128 178.724 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.16 -150.54 1.94 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.665 1.126 . . . . 0.0 112.316 179.508 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.4 -55.3 4.72 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -178.997 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.4 t -137.8 79.52 33.54 Favored Pre-proline 0 N--CA 1.451 -0.386 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.647 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -35.09 -54.63 0.63 Allowed 'Trans proline' 0 C--N 1.349 0.595 1 C-N-CA 126.242 4.628 . . . . 0.0 116.362 -175.824 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.72 99.26 0.16 Allowed Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.59 -0.815 . . . . 0.0 113.559 -179.231 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.442 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -155.11 -76.52 0.1 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 177.244 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.59 110.53 1.15 Allowed 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.761 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -136.29 119.66 16.84 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.821 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.4 m -89.15 152.0 3.4 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 176.622 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -137.75 141.77 38.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -176.982 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.59 179.56 4.17 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 123.72 0.808 . . . . 0.0 112.531 -178.485 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -96.38 169.84 9.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.461 1.905 . . . . 0.0 110.015 -178.62 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.278 6.5 t -76.56 28.03 0.13 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 118.051 2.611 . . . . 0.0 118.051 -177.967 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -129.5 -78.0 0.55 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 102.648 -3.093 . . . . 0.0 102.648 177.167 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.09 -19.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -178.686 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -79.28 145.57 33.45 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -175.4 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . 0.267 31.7 m-85 -63.61 157.16 24.55 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 127.498 2.319 . . . . 0.0 115.497 -179.042 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -113.84 -44.53 3.16 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 175.556 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.01 -148.45 20.22 Favored Glycine 0 C--N 1.349 1.262 0 C-N-CA 126.222 1.867 . . . . 0.0 111.752 177.576 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.84 147.77 35.96 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-O 121.554 0.693 . . . . 0.0 112.283 -178.79 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 pt -147.0 167.39 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 127.017 2.127 . . . . 0.0 108.376 -179.108 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.6 t -158.88 148.13 18.82 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 179.548 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.442 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 24.7 m170 -83.67 36.1 0.53 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.196 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.3 t -58.72 -35.51 72.79 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.46 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -173.25 60.35 0.14 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.568 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -97.17 -71.06 0.69 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.279 1.032 . . . . 0.0 108.999 179.323 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.3 t -170.66 -62.86 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.758 1.623 . . . . 0.0 109.041 179.219 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.46 -87.11 0.06 OUTLIER Glycine 0 C--N 1.338 0.671 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 179.407 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -79.87 -18.25 51.16 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.531 0.732 . . . . 0.0 110.215 178.743 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -65.03 168.36 6.64 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.369 1.468 . . . . 0.0 110.727 179.327 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -136.27 169.79 17.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.914 1.285 . . . . 0.0 113.056 -177.972 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.3 m -141.38 164.82 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.94 2.096 . . . . 0.0 106.424 176.65 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.47 142.65 27.26 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 115.029 0.772 . . . . 0.0 115.029 -177.493 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 24.6 t -109.37 169.99 8.35 Favored 'General case' 0 C--N 1.341 0.202 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 177.671 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.36 -157.57 0.33 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.684 -0.635 . . . . 0.0 109.425 -178.3 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.53 -9.34 58.25 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 124.183 0.897 . . . . 0.0 111.396 177.346 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.7 m -79.41 143.42 35.06 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 125.17 1.388 . . . . 0.0 108.982 179.213 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.189 1.396 . . . . 0.0 109.956 -179.217 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 121.215 0.531 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 81.6 p -85.93 176.86 7.83 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.419 1.087 . . . . 0.0 109.762 179.117 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.33 127.43 8.96 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.061 1.345 . . . . 0.0 111.084 179.104 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -111.61 123.48 50.32 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.814 1.246 . . . . 0.0 109.713 -178.802 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -129.71 93.66 3.57 Favored 'General case' 0 N--CA 1.428 -1.53 1 N-CA-C 98.558 -4.608 . . . . 0.0 98.558 176.839 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.5 m -102.91 88.3 3.15 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.195 0.598 . . . . 0.0 110.295 -177.655 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.07 -79.38 1.02 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -178.946 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.2 p -132.83 -31.69 1.3 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.304 1.842 . . . . 0.0 110.464 178.521 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 m -67.41 106.7 2.19 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.024 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -108.07 141.66 39.42 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.546 1.138 . . . . 0.0 111.738 -178.352 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -144.45 144.33 31.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.779 1.632 . . . . 0.0 108.155 179.356 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.8 t -70.11 155.43 40.63 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 124.448 1.099 . . . . 0.0 109.912 178.957 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.71 -21.94 56.23 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 176.388 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -73.2 -35.85 66.43 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 125.157 1.383 . . . . 0.0 109.959 179.215 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.2 tp-100 -73.75 -35.56 65.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.173 0.589 . . . . 0.0 112.384 179.185 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 t -69.02 -47.13 77.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.377 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.3 ptt85 -65.26 -43.26 91.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.02 0.528 . . . . 0.0 110.554 179.551 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.72 89.5 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.543 0.737 . . . . 0.0 109.398 179.023 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.81 -38.98 79.81 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.369 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.92 -29.73 62.2 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 178.506 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -70.81 -24.1 62.49 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.494 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HB1' ' CE2' ' A' ' 26' ' ' TYR . . . -77.36 -64.3 1.17 Allowed 'General case' 0 C--N 1.346 0.441 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 -178.76 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.535 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -39.25 -50.59 1.98 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.078 1.351 . . . . 0.0 112.211 176.445 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -51.99 -62.88 1.35 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 128.029 2.531 . . . . 0.0 111.586 179.324 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -66.03 -42.12 90.03 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.543 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.422 ' CE2' ' HB1' ' A' ' 22' ' ' ALA . 6.4 m-30 -67.54 -30.85 70.6 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.418 1.087 . . . . 0.0 113.149 -177.728 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -84.48 -44.64 13.43 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 118.957 0.799 . . . . 0.0 112.12 -179.739 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -69.56 -51.13 38.25 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.233 0.613 . . . . 0.0 111.648 -179.007 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -78.03 -20.61 52.11 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.789 -179.458 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 63.74 65.21 0.73 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 124.935 1.294 . . . . 0.0 110.362 179.815 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -150.55 167.38 27.38 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 126.032 1.733 . . . . 0.0 108.049 179.099 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.287 0.0 OUTLIER 49.53 71.58 0.38 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.263 1.025 . . . . 0.0 113.46 -179.459 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.63 144.91 25.54 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.06 1.344 . . . . 0.0 108.549 179.179 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.72 -165.85 23.0 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.804 -0.519 . . . . 0.0 111.804 -179.42 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.1 m -83.86 46.66 1.2 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.904 0.882 . . . . 0.0 111.139 -179.384 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 87.7 p -146.75 161.54 40.4 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 178.733 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.7 p -80.11 33.31 0.28 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.885 -179.556 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -92.65 127.23 48.99 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 119.922 1.237 . . . . 0.0 109.504 -178.462 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -60.95 120.67 1.21 Allowed 'Cis proline' 0 C--N 1.348 0.506 0 N-CA-C 116.144 1.556 . . . . 0.0 116.144 -1.426 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -103.65 157.3 17.16 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.488 1.115 . . . . 0.0 108.84 178.933 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.92 118.86 8.36 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 122.706 0.403 . . . . 0.0 110.956 179.871 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.92 105.4 13.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 178.771 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -153.59 143.16 21.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.93 0.892 . . . . 0.0 110.296 -178.664 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 56.0 -134.0 1.44 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.07 1.348 . . . . 0.0 110.999 178.998 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 73.92 -73.7 0.09 Allowed 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.139 1.776 . . . . 0.0 109.065 -179.302 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -127.82 -37.09 1.96 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.787 1.635 . . . . 0.0 109.176 178.949 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.09 70.65 1.3 Allowed Glycine 0 C--N 1.342 0.874 0 C-N-CA 124.243 0.925 . . . . 0.0 112.027 178.92 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.33 -169.05 2.42 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.689 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -154.64 156.94 37.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.487 0.715 . . . . 0.0 110.689 179.449 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -148.92 144.51 18.24 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 125.739 1.616 . . . . 0.0 107.616 178.681 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -45.19 -45.47 14.74 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.49 3.46 . . . . 0.0 113.371 178.649 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -83.31 149.11 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 124.158 0.983 . . . . 0.0 110.482 179.323 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -91.61 168.7 11.32 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.855 1.262 . . . . 0.0 111.162 -178.854 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.08 -158.16 27.3 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.386 0.993 . . . . 0.0 111.797 -179.244 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.91 128.09 2.94 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 CA-C-N 118.215 1.007 . . . . 0.0 112.202 -0.362 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.44 158.33 21.71 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.907 2.083 . . . . 0.0 109.025 178.793 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -137.08 164.28 28.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.558 -177.954 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.98 157.54 26.8 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 126.709 2.004 . . . . 0.0 110.698 -178.078 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.535 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 56.9 t80 -160.12 96.77 1.51 Allowed Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 176.246 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.58 145.76 47.78 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 C-N-CA 120.379 0.719 . . . . 0.0 110.935 -176.119 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.589 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 2.9 tt -109.33 -172.77 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 124.253 1.978 . . . . 0.0 111.589 178.639 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.589 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 2.9 tttm -160.02 152.13 20.55 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 109.12 -3.673 . . . . 0.0 109.84 -179.397 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.1 t -76.58 52.27 0.79 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.628 1.571 . . . . 0.0 113.748 -178.165 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.0 43.05 0.24 Allowed Glycine 0 CA--C 1.526 0.759 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.402 178.016 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.58 76.48 0.03 OUTLIER Glycine 0 C--N 1.345 1.049 0 CA-C-N 119.53 1.665 . . . . 0.0 116.247 178.767 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 67' ' ' TYR 0.333 8.6 p 37.06 -139.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.43 0 C-N-CA 126.167 1.787 . . . . 0.0 113.385 177.683 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.422 ' H ' HG22 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -58.12 -175.9 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.604 2.362 . . . . 0.0 114.173 178.548 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.1 p -78.92 158.74 27.98 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.398 1.079 . . . . 0.0 113.854 -177.373 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 178.77 47.98 0.07 OUTLIER Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.247 1.88 . . . . 0.0 108.686 179.247 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 170.25 -160.19 32.91 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.139 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 76.9 p -158.84 156.71 27.36 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 124.752 1.221 . . . . 0.0 109.437 -179.329 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -79.74 166.07 78.22 Favored 'Cis proline' 0 N--CA 1.458 -0.56 0 CA-C-N 119.427 0.831 . . . . 0.0 111.36 -2.505 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.64 -109.45 1.1 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 124.224 0.916 . . . . 0.0 112.406 -178.935 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.484 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . 58.68 35.39 24.41 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 125.362 1.465 . . . . 0.0 111.541 -178.753 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -152.51 107.77 3.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.324 1.05 . . . . 0.0 110.529 178.377 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.44 130.56 19.54 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.51 -179.314 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.4 m -98.52 157.29 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 176.361 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.6 t -135.44 133.15 52.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -178.479 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -116.61 -179.95 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.781 1.232 . . . . 0.0 112.444 -178.307 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -101.45 174.82 5.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.952 2.101 . . . . 0.0 109.548 179.128 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.31 13.7 t -82.19 49.08 1.34 Allowed 'General case' 0 C--N 1.345 0.386 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -178.576 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -152.46 -87.99 0.06 Allowed 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 177.429 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 94.9 m -161.83 -0.22 0.05 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.874 2.469 . . . . 0.0 113.879 -176.898 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -80.06 138.85 37.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.364 0.984 . . . . 0.0 113.063 -176.866 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -80.0 128.39 33.42 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.405 1.482 . . . . 0.0 108.042 178.829 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.28 -47.89 6.42 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 123.556 0.743 . . . . 0.0 110.505 179.605 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.15 -174.24 46.25 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 179.339 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.97 141.88 44.48 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.39 1.476 . . . . 0.0 109.915 179.329 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.5 pt -141.07 157.26 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.795 1.238 . . . . 0.0 109.621 -179.079 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.0 t -150.81 149.81 30.19 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.126 0.97 . . . . 0.0 113.402 -178.48 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.484 ' HB2' ' CB ' ' A' ' 74' ' ' ALA 0.266 37.8 m170 -79.51 -24.1 42.49 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.972 0.805 . . . . 0.0 109.118 175.999 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.1 m -50.75 102.55 0.04 OUTLIER 'General case' 0 C--N 1.343 0.299 0 C-N-CA 126.339 1.855 . . . . 0.0 109.255 178.994 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.13 63.23 1.75 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -178.646 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.47 179.57 8.05 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.385 1.074 . . . . 0.0 110.609 179.571 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.7 t -86.18 62.07 7.21 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.507 1.523 . . . . 0.0 110.527 -179.353 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.21 -90.03 0.43 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.824 1.678 . . . . 0.0 113.199 178.418 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.35 -23.12 43.62 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.148 0.979 . . . . 0.0 111.344 -179.064 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -59.75 158.38 10.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.472 1.109 . . . . 0.0 112.129 -179.086 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -121.15 135.0 55.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.084 1.754 . . . . 0.0 108.991 -179.459 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 m -110.06 163.5 6.97 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.697 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.65 149.34 31.62 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.894 0.759 . . . . 0.0 112.935 -178.439 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.7 t -137.26 164.67 27.97 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 125.725 1.61 . . . . 0.0 108.849 178.76 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 96.4 p 46.47 50.65 12.47 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.366 2.267 . . . . 0.0 112.631 -179.649 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.12 64.04 2.28 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.241 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -146.01 132.99 20.22 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.863 1.265 . . . . 0.0 108.132 179.083 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 116.756 -1.592 . . . . 0.0 109.036 179.352 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 121.235 0.54 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t -159.88 71.86 0.49 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.272 1.029 . . . . 0.0 108.576 -179.338 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.84 97.52 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.416 1.886 . . . . 0.0 110.878 179.34 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.5 m -99.69 121.73 41.67 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.46 1.904 . . . . 0.0 107.504 -178.733 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -122.59 111.29 16.6 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -179.683 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.3 m -100.04 81.91 2.48 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.484 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.89 -95.36 0.72 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.317 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.6 p -104.23 -36.33 7.68 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.116 1.366 . . . . 0.0 110.977 179.375 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -73.83 103.77 4.48 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.113 0.565 . . . . 0.0 110.099 -178.876 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -83.06 152.91 25.16 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.43 1.092 . . . . 0.0 110.622 -179.243 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -148.11 137.71 22.33 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.964 0.906 . . . . 0.0 111.281 -179.815 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.5 m -78.17 150.44 33.56 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.475 1.51 . . . . 0.0 107.757 178.295 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.96 -17.5 25.3 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.087 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.2 t -74.55 -44.99 48.43 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 124.506 1.122 . . . . 0.0 109.513 178.956 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -68.7 -43.73 75.42 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.051 0.94 . . . . 0.0 110.917 -179.894 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.9 t -56.72 -54.4 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 C-N-CA 126.988 2.115 . . . . 0.0 109.135 178.954 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -67.93 -43.05 80.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.071 -178.128 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.8 -49.48 77.33 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.694 0.679 . . . . 0.0 109.674 179.297 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.82 -31.75 68.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.313 1.045 . . . . 0.0 110.478 178.837 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.47 -38.47 29.87 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 179.769 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -66.7 -22.12 66.08 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.419 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.09 -54.91 5.53 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -179.182 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.439 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -46.77 -43.71 18.43 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.431 1.492 . . . . 0.0 112.499 177.853 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.0 p -73.28 -43.42 61.04 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.996 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -60.99 -31.02 70.63 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.137 0.426 . . . . 0.0 110.685 178.737 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -97.14 -3.88 40.26 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.341 1.457 . . . . 0.0 113.135 -179.177 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -57.45 -24.82 57.92 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.358 -0.839 . . . . 0.0 111.663 178.722 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.467 0.0 OUTLIER 127.73 59.44 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.634 1 C-N-CA 135.15 5.38 . . . . 0.0 112.837 -178.221 . . . . . . . . 4 3 . 1 . 041 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -129.16 -35.11 1.83 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.696 1.198 . . . . 0.0 112.188 -179.109 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -153.96 64.72 0.71 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.22 0.918 . . . . 0.0 113.127 179.505 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 t70 57.89 -170.32 0.11 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.315 1.446 . . . . 0.0 113.285 178.154 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.3 p 47.68 43.67 16.79 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.924 1.69 . . . . 0.0 112.94 179.049 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.85 -175.59 3.54 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.279 1.431 . . . . 0.0 114.426 -178.532 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -32.35 138.02 0.1 Allowed Glycine 0 C--N 1.341 0.846 0 C-N-CA 128.118 2.771 . . . . 0.0 117.558 -178.217 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.9 m -101.88 -55.94 2.39 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.311 1.444 . . . . 0.0 110.629 -179.519 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.6 p -97.65 -63.57 1.12 Allowed 'General case' 0 C--N 1.346 0.454 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -179.256 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.8 p -146.41 -42.03 0.2 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.598 1.959 . . . . 0.0 110.376 -179.532 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -91.59 151.6 42.62 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 124.692 1.197 . . . . 0.0 109.746 -178.088 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -84.38 134.2 20.57 Favored 'Cis proline' 0 N--CA 1.45 -1.048 0 CA-C-N 119.655 0.913 . . . . 0.0 111.127 -1.72 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.05 172.9 15.15 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 126.033 1.733 . . . . 0.0 108.207 179.412 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 t -60.4 147.77 39.66 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.715 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -80.01 116.61 20.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.998 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -68.48 -52.75 28.9 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.654 1.181 . . . . 0.0 112.301 -179.345 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -88.38 -170.04 2.8 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.482 1.113 . . . . 0.0 111.173 -179.061 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -129.07 -50.78 1.21 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.635 1.974 . . . . 0.0 108.638 179.505 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 53.99 70.61 0.59 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.326 1.85 . . . . 0.0 113.763 178.455 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.45 -98.38 0.24 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.684 1.135 . . . . 0.0 113.217 178.579 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.05 154.15 16.27 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.689 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -121.21 -170.11 1.96 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 126.23 1.812 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -131.25 158.38 75.41 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 125.328 1.451 . . . . 0.0 108.233 -178.63 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.409 ' O ' HG13 ' A' ' 52' ' ' VAL . 81.2 Cg_endo -73.5 66.57 4.58 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 124.006 3.137 . . . . 0.0 113.226 -178.766 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 51' ' ' PRO . 3.0 m -163.1 164.94 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 126.86 2.064 . . . . 0.0 108.873 179.315 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -84.77 -58.99 2.49 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.478 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.95 177.63 15.02 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.11 1.338 . . . . 0.0 110.516 -179.321 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.57 139.17 58.46 Favored 'Cis proline' 0 N--CA 1.457 -0.629 0 CA-C-N 117.916 0.858 . . . . 0.0 111.442 0.127 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -114.8 150.79 34.89 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.891 1.277 . . . . 0.0 109.511 178.698 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -113.7 159.32 19.84 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -177.002 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -98.7 152.48 19.61 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.133 1.773 . . . . 0.0 109.529 179.132 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 58.6 t80 -160.84 119.83 1.53 Allowed Pre-proline 0 C--O 1.223 -0.301 0 C-N-CA 124.008 0.923 . . . . 0.0 108.707 177.272 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.91 122.97 3.09 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 121.229 1.286 . . . . 0.0 113.795 -177.572 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 62' ' ' LYS . 4.4 tp -86.17 168.25 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 CA-C-O 123.678 1.704 . . . . 0.0 111.998 179.293 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.408 ' N ' HG13 ' A' ' 61' ' ' ILE . 25.9 mmtt -158.64 158.11 33.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 109.233 -3.621 . . . . 0.0 111.604 -178.851 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.1 m -84.92 60.04 5.97 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.813 1.645 . . . . 0.0 110.36 -178.946 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.85 -61.69 0.01 OUTLIER Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 179.083 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.85 -104.47 0.19 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.207 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.24 163.97 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.429 1.092 . . . . 0.0 108.438 -179.455 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.93 152.63 12.52 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -178.37 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.8 p -139.21 -65.68 0.48 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.649 1.58 . . . . 0.0 108.575 179.378 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.02 105.11 0.27 Allowed Glycine 0 C--N 1.341 0.837 0 C-N-CA 124.417 1.008 . . . . 0.0 110.783 179.301 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -150.1 19.97 1.09 Allowed Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.808 -0.996 . . . . 0.0 113.069 179.313 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.1 m 67.42 119.97 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 126.375 1.87 . . . . 0.0 112.069 179.204 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.71 -176.24 17.91 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 CA-C-N 119.785 0.959 . . . . 0.0 112.499 0.131 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.07 66.99 0.32 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 108.19 -1.964 . . . . 0.0 108.19 179.287 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.95 -58.85 2.27 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.474 0.71 . . . . 0.0 112.097 -178.831 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -61.14 117.83 6.05 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.434 1.494 . . . . 0.0 113.398 -178.116 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -138.56 118.15 13.02 Favored 'General case' 0 C--N 1.344 0.368 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.159 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.5 m -81.64 148.39 5.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 176.879 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.27 53.6 t -130.97 111.51 20.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -178.071 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -101.12 -179.67 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 125.861 1.664 . . . . 0.0 113.936 -176.382 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -101.86 155.16 18.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 127.957 2.503 . . . . 0.0 108.62 179.875 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.282 11.4 t -64.11 -8.45 12.1 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -178.323 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -84.27 -80.74 0.19 Allowed 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 102.485 -3.154 . . . . 0.0 102.485 177.645 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 23.4 m -164.34 -7.39 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 129.589 3.155 . . . . 0.0 114.951 -179.17 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -79.68 132.76 36.29 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 116.501 2.038 . . . . 0.0 116.501 -175.314 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -75.34 123.16 24.87 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.152 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.51 -59.55 2.28 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.825 0.85 . . . . 0.0 111.258 -178.184 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.11 164.28 33.54 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -179.899 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.29 158.81 19.29 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.814 0.816 . . . . 0.0 112.25 -178.858 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.8 pt -140.46 160.3 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.329 2.252 . . . . 0.0 106.859 179.288 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.3 t -156.65 152.15 26.78 Favored 'General case' 0 C--N 1.343 0.326 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -179.046 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -83.57 38.34 0.62 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.337 0.655 . . . . 0.0 111.07 176.571 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.2 m -77.7 -73.3 0.31 Allowed 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.369 0.986 . . . . 0.0 109.624 -179.334 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.35 -9.21 60.63 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.489 1.043 . . . . 0.0 112.116 178.939 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.81 155.07 27.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.555 1.542 . . . . 0.0 111.748 178.993 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.8 m -68.89 -50.09 52.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.659 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.93 -84.29 0.05 OUTLIER Glycine 0 CA--C 1.527 0.787 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.193 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -89.01 0.32 56.77 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.127 0.971 . . . . 0.0 111.891 179.828 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -71.34 -170.57 0.51 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.863 0.865 . . . . 0.0 110.56 179.516 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -147.78 160.88 42.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.644 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.1 m -142.41 162.7 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 127.585 2.354 . . . . 0.0 106.334 177.012 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.98 121.53 5.55 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.074 0.845 . . . . 0.0 114.401 -178.808 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.44 159.6 15.03 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.65 1.18 . . . . 0.0 109.404 178.502 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.7 p 60.27 45.22 11.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.472 1.909 . . . . 0.0 111.042 -178.781 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.01 44.17 96.3 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.299 0.952 . . . . 0.0 111.928 179.448 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.9 m -104.84 149.53 25.59 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.625 1.17 . . . . 0.0 109.362 179.316 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.106 0 C-N-CA 124.445 1.098 . . . . 0.0 108.146 179.083 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 110.727 -0.101 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.9 m -146.33 163.2 36.31 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.607 1.163 . . . . 0.0 109.684 -179.312 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.03 124.58 19.18 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.427 1.091 . . . . 0.0 109.817 179.274 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 p -89.46 81.39 6.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -178.309 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.27 92.09 6.88 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 175.877 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -100.51 79.06 2.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.535 1.534 . . . . 0.0 109.324 -177.643 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.76 -70.62 1.98 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.345 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.2 p -137.98 -34.11 0.68 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.632 1.573 . . . . 0.0 111.877 179.453 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 m -72.67 93.55 1.65 Allowed 'General case' 0 C--N 1.345 0.389 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.148 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -96.6 113.74 25.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.777 1.631 . . . . 0.0 112.869 -178.43 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -109.78 144.75 37.77 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.885 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 16' ' ' VAL . 50.0 m -66.37 152.3 45.33 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 124.229 1.011 . . . . 0.0 109.527 179.148 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.94 -24.73 25.16 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.705 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.4 t -71.33 -43.79 66.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.146 1.378 . . . . 0.0 109.594 179.31 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -71.86 -29.47 64.41 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -179.263 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 12' ' ' SER . 1.9 t -72.29 -45.26 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.28 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -67.86 -32.94 73.79 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.37 1.068 . . . . 0.0 111.857 179.393 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.04 -58.17 5.43 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.444 1.02 . . . . 0.0 110.135 -179.265 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.4 ' HB1' ' HE2' ' A' ' 59' ' ' PHE . . . -60.53 -37.09 80.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.787 -178.843 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.78 58.63 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 179.413 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -68.78 -19.89 64.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.785 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.54 -60.86 2.17 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 179.525 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.463 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . . . -48.71 -41.34 31.55 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.371 1.068 . . . . 0.0 112.4 177.219 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -55.74 30.86 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.002 1.321 . . . . 0.0 109.906 179.014 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -56.55 -31.47 64.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.675 1.19 . . . . 0.0 110.893 -178.379 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 -89.07 -32.05 17.74 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -178.832 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -63.94 -36.53 84.26 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.636 1.107 . . . . 0.0 113.927 -177.7 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -105.33 27.0 8.72 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.975 0.91 . . . . 0.0 111.98 -178.513 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.99 -36.83 8.46 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.076 0.95 . . . . 0.0 111.992 179.338 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.7 t70 83.49 96.19 0.04 OUTLIER 'General case' 0 C--N 1.344 0.345 0 C-N-CA 127.354 2.262 . . . . 0.0 108.789 -178.597 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 70.99 109.0 0.06 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 127.192 2.197 . . . . 0.0 109.65 -178.755 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -175.97 -47.98 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.25 1.42 . . . . 0.0 111.422 -177.622 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.88 96.92 3.21 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.986 0.514 . . . . 0.0 109.845 -179.288 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.16 49.62 3.78 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.564 1.078 . . . . 0.0 110.461 179.705 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.0 m -89.14 -76.49 0.41 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.799 1.239 . . . . 0.0 108.374 -179.463 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.8 t -173.72 -64.98 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.114 1.765 . . . . 0.0 106.48 179.235 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.525 HG23 ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -150.08 8.67 0.65 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.388 1.475 . . . . 0.0 111.857 178.84 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -94.95 129.8 34.7 Favored Pre-proline 0 C--N 1.345 0.382 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.294 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -70.15 129.0 13.94 Favored 'Cis proline' 0 N--CA 1.456 -0.726 0 N-CA-C 115.444 1.286 . . . . 0.0 115.444 0.115 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.525 ' CE1' HG23 ' A' ' 37' ' ' THR 0.252 21.3 m-70 -96.87 143.65 27.57 Favored 'General case' 0 C--N 1.343 0.298 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 178.059 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 t -63.14 142.15 58.49 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.584 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -107.35 119.26 38.92 Favored 'General case' 0 C--O 1.23 0.048 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.04 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -149.64 -63.57 0.22 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.279 1.832 . . . . 0.0 107.085 178.921 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.4 t30 50.91 -115.56 0.88 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.03 1.732 . . . . 0.0 112.044 178.798 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -169.37 -174.96 2.08 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.02 2.128 . . . . 0.0 107.627 -179.165 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 76.93 157.42 0.18 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.801 1.641 . . . . 0.0 110.869 179.319 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.45 70.14 2.47 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.077 0.846 . . . . 0.0 111.292 179.19 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.5 111.74 6.55 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.167 1.387 . . . . 0.0 107.809 179.042 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -148.31 -175.49 4.93 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.847 1.259 . . . . 0.0 108.355 179.721 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -132.01 144.97 55.42 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.662 1.185 . . . . 0.0 108.647 -179.076 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.23 67.3 6.95 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 124.36 3.373 . . . . 0.0 112.293 -179.226 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.05 -170.65 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 127.496 2.318 . . . . 0.0 107.573 179.246 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -118.57 131.33 56.21 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.765 1.226 . . . . 0.0 109.606 179.18 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.02 -172.23 45.92 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.324 0.964 . . . . 0.0 112.341 -179.353 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.95 151.93 97.61 Favored 'Cis proline' 0 N--CA 1.458 -0.594 0 CA-C-N 118.041 0.92 . . . . 0.0 111.809 0.078 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -118.14 176.28 5.29 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.861 1.265 . . . . 0.0 109.942 179.324 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.12 153.51 31.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.972 178.992 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.274 8.0 tp10 -79.92 150.05 30.67 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.099 2.56 . . . . 0.0 111.579 -177.7 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 77.7 t80 -155.27 106.0 2.23 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.004 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.429 ' HG2' ' CD1' ' A' ' 67' ' ' TYR . 60.5 Cg_endo -72.71 135.06 23.11 Favored 'Trans proline' 0 N--CA 1.442 -1.542 0 N-CA-C 107.674 -1.702 . . . . 0.0 107.674 -177.311 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.466 ' CG1' ' H ' ' A' ' 62' ' ' LYS 0.266 0.1 OUTLIER -85.76 -147.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.34 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -176.1 . . . . . . . . 4 4 . 1 . 042 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.466 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.9 mmmm -79.25 166.28 22.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 110.936 -2.847 . . . . 0.0 111.401 -178.287 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.2 m 132.31 51.73 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.493 1 C-N-CA 133.199 4.599 . . . . 0.0 104.723 -177.987 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.54 -52.09 0.59 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.665 1.602 . . . . 0.0 109.243 -178.545 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 177.53 -164.72 34.02 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.483 1.04 . . . . 0.0 110.562 179.728 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.6 p -75.25 71.33 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.92 1.288 . . . . 0.0 107.975 178.888 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.429 ' CD1' ' HG2' ' A' ' 60' ' ' PRO . 34.7 t80 65.81 80.07 0.23 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 128.484 2.713 . . . . 0.0 111.251 -178.269 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 t -157.78 105.59 2.01 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.782 1.233 . . . . 0.0 108.909 179.083 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 179.13 -118.71 0.61 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.4 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 174.29 -99.4 0.14 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.159 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.0 m -60.84 -58.2 21.0 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.241 1.016 . . . . 0.0 112.138 179.534 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.17 134.31 36.17 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.064 1.843 . . . . 0.0 110.497 177.788 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.99 -103.64 0.17 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 179.522 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.441 ' HB1' ' H ' ' A' ' 91' ' ' HIS . . . 72.66 -46.42 0.65 Allowed 'General case' 0 C--N 1.344 0.366 0 C-N-CA 127.257 2.223 . . . . 0.0 113.502 -179.645 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.24 125.17 28.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.848 1.659 . . . . 0.0 112.744 -178.488 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -146.28 124.18 12.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.686 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.5 m -86.76 156.17 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 103.317 -2.846 . . . . 0.0 103.317 177.098 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 73.3 t -134.89 115.49 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 -178.08 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 85' ' ' TYR . 1.8 pt -95.52 165.92 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.428 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -176.313 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -99.75 163.03 12.65 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 124.677 1.191 . . . . 0.0 108.185 178.949 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.327 5.2 t -74.11 27.84 0.08 Allowed 'General case' 0 C--N 1.339 0.144 0 N-CA-C 119.698 3.221 . . . . 0.0 119.698 -177.232 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -123.35 -79.32 0.61 Allowed 'General case' 0 N--CA 1.441 -0.917 1 N-CA-C 100.058 -4.053 . . . . 0.0 100.058 176.61 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.0 t -164.13 -24.03 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.14 1.776 . . . . 0.0 114.409 179.008 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -79.68 127.42 32.17 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -176.442 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 79' ' ' ILE 0.344 4.5 p90 -82.24 147.67 28.82 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 123.665 0.603 . . . . 0.0 111.343 -178.922 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.81 -46.26 19.13 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.655 1.182 . . . . 0.0 111.335 -177.338 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.79 -153.69 16.6 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.116 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.82 150.36 32.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.393 0.616 . . . . 0.0 111.402 -179.308 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 44.2 pt -138.47 157.86 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.031 1.733 . . . . 0.0 108.043 -179.337 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.8 t -157.7 154.89 29.01 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.063 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.441 ' H ' ' HB1' ' A' ' 74' ' ' ALA . 11.3 m170 -79.34 -14.89 58.69 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 123.344 0.403 . . . . 0.0 110.297 175.517 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.3 m -62.0 115.3 3.96 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 123.873 0.869 . . . . 0.0 109.832 -179.304 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.27 -15.3 63.52 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.959 0.79 . . . . 0.0 112.382 -179.11 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.97 -177.45 5.57 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.446 1.098 . . . . 0.0 111.4 -179.564 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.8 t -87.36 59.46 5.54 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.836 1.255 . . . . 0.0 111.141 -179.396 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.34 -89.31 1.01 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.971 1.272 . . . . 0.0 112.865 178.486 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -79.8 -31.6 40.74 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.405 1.082 . . . . 0.0 111.22 -179.35 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -55.21 165.65 0.69 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.685 1.594 . . . . 0.0 111.709 179.627 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -120.18 155.25 33.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.48 1.512 . . . . 0.0 111.956 -179.178 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.3 m -139.17 163.05 27.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 C-N-CA 125.949 1.7 . . . . 0.0 107.96 177.794 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.81 140.15 19.94 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.892 0.758 . . . . 0.0 112.183 -178.717 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 t -83.22 -177.41 6.74 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.658 1.183 . . . . 0.0 109.73 178.949 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.8 t -70.51 112.35 6.72 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.822 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.86 -41.24 2.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -178.95 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.1 m -86.49 94.19 9.35 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.988 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 t30 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.225 -1.369 . . . . 0.0 109.445 -178.918 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 N--CA 1.456 -0.159 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 77.29 66.77 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.31 140.28 29.76 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 125.502 1.521 . . . . 0.0 109.136 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.02 121.95 35.86 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.5 m -102.14 78.8 1.8 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.154 1.381 . . . . 0.0 107.864 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.38 -97.45 0.68 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 t -100.35 -39.56 7.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.933 1.293 . . . . 0.0 110.034 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.5 m -72.25 96.49 1.84 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.347 1.059 . . . . 0.0 109.767 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -79.92 155.67 27.63 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.257 1.023 . . . . 0.0 110.867 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -143.35 119.76 10.96 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.218 1.007 . . . . 0.0 110.744 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.5 t -60.24 159.09 10.37 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.147 1.779 . . . . 0.0 110.663 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.02 -17.34 51.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 t -76.86 -43.93 34.18 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.601 1.16 . . . . 0.0 108.743 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.81 -45.89 80.66 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.665 1.186 . . . . 0.0 111.305 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.433 HG13 ' CE2' ' A' ' 85' ' ' TYR . 73.6 t -58.2 -52.6 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.739 1.216 . . . . 0.0 108.345 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -68.18 -31.6 71.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.3 1.44 . . . . 0.0 113.484 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.14 -60.05 2.93 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.933 0.788 . . . . 0.0 109.417 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 -30.25 71.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.462 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.07 -51.51 15.54 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 119.507 -0.283 . . . . 0.0 111.494 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -60.36 -19.7 56.66 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.32 -72.16 0.27 Allowed 'General case' 0 C--N 1.347 0.49 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.599 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -56.03 -29.47 60.46 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.224 0.92 . . . . 0.0 111.788 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.6 t -56.86 -44.13 81.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.485 1.039 . . . . 0.0 109.005 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -96.58 4.01 52.24 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -126.54 -12.43 6.12 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -74.65 -53.09 9.98 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 119.186 0.903 . . . . 0.0 113.089 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.326 0.0 OUTLIER -137.47 33.56 2.51 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.949 0.881 . . . . 0.0 112.275 -177.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -74.0 -64.93 0.91 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 176.7 37.68 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 129.024 2.93 . . . . 0.0 109.284 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -176.14 -171.13 0.41 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.134 1.774 . . . . 0.0 109.246 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.5 p -122.63 -51.65 1.93 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.929 2.092 . . . . 0.0 109.195 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 43.62 55.03 5.2 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 126.666 1.986 . . . . 0.0 112.081 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.33 179.68 25.93 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 112.251 -2.25 . . . . 0.0 111.625 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.8 p -61.44 -66.99 0.45 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.048 0.939 . . . . 0.0 110.215 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.0 t -163.7 -66.33 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.594 1.158 . . . . 0.0 108.541 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.1 p -106.48 31.27 5.32 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.364 1.066 . . . . 0.0 110.999 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -164.95 104.75 0.8 Allowed Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.538 1.535 . . . . 0.0 107.723 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -64.17 156.42 72.75 Favored 'Cis proline' 0 N--CA 1.456 -0.731 0 CA-C-N 120.289 1.139 . . . . 0.0 113.555 -0.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.63 168.54 6.27 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.884 1.673 . . . . 0.0 108.985 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 t -68.25 151.62 46.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -79.84 110.34 15.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -10.69 -91.14 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.951 3.301 . . . . 0.0 115.488 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 143.78 -54.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 130.269 3.428 . . . . 0.0 106.929 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -56.94 124.32 18.21 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.062 1.345 . . . . 0.0 109.888 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 62.28 58.59 1.74 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.954 1.302 . . . . 0.0 108.536 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.41 111.34 4.1 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.712 1.149 . . . . 0.0 110.624 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.24 169.2 16.84 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.572 0.749 . . . . 0.0 110.626 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -71.2 130.2 40.83 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.121 1.369 . . . . 0.0 113.682 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -163.6 120.98 1.2 Allowed Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 126.152 1.781 . . . . 0.0 108.706 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -65.29 -165.64 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.987 2.458 . . . . 0.0 111.111 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.7 t 76.96 -101.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.178 1.391 . . . . 0.0 110.045 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -167.8 -67.09 0.03 OUTLIER 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.178 0.899 . . . . 0.0 111.609 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.68 -172.7 14.75 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.256 1.408 . . . . 0.0 109.584 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.55 163.59 52.05 Favored 'Cis proline' 0 N--CA 1.456 -0.715 0 CA-C-N 119.118 1.459 . . . . 0.0 111.707 -1.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -110.71 172.9 6.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.343 1.057 . . . . 0.0 111.363 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -140.25 131.15 26.03 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.158 1.383 . . . . 0.0 108.606 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -94.58 161.82 14.05 Favored 'General case' 0 C--O 1.227 -0.09 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.599 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -160.03 105.99 1.41 Allowed Pre-proline 0 N--CA 1.455 -0.176 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.025 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.22 120.45 6.57 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 121.101 1.2 . . . . 0.0 109.866 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.612 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.6 tt -83.62 -175.43 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 123.665 1.698 . . . . 0.0 112.423 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.612 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 13.7 mmtt -160.31 163.02 33.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 109.82 -3.354 . . . . 0.0 110.816 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.0 t -78.82 56.86 1.98 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.998 1.719 . . . . 0.0 112.135 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.32 60.9 0.21 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 125.088 1.328 . . . . 0.0 112.474 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.18 140.3 3.05 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 117.695 0.747 . . . . 0.0 113.86 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.5 p -100.17 157.61 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 126.785 2.034 . . . . 0.0 107.239 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 64.91 74.21 0.4 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.134 0.974 . . . . 0.0 108.675 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.0 p -134.65 -169.39 2.33 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.409 1.483 . . . . 0.0 109.714 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.41 124.13 24.71 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.084 1.326 . . . . 0.0 113.695 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.37 101.0 0.87 Allowed Glycine 0 C--N 1.339 0.741 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.0 t 64.63 86.07 0.15 Allowed Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 125.363 1.465 . . . . 0.0 109.302 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.1 164.03 88.72 Favored 'Cis proline' 0 N--CA 1.458 -0.597 0 CA-C-N 119.571 0.882 . . . . 0.0 112.503 5.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.89 -58.07 0.17 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.473 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . 87.11 -67.71 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 129.128 2.971 . . . . 0.0 108.321 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -70.48 119.93 15.37 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.484 1.914 . . . . 0.0 113.149 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.1 mtt-85 -141.48 147.8 38.44 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.121 1.369 . . . . 0.0 112.301 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -112.61 144.05 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.4 t -139.92 127.04 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.88 0.372 . . . . 0.0 110.647 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -106.39 174.15 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.358 0 C-N-CA 126.922 2.089 . . . . 0.0 111.202 -178.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -93.56 169.08 10.61 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.952 2.101 . . . . 0.0 105.589 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.367 14.5 t -76.29 53.35 0.82 Allowed 'General case' 0 C--N 1.341 0.223 0 N-CA-C 117.775 2.509 . . . . 0.0 117.775 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -160.05 -83.31 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.82 -0.29 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.654 1.581 . . . . 0.0 114.27 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.57 110.56 16.16 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.016 1.28 . . . . 0.0 113.842 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.433 ' CE2' HG13 ' A' ' 16' ' ' VAL . 8.2 t80 -60.04 111.64 1.58 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.712 0.805 . . . . 0.0 109.707 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.25 -40.13 31.38 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.629 1.171 . . . . 0.0 111.349 -178.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.4 168.81 17.02 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.422 ' HB2' ' OH ' ' A' ' 85' ' ' TYR . . . -109.75 154.31 23.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.679 0.792 . . . . 0.0 110.353 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.8 pt -131.51 157.7 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 125.78 1.632 . . . . 0.0 107.99 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.0 t -159.53 139.28 11.58 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.473 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 24.9 m170 -84.36 46.77 1.26 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.7 t -65.65 -38.6 89.81 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.3 56.72 0.54 Allowed Glycine 0 C--N 1.335 0.486 0 N-CA-C 106.119 -2.792 . . . . 0.0 106.119 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -106.92 -17.56 14.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.3 m 64.39 35.54 9.6 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.6 21.93 78.72 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.704 2.097 . . . . 0.0 113.899 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -146.76 -70.58 0.24 Allowed 'General case' 0 C--N 1.347 0.484 0 CA-C-N 119.44 1.62 . . . . 0.0 114.216 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -58.9 100.36 0.07 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.054 1.742 . . . . 0.0 114.042 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.281 0.5 OUTLIER -78.14 140.98 39.02 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.439 0.695 . . . . 0.0 109.613 -178.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.17 160.86 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.74 160.65 29.0 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.31 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.8 m -117.93 159.55 22.94 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.638 1.175 . . . . 0.0 110.583 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.3 t 44.19 69.11 0.45 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.046 1.738 . . . . 0.0 115.429 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.43 -4.13 74.39 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.094 -0.837 . . . . 0.0 114.334 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.8 m -84.29 104.63 14.48 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 116.622 -1.656 . . . . 0.0 111.231 179.417 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.322 0.106 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.5 136.4 0.03 OUTLIER 'General case' 0 C--N 1.341 0.208 0 C-N-CA 126.664 1.985 . . . . 0.0 111.592 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.1 p -116.82 109.88 17.67 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.79 98.23 7.92 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 100.636 -3.838 . . . . 0.0 100.636 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.1 m -94.35 79.37 3.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.141 0.976 . . . . 0.0 109.102 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.09 -86.06 1.0 Allowed Glycine 0 C--N 1.34 0.777 0 C-N-CA 125.061 1.315 . . . . 0.0 110.013 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.4 p -119.58 -38.87 2.93 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 125.598 1.559 . . . . 0.0 110.156 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 m -74.14 100.78 3.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -95.04 149.43 21.26 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.85 0.86 . . . . 0.0 113.223 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -144.22 152.73 41.24 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.321 1.449 . . . . 0.0 110.043 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.9 m -74.55 159.6 31.98 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 125.556 1.542 . . . . 0.0 111.449 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.26 -22.67 67.02 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.5 t -70.49 -37.08 74.15 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 125.076 1.35 . . . . 0.0 109.062 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -65.69 -42.57 91.04 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.116 0.966 . . . . 0.0 109.731 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.1 t -61.27 -47.86 91.58 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.2 mtp85 -66.64 -26.55 67.12 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.214 1.406 . . . . 0.0 112.383 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.15 -60.58 2.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.71 -28.25 69.46 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.858 -0.592 . . . . 0.0 111.279 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.69 -37.1 50.34 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 118.941 -0.552 . . . . 0.0 112.38 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -70.5 -22.03 62.69 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.53 -59.74 2.61 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.49 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -45.96 -47.89 16.51 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.697 1.199 . . . . 0.0 110.33 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 m -51.1 -54.57 23.83 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.227 1.011 . . . . 0.0 110.961 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -77.09 -27.51 54.21 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -113.34 -6.0 13.55 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.289 0.0 OUTLIER -95.23 -38.96 10.32 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -179.077 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -147.29 33.53 0.88 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.326 0.966 . . . . 0.0 112.043 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -132.78 -70.71 0.54 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -136.49 85.49 2.15 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -56.77 118.76 5.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.022 1.329 . . . . 0.0 113.678 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.8 p -143.65 49.53 1.4 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.124 1.769 . . . . 0.0 108.681 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -163.26 153.05 15.4 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.116 0.966 . . . . 0.0 110.014 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.98 155.64 52.99 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.1 t -133.45 77.92 1.75 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.163 0.985 . . . . 0.0 108.87 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 p -107.09 -59.19 1.84 Allowed 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.87 -11.5 7.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.559 1.944 . . . . 0.0 110.733 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.66 129.95 3.53 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.93 139.71 55.04 Favored 'Cis proline' 0 N--CA 1.452 -0.959 0 CA-C-N 120.153 1.09 . . . . 0.0 110.536 -0.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -155.09 148.14 24.7 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 t -56.08 144.73 28.07 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -79.41 112.66 16.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -71.33 81.6 0.75 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.98 1.312 . . . . 0.0 109.215 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -156.76 76.04 0.86 Allowed 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.21 -37.97 73.02 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.862 1.265 . . . . 0.0 110.699 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -64.43 -35.59 81.42 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.29 114.76 0.24 Allowed Glycine 0 C--N 1.342 0.881 0 C-N-CA 125.875 1.702 . . . . 0.0 114.301 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -78.94 106.22 10.82 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.0 p-10 -28.98 111.03 0.06 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.484 1.914 . . . . 0.0 115.842 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -147.88 151.0 37.46 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 126.895 2.078 . . . . 0.0 108.076 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.02 78.04 3.72 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.327 2.685 . . . . 0.0 107.391 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.17 171.25 12.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 C-N-CA 124.841 1.256 . . . . 0.0 113.569 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -125.93 -49.61 1.6 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 128.034 2.534 . . . . 0.0 105.997 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.69 170.73 46.5 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.862 1.696 . . . . 0.0 113.914 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.55 134.74 32.26 Favored 'Cis proline' 0 N--CA 1.46 -0.498 0 O-C-N 122.419 0.694 . . . . 0.0 112.18 -0.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -107.49 136.5 47.17 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.602 1.561 . . . . 0.0 109.541 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -125.49 161.83 26.24 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 123.641 0.777 . . . . 0.0 111.24 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -83.88 153.34 24.05 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.597 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.49 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 17.1 t80 -155.44 103.21 2.2 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 102.791 -3.04 . . . . 0.0 102.791 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -76.46 136.59 17.69 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.027 1.818 . . . . 0.0 115.832 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 62' ' ' LYS . 1.2 tp -89.87 171.24 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 126.086 1.754 . . . . 0.0 112.787 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -159.06 170.31 22.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 110.62 -2.991 . . . . 0.0 113.067 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -82.0 57.92 3.71 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.86 2.064 . . . . 0.0 112.029 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.28 73.43 0.77 Allowed Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.34 -177.58 40.63 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-O 121.631 0.573 . . . . 0.0 112.808 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.71 148.4 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 127.374 2.269 . . . . 0.0 106.39 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.312 51.4 p90 58.4 -170.11 0.12 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.78 1.632 . . . . 0.0 111.924 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.2 t -79.61 166.36 21.96 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.696 0.799 . . . . 0.0 112.577 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.08 140.24 3.1 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.29 -114.12 4.85 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 124.689 1.137 . . . . 0.0 111.103 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -155.31 -68.52 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.441 1.096 . . . . 0.0 109.972 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.55 160.46 46.56 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.292 1.995 . . . . 0.0 110.547 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.53 -83.4 0.06 OUTLIER Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.47 ' HB1' ' H ' ' A' ' 91' ' ' HIS . . . 81.77 -39.89 0.13 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.186 1.794 . . . . 0.0 111.041 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -71.3 125.41 26.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.061 1.744 . . . . 0.0 115.064 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -139.5 131.33 27.57 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 123.723 0.809 . . . . 0.0 112.254 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.7 m -94.64 148.15 5.2 Favored 'Isoleucine or valine' 0 C--N 1.345 0.406 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -134.35 139.71 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 pt -135.16 165.75 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.256 0.622 . . . . 0.0 112.497 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -93.55 155.41 17.33 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 127.9 2.48 . . . . 0.0 108.621 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.37 15.0 t -79.55 65.64 4.78 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -156.86 -94.58 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.172 1 N-CA-C 98.856 -4.498 . . . . 0.0 98.856 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.4 m -162.98 9.4 0.06 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.698 2.399 . . . . 0.0 113.035 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -82.84 132.46 35.16 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.548 1.067 . . . . 0.0 112.609 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -73.12 122.72 22.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.54 -57.96 3.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.69 153.21 11.56 Favored Glycine 0 C--N 1.339 0.717 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.465 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.03 112.03 24.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.58 162.34 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.709 0.804 . . . . 0.0 109.181 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.6 t -160.3 150.13 17.92 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.47 ' H ' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -89.47 63.97 6.55 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 175.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.1 t -63.75 -38.87 92.74 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.021 -1.049 . . . . 0.0 112.739 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.79 54.32 0.04 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.21 -78.78 0.4 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.77 0.828 . . . . 0.0 108.813 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.6 m -159.42 73.96 0.6 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.658 1.583 . . . . 0.0 108.72 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.83 -102.75 0.94 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.032 0.825 . . . . 0.0 111.719 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -79.77 -25.85 40.84 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.756 0.822 . . . . 0.0 111.83 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -49.15 129.69 18.2 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 124.52 1.128 . . . . 0.0 111.4 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -97.39 153.0 18.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.341 1.456 . . . . 0.0 113.405 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.0 m -135.21 167.26 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 126.957 2.103 . . . . 0.0 107.032 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.1 151.34 30.01 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 116.542 1.377 . . . . 0.0 116.542 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 38.7 m -106.53 -173.67 2.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.859 1.664 . . . . 0.0 106.641 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.0 t -69.32 140.98 54.37 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.454 -0.779 . . . . 0.0 108.984 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.31 32.54 59.97 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.936 0.779 . . . . 0.0 111.332 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.9 m -137.85 108.38 6.56 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 117.192 -1.385 . . . . 0.0 109.474 -178.984 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.0 m . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -40.24 132.22 1.98 Allowed 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.485 1.914 . . . . 0.0 112.664 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.8 p -102.65 89.06 3.38 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.272 1.029 . . . . 0.0 111.372 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -94.87 98.3 10.62 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.02 -165.14 0.92 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.118 1.367 . . . . 0.0 108.049 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -31.09 -57.87 0.27 Allowed Glycine 0 C--N 1.343 0.971 0 C-N-CA 125.993 1.758 . . . . 0.0 112.159 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.9 p -160.31 38.1 0.17 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.225 1.01 . . . . 0.0 109.687 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 m -129.49 94.15 3.71 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.7 110.47 15.06 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.697 1.199 . . . . 0.0 111.459 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -110.26 128.92 55.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.3 m -65.89 158.13 28.78 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 124.713 1.205 . . . . 0.0 110.726 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.64 -17.32 54.89 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.1 p -77.55 -37.98 49.56 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 124.0 0.92 . . . . 0.0 108.719 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -68.77 -36.04 77.82 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.027 0.931 . . . . 0.0 109.974 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.407 HG11 ' CE2' ' A' ' 85' ' ' TYR . 58.7 t -63.44 -47.82 89.96 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -64.49 -37.45 87.57 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.014 0.926 . . . . 0.0 111.374 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 -55.16 15.49 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.541 0.61 . . . . 0.0 110.225 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.44 -37.13 82.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.136 0.975 . . . . 0.0 111.172 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.32 -34.34 42.35 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -70.87 -22.02 62.34 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.1 -51.62 9.99 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.486 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -47.32 -67.07 0.31 Allowed 'General case' 0 C--N 1.345 0.375 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 176.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.2 t -39.09 -46.31 1.39 Allowed 'General case' 0 C--N 1.343 0.287 0 C-N-CA 127.892 2.477 . . . . 0.0 112.475 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -65.14 -58.34 6.27 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -71.73 -8.62 55.28 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 57' ' ' GLN . 6.4 t80 -79.38 -47.94 14.88 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.957 1.303 . . . . 0.0 111.376 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -135.51 -26.66 1.23 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -72.89 -56.44 5.19 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.43 1.014 . . . . 0.0 112.861 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -128.13 73.02 1.44 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.472 1.509 . . . . 0.0 108.775 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -55.06 153.4 6.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.704 1.202 . . . . 0.0 113.058 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 59.6 p 56.17 70.85 0.6 Allowed 'General case' 0 C--N 1.34 0.164 0 C-N-CA 127.153 2.181 . . . . 0.0 112.437 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -158.17 91.15 1.08 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.65 -78.23 0.2 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.8 m -145.55 -116.39 0.08 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.159 0.983 . . . . 0.0 108.675 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.9 m -158.26 -50.51 0.06 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.597 1.559 . . . . 0.0 109.35 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.0 p -79.73 6.26 11.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.293 1.037 . . . . 0.0 112.868 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -151.94 95.29 3.23 Favored Pre-proline 0 N--CA 1.455 -0.208 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -84.22 142.75 40.07 Favored 'Cis proline' 0 N--CA 1.455 -0.746 0 N-CA-C 116.263 1.601 . . . . 0.0 116.263 2.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.15 158.83 25.19 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.703 2.401 . . . . 0.0 107.377 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 m -42.38 120.0 1.54 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.022 2.129 . . . . 0.0 113.555 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -138.13 86.47 2.17 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -167.63 -49.67 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.676 1.19 . . . . 0.0 109.039 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.96 59.7 5.79 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.156 1.382 . . . . 0.0 110.141 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.36 14.98 1.46 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.817 0.847 . . . . 0.0 112.117 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 56.9 83.62 0.1 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 125.222 1.409 . . . . 0.0 111.267 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.24 167.09 36.04 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.67 100.5 0.28 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.147 0.979 . . . . 0.0 112.989 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.97 164.86 26.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.537 0.735 . . . . 0.0 109.976 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -106.08 151.07 40.01 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -58.13 -95.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 124.524 3.482 . . . . 0.0 114.152 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m 24.92 -106.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 127.062 2.145 . . . . 0.0 113.521 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -163.01 -44.78 0.03 OUTLIER 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.076 0.853 . . . . 0.0 112.214 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.16 -167.54 29.19 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -60.94 165.65 30.04 Favored 'Cis proline' 0 CA--C 1.535 0.547 0 CA-C-N 119.572 1.686 . . . . 0.0 114.123 -0.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -132.15 143.15 49.78 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.541 1.136 . . . . 0.0 111.502 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.466 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -139.99 153.32 46.83 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.325 1.05 . . . . 0.0 108.231 177.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.75 154.28 23.68 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.486 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 26.9 t80 -160.74 106.68 1.3 Allowed Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.399 1.08 . . . . 0.0 109.006 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.92 155.75 15.25 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 N-CA-C 119.008 2.657 . . . . 0.0 119.008 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.496 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 6.5 tt -105.63 175.37 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 C-N-CA 126.984 2.114 . . . . 0.0 110.035 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.496 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 6.9 tptp -160.9 166.59 28.17 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 109.352 -3.567 . . . . 0.0 112.454 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.1 t -88.83 62.15 6.27 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.542 1.537 . . . . 0.0 108.764 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.06 64.19 0.66 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 167.5 145.0 4.34 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.1 t -123.56 66.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.0 t80 64.08 103.26 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.086 2.155 . . . . 0.0 112.863 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.8 p -138.96 64.23 1.49 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.3 -68.95 2.38 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.06 -135.38 22.74 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.8 p 54.16 102.08 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 127.39 2.276 . . . . 0.0 113.282 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.84 176.49 40.37 Favored 'Cis proline' 0 N--CA 1.457 -0.663 0 CA-C-N 119.707 0.931 . . . . 0.0 112.177 4.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.38 163.54 31.6 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.45 -43.64 0.15 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 118.375 -0.821 . . . . 0.0 111.655 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -69.36 107.08 3.16 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -119.24 129.23 54.83 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.434 1.094 . . . . 0.0 111.451 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.65 151.43 6.04 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -135.12 135.74 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -123.08 164.14 20.97 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -80.98 173.25 12.79 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.674 1.99 . . . . 0.0 108.598 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.447 ' HA ' ' CE1' ' A' ' 27' ' ' TYR 0.43 1.5 m -73.59 -15.04 61.28 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -177.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -81.02 -83.88 0.11 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 101.327 -3.583 . . . . 0.0 101.327 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.1 m -164.05 0.12 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.639 2.775 . . . . 0.0 113.895 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -79.39 132.19 36.33 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.407 ' CE2' HG11 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -73.37 117.27 14.93 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.996 2.118 . . . . 0.0 108.222 178.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.01 -66.1 1.11 Allowed 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.265 1.426 . . . . 0.0 111.952 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.49 146.71 20.99 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 115.976 1.15 . . . . 0.0 115.976 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.65 99.62 3.38 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 103.746 -2.686 . . . . 0.0 103.746 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.5 pt -136.77 165.49 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.073 0.949 . . . . 0.0 111.428 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.0 t -160.27 145.74 15.05 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -79.87 29.44 0.26 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.21 0.604 . . . . 0.0 111.791 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.8 t -65.19 -30.28 71.17 Favored 'General case' 0 C--N 1.343 0.307 0 O-C-N 120.797 -1.19 . . . . 0.0 113.405 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -138.39 49.32 0.84 Allowed Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.29 151.86 21.74 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.114 1.366 . . . . 0.0 110.86 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.1 t -66.39 -45.37 80.25 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.35 1.06 . . . . 0.0 109.495 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.7 -79.43 0.03 OUTLIER Glycine 0 C--N 1.339 0.741 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -97.4 7.52 46.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.352 1.061 . . . . 0.0 111.027 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -74.0 -174.21 1.81 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.4 1.08 . . . . 0.0 110.426 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -153.45 159.9 42.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.174 0.989 . . . . 0.0 110.976 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.6 157.99 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.954 1.702 . . . . 0.0 106.783 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.39 153.25 49.12 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 116.106 1.202 . . . . 0.0 116.106 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.4 t -107.28 -175.3 2.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.335 2.254 . . . . 0.0 106.752 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.6 t -64.94 117.72 8.02 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.4 -0.813 . . . . 0.0 109.95 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.42 -36.97 3.65 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.121 1.343 . . . . 0.0 109.812 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.5 m -93.74 132.78 37.78 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.245 1.418 . . . . 0.0 108.932 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.225 -1.369 . . . . 0.0 109.254 -179.546 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.7 p . . . . . 0 N--CA 1.456 -0.168 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.97 133.86 55.2 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.882 1.273 . . . . 0.0 110.873 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 p -97.35 121.03 38.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.579 1.152 . . . . 0.0 109.117 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -115.33 99.31 7.3 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 100.595 -3.854 . . . . 0.0 100.595 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -103.49 90.28 3.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.157 1.383 . . . . 0.0 109.563 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.46 -76.23 0.96 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.012 1.291 . . . . 0.0 110.862 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.5 t -132.48 -43.17 0.93 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.819 1.648 . . . . 0.0 109.921 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.6 m -68.74 112.54 5.54 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -102.21 152.63 20.8 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.471 1.108 . . . . 0.0 110.812 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -144.23 143.54 31.1 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.363 1.065 . . . . 0.0 108.21 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.9 t -68.27 154.74 41.13 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.765 1.226 . . . . 0.0 110.549 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.93 -19.89 54.39 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.6 t -73.52 -41.15 63.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.652 1.581 . . . . 0.0 109.339 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -68.35 -43.17 78.02 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.256 0.622 . . . . 0.0 110.963 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.8 t -59.8 -47.18 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -41.5 86.72 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.278 1.031 . . . . 0.0 111.686 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.48 -49.47 68.93 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.333 0.515 . . . . 0.0 109.87 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.56 -37.36 78.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.799 0.839 . . . . 0.0 109.938 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.44 -32.28 60.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -66.38 -27.33 67.78 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.03 -56.98 3.98 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.458 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -44.99 -58.35 3.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.528 1.531 . . . . 0.0 110.147 177.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.5 t -54.11 -50.71 66.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.366 1.467 . . . . 0.0 112.296 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -58.08 -34.57 70.3 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -92.13 -3.26 55.91 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -124.38 37.16 4.46 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.473 1.109 . . . . 0.0 111.132 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -89.84 -72.51 0.56 Allowed 'General case' 0 C--N 1.343 0.283 0 O-C-N 121.364 -0.835 . . . . 0.0 110.031 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -148.91 -61.17 0.23 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.933 1.293 . . . . 0.0 108.713 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -90.44 63.83 5.71 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.112 1.365 . . . . 0.0 107.95 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -51.83 138.28 24.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.711 1.604 . . . . 0.0 112.396 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.0 t -106.16 -33.5 7.82 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.367 1.067 . . . . 0.0 112.198 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.63 159.86 31.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.763 0.825 . . . . 0.0 110.97 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.94 166.48 47.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.399 0.999 . . . . 0.0 114.232 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -120.49 65.09 0.84 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.833 1.653 . . . . 0.0 107.977 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.7 m -167.32 -46.02 0.02 OUTLIER 'General case' 0 C--N 1.339 0.124 0 C-N-CA 127.192 2.197 . . . . 0.0 107.374 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.7 p -105.12 29.18 6.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.145 1.378 . . . . 0.0 111.131 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 73.32 157.39 0.16 Allowed Pre-proline 0 C--N 1.351 0.651 0 C-N-CA 125.144 1.378 . . . . 0.0 107.728 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.401 ' HB3' HE21 ' A' ' 57' ' ' GLN . 86.0 Cg_endo -71.1 118.72 4.26 Favored 'Cis proline' 0 N--CA 1.452 -0.969 0 N-CA-C 115.404 1.271 . . . . 0.0 115.404 3.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -103.86 -170.24 1.75 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 126.518 1.927 . . . . 0.0 106.686 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.3 t -155.87 159.0 38.95 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.514 0.326 . . . . 0.0 111.267 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -153.43 167.09 30.61 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 122.774 0.43 . . . . 0.0 111.68 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -141.56 -51.76 0.43 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.609 1.563 . . . . 0.0 109.998 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -67.47 -78.81 0.06 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.966 0.906 . . . . 0.0 110.731 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 67.9 179.97 0.23 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.767 1.227 . . . . 0.0 111.345 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -74.63 -62.62 1.47 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.98 57.67 0.14 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -154.19 103.04 2.51 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.489 1.116 . . . . 0.0 108.346 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -141.57 176.43 8.9 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.307 1.443 . . . . 0.0 109.05 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -127.87 138.11 32.21 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 124.361 1.065 . . . . 0.0 109.043 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.66 66.17 8.81 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.713 2.942 . . . . 0.0 110.043 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.3 t -120.31 -95.06 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -153.35 -71.02 0.14 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.174 0.99 . . . . 0.0 109.695 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.11 -175.37 54.96 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.074 0.845 . . . . 0.0 111.225 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.97 126.85 1.93 Allowed 'Cis proline' 0 N--CA 1.459 -0.519 0 CA-C-N 118.982 1.391 . . . . 0.0 111.989 -0.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.69 130.69 35.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.446 0.641 . . . . 0.0 111.008 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' A' ' 39' ' ' PRO . 53.4 tt0 -75.03 139.02 42.58 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 127.852 2.461 . . . . 0.0 111.235 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -98.16 146.57 25.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.574 1.15 . . . . 0.0 108.66 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.458 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 8.0 t80 -160.1 110.33 1.41 Allowed Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -81.15 131.93 8.03 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 122.006 1.804 . . . . 0.0 114.302 -176.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.54 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.7 tt -100.01 178.0 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 124.282 1.992 . . . . 0.0 110.875 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.54 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 4.8 tmtt? -160.46 153.71 21.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 109.063 -3.698 . . . . 0.0 110.721 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.2 p -80.81 56.5 2.72 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.566 1.546 . . . . 0.0 109.706 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.9 -61.99 0.04 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.32 -172.62 32.97 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 117.165 0.483 . . . . 0.0 112.705 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.95 143.57 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.568 1.547 . . . . 0.0 111.353 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.292 0.0 OUTLIER 25.45 55.68 0.04 OUTLIER 'General case' 0 C--N 1.345 0.37 0 C-N-CA 129.367 3.067 . . . . 0.0 116.41 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.8 p -79.77 85.36 5.46 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.98 173.6 39.24 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.89 -69.01 1.47 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.0 m -80.3 127.5 76.09 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.7 -88.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.225 2.617 . . . . 0.0 110.057 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.97 -51.32 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 106.019 -2.832 . . . . 0.0 106.019 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -169.72 -50.43 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.667 0.787 . . . . 0.0 112.02 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -73.9 130.07 39.16 Favored 'General case' 0 C--N 1.344 0.362 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -138.54 122.21 17.48 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.029 1.331 . . . . 0.0 110.43 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -83.64 148.77 4.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.3 t -136.91 114.9 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -177.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 pt -101.56 177.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.371 0 C-N-CA 124.585 1.154 . . . . 0.0 111.855 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -90.46 171.82 9.16 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 125.255 1.422 . . . . 0.0 108.024 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.7 -33.24 69.94 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 119.048 2.981 . . . . 0.0 119.048 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -87.75 -65.81 0.98 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.857 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.5 -7.58 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -175.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -78.9 108.82 12.63 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -56.33 118.52 4.83 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.51 -59.56 2.2 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.258 0.623 . . . . 0.0 110.655 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.35 164.74 34.15 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.28 153.22 27.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.1 0.96 . . . . 0.0 110.453 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.6 pt -138.89 155.57 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.746 1.618 . . . . 0.0 107.881 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.6 t -153.45 153.25 32.13 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -79.34 -22.62 44.25 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.354 0.662 . . . . 0.0 111.988 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 t -65.68 139.84 58.43 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 119.585 1.084 . . . . 0.0 109.905 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.08 -24.97 28.93 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.98 -159.02 0.66 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.262 1.425 . . . . 0.0 109.397 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.2 m -152.37 88.9 1.39 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.417 0.687 . . . . 0.0 111.06 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.06 -131.07 9.24 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.288 0.947 . . . . 0.0 112.53 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -79.38 -34.95 41.52 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 125.099 1.36 . . . . 0.0 110.619 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -44.12 134.05 4.95 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.863 1.665 . . . . 0.0 112.473 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.54 160.8 14.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.203 1.801 . . . . 0.0 111.203 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 m -139.32 166.04 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 126.531 1.932 . . . . 0.0 106.916 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.64 151.61 20.66 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.365 0.507 . . . . 0.0 113.726 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.81 -166.43 1.6 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.194 1.398 . . . . 0.0 109.198 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.5 t -62.55 129.58 41.23 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.908 0.483 . . . . 0.0 109.767 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.31 28.5 69.79 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.004 0.811 . . . . 0.0 112.095 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.8 m -151.52 116.49 5.22 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.168 -179.51 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 N--CA 1.455 -0.225 0 N-CA-C 101.342 -3.577 . . . . 0.0 101.342 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 70.21 73.59 0.22 Allowed 'General case' 0 C--N 1.343 0.32 0 N-CA-C 102.389 -3.189 . . . . 0.0 102.389 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.5 t -116.03 152.87 32.72 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -118.88 116.39 26.39 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 102.259 -3.237 . . . . 0.0 102.259 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -91.91 58.9 3.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.31 -78.53 0.82 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.556 1.074 . . . . 0.0 111.178 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 m -118.29 39.99 3.3 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.947 1.299 . . . . 0.0 110.274 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.33 152.88 38.96 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -150.51 113.94 4.92 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.621 0.646 . . . . 0.0 111.745 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.81 137.55 52.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.514 1.126 . . . . 0.0 111.251 178.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.9 t -70.11 160.31 32.27 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 126.368 1.867 . . . . 0.0 108.264 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.25 -19.05 30.95 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 t -72.57 -47.29 49.34 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -72.22 -28.22 63.04 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.638 1.175 . . . . 0.0 113.46 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.4 t -70.21 -51.79 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -58.83 -35.63 73.22 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 125.987 1.715 . . . . 0.0 111.277 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.67 -52.61 56.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.9 82.47 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.031 0.932 . . . . 0.0 112.033 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.43 -45.55 30.97 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -62.29 -22.43 66.02 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.406 ' CB ' HG21 ' A' ' 66' ' ' VAL . . . -79.9 -55.08 5.22 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.68 -42.9 12.14 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.209 1.004 . . . . 0.0 111.261 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 85.2 m -61.61 -52.77 63.02 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.178 0.991 . . . . 0.0 110.366 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -59.57 -41.45 90.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.364 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -69.32 -40.1 77.81 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.42 -0.8 . . . . 0.0 112.067 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -78.52 -32.63 48.14 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -136.49 -43.8 0.61 Allowed 'General case' 0 C--N 1.348 0.533 0 N-CA-C 118.216 2.672 . . . . 0.0 118.216 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -70.69 -22.95 62.4 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -165.48 102.41 0.71 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 77.27 -166.32 0.05 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.552 1.941 . . . . 0.0 111.169 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.4 p -123.79 -63.96 1.18 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.86 1.664 . . . . 0.0 109.07 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 52.07 90.84 0.02 OUTLIER 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.519 1.928 . . . . 0.0 112.062 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.02 -166.98 14.22 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.23 0.919 . . . . 0.0 110.821 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m 71.63 -11.43 0.73 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.987 1.715 . . . . 0.0 113.71 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.7 m -149.47 -43.35 0.14 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.806 0.842 . . . . 0.0 111.74 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.9 p -104.25 -22.96 13.29 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 77.41 152.43 0.13 Allowed Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.3 150.99 96.51 Favored 'Cis proline' 0 N--CA 1.45 -1.05 0 CA-C-N 121.088 1.424 . . . . 0.0 115.065 2.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -159.79 157.82 30.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 128.551 2.74 . . . . 0.0 105.713 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 t -53.28 149.49 7.25 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -89.09 161.92 16.26 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.692 1.597 . . . . 0.0 109.1 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -63.53 137.77 58.26 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.953 0.901 . . . . 0.0 111.706 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.69 -49.96 75.4 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.761 0.824 . . . . 0.0 108.908 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -59.1 137.38 57.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -71.96 88.92 1.08 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.986 0.515 . . . . 0.0 111.228 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.08 -29.53 66.64 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.88 164.09 36.32 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.212 1.405 . . . . 0.0 110.695 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -116.91 122.12 43.4 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.612 1.565 . . . . 0.0 107.835 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.405 ' CD1' ' HA3' ' A' ' 87' ' ' GLY . 17.4 m-85 -119.42 157.69 50.86 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 124.821 1.248 . . . . 0.0 109.536 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -52.81 -35.36 69.43 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.825 3.017 . . . . 0.0 114.239 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.1 m -110.05 164.69 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.528 1.531 . . . . 0.0 112.044 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -95.75 159.53 14.93 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.573 1.549 . . . . 0.0 110.243 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.75 -154.54 30.87 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.4 1.0 . . . . 0.0 111.452 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.53 153.25 18.93 Favored 'Cis proline' 0 C--N 1.346 0.441 0 CA-C-N 118.722 1.261 . . . . 0.0 114.132 -0.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.67 167.07 17.74 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.165 0.986 . . . . 0.0 111.462 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -138.43 156.3 47.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.411 1.485 . . . . 0.0 109.253 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -90.17 157.84 17.53 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -160.15 108.9 1.4 Allowed Pre-proline 0 N--CA 1.454 -0.255 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -89.23 113.56 0.61 Allowed 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 122.65 2.233 . . . . 0.0 111.797 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.483 HG13 ' H ' ' A' ' 62' ' ' LYS . 7.4 tt -86.22 174.67 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-O 123.632 1.682 . . . . 0.0 110.909 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.483 ' H ' HG13 ' A' ' 61' ' ' ILE . 11.7 mmtp -155.48 150.73 26.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 109.851 -3.34 . . . . 0.0 110.912 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.5 p -88.68 61.03 5.85 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.311 1.444 . . . . 0.0 108.865 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.75 -61.58 0.02 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.05 166.12 36.18 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.406 HG21 ' CB ' ' A' ' 22' ' ' ALA . 10.0 p -77.6 138.0 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.505 1.122 . . . . 0.0 110.931 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.1 t80 53.57 86.92 0.04 OUTLIER 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.894 1.678 . . . . 0.0 112.111 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.4 t -151.41 158.97 44.41 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.21 1.004 . . . . 0.0 110.373 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.79 -133.11 2.65 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.501 1.048 . . . . 0.0 111.266 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.14 54.94 4.22 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 94.6 p 45.52 60.17 13.88 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.063 1.745 . . . . 0.0 112.64 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.1 141.24 18.48 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.749 2.966 . . . . 0.0 110.847 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 158.0 35.19 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.519 -0.601 . . . . 0.0 114.246 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -169.03 35.07 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.034 0.934 . . . . 0.0 110.764 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.25 93.85 0.29 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -145.96 153.48 40.85 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 m -119.86 146.6 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 102.474 -3.158 . . . . 0.0 102.474 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.255 81.2 t -125.55 113.14 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.1 pt -86.31 168.03 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.381 0 C-N-CA 125.704 1.602 . . . . 0.0 114.577 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -90.69 170.95 9.71 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.965 2.106 . . . . 0.0 107.374 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.367 11.6 t -85.35 52.93 2.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 118.048 2.611 . . . . 0.0 118.048 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -156.04 -89.81 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 101.245 -3.613 . . . . 0.0 101.245 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 36.3 t -163.94 66.43 0.17 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.198 1.399 . . . . 0.0 112.508 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -150.26 127.58 11.38 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 120.016 1.28 . . . . 0.0 113.051 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -64.46 117.29 7.1 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 177.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.39 -59.23 2.34 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 124.322 1.049 . . . . 0.0 110.631 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.405 ' HA3' ' CD1' ' A' ' 50' ' ' PHE . . . -145.57 -172.46 15.98 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.761 1.172 . . . . 0.0 111.472 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.31 144.05 13.94 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 122.802 0.441 . . . . 0.0 111.438 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.0 pt -131.06 159.34 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 125.487 1.515 . . . . 0.0 110.068 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.0 t -160.12 150.31 18.39 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.462 1.505 . . . . 0.0 109.418 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.539 ' HB2' ' HB1' ' A' ' 74' ' ' ALA 0.265 49.3 m170 -78.98 -51.87 9.03 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.409 1.004 . . . . 0.0 108.951 177.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.379 11.8 t 48.96 -69.82 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.706 2.802 . . . . 0.0 116.773 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.42 51.17 0.56 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 126.032 1.777 . . . . 0.0 108.879 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.79 158.02 36.24 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.913 1.285 . . . . 0.0 110.949 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.5 t -62.06 -40.51 96.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.214 0.606 . . . . 0.0 110.183 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -150.5 -109.64 0.47 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -94.38 -4.93 47.57 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.508 1.123 . . . . 0.0 112.083 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -65.17 174.5 2.0 Allowed 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.114 0.966 . . . . 0.0 112.113 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -125.64 150.99 47.11 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.735 1.614 . . . . 0.0 111.911 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.5 m -124.31 166.33 19.82 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 126.308 1.843 . . . . 0.0 107.009 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.04 160.21 24.87 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.3 m -100.66 174.22 6.17 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.136 0.975 . . . . 0.0 111.694 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.2 m 46.77 46.13 15.02 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.709 0.804 . . . . 0.0 112.069 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.67 22.95 73.81 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 119.311 -0.716 . . . . 0.0 114.052 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 55.0 m -86.57 146.77 26.22 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.974 0.909 . . . . 0.0 108.785 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 t30 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.055 -1.45 . . . . 0.0 109.437 -179.246 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 t . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.41 138.34 56.64 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.437 0.695 . . . . 0.0 109.134 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 t -141.81 119.99 12.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.487 0.315 . . . . 0.0 111.038 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.41 108.3 19.59 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.6 m -97.46 78.99 2.71 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.122 0.969 . . . . 0.0 109.177 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.83 -95.56 0.82 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.8 m -108.42 -31.78 7.69 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.851 1.26 . . . . 0.0 110.51 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 m -81.69 101.12 9.87 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -85.02 152.14 23.66 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 123.194 0.598 . . . . 0.0 111.322 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -142.06 133.73 26.93 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.645 1.178 . . . . 0.0 109.096 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.7 m -72.25 158.04 36.59 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 125.007 1.323 . . . . 0.0 111.314 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.08 -21.41 64.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.0 m -72.54 -39.35 67.58 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.076 0.95 . . . . 0.0 108.535 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -69.6 -50.22 46.6 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.547 1.139 . . . . 0.0 112.023 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.466 HG13 HG11 ' A' ' 77' ' ' VAL . 50.8 t -57.45 -48.23 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 123.608 0.763 . . . . 0.0 109.212 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -64.53 -43.31 94.41 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.545 1.138 . . . . 0.0 112.065 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.0 -54.24 14.1 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.972 0.509 . . . . 0.0 111.228 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.595 ' HB1' ' HE2' ' A' ' 59' ' ' PHE . . . -60.92 -26.76 67.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.421 0.689 . . . . 0.0 110.543 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.75 -38.09 29.28 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.481 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -65.79 -25.19 67.13 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.79 -60.0 2.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.402 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -44.97 -51.0 10.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.672 1.189 . . . . 0.0 110.196 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.01 -48.33 32.79 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.257 2.223 . . . . 0.0 111.796 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -81.75 -40.89 22.01 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.264 0.0 OUTLIER -67.75 -37.54 82.28 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 116.799 2.148 . . . . 0.0 116.799 -177.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.299 0.0 OUTLIER -82.14 6.27 17.02 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -179.09 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -77.49 -3.43 40.46 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.131 0.572 . . . . 0.0 110.786 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 64.02 48.11 3.16 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.442 1.897 . . . . 0.0 111.707 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -159.35 30.47 0.2 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.842 1.257 . . . . 0.0 110.658 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 176.88 165.69 0.51 Allowed 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 128.798 2.839 . . . . 0.0 108.86 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.263 0.0 OUTLIER -12.65 100.09 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.825 2.85 . . . . 0.0 115.233 -179.33 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 74.77 163.3 0.26 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 127.608 2.363 . . . . 0.0 115.792 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.98 82.57 0.06 OUTLIER Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.137 -0.813 . . . . 0.0 113.047 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.8 m 69.85 104.69 0.06 Allowed 'General case' 0 C--N 1.344 0.367 0 C-N-CA 126.384 1.873 . . . . 0.0 113.621 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -152.93 -55.89 0.12 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 100.988 -3.708 . . . . 0.0 100.988 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.575 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 40.7 p -130.64 -62.58 0.91 Allowed 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 101.006 -3.701 . . . . 0.0 101.006 175.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.575 ' CD1' ' C ' ' A' ' 37' ' ' THR . 23.9 m-85 -144.06 143.62 23.33 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 129.242 3.017 . . . . 0.0 106.072 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.67 144.73 62.24 Favored 'Cis proline' 0 N--CA 1.458 -0.567 0 CA-C-N 118.581 0.529 . . . . 0.0 112.596 1.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -156.54 151.76 26.48 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.537 0.608 . . . . 0.0 112.32 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.6 m -53.27 142.34 21.36 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.049 2.54 . . . . 0.0 113.121 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -91.9 136.76 32.91 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.705 1.202 . . . . 0.0 110.028 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -70.32 129.54 39.59 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.22 1.008 . . . . 0.0 111.864 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -86.17 61.04 6.59 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.936 1.294 . . . . 0.0 109.13 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -121.56 167.83 12.43 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.066 1.746 . . . . 0.0 109.076 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.49 154.16 41.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.382 0.673 . . . . 0.0 110.333 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.1 -88.27 0.32 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -121.51 152.91 38.64 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.241 1.417 . . . . 0.0 109.809 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 166.89 130.4 0.01 OUTLIER 'General case' 0 C--N 1.34 0.183 0 C-N-CA 128.109 2.564 . . . . 0.0 107.62 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -88.67 169.34 13.59 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.333 1.053 . . . . 0.0 108.96 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.19 -52.44 8.75 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.915 3.076 . . . . 0.0 113.024 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.444 HG21 HD21 ' A' ' 80' ' ' ASN . 31.9 m -65.05 156.62 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.11 1.364 . . . . 0.0 109.854 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -134.36 -168.66 2.18 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -46.32 138.55 7.52 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 127.608 2.527 . . . . 0.0 114.205 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.37 133.87 12.23 Favored 'Cis proline' 0 C--N 1.35 0.655 0 CA-C-N 119.933 1.866 . . . . 0.0 111.2 -2.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.53 108.99 1.64 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -177.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -123.35 157.7 32.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.994 1.718 . . . . 0.0 109.27 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -89.34 158.8 17.65 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.688 1.595 . . . . 0.0 112.633 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.595 ' HE2' ' HB1' ' A' ' 19' ' ' ALA . 89.1 t80 -159.18 117.96 1.68 Allowed Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.242 1.017 . . . . 0.0 108.917 177.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -81.44 137.83 10.6 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 N-CA-C 117.705 2.156 . . . . 0.0 117.705 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.625 HG13 HG13 ' A' ' 77' ' ' VAL 0.256 3.3 mm -109.81 -0.32 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 1 C-N-CA 134.408 5.083 . . . . 0.0 115.207 179.116 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -75.41 104.62 6.05 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 126.704 2.002 . . . . 0.0 114.165 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.6 m 24.06 34.18 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.201 1 C-N-CA 131.884 4.074 . . . . 0.0 115.712 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.84 40.38 1.49 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.957 1.265 . . . . 0.0 111.534 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.13 -115.33 1.01 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.127 1.346 . . . . 0.0 113.211 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.16 48.58 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.983 1.313 . . . . 0.0 109.594 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 27.0 t80 61.21 71.42 0.56 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.472 1.909 . . . . 0.0 111.327 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 49.5 p -121.18 61.11 0.91 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.75 -153.62 24.06 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.5 -169.54 32.25 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 m -158.86 -68.34 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 125.111 1.364 . . . . 0.0 110.172 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.58 104.33 1.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.456 2.104 . . . . 0.0 109.799 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.15 79.85 1.15 Allowed Glycine 0 C--N 1.339 0.712 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.13 -70.84 0.25 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.05 123.06 18.05 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.619 1.1 . . . . 0.0 113.597 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -160.6 134.81 7.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.625 HG13 HG13 ' A' ' 61' ' ' ILE . 11.8 m -93.14 142.88 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 177.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.272 72.6 t -125.32 124.45 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 85' ' ' TYR . 7.2 pt -130.99 175.09 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 123.934 0.771 . . . . 0.0 112.255 -175.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.444 HD21 HG21 ' A' ' 52' ' ' VAL . 49.7 m-80 -99.18 139.23 35.13 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 125.447 1.499 . . . . 0.0 109.199 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.548 0.5 OUTLIER -47.52 -12.72 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.401 1 N-CA-C 121.898 4.036 . . . . 0.0 121.898 -176.615 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -80.01 -81.85 0.12 Allowed 'General case' 0 N--CA 1.441 -0.884 1 N-CA-C 99.618 -4.216 . . . . 0.0 99.618 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.75 0.47 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.632 1.573 . . . . 0.0 114.472 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -82.27 127.73 33.49 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.584 ' HA ' HG22 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -65.33 135.34 55.19 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.641 1.577 . . . . 0.0 109.489 178.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.43 -50.83 3.49 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 122.982 0.513 . . . . 0.0 110.678 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.29 140.23 3.59 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.503 -0.379 . . . . 0.0 112.769 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.07 131.12 36.84 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.056 1.342 . . . . 0.0 108.034 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.8 pt -141.77 165.8 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.668 1.187 . . . . 0.0 110.391 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.421 HG23 HG22 ' A' ' 92' ' ' THR . 9.8 t -158.57 146.54 18.21 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -83.58 15.13 3.29 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 122.665 0.386 . . . . 0.0 110.917 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.421 HG22 HG23 ' A' ' 90' ' ' THR . 6.2 t -40.98 -45.29 2.56 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 116.92 2.192 . . . . 0.0 116.92 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -150.54 57.26 0.45 Allowed Glycine 0 C--N 1.331 0.301 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.02 175.89 5.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.891 1.276 . . . . 0.0 109.77 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.8 t -83.0 58.91 4.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.803 1.241 . . . . 0.0 111.028 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.37 -87.5 0.81 Allowed Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.228 1.394 . . . . 0.0 112.71 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -79.52 -24.75 42.01 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.114 0.966 . . . . 0.0 111.294 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -63.04 170.23 2.89 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.517 1.127 . . . . 0.0 110.178 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -130.31 168.19 17.3 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.617 1.567 . . . . 0.0 111.811 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.1 m -139.51 161.13 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 126.886 2.074 . . . . 0.0 105.748 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.25 131.7 10.58 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 114.775 0.67 . . . . 0.0 114.775 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.8 t -98.19 172.33 7.65 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.2 t 53.95 -153.63 0.28 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.904 1.229 . . . . 0.0 109.198 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.76 0.66 76.55 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.593 1.092 . . . . 0.0 110.401 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 m -79.69 149.15 31.31 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 125.495 1.518 . . . . 0.0 108.727 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.004 -1.474 . . . . 0.0 108.914 -179.186 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.6 m . . . . . 0 CA--C 1.528 0.133 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.44 122.7 11.02 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.8 0.84 . . . . 0.0 109.904 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.517 HG22 ' HB3' ' A' ' 103' ' ' SER . 3.0 p -91.69 87.98 6.52 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -92.2 96.93 10.59 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 102.447 -3.168 . . . . 0.0 102.447 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.1 m -98.3 81.73 2.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.472 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.4 -86.98 0.91 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.9 p -122.12 -23.22 5.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.333 1.453 . . . . 0.0 110.929 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.55 91.6 3.98 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -84.15 127.99 34.27 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.933 1.293 . . . . 0.0 112.772 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -127.57 134.5 49.72 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.5 p -69.24 152.76 44.66 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 124.689 1.196 . . . . 0.0 110.194 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.38 -22.94 55.59 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.3 p -77.4 -35.51 54.19 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 123.284 0.634 . . . . 0.0 109.519 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -69.11 -33.87 74.17 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.423 0.689 . . . . 0.0 110.986 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.1 t -66.77 -50.56 64.52 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.0 tmt_? -61.49 -38.92 89.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.212 1.405 . . . . 0.0 110.99 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.44 -51.77 53.42 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.636 0.774 . . . . 0.0 109.58 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.83 -23.93 66.79 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 118.809 -0.615 . . . . 0.0 111.115 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.13 -41.77 33.96 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 118.468 0.577 . . . . 0.0 110.835 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -68.63 -20.89 64.5 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.09 -64.45 1.16 Allowed 'General case' 0 C--N 1.35 0.591 0 N-CA-C 103.292 -2.855 . . . . 0.0 103.292 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -39.88 -45.01 1.75 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.187 1.395 . . . . 0.0 111.473 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.5 m -55.26 -58.77 6.36 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.882 1.273 . . . . 0.0 109.753 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.2 tp-100 -65.84 -36.84 84.59 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -86.22 -10.13 55.23 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 128.772 2.829 . . . . 0.0 115.512 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -90.74 -61.48 1.66 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-N 120.07 1.304 . . . . 0.0 113.21 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -137.56 -10.0 1.64 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -66.46 -48.7 69.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.357 0.98 . . . . 0.0 111.276 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -172.38 108.61 0.21 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.045 1.338 . . . . 0.0 107.47 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.251 0.1 OUTLIER 89.26 163.61 0.05 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 128.724 2.81 . . . . 0.0 112.648 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.9 p -138.02 -45.45 0.52 Allowed 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 126.691 1.996 . . . . 0.0 109.026 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 85.62 165.35 0.09 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 127.844 2.458 . . . . 0.0 111.558 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.97 85.77 1.09 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.535 1.064 . . . . 0.0 111.781 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.9 p -132.47 -124.29 0.19 Allowed 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 m -177.69 -75.88 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.14 1.376 . . . . 0.0 109.711 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.02 0.5 57.53 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.776 1.63 . . . . 0.0 113.35 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -152.32 104.89 2.76 Favored Pre-proline 0 C--N 1.343 0.284 0 O-C-N 120.924 -1.11 . . . . 0.0 108.728 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -72.14 155.47 98.37 Favored 'Cis proline' 0 N--CA 1.459 -0.501 0 CA-C-N 119.942 1.015 . . . . 0.0 113.608 0.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.15 162.62 4.54 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.573 1.549 . . . . 0.0 109.945 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.6 m -70.27 136.63 50.04 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.869 1.668 . . . . 0.0 109.775 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -96.12 150.24 20.73 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.401 1.08 . . . . 0.0 109.96 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -78.88 165.75 23.17 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.108 0.963 . . . . 0.0 111.475 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -159.0 93.21 1.14 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.469 0.708 . . . . 0.0 110.337 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -164.23 -56.57 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.22 1.008 . . . . 0.0 109.894 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -166.07 134.05 2.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.801 1.24 . . . . 0.0 108.36 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.83 -83.68 0.15 Allowed Glycine 0 C--N 1.338 0.674 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -159.36 46.69 0.28 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.572 1.149 . . . . 0.0 107.992 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -74.95 164.23 26.78 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -127.95 94.67 36.29 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 125.481 1.512 . . . . 0.0 108.329 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.34 84.15 1.4 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.389 2.726 . . . . 0.0 110.982 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.7 t -113.17 -49.51 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.282 1.433 . . . . 0.0 109.198 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -154.15 -73.97 0.12 Allowed 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.854 0.861 . . . . 0.0 109.243 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.96 140.23 8.04 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.81 175.25 45.47 Favored 'Cis proline' 0 N--CA 1.459 -0.557 0 CA-C-N 118.845 1.322 . . . . 0.0 112.036 -0.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.59 -174.15 3.43 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.297 1.439 . . . . 0.0 108.75 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -157.12 146.14 20.03 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 122.968 0.507 . . . . 0.0 111.981 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -89.74 144.37 26.03 Favored 'General case' 0 C--N 1.343 0.295 0 O-C-N 123.687 0.617 . . . . 0.0 110.677 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -153.87 110.95 2.51 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -82.66 148.88 14.22 Favored 'Trans proline' 0 N--CA 1.439 -1.727 0 C-N-CA 121.824 1.683 . . . . 0.0 113.48 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.526 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.5 tt -106.73 -177.57 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-O 123.87 1.795 . . . . 0.0 111.7 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.526 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 18.5 tptt -160.29 159.35 31.23 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 109.622 -3.445 . . . . 0.0 113.041 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.5 p -90.11 60.41 4.82 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 126.515 1.926 . . . . 0.0 110.887 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.36 -53.94 0.05 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.66 -151.93 6.32 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.5 p -72.24 165.26 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.79 1.236 . . . . 0.0 109.083 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.44 141.91 14.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.9 m -118.09 -56.03 2.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.908 2.083 . . . . 0.0 107.427 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.61 -157.58 16.17 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.828 1.204 . . . . 0.0 111.42 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.39 36.34 59.44 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.375 0.988 . . . . 0.0 112.318 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.7 m -160.86 157.87 23.62 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 125.7 1.6 . . . . 0.0 108.274 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -45.36 -58.44 1.6 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.783 2.989 . . . . 0.0 111.884 169.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.4 141.47 12.24 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -148.3 -40.96 0.16 Allowed 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 117.428 -1.272 . . . . 0.0 112.273 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -88.14 120.45 29.5 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.032 0.933 . . . . 0.0 109.351 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.4 138.89 16.81 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -90.82 151.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.1 t -135.98 117.82 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.7 pt -109.68 164.12 6.29 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 C-N-CA 124.091 0.957 . . . . 0.0 112.18 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -79.41 157.87 27.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.312 1.845 . . . . 0.0 106.76 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.291 5.6 t -63.01 -10.14 12.8 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 -177.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -85.95 -80.54 0.22 Allowed 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.93 -5.45 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.666 2.386 . . . . 0.0 115.485 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.16 143.81 35.08 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 119.867 1.212 . . . . 0.0 114.021 -175.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -70.83 124.54 24.55 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.75 -48.08 6.75 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.028 0.531 . . . . 0.0 109.684 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.79 -170.08 41.22 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.12 141.07 22.01 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.508 1.123 . . . . 0.0 108.481 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.7 pt -137.71 166.34 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 124.598 1.159 . . . . 0.0 109.911 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.4 t -154.57 156.04 35.87 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.539 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 64.5 m170 -77.27 -40.85 43.18 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.763 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.6 t -54.67 142.97 26.41 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 123.127 0.571 . . . . 0.0 111.801 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.1 -24.01 33.22 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.71 -141.94 0.23 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.012 1.325 . . . . 0.0 109.087 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.2 t -155.23 80.63 1.05 Allowed 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.431 0.56 . . . . 0.0 111.114 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.94 -133.2 11.02 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.033 1.301 . . . . 0.0 111.963 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -79.77 -30.06 40.6 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.983 0.913 . . . . 0.0 111.376 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -52.58 140.02 24.11 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.032 0.933 . . . . 0.0 109.78 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.64 167.03 10.59 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.3 m -145.01 166.56 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 128.944 2.897 . . . . 0.0 106.064 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.6 164.59 39.73 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 123.64 0.638 . . . . 0.0 114.539 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 49.6 t -139.36 163.71 31.76 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.986 1.714 . . . . 0.0 108.304 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.517 ' HB3' HG22 ' A' ' 4' ' ' THR . 59.6 p 54.92 43.81 29.33 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.51 1.924 . . . . 0.0 111.773 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.64 15.87 81.21 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.006 -0.885 . . . . 0.0 113.664 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.3 m -82.7 140.9 32.83 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.596 1.198 . . . . 0.0 108.59 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.107 -1.425 . . . . 0.0 108.986 179.652 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.3 p . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.54 164.56 0.14 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.485 1.914 . . . . 0.0 112.027 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.07 151.84 25.72 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.261 -0.274 . . . . 0.0 110.97 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.2 115.82 21.02 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.7 m -103.37 97.17 7.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.47 0.708 . . . . 0.0 109.819 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.9 -78.4 0.91 Allowed Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.768 1.175 . . . . 0.0 111.297 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 t -135.71 -8.42 2.15 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.547 1.139 . . . . 0.0 112.778 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.64 134.94 42.86 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 119.194 0.907 . . . . 0.0 109.502 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -94.4 154.69 17.34 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.809 0.844 . . . . 0.0 110.879 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -145.28 126.38 14.65 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.267 1.427 . . . . 0.0 108.836 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t -69.94 155.51 40.47 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.16 -16.65 34.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.6 t -76.28 -37.9 56.91 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.079 0.952 . . . . 0.0 109.459 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -74.6 -51.04 15.63 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.957 1.703 . . . . 0.0 111.152 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.84 -47.72 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.934 1.294 . . . . 0.0 107.524 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -69.67 -36.79 76.33 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.037 0.935 . . . . 0.0 111.94 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.13 -51.17 68.96 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.687 1.131 . . . . 0.0 109.859 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -34.72 74.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.775 0.83 . . . . 0.0 111.055 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.18 -33.35 33.08 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -69.94 -23.42 63.19 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.441 ' CB ' HG11 ' A' ' 66' ' ' VAL . . . -80.64 -53.15 6.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.482 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -50.19 -38.45 39.98 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.282 1.033 . . . . 0.0 110.41 176.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -55.3 35.31 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 126.171 1.789 . . . . 0.0 109.608 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.29 -30.97 68.11 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -90.55 -26.72 19.58 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -62.15 -32.75 73.39 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 119.202 0.91 . . . . 0.0 109.922 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -59.41 -19.03 44.13 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.024 0.929 . . . . 0.0 110.875 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 76.08 59.06 0.05 OUTLIER 'General case' 0 C--N 1.344 0.359 0 C-N-CA 127.294 2.237 . . . . 0.0 110.588 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -145.21 34.95 1.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.999 1.32 . . . . 0.0 109.529 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -175.27 130.99 0.29 Allowed 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 128.677 2.791 . . . . 0.0 106.455 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.7 p -84.35 85.79 7.34 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.26 0.552 . . . . 0.0 111.83 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.71 -160.23 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.044 1.737 . . . . 0.0 109.795 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -44.54 -49.8 8.47 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.233 1.397 . . . . 0.0 110.947 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.3 t 67.09 2.52 2.78 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.09 1.756 . . . . 0.0 115.735 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.9 m -67.77 -63.21 1.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -160.47 42.67 0.18 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.968 2.107 . . . . 0.0 107.076 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.438 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 9.8 m-85 -156.44 115.7 2.11 Favored Pre-proline 0 C--N 1.34 0.186 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.26 150.56 91.62 Favored 'Cis proline' 0 N--CA 1.456 -0.722 0 N-CA-C 114.239 0.823 . . . . 0.0 114.239 1.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.19 145.1 8.38 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.628 1.571 . . . . 0.0 108.577 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -60.44 145.47 48.1 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.849 1.66 . . . . 0.0 112.13 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -145.37 84.38 1.69 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -153.38 -158.47 0.88 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.934 1.294 . . . . 0.0 108.31 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.0 m120 67.83 2.52 3.1 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.629 1.572 . . . . 0.0 113.662 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -165.37 105.84 0.76 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -80.93 69.9 7.62 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.68 0.792 . . . . 0.0 110.659 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.28 11.91 56.6 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.945 0.783 . . . . 0.0 112.248 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -157.53 162.92 38.85 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 118.186 0.993 . . . . 0.0 111.809 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -116.03 119.72 36.78 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.131 1.373 . . . . 0.0 108.299 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -135.94 156.72 76.96 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 125.993 1.717 . . . . 0.0 107.722 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.401 ' O ' HG22 ' A' ' 52' ' ' VAL . 37.3 Cg_endo -61.74 163.36 18.92 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.095 2.53 . . . . 0.0 109.341 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 51' ' ' PRO 0.284 8.6 m 60.21 -165.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.176 1.39 . . . . 0.0 110.686 -178.201 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -112.79 -16.97 12.65 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.571 1.148 . . . . 0.0 113.392 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.07 -156.65 22.41 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.34 -177.05 5.33 Favored 'Cis proline' 0 CA--C 1.535 0.545 0 CA-C-N 119.037 1.418 . . . . 0.0 113.211 -0.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -148.25 155.27 41.14 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.615 0.366 . . . . 0.0 111.478 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -132.43 146.74 52.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.257 1.423 . . . . 0.0 107.777 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -86.6 156.8 19.89 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.482 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 35.8 t80 -152.5 109.7 2.76 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 13.0 Cg_endo -85.21 128.8 3.69 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.34 2.694 . . . . 0.0 116.965 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.444 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 10.1 tt -97.4 170.13 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 123.969 1.842 . . . . 0.0 112.193 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.444 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 8.3 mtpm? -160.74 113.51 1.99 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 109.394 -3.548 . . . . 0.0 111.623 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.9 p 10.76 50.14 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 129.806 3.242 . . . . 0.0 116.471 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.34 70.82 1.33 Allowed Glycine 0 C--N 1.337 0.639 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.08 113.89 0.54 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.441 HG11 ' CB ' ' A' ' 22' ' ' ALA . 26.9 t -84.08 137.77 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.103 1.361 . . . . 0.0 109.416 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.322 9.6 p90 46.17 53.38 9.41 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.027 2.131 . . . . 0.0 113.979 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.8 p -129.63 -33.44 1.85 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.963 1.705 . . . . 0.0 109.726 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.11 149.57 44.85 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 123.588 0.613 . . . . 0.0 112.815 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 172.07 -74.82 0.1 OUTLIER Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.8 t -153.0 105.22 2.64 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 124.121 0.968 . . . . 0.0 109.343 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -58.41 157.47 35.39 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 CA-C-N 119.735 0.941 . . . . 0.0 113.23 -5.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.81 -104.49 0.21 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 79.06 -60.18 0.37 Allowed 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 127.683 2.393 . . . . 0.0 109.052 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.92 121.9 18.25 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.445 1.498 . . . . 0.0 109.923 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -152.76 141.66 21.15 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.9 m -97.63 150.14 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.9 t -131.82 119.13 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.2 pt -100.62 167.75 2.01 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 C-N-CA 124.783 1.233 . . . . 0.0 113.17 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -82.46 168.26 17.62 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.875 2.07 . . . . 0.0 107.887 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.51 46.18 0.42 Allowed 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -160.36 -83.43 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.4 m -163.44 63.12 0.17 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.96 2.104 . . . . 0.0 112.034 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -148.83 114.74 5.72 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.445 1.93 . . . . 0.0 113.88 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -60.47 107.35 0.66 Allowed 'General case' 0 C--N 1.344 0.357 0 C-N-CA 123.56 0.744 . . . . 0.0 109.808 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.96 -68.22 0.72 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.34 169.35 35.46 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.87 146.64 48.26 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.25 1.02 . . . . 0.0 111.439 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.6 pt -139.28 166.04 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.577 1.551 . . . . 0.0 109.631 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.5 t -156.01 148.67 23.92 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -79.05 4.68 13.81 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 118.666 -0.683 . . . . 0.0 112.092 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.1 m -47.79 -49.94 27.24 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.73 32.68 6.4 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.577 1.084 . . . . 0.0 110.986 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -111.52 166.45 11.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.596 1.159 . . . . 0.0 112.641 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.2 t -103.49 67.61 0.92 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.707 1.603 . . . . 0.0 108.625 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.97 -109.8 3.79 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.763 1.173 . . . . 0.0 112.207 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -79.61 -9.18 59.59 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.175 0.99 . . . . 0.0 113.1 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -66.87 -179.65 0.94 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.062 0.945 . . . . 0.0 108.77 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -147.53 167.94 23.2 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.3 m -139.23 160.49 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 128.038 2.535 . . . . 0.0 105.381 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.67 149.6 20.17 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 115.527 0.971 . . . . 0.0 115.527 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.1 m -99.38 154.37 18.26 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.1 p 33.02 38.63 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 62.71 52.41 48.77 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.165 0.888 . . . . 0.0 111.853 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.1 t -81.65 28.95 0.39 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.517 1.127 . . . . 0.0 113.996 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 . . . . . 0 C--O 1.25 1.103 0 C-N-CA 125.974 1.709 . . . . 0.0 109.369 -179.243 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 110.53 98.35 0.0 OUTLIER 'General case' 0 C--N 1.345 0.393 0 C-N-CA 131.157 3.783 . . . . 0.0 107.096 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -107.28 94.61 5.18 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.84 1.256 . . . . 0.0 111.563 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.04 99.6 9.49 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 102.105 -3.294 . . . . 0.0 102.105 177.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -92.13 80.81 5.05 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.755 1.622 . . . . 0.0 109.211 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.41 -82.49 0.91 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.4 t -117.89 -45.81 2.66 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.49 1.516 . . . . 0.0 109.67 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.8 m -63.42 103.91 0.57 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.725 1.21 . . . . 0.0 109.885 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.82 131.42 34.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.097 1.359 . . . . 0.0 110.847 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -131.21 138.54 49.42 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.6 p -77.68 160.68 28.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 124.113 0.965 . . . . 0.0 111.773 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.87 -13.21 43.22 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.9 t -81.42 -41.38 21.96 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.92 -37.2 86.52 Favored 'General case' 0 C--N 1.345 0.402 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.53 HG13 ' CE2' ' A' ' 85' ' ' TYR . 3.3 t -59.86 -51.23 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 126.28 1.832 . . . . 0.0 108.538 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.79 -39.16 93.36 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.139 0.976 . . . . 0.0 111.805 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.94 -51.71 36.85 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.055 0.542 . . . . 0.0 110.419 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.41 -38.77 81.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.669 1.188 . . . . 0.0 110.884 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.89 -41.03 45.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -64.3 -21.5 66.63 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.64 -59.22 2.5 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.07 -47.4 11.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.906 1.283 . . . . 0.0 110.239 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.9 t -61.18 -53.95 50.51 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.474 1.509 . . . . 0.0 111.595 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -57.37 -46.69 83.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.943 0.497 . . . . 0.0 110.907 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -67.46 -48.96 65.66 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.685 1.194 . . . . 0.0 113.137 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -65.05 -34.33 78.18 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.694 0.798 . . . . 0.0 112.146 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -82.78 -47.16 12.23 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 123.033 0.533 . . . . 0.0 111.52 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -70.98 -3.56 20.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.533 1.133 . . . . 0.0 112.539 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.8 t70 69.16 76.69 0.23 Allowed 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.662 1.585 . . . . 0.0 110.812 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -144.88 122.79 11.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.0 1.72 . . . . 0.0 107.172 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.9 p -103.22 82.43 2.07 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.02 111.98 2.15 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.236 1.015 . . . . 0.0 110.35 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.63 112.53 3.14 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.414 1.006 . . . . 0.0 111.867 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.2 m -135.88 -56.97 0.77 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.993 1.317 . . . . 0.0 108.064 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -157.67 -68.18 0.09 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.089 1.755 . . . . 0.0 106.507 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.3 t -159.95 30.67 0.18 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.351 1.86 . . . . 0.0 108.639 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -124.43 155.04 69.4 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.569 1.947 . . . . 0.0 108.825 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -80.51 133.72 27.36 Favored 'Cis proline' 0 N--CA 1.452 -0.935 0 CA-C-N 119.519 0.864 . . . . 0.0 112.438 -0.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.97 166.17 33.23 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.997 1.319 . . . . 0.0 108.652 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.6 m -51.81 140.47 19.32 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 126.051 1.741 . . . . 0.0 112.107 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -129.71 119.7 23.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.738 1.215 . . . . 0.0 109.204 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -165.08 92.36 0.57 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -159.32 159.65 34.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.314 0.646 . . . . 0.0 111.149 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.8 t80 67.79 165.59 0.23 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.875 1.67 . . . . 0.0 112.615 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -109.62 -45.17 3.72 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 124.778 1.231 . . . . 0.0 110.788 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.13 38.21 2.2 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.006 0.812 . . . . 0.0 113.85 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -157.82 128.22 6.29 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.012 1.325 . . . . 0.0 108.653 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -165.27 -175.32 3.57 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.165 1.386 . . . . 0.0 108.954 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -143.06 157.11 61.31 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 125.459 1.504 . . . . 0.0 107.903 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -81.85 48.99 3.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.668 2.912 . . . . 0.0 111.506 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 m -153.45 171.88 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 127.547 2.339 . . . . 0.0 107.441 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -109.32 143.65 38.54 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.265 1.026 . . . . 0.0 110.33 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.71 -160.66 35.84 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.65 151.38 23.55 Favored 'Cis proline' 0 N--CA 1.46 -0.467 0 CA-C-N 118.793 1.297 . . . . 0.0 113.634 -0.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -111.74 174.09 6.04 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.669 1.188 . . . . 0.0 109.848 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -155.57 144.0 20.25 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.11 0.564 . . . . 0.0 110.508 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -87.81 149.93 23.85 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.877 0.871 . . . . 0.0 111.092 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -158.34 109.24 1.69 Allowed Pre-proline 0 N--CA 1.45 -0.444 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -79.92 136.1 11.63 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 121.344 1.363 . . . . 0.0 113.454 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.503 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.3 tt -98.51 177.25 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 124.089 1.899 . . . . 0.0 110.801 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.503 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.7 tptm -156.52 -169.63 3.08 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 109.295 -3.593 . . . . 0.0 110.835 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t -76.64 52.44 0.81 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.574 1.549 . . . . 0.0 112.464 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.35 68.45 1.46 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.34 103.14 0.2 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 51.7 t -66.21 120.32 13.09 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 124.43 1.092 . . . . 0.0 108.661 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 64.47 115.67 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.543 1.537 . . . . 0.0 111.308 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.2 p -97.34 -72.74 0.63 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.495 1.118 . . . . 0.0 111.867 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.71 -10.88 73.59 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.897 0.76 . . . . 0.0 111.854 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.52 -90.68 1.04 Allowed Glycine 0 C--N 1.343 0.96 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.9 m -141.39 72.81 25.82 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 123.339 0.656 . . . . 0.0 112.229 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.55 111.33 3.2 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 N-CA-C 105.761 -2.438 . . . . 0.0 105.761 163.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.08 -8.28 8.02 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-O 117.243 -1.865 . . . . 0.0 117.081 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.452 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -150.05 -60.19 0.2 Allowed 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 120.84 2.32 . . . . 0.0 114.315 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.52 118.33 13.18 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -147.2 137.22 23.19 Favored 'General case' 0 C--N 1.347 0.483 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.9 m -94.69 149.33 4.48 Favored 'Isoleucine or valine' 0 C--N 1.343 0.318 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.5 t -134.72 117.68 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 pt -103.53 -177.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.372 0 C-N-CA 124.407 1.083 . . . . 0.0 112.145 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -99.79 151.91 20.72 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 127.312 2.245 . . . . 0.0 105.308 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.326 5.3 t -63.07 -7.22 5.07 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 119.2 3.037 . . . . 0.0 119.2 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -89.29 -78.03 0.36 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.54 -9.96 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -79.21 151.49 31.19 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 118.868 0.758 . . . . 0.0 110.509 -176.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.53 ' CE2' HG13 ' A' ' 16' ' ' VAL . 7.0 t80 -93.53 137.55 32.69 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.514 1.125 . . . . 0.0 109.763 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.86 -57.59 2.32 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 123.258 0.623 . . . . 0.0 110.767 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.86 168.86 30.6 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.29 155.72 20.19 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 122.203 1.002 . . . . 0.0 112.794 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.2 pt -139.55 155.77 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 126.699 1.999 . . . . 0.0 106.575 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.5 t -154.69 156.47 36.46 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.452 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 53.2 m170 -77.96 -50.06 12.9 Favored 'General case' 0 C--N 1.346 0.442 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.673 176.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t 45.4 15.1 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.621 2.768 . . . . 0.0 116.248 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.76 49.79 3.28 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.174 1.369 . . . . 0.0 110.791 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.24 -87.13 0.11 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 124.293 1.037 . . . . 0.0 109.721 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.7 m -147.64 63.19 1.14 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.729 1.211 . . . . 0.0 108.756 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.04 -102.21 1.13 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.282 0.944 . . . . 0.0 111.737 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -79.53 -26.93 41.36 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.91 0.884 . . . . 0.0 112.006 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -50.31 129.96 22.4 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.989 0.916 . . . . 0.0 111.374 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -103.62 133.93 47.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.28 1.432 . . . . 0.0 110.266 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.6 m -111.15 164.81 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.33 137.76 17.45 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.872 -0.604 . . . . 0.0 114.105 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.8 t -83.29 -172.5 4.18 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.3 m -67.65 138.97 56.77 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.217 -0.927 . . . . 0.0 108.643 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.63 33.11 35.34 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.2 m -155.24 119.3 4.61 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.533 1.533 . . . . 0.0 110.574 -179.088 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -49.32 136.81 15.22 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.808 1.243 . . . . 0.0 110.485 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.7 p -112.45 117.58 32.78 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -117.41 94.59 4.61 Favored 'General case' 0 N--CA 1.422 -1.872 1 N-CA-C 100.176 -4.009 . . . . 0.0 100.176 177.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 54.2 m -95.02 71.87 3.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.29 -79.22 1.51 Allowed Glycine 0 C--N 1.34 0.799 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.3 t -123.29 -35.32 2.98 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.99 1.316 . . . . 0.0 111.344 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 m -72.86 99.25 2.62 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -95.58 148.36 22.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.264 1.026 . . . . 0.0 110.803 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.61 143.62 31.56 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.691 1.196 . . . . 0.0 108.003 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -68.71 150.73 47.57 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.86 -21.27 10.84 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.8 t -71.14 -44.51 65.41 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.387 1.075 . . . . 0.0 109.574 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.1 -39.01 92.53 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 118.682 0.673 . . . . 0.0 112.628 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.447 HG12 ' CE2' ' A' ' 85' ' ' TYR . 2.1 t -62.88 -53.31 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -57.13 -44.49 83.41 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.811 1.245 . . . . 0.0 110.291 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.03 -45.11 95.0 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.647 0.779 . . . . 0.0 110.077 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.13 -33.95 69.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.511 0.725 . . . . 0.0 110.372 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.08 -39.55 25.54 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -62.4 -25.93 68.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.934 1.243 . . . . 0.0 108.312 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.55 -64.51 1.13 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.57 -33.54 15.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.962 0.905 . . . . 0.0 111.346 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 t -61.89 -61.4 2.52 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.308 1.443 . . . . 0.0 110.05 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -65.7 -42.3 91.32 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -71.52 -48.7 47.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.329 1.451 . . . . 0.0 113.722 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.457 ' CE2' ' HG2' ' A' ' 57' ' ' GLN . 39.6 t80 -62.08 -34.68 76.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.48 0.582 . . . . 0.0 110.177 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -58.02 -34.81 70.45 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 118.432 -0.794 . . . . 0.0 112.447 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 122.08 73.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 129.577 3.151 . . . . 0.0 110.604 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -162.08 58.82 0.24 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.1 t70 124.18 154.52 0.0 OUTLIER 'General case' 0 C--N 1.344 0.343 0 C-N-CA 130.027 3.331 . . . . 0.0 109.257 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.6 p -110.78 67.65 0.65 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 126.044 1.738 . . . . 0.0 108.653 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.06 93.79 1.83 Allowed 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.047 0.539 . . . . 0.0 109.751 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.21 135.33 3.41 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.1 t -136.4 67.03 1.47 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.642 0.777 . . . . 0.0 110.589 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.1 m -122.24 -76.77 0.59 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -160.29 30.97 0.17 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.835 1.654 . . . . 0.0 109.105 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -149.05 134.3 9.47 Favored Pre-proline 0 C--N 1.342 0.278 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.68 145.9 85.35 Favored 'Cis proline' 0 N--CA 1.455 -0.776 0 CA-C-N 119.373 0.812 . . . . 0.0 112.483 -0.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -159.89 162.47 34.58 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 126.079 1.752 . . . . 0.0 108.459 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 t -59.91 150.23 29.32 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -106.56 88.44 2.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.11 1.364 . . . . 0.0 107.707 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -68.31 100.4 1.05 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.687 1.195 . . . . 0.0 109.943 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -66.17 -65.48 0.67 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.679 0.791 . . . . 0.0 111.105 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 58.41 56.03 4.61 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 68.06 -17.0 0.17 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.731 2.012 . . . . 0.0 114.593 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.75 -99.32 0.01 OUTLIER Glycine 0 CA--C 1.532 1.136 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.62 133.94 38.31 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -109.81 162.83 14.1 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.948 1.299 . . . . 0.0 110.88 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -153.95 153.21 28.26 Favored Pre-proline 0 N--CA 1.454 -0.257 0 C-N-CA 126.149 1.78 . . . . 0.0 107.231 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.99 -30.02 76.17 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.92 2.413 . . . . 0.0 112.026 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 t -91.06 -74.39 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.069 0.947 . . . . 0.0 108.462 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 t70 54.87 105.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.967 2.507 . . . . 0.0 115.405 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.81 117.68 2.0 Allowed Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.839 -0.978 . . . . 0.0 112.082 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -68.8 157.33 89.34 Favored 'Cis proline' 0 C--N 1.348 0.515 0 CA-C-N 119.521 1.661 . . . . 0.0 108.543 -1.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.56 134.75 15.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 119.85 3.278 . . . . 0.0 119.85 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.457 ' HG2' ' CE2' ' A' ' 27' ' ' TYR . 20.0 mp0 -145.07 144.97 31.24 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.476 1.11 . . . . 0.0 112.78 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -81.86 156.15 24.98 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.674 0.749 . . . . 0.0 110.346 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -160.63 107.53 1.32 Allowed Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.39 134.88 21.46 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 CA-C-N 120.913 1.362 . . . . 0.0 112.336 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.45 HG13 ' H ' ' A' ' 62' ' ' LYS . 6.9 tp -82.27 176.14 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-O 123.863 1.792 . . . . 0.0 111.114 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.45 ' H ' HG13 ' A' ' 61' ' ' ILE . 55.9 tptt -155.56 154.57 31.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 109.703 -3.408 . . . . 0.0 112.813 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.4 m -83.83 51.0 1.93 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 127.467 2.307 . . . . 0.0 108.367 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.62 65.03 0.07 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.48 -102.9 1.66 Allowed Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 67' ' ' TYR . 8.2 p -110.6 -176.93 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.823 2.049 . . . . 0.0 109.886 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.498 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -41.27 166.72 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.291 2.636 . . . . 0.0 117.258 -178.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.3 p -96.37 -64.17 1.07 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.375 1.47 . . . . 0.0 110.057 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.12 62.88 0.77 Allowed Glycine 0 C--N 1.338 0.679 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -170.76 -61.8 0.04 OUTLIER Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.2 t -154.13 147.4 18.2 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.288 1.035 . . . . 0.0 109.924 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.31 -158.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.193 3.262 . . . . 0.0 110.419 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.39 41.95 0.13 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 107.391 -2.284 . . . . 0.0 107.391 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.44 ' HB1' ' H ' ' A' ' 91' ' ' HIS . . . 71.12 -27.07 0.17 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.824 2.049 . . . . 0.0 116.305 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.9 111.43 19.66 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 120.332 1.424 . . . . 0.0 110.438 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -120.1 154.09 35.2 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.101 0.96 . . . . 0.0 113.146 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.3 m -128.02 143.21 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -134.89 126.67 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pt -110.29 -165.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.371 0 C-N-CA 125.016 1.326 . . . . 0.0 114.447 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -122.97 136.87 55.02 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 128.48 2.712 . . . . 0.0 106.849 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.29 1.7 t -56.65 -15.55 4.67 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 118.746 2.869 . . . . 0.0 118.746 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -79.55 -77.15 0.19 Allowed 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 102.693 -3.077 . . . . 0.0 102.693 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.11 -2.16 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.012 2.125 . . . . 0.0 114.902 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -79.17 170.25 16.93 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 119.646 1.112 . . . . 0.0 112.155 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.447 ' CE2' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -112.65 126.95 55.93 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.767 1.227 . . . . 0.0 111.565 -178.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.5 -51.82 7.44 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.63 -158.26 31.07 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 112.28 -0.328 . . . . 0.0 112.28 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.54 145.22 29.0 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.357 1.063 . . . . 0.0 110.174 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 pt -138.32 166.81 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.705 1.202 . . . . 0.0 110.95 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.3 t -156.18 156.69 34.63 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.44 ' H ' ' HB1' ' A' ' 74' ' ' ALA . 44.7 m170 -78.5 -30.67 47.33 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.117 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.5 m -29.48 -70.14 0.05 Allowed 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.987 2.115 . . . . 0.0 116.504 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.97 -12.84 79.25 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.111 0.862 . . . . 0.0 114.769 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.96 -142.21 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.345 1.073 . . . . 0.0 111.064 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.7 t -151.17 92.27 1.78 Allowed 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.033 0.933 . . . . 0.0 109.941 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.98 -105.97 2.21 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.97 1.272 . . . . 0.0 112.632 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -79.47 -32.03 42.52 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.871 0.868 . . . . 0.0 111.312 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -54.79 160.62 1.83 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.318 1.047 . . . . 0.0 111.685 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -125.09 163.37 22.54 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.239 1.416 . . . . 0.0 112.859 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.5 m -144.53 165.68 12.78 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 128.123 2.569 . . . . 0.0 106.473 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.68 157.34 23.63 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.232 0.444 . . . . 0.0 113.477 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.5 m -116.24 167.63 10.84 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.2 m 61.7 -157.31 0.34 Allowed 'General case' 0 C--N 1.342 0.243 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.37 -19.62 57.77 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.489 1.042 . . . . 0.0 111.359 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.8 m -79.46 144.69 33.81 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 125.011 1.324 . . . . 0.0 109.122 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 C--O 1.253 1.285 0 CA-C-O 117.066 -1.445 . . . . 0.0 109.193 179.039 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 CA--C 1.529 0.167 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 73.41 146.34 0.08 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 126.874 2.07 . . . . 0.0 109.974 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 t -151.15 135.45 16.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.506 0.193 . . . . 0.0 110.525 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.88 107.91 18.02 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -98.69 85.89 3.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.47 -115.06 4.93 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.0 m -91.15 -27.79 18.29 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.404 1.082 . . . . 0.0 110.23 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -76.33 94.53 3.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.202 1.001 . . . . 0.0 109.351 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -85.82 113.15 21.75 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.723 1.209 . . . . 0.0 109.977 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -103.99 133.02 49.65 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.124 0.97 . . . . 0.0 111.218 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.7 m -72.46 154.31 40.93 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.3 1.44 . . . . 0.0 108.951 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.08 -20.84 60.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.0 m -74.5 -37.91 62.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.774 0.829 . . . . 0.0 109.449 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -73.66 -47.72 37.7 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.751 1.22 . . . . 0.0 111.596 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.0 t -54.39 -50.29 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -71.81 -34.64 69.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.226 1.411 . . . . 0.0 113.272 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.76 -52.76 55.26 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.279 0.945 . . . . 0.0 109.396 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.59 87.75 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.91 -37.54 81.82 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.63 -22.51 61.68 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.33 -59.44 2.77 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -55.44 -41.72 73.25 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.365 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.74 -50.47 33.61 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.853 1.206 . . . . 0.0 110.577 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -68.52 -43.87 75.84 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.353 0.0 OUTLIER -75.08 -43.05 55.32 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -177.394 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -39.24 62.98 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.59 1.956 . . . . 0.0 107.928 177.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -76.81 -37.51 55.62 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.884 1.274 . . . . 0.0 112.867 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -63.16 -32.18 73.51 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 t0 67.92 32.0 5.38 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.439 1.495 . . . . 0.0 110.87 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -163.5 -165.18 1.01 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 129.283 3.033 . . . . 0.0 105.065 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.284 3.7 t 47.27 57.96 5.31 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.804 1.242 . . . . 0.0 110.518 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.52 172.16 13.35 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.663 1.585 . . . . 0.0 109.67 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.8 58.25 0.07 OUTLIER Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.3 t -118.95 -94.49 0.5 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.716 1.206 . . . . 0.0 108.207 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.9 m -158.1 -59.34 0.08 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.804 1.242 . . . . 0.0 108.223 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 82.7 p -130.56 -52.27 1.08 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.697 1.599 . . . . 0.0 108.439 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -45.24 124.57 5.58 Favored Pre-proline 0 C--N 1.342 0.271 0 C-N-CA 127.821 2.448 . . . . 0.0 108.531 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.52 119.22 5.08 Favored 'Cis proline' 0 N--CA 1.453 -0.857 0 CA-C-N 118.583 0.53 . . . . 0.0 111.613 1.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -135.85 146.35 47.37 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 124.643 1.177 . . . . 0.0 111.129 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -43.0 151.3 0.14 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.257 2.223 . . . . 0.0 114.743 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -126.4 127.23 45.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.742 2.017 . . . . 0.0 105.853 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -74.32 -103.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 122.79 0.436 . . . . 0.0 111.3 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -178.46 -46.08 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.212 1.405 . . . . 0.0 109.06 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -41.48 128.76 3.14 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 128.002 2.521 . . . . 0.0 115.106 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 43.87 82.5 0.03 OUTLIER 'General case' 0 C--N 1.342 0.267 0 C-N-CA 127.325 2.25 . . . . 0.0 113.361 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.46 -156.94 28.4 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.52 154.35 20.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.66 1.584 . . . . 0.0 108.339 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -132.29 129.65 39.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -72.32 151.57 92.1 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.722 1.209 . . . . 0.0 111.397 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -63.6 -12.52 31.58 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 124.05 3.167 . . . . 0.0 115.618 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.94 -64.18 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.063 0.847 . . . . 0.0 110.281 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 143.17 -52.03 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 129.601 3.16 . . . . 0.0 108.457 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.5 -162.96 28.38 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.436 1.017 . . . . 0.0 110.952 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.6 170.59 9.27 Favored 'Cis proline' 0 CA--C 1.535 0.542 0 CA-C-N 119.208 1.504 . . . . 0.0 114.999 -0.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.29 -179.17 6.36 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 125.061 1.344 . . . . 0.0 109.229 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.19 147.77 25.18 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.24 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -79.41 148.8 31.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.832 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.489 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 20.4 t80 -144.13 104.91 4.78 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.468 ' HB3' HH11 ' A' ' 76' ' ' ARG . 26.3 Cg_endo -77.54 128.09 9.3 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 121.024 1.149 . . . . 0.0 113.319 -175.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.557 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.1 tt -90.83 179.33 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 124.281 1.991 . . . . 0.0 110.275 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.557 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 10.4 tptp -160.2 147.55 16.26 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 109.26 -3.609 . . . . 0.0 110.58 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.0 p -93.35 56.89 2.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.604 1.162 . . . . 0.0 108.531 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 178.78 57.3 0.07 OUTLIER Glycine 0 C--N 1.339 0.713 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.95 153.16 19.1 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.023 0.821 . . . . 0.0 111.951 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.57 147.61 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.489 1.116 . . . . 0.0 109.091 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.399 0.0 OUTLIER 28.97 44.5 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 128.794 2.837 . . . . 0.0 116.486 -178.567 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.8 p -141.72 108.41 5.37 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.459 1.504 . . . . 0.0 107.395 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -179.71 -177.53 47.94 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.06 160.42 33.97 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.2 t 72.18 145.85 0.11 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.056 1.742 . . . . 0.0 110.219 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -42.15 110.46 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.91 3.074 . . . . 0.0 113.715 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.62 -39.03 2.64 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.455 ' HB1' ' H ' ' A' ' 91' ' ' HIS . . . 71.74 -12.08 0.68 Allowed 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 126.769 2.028 . . . . 0.0 115.814 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -88.78 126.41 35.33 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 120.568 1.531 . . . . 0.0 112.427 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.468 HH11 ' HB3' ' A' ' 60' ' ' PRO . 33.0 mtt-85 -136.91 145.82 44.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.34 150.04 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 102.389 -3.189 . . . . 0.0 102.389 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.33 127.03 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 O-C-N 121.543 -0.723 . . . . 0.0 109.284 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.9 pt -113.61 158.18 14.04 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 124.924 1.29 . . . . 0.0 108.424 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -79.28 172.98 13.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.869 0.868 . . . . 0.0 109.273 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.299 3.0 t -76.66 30.02 0.13 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -128.33 -80.19 0.58 Allowed 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 101.66 -3.459 . . . . 0.0 101.66 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.5 -19.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -84.65 139.42 32.06 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -55.67 129.68 40.14 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 125.117 1.367 . . . . 0.0 109.01 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.38 -45.0 5.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.205 1.402 . . . . 0.0 108.947 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.72 -160.98 24.25 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.42 148.55 23.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.347 1.459 . . . . 0.0 108.707 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.3 pt -142.97 164.56 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.929 1.292 . . . . 0.0 110.227 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -159.47 162.84 35.66 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.895 0.478 . . . . 0.0 111.728 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.455 ' H ' ' HB1' ' A' ' 74' ' ' ALA . 22.4 m170 -78.89 -56.62 4.26 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.272 5.8 t 49.26 11.01 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.352 2.661 . . . . 0.0 115.606 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.36 -55.85 0.62 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 106.98 -2.448 . . . . 0.0 106.98 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 52.28 -169.33 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.483 1.913 . . . . 0.0 112.133 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.8 t -83.27 -42.24 17.4 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -147.54 -79.87 0.03 OUTLIER Glycine 0 C--N 1.342 0.891 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -130.47 3.2 4.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.182 1.393 . . . . 0.0 111.55 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -73.07 -169.84 0.66 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.962 1.305 . . . . 0.0 111.725 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -127.37 154.42 45.0 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.933 1.293 . . . . 0.0 112.224 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.81 162.75 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 126.215 1.806 . . . . 0.0 107.144 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.84 147.26 39.66 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.68 -178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.0 t -79.83 178.89 7.87 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.1 m -93.21 100.48 12.85 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.944 0.793 . . . . 0.0 108.869 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.65 75.49 1.27 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.1 t -135.13 29.82 3.35 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.54 1.536 . . . . 0.0 111.459 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.962 1.705 . . . . 0.0 110.519 -179.228 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 CA--C 1.53 0.205 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.58 156.6 0.14 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.639 1.976 . . . . 0.0 111.929 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 t -154.51 137.8 15.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.86 122.02 45.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.03 80.2 1.49 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.436 1.495 . . . . 0.0 108.058 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.74 -86.41 0.75 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.5 t -114.82 -41.86 3.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.108 1.363 . . . . 0.0 110.053 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.4 m -68.91 100.19 1.16 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.559 0.744 . . . . 0.0 109.45 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -80.03 151.97 29.67 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.895 0.878 . . . . 0.0 110.506 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -139.0 131.11 28.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.988 0.915 . . . . 0.0 110.225 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.9 m -72.21 156.43 39.16 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.42 1.488 . . . . 0.0 109.057 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.47 -21.35 62.27 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.6 m -70.88 -40.72 72.08 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.748 1.219 . . . . 0.0 109.373 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -49.07 67.8 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.53 1.132 . . . . 0.0 111.004 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.93 -49.34 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.241 1.416 . . . . 0.0 109.626 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -67.79 -40.26 83.97 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.765 0.826 . . . . 0.0 112.393 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.27 -49.97 71.96 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.54 -38.7 81.72 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.001 0.92 . . . . 0.0 110.098 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.88 -46.27 62.89 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -64.31 -20.35 66.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.14 -55.27 4.86 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.705 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -55.21 -43.12 74.18 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 t -50.31 -53.24 30.18 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.044 0.938 . . . . 0.0 110.812 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -66.37 -44.4 83.25 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -65.07 -59.54 4.01 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.843 2.457 . . . . 0.0 112.204 -177.713 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -64.92 -24.97 67.69 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.939 2.095 . . . . 0.0 113.758 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -76.11 -62.86 1.46 Allowed 'General case' 0 C--N 1.338 0.095 0 CA-C-N 118.763 0.71 . . . . 0.0 111.964 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -164.89 -37.61 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -81.3 61.76 4.94 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.576 1.151 . . . . 0.0 108.785 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -50.05 117.9 2.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.464 1.906 . . . . 0.0 111.935 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 t -90.48 -20.71 22.41 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.369 1.068 . . . . 0.0 108.983 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 26' ' ' TYR . . . -155.4 -168.65 2.9 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.773 2.429 . . . . 0.0 107.888 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -176.62 150.11 10.19 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 121.589 -0.695 . . . . 0.0 113.213 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 m -153.55 -111.14 0.04 OUTLIER 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.696 1.199 . . . . 0.0 109.405 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.9 m -155.89 -55.67 0.09 Allowed 'General case' 0 C--N 1.347 0.476 0 CA-C-N 118.813 0.733 . . . . 0.0 112.36 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.2 p -87.87 -57.42 2.95 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.141 0.976 . . . . 0.0 110.351 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -92.19 153.37 43.09 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.522 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.434 ' HG3' ' CE2' ' A' ' 26' ' ' TYR . 26.8 Cg_endo -98.31 56.04 1.0 Allowed 'Cis proline' 0 N--CA 1.442 -1.517 0 N-CA-C 105.139 -2.677 . . . . 0.0 105.139 -5.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.416 ' CE1' ' HD2' ' A' ' 39' ' ' PRO . 6.1 m-70 -107.08 -168.39 1.4 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.555 1.142 . . . . 0.0 112.417 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.0 p -33.02 139.92 0.05 OUTLIER 'General case' 0 C--N 1.34 0.185 0 C-N-CA 128.56 2.744 . . . . 0.0 115.784 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -152.13 127.17 9.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.054 2.142 . . . . 0.0 105.515 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -149.24 -51.63 0.15 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.813 0.845 . . . . 0.0 110.171 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -58.02 158.13 7.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.842 1.257 . . . . 0.0 111.686 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 66.62 102.29 0.04 OUTLIER 'General case' 0 C--N 1.343 0.291 0 C-N-CA 125.927 1.691 . . . . 0.0 109.694 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -82.61 -142.44 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.147 0.979 . . . . 0.0 110.097 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.0 12.81 65.76 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -159.17 139.57 12.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.321 1.849 . . . . 0.0 108.584 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.06 166.22 17.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.671 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -134.97 162.19 59.19 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 124.772 1.229 . . . . 0.0 109.117 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -51.38 -41.12 60.86 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.852 3.035 . . . . 0.0 112.774 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.93 167.34 2.33 Favored 'Isoleucine or valine' 0 C--N 1.343 0.32 0 C-N-CA 123.585 0.754 . . . . 0.0 110.152 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -101.53 -177.22 3.37 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.981 1.313 . . . . 0.0 109.7 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -132.09 -156.76 8.41 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.471 1.034 . . . . 0.0 110.724 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.33 125.56 1.56 Allowed 'Cis proline' 0 N--CA 1.456 -0.712 0 CA-C-N 118.274 1.037 . . . . 0.0 113.436 -0.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -98.49 169.34 9.6 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.82 1.648 . . . . 0.0 109.261 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -138.83 156.18 47.53 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.45 159.8 17.1 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.705 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -161.18 102.32 1.25 Allowed Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 66.0 Cg_endo -66.87 121.74 8.99 Favored 'Trans proline' 0 N--CA 1.425 -2.546 0 CA-C-N 121.353 1.519 . . . . 0.0 114.098 -177.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 62' ' ' LYS . 3.2 tp -84.24 167.3 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-O 124.573 2.13 . . . . 0.0 112.127 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.449 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -160.25 151.62 19.5 Favored 'General case' 0 C--N 1.317 -0.843 1 CA-C-N 108.394 -4.003 . . . . 0.0 111.882 -178.887 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.6 p -86.49 57.36 4.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.998 1.719 . . . . 0.0 110.635 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.58 -73.39 0.03 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.27 137.64 5.48 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.45 131.6 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 117.32 0.56 . . . . 0.0 111.405 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.273 0.7 OUTLIER 64.65 131.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.717 2.807 . . . . 0.0 113.359 -178.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.6 p -136.59 -50.28 0.67 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.913 1.685 . . . . 0.0 108.435 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.9 61.66 1.49 Allowed Glycine 0 C--N 1.341 0.807 0 C-N-CA 124.374 0.988 . . . . 0.0 111.324 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 168.76 34.27 0.02 OUTLIER Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.271 -0.738 . . . . 0.0 113.206 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.8 p -170.38 139.76 1.47 Allowed Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.812 0.845 . . . . 0.0 110.094 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.73 -72.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.848 2.365 . . . . 0.0 108.5 170.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.74 -25.28 27.13 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 118.406 -1.219 . . . . 0.0 112.886 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 76.03 -43.54 0.48 Allowed 'General case' 0 C--N 1.346 0.448 0 C-N-CA 126.31 1.844 . . . . 0.0 111.081 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.92 121.76 28.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.88 0.872 . . . . 0.0 110.598 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -130.03 121.38 26.36 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.89 0.876 . . . . 0.0 112.896 -178.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.7 m -85.01 145.33 8.13 Favored 'Isoleucine or valine' 0 C--N 1.346 0.439 0 N-CA-C 102.692 -3.077 . . . . 0.0 102.692 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.8 t -131.47 115.89 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 pt -93.78 -177.97 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.454 0 C-N-CA 124.987 1.315 . . . . 0.0 110.663 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -123.23 166.9 14.47 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.356 14.9 t -75.99 62.83 1.68 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -149.57 -94.33 0.07 Allowed 'General case' 0 N--CA 1.432 -1.333 1 N-CA-C 99.55 -4.241 . . . . 0.0 99.55 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.5 t -164.12 8.92 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.771 1.228 . . . . 0.0 113.818 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -112.81 156.51 22.76 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -175.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -75.14 116.45 15.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.892 2.477 . . . . 0.0 108.456 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.23 -49.57 9.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.88 172.66 42.57 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.65 150.78 43.79 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.154 0.982 . . . . 0.0 111.087 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.4 pt -131.82 161.48 41.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.163 1.785 . . . . 0.0 108.15 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 92' ' ' THR . 0.8 OUTLIER -156.66 139.21 14.96 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -177.621 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -86.26 15.98 4.8 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.513 ' H ' HG23 ' A' ' 90' ' ' THR . 98.0 m -69.74 -51.73 31.55 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 120.703 -1.248 . . . . 0.0 111.0 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.88 9.5 65.65 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.556 1.074 . . . . 0.0 112.385 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.18 158.66 16.49 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.004 1.322 . . . . 0.0 111.086 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.8 t -104.62 69.32 0.89 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.326 1.45 . . . . 0.0 108.436 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.06 -115.21 3.29 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.463 1.506 . . . . 0.0 109.548 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -102.68 22.06 14.32 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.558 1.143 . . . . 0.0 111.778 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.71 -164.73 0.45 Allowed 'General case' 0 C--N 1.342 0.266 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -146.94 155.18 42.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.5 m -140.95 165.03 20.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 126.856 2.062 . . . . 0.0 106.622 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.87 141.91 16.29 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 116.637 -0.256 . . . . 0.0 113.538 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.3 t -83.07 -174.82 5.51 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.6 m -68.82 127.64 33.82 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.101 -0.999 . . . . 0.0 109.023 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.36 42.1 12.41 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.4 m -149.98 124.86 9.88 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.806 1.242 . . . . 0.0 108.144 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t30 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 117.038 -1.458 . . . . 0.0 109.173 179.171 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 CA--C 1.529 0.169 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.46 123.41 14.65 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.412 HG22 ' CG2' ' A' ' 16' ' ' VAL . 3.8 t -130.8 124.39 31.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 123.73 0.644 . . . . 0.0 111.075 -178.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -107.55 129.69 54.95 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.68 1.992 . . . . 0.0 106.507 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -119.81 93.39 4.05 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.879 0.371 . . . . 0.0 110.353 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.6 -84.01 0.66 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.9 m -115.53 -27.4 7.15 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.888 1.275 . . . . 0.0 110.802 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -66.71 155.12 38.9 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.733 0.697 . . . . 0.0 109.884 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -142.15 86.24 1.96 Allowed 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 123.788 0.68 . . . . 0.0 110.855 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.58 136.98 32.72 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.7 t -76.7 158.45 30.98 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.69 -19.55 50.45 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.7 m -71.54 -39.43 70.71 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.21 1.004 . . . . 0.0 109.214 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.99 -50.12 37.8 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.35 1.06 . . . . 0.0 112.459 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.437 HG11 ' CE2' ' A' ' 85' ' ' TYR . 21.7 t -54.79 -48.08 73.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.332 1.053 . . . . 0.0 108.917 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -71.11 -41.84 70.03 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.178 1.391 . . . . 0.0 113.363 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.72 -52.17 53.38 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.702 0.683 . . . . 0.0 110.651 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.432 ' HB1' ' CE2' ' A' ' 59' ' ' PHE . . . -60.93 -36.95 80.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.448 0.699 . . . . 0.0 110.703 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.52 -39.02 67.91 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.802 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -67.12 -21.86 65.83 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.84 -63.53 1.39 Allowed 'General case' 0 C--N 1.347 0.48 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.435 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -47.33 -37.35 10.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.332 1.453 . . . . 0.0 111.535 177.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -61.7 2.44 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.473 1.909 . . . . 0.0 108.884 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -63.23 -36.7 84.51 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -66.87 -43.06 84.54 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.673 1.189 . . . . 0.0 111.987 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -74.36 -27.59 60.74 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.074 0.397 . . . . 0.0 111.798 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -89.07 9.39 25.53 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.338 1.055 . . . . 0.0 113.146 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.7 p30 -130.84 45.83 2.76 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.085 0.857 . . . . 0.0 110.54 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 70.66 37.28 1.44 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.849 2.06 . . . . 0.0 113.274 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.45 176.36 0.08 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.565 1.946 . . . . 0.0 114.905 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.1 t 21.35 79.38 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 129.351 3.061 . . . . 0.0 115.857 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.89 98.3 7.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.16 53.61 41.12 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.498 1.047 . . . . 0.0 111.034 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.3 m -140.38 -114.89 0.13 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.2 t -157.9 -82.33 0.06 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.3 p -115.44 -44.09 3.0 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.842 1.657 . . . . 0.0 107.528 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.49 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 15.2 m-85 -69.49 131.99 89.67 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 126.664 1.986 . . . . 0.0 106.514 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.91 137.18 48.42 Favored 'Cis proline' 0 N--CA 1.453 -0.896 0 CA-C-N 120.823 1.33 . . . . 0.0 113.314 0.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -159.91 150.16 18.63 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.895 1.678 . . . . 0.0 109.963 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -47.72 141.39 5.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.094 2.157 . . . . 0.0 113.451 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -113.89 97.18 6.24 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.784 1.634 . . . . 0.0 108.383 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -157.94 33.55 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -66.11 -50.53 63.7 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.06 0.544 . . . . 0.0 111.347 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -161.6 91.57 0.84 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 72.13 171.45 0.31 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.233 1.813 . . . . 0.0 110.741 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.22 8.2 7.99 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 118.315 -1.27 . . . . 0.0 114.559 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.3 t80 62.61 -158.98 0.32 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.016 1.408 . . . . 0.0 110.016 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -61.82 -172.73 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.828 1.651 . . . . 0.0 112.325 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.0 p90 51.7 63.39 9.43 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 125.748 1.619 . . . . 0.0 110.741 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.64 111.44 3.13 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.687 2.924 . . . . 0.0 110.075 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.76 170.68 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.199 1.399 . . . . 0.0 109.72 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.7 -57.97 6.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.23 -149.35 49.93 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 119.521 -0.6 . . . . 0.0 112.267 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.98 148.64 19.9 Favored 'Cis proline' 0 N--CA 1.459 -0.512 0 CA-C-N 118.604 1.202 . . . . 0.0 112.999 -0.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -111.18 140.69 45.52 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 125.742 1.617 . . . . 0.0 108.645 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -113.88 149.65 34.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.77 1.228 . . . . 0.0 113.42 -177.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -84.83 155.12 21.91 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.095 0.958 . . . . 0.0 110.553 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.435 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 62.7 t80 -153.53 108.71 2.57 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 176.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.49 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 11.2 Cg_endo -82.04 133.44 7.75 Favored 'Trans proline' 0 N--CA 1.432 -2.131 0 C-N-CA 121.931 1.754 . . . . 0.0 113.287 -175.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.45 ' CG2' ' H ' ' A' ' 62' ' ' LYS . 0.7 OUTLIER -106.21 -171.58 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 127.247 2.219 . . . . 0.0 106.298 178.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.45 ' H ' ' CG2' ' A' ' 61' ' ' ILE . 10.5 mmtt -162.74 -174.99 4.19 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 129.374 3.069 . . . . 0.0 108.396 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.2 m -88.74 53.46 2.71 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.96 -51.25 0.01 OUTLIER Glycine 0 C--N 1.344 1.025 0 C-N-CA 124.666 1.127 . . . . 0.0 111.87 -178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.87 -139.12 7.33 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 118.289 1.045 . . . . 0.0 112.966 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.0 p -52.96 142.4 5.81 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 125.716 1.606 . . . . 0.0 110.436 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.03 164.0 27.98 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.297 0.639 . . . . 0.0 112.124 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 t -134.18 63.97 1.61 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.538 1.535 . . . . 0.0 109.419 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 151.53 -177.32 29.52 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.54 -98.21 0.15 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.414 ' CB ' ' CD ' ' A' ' 72' ' ' PRO 0.327 67.3 m 56.19 -105.88 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.952 1.701 . . . . 0.0 111.08 -179.084 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 71' ' ' SER . 83.0 Cg_endo -75.64 131.07 13.2 Favored 'Trans proline' 0 C--N 1.352 0.711 0 CA-C-N 123.584 2.316 . . . . 0.0 109.07 175.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.47 162.86 25.34 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -157.51 48.86 0.42 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.919 0.888 . . . . 0.0 109.303 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.18 116.89 3.42 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.975 2.11 . . . . 0.0 105.881 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.22 165.53 30.67 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 m -135.58 142.62 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 102.259 -3.237 . . . . 0.0 102.259 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.0 t -133.08 120.38 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.0 pt -97.99 179.33 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.407 0 C-N-CA 126.395 1.878 . . . . 0.0 112.028 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -113.59 177.1 4.75 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.416 1.486 . . . . 0.0 109.681 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.332 11.5 t -77.88 55.29 1.39 Allowed 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 118.047 2.61 . . . . 0.0 118.047 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -160.71 -95.23 0.02 OUTLIER 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 101.626 -3.472 . . . . 0.0 101.626 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 90.8 m -163.92 47.9 0.12 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 129.209 3.004 . . . . 0.0 109.863 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -121.7 108.28 13.35 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.625 1.557 . . . . 0.0 114.202 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.437 ' CE2' HG11 ' A' ' 16' ' ' VAL . 3.3 t80 -65.35 104.68 0.99 Allowed 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.381 1.472 . . . . 0.0 107.718 178.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.93 -54.27 5.97 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.569 0.748 . . . . 0.0 111.994 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.35 149.01 12.12 Favored Glycine 0 C--N 1.34 0.799 0 C-N-CA 119.25 -1.452 . . . . 0.0 113.963 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.99 140.36 29.56 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.947 1.299 . . . . 0.0 109.162 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.7 pt -135.74 161.7 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.017 1.327 . . . . 0.0 109.812 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.0 t -159.92 148.67 17.42 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.523 0.729 . . . . 0.0 112.169 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.47 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 5.0 m170 -85.65 -25.81 26.38 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.8 m -49.26 109.4 0.26 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 126.282 1.833 . . . . 0.0 110.337 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.27 52.31 4.06 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.183 0.897 . . . . 0.0 111.041 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.49 -128.38 0.09 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.615 1.166 . . . . 0.0 108.721 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.8 m -145.85 71.39 1.27 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.016 0.926 . . . . 0.0 110.12 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.87 -91.28 0.27 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.758 1.171 . . . . 0.0 112.851 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -79.89 -34.74 38.86 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.651 1.18 . . . . 0.0 111.579 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -53.39 138.48 32.98 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.943 0.897 . . . . 0.0 111.016 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -106.27 147.82 28.7 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.529 1.532 . . . . 0.0 110.318 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.5 m -128.99 160.79 39.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 124.546 1.138 . . . . 0.0 108.288 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.06 142.39 21.42 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.994 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 8.7 t -85.26 -174.66 5.35 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.302 1.441 . . . . 0.0 108.332 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.3 m -65.11 131.06 45.57 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 121.344 -0.848 . . . . 0.0 109.101 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.61 43.85 51.09 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 16.3 m -146.78 144.41 29.35 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 57.5 t30 . . . . . 0 C--O 1.251 1.137 0 C-N-CA 125.344 1.458 . . . . 0.0 110.345 -179.116 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.68 155.86 0.16 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.501 1.921 . . . . 0.0 110.495 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.5 p -135.53 93.6 2.98 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.87 95.91 10.04 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 102.067 -3.309 . . . . 0.0 102.067 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.7 m -95.08 83.12 3.86 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.008 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.14 -87.74 0.58 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.0 p -120.01 -23.29 6.4 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.076 1.751 . . . . 0.0 110.657 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.6 m -75.65 91.25 2.86 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -84.22 106.52 15.91 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.882 1.273 . . . . 0.0 110.911 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -98.32 138.84 34.97 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.108 0.963 . . . . 0.0 110.057 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.2 t -72.5 152.72 41.73 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 124.69 1.196 . . . . 0.0 108.839 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.4 -18.09 48.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 t -76.34 -38.52 55.8 Favored 'General case' 0 C--N 1.345 0.391 0 C-N-CA 124.382 1.073 . . . . 0.0 108.334 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -67.81 -36.37 80.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.298 1.039 . . . . 0.0 111.514 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.4 t -67.56 -48.27 77.37 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -62.77 -38.01 88.9 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.734 1.214 . . . . 0.0 111.3 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.32 -51.97 26.25 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.9 0.88 . . . . 0.0 110.541 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.69 -41.96 74.48 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.476 1.11 . . . . 0.0 110.116 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.7 -25.38 38.19 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -69.44 -24.64 63.85 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.41 -55.7 4.87 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.36 -51.68 25.21 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 124.266 0.979 . . . . 0.0 111.711 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 t -61.98 -47.21 85.87 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.111 1.764 . . . . 0.0 112.515 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -63.22 -51.02 67.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.307 0.643 . . . . 0.0 111.939 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -68.95 -48.16 63.89 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -63.54 -22.09 66.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -110.14 9.86 23.95 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -157.98 61.22 0.46 Allowed 'General case' 0 C--N 1.339 0.143 0 CA-C-N 119.361 0.982 . . . . 0.0 109.123 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t70 64.22 99.01 0.04 OUTLIER 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.954 1.702 . . . . 0.0 109.27 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -61.42 114.57 3.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.6 p -105.99 -76.82 0.6 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.14 -179.9 0.09 Allowed 'General case' 0 C--N 1.342 0.242 0 C-N-CA 125.758 1.623 . . . . 0.0 113.876 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.38 -62.59 3.03 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 p -82.05 -108.87 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.909 0.884 . . . . 0.0 109.636 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.8 p -170.06 -51.35 0.02 OUTLIER 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.538 1.135 . . . . 0.0 110.045 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.4 t -80.24 31.38 0.27 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.029 1.332 . . . . 0.0 112.833 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.497 ' CD1' ' HD3' ' A' ' 60' ' ' PRO . 96.8 m-85 -170.01 113.96 0.48 Allowed Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 128.339 2.656 . . . . 0.0 104.334 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.54 134.48 35.79 Favored 'Cis proline' 0 N--CA 1.448 -1.157 0 CA-C-N 120.763 1.308 . . . . 0.0 111.333 1.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.23 161.44 41.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.987 1.315 . . . . 0.0 108.216 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 t -60.87 143.24 55.26 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-O 120.748 0.308 . . . . 0.0 110.881 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.34 122.72 27.82 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -64.44 161.98 16.06 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.276 1.03 . . . . 0.0 111.189 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -105.06 73.0 1.03 Allowed 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.158 0.983 . . . . 0.0 110.068 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -81.6 -89.01 0.08 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -155.46 -56.38 0.09 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.003 1.321 . . . . 0.0 109.304 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.69 135.18 44.28 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.044 1.307 . . . . 0.0 114.496 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 53.6 162.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 129.121 2.969 . . . . 0.0 117.816 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -161.68 160.98 29.27 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.09 2.156 . . . . 0.0 107.241 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -137.31 78.62 38.66 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.28 71.24 5.87 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.014 3.142 . . . . 0.0 110.09 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.4 t -119.73 -67.22 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 125.754 1.622 . . . . 0.0 107.919 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -165.87 78.76 0.27 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.05 162.22 54.68 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.2 152.9 97.64 Favored 'Cis proline' 0 N--CA 1.459 -0.54 0 CA-C-N 118.302 1.051 . . . . 0.0 112.902 0.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -121.75 156.92 32.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.931 2.093 . . . . 0.0 110.493 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -127.87 152.45 47.82 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.295 1.438 . . . . 0.0 112.462 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -94.04 156.17 16.74 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.242 1.017 . . . . 0.0 111.772 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -159.35 112.7 1.54 Allowed Pre-proline 0 N--CA 1.455 -0.188 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.497 ' HD3' ' CD1' ' A' ' 38' ' ' TYR . 31.2 Cg_endo -81.7 127.24 5.55 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 121.389 1.393 . . . . 0.0 112.506 -175.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.502 HG13 ' H ' ' A' ' 62' ' ' LYS . 6.5 tt -84.47 167.2 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-O 123.816 1.769 . . . . 0.0 112.709 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.502 ' H ' HG13 ' A' ' 61' ' ' ILE . 48.0 mmtm -142.71 145.36 33.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 109.098 -3.683 . . . . 0.0 112.71 -178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.5 t -91.61 58.24 3.47 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 125.585 1.554 . . . . 0.0 108.833 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.06 -64.8 0.03 OUTLIER Glycine 0 C--N 1.337 0.6 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.31 159.49 32.69 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.0 p -74.53 156.47 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.515 1.126 . . . . 0.0 109.603 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.3 t80 66.44 56.65 0.76 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.501 1.12 . . . . 0.0 111.099 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.9 p -149.96 166.29 30.09 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.303 1.041 . . . . 0.0 109.509 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -144.83 148.03 19.56 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.614 1.102 . . . . 0.0 110.824 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.19 170.18 33.82 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.1 t -52.5 -66.02 0.89 Allowed Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.941 1.297 . . . . 0.0 112.96 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.87 146.7 48.36 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.243 1.962 . . . . 0.0 111.51 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.83 139.57 6.58 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -173.39 -33.3 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.355 1.462 . . . . 0.0 111.833 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.07 120.06 29.05 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.658 1.583 . . . . 0.0 111.551 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -139.03 130.56 27.22 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.9 m -96.44 148.1 5.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.276 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.8 t -136.7 137.24 47.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.7 pt -117.3 176.3 2.81 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 C-N-CA 125.188 1.395 . . . . 0.0 112.904 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -97.28 163.58 12.84 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 128.08 2.552 . . . . 0.0 107.19 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.302 12.8 t -72.41 3.72 4.51 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -93.43 -86.87 0.25 Allowed 'General case' 0 N--CA 1.434 -1.267 1 N-CA-C 98.711 -4.551 . . . . 0.0 98.711 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.5 m -164.49 -5.63 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 128.253 2.621 . . . . 0.0 114.105 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -79.48 148.87 31.7 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.31 129.85 39.91 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.071 1.349 . . . . 0.0 107.754 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.91 -51.72 4.94 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.941 1.296 . . . . 0.0 108.958 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.35 -166.57 32.57 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.75 116.97 3.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.034 0.934 . . . . 0.0 108.802 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 45.4 pt -107.96 160.26 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.796 1.238 . . . . 0.0 110.649 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t -159.86 149.08 17.8 Favored 'General case' 0 C--N 1.343 0.284 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.541 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 27.2 m170 -79.75 -36.29 37.47 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.162 175.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.8 m -34.02 -58.99 0.44 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 128.478 2.711 . . . . 0.0 115.131 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.83 -36.33 92.61 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.521 1.057 . . . . 0.0 112.556 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.44 -159.66 0.29 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.933 1.293 . . . . 0.0 111.383 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.7 t -80.91 -81.46 0.13 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.626 0.77 . . . . 0.0 111.694 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -135.02 -78.45 0.1 Allowed Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.04 0.829 . . . . 0.0 111.805 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -79.82 -27.12 40.29 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.511 0.655 . . . . 0.0 111.519 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -59.48 151.85 23.14 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.976 1.31 . . . . 0.0 110.407 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -120.08 151.04 39.62 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.535 1.534 . . . . 0.0 110.069 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.1 m -147.69 166.14 5.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 125.942 1.697 . . . . 0.0 108.238 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.8 156.29 25.39 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.501 0.572 . . . . 0.0 112.69 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.3 m -104.84 -169.07 1.56 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.126 1.37 . . . . 0.0 108.244 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.4 t -61.33 113.99 2.94 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.83 60.51 1.96 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.3 m -154.78 121.14 5.33 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.98 0.912 . . . . 0.0 108.542 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.157 -1.402 . . . . 0.0 108.746 179.353 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 CA--C 1.529 0.169 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.27 136.0 57.73 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.815 0.846 . . . . 0.0 109.463 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.56 HG23 HG21 ' A' ' 16' ' ' VAL . 48.4 p -111.37 146.14 37.65 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.47 0.708 . . . . 0.0 109.68 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.83 117.92 8.88 Favored 'General case' 0 N--CA 1.44 -0.928 1 N-CA-C 99.675 -4.194 . . . . 0.0 99.675 177.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.26 103.55 5.8 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.896 0.379 . . . . 0.0 111.012 -177.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.91 -63.63 4.35 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 125.109 1.338 . . . . 0.0 109.807 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.4 p -155.65 -44.69 0.08 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.932 1.693 . . . . 0.0 109.275 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -54.65 115.83 2.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.612 1.965 . . . . 0.0 109.409 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -104.55 150.3 24.75 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.982 1.313 . . . . 0.0 111.068 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.88 141.03 26.15 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.018 1.327 . . . . 0.0 109.14 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.6 m -72.59 152.54 41.74 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 124.726 1.211 . . . . 0.0 110.142 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.61 -21.34 53.16 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.8 m -71.94 -41.22 68.06 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.873 1.269 . . . . 0.0 109.86 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -72.34 -41.11 66.85 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.022 0.929 . . . . 0.0 112.082 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.56 HG21 HG23 ' A' ' 4' ' ' THR . 23.6 t -63.25 -47.73 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -67.07 -36.05 81.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.678 1.191 . . . . 0.0 110.999 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.08 -51.2 65.2 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 118.894 0.77 . . . . 0.0 109.391 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.45 -37.3 87.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.63 -41.71 87.87 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.349 -0.844 . . . . 0.0 111.967 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -69.46 -18.81 63.75 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.61 -62.54 1.64 Allowed 'General case' 0 C--N 1.347 0.464 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.461 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -46.41 -44.43 17.19 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.923 0.889 . . . . 0.0 111.19 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.9 t -61.37 -49.73 75.73 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 118.938 0.79 . . . . 0.0 110.293 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -68.84 -9.58 52.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.659 0.784 . . . . 0.0 112.65 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -115.12 -16.23 11.61 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.815 0.846 . . . . 0.0 112.915 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.42 ' CD2' ' HG3' ' A' ' 57' ' ' GLN . 48.2 t80 -65.57 -51.8 57.06 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.006 0.923 . . . . 0.0 110.427 -178.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -90.98 -27.11 18.89 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -63.66 -25.0 68.02 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.901 0.773 . . . . 0.0 112.989 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 t70 65.15 45.56 2.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.626 1.17 . . . . 0.0 111.571 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -168.03 151.04 5.72 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.005 1.322 . . . . 0.0 108.909 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.0 p 47.5 39.52 9.63 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.727 1.611 . . . . 0.0 112.344 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.07 89.07 6.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.895 1.278 . . . . 0.0 110.979 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 52.78 -141.32 28.59 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.959 1.742 . . . . 0.0 112.578 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.1 p -154.27 -33.98 0.1 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.332 1.053 . . . . 0.0 112.637 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.7 t -82.14 -102.67 0.04 OUTLIER 'General case' 0 C--N 1.343 0.311 0 C-N-CA 123.627 0.771 . . . . 0.0 109.358 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.0 p -137.82 35.27 2.4 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.629 1.172 . . . . 0.0 109.209 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -133.24 148.2 68.12 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 124.0 0.92 . . . . 0.0 109.118 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.29 125.08 10.27 Favored 'Cis proline' 0 N--CA 1.452 -0.938 0 CA-C-N 118.733 0.583 . . . . 0.0 112.564 0.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.3 163.01 33.6 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.018 0.927 . . . . 0.0 110.881 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 m -48.19 124.18 7.41 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 127.952 2.501 . . . . 0.0 113.012 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -115.89 68.47 0.72 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.71 85.4 0.47 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.099 1.36 . . . . 0.0 112.778 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -131.19 137.16 48.83 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.852 1.661 . . . . 0.0 106.962 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -116.62 132.94 56.55 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.473 1.109 . . . . 0.0 110.847 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 40.72 45.89 2.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.175 2.19 . . . . 0.0 114.09 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.57 -79.26 1.42 Allowed Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -80.27 173.48 12.55 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.328 1.051 . . . . 0.0 112.097 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -79.52 6.18 11.06 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -127.13 67.2 70.01 Favored Pre-proline 0 C--N 1.318 -0.772 0 C-N-CA 127.93 2.492 . . . . 0.0 110.146 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.73 -41.84 3.95 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.82 2.346 . . . . 0.0 110.291 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.7 t 62.54 -97.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.885 1.674 . . . . 0.0 108.816 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -165.88 -58.16 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 126.319 1.848 . . . . 0.0 107.883 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.95 -175.79 51.79 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -58.21 151.67 36.73 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 CA-C-N 119.043 1.422 . . . . 0.0 113.5 -0.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -146.03 159.3 43.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.573 1.149 . . . . 0.0 109.778 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.42 ' HG3' ' CD2' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -129.2 161.69 29.55 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -175.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -88.1 157.24 18.91 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 113.699 -1.591 . . . . 0.0 108.89 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.461 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 15.2 t80 -160.24 112.6 1.4 Allowed Pre-proline 0 C--O 1.224 -0.259 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -82.15 137.16 9.42 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 121.387 1.391 . . . . 0.0 115.211 -175.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.606 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 3.0 tt -110.37 -175.85 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 124.034 1.873 . . . . 0.0 112.188 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.606 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -160.8 152.01 19.01 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 108.724 -3.853 . . . . 0.0 111.004 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.7 t -84.44 59.87 5.69 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.969 1.307 . . . . 0.0 108.878 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.05 -50.37 0.03 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.04 172.27 45.18 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.75 119.13 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.364 1.065 . . . . 0.0 109.587 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.3 t80 62.47 118.44 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.255 1.822 . . . . 0.0 112.665 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 79.6 p -126.84 154.12 44.77 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.94 1.296 . . . . 0.0 109.79 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.86 72.24 2.83 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.98 -48.39 0.02 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.8 m 60.7 80.12 0.27 Allowed Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 125.339 1.456 . . . . 0.0 110.694 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.49 -56.16 3.37 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.385 3.39 . . . . 0.0 112.026 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.41 39.24 3.51 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.967 1.27 . . . . 0.0 110.478 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -154.41 -73.2 0.12 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 117.959 -1.019 . . . . 0.0 112.567 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -67.38 117.16 8.99 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.8 mtt85 -146.73 129.46 16.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.74 155.37 3.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 103.601 -2.74 . . . . 0.0 103.601 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.0 t -136.14 123.35 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 O-C-N 120.587 -1.32 . . . . 0.0 108.146 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.7 pt -105.46 175.44 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.417 0 C-N-CA 125.775 1.63 . . . . 0.0 112.756 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -101.83 165.03 11.41 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 127.47 2.308 . . . . 0.0 108.364 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.251 11.4 t -67.26 -29.78 69.49 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 118.302 2.705 . . . . 0.0 118.302 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -79.14 -73.16 0.35 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.8 t -164.72 3.52 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -78.65 164.03 24.97 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 119.723 1.147 . . . . 0.0 113.953 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -104.68 117.53 34.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.59 -45.96 12.02 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.099 0.559 . . . . 0.0 110.188 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.66 -160.48 33.9 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.6 145.09 31.61 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.823 0.849 . . . . 0.0 109.652 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.5 pt -143.14 164.93 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.923 1.289 . . . . 0.0 111.571 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.2 t -155.79 146.5 22.08 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.46 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 24.0 m170 -79.1 -15.45 58.14 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.809 174.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.0 m -39.8 -55.36 1.97 Allowed 'General case' 0 C--N 1.345 0.409 0 C-N-CA 126.859 2.063 . . . . 0.0 114.576 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.83 28.14 11.04 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.519 1.057 . . . . 0.0 112.816 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.76 177.02 5.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.078 0.951 . . . . 0.0 111.325 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 84.2 p -68.0 -48.42 65.79 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.097 0.959 . . . . 0.0 111.378 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.8 -69.68 0.08 OUTLIER Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -102.23 29.17 5.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.722 1.209 . . . . 0.0 109.654 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -131.83 176.94 7.92 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.769 1.228 . . . . 0.0 109.618 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -127.42 164.52 21.67 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.164 1.786 . . . . 0.0 110.824 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.87 156.23 40.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 C-N-CA 124.875 1.27 . . . . 0.0 107.581 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.8 142.33 25.43 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.298 0.952 . . . . 0.0 112.762 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.7 m -96.27 179.03 5.18 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.797 0.839 . . . . 0.0 110.517 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 27.0 t -69.24 140.69 54.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.89 47.05 62.72 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.5 m -131.49 96.31 3.95 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.371 1.468 . . . . 0.0 107.085 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.7 t30 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 117.028 -1.463 . . . . 0.0 109.229 -179.1 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 CA--C 1.529 0.17 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 73.03 160.93 0.24 Allowed 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.353 1.461 . . . . 0.0 109.808 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 t -157.7 148.68 21.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.28 120.12 29.15 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 104.794 -2.298 . . . . 0.0 104.794 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.6 m -112.95 111.4 22.12 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.65 -95.17 0.18 Allowed Glycine 0 CA--C 1.529 0.923 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.8 p -118.54 -39.19 3.03 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.109 1.763 . . . . 0.0 109.7 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.4 m -61.28 126.06 26.0 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.024 1.33 . . . . 0.0 109.721 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -99.02 153.6 18.74 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.565 1.146 . . . . 0.0 110.289 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -142.77 121.3 12.47 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.678 1.191 . . . . 0.0 108.52 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.5 t -67.34 154.32 41.61 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 125.06 1.344 . . . . 0.0 110.473 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.85 -22.01 61.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.401 -1.704 . . . . 0.0 106.401 176.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.4 t -72.47 -39.76 67.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.324 1.049 . . . . 0.0 109.209 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -73.43 -44.08 59.05 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.342 0.657 . . . . 0.0 112.116 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.5 t -59.03 -51.47 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 124.993 1.317 . . . . 0.0 109.086 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -68.42 -41.05 80.93 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.921 0.888 . . . . 0.0 112.925 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.58 -47.16 87.4 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 123.753 0.658 . . . . 0.0 109.427 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.44 ' HA ' HG23 ' A' ' 66' ' ' VAL . . . -58.0 -39.54 78.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.314 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.36 -30.33 61.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -69.8 -25.48 63.8 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.19 -61.07 2.11 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 104.167 -2.531 . . . . 0.0 104.167 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.532 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . . . -43.77 -43.65 6.22 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 124.763 1.289 . . . . 0.0 111.614 176.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.57 -64.03 0.98 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 126.385 1.874 . . . . 0.0 111.667 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.5 -36.67 83.3 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -88.65 -22.51 23.41 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.306 0.0 OUTLIER -92.65 16.76 11.44 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.779 1.627 . . . . 0.0 114.966 -178.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.6 -38.96 70.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.57 1.148 . . . . 0.0 110.368 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -145.6 -67.87 0.29 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.659 1.184 . . . . 0.0 109.003 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -177.37 91.73 0.03 OUTLIER 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.518 1.527 . . . . 0.0 108.104 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -119.17 -170.51 1.94 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.737 1.215 . . . . 0.0 109.897 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.9 p -70.88 83.89 0.66 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.254 1.422 . . . . 0.0 111.236 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.91 156.91 39.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.272 1.029 . . . . 0.0 110.784 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.15 -141.5 45.47 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.474 1.035 . . . . 0.0 112.438 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.0 t -90.32 -74.34 0.49 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.64 1.176 . . . . 0.0 109.935 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 t -151.54 -56.09 0.15 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.055 1.342 . . . . 0.0 108.32 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.3 p -79.36 -53.75 6.62 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -59.62 135.3 89.29 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -71.77 131.09 20.4 Favored 'Cis proline' 0 N--CA 1.454 -0.801 0 CA-C-N 119.123 0.723 . . . . 0.0 112.489 2.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.02 156.6 41.48 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 123.469 0.707 . . . . 0.0 111.555 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.9 p -34.45 137.24 0.12 Allowed 'General case' 0 C--N 1.34 0.166 0 C-N-CA 127.764 2.426 . . . . 0.0 115.096 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -135.52 88.01 2.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.081 1.352 . . . . 0.0 108.286 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -167.93 -39.61 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.867 1.667 . . . . 0.0 108.462 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -61.69 -35.77 78.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.888 1.275 . . . . 0.0 110.348 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -61.77 -77.28 0.05 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.243 1.017 . . . . 0.0 109.56 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -171.22 138.33 1.22 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.177 1.391 . . . . 0.0 108.254 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.4 132.79 23.26 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -144.2 108.21 4.74 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.279 0.632 . . . . 0.0 110.264 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 t70 51.17 -168.64 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.572 1.549 . . . . 0.0 113.517 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.0 p90 38.03 79.04 0.33 Allowed Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 127.159 2.184 . . . . 0.0 114.265 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.82 64.67 8.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.829 3.019 . . . . 0.0 107.833 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.34 -154.62 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 126.078 1.751 . . . . 0.0 110.112 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -100.99 118.58 37.28 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.509 1.123 . . . . 0.0 110.197 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.21 -176.46 30.32 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.218 0.914 . . . . 0.0 111.581 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.73 127.85 15.12 Favored 'Cis proline' 0 N--CA 1.453 -0.884 0 CA-C-N 117.527 0.664 . . . . 0.0 111.414 -0.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -102.47 140.26 36.99 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -115.66 162.17 17.63 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 123.878 0.736 . . . . 0.0 110.876 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -79.38 144.67 33.94 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.578 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.532 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 69.2 t80 -138.89 103.03 7.54 Favored Pre-proline 0 N--CA 1.443 -0.804 0 N-CA-C 102.086 -3.301 . . . . 0.0 102.086 176.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HB3' ' HD2' ' A' ' 76' ' ' ARG . 11.5 Cg_endo -77.99 137.25 15.45 Favored 'Trans proline' 0 N--CA 1.439 -1.691 0 C-N-CA 121.224 1.283 . . . . 0.0 111.964 -176.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.574 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.5 tt -116.96 -177.98 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 124.581 2.134 . . . . 0.0 113.366 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.574 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -161.32 153.93 20.46 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 108.428 -3.987 . . . . 0.0 111.613 178.164 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.0 t -88.62 58.5 4.69 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.874 1.27 . . . . 0.0 108.165 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.48 -74.79 0.01 OUTLIER Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.29 86.77 0.1 OUTLIER Glycine 0 CA--C 1.527 0.793 0 CA-C-N 117.385 0.593 . . . . 0.0 111.973 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.44 HG23 ' HA ' ' A' ' 19' ' ' ALA 0.266 12.9 p 41.12 60.43 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.958 2.103 . . . . 0.0 113.407 178.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 21.5 t80 58.2 93.97 0.03 OUTLIER 'General case' 0 C--N 1.344 0.339 0 C-N-CA 126.69 1.996 . . . . 0.0 114.047 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.0 t -155.99 124.41 5.85 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.901 1.28 . . . . 0.0 108.771 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.18 66.45 2.49 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.73 1.157 . . . . 0.0 111.492 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -164.97 77.8 0.14 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.5 t -146.02 108.74 4.31 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -61.37 160.11 48.73 Favored 'Cis proline' 0 N--CA 1.459 -0.537 0 CA-C-N 119.969 1.025 . . . . 0.0 113.987 0.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.68 -42.59 0.05 OUTLIER Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.167 1.365 . . . . 0.0 110.907 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 78.7 -48.29 0.44 Allowed 'General case' 0 C--N 1.342 0.281 0 C-N-CA 127.364 2.266 . . . . 0.0 112.538 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -75.93 124.9 28.1 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.437 ' HD2' ' HB3' ' A' ' 60' ' ' PRO . 14.5 mmt180 -136.99 118.0 14.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.366 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.4 m -84.2 164.55 2.58 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.3 t -140.26 137.19 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 pt -131.06 159.73 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.761 0.825 . . . . 0.0 112.513 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -89.16 146.04 25.04 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 127.464 2.306 . . . . 0.0 108.205 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.37 15.3 t -73.78 66.17 1.08 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -177.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -157.32 -94.45 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.184 1 N-CA-C 97.458 -5.016 . . . . 0.0 97.458 176.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -162.84 10.69 0.06 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.996 1.718 . . . . 0.0 113.774 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.3 140.93 29.04 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.993 0.815 . . . . 0.0 112.178 -177.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -73.52 131.49 41.82 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.95 -56.79 2.86 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.89 -177.29 40.72 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 112.25 -0.34 . . . . 0.0 112.25 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.98 117.6 13.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.837 1.655 . . . . 0.0 107.056 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 41.0 pt -128.27 153.52 37.8 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 C-N-CA 124.075 0.95 . . . . 0.0 109.814 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -152.18 150.85 30.29 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.34 75.85 5.91 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.3 m -70.57 -84.54 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.086 -1.634 . . . . 0.0 110.24 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.7 34.57 5.56 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.85 153.17 42.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.224 1.81 . . . . 0.0 110.957 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -74.37 -11.55 60.28 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.588 0.755 . . . . 0.0 112.227 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.73 -94.86 0.1 OUTLIER Glycine 0 C--N 1.341 0.841 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -103.22 22.62 13.76 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.156 0.982 . . . . 0.0 110.54 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -72.26 178.78 3.71 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -151.82 133.98 15.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 m -115.12 166.53 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.56 145.21 19.41 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.105 0.802 . . . . 0.0 115.105 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.8 m -97.54 177.5 5.49 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 124.53 1.132 . . . . 0.0 110.559 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.3 t 44.06 41.76 4.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.667 0.787 . . . . 0.0 112.094 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.5 30.06 75.86 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.384 0.992 . . . . 0.0 113.922 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.4 m -86.54 151.14 23.73 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.654 1.182 . . . . 0.0 109.083 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 116.346 -1.788 . . . . 0.0 108.677 179.842 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.5 p . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.32 61.75 0.71 Allowed 'General case' 0 C--N 1.342 0.244 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 t -107.48 135.95 48.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.874 1.269 . . . . 0.0 110.67 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -110.57 108.41 18.35 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 103.393 -2.818 . . . . 0.0 103.393 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.34 85.42 4.6 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.02 -104.63 1.44 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.2 p -94.49 -44.52 7.84 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.494 1.118 . . . . 0.0 110.188 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.6 m -70.0 110.37 5.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.856 0.862 . . . . 0.0 110.24 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -84.72 148.52 26.34 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.684 1.193 . . . . 0.0 111.061 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -142.03 112.91 7.37 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.101 0.96 . . . . 0.0 111.098 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.7 t -65.37 157.49 29.13 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 125.84 1.656 . . . . 0.0 110.429 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.0 -19.27 29.66 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.5 m -73.43 -44.54 58.02 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.521 1.128 . . . . 0.0 109.184 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -71.91 -44.15 64.16 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 124.718 1.207 . . . . 0.0 112.34 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.25 -51.2 75.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -41.92 96.57 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.633 1.973 . . . . 0.0 112.517 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.34 -54.44 28.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.004 0.365 . . . . 0.0 110.191 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.73 72.37 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.207 0.603 . . . . 0.0 111.679 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.85 -44.97 30.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.06 -22.11 65.49 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.51 -65.83 0.88 Allowed 'General case' 0 C--N 1.345 0.409 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.513 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . . . -44.22 -48.59 9.35 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 124.577 1.173 . . . . 0.0 111.83 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.8 t -54.13 -51.89 62.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.366 1.866 . . . . 0.0 111.924 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -58.34 -40.73 82.92 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.176 0.59 . . . . 0.0 111.253 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -70.9 -38.37 72.99 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -90.6 22.8 3.31 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-N 118.91 0.777 . . . . 0.0 112.468 -177.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -110.2 -48.96 3.12 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 124.361 1.064 . . . . 0.0 109.209 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -74.11 -38.69 63.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.383 0.673 . . . . 0.0 112.154 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 108.19 72.52 0.0 OUTLIER 'General case' 0 C--N 1.345 0.397 0 C-N-CA 129.674 3.189 . . . . 0.0 110.932 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -151.89 136.37 16.88 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.692 1.597 . . . . 0.0 107.57 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.6 p -80.31 -56.89 3.88 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.446 0.698 . . . . 0.0 111.786 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.87 82.71 0.16 Allowed 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.55 -48.59 0.96 Allowed Glycine 0 CA--C 1.528 0.886 0 N-CA-C 107.093 -2.403 . . . . 0.0 107.093 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.8 t 57.52 67.38 0.98 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.26 1.824 . . . . 0.0 113.713 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.2 m -143.86 -75.96 0.24 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.165 0.986 . . . . 0.0 108.771 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.3 t -160.35 41.22 0.18 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.497 0.59 . . . . 0.0 112.224 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -172.25 127.62 0.57 Allowed Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 125.649 1.58 . . . . 0.0 107.479 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -86.06 63.32 0.16 OUTLIER 'Cis proline' 0 N--CA 1.439 -1.702 0 CA-C-N 121.409 1.539 . . . . 0.0 110.1 -2.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -84.27 173.09 11.26 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 t -69.3 145.54 52.95 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 111.426 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -95.82 55.09 1.58 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.481 1.512 . . . . 0.0 109.291 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.483 ' H ' HD22 ' A' ' 43' ' ' ASN . 0.0 OUTLIER -79.01 51.56 1.16 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.639 1.576 . . . . 0.0 112.347 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -160.84 53.44 0.29 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.381 1.472 . . . . 0.0 107.426 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.12 -55.99 8.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.499 1.519 . . . . 0.0 110.906 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 68.62 -72.41 0.1 Allowed 'General case' 0 C--N 1.343 0.292 0 C-N-CA 127.079 2.152 . . . . 0.0 111.168 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.24 -121.36 2.16 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.42 -169.3 0.17 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.356 1.062 . . . . 0.0 112.315 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -127.67 -164.06 1.33 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.998 0.919 . . . . 0.0 110.925 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.328 40.3 p90 61.63 47.33 1.13 Allowed Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 128.788 2.835 . . . . 0.0 115.855 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.7 125.94 8.54 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.175 1.916 . . . . 0.0 107.702 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.51 -125.0 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -153.72 127.57 8.86 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 125.711 1.605 . . . . 0.0 107.237 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.17 -85.04 0.05 OUTLIER Glycine 0 CA--C 1.531 1.063 0 CA-C-O 117.49 -1.728 . . . . 0.0 111.737 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.4 168.76 7.45 Favored 'Cis proline' 0 C--N 1.35 0.642 0 CA-C-N 121.676 2.738 . . . . 0.0 116.427 0.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.51 159.34 28.24 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.036 1.335 . . . . 0.0 113.188 -177.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -152.72 150.65 29.65 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.464 1.506 . . . . 0.0 111.948 -178.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -102.41 166.55 10.49 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 48.0 t80 -158.44 114.69 1.72 Allowed Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -86.79 108.06 0.77 Allowed 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 122.706 2.271 . . . . 0.0 112.342 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.534 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 9.3 tt -81.5 173.88 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 124.329 2.014 . . . . 0.0 110.966 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.534 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 14.2 mmtt -160.27 159.43 31.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 109.183 -3.644 . . . . 0.0 109.49 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 57.2 m -81.81 57.44 3.43 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.458 1.103 . . . . 0.0 109.539 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.46 62.71 0.24 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.95 -106.63 1.64 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 123.76 0.695 . . . . 0.0 112.376 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.1 95.05 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.32 1.048 . . . . 0.0 111.099 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 t80 44.98 80.74 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.879 1.672 . . . . 0.0 112.971 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.1 p -125.22 -29.94 3.23 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.744 1.218 . . . . 0.0 111.44 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.42 -69.2 1.25 Allowed Glycine 0 C--N 1.342 0.886 0 C-N-CA 124.838 1.209 . . . . 0.0 112.426 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.09 113.98 1.27 Allowed Glycine 0 C--N 1.34 0.76 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.9 m 54.17 69.89 1.96 Allowed Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 125.348 1.459 . . . . 0.0 112.715 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.11 149.65 82.19 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.369 2.713 . . . . 0.0 109.96 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -159.11 35.58 0.49 Allowed Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.109 -0.829 . . . . 0.0 115.152 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.741 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -153.87 -67.94 0.14 Allowed 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 118.452 1.126 . . . . 0.0 110.25 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.43 118.24 16.15 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.926 1.239 . . . . 0.0 108.384 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -140.14 117.44 11.32 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 m -85.1 146.67 6.29 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 176.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.2 t -132.84 135.81 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -177.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.482 HG22 ' H ' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -126.86 -176.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 C-N-CA 126.74 2.016 . . . . 0.0 110.186 -177.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.482 ' H ' HG22 ' A' ' 79' ' ' ILE . 63.5 m-80 -99.26 159.72 14.79 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 102.977 -2.972 . . . . 0.0 102.977 175.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.301 7.2 t -66.92 2.57 1.38 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 -178.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -95.58 -83.69 0.36 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 102.301 -3.222 . . . . 0.0 102.301 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.81 -5.07 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.721 2.408 . . . . 0.0 114.791 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -79.46 121.1 24.76 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -52.98 123.25 11.08 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 126.051 1.74 . . . . 0.0 108.497 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.56 -55.75 2.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.4 -164.43 23.06 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.45 137.02 8.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.482 1.113 . . . . 0.0 108.355 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 pt -133.89 174.25 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.438 1.095 . . . . 0.0 113.092 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 74' ' ' ALA . 12.6 t -158.16 137.03 11.37 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.741 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -77.31 -24.11 50.92 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 118.211 0.46 . . . . 0.0 112.034 175.003 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.1 t -45.33 -25.52 0.41 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -145.03 51.57 0.61 Allowed Glycine 0 C--N 1.339 0.731 0 CA-C-N 119.165 0.893 . . . . 0.0 111.534 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.73 -177.37 3.11 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.817 1.247 . . . . 0.0 111.487 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.3 t -58.27 -53.33 59.47 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.554 1.541 . . . . 0.0 111.547 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.38 -70.06 0.05 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -112.54 35.03 4.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.854 1.262 . . . . 0.0 109.133 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -125.1 176.21 6.85 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.18 1.392 . . . . 0.0 109.955 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.446 ' CZ ' ' CD2' ' A' ' 91' ' ' HIS . 64.1 m-85 -125.17 159.3 31.86 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.11 1.364 . . . . 0.0 111.093 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.8 m -135.33 161.48 39.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 125.449 1.499 . . . . 0.0 107.864 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.26 156.65 34.08 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 123.862 0.744 . . . . 0.0 113.707 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.6 m -85.75 -170.67 3.22 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 123.607 0.763 . . . . 0.0 110.094 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.1 p -73.65 127.53 33.01 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.47 -1.0 88.64 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.815 -0.992 . . . . 0.0 113.361 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.7 m -79.38 91.22 5.05 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.4 t30 . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.953 -1.499 . . . . 0.0 109.439 -178.729 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.457 -0.103 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.31 89.74 0.09 Allowed 'General case' 0 C--N 1.344 0.357 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.81 132.22 36.41 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.91 114.76 23.69 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.5 m -105.49 88.82 2.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.03 -114.64 4.62 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.8 p -93.25 -29.23 15.79 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.282 1.033 . . . . 0.0 109.972 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -71.99 95.13 1.55 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.273 1.429 . . . . 0.0 108.776 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -89.95 147.19 23.86 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.527 1.131 . . . . 0.0 112.508 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -142.13 129.46 21.14 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -72.79 155.13 40.26 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 126.531 1.932 . . . . 0.0 107.315 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.47 -16.79 16.63 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.4 m -76.15 -35.2 59.3 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -51.9 15.84 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.755 1.222 . . . . 0.0 113.601 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . 0.273 17.9 m -60.99 -41.58 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.647 0 C-N-CA 127.239 2.216 . . . . 0.0 109.242 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -71.02 -44.58 65.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.886 0.874 . . . . 0.0 111.69 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.15 -54.64 26.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.096 0.407 . . . . 0.0 112.077 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.45 ' HB1' ' HE2' ' A' ' 59' ' ' PHE . . . -62.05 -37.56 85.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.481 -178.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.33 -40.39 70.75 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -65.86 -19.74 65.99 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.46 -53.96 7.01 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.559 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -47.0 -51.38 17.29 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.229 1.412 . . . . 0.0 110.776 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 t -57.92 -46.19 85.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.748 0.819 . . . . 0.0 110.559 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -57.09 -38.0 72.72 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.529 0.731 . . . . 0.0 111.394 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -89.08 -9.04 52.63 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.71 -27.38 67.59 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.725 0.693 . . . . 0.0 112.208 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -80.54 -75.69 0.26 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 p30 171.94 68.62 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.696 1.998 . . . . 0.0 109.809 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -117.5 58.72 0.79 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.93 0.892 . . . . 0.0 109.438 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.84 162.72 0.08 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.86 2.464 . . . . 0.0 114.429 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 t -88.37 76.66 8.29 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.458 1.103 . . . . 0.0 110.182 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.52 102.37 4.48 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.314 1.045 . . . . 0.0 110.319 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.99 -114.26 4.48 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.5 t -75.8 -95.99 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 m 88.05 23.18 0.04 OUTLIER 'General case' 0 C--N 1.341 0.212 0 C-N-CA 125.018 1.327 . . . . 0.0 113.327 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t -78.95 -38.72 36.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 102.743 -3.058 . . . . 0.0 102.743 176.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.488 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 17.0 m-85 -89.18 151.82 47.17 Favored Pre-proline 0 N--CA 1.451 -0.405 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.14 142.52 57.81 Favored 'Cis proline' 0 N--CA 1.455 -0.791 0 N-CA-C 116.78 1.8 . . . . 0.0 116.78 0.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.65 147.54 39.43 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 127.912 2.485 . . . . 0.0 109.579 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.25 123.47 14.68 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 178.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -83.78 118.91 24.23 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -59.0 159.84 6.69 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.308 1.443 . . . . 0.0 111.013 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -134.42 59.95 1.72 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.037 0.935 . . . . 0.0 109.964 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -154.36 -22.32 0.13 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 112.068 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.74 -46.34 88.55 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.127 0.571 . . . . 0.0 111.386 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.31 -61.88 0.41 Allowed Glycine 0 C--N 1.339 0.723 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.06 148.19 52.2 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 123.81 0.844 . . . . 0.0 113.099 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -166.26 -178.49 4.59 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.094 1.758 . . . . 0.0 109.231 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -145.37 118.58 5.37 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.74 1.216 . . . . 0.0 108.555 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.32 84.99 1.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.08 2.52 . . . . 0.0 110.448 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -129.62 -97.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.245 0 C-N-CA 124.227 1.011 . . . . 0.0 108.379 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -153.17 117.47 4.9 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.156 0.982 . . . . 0.0 109.618 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.48 146.39 22.54 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -68.72 157.58 88.76 Favored 'Cis proline' 0 N--CA 1.457 -0.633 0 CA-C-N 119.983 1.891 . . . . 0.0 113.447 0.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.21 141.93 26.72 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.1 2.16 . . . . 0.0 108.235 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -134.39 166.56 22.55 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.59 164.56 23.74 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 126.481 1.912 . . . . 0.0 115.541 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.559 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 75.4 t80 -161.87 104.13 1.16 Allowed Pre-proline 0 N--CA 1.454 -0.246 0 O-C-N 121.43 -0.794 . . . . 0.0 110.571 175.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.488 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 12.8 Cg_endo -74.69 137.35 22.36 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 121.088 1.424 . . . . 0.0 113.892 -177.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.55 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.2 tt -109.27 178.97 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-O 124.444 2.069 . . . . 0.0 113.058 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.55 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 7.8 mmtt -153.12 153.77 33.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 108.647 -3.888 . . . . 0.0 109.869 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.8 p -76.08 51.94 0.7 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.63 1.972 . . . . 0.0 113.014 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.81 50.63 0.08 OUTLIER Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.405 1.002 . . . . 0.0 112.791 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.31 174.22 17.32 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 117.686 0.743 . . . . 0.0 112.783 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.8 t -80.86 131.79 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.834 1.253 . . . . 0.0 108.542 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -70.15 135.02 48.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.206 1.003 . . . . 0.0 110.907 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.9 p -139.27 75.61 1.52 Allowed 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.88 1.272 . . . . 0.0 107.583 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.47 -143.21 3.6 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.3 -50.73 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.9 p -153.35 150.1 22.89 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 124.218 1.007 . . . . 0.0 109.792 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -66.16 145.33 69.31 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 CA-C-N 119.393 0.819 . . . . 0.0 112.001 -8.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.28 -113.16 2.27 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . 62.92 28.99 16.54 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.047 1.339 . . . . 0.0 113.866 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -155.02 84.15 1.08 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.16 132.64 47.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.522 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.72 159.79 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 103.311 -2.848 . . . . 0.0 103.311 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.2 t -139.17 131.39 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 120.479 -1.388 . . . . 0.0 108.089 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.7 pt -114.14 -179.46 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.311 1.444 . . . . 0.0 113.35 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -104.71 -174.38 2.52 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.099 2.159 . . . . 0.0 109.631 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.318 12.4 t -79.58 -30.17 41.49 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 120.402 3.482 . . . . 0.0 120.402 -177.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -79.32 -73.56 0.33 Allowed 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.7 t -164.75 1.22 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.849 2.06 . . . . 0.0 114.169 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -78.64 150.69 32.6 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 119.846 1.203 . . . . 0.0 113.813 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -95.85 117.98 31.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.34 1.856 . . . . 0.0 108.651 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.94 -52.69 7.54 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.35 0.66 . . . . 0.0 110.658 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.38 -169.21 38.38 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.9 162.37 31.77 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.827 0.813 . . . . 0.0 113.022 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.8 pt -142.21 163.67 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.59 1.556 . . . . 0.0 110.263 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.6 t -158.84 159.04 34.6 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.867 1.267 . . . . 0.0 111.016 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.449 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 49.9 m170 -79.6 -51.08 9.74 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.6 m -32.72 106.51 0.04 OUTLIER 'General case' 0 C--N 1.345 0.382 0 C-N-CA 127.852 2.461 . . . . 0.0 111.998 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.56 32.29 5.2 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.201 1.381 . . . . 0.0 111.079 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -134.5 -142.82 0.2 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.759 1.224 . . . . 0.0 109.248 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.6 t -151.46 62.86 0.88 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.26 0.624 . . . . 0.0 111.141 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.71 -125.29 6.73 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.534 1.064 . . . . 0.0 113.367 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -79.28 -26.2 42.37 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.643 1.177 . . . . 0.0 113.046 -178.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -56.3 118.05 4.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.984 0.914 . . . . 0.0 110.621 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -83.75 153.95 23.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.044 0.938 . . . . 0.0 111.145 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.6 m -126.76 166.54 23.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 C-N-CA 125.635 1.574 . . . . 0.0 107.556 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.38 148.03 23.74 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 123.891 0.758 . . . . 0.0 114.26 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.0 t -96.59 -175.09 3.21 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.716 2.006 . . . . 0.0 107.418 178.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.2 p -59.76 136.73 58.09 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.439 1.018 . . . . 0.0 109.851 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.06 26.56 74.6 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.566 0.603 . . . . 0.0 111.81 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.7 m -150.3 114.81 5.21 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.144 1.378 . . . . 0.0 107.497 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 . . . . . 0 C--O 1.251 1.154 0 CA-C-O 116.83 -1.557 . . . . 0.0 109.458 -179.82 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.1 m . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 72.91 139.74 0.06 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 127.184 2.194 . . . . 0.0 109.682 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 t -146.67 124.15 11.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.281 0.562 . . . . 0.0 111.641 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -100.66 101.16 11.98 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 32.8 m -85.72 74.96 10.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.615 1.166 . . . . 0.0 108.249 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.82 -98.71 1.08 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.8 m -88.14 -44.71 10.71 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.387 1.075 . . . . 0.0 110.433 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.0 107.15 1.42 Allowed 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.039 1.336 . . . . 0.0 112.493 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -91.41 103.69 16.3 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.572 1.149 . . . . 0.0 109.027 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -102.39 148.69 25.18 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.277 0.631 . . . . 0.0 110.713 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.4 m -83.13 157.6 22.72 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 125.476 1.51 . . . . 0.0 108.858 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.66 -19.55 63.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.2 m -71.95 -35.22 69.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.109 0.964 . . . . 0.0 109.026 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.64 -53.81 10.78 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 123.953 0.901 . . . . 0.0 112.679 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.95 -41.31 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -67.61 -44.75 77.32 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.663 0.785 . . . . 0.0 111.007 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.25 -48.45 78.17 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.498 0.59 . . . . 0.0 110.253 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.05 -32.1 73.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.157 0.983 . . . . 0.0 111.166 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.43 -36.84 52.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.776 0.262 . . . . 0.0 110.666 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -69.29 -20.33 63.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.72 -53.59 5.79 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.59 -40.31 59.57 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.54 1.136 . . . . 0.0 109.228 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.41 -53.94 52.61 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.366 1.466 . . . . 0.0 109.374 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -63.58 -49.49 73.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -70.79 -46.15 63.39 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.474 ' CD1' ' HG2' ' A' ' 57' ' ' GLN . 63.6 t80 -70.23 -19.55 63.13 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.465 -177.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -90.14 -77.68 0.39 Allowed 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.534 1.061 . . . . 0.0 110.207 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.8 p30 174.49 56.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.1 1.36 . . . . 0.0 111.616 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -146.01 92.7 2.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 86.19 117.59 0.04 OUTLIER 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 127.326 2.25 . . . . 0.0 105.819 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -92.05 85.17 5.43 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.045 0.938 . . . . 0.0 109.916 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.15 150.21 8.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.253 1.421 . . . . 0.0 112.722 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.61 -38.37 95.59 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.4 t 65.49 97.13 0.05 OUTLIER 'General case' 0 C--N 1.343 0.297 0 C-N-CA 126.773 2.029 . . . . 0.0 113.242 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.5 m -68.95 -55.65 10.29 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 t -159.81 16.89 0.15 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.171 1.388 . . . . 0.0 111.495 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -142.02 149.76 53.61 Favored Pre-proline 0 CA--C 1.511 -0.553 0 C-N-CA 126.067 1.747 . . . . 0.0 107.327 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.4 122.76 7.96 Favored 'Cis proline' 0 CA--C 1.557 1.651 0 N-CA-C 115.425 1.279 . . . . 0.0 115.425 0.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . 0.318 29.3 m-70 -82.84 138.33 33.98 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 127.358 2.263 . . . . 0.0 114.457 -178.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -70.77 133.17 46.33 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 102.829 -3.026 . . . . 0.0 102.829 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.28 63.1 3.82 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.211 0.914 . . . . 0.0 113.278 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.1 m120 30.98 -138.0 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 130.87 3.668 . . . . 0.0 114.912 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -111.73 140.25 46.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.854 2.061 . . . . 0.0 107.701 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 71.93 179.46 0.23 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.514 1.526 . . . . 0.0 109.998 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -84.76 98.08 10.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.35 -42.48 83.1 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.171 0.891 . . . . 0.0 111.694 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -145.25 162.71 36.51 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.127 0.971 . . . . 0.0 109.458 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -76.69 132.9 39.61 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.777 1.231 . . . . 0.0 112.612 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -149.28 154.01 38.3 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.428 1.491 . . . . 0.0 108.385 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.96 -47.63 23.92 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.023 2.482 . . . . 0.0 111.351 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.42 HG21 HD21 ' A' ' 80' ' ' ASN . 22.4 m -81.0 168.0 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.544 1.538 . . . . 0.0 109.755 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -98.53 -16.68 19.06 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.633 1.173 . . . . 0.0 112.406 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.66 -159.69 22.41 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.35 160.77 72.05 Favored 'Cis proline' 0 N--CA 1.459 -0.549 0 CA-C-N 118.783 1.291 . . . . 0.0 112.422 1.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.91 159.94 35.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.742 1.217 . . . . 0.0 111.465 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.474 ' HG2' ' CD1' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -132.96 135.95 45.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.9 178.058 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -80.68 162.43 24.16 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -160.77 117.91 1.45 Allowed Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -82.9 146.03 12.83 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 121.405 1.404 . . . . 0.0 113.103 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 62' ' ' LYS . 0.5 OUTLIER -112.84 -165.48 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-O 123.81 1.767 . . . . 0.0 113.731 -178.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.467 ' N ' HG23 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -161.65 176.09 11.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 109.678 -3.419 . . . . 0.0 111.586 -177.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.0 t -99.81 63.57 1.22 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.342 1.457 . . . . 0.0 110.673 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.68 -63.43 0.09 OUTLIER Glycine 0 C--N 1.337 0.593 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.85 -164.88 11.57 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.6 p -83.98 160.6 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.03 0.932 . . . . 0.0 111.643 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -37.93 126.68 1.24 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 128.097 2.559 . . . . 0.0 113.754 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.0 t -160.02 -40.98 0.05 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.496 1.518 . . . . 0.0 110.383 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.87 -80.3 0.75 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.93 95.08 2.29 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.8 p -157.13 153.04 22.9 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 125.024 1.33 . . . . 0.0 108.417 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.23 154.17 74.79 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.958 2.439 . . . . 0.0 110.642 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 74' ' ' ALA . . . -165.05 -25.73 0.02 OUTLIER Glycine 0 CA--C 1.53 1.022 0 CA-C-O 117.956 -1.469 . . . . 0.0 114.655 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.602 ' HB1' ' H ' ' A' ' 91' ' ' HIS . . . 88.95 -31.28 0.03 OUTLIER 'General case' 0 C--N 1.346 0.418 0 C-N-CA 126.205 1.802 . . . . 0.0 111.167 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -79.37 124.52 28.5 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.234 1.813 . . . . 0.0 113.391 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.84 128.08 7.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.804 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.7 m -85.9 146.03 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.7 t -133.96 122.87 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.3 pt -106.23 171.59 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 125.169 1.388 . . . . 0.0 111.566 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.42 HD21 HG21 ' A' ' 52' ' ' VAL . 8.8 m120 -79.68 165.47 22.82 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 178.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.285 2.1 m -67.98 -5.78 18.93 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -178.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -102.29 -73.3 0.66 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -165.17 -12.01 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 117.935 2.568 . . . . 0.0 117.935 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -78.77 126.96 31.43 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -57.33 111.21 1.02 Allowed 'General case' 0 C--N 1.344 0.346 0 C-N-CA 125.353 1.461 . . . . 0.0 107.454 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.99 -48.76 11.81 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.53 151.33 8.31 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.56 125.88 38.41 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.5 pt -127.13 155.74 38.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 C-N-CA 122.727 0.411 . . . . 0.0 110.11 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.8 t -156.73 154.06 29.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.602 ' H ' ' HB1' ' A' ' 74' ' ' ALA . 2.5 m170 -79.04 -15.38 58.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.821 175.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.7 m -58.51 103.72 0.17 Allowed 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.668 1.187 . . . . 0.0 109.385 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.76 55.0 1.96 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.23 -174.95 4.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.729 1.212 . . . . 0.0 109.915 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -57.15 -47.56 80.86 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.249 1.019 . . . . 0.0 111.082 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.96 -70.37 0.12 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -86.63 -28.55 23.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.76 1.224 . . . . 0.0 109.305 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -57.06 160.61 3.54 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 126.304 1.842 . . . . 0.0 111.285 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -114.85 161.46 18.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.882 1.673 . . . . 0.0 112.029 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 m -146.28 164.08 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 126.615 1.966 . . . . 0.0 107.434 177.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.54 156.55 26.9 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 123.972 0.796 . . . . 0.0 112.414 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.0 m -103.39 -171.16 1.89 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.151 0.98 . . . . 0.0 110.897 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -82.87 79.32 9.28 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 121.599 0.714 . . . . 0.0 109.624 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.94 -26.22 0.2 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.259 1.409 . . . . 0.0 109.674 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.0 m -79.36 123.35 27.41 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.015 1.726 . . . . 0.0 107.412 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 126.199 1.8 . . . . 0.0 109.865 -179.056 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 119.919 -0.086 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.53 91.53 0.03 OUTLIER 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.807 1.643 . . . . 0.0 111.666 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 p -83.41 92.5 7.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.087 0.955 . . . . 0.0 112.068 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -99.71 96.25 7.49 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 101.481 -3.526 . . . . 0.0 101.481 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.9 m -89.12 73.04 8.23 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.94 -98.65 1.21 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 108.611 -1.795 . . . . 0.0 108.611 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.5 p -95.53 -42.13 8.59 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.41 1.084 . . . . 0.0 109.182 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.21 137.32 58.24 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -140.17 126.75 20.31 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.79 136.78 50.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.522 1.529 . . . . 0.0 108.338 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.7 p -64.73 161.57 17.67 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 125.152 1.381 . . . . 0.0 110.807 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.21 -16.78 36.39 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -78.28 -37.16 45.58 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 123.785 0.834 . . . . 0.0 109.986 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -66.64 -39.94 88.49 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.726 0.81 . . . . 0.0 109.992 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.5 t -60.2 -50.69 79.25 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -64.87 -23.29 67.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.138 1.375 . . . . 0.0 111.378 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.64 -61.11 1.89 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 119.202 0.91 . . . . 0.0 108.668 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.86 -24.93 66.19 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.679 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.2 -38.59 30.87 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 118.501 0.592 . . . . 0.0 112.012 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -69.5 -22.55 63.6 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.3 -65.22 0.95 Allowed 'General case' 0 C--N 1.347 0.487 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.431 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -45.38 -43.68 11.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.783 1.233 . . . . 0.0 111.941 177.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 t -61.81 -48.33 81.09 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 121.335 -0.853 . . . . 0.0 111.682 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -80.21 -24.33 40.32 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -112.6 -28.72 7.72 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -3.06 28.21 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -66.75 -46.64 74.73 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.175 0.99 . . . . 0.0 112.979 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -133.69 -80.69 0.47 Allowed 'General case' 0 C--N 1.34 0.183 0 O-C-N 123.354 0.409 . . . . 0.0 111.328 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -170.66 101.67 0.24 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -141.2 -169.38 2.83 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.963 0.905 . . . . 0.0 110.35 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.3 p -71.08 84.9 0.72 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.455 1.502 . . . . 0.0 112.152 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 137.94 162.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 129.464 3.106 . . . . 0.0 111.895 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 152.65 -87.88 0.13 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 126.169 1.842 . . . . 0.0 108.647 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.1 t 158.31 -94.75 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 129.21 3.004 . . . . 0.0 105.91 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.6 p -160.22 -55.05 0.06 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 p -81.36 -69.15 0.63 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.24 141.07 98.07 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 124.075 0.95 . . . . 0.0 109.129 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.18 133.33 27.46 Favored 'Cis proline' 0 N--CA 1.459 -0.504 0 N-CA-C 116.061 1.523 . . . . 0.0 116.061 3.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -132.49 136.97 47.03 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.963 2.105 . . . . 0.0 108.423 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.5 m -49.58 125.66 11.87 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.819 2.048 . . . . 0.0 110.195 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -80.03 70.61 6.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.703 1.201 . . . . 0.0 110.407 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -164.31 147.59 9.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.592 0.757 . . . . 0.0 110.027 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -162.29 -72.83 0.05 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.618 1.567 . . . . 0.0 107.03 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -152.76 -40.7 0.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.711 2.004 . . . . 0.0 108.31 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -118.28 161.96 19.06 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 125.392 1.477 . . . . 0.0 110.103 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.84 156.65 14.52 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.634 1.112 . . . . 0.0 110.459 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.55 156.78 37.77 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.655 0.782 . . . . 0.0 111.302 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -88.55 119.49 29.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.868 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -130.77 101.03 17.16 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.57 75.81 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.759 2.972 . . . . 0.0 111.286 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.9 t -140.04 -38.56 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.023 1.729 . . . . 0.0 109.238 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 80.57 108.88 0.07 Allowed 'General case' 0 C--N 1.345 0.387 0 C-N-CA 127.132 2.173 . . . . 0.0 109.251 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.84 -143.17 0.7 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.865 1.697 . . . . 0.0 113.533 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -65.99 139.06 40.76 Favored 'Cis proline' 0 N--CA 1.456 -0.717 0 CA-C-N 118.299 1.049 . . . . 0.0 112.652 1.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.37 163.72 12.61 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 126.351 1.86 . . . . 0.0 108.24 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -139.75 156.25 46.88 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -79.63 157.3 27.31 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.227 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.431 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 7.3 t80 -160.21 89.22 1.82 Allowed Pre-proline 0 N--CA 1.449 -0.511 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . 0.253 6.3 Cg_exo -63.84 137.46 58.33 Favored 'Trans proline' 0 N--CA 1.44 -1.657 0 C-N-CA 122.474 2.116 . . . . 0.0 116.757 -176.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.531 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.0 tt -108.14 176.96 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 124.278 1.99 . . . . 0.0 111.904 178.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.531 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -162.05 179.78 7.72 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 108.58 -3.918 . . . . 0.0 111.31 179.082 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.9 p -87.42 52.85 2.61 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.32 -65.57 0.02 OUTLIER Glycine 0 C--N 1.342 0.879 0 C-N-CA 125.187 1.375 . . . . 0.0 110.136 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.85 -127.13 1.62 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -68.27 164.94 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.89 1.276 . . . . 0.0 109.225 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -51.42 140.44 17.57 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.4 p -141.56 -55.79 0.47 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.566 1.946 . . . . 0.0 108.422 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.01 170.52 20.79 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.024 1.297 . . . . 0.0 111.248 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.38 151.15 25.33 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.506 1.05 . . . . 0.0 111.924 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.5 p 63.82 171.99 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.014 2.126 . . . . 0.0 112.657 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.55 159.89 30.24 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.012 2.475 . . . . 0.0 111.097 172.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.08 71.83 0.19 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.487 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -69.36 -16.52 63.55 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 118.142 -0.933 . . . . 0.0 112.575 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.54 125.12 38.99 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.322 1.849 . . . . 0.0 112.297 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.0 mtt85 -135.18 137.47 42.72 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.893 0.877 . . . . 0.0 113.115 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.9 m -103.07 145.3 12.56 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 176.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.262 91.7 t -134.73 133.99 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -176.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.7 pt -126.72 165.84 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -87.9 157.16 19.04 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 126.16 1.784 . . . . 0.0 109.79 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.377 8.2 t -79.73 56.06 2.18 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 -177.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -157.47 -87.07 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 100.785 -3.783 . . . . 0.0 100.785 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.45 1.85 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -83.91 127.1 33.61 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -64.35 127.87 33.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.325 1.05 . . . . 0.0 108.537 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.36 -44.89 8.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.563 0.745 . . . . 0.0 109.99 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.67 175.32 42.09 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.173 -0.537 . . . . 0.0 114.108 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.54 121.85 21.56 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 127.123 2.169 . . . . 0.0 106.166 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.3 pt -128.16 161.19 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.478 1.111 . . . . 0.0 110.243 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 t -157.91 159.81 36.95 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.487 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 21.8 m170 -78.45 -24.09 46.22 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.4 m -61.56 108.07 0.91 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.793 0.837 . . . . 0.0 110.863 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.54 -15.71 19.67 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.818 1.199 . . . . 0.0 112.323 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.93 163.73 26.89 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.409 1.083 . . . . 0.0 111.8 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.8 t -104.05 52.03 0.77 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.957 1.303 . . . . 0.0 109.6 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 143.24 -147.67 19.14 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.796 1.189 . . . . 0.0 110.752 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -79.61 -14.84 58.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.496 1.119 . . . . 0.0 111.367 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -60.09 167.64 2.25 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 123.779 0.832 . . . . 0.0 110.919 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -106.71 159.66 16.05 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.437 1.095 . . . . 0.0 112.85 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 m -134.85 165.46 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 127.046 2.138 . . . . 0.0 106.399 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.14 138.01 13.91 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 122.984 0.326 . . . . 0.0 113.39 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.3 m -85.13 -174.37 5.21 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -77.44 121.33 23.67 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.745 -0.597 . . . . 0.0 110.648 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.03 66.2 1.59 Allowed Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.387 0.994 . . . . 0.0 110.789 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.4 t -139.31 29.37 2.21 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.984 1.314 . . . . 0.0 112.198 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 C--O 1.251 1.168 0 C-N-CA 127.68 2.392 . . . . 0.0 110.268 -179.13 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.5 p . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.08 147.29 35.41 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.473 1.109 . . . . 0.0 109.76 178.551 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.1 p -121.57 119.22 31.28 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 123.137 0.575 . . . . 0.0 110.239 -178.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.18 108.29 13.14 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 100.313 -3.958 . . . . 0.0 100.313 177.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.9 110.16 13.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.724 0.409 . . . . 0.0 110.242 -178.053 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.12 -82.71 0.75 Allowed Glycine 0 C--N 1.339 0.746 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.34 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.2 t -156.99 45.77 0.4 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.642 1.177 . . . . 0.0 108.874 179.057 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 m -141.39 96.92 3.06 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -85.68 139.05 31.69 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.71 1.604 . . . . 0.0 110.932 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -137.89 137.15 37.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.079 1.352 . . . . 0.0 108.271 178.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.447 ' O ' HG23 ' A' ' 16' ' ' VAL . 44.5 m -70.58 149.18 47.35 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.29 -21.55 5.69 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.2 m -71.0 -47.66 57.54 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.153 0.981 . . . . 0.0 109.267 179.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.79 -38.04 85.74 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 12' ' ' SER . 2.6 t -63.81 -51.06 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.315 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.8 ttt-85 -64.19 -36.09 82.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.726 1.61 . . . . 0.0 111.785 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.29 -50.5 46.16 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.051 0.541 . . . . 0.0 109.908 179.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.517 ' HB1' ' HE2' ' A' ' 59' ' ' PHE . . . -57.58 -41.72 81.71 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.325 1.05 . . . . 0.0 110.213 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.91 -46.19 54.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -61.21 -21.81 64.19 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.64 -59.64 2.54 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -177.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.88 -32.54 53.61 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.817 0.698 . . . . 0.0 110.945 178.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.25 -53.84 42.7 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -56.44 -38.85 72.18 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.787 0.435 . . . . 0.0 110.549 178.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -74.38 -3.31 29.67 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 126.589 1.956 . . . . 0.0 113.147 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -134.41 17.84 3.67 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -99.3 -80.55 0.47 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.957 1.253 . . . . 0.0 108.823 179.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -157.97 17.2 0.24 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.245 1.018 . . . . 0.0 112.846 -179.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -122.3 67.7 0.94 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 77.1 116.53 0.06 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 127.406 2.283 . . . . 0.0 105.294 -177.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -96.03 -58.08 2.18 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 124.157 0.983 . . . . 0.0 112.159 -177.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 50.83 82.41 0.06 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.831 1.252 . . . . 0.0 112.534 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -112.75 33.09 5.81 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.768 1.651 . . . . 0.0 110.805 -179.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.7 m -149.24 65.08 1.02 Allowed 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.297 1.439 . . . . 0.0 107.212 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.6 p -161.33 -167.77 1.85 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.316 1.046 . . . . 0.0 108.765 -178.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.4 p -85.93 58.04 4.82 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 74.35 147.53 0.12 Allowed Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 126.885 2.074 . . . . 0.0 110.443 179.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.66 137.57 46.7 Favored 'Cis proline' 0 C--N 1.349 0.558 0 CA-C-N 119.73 0.939 . . . . 0.0 113.725 2.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -134.98 168.58 18.85 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.801 2.04 . . . . 0.0 110.216 -179.128 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.4 m -74.08 140.06 45.06 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.596 1.958 . . . . 0.0 109.489 178.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.49 81.78 5.92 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.86 146.49 49.6 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 71.77 126.23 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.054 2.142 . . . . 0.0 111.174 -178.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -98.67 53.19 1.01 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.91 0.884 . . . . 0.0 109.476 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -153.6 56.81 0.75 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.708 1.203 . . . . 0.0 108.102 179.123 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.8 -55.58 0.23 Allowed Glycine 0 C--N 1.341 0.855 0 C-N-CA 125.725 1.631 . . . . 0.0 109.042 179.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.61 175.65 13.65 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.313 1.045 . . . . 0.0 109.52 178.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -90.52 136.63 32.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.873 1.269 . . . . 0.0 110.871 -178.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -150.87 103.51 3.02 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 178.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.63 58.03 6.23 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.125 3.217 . . . . 0.0 114.074 -177.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -145.37 -134.22 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 178.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -146.5 143.23 28.8 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.183 0.901 . . . . 0.0 109.225 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.74 -176.19 50.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.214 0.911 . . . . 0.0 111.892 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.23 160.89 93.41 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 CA-C-N 118.174 0.987 . . . . 0.0 110.693 -1.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -112.4 171.82 7.29 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.267 1.027 . . . . 0.0 110.289 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -132.56 137.31 47.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.169 1.388 . . . . 0.0 109.055 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -93.7 155.29 17.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.603 0.761 . . . . 0.0 110.323 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.517 ' HE2' ' HB1' ' A' ' 19' ' ' ALA . 22.4 t80 -160.21 102.55 1.39 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.12 119.94 4.81 Favored 'Trans proline' 0 N--CA 1.442 -1.532 0 C-N-CA 122.226 1.951 . . . . 0.0 109.789 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.52 HG13 ' H ' ' A' ' 62' ' ' LYS . 6.2 tt -79.38 170.63 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 124.109 1.909 . . . . 0.0 111.349 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.52 ' H ' HG13 ' A' ' 61' ' ' ILE . 14.1 tptm -140.49 149.11 42.1 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 109.468 -3.515 . . . . 0.0 111.641 -178.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.4 m -89.48 60.28 5.12 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.129 1.771 . . . . 0.0 109.267 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.03 -55.79 0.03 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.29 -167.82 36.75 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.6 158.83 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.679 1.192 . . . . 0.0 110.899 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.18 -173.37 4.17 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.352 1.461 . . . . 0.0 108.341 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.2 t -160.36 33.11 0.17 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.752 1.221 . . . . 0.0 110.069 178.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -141.9 -24.38 0.21 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.824 1.202 . . . . 0.0 113.024 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.96 -143.86 49.01 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.643 1.222 . . . . 0.0 111.827 179.377 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.1 t 63.11 102.33 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.421 1.888 . . . . 0.0 111.975 179.211 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.85 161.7 29.68 Favored 'Cis proline' 0 C--N 1.349 0.567 0 CA-C-N 119.981 1.029 . . . . 0.0 113.619 -3.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.78 41.35 1.88 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.864 -0.964 . . . . 0.0 113.546 -179.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.54 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -88.54 -73.28 0.5 Allowed 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -60.99 112.92 2.26 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.603 1.161 . . . . 0.0 111.147 179.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -132.22 161.01 34.48 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -178.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 m -132.88 142.11 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 101.16 -3.644 . . . . 0.0 101.16 175.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.9 t -138.24 120.13 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -176.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -102.54 173.12 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.115 0 C-N-CA 125.85 1.66 . . . . 0.0 110.15 -178.979 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -88.56 161.06 17.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 103.184 -2.895 . . . . 0.0 103.184 176.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.366 13.4 t -57.09 -22.54 40.29 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 -177.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -85.97 -75.46 0.38 Allowed 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.62 -1.84 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -176.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -78.94 109.03 12.85 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -175.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -56.51 108.6 0.5 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.929 1.292 . . . . 0.0 109.228 -179.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.08 -60.05 2.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.604 1.162 . . . . 0.0 112.461 -177.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.8 175.57 46.39 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.62 146.12 52.04 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.424 1.089 . . . . 0.0 110.58 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.2 pt -143.61 171.37 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.292 1.037 . . . . 0.0 110.781 -178.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t -159.71 143.23 14.36 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 116.426 2.009 . . . . 0.0 116.426 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.54 ' HB2' ' CB ' ' A' ' 74' ' ' ALA 0.265 32.2 m170 -79.51 -29.36 41.53 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.094 174.542 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.2 -45.33 68.54 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.607 1.163 . . . . 0.0 113.666 -177.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -78.62 -21.9 68.14 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 124.047 0.832 . . . . 0.0 111.565 179.226 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.26 166.5 23.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.897 0.879 . . . . 0.0 112.003 -179.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.7 t -65.9 -36.02 82.23 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.158 0.983 . . . . 0.0 111.64 -179.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.53 -101.51 0.15 Allowed Glycine 0 C--N 1.341 0.808 0 CA-C-N 118.206 0.457 . . . . 0.0 112.26 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -79.58 -22.12 44.18 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.046 0.938 . . . . 0.0 113.017 -178.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -74.68 179.01 5.0 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.656 0.662 . . . . 0.0 110.584 179.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -119.41 159.03 24.99 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.563 1.545 . . . . 0.0 109.905 179.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.7 m -134.96 162.4 38.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 125.209 1.404 . . . . 0.0 107.542 177.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.44 147.94 30.41 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 116.311 -0.404 . . . . 0.0 113.51 -178.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 34.0 m -85.75 -173.91 4.87 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.309 1.444 . . . . 0.0 107.946 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.3 t -57.23 110.27 0.81 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.263 1.025 . . . . 0.0 111.841 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.95 34.2 76.38 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.939 1.256 . . . . 0.0 114.322 178.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 93.6 m -83.43 130.8 35.05 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 118.091 0.945 . . . . 0.0 109.169 179.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 117.238 -1.363 . . . . 0.0 108.927 179.438 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.4 t . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 120.722 0.296 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.53 147.02 0.06 Allowed 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 127.007 2.123 . . . . 0.0 112.227 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 t -159.66 156.3 27.61 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.533 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.87 121.23 18.11 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -178.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.4 m -103.28 91.04 3.91 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.285 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.28 -106.93 1.87 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.7 m -92.84 -33.32 14.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.527 1.131 . . . . 0.0 111.173 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 m -74.65 103.15 4.83 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.352 0.661 . . . . 0.0 110.275 -178.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -87.92 151.94 22.44 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.961 1.304 . . . . 0.0 111.684 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -142.54 134.23 26.77 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 123.481 0.713 . . . . 0.0 112.354 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.7 m -77.07 155.11 32.71 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.241 1.417 . . . . 0.0 107.465 177.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.82 -16.89 13.01 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 177.087 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -70.88 -43.29 68.71 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.871 0.868 . . . . 0.0 109.587 179.054 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -71.15 -47.3 58.65 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 123.932 0.893 . . . . 0.0 113.138 -179.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.4 t -60.1 -46.12 94.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -68.18 -40.84 82.15 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.84 1.256 . . . . 0.0 111.901 -179.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.98 -49.6 71.87 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.588 0.631 . . . . 0.0 110.021 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.33 -35.2 79.61 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.893 0.877 . . . . 0.0 111.563 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.21 -40.85 58.82 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 117.76 0.255 . . . . 0.0 111.661 179.12 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -65.38 -22.07 66.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.34 -61.73 1.91 Allowed 'General case' 0 C--N 1.348 0.505 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 -178.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -42.34 -47.54 4.9 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.097 1.359 . . . . 0.0 110.486 178.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.7 t -57.88 -66.61 0.45 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.767 1.627 . . . . 0.0 112.687 179.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -23.18 66.36 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.181 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -94.9 4.95 53.22 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.556 1.942 . . . . 0.0 113.413 -178.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -144.82 51.81 1.24 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.268 1.427 . . . . 0.0 110.63 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -95.13 -77.15 0.47 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 119.36 -0.352 . . . . 0.0 110.19 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 169.63 -65.4 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.683 1.593 . . . . 0.0 108.828 -178.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.25 69.79 7.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 111.22 116.19 0.0 OUTLIER 'General case' 0 C--O 1.231 0.102 0 C-N-CA 131.033 3.733 . . . . 0.0 106.743 -179.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.48 -63.95 0.3 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.483 1.113 . . . . 0.0 109.982 -178.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 66.52 163.35 0.18 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.562 1.545 . . . . 0.0 112.453 -179.186 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.93 106.7 0.15 Allowed Glycine 0 C--N 1.341 0.811 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -178.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m -139.1 57.21 1.67 Allowed 'General case' 0 C--N 1.34 0.173 0 CA-C-N 117.696 0.748 . . . . 0.0 112.149 -178.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -100.02 -75.93 0.56 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 177.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.261 3.6 t -160.23 26.56 0.17 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.682 1.593 . . . . 0.0 109.823 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.409 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -171.3 129.78 0.73 Allowed Pre-proline 0 C--N 1.349 0.548 0 C-N-CA 128.307 2.643 . . . . 0.0 106.872 178.329 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.6 132.3 25.84 Favored 'Cis proline' 0 N--CA 1.45 -1.083 0 N-CA-C 108.354 -1.441 . . . . 0.0 108.354 -2.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.3 158.17 43.88 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.874 0.47 . . . . 0.0 109.76 -179.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.4 m -55.64 130.97 45.24 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 125.97 1.708 . . . . 0.0 110.584 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -79.8 121.24 25.13 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.347 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -146.63 177.87 8.74 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.26 1.024 . . . . 0.0 110.514 -179.139 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 t30 59.13 73.27 0.49 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.259 1.424 . . . . 0.0 108.565 -178.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -82.01 91.23 6.58 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.051 0.94 . . . . 0.0 110.853 -178.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -62.08 -50.51 71.66 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -169.74 42.4 0.21 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 178.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -150.73 143.48 24.54 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 123.557 0.743 . . . . 0.0 112.159 -179.283 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -161.6 179.63 8.03 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.836 2.054 . . . . 0.0 107.677 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -137.93 119.33 10.58 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.84 74.37 5.26 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.981 3.121 . . . . 0.0 112.45 -178.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.26 -90.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.405 1.082 . . . . 0.0 108.714 178.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -145.93 -78.72 0.18 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-N 119.215 0.916 . . . . 0.0 110.228 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.22 -175.06 35.97 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.632 1.11 . . . . 0.0 111.045 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.25 140.33 32.48 Favored 'Cis proline' 0 N--CA 1.458 -0.59 0 CA-C-N 118.796 1.298 . . . . 0.0 110.422 1.031 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.38 172.27 11.91 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.954 0.902 . . . . 0.0 110.351 -178.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -153.9 137.82 16.29 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.064 0.459 . . . . 0.0 111.834 -178.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.55 143.81 30.8 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.697 1.599 . . . . 0.0 112.626 -178.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -154.48 113.85 2.44 Favored Pre-proline 0 C--N 1.342 0.251 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 178.286 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.409 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 17.6 Cg_endo -81.12 144.54 14.87 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 121.79 1.66 . . . . 0.0 114.389 -175.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.544 HG12 ' H ' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -117.12 -171.64 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-O 124.671 2.176 . . . . 0.0 113.125 179.419 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.544 ' H ' HG12 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -162.41 -175.47 4.54 Favored 'General case' 0 C--N 1.318 -0.796 2 CA-C-N 108.05 -4.159 . . . . 0.0 107.443 -178.656 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.3 m -92.81 61.27 3.54 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.54 58.88 0.99 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -178.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.27 61.13 0.17 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.02 116.86 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.426 0.691 . . . . 0.0 111.206 -179.35 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.6 t80 53.64 65.64 1.46 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.248 1.419 . . . . 0.0 111.248 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.6 p -138.12 77.57 1.64 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.246 1.018 . . . . 0.0 110.825 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.95 99.92 0.07 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.738 0.685 . . . . 0.0 113.262 178.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.74 -174.35 49.31 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.2 m 56.8 86.63 0.16 Allowed Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 125.318 1.447 . . . . 0.0 111.602 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -62.72 142.6 42.14 Favored 'Cis proline' 0 N--CA 1.459 -0.505 0 CA-C-N 119.322 0.794 . . . . 0.0 112.76 -0.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.85 48.09 0.49 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.29 -55.6 8.82 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.693 0.797 . . . . 0.0 109.455 179.267 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -61.93 118.61 7.47 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.436 1.894 . . . . 0.0 112.843 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -143.37 126.91 16.89 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.0 m -92.9 148.05 4.98 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 177.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.6 t -137.06 131.81 46.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 pt -119.92 -175.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.394 0 C-N-CA 124.365 1.066 . . . . 0.0 112.301 -178.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -96.74 153.64 17.75 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 127.009 2.123 . . . . 0.0 106.071 177.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.6 t -67.31 -1.4 4.55 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 -178.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -93.29 -75.31 0.5 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 178.397 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -164.39 -12.04 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -179.094 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.72 132.82 36.28 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 -174.398 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -62.24 125.24 23.21 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.8 -42.41 8.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.2 1.0 . . . . 0.0 109.463 -178.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.18 -165.07 38.16 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.86 140.61 25.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.698 1.599 . . . . 0.0 107.678 179.421 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.8 pt -142.56 165.87 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.091 1.356 . . . . 0.0 109.129 -178.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.3 t -159.33 150.83 20.23 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.19 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -79.13 -9.8 59.65 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 175.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 54.1 m -66.16 112.0 3.7 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.477 1.111 . . . . 0.0 109.12 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.91 34.38 42.86 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.952 0.787 . . . . 0.0 111.669 -179.301 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.43 -21.2 11.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.21 1.404 . . . . 0.0 111.386 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.6 m 70.05 85.12 0.14 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 126.185 1.794 . . . . 0.0 110.639 179.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.91 -146.77 17.95 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.702 1.144 . . . . 0.0 111.359 179.192 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -80.0 3.61 19.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.681 1.192 . . . . 0.0 112.913 -179.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -68.28 -174.85 0.55 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.876 1.27 . . . . 0.0 111.594 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -140.7 157.56 45.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.81 0.844 . . . . 0.0 112.503 -178.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 m -143.94 163.29 15.18 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 127.095 2.158 . . . . 0.0 106.955 177.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.27 153.35 26.41 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 123.53 0.586 . . . . 0.0 113.302 -178.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -84.13 -179.85 7.32 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.27 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.9 t -79.53 122.69 26.79 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.351 -0.843 . . . . 0.0 112.219 -178.395 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.64 36.39 92.59 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.726 1.155 . . . . 0.0 112.361 179.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.5 t -80.05 146.69 31.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.0 p30 . . . . . 0 C--O 1.252 1.191 0 C-N-CA 125.397 1.479 . . . . 0.0 109.741 -179.031 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 CA--C 1.529 0.154 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -44.46 117.97 1.42 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.984 1.313 . . . . 0.0 110.764 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.51 121.87 41.78 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 124.964 1.306 . . . . 0.0 110.41 -178.124 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -119.07 92.14 3.73 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 100.285 -3.968 . . . . 0.0 100.285 177.126 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.8 m -98.93 91.13 4.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.982 0.913 . . . . 0.0 111.455 -177.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.72 -81.68 0.63 Allowed Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.979 1.276 . . . . 0.0 110.759 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.3 t -145.07 23.92 1.49 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.813 1.245 . . . . 0.0 110.339 179.11 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 m -129.29 102.01 6.25 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 179.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -95.18 151.72 18.98 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.347 0.659 . . . . 0.0 111.967 -178.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.26 155.69 41.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.01 1.324 . . . . 0.0 109.543 178.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.0 p -75.77 154.2 36.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.509 1.523 . . . . 0.0 110.352 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.5 -21.19 59.81 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 176.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.7 t -71.09 -41.22 70.91 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 124.648 1.179 . . . . 0.0 109.892 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -66.78 -39.83 87.94 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 118.65 0.659 . . . . 0.0 111.09 178.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.42 -50.68 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 123.741 0.816 . . . . 0.0 109.13 178.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -62.76 -39.14 93.24 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 123.71 0.804 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.6 -47.13 76.75 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.41 -31.24 72.34 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.56 0.744 . . . . 0.0 111.211 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.87 -42.52 24.06 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 178.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -68.4 -20.39 64.67 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.406 ' HB1' ' CE2' ' A' ' 26' ' ' TYR . . . -79.96 -65.42 1.01 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 104.33 -2.471 . . . . 0.0 104.33 -178.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -41.23 -53.68 3.12 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 124.708 1.255 . . . . 0.0 110.125 176.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 t -49.96 -61.87 1.9 Allowed 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.853 1.661 . . . . 0.0 113.319 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -61.55 -51.43 68.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.118 0.567 . . . . 0.0 111.458 -178.054 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.406 ' CE2' ' HB1' ' A' ' 22' ' ' ALA . 1.6 m-30 -63.07 -28.6 70.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.722 1.209 . . . . 0.0 112.041 -177.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.407 ' CE2' ' HG3' ' A' ' 57' ' ' GLN . 6.3 t80 -71.92 -56.02 6.44 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.102 0.961 . . . . 0.0 109.557 179.043 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -60.25 -36.86 78.74 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.031 0.932 . . . . 0.0 110.994 -179.079 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -73.69 -35.88 65.23 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.311 0.645 . . . . 0.0 110.683 178.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 68.48 51.05 0.67 Allowed 'General case' 0 C--N 1.344 0.362 0 C-N-CA 126.09 1.756 . . . . 0.0 109.813 -178.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -172.56 -165.55 0.33 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.818 2.047 . . . . 0.0 107.823 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.36 8.8 t 49.65 51.79 15.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.871 2.069 . . . . 0.0 113.682 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.94 99.65 0.08 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.827 2.051 . . . . 0.0 107.081 178.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.91 33.31 3.1 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.033 0.825 . . . . 0.0 113.567 -178.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -78.49 -73.09 0.34 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -167.27 -72.71 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.79 2.036 . . . . 0.0 105.925 179.295 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.3 t -152.21 14.78 0.61 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.298 1.039 . . . . 0.0 111.557 178.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.43 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 8.8 m-85 -76.95 130.79 74.69 Favored Pre-proline 0 C--N 1.346 0.421 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -69.89 121.25 5.32 Favored 'Cis proline' 0 N--CA 1.455 -0.738 0 N-CA-C 115.938 1.476 . . . . 0.0 115.938 -0.002 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -115.19 161.12 18.87 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.497 1.919 . . . . 0.0 106.053 178.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 t -52.31 143.04 15.66 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -118.31 152.64 35.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.198 1.399 . . . . 0.0 107.75 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 177.46 -65.04 0.01 OUTLIER 'General case' 0 C--O 1.231 0.082 0 C-N-CA 124.912 1.285 . . . . 0.0 108.848 -178.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 m120 53.05 44.59 30.2 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.811 1.644 . . . . 0.0 110.026 -179.247 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 59.38 -98.98 0.09 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.206 1.802 . . . . 0.0 109.287 -178.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -134.34 68.76 1.47 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.013 1.325 . . . . 0.0 107.792 178.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.05 -73.53 0.91 Allowed Glycine 0 C--N 1.341 0.859 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.209 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.29 116.73 12.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -141.19 121.31 13.78 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.851 0.86 . . . . 0.0 108.881 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -88.31 178.6 2.02 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 125.428 1.491 . . . . 0.0 107.985 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.66 -72.04 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.011 2.474 . . . . 0.0 111.113 178.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.416 ' CG1' ' ND2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER 41.77 -150.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 127.319 2.247 . . . . 0.0 114.197 178.546 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -124.23 -57.03 1.61 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.958 2.103 . . . . 0.0 107.797 178.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.84 129.93 6.7 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.648 -1.084 . . . . 0.0 111.153 179.217 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.17 -177.89 9.67 Favored 'Cis proline' 0 C--N 1.35 0.651 0 CA-C-N 119.813 1.807 . . . . 0.0 114.635 -0.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.86 163.36 38.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 128.716 2.807 . . . . 0.0 106.315 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.407 ' HG3' ' CE2' ' A' ' 27' ' ' TYR . 10.0 mm100 -132.33 152.26 51.49 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.9 161.8 15.05 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -161.12 95.51 1.39 Allowed Pre-proline 0 N--CA 1.455 -0.203 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.43 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 95.9 Cg_endo -67.69 132.26 26.43 Favored 'Trans proline' 0 N--CA 1.438 -1.744 0 CA-C-N 120.82 1.328 . . . . 0.0 112.727 -178.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.547 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.3 tt -101.81 179.33 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 123.93 1.824 . . . . 0.0 111.707 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.547 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 10.4 mttm -160.99 157.73 26.79 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 109.08 -3.691 . . . . 0.0 111.51 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.9 p -88.41 59.89 5.41 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.813 1.245 . . . . 0.0 111.234 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.11 31.0 0.13 Allowed Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.302 -0.721 . . . . 0.0 111.621 178.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.01 179.97 28.82 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.922 0.772 . . . . 0.0 112.056 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.8 p -73.64 131.15 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.094 1.358 . . . . 0.0 111.545 -179.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 41.8 t80 39.04 82.48 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.359 2.263 . . . . 0.0 114.09 178.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.2 t -160.59 125.3 3.72 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.104 0.961 . . . . 0.0 109.422 178.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 162.46 -83.16 0.12 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 154.16 -58.4 0.4 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.3 m -138.29 93.15 11.63 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.181 0.992 . . . . 0.0 110.518 -178.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -49.45 139.0 30.23 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 124.11 3.207 . . . . 0.0 111.565 169.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.14 -21.02 2.38 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 118.259 -1.301 . . . . 0.0 115.162 -178.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.476 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -151.94 -60.14 0.16 Allowed 'General case' 0 C--N 1.345 0.374 0 CA-C-N 119.657 1.729 . . . . 0.0 114.454 -178.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.42 117.52 12.06 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -177.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -146.0 125.67 13.38 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.422 0.689 . . . . 0.0 112.036 178.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.6 148.49 4.53 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.09 137.71 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.3 pt -117.42 -177.62 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.803 1.641 . . . . 0.0 112.143 -178.442 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.416 ' ND2' ' CG1' ' A' ' 52' ' ' VAL . 4.6 m120 -83.65 178.55 7.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 129.397 3.079 . . . . 0.0 107.118 178.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.1 t -90.71 24.76 2.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -140.57 -65.21 0.45 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 177.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -163.27 -21.03 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 118.741 2.867 . . . . 0.0 118.741 -177.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -79.82 150.2 30.77 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -175.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -75.44 134.52 40.85 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.149 1.78 . . . . 0.0 108.296 178.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.22 -53.7 2.86 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.942 0.897 . . . . 0.0 110.248 -179.357 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.91 152.11 10.95 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.15 127.67 53.02 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.377 1.471 . . . . 0.0 107.551 178.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.0 pt -132.19 157.59 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.457 1.103 . . . . 0.0 109.969 -178.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.4 t -158.07 151.8 23.75 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -179.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.476 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 27.8 m170 -80.21 -20.57 44.37 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.562 0.539 . . . . 0.0 110.509 174.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.0 m -49.01 -59.64 3.44 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 126.182 1.793 . . . . 0.0 112.714 -178.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.02 -27.45 70.37 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 123.846 0.736 . . . . 0.0 111.96 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.02 172.35 5.72 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.211 1.004 . . . . 0.0 112.27 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.3 t -60.79 -54.8 40.7 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.448 1.099 . . . . 0.0 111.564 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.68 -88.39 0.07 OUTLIER Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.428 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -80.23 -24.1 40.41 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.978 0.911 . . . . 0.0 112.001 -179.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -68.71 -178.18 1.12 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.518 1.127 . . . . 0.0 112.268 -178.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -128.17 160.46 31.97 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.524 1.529 . . . . 0.0 112.031 -179.007 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 m -148.27 161.25 6.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 126.747 2.019 . . . . 0.0 106.917 177.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.1 161.39 27.85 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 p -147.63 160.68 42.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.2 1.8 . . . . 0.0 109.4 178.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.2 t 70.51 58.76 0.23 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.046 1.738 . . . . 0.0 110.684 -178.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.59 28.74 70.26 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.306 -179.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.2 m -113.79 106.24 14.24 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.215 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.3 t30 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 116.851 -1.547 . . . . 0.0 109.822 179.704 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.6 p . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.83 152.05 45.28 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.706 0.802 . . . . 0.0 109.406 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 t -146.53 136.97 23.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.73 0.3 . . . . 0.0 111.705 -179.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.06 113.08 25.5 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.1 m -98.54 75.27 2.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.8 -84.11 1.59 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.0 m -123.44 -29.49 3.79 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.352 1.461 . . . . 0.0 110.816 179.112 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -71.73 98.04 1.87 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -79.56 141.58 36.49 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.138 1.375 . . . . 0.0 110.578 -178.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -137.14 129.01 29.04 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.325 1.05 . . . . 0.0 109.547 178.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.1 m -68.98 155.1 40.92 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.88 1.272 . . . . 0.0 108.652 178.209 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.71 -22.62 57.93 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 176.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.8 t -71.13 -37.74 72.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.034 0.934 . . . . 0.0 109.683 179.228 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -75.32 -44.89 42.88 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.102 1.361 . . . . 0.0 113.57 -178.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.2 t -60.48 -48.02 90.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -43.26 74.37 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 123.765 0.826 . . . . 0.0 112.258 -179.187 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.18 -47.24 85.37 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.301 0.376 . . . . 0.0 110.69 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.6 94.57 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.712 0.805 . . . . 0.0 109.566 -179.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.91 -27.86 60.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -71.51 -23.47 61.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.03 -58.03 3.26 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -179.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.482 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -44.28 -44.6 8.15 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.48 1.512 . . . . 0.0 111.002 176.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -62.9 -52.56 62.61 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.163 0.985 . . . . 0.0 109.862 178.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -61.14 -22.22 64.48 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.445 0.698 . . . . 0.0 112.182 179.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -99.74 7.4 45.1 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.898 1.679 . . . . 0.0 110.735 179.328 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -151.31 63.89 0.89 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.587 1.184 . . . . 0.0 108.51 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -100.59 -39.88 7.68 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 113.532 -1.667 . . . . 0.0 112.16 178.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -139.05 48.41 1.88 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.876 0.871 . . . . 0.0 111.062 -179.048 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 p30 46.46 41.75 9.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.584 1.954 . . . . 0.0 114.61 178.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -138.94 123.74 18.69 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 103.347 -2.834 . . . . 0.0 103.347 178.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 p -109.54 -84.09 0.55 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -176.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 163.24 97.57 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 128.394 2.677 . . . . 0.0 104.184 -178.139 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.5 -48.22 3.09 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -178.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m 59.17 71.64 0.57 Allowed 'General case' 0 C--N 1.345 0.402 0 C-N-CA 125.344 1.458 . . . . 0.0 110.267 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.3 t 179.68 -42.3 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.992 2.117 . . . . 0.0 107.238 -178.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.3 t -79.91 12.32 2.79 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.96 1.704 . . . . 0.0 112.667 179.223 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 71.94 136.57 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.792 1.637 . . . . 0.0 108.717 179.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.35 163.41 89.95 Favored 'Cis proline' 0 N--CA 1.449 -1.143 0 CA-C-N 119.616 0.899 . . . . 0.0 113.979 2.476 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -166.46 151.75 8.16 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 127.06 2.144 . . . . 0.0 107.131 178.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 t -52.0 155.66 1.78 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -178.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -138.36 99.01 3.73 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.345 2.258 . . . . 0.0 106.738 -179.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -131.04 153.65 49.05 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.28 1.032 . . . . 0.0 111.747 -178.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 54.47 32.22 16.3 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.873 2.069 . . . . 0.0 113.612 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -123.62 75.96 1.38 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -77.85 -1.46 31.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.413 1.085 . . . . 0.0 112.722 179.353 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.83 -43.34 96.64 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 124.346 0.975 . . . . 0.0 111.964 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.47 66.8 1.32 Allowed 'General case' 0 C--N 1.341 0.221 0 CA-C-O 121.658 0.742 . . . . 0.0 109.403 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -87.57 -175.16 5.1 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.632 1.173 . . . . 0.0 112.968 -178.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -141.3 143.58 31.02 Favored Pre-proline 0 N--CA 1.454 -0.226 0 C-N-CA 126.699 1.999 . . . . 0.0 106.73 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.14 -87.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.837 2.358 . . . . 0.0 110.272 179.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.1 t 31.23 -102.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 128.046 2.538 . . . . 0.0 113.358 178.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -167.76 115.43 0.75 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.246 1.019 . . . . 0.0 109.57 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.06 170.98 50.14 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.69 170.71 64.7 Favored 'Cis proline' 0 N--CA 1.459 -0.533 0 CA-C-N 118.645 1.223 . . . . 0.0 112.423 -0.147 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -130.5 170.84 13.7 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.92 1.288 . . . . 0.0 109.868 -178.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -149.99 148.5 29.13 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.172 0.989 . . . . 0.0 109.731 179.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -79.54 155.08 28.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.044 2.537 . . . . 0.0 112.369 -177.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.482 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 28.0 t80 -160.51 102.1 1.35 Allowed Pre-proline 0 N--CA 1.454 -0.258 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -78.79 126.36 7.25 Favored 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 121.786 1.658 . . . . 0.0 111.632 -176.422 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 62' ' ' LYS . 2.3 tp -79.2 164.41 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 123.845 1.783 . . . . 0.0 113.186 -178.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.414 ' N ' HG13 ' A' ' 61' ' ' ILE . 33.3 mmtp -142.93 145.55 33.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 109.316 -3.584 . . . . 0.0 110.752 -178.458 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.8 p -85.34 57.65 4.58 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.068 1.347 . . . . 0.0 108.421 179.046 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.59 -44.23 0.03 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -178.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.62 -132.59 2.18 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 117.788 0.794 . . . . 0.0 111.822 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -77.77 167.29 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.961 1.704 . . . . 0.0 110.3 -179.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -65.01 141.96 58.59 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 118.406 0.548 . . . . 0.0 110.965 -179.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -130.78 120.72 24.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.229 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.69 -66.17 3.58 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.271 0.939 . . . . 0.0 111.74 179.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.32 -115.56 1.76 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 -179.261 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.15 -178.76 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.61 1.164 . . . . 0.0 111.067 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.71 159.55 4.77 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.411 2.741 . . . . 0.0 113.34 172.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.59 82.49 0.05 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 -178.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.461 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -50.95 -35.87 35.79 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.477 1.111 . . . . 0.0 113.487 -178.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -74.96 118.48 17.97 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.564 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -144.57 133.65 22.77 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -178.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.8 m -100.12 145.83 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 176.133 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -130.81 136.49 58.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -177.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.0 pt -116.08 174.07 3.53 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 C-N-CA 125.066 1.346 . . . . 0.0 113.512 -178.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -99.99 162.67 12.84 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.885 2.074 . . . . 0.0 107.735 178.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.379 5.7 t -79.09 32.69 0.22 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 118.993 2.961 . . . . 0.0 118.993 -177.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.31 -85.62 0.63 Allowed 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 176.377 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.7 t -162.98 -6.31 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.12 1.768 . . . . 0.0 114.848 179.281 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -79.0 139.14 38.26 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.466 1.03 . . . . 0.0 112.984 -176.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -81.78 121.21 26.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.444 1.898 . . . . 0.0 106.522 178.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.72 -59.27 2.8 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 123.548 0.739 . . . . 0.0 111.691 -178.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.52 154.28 13.01 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.703 -0.76 . . . . 0.0 114.098 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.96 124.77 37.17 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.491 1.516 . . . . 0.0 109.399 179.219 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.5 pt -131.09 159.7 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 125.296 1.438 . . . . 0.0 108.414 -179.334 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.8 t -154.07 154.22 33.26 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.273 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.461 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 13.4 m170 -79.42 11.34 3.05 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 176.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.4 m -56.38 -69.66 0.14 Allowed 'General case' 0 C--N 1.343 0.316 0 CA-C-N 120.135 1.334 . . . . 0.0 112.449 -178.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.26 3.42 72.29 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.369 0.985 . . . . 0.0 112.965 -179.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.34 159.45 33.32 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.993 0.917 . . . . 0.0 111.365 179.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.5 t -69.45 -46.48 66.62 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.64 0.776 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -161.94 -86.73 0.06 OUTLIER Glycine 0 C--N 1.34 0.761 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -91.67 15.27 13.03 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.216 1.006 . . . . 0.0 111.296 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -91.17 -168.17 1.99 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.892 1.277 . . . . 0.0 109.727 -179.401 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -147.24 159.44 43.65 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.903 0.881 . . . . 0.0 112.201 -178.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.4 m -138.52 165.62 24.52 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 126.959 2.104 . . . . 0.0 107.21 177.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.71 138.58 14.33 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 123.566 0.603 . . . . 0.0 113.492 -178.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.7 m -84.81 -169.54 2.69 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.269 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -69.97 134.36 48.26 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.954 -0.466 . . . . 0.0 110.791 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.66 34.57 72.97 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.4 m -149.08 104.61 3.44 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.5 t30 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 116.873 -1.537 . . . . 0.0 109.454 179.446 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.2 p . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 67.13 163.97 0.2 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.8 2.04 . . . . 0.0 111.687 -179.202 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 t -156.32 128.52 7.51 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.98 115.37 29.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 178.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 23.1 m -101.06 72.82 1.49 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.777 1.631 . . . . 0.0 107.511 -179.048 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.02 -90.82 0.8 Allowed Glycine 0 C--N 1.34 0.754 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.3 t -106.53 -36.86 6.64 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.078 1.351 . . . . 0.0 110.416 179.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.7 m -71.39 112.96 7.94 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.616 0.766 . . . . 0.0 110.003 -179.15 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -92.29 147.39 22.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.093 0.957 . . . . 0.0 110.782 -179.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -142.08 122.23 13.81 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.778 1.231 . . . . 0.0 108.345 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.2 m -69.45 155.84 39.81 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 125.443 1.497 . . . . 0.0 110.163 178.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.9 -18.78 47.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.069 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.4 p -77.81 -39.48 43.61 Favored 'General case' 0 C--N 1.345 0.382 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -68.72 -45.97 70.15 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.278 1.031 . . . . 0.0 111.457 179.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 51.5 t -60.08 -49.78 82.71 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.095 0 C-N-CA 124.22 1.008 . . . . 0.0 109.242 179.056 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -63.6 -46.81 84.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.92 0.888 . . . . 0.0 111.434 -178.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.13 -52.57 58.48 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.589 0.756 . . . . 0.0 111.048 -177.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.04 -41.57 83.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.75 -29.29 66.61 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 179.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -68.41 -26.11 65.37 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.9 -59.5 2.69 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -43.93 -44.52 7.17 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.138 1.375 . . . . 0.0 112.145 177.346 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.9 t -60.08 -53.83 53.17 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.15 1.38 . . . . 0.0 111.06 -179.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -66.91 -43.15 84.08 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -81.37 -2.57 49.8 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 127.103 2.161 . . . . 0.0 114.03 -178.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -60.29 -45.73 92.33 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 120.288 1.404 . . . . 0.0 110.611 179.051 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -57.59 -46.28 84.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.974 1.31 . . . . 0.0 110.886 -178.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -84.45 -16.55 42.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.185 1.394 . . . . 0.0 113.277 -178.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.7 t0 65.26 79.18 0.26 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.533 1.933 . . . . 0.0 107.867 -178.234 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 83.94 -163.09 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.467 2.307 . . . . 0.0 107.198 -178.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.7 p -36.97 -41.2 0.33 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.087 1.355 . . . . 0.0 108.954 177.069 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 156.6 90.09 0.0 OUTLIER 'General case' 0 C--N 1.345 0.373 0 C-N-CA 129.971 3.308 . . . . 0.0 108.819 177.143 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -141.14 -136.0 3.24 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.278 1.894 . . . . 0.0 110.983 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.5 p 177.52 111.79 0.03 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 125.293 1.437 . . . . 0.0 109.407 -178.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 m 89.68 -8.72 0.39 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 128.74 2.816 . . . . 0.0 114.233 178.047 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 t -82.52 3.8 27.01 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.602 0.637 . . . . 0.0 112.225 179.099 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 81.21 141.21 0.07 OUTLIER Pre-proline 0 C--N 1.347 0.462 0 C-N-CA 127.818 2.447 . . . . 0.0 109.734 178.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.06 144.11 74.3 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 N-CA-C 117.258 1.984 . . . . 0.0 117.258 2.307 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.78 161.52 34.64 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 127.583 2.353 . . . . 0.0 106.324 178.406 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.2 t -59.13 149.04 29.15 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.631 0.65 . . . . 0.0 111.52 -179.281 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -90.69 143.53 26.65 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.209 1.004 . . . . 0.0 109.325 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -65.15 -49.24 70.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.817 1.647 . . . . 0.0 112.959 -178.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 71.22 -168.02 0.15 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.125 1.37 . . . . 0.0 109.851 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 68.5 168.71 0.28 Allowed 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.76 1.624 . . . . 0.0 112.471 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 55.65 50.91 13.42 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -178.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.81 -159.08 34.15 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 108.154 -1.978 . . . . 0.0 108.154 -177.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 35.58 96.94 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 127.403 2.281 . . . . 0.0 116.853 179.07 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -158.83 143.03 15.55 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.0 0.92 . . . . 0.0 109.427 178.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -102.24 153.53 38.01 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.036 1.335 . . . . 0.0 108.728 -179.306 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -78.17 42.18 1.16 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 124.102 3.201 . . . . 0.0 112.518 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.5 m -149.11 152.59 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 126.683 1.993 . . . . 0.0 107.161 178.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -144.87 113.58 6.75 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.18 -57.02 3.08 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.18 -1.344 . . . . 0.0 112.689 -178.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -53.8 149.16 16.64 Favored 'Cis proline' 0 C--N 1.351 0.68 0 CA-C-N 120.586 2.193 . . . . 0.0 113.944 0.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -92.94 156.69 16.76 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.649 1.179 . . . . 0.0 111.286 -178.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.78 154.29 45.57 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.373 1.869 . . . . 0.0 115.378 -176.203 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -80.46 150.45 29.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.654 1.982 . . . . 0.0 110.002 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.524 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 65.7 t80 -160.02 99.38 1.46 Allowed Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -79.38 120.11 4.36 Favored 'Trans proline' 0 N--CA 1.442 -1.531 0 C-N-CA 122.114 1.876 . . . . 0.0 113.768 -176.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.561 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.9 tt -85.8 -178.81 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-O 123.845 1.783 . . . . 0.0 108.841 178.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.561 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 7.6 mmtt -160.43 139.91 10.92 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 109.788 -3.369 . . . . 0.0 111.466 -178.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.5 p -90.22 63.17 5.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.231 1.412 . . . . 0.0 107.309 178.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.87 -51.16 0.04 OUTLIER Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.222 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.18 177.98 35.52 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.27 104.93 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 39.6 p90 47.86 71.31 0.35 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.597 1.959 . . . . 0.0 112.343 -178.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.9 p -110.24 138.36 46.73 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.061 1.344 . . . . 0.0 109.273 179.306 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.36 -80.09 1.86 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.82 111.29 0.09 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.04 0.828 . . . . 0.0 111.615 179.262 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.9 m 64.93 90.66 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.719 1.607 . . . . 0.0 110.723 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.29 165.86 84.69 Favored 'Cis proline' 0 N--CA 1.457 -0.63 0 CA-C-N 119.323 0.794 . . . . 0.0 112.055 4.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.35 -67.48 0.02 OUTLIER Glycine 0 CA--C 1.525 0.716 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.413 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . 80.1 -59.72 0.32 Allowed 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 127.928 2.491 . . . . 0.0 109.478 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -65.52 115.6 5.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -135.52 159.69 40.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 122.148 0.975 . . . . 0.0 112.481 178.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.0 m -130.42 147.64 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 102.326 -3.212 . . . . 0.0 102.326 176.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.4 t -127.83 108.85 18.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -177.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -98.75 175.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.413 1.085 . . . . 0.0 111.498 -177.227 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -96.42 146.7 24.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.069 1.748 . . . . 0.0 107.108 179.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.9 t -61.11 -10.01 5.58 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 117.563 2.431 . . . . 0.0 117.563 -178.129 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -86.32 -76.51 0.34 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 178.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.48 -7.89 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 -178.473 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -79.07 169.53 18.05 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 119.339 0.972 . . . . 0.0 111.653 -176.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -113.46 125.81 54.64 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.513 1.925 . . . . 0.0 108.848 179.238 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.62 -62.99 1.35 Allowed 'General case' 0 C--N 1.346 0.431 0 C-N-CA 123.463 0.705 . . . . 0.0 111.241 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.26 170.04 43.09 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.66 153.82 38.86 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 123.931 0.892 . . . . 0.0 113.395 -178.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.5 pt -142.7 161.24 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 127.04 2.136 . . . . 0.0 109.392 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.4 t -160.57 142.76 12.74 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -177.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.413 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 9.6 m170 -78.35 64.35 3.43 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-N 120.89 1.677 . . . . 0.0 108.679 173.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.7 t -95.94 -34.45 11.8 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.227 -0.921 . . . . 0.0 109.652 178.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.68 -59.32 0.27 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 178.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 64.82 177.61 0.19 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.152 1.781 . . . . 0.0 113.591 178.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.4 t -150.64 56.98 0.92 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.553 1.541 . . . . 0.0 107.158 179.129 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.47 -77.28 0.23 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 107.503 -2.239 . . . . 0.0 107.503 -178.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -144.5 45.91 1.4 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.556 1.143 . . . . 0.0 108.985 178.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -114.17 160.59 18.8 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.613 1.165 . . . . 0.0 111.092 -179.059 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -109.49 109.84 20.78 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.743 1.617 . . . . 0.0 107.467 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.2 m -79.41 161.14 4.2 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.332 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.15 143.56 29.76 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 116.439 1.336 . . . . 0.0 116.439 -177.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.9 t -121.86 163.62 18.91 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 177.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.2 t 61.8 37.01 15.85 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.025 0.93 . . . . 0.0 109.865 -176.077 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.13 33.69 85.17 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.473 1.035 . . . . 0.0 111.892 -178.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.4 m -81.42 137.31 35.68 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.211 1.004 . . . . 0.0 109.387 179.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 116.921 -1.514 . . . . 0.0 108.535 179.219 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 CA--C 1.532 0.282 0 CA-C-O 121.336 0.589 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 145.26 109.36 0.0 OUTLIER 'General case' 0 C--O 1.231 0.102 1 C-N-CA 132.274 4.23 . . . . 0.0 103.403 179.765 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -122.57 125.56 45.95 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.594 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.34 99.92 5.84 Favored 'General case' 0 N--CA 1.444 -0.774 1 N-CA-C 100.04 -4.059 . . . . 0.0 100.04 176.355 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -102.94 85.66 2.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.601 1.56 . . . . 0.0 109.23 -177.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.21 -77.48 1.36 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.7 p -130.6 -33.63 1.62 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.303 1.441 . . . . 0.0 111.633 179.402 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -74.15 101.9 4.09 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.038 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -92.67 152.37 19.58 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.933 1.293 . . . . 0.0 111.379 -178.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -150.09 137.5 19.75 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.693 1.597 . . . . 0.0 108.677 178.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.1 p -71.56 154.0 41.76 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.216 1.407 . . . . 0.0 109.554 179.189 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.33 -22.59 12.51 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.1 t -72.1 -45.08 62.03 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 124.13 0.972 . . . . 0.0 109.279 179.391 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -69.69 -34.48 74.0 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.816 0.847 . . . . 0.0 113.159 179.524 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 85' ' ' TYR . 33.0 t -64.63 -50.69 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.075 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -60.83 -44.24 97.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.791 1.636 . . . . 0.0 110.67 -178.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.03 -52.29 56.79 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.896 0.478 . . . . 0.0 110.439 -179.115 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.38 73.53 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.222 1.009 . . . . 0.0 111.053 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.91 -39.69 42.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.258 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -66.73 -22.3 66.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.76 -64.19 1.21 Allowed 'General case' 0 C--N 1.348 0.519 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 -178.158 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.3 -34.88 16.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.664 0.786 . . . . 0.0 112.322 177.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -59.9 4.68 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.877 1.271 . . . . 0.0 109.547 178.622 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -64.63 -21.08 66.63 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.119 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -94.19 -20.68 19.64 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.602 1.161 . . . . 0.0 112.532 -178.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.411 ' CD1' ' HG3' ' A' ' 57' ' ' GLN . 9.7 t80 -74.31 -33.29 63.16 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.309 0.959 . . . . 0.0 112.841 -179.173 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -62.27 -14.68 41.32 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -178.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 t30 72.93 69.99 0.13 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.665 1.586 . . . . 0.0 111.025 177.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -136.12 58.24 1.75 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 178.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.8 t70 74.56 163.17 0.26 Allowed 'General case' 0 C--N 1.345 0.386 0 C-N-CA 126.91 2.084 . . . . 0.0 107.69 -177.588 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.3 p 54.45 56.5 6.78 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -151.07 158.12 43.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.262 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.37 73.72 0.44 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.698 1.618 . . . . 0.0 112.489 -179.428 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.1 p -72.45 -65.37 0.79 Allowed 'General case' 0 C--N 1.341 0.234 0 CA-C-N 117.876 0.838 . . . . 0.0 109.806 179.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.3 m -137.07 -58.16 0.71 Allowed 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 125.235 1.414 . . . . 0.0 107.771 178.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.0 t -157.35 40.94 0.31 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.72 1.208 . . . . 0.0 109.671 178.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -170.55 124.43 0.62 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 127.539 2.336 . . . . 0.0 106.666 179.355 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.36 140.52 66.73 Favored 'Cis proline' 0 N--CA 1.449 -1.106 0 CA-C-N 121.453 1.555 . . . . 0.0 109.657 -2.753 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -155.47 155.62 33.81 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.972 0.909 . . . . 0.0 109.355 179.602 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.9 p -66.39 152.99 43.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.55 0.74 . . . . 0.0 110.741 179.226 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.44 121.22 6.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.909 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -95.64 177.93 5.63 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.162 0.985 . . . . 0.0 111.223 -178.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -78.89 96.05 5.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.497 1.119 . . . . 0.0 109.166 -179.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -80.93 -98.23 0.04 OUTLIER 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.379 0.672 . . . . 0.0 110.111 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -158.55 35.7 0.23 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.333 0.653 . . . . 0.0 111.342 -179.369 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.75 -153.7 9.15 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.077 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.99 69.38 6.35 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 123.463 0.705 . . . . 0.0 109.953 178.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -75.65 118.63 18.68 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 178.629 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.03 117.74 39.14 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 125.448 1.499 . . . . 0.0 111.048 -177.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -78.5 89.55 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.125 2.55 . . . . 0.0 109.834 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 t -135.16 -63.52 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.328 0 C-N-CA 123.871 0.868 . . . . 0.0 110.621 -178.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 p30 -148.32 -122.48 0.06 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.35 1.06 . . . . 0.0 110.344 -179.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.28 132.55 2.29 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 118.35 -1.25 . . . . 0.0 110.738 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -68.04 -166.25 2.65 Favored 'Cis proline' 0 CA--C 1.538 0.689 0 CA-C-N 120.108 1.954 . . . . 0.0 114.369 -1.105 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -145.45 173.52 11.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.52 1.928 . . . . 0.0 108.255 179.386 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.411 ' HG3' ' CD1' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -148.01 143.05 26.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.059 0.544 . . . . 0.0 110.825 179.31 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -100.31 148.78 24.3 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.941 1.296 . . . . 0.0 111.263 179.34 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -158.39 127.46 3.1 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -75.54 147.26 31.74 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 CA-C-N 120.522 1.222 . . . . 0.0 112.27 -176.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.611 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 3.8 tp -79.4 -161.76 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 123.438 1.59 . . . . 0.0 110.869 -178.455 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.611 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 12.2 tttm -78.62 -163.84 0.51 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 111.321 -2.672 . . . . 0.0 111.64 -178.376 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.2 p 91.48 39.78 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 130.456 3.503 . . . . 0.0 107.277 -177.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.07 -54.56 0.24 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 108.386 -1.886 . . . . 0.0 108.386 -178.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.25 157.72 10.43 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.222 0.439 . . . . 0.0 112.169 179.123 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.486 HG12 ' CD2' ' A' ' 67' ' ' TYR . 24.1 t -127.26 120.94 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 179.061 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.486 ' CD2' HG12 ' A' ' 66' ' ' VAL 0.29 47.3 p90 58.17 43.36 20.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.581 2.352 . . . . 0.0 112.713 -177.935 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.4 t -148.83 -41.09 0.15 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.348 0.659 . . . . 0.0 111.194 -179.68 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.3 55.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.94 87.13 1.35 Allowed Glycine 0 C--N 1.339 0.749 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.0 m -59.28 142.55 86.24 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 123.929 0.892 . . . . 0.0 110.394 179.436 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.3 140.28 30.31 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.803 2.335 . . . . 0.0 108.482 176.501 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.64 -61.28 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 105.451 -3.06 . . . . 0.0 105.451 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -168.94 -55.82 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -178.656 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -62.95 109.84 1.59 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 117.959 2.577 . . . . 0.0 117.959 -177.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -129.41 153.87 47.49 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.764 0.825 . . . . 0.0 112.056 178.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.6 143.31 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 176.429 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 89' ' ' ILE . 83.8 t -137.05 136.24 47.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -175.659 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.3 pt -121.69 -177.71 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.376 0 C-N-CA 124.537 1.135 . . . . 0.0 113.606 -177.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -80.93 -175.2 5.25 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.133 2.173 . . . . 0.0 109.375 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.281 8.3 t -85.41 27.68 0.8 Allowed 'General case' 0 C--N 1.342 0.24 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 -178.328 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -150.62 -67.3 0.19 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.109 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.25 -14.61 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -176.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -78.91 128.65 33.59 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -175.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.489 ' CE2' ' CG1' ' A' ' 16' ' ' VAL . 16.3 t80 -60.11 136.41 58.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.631 1.173 . . . . 0.0 111.093 -179.186 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.24 -61.84 1.5 Allowed 'General case' 0 C--N 1.345 0.397 0 C-N-CA 124.422 1.089 . . . . 0.0 111.972 -178.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.14 170.05 42.82 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.115 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.67 145.89 46.98 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 125.039 1.336 . . . . 0.0 110.021 178.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.412 HD11 HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -144.28 162.63 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.352 1.061 . . . . 0.0 108.895 179.426 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 t -159.34 143.29 14.96 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -178.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -82.11 40.63 0.63 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.733 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -55.49 -31.32 61.92 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.946 -1.096 . . . . 0.0 113.224 -178.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.09 -69.61 0.02 OUTLIER Glycine 0 C--N 1.337 0.591 0 N-CA-C 106.614 -2.594 . . . . 0.0 106.614 178.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 50.67 -111.48 0.53 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.537 1.535 . . . . 0.0 111.546 178.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.1 m -157.13 77.3 0.87 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.456 1.502 . . . . 0.0 107.162 179.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.63 -105.34 2.39 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -101.61 22.93 11.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.333 1.053 . . . . 0.0 111.506 -179.351 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -89.86 177.46 6.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.502 0.721 . . . . 0.0 109.979 179.527 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -121.76 158.87 27.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.961 1.705 . . . . 0.0 110.899 -179.137 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.3 m -141.59 158.14 21.48 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.79 146.98 36.07 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.747 -178.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.2 t -89.5 -167.32 1.83 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.587 1.555 . . . . 0.0 107.274 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.8 m -63.66 121.27 13.52 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.749 0.419 . . . . 0.0 110.804 178.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.99 9.01 85.88 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.379 0.99 . . . . 0.0 113.917 179.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.5 m -91.93 137.57 32.26 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.434 1.117 . . . . 0.0 108.983 179.179 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 t30 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 116.458 -1.734 . . . . 0.0 110.915 179.333 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.56 141.71 0.05 Allowed 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 127.155 2.182 . . . . 0.0 111.163 -179.356 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -129.15 96.06 4.22 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.046 0.938 . . . . 0.0 111.48 -179.504 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -98.97 94.52 6.6 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 101.42 -3.548 . . . . 0.0 101.42 177.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 59.7 m -90.98 73.67 6.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.241 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.34 -99.67 1.73 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 -178.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.6 m -101.54 -39.43 7.52 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.29 1.436 . . . . 0.0 109.249 178.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.71 105.54 4.34 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.047 1.339 . . . . 0.0 108.555 -179.344 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -111.36 134.37 52.99 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.152 0.981 . . . . 0.0 112.481 -178.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.49 149.87 44.61 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.718 1.607 . . . . 0.0 107.186 178.514 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.0 m -72.72 155.24 40.18 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.317 1.047 . . . . 0.0 110.507 -179.018 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.1 -19.3 43.25 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 176.71 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.6 t -72.54 -40.79 66.45 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 124.954 1.302 . . . . 0.0 109.461 178.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -70.93 -35.23 72.15 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.029 0.532 . . . . 0.0 111.153 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.1 t -59.6 -48.31 87.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.643 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -65.74 -38.03 88.01 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.203 1.401 . . . . 0.0 111.431 179.51 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 -55.19 15.34 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 118.489 0.586 . . . . 0.0 110.168 -179.285 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.45 -31.3 70.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.073 0.949 . . . . 0.0 110.852 179.451 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.98 -44.78 46.34 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 118.905 -0.569 . . . . 0.0 111.558 179.032 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -60.62 -24.53 65.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.479 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.37 -51.53 10.67 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -178.451 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.81 -32.38 31.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.89 1.276 . . . . 0.0 110.886 177.125 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 64.3 m -70.8 -54.07 13.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.772 0.715 . . . . 0.0 110.536 178.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -58.56 -42.28 87.55 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.753 0.421 . . . . 0.0 111.162 -178.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -74.47 -44.2 52.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.485 1.114 . . . . 0.0 110.96 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 27' ' ' TYR . 2.1 t80 -55.23 -36.39 65.96 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.568 1.076 . . . . 0.0 108.789 179.034 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -71.33 -67.23 0.53 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 155.51 -6.34 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.904 2.481 . . . . 0.0 113.57 -179.068 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.01 56.02 1.9 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.738 1.153 . . . . 0.0 113.153 -178.469 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 138.36 115.77 0.0 OUTLIER 'General case' 0 C--N 1.344 0.349 1 C-N-CA 131.97 4.108 . . . . 0.0 108.525 178.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.3 p -95.95 63.9 2.36 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.687 0.795 . . . . 0.0 109.243 -179.462 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.39 -161.03 0.42 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.848 1.259 . . . . 0.0 110.53 -179.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 45.79 -120.47 4.43 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.394 1.949 . . . . 0.0 113.868 178.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.1 t -139.68 -92.01 0.17 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.04 0.936 . . . . 0.0 110.874 -179.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 m -161.93 -41.71 0.04 OUTLIER 'General case' 0 C--N 1.344 0.337 0 C-N-CA 124.174 0.99 . . . . 0.0 111.102 -178.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 64.2 p -79.78 37.33 0.35 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.511 1.124 . . . . 0.0 112.932 -178.703 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 163.4 117.62 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 131.237 3.815 . . . . 0.0 104.453 179.114 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.97 126.23 11.99 Favored 'Cis proline' 0 N--CA 1.447 -1.236 0 N-CA-C 110.273 -0.703 . . . . 0.0 110.273 0.046 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.91 147.29 27.02 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 125.342 1.457 . . . . 0.0 110.28 179.425 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.19 139.42 58.66 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.969 1.308 . . . . 0.0 112.082 179.256 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -140.2 158.48 43.98 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 123.362 0.414 . . . . 0.0 111.028 178.083 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -154.01 -179.71 8.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.724 1.21 . . . . 0.0 109.617 -178.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.2 m120 73.52 165.96 0.29 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 126.79 2.036 . . . . 0.0 112.476 178.832 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 61.71 72.23 0.52 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.51 1.524 . . . . 0.0 110.775 179.337 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -74.36 162.25 29.05 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.073 0.949 . . . . 0.0 110.897 -179.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -178.35 -65.58 0.07 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 179.414 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.6 164.53 11.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.165 1.786 . . . . 0.0 108.74 179.009 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -131.56 124.22 29.57 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.834 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.417 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 58.0 m-85 -89.95 154.49 47.54 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.711 1.204 . . . . 0.0 110.195 -178.799 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -45.8 -60.16 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 124.41 3.406 . . . . 0.0 114.125 179.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.1 m -76.81 152.92 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.663 0.785 . . . . 0.0 109.884 179.283 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -81.6 -80.1 0.16 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.756 0.822 . . . . 0.0 110.399 -179.179 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -175.12 171.26 44.43 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 118.853 -0.971 . . . . 0.0 111.147 179.545 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.11 157.95 27.13 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 119.799 1.8 . . . . 0.0 112.847 -1.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.637 ' CZ ' HG12 ' A' ' 78' ' ' VAL . 32.4 t80 -150.41 129.38 12.57 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.208 0.603 . . . . 0.0 109.698 -177.082 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -117.68 152.82 34.45 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -176.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -90.53 144.87 25.36 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.763 2.825 . . . . 0.0 111.041 -177.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -147.75 109.69 3.82 Favored Pre-proline 0 C--N 1.346 0.447 0 C-N-CA 123.409 0.683 . . . . 0.0 109.157 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -78.14 142.82 19.63 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.189 1.926 . . . . 0.0 115.996 -175.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.512 HG12 ' H ' ' A' ' 62' ' ' LYS . 1.2 tt -122.04 -165.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-O 124.177 1.942 . . . . 0.0 111.943 179.206 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.512 ' H ' HG12 ' A' ' 61' ' ' ILE . 79.6 tttt -161.55 -179.73 7.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 109.233 -3.622 . . . . 0.0 109.191 -179.319 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.5 t -87.33 62.03 6.98 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.19 67.66 0.91 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.126 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.39 101.63 0.16 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.97 133.68 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.993 0.917 . . . . 0.0 109.174 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 p90 43.8 46.09 6.39 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.152 1.781 . . . . 0.0 113.402 -178.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.8 t -150.01 163.74 37.33 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.725 0.81 . . . . 0.0 110.451 -179.499 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.87 155.63 32.14 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -178.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -179.7 86.27 0.07 OUTLIER Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -179.322 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 m -148.39 -68.95 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.458 1.103 . . . . 0.0 109.178 179.304 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.06 -45.86 0.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.082 1.854 . . . . 0.0 110.925 173.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.47 58.5 12.97 Favored Glycine 0 C--N 1.342 0.892 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.432 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -129.77 -58.57 1.09 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.317 1.047 . . . . 0.0 112.058 -178.381 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -56.91 109.44 0.64 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.184 2.594 . . . . 0.0 117.154 -178.031 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -147.95 122.13 9.55 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -179.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.0 m -81.13 160.67 3.92 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.662 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.637 HG12 ' CZ ' ' A' ' 56' ' ' TYR . 45.4 t -141.04 126.87 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 120.789 -1.195 . . . . 0.0 108.688 -178.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.2 pt -117.28 173.93 4.06 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 C-N-CA 125.176 1.39 . . . . 0.0 113.233 -177.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -79.54 -164.94 0.71 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 124.464 1.106 . . . . 0.0 111.182 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.427 0.6 OUTLIER -96.62 37.89 1.25 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 117.193 2.294 . . . . 0.0 117.193 -178.145 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -160.52 -78.4 0.05 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.2 t -163.32 63.92 0.18 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 113.619 -1.628 . . . . 0.0 114.125 -177.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -147.07 120.17 8.83 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.394 1.452 . . . . 0.0 113.744 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -65.84 122.45 17.35 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 177.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 50' ' ' PHE . . . -103.77 -39.37 6.68 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.69 -172.89 39.47 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.019 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.33 139.0 28.26 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.936 0.894 . . . . 0.0 109.912 179.252 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.0 pt -132.45 166.57 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.728 1.211 . . . . 0.0 110.439 -178.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.3 t -160.46 150.06 17.57 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.974 0.91 . . . . 0.0 111.664 179.357 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.432 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 34.0 m170 -79.35 55.26 1.86 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 118.453 0.57 . . . . 0.0 109.73 175.113 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.9 m -80.34 -85.39 0.09 Allowed 'General case' 0 C--N 1.342 0.259 0 O-C-N 120.766 -1.209 . . . . 0.0 109.318 179.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.412 ' H ' HG21 ' A' ' 100' ' ' VAL . . . -80.31 7.03 58.55 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.688 1.137 . . . . 0.0 112.006 179.011 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.92 162.87 23.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.17 1.388 . . . . 0.0 111.203 179.234 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.6 t -66.99 -48.8 67.35 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.567 0.747 . . . . 0.0 109.833 179.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.29 -51.08 0.2 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.298 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -87.52 -46.03 9.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.23 1.012 . . . . 0.0 110.597 -179.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -70.79 -171.23 0.5 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.626 0.77 . . . . 0.0 112.379 -179.109 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -137.07 172.05 13.59 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.014 1.325 . . . . 0.0 113.553 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.412 HG21 ' H ' ' A' ' 93' ' ' GLY . 12.8 m -140.02 161.44 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 127.659 2.384 . . . . 0.0 106.019 176.725 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.4 164.91 38.56 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 116.515 1.366 . . . . 0.0 116.515 -177.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.8 m -113.56 -175.08 2.59 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.76 2.024 . . . . 0.0 107.442 177.78 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.9 p -69.56 110.99 5.08 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.713 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.67 36.1 2.12 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.648 1.594 . . . . 0.0 110.078 -178.73 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.0 m -153.54 100.02 2.38 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.129 1.771 . . . . 0.0 107.129 179.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 116.782 -1.58 . . . . 0.0 108.257 -179.298 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 CA--C 1.532 0.28 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.18 149.56 6.9 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.718 1.207 . . . . 0.0 113.181 -178.661 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 t -148.92 156.41 42.25 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.812 0.845 . . . . 0.0 109.31 179.287 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.99 110.95 9.42 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.254 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 93.0 m -90.62 72.97 6.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.46 -93.06 0.89 Allowed Glycine 0 C--N 1.34 0.792 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.0 p -98.99 -36.38 9.75 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.884 1.274 . . . . 0.0 110.612 179.102 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -71.24 97.59 1.58 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.668 0.787 . . . . 0.0 110.116 -178.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -82.31 151.6 26.67 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.553 1.141 . . . . 0.0 110.617 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -144.53 129.89 18.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.899 0.88 . . . . 0.0 111.015 179.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.2 p -69.67 155.97 39.69 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 125.11 1.364 . . . . 0.0 108.047 177.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.63 -22.61 62.1 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 176.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.5 t -69.2 -40.85 77.79 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -68.83 -48.45 63.49 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.095 0.958 . . . . 0.0 112.915 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.2 t -61.25 -46.99 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -64.42 -39.16 93.3 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.775 0.83 . . . . 0.0 110.719 179.169 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.42 -52.03 56.18 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.63 0.65 . . . . 0.0 110.423 -179.052 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.573 ' HA ' HG13 ' A' ' 66' ' ' VAL . . . -61.14 -34.14 74.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.26 0.624 . . . . 0.0 111.554 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.81 -43.82 24.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -179.368 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -69.98 -14.81 62.88 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.72 -61.08 1.87 Allowed 'General case' 0 C--N 1.346 0.42 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.3 -36.35 14.01 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.687 1.195 . . . . 0.0 110.752 177.232 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -66.01 -63.47 1.08 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.958 1.303 . . . . 0.0 109.908 178.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -56.03 -28.88 59.25 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.537 0.735 . . . . 0.0 111.848 -178.789 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -79.61 -40.89 28.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.061 0.945 . . . . 0.0 111.486 179.148 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.462 ' CD2' ' HG3' ' A' ' 57' ' ' GLN . 23.9 t80 -101.25 23.88 10.3 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.799 0.84 . . . . 0.0 112.425 -178.298 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -86.0 14.6 5.95 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.942 -1.099 . . . . 0.0 112.076 179.176 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.3 m120 60.07 46.17 11.06 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.282 1.433 . . . . 0.0 111.527 178.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -154.72 73.03 0.88 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 80.62 110.67 0.07 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 127.617 2.367 . . . . 0.0 107.272 -178.128 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.6 t -87.66 -42.34 12.74 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.306 1.442 . . . . 0.0 113.332 -177.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 61.56 -171.46 0.15 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.628 1.171 . . . . 0.0 110.811 -178.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.35 167.07 39.3 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 121.96 -0.463 . . . . 0.0 112.326 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.9 t -148.99 -60.32 0.22 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.399 1.48 . . . . 0.0 107.685 179.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.4 p -124.55 -79.87 0.62 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.481 1.113 . . . . 0.0 108.125 178.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.488 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -160.39 41.65 0.18 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.233 1.013 . . . . 0.0 109.74 -179.0 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.488 ' CD1' ' C ' ' A' ' 37' ' ' THR . 43.0 m-85 -151.0 147.58 21.0 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 126.053 1.741 . . . . 0.0 107.993 -178.822 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.88 125.39 11.79 Favored 'Cis proline' 0 CA--C 1.539 0.75 0 CA-C-N 119.083 0.708 . . . . 0.0 111.726 0.219 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -119.14 165.61 13.96 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 125.994 1.717 . . . . 0.0 111.066 -179.269 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.8 p -67.8 145.83 54.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.443 0.697 . . . . 0.0 110.935 178.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -87.03 50.67 2.06 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.309 178.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -58.71 120.58 9.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.935 1.694 . . . . 0.0 108.052 179.751 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.7 m120 78.43 129.06 0.05 OUTLIER 'General case' 0 C--N 1.341 0.216 0 C-N-CA 126.42 1.888 . . . . 0.0 107.516 -178.223 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -82.41 20.43 1.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.346 -0.835 . . . . 0.0 112.691 -179.036 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 33.04 -99.13 0.02 OUTLIER 'General case' 0 C--N 1.347 0.485 0 C-N-CA 127.156 2.183 . . . . 0.0 112.025 179.437 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.45 23.16 2.84 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.572 1.082 . . . . 0.0 110.49 178.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.66 149.55 25.37 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 118.188 0.994 . . . . 0.0 111.271 -179.301 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -153.03 179.9 8.28 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.628 0.771 . . . . 0.0 111.701 -178.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -139.94 165.19 32.62 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 127.425 2.29 . . . . 0.0 106.552 -179.262 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.3 -51.86 10.14 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.435 2.756 . . . . 0.0 111.843 178.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 52' ' ' VAL . 3.7 m -82.24 151.17 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.803 1.241 . . . . 0.0 109.338 178.842 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -172.36 127.22 0.54 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.742 0.817 . . . . 0.0 112.613 -178.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.99 114.84 0.02 OUTLIER Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.008 1.766 . . . . 0.0 115.798 177.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -62.8 149.72 64.31 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.084 1.942 . . . . 0.0 109.85 -2.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.13 150.18 28.82 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.538 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.542 ' O ' HG13 ' A' ' 78' ' ' VAL . 63.0 mm-40 -133.4 157.82 44.57 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -178.115 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -112.01 151.04 29.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.715 2.406 . . . . 0.0 109.741 179.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -160.54 112.14 1.35 Allowed Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 177.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.434 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 24.3 Cg_endo -81.06 135.72 9.95 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.063 1.175 . . . . 0.0 111.08 -176.924 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.549 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.2 tt -109.32 178.13 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-O 124.22 1.962 . . . . 0.0 113.119 -179.419 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.549 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 19.9 ptmt -161.59 151.9 17.38 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 108.486 -3.961 . . . . 0.0 111.255 178.411 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.6 p -86.22 59.05 5.4 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.501 1.12 . . . . 0.0 108.656 179.462 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.92 71.82 0.06 OUTLIER Glycine 0 C--N 1.338 0.644 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.123 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.48 -178.83 47.64 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 123.942 0.782 . . . . 0.0 112.184 178.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.573 HG13 ' HA ' ' A' ' 19' ' ' ALA . 67.5 t -86.71 62.48 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.622 1.169 . . . . 0.0 109.924 -179.024 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 62.35 158.97 0.06 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.053 1.341 . . . . 0.0 114.287 178.646 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.9 p -138.53 -62.09 0.57 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.378 1.471 . . . . 0.0 108.435 178.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.38 -137.6 3.53 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.121 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.38 168.72 44.57 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.056 0.836 . . . . 0.0 113.145 178.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 m -74.11 174.5 4.89 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 125.815 1.646 . . . . 0.0 110.177 179.385 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -58.31 170.43 2.35 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.541 2.828 . . . . 0.0 112.804 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 74' ' ' ALA . . . -152.62 -69.54 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 103.953 -3.659 . . . . 0.0 103.953 -179.331 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . 170.75 -50.03 0.01 OUTLIER 'General case' 0 C--N 1.346 0.434 0 O-C-N 124.981 1.048 . . . . 0.0 113.296 -179.294 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -74.44 113.63 11.9 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 119.842 3.275 . . . . 0.0 119.842 -176.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 ptt180 -143.02 133.05 24.26 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.009 0.924 . . . . 0.0 110.552 177.772 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -90.48 147.04 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 178.308 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 57' ' ' GLN 0.254 78.0 t -133.61 123.83 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -176.791 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pt -105.75 -175.48 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.586 0 C-N-CA 126.455 1.902 . . . . 0.0 114.973 -177.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -112.82 145.21 41.02 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 128.903 2.881 . . . . 0.0 105.084 177.39 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.277 1.4 t -59.67 -16.84 29.34 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 120.783 3.623 . . . . 0.0 120.783 -177.072 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -79.61 -77.5 0.18 Allowed 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 103.625 -2.732 . . . . 0.0 103.625 178.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.53 -3.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.678 1.591 . . . . 0.0 114.598 -178.883 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.11 156.36 28.33 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 119.049 0.84 . . . . 0.0 111.151 -176.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -109.26 133.57 52.87 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.124 0.97 . . . . 0.0 110.709 -179.213 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.48 -64.84 1.08 Allowed 'General case' 0 C--N 1.342 0.268 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.042 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.25 168.4 37.0 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.183 -179.436 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.54 127.4 46.92 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.377 1.471 . . . . 0.0 109.638 -179.305 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 35.0 pt -120.52 154.61 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.656 1.182 . . . . 0.0 108.024 179.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.1 t -158.73 135.53 9.6 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -178.373 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.401 ' N ' ' HB1' ' A' ' 74' ' ' ALA . 4.0 p80 -105.9 52.88 0.72 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.018 0.372 . . . . 0.0 110.685 174.851 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.7 t -60.12 -48.01 83.51 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.134 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.01 42.65 0.2 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.91 -40.23 11.27 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.533 1.133 . . . . 0.0 109.673 179.094 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.9 t -152.64 -51.8 0.11 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.193 1.397 . . . . 0.0 109.834 -179.512 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.82 -37.48 1.02 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -178.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -126.0 -40.9 1.98 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.753 1.621 . . . . 0.0 110.031 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -64.45 124.01 20.7 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.053 0.541 . . . . 0.0 109.553 179.457 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -79.48 162.43 25.45 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.026 1.73 . . . . 0.0 112.06 -178.594 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.2 m -137.41 164.2 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 127.922 2.489 . . . . 0.0 105.979 176.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.74 137.88 15.19 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 123.134 0.397 . . . . 0.0 112.948 -177.751 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.4 m -81.58 -171.18 3.17 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.33 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.0 p -72.21 123.02 22.06 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.692 -0.63 . . . . 0.0 111.271 -177.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.77 38.15 28.22 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -178.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -148.75 127.78 12.76 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.054 1.342 . . . . 0.0 108.395 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.3 t30 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 116.524 -1.703 . . . . 0.0 109.041 179.336 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 CA--C 1.53 0.177 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.15 160.03 31.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.509 0.724 . . . . 0.0 110.645 -179.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 t -152.21 139.51 19.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.08 103.96 11.08 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 179.204 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.5 m -90.3 82.14 6.0 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.453 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.25 -111.0 3.47 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.165 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.4 t -88.31 -43.24 11.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.129 0.972 . . . . 0.0 109.64 178.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 m -69.98 106.29 3.15 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.463 1.105 . . . . 0.0 109.741 -179.294 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -86.38 157.99 19.73 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.089 0.956 . . . . 0.0 111.979 -179.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -144.3 136.8 26.71 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.624 1.17 . . . . 0.0 110.582 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.5 t -79.91 154.27 28.43 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 125.215 1.406 . . . . 0.0 109.78 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.25 -18.93 64.09 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 176.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.6 m -78.78 -38.84 37.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.014 0.925 . . . . 0.0 108.731 178.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -71.48 -48.57 48.3 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.613 1.565 . . . . 0.0 110.811 -179.201 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.4 t -58.96 -46.71 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.948 1.699 . . . . 0.0 107.571 177.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -64.89 -39.49 93.61 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 124.204 1.002 . . . . 0.0 111.412 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.26 -52.42 62.13 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.061 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.29 74.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.73 1.212 . . . . 0.0 110.921 179.564 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.22 -51.82 16.32 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.226 -179.205 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -60.68 -18.08 51.71 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.87 -64.71 1.12 Allowed 'General case' 0 C--N 1.347 0.5 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -178.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.478 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -43.93 -48.91 8.59 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.638 1.575 . . . . 0.0 110.495 177.494 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -55.51 -49.77 71.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 128.251 2.62 . . . . 0.0 111.268 178.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -68.11 -22.11 64.91 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.238 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -108.52 -19.47 13.43 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -179.117 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -71.87 -40.37 69.0 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -177.539 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -115.7 -28.18 6.83 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.04 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -67.57 -59.04 3.67 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.73 0.695 . . . . 0.0 110.228 -178.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 168.87 115.5 0.01 OUTLIER 'General case' 0 C--N 1.341 0.208 0 C-N-CA 128.192 2.597 . . . . 0.0 106.238 -178.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -54.85 127.25 27.7 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.341 1.057 . . . . 0.0 110.191 178.634 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.0 t -134.2 -51.4 0.82 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.684 0.794 . . . . 0.0 112.657 -178.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.56 172.82 8.91 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.917 0.487 . . . . 0.0 110.659 -179.426 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.87 82.27 0.52 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 107.908 -2.077 . . . . 0.0 107.908 179.056 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 p -168.14 101.35 0.45 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -176.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.5 p -128.63 -50.88 1.26 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.903 0.881 . . . . 0.0 109.678 -178.454 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 p -79.5 -6.34 56.75 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.572 0.749 . . . . 0.0 109.183 178.337 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -157.5 121.84 2.27 Favored Pre-proline 0 C--N 1.343 0.319 0 C-N-CA 128.147 2.579 . . . . 0.0 104.375 177.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.22 147.66 49.28 Favored 'Cis proline' 0 N--CA 1.453 -0.886 0 N-CA-C 117.468 2.065 . . . . 0.0 117.468 -0.091 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.98 136.7 37.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 128.162 2.585 . . . . 0.0 105.386 178.691 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.7 m -56.63 127.87 33.55 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.753 1.221 . . . . 0.0 110.067 179.078 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -79.85 78.24 6.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.561 1.144 . . . . 0.0 110.242 -178.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -80.66 -17.69 50.39 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.19 0.996 . . . . 0.0 112.535 179.46 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -79.33 149.89 31.61 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.683 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -168.43 89.68 0.25 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.681 1.992 . . . . 0.0 107.468 178.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -150.37 55.26 0.92 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.168 0.987 . . . . 0.0 108.689 179.818 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.07 -64.88 0.58 Allowed Glycine 0 C--N 1.338 0.651 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -179.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -99.92 132.92 44.98 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.401 1.08 . . . . 0.0 110.767 179.312 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -178.7 154.3 0.74 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 126.438 1.895 . . . . 0.0 109.428 178.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -123.26 105.37 34.05 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.503 1.121 . . . . 0.0 109.738 -178.087 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.23 84.83 1.93 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.519 2.812 . . . . 0.0 110.49 179.169 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.49 -72.64 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.226 0 C-N-CA 124.476 1.11 . . . . 0.0 110.908 179.191 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -133.71 -90.01 0.38 Allowed 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.516 0.598 . . . . 0.0 111.562 -179.114 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.81 131.97 4.28 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -178.515 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -71.98 -177.89 18.8 Favored 'Cis proline' 0 N--CA 1.456 -0.7 0 CA-C-N 119.686 1.743 . . . . 0.0 111.699 1.238 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.05 173.25 11.66 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.182 1.793 . . . . 0.0 106.231 179.184 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.4 146.32 22.43 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -178.666 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -81.25 156.14 25.75 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 126.575 1.95 . . . . 0.0 112.397 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.478 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 14.5 t80 -160.87 102.1 1.29 Allowed Pre-proline 0 N--CA 1.452 -0.333 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.441 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -77.82 115.2 3.78 Favored 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 122.674 2.25 . . . . 0.0 111.802 -177.572 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.44 HG13 ' H ' ' A' ' 62' ' ' LYS . 6.4 tt -89.64 173.76 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-O 123.767 1.746 . . . . 0.0 111.747 -179.095 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.44 ' H ' HG13 ' A' ' 61' ' ' ILE . 63.2 pttt -160.45 151.86 19.44 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 109.849 -3.341 . . . . 0.0 112.213 179.114 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 t -88.68 58.95 4.88 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.932 1.293 . . . . 0.0 110.126 -179.348 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 169.05 34.37 0.02 OUTLIER Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.177 -0.791 . . . . 0.0 112.858 179.182 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.97 176.63 17.2 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 118.014 0.907 . . . . 0.0 112.807 179.111 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.6 t -95.35 144.9 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.345 1.858 . . . . 0.0 107.932 179.333 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.6 p90 56.92 -172.95 0.08 Allowed 'General case' 0 C--N 1.345 0.401 0 C-N-CA 126.76 2.024 . . . . 0.0 113.118 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.8 t -137.34 166.79 22.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.707 1.203 . . . . 0.0 110.696 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.89 133.71 8.93 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.048 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.2 -64.52 4.18 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.36 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.5 p -164.6 168.26 9.19 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.618 1.167 . . . . 0.0 109.489 -179.18 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -58.57 -170.52 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.131 3.221 . . . . 0.0 112.521 167.251 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.0 -55.37 0.07 OUTLIER Glycine 0 C--N 1.341 0.856 0 N-CA-C 105.276 -3.129 . . . . 0.0 105.276 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.447 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -165.03 -63.52 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.637 0.775 . . . . 0.0 110.472 179.348 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -70.72 126.01 28.42 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.038 1.735 . . . . 0.0 113.961 -178.593 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -145.28 126.35 14.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.18 0.992 . . . . 0.0 111.747 -179.714 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.9 m -91.69 147.69 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 176.672 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.3 t -136.08 115.9 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -177.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.5 pt -89.92 -178.89 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.652 0 C-N-CA 124.506 1.123 . . . . 0.0 112.892 -178.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -124.49 58.34 1.22 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 124.678 2.18 . . . . 0.0 112.549 -177.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.258 5.9 t 46.58 -21.31 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.245 1 C-N-CA 134.571 5.148 . . . . 0.0 121.707 177.499 . . . . . . . . 3 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -79.47 -74.16 0.31 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 178.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.47 -13.74 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.627 1.971 . . . . 0.0 114.078 -179.207 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -79.47 125.53 29.67 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.777 1.231 . . . . 0.0 113.795 -176.385 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -68.46 115.9 8.39 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.643 2.377 . . . . 0.0 109.453 178.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.26 -60.68 2.23 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 124.741 1.216 . . . . 0.0 111.239 -178.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.57 156.77 28.93 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.375 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.99 137.27 52.26 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.1 0.96 . . . . 0.0 109.273 -179.252 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.3 pt -125.43 156.77 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.3 1.44 . . . . 0.0 107.824 -179.455 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -158.85 150.05 20.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 33.2 m170 -79.03 -21.57 46.69 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 123.423 0.452 . . . . 0.0 111.251 176.093 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.3 m -59.65 109.03 0.82 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.032 1.333 . . . . 0.0 109.91 179.287 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.78 -29.49 8.9 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.762 1.172 . . . . 0.0 111.329 -179.236 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.4 -176.45 2.69 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.667 1.187 . . . . 0.0 111.95 -179.294 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -83.65 54.98 3.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.686 1.194 . . . . 0.0 111.614 -179.416 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.69 -74.47 1.55 Allowed Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.606 1.098 . . . . 0.0 113.055 178.634 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -80.05 -44.77 19.51 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.863 1.265 . . . . 0.0 111.03 -179.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -51.52 166.58 0.12 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.835 1.654 . . . . 0.0 113.459 -178.652 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -121.3 156.65 32.08 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.339 1.456 . . . . 0.0 112.308 -178.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.5 m -144.56 164.67 13.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 126.844 2.058 . . . . 0.0 107.139 177.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.75 138.76 14.54 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 123.679 0.657 . . . . 0.0 112.082 -178.261 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 34.0 m -82.24 -171.39 3.4 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.498 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.1 t -75.83 123.08 25.06 Favored 'General case' 0 C--N 1.341 0.197 0 O-C-N 121.833 -0.542 . . . . 0.0 109.611 -179.026 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.62 52.15 3.25 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -178.755 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.8 m -147.41 121.39 9.4 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.614 1.566 . . . . 0.0 106.833 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.7 t30 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 125.307 1.443 . . . . 0.0 110.685 -179.247 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.81 148.17 25.99 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.228 1.011 . . . . 0.0 109.857 179.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 t -150.18 156.27 41.29 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.66 128.5 42.72 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.249 1.82 . . . . 0.0 106.186 178.754 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -116.72 90.08 3.25 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.46 -86.4 1.03 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -178.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.1 m -127.77 -16.05 4.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.642 1.577 . . . . 0.0 111.364 178.759 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -81.55 98.55 8.36 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.182 0.993 . . . . 0.0 109.627 -179.164 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -80.08 155.8 27.37 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.112 0.965 . . . . 0.0 110.685 179.449 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -147.06 141.45 26.37 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.924 1.29 . . . . 0.0 110.782 179.294 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 p -78.21 148.38 34.02 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 177.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.61 -23.37 16.75 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.182 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.0 t -67.63 -44.52 77.77 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.54 0.736 . . . . 0.0 109.603 179.451 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -69.6 -41.03 76.27 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -178.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.431 HG23 ' H ' ' A' ' 16' ' ' VAL . 2.2 t -61.75 -54.59 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -179.449 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.8 mtp85 -66.78 -34.92 78.88 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.795 1.238 . . . . 0.0 112.225 -178.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.79 -44.34 86.03 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 118.768 0.713 . . . . 0.0 109.737 179.366 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.19 80.48 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.08 0.552 . . . . 0.0 110.155 178.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.26 -40.46 62.33 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 119.109 -0.472 . . . . 0.0 112.252 178.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -66.01 -21.05 66.37 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.39 1.68 Allowed 'General case' 0 C--N 1.344 0.363 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -46.4 -44.22 16.97 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 124.376 1.047 . . . . 0.0 110.83 176.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.7 t -55.02 -51.17 67.1 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.045 1.738 . . . . 0.0 111.361 179.243 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -63.99 -48.41 76.49 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.629 0.65 . . . . 0.0 112.012 -178.848 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -68.84 -32.58 72.37 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -63.75 -39.05 93.33 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.443 0.565 . . . . 0.0 111.626 -178.061 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -99.82 -49.18 4.44 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -178.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -75.46 -45.58 37.69 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -176.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -158.36 94.05 1.26 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.593 0.633 . . . . 0.0 110.609 -178.014 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.37 104.95 2.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.43 179.352 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.257 5.0 t 165.0 83.26 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.691 2.796 . . . . 0.0 110.812 -179.218 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -177.69 103.6 0.05 OUTLIER 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.493 1.517 . . . . 0.0 107.423 179.12 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 153.19 -179.24 29.75 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.1 m -50.41 -52.04 41.15 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.954 1.301 . . . . 0.0 112.117 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.3 t -165.22 -61.56 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.856 0.862 . . . . 0.0 108.742 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -126.94 75.97 1.61 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.024 1.33 . . . . 0.0 108.309 -179.514 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 86.3 m-85 -157.68 111.15 1.81 Allowed Pre-proline 0 C--O 1.23 0.053 0 N-CA-C 102.524 -3.139 . . . . 0.0 102.524 179.073 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.98 142.18 63.64 Favored 'Cis proline' 0 CA--C 1.536 0.611 0 N-CA-C 116.37 1.642 . . . . 0.0 116.37 2.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -157.77 152.92 25.73 Favored 'General case' 0 C--N 1.345 0.37 0 C-N-CA 127.238 2.215 . . . . 0.0 109.895 178.238 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 p -41.73 138.89 1.32 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 126.307 1.843 . . . . 0.0 114.233 -178.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -138.97 59.04 1.63 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.332 1.453 . . . . 0.0 108.399 179.308 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -154.62 2.02 0.21 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.919 0.888 . . . . 0.0 112.882 -179.158 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -63.99 -52.43 59.67 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.543 0.737 . . . . 0.0 110.188 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -109.83 127.55 54.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.041 1.337 . . . . 0.0 108.317 178.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -85.89 164.34 17.53 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.834 0.854 . . . . 0.0 109.704 179.408 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.38 -77.88 0.36 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 107.052 -2.419 . . . . 0.0 107.052 -179.231 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.99 89.46 8.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.751 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -147.39 143.08 27.7 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.482 1.513 . . . . 0.0 108.26 179.501 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -95.44 154.16 39.4 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 125.073 1.349 . . . . 0.0 109.989 -178.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.83 81.81 2.09 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.37 3.38 . . . . 0.0 111.425 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.4 169.7 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 125.927 1.691 . . . . 0.0 108.559 179.459 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -92.34 121.17 33.57 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.42 -177.45 51.91 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.651 0.643 . . . . 0.0 112.961 -179.041 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.99 161.35 87.03 Favored 'Cis proline' 0 CA--C 1.534 0.502 0 CA-C-N 117.536 0.668 . . . . 0.0 113.789 0.139 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.47 153.86 50.93 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 126.332 1.853 . . . . 0.0 106.746 178.788 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.74 153.35 47.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 123.703 0.627 . . . . 0.0 111.536 -178.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -84.48 163.81 19.2 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -160.4 110.1 1.36 Allowed Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 178.396 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 23.0 Cg_endo -80.35 125.95 5.96 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.906 1.737 . . . . 0.0 114.989 -175.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.425 HG13 ' H ' ' A' ' 62' ' ' LYS . 9.3 tt -87.79 159.1 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-O 124.45 2.071 . . . . 0.0 112.668 179.014 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.425 ' H ' HG13 ' A' ' 61' ' ' ILE . 3.1 mptp? -135.62 135.88 40.56 Favored 'General case' 0 C--N 1.316 -0.868 1 CA-C-N 107.974 -4.194 . . . . 0.0 109.486 -177.991 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t -87.52 59.82 5.68 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.094 1.358 . . . . 0.0 109.993 -179.179 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.36 50.41 0.03 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.251 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.0 153.32 26.32 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.621 1.105 . . . . 0.0 110.378 -179.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.5 p -74.3 115.47 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.276 1.03 . . . . 0.0 110.868 -179.104 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.0 t80 53.15 76.95 0.18 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 125.535 1.534 . . . . 0.0 110.677 -179.26 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.0 p -138.73 64.02 1.5 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.468 1.107 . . . . 0.0 110.515 -178.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.11 -86.91 0.89 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.96 0.79 . . . . 0.0 111.97 178.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.83 -93.58 0.4 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.458 1.028 . . . . 0.0 110.613 -179.072 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.8 t 74.48 133.1 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 127.066 2.146 . . . . 0.0 111.593 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -67.72 -51.71 0.16 OUTLIER 'Cis proline' 0 C--N 1.348 0.532 0 CA-C-N 119.731 0.94 . . . . 0.0 112.042 -5.198 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.96 61.27 0.19 Allowed Glycine 0 C--N 1.341 0.856 0 C-N-CA 124.517 1.056 . . . . 0.0 111.594 179.379 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -79.06 -41.86 27.79 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.559 0.743 . . . . 0.0 109.05 178.441 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -70.3 111.49 5.93 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.085 1.754 . . . . 0.0 112.426 -178.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.05 128.88 46.99 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.959 0.903 . . . . 0.0 113.048 -178.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.0 m -100.34 148.36 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 102.595 -3.113 . . . . 0.0 102.595 176.04 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.5 t -140.13 135.96 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 O-C-N 121.873 -0.517 . . . . 0.0 109.651 -176.83 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.5 pt -126.46 165.55 24.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.308 0 C-N-CA 124.107 0.963 . . . . 0.0 111.865 -178.683 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -81.35 165.97 20.88 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 127.268 2.227 . . . . 0.0 108.186 178.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.356 12.2 t -64.77 -19.71 65.96 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 118.634 2.827 . . . . 0.0 118.634 -178.128 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -79.59 -85.54 0.08 Allowed 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 101.067 -3.679 . . . . 0.0 101.067 176.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 98.3 m -164.57 8.14 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 130.438 3.495 . . . . 0.0 112.832 -178.703 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -78.86 134.65 36.92 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 120.171 1.351 . . . . 0.0 111.798 -176.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.422 ' CE2' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -70.84 120.18 16.05 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.873 0.469 . . . . 0.0 110.09 -178.952 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.64 -48.95 7.86 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.178 0.991 . . . . 0.0 110.175 -179.082 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.12 -179.48 46.36 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-O 121.16 0.311 . . . . 0.0 112.686 179.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.0 135.24 45.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.842 2.057 . . . . 0.0 107.771 179.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.4 pt -146.61 171.67 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.785 1.234 . . . . 0.0 110.553 -178.392 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.5 t -160.06 151.77 20.03 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 179.349 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.445 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 9.0 m170 -79.28 -13.12 59.86 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 175.188 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.4 m -60.92 109.17 0.99 Allowed 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.003 1.321 . . . . 0.0 110.295 -179.333 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.5 59.46 5.27 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.407 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.52 -124.65 0.22 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.709 1.204 . . . . 0.0 108.558 179.467 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.5 m -149.16 73.17 1.19 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.793 1.237 . . . . 0.0 107.95 179.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.72 -104.86 1.61 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 179.587 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -79.8 -22.72 42.75 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.114 0.966 . . . . 0.0 111.18 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -56.16 159.07 3.62 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.577 1.151 . . . . 0.0 111.35 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -114.74 163.51 15.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.96 1.704 . . . . 0.0 111.854 -178.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.4 m -141.07 160.85 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 C-N-CA 126.228 1.811 . . . . 0.0 107.092 176.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.02 141.2 20.65 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 123.838 0.732 . . . . 0.0 114.158 -178.092 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -83.35 179.73 7.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 177.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.9 m -70.31 131.04 43.54 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.205 -0.935 . . . . 0.0 110.598 179.566 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.17 15.72 80.98 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.032 0.825 . . . . 0.0 113.712 179.322 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.3 m -80.01 131.71 35.85 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.323 1.061 . . . . 0.0 108.695 179.306 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 p30 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.816 -1.088 . . . . 0.0 110.558 -179.309 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.31 154.35 0.13 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 126.831 2.052 . . . . 0.0 112.52 179.015 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.4 t -152.81 123.43 7.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.573 179.066 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -96.79 109.74 22.36 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 178.901 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.8 m -87.7 63.21 7.41 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.468 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.55 -91.54 0.4 Allowed Glycine 0 C--N 1.342 0.886 0 C-N-CA 126.03 1.776 . . . . 0.0 109.08 -178.761 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.3 p -92.82 -47.98 6.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.396 1.079 . . . . 0.0 109.817 179.13 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.2 m -66.83 100.01 0.67 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.488 1.515 . . . . 0.0 108.168 179.388 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -88.4 148.2 24.35 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.12 0.568 . . . . 0.0 111.978 -178.783 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -136.44 135.74 38.93 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 123.996 0.918 . . . . 0.0 111.249 178.606 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.7 m -82.46 150.34 27.1 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 126.571 1.948 . . . . 0.0 108.647 178.62 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.61 -21.86 29.95 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.137 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 84.2 p -72.96 -46.71 50.82 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.565 0.746 . . . . 0.0 109.529 179.455 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -69.08 -38.72 79.17 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.761 1.224 . . . . 0.0 111.418 -179.307 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.3 t -57.98 -53.19 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.836 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -33.37 75.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.67 1.588 . . . . 0.0 112.032 -179.336 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.11 -57.63 8.11 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.018 0.527 . . . . 0.0 109.725 -178.678 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.84 -26.75 67.8 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 123.538 0.523 . . . . 0.0 110.953 -179.295 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.01 -54.03 12.67 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.867 0.758 . . . . 0.0 111.035 179.248 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -61.2 -19.91 62.16 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.191 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.73 -67.95 0.62 Allowed 'General case' 0 C--N 1.349 0.574 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 -178.085 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.48 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -39.54 -46.07 1.68 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.625 1.17 . . . . 0.0 112.19 176.532 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 74.4 m -55.28 -68.49 0.19 Allowed 'General case' 0 C--N 1.346 0.417 0 C-N-CA 123.379 0.672 . . . . 0.0 110.342 179.366 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -53.81 -31.09 47.79 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.833 1.253 . . . . 0.0 112.928 -176.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -79.49 -48.0 14.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -179.066 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.37 0.1 OUTLIER -91.85 -2.58 56.79 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 119.381 3.104 . . . . 0.0 119.381 -176.539 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -57.04 -52.48 65.12 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.011 1.278 . . . . 0.0 109.382 178.975 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 152.03 66.14 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 130.438 3.495 . . . . 0.0 105.561 179.553 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -165.32 98.38 0.71 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.551 1.14 . . . . 0.0 107.984 -178.915 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.266 4.4 p30 52.27 -165.92 0.06 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.236 1.815 . . . . 0.0 111.982 -179.203 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.1 t -152.57 -49.12 0.1 Allowed 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.646 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 55.82 84.07 0.08 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 125.063 1.345 . . . . 0.0 109.396 -178.238 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.23 162.48 6.03 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.24 1.4 . . . . 0.0 111.849 -178.856 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.1 p -176.98 102.84 0.05 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.979 1.311 . . . . 0.0 108.915 -179.231 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.8 m -68.64 -67.46 0.47 Allowed 'General case' 0 C--N 1.34 0.167 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.895 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.6 p -147.45 18.91 1.19 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.468 1.907 . . . . 0.0 108.502 178.008 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -144.34 154.95 57.73 Favored Pre-proline 0 C--N 1.348 0.528 0 C-N-CA 129.798 3.239 . . . . 0.0 105.95 -178.297 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -80.38 111.41 2.24 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 CA-C-N 120.932 1.369 . . . . 0.0 113.58 3.855 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -122.27 158.86 28.58 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.426 1.491 . . . . 0.0 108.441 179.114 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -63.26 154.84 30.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.701 1.6 . . . . 0.0 108.617 178.755 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -77.97 119.78 21.9 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.296 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.27 145.91 10.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.937 2.095 . . . . 0.0 114.2 -178.152 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -73.44 148.17 43.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.381 1.472 . . . . 0.0 110.1 179.495 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.7 t80 74.22 146.15 0.08 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.764 2.025 . . . . 0.0 110.972 179.411 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 58.35 53.0 6.7 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.568 1.147 . . . . 0.0 108.933 -178.599 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.23 106.84 2.03 Favored Glycine 0 C--N 1.339 0.729 0 C-N-CA 124.751 1.167 . . . . 0.0 112.324 -178.698 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -73.31 106.99 5.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 178.494 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -53.88 120.99 7.05 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.069 1.347 . . . . 0.0 113.109 -178.4 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -132.75 151.96 79.03 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.351 1.861 . . . . 0.0 108.217 179.081 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.57 166.98 28.3 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.505 2.803 . . . . 0.0 112.464 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.273 22.9 m 55.03 171.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 129.03 2.932 . . . . 0.0 115.445 179.321 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -81.2 153.59 27.11 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.971 1.308 . . . . 0.0 111.999 -178.847 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.77 -147.73 23.1 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.527 1.537 . . . . 0.0 110.251 179.202 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.39 133.21 17.27 Favored 'Cis proline' 0 N--CA 1.458 -0.605 0 CA-C-N 118.847 1.324 . . . . 0.0 110.031 -1.782 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -108.62 140.53 41.87 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.935 0.894 . . . . 0.0 111.847 179.343 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -122.91 159.17 28.79 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.051 1.741 . . . . 0.0 109.613 -179.027 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -87.7 159.59 18.44 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.561 1.544 . . . . 0.0 111.928 -178.553 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.48 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 18.4 t80 -160.41 109.74 1.36 Allowed Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.267 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -79.11 129.65 8.93 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 121.88 1.72 . . . . 0.0 111.151 -177.178 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.549 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.2 tt -87.71 -176.83 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-O 123.796 1.76 . . . . 0.0 110.237 179.096 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.549 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -152.52 141.24 20.94 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 110.07 -3.241 . . . . 0.0 111.623 -179.095 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 t -81.41 57.73 3.38 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.948 1.699 . . . . 0.0 109.942 179.647 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.21 45.54 0.08 OUTLIER Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.282 1.42 . . . . 0.0 112.008 179.059 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.76 176.36 26.08 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 117.884 0.842 . . . . 0.0 112.782 179.052 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 t -132.15 139.06 51.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.322 1.449 . . . . 0.0 108.278 178.961 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.263 26.4 p90 46.42 52.51 10.68 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.351 2.261 . . . . 0.0 114.487 179.473 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.9 p -80.49 -44.34 19.34 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.837 -0.539 . . . . 0.0 110.184 179.06 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.2 56.77 1.44 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.09 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -117.33 73.44 0.28 Allowed Glycine 0 C--N 1.34 0.793 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.485 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 92.0 p -71.17 152.16 94.6 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 124.082 0.953 . . . . 0.0 110.717 -179.938 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.98 -43.17 0.69 Allowed 'Cis proline' 0 N--CA 1.457 -0.672 0 CA-C-N 119.196 0.748 . . . . 0.0 110.904 -4.129 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.87 -54.61 3.7 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 179.187 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . 64.3 43.97 4.52 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.632 1.173 . . . . 0.0 110.312 -178.678 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.83 101.19 1.29 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.641 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.28 148.56 50.82 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.251 0.621 . . . . 0.0 111.398 -179.032 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.1 m -111.26 144.32 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 176.909 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.17 121.83 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 -177.673 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.478 HG22 ' HA ' ' A' ' 85' ' ' TYR . 3.2 pt -127.12 167.84 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.615 -176.517 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -94.31 166.99 11.82 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 123.996 0.918 . . . . 0.0 110.809 -179.641 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.432 1.9 t -73.29 8.51 1.67 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 121.396 3.851 . . . . 0.0 121.396 -177.07 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -91.05 -94.88 0.12 Allowed 'General case' 0 N--CA 1.437 -1.101 1 N-CA-C 93.486 -6.487 . . . . 0.0 93.486 174.859 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . 0.353 9.8 t -165.93 54.29 0.1 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 127.634 2.374 . . . . 0.0 111.44 176.955 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -136.06 127.64 28.82 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 120.186 1.357 . . . . 0.0 112.957 -178.063 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.478 ' HA ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -69.2 121.61 17.14 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 127.264 2.226 . . . . 0.0 108.138 179.055 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.63 -54.55 2.6 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 123.552 0.741 . . . . 0.0 111.774 -178.605 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -119.15 155.32 16.11 Favored Glycine 0 C--N 1.341 0.853 0 C-N-CA 124.428 1.014 . . . . 0.0 113.907 -178.72 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.91 102.07 3.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 178.539 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.9 pt -112.75 157.05 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.903 0.881 . . . . 0.0 111.633 -178.293 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.2 t -155.89 155.32 32.67 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.083 1.353 . . . . 0.0 112.197 -178.368 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.501 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 38.6 m170 -80.34 3.78 20.01 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 119.156 -0.45 . . . . 0.0 110.954 177.208 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -43.64 -39.59 3.65 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -177.671 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.46 44.44 1.22 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.573 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -110.83 155.16 22.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.315 1.446 . . . . 0.0 110.924 -179.769 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.8 t -89.84 61.29 5.3 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.536 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.9 -86.93 0.96 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.659 1.123 . . . . 0.0 112.381 179.028 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -96.91 -6.17 36.35 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -178.073 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -69.26 -173.44 0.54 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.191 0.905 . . . . 0.0 110.592 -179.401 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -147.0 153.89 40.59 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.182 0.593 . . . . 0.0 111.379 -178.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.1 m -142.55 163.66 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 126.483 1.913 . . . . 0.0 107.57 178.129 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.85 152.35 28.54 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.701 0.667 . . . . 0.0 114.056 -177.928 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 51.8 m -87.71 -168.27 2.17 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.92 1.288 . . . . 0.0 108.331 178.191 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.2 t -68.35 112.92 5.51 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.036 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.58 50.21 4.31 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.258 0.932 . . . . 0.0 110.802 -179.201 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.4 m -147.9 97.75 2.85 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.06 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 116.585 -1.674 . . . . 0.0 108.833 -179.385 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 54.69 81.13 0.11 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 125.533 1.533 . . . . 0.0 109.29 -179.405 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.405 HG22 ' CG2' ' A' ' 16' ' ' VAL . 7.5 t -105.35 138.12 42.05 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.362 0.665 . . . . 0.0 111.977 -177.37 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.94 125.34 52.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.292 1.837 . . . . 0.0 109.773 179.405 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -105.87 71.27 0.89 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 178.841 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.17 -80.73 1.49 Allowed Glycine 0 C--N 1.342 0.889 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 -178.868 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.1 t -123.64 -30.49 3.6 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.975 1.71 . . . . 0.0 110.757 178.943 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 m -70.36 92.0 0.78 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.126 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -89.15 145.06 25.68 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.477 1.511 . . . . 0.0 114.074 -177.819 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -141.48 134.93 29.71 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.243 1.417 . . . . 0.0 111.682 178.376 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.6 m -72.32 156.57 38.96 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 126.057 1.743 . . . . 0.0 108.618 177.677 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.21 -22.88 44.01 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.029 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 98.3 p -76.45 -34.45 58.72 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.916 -179.143 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -75.55 -38.21 59.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.418 1.487 . . . . 0.0 111.617 -179.526 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.405 ' CG2' HG22 ' A' ' 4' ' ' THR . 43.1 t -63.42 -47.99 89.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.264 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -64.15 -32.1 73.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.7 1.6 . . . . 0.0 111.532 179.094 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.34 -56.65 7.8 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.078 0.551 . . . . 0.0 109.888 -179.081 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.5 -27.86 68.11 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 123.105 0.253 . . . . 0.0 110.551 179.656 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.34 -44.68 67.7 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.299 -0.876 . . . . 0.0 110.088 178.586 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -68.83 -17.51 64.02 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.338 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.32 -69.24 0.57 Allowed 'General case' 0 C--N 1.346 0.424 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 -178.387 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.511 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -38.1 -58.13 0.99 Allowed 'General case' 0 CA--C 1.537 0.463 0 O-C-N 124.527 1.142 . . . . 0.0 112.438 175.93 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.5 t -56.23 -40.9 74.81 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 123.835 0.854 . . . . 0.0 112.668 -178.952 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -87.24 -2.96 59.0 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 179.442 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -117.26 -63.15 1.48 Allowed 'General case' 0 C--N 1.347 0.5 0 CA-C-N 120.163 1.347 . . . . 0.0 114.097 -178.616 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -49.98 -42.2 48.41 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.894 1.278 . . . . 0.0 111.99 -177.036 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -103.85 14.11 31.51 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -177.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -154.51 62.95 0.68 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.176 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 63.24 91.03 0.07 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.174 1.79 . . . . 0.0 109.206 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -57.06 112.69 1.42 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.556 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.9 t -97.65 -34.63 10.87 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.348 1.459 . . . . 0.0 107.593 178.284 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.53 97.9 7.36 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.512 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -142.49 52.07 0.66 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.359 0.98 . . . . 0.0 111.155 -179.088 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 m -71.95 -53.06 14.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.501 0.72 . . . . 0.0 109.789 178.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.5 m -111.38 -162.07 0.78 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.037 1.335 . . . . 0.0 107.98 -179.063 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.4 t -83.08 49.9 1.63 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.98 0.912 . . . . 0.0 109.747 179.145 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -140.79 142.82 29.68 Favored Pre-proline 0 C--N 1.342 0.257 0 C-N-CA 126.311 1.845 . . . . 0.0 106.638 -179.026 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -69.6 145.68 79.73 Favored 'Cis proline' 0 CA--C 1.535 0.56 0 N-CA-C 115.053 1.136 . . . . 0.0 115.053 2.917 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.57 140.2 49.39 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -177.514 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.3 m -57.12 120.07 7.41 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 127.359 2.263 . . . . 0.0 110.564 178.983 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -79.43 99.56 7.25 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.656 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -140.53 61.83 1.5 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.215 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -105.63 -178.67 3.72 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.231 1.412 . . . . 0.0 109.183 -179.584 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -67.78 102.92 1.31 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.954 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.3 144.21 42.07 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.575 0.75 . . . . 0.0 111.501 -179.102 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.68 68.28 0.16 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 107.849 -2.101 . . . . 0.0 107.849 -178.938 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -162.65 173.01 14.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.51 1.124 . . . . 0.0 109.331 -179.627 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -59.93 162.85 5.11 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.591 1.156 . . . . 0.0 111.171 178.904 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 49.4 p90 44.65 53.7 11.63 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 126.239 1.816 . . . . 0.0 113.134 -179.345 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.75 -47.74 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.606 2.204 . . . . 0.0 110.834 -179.239 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.4 t 57.58 -100.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.768 1.627 . . . . 0.0 109.995 -179.577 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 p30 178.8 -45.61 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.437 1.895 . . . . 0.0 108.952 -179.382 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.89 -158.83 41.2 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.781 0.705 . . . . 0.0 112.362 179.199 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.01 130.35 1.67 Allowed 'Cis proline' 0 N--CA 1.46 -0.472 0 CA-C-N 118.372 1.086 . . . . 0.0 113.423 1.549 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -134.25 141.93 47.16 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.834 0.854 . . . . 0.0 109.412 179.391 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -132.07 164.94 25.13 Favored 'General case' 0 C--N 1.344 0.359 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -177.372 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -79.86 153.25 29.19 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.934 2.093 . . . . 0.0 112.059 -178.942 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.511 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 52.5 t80 -160.39 106.43 1.36 Allowed Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 178.731 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -67.71 141.96 56.46 Favored 'Trans proline' 0 N--CA 1.441 -1.584 0 CA-C-N 120.302 1.144 . . . . 0.0 110.676 -176.81 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.42 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -90.03 -145.21 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-O 122.972 1.368 . . . . 0.0 111.972 -177.607 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.42 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 36.0 ttpt -79.77 149.51 31.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.381 -179.022 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.0 t 170.09 48.28 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.455 1 C-N-CA 132.088 4.155 . . . . 0.0 103.641 178.482 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.58 -46.26 1.07 Allowed Glycine 0 CA--C 1.534 1.229 0 N-CA-C 105.984 -2.846 . . . . 0.0 105.984 -177.45 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.4 165.22 25.43 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.433 1.016 . . . . 0.0 111.742 178.68 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.59 131.31 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.514 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.9 t80 57.2 83.34 0.11 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.703 1.201 . . . . 0.0 110.845 -179.381 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.5 p -131.54 -48.61 0.98 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.465 1.106 . . . . 0.0 111.753 -179.076 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.56 51.78 3.18 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -178.782 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.16 47.69 0.07 OUTLIER Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.533 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.5 t -69.52 -59.58 4.68 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.376 1.07 . . . . 0.0 111.252 179.567 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -82.32 -26.18 9.15 Favored 'Cis proline' 0 C--N 1.347 0.483 0 CA-C-N 121.573 1.597 . . . . 0.0 112.246 -6.2 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.29 -160.49 22.56 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.562 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.758 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . 69.21 21.71 7.03 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 126.349 1.86 . . . . 0.0 112.331 -178.912 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.4 91.69 0.61 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.986 1.314 . . . . 0.0 107.926 179.099 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.8 mtt85 -138.3 134.05 33.83 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.334 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 m -93.74 153.05 3.43 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 177.065 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.96 120.11 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -178.867 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -110.48 174.04 2.05 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 C-N-CA 125.015 1.326 . . . . 0.0 114.073 -177.645 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -100.55 154.62 18.41 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.755 2.422 . . . . 0.0 108.544 179.054 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.283 3.3 t -71.92 0.93 8.0 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -178.599 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -86.0 -83.22 0.18 Allowed 'General case' 0 N--CA 1.441 -0.888 1 N-CA-C 100.115 -4.031 . . . . 0.0 100.115 177.07 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.7 t -165.08 -4.29 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.295 2.238 . . . . 0.0 114.157 177.619 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -79.35 130.59 35.59 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -175.098 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -78.64 117.89 20.23 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.82 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.59 -59.73 2.63 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.344 0.658 . . . . 0.0 111.862 -177.557 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.45 156.83 17.82 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 179.61 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.49 155.27 18.38 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.588 1.155 . . . . 0.0 111.748 -179.249 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.5 pt -136.62 165.3 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 125.241 1.416 . . . . 0.0 110.802 179.28 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.1 t -159.32 144.84 16.0 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.666 0.786 . . . . 0.0 112.787 -178.774 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.758 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -82.42 -37.24 25.78 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.618 0.767 . . . . 0.0 111.073 177.892 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 m -49.97 -55.97 12.5 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.479 1.512 . . . . 0.0 112.367 -178.756 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -63.47 -27.0 70.15 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.108 0.861 . . . . 0.0 112.637 -179.58 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.39 178.76 6.91 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.288 1.035 . . . . 0.0 112.579 -178.925 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.9 m -65.59 -45.89 81.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.512 1.125 . . . . 0.0 110.54 179.07 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.05 -80.62 0.06 OUTLIER Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.466 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -79.53 -17.83 53.19 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.182 0.993 . . . . 0.0 112.039 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -79.74 163.85 24.16 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.326 0.65 . . . . 0.0 110.263 179.298 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.05 113.35 19.42 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.63 1.572 . . . . 0.0 107.671 179.209 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.4 m -97.47 161.55 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.436 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.88 155.65 51.07 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.395 -179.063 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.25 -173.31 4.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.342 1.457 . . . . 0.0 109.008 178.924 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.2 t -68.02 133.67 49.41 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.825 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.66 23.2 73.42 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -178.775 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.3 m -144.05 93.87 2.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.065 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 116.747 -1.597 . . . . 0.0 109.688 -178.658 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.37 152.86 0.57 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 126.612 1.965 . . . . 0.0 113.028 179.296 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.66 94.37 3.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.076 1.35 . . . . 0.0 110.571 -178.517 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 5' ' ' THR . 1.1 m -99.58 94.53 6.44 Favored 'General case' 0 N--CA 1.437 -1.099 1 N-CA-C 100.179 -4.008 . . . . 0.0 100.179 177.808 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.0 m -96.19 75.48 3.0 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.246 -177.696 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.0 -97.42 1.64 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 -178.804 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.3 t -114.76 -31.71 6.06 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.442 1.497 . . . . 0.0 109.253 178.479 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.1 m -77.06 95.53 4.22 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 102.059 -3.312 . . . . 0.0 102.059 178.051 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -114.28 152.24 31.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.552 1.141 . . . . 0.0 113.098 -176.425 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -143.76 165.78 26.71 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 125.041 1.336 . . . . 0.0 111.229 -179.214 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.3 m -85.97 156.94 20.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.334 1.453 . . . . 0.0 110.652 178.88 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.95 -20.78 40.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.915 -1.493 . . . . 0.0 107.164 176.875 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -68.77 -46.01 69.88 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.538 1.135 . . . . 0.0 109.939 179.379 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -43.38 93.21 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 123.135 0.574 . . . . 0.0 111.4 179.195 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.0 t -61.25 -46.07 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 123.013 0.525 . . . . 0.0 109.754 178.776 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 ttp-105 -62.76 -43.8 97.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.587 0.755 . . . . 0.0 110.177 -179.217 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.55 -45.41 87.25 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.546 0.738 . . . . 0.0 110.772 179.122 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.98 -33.22 75.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.46 1.104 . . . . 0.0 110.753 179.329 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.84 -37.71 47.8 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.964 0.505 . . . . 0.0 110.456 178.881 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -68.22 -20.64 64.84 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.229 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.25 -61.38 1.97 Allowed 'General case' 0 C--N 1.346 0.449 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 -178.807 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -41.13 -52.05 3.33 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.336 1.054 . . . . 0.0 111.46 176.663 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 46.4 t -61.97 -39.77 93.31 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.693 1.597 . . . . 0.0 111.04 179.017 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -88.01 7.08 32.95 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.768 1.227 . . . . 0.0 113.527 179.015 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -129.73 -10.87 4.43 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.455 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -115.18 -27.28 7.34 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -179.059 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.95 -14.86 11.25 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.828 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -78.86 17.82 0.68 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.503 1.047 . . . . 0.0 113.616 -176.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.5 t70 86.51 40.22 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 127.941 2.496 . . . . 0.0 109.166 178.9 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -151.7 148.99 28.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.827 2.051 . . . . 0.0 106.232 179.269 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 t -166.24 77.99 0.24 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.127 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.19 96.04 0.1 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.182 0.993 . . . . 0.0 110.552 -179.228 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.94 58.87 4.58 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 125.226 1.393 . . . . 0.0 110.197 -179.265 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.4 t -72.78 -73.27 0.21 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.706 0.802 . . . . 0.0 110.147 -179.011 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 m -176.49 -49.63 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 127.441 2.297 . . . . 0.0 106.671 -178.584 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.0 t -79.95 25.04 0.38 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.485 1.914 . . . . 0.0 113.939 -178.844 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 74.49 163.69 0.14 Allowed Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 119.279 0.945 . . . . 0.0 109.839 178.414 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.25 117.94 3.5 Favored 'Cis proline' 0 N--CA 1.454 -0.838 0 N-CA-C 115.166 1.179 . . . . 0.0 115.166 2.65 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -125.71 150.86 47.32 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 127.223 2.209 . . . . 0.0 106.937 178.912 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 m -80.99 132.19 35.36 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.564 1.146 . . . . 0.0 109.777 -179.972 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -88.53 149.55 23.56 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.48 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -153.03 134.3 14.24 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.024 0.53 . . . . 0.0 110.494 -179.273 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 64.43 121.61 0.02 OUTLIER 'General case' 0 C--N 1.343 0.293 0 C-N-CA 127.378 2.271 . . . . 0.0 112.053 179.367 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -77.16 135.38 38.53 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.268 0.627 . . . . 0.0 109.699 179.433 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -126.91 75.3 1.56 Allowed 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.188 0.995 . . . . 0.0 109.407 -178.691 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.16 50.49 51.06 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.221 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -164.83 121.76 1.55 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.857 1.263 . . . . 0.0 108.69 -178.648 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -142.68 110.43 5.85 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.373 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -144.42 49.87 1.11 Allowed Pre-proline 0 N--CA 1.439 -1.014 0 C-N-CA 129.91 3.284 . . . . 0.0 108.879 177.635 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.56 150.3 27.87 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.006 2.471 . . . . 0.0 112.031 -178.998 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.7 t -142.03 -53.19 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.862 1.665 . . . . 0.0 106.892 178.757 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -160.19 126.38 4.19 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.136 1.375 . . . . 0.0 109.002 178.727 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.85 150.95 18.43 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.881 1.229 . . . . 0.0 112.238 -178.875 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.65 173.04 29.17 Favored 'Cis proline' 0 C--N 1.35 0.655 0 CA-C-N 119.375 1.588 . . . . 0.0 113.27 -2.251 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -126.17 174.71 8.3 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.292 1.437 . . . . 0.0 108.174 -179.256 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.63 154.01 37.96 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.879 0.371 . . . . 0.0 111.658 -179.491 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.18 153.17 19.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.594 1.558 . . . . 0.0 111.683 -178.889 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -157.33 117.17 1.99 Allowed Pre-proline 0 C--N 1.342 0.273 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.288 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.7 152.14 13.16 Favored 'Trans proline' 0 N--CA 1.438 -1.769 0 C-N-CA 121.187 1.258 . . . . 0.0 114.675 -176.382 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.52 178.32 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 127.77 2.428 . . . . 0.0 105.868 178.803 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -164.77 -168.92 1.58 Allowed 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 109.586 -3.461 . . . . 0.0 108.462 -178.879 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.2 m -84.65 60.71 6.28 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 177.136 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.54 71.53 1.16 Allowed Glycine 0 CA--C 1.53 0.999 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 -178.222 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.18 89.68 0.09 OUTLIER Glycine 0 CA--C 1.53 1.01 0 CA-C-N 117.295 0.547 . . . . 0.0 111.8 -179.329 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.1 t -94.68 97.49 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.317 1.447 . . . . 0.0 108.003 179.339 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 t80 48.82 66.21 1.15 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.394 1.478 . . . . 0.0 110.693 -179.586 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.2 p -104.53 -68.82 0.83 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.792 1.237 . . . . 0.0 109.43 179.853 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.33 177.23 47.3 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 179.47 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.54 -19.59 10.82 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 118.887 -0.952 . . . . 0.0 113.378 -179.787 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 92.0 p 50.35 71.69 1.48 Allowed Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.201 1.8 . . . . 0.0 111.6 -179.604 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.89 143.28 54.55 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.181 2.587 . . . . 0.0 109.403 -178.382 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.43 48.74 0.95 Allowed Glycine 0 C--N 1.338 0.691 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.252 -178.518 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.15 21.75 0.13 Allowed 'General case' 0 C--N 1.342 0.27 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 177.784 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.26 112.64 0.13 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.708 2.803 . . . . 0.0 105.85 176.18 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.91 134.31 9.58 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.387 1.875 . . . . 0.0 109.53 -176.298 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.9 m -90.8 152.8 3.29 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 177.615 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.1 t -135.62 119.21 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -178.694 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -102.54 176.54 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.4 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -99.28 168.42 10.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 127.258 2.223 . . . . 0.0 109.16 178.847 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.306 14.7 t -82.01 50.24 1.52 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -178.414 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -147.54 -90.1 0.09 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 102.545 -3.132 . . . . 0.0 102.545 177.477 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.16 0.44 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.657 1.983 . . . . 0.0 113.007 -178.939 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -82.7 133.68 35.16 Favored 'General case' 0 C--N 1.346 0.44 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -176.773 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -78.05 112.88 15.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.592 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.0 -49.65 11.52 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.322 1.049 . . . . 0.0 111.363 -178.171 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.07 151.29 7.95 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.108 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.56 158.18 17.12 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.855 0.862 . . . . 0.0 110.159 178.97 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.0 pt -138.71 151.84 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.602 -178.918 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.1 t -147.67 165.43 30.49 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 125.301 1.441 . . . . 0.0 112.749 -178.756 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -79.01 -50.86 10.42 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.457 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 m -39.9 107.8 0.08 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 127.026 2.13 . . . . 0.0 112.631 -178.763 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.8 -43.42 1.35 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.74 1.638 . . . . 0.0 109.259 -179.153 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.95 -175.89 0.62 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.799 1.639 . . . . 0.0 112.131 179.654 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.3 p -70.88 -50.76 31.53 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.171 0.988 . . . . 0.0 111.453 -179.894 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.54 -78.9 0.04 OUTLIER Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.372 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -79.35 -34.1 42.39 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.046 0.939 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -55.82 158.63 3.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.366 1.066 . . . . 0.0 111.046 179.205 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -118.5 157.98 26.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.67 1.188 . . . . 0.0 113.175 -178.298 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.6 160.94 41.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 C-N-CA 126.428 1.891 . . . . 0.0 107.192 177.712 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.52 161.11 46.21 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.068 0.842 . . . . 0.0 114.197 -177.928 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.6 t -143.06 163.75 31.98 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 126.002 1.721 . . . . 0.0 109.147 178.825 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.0 t 53.43 51.59 15.04 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.079 1.752 . . . . 0.0 111.468 -178.577 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.66 -10.79 70.73 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.087 -0.84 . . . . 0.0 113.285 179.2 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.9 m -79.55 143.95 34.36 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.604 1.202 . . . . 0.0 108.746 -179.351 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 p30 . . . . . 0 C--O 1.251 1.182 0 CA-C-O 117.528 -1.225 . . . . 0.0 110.045 -179.271 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.46 75.1 0.37 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.311 1.444 . . . . 0.0 109.393 179.72 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.5 m -79.35 101.06 7.89 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.104 1.762 . . . . 0.0 109.668 -178.001 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -115.96 115.85 26.9 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.553 1.541 . . . . 0.0 106.863 -179.154 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.4 m -113.39 93.82 4.58 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.58 0.752 . . . . 0.0 109.797 -179.223 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.07 -93.8 0.43 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.438 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.3 m -133.77 41.58 3.02 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.607 1.163 . . . . 0.0 109.233 179.184 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.4 m -141.16 89.2 2.22 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 179.075 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -85.67 141.57 29.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.656 1.182 . . . . 0.0 113.657 -177.594 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -141.81 136.72 30.91 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.69 1.596 . . . . 0.0 109.816 178.74 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.5 m -65.94 158.2 28.72 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.979 1.312 . . . . 0.0 110.266 178.231 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.05 -23.17 66.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.1 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.2 t -76.73 -33.25 58.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.145 1.378 . . . . 0.0 109.966 179.259 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -74.74 -39.55 61.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.867 0.867 . . . . 0.0 109.841 -179.028 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.47 -44.6 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.499 0.72 . . . . 0.0 110.43 178.342 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.48 -38.55 90.1 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 123.304 0.642 . . . . 0.0 110.46 179.47 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.08 -46.33 74.63 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.868 0.867 . . . . 0.0 109.259 179.029 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.58 -42.14 82.55 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.961 0.904 . . . . 0.0 108.953 178.775 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.91 -20.03 50.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 179.324 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -74.52 -26.21 59.84 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.315 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.74 -49.81 10.68 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -179.445 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.14 -48.83 23.19 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 124.612 1.195 . . . . 0.0 109.661 176.233 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.5 t -68.73 -29.79 68.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.82 2.048 . . . . 0.0 113.189 -179.922 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -73.35 -63.78 1.12 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.45 1.023 . . . . 0.0 112.206 -178.611 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.351 0.1 OUTLIER -66.79 -47.01 73.45 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 -176.035 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -60.02 -28.2 67.54 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.552 1.141 . . . . 0.0 112.32 -178.722 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -82.7 -71.5 0.49 Allowed 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -178.435 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -171.19 23.28 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -178.718 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -121.28 76.72 1.26 Allowed 'General case' 0 C--N 1.339 0.128 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.803 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 111.19 133.79 0.0 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 131.355 3.862 . . . . 0.0 108.294 -178.713 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -90.96 81.58 5.66 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.004 1.321 . . . . 0.0 108.845 179.688 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.44 162.43 12.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.879 0.872 . . . . 0.0 112.387 -179.263 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -42.37 96.67 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.592 1.091 . . . . 0.0 114.947 -178.706 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.4 m 61.08 75.81 0.39 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -178.288 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 p 175.39 -43.85 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 103.471 -2.789 . . . . 0.0 103.471 -176.361 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.7 p -115.69 51.25 0.95 Allowed 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.856 2.062 . . . . 0.0 110.437 178.432 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 23.4 m-85 64.08 133.21 0.03 OUTLIER Pre-proline 0 C--N 1.355 0.83 0 C-N-CA 126.093 1.757 . . . . 0.0 110.76 176.504 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -76.39 161.58 93.57 Favored 'Cis proline' 0 N--CA 1.45 -1.035 0 CA-C-N 120.18 1.1 . . . . 0.0 109.931 3.555 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.74 147.25 37.08 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.026 1.331 . . . . 0.0 109.919 -177.788 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 t -76.31 132.1 39.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 103.46 -2.793 . . . . 0.0 103.46 177.12 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -95.6 106.1 18.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 -178.115 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -162.31 -58.07 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.567 1.147 . . . . 0.0 108.771 -179.241 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -81.39 70.65 8.3 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.559 1.144 . . . . 0.0 109.618 -179.367 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.55 -72.9 0.09 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.11 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -176.39 147.82 0.71 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.493 1.117 . . . . 0.0 109.275 179.18 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.75 150.82 49.83 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 178.93 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.17 170.56 18.16 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.104 0.562 . . . . 0.0 110.415 -179.209 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -71.6 -163.94 0.11 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.293 0.637 . . . . 0.0 111.63 -179.352 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.0 p90 54.28 58.73 12.11 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 125.889 1.676 . . . . 0.0 111.088 -178.178 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.28 66.83 8.74 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 124.016 3.144 . . . . 0.0 110.445 -179.429 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.37 -65.31 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.135 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -166.32 -165.09 0.74 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.048 1.339 . . . . 0.0 107.987 179.294 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.99 -174.88 45.98 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 121.91 -0.494 . . . . 0.0 112.879 179.103 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.2 128.37 6.42 Favored 'Cis proline' 0 N--CA 1.458 -0.568 0 O-C-N 122.526 0.75 . . . . 0.0 112.364 -0.292 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.72 150.57 25.01 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.114 0.966 . . . . 0.0 110.536 179.343 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -103.22 162.95 12.55 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.547 1.539 . . . . 0.0 112.82 -178.709 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.278 14.9 tp10 -101.3 151.82 21.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.646 2.379 . . . . 0.0 110.496 -178.783 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -160.16 107.43 1.39 Allowed Pre-proline 0 C--N 1.342 0.244 0 C-N-CA 124.567 1.147 . . . . 0.0 108.494 177.546 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -83.3 132.43 6.02 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 121.653 1.569 . . . . 0.0 112.607 -177.532 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.501 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.7 tt -107.81 172.41 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 124.466 2.079 . . . . 0.0 113.234 -179.289 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.501 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 16.5 ptpt -161.65 164.51 29.2 Favored 'General case' 0 C--N 1.316 -0.871 1 CA-C-N 108.191 -4.095 . . . . 0.0 112.379 179.974 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.1 m -92.33 60.33 3.63 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.536 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.5 -62.75 0.03 OUTLIER Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -179.271 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.31 -172.27 13.13 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.647 0.642 . . . . 0.0 113.939 -178.663 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.3 t -124.33 103.99 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 127.889 2.476 . . . . 0.0 105.678 -179.418 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.9 t80 60.56 92.78 0.04 OUTLIER 'General case' 0 C--N 1.345 0.38 0 C-N-CA 126.09 1.756 . . . . 0.0 110.871 -178.519 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.3 p -142.85 39.68 1.5 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.844 0.858 . . . . 0.0 110.336 179.302 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.11 98.38 0.06 OUTLIER Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.979 0.8 . . . . 0.0 112.25 179.178 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.92 -178.54 48.96 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 123.718 0.675 . . . . 0.0 111.512 179.13 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.0 t 63.12 91.81 0.07 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.684 1.593 . . . . 0.0 110.5 -179.124 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -59.87 132.31 8.07 Favored 'Cis proline' 0 C--N 1.348 0.534 0 CA-C-N 119.355 0.805 . . . . 0.0 113.338 1.901 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.79 71.57 0.03 OUTLIER Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.507 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.495 ' HB1' ' CB ' ' A' ' 91' ' ' HIS . . . -62.93 -20.64 65.4 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.861 178.863 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.72 137.4 33.86 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.289 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -157.66 147.28 20.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.522 -179.069 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.9 m -110.04 145.98 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 177.237 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.5 t -127.66 121.24 56.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -177.328 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -107.84 173.17 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.38 0 C-N-CA 125.189 1.396 . . . . 0.0 112.45 -177.58 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -91.56 161.89 14.75 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.248 1.419 . . . . 0.0 109.293 179.363 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.32 15.3 t -79.16 54.08 1.58 Allowed 'General case' 0 C--N 1.341 0.223 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -179.076 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -151.81 -88.45 0.06 Allowed 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 101.982 -3.34 . . . . 0.0 101.982 177.209 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.24 5.51 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.181 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -91.3 129.75 37.25 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 -175.48 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.56 124.14 20.61 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 177.447 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.8 -51.73 5.08 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.166 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.24 153.45 10.93 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.075 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.84 141.28 31.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.569 1.148 . . . . 0.0 110.062 179.3 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.0 pt -135.14 156.76 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 125.267 1.427 . . . . 0.0 108.081 179.157 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.58 159.67 37.33 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 119.113 -0.47 . . . . 0.0 111.308 -178.731 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.495 ' CB ' ' HB1' ' A' ' 74' ' ' ALA . 21.4 m170 -78.88 -58.76 3.08 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.015 177.412 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.288 4.8 t 48.06 9.35 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 129.228 3.011 . . . . 0.0 117.168 -178.053 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.68 44.98 0.21 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.142 1.353 . . . . 0.0 110.505 179.399 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.88 -168.6 2.29 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.985 0.914 . . . . 0.0 109.073 179.086 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.8 m -59.84 -46.57 88.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.321 0.648 . . . . 0.0 110.426 179.167 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.28 -91.48 0.08 OUTLIER Glycine 0 C--N 1.337 0.619 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 179.157 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -85.37 -2.5 58.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.022 0.929 . . . . 0.0 110.234 178.458 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -63.51 168.21 4.86 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.629 1.172 . . . . 0.0 110.708 179.114 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -138.85 156.21 47.49 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -177.608 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 m -132.61 165.54 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 127.331 2.253 . . . . 0.0 106.692 177.093 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -75.2 162.07 53.42 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 114.668 0.627 . . . . 0.0 114.668 -178.185 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 6.6 t -148.26 159.15 44.27 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 126.096 1.758 . . . . 0.0 108.953 178.289 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t 61.38 38.11 16.4 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.726 2.01 . . . . 0.0 111.819 -178.328 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.72 42.98 99.59 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.154 1.359 . . . . 0.0 112.239 179.041 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.6 t -88.21 26.03 1.49 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 179.871 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 116.618 -1.658 . . . . 0.0 110.615 -179.31 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.5 p . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.8 0.333 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.13 152.66 39.96 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.791 1.236 . . . . 0.0 110.777 179.359 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.4 t -140.4 134.21 30.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.155 0.582 . . . . 0.0 110.508 179.043 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -109.92 103.33 12.09 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 178.854 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 20.6 m -88.24 70.21 9.19 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.184 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.08 -82.24 0.88 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.416 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.5 p -106.1 -48.14 3.67 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.161 1.384 . . . . 0.0 112.058 -178.887 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.5 m -72.79 105.59 4.41 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.984 0.513 . . . . 0.0 111.694 -178.436 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -81.8 148.51 28.84 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.219 1.408 . . . . 0.0 110.531 179.869 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -148.08 127.68 13.29 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.383 1.073 . . . . 0.0 109.495 179.156 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.9 p -71.15 160.12 33.45 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 125.133 1.373 . . . . 0.0 110.504 178.323 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.36 -19.73 37.96 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.164 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.4 t -77.74 -36.72 50.45 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 123.604 0.762 . . . . 0.0 109.385 -179.986 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -42.5 64.86 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.67 1.188 . . . . 0.0 111.069 179.205 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.477 HG11 ' CE2' ' A' ' 85' ' ' TYR . 22.3 t -61.87 -45.93 97.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.297 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -66.91 -41.48 87.04 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 124.883 1.273 . . . . 0.0 112.967 179.821 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.88 -53.61 53.42 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.749 0.42 . . . . 0.0 110.294 -178.122 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.16 -32.38 72.1 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.086 179.439 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.36 -49.32 43.39 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 179.874 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -61.87 -22.94 65.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.693 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.23 -71.98 0.28 Allowed 'General case' 0 C--N 1.348 0.52 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 -177.698 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -38.53 -44.44 0.95 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.912 0.885 . . . . 0.0 112.261 178.096 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.3 m -55.82 -52.71 63.05 Favored 'General case' 0 C--N 1.346 0.447 0 O-C-N 123.288 0.367 . . . . 0.0 111.784 179.184 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -56.16 -40.15 73.42 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.755 0.822 . . . . 0.0 112.421 -178.124 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -89.38 -16.48 30.88 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -178.875 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -80.45 -24.04 39.82 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.791 1.236 . . . . 0.0 113.826 179.367 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -60.64 -33.54 72.95 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.297 0.639 . . . . 0.0 112.692 -177.921 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -126.17 -86.27 0.61 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.147 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t0 168.13 59.05 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 128.354 2.662 . . . . 0.0 105.701 -178.379 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -81.66 -178.5 6.99 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.597 179.441 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.338 11.3 t -69.07 86.68 0.37 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -177.838 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.03 -161.66 1.07 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 127.242 2.217 . . . . 0.0 107.07 177.363 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -45.55 -49.21 11.82 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.478 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.1 m 47.62 50.04 15.57 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.181 1.792 . . . . 0.0 113.606 178.051 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.1 p -143.48 -54.3 0.38 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.776 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.456 HG23 ' CE1' ' A' ' 38' ' ' TYR . 1.1 t -154.3 19.44 0.49 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.387 1.475 . . . . 0.0 110.543 178.984 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.474 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 12.8 m-85 -166.03 129.39 1.58 Allowed Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 126.403 1.881 . . . . 0.0 106.32 178.879 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.64 135.8 34.03 Favored 'Cis proline' 0 N--CA 1.449 -1.118 0 CA-C-N 120.355 1.163 . . . . 0.0 110.402 -1.53 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.88 155.97 36.7 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.932 0.493 . . . . 0.0 110.214 178.762 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -64.02 157.73 24.42 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.845 1.258 . . . . 0.0 112.297 -179.332 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.92 45.14 1.13 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.956 0.903 . . . . 0.0 110.212 179.263 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 48.0 -121.56 1.38 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.84 2.056 . . . . 0.0 112.103 179.895 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -137.64 -179.27 5.65 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.858 1.663 . . . . 0.0 108.813 -179.367 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 66.91 -142.53 0.14 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.066 1.346 . . . . 0.0 110.965 178.933 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -126.29 106.53 9.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.188 1.395 . . . . 0.0 109.252 -178.571 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.98 93.0 0.31 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.295 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.4 t80 51.26 65.32 1.52 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.438 1.495 . . . . 0.0 109.666 -179.138 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.36 153.31 42.43 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.792 0.806 . . . . 0.0 112.684 -178.499 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -109.31 163.88 16.01 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 127.53 2.332 . . . . 0.0 108.522 -179.124 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.98 53.66 4.27 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.848 3.032 . . . . 0.0 111.837 178.865 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.2 m -155.04 171.09 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 127.842 2.457 . . . . 0.0 108.058 -179.333 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -92.46 -133.94 0.14 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.949 0.9 . . . . 0.0 109.52 179.983 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 166.32 -156.48 28.4 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.386 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.45 151.79 12.9 Favored 'Cis proline' 0 C--N 1.349 0.587 0 CA-C-N 119.205 1.503 . . . . 0.0 113.097 -1.5 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -134.26 148.38 50.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.205 1.002 . . . . 0.0 111.877 -178.635 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.57 152.31 22.57 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -177.659 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -104.81 146.59 28.77 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 127.471 2.308 . . . . 0.0 108.459 179.276 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.631 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 52.8 t80 -160.05 121.92 1.81 Allowed Pre-proline 0 C--O 1.224 -0.238 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 179.347 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.474 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 22.8 Cg_endo -75.97 145.28 28.07 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 CA-C-N 120.624 1.259 . . . . 0.0 112.753 -176.031 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.271 5.0 tp -78.99 159.83 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 124.483 2.087 . . . . 0.0 114.094 -178.07 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.94 118.74 37.4 Favored 'General case' 0 C--N 1.321 -0.672 1 CA-C-N 108.004 -4.18 . . . . 0.0 118.222 -176.372 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.1 m -105.86 43.99 1.08 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.743 1.617 . . . . 0.0 107.075 177.997 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.41 -6.28 5.94 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 118.279 -1.29 . . . . 0.0 115.366 -179.388 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.71 134.27 2.92 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 120.15 1.975 . . . . 0.0 113.064 179.462 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.94 141.83 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.194 1.398 . . . . 0.0 110.357 -179.005 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.8 p90 39.94 54.47 2.63 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.407 2.283 . . . . 0.0 114.527 179.311 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.2 p -134.09 34.32 3.34 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.833 1.253 . . . . 0.0 108.887 178.717 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.41 -154.6 11.45 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 124.294 0.95 . . . . 0.0 111.251 -179.257 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 47.71 74.93 0.21 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.856 1.217 . . . . 0.0 112.834 178.992 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.1 m -55.53 143.41 57.97 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.178 179.314 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -45.85 -50.72 9.28 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.554 2.836 . . . . 0.0 110.993 172.829 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.41 -39.85 0.22 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 178.526 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -171.11 29.21 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 116.429 -1.748 . . . . 0.0 113.629 -177.92 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -108.57 130.39 55.3 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 122.453 2.388 . . . . 0.0 113.749 -178.464 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -134.27 155.41 50.25 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 124.372 1.069 . . . . 0.0 113.112 179.884 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 m -124.97 142.04 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 103.404 -2.813 . . . . 0.0 103.404 176.115 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.9 t -136.45 127.9 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -176.955 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.63 172.5 5.21 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 C-N-CA 127.065 2.146 . . . . 0.0 110.71 -177.901 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -100.49 -178.24 3.74 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 126.066 1.746 . . . . 0.0 110.138 179.044 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.371 13.8 t -80.33 52.48 1.61 Allowed 'General case' 0 C--N 1.344 0.34 0 N-CA-C 118.524 2.787 . . . . 0.0 118.524 -178.068 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -160.5 -93.37 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 100.394 -3.928 . . . . 0.0 100.394 176.752 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 58.2 m -163.68 16.19 0.06 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 130.101 3.36 . . . . 0.0 112.353 179.398 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -79.21 97.65 6.31 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.778 1.172 . . . . 0.0 110.256 -177.69 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.477 ' CE2' HG11 ' A' ' 16' ' ' VAL . 9.1 t80 -55.64 112.72 1.21 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.667 1.587 . . . . 0.0 108.699 178.998 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.05 -51.52 9.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.449 0.7 . . . . 0.0 110.822 -178.641 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 166.66 162.27 17.8 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.275 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.84 147.06 24.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.059 0.944 . . . . 0.0 109.104 179.028 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.2 pt -134.52 160.59 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.966 1.306 . . . . 0.0 109.241 -178.969 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 74' ' ' ALA . 11.9 t -158.43 167.43 29.69 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.453 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.431 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 17.1 m170 -78.45 -65.3 1.0 Allowed 'General case' 0 C--N 1.348 0.511 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.343 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.1 t 42.78 14.28 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 129.249 3.02 . . . . 0.0 116.778 -179.364 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.99 -32.71 0.15 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.466 1.507 . . . . 0.0 110.44 -179.038 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.18 127.57 17.27 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.829 1.652 . . . . 0.0 112.09 179.233 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.9 t -105.89 69.19 0.81 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.986 1.315 . . . . 0.0 109.114 179.718 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.67 -161.01 30.35 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.452 1.025 . . . . 0.0 110.921 179.373 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -79.5 8.55 6.14 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.071 0.948 . . . . 0.0 111.388 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -80.24 156.83 26.69 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.233 1.413 . . . . 0.0 110.286 178.852 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -137.78 159.96 40.56 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.279 1.432 . . . . 0.0 111.195 -178.192 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.9 m -128.38 176.15 8.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 C-N-CA 127.877 2.471 . . . . 0.0 106.969 178.05 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.31 171.07 43.6 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 117.054 1.581 . . . . 0.0 117.054 -177.647 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.3 m -129.26 -176.49 3.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.917 2.487 . . . . 0.0 107.206 177.963 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.6 t 28.5 38.84 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -177.099 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 53.32 48.94 58.49 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.324 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.6 t -79.23 150.54 31.58 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.596 0.759 . . . . 0.0 111.801 -178.615 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.1 t30 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.245 -1.36 . . . . 0.0 108.717 -179.386 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 76.82 63.08 0.04 OUTLIER 'General case' 0 C--N 1.34 0.167 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 -177.433 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 t -106.02 156.43 18.41 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.893 0.877 . . . . 0.0 111.354 -177.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.08 112.28 12.2 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 178.723 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.6 m -96.55 74.93 2.82 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.242 1.017 . . . . 0.0 110.012 -178.825 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.3 -70.81 2.1 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 125.097 1.332 . . . . 0.0 111.524 179.121 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.2 t -126.49 -44.58 1.69 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.896 1.678 . . . . 0.0 109.919 -179.222 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 m -68.5 111.06 4.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.644 0.778 . . . . 0.0 109.514 -179.349 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -81.41 151.94 27.66 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.083 0.953 . . . . 0.0 110.532 179.911 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -143.27 110.14 5.58 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.427 1.091 . . . . 0.0 110.326 -179.551 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.8 m -63.1 154.15 31.88 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 125.275 1.43 . . . . 0.0 109.171 178.77 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -20.9 57.81 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.865 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.4 m -74.35 -43.22 57.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.042 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -67.82 -47.29 69.46 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.189 0.995 . . . . 0.0 112.343 -179.174 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -60.19 -52.65 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 124.194 0.998 . . . . 0.0 109.215 -179.342 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -66.38 -38.8 88.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.141 1.377 . . . . 0.0 113.002 -177.841 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.51 -52.6 60.54 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.355 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.488 ' HB1' ' HE2' ' A' ' 59' ' ' PHE . . . -61.96 -32.55 73.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.431 179.237 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.92 -32.29 61.75 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 178.896 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -69.74 -24.66 63.57 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 176.959 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.06 -63.67 1.26 Allowed 'General case' 0 C--N 1.349 0.57 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 -179.222 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.497 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -41.58 -40.1 1.79 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.273 1.429 . . . . 0.0 112.447 176.852 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -60.89 -63.54 1.26 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.282 1.433 . . . . 0.0 110.247 179.219 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -66.43 -24.17 66.41 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -179.065 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -82.25 -45.31 15.18 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.211 1.404 . . . . 0.0 113.531 -177.798 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -66.23 -28.26 68.6 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.374 1.069 . . . . 0.0 112.589 -178.525 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -74.84 -64.73 0.98 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.407 0.548 . . . . 0.0 110.904 -177.738 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -172.49 -29.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.546 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -75.49 39.02 0.15 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -177.502 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.05 169.7 0.06 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.224 2.21 . . . . 0.0 110.689 178.608 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.0 t -158.28 37.19 0.24 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.388 1.475 . . . . 0.0 110.337 179.322 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.04 158.98 27.78 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.754 0.822 . . . . 0.0 111.835 -179.149 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.64 -137.59 7.33 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.573 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.7 t -145.32 -68.53 0.29 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.625 1.17 . . . . 0.0 108.452 179.091 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.2 m -83.33 -94.1 0.06 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.908 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.3 p -140.63 40.57 1.86 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.389 0.675 . . . . 0.0 110.677 178.571 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -82.17 132.06 54.49 Favored Pre-proline 0 C--N 1.345 0.389 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 177.66 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.49 123.75 5.73 Favored 'Cis proline' 0 CA--C 1.544 1.015 0 N-CA-C 114.044 0.748 . . . . 0.0 114.044 3.005 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.85 148.4 22.52 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 128.452 2.701 . . . . 0.0 113.758 -177.319 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.97 113.76 2.99 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.933 0.893 . . . . 0.0 109.264 179.047 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -95.03 90.38 5.92 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 120.838 0.352 . . . . 0.0 110.072 -178.821 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -156.12 119.21 4.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.162 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -128.58 -79.82 0.57 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.295 1.038 . . . . 0.0 109.336 -179.089 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -143.61 11.26 1.66 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.904 1.281 . . . . 0.0 110.884 179.467 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 55.45 47.64 20.66 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.225 1.41 . . . . 0.0 110.682 -178.852 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.67 -31.53 6.67 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.292 1.425 . . . . 0.0 111.303 179.413 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -127.44 94.02 3.87 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.041 1.336 . . . . 0.0 108.391 -179.195 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -118.88 -177.95 3.44 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.582 1.153 . . . . 0.0 111.487 -178.837 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.21 175.53 3.21 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.989 1.716 . . . . 0.0 108.553 -178.714 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.63 68.07 7.11 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.352 2.701 . . . . 0.0 111.573 -179.403 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.5 m -143.18 157.28 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 125.668 1.587 . . . . 0.0 109.78 179.695 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -85.5 -44.97 12.24 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.797 1.239 . . . . 0.0 111.235 -179.326 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.79 177.82 43.81 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.72 1.152 . . . . 0.0 111.865 -179.423 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.29 152.96 85.19 Favored 'Cis proline' 0 N--CA 1.458 -0.594 0 CA-C-N 117.973 0.886 . . . . 0.0 112.409 0.763 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.1 154.96 47.74 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 127.185 2.194 . . . . 0.0 109.981 179.325 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -135.85 160.81 37.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.049 -178.743 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.98 162.26 26.08 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.719 1.608 . . . . 0.0 112.14 -177.552 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.497 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 70.9 t80 -160.61 104.38 1.32 Allowed Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 177.388 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -80.84 135.46 10.09 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 121.899 1.733 . . . . 0.0 112.774 -175.778 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.58 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 3.7 tt -105.35 -176.34 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-O 124.249 1.976 . . . . 0.0 112.401 -179.223 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.58 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.3 mmtm -160.51 142.84 12.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 108.945 -3.752 . . . . 0.0 110.229 179.72 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.7 t -85.83 60.83 6.47 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.71 1.204 . . . . 0.0 109.138 -179.134 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.51 49.81 0.1 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.93 1.729 . . . . 0.0 109.003 -179.214 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.6 154.39 7.57 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.328 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.8 t -135.61 150.94 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.168 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 16.6 p90 48.33 48.47 18.93 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.818 1.647 . . . . 0.0 111.963 -179.051 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.1 m -79.29 138.31 37.7 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 125.027 1.331 . . . . 0.0 108.964 -178.896 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.91 -84.15 0.23 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.871 0.748 . . . . 0.0 112.791 -178.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.56 76.56 1.32 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.165 0.888 . . . . 0.0 112.096 -178.825 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.3 m -98.65 157.78 33.65 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.229 1.412 . . . . 0.0 110.177 179.338 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.9 -44.28 49.74 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.731 2.954 . . . . 0.0 111.495 164.61 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.57 24.23 26.49 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.773 1.178 . . . . 0.0 112.11 179.18 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.539 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -94.16 -68.92 0.77 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.158 -0.925 . . . . 0.0 109.548 179.203 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -70.4 107.1 3.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.096 0.958 . . . . 0.0 112.622 -178.621 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -140.03 131.65 27.2 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.338 0.655 . . . . 0.0 111.719 -179.074 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -94.19 153.16 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 176.882 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.7 t -132.95 130.42 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -178.348 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.5 pt -116.79 176.22 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.6 1.16 . . . . 0.0 112.634 -177.997 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -90.49 177.34 6.4 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 126.442 1.897 . . . . 0.0 110.022 179.763 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.322 12.9 t -81.2 47.71 1.05 Allowed 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 118.58 2.807 . . . . 0.0 118.58 -178.651 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -160.41 -87.04 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 177.05 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 76.7 m -162.97 62.6 0.19 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.198 2.599 . . . . 0.0 110.082 -176.793 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -144.02 117.74 9.27 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.202 1.819 . . . . 0.0 114.391 -179.416 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -55.74 128.83 36.73 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.365 1.066 . . . . 0.0 108.449 178.622 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.61 -59.6 1.68 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.931 0.892 . . . . 0.0 108.833 178.805 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.91 173.57 41.51 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.369 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.47 115.95 22.42 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.681 1.593 . . . . 0.0 109.231 179.267 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.9 pt -108.83 158.01 8.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 125.06 1.344 . . . . 0.0 110.017 -179.235 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 t -159.61 137.11 9.84 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 -179.529 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.539 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 6.5 m170 -78.1 -11.22 59.9 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 117.881 -1.057 . . . . 0.0 112.034 174.997 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.7 m -26.53 -65.63 0.06 Allowed 'General case' 0 C--N 1.349 0.549 0 C-N-CA 126.447 1.899 . . . . 0.0 114.937 -178.469 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.04 -75.51 1.25 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -179.348 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 50.81 -150.23 0.26 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.064 1.346 . . . . 0.0 112.27 -179.306 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 60.1 p -153.97 -51.41 0.1 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.163 1.385 . . . . 0.0 108.651 179.118 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -121.55 -86.38 0.86 Allowed Glycine 0 C--N 1.34 0.791 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 178.817 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -134.13 28.13 3.8 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.547 1.539 . . . . 0.0 110.734 179.23 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -85.96 164.96 17.1 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.906 1.282 . . . . 0.0 111.628 -178.885 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.454 ' CE2' ' NE2' ' A' ' 91' ' ' HIS . 13.5 m-85 -118.65 116.05 25.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.122 1.769 . . . . 0.0 107.781 179.098 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.4 m -90.89 164.44 2.12 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.255 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.15 133.83 11.99 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.071 -178.32 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 26.2 m -81.32 -172.99 4.09 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.526 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.9 t -75.8 93.06 3.1 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.993 -0.442 . . . . 0.0 110.12 -179.03 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.49 51.27 0.24 Allowed Glycine 0 CA--C 1.527 0.834 0 C-N-CA 126.105 1.812 . . . . 0.0 109.397 -179.37 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.0 m -154.66 110.82 3.22 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 125.2 1.4 . . . . 0.0 108.853 -179.14 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.5 m120 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.217 -1.373 . . . . 0.0 109.414 179.111 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -50.29 136.55 19.8 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.541 1.536 . . . . 0.0 111.436 -179.784 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.3 p -104.0 150.13 24.53 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.976 1.31 . . . . 0.0 111.379 -179.034 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -133.46 97.03 3.84 Favored 'General case' 0 N--CA 1.424 -1.772 1 N-CA-C 97.38 -5.044 . . . . 0.0 97.38 176.591 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -97.31 85.57 3.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.471 0.653 . . . . 0.0 110.668 -177.185 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.12 -96.2 1.58 Allowed Glycine 0 C--N 1.34 0.762 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 -178.879 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.7 m -104.91 -36.61 7.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.353 1.061 . . . . 0.0 110.307 179.23 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.38 168.03 19.27 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.346 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -156.75 132.45 9.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.091 0.156 . . . . 0.0 110.86 179.323 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -123.74 158.35 31.89 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.876 1.27 . . . . 0.0 109.947 -179.683 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.1 m -78.05 156.26 30.17 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.224 1.41 . . . . 0.0 110.479 -179.667 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.38 -18.9 42.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.83 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.7 p -72.66 -38.05 67.75 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 123.637 0.775 . . . . 0.0 109.966 179.248 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.93 -47.93 67.34 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.807 0.731 . . . . 0.0 110.236 178.654 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.2 t -53.14 -49.89 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 125.077 1.351 . . . . 0.0 108.496 179.09 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -69.51 -38.32 77.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.372 1.469 . . . . 0.0 113.083 -178.819 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.59 -54.18 31.43 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.817 0.735 . . . . 0.0 110.79 -178.507 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.25 -34.1 75.88 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.584 0.754 . . . . 0.0 111.118 179.43 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.11 -36.89 61.63 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 119.477 -0.297 . . . . 0.0 111.506 178.957 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -69.32 -20.78 63.87 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.449 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.5 -57.41 3.36 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -178.224 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.8 -38.26 47.38 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.088 1.355 . . . . 0.0 109.822 177.269 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.2 t -60.69 -54.57 43.68 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.358 1.463 . . . . 0.0 109.158 178.506 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -56.79 -36.85 70.35 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.687 0.395 . . . . 0.0 110.837 179.532 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.25 -6.52 59.28 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.714 1.206 . . . . 0.0 114.098 -179.863 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.46 ' CD2' ' HG3' ' A' ' 57' ' ' GLN . 8.7 t80 -128.23 43.96 3.04 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.154 0.888 . . . . 0.0 111.402 178.926 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -130.78 -84.46 0.52 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.338 1.455 . . . . 0.0 107.598 177.483 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -162.93 -14.75 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.274 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -84.17 65.21 8.66 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.586 1.554 . . . . 0.0 107.576 179.89 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 78.04 111.35 0.07 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 128.138 2.575 . . . . 0.0 108.475 -178.971 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.4 p -87.49 77.63 8.78 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.544 1.138 . . . . 0.0 109.295 -178.68 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.59 91.93 2.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.516 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.48 108.34 2.77 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 126.113 1.816 . . . . 0.0 108.57 -179.519 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 m -71.18 -66.9 0.56 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.834 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.0 p 156.49 -47.87 0.0 OUTLIER 'General case' 0 C--N 1.34 0.184 0 N-CA-C 100.537 -3.875 . . . . 0.0 100.537 -177.664 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.442 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 7.5 t -93.11 53.2 1.92 Allowed 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 125.838 1.655 . . . . 0.0 107.308 176.951 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER 79.69 155.15 0.13 Allowed Pre-proline 0 C--N 1.348 0.53 0 C-N-CA 127.376 2.27 . . . . 0.0 115.086 175.737 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.93 127.66 13.1 Favored 'Cis proline' 0 C--N 1.349 0.582 0 N-CA-C 114.93 1.089 . . . . 0.0 114.93 1.899 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.04 169.56 20.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.748 1.219 . . . . 0.0 110.212 178.913 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 m -37.52 131.66 0.9 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 128.737 2.815 . . . . 0.0 115.828 -178.911 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -109.07 109.21 20.17 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.975 1.71 . . . . 0.0 106.708 178.418 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -70.91 -36.34 72.67 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.616 1.166 . . . . 0.0 113.636 -178.788 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 70.86 77.26 0.18 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.198 1.399 . . . . 0.0 108.134 -178.465 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -72.76 91.53 1.49 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.111 1.364 . . . . 0.0 111.747 -178.641 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 54.75 152.83 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 129.305 3.042 . . . . 0.0 115.821 179.191 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.61 -145.25 24.26 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.774 1.178 . . . . 0.0 112.583 179.236 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.04 172.27 0.09 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.05 1.74 . . . . 0.0 113.46 -179.36 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -158.45 121.93 3.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 179.395 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -132.81 105.34 12.78 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 178.448 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.64 80.86 1.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.699 2.933 . . . . 0.0 113.397 -178.223 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.04 160.5 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.472 1.909 . . . . 0.0 107.81 178.822 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.57 -50.51 8.71 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.726 0.81 . . . . 0.0 110.623 179.557 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.54 -159.76 35.3 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.059 0.837 . . . . 0.0 111.257 -179.389 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.82 153.67 13.38 Favored 'Cis proline' 0 C--N 1.347 0.478 0 CA-C-N 119.092 1.446 . . . . 0.0 113.802 -0.172 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.87 158.25 20.41 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 123.877 0.871 . . . . 0.0 110.933 -178.994 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.46 ' HG3' ' CD2' ' A' ' 27' ' ' TYR . 6.2 mm100 -130.98 150.89 51.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.51 1.124 . . . . 0.0 111.687 -178.601 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -88.04 156.28 19.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.556 1.142 . . . . 0.0 110.653 179.216 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -159.74 109.22 1.46 Allowed Pre-proline 0 N--CA 1.457 -0.121 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.24 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -81.28 136.63 10.15 Favored 'Trans proline' 0 N--CA 1.436 -1.897 0 C-N-CA 121.043 1.162 . . . . 0.0 113.088 -177.827 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.26 -173.78 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 128.868 2.867 . . . . 0.0 103.891 178.896 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.36 -179.38 6.52 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 112.308 -2.224 . . . . 0.0 113.022 -177.989 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.3 t -89.42 51.05 2.03 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.075 1.35 . . . . 0.0 107.647 178.013 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.33 -66.78 0.03 OUTLIER Glycine 0 C--N 1.344 0.975 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.097 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.22 -149.41 7.28 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 117.75 0.775 . . . . 0.0 113.14 -179.774 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 t -61.86 130.72 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 126.509 1.923 . . . . 0.0 108.941 -179.165 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.1 133.14 45.36 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.879 0.872 . . . . 0.0 112.752 -178.732 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 m -132.34 -33.85 1.26 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.544 1.938 . . . . 0.0 110.352 179.394 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.26 -141.21 0.36 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.307 1.432 . . . . 0.0 114.851 -178.636 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.77 -151.69 1.55 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.364 1.459 . . . . 0.0 113.957 -178.777 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 m 72.88 151.33 0.14 Allowed Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 126.545 1.938 . . . . 0.0 110.664 -179.246 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -57.95 -72.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.042 2.495 . . . . 0.0 110.537 179.146 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.24 64.69 1.45 Allowed Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 178.304 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -61.69 -49.0 78.24 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.434 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.01 132.48 48.68 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.742 1.617 . . . . 0.0 108.218 178.725 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -157.96 132.73 8.47 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -178.512 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.6 m -95.95 147.66 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 176.309 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -128.65 117.32 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -178.635 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 35.4 pt -99.96 174.1 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.412 0 C-N-CA 126.345 1.858 . . . . 0.0 112.684 -178.287 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -94.85 -175.36 3.54 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.135 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.295 13.8 t -84.51 42.85 0.92 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 -179.9 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.8 -72.49 0.1 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.054 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.68 -9.04 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 -177.227 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -79.3 118.59 21.36 Favored 'General case' 0 N--CA 1.458 -0.061 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -175.921 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -71.29 115.03 9.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.249 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.76 -57.97 3.41 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.945 0.898 . . . . 0.0 112.126 -178.548 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.77 151.6 12.03 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.769 179.716 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.07 131.11 44.76 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.291 1.436 . . . . 0.0 110.847 -179.052 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.6 pt -130.99 162.56 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 125.45 1.5 . . . . 0.0 109.638 -179.019 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 t -156.56 146.83 21.34 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -179.606 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.459 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 19.8 m170 -79.26 -26.64 42.36 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.237 175.177 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.0 m -31.05 -59.94 0.21 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 127.946 2.498 . . . . 0.0 115.347 -178.13 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.39 34.06 4.57 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.297 0.951 . . . . 0.0 112.231 -178.908 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.81 -87.51 0.16 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 117.604 0.702 . . . . 0.0 110.981 179.511 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.2 t -162.29 -51.94 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.083 1.353 . . . . 0.0 108.723 -179.188 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.46 -88.96 0.07 OUTLIER Glycine 0 C--N 1.339 0.71 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 179.24 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -79.94 -28.61 39.65 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.115 0.966 . . . . 0.0 110.325 178.725 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -63.19 169.3 3.6 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.287 1.435 . . . . 0.0 111.538 -179.541 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -128.64 156.71 42.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.899 2.08 . . . . 0.0 109.743 -179.711 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.7 m -141.88 155.84 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 C-N-CA 124.432 1.093 . . . . 0.0 108.17 177.094 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.47 129.05 9.05 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.122 -177.775 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 37.4 m -79.93 179.75 7.41 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.298 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.2 p -61.19 124.7 21.3 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.872 -1.143 . . . . 0.0 109.683 179.152 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.04 37.61 5.65 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -178.752 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 60.5 m -152.52 145.68 24.64 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.759 1.624 . . . . 0.0 107.965 -179.732 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 125.948 1.699 . . . . 0.0 110.952 179.47 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.1 t . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.59 177.29 0.21 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.47 1.508 . . . . 0.0 110.274 -178.877 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.6 p -143.95 94.13 2.54 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.08 0.552 . . . . 0.0 110.273 178.869 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.0 m -87.76 89.61 8.06 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 102.51 -3.144 . . . . 0.0 102.51 177.792 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.3 m -86.92 63.76 8.12 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.308 1.843 . . . . 0.0 108.852 -178.952 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.13 -79.29 1.88 Allowed Glycine 0 C--N 1.34 0.779 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.085 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.7 p -115.07 -42.45 3.2 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.429 1.491 . . . . 0.0 109.68 179.256 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.35 114.3 3.11 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 124.514 1.125 . . . . 0.0 108.568 178.925 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.65 99.75 7.96 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.709 0.804 . . . . 0.0 110.368 -178.176 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -94.67 146.24 24.29 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.559 0.743 . . . . 0.0 109.08 179.048 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.4 m -72.15 153.12 41.84 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 124.094 0.958 . . . . 0.0 109.979 -179.555 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.44 -18.87 43.09 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 176.822 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 63.3 m -75.28 -39.75 59.37 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 125.002 1.321 . . . . 0.0 109.176 178.705 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -68.92 -40.84 78.83 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 123.946 0.899 . . . . 0.0 110.85 179.188 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.1 t -61.53 -48.32 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.888 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 ttt85 -65.83 -39.82 91.2 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.58 1.552 . . . . 0.0 112.125 -179.715 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.19 -51.83 66.23 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.178 0.591 . . . . 0.0 109.65 -179.074 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.51 -30.67 71.44 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.272 0.629 . . . . 0.0 111.477 179.256 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.65 -46.71 45.01 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.302 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -65.71 -20.24 66.2 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.76 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.96 -61.49 2.0 Allowed 'General case' 0 C--N 1.346 0.456 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -177.643 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -43.83 -51.64 7.27 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 124.849 1.343 . . . . 0.0 109.313 176.732 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 m -48.19 -54.25 14.09 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 126.479 1.912 . . . . 0.0 111.155 178.775 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -70.99 -25.92 62.91 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -178.729 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -106.08 -2.21 22.94 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 -176.93 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.416 ' CD2' ' HB2' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -110.48 -5.66 15.09 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.076 1.307 . . . . 0.0 114.275 178.683 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -78.3 -62.95 1.52 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.062 0.846 . . . . 0.0 112.134 -178.102 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -159.68 -41.32 0.05 Allowed 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.124 0.57 . . . . 0.0 110.916 -178.785 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.68 60.71 5.4 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.222 1.409 . . . . 0.0 107.643 178.814 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -69.99 123.24 21.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.611 1.564 . . . . 0.0 111.408 -178.423 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.8 t -149.41 39.56 0.82 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.871 0.869 . . . . 0.0 110.906 179.032 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.69 105.01 0.1 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.47 1.908 . . . . 0.0 106.025 179.122 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.32 114.59 0.63 Allowed Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.242 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 78.8 p -70.59 -67.84 0.47 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.411 1.084 . . . . 0.0 111.038 -179.031 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.1 m -143.09 -69.44 0.33 Allowed 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.156 0.983 . . . . 0.0 108.69 179.421 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.0 p -104.62 -58.44 1.88 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.494 1.118 . . . . 0.0 108.091 179.338 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.95 123.62 82.5 Favored Pre-proline 0 N--CA 1.468 0.457 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 178.316 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.31 123.59 8.67 Favored 'Cis proline' 0 N--CA 1.456 -0.699 0 N-CA-C 116.662 1.755 . . . . 0.0 116.662 3.892 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.64 173.23 2.02 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 128.207 2.603 . . . . 0.0 108.031 178.051 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 52.4 p -72.15 160.14 32.95 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.68 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -117.86 119.47 34.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.131 2.172 . . . . 0.0 108.658 179.554 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -166.68 44.95 0.06 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.288 1.435 . . . . 0.0 108.703 179.138 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -95.2 77.47 3.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.257 1.023 . . . . 0.0 110.384 -179.013 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 63.28 -177.21 0.15 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.614 1.566 . . . . 0.0 113.685 178.505 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -74.25 -173.0 1.55 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.722 1.609 . . . . 0.0 111.295 179.127 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.09 -52.56 0.63 Allowed Glycine 0 C--N 1.34 0.782 0 C-N-CA 124.603 1.097 . . . . 0.0 110.46 179.452 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -138.36 131.52 30.09 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.103 0.961 . . . . 0.0 110.312 179.274 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -161.04 137.29 8.36 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.223 1.809 . . . . 0.0 107.278 179.302 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -94.47 151.71 39.52 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.943 0.897 . . . . 0.0 110.339 -178.86 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.88 67.29 6.67 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 124.244 3.296 . . . . 0.0 112.044 -179.368 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.0 m -147.65 163.94 6.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 125.866 1.666 . . . . 0.0 108.066 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -66.27 -44.42 83.65 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.749 0.819 . . . . 0.0 111.725 -179.652 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.3 -171.29 49.18 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.182 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.53 167.11 24.25 Favored 'Cis proline' 0 C--N 1.348 0.526 0 CA-C-N 119.529 1.665 . . . . 0.0 113.766 -1.5 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -128.69 146.97 50.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.178 1.391 . . . . 0.0 110.832 -179.338 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.416 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 2.5 tp60 -91.69 138.2 31.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 128.086 2.554 . . . . 0.0 113.43 -178.342 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.1 141.52 30.94 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.285 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -149.75 114.46 3.47 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.862 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -80.59 133.36 9.37 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.141 1.894 . . . . 0.0 112.516 -176.882 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.58 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 2.3 tt -106.05 -170.23 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-O 123.481 1.61 . . . . 0.0 111.984 -179.262 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.58 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.2 mmtp -160.76 -170.06 2.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 109.962 -3.29 . . . . 0.0 112.493 179.37 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.1 t -85.77 63.05 7.83 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 126.705 2.002 . . . . 0.0 108.108 -179.667 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.47 59.99 2.06 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -179.261 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.13 98.24 0.18 Allowed Glycine 0 C--N 1.338 0.668 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.076 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.3 t -64.42 147.26 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 178.207 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.5 t80 69.85 -167.43 0.17 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.093 0.957 . . . . 0.0 108.693 -179.041 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.2 p -78.73 114.91 18.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.256 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.56 -130.31 5.58 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.826 1.203 . . . . 0.0 110.816 -179.285 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.65 73.18 2.7 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.195 0.903 . . . . 0.0 112.981 -178.94 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.3 m 56.55 69.82 1.64 Allowed Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.153 1.381 . . . . 0.0 112.401 178.885 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.99 85.03 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.212 3.274 . . . . 0.0 111.463 179.39 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.77 31.54 8.56 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.01 -0.883 . . . . 0.0 113.717 -179.203 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.4 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -157.08 -71.5 0.1 Allowed 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.75 1.275 . . . . 0.0 111.251 178.932 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -68.93 108.63 3.57 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.356 1.862 . . . . 0.0 114.926 -178.728 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -128.35 126.2 40.23 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 125.253 1.421 . . . . 0.0 111.846 179.693 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 m -93.74 144.2 10.03 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 176.699 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.7 t -137.63 127.18 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.042 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.7 pt -113.81 171.36 4.07 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 C-N-CA 125.188 1.395 . . . . 0.0 111.655 -178.352 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -85.22 165.95 16.94 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.881 1.672 . . . . 0.0 107.897 178.833 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.389 5.9 t -80.04 48.16 0.96 Allowed 'General case' 0 C--N 1.343 0.309 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -178.204 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -143.64 -85.59 0.14 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 102.071 -3.307 . . . . 0.0 102.071 176.754 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -163.61 -3.57 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.579 1.951 . . . . 0.0 114.616 178.687 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -79.67 122.4 26.5 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -176.084 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -63.32 117.15 6.22 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.507 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.65 -53.41 4.65 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 123.515 0.726 . . . . 0.0 110.761 -177.647 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.66 150.94 9.97 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.356 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.97 130.37 54.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.648 1.179 . . . . 0.0 108.145 179.565 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.8 pt -122.27 157.43 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.938 1.295 . . . . 0.0 108.579 -179.27 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.3 t -156.97 146.08 20.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -178.661 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.4 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 24.7 m170 -84.33 65.0 8.64 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 174.571 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.5 m -51.07 -46.61 61.81 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.927 0.785 . . . . 0.0 110.387 179.236 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.57 -51.48 0.03 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 179.401 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 30.25 -99.35 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 128.071 2.548 . . . . 0.0 112.669 -179.13 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.4 m -159.58 79.46 0.72 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.854 1.662 . . . . 0.0 107.251 179.141 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.49 -108.05 2.31 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.462 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -79.77 -5.9 56.23 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.736 0.814 . . . . 0.0 113.0 -179.325 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -64.64 160.86 18.86 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.002 0.819 . . . . 0.0 110.339 179.288 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -121.82 167.55 12.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.572 1.549 . . . . 0.0 113.656 -177.832 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.8 m -146.19 165.99 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 128.953 2.901 . . . . 0.0 105.928 176.737 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.2 144.96 17.09 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.369 0.509 . . . . 0.0 113.946 -178.238 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 13.9 m -94.3 165.24 12.68 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 124.092 0.957 . . . . 0.0 109.049 178.43 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 88.1 p 21.81 43.47 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 129.11 2.964 . . . . 0.0 118.091 -177.887 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.77 59.38 9.8 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.587 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.3 t -78.99 151.31 31.64 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.983 0.42 . . . . 0.0 110.689 -179.397 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 . . . . . 0 C--O 1.251 1.132 0 CA-C-O 116.468 -1.73 . . . . 0.0 110.779 -178.956 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.51 132.61 45.14 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.14 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.4 t -132.93 143.34 49.42 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -177.76 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.82 117.34 29.93 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.952 1.701 . . . . 0.0 108.212 178.885 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.8 m -103.76 78.18 1.54 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.896 1.278 . . . . 0.0 108.506 -178.814 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.51 -57.75 4.89 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.415 1.007 . . . . 0.0 111.723 179.392 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.1 t -150.79 -42.1 0.12 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.963 1.305 . . . . 0.0 110.56 -179.369 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.71 113.31 5.39 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.382 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -82.29 155.11 25.0 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.564 1.546 . . . . 0.0 111.394 -178.876 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -149.74 139.96 22.2 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.077 1.351 . . . . 0.0 109.092 178.956 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 m -81.52 160.19 23.98 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 124.862 1.265 . . . . 0.0 108.502 177.7 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.33 -23.42 48.71 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.863 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.2 p -77.85 -31.12 51.3 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.678 0.611 . . . . 0.0 110.286 -178.955 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.63 -39.43 70.42 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.939 0.896 . . . . 0.0 111.525 179.162 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.03 -38.66 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -179.141 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -72.0 -24.71 61.62 Favored 'General case' 0 C--N 1.347 0.461 0 C-N-CA 124.576 1.15 . . . . 0.0 112.384 179.124 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.47 -58.32 4.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.381 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.18 -23.34 63.92 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.076 179.33 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.73 -43.48 54.78 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 120.693 1.588 . . . . 0.0 111.292 178.944 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -66.93 -21.62 65.98 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.982 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.18 -64.3 1.17 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 -178.733 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.553 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -34.7 -53.05 0.54 Allowed 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.35 1.86 . . . . 0.0 111.226 175.952 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.3 t -56.75 -53.63 55.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.316 1.446 . . . . 0.0 110.919 179.446 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -73.87 -12.51 60.69 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -179.169 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -108.88 -19.24 13.47 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -178.832 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -80.84 -59.32 2.72 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.516 1.507 . . . . 0.0 112.785 -177.735 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -143.81 51.9 1.32 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.927 0.785 . . . . 0.0 111.713 -178.784 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -134.99 -53.58 0.8 Allowed 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.665 1.186 . . . . 0.0 108.835 178.764 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -138.4 86.21 2.14 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -178.977 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 68.23 -167.92 0.19 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.81 1.244 . . . . 0.0 110.215 -179.507 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.5 p -107.41 -41.02 5.2 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.17 1.388 . . . . 0.0 110.024 178.748 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 52.08 95.63 0.01 OUTLIER 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.505 1.922 . . . . 0.0 113.329 178.888 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.72 -95.64 0.99 Allowed Glycine 0 C--N 1.336 0.563 0 C-N-CA 124.816 1.198 . . . . 0.0 110.363 179.936 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m 54.8 67.48 1.01 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.413 1.085 . . . . 0.0 110.095 -179.09 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.4 t -113.08 -56.03 2.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 102.311 -3.218 . . . . 0.0 102.311 179.436 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.49 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 22.3 p -119.9 -31.54 4.46 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 127.645 2.378 . . . . 0.0 107.464 177.047 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' A' ' 37' ' ' THR . 1.8 m-85 -149.19 154.51 39.18 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 127.377 2.271 . . . . 0.0 110.044 -178.786 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.17 119.71 6.59 Favored 'Cis proline' 0 CA--C 1.542 0.907 0 N-CA-C 114.082 0.762 . . . . 0.0 114.082 1.93 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -127.85 158.83 36.67 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 125.966 1.706 . . . . 0.0 110.71 -179.343 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.9 m -59.64 135.7 57.76 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.996 2.118 . . . . 0.0 110.104 178.708 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -135.94 60.58 1.67 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.019 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -161.79 58.31 0.26 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.874 1.27 . . . . 0.0 109.076 -179.033 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -70.98 -62.69 1.3 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.968 0.907 . . . . 0.0 110.196 179.802 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -141.14 -80.66 0.25 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.949 1.3 . . . . 0.0 108.152 179.458 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -166.04 121.7 1.26 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -179.373 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.69 -73.59 0.05 OUTLIER Glycine 0 C--N 1.336 0.565 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 178.941 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.21 171.71 8.43 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.012 0.925 . . . . 0.0 109.446 179.068 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -128.46 146.37 50.83 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.142 0.977 . . . . 0.0 111.168 -179.201 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -153.1 155.17 31.76 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 125.866 1.667 . . . . 0.0 108.201 -179.707 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.28 -32.63 61.58 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.945 2.43 . . . . 0.0 111.137 178.874 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.9 m -74.78 164.93 3.38 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 C-N-CA 123.576 0.75 . . . . 0.0 111.094 179.276 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -100.43 -61.3 1.39 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.024 1.33 . . . . 0.0 109.203 179.431 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 135.77 -165.72 24.75 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.71 1.148 . . . . 0.0 110.998 179.441 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.61 138.21 23.31 Favored 'Cis proline' 0 C--N 1.345 0.392 0 CA-C-N 118.247 1.024 . . . . 0.0 111.533 -0.632 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -135.25 138.95 44.04 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 179.989 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -125.3 157.81 35.73 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.626 1.57 . . . . 0.0 112.116 -178.748 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.33 157.26 25.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 127.631 2.373 . . . . 0.0 114.151 -177.934 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.553 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 60.7 t80 -160.8 113.36 1.32 Allowed Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.248 1.019 . . . . 0.0 110.157 177.915 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . 0.269 24.8 Cg_endo -70.52 138.64 35.86 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 CA-C-N 120.17 1.097 . . . . 0.0 112.731 -177.243 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.499 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -80.96 -149.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -176.969 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.499 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 27.0 mmmt -83.35 -171.04 3.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 131.156 3.783 . . . . 0.0 111.945 -178.15 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.3 t 91.56 54.97 0.0 OUTLIER 'General case' 0 C--N 1.343 0.295 0 C-N-CA 129.56 3.144 . . . . 0.0 105.383 -178.008 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.21 -46.02 0.84 Allowed Glycine 0 CA--C 1.53 0.997 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -178.377 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.29 172.09 24.09 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.364 1.459 . . . . 0.0 109.989 179.41 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.35 114.46 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 178.939 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 75.1 t80 61.63 75.81 0.39 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.163 1.385 . . . . 0.0 111.462 -179.181 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 t -160.26 -178.34 6.89 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.341 1.057 . . . . 0.0 110.128 178.724 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.16 -150.54 1.94 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.665 1.126 . . . . 0.0 112.316 179.508 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.4 -55.3 4.72 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -178.997 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.4 t -137.8 79.52 33.54 Favored Pre-proline 0 N--CA 1.451 -0.386 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.647 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -35.09 -54.63 0.63 Allowed 'Trans proline' 0 C--N 1.349 0.595 1 C-N-CA 126.242 4.628 . . . . 0.0 116.362 -175.824 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.72 99.26 0.16 Allowed Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.59 -0.815 . . . . 0.0 113.559 -179.231 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.442 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -155.11 -76.52 0.1 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 177.244 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.59 110.53 1.15 Allowed 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.761 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -136.29 119.66 16.84 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.821 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.4 m -89.15 152.0 3.4 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 176.622 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -137.75 141.77 38.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -176.982 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.59 179.56 4.17 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 123.72 0.808 . . . . 0.0 112.531 -178.485 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -96.38 169.84 9.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.461 1.905 . . . . 0.0 110.015 -178.62 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.278 6.5 t -76.56 28.03 0.13 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 118.051 2.611 . . . . 0.0 118.051 -177.967 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -129.5 -78.0 0.55 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 102.648 -3.093 . . . . 0.0 102.648 177.167 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.09 -19.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -178.686 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -79.28 145.57 33.45 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -175.4 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . 0.267 31.7 m-85 -63.61 157.16 24.55 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 127.498 2.319 . . . . 0.0 115.497 -179.042 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -113.84 -44.53 3.16 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 175.556 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.01 -148.45 20.22 Favored Glycine 0 C--N 1.349 1.262 0 C-N-CA 126.222 1.867 . . . . 0.0 111.752 177.576 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.84 147.77 35.96 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-O 121.554 0.693 . . . . 0.0 112.283 -178.79 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 pt -147.0 167.39 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 127.017 2.127 . . . . 0.0 108.376 -179.108 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.6 t -158.88 148.13 18.82 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 179.548 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.442 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 24.7 m170 -83.67 36.1 0.53 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.196 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.3 t -58.72 -35.51 72.79 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.46 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -173.25 60.35 0.14 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.568 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -97.17 -71.06 0.69 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.279 1.032 . . . . 0.0 108.999 179.323 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.3 t -170.66 -62.86 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.758 1.623 . . . . 0.0 109.041 179.219 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.46 -87.11 0.06 OUTLIER Glycine 0 C--N 1.338 0.671 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 179.407 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -79.87 -18.25 51.16 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.531 0.732 . . . . 0.0 110.215 178.743 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -65.03 168.36 6.64 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.369 1.468 . . . . 0.0 110.727 179.327 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -136.27 169.79 17.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.914 1.285 . . . . 0.0 113.056 -177.972 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.3 m -141.38 164.82 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.94 2.096 . . . . 0.0 106.424 176.65 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.47 142.65 27.26 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 115.029 0.772 . . . . 0.0 115.029 -177.493 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 24.6 t -109.37 169.99 8.35 Favored 'General case' 0 C--N 1.341 0.202 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 177.671 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.36 -157.57 0.33 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.684 -0.635 . . . . 0.0 109.425 -178.3 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.53 -9.34 58.25 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 124.183 0.897 . . . . 0.0 111.396 177.346 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.7 m -79.41 143.42 35.06 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 125.17 1.388 . . . . 0.0 108.982 179.213 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.189 1.396 . . . . 0.0 109.956 -179.217 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 81.6 p . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.33 127.43 8.96 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.061 1.345 . . . . 0.0 111.084 179.104 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -111.61 123.48 50.32 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.814 1.246 . . . . 0.0 109.713 -178.802 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -129.71 93.66 3.57 Favored 'General case' 0 N--CA 1.428 -1.53 1 N-CA-C 98.558 -4.608 . . . . 0.0 98.558 176.839 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.5 m -102.91 88.3 3.15 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.195 0.598 . . . . 0.0 110.295 -177.655 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.07 -79.38 1.02 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -178.946 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.2 p -132.83 -31.69 1.3 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.304 1.842 . . . . 0.0 110.464 178.521 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 m -67.41 106.7 2.19 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.024 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -108.07 141.66 39.42 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.546 1.138 . . . . 0.0 111.738 -178.352 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -144.45 144.33 31.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.779 1.632 . . . . 0.0 108.155 179.356 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.8 t -70.11 155.43 40.63 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 124.448 1.099 . . . . 0.0 109.912 178.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.71 -21.94 56.23 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 176.388 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -73.2 -35.85 66.43 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 125.157 1.383 . . . . 0.0 109.959 179.215 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.2 tp-100 -73.75 -35.56 65.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.173 0.589 . . . . 0.0 112.384 179.185 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 t -69.02 -47.13 77.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.377 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.3 ptt85 -65.26 -43.26 91.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.02 0.528 . . . . 0.0 110.554 179.551 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.72 89.5 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.543 0.737 . . . . 0.0 109.398 179.023 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.81 -38.98 79.81 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.369 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.92 -29.73 62.2 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 178.506 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -70.81 -24.1 62.49 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.494 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HB1' ' CE2' ' A' ' 26' ' ' TYR . . . -77.36 -64.3 1.17 Allowed 'General case' 0 C--N 1.346 0.441 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 -178.76 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.535 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -39.25 -50.59 1.98 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.078 1.351 . . . . 0.0 112.211 176.445 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -51.99 -62.88 1.35 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 128.029 2.531 . . . . 0.0 111.586 179.324 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -66.03 -42.12 90.03 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.543 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.422 ' CE2' ' HB1' ' A' ' 22' ' ' ALA . 6.4 m-30 -67.54 -30.85 70.6 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.418 1.087 . . . . 0.0 113.149 -177.728 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -84.48 -44.64 13.43 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 118.957 0.799 . . . . 0.0 112.12 -179.739 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -69.56 -51.13 38.25 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.233 0.613 . . . . 0.0 111.648 -179.007 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -78.03 -20.61 52.11 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.789 -179.458 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 63.74 65.21 0.73 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 124.935 1.294 . . . . 0.0 110.362 179.815 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -150.55 167.38 27.38 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 126.032 1.733 . . . . 0.0 108.049 179.099 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.287 0.0 OUTLIER 49.53 71.58 0.38 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.263 1.025 . . . . 0.0 113.46 -179.459 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.63 144.91 25.54 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.06 1.344 . . . . 0.0 108.549 179.179 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.72 -165.85 23.0 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.804 -0.519 . . . . 0.0 111.804 -179.42 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.1 m -83.86 46.66 1.2 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.904 0.882 . . . . 0.0 111.139 -179.384 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 87.7 p -146.75 161.54 40.4 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 178.733 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.7 p -80.11 33.31 0.28 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.885 -179.556 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -92.65 127.23 48.99 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 119.922 1.237 . . . . 0.0 109.504 -178.462 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -60.95 120.67 1.21 Allowed 'Cis proline' 0 C--N 1.348 0.506 0 N-CA-C 116.144 1.556 . . . . 0.0 116.144 -1.426 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -103.65 157.3 17.16 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.488 1.115 . . . . 0.0 108.84 178.933 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.92 118.86 8.36 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 122.706 0.403 . . . . 0.0 110.956 179.871 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.92 105.4 13.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 178.771 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -153.59 143.16 21.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.93 0.892 . . . . 0.0 110.296 -178.664 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 56.0 -134.0 1.44 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.07 1.348 . . . . 0.0 110.999 178.998 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 73.92 -73.7 0.09 Allowed 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.139 1.776 . . . . 0.0 109.065 -179.302 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -127.82 -37.09 1.96 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.787 1.635 . . . . 0.0 109.176 178.949 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.09 70.65 1.3 Allowed Glycine 0 C--N 1.342 0.874 0 C-N-CA 124.243 0.925 . . . . 0.0 112.027 178.92 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.33 -169.05 2.42 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.689 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -154.64 156.94 37.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.487 0.715 . . . . 0.0 110.689 179.449 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -148.92 144.51 18.24 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 125.739 1.616 . . . . 0.0 107.616 178.681 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -45.19 -45.47 14.74 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.49 3.46 . . . . 0.0 113.371 178.649 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -83.31 149.11 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 124.158 0.983 . . . . 0.0 110.482 179.323 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -91.61 168.7 11.32 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.855 1.262 . . . . 0.0 111.162 -178.854 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.08 -158.16 27.3 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.386 0.993 . . . . 0.0 111.797 -179.244 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.91 128.09 2.94 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 CA-C-N 118.215 1.007 . . . . 0.0 112.202 -0.362 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.44 158.33 21.71 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.907 2.083 . . . . 0.0 109.025 178.793 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -137.08 164.28 28.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.558 -177.954 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.98 157.54 26.8 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 126.709 2.004 . . . . 0.0 110.698 -178.078 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.535 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 56.9 t80 -160.12 96.77 1.51 Allowed Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 176.246 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.58 145.76 47.78 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 C-N-CA 120.379 0.719 . . . . 0.0 110.935 -176.119 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.589 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 2.9 tt -109.33 -172.77 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 124.253 1.978 . . . . 0.0 111.589 178.639 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.589 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 2.9 tttm -160.02 152.13 20.55 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 109.12 -3.673 . . . . 0.0 109.84 -179.397 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.1 t -76.58 52.27 0.79 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.628 1.571 . . . . 0.0 113.748 -178.165 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.0 43.05 0.24 Allowed Glycine 0 CA--C 1.526 0.759 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.402 178.016 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.58 76.48 0.03 OUTLIER Glycine 0 C--N 1.345 1.049 0 CA-C-N 119.53 1.665 . . . . 0.0 116.247 178.767 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 67' ' ' TYR 0.333 8.6 p 37.06 -139.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.43 0 C-N-CA 126.167 1.787 . . . . 0.0 113.385 177.683 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.422 ' H ' HG22 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -58.12 -175.9 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.604 2.362 . . . . 0.0 114.173 178.548 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.1 p -78.92 158.74 27.98 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.398 1.079 . . . . 0.0 113.854 -177.373 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 178.77 47.98 0.07 OUTLIER Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.247 1.88 . . . . 0.0 108.686 179.247 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 170.25 -160.19 32.91 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.139 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 76.9 p -158.84 156.71 27.36 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 124.752 1.221 . . . . 0.0 109.437 -179.329 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -79.74 166.07 78.22 Favored 'Cis proline' 0 N--CA 1.458 -0.56 0 CA-C-N 119.427 0.831 . . . . 0.0 111.36 -2.505 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.64 -109.45 1.1 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 124.224 0.916 . . . . 0.0 112.406 -178.935 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.484 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . 58.68 35.39 24.41 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 125.362 1.465 . . . . 0.0 111.541 -178.753 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -152.51 107.77 3.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.324 1.05 . . . . 0.0 110.529 178.377 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.44 130.56 19.54 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.51 -179.314 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.4 m -98.52 157.29 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 176.361 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.6 t -135.44 133.15 52.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -178.479 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -116.61 -179.95 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.781 1.232 . . . . 0.0 112.444 -178.307 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -101.45 174.82 5.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.952 2.101 . . . . 0.0 109.548 179.128 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.31 13.7 t -82.19 49.08 1.34 Allowed 'General case' 0 C--N 1.345 0.386 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -178.576 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -152.46 -87.99 0.06 Allowed 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 177.429 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 94.9 m -161.83 -0.22 0.05 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.874 2.469 . . . . 0.0 113.879 -176.898 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -80.06 138.85 37.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.364 0.984 . . . . 0.0 113.063 -176.866 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -80.0 128.39 33.42 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.405 1.482 . . . . 0.0 108.042 178.829 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.28 -47.89 6.42 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 123.556 0.743 . . . . 0.0 110.505 179.605 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.15 -174.24 46.25 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 179.339 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.97 141.88 44.48 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.39 1.476 . . . . 0.0 109.915 179.329 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.5 pt -141.07 157.26 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.795 1.238 . . . . 0.0 109.621 -179.079 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.0 t -150.81 149.81 30.19 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.126 0.97 . . . . 0.0 113.402 -178.48 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.484 ' HB2' ' CB ' ' A' ' 74' ' ' ALA 0.266 37.8 m170 -79.51 -24.1 42.49 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.972 0.805 . . . . 0.0 109.118 175.999 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.1 m -50.75 102.55 0.04 OUTLIER 'General case' 0 C--N 1.343 0.299 0 C-N-CA 126.339 1.855 . . . . 0.0 109.255 178.994 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.13 63.23 1.75 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -178.646 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.47 179.57 8.05 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.385 1.074 . . . . 0.0 110.609 179.571 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.7 t -86.18 62.07 7.21 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.507 1.523 . . . . 0.0 110.527 -179.353 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.21 -90.03 0.43 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.824 1.678 . . . . 0.0 113.199 178.418 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.35 -23.12 43.62 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.148 0.979 . . . . 0.0 111.344 -179.064 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -59.75 158.38 10.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.472 1.109 . . . . 0.0 112.129 -179.086 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -121.15 135.0 55.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.084 1.754 . . . . 0.0 108.991 -179.459 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 m -110.06 163.5 6.97 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.697 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.65 149.34 31.62 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.894 0.759 . . . . 0.0 112.935 -178.439 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.7 t -137.26 164.67 27.97 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 125.725 1.61 . . . . 0.0 108.849 178.76 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 96.4 p 46.47 50.65 12.47 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.366 2.267 . . . . 0.0 112.631 -179.649 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.12 64.04 2.28 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.241 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -146.01 132.99 20.22 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.863 1.265 . . . . 0.0 108.132 179.083 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 116.756 -1.592 . . . . 0.0 109.036 179.352 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.84 97.52 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.416 1.886 . . . . 0.0 110.878 179.34 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.5 m -99.69 121.73 41.67 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.46 1.904 . . . . 0.0 107.504 -178.733 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -122.59 111.29 16.6 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -179.683 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.3 m -100.04 81.91 2.48 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.484 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.89 -95.36 0.72 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.317 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.6 p -104.23 -36.33 7.68 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.116 1.366 . . . . 0.0 110.977 179.375 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -73.83 103.77 4.48 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.113 0.565 . . . . 0.0 110.099 -178.876 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -83.06 152.91 25.16 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.43 1.092 . . . . 0.0 110.622 -179.243 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -148.11 137.71 22.33 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.964 0.906 . . . . 0.0 111.281 -179.815 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.5 m -78.17 150.44 33.56 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.475 1.51 . . . . 0.0 107.757 178.295 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.96 -17.5 25.3 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.087 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.2 t -74.55 -44.99 48.43 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 124.506 1.122 . . . . 0.0 109.513 178.956 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -68.7 -43.73 75.42 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.051 0.94 . . . . 0.0 110.917 -179.894 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.9 t -56.72 -54.4 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 C-N-CA 126.988 2.115 . . . . 0.0 109.135 178.954 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -67.93 -43.05 80.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.071 -178.128 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.8 -49.48 77.33 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.694 0.679 . . . . 0.0 109.674 179.297 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.82 -31.75 68.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.313 1.045 . . . . 0.0 110.478 178.837 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.47 -38.47 29.87 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 179.769 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -66.7 -22.12 66.08 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.419 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.09 -54.91 5.53 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -179.182 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.439 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -46.77 -43.71 18.43 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.431 1.492 . . . . 0.0 112.499 177.853 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.0 p -73.28 -43.42 61.04 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.996 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -60.99 -31.02 70.63 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.137 0.426 . . . . 0.0 110.685 178.737 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -97.14 -3.88 40.26 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.341 1.457 . . . . 0.0 113.135 -179.177 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -57.45 -24.82 57.92 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.358 -0.839 . . . . 0.0 111.663 178.722 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.467 0.0 OUTLIER 127.73 59.44 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.634 1 C-N-CA 135.15 5.38 . . . . 0.0 112.837 -178.221 . . . . . . . . 4 3 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -129.16 -35.11 1.83 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.696 1.198 . . . . 0.0 112.188 -179.109 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -153.96 64.72 0.71 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.22 0.918 . . . . 0.0 113.127 179.505 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 t70 57.89 -170.32 0.11 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.315 1.446 . . . . 0.0 113.285 178.154 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.3 p 47.68 43.67 16.79 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.924 1.69 . . . . 0.0 112.94 179.049 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.85 -175.59 3.54 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.279 1.431 . . . . 0.0 114.426 -178.532 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -32.35 138.02 0.1 Allowed Glycine 0 C--N 1.341 0.846 0 C-N-CA 128.118 2.771 . . . . 0.0 117.558 -178.217 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.9 m -101.88 -55.94 2.39 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.311 1.444 . . . . 0.0 110.629 -179.519 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.6 p -97.65 -63.57 1.12 Allowed 'General case' 0 C--N 1.346 0.454 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -179.256 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.8 p -146.41 -42.03 0.2 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.598 1.959 . . . . 0.0 110.376 -179.532 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -91.59 151.6 42.62 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 124.692 1.197 . . . . 0.0 109.746 -178.088 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -84.38 134.2 20.57 Favored 'Cis proline' 0 N--CA 1.45 -1.048 0 CA-C-N 119.655 0.913 . . . . 0.0 111.127 -1.72 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.05 172.9 15.15 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 126.033 1.733 . . . . 0.0 108.207 179.412 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 t -60.4 147.77 39.66 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.715 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -80.01 116.61 20.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.998 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -68.48 -52.75 28.9 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.654 1.181 . . . . 0.0 112.301 -179.345 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -88.38 -170.04 2.8 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.482 1.113 . . . . 0.0 111.173 -179.061 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -129.07 -50.78 1.21 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.635 1.974 . . . . 0.0 108.638 179.505 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 53.99 70.61 0.59 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.326 1.85 . . . . 0.0 113.763 178.455 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.45 -98.38 0.24 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.684 1.135 . . . . 0.0 113.217 178.579 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.05 154.15 16.27 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.689 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -121.21 -170.11 1.96 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 126.23 1.812 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -131.25 158.38 75.41 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 125.328 1.451 . . . . 0.0 108.233 -178.63 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.409 ' O ' HG13 ' A' ' 52' ' ' VAL . 81.2 Cg_endo -73.5 66.57 4.58 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 124.006 3.137 . . . . 0.0 113.226 -178.766 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 51' ' ' PRO . 3.0 m -163.1 164.94 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 126.86 2.064 . . . . 0.0 108.873 179.315 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -84.77 -58.99 2.49 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.478 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.95 177.63 15.02 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.11 1.338 . . . . 0.0 110.516 -179.321 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.57 139.17 58.46 Favored 'Cis proline' 0 N--CA 1.457 -0.629 0 CA-C-N 117.916 0.858 . . . . 0.0 111.442 0.127 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -114.8 150.79 34.89 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.891 1.277 . . . . 0.0 109.511 178.698 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -113.7 159.32 19.84 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -177.002 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -98.7 152.48 19.61 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.133 1.773 . . . . 0.0 109.529 179.132 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 58.6 t80 -160.84 119.83 1.53 Allowed Pre-proline 0 C--O 1.223 -0.301 0 C-N-CA 124.008 0.923 . . . . 0.0 108.707 177.272 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.91 122.97 3.09 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 121.229 1.286 . . . . 0.0 113.795 -177.572 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 62' ' ' LYS . 4.4 tp -86.17 168.25 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 CA-C-O 123.678 1.704 . . . . 0.0 111.998 179.293 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.408 ' N ' HG13 ' A' ' 61' ' ' ILE . 25.9 mmtt -158.64 158.11 33.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 109.233 -3.621 . . . . 0.0 111.604 -178.851 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.1 m -84.92 60.04 5.97 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.813 1.645 . . . . 0.0 110.36 -178.946 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.85 -61.69 0.01 OUTLIER Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 179.083 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.85 -104.47 0.19 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.207 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.24 163.97 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.429 1.092 . . . . 0.0 108.438 -179.455 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.93 152.63 12.52 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -178.37 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.8 p -139.21 -65.68 0.48 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.649 1.58 . . . . 0.0 108.575 179.378 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.02 105.11 0.27 Allowed Glycine 0 C--N 1.341 0.837 0 C-N-CA 124.417 1.008 . . . . 0.0 110.783 179.301 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -150.1 19.97 1.09 Allowed Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.808 -0.996 . . . . 0.0 113.069 179.313 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.1 m 67.42 119.97 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 126.375 1.87 . . . . 0.0 112.069 179.204 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.71 -176.24 17.91 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 CA-C-N 119.785 0.959 . . . . 0.0 112.499 0.131 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.07 66.99 0.32 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 108.19 -1.964 . . . . 0.0 108.19 179.287 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.95 -58.85 2.27 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.474 0.71 . . . . 0.0 112.097 -178.831 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -61.14 117.83 6.05 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.434 1.494 . . . . 0.0 113.398 -178.116 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -138.56 118.15 13.02 Favored 'General case' 0 C--N 1.344 0.368 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.159 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.5 m -81.64 148.39 5.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 176.879 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.27 53.6 t -130.97 111.51 20.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -178.071 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -101.12 -179.67 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 125.861 1.664 . . . . 0.0 113.936 -176.382 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -101.86 155.16 18.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 127.957 2.503 . . . . 0.0 108.62 179.875 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.282 11.4 t -64.11 -8.45 12.1 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -178.323 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -84.27 -80.74 0.19 Allowed 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 102.485 -3.154 . . . . 0.0 102.485 177.645 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 23.4 m -164.34 -7.39 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 129.589 3.155 . . . . 0.0 114.951 -179.17 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -79.68 132.76 36.29 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 116.501 2.038 . . . . 0.0 116.501 -175.314 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -75.34 123.16 24.87 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.152 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.51 -59.55 2.28 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.825 0.85 . . . . 0.0 111.258 -178.184 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.11 164.28 33.54 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -179.899 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.29 158.81 19.29 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.814 0.816 . . . . 0.0 112.25 -178.858 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.8 pt -140.46 160.3 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.329 2.252 . . . . 0.0 106.859 179.288 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.3 t -156.65 152.15 26.78 Favored 'General case' 0 C--N 1.343 0.326 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -179.046 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -83.57 38.34 0.62 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.337 0.655 . . . . 0.0 111.07 176.571 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.2 m -77.7 -73.3 0.31 Allowed 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.369 0.986 . . . . 0.0 109.624 -179.334 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.35 -9.21 60.63 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.489 1.043 . . . . 0.0 112.116 178.939 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.81 155.07 27.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.555 1.542 . . . . 0.0 111.748 178.993 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.8 m -68.89 -50.09 52.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.659 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.93 -84.29 0.05 OUTLIER Glycine 0 CA--C 1.527 0.787 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.193 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -89.01 0.32 56.77 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.127 0.971 . . . . 0.0 111.891 179.828 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -71.34 -170.57 0.51 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.863 0.865 . . . . 0.0 110.56 179.516 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -147.78 160.88 42.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.644 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.1 m -142.41 162.7 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 127.585 2.354 . . . . 0.0 106.334 177.012 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.98 121.53 5.55 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.074 0.845 . . . . 0.0 114.401 -178.808 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.44 159.6 15.03 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.65 1.18 . . . . 0.0 109.404 178.502 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.7 p 60.27 45.22 11.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.472 1.909 . . . . 0.0 111.042 -178.781 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.01 44.17 96.3 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.299 0.952 . . . . 0.0 111.928 179.448 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.9 m -104.84 149.53 25.59 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.625 1.17 . . . . 0.0 109.362 179.316 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.106 0 C-N-CA 124.445 1.098 . . . . 0.0 108.146 179.083 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.03 124.58 19.18 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.427 1.091 . . . . 0.0 109.817 179.274 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 p -89.46 81.39 6.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -178.309 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.27 92.09 6.88 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 175.877 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -100.51 79.06 2.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.535 1.534 . . . . 0.0 109.324 -177.643 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.76 -70.62 1.98 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.345 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.2 p -137.98 -34.11 0.68 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.632 1.573 . . . . 0.0 111.877 179.453 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 m -72.67 93.55 1.65 Allowed 'General case' 0 C--N 1.345 0.389 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.148 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -96.6 113.74 25.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.777 1.631 . . . . 0.0 112.869 -178.43 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -109.78 144.75 37.77 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.885 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 16' ' ' VAL . 50.0 m -66.37 152.3 45.33 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 124.229 1.011 . . . . 0.0 109.527 179.148 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.94 -24.73 25.16 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.705 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.4 t -71.33 -43.79 66.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.146 1.378 . . . . 0.0 109.594 179.31 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -71.86 -29.47 64.41 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -179.263 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 12' ' ' SER . 1.9 t -72.29 -45.26 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.28 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -67.86 -32.94 73.79 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.37 1.068 . . . . 0.0 111.857 179.393 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.04 -58.17 5.43 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.444 1.02 . . . . 0.0 110.135 -179.265 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.4 ' HB1' ' HE2' ' A' ' 59' ' ' PHE . . . -60.53 -37.09 80.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.787 -178.843 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.78 58.63 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 179.413 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -68.78 -19.89 64.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.785 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.54 -60.86 2.17 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 179.525 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.463 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . . . -48.71 -41.34 31.55 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.371 1.068 . . . . 0.0 112.4 177.219 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -55.74 30.86 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.002 1.321 . . . . 0.0 109.906 179.014 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -56.55 -31.47 64.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.675 1.19 . . . . 0.0 110.893 -178.379 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 -89.07 -32.05 17.74 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -178.832 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -63.94 -36.53 84.26 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.636 1.107 . . . . 0.0 113.927 -177.7 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -105.33 27.0 8.72 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.975 0.91 . . . . 0.0 111.98 -178.513 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.99 -36.83 8.46 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.076 0.95 . . . . 0.0 111.992 179.338 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.7 t70 83.49 96.19 0.04 OUTLIER 'General case' 0 C--N 1.344 0.345 0 C-N-CA 127.354 2.262 . . . . 0.0 108.789 -178.597 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 70.99 109.0 0.06 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 127.192 2.197 . . . . 0.0 109.65 -178.755 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -175.97 -47.98 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.25 1.42 . . . . 0.0 111.422 -177.622 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.88 96.92 3.21 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.986 0.514 . . . . 0.0 109.845 -179.288 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.16 49.62 3.78 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.564 1.078 . . . . 0.0 110.461 179.705 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.0 m -89.14 -76.49 0.41 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.799 1.239 . . . . 0.0 108.374 -179.463 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.8 t -173.72 -64.98 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.114 1.765 . . . . 0.0 106.48 179.235 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.525 HG23 ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -150.08 8.67 0.65 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.388 1.475 . . . . 0.0 111.857 178.84 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -94.95 129.8 34.7 Favored Pre-proline 0 C--N 1.345 0.382 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.294 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -70.15 129.0 13.94 Favored 'Cis proline' 0 N--CA 1.456 -0.726 0 N-CA-C 115.444 1.286 . . . . 0.0 115.444 0.115 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.525 ' CE1' HG23 ' A' ' 37' ' ' THR 0.252 21.3 m-70 -96.87 143.65 27.57 Favored 'General case' 0 C--N 1.343 0.298 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 178.059 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 t -63.14 142.15 58.49 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.584 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -107.35 119.26 38.92 Favored 'General case' 0 C--O 1.23 0.048 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.04 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -149.64 -63.57 0.22 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.279 1.832 . . . . 0.0 107.085 178.921 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.4 t30 50.91 -115.56 0.88 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.03 1.732 . . . . 0.0 112.044 178.798 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -169.37 -174.96 2.08 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.02 2.128 . . . . 0.0 107.627 -179.165 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 76.93 157.42 0.18 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.801 1.641 . . . . 0.0 110.869 179.319 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.45 70.14 2.47 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.077 0.846 . . . . 0.0 111.292 179.19 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.5 111.74 6.55 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.167 1.387 . . . . 0.0 107.809 179.042 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -148.31 -175.49 4.93 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.847 1.259 . . . . 0.0 108.355 179.721 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -132.01 144.97 55.42 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.662 1.185 . . . . 0.0 108.647 -179.076 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.23 67.3 6.95 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 124.36 3.373 . . . . 0.0 112.293 -179.226 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.05 -170.65 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 127.496 2.318 . . . . 0.0 107.573 179.246 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -118.57 131.33 56.21 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.765 1.226 . . . . 0.0 109.606 179.18 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.02 -172.23 45.92 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.324 0.964 . . . . 0.0 112.341 -179.353 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.95 151.93 97.61 Favored 'Cis proline' 0 N--CA 1.458 -0.594 0 CA-C-N 118.041 0.92 . . . . 0.0 111.809 0.078 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -118.14 176.28 5.29 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.861 1.265 . . . . 0.0 109.942 179.324 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.12 153.51 31.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.972 178.992 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.274 8.0 tp10 -79.92 150.05 30.67 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.099 2.56 . . . . 0.0 111.579 -177.7 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 77.7 t80 -155.27 106.0 2.23 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.004 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.429 ' HG2' ' CD1' ' A' ' 67' ' ' TYR . 60.5 Cg_endo -72.71 135.06 23.11 Favored 'Trans proline' 0 N--CA 1.442 -1.542 0 N-CA-C 107.674 -1.702 . . . . 0.0 107.674 -177.311 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.466 ' CG1' ' H ' ' A' ' 62' ' ' LYS 0.266 0.1 OUTLIER -85.76 -147.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.34 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -176.1 . . . . . . . . 4 4 . 1 . 042 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.466 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.9 mmmm -79.25 166.28 22.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 110.936 -2.847 . . . . 0.0 111.401 -178.287 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.2 m 132.31 51.73 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.493 1 C-N-CA 133.199 4.599 . . . . 0.0 104.723 -177.987 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.54 -52.09 0.59 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.665 1.602 . . . . 0.0 109.243 -178.545 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 177.53 -164.72 34.02 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.483 1.04 . . . . 0.0 110.562 179.728 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.6 p -75.25 71.33 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.92 1.288 . . . . 0.0 107.975 178.888 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.429 ' CD1' ' HG2' ' A' ' 60' ' ' PRO . 34.7 t80 65.81 80.07 0.23 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 128.484 2.713 . . . . 0.0 111.251 -178.269 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 t -157.78 105.59 2.01 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.782 1.233 . . . . 0.0 108.909 179.083 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 179.13 -118.71 0.61 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.4 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 174.29 -99.4 0.14 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.159 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.0 m -60.84 -58.2 21.0 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.241 1.016 . . . . 0.0 112.138 179.534 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.17 134.31 36.17 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.064 1.843 . . . . 0.0 110.497 177.788 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.99 -103.64 0.17 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 179.522 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.441 ' HB1' ' H ' ' A' ' 91' ' ' HIS . . . 72.66 -46.42 0.65 Allowed 'General case' 0 C--N 1.344 0.366 0 C-N-CA 127.257 2.223 . . . . 0.0 113.502 -179.645 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.24 125.17 28.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.848 1.659 . . . . 0.0 112.744 -178.488 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -146.28 124.18 12.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.686 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.5 m -86.76 156.17 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 103.317 -2.846 . . . . 0.0 103.317 177.098 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 73.3 t -134.89 115.49 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 -178.08 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 85' ' ' TYR . 1.8 pt -95.52 165.92 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.428 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -176.313 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -99.75 163.03 12.65 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 124.677 1.191 . . . . 0.0 108.185 178.949 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.327 5.2 t -74.11 27.84 0.08 Allowed 'General case' 0 C--N 1.339 0.144 0 N-CA-C 119.698 3.221 . . . . 0.0 119.698 -177.232 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -123.35 -79.32 0.61 Allowed 'General case' 0 N--CA 1.441 -0.917 1 N-CA-C 100.058 -4.053 . . . . 0.0 100.058 176.61 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.0 t -164.13 -24.03 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.14 1.776 . . . . 0.0 114.409 179.008 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -79.68 127.42 32.17 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -176.442 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 79' ' ' ILE 0.344 4.5 p90 -82.24 147.67 28.82 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 123.665 0.603 . . . . 0.0 111.343 -178.922 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.81 -46.26 19.13 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.655 1.182 . . . . 0.0 111.335 -177.338 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.79 -153.69 16.6 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.116 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.82 150.36 32.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.393 0.616 . . . . 0.0 111.402 -179.308 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 44.2 pt -138.47 157.86 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.031 1.733 . . . . 0.0 108.043 -179.337 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.8 t -157.7 154.89 29.01 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.063 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.441 ' H ' ' HB1' ' A' ' 74' ' ' ALA . 11.3 m170 -79.34 -14.89 58.69 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 123.344 0.403 . . . . 0.0 110.297 175.517 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.3 m -62.0 115.3 3.96 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 123.873 0.869 . . . . 0.0 109.832 -179.304 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.27 -15.3 63.52 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.959 0.79 . . . . 0.0 112.382 -179.11 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.97 -177.45 5.57 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.446 1.098 . . . . 0.0 111.4 -179.564 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.8 t -87.36 59.46 5.54 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.836 1.255 . . . . 0.0 111.141 -179.396 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.34 -89.31 1.01 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.971 1.272 . . . . 0.0 112.865 178.486 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -79.8 -31.6 40.74 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.405 1.082 . . . . 0.0 111.22 -179.35 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -55.21 165.65 0.69 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.685 1.594 . . . . 0.0 111.709 179.627 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -120.18 155.25 33.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.48 1.512 . . . . 0.0 111.956 -179.178 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.3 m -139.17 163.05 27.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 C-N-CA 125.949 1.7 . . . . 0.0 107.96 177.794 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.81 140.15 19.94 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.892 0.758 . . . . 0.0 112.183 -178.717 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 t -83.22 -177.41 6.74 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.658 1.183 . . . . 0.0 109.73 178.949 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.8 t -70.51 112.35 6.72 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.822 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.86 -41.24 2.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -178.95 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.1 m -86.49 94.19 9.35 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.988 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 t30 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.225 -1.369 . . . . 0.0 109.445 -178.918 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.2 m -77.29 123.5 26.56 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 77.29 66.77 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.31 140.28 29.76 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 125.502 1.521 . . . . 0.0 109.136 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.02 121.95 35.86 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.5 m -102.14 78.8 1.8 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.154 1.381 . . . . 0.0 107.864 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.38 -97.45 0.68 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 t -100.35 -39.56 7.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.933 1.293 . . . . 0.0 110.034 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.5 m -72.25 96.49 1.84 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.347 1.059 . . . . 0.0 109.767 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -79.92 155.67 27.63 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.257 1.023 . . . . 0.0 110.867 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -143.35 119.76 10.96 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.218 1.007 . . . . 0.0 110.744 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.5 t -60.24 159.09 10.37 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.147 1.779 . . . . 0.0 110.663 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.02 -17.34 51.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.3 t -76.86 -43.93 34.18 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.601 1.16 . . . . 0.0 108.743 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.81 -45.89 80.66 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 124.665 1.186 . . . . 0.0 111.305 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.433 HG13 ' CE2' ' A' ' 85' ' ' TYR . 73.6 t -58.2 -52.6 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.739 1.216 . . . . 0.0 108.345 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -68.18 -31.6 71.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.3 1.44 . . . . 0.0 113.484 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.14 -60.05 2.93 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.933 0.788 . . . . 0.0 109.417 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 -30.25 71.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.462 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.07 -51.51 15.54 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 119.507 -0.283 . . . . 0.0 111.494 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -60.36 -19.7 56.66 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.32 -72.16 0.27 Allowed 'General case' 0 C--N 1.347 0.49 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.599 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -56.03 -29.47 60.46 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.224 0.92 . . . . 0.0 111.788 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.6 t -56.86 -44.13 81.87 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.485 1.039 . . . . 0.0 109.005 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -96.58 4.01 52.24 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -126.54 -12.43 6.12 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -74.65 -53.09 9.98 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 119.186 0.903 . . . . 0.0 113.089 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.326 0.0 OUTLIER -137.47 33.56 2.51 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.949 0.881 . . . . 0.0 112.275 -177.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -74.0 -64.93 0.91 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 176.7 37.68 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 129.024 2.93 . . . . 0.0 109.284 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -176.14 -171.13 0.41 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.134 1.774 . . . . 0.0 109.246 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.5 p -122.63 -51.65 1.93 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.929 2.092 . . . . 0.0 109.195 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 43.62 55.03 5.2 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 126.666 1.986 . . . . 0.0 112.081 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.33 179.68 25.93 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 112.251 -2.25 . . . . 0.0 111.625 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.8 p -61.44 -66.99 0.45 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.048 0.939 . . . . 0.0 110.215 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.0 t -163.7 -66.33 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.594 1.158 . . . . 0.0 108.541 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.1 p -106.48 31.27 5.32 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.364 1.066 . . . . 0.0 110.999 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -164.95 104.75 0.8 Allowed Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.538 1.535 . . . . 0.0 107.723 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -64.17 156.42 72.75 Favored 'Cis proline' 0 N--CA 1.456 -0.731 0 CA-C-N 120.289 1.139 . . . . 0.0 113.555 -0.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.63 168.54 6.27 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.884 1.673 . . . . 0.0 108.985 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 t -68.25 151.62 46.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -79.84 110.34 15.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -10.69 -91.14 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.951 3.301 . . . . 0.0 115.488 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 143.78 -54.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 130.269 3.428 . . . . 0.0 106.929 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -56.94 124.32 18.21 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.062 1.345 . . . . 0.0 109.888 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 62.28 58.59 1.74 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.954 1.302 . . . . 0.0 108.536 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.41 111.34 4.1 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.712 1.149 . . . . 0.0 110.624 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.24 169.2 16.84 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.572 0.749 . . . . 0.0 110.626 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -71.2 130.2 40.83 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.121 1.369 . . . . 0.0 113.682 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -163.6 120.98 1.2 Allowed Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 126.152 1.781 . . . . 0.0 108.706 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -65.29 -165.64 0.08 OUTLIER 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.987 2.458 . . . . 0.0 111.111 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.7 t 76.96 -101.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.178 1.391 . . . . 0.0 110.045 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -167.8 -67.09 0.03 OUTLIER 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.178 0.899 . . . . 0.0 111.609 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.68 -172.7 14.75 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.256 1.408 . . . . 0.0 109.584 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.55 163.59 52.05 Favored 'Cis proline' 0 N--CA 1.456 -0.715 0 CA-C-N 119.118 1.459 . . . . 0.0 111.707 -1.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -110.71 172.9 6.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.343 1.057 . . . . 0.0 111.363 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -140.25 131.15 26.03 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.158 1.383 . . . . 0.0 108.606 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -94.58 161.82 14.05 Favored 'General case' 0 C--O 1.227 -0.09 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.599 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -160.03 105.99 1.41 Allowed Pre-proline 0 N--CA 1.455 -0.176 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.025 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.22 120.45 6.57 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 121.101 1.2 . . . . 0.0 109.866 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.612 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.6 tt -83.62 -175.43 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 123.665 1.698 . . . . 0.0 112.423 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.612 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 13.7 mmtt -160.31 163.02 33.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 109.82 -3.354 . . . . 0.0 110.816 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.0 t -78.82 56.86 1.98 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.998 1.719 . . . . 0.0 112.135 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.32 60.9 0.21 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 125.088 1.328 . . . . 0.0 112.474 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.18 140.3 3.05 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 117.695 0.747 . . . . 0.0 113.86 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.5 p -100.17 157.61 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 126.785 2.034 . . . . 0.0 107.239 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 64.91 74.21 0.4 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.134 0.974 . . . . 0.0 108.675 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.0 p -134.65 -169.39 2.33 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.409 1.483 . . . . 0.0 109.714 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.41 124.13 24.71 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.084 1.326 . . . . 0.0 113.695 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.37 101.0 0.87 Allowed Glycine 0 C--N 1.339 0.741 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.0 t 64.63 86.07 0.15 Allowed Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 125.363 1.465 . . . . 0.0 109.302 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.1 164.03 88.72 Favored 'Cis proline' 0 N--CA 1.458 -0.597 0 CA-C-N 119.571 0.882 . . . . 0.0 112.503 5.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.89 -58.07 0.17 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.473 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . 87.11 -67.71 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 129.128 2.971 . . . . 0.0 108.321 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -70.48 119.93 15.37 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.484 1.914 . . . . 0.0 113.149 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.1 mtt-85 -141.48 147.8 38.44 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.121 1.369 . . . . 0.0 112.301 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -112.61 144.05 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.4 t -139.92 127.04 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.88 0.372 . . . . 0.0 110.647 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -106.39 174.15 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.358 0 C-N-CA 126.922 2.089 . . . . 0.0 111.202 -178.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -93.56 169.08 10.61 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.952 2.101 . . . . 0.0 105.589 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.367 14.5 t -76.29 53.35 0.82 Allowed 'General case' 0 C--N 1.341 0.223 0 N-CA-C 117.775 2.509 . . . . 0.0 117.775 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -160.05 -83.31 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.82 -0.29 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.654 1.581 . . . . 0.0 114.27 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.57 110.56 16.16 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.016 1.28 . . . . 0.0 113.842 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.433 ' CE2' HG13 ' A' ' 16' ' ' VAL . 8.2 t80 -60.04 111.64 1.58 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.712 0.805 . . . . 0.0 109.707 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.25 -40.13 31.38 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.629 1.171 . . . . 0.0 111.349 -178.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.4 168.81 17.02 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' HB2' ' OH ' ' A' ' 85' ' ' TYR . . . -109.75 154.31 23.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.679 0.792 . . . . 0.0 110.353 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.8 pt -131.51 157.7 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 125.78 1.632 . . . . 0.0 107.99 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.0 t -159.53 139.28 11.58 Favored 'General case' 0 C--N 1.344 0.357 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.473 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 24.9 m170 -84.36 46.77 1.26 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.7 t -65.65 -38.6 89.81 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -144.3 56.72 0.54 Allowed Glycine 0 C--N 1.335 0.486 0 N-CA-C 106.119 -2.792 . . . . 0.0 106.119 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -106.92 -17.56 14.16 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.3 m 64.39 35.54 9.6 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.6 21.93 78.72 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 126.704 2.097 . . . . 0.0 113.899 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -146.76 -70.58 0.24 Allowed 'General case' 0 C--N 1.347 0.484 0 CA-C-N 119.44 1.62 . . . . 0.0 114.216 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -58.9 100.36 0.07 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.054 1.742 . . . . 0.0 114.042 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.281 0.5 OUTLIER -78.14 140.98 39.02 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.439 0.695 . . . . 0.0 109.613 -178.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.17 160.86 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.74 160.65 29.0 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.31 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.8 m -117.93 159.55 22.94 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.638 1.175 . . . . 0.0 110.583 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.3 t 44.19 69.11 0.45 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.046 1.738 . . . . 0.0 115.429 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.43 -4.13 74.39 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.094 -0.837 . . . . 0.0 114.334 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.8 m -84.29 104.63 14.48 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 116.622 -1.656 . . . . 0.0 111.231 179.417 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 120.597 0.237 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.9 p -127.8 58.75 1.49 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.23 1.412 . . . . 0.0 111.234 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.5 136.4 0.03 OUTLIER 'General case' 0 C--N 1.341 0.208 0 C-N-CA 126.664 1.985 . . . . 0.0 111.592 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.1 p -116.82 109.88 17.67 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.79 98.23 7.92 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 100.636 -3.838 . . . . 0.0 100.636 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.1 m -94.35 79.37 3.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.141 0.976 . . . . 0.0 109.102 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.09 -86.06 1.0 Allowed Glycine 0 C--N 1.34 0.777 0 C-N-CA 125.061 1.315 . . . . 0.0 110.013 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.4 p -119.58 -38.87 2.93 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 125.598 1.559 . . . . 0.0 110.156 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 m -74.14 100.78 3.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -95.04 149.43 21.26 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.85 0.86 . . . . 0.0 113.223 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -144.22 152.73 41.24 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.321 1.449 . . . . 0.0 110.043 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.9 m -74.55 159.6 31.98 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 125.556 1.542 . . . . 0.0 111.449 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.26 -22.67 67.02 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.5 t -70.49 -37.08 74.15 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 125.076 1.35 . . . . 0.0 109.062 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -65.69 -42.57 91.04 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.116 0.966 . . . . 0.0 109.731 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.1 t -61.27 -47.86 91.58 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.2 mtp85 -66.64 -26.55 67.12 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.214 1.406 . . . . 0.0 112.383 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.15 -60.58 2.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.71 -28.25 69.46 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.858 -0.592 . . . . 0.0 111.279 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.69 -37.1 50.34 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 118.941 -0.552 . . . . 0.0 112.38 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -70.5 -22.03 62.69 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.53 -59.74 2.61 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.49 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -45.96 -47.89 16.51 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.697 1.199 . . . . 0.0 110.33 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 m -51.1 -54.57 23.83 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.227 1.011 . . . . 0.0 110.961 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -77.09 -27.51 54.21 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -113.34 -6.0 13.55 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.289 0.0 OUTLIER -95.23 -38.96 10.32 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -179.077 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -147.29 33.53 0.88 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.326 0.966 . . . . 0.0 112.043 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -132.78 -70.71 0.54 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -136.49 85.49 2.15 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -56.77 118.76 5.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.022 1.329 . . . . 0.0 113.678 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.8 p -143.65 49.53 1.4 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.124 1.769 . . . . 0.0 108.681 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -163.26 153.05 15.4 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.116 0.966 . . . . 0.0 110.014 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.98 155.64 52.99 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.1 t -133.45 77.92 1.75 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.163 0.985 . . . . 0.0 108.87 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 p -107.09 -59.19 1.84 Allowed 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.87 -11.5 7.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.559 1.944 . . . . 0.0 110.733 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.66 129.95 3.53 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.93 139.71 55.04 Favored 'Cis proline' 0 N--CA 1.452 -0.959 0 CA-C-N 120.153 1.09 . . . . 0.0 110.536 -0.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -155.09 148.14 24.7 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 t -56.08 144.73 28.07 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -79.41 112.66 16.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -71.33 81.6 0.75 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.98 1.312 . . . . 0.0 109.215 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -156.76 76.04 0.86 Allowed 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.21 -37.97 73.02 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.862 1.265 . . . . 0.0 110.699 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -64.43 -35.59 81.42 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.29 114.76 0.24 Allowed Glycine 0 C--N 1.342 0.881 0 C-N-CA 125.875 1.702 . . . . 0.0 114.301 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -78.94 106.22 10.82 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.0 p-10 -28.98 111.03 0.06 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.484 1.914 . . . . 0.0 115.842 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -147.88 151.0 37.46 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 126.895 2.078 . . . . 0.0 108.076 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.02 78.04 3.72 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.327 2.685 . . . . 0.0 107.391 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.17 171.25 12.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 C-N-CA 124.841 1.256 . . . . 0.0 113.569 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -125.93 -49.61 1.6 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 128.034 2.534 . . . . 0.0 105.997 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.69 170.73 46.5 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.862 1.696 . . . . 0.0 113.914 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.55 134.74 32.26 Favored 'Cis proline' 0 N--CA 1.46 -0.498 0 O-C-N 122.419 0.694 . . . . 0.0 112.18 -0.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -107.49 136.5 47.17 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.602 1.561 . . . . 0.0 109.541 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -125.49 161.83 26.24 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 123.641 0.777 . . . . 0.0 111.24 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -83.88 153.34 24.05 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.597 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.49 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 17.1 t80 -155.44 103.21 2.2 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 102.791 -3.04 . . . . 0.0 102.791 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -76.46 136.59 17.69 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.027 1.818 . . . . 0.0 115.832 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.446 HG13 ' N ' ' A' ' 62' ' ' LYS . 1.2 tp -89.87 171.24 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 126.086 1.754 . . . . 0.0 112.787 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -159.06 170.31 22.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 110.62 -2.991 . . . . 0.0 113.067 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -82.0 57.92 3.71 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.86 2.064 . . . . 0.0 112.029 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.28 73.43 0.77 Allowed Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.34 -177.58 40.63 Favored Glycine 0 C--N 1.338 0.679 0 CA-C-O 121.631 0.573 . . . . 0.0 112.808 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.71 148.4 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 127.374 2.269 . . . . 0.0 106.39 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.312 51.4 p90 58.4 -170.11 0.12 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.78 1.632 . . . . 0.0 111.924 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.2 t -79.61 166.36 21.96 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.696 0.799 . . . . 0.0 112.577 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.08 140.24 3.1 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.29 -114.12 4.85 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 124.689 1.137 . . . . 0.0 111.103 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -155.31 -68.52 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.441 1.096 . . . . 0.0 109.972 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.55 160.46 46.56 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.292 1.995 . . . . 0.0 110.547 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.53 -83.4 0.06 OUTLIER Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.47 ' HB1' ' H ' ' A' ' 91' ' ' HIS . . . 81.77 -39.89 0.13 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.186 1.794 . . . . 0.0 111.041 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -71.3 125.41 26.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.061 1.744 . . . . 0.0 115.064 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -139.5 131.33 27.57 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 123.723 0.809 . . . . 0.0 112.254 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.7 m -94.64 148.15 5.2 Favored 'Isoleucine or valine' 0 C--N 1.345 0.406 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -134.35 139.71 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 pt -135.16 165.75 29.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.256 0.622 . . . . 0.0 112.497 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -93.55 155.41 17.33 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 127.9 2.48 . . . . 0.0 108.621 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.37 15.0 t -79.55 65.64 4.78 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -156.86 -94.58 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.172 1 N-CA-C 98.856 -4.498 . . . . 0.0 98.856 176.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.4 m -162.98 9.4 0.06 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.698 2.399 . . . . 0.0 113.035 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -82.84 132.46 35.16 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.548 1.067 . . . . 0.0 112.609 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -73.12 122.72 22.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.54 -57.96 3.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.69 153.21 11.56 Favored Glycine 0 C--N 1.339 0.717 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.465 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.03 112.03 24.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.58 162.34 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.709 0.804 . . . . 0.0 109.181 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.6 t -160.3 150.13 17.92 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.47 ' H ' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -89.47 63.97 6.55 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 175.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.1 t -63.75 -38.87 92.74 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.021 -1.049 . . . . 0.0 112.739 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.79 54.32 0.04 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -92.21 -78.78 0.4 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.77 0.828 . . . . 0.0 108.813 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.6 m -159.42 73.96 0.6 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.658 1.583 . . . . 0.0 108.72 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.83 -102.75 0.94 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.032 0.825 . . . . 0.0 111.719 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -79.77 -25.85 40.84 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.756 0.822 . . . . 0.0 111.83 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -49.15 129.69 18.2 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 124.52 1.128 . . . . 0.0 111.4 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -97.39 153.0 18.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.341 1.456 . . . . 0.0 113.405 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.0 m -135.21 167.26 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 126.957 2.103 . . . . 0.0 107.032 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.1 151.34 30.01 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 116.542 1.377 . . . . 0.0 116.542 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 38.7 m -106.53 -173.67 2.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.859 1.664 . . . . 0.0 106.641 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.0 t -69.32 140.98 54.37 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.454 -0.779 . . . . 0.0 108.984 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.31 32.54 59.97 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.936 0.779 . . . . 0.0 111.332 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.9 m -137.85 108.38 6.56 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 117.192 -1.385 . . . . 0.0 109.474 -178.984 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.491 0 CA-C-O 120.511 0.196 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.0 m -152.93 129.5 10.74 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.496 1.518 . . . . 0.0 107.613 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -40.24 132.22 1.98 Allowed 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.485 1.914 . . . . 0.0 112.664 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.8 p -102.65 89.06 3.38 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.272 1.029 . . . . 0.0 111.372 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -94.87 98.3 10.62 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.02 -165.14 0.92 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.118 1.367 . . . . 0.0 108.049 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -31.09 -57.87 0.27 Allowed Glycine 0 C--N 1.343 0.971 0 C-N-CA 125.993 1.758 . . . . 0.0 112.159 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.9 p -160.31 38.1 0.17 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.225 1.01 . . . . 0.0 109.687 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 m -129.49 94.15 3.71 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.7 110.47 15.06 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.697 1.199 . . . . 0.0 111.459 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -110.26 128.92 55.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.3 m -65.89 158.13 28.78 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 124.713 1.205 . . . . 0.0 110.726 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.64 -17.32 54.89 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.1 p -77.55 -37.98 49.56 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 124.0 0.92 . . . . 0.0 108.719 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -68.77 -36.04 77.82 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.027 0.931 . . . . 0.0 109.974 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.407 HG11 ' CE2' ' A' ' 85' ' ' TYR . 58.7 t -63.44 -47.82 89.96 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -64.49 -37.45 87.57 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.014 0.926 . . . . 0.0 111.374 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 -55.16 15.49 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.541 0.61 . . . . 0.0 110.225 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.44 -37.13 82.41 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.136 0.975 . . . . 0.0 111.172 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.32 -34.34 42.35 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -70.87 -22.02 62.34 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.1 -51.62 9.99 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.486 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -47.32 -67.07 0.31 Allowed 'General case' 0 C--N 1.345 0.375 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 176.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.2 t -39.09 -46.31 1.39 Allowed 'General case' 0 C--N 1.343 0.287 0 C-N-CA 127.892 2.477 . . . . 0.0 112.475 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -65.14 -58.34 6.27 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -71.73 -8.62 55.28 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 57' ' ' GLN . 6.4 t80 -79.38 -47.94 14.88 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.957 1.303 . . . . 0.0 111.376 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -135.51 -26.66 1.23 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -72.89 -56.44 5.19 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.43 1.014 . . . . 0.0 112.861 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -128.13 73.02 1.44 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.472 1.509 . . . . 0.0 108.775 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -55.06 153.4 6.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.704 1.202 . . . . 0.0 113.058 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 59.6 p 56.17 70.85 0.6 Allowed 'General case' 0 C--N 1.34 0.164 0 C-N-CA 127.153 2.181 . . . . 0.0 112.437 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -158.17 91.15 1.08 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.65 -78.23 0.2 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.8 m -145.55 -116.39 0.08 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.159 0.983 . . . . 0.0 108.675 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.9 m -158.26 -50.51 0.06 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.597 1.559 . . . . 0.0 109.35 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.0 p -79.73 6.26 11.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.293 1.037 . . . . 0.0 112.868 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -151.94 95.29 3.23 Favored Pre-proline 0 N--CA 1.455 -0.208 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -84.22 142.75 40.07 Favored 'Cis proline' 0 N--CA 1.455 -0.746 0 N-CA-C 116.263 1.601 . . . . 0.0 116.263 2.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.15 158.83 25.19 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.703 2.401 . . . . 0.0 107.377 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 m -42.38 120.0 1.54 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.022 2.129 . . . . 0.0 113.555 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -138.13 86.47 2.17 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -167.63 -49.67 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.676 1.19 . . . . 0.0 109.039 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.96 59.7 5.79 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.156 1.382 . . . . 0.0 110.141 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.36 14.98 1.46 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.817 0.847 . . . . 0.0 112.117 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 56.9 83.62 0.1 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 125.222 1.409 . . . . 0.0 111.267 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.24 167.09 36.04 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.67 100.5 0.28 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.147 0.979 . . . . 0.0 112.989 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -73.97 164.86 26.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.537 0.735 . . . . 0.0 109.976 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -106.08 151.07 40.01 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -58.13 -95.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 124.524 3.482 . . . . 0.0 114.152 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m 24.92 -106.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 127.062 2.145 . . . . 0.0 113.521 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -163.01 -44.78 0.03 OUTLIER 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.076 0.853 . . . . 0.0 112.214 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.16 -167.54 29.19 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -60.94 165.65 30.04 Favored 'Cis proline' 0 CA--C 1.535 0.547 0 CA-C-N 119.572 1.686 . . . . 0.0 114.123 -0.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -132.15 143.15 49.78 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.541 1.136 . . . . 0.0 111.502 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.466 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -139.99 153.32 46.83 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.325 1.05 . . . . 0.0 108.231 177.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.75 154.28 23.68 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.486 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 26.9 t80 -160.74 106.68 1.3 Allowed Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.399 1.08 . . . . 0.0 109.006 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.92 155.75 15.25 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 N-CA-C 119.008 2.657 . . . . 0.0 119.008 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.496 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 6.5 tt -105.63 175.37 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 C-N-CA 126.984 2.114 . . . . 0.0 110.035 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.496 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 6.9 tptp -160.9 166.59 28.17 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 109.352 -3.567 . . . . 0.0 112.454 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.1 t -88.83 62.15 6.27 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.542 1.537 . . . . 0.0 108.764 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.06 64.19 0.66 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 167.5 145.0 4.34 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.1 t -123.56 66.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.0 t80 64.08 103.26 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.086 2.155 . . . . 0.0 112.863 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.8 p -138.96 64.23 1.49 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.3 -68.95 2.38 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.06 -135.38 22.74 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.8 p 54.16 102.08 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 127.39 2.276 . . . . 0.0 113.282 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.84 176.49 40.37 Favored 'Cis proline' 0 N--CA 1.457 -0.663 0 CA-C-N 119.707 0.931 . . . . 0.0 112.177 4.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -178.38 163.54 31.6 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.45 -43.64 0.15 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-O 118.375 -0.821 . . . . 0.0 111.655 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -69.36 107.08 3.16 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -119.24 129.23 54.83 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.434 1.094 . . . . 0.0 111.451 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.65 151.43 6.04 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -135.12 135.74 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -123.08 164.14 20.97 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -80.98 173.25 12.79 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.674 1.99 . . . . 0.0 108.598 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.447 ' HA ' ' CE1' ' A' ' 27' ' ' TYR 0.43 1.5 m -73.59 -15.04 61.28 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -177.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -81.02 -83.88 0.11 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 101.327 -3.583 . . . . 0.0 101.327 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 5.1 m -164.05 0.12 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.639 2.775 . . . . 0.0 113.895 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -79.39 132.19 36.33 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.407 ' CE2' HG11 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -73.37 117.27 14.93 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.996 2.118 . . . . 0.0 108.222 178.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.01 -66.1 1.11 Allowed 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.265 1.426 . . . . 0.0 111.952 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.49 146.71 20.99 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 115.976 1.15 . . . . 0.0 115.976 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.65 99.62 3.38 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 103.746 -2.686 . . . . 0.0 103.746 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.5 pt -136.77 165.49 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.073 0.949 . . . . 0.0 111.428 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.0 t -160.27 145.74 15.05 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -79.87 29.44 0.26 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.21 0.604 . . . . 0.0 111.791 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.8 t -65.19 -30.28 71.17 Favored 'General case' 0 C--N 1.343 0.307 0 O-C-N 120.797 -1.19 . . . . 0.0 113.405 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -138.39 49.32 0.84 Allowed Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.29 151.86 21.74 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.114 1.366 . . . . 0.0 110.86 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.1 t -66.39 -45.37 80.25 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.35 1.06 . . . . 0.0 109.495 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.7 -79.43 0.03 OUTLIER Glycine 0 C--N 1.339 0.741 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -97.4 7.52 46.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.352 1.061 . . . . 0.0 111.027 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -74.0 -174.21 1.81 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.4 1.08 . . . . 0.0 110.426 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -153.45 159.9 42.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.174 0.989 . . . . 0.0 110.976 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.6 157.99 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.954 1.702 . . . . 0.0 106.783 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.39 153.25 49.12 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 116.106 1.202 . . . . 0.0 116.106 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.4 t -107.28 -175.3 2.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.335 2.254 . . . . 0.0 106.752 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.6 t -64.94 117.72 8.02 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.4 -0.813 . . . . 0.0 109.95 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.42 -36.97 3.65 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.121 1.343 . . . . 0.0 109.812 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.5 m -93.74 132.78 37.78 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.245 1.418 . . . . 0.0 108.932 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.225 -1.369 . . . . 0.0 109.254 -179.546 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.7 p -127.35 154.23 45.22 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.926 1.29 . . . . 0.0 110.141 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.97 133.86 55.2 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.882 1.273 . . . . 0.0 110.873 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 p -97.35 121.03 38.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.579 1.152 . . . . 0.0 109.117 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -115.33 99.31 7.3 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 100.595 -3.854 . . . . 0.0 100.595 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -103.49 90.28 3.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.157 1.383 . . . . 0.0 109.563 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.46 -76.23 0.96 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.012 1.291 . . . . 0.0 110.862 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.5 t -132.48 -43.17 0.93 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.819 1.648 . . . . 0.0 109.921 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.6 m -68.74 112.54 5.54 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -102.21 152.63 20.8 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.471 1.108 . . . . 0.0 110.812 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -144.23 143.54 31.1 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.363 1.065 . . . . 0.0 108.21 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.9 t -68.27 154.74 41.13 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.765 1.226 . . . . 0.0 110.549 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.93 -19.89 54.39 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.6 t -73.52 -41.15 63.41 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.652 1.581 . . . . 0.0 109.339 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -68.35 -43.17 78.02 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.256 0.622 . . . . 0.0 110.963 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.8 t -59.8 -47.18 92.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -41.5 86.72 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.278 1.031 . . . . 0.0 111.686 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.48 -49.47 68.93 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.333 0.515 . . . . 0.0 109.87 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.56 -37.36 78.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.799 0.839 . . . . 0.0 109.938 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.44 -32.28 60.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -66.38 -27.33 67.78 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.03 -56.98 3.98 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.458 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -44.99 -58.35 3.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.528 1.531 . . . . 0.0 110.147 177.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.5 t -54.11 -50.71 66.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.366 1.467 . . . . 0.0 112.296 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -58.08 -34.57 70.3 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -92.13 -3.26 55.91 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -124.38 37.16 4.46 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.473 1.109 . . . . 0.0 111.132 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -89.84 -72.51 0.56 Allowed 'General case' 0 C--N 1.343 0.283 0 O-C-N 121.364 -0.835 . . . . 0.0 110.031 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -148.91 -61.17 0.23 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 124.933 1.293 . . . . 0.0 108.713 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -90.44 63.83 5.71 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.112 1.365 . . . . 0.0 107.95 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -51.83 138.28 24.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.711 1.604 . . . . 0.0 112.396 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.0 t -106.16 -33.5 7.82 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.367 1.067 . . . . 0.0 112.198 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.63 159.86 31.58 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.763 0.825 . . . . 0.0 110.97 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.94 166.48 47.19 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.399 0.999 . . . . 0.0 114.232 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -120.49 65.09 0.84 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.833 1.653 . . . . 0.0 107.977 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.7 m -167.32 -46.02 0.02 OUTLIER 'General case' 0 C--N 1.339 0.124 0 C-N-CA 127.192 2.197 . . . . 0.0 107.374 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.7 p -105.12 29.18 6.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.145 1.378 . . . . 0.0 111.131 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 73.32 157.39 0.16 Allowed Pre-proline 0 C--N 1.351 0.651 0 C-N-CA 125.144 1.378 . . . . 0.0 107.728 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.401 ' HB3' HE21 ' A' ' 57' ' ' GLN . 86.0 Cg_endo -71.1 118.72 4.26 Favored 'Cis proline' 0 N--CA 1.452 -0.969 0 N-CA-C 115.404 1.271 . . . . 0.0 115.404 3.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -103.86 -170.24 1.75 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 126.518 1.927 . . . . 0.0 106.686 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.3 t -155.87 159.0 38.95 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.514 0.326 . . . . 0.0 111.267 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -153.43 167.09 30.61 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 122.774 0.43 . . . . 0.0 111.68 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -141.56 -51.76 0.43 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.609 1.563 . . . . 0.0 109.998 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -67.47 -78.81 0.06 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.966 0.906 . . . . 0.0 110.731 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 67.9 179.97 0.23 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.767 1.227 . . . . 0.0 111.345 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -74.63 -62.62 1.47 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.98 57.67 0.14 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -154.19 103.04 2.51 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.489 1.116 . . . . 0.0 108.346 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -141.57 176.43 8.9 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.307 1.443 . . . . 0.0 109.05 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -127.87 138.11 32.21 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 124.361 1.065 . . . . 0.0 109.043 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.66 66.17 8.81 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.713 2.942 . . . . 0.0 110.043 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.3 t -120.31 -95.06 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -153.35 -71.02 0.14 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.174 0.99 . . . . 0.0 109.695 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.11 -175.37 54.96 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.074 0.845 . . . . 0.0 111.225 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.97 126.85 1.93 Allowed 'Cis proline' 0 N--CA 1.459 -0.519 0 CA-C-N 118.982 1.391 . . . . 0.0 111.989 -0.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.69 130.69 35.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.446 0.641 . . . . 0.0 111.008 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' A' ' 39' ' ' PRO . 53.4 tt0 -75.03 139.02 42.58 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 127.852 2.461 . . . . 0.0 111.235 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -98.16 146.57 25.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.574 1.15 . . . . 0.0 108.66 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.458 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 8.0 t80 -160.1 110.33 1.41 Allowed Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -81.15 131.93 8.03 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 122.006 1.804 . . . . 0.0 114.302 -176.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.54 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.7 tt -100.01 178.0 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 124.282 1.992 . . . . 0.0 110.875 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.54 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 4.8 tmtt? -160.46 153.71 21.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 109.063 -3.698 . . . . 0.0 110.721 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.2 p -80.81 56.5 2.72 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.566 1.546 . . . . 0.0 109.706 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.9 -61.99 0.04 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.32 -172.62 32.97 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 117.165 0.483 . . . . 0.0 112.705 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.95 143.57 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.568 1.547 . . . . 0.0 111.353 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.292 0.0 OUTLIER 25.45 55.68 0.04 OUTLIER 'General case' 0 C--N 1.345 0.37 0 C-N-CA 129.367 3.067 . . . . 0.0 116.41 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.8 p -79.77 85.36 5.46 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.98 173.6 39.24 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.89 -69.01 1.47 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.0 m -80.3 127.5 76.09 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.7 -88.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.225 2.617 . . . . 0.0 110.057 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.97 -51.32 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 106.019 -2.832 . . . . 0.0 106.019 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -169.72 -50.43 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.667 0.787 . . . . 0.0 112.02 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -73.9 130.07 39.16 Favored 'General case' 0 C--N 1.344 0.362 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -138.54 122.21 17.48 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.029 1.331 . . . . 0.0 110.43 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -83.64 148.77 4.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.3 t -136.91 114.9 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -177.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 pt -101.56 177.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.371 0 C-N-CA 124.585 1.154 . . . . 0.0 111.855 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -90.46 171.82 9.16 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 125.255 1.422 . . . . 0.0 108.024 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.7 -33.24 69.94 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 119.048 2.981 . . . . 0.0 119.048 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -87.75 -65.81 0.98 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.857 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.5 -7.58 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 -175.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -78.9 108.82 12.63 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -56.33 118.52 4.83 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.51 -59.56 2.2 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.258 0.623 . . . . 0.0 110.655 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.35 164.74 34.15 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.28 153.22 27.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.1 0.96 . . . . 0.0 110.453 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.6 pt -138.89 155.57 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.746 1.618 . . . . 0.0 107.881 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.6 t -153.45 153.25 32.13 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -79.34 -22.62 44.25 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.354 0.662 . . . . 0.0 111.988 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 t -65.68 139.84 58.43 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 119.585 1.084 . . . . 0.0 109.905 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.08 -24.97 28.93 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.98 -159.02 0.66 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.262 1.425 . . . . 0.0 109.397 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.2 m -152.37 88.9 1.39 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.417 0.687 . . . . 0.0 111.06 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.06 -131.07 9.24 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.288 0.947 . . . . 0.0 112.53 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -79.38 -34.95 41.52 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 125.099 1.36 . . . . 0.0 110.619 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -44.12 134.05 4.95 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.863 1.665 . . . . 0.0 112.473 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.54 160.8 14.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.203 1.801 . . . . 0.0 111.203 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 m -139.32 166.04 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 126.531 1.932 . . . . 0.0 106.916 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.64 151.61 20.66 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.365 0.507 . . . . 0.0 113.726 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.81 -166.43 1.6 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.194 1.398 . . . . 0.0 109.198 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.5 t -62.55 129.58 41.23 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.908 0.483 . . . . 0.0 109.767 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.31 28.5 69.79 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.004 0.811 . . . . 0.0 112.095 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.8 m -151.52 116.49 5.22 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.168 -179.51 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . 0.415 ' H2 ' ' OH ' ' A' ' 85' ' ' TYR 0.518 . . . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 123.605 1.669 . . . . 0.0 115.355 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.8 m -160.42 74.29 0.54 Allowed 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 101.342 -3.577 . . . . 0.0 101.342 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 70.21 73.59 0.22 Allowed 'General case' 0 C--N 1.343 0.32 0 N-CA-C 102.389 -3.189 . . . . 0.0 102.389 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.5 t -116.03 152.87 32.72 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -118.88 116.39 26.39 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 102.259 -3.237 . . . . 0.0 102.259 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 m -91.91 58.9 3.51 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.31 -78.53 0.82 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.556 1.074 . . . . 0.0 111.178 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 m -118.29 39.99 3.3 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.947 1.299 . . . . 0.0 110.274 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.33 152.88 38.96 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 104.565 -2.383 . . . . 0.0 104.565 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -150.51 113.94 4.92 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.621 0.646 . . . . 0.0 111.745 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.81 137.55 52.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.514 1.126 . . . . 0.0 111.251 178.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.9 t -70.11 160.31 32.27 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 126.368 1.867 . . . . 0.0 108.264 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.25 -19.05 30.95 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.3 t -72.57 -47.29 49.34 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -72.22 -28.22 63.04 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.638 1.175 . . . . 0.0 113.46 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.4 t -70.21 -51.79 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -58.83 -35.63 73.22 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 125.987 1.715 . . . . 0.0 111.277 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.67 -52.61 56.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.9 82.47 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.031 0.932 . . . . 0.0 112.033 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.43 -45.55 30.97 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -62.29 -22.43 66.02 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.406 ' CB ' HG21 ' A' ' 66' ' ' VAL . . . -79.9 -55.08 5.22 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.68 -42.9 12.14 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.209 1.004 . . . . 0.0 111.261 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 85.2 m -61.61 -52.77 63.02 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.178 0.991 . . . . 0.0 110.366 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -59.57 -41.45 90.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.364 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -69.32 -40.1 77.81 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.42 -0.8 . . . . 0.0 112.067 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -78.52 -32.63 48.14 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -136.49 -43.8 0.61 Allowed 'General case' 0 C--N 1.348 0.533 0 N-CA-C 118.216 2.672 . . . . 0.0 118.216 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -70.69 -22.95 62.4 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -165.48 102.41 0.71 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 77.27 -166.32 0.05 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.552 1.941 . . . . 0.0 111.169 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.4 p -123.79 -63.96 1.18 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.86 1.664 . . . . 0.0 109.07 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 52.07 90.84 0.02 OUTLIER 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.519 1.928 . . . . 0.0 112.062 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.02 -166.98 14.22 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.23 0.919 . . . . 0.0 110.821 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m 71.63 -11.43 0.73 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.987 1.715 . . . . 0.0 113.71 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 68.7 m -149.47 -43.35 0.14 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.806 0.842 . . . . 0.0 111.74 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.9 p -104.25 -22.96 13.29 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 77.41 152.43 0.13 Allowed Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.3 150.99 96.51 Favored 'Cis proline' 0 N--CA 1.45 -1.05 0 CA-C-N 121.088 1.424 . . . . 0.0 115.065 2.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -159.79 157.82 30.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 128.551 2.74 . . . . 0.0 105.713 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 t -53.28 149.49 7.25 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -89.09 161.92 16.26 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.692 1.597 . . . . 0.0 109.1 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -63.53 137.77 58.26 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.953 0.901 . . . . 0.0 111.706 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.69 -49.96 75.4 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.761 0.824 . . . . 0.0 108.908 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -59.1 137.38 57.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -71.96 88.92 1.08 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.986 0.515 . . . . 0.0 111.228 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.08 -29.53 66.64 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.88 164.09 36.32 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.212 1.405 . . . . 0.0 110.695 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -116.91 122.12 43.4 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.612 1.565 . . . . 0.0 107.835 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.405 ' CD1' ' HA3' ' A' ' 87' ' ' GLY . 17.4 m-85 -119.42 157.69 50.86 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 124.821 1.248 . . . . 0.0 109.536 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -52.81 -35.36 69.43 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.825 3.017 . . . . 0.0 114.239 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.1 m -110.05 164.69 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.528 1.531 . . . . 0.0 112.044 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -95.75 159.53 14.93 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.573 1.549 . . . . 0.0 110.243 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.75 -154.54 30.87 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.4 1.0 . . . . 0.0 111.452 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.53 153.25 18.93 Favored 'Cis proline' 0 C--N 1.346 0.441 0 CA-C-N 118.722 1.261 . . . . 0.0 114.132 -0.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.67 167.07 17.74 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.165 0.986 . . . . 0.0 111.462 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -138.43 156.3 47.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.411 1.485 . . . . 0.0 109.253 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -90.17 157.84 17.53 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -160.15 108.9 1.4 Allowed Pre-proline 0 N--CA 1.454 -0.255 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -89.23 113.56 0.61 Allowed 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 122.65 2.233 . . . . 0.0 111.797 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.483 HG13 ' H ' ' A' ' 62' ' ' LYS . 7.4 tt -86.22 174.67 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-O 123.632 1.682 . . . . 0.0 110.909 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.483 ' H ' HG13 ' A' ' 61' ' ' ILE . 11.7 mmtp -155.48 150.73 26.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 109.851 -3.34 . . . . 0.0 110.912 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.5 p -88.68 61.03 5.85 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.311 1.444 . . . . 0.0 108.865 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.75 -61.58 0.02 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.05 166.12 36.18 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.406 HG21 ' CB ' ' A' ' 22' ' ' ALA . 10.0 p -77.6 138.0 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.505 1.122 . . . . 0.0 110.931 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.1 t80 53.57 86.92 0.04 OUTLIER 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.894 1.678 . . . . 0.0 112.111 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.4 t -151.41 158.97 44.41 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.21 1.004 . . . . 0.0 110.373 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.79 -133.11 2.65 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.501 1.048 . . . . 0.0 111.266 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.14 54.94 4.22 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 94.6 p 45.52 60.17 13.88 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.063 1.745 . . . . 0.0 112.64 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.1 141.24 18.48 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.749 2.966 . . . . 0.0 110.847 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 158.0 35.19 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.519 -0.601 . . . . 0.0 114.246 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -169.03 35.07 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.034 0.934 . . . . 0.0 110.764 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.25 93.85 0.29 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -145.96 153.48 40.85 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 m -119.86 146.6 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 102.474 -3.158 . . . . 0.0 102.474 175.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.255 81.2 t -125.55 113.14 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.1 pt -86.31 168.03 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.381 0 C-N-CA 125.704 1.602 . . . . 0.0 114.577 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -90.69 170.95 9.71 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 126.965 2.106 . . . . 0.0 107.374 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.367 11.6 t -85.35 52.93 2.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 118.048 2.611 . . . . 0.0 118.048 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -156.04 -89.81 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 101.245 -3.613 . . . . 0.0 101.245 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 36.3 t -163.94 66.43 0.17 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.198 1.399 . . . . 0.0 112.508 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -150.26 127.58 11.38 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 120.016 1.28 . . . . 0.0 113.051 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -64.46 117.29 7.1 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 177.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.39 -59.23 2.34 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 124.322 1.049 . . . . 0.0 110.631 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.405 ' HA3' ' CD1' ' A' ' 50' ' ' PHE . . . -145.57 -172.46 15.98 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.761 1.172 . . . . 0.0 111.472 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.31 144.05 13.94 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 122.802 0.441 . . . . 0.0 111.438 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.0 pt -131.06 159.34 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 125.487 1.515 . . . . 0.0 110.068 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.0 t -160.12 150.31 18.39 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.462 1.505 . . . . 0.0 109.418 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.539 ' HB2' ' HB1' ' A' ' 74' ' ' ALA 0.265 49.3 m170 -78.98 -51.87 9.03 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.409 1.004 . . . . 0.0 108.951 177.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.379 11.8 t 48.96 -69.82 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.706 2.802 . . . . 0.0 116.773 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.42 51.17 0.56 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 126.032 1.777 . . . . 0.0 108.879 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.79 158.02 36.24 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.913 1.285 . . . . 0.0 110.949 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.5 t -62.06 -40.51 96.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.214 0.606 . . . . 0.0 110.183 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -150.5 -109.64 0.47 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -94.38 -4.93 47.57 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.508 1.123 . . . . 0.0 112.083 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -65.17 174.5 2.0 Allowed 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.114 0.966 . . . . 0.0 112.113 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -125.64 150.99 47.11 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.735 1.614 . . . . 0.0 111.911 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.5 m -124.31 166.33 19.82 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 C-N-CA 126.308 1.843 . . . . 0.0 107.009 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.04 160.21 24.87 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.3 m -100.66 174.22 6.17 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.136 0.975 . . . . 0.0 111.694 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.2 m 46.77 46.13 15.02 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.709 0.804 . . . . 0.0 112.069 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.67 22.95 73.81 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 119.311 -0.716 . . . . 0.0 114.052 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 55.0 m -86.57 146.77 26.22 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.974 0.909 . . . . 0.0 108.785 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.8 t30 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.055 -1.45 . . . . 0.0 109.437 -179.246 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 120.596 0.236 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 t -158.14 -175.24 5.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.126 1.37 . . . . 0.0 108.595 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.41 138.34 56.64 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.437 0.695 . . . . 0.0 109.134 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 t -141.81 119.99 12.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.487 0.315 . . . . 0.0 111.038 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.41 108.3 19.59 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 86.6 m -97.46 78.99 2.71 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.122 0.969 . . . . 0.0 109.177 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.83 -95.56 0.82 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.8 m -108.42 -31.78 7.69 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.851 1.26 . . . . 0.0 110.51 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 m -81.69 101.12 9.87 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -85.02 152.14 23.66 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 123.194 0.598 . . . . 0.0 111.322 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -142.06 133.73 26.93 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.645 1.178 . . . . 0.0 109.096 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.7 m -72.25 158.04 36.59 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 125.007 1.323 . . . . 0.0 111.314 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.08 -21.41 64.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.0 m -72.54 -39.35 67.58 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.076 0.95 . . . . 0.0 108.535 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -69.6 -50.22 46.6 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.547 1.139 . . . . 0.0 112.023 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.466 HG13 HG11 ' A' ' 77' ' ' VAL . 50.8 t -57.45 -48.23 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 123.608 0.763 . . . . 0.0 109.212 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -64.53 -43.31 94.41 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.545 1.138 . . . . 0.0 112.065 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.0 -54.24 14.1 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.972 0.509 . . . . 0.0 111.228 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.595 ' HB1' ' HE2' ' A' ' 59' ' ' PHE . . . -60.92 -26.76 67.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.421 0.689 . . . . 0.0 110.543 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.75 -38.09 29.28 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.481 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -65.79 -25.19 67.13 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.79 -60.0 2.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.402 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -44.97 -51.0 10.27 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.672 1.189 . . . . 0.0 110.196 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.01 -48.33 32.79 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.257 2.223 . . . . 0.0 111.796 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -81.75 -40.89 22.01 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.264 0.0 OUTLIER -67.75 -37.54 82.28 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 116.799 2.148 . . . . 0.0 116.799 -177.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.299 0.0 OUTLIER -82.14 6.27 17.02 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -179.09 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -77.49 -3.43 40.46 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.131 0.572 . . . . 0.0 110.786 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 64.02 48.11 3.16 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.442 1.897 . . . . 0.0 111.707 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -159.35 30.47 0.2 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.842 1.257 . . . . 0.0 110.658 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 176.88 165.69 0.51 Allowed 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 128.798 2.839 . . . . 0.0 108.86 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.263 0.0 OUTLIER -12.65 100.09 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 128.825 2.85 . . . . 0.0 115.233 -179.33 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 74.77 163.3 0.26 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 127.608 2.363 . . . . 0.0 115.792 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.98 82.57 0.06 OUTLIER Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.137 -0.813 . . . . 0.0 113.047 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.8 m 69.85 104.69 0.06 Allowed 'General case' 0 C--N 1.344 0.367 0 C-N-CA 126.384 1.873 . . . . 0.0 113.621 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -152.93 -55.89 0.12 Allowed 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 100.988 -3.708 . . . . 0.0 100.988 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.575 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 40.7 p -130.64 -62.58 0.91 Allowed 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 101.006 -3.701 . . . . 0.0 101.006 175.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.575 ' CD1' ' C ' ' A' ' 37' ' ' THR . 23.9 m-85 -144.06 143.62 23.33 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 129.242 3.017 . . . . 0.0 106.072 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.67 144.73 62.24 Favored 'Cis proline' 0 N--CA 1.458 -0.567 0 CA-C-N 118.581 0.529 . . . . 0.0 112.596 1.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -156.54 151.76 26.48 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.537 0.608 . . . . 0.0 112.32 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.6 m -53.27 142.34 21.36 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.049 2.54 . . . . 0.0 113.121 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -91.9 136.76 32.91 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.705 1.202 . . . . 0.0 110.028 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -70.32 129.54 39.59 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.22 1.008 . . . . 0.0 111.864 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -86.17 61.04 6.59 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.936 1.294 . . . . 0.0 109.13 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -121.56 167.83 12.43 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.066 1.746 . . . . 0.0 109.076 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.49 154.16 41.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.382 0.673 . . . . 0.0 110.333 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.1 -88.27 0.32 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -121.51 152.91 38.64 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.241 1.417 . . . . 0.0 109.809 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 166.89 130.4 0.01 OUTLIER 'General case' 0 C--N 1.34 0.183 0 C-N-CA 128.109 2.564 . . . . 0.0 107.62 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -88.67 169.34 13.59 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.333 1.053 . . . . 0.0 108.96 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.19 -52.44 8.75 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.915 3.076 . . . . 0.0 113.024 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.444 HG21 HD21 ' A' ' 80' ' ' ASN . 31.9 m -65.05 156.62 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.11 1.364 . . . . 0.0 109.854 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -134.36 -168.66 2.18 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -46.32 138.55 7.52 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 127.608 2.527 . . . . 0.0 114.205 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.37 133.87 12.23 Favored 'Cis proline' 0 C--N 1.35 0.655 0 CA-C-N 119.933 1.866 . . . . 0.0 111.2 -2.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.53 108.99 1.64 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -177.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -123.35 157.7 32.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.994 1.718 . . . . 0.0 109.27 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -89.34 158.8 17.65 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.688 1.595 . . . . 0.0 112.633 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.595 ' HE2' ' HB1' ' A' ' 19' ' ' ALA . 89.1 t80 -159.18 117.96 1.68 Allowed Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.242 1.017 . . . . 0.0 108.917 177.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -81.44 137.83 10.6 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 N-CA-C 117.705 2.156 . . . . 0.0 117.705 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.625 HG13 HG13 ' A' ' 77' ' ' VAL 0.256 3.3 mm -109.81 -0.32 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 1 C-N-CA 134.408 5.083 . . . . 0.0 115.207 179.116 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -75.41 104.62 6.05 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 126.704 2.002 . . . . 0.0 114.165 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.6 m 24.06 34.18 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.201 1 C-N-CA 131.884 4.074 . . . . 0.0 115.712 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.84 40.38 1.49 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.957 1.265 . . . . 0.0 111.534 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.13 -115.33 1.01 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.127 1.346 . . . . 0.0 113.211 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.16 48.58 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.983 1.313 . . . . 0.0 109.594 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 27.0 t80 61.21 71.42 0.56 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.472 1.909 . . . . 0.0 111.327 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 49.5 p -121.18 61.11 0.91 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.75 -153.62 24.06 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.5 -169.54 32.25 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 m -158.86 -68.34 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 125.111 1.364 . . . . 0.0 110.172 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.58 104.33 1.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.456 2.104 . . . . 0.0 109.799 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.15 79.85 1.15 Allowed Glycine 0 C--N 1.339 0.712 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.13 -70.84 0.25 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.05 123.06 18.05 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.619 1.1 . . . . 0.0 113.597 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -160.6 134.81 7.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.625 HG13 HG13 ' A' ' 61' ' ' ILE . 11.8 m -93.14 142.88 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 177.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.272 72.6 t -125.32 124.45 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 -178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 85' ' ' TYR . 7.2 pt -130.99 175.09 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 123.934 0.771 . . . . 0.0 112.255 -175.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.444 HD21 HG21 ' A' ' 52' ' ' VAL . 49.7 m-80 -99.18 139.23 35.13 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 125.447 1.499 . . . . 0.0 109.199 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.548 0.5 OUTLIER -47.52 -12.72 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.401 1 N-CA-C 121.898 4.036 . . . . 0.0 121.898 -176.615 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -80.01 -81.85 0.12 Allowed 'General case' 0 N--CA 1.441 -0.884 1 N-CA-C 99.618 -4.216 . . . . 0.0 99.618 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.75 0.47 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.632 1.573 . . . . 0.0 114.472 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -82.27 127.73 33.49 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.584 ' HA ' HG22 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -65.33 135.34 55.19 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.641 1.577 . . . . 0.0 109.489 178.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.43 -50.83 3.49 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 122.982 0.513 . . . . 0.0 110.678 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.29 140.23 3.59 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.503 -0.379 . . . . 0.0 112.769 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.07 131.12 36.84 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.056 1.342 . . . . 0.0 108.034 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.8 pt -141.77 165.8 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.668 1.187 . . . . 0.0 110.391 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.421 HG23 HG22 ' A' ' 92' ' ' THR . 9.8 t -158.57 146.54 18.21 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -83.58 15.13 3.29 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 122.665 0.386 . . . . 0.0 110.917 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.421 HG22 HG23 ' A' ' 90' ' ' THR . 6.2 t -40.98 -45.29 2.56 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 116.92 2.192 . . . . 0.0 116.92 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -150.54 57.26 0.45 Allowed Glycine 0 C--N 1.331 0.301 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.02 175.89 5.34 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.891 1.276 . . . . 0.0 109.77 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.8 t -83.0 58.91 4.63 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.803 1.241 . . . . 0.0 111.028 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.37 -87.5 0.81 Allowed Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.228 1.394 . . . . 0.0 112.71 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -79.52 -24.75 42.01 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.114 0.966 . . . . 0.0 111.294 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -63.04 170.23 2.89 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.517 1.127 . . . . 0.0 110.178 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -130.31 168.19 17.3 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.617 1.567 . . . . 0.0 111.811 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.1 m -139.51 161.13 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 126.886 2.074 . . . . 0.0 105.748 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.25 131.7 10.58 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 114.775 0.67 . . . . 0.0 114.775 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.8 t -98.19 172.33 7.65 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.2 t 53.95 -153.63 0.28 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.904 1.229 . . . . 0.0 109.198 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -78.76 0.66 76.55 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 124.593 1.092 . . . . 0.0 110.401 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 m -79.69 149.15 31.31 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 125.495 1.518 . . . . 0.0 108.727 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.004 -1.474 . . . . 0.0 108.914 -179.186 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 121.143 0.497 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.6 m -136.5 -170.19 2.62 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.44 1.496 . . . . 0.0 108.117 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.44 122.7 11.02 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.8 0.84 . . . . 0.0 109.904 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.517 HG22 ' HB3' ' A' ' 103' ' ' SER . 3.0 p -91.69 87.98 6.52 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -92.2 96.93 10.59 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 102.447 -3.168 . . . . 0.0 102.447 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.1 m -98.3 81.73 2.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.472 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.4 -86.98 0.91 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.9 p -122.12 -23.22 5.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.333 1.453 . . . . 0.0 110.929 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.55 91.6 3.98 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -84.15 127.99 34.27 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.933 1.293 . . . . 0.0 112.772 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -127.57 134.5 49.72 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.5 p -69.24 152.76 44.66 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 124.689 1.196 . . . . 0.0 110.194 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.38 -22.94 55.59 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.3 p -77.4 -35.51 54.19 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 123.284 0.634 . . . . 0.0 109.519 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.6 tp-100 -69.11 -33.87 74.17 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.423 0.689 . . . . 0.0 110.986 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.1 t -66.77 -50.56 64.52 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.0 tmt_? -61.49 -38.92 89.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.212 1.405 . . . . 0.0 110.99 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.44 -51.77 53.42 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.636 0.774 . . . . 0.0 109.58 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.83 -23.93 66.79 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 118.809 -0.615 . . . . 0.0 111.115 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.13 -41.77 33.96 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 118.468 0.577 . . . . 0.0 110.835 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -68.63 -20.89 64.5 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.09 -64.45 1.16 Allowed 'General case' 0 C--N 1.35 0.591 0 N-CA-C 103.292 -2.855 . . . . 0.0 103.292 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -39.88 -45.01 1.75 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.187 1.395 . . . . 0.0 111.473 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.5 m -55.26 -58.77 6.36 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.882 1.273 . . . . 0.0 109.753 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.2 tp-100 -65.84 -36.84 84.59 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -86.22 -10.13 55.23 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 128.772 2.829 . . . . 0.0 115.512 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -90.74 -61.48 1.66 Allowed 'General case' 0 C--N 1.342 0.276 0 CA-C-N 120.07 1.304 . . . . 0.0 113.21 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -137.56 -10.0 1.64 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -66.46 -48.7 69.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.357 0.98 . . . . 0.0 111.276 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -172.38 108.61 0.21 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.045 1.338 . . . . 0.0 107.47 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.251 0.1 OUTLIER 89.26 163.61 0.05 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 128.724 2.81 . . . . 0.0 112.648 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.9 p -138.02 -45.45 0.52 Allowed 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 126.691 1.996 . . . . 0.0 109.026 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 85.62 165.35 0.09 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 127.844 2.458 . . . . 0.0 111.558 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -77.97 85.77 1.09 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.535 1.064 . . . . 0.0 111.781 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.9 p -132.47 -124.29 0.19 Allowed 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 m -177.69 -75.88 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 125.14 1.376 . . . . 0.0 109.711 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.02 0.5 57.53 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.776 1.63 . . . . 0.0 113.35 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -152.32 104.89 2.76 Favored Pre-proline 0 C--N 1.343 0.284 0 O-C-N 120.924 -1.11 . . . . 0.0 108.728 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -72.14 155.47 98.37 Favored 'Cis proline' 0 N--CA 1.459 -0.501 0 CA-C-N 119.942 1.015 . . . . 0.0 113.608 0.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.15 162.62 4.54 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.573 1.549 . . . . 0.0 109.945 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.6 m -70.27 136.63 50.04 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.869 1.668 . . . . 0.0 109.775 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -96.12 150.24 20.73 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.401 1.08 . . . . 0.0 109.96 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -78.88 165.75 23.17 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.108 0.963 . . . . 0.0 111.475 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -159.0 93.21 1.14 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.469 0.708 . . . . 0.0 110.337 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -164.23 -56.57 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.22 1.008 . . . . 0.0 109.894 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -166.07 134.05 2.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.801 1.24 . . . . 0.0 108.36 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.83 -83.68 0.15 Allowed Glycine 0 C--N 1.338 0.674 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -159.36 46.69 0.28 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.572 1.149 . . . . 0.0 107.992 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -74.95 164.23 26.78 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -127.95 94.67 36.29 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 125.481 1.512 . . . . 0.0 108.329 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.34 84.15 1.4 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.389 2.726 . . . . 0.0 110.982 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.7 t -113.17 -49.51 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.282 1.433 . . . . 0.0 109.198 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -154.15 -73.97 0.12 Allowed 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.854 0.861 . . . . 0.0 109.243 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.96 140.23 8.04 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.81 175.25 45.47 Favored 'Cis proline' 0 N--CA 1.459 -0.557 0 CA-C-N 118.845 1.322 . . . . 0.0 112.036 -0.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.59 -174.15 3.43 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.297 1.439 . . . . 0.0 108.75 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -157.12 146.14 20.03 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 122.968 0.507 . . . . 0.0 111.981 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -89.74 144.37 26.03 Favored 'General case' 0 C--N 1.343 0.295 0 O-C-N 123.687 0.617 . . . . 0.0 110.677 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -153.87 110.95 2.51 Favored Pre-proline 0 N--CA 1.451 -0.401 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -82.66 148.88 14.22 Favored 'Trans proline' 0 N--CA 1.439 -1.727 0 C-N-CA 121.824 1.683 . . . . 0.0 113.48 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.526 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.5 tt -106.73 -177.57 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-O 123.87 1.795 . . . . 0.0 111.7 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.526 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 18.5 tptt -160.29 159.35 31.23 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 109.622 -3.445 . . . . 0.0 113.041 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.5 p -90.11 60.41 4.82 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 126.515 1.926 . . . . 0.0 110.887 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.36 -53.94 0.05 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.66 -151.93 6.32 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.5 p -72.24 165.26 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.79 1.236 . . . . 0.0 109.083 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.44 141.91 14.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.9 m -118.09 -56.03 2.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.908 2.083 . . . . 0.0 107.427 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.61 -157.58 16.17 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.828 1.204 . . . . 0.0 111.42 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.39 36.34 59.44 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.375 0.988 . . . . 0.0 112.318 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.7 m -160.86 157.87 23.62 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 125.7 1.6 . . . . 0.0 108.274 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -45.36 -58.44 1.6 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.783 2.989 . . . . 0.0 111.884 169.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.4 141.47 12.24 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -148.3 -40.96 0.16 Allowed 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 117.428 -1.272 . . . . 0.0 112.273 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -88.14 120.45 29.5 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.032 0.933 . . . . 0.0 109.351 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.4 138.89 16.81 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -90.82 151.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.1 t -135.98 117.82 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.7 pt -109.68 164.12 6.29 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 C-N-CA 124.091 0.957 . . . . 0.0 112.18 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -79.41 157.87 27.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.312 1.845 . . . . 0.0 106.76 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.291 5.6 t -63.01 -10.14 12.8 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 -177.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -85.95 -80.54 0.22 Allowed 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.93 -5.45 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.666 2.386 . . . . 0.0 115.485 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.16 143.81 35.08 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 119.867 1.212 . . . . 0.0 114.021 -175.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -70.83 124.54 24.55 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.75 -48.08 6.75 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.028 0.531 . . . . 0.0 109.684 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.79 -170.08 41.22 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.12 141.07 22.01 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.508 1.123 . . . . 0.0 108.481 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.7 pt -137.71 166.34 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 124.598 1.159 . . . . 0.0 109.911 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.4 t -154.57 156.04 35.87 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.539 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 64.5 m170 -77.27 -40.85 43.18 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.763 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.6 t -54.67 142.97 26.41 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 123.127 0.571 . . . . 0.0 111.801 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.1 -24.01 33.22 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.71 -141.94 0.23 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.012 1.325 . . . . 0.0 109.087 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.2 t -155.23 80.63 1.05 Allowed 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.431 0.56 . . . . 0.0 111.114 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.94 -133.2 11.02 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.033 1.301 . . . . 0.0 111.963 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -79.77 -30.06 40.6 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.983 0.913 . . . . 0.0 111.376 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -52.58 140.02 24.11 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.032 0.933 . . . . 0.0 109.78 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.64 167.03 10.59 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.3 m -145.01 166.56 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 128.944 2.897 . . . . 0.0 106.064 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.6 164.59 39.73 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 123.64 0.638 . . . . 0.0 114.539 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 49.6 t -139.36 163.71 31.76 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.986 1.714 . . . . 0.0 108.304 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.517 ' HB3' HG22 ' A' ' 4' ' ' THR . 59.6 p 54.92 43.81 29.33 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.51 1.924 . . . . 0.0 111.773 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.64 15.87 81.21 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.006 -0.885 . . . . 0.0 113.664 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.3 m -82.7 140.9 32.83 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.596 1.198 . . . . 0.0 108.59 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.107 -1.425 . . . . 0.0 108.986 179.652 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.3 p -127.9 44.05 3.01 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.129 1.372 . . . . 0.0 110.411 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.54 164.56 0.14 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.485 1.914 . . . . 0.0 112.027 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.07 151.84 25.72 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.261 -0.274 . . . . 0.0 110.97 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.2 115.82 21.02 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.7 m -103.37 97.17 7.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.47 0.708 . . . . 0.0 109.819 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.9 -78.4 0.91 Allowed Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.768 1.175 . . . . 0.0 111.297 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 t -135.71 -8.42 2.15 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.547 1.139 . . . . 0.0 112.778 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.64 134.94 42.86 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 119.194 0.907 . . . . 0.0 109.502 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -94.4 154.69 17.34 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.809 0.844 . . . . 0.0 110.879 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -145.28 126.38 14.65 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.267 1.427 . . . . 0.0 108.836 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t -69.94 155.51 40.47 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.16 -16.65 34.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.6 t -76.28 -37.9 56.91 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.079 0.952 . . . . 0.0 109.459 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -74.6 -51.04 15.63 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.957 1.703 . . . . 0.0 111.152 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.84 -47.72 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.934 1.294 . . . . 0.0 107.524 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -69.67 -36.79 76.33 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.037 0.935 . . . . 0.0 111.94 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.13 -51.17 68.96 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 119.687 1.131 . . . . 0.0 109.859 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -34.72 74.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.775 0.83 . . . . 0.0 111.055 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.18 -33.35 33.08 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -69.94 -23.42 63.19 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.441 ' CB ' HG11 ' A' ' 66' ' ' VAL . . . -80.64 -53.15 6.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.482 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -50.19 -38.45 39.98 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.282 1.033 . . . . 0.0 110.41 176.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -55.3 35.31 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 126.171 1.789 . . . . 0.0 109.608 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.29 -30.97 68.11 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -90.55 -26.72 19.58 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -62.15 -32.75 73.39 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 119.202 0.91 . . . . 0.0 109.922 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -59.41 -19.03 44.13 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.024 0.929 . . . . 0.0 110.875 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 76.08 59.06 0.05 OUTLIER 'General case' 0 C--N 1.344 0.359 0 C-N-CA 127.294 2.237 . . . . 0.0 110.588 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -145.21 34.95 1.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.999 1.32 . . . . 0.0 109.529 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -175.27 130.99 0.29 Allowed 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 128.677 2.791 . . . . 0.0 106.455 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.7 p -84.35 85.79 7.34 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.26 0.552 . . . . 0.0 111.83 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.71 -160.23 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.044 1.737 . . . . 0.0 109.795 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -44.54 -49.8 8.47 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.233 1.397 . . . . 0.0 110.947 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.3 t 67.09 2.52 2.78 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.09 1.756 . . . . 0.0 115.735 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.9 m -67.77 -63.21 1.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -160.47 42.67 0.18 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.968 2.107 . . . . 0.0 107.076 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.438 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 9.8 m-85 -156.44 115.7 2.11 Favored Pre-proline 0 C--N 1.34 0.186 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.26 150.56 91.62 Favored 'Cis proline' 0 N--CA 1.456 -0.722 0 N-CA-C 114.239 0.823 . . . . 0.0 114.239 1.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.19 145.1 8.38 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.628 1.571 . . . . 0.0 108.577 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 m -60.44 145.47 48.1 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.849 1.66 . . . . 0.0 112.13 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -145.37 84.38 1.69 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -153.38 -158.47 0.88 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.934 1.294 . . . . 0.0 108.31 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.0 m120 67.83 2.52 3.1 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.629 1.572 . . . . 0.0 113.662 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -165.37 105.84 0.76 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -80.93 69.9 7.62 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.68 0.792 . . . . 0.0 110.659 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.28 11.91 56.6 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.945 0.783 . . . . 0.0 112.248 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -157.53 162.92 38.85 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 118.186 0.993 . . . . 0.0 111.809 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -116.03 119.72 36.78 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.131 1.373 . . . . 0.0 108.299 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -135.94 156.72 76.96 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 125.993 1.717 . . . . 0.0 107.722 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.401 ' O ' HG22 ' A' ' 52' ' ' VAL . 37.3 Cg_endo -61.74 163.36 18.92 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.095 2.53 . . . . 0.0 109.341 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 51' ' ' PRO 0.284 8.6 m 60.21 -165.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.176 1.39 . . . . 0.0 110.686 -178.201 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -112.79 -16.97 12.65 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.571 1.148 . . . . 0.0 113.392 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.07 -156.65 22.41 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.34 -177.05 5.33 Favored 'Cis proline' 0 CA--C 1.535 0.545 0 CA-C-N 119.037 1.418 . . . . 0.0 113.211 -0.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -148.25 155.27 41.14 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.615 0.366 . . . . 0.0 111.478 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -132.43 146.74 52.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.257 1.423 . . . . 0.0 107.777 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -86.6 156.8 19.89 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.482 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 35.8 t80 -152.5 109.7 2.76 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 13.0 Cg_endo -85.21 128.8 3.69 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 123.34 2.694 . . . . 0.0 116.965 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.444 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 10.1 tt -97.4 170.13 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-O 123.969 1.842 . . . . 0.0 112.193 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.444 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 8.3 mtpm? -160.74 113.51 1.99 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 109.394 -3.548 . . . . 0.0 111.623 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.9 p 10.76 50.14 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 129.806 3.242 . . . . 0.0 116.471 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.34 70.82 1.33 Allowed Glycine 0 C--N 1.337 0.639 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.08 113.89 0.54 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.441 HG11 ' CB ' ' A' ' 22' ' ' ALA . 26.9 t -84.08 137.77 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.103 1.361 . . . . 0.0 109.416 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.322 9.6 p90 46.17 53.38 9.41 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.027 2.131 . . . . 0.0 113.979 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.8 p -129.63 -33.44 1.85 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.963 1.705 . . . . 0.0 109.726 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.11 149.57 44.85 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 123.588 0.613 . . . . 0.0 112.815 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 172.07 -74.82 0.1 OUTLIER Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.8 t -153.0 105.22 2.64 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 124.121 0.968 . . . . 0.0 109.343 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -58.41 157.47 35.39 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 CA-C-N 119.735 0.941 . . . . 0.0 113.23 -5.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.81 -104.49 0.21 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 79.06 -60.18 0.37 Allowed 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 127.683 2.393 . . . . 0.0 109.052 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.92 121.9 18.25 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.445 1.498 . . . . 0.0 109.923 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -152.76 141.66 21.15 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.9 m -97.63 150.14 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.9 t -131.82 119.13 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.2 pt -100.62 167.75 2.01 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 C-N-CA 124.783 1.233 . . . . 0.0 113.17 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -82.46 168.26 17.62 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.875 2.07 . . . . 0.0 107.887 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.51 46.18 0.42 Allowed 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -160.36 -83.43 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.4 m -163.44 63.12 0.17 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.96 2.104 . . . . 0.0 112.034 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -148.83 114.74 5.72 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.445 1.93 . . . . 0.0 113.88 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -60.47 107.35 0.66 Allowed 'General case' 0 C--N 1.344 0.357 0 C-N-CA 123.56 0.744 . . . . 0.0 109.808 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.96 -68.22 0.72 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.34 169.35 35.46 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.87 146.64 48.26 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.25 1.02 . . . . 0.0 111.439 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.6 pt -139.28 166.04 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.577 1.551 . . . . 0.0 109.631 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.5 t -156.01 148.67 23.92 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -79.05 4.68 13.81 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 118.666 -0.683 . . . . 0.0 112.092 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 44.1 m -47.79 -49.94 27.24 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.73 32.68 6.4 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.577 1.084 . . . . 0.0 110.986 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -111.52 166.45 11.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.596 1.159 . . . . 0.0 112.641 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.2 t -103.49 67.61 0.92 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.707 1.603 . . . . 0.0 108.625 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.97 -109.8 3.79 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.763 1.173 . . . . 0.0 112.207 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -79.61 -9.18 59.59 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.175 0.99 . . . . 0.0 113.1 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -66.87 -179.65 0.94 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.062 0.945 . . . . 0.0 108.77 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -147.53 167.94 23.2 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.3 m -139.23 160.49 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 128.038 2.535 . . . . 0.0 105.381 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.67 149.6 20.17 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 115.527 0.971 . . . . 0.0 115.527 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.1 m -99.38 154.37 18.26 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.1 p 33.02 38.63 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 62.71 52.41 48.77 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.165 0.888 . . . . 0.0 111.853 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.1 t -81.65 28.95 0.39 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.517 1.127 . . . . 0.0 113.996 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 . . . . . 0 C--O 1.25 1.103 0 C-N-CA 125.974 1.709 . . . . 0.0 109.369 -179.243 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 t -77.96 92.5 4.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.722 1.209 . . . . 0.0 107.828 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 110.53 98.35 0.0 OUTLIER 'General case' 0 C--N 1.345 0.393 0 C-N-CA 131.157 3.783 . . . . 0.0 107.096 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -107.28 94.61 5.18 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.84 1.256 . . . . 0.0 111.563 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.04 99.6 9.49 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 102.105 -3.294 . . . . 0.0 102.105 177.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -92.13 80.81 5.05 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.755 1.622 . . . . 0.0 109.211 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.41 -82.49 0.91 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.4 t -117.89 -45.81 2.66 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.49 1.516 . . . . 0.0 109.67 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.8 m -63.42 103.91 0.57 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.725 1.21 . . . . 0.0 109.885 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.82 131.42 34.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.097 1.359 . . . . 0.0 110.847 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -131.21 138.54 49.42 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.6 p -77.68 160.68 28.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 124.113 0.965 . . . . 0.0 111.773 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.87 -13.21 43.22 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.9 t -81.42 -41.38 21.96 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.92 -37.2 86.52 Favored 'General case' 0 C--N 1.345 0.402 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.53 HG13 ' CE2' ' A' ' 85' ' ' TYR . 3.3 t -59.86 -51.23 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 126.28 1.832 . . . . 0.0 108.538 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.79 -39.16 93.36 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.139 0.976 . . . . 0.0 111.805 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.94 -51.71 36.85 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.055 0.542 . . . . 0.0 110.419 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.41 -38.77 81.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.669 1.188 . . . . 0.0 110.884 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.89 -41.03 45.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -64.3 -21.5 66.63 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.64 -59.22 2.5 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.07 -47.4 11.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.906 1.283 . . . . 0.0 110.239 177.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.9 t -61.18 -53.95 50.51 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.474 1.509 . . . . 0.0 111.595 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -57.37 -46.69 83.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.943 0.497 . . . . 0.0 110.907 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -67.46 -48.96 65.66 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.685 1.194 . . . . 0.0 113.137 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -65.05 -34.33 78.18 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.694 0.798 . . . . 0.0 112.146 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -82.78 -47.16 12.23 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 123.033 0.533 . . . . 0.0 111.52 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -70.98 -3.56 20.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.533 1.133 . . . . 0.0 112.539 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.8 t70 69.16 76.69 0.23 Allowed 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.662 1.585 . . . . 0.0 110.812 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -144.88 122.79 11.99 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.0 1.72 . . . . 0.0 107.172 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.9 p -103.22 82.43 2.07 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.02 111.98 2.15 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.236 1.015 . . . . 0.0 110.35 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.63 112.53 3.14 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.414 1.006 . . . . 0.0 111.867 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.2 m -135.88 -56.97 0.77 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.993 1.317 . . . . 0.0 108.064 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -157.67 -68.18 0.09 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.089 1.755 . . . . 0.0 106.507 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.3 t -159.95 30.67 0.18 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.351 1.86 . . . . 0.0 108.639 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -124.43 155.04 69.4 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.569 1.947 . . . . 0.0 108.825 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -80.51 133.72 27.36 Favored 'Cis proline' 0 N--CA 1.452 -0.935 0 CA-C-N 119.519 0.864 . . . . 0.0 112.438 -0.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.97 166.17 33.23 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.997 1.319 . . . . 0.0 108.652 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.6 m -51.81 140.47 19.32 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 126.051 1.741 . . . . 0.0 112.107 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -129.71 119.7 23.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.738 1.215 . . . . 0.0 109.204 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -165.08 92.36 0.57 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -159.32 159.65 34.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.314 0.646 . . . . 0.0 111.149 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.8 t80 67.79 165.59 0.23 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.875 1.67 . . . . 0.0 112.615 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -109.62 -45.17 3.72 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 124.778 1.231 . . . . 0.0 110.788 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.13 38.21 2.2 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.006 0.812 . . . . 0.0 113.85 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -157.82 128.22 6.29 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.012 1.325 . . . . 0.0 108.653 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -165.27 -175.32 3.57 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.165 1.386 . . . . 0.0 108.954 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -143.06 157.11 61.31 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 125.459 1.504 . . . . 0.0 107.903 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -81.85 48.99 3.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.668 2.912 . . . . 0.0 111.506 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 m -153.45 171.88 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 127.547 2.339 . . . . 0.0 107.441 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -109.32 143.65 38.54 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.265 1.026 . . . . 0.0 110.33 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.71 -160.66 35.84 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.65 151.38 23.55 Favored 'Cis proline' 0 N--CA 1.46 -0.467 0 CA-C-N 118.793 1.297 . . . . 0.0 113.634 -0.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -111.74 174.09 6.04 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.669 1.188 . . . . 0.0 109.848 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -155.57 144.0 20.25 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.11 0.564 . . . . 0.0 110.508 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -87.81 149.93 23.85 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.877 0.871 . . . . 0.0 111.092 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -158.34 109.24 1.69 Allowed Pre-proline 0 N--CA 1.45 -0.444 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -79.92 136.1 11.63 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 121.344 1.363 . . . . 0.0 113.454 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.503 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.3 tt -98.51 177.25 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 124.089 1.899 . . . . 0.0 110.801 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.503 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.7 tptm -156.52 -169.63 3.08 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 109.295 -3.593 . . . . 0.0 110.835 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t -76.64 52.44 0.81 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.574 1.549 . . . . 0.0 112.464 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.35 68.45 1.46 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.34 103.14 0.2 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 51.7 t -66.21 120.32 13.09 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 124.43 1.092 . . . . 0.0 108.661 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 64.47 115.67 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.543 1.537 . . . . 0.0 111.308 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.2 p -97.34 -72.74 0.63 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.495 1.118 . . . . 0.0 111.867 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.71 -10.88 73.59 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.897 0.76 . . . . 0.0 111.854 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -87.52 -90.68 1.04 Allowed Glycine 0 C--N 1.343 0.96 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.9 m -141.39 72.81 25.82 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 123.339 0.656 . . . . 0.0 112.229 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.55 111.33 3.2 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 N-CA-C 105.761 -2.438 . . . . 0.0 105.761 163.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.08 -8.28 8.02 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-O 117.243 -1.865 . . . . 0.0 117.081 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.452 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -150.05 -60.19 0.2 Allowed 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 120.84 2.32 . . . . 0.0 114.315 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.52 118.33 13.18 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -147.2 137.22 23.19 Favored 'General case' 0 C--N 1.347 0.483 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.9 m -94.69 149.33 4.48 Favored 'Isoleucine or valine' 0 C--N 1.343 0.318 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.5 t -134.72 117.68 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 pt -103.53 -177.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.372 0 C-N-CA 124.407 1.083 . . . . 0.0 112.145 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -99.79 151.91 20.72 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 127.312 2.245 . . . . 0.0 105.308 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.326 5.3 t -63.07 -7.22 5.07 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 119.2 3.037 . . . . 0.0 119.2 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -89.29 -78.03 0.36 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.54 -9.96 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -79.21 151.49 31.19 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 118.868 0.758 . . . . 0.0 110.509 -176.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.53 ' CE2' HG13 ' A' ' 16' ' ' VAL . 7.0 t80 -93.53 137.55 32.69 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.514 1.125 . . . . 0.0 109.763 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -95.86 -57.59 2.32 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 123.258 0.623 . . . . 0.0 110.767 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.86 168.86 30.6 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.29 155.72 20.19 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 122.203 1.002 . . . . 0.0 112.794 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.2 pt -139.55 155.77 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 126.699 1.999 . . . . 0.0 106.575 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.5 t -154.69 156.47 36.46 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.452 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 53.2 m170 -77.96 -50.06 12.9 Favored 'General case' 0 C--N 1.346 0.442 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.673 176.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 t 45.4 15.1 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.621 2.768 . . . . 0.0 116.248 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.76 49.79 3.28 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.174 1.369 . . . . 0.0 110.791 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.24 -87.13 0.11 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 124.293 1.037 . . . . 0.0 109.721 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.7 m -147.64 63.19 1.14 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.729 1.211 . . . . 0.0 108.756 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.04 -102.21 1.13 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.282 0.944 . . . . 0.0 111.737 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -79.53 -26.93 41.36 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.91 0.884 . . . . 0.0 112.006 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -50.31 129.96 22.4 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.989 0.916 . . . . 0.0 111.374 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -103.62 133.93 47.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.28 1.432 . . . . 0.0 110.266 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.6 m -111.15 164.81 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.33 137.76 17.45 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.872 -0.604 . . . . 0.0 114.105 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.8 t -83.29 -172.5 4.18 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.3 m -67.65 138.97 56.77 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.217 -0.927 . . . . 0.0 108.643 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.63 33.11 35.34 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.2 m -155.24 119.3 4.61 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.533 1.533 . . . . 0.0 110.574 -179.088 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t -160.02 148.5 17.15 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.417 1.087 . . . . 0.0 108.318 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -49.32 136.81 15.22 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.808 1.243 . . . . 0.0 110.485 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.7 p -112.45 117.58 32.78 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -117.41 94.59 4.61 Favored 'General case' 0 N--CA 1.422 -1.872 1 N-CA-C 100.176 -4.009 . . . . 0.0 100.176 177.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 54.2 m -95.02 71.87 3.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.29 -79.22 1.51 Allowed Glycine 0 C--N 1.34 0.799 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.3 t -123.29 -35.32 2.98 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.99 1.316 . . . . 0.0 111.344 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 m -72.86 99.25 2.62 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -95.58 148.36 22.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.264 1.026 . . . . 0.0 110.803 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.61 143.62 31.56 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.691 1.196 . . . . 0.0 108.003 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -68.71 150.73 47.57 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.86 -21.27 10.84 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.8 t -71.14 -44.51 65.41 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.387 1.075 . . . . 0.0 109.574 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.1 -39.01 92.53 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 118.682 0.673 . . . . 0.0 112.628 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.447 HG12 ' CE2' ' A' ' 85' ' ' TYR . 2.1 t -62.88 -53.31 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -57.13 -44.49 83.41 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.811 1.245 . . . . 0.0 110.291 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.03 -45.11 95.0 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.647 0.779 . . . . 0.0 110.077 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.13 -33.95 69.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.511 0.725 . . . . 0.0 110.372 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.08 -39.55 25.54 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -62.4 -25.93 68.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.934 1.243 . . . . 0.0 108.312 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.55 -64.51 1.13 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.57 -33.54 15.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.962 0.905 . . . . 0.0 111.346 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 t -61.89 -61.4 2.52 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.308 1.443 . . . . 0.0 110.05 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -65.7 -42.3 91.32 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -71.52 -48.7 47.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.329 1.451 . . . . 0.0 113.722 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.457 ' CE2' ' HG2' ' A' ' 57' ' ' GLN . 39.6 t80 -62.08 -34.68 76.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.48 0.582 . . . . 0.0 110.177 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -58.02 -34.81 70.45 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 118.432 -0.794 . . . . 0.0 112.447 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 122.08 73.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 129.577 3.151 . . . . 0.0 110.604 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -162.08 58.82 0.24 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.1 t70 124.18 154.52 0.0 OUTLIER 'General case' 0 C--N 1.344 0.343 0 C-N-CA 130.027 3.331 . . . . 0.0 109.257 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.6 p -110.78 67.65 0.65 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 126.044 1.738 . . . . 0.0 108.653 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.06 93.79 1.83 Allowed 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.047 0.539 . . . . 0.0 109.751 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.21 135.33 3.41 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.1 t -136.4 67.03 1.47 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.642 0.777 . . . . 0.0 110.589 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.1 m -122.24 -76.77 0.59 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -160.29 30.97 0.17 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.835 1.654 . . . . 0.0 109.105 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -149.05 134.3 9.47 Favored Pre-proline 0 C--N 1.342 0.278 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.68 145.9 85.35 Favored 'Cis proline' 0 N--CA 1.455 -0.776 0 CA-C-N 119.373 0.812 . . . . 0.0 112.483 -0.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -159.89 162.47 34.58 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 126.079 1.752 . . . . 0.0 108.459 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 t -59.91 150.23 29.32 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -106.56 88.44 2.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.11 1.364 . . . . 0.0 107.707 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -68.31 100.4 1.05 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.687 1.195 . . . . 0.0 109.943 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -66.17 -65.48 0.67 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.679 0.791 . . . . 0.0 111.105 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 58.41 56.03 4.61 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 69.2 tt0 68.06 -17.0 0.17 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.731 2.012 . . . . 0.0 114.593 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.75 -99.32 0.01 OUTLIER Glycine 0 CA--C 1.532 1.136 0 N-CA-C 116.455 1.342 . . . . 0.0 116.455 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.62 133.94 38.31 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -109.81 162.83 14.1 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.948 1.299 . . . . 0.0 110.88 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -153.95 153.21 28.26 Favored Pre-proline 0 N--CA 1.454 -0.257 0 C-N-CA 126.149 1.78 . . . . 0.0 107.231 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -62.99 -30.02 76.17 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.92 2.413 . . . . 0.0 112.026 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 t -91.06 -74.39 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.069 0.947 . . . . 0.0 108.462 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 t70 54.87 105.59 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.967 2.507 . . . . 0.0 115.405 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.81 117.68 2.0 Allowed Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.839 -0.978 . . . . 0.0 112.082 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -68.8 157.33 89.34 Favored 'Cis proline' 0 C--N 1.348 0.515 0 CA-C-N 119.521 1.661 . . . . 0.0 108.543 -1.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.56 134.75 15.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 119.85 3.278 . . . . 0.0 119.85 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.457 ' HG2' ' CE2' ' A' ' 27' ' ' TYR . 20.0 mp0 -145.07 144.97 31.24 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 124.476 1.11 . . . . 0.0 112.78 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -81.86 156.15 24.98 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.674 0.749 . . . . 0.0 110.346 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -160.63 107.53 1.32 Allowed Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 103.352 -2.833 . . . . 0.0 103.352 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.39 134.88 21.46 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 CA-C-N 120.913 1.362 . . . . 0.0 112.336 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.45 HG13 ' H ' ' A' ' 62' ' ' LYS . 6.9 tp -82.27 176.14 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-O 123.863 1.792 . . . . 0.0 111.114 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.45 ' H ' HG13 ' A' ' 61' ' ' ILE . 55.9 tptt -155.56 154.57 31.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 109.703 -3.408 . . . . 0.0 112.813 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.4 m -83.83 51.0 1.93 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 127.467 2.307 . . . . 0.0 108.367 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.62 65.03 0.07 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.48 -102.9 1.66 Allowed Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 67' ' ' TYR . 8.2 p -110.6 -176.93 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.823 2.049 . . . . 0.0 109.886 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.498 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -41.27 166.72 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.291 2.636 . . . . 0.0 117.258 -178.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.3 p -96.37 -64.17 1.07 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.375 1.47 . . . . 0.0 110.057 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.12 62.88 0.77 Allowed Glycine 0 C--N 1.338 0.679 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -170.76 -61.8 0.04 OUTLIER Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.2 t -154.13 147.4 18.2 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.288 1.035 . . . . 0.0 109.924 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.31 -158.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.193 3.262 . . . . 0.0 110.419 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.39 41.95 0.13 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 107.391 -2.284 . . . . 0.0 107.391 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.44 ' HB1' ' H ' ' A' ' 91' ' ' HIS . . . 71.12 -27.07 0.17 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.824 2.049 . . . . 0.0 116.305 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.9 111.43 19.66 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 120.332 1.424 . . . . 0.0 110.438 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -120.1 154.09 35.2 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.101 0.96 . . . . 0.0 113.146 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.3 m -128.02 143.21 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -134.89 126.67 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pt -110.29 -165.27 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.371 0 C-N-CA 125.016 1.326 . . . . 0.0 114.447 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -122.97 136.87 55.02 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 128.48 2.712 . . . . 0.0 106.849 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.29 1.7 t -56.65 -15.55 4.67 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 118.746 2.869 . . . . 0.0 118.746 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -79.55 -77.15 0.19 Allowed 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 102.693 -3.077 . . . . 0.0 102.693 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.11 -2.16 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.012 2.125 . . . . 0.0 114.902 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -79.17 170.25 16.93 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 119.646 1.112 . . . . 0.0 112.155 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.447 ' CE2' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -112.65 126.95 55.93 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.767 1.227 . . . . 0.0 111.565 -178.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.5 -51.82 7.44 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.63 -158.26 31.07 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 112.28 -0.328 . . . . 0.0 112.28 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.54 145.22 29.0 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.357 1.063 . . . . 0.0 110.174 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 pt -138.32 166.81 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.705 1.202 . . . . 0.0 110.95 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.3 t -156.18 156.69 34.63 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.44 ' H ' ' HB1' ' A' ' 74' ' ' ALA . 44.7 m170 -78.5 -30.67 47.33 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.117 177.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.5 m -29.48 -70.14 0.05 Allowed 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.987 2.115 . . . . 0.0 116.504 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.97 -12.84 79.25 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.111 0.862 . . . . 0.0 114.769 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.96 -142.21 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.345 1.073 . . . . 0.0 111.064 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.7 t -151.17 92.27 1.78 Allowed 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.033 0.933 . . . . 0.0 109.941 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.98 -105.97 2.21 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.97 1.272 . . . . 0.0 112.632 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -79.47 -32.03 42.52 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.871 0.868 . . . . 0.0 111.312 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -54.79 160.62 1.83 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.318 1.047 . . . . 0.0 111.685 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -125.09 163.37 22.54 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.239 1.416 . . . . 0.0 112.859 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.5 m -144.53 165.68 12.78 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 128.123 2.569 . . . . 0.0 106.473 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.68 157.34 23.63 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.232 0.444 . . . . 0.0 113.477 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.5 m -116.24 167.63 10.84 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.2 m 61.7 -157.31 0.34 Allowed 'General case' 0 C--N 1.342 0.243 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.37 -19.62 57.77 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.489 1.042 . . . . 0.0 111.359 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.8 m -79.46 144.69 33.81 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 125.011 1.324 . . . . 0.0 109.122 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 C--O 1.253 1.285 0 CA-C-O 117.066 -1.445 . . . . 0.0 109.193 179.039 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 121.261 0.553 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -148.69 54.24 1.0 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.921 1.288 . . . . 0.0 107.937 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 73.41 146.34 0.08 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 126.874 2.07 . . . . 0.0 109.974 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 t -151.15 135.45 16.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.506 0.193 . . . . 0.0 110.525 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.88 107.91 18.02 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -98.69 85.89 3.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.47 -115.06 4.93 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.0 m -91.15 -27.79 18.29 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.404 1.082 . . . . 0.0 110.23 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -76.33 94.53 3.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.202 1.001 . . . . 0.0 109.351 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -85.82 113.15 21.75 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.723 1.209 . . . . 0.0 109.977 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -103.99 133.02 49.65 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.124 0.97 . . . . 0.0 111.218 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.7 m -72.46 154.31 40.93 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.3 1.44 . . . . 0.0 108.951 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.08 -20.84 60.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.0 m -74.5 -37.91 62.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.774 0.829 . . . . 0.0 109.449 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -73.66 -47.72 37.7 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.751 1.22 . . . . 0.0 111.596 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.0 t -54.39 -50.29 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -71.81 -34.64 69.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.226 1.411 . . . . 0.0 113.272 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.76 -52.76 55.26 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.279 0.945 . . . . 0.0 109.396 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.59 87.75 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.91 -37.54 81.82 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.63 -22.51 61.68 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.33 -59.44 2.77 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -55.44 -41.72 73.25 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.365 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.74 -50.47 33.61 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.853 1.206 . . . . 0.0 110.577 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -68.52 -43.87 75.84 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.353 0.0 OUTLIER -75.08 -43.05 55.32 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -177.394 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -53.01 -39.24 62.98 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.59 1.956 . . . . 0.0 107.928 177.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -76.81 -37.51 55.62 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.884 1.274 . . . . 0.0 112.867 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -63.16 -32.18 73.51 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 t0 67.92 32.0 5.38 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.439 1.495 . . . . 0.0 110.87 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -163.5 -165.18 1.01 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 129.283 3.033 . . . . 0.0 105.065 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.284 3.7 t 47.27 57.96 5.31 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.804 1.242 . . . . 0.0 110.518 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -144.52 172.16 13.35 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.663 1.585 . . . . 0.0 109.67 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.8 58.25 0.07 OUTLIER Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.3 t -118.95 -94.49 0.5 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.716 1.206 . . . . 0.0 108.207 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.9 m -158.1 -59.34 0.08 Allowed 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.804 1.242 . . . . 0.0 108.223 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 82.7 p -130.56 -52.27 1.08 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.697 1.599 . . . . 0.0 108.439 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -45.24 124.57 5.58 Favored Pre-proline 0 C--N 1.342 0.271 0 C-N-CA 127.821 2.448 . . . . 0.0 108.531 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.52 119.22 5.08 Favored 'Cis proline' 0 N--CA 1.453 -0.857 0 CA-C-N 118.583 0.53 . . . . 0.0 111.613 1.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -135.85 146.35 47.37 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 124.643 1.177 . . . . 0.0 111.129 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -43.0 151.3 0.14 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.257 2.223 . . . . 0.0 114.743 -178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -126.4 127.23 45.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.742 2.017 . . . . 0.0 105.853 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -74.32 -103.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 122.79 0.436 . . . . 0.0 111.3 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -178.46 -46.08 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.212 1.405 . . . . 0.0 109.06 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -41.48 128.76 3.14 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 128.002 2.521 . . . . 0.0 115.106 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 43.87 82.5 0.03 OUTLIER 'General case' 0 C--N 1.342 0.267 0 C-N-CA 127.325 2.25 . . . . 0.0 113.361 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.46 -156.94 28.4 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.52 154.35 20.02 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.66 1.584 . . . . 0.0 108.339 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -132.29 129.65 39.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -72.32 151.57 92.1 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.722 1.209 . . . . 0.0 111.397 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -63.6 -12.52 31.58 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 124.05 3.167 . . . . 0.0 115.618 -178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.94 -64.18 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.063 0.847 . . . . 0.0 110.281 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 143.17 -52.03 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 129.601 3.16 . . . . 0.0 108.457 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.5 -162.96 28.38 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.436 1.017 . . . . 0.0 110.952 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.6 170.59 9.27 Favored 'Cis proline' 0 CA--C 1.535 0.542 0 CA-C-N 119.208 1.504 . . . . 0.0 114.999 -0.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.29 -179.17 6.36 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 125.061 1.344 . . . . 0.0 109.229 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -154.19 147.77 25.18 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.24 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -79.41 148.8 31.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.832 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.489 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 20.4 t80 -144.13 104.91 4.78 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.468 ' HB3' HH11 ' A' ' 76' ' ' ARG . 26.3 Cg_endo -77.54 128.09 9.3 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 121.024 1.149 . . . . 0.0 113.319 -175.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.557 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.1 tt -90.83 179.33 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 CA-C-O 124.281 1.991 . . . . 0.0 110.275 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.557 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 10.4 tptp -160.2 147.55 16.26 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 109.26 -3.609 . . . . 0.0 110.58 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.0 p -93.35 56.89 2.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.604 1.162 . . . . 0.0 108.531 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 178.78 57.3 0.07 OUTLIER Glycine 0 C--N 1.339 0.713 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.95 153.16 19.1 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.023 0.821 . . . . 0.0 111.951 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.57 147.61 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.489 1.116 . . . . 0.0 109.091 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.399 0.0 OUTLIER 28.97 44.5 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 128.794 2.837 . . . . 0.0 116.486 -178.567 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.8 p -141.72 108.41 5.37 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.459 1.504 . . . . 0.0 107.395 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -179.71 -177.53 47.94 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.06 160.42 33.97 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.2 t 72.18 145.85 0.11 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.056 1.742 . . . . 0.0 110.219 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -42.15 110.46 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.91 3.074 . . . . 0.0 113.715 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.62 -39.03 2.64 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.455 ' HB1' ' H ' ' A' ' 91' ' ' HIS . . . 71.74 -12.08 0.68 Allowed 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 126.769 2.028 . . . . 0.0 115.814 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -88.78 126.41 35.33 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 120.568 1.531 . . . . 0.0 112.427 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.468 HH11 ' HB3' ' A' ' 60' ' ' PRO . 33.0 mtt-85 -136.91 145.82 44.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.34 150.04 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 102.389 -3.189 . . . . 0.0 102.389 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.2 t -134.33 127.03 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 O-C-N 121.543 -0.723 . . . . 0.0 109.284 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.9 pt -113.61 158.18 14.04 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 C-N-CA 124.924 1.29 . . . . 0.0 108.424 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -79.28 172.98 13.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.869 0.868 . . . . 0.0 109.273 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.299 3.0 t -76.66 30.02 0.13 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -128.33 -80.19 0.58 Allowed 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 101.66 -3.459 . . . . 0.0 101.66 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.5 -19.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -84.65 139.42 32.06 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -55.67 129.68 40.14 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 125.117 1.367 . . . . 0.0 109.01 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.38 -45.0 5.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.205 1.402 . . . . 0.0 108.947 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.72 -160.98 24.25 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.42 148.55 23.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.347 1.459 . . . . 0.0 108.707 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.3 pt -142.97 164.56 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.929 1.292 . . . . 0.0 110.227 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -159.47 162.84 35.66 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.895 0.478 . . . . 0.0 111.728 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.455 ' H ' ' HB1' ' A' ' 74' ' ' ALA . 22.4 m170 -78.89 -56.62 4.26 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.272 5.8 t 49.26 11.01 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.352 2.661 . . . . 0.0 115.606 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.36 -55.85 0.62 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 106.98 -2.448 . . . . 0.0 106.98 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 52.28 -169.33 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.483 1.913 . . . . 0.0 112.133 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.8 t -83.27 -42.24 17.4 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -147.54 -79.87 0.03 OUTLIER Glycine 0 C--N 1.342 0.891 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -130.47 3.2 4.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.182 1.393 . . . . 0.0 111.55 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -73.07 -169.84 0.66 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.962 1.305 . . . . 0.0 111.725 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -127.37 154.42 45.0 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.933 1.293 . . . . 0.0 112.224 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.81 162.75 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 126.215 1.806 . . . . 0.0 107.144 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.84 147.26 39.66 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.68 -178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.0 t -79.83 178.89 7.87 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.1 m -93.21 100.48 12.85 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.944 0.793 . . . . 0.0 108.869 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.65 75.49 1.27 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.1 t -135.13 29.82 3.35 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.54 1.536 . . . . 0.0 111.459 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.962 1.705 . . . . 0.0 110.519 -179.228 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.526 0 CA-C-O 119.982 -0.056 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -157.88 55.9 0.48 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.58 156.6 0.14 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.639 1.976 . . . . 0.0 111.929 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 t -154.51 137.8 15.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.86 122.02 45.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -106.03 80.2 1.49 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.436 1.495 . . . . 0.0 108.058 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.74 -86.41 0.75 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.5 t -114.82 -41.86 3.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.108 1.363 . . . . 0.0 110.053 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.4 m -68.91 100.19 1.16 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.559 0.744 . . . . 0.0 109.45 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -80.03 151.97 29.67 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.895 0.878 . . . . 0.0 110.506 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -139.0 131.11 28.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.988 0.915 . . . . 0.0 110.225 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.9 m -72.21 156.43 39.16 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.42 1.488 . . . . 0.0 109.057 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.47 -21.35 62.27 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.6 m -70.88 -40.72 72.08 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.748 1.219 . . . . 0.0 109.373 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -49.07 67.8 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.53 1.132 . . . . 0.0 111.004 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.93 -49.34 84.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 125.241 1.416 . . . . 0.0 109.626 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -67.79 -40.26 83.97 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.765 0.826 . . . . 0.0 112.393 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.27 -49.97 71.96 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.54 -38.7 81.72 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.001 0.92 . . . . 0.0 110.098 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.88 -46.27 62.89 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -64.31 -20.35 66.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.14 -55.27 4.86 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.705 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -55.21 -43.12 74.18 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 t -50.31 -53.24 30.18 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.044 0.938 . . . . 0.0 110.812 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -66.37 -44.4 83.25 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -65.07 -59.54 4.01 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.843 2.457 . . . . 0.0 112.204 -177.713 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -64.92 -24.97 67.69 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.939 2.095 . . . . 0.0 113.758 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -76.11 -62.86 1.46 Allowed 'General case' 0 C--N 1.338 0.095 0 CA-C-N 118.763 0.71 . . . . 0.0 111.964 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -164.89 -37.61 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -81.3 61.76 4.94 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.576 1.151 . . . . 0.0 108.785 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -50.05 117.9 2.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.464 1.906 . . . . 0.0 111.935 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 t -90.48 -20.71 22.41 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.369 1.068 . . . . 0.0 108.983 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 26' ' ' TYR . . . -155.4 -168.65 2.9 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.773 2.429 . . . . 0.0 107.888 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -176.62 150.11 10.19 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 121.589 -0.695 . . . . 0.0 113.213 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 m -153.55 -111.14 0.04 OUTLIER 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.696 1.199 . . . . 0.0 109.405 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.9 m -155.89 -55.67 0.09 Allowed 'General case' 0 C--N 1.347 0.476 0 CA-C-N 118.813 0.733 . . . . 0.0 112.36 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.2 p -87.87 -57.42 2.95 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.141 0.976 . . . . 0.0 110.351 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.533 ' CD1' ' C ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -92.19 153.37 43.09 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.522 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.434 ' HG3' ' CE2' ' A' ' 26' ' ' TYR . 26.8 Cg_endo -98.31 56.04 1.0 Allowed 'Cis proline' 0 N--CA 1.442 -1.517 0 N-CA-C 105.139 -2.677 . . . . 0.0 105.139 -5.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.416 ' CE1' ' HD2' ' A' ' 39' ' ' PRO . 6.1 m-70 -107.08 -168.39 1.4 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.555 1.142 . . . . 0.0 112.417 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.0 p -33.02 139.92 0.05 OUTLIER 'General case' 0 C--N 1.34 0.185 0 C-N-CA 128.56 2.744 . . . . 0.0 115.784 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -152.13 127.17 9.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.054 2.142 . . . . 0.0 105.515 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -149.24 -51.63 0.15 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.813 0.845 . . . . 0.0 110.171 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -58.02 158.13 7.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.842 1.257 . . . . 0.0 111.686 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 66.62 102.29 0.04 OUTLIER 'General case' 0 C--N 1.343 0.291 0 C-N-CA 125.927 1.691 . . . . 0.0 109.694 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -82.61 -142.44 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.147 0.979 . . . . 0.0 110.097 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.0 12.81 65.76 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -159.17 139.57 12.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.321 1.849 . . . . 0.0 108.584 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.06 166.22 17.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.671 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -134.97 162.19 59.19 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 124.772 1.229 . . . . 0.0 109.117 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -51.38 -41.12 60.86 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.852 3.035 . . . . 0.0 112.774 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.93 167.34 2.33 Favored 'Isoleucine or valine' 0 C--N 1.343 0.32 0 C-N-CA 123.585 0.754 . . . . 0.0 110.152 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -101.53 -177.22 3.37 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.981 1.313 . . . . 0.0 109.7 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -132.09 -156.76 8.41 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.471 1.034 . . . . 0.0 110.724 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.33 125.56 1.56 Allowed 'Cis proline' 0 N--CA 1.456 -0.712 0 CA-C-N 118.274 1.037 . . . . 0.0 113.436 -0.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -98.49 169.34 9.6 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.82 1.648 . . . . 0.0 109.261 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -138.83 156.18 47.53 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.45 159.8 17.1 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.705 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -161.18 102.32 1.25 Allowed Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 76' ' ' ARG . 66.0 Cg_endo -66.87 121.74 8.99 Favored 'Trans proline' 0 N--CA 1.425 -2.546 0 CA-C-N 121.353 1.519 . . . . 0.0 114.098 -177.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 62' ' ' LYS . 3.2 tp -84.24 167.3 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-O 124.573 2.13 . . . . 0.0 112.127 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.449 ' N ' HG13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -160.25 151.62 19.5 Favored 'General case' 0 C--N 1.317 -0.843 1 CA-C-N 108.394 -4.003 . . . . 0.0 111.882 -178.887 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.6 p -86.49 57.36 4.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.998 1.719 . . . . 0.0 110.635 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.58 -73.39 0.03 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.27 137.64 5.48 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -61.45 131.6 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 117.32 0.56 . . . . 0.0 111.405 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.273 0.7 OUTLIER 64.65 131.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.717 2.807 . . . . 0.0 113.359 -178.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.6 p -136.59 -50.28 0.67 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.913 1.685 . . . . 0.0 108.435 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.9 61.66 1.49 Allowed Glycine 0 C--N 1.341 0.807 0 C-N-CA 124.374 0.988 . . . . 0.0 111.324 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 168.76 34.27 0.02 OUTLIER Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.271 -0.738 . . . . 0.0 113.206 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.8 p -170.38 139.76 1.47 Allowed Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.812 0.845 . . . . 0.0 110.094 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.73 -72.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.848 2.365 . . . . 0.0 108.5 170.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.74 -25.28 27.13 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 118.406 -1.219 . . . . 0.0 112.886 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 76.03 -43.54 0.48 Allowed 'General case' 0 C--N 1.346 0.448 0 C-N-CA 126.31 1.844 . . . . 0.0 111.081 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.92 121.76 28.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.88 0.872 . . . . 0.0 110.598 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -130.03 121.38 26.36 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.89 0.876 . . . . 0.0 112.896 -178.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.7 m -85.01 145.33 8.13 Favored 'Isoleucine or valine' 0 C--N 1.346 0.439 0 N-CA-C 102.692 -3.077 . . . . 0.0 102.692 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.8 t -131.47 115.89 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 pt -93.78 -177.97 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.454 0 C-N-CA 124.987 1.315 . . . . 0.0 110.663 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -123.23 166.9 14.47 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.356 14.9 t -75.99 62.83 1.68 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -149.57 -94.33 0.07 Allowed 'General case' 0 N--CA 1.432 -1.333 1 N-CA-C 99.55 -4.241 . . . . 0.0 99.55 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.5 t -164.12 8.92 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.771 1.228 . . . . 0.0 113.818 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -112.81 156.51 22.76 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -175.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -75.14 116.45 15.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.892 2.477 . . . . 0.0 108.456 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.23 -49.57 9.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.88 172.66 42.57 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.65 150.78 43.79 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.154 0.982 . . . . 0.0 111.087 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.4 pt -131.82 161.48 41.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.163 1.785 . . . . 0.0 108.15 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 92' ' ' THR . 0.8 OUTLIER -156.66 139.21 14.96 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -177.621 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -86.26 15.98 4.8 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.513 ' H ' HG23 ' A' ' 90' ' ' THR . 98.0 m -69.74 -51.73 31.55 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 120.703 -1.248 . . . . 0.0 111.0 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.88 9.5 65.65 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.556 1.074 . . . . 0.0 112.385 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.18 158.66 16.49 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.004 1.322 . . . . 0.0 111.086 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.8 t -104.62 69.32 0.89 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.326 1.45 . . . . 0.0 108.436 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.06 -115.21 3.29 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.463 1.506 . . . . 0.0 109.548 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -102.68 22.06 14.32 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.558 1.143 . . . . 0.0 111.778 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.71 -164.73 0.45 Allowed 'General case' 0 C--N 1.342 0.266 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -146.94 155.18 42.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.5 m -140.95 165.03 20.15 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 C-N-CA 126.856 2.062 . . . . 0.0 106.622 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.87 141.91 16.29 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 116.637 -0.256 . . . . 0.0 113.538 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.3 t -83.07 -174.82 5.51 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.6 m -68.82 127.64 33.82 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.101 -0.999 . . . . 0.0 109.023 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.36 42.1 12.41 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.4 m -149.98 124.86 9.88 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.806 1.242 . . . . 0.0 108.144 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 t30 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 117.038 -1.458 . . . . 0.0 109.173 179.171 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 121.155 0.502 . . . . 0.0 111.992 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 t -127.05 164.51 21.38 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.943 1.697 . . . . 0.0 108.682 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.46 123.41 14.65 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.412 HG22 ' CG2' ' A' ' 16' ' ' VAL . 3.8 t -130.8 124.39 31.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 123.73 0.644 . . . . 0.0 111.075 -178.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -107.55 129.69 54.95 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.68 1.992 . . . . 0.0 106.507 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -119.81 93.39 4.05 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.879 0.371 . . . . 0.0 110.353 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.6 -84.01 0.66 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.9 m -115.53 -27.4 7.15 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.888 1.275 . . . . 0.0 110.802 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -66.71 155.12 38.9 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.733 0.697 . . . . 0.0 109.884 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -142.15 86.24 1.96 Allowed 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 123.788 0.68 . . . . 0.0 110.855 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.58 136.98 32.72 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.7 t -76.7 158.45 30.98 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.69 -19.55 50.45 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.7 m -71.54 -39.43 70.71 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.21 1.004 . . . . 0.0 109.214 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.99 -50.12 37.8 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.35 1.06 . . . . 0.0 112.459 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.437 HG11 ' CE2' ' A' ' 85' ' ' TYR . 21.7 t -54.79 -48.08 73.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 124.332 1.053 . . . . 0.0 108.917 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -71.11 -41.84 70.03 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.178 1.391 . . . . 0.0 113.363 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.72 -52.17 53.38 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.702 0.683 . . . . 0.0 110.651 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.432 ' HB1' ' CE2' ' A' ' 59' ' ' PHE . . . -60.93 -36.95 80.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.448 0.699 . . . . 0.0 110.703 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.52 -39.02 67.91 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.802 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -67.12 -21.86 65.83 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.84 -63.53 1.39 Allowed 'General case' 0 C--N 1.347 0.48 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.435 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -47.33 -37.35 10.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.332 1.453 . . . . 0.0 111.535 177.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -61.7 2.44 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.473 1.909 . . . . 0.0 108.884 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -63.23 -36.7 84.51 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -66.87 -43.06 84.54 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.673 1.189 . . . . 0.0 111.987 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -74.36 -27.59 60.74 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.074 0.397 . . . . 0.0 111.798 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -89.07 9.39 25.53 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.338 1.055 . . . . 0.0 113.146 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.7 p30 -130.84 45.83 2.76 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 119.085 0.857 . . . . 0.0 110.54 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 70.66 37.28 1.44 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 126.849 2.06 . . . . 0.0 113.274 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.45 176.36 0.08 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.565 1.946 . . . . 0.0 114.905 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.1 t 21.35 79.38 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 129.351 3.061 . . . . 0.0 115.857 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.89 98.3 7.89 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.16 53.61 41.12 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.498 1.047 . . . . 0.0 111.034 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.3 m -140.38 -114.89 0.13 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.2 t -157.9 -82.33 0.06 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.3 p -115.44 -44.09 3.0 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.842 1.657 . . . . 0.0 107.528 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.49 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 15.2 m-85 -69.49 131.99 89.67 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 126.664 1.986 . . . . 0.0 106.514 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.91 137.18 48.42 Favored 'Cis proline' 0 N--CA 1.453 -0.896 0 CA-C-N 120.823 1.33 . . . . 0.0 113.314 0.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -159.91 150.16 18.63 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.895 1.678 . . . . 0.0 109.963 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -47.72 141.39 5.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.094 2.157 . . . . 0.0 113.451 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -113.89 97.18 6.24 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.784 1.634 . . . . 0.0 108.383 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -157.94 33.55 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -66.11 -50.53 63.7 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.06 0.544 . . . . 0.0 111.347 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -161.6 91.57 0.84 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 72.13 171.45 0.31 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.233 1.813 . . . . 0.0 110.741 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.22 8.2 7.99 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 118.315 -1.27 . . . . 0.0 114.559 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.3 t80 62.61 -158.98 0.32 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.016 1.408 . . . . 0.0 110.016 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -61.82 -172.73 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.828 1.651 . . . . 0.0 112.325 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.0 p90 51.7 63.39 9.43 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 125.748 1.619 . . . . 0.0 110.741 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.64 111.44 3.13 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.687 2.924 . . . . 0.0 110.075 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.76 170.68 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.199 1.399 . . . . 0.0 109.72 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.7 -57.97 6.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.23 -149.35 49.93 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 119.521 -0.6 . . . . 0.0 112.267 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.98 148.64 19.9 Favored 'Cis proline' 0 N--CA 1.459 -0.512 0 CA-C-N 118.604 1.202 . . . . 0.0 112.999 -0.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -111.18 140.69 45.52 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 125.742 1.617 . . . . 0.0 108.645 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -113.88 149.65 34.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.77 1.228 . . . . 0.0 113.42 -177.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -84.83 155.12 21.91 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.095 0.958 . . . . 0.0 110.553 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.435 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 62.7 t80 -153.53 108.71 2.57 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 176.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.49 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 11.2 Cg_endo -82.04 133.44 7.75 Favored 'Trans proline' 0 N--CA 1.432 -2.131 0 C-N-CA 121.931 1.754 . . . . 0.0 113.287 -175.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.45 ' CG2' ' H ' ' A' ' 62' ' ' LYS . 0.7 OUTLIER -106.21 -171.58 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 127.247 2.219 . . . . 0.0 106.298 178.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.45 ' H ' ' CG2' ' A' ' 61' ' ' ILE . 10.5 mmtt -162.74 -174.99 4.19 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 129.374 3.069 . . . . 0.0 108.396 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.2 m -88.74 53.46 2.71 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.96 -51.25 0.01 OUTLIER Glycine 0 C--N 1.344 1.025 0 C-N-CA 124.666 1.127 . . . . 0.0 111.87 -178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.87 -139.12 7.33 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 118.289 1.045 . . . . 0.0 112.966 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.0 p -52.96 142.4 5.81 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 125.716 1.606 . . . . 0.0 110.436 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.03 164.0 27.98 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.297 0.639 . . . . 0.0 112.124 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 t -134.18 63.97 1.61 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.538 1.535 . . . . 0.0 109.419 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 151.53 -177.32 29.52 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.54 -98.21 0.15 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.414 ' CB ' ' CD ' ' A' ' 72' ' ' PRO 0.327 67.3 m 56.19 -105.88 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.952 1.701 . . . . 0.0 111.08 -179.084 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 71' ' ' SER . 83.0 Cg_endo -75.64 131.07 13.2 Favored 'Trans proline' 0 C--N 1.352 0.711 0 CA-C-N 123.584 2.316 . . . . 0.0 109.07 175.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.47 162.86 25.34 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -157.51 48.86 0.42 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.919 0.888 . . . . 0.0 109.303 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.18 116.89 3.42 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.975 2.11 . . . . 0.0 105.881 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.22 165.53 30.67 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 m -135.58 142.62 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 102.259 -3.237 . . . . 0.0 102.259 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.0 t -133.08 120.38 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.0 pt -97.99 179.33 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.407 0 C-N-CA 126.395 1.878 . . . . 0.0 112.028 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -113.59 177.1 4.75 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.416 1.486 . . . . 0.0 109.681 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.332 11.5 t -77.88 55.29 1.39 Allowed 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 118.047 2.61 . . . . 0.0 118.047 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -160.71 -95.23 0.02 OUTLIER 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 101.626 -3.472 . . . . 0.0 101.626 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 90.8 m -163.92 47.9 0.12 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 129.209 3.004 . . . . 0.0 109.863 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -121.7 108.28 13.35 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.625 1.557 . . . . 0.0 114.202 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.437 ' CE2' HG11 ' A' ' 16' ' ' VAL . 3.3 t80 -65.35 104.68 0.99 Allowed 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.381 1.472 . . . . 0.0 107.718 178.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.93 -54.27 5.97 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.569 0.748 . . . . 0.0 111.994 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.35 149.01 12.12 Favored Glycine 0 C--N 1.34 0.799 0 C-N-CA 119.25 -1.452 . . . . 0.0 113.963 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.99 140.36 29.56 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.947 1.299 . . . . 0.0 109.162 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.7 pt -135.74 161.7 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.017 1.327 . . . . 0.0 109.812 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.0 t -159.92 148.67 17.42 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.523 0.729 . . . . 0.0 112.169 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.47 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 5.0 m170 -85.65 -25.81 26.38 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.8 m -49.26 109.4 0.26 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 126.282 1.833 . . . . 0.0 110.337 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.27 52.31 4.06 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.183 0.897 . . . . 0.0 111.041 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.49 -128.38 0.09 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.615 1.166 . . . . 0.0 108.721 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.8 m -145.85 71.39 1.27 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.016 0.926 . . . . 0.0 110.12 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.87 -91.28 0.27 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.758 1.171 . . . . 0.0 112.851 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -79.89 -34.74 38.86 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.651 1.18 . . . . 0.0 111.579 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -53.39 138.48 32.98 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.943 0.897 . . . . 0.0 111.016 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -106.27 147.82 28.7 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.529 1.532 . . . . 0.0 110.318 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.5 m -128.99 160.79 39.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.154 0 C-N-CA 124.546 1.138 . . . . 0.0 108.288 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.06 142.39 21.42 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.994 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 8.7 t -85.26 -174.66 5.35 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.302 1.441 . . . . 0.0 108.332 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.3 m -65.11 131.06 45.57 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 121.344 -0.848 . . . . 0.0 109.101 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.61 43.85 51.09 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 16.3 m -146.78 144.41 29.35 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 57.5 t30 . . . . . 0 C--O 1.251 1.137 0 C-N-CA 125.344 1.458 . . . . 0.0 110.345 -179.116 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 120.844 0.354 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.5 t -158.07 68.69 0.5 Allowed 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.68 155.86 0.16 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.501 1.921 . . . . 0.0 110.495 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.5 p -135.53 93.6 2.98 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.87 95.91 10.04 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 102.067 -3.309 . . . . 0.0 102.067 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 62.7 m -95.08 83.12 3.86 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.008 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.14 -87.74 0.58 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.0 p -120.01 -23.29 6.4 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.076 1.751 . . . . 0.0 110.657 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.6 m -75.65 91.25 2.86 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -84.22 106.52 15.91 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.882 1.273 . . . . 0.0 110.911 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -98.32 138.84 34.97 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.108 0.963 . . . . 0.0 110.057 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.2 t -72.5 152.72 41.73 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 124.69 1.196 . . . . 0.0 108.839 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.4 -18.09 48.39 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 t -76.34 -38.52 55.8 Favored 'General case' 0 C--N 1.345 0.391 0 C-N-CA 124.382 1.073 . . . . 0.0 108.334 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -67.81 -36.37 80.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.298 1.039 . . . . 0.0 111.514 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.4 t -67.56 -48.27 77.37 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -62.77 -38.01 88.9 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.734 1.214 . . . . 0.0 111.3 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.32 -51.97 26.25 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.9 0.88 . . . . 0.0 110.541 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.69 -41.96 74.48 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.476 1.11 . . . . 0.0 110.116 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.7 -25.38 38.19 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -69.44 -24.64 63.85 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.41 -55.7 4.87 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.36 -51.68 25.21 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 124.266 0.979 . . . . 0.0 111.711 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.4 t -61.98 -47.21 85.87 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.111 1.764 . . . . 0.0 112.515 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -63.22 -51.02 67.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.307 0.643 . . . . 0.0 111.939 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -68.95 -48.16 63.89 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -63.54 -22.09 66.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -110.14 9.86 23.95 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -157.98 61.22 0.46 Allowed 'General case' 0 C--N 1.339 0.143 0 CA-C-N 119.361 0.982 . . . . 0.0 109.123 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t70 64.22 99.01 0.04 OUTLIER 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.954 1.702 . . . . 0.0 109.27 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -61.42 114.57 3.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.6 p -105.99 -76.82 0.6 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.14 -179.9 0.09 Allowed 'General case' 0 C--N 1.342 0.242 0 C-N-CA 125.758 1.623 . . . . 0.0 113.876 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.38 -62.59 3.03 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 p -82.05 -108.87 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.909 0.884 . . . . 0.0 109.636 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.8 p -170.06 -51.35 0.02 OUTLIER 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.538 1.135 . . . . 0.0 110.045 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.4 t -80.24 31.38 0.27 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.029 1.332 . . . . 0.0 112.833 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.497 ' CD1' ' HD3' ' A' ' 60' ' ' PRO . 96.8 m-85 -170.01 113.96 0.48 Allowed Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 128.339 2.656 . . . . 0.0 104.334 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.54 134.48 35.79 Favored 'Cis proline' 0 N--CA 1.448 -1.157 0 CA-C-N 120.763 1.308 . . . . 0.0 111.333 1.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.23 161.44 41.16 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.987 1.315 . . . . 0.0 108.216 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 t -60.87 143.24 55.26 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-O 120.748 0.308 . . . . 0.0 110.881 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.34 122.72 27.82 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -64.44 161.98 16.06 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.276 1.03 . . . . 0.0 111.189 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -105.06 73.0 1.03 Allowed 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.158 0.983 . . . . 0.0 110.068 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -81.6 -89.01 0.08 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -155.46 -56.38 0.09 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.003 1.321 . . . . 0.0 109.304 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.69 135.18 44.28 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.044 1.307 . . . . 0.0 114.496 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 53.6 162.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 129.121 2.969 . . . . 0.0 117.816 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -161.68 160.98 29.27 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.09 2.156 . . . . 0.0 107.241 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -137.31 78.62 38.66 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.28 71.24 5.87 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.014 3.142 . . . . 0.0 110.09 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.4 t -119.73 -67.22 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 125.754 1.622 . . . . 0.0 107.919 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -165.87 78.76 0.27 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.05 162.22 54.68 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.2 152.9 97.64 Favored 'Cis proline' 0 N--CA 1.459 -0.54 0 CA-C-N 118.302 1.051 . . . . 0.0 112.902 0.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -121.75 156.92 32.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.931 2.093 . . . . 0.0 110.493 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -127.87 152.45 47.82 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.295 1.438 . . . . 0.0 112.462 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -94.04 156.17 16.74 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.242 1.017 . . . . 0.0 111.772 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -159.35 112.7 1.54 Allowed Pre-proline 0 N--CA 1.455 -0.188 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.497 ' HD3' ' CD1' ' A' ' 38' ' ' TYR . 31.2 Cg_endo -81.7 127.24 5.55 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 121.389 1.393 . . . . 0.0 112.506 -175.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.502 HG13 ' H ' ' A' ' 62' ' ' LYS . 6.5 tt -84.47 167.2 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-O 123.816 1.769 . . . . 0.0 112.709 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.502 ' H ' HG13 ' A' ' 61' ' ' ILE . 48.0 mmtm -142.71 145.36 33.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 109.098 -3.683 . . . . 0.0 112.71 -178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.5 t -91.61 58.24 3.47 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 125.585 1.554 . . . . 0.0 108.833 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.06 -64.8 0.03 OUTLIER Glycine 0 C--N 1.337 0.6 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.31 159.49 32.69 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.0 p -74.53 156.47 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.515 1.126 . . . . 0.0 109.603 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 12.3 t80 66.44 56.65 0.76 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.501 1.12 . . . . 0.0 111.099 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.9 p -149.96 166.29 30.09 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.303 1.041 . . . . 0.0 109.509 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -144.83 148.03 19.56 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.614 1.102 . . . . 0.0 110.824 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.19 170.18 33.82 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.1 t -52.5 -66.02 0.89 Allowed Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.941 1.297 . . . . 0.0 112.96 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.87 146.7 48.36 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.243 1.962 . . . . 0.0 111.51 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.83 139.57 6.58 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -173.39 -33.3 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.355 1.462 . . . . 0.0 111.833 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.07 120.06 29.05 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.658 1.583 . . . . 0.0 111.551 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -139.03 130.56 27.22 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.9 m -96.44 148.1 5.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.276 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.8 t -136.7 137.24 47.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.7 pt -117.3 176.3 2.81 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 C-N-CA 125.188 1.395 . . . . 0.0 112.904 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -97.28 163.58 12.84 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 128.08 2.552 . . . . 0.0 107.19 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.302 12.8 t -72.41 3.72 4.51 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -93.43 -86.87 0.25 Allowed 'General case' 0 N--CA 1.434 -1.267 1 N-CA-C 98.711 -4.551 . . . . 0.0 98.711 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.5 m -164.49 -5.63 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 128.253 2.621 . . . . 0.0 114.105 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -79.48 148.87 31.7 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.31 129.85 39.91 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.071 1.349 . . . . 0.0 107.754 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.91 -51.72 4.94 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.941 1.296 . . . . 0.0 108.958 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.35 -166.57 32.57 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.75 116.97 3.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.034 0.934 . . . . 0.0 108.802 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 45.4 pt -107.96 160.26 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.796 1.238 . . . . 0.0 110.649 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t -159.86 149.08 17.8 Favored 'General case' 0 C--N 1.343 0.284 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.541 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 27.2 m170 -79.75 -36.29 37.47 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.162 175.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.8 m -34.02 -58.99 0.44 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 128.478 2.711 . . . . 0.0 115.131 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.83 -36.33 92.61 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.521 1.057 . . . . 0.0 112.556 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.44 -159.66 0.29 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.933 1.293 . . . . 0.0 111.383 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.7 t -80.91 -81.46 0.13 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.626 0.77 . . . . 0.0 111.694 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -135.02 -78.45 0.1 Allowed Glycine 0 C--N 1.343 0.944 0 C-N-CA 124.04 0.829 . . . . 0.0 111.805 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -79.82 -27.12 40.29 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.511 0.655 . . . . 0.0 111.519 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -59.48 151.85 23.14 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.976 1.31 . . . . 0.0 110.407 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -120.08 151.04 39.62 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.535 1.534 . . . . 0.0 110.069 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.1 m -147.69 166.14 5.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 125.942 1.697 . . . . 0.0 108.238 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -89.8 156.29 25.39 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.501 0.572 . . . . 0.0 112.69 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.3 m -104.84 -169.07 1.56 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.126 1.37 . . . . 0.0 108.244 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.4 t -61.33 113.99 2.94 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.83 60.51 1.96 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.3 m -154.78 121.14 5.33 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.98 0.912 . . . . 0.0 108.542 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.157 -1.402 . . . . 0.0 108.746 179.353 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.467 0 CA-C-O 120.326 0.108 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -145.25 159.9 42.31 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.819 1.248 . . . . 0.0 109.391 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.27 136.0 57.73 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.815 0.846 . . . . 0.0 109.463 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.56 HG23 HG21 ' A' ' 16' ' ' VAL . 48.4 p -111.37 146.14 37.65 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.47 0.708 . . . . 0.0 109.68 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.83 117.92 8.88 Favored 'General case' 0 N--CA 1.44 -0.928 1 N-CA-C 99.675 -4.194 . . . . 0.0 99.675 177.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.26 103.55 5.8 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.896 0.379 . . . . 0.0 111.012 -177.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.91 -63.63 4.35 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 125.109 1.338 . . . . 0.0 109.807 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.4 p -155.65 -44.69 0.08 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.932 1.693 . . . . 0.0 109.275 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -54.65 115.83 2.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.612 1.965 . . . . 0.0 109.409 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -104.55 150.3 24.75 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.982 1.313 . . . . 0.0 111.068 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.88 141.03 26.15 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.018 1.327 . . . . 0.0 109.14 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.6 m -72.59 152.54 41.74 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 124.726 1.211 . . . . 0.0 110.142 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.61 -21.34 53.16 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.8 m -71.94 -41.22 68.06 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.873 1.269 . . . . 0.0 109.86 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -72.34 -41.11 66.85 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.022 0.929 . . . . 0.0 112.082 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.56 HG21 HG23 ' A' ' 4' ' ' THR . 23.6 t -63.25 -47.73 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -67.07 -36.05 81.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.678 1.191 . . . . 0.0 110.999 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.08 -51.2 65.2 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 118.894 0.77 . . . . 0.0 109.391 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.45 -37.3 87.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.63 -41.71 87.87 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.349 -0.844 . . . . 0.0 111.967 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -69.46 -18.81 63.75 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.61 -62.54 1.64 Allowed 'General case' 0 C--N 1.347 0.464 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.461 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -46.41 -44.43 17.19 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.923 0.889 . . . . 0.0 111.19 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.9 t -61.37 -49.73 75.73 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 118.938 0.79 . . . . 0.0 110.293 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -68.84 -9.58 52.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.659 0.784 . . . . 0.0 112.65 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -115.12 -16.23 11.61 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.815 0.846 . . . . 0.0 112.915 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.42 ' CD2' ' HG3' ' A' ' 57' ' ' GLN . 48.2 t80 -65.57 -51.8 57.06 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.006 0.923 . . . . 0.0 110.427 -178.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -90.98 -27.11 18.89 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -63.66 -25.0 68.02 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.901 0.773 . . . . 0.0 112.989 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 t70 65.15 45.56 2.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.626 1.17 . . . . 0.0 111.571 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -168.03 151.04 5.72 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.005 1.322 . . . . 0.0 108.909 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.0 p 47.5 39.52 9.63 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.727 1.611 . . . . 0.0 112.344 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.07 89.07 6.34 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.895 1.278 . . . . 0.0 110.979 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 52.78 -141.32 28.59 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.959 1.742 . . . . 0.0 112.578 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.1 p -154.27 -33.98 0.1 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.332 1.053 . . . . 0.0 112.637 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.7 t -82.14 -102.67 0.04 OUTLIER 'General case' 0 C--N 1.343 0.311 0 C-N-CA 123.627 0.771 . . . . 0.0 109.358 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.0 p -137.82 35.27 2.4 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.629 1.172 . . . . 0.0 109.209 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -133.24 148.2 68.12 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 124.0 0.92 . . . . 0.0 109.118 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.29 125.08 10.27 Favored 'Cis proline' 0 N--CA 1.452 -0.938 0 CA-C-N 118.733 0.583 . . . . 0.0 112.564 0.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.3 163.01 33.6 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.018 0.927 . . . . 0.0 110.881 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 m -48.19 124.18 7.41 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 127.952 2.501 . . . . 0.0 113.012 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -115.89 68.47 0.72 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.71 85.4 0.47 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.099 1.36 . . . . 0.0 112.778 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -131.19 137.16 48.83 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.852 1.661 . . . . 0.0 106.962 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -116.62 132.94 56.55 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.473 1.109 . . . . 0.0 110.847 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 40.72 45.89 2.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.175 2.19 . . . . 0.0 114.09 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.57 -79.26 1.42 Allowed Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -80.27 173.48 12.55 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.328 1.051 . . . . 0.0 112.097 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -79.52 6.18 11.06 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -127.13 67.2 70.01 Favored Pre-proline 0 C--N 1.318 -0.772 0 C-N-CA 127.93 2.492 . . . . 0.0 110.146 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.73 -41.84 3.95 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.82 2.346 . . . . 0.0 110.291 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.7 t 62.54 -97.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.885 1.674 . . . . 0.0 108.816 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -165.88 -58.16 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 126.319 1.848 . . . . 0.0 107.883 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.95 -175.79 51.79 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -58.21 151.67 36.73 Favored 'Cis proline' 0 N--CA 1.458 -0.574 0 CA-C-N 119.043 1.422 . . . . 0.0 113.5 -0.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -146.03 159.3 43.46 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.573 1.149 . . . . 0.0 109.778 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.42 ' HG3' ' CD2' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -129.2 161.69 29.55 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -175.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -88.1 157.24 18.91 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 113.699 -1.591 . . . . 0.0 108.89 178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.461 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 15.2 t80 -160.24 112.6 1.4 Allowed Pre-proline 0 C--O 1.224 -0.259 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -82.15 137.16 9.42 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 C-N-CA 121.387 1.391 . . . . 0.0 115.211 -175.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.606 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 3.0 tt -110.37 -175.85 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 CA-C-O 124.034 1.873 . . . . 0.0 112.188 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.606 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -160.8 152.01 19.01 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 108.724 -3.853 . . . . 0.0 111.004 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.7 t -84.44 59.87 5.69 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.969 1.307 . . . . 0.0 108.878 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.05 -50.37 0.03 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.04 172.27 45.18 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.75 119.13 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.364 1.065 . . . . 0.0 109.587 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.3 t80 62.47 118.44 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.255 1.822 . . . . 0.0 112.665 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 79.6 p -126.84 154.12 44.77 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.94 1.296 . . . . 0.0 109.79 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.86 72.24 2.83 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -160.98 -48.39 0.02 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.8 m 60.7 80.12 0.27 Allowed Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 125.339 1.456 . . . . 0.0 110.694 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.49 -56.16 3.37 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.385 3.39 . . . . 0.0 112.026 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.41 39.24 3.51 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.967 1.27 . . . . 0.0 110.478 178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -154.41 -73.2 0.12 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 117.959 -1.019 . . . . 0.0 112.567 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -67.38 117.16 8.99 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.8 mtt85 -146.73 129.46 16.15 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.74 155.37 3.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 N-CA-C 103.601 -2.74 . . . . 0.0 103.601 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.0 t -136.14 123.35 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 O-C-N 120.587 -1.32 . . . . 0.0 108.146 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.7 pt -105.46 175.44 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.417 0 C-N-CA 125.775 1.63 . . . . 0.0 112.756 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -101.83 165.03 11.41 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 127.47 2.308 . . . . 0.0 108.364 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.251 11.4 t -67.26 -29.78 69.49 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 118.302 2.705 . . . . 0.0 118.302 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -79.14 -73.16 0.35 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.8 t -164.72 3.52 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -78.65 164.03 24.97 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 119.723 1.147 . . . . 0.0 113.953 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -104.68 117.53 34.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.59 -45.96 12.02 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.099 0.559 . . . . 0.0 110.188 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.66 -160.48 33.9 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.6 145.09 31.61 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.823 0.849 . . . . 0.0 109.652 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.5 pt -143.14 164.93 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.923 1.289 . . . . 0.0 111.571 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.2 t -155.79 146.5 22.08 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.46 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 24.0 m170 -79.1 -15.45 58.14 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.809 174.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.0 m -39.8 -55.36 1.97 Allowed 'General case' 0 C--N 1.345 0.409 0 C-N-CA 126.859 2.063 . . . . 0.0 114.576 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.83 28.14 11.04 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.519 1.057 . . . . 0.0 112.816 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.76 177.02 5.42 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.078 0.951 . . . . 0.0 111.325 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 84.2 p -68.0 -48.42 65.79 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.097 0.959 . . . . 0.0 111.378 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.8 -69.68 0.08 OUTLIER Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -102.23 29.17 5.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.722 1.209 . . . . 0.0 109.654 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -131.83 176.94 7.92 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.769 1.228 . . . . 0.0 109.618 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -127.42 164.52 21.67 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.164 1.786 . . . . 0.0 110.824 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.87 156.23 40.87 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 C-N-CA 124.875 1.27 . . . . 0.0 107.581 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.8 142.33 25.43 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.298 0.952 . . . . 0.0 112.762 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 25.7 m -96.27 179.03 5.18 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.797 0.839 . . . . 0.0 110.517 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 27.0 t -69.24 140.69 54.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.89 47.05 62.72 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.5 m -131.49 96.31 3.95 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.371 1.468 . . . . 0.0 107.085 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.7 t30 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 117.028 -1.463 . . . . 0.0 109.229 -179.1 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 121.234 0.54 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.5 m -160.85 80.24 0.63 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 126.208 1.803 . . . . 0.0 106.849 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 73.03 160.93 0.24 Allowed 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.353 1.461 . . . . 0.0 109.808 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 t -157.7 148.68 21.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.28 120.12 29.15 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 104.794 -2.298 . . . . 0.0 104.794 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.6 m -112.95 111.4 22.12 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.65 -95.17 0.18 Allowed Glycine 0 CA--C 1.529 0.923 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.8 p -118.54 -39.19 3.03 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.109 1.763 . . . . 0.0 109.7 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.4 m -61.28 126.06 26.0 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.024 1.33 . . . . 0.0 109.721 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -99.02 153.6 18.74 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.565 1.146 . . . . 0.0 110.289 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -142.77 121.3 12.47 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.678 1.191 . . . . 0.0 108.52 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.5 t -67.34 154.32 41.61 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 125.06 1.344 . . . . 0.0 110.473 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.85 -22.01 61.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.401 -1.704 . . . . 0.0 106.401 176.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.4 t -72.47 -39.76 67.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.324 1.049 . . . . 0.0 109.209 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -73.43 -44.08 59.05 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.342 0.657 . . . . 0.0 112.116 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.5 t -59.03 -51.47 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 124.993 1.317 . . . . 0.0 109.086 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -68.42 -41.05 80.93 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.921 0.888 . . . . 0.0 112.925 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.58 -47.16 87.4 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 123.753 0.658 . . . . 0.0 109.427 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.44 ' HA ' HG23 ' A' ' 66' ' ' VAL . . . -58.0 -39.54 78.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.314 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.36 -30.33 61.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -69.8 -25.48 63.8 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.19 -61.07 2.11 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 104.167 -2.531 . . . . 0.0 104.167 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.532 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . . . -43.77 -43.65 6.22 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 124.763 1.289 . . . . 0.0 111.614 176.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.57 -64.03 0.98 Allowed 'General case' 0 C--N 1.343 0.299 0 C-N-CA 126.385 1.874 . . . . 0.0 111.667 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -66.5 -36.67 83.3 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -88.65 -22.51 23.41 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.306 0.0 OUTLIER -92.65 16.76 11.44 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.779 1.627 . . . . 0.0 114.966 -178.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.6 -38.96 70.12 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.57 1.148 . . . . 0.0 110.368 178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -145.6 -67.87 0.29 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.659 1.184 . . . . 0.0 109.003 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -177.37 91.73 0.03 OUTLIER 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.518 1.527 . . . . 0.0 108.104 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -119.17 -170.51 1.94 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.737 1.215 . . . . 0.0 109.897 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.9 p -70.88 83.89 0.66 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.254 1.422 . . . . 0.0 111.236 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -152.91 156.91 39.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.272 1.029 . . . . 0.0 110.784 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.15 -141.5 45.47 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.474 1.035 . . . . 0.0 112.438 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.0 t -90.32 -74.34 0.49 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.64 1.176 . . . . 0.0 109.935 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 t -151.54 -56.09 0.15 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.055 1.342 . . . . 0.0 108.32 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.3 p -79.36 -53.75 6.62 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -59.62 135.3 89.29 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -71.77 131.09 20.4 Favored 'Cis proline' 0 N--CA 1.454 -0.801 0 CA-C-N 119.123 0.723 . . . . 0.0 112.489 2.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.02 156.6 41.48 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 123.469 0.707 . . . . 0.0 111.555 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.9 p -34.45 137.24 0.12 Allowed 'General case' 0 C--N 1.34 0.166 0 C-N-CA 127.764 2.426 . . . . 0.0 115.096 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -135.52 88.01 2.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.081 1.352 . . . . 0.0 108.286 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -167.93 -39.61 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.867 1.667 . . . . 0.0 108.462 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -61.69 -35.77 78.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.888 1.275 . . . . 0.0 110.348 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -61.77 -77.28 0.05 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.243 1.017 . . . . 0.0 109.56 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -171.22 138.33 1.22 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.177 1.391 . . . . 0.0 108.254 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.4 132.79 23.26 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -144.2 108.21 4.74 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.279 0.632 . . . . 0.0 110.264 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 t70 51.17 -168.64 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.572 1.549 . . . . 0.0 113.517 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.0 p90 38.03 79.04 0.33 Allowed Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 127.159 2.184 . . . . 0.0 114.265 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.82 64.67 8.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.829 3.019 . . . . 0.0 107.833 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.34 -154.62 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 126.078 1.751 . . . . 0.0 110.112 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -100.99 118.58 37.28 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.509 1.123 . . . . 0.0 110.197 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.21 -176.46 30.32 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.218 0.914 . . . . 0.0 111.581 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.73 127.85 15.12 Favored 'Cis proline' 0 N--CA 1.453 -0.884 0 CA-C-N 117.527 0.664 . . . . 0.0 111.414 -0.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -102.47 140.26 36.99 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -115.66 162.17 17.63 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 123.878 0.736 . . . . 0.0 110.876 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -79.38 144.67 33.94 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.578 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.532 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 69.2 t80 -138.89 103.03 7.54 Favored Pre-proline 0 N--CA 1.443 -0.804 0 N-CA-C 102.086 -3.301 . . . . 0.0 102.086 176.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.437 ' HB3' ' HD2' ' A' ' 76' ' ' ARG . 11.5 Cg_endo -77.99 137.25 15.45 Favored 'Trans proline' 0 N--CA 1.439 -1.691 0 C-N-CA 121.224 1.283 . . . . 0.0 111.964 -176.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.574 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.5 tt -116.96 -177.98 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 124.581 2.134 . . . . 0.0 113.366 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.574 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -161.32 153.93 20.46 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 108.428 -3.987 . . . . 0.0 111.613 178.164 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.0 t -88.62 58.5 4.69 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.874 1.27 . . . . 0.0 108.165 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.48 -74.79 0.01 OUTLIER Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.29 86.77 0.1 OUTLIER Glycine 0 CA--C 1.527 0.793 0 CA-C-N 117.385 0.593 . . . . 0.0 111.973 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.44 HG23 ' HA ' ' A' ' 19' ' ' ALA 0.266 12.9 p 41.12 60.43 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.958 2.103 . . . . 0.0 113.407 178.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 21.5 t80 58.2 93.97 0.03 OUTLIER 'General case' 0 C--N 1.344 0.339 0 C-N-CA 126.69 1.996 . . . . 0.0 114.047 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.0 t -155.99 124.41 5.85 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.901 1.28 . . . . 0.0 108.771 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.18 66.45 2.49 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.73 1.157 . . . . 0.0 111.492 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -164.97 77.8 0.14 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.5 t -146.02 108.74 4.31 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -61.37 160.11 48.73 Favored 'Cis proline' 0 N--CA 1.459 -0.537 0 CA-C-N 119.969 1.025 . . . . 0.0 113.987 0.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.68 -42.59 0.05 OUTLIER Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.167 1.365 . . . . 0.0 110.907 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 78.7 -48.29 0.44 Allowed 'General case' 0 C--N 1.342 0.281 0 C-N-CA 127.364 2.266 . . . . 0.0 112.538 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -75.93 124.9 28.1 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.437 ' HD2' ' HB3' ' A' ' 60' ' ' PRO . 14.5 mmt180 -136.99 118.0 14.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.366 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.4 m -84.2 164.55 2.58 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.3 t -140.26 137.19 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.3 pt -131.06 159.73 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.761 0.825 . . . . 0.0 112.513 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -89.16 146.04 25.04 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 127.464 2.306 . . . . 0.0 108.205 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.37 15.3 t -73.78 66.17 1.08 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -177.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -157.32 -94.45 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.184 1 N-CA-C 97.458 -5.016 . . . . 0.0 97.458 176.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -162.84 10.69 0.06 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.996 1.718 . . . . 0.0 113.774 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.3 140.93 29.04 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.993 0.815 . . . . 0.0 112.178 -177.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -73.52 131.49 41.82 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.95 -56.79 2.86 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.89 -177.29 40.72 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 112.25 -0.34 . . . . 0.0 112.25 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.98 117.6 13.03 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.837 1.655 . . . . 0.0 107.056 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 41.0 pt -128.27 153.52 37.8 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 C-N-CA 124.075 0.95 . . . . 0.0 109.814 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -152.18 150.85 30.29 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.34 75.85 5.91 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.3 m -70.57 -84.54 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.086 -1.634 . . . . 0.0 110.24 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.7 34.57 5.56 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.85 153.17 42.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.224 1.81 . . . . 0.0 110.957 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -74.37 -11.55 60.28 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.588 0.755 . . . . 0.0 112.227 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.73 -94.86 0.1 OUTLIER Glycine 0 C--N 1.341 0.841 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -103.22 22.62 13.76 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.156 0.982 . . . . 0.0 110.54 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -72.26 178.78 3.71 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -151.82 133.98 15.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 m -115.12 166.53 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.56 145.21 19.41 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.105 0.802 . . . . 0.0 115.105 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.8 m -97.54 177.5 5.49 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 124.53 1.132 . . . . 0.0 110.559 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.3 t 44.06 41.76 4.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.667 0.787 . . . . 0.0 112.094 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.5 30.06 75.86 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.384 0.992 . . . . 0.0 113.922 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.4 m -86.54 151.14 23.73 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.654 1.182 . . . . 0.0 109.083 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 116.346 -1.788 . . . . 0.0 108.677 179.842 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 121.025 0.44 . . . . 0.0 111.529 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.5 p -78.39 152.03 32.47 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.012 1.325 . . . . 0.0 108.365 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.32 61.75 0.71 Allowed 'General case' 0 C--N 1.342 0.244 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 t -107.48 135.95 48.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.874 1.269 . . . . 0.0 110.67 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -110.57 108.41 18.35 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 103.393 -2.818 . . . . 0.0 103.393 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.34 85.42 4.6 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.02 -104.63 1.44 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.2 p -94.49 -44.52 7.84 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.494 1.118 . . . . 0.0 110.188 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.6 m -70.0 110.37 5.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.856 0.862 . . . . 0.0 110.24 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -84.72 148.52 26.34 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.684 1.193 . . . . 0.0 111.061 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -142.03 112.91 7.37 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.101 0.96 . . . . 0.0 111.098 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.7 t -65.37 157.49 29.13 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 125.84 1.656 . . . . 0.0 110.429 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.0 -19.27 29.66 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.5 m -73.43 -44.54 58.02 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.521 1.128 . . . . 0.0 109.184 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -71.91 -44.15 64.16 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 124.718 1.207 . . . . 0.0 112.34 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.25 -51.2 75.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -41.92 96.57 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.633 1.973 . . . . 0.0 112.517 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.34 -54.44 28.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.004 0.365 . . . . 0.0 110.191 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.73 72.37 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.207 0.603 . . . . 0.0 111.679 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.85 -44.97 30.13 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.06 -22.11 65.49 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.51 -65.83 0.88 Allowed 'General case' 0 C--N 1.345 0.409 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.513 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . . . -44.22 -48.59 9.35 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 124.577 1.173 . . . . 0.0 111.83 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.8 t -54.13 -51.89 62.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.366 1.866 . . . . 0.0 111.924 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -58.34 -40.73 82.92 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.176 0.59 . . . . 0.0 111.253 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -70.9 -38.37 72.99 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -90.6 22.8 3.31 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-N 118.91 0.777 . . . . 0.0 112.468 -177.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -110.2 -48.96 3.12 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 124.361 1.064 . . . . 0.0 109.209 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -74.11 -38.69 63.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.383 0.673 . . . . 0.0 112.154 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 108.19 72.52 0.0 OUTLIER 'General case' 0 C--N 1.345 0.397 0 C-N-CA 129.674 3.189 . . . . 0.0 110.932 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -151.89 136.37 16.88 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.692 1.597 . . . . 0.0 107.57 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.6 p -80.31 -56.89 3.88 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.446 0.698 . . . . 0.0 111.786 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 60.87 82.71 0.16 Allowed 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.55 -48.59 0.96 Allowed Glycine 0 CA--C 1.528 0.886 0 N-CA-C 107.093 -2.403 . . . . 0.0 107.093 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.8 t 57.52 67.38 0.98 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.26 1.824 . . . . 0.0 113.713 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.2 m -143.86 -75.96 0.24 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.165 0.986 . . . . 0.0 108.771 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.3 t -160.35 41.22 0.18 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.497 0.59 . . . . 0.0 112.224 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -172.25 127.62 0.57 Allowed Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 125.649 1.58 . . . . 0.0 107.479 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -86.06 63.32 0.16 OUTLIER 'Cis proline' 0 N--CA 1.439 -1.702 0 CA-C-N 121.409 1.539 . . . . 0.0 110.1 -2.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -84.27 173.09 11.26 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 t -69.3 145.54 52.95 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 111.426 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -95.82 55.09 1.58 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.481 1.512 . . . . 0.0 109.291 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.483 ' H ' HD22 ' A' ' 43' ' ' ASN . 0.0 OUTLIER -79.01 51.56 1.16 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.639 1.576 . . . . 0.0 112.347 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -160.84 53.44 0.29 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.381 1.472 . . . . 0.0 107.426 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.12 -55.99 8.02 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.499 1.519 . . . . 0.0 110.906 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 68.62 -72.41 0.1 Allowed 'General case' 0 C--N 1.343 0.292 0 C-N-CA 127.079 2.152 . . . . 0.0 111.168 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.24 -121.36 2.16 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.42 -169.3 0.17 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.356 1.062 . . . . 0.0 112.315 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -127.67 -164.06 1.33 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.998 0.919 . . . . 0.0 110.925 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . 0.328 40.3 p90 61.63 47.33 1.13 Allowed Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 128.788 2.835 . . . . 0.0 115.855 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.7 125.94 8.54 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.175 1.916 . . . . 0.0 107.702 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.51 -125.0 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -153.72 127.57 8.86 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 125.711 1.605 . . . . 0.0 107.237 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.17 -85.04 0.05 OUTLIER Glycine 0 CA--C 1.531 1.063 0 CA-C-O 117.49 -1.728 . . . . 0.0 111.737 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.4 168.76 7.45 Favored 'Cis proline' 0 C--N 1.35 0.642 0 CA-C-N 121.676 2.738 . . . . 0.0 116.427 0.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.51 159.34 28.24 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 125.036 1.335 . . . . 0.0 113.188 -177.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -152.72 150.65 29.65 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.464 1.506 . . . . 0.0 111.948 -178.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -102.41 166.55 10.49 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 48.0 t80 -158.44 114.69 1.72 Allowed Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -86.79 108.06 0.77 Allowed 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 122.706 2.271 . . . . 0.0 112.342 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.534 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 9.3 tt -81.5 173.88 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 124.329 2.014 . . . . 0.0 110.966 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.534 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 14.2 mmtt -160.27 159.43 31.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 109.183 -3.644 . . . . 0.0 109.49 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 57.2 m -81.81 57.44 3.43 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.458 1.103 . . . . 0.0 109.539 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.46 62.71 0.24 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.95 -106.63 1.64 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 123.76 0.695 . . . . 0.0 112.376 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.1 95.05 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.32 1.048 . . . . 0.0 111.099 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 t80 44.98 80.74 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.879 1.672 . . . . 0.0 112.971 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.1 p -125.22 -29.94 3.23 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.744 1.218 . . . . 0.0 111.44 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.42 -69.2 1.25 Allowed Glycine 0 C--N 1.342 0.886 0 C-N-CA 124.838 1.209 . . . . 0.0 112.426 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.09 113.98 1.27 Allowed Glycine 0 C--N 1.34 0.76 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.9 m 54.17 69.89 1.96 Allowed Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 125.348 1.459 . . . . 0.0 112.715 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.11 149.65 82.19 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.369 2.713 . . . . 0.0 109.96 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -159.11 35.58 0.49 Allowed Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.109 -0.829 . . . . 0.0 115.152 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.741 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -153.87 -67.94 0.14 Allowed 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 118.452 1.126 . . . . 0.0 110.25 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.43 118.24 16.15 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.926 1.239 . . . . 0.0 108.384 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -140.14 117.44 11.32 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 m -85.1 146.67 6.29 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 176.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.2 t -132.84 135.81 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -177.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.482 HG22 ' H ' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -126.86 -176.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 C-N-CA 126.74 2.016 . . . . 0.0 110.186 -177.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.482 ' H ' HG22 ' A' ' 79' ' ' ILE . 63.5 m-80 -99.26 159.72 14.79 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 102.977 -2.972 . . . . 0.0 102.977 175.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.301 7.2 t -66.92 2.57 1.38 Allowed 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 -178.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -95.58 -83.69 0.36 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 102.301 -3.222 . . . . 0.0 102.301 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -164.81 -5.07 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.721 2.408 . . . . 0.0 114.791 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -79.46 121.1 24.76 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -52.98 123.25 11.08 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 126.051 1.74 . . . . 0.0 108.497 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.56 -55.75 2.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -167.4 -164.43 23.06 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.45 137.02 8.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.482 1.113 . . . . 0.0 108.355 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 pt -133.89 174.25 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.438 1.095 . . . . 0.0 113.092 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 74' ' ' ALA . 12.6 t -158.16 137.03 11.37 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.741 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -77.31 -24.11 50.92 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 118.211 0.46 . . . . 0.0 112.034 175.003 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.1 t -45.33 -25.52 0.41 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -145.03 51.57 0.61 Allowed Glycine 0 C--N 1.339 0.731 0 CA-C-N 119.165 0.893 . . . . 0.0 111.534 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.73 -177.37 3.11 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.817 1.247 . . . . 0.0 111.487 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.3 t -58.27 -53.33 59.47 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.554 1.541 . . . . 0.0 111.547 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.38 -70.06 0.05 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -112.54 35.03 4.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.854 1.262 . . . . 0.0 109.133 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -125.1 176.21 6.85 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.18 1.392 . . . . 0.0 109.955 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.446 ' CZ ' ' CD2' ' A' ' 91' ' ' HIS . 64.1 m-85 -125.17 159.3 31.86 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.11 1.364 . . . . 0.0 111.093 -178.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.8 m -135.33 161.48 39.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 125.449 1.499 . . . . 0.0 107.864 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.26 156.65 34.08 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 123.862 0.744 . . . . 0.0 113.707 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.6 m -85.75 -170.67 3.22 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 123.607 0.763 . . . . 0.0 110.094 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.1 p -73.65 127.53 33.01 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.47 -1.0 88.64 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.815 -0.992 . . . . 0.0 113.361 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.7 m -79.38 91.22 5.05 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.4 t30 . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.953 -1.499 . . . . 0.0 109.439 -178.729 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 111.287 0.106 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.0 t -77.83 119.4 21.26 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.441 1.097 . . . . 0.0 108.316 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.31 89.74 0.09 Allowed 'General case' 0 C--N 1.344 0.357 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.81 132.22 36.41 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.91 114.76 23.69 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.5 m -105.49 88.82 2.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.03 -114.64 4.62 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.8 p -93.25 -29.23 15.79 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.282 1.033 . . . . 0.0 109.972 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -71.99 95.13 1.55 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.273 1.429 . . . . 0.0 108.776 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -89.95 147.19 23.86 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.527 1.131 . . . . 0.0 112.508 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -142.13 129.46 21.14 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -72.79 155.13 40.26 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 126.531 1.932 . . . . 0.0 107.315 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.47 -16.79 16.63 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.4 m -76.15 -35.2 59.3 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -51.9 15.84 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.755 1.222 . . . . 0.0 113.601 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . 0.273 17.9 m -60.99 -41.58 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.647 0 C-N-CA 127.239 2.216 . . . . 0.0 109.242 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -71.02 -44.58 65.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.886 0.874 . . . . 0.0 111.69 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.15 -54.64 26.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.096 0.407 . . . . 0.0 112.077 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.45 ' HB1' ' HE2' ' A' ' 59' ' ' PHE . . . -62.05 -37.56 85.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.481 -178.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.33 -40.39 70.75 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -65.86 -19.74 65.99 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.46 -53.96 7.01 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.559 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -47.0 -51.38 17.29 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.229 1.412 . . . . 0.0 110.776 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 t -57.92 -46.19 85.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.748 0.819 . . . . 0.0 110.559 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -57.09 -38.0 72.72 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.529 0.731 . . . . 0.0 111.394 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -89.08 -9.04 52.63 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -66.71 -27.38 67.59 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.725 0.693 . . . . 0.0 112.208 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -80.54 -75.69 0.26 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 p30 171.94 68.62 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.696 1.998 . . . . 0.0 109.809 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -117.5 58.72 0.79 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.93 0.892 . . . . 0.0 109.438 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.84 162.72 0.08 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.86 2.464 . . . . 0.0 114.429 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 t -88.37 76.66 8.29 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.458 1.103 . . . . 0.0 110.182 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.52 102.37 4.48 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.314 1.045 . . . . 0.0 110.319 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.99 -114.26 4.48 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.5 t -75.8 -95.99 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 m 88.05 23.18 0.04 OUTLIER 'General case' 0 C--N 1.341 0.212 0 C-N-CA 125.018 1.327 . . . . 0.0 113.327 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.9 t -78.95 -38.72 36.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 102.743 -3.058 . . . . 0.0 102.743 176.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.488 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 17.0 m-85 -89.18 151.82 47.17 Favored Pre-proline 0 N--CA 1.451 -0.405 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.14 142.52 57.81 Favored 'Cis proline' 0 N--CA 1.455 -0.791 0 N-CA-C 116.78 1.8 . . . . 0.0 116.78 0.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.65 147.54 39.43 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 127.912 2.485 . . . . 0.0 109.579 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.25 123.47 14.68 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 178.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -83.78 118.91 24.23 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -59.0 159.84 6.69 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.308 1.443 . . . . 0.0 111.013 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -134.42 59.95 1.72 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.037 0.935 . . . . 0.0 109.964 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -154.36 -22.32 0.13 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 112.068 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.74 -46.34 88.55 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.127 0.571 . . . . 0.0 111.386 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 150.31 -61.88 0.41 Allowed Glycine 0 C--N 1.339 0.723 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.06 148.19 52.2 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 123.81 0.844 . . . . 0.0 113.099 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -166.26 -178.49 4.59 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.094 1.758 . . . . 0.0 109.231 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -145.37 118.58 5.37 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 124.74 1.216 . . . . 0.0 108.555 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.32 84.99 1.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.08 2.52 . . . . 0.0 110.448 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.9 t -129.62 -97.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.245 0 C-N-CA 124.227 1.011 . . . . 0.0 108.379 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -153.17 117.47 4.9 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.156 0.982 . . . . 0.0 109.618 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.48 146.39 22.54 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -68.72 157.58 88.76 Favored 'Cis proline' 0 N--CA 1.457 -0.633 0 CA-C-N 119.983 1.891 . . . . 0.0 113.447 0.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.21 141.93 26.72 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.1 2.16 . . . . 0.0 108.235 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -134.39 166.56 22.55 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.59 164.56 23.74 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 126.481 1.912 . . . . 0.0 115.541 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.559 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 75.4 t80 -161.87 104.13 1.16 Allowed Pre-proline 0 N--CA 1.454 -0.246 0 O-C-N 121.43 -0.794 . . . . 0.0 110.571 175.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.488 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 12.8 Cg_endo -74.69 137.35 22.36 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 121.088 1.424 . . . . 0.0 113.892 -177.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.55 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.2 tt -109.27 178.97 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 CA-C-O 124.444 2.069 . . . . 0.0 113.058 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.55 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 7.8 mmtt -153.12 153.77 33.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 108.647 -3.888 . . . . 0.0 109.869 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.8 p -76.08 51.94 0.7 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.63 1.972 . . . . 0.0 113.014 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.81 50.63 0.08 OUTLIER Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.405 1.002 . . . . 0.0 112.791 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.31 174.22 17.32 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 117.686 0.743 . . . . 0.0 112.783 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.8 t -80.86 131.79 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.834 1.253 . . . . 0.0 108.542 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -70.15 135.02 48.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.206 1.003 . . . . 0.0 110.907 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.9 p -139.27 75.61 1.52 Allowed 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.88 1.272 . . . . 0.0 107.583 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.47 -143.21 3.6 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.3 -50.73 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.9 p -153.35 150.1 22.89 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 124.218 1.007 . . . . 0.0 109.792 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -66.16 145.33 69.31 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 CA-C-N 119.393 0.819 . . . . 0.0 112.001 -8.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.28 -113.16 2.27 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . 62.92 28.99 16.54 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.047 1.339 . . . . 0.0 113.866 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -155.02 84.15 1.08 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.16 132.64 47.36 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.522 -178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.72 159.79 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 103.311 -2.848 . . . . 0.0 103.311 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.2 t -139.17 131.39 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 120.479 -1.388 . . . . 0.0 108.089 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.7 pt -114.14 -179.46 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.311 1.444 . . . . 0.0 113.35 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -104.71 -174.38 2.52 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.099 2.159 . . . . 0.0 109.631 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.318 12.4 t -79.58 -30.17 41.49 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 120.402 3.482 . . . . 0.0 120.402 -177.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -79.32 -73.56 0.33 Allowed 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.7 t -164.75 1.22 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.849 2.06 . . . . 0.0 114.169 -177.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -78.64 150.69 32.6 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 119.846 1.203 . . . . 0.0 113.813 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -95.85 117.98 31.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.34 1.856 . . . . 0.0 108.651 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.94 -52.69 7.54 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 123.35 0.66 . . . . 0.0 110.658 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.38 -169.21 38.38 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.9 162.37 31.77 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.827 0.813 . . . . 0.0 113.022 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.8 pt -142.21 163.67 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.59 1.556 . . . . 0.0 110.263 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.6 t -158.84 159.04 34.6 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.867 1.267 . . . . 0.0 111.016 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.449 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 49.9 m170 -79.6 -51.08 9.74 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.6 m -32.72 106.51 0.04 OUTLIER 'General case' 0 C--N 1.345 0.382 0 C-N-CA 127.852 2.461 . . . . 0.0 111.998 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.56 32.29 5.2 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.201 1.381 . . . . 0.0 111.079 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -134.5 -142.82 0.2 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.759 1.224 . . . . 0.0 109.248 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.6 t -151.46 62.86 0.88 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 123.26 0.624 . . . . 0.0 111.141 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.71 -125.29 6.73 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.534 1.064 . . . . 0.0 113.367 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -79.28 -26.2 42.37 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.643 1.177 . . . . 0.0 113.046 -178.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -56.3 118.05 4.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.984 0.914 . . . . 0.0 110.621 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -83.75 153.95 23.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.044 0.938 . . . . 0.0 111.145 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.6 m -126.76 166.54 23.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 C-N-CA 125.635 1.574 . . . . 0.0 107.556 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -84.38 148.03 23.74 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 123.891 0.758 . . . . 0.0 114.26 -177.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 18.0 t -96.59 -175.09 3.21 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.716 2.006 . . . . 0.0 107.418 178.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.2 p -59.76 136.73 58.09 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.439 1.018 . . . . 0.0 109.851 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.06 26.56 74.6 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.566 0.603 . . . . 0.0 111.81 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.7 m -150.3 114.81 5.21 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.144 1.378 . . . . 0.0 107.497 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 . . . . . 0 C--O 1.251 1.154 0 CA-C-O 116.83 -1.557 . . . . 0.0 109.458 -179.82 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 120.592 0.234 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.1 m -147.92 52.93 1.03 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.601 1.16 . . . . 0.0 108.981 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 72.91 139.74 0.06 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 127.184 2.194 . . . . 0.0 109.682 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 t -146.67 124.15 11.71 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.281 0.562 . . . . 0.0 111.641 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -100.66 101.16 11.98 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 32.8 m -85.72 74.96 10.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.615 1.166 . . . . 0.0 108.249 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.82 -98.71 1.08 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.8 m -88.14 -44.71 10.71 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.387 1.075 . . . . 0.0 110.433 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.0 107.15 1.42 Allowed 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 125.039 1.336 . . . . 0.0 112.493 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -91.41 103.69 16.3 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.572 1.149 . . . . 0.0 109.027 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -102.39 148.69 25.18 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.277 0.631 . . . . 0.0 110.713 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.4 m -83.13 157.6 22.72 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 125.476 1.51 . . . . 0.0 108.858 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.66 -19.55 63.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.2 m -71.95 -35.22 69.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.109 0.964 . . . . 0.0 109.026 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.64 -53.81 10.78 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 123.953 0.901 . . . . 0.0 112.679 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.95 -41.31 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -67.61 -44.75 77.32 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.663 0.785 . . . . 0.0 111.007 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.25 -48.45 78.17 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.498 0.59 . . . . 0.0 110.253 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.05 -32.1 73.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.157 0.983 . . . . 0.0 111.166 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.43 -36.84 52.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.776 0.262 . . . . 0.0 110.666 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -69.29 -20.33 63.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.72 -53.59 5.79 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.59 -40.31 59.57 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.54 1.136 . . . . 0.0 109.228 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.41 -53.94 52.61 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.366 1.466 . . . . 0.0 109.374 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -63.58 -49.49 73.18 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -70.79 -46.15 63.39 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.474 ' CD1' ' HG2' ' A' ' 57' ' ' GLN . 63.6 t80 -70.23 -19.55 63.13 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.465 -177.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -90.14 -77.68 0.39 Allowed 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.534 1.061 . . . . 0.0 110.207 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.8 p30 174.49 56.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.1 1.36 . . . . 0.0 111.616 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -146.01 92.7 2.23 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 86.19 117.59 0.04 OUTLIER 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 127.326 2.25 . . . . 0.0 105.819 -177.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -92.05 85.17 5.43 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.045 0.938 . . . . 0.0 109.916 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.15 150.21 8.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.253 1.421 . . . . 0.0 112.722 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.61 -38.37 95.59 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.4 t 65.49 97.13 0.05 OUTLIER 'General case' 0 C--N 1.343 0.297 0 C-N-CA 126.773 2.029 . . . . 0.0 113.242 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.5 m -68.95 -55.65 10.29 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 t -159.81 16.89 0.15 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.171 1.388 . . . . 0.0 111.495 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -142.02 149.76 53.61 Favored Pre-proline 0 CA--C 1.511 -0.553 0 C-N-CA 126.067 1.747 . . . . 0.0 107.327 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.4 122.76 7.96 Favored 'Cis proline' 0 CA--C 1.557 1.651 0 N-CA-C 115.425 1.279 . . . . 0.0 115.425 0.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . 0.318 29.3 m-70 -82.84 138.33 33.98 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 127.358 2.263 . . . . 0.0 114.457 -178.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.6 m -70.77 133.17 46.33 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 102.829 -3.026 . . . . 0.0 102.829 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.28 63.1 3.82 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.211 0.914 . . . . 0.0 113.278 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.1 m120 30.98 -138.0 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 130.87 3.668 . . . . 0.0 114.912 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -111.73 140.25 46.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.854 2.061 . . . . 0.0 107.701 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 71.93 179.46 0.23 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.514 1.526 . . . . 0.0 109.998 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -84.76 98.08 10.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.35 -42.48 83.1 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.171 0.891 . . . . 0.0 111.694 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -145.25 162.71 36.51 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.127 0.971 . . . . 0.0 109.458 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -76.69 132.9 39.61 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.777 1.231 . . . . 0.0 112.612 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -149.28 154.01 38.3 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.428 1.491 . . . . 0.0 108.385 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.96 -47.63 23.92 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.023 2.482 . . . . 0.0 111.351 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.42 HG21 HD21 ' A' ' 80' ' ' ASN . 22.4 m -81.0 168.0 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.544 1.538 . . . . 0.0 109.755 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -98.53 -16.68 19.06 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.633 1.173 . . . . 0.0 112.406 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.66 -159.69 22.41 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.35 160.77 72.05 Favored 'Cis proline' 0 N--CA 1.459 -0.549 0 CA-C-N 118.783 1.291 . . . . 0.0 112.422 1.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.91 159.94 35.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.742 1.217 . . . . 0.0 111.465 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.474 ' HG2' ' CD1' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -132.96 135.95 45.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.9 178.058 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -80.68 162.43 24.16 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -160.77 117.91 1.45 Allowed Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -82.9 146.03 12.83 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 121.405 1.404 . . . . 0.0 113.103 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 62' ' ' LYS . 0.5 OUTLIER -112.84 -165.48 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-O 123.81 1.767 . . . . 0.0 113.731 -178.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.467 ' N ' HG23 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -161.65 176.09 11.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 109.678 -3.419 . . . . 0.0 111.586 -177.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.0 t -99.81 63.57 1.22 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.342 1.457 . . . . 0.0 110.673 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.68 -63.43 0.09 OUTLIER Glycine 0 C--N 1.337 0.593 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.85 -164.88 11.57 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.6 p -83.98 160.6 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.03 0.932 . . . . 0.0 111.643 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -37.93 126.68 1.24 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 128.097 2.559 . . . . 0.0 113.754 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.0 t -160.02 -40.98 0.05 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.496 1.518 . . . . 0.0 110.383 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.87 -80.3 0.75 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.93 95.08 2.29 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 77.8 p -157.13 153.04 22.9 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 125.024 1.33 . . . . 0.0 108.417 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.23 154.17 74.79 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.958 2.439 . . . . 0.0 110.642 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 74' ' ' ALA . . . -165.05 -25.73 0.02 OUTLIER Glycine 0 CA--C 1.53 1.022 0 CA-C-O 117.956 -1.469 . . . . 0.0 114.655 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.602 ' HB1' ' H ' ' A' ' 91' ' ' HIS . . . 88.95 -31.28 0.03 OUTLIER 'General case' 0 C--N 1.346 0.418 0 C-N-CA 126.205 1.802 . . . . 0.0 111.167 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -79.37 124.52 28.5 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.234 1.813 . . . . 0.0 113.391 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.84 128.08 7.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.804 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.7 m -85.9 146.03 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.7 t -133.96 122.87 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.3 pt -106.23 171.59 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 125.169 1.388 . . . . 0.0 111.566 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.42 HD21 HG21 ' A' ' 52' ' ' VAL . 8.8 m120 -79.68 165.47 22.82 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 178.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.285 2.1 m -67.98 -5.78 18.93 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -178.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -102.29 -73.3 0.66 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -165.17 -12.01 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 117.935 2.568 . . . . 0.0 117.935 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -78.77 126.96 31.43 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -57.33 111.21 1.02 Allowed 'General case' 0 C--N 1.344 0.346 0 C-N-CA 125.353 1.461 . . . . 0.0 107.454 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.99 -48.76 11.81 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.53 151.33 8.31 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.56 125.88 38.41 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.5 pt -127.13 155.74 38.29 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 C-N-CA 122.727 0.411 . . . . 0.0 110.11 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.8 t -156.73 154.06 29.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.602 ' H ' ' HB1' ' A' ' 74' ' ' ALA . 2.5 m170 -79.04 -15.38 58.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.821 175.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.7 m -58.51 103.72 0.17 Allowed 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.668 1.187 . . . . 0.0 109.385 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.76 55.0 1.96 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.23 -174.95 4.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.729 1.212 . . . . 0.0 109.915 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -57.15 -47.56 80.86 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.249 1.019 . . . . 0.0 111.082 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.96 -70.37 0.12 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -86.63 -28.55 23.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.76 1.224 . . . . 0.0 109.305 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -57.06 160.61 3.54 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 126.304 1.842 . . . . 0.0 111.285 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -114.85 161.46 18.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.882 1.673 . . . . 0.0 112.029 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 m -146.28 164.08 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 126.615 1.966 . . . . 0.0 107.434 177.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.54 156.55 26.9 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 123.972 0.796 . . . . 0.0 112.414 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.0 m -103.39 -171.16 1.89 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.151 0.98 . . . . 0.0 110.897 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.9 m -82.87 79.32 9.28 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-O 121.599 0.714 . . . . 0.0 109.624 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.94 -26.22 0.2 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.259 1.409 . . . . 0.0 109.674 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.0 m -79.36 123.35 27.41 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.015 1.726 . . . . 0.0 107.412 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 126.199 1.8 . . . . 0.0 109.865 -179.056 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.1 m -143.39 80.49 1.67 Allowed 'General case' 0 C--N 1.342 0.242 0 C-N-CA 123.585 0.754 . . . . 0.0 110.819 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.53 91.53 0.03 OUTLIER 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.807 1.643 . . . . 0.0 111.666 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 p -83.41 92.5 7.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.087 0.955 . . . . 0.0 112.068 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -99.71 96.25 7.49 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 101.481 -3.526 . . . . 0.0 101.481 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.9 m -89.12 73.04 8.23 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.94 -98.65 1.21 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 108.611 -1.795 . . . . 0.0 108.611 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.5 p -95.53 -42.13 8.59 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.41 1.084 . . . . 0.0 109.182 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.21 137.32 58.24 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -140.17 126.75 20.31 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.79 136.78 50.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.522 1.529 . . . . 0.0 108.338 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.7 p -64.73 161.57 17.67 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 125.152 1.381 . . . . 0.0 110.807 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.21 -16.78 36.39 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -78.28 -37.16 45.58 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 123.785 0.834 . . . . 0.0 109.986 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -66.64 -39.94 88.49 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.726 0.81 . . . . 0.0 109.992 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.5 t -60.2 -50.69 79.25 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -64.87 -23.29 67.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.138 1.375 . . . . 0.0 111.378 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.64 -61.11 1.89 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 119.202 0.91 . . . . 0.0 108.668 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.86 -24.93 66.19 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.679 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.2 -38.59 30.87 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 118.501 0.592 . . . . 0.0 112.012 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -69.5 -22.55 63.6 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.3 -65.22 0.95 Allowed 'General case' 0 C--N 1.347 0.487 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.431 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -45.38 -43.68 11.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.783 1.233 . . . . 0.0 111.941 177.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 t -61.81 -48.33 81.09 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 121.335 -0.853 . . . . 0.0 111.682 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -80.21 -24.33 40.32 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -112.6 -28.72 7.72 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -3.06 28.21 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -66.75 -46.64 74.73 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.175 0.99 . . . . 0.0 112.979 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -133.69 -80.69 0.47 Allowed 'General case' 0 C--N 1.34 0.183 0 O-C-N 123.354 0.409 . . . . 0.0 111.328 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -170.66 101.67 0.24 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -141.2 -169.38 2.83 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.963 0.905 . . . . 0.0 110.35 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.3 p -71.08 84.9 0.72 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.455 1.502 . . . . 0.0 112.152 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 137.94 162.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 129.464 3.106 . . . . 0.0 111.895 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 152.65 -87.88 0.13 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 126.169 1.842 . . . . 0.0 108.647 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.1 t 158.31 -94.75 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 129.21 3.004 . . . . 0.0 105.91 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.6 p -160.22 -55.05 0.06 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 p -81.36 -69.15 0.63 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -65.24 141.07 98.07 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 124.075 0.95 . . . . 0.0 109.129 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.18 133.33 27.46 Favored 'Cis proline' 0 N--CA 1.459 -0.504 0 N-CA-C 116.061 1.523 . . . . 0.0 116.061 3.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -132.49 136.97 47.03 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.963 2.105 . . . . 0.0 108.423 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.5 m -49.58 125.66 11.87 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.819 2.048 . . . . 0.0 110.195 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -80.03 70.61 6.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.703 1.201 . . . . 0.0 110.407 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -164.31 147.59 9.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.592 0.757 . . . . 0.0 110.027 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -162.29 -72.83 0.05 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.618 1.567 . . . . 0.0 107.03 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -152.76 -40.7 0.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.711 2.004 . . . . 0.0 108.31 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -118.28 161.96 19.06 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 125.392 1.477 . . . . 0.0 110.103 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.84 156.65 14.52 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.634 1.112 . . . . 0.0 110.459 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.55 156.78 37.77 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.655 0.782 . . . . 0.0 111.302 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -88.55 119.49 29.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.868 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -130.77 101.03 17.16 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.57 75.81 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.759 2.972 . . . . 0.0 111.286 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.9 t -140.04 -38.56 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.023 1.729 . . . . 0.0 109.238 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 80.57 108.88 0.07 Allowed 'General case' 0 C--N 1.345 0.387 0 C-N-CA 127.132 2.173 . . . . 0.0 109.251 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.84 -143.17 0.7 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.865 1.697 . . . . 0.0 113.533 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -65.99 139.06 40.76 Favored 'Cis proline' 0 N--CA 1.456 -0.717 0 CA-C-N 118.299 1.049 . . . . 0.0 112.652 1.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.37 163.72 12.61 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 126.351 1.86 . . . . 0.0 108.24 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -139.75 156.25 46.88 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -79.63 157.3 27.31 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.227 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.431 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 7.3 t80 -160.21 89.22 1.82 Allowed Pre-proline 0 N--CA 1.449 -0.511 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . 0.253 6.3 Cg_exo -63.84 137.46 58.33 Favored 'Trans proline' 0 N--CA 1.44 -1.657 0 C-N-CA 122.474 2.116 . . . . 0.0 116.757 -176.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.531 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.0 tt -108.14 176.96 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 124.278 1.99 . . . . 0.0 111.904 178.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.531 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -162.05 179.78 7.72 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 108.58 -3.918 . . . . 0.0 111.31 179.082 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.9 p -87.42 52.85 2.61 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.32 -65.57 0.02 OUTLIER Glycine 0 C--N 1.342 0.879 0 C-N-CA 125.187 1.375 . . . . 0.0 110.136 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.85 -127.13 1.62 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -68.27 164.94 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.89 1.276 . . . . 0.0 109.225 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -51.42 140.44 17.57 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 43.4 p -141.56 -55.79 0.47 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.566 1.946 . . . . 0.0 108.422 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.01 170.52 20.79 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.024 1.297 . . . . 0.0 111.248 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.38 151.15 25.33 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.506 1.05 . . . . 0.0 111.924 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.5 p 63.82 171.99 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.014 2.126 . . . . 0.0 112.657 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.55 159.89 30.24 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.012 2.475 . . . . 0.0 111.097 172.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.08 71.83 0.19 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.487 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -69.36 -16.52 63.55 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 118.142 -0.933 . . . . 0.0 112.575 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.54 125.12 38.99 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.322 1.849 . . . . 0.0 112.297 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.0 mtt85 -135.18 137.47 42.72 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.893 0.877 . . . . 0.0 113.115 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.9 m -103.07 145.3 12.56 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 176.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.262 91.7 t -134.73 133.99 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -176.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.7 pt -126.72 165.84 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -87.9 157.16 19.04 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 126.16 1.784 . . . . 0.0 109.79 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.377 8.2 t -79.73 56.06 2.18 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 -177.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -157.47 -87.07 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 100.785 -3.783 . . . . 0.0 100.785 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.45 1.85 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -83.91 127.1 33.61 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -64.35 127.87 33.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.325 1.05 . . . . 0.0 108.537 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -92.36 -44.89 8.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.563 0.745 . . . . 0.0 109.99 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.67 175.32 42.09 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.173 -0.537 . . . . 0.0 114.108 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.54 121.85 21.56 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 127.123 2.169 . . . . 0.0 106.166 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.3 pt -128.16 161.19 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.478 1.111 . . . . 0.0 110.243 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 t -157.91 159.81 36.95 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.487 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 21.8 m170 -78.45 -24.09 46.22 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.4 m -61.56 108.07 0.91 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.793 0.837 . . . . 0.0 110.863 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.54 -15.71 19.67 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.818 1.199 . . . . 0.0 112.323 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.93 163.73 26.89 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.409 1.083 . . . . 0.0 111.8 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.8 t -104.05 52.03 0.77 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.957 1.303 . . . . 0.0 109.6 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 143.24 -147.67 19.14 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.796 1.189 . . . . 0.0 110.752 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -79.61 -14.84 58.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.496 1.119 . . . . 0.0 111.367 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -60.09 167.64 2.25 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 123.779 0.832 . . . . 0.0 110.919 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -106.71 159.66 16.05 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.437 1.095 . . . . 0.0 112.85 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 m -134.85 165.46 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 127.046 2.138 . . . . 0.0 106.399 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.14 138.01 13.91 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 122.984 0.326 . . . . 0.0 113.39 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.3 m -85.13 -174.37 5.21 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -77.44 121.33 23.67 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.745 -0.597 . . . . 0.0 110.648 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.03 66.2 1.59 Allowed Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.387 0.994 . . . . 0.0 110.789 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.4 t -139.31 29.37 2.21 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.984 1.314 . . . . 0.0 112.198 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 C--O 1.251 1.168 0 C-N-CA 127.68 2.392 . . . . 0.0 110.268 -179.13 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 121.1 0.476 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.5 p -139.37 -166.5 2.06 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.305 1.442 . . . . 0.0 110.009 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.08 147.29 35.41 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.473 1.109 . . . . 0.0 109.76 178.551 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.1 p -121.57 119.22 31.28 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 123.137 0.575 . . . . 0.0 110.239 -178.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.18 108.29 13.14 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 100.313 -3.958 . . . . 0.0 100.313 177.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.9 110.16 13.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.724 0.409 . . . . 0.0 110.242 -178.053 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.12 -82.71 0.75 Allowed Glycine 0 C--N 1.339 0.746 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.34 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.2 t -156.99 45.77 0.4 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.642 1.177 . . . . 0.0 108.874 179.057 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 m -141.39 96.92 3.06 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -85.68 139.05 31.69 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.71 1.604 . . . . 0.0 110.932 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -137.89 137.15 37.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.079 1.352 . . . . 0.0 108.271 178.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.447 ' O ' HG23 ' A' ' 16' ' ' VAL . 44.5 m -70.58 149.18 47.35 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.29 -21.55 5.69 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.2 m -71.0 -47.66 57.54 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.153 0.981 . . . . 0.0 109.267 179.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.79 -38.04 85.74 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 12' ' ' SER . 2.6 t -63.81 -51.06 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.315 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.8 ttt-85 -64.19 -36.09 82.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.726 1.61 . . . . 0.0 111.785 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.29 -50.5 46.16 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.051 0.541 . . . . 0.0 109.908 179.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.517 ' HB1' ' HE2' ' A' ' 59' ' ' PHE . . . -57.58 -41.72 81.71 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.325 1.05 . . . . 0.0 110.213 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.91 -46.19 54.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -61.21 -21.81 64.19 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.64 -59.64 2.54 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -177.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.88 -32.54 53.61 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.817 0.698 . . . . 0.0 110.945 178.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -64.25 -53.84 42.7 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -56.44 -38.85 72.18 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.787 0.435 . . . . 0.0 110.549 178.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -74.38 -3.31 29.67 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 126.589 1.956 . . . . 0.0 113.147 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -134.41 17.84 3.67 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -99.3 -80.55 0.47 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.957 1.253 . . . . 0.0 108.823 179.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -157.97 17.2 0.24 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.245 1.018 . . . . 0.0 112.846 -179.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -122.3 67.7 0.94 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 77.1 116.53 0.06 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 127.406 2.283 . . . . 0.0 105.294 -177.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -96.03 -58.08 2.18 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 124.157 0.983 . . . . 0.0 112.159 -177.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 50.83 82.41 0.06 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.831 1.252 . . . . 0.0 112.534 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -112.75 33.09 5.81 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.768 1.651 . . . . 0.0 110.805 -179.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.7 m -149.24 65.08 1.02 Allowed 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.297 1.439 . . . . 0.0 107.212 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.6 p -161.33 -167.77 1.85 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.316 1.046 . . . . 0.0 108.765 -178.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.4 p -85.93 58.04 4.82 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 74.35 147.53 0.12 Allowed Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 126.885 2.074 . . . . 0.0 110.443 179.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.66 137.57 46.7 Favored 'Cis proline' 0 C--N 1.349 0.558 0 CA-C-N 119.73 0.939 . . . . 0.0 113.725 2.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -134.98 168.58 18.85 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.801 2.04 . . . . 0.0 110.216 -179.128 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.4 m -74.08 140.06 45.06 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.596 1.958 . . . . 0.0 109.489 178.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.49 81.78 5.92 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.86 146.49 49.6 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 71.77 126.23 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.054 2.142 . . . . 0.0 111.174 -178.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -98.67 53.19 1.01 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.91 0.884 . . . . 0.0 109.476 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -153.6 56.81 0.75 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.708 1.203 . . . . 0.0 108.102 179.123 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.8 -55.58 0.23 Allowed Glycine 0 C--N 1.341 0.855 0 C-N-CA 125.725 1.631 . . . . 0.0 109.042 179.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.61 175.65 13.65 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.313 1.045 . . . . 0.0 109.52 178.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -90.52 136.63 32.94 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.873 1.269 . . . . 0.0 110.871 -178.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -150.87 103.51 3.02 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 178.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.63 58.03 6.23 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.125 3.217 . . . . 0.0 114.074 -177.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -145.37 -134.22 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 178.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -146.5 143.23 28.8 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.183 0.901 . . . . 0.0 109.225 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.74 -176.19 50.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.214 0.911 . . . . 0.0 111.892 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.23 160.89 93.41 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 CA-C-N 118.174 0.987 . . . . 0.0 110.693 -1.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -112.4 171.82 7.29 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.267 1.027 . . . . 0.0 110.289 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -132.56 137.31 47.06 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.169 1.388 . . . . 0.0 109.055 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -93.7 155.29 17.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.603 0.761 . . . . 0.0 110.323 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.517 ' HE2' ' HB1' ' A' ' 19' ' ' ALA . 22.4 t80 -160.21 102.55 1.39 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.12 119.94 4.81 Favored 'Trans proline' 0 N--CA 1.442 -1.532 0 C-N-CA 122.226 1.951 . . . . 0.0 109.789 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.52 HG13 ' H ' ' A' ' 62' ' ' LYS . 6.2 tt -79.38 170.63 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 124.109 1.909 . . . . 0.0 111.349 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.52 ' H ' HG13 ' A' ' 61' ' ' ILE . 14.1 tptm -140.49 149.11 42.1 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 109.468 -3.515 . . . . 0.0 111.641 -178.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.4 m -89.48 60.28 5.12 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 126.129 1.771 . . . . 0.0 109.267 -179.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.03 -55.79 0.03 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.29 -167.82 36.75 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.6 158.83 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.679 1.192 . . . . 0.0 110.899 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.18 -173.37 4.17 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.352 1.461 . . . . 0.0 108.341 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.2 t -160.36 33.11 0.17 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.752 1.221 . . . . 0.0 110.069 178.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -141.9 -24.38 0.21 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.824 1.202 . . . . 0.0 113.024 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.96 -143.86 49.01 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.643 1.222 . . . . 0.0 111.827 179.377 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.1 t 63.11 102.33 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 126.421 1.888 . . . . 0.0 111.975 179.211 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.85 161.7 29.68 Favored 'Cis proline' 0 C--N 1.349 0.567 0 CA-C-N 119.981 1.029 . . . . 0.0 113.619 -3.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.78 41.35 1.88 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.864 -0.964 . . . . 0.0 113.546 -179.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.54 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -88.54 -73.28 0.5 Allowed 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -60.99 112.92 2.26 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.603 1.161 . . . . 0.0 111.147 179.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -132.22 161.01 34.48 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -178.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 m -132.88 142.11 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 101.16 -3.644 . . . . 0.0 101.16 175.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.9 t -138.24 120.13 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -176.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -102.54 173.12 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.115 0 C-N-CA 125.85 1.66 . . . . 0.0 110.15 -178.979 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -88.56 161.06 17.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 103.184 -2.895 . . . . 0.0 103.184 176.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.366 13.4 t -57.09 -22.54 40.29 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 118.057 2.614 . . . . 0.0 118.057 -177.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -85.97 -75.46 0.38 Allowed 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.62 -1.84 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -176.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -78.94 109.03 12.85 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -175.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -56.51 108.6 0.5 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.929 1.292 . . . . 0.0 109.228 -179.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.08 -60.05 2.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.604 1.162 . . . . 0.0 112.461 -177.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.8 175.57 46.39 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.62 146.12 52.04 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.424 1.089 . . . . 0.0 110.58 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.2 pt -143.61 171.37 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.292 1.037 . . . . 0.0 110.781 -178.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.9 t -159.71 143.23 14.36 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 116.426 2.009 . . . . 0.0 116.426 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.54 ' HB2' ' CB ' ' A' ' 74' ' ' ALA 0.265 32.2 m170 -79.51 -29.36 41.53 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.094 174.542 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.2 -45.33 68.54 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.607 1.163 . . . . 0.0 113.666 -177.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -78.62 -21.9 68.14 Favored Glycine 0 CA--C 1.529 0.969 0 C-N-CA 124.047 0.832 . . . . 0.0 111.565 179.226 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.26 166.5 23.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.897 0.879 . . . . 0.0 112.003 -179.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.7 t -65.9 -36.02 82.23 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.158 0.983 . . . . 0.0 111.64 -179.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.53 -101.51 0.15 Allowed Glycine 0 C--N 1.341 0.808 0 CA-C-N 118.206 0.457 . . . . 0.0 112.26 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -79.58 -22.12 44.18 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.046 0.938 . . . . 0.0 113.017 -178.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -74.68 179.01 5.0 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.656 0.662 . . . . 0.0 110.584 179.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -119.41 159.03 24.99 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.563 1.545 . . . . 0.0 109.905 179.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.7 m -134.96 162.4 38.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 125.209 1.404 . . . . 0.0 107.542 177.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.44 147.94 30.41 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-N 116.311 -0.404 . . . . 0.0 113.51 -178.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 34.0 m -85.75 -173.91 4.87 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.309 1.444 . . . . 0.0 107.946 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.3 t -57.23 110.27 0.81 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.263 1.025 . . . . 0.0 111.841 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.95 34.2 76.38 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.939 1.256 . . . . 0.0 114.322 178.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 93.6 m -83.43 130.8 35.05 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 118.091 0.945 . . . . 0.0 109.169 179.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 117.238 -1.363 . . . . 0.0 108.927 179.438 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.574 0 CA-C-O 120.727 0.299 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.4 t -106.01 60.17 0.65 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.934 1.294 . . . . 0.0 110.269 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.53 147.02 0.06 Allowed 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 127.007 2.123 . . . . 0.0 112.227 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 t -159.66 156.3 27.61 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.533 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.87 121.23 18.11 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -178.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 3.4 m -103.28 91.04 3.91 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.285 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.28 -106.93 1.87 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.7 m -92.84 -33.32 14.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.527 1.131 . . . . 0.0 111.173 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 m -74.65 103.15 4.83 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.352 0.661 . . . . 0.0 110.275 -178.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -87.92 151.94 22.44 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.961 1.304 . . . . 0.0 111.684 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -142.54 134.23 26.77 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 123.481 0.713 . . . . 0.0 112.354 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.7 m -77.07 155.11 32.71 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 125.241 1.417 . . . . 0.0 107.465 177.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.82 -16.89 13.01 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 177.087 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -70.88 -43.29 68.71 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.871 0.868 . . . . 0.0 109.587 179.054 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -71.15 -47.3 58.65 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 123.932 0.893 . . . . 0.0 113.138 -179.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.4 t -60.1 -46.12 94.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.4 ttt85 -68.18 -40.84 82.15 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.84 1.256 . . . . 0.0 111.901 -179.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.98 -49.6 71.87 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.588 0.631 . . . . 0.0 110.021 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.33 -35.2 79.61 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.893 0.877 . . . . 0.0 111.563 -179.57 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.21 -40.85 58.82 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 117.76 0.255 . . . . 0.0 111.661 179.12 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -65.38 -22.07 66.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.34 -61.73 1.91 Allowed 'General case' 0 C--N 1.348 0.505 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 -178.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -42.34 -47.54 4.9 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.097 1.359 . . . . 0.0 110.486 178.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.7 t -57.88 -66.61 0.45 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.767 1.627 . . . . 0.0 112.687 179.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -23.18 66.36 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.181 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -94.9 4.95 53.22 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.556 1.942 . . . . 0.0 113.413 -178.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -144.82 51.81 1.24 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.268 1.427 . . . . 0.0 110.63 -179.327 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -95.13 -77.15 0.47 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 119.36 -0.352 . . . . 0.0 110.19 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 169.63 -65.4 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.683 1.593 . . . . 0.0 108.828 -178.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -90.25 69.79 7.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 111.22 116.19 0.0 OUTLIER 'General case' 0 C--O 1.231 0.102 0 C-N-CA 131.033 3.733 . . . . 0.0 106.743 -179.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.48 -63.95 0.3 Allowed 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.483 1.113 . . . . 0.0 109.982 -178.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 66.52 163.35 0.18 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.562 1.545 . . . . 0.0 112.453 -179.186 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.93 106.7 0.15 Allowed Glycine 0 C--N 1.341 0.811 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -178.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m -139.1 57.21 1.67 Allowed 'General case' 0 C--N 1.34 0.173 0 CA-C-N 117.696 0.748 . . . . 0.0 112.149 -178.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -100.02 -75.93 0.56 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 103.953 -2.61 . . . . 0.0 103.953 177.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.261 3.6 t -160.23 26.56 0.17 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.682 1.593 . . . . 0.0 109.823 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.409 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -171.3 129.78 0.73 Allowed Pre-proline 0 C--N 1.349 0.548 0 C-N-CA 128.307 2.643 . . . . 0.0 106.872 178.329 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.6 132.3 25.84 Favored 'Cis proline' 0 N--CA 1.45 -1.083 0 N-CA-C 108.354 -1.441 . . . . 0.0 108.354 -2.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -144.3 158.17 43.88 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.874 0.47 . . . . 0.0 109.76 -179.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.4 m -55.64 130.97 45.24 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 125.97 1.708 . . . . 0.0 110.584 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -79.8 121.24 25.13 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.347 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -146.63 177.87 8.74 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.26 1.024 . . . . 0.0 110.514 -179.139 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 t30 59.13 73.27 0.49 Allowed 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.259 1.424 . . . . 0.0 108.565 -178.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -82.01 91.23 6.58 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.051 0.94 . . . . 0.0 110.853 -178.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -62.08 -50.51 71.66 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -169.74 42.4 0.21 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 178.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -150.73 143.48 24.54 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 123.557 0.743 . . . . 0.0 112.159 -179.283 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -161.6 179.63 8.03 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.836 2.054 . . . . 0.0 107.677 179.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -137.93 119.33 10.58 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.84 74.37 5.26 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.981 3.121 . . . . 0.0 112.45 -178.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.26 -90.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.405 1.082 . . . . 0.0 108.714 178.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -145.93 -78.72 0.18 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-N 119.215 0.916 . . . . 0.0 110.228 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.22 -175.06 35.97 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.632 1.11 . . . . 0.0 111.045 -178.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.25 140.33 32.48 Favored 'Cis proline' 0 N--CA 1.458 -0.59 0 CA-C-N 118.796 1.298 . . . . 0.0 110.422 1.031 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.38 172.27 11.91 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.954 0.902 . . . . 0.0 110.351 -178.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -153.9 137.82 16.29 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.064 0.459 . . . . 0.0 111.834 -178.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.55 143.81 30.8 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.697 1.599 . . . . 0.0 112.626 -178.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -154.48 113.85 2.44 Favored Pre-proline 0 C--N 1.342 0.251 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 178.286 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.409 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 17.6 Cg_endo -81.12 144.54 14.87 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 121.79 1.66 . . . . 0.0 114.389 -175.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.544 HG12 ' H ' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -117.12 -171.64 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.45 0 CA-C-O 124.671 2.176 . . . . 0.0 113.125 179.419 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.544 ' H ' HG12 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -162.41 -175.47 4.54 Favored 'General case' 0 C--N 1.318 -0.796 2 CA-C-N 108.05 -4.159 . . . . 0.0 107.443 -178.656 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.3 m -92.81 61.27 3.54 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.54 58.88 0.99 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 108.653 -1.779 . . . . 0.0 108.653 -178.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.27 61.13 0.17 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.02 116.86 4.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.426 0.691 . . . . 0.0 111.206 -179.35 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.6 t80 53.64 65.64 1.46 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.248 1.419 . . . . 0.0 111.248 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.6 p -138.12 77.57 1.64 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.246 1.018 . . . . 0.0 110.825 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.95 99.92 0.07 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.738 0.685 . . . . 0.0 113.262 178.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.74 -174.35 49.31 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.2 m 56.8 86.63 0.16 Allowed Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 125.318 1.447 . . . . 0.0 111.602 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -62.72 142.6 42.14 Favored 'Cis proline' 0 N--CA 1.459 -0.505 0 CA-C-N 119.322 0.794 . . . . 0.0 112.76 -0.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.85 48.09 0.49 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.29 -55.6 8.82 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.693 0.797 . . . . 0.0 109.455 179.267 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -61.93 118.61 7.47 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.436 1.894 . . . . 0.0 112.843 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -143.37 126.91 16.89 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.0 m -92.9 148.05 4.98 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 177.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.6 t -137.06 131.81 46.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 pt -119.92 -175.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.394 0 C-N-CA 124.365 1.066 . . . . 0.0 112.301 -178.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -96.74 153.64 17.75 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 127.009 2.123 . . . . 0.0 106.071 177.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.6 t -67.31 -1.4 4.55 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 -178.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -93.29 -75.31 0.5 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 178.397 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -164.39 -12.04 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.227 1.936 . . . . 0.0 116.227 -179.094 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.72 132.82 36.28 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 -174.398 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -62.24 125.24 23.21 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.8 -42.41 8.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.2 1.0 . . . . 0.0 109.463 -178.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.18 -165.07 38.16 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.86 140.61 25.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.698 1.599 . . . . 0.0 107.678 179.421 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.8 pt -142.56 165.87 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.091 1.356 . . . . 0.0 109.129 -178.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.3 t -159.33 150.83 20.23 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.19 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -79.13 -9.8 59.65 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 175.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 54.1 m -66.16 112.0 3.7 Favored 'General case' 0 C--N 1.344 0.365 0 C-N-CA 124.477 1.111 . . . . 0.0 109.12 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.91 34.38 42.86 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.952 0.787 . . . . 0.0 111.669 -179.301 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.43 -21.2 11.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.21 1.404 . . . . 0.0 111.386 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.6 m 70.05 85.12 0.14 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 126.185 1.794 . . . . 0.0 110.639 179.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.91 -146.77 17.95 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.702 1.144 . . . . 0.0 111.359 179.192 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -80.0 3.61 19.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.681 1.192 . . . . 0.0 112.913 -179.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -68.28 -174.85 0.55 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.876 1.27 . . . . 0.0 111.594 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -140.7 157.56 45.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.81 0.844 . . . . 0.0 112.503 -178.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 m -143.94 163.29 15.18 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 127.095 2.158 . . . . 0.0 106.955 177.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.27 153.35 26.41 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 123.53 0.586 . . . . 0.0 113.302 -178.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -84.13 -179.85 7.32 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.27 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.9 t -79.53 122.69 26.79 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.351 -0.843 . . . . 0.0 112.219 -178.395 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.64 36.39 92.59 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.726 1.155 . . . . 0.0 112.361 179.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.5 t -80.05 146.69 31.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.0 p30 . . . . . 0 C--O 1.252 1.191 0 C-N-CA 125.397 1.479 . . . . 0.0 109.741 -179.031 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m -133.29 176.95 8.06 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.14 1.376 . . . . 0.0 108.994 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -44.46 117.97 1.42 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.984 1.313 . . . . 0.0 110.764 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.51 121.87 41.78 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 124.964 1.306 . . . . 0.0 110.41 -178.124 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -119.07 92.14 3.73 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 100.285 -3.968 . . . . 0.0 100.285 177.126 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.8 m -98.93 91.13 4.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.982 0.913 . . . . 0.0 111.455 -177.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.72 -81.68 0.63 Allowed Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.979 1.276 . . . . 0.0 110.759 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.3 t -145.07 23.92 1.49 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.813 1.245 . . . . 0.0 110.339 179.11 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 m -129.29 102.01 6.25 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 179.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -95.18 151.72 18.98 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.347 0.659 . . . . 0.0 111.967 -178.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.26 155.69 41.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.01 1.324 . . . . 0.0 109.543 178.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.0 p -75.77 154.2 36.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.509 1.523 . . . . 0.0 110.352 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.5 -21.19 59.81 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 176.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.7 t -71.09 -41.22 70.91 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 124.648 1.179 . . . . 0.0 109.892 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -66.78 -39.83 87.94 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 118.65 0.659 . . . . 0.0 111.09 178.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.42 -50.68 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 123.741 0.816 . . . . 0.0 109.13 178.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -62.76 -39.14 93.24 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 123.71 0.804 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.6 -47.13 76.75 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.41 -31.24 72.34 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.56 0.744 . . . . 0.0 111.211 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.87 -42.52 24.06 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 178.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -68.4 -20.39 64.67 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 177.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.406 ' HB1' ' CE2' ' A' ' 26' ' ' TYR . . . -79.96 -65.42 1.01 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 104.33 -2.471 . . . . 0.0 104.33 -178.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -41.23 -53.68 3.12 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 124.708 1.255 . . . . 0.0 110.125 176.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 t -49.96 -61.87 1.9 Allowed 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.853 1.661 . . . . 0.0 113.319 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -61.55 -51.43 68.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.118 0.567 . . . . 0.0 111.458 -178.054 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.406 ' CE2' ' HB1' ' A' ' 22' ' ' ALA . 1.6 m-30 -63.07 -28.6 70.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.722 1.209 . . . . 0.0 112.041 -177.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.407 ' CE2' ' HG3' ' A' ' 57' ' ' GLN . 6.3 t80 -71.92 -56.02 6.44 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.102 0.961 . . . . 0.0 109.557 179.043 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -60.25 -36.86 78.74 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.031 0.932 . . . . 0.0 110.994 -179.079 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -73.69 -35.88 65.23 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.311 0.645 . . . . 0.0 110.683 178.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 68.48 51.05 0.67 Allowed 'General case' 0 C--N 1.344 0.362 0 C-N-CA 126.09 1.756 . . . . 0.0 109.813 -178.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -172.56 -165.55 0.33 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.818 2.047 . . . . 0.0 107.823 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.36 8.8 t 49.65 51.79 15.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.871 2.069 . . . . 0.0 113.682 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.94 99.65 0.08 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.827 2.051 . . . . 0.0 107.081 178.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.91 33.31 3.1 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.033 0.825 . . . . 0.0 113.567 -178.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -78.49 -73.09 0.34 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -167.27 -72.71 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.79 2.036 . . . . 0.0 105.925 179.295 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.3 t -152.21 14.78 0.61 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.298 1.039 . . . . 0.0 111.557 178.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.43 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 8.8 m-85 -76.95 130.79 74.69 Favored Pre-proline 0 C--N 1.346 0.421 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -69.89 121.25 5.32 Favored 'Cis proline' 0 N--CA 1.455 -0.738 0 N-CA-C 115.938 1.476 . . . . 0.0 115.938 -0.002 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -115.19 161.12 18.87 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.497 1.919 . . . . 0.0 106.053 178.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.3 t -52.31 143.04 15.66 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -118.31 152.64 35.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.198 1.399 . . . . 0.0 107.75 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 177.46 -65.04 0.01 OUTLIER 'General case' 0 C--O 1.231 0.082 0 C-N-CA 124.912 1.285 . . . . 0.0 108.848 -178.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 m120 53.05 44.59 30.2 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.811 1.644 . . . . 0.0 110.026 -179.247 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 59.38 -98.98 0.09 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.206 1.802 . . . . 0.0 109.287 -178.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -134.34 68.76 1.47 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.013 1.325 . . . . 0.0 107.792 178.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.05 -73.53 0.91 Allowed Glycine 0 C--N 1.341 0.859 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.209 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.29 116.73 12.01 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.241 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -141.19 121.31 13.78 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.851 0.86 . . . . 0.0 108.881 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -88.31 178.6 2.02 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 125.428 1.491 . . . . 0.0 107.985 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.66 -72.04 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.011 2.474 . . . . 0.0 111.113 178.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.416 ' CG1' ' ND2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER 41.77 -150.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 127.319 2.247 . . . . 0.0 114.197 178.546 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -124.23 -57.03 1.61 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.958 2.103 . . . . 0.0 107.797 178.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.84 129.93 6.7 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.648 -1.084 . . . . 0.0 111.153 179.217 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.17 -177.89 9.67 Favored 'Cis proline' 0 C--N 1.35 0.651 0 CA-C-N 119.813 1.807 . . . . 0.0 114.635 -0.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.86 163.36 38.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 128.716 2.807 . . . . 0.0 106.315 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.407 ' HG3' ' CE2' ' A' ' 27' ' ' TYR . 10.0 mm100 -132.33 152.26 51.49 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.9 161.8 15.05 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -178.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -161.12 95.51 1.39 Allowed Pre-proline 0 N--CA 1.455 -0.203 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.43 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 95.9 Cg_endo -67.69 132.26 26.43 Favored 'Trans proline' 0 N--CA 1.438 -1.744 0 CA-C-N 120.82 1.328 . . . . 0.0 112.727 -178.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.547 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.3 tt -101.81 179.33 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 CA-C-O 123.93 1.824 . . . . 0.0 111.707 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.547 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 10.4 mttm -160.99 157.73 26.79 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 109.08 -3.691 . . . . 0.0 111.51 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.9 p -88.41 59.89 5.41 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.813 1.245 . . . . 0.0 111.234 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.11 31.0 0.13 Allowed Glycine 0 CA--C 1.529 0.91 0 CA-C-O 119.302 -0.721 . . . . 0.0 111.621 178.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.01 179.97 28.82 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.922 0.772 . . . . 0.0 112.056 -179.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.8 p -73.64 131.15 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.094 1.358 . . . . 0.0 111.545 -179.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 41.8 t80 39.04 82.48 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.359 2.263 . . . . 0.0 114.09 178.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.2 t -160.59 125.3 3.72 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.104 0.961 . . . . 0.0 109.422 178.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 162.46 -83.16 0.12 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 154.16 -58.4 0.4 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.3 m -138.29 93.15 11.63 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.181 0.992 . . . . 0.0 110.518 -178.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -49.45 139.0 30.23 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 124.11 3.207 . . . . 0.0 111.565 169.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.14 -21.02 2.38 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 118.259 -1.301 . . . . 0.0 115.162 -178.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.476 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -151.94 -60.14 0.16 Allowed 'General case' 0 C--N 1.345 0.374 0 CA-C-N 119.657 1.729 . . . . 0.0 114.454 -178.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.42 117.52 12.06 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -177.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -146.0 125.67 13.38 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.422 0.689 . . . . 0.0 112.036 178.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.6 148.49 4.53 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 177.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.09 137.71 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.3 pt -117.42 -177.62 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.803 1.641 . . . . 0.0 112.143 -178.442 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.416 ' ND2' ' CG1' ' A' ' 52' ' ' VAL . 4.6 m120 -83.65 178.55 7.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 129.397 3.079 . . . . 0.0 107.118 178.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.1 t -90.71 24.76 2.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -140.57 -65.21 0.45 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 177.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -163.27 -21.03 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 118.741 2.867 . . . . 0.0 118.741 -177.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -79.82 150.2 30.77 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -175.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -75.44 134.52 40.85 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.149 1.78 . . . . 0.0 108.296 178.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.22 -53.7 2.86 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.942 0.897 . . . . 0.0 110.248 -179.357 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.91 152.11 10.95 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.15 127.67 53.02 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.377 1.471 . . . . 0.0 107.551 178.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.0 pt -132.19 157.59 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.457 1.103 . . . . 0.0 109.969 -178.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.4 t -158.07 151.8 23.75 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -179.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.476 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 27.8 m170 -80.21 -20.57 44.37 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.562 0.539 . . . . 0.0 110.509 174.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.0 m -49.01 -59.64 3.44 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 126.182 1.793 . . . . 0.0 112.714 -178.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.02 -27.45 70.37 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 123.846 0.736 . . . . 0.0 111.96 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.02 172.35 5.72 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.211 1.004 . . . . 0.0 112.27 -179.066 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.3 t -60.79 -54.8 40.7 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.448 1.099 . . . . 0.0 111.564 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.68 -88.39 0.07 OUTLIER Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.428 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -80.23 -24.1 40.41 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.978 0.911 . . . . 0.0 112.001 -179.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -68.71 -178.18 1.12 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.518 1.127 . . . . 0.0 112.268 -178.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -128.17 160.46 31.97 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.524 1.529 . . . . 0.0 112.031 -179.007 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 m -148.27 161.25 6.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 126.747 2.019 . . . . 0.0 106.917 177.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.1 161.39 27.85 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 -178.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 p -147.63 160.68 42.4 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.2 1.8 . . . . 0.0 109.4 178.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.2 t 70.51 58.76 0.23 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.046 1.738 . . . . 0.0 110.684 -178.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.59 28.74 70.26 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.306 -179.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.2 m -113.79 106.24 14.24 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.215 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.3 t30 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 116.851 -1.547 . . . . 0.0 109.822 179.704 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.493 0 CA-C-O 121.142 0.496 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.6 p -136.42 -174.34 3.67 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.255 1.422 . . . . 0.0 109.945 179.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.83 152.05 45.28 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.706 0.802 . . . . 0.0 109.406 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.4 t -146.53 136.97 23.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.73 0.3 . . . . 0.0 111.705 -179.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.06 113.08 25.5 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.1 m -98.54 75.27 2.17 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.8 -84.11 1.59 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.0 m -123.44 -29.49 3.79 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.352 1.461 . . . . 0.0 110.816 179.112 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.8 m -71.73 98.04 1.87 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -79.56 141.58 36.49 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.138 1.375 . . . . 0.0 110.578 -178.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -137.14 129.01 29.04 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.325 1.05 . . . . 0.0 109.547 178.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.1 m -68.98 155.1 40.92 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.88 1.272 . . . . 0.0 108.652 178.209 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.71 -22.62 57.93 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 176.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.8 t -71.13 -37.74 72.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.034 0.934 . . . . 0.0 109.683 179.228 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -75.32 -44.89 42.88 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.102 1.361 . . . . 0.0 113.57 -178.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.2 t -60.48 -48.02 90.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -43.26 74.37 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 123.765 0.826 . . . . 0.0 112.258 -179.187 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.18 -47.24 85.37 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.301 0.376 . . . . 0.0 110.69 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.6 94.57 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.712 0.805 . . . . 0.0 109.566 -179.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.91 -27.86 60.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -71.51 -23.47 61.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.03 -58.03 3.26 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -179.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.482 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -44.28 -44.6 8.15 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.48 1.512 . . . . 0.0 111.002 176.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -62.9 -52.56 62.61 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.163 0.985 . . . . 0.0 109.862 178.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -61.14 -22.22 64.48 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.445 0.698 . . . . 0.0 112.182 179.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -99.74 7.4 45.1 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.898 1.679 . . . . 0.0 110.735 179.328 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -151.31 63.89 0.89 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.587 1.184 . . . . 0.0 108.51 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -100.59 -39.88 7.68 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 113.532 -1.667 . . . . 0.0 112.16 178.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -139.05 48.41 1.88 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.876 0.871 . . . . 0.0 111.062 -179.048 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 p30 46.46 41.75 9.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.584 1.954 . . . . 0.0 114.61 178.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -138.94 123.74 18.69 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 103.347 -2.834 . . . . 0.0 103.347 178.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 p -109.54 -84.09 0.55 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -176.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 163.24 97.57 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 128.394 2.677 . . . . 0.0 104.184 -178.139 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.5 -48.22 3.09 Favored Glycine 0 CA--C 1.533 1.184 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -178.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m 59.17 71.64 0.57 Allowed 'General case' 0 C--N 1.345 0.402 0 C-N-CA 125.344 1.458 . . . . 0.0 110.267 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.3 t 179.68 -42.3 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.992 2.117 . . . . 0.0 107.238 -178.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.3 t -79.91 12.32 2.79 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.96 1.704 . . . . 0.0 112.667 179.223 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 71.94 136.57 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.792 1.637 . . . . 0.0 108.717 179.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.35 163.41 89.95 Favored 'Cis proline' 0 N--CA 1.449 -1.143 0 CA-C-N 119.616 0.899 . . . . 0.0 113.979 2.476 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -166.46 151.75 8.16 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 127.06 2.144 . . . . 0.0 107.131 178.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 t -52.0 155.66 1.78 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -178.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.1 t80 -138.36 99.01 3.73 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.345 2.258 . . . . 0.0 106.738 -179.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -131.04 153.65 49.05 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 124.28 1.032 . . . . 0.0 111.747 -178.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 54.47 32.22 16.3 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.873 2.069 . . . . 0.0 113.612 178.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -123.62 75.96 1.38 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -77.85 -1.46 31.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.413 1.085 . . . . 0.0 112.722 179.353 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.83 -43.34 96.64 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 124.346 0.975 . . . . 0.0 111.964 179.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.47 66.8 1.32 Allowed 'General case' 0 C--N 1.341 0.221 0 CA-C-O 121.658 0.742 . . . . 0.0 109.403 179.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -87.57 -175.16 5.1 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.632 1.173 . . . . 0.0 112.968 -178.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -141.3 143.58 31.02 Favored Pre-proline 0 N--CA 1.454 -0.226 0 C-N-CA 126.699 1.999 . . . . 0.0 106.73 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.14 -87.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.837 2.358 . . . . 0.0 110.272 179.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.1 t 31.23 -102.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 128.046 2.538 . . . . 0.0 113.358 178.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -167.76 115.43 0.75 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.246 1.019 . . . . 0.0 109.57 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.06 170.98 50.14 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.69 170.71 64.7 Favored 'Cis proline' 0 N--CA 1.459 -0.533 0 CA-C-N 118.645 1.223 . . . . 0.0 112.423 -0.147 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -130.5 170.84 13.7 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.92 1.288 . . . . 0.0 109.868 -178.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -149.99 148.5 29.13 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.172 0.989 . . . . 0.0 109.731 179.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -79.54 155.08 28.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.044 2.537 . . . . 0.0 112.369 -177.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.482 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 28.0 t80 -160.51 102.1 1.35 Allowed Pre-proline 0 N--CA 1.454 -0.258 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 177.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -78.79 126.36 7.25 Favored 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 121.786 1.658 . . . . 0.0 111.632 -176.422 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 62' ' ' LYS . 2.3 tp -79.2 164.41 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 123.845 1.783 . . . . 0.0 113.186 -178.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.414 ' N ' HG13 ' A' ' 61' ' ' ILE . 33.3 mmtp -142.93 145.55 33.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 109.316 -3.584 . . . . 0.0 110.752 -178.458 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.8 p -85.34 57.65 4.58 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.068 1.347 . . . . 0.0 108.421 179.046 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.59 -44.23 0.03 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -178.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.62 -132.59 2.18 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 117.788 0.794 . . . . 0.0 111.822 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 p -77.77 167.29 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.961 1.704 . . . . 0.0 110.3 -179.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -65.01 141.96 58.59 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 118.406 0.548 . . . . 0.0 110.965 -179.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -130.78 120.72 24.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.229 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.69 -66.17 3.58 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.271 0.939 . . . . 0.0 111.74 179.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.32 -115.56 1.76 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 -179.261 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.15 -178.76 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.61 1.164 . . . . 0.0 111.067 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.71 159.55 4.77 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.411 2.741 . . . . 0.0 113.34 172.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.59 82.49 0.05 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 -178.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.461 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -50.95 -35.87 35.79 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.477 1.111 . . . . 0.0 113.487 -178.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -74.96 118.48 17.97 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.564 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -144.57 133.65 22.77 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -178.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.8 m -100.12 145.83 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 176.133 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -130.81 136.49 58.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -177.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.0 pt -116.08 174.07 3.53 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 C-N-CA 125.066 1.346 . . . . 0.0 113.512 -178.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -99.99 162.67 12.84 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.885 2.074 . . . . 0.0 107.735 178.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.379 5.7 t -79.09 32.69 0.22 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 118.993 2.961 . . . . 0.0 118.993 -177.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.31 -85.62 0.63 Allowed 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 176.377 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.7 t -162.98 -6.31 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.12 1.768 . . . . 0.0 114.848 179.281 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -79.0 139.14 38.26 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.466 1.03 . . . . 0.0 112.984 -176.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -81.78 121.21 26.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.444 1.898 . . . . 0.0 106.522 178.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.72 -59.27 2.8 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 123.548 0.739 . . . . 0.0 111.691 -178.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.52 154.28 13.01 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.703 -0.76 . . . . 0.0 114.098 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.96 124.77 37.17 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.491 1.516 . . . . 0.0 109.399 179.219 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.5 pt -131.09 159.7 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 125.296 1.438 . . . . 0.0 108.414 -179.334 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.8 t -154.07 154.22 33.26 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.273 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.461 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 13.4 m170 -79.42 11.34 3.05 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 176.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.4 m -56.38 -69.66 0.14 Allowed 'General case' 0 C--N 1.343 0.316 0 CA-C-N 120.135 1.334 . . . . 0.0 112.449 -178.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.26 3.42 72.29 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.369 0.985 . . . . 0.0 112.965 -179.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.34 159.45 33.32 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.993 0.917 . . . . 0.0 111.365 179.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.5 t -69.45 -46.48 66.62 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.64 0.776 . . . . 0.0 109.847 179.055 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -161.94 -86.73 0.06 OUTLIER Glycine 0 C--N 1.34 0.761 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -91.67 15.27 13.03 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.216 1.006 . . . . 0.0 111.296 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -91.17 -168.17 1.99 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.892 1.277 . . . . 0.0 109.727 -179.401 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -147.24 159.44 43.65 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.903 0.881 . . . . 0.0 112.201 -178.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.4 m -138.52 165.62 24.52 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 126.959 2.104 . . . . 0.0 107.21 177.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.71 138.58 14.33 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 123.566 0.603 . . . . 0.0 113.492 -178.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.7 m -84.81 -169.54 2.69 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.269 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -69.97 134.36 48.26 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.954 -0.466 . . . . 0.0 110.791 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.66 34.57 72.97 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.4 m -149.08 104.61 3.44 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.5 t30 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 116.873 -1.537 . . . . 0.0 109.454 179.446 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.2 p -130.07 46.93 2.57 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.231 1.413 . . . . 0.0 109.593 179.235 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 67.13 163.97 0.2 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 126.8 2.04 . . . . 0.0 111.687 -179.202 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 t -156.32 128.52 7.51 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.98 115.37 29.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 178.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 23.1 m -101.06 72.82 1.49 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.777 1.631 . . . . 0.0 107.511 -179.048 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.02 -90.82 0.8 Allowed Glycine 0 C--N 1.34 0.754 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.3 t -106.53 -36.86 6.64 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.078 1.351 . . . . 0.0 110.416 179.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.7 m -71.39 112.96 7.94 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 123.616 0.766 . . . . 0.0 110.003 -179.15 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -92.29 147.39 22.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.093 0.957 . . . . 0.0 110.782 -179.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -142.08 122.23 13.81 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.778 1.231 . . . . 0.0 108.345 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.2 m -69.45 155.84 39.81 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 125.443 1.497 . . . . 0.0 110.163 178.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.9 -18.78 47.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 177.069 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.4 p -77.81 -39.48 43.61 Favored 'General case' 0 C--N 1.345 0.382 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -68.72 -45.97 70.15 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.278 1.031 . . . . 0.0 111.457 179.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 51.5 t -60.08 -49.78 82.71 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.095 0 C-N-CA 124.22 1.008 . . . . 0.0 109.242 179.056 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -63.6 -46.81 84.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.92 0.888 . . . . 0.0 111.434 -178.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.13 -52.57 58.48 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.589 0.756 . . . . 0.0 111.048 -177.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.04 -41.57 83.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.75 -29.29 66.61 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 179.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -68.41 -26.11 65.37 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 176.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.9 -59.5 2.69 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -43.93 -44.52 7.17 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.138 1.375 . . . . 0.0 112.145 177.346 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.9 t -60.08 -53.83 53.17 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.15 1.38 . . . . 0.0 111.06 -179.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -66.91 -43.15 84.08 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -81.37 -2.57 49.8 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 127.103 2.161 . . . . 0.0 114.03 -178.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -60.29 -45.73 92.33 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 120.288 1.404 . . . . 0.0 110.611 179.051 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -57.59 -46.28 84.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.974 1.31 . . . . 0.0 110.886 -178.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -84.45 -16.55 42.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.185 1.394 . . . . 0.0 113.277 -178.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.7 t0 65.26 79.18 0.26 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 126.533 1.933 . . . . 0.0 107.867 -178.234 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 83.94 -163.09 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 127.467 2.307 . . . . 0.0 107.198 -178.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.7 p -36.97 -41.2 0.33 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.087 1.355 . . . . 0.0 108.954 177.069 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 156.6 90.09 0.0 OUTLIER 'General case' 0 C--N 1.345 0.373 0 C-N-CA 129.971 3.308 . . . . 0.0 108.819 177.143 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -141.14 -136.0 3.24 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.278 1.894 . . . . 0.0 110.983 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.5 p 177.52 111.79 0.03 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 125.293 1.437 . . . . 0.0 109.407 -178.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 m 89.68 -8.72 0.39 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 128.74 2.816 . . . . 0.0 114.233 178.047 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 t -82.52 3.8 27.01 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.602 0.637 . . . . 0.0 112.225 179.099 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 81.21 141.21 0.07 OUTLIER Pre-proline 0 C--N 1.347 0.462 0 C-N-CA 127.818 2.447 . . . . 0.0 109.734 178.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.06 144.11 74.3 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 N-CA-C 117.258 1.984 . . . . 0.0 117.258 2.307 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.78 161.52 34.64 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 127.583 2.353 . . . . 0.0 106.324 178.406 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.2 t -59.13 149.04 29.15 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.631 0.65 . . . . 0.0 111.52 -179.281 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -90.69 143.53 26.65 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.209 1.004 . . . . 0.0 109.325 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -65.15 -49.24 70.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.817 1.647 . . . . 0.0 112.959 -178.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 71.22 -168.02 0.15 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.125 1.37 . . . . 0.0 109.851 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 68.5 168.71 0.28 Allowed 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.76 1.624 . . . . 0.0 112.471 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 55.65 50.91 13.42 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -178.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.81 -159.08 34.15 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 108.154 -1.978 . . . . 0.0 108.154 -177.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 35.58 96.94 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 127.403 2.281 . . . . 0.0 116.853 179.07 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -158.83 143.03 15.55 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.0 0.92 . . . . 0.0 109.427 178.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -102.24 153.53 38.01 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.036 1.335 . . . . 0.0 108.728 -179.306 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -78.17 42.18 1.16 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 124.102 3.201 . . . . 0.0 112.518 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.5 m -149.11 152.59 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 126.683 1.993 . . . . 0.0 107.161 178.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -144.87 113.58 6.75 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.18 -57.02 3.08 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.18 -1.344 . . . . 0.0 112.689 -178.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -53.8 149.16 16.64 Favored 'Cis proline' 0 C--N 1.351 0.68 0 CA-C-N 120.586 2.193 . . . . 0.0 113.944 0.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -92.94 156.69 16.76 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.649 1.179 . . . . 0.0 111.286 -178.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.78 154.29 45.57 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.373 1.869 . . . . 0.0 115.378 -176.203 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -80.46 150.45 29.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.654 1.982 . . . . 0.0 110.002 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.524 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 65.7 t80 -160.02 99.38 1.46 Allowed Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -79.38 120.11 4.36 Favored 'Trans proline' 0 N--CA 1.442 -1.531 0 C-N-CA 122.114 1.876 . . . . 0.0 113.768 -176.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.561 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.9 tt -85.8 -178.81 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 CA-C-O 123.845 1.783 . . . . 0.0 108.841 178.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.561 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 7.6 mmtt -160.43 139.91 10.92 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 109.788 -3.369 . . . . 0.0 111.466 -178.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.5 p -90.22 63.17 5.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.231 1.412 . . . . 0.0 107.309 178.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.87 -51.16 0.04 OUTLIER Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.222 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.18 177.98 35.52 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.27 104.93 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 39.6 p90 47.86 71.31 0.35 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.597 1.959 . . . . 0.0 112.343 -178.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.9 p -110.24 138.36 46.73 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.061 1.344 . . . . 0.0 109.273 179.306 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.36 -80.09 1.86 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.82 111.29 0.09 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.04 0.828 . . . . 0.0 111.615 179.262 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.9 m 64.93 90.66 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.719 1.607 . . . . 0.0 110.723 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.29 165.86 84.69 Favored 'Cis proline' 0 N--CA 1.457 -0.63 0 CA-C-N 119.323 0.794 . . . . 0.0 112.055 4.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.35 -67.48 0.02 OUTLIER Glycine 0 CA--C 1.525 0.716 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.413 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . 80.1 -59.72 0.32 Allowed 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 127.928 2.491 . . . . 0.0 109.478 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -65.52 115.6 5.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -135.52 159.69 40.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 122.148 0.975 . . . . 0.0 112.481 178.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.0 m -130.42 147.64 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 102.326 -3.212 . . . . 0.0 102.326 176.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.4 t -127.83 108.85 18.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -177.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -98.75 175.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.413 1.085 . . . . 0.0 111.498 -177.227 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -96.42 146.7 24.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.069 1.748 . . . . 0.0 107.108 179.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.9 t -61.11 -10.01 5.58 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 117.563 2.431 . . . . 0.0 117.563 -178.129 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -86.32 -76.51 0.34 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 178.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.48 -7.89 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 -178.473 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -79.07 169.53 18.05 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 119.339 0.972 . . . . 0.0 111.653 -176.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -113.46 125.81 54.64 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.513 1.925 . . . . 0.0 108.848 179.238 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.62 -62.99 1.35 Allowed 'General case' 0 C--N 1.346 0.431 0 C-N-CA 123.463 0.705 . . . . 0.0 111.241 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.26 170.04 43.09 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.66 153.82 38.86 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 123.931 0.892 . . . . 0.0 113.395 -178.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.5 pt -142.7 161.24 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 127.04 2.136 . . . . 0.0 109.392 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.4 t -160.57 142.76 12.74 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -177.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.413 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 9.6 m170 -78.35 64.35 3.43 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-N 120.89 1.677 . . . . 0.0 108.679 173.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.7 t -95.94 -34.45 11.8 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.227 -0.921 . . . . 0.0 109.652 178.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.68 -59.32 0.27 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 178.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 64.82 177.61 0.19 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.152 1.781 . . . . 0.0 113.591 178.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.4 t -150.64 56.98 0.92 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.553 1.541 . . . . 0.0 107.158 179.129 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.47 -77.28 0.23 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 107.503 -2.239 . . . . 0.0 107.503 -178.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -144.5 45.91 1.4 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.556 1.143 . . . . 0.0 108.985 178.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -114.17 160.59 18.8 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.613 1.165 . . . . 0.0 111.092 -179.059 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -109.49 109.84 20.78 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.743 1.617 . . . . 0.0 107.467 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.2 m -79.41 161.14 4.2 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.332 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.15 143.56 29.76 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 116.439 1.336 . . . . 0.0 116.439 -177.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.9 t -121.86 163.62 18.91 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 177.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.2 t 61.8 37.01 15.85 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.025 0.93 . . . . 0.0 109.865 -176.077 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.13 33.69 85.17 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.473 1.035 . . . . 0.0 111.892 -178.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.4 m -81.42 137.31 35.68 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.211 1.004 . . . . 0.0 109.387 179.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 116.921 -1.514 . . . . 0.0 108.535 179.219 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.2 t -79.19 75.36 5.75 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.056 1.342 . . . . 0.0 110.374 -178.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 145.26 109.36 0.0 OUTLIER 'General case' 0 C--O 1.231 0.102 1 C-N-CA 132.274 4.23 . . . . 0.0 103.403 179.765 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -122.57 125.56 45.95 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.594 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.34 99.92 5.84 Favored 'General case' 0 N--CA 1.444 -0.774 1 N-CA-C 100.04 -4.059 . . . . 0.0 100.04 176.355 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -102.94 85.66 2.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.601 1.56 . . . . 0.0 109.23 -177.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.21 -77.48 1.36 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.7 p -130.6 -33.63 1.62 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.303 1.441 . . . . 0.0 111.633 179.402 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -74.15 101.9 4.09 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.038 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -92.67 152.37 19.58 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.933 1.293 . . . . 0.0 111.379 -178.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -150.09 137.5 19.75 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.693 1.597 . . . . 0.0 108.677 178.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.1 p -71.56 154.0 41.76 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.216 1.407 . . . . 0.0 109.554 179.189 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.33 -22.59 12.51 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.1 t -72.1 -45.08 62.03 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 124.13 0.972 . . . . 0.0 109.279 179.391 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -69.69 -34.48 74.0 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.816 0.847 . . . . 0.0 113.159 179.524 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 85' ' ' TYR . 33.0 t -64.63 -50.69 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.075 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -60.83 -44.24 97.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.791 1.636 . . . . 0.0 110.67 -178.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.03 -52.29 56.79 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.896 0.478 . . . . 0.0 110.439 -179.115 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.22 -35.38 73.53 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.222 1.009 . . . . 0.0 111.053 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.91 -39.69 42.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.258 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -66.73 -22.3 66.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.76 -64.19 1.21 Allowed 'General case' 0 C--N 1.348 0.519 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 -178.158 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.3 -34.88 16.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.664 0.786 . . . . 0.0 112.322 177.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -59.9 4.68 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.877 1.271 . . . . 0.0 109.547 178.622 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -64.63 -21.08 66.63 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.119 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -94.19 -20.68 19.64 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.602 1.161 . . . . 0.0 112.532 -178.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.411 ' CD1' ' HG3' ' A' ' 57' ' ' GLN . 9.7 t80 -74.31 -33.29 63.16 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.309 0.959 . . . . 0.0 112.841 -179.173 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -62.27 -14.68 41.32 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -178.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 t30 72.93 69.99 0.13 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.665 1.586 . . . . 0.0 111.025 177.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -136.12 58.24 1.75 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 178.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.8 t70 74.56 163.17 0.26 Allowed 'General case' 0 C--N 1.345 0.386 0 C-N-CA 126.91 2.084 . . . . 0.0 107.69 -177.588 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.3 p 54.45 56.5 6.78 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -151.07 158.12 43.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.262 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.37 73.72 0.44 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.698 1.618 . . . . 0.0 112.489 -179.428 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.1 p -72.45 -65.37 0.79 Allowed 'General case' 0 C--N 1.341 0.234 0 CA-C-N 117.876 0.838 . . . . 0.0 109.806 179.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.3 m -137.07 -58.16 0.71 Allowed 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 125.235 1.414 . . . . 0.0 107.771 178.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.0 t -157.35 40.94 0.31 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.72 1.208 . . . . 0.0 109.671 178.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -170.55 124.43 0.62 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 127.539 2.336 . . . . 0.0 106.666 179.355 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.36 140.52 66.73 Favored 'Cis proline' 0 N--CA 1.449 -1.106 0 CA-C-N 121.453 1.555 . . . . 0.0 109.657 -2.753 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -155.47 155.62 33.81 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.972 0.909 . . . . 0.0 109.355 179.602 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.9 p -66.39 152.99 43.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.55 0.74 . . . . 0.0 110.741 179.226 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.44 121.22 6.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.909 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -95.64 177.93 5.63 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.162 0.985 . . . . 0.0 111.223 -178.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -78.89 96.05 5.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.497 1.119 . . . . 0.0 109.166 -179.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -80.93 -98.23 0.04 OUTLIER 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.379 0.672 . . . . 0.0 110.111 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -158.55 35.7 0.23 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.333 0.653 . . . . 0.0 111.342 -179.369 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.75 -153.7 9.15 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.077 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.99 69.38 6.35 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 123.463 0.705 . . . . 0.0 109.953 178.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -75.65 118.63 18.68 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 178.629 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.03 117.74 39.14 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 125.448 1.499 . . . . 0.0 111.048 -177.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -78.5 89.55 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.125 2.55 . . . . 0.0 109.834 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 t -135.16 -63.52 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.328 0 C-N-CA 123.871 0.868 . . . . 0.0 110.621 -178.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.4 p30 -148.32 -122.48 0.06 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.35 1.06 . . . . 0.0 110.344 -179.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.28 132.55 2.29 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 118.35 -1.25 . . . . 0.0 110.738 -179.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -68.04 -166.25 2.65 Favored 'Cis proline' 0 CA--C 1.538 0.689 0 CA-C-N 120.108 1.954 . . . . 0.0 114.369 -1.105 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -145.45 173.52 11.93 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.52 1.928 . . . . 0.0 108.255 179.386 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.411 ' HG3' ' CD1' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -148.01 143.05 26.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.059 0.544 . . . . 0.0 110.825 179.31 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -100.31 148.78 24.3 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.941 1.296 . . . . 0.0 111.263 179.34 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -158.39 127.46 3.1 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -75.54 147.26 31.74 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 CA-C-N 120.522 1.222 . . . . 0.0 112.27 -176.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.611 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 3.8 tp -79.4 -161.76 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 123.438 1.59 . . . . 0.0 110.869 -178.455 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.611 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 12.2 tttm -78.62 -163.84 0.51 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 111.321 -2.672 . . . . 0.0 111.64 -178.376 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.2 p 91.48 39.78 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 130.456 3.503 . . . . 0.0 107.277 -177.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.07 -54.56 0.24 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 108.386 -1.886 . . . . 0.0 108.386 -178.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.25 157.72 10.43 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.222 0.439 . . . . 0.0 112.169 179.123 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.486 HG12 ' CD2' ' A' ' 67' ' ' TYR . 24.1 t -127.26 120.94 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 179.061 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.486 ' CD2' HG12 ' A' ' 66' ' ' VAL 0.29 47.3 p90 58.17 43.36 20.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.581 2.352 . . . . 0.0 112.713 -177.935 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.4 t -148.83 -41.09 0.15 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.348 0.659 . . . . 0.0 111.194 -179.68 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.3 55.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.94 87.13 1.35 Allowed Glycine 0 C--N 1.339 0.749 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.0 m -59.28 142.55 86.24 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 123.929 0.892 . . . . 0.0 110.394 179.436 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.3 140.28 30.31 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.803 2.335 . . . . 0.0 108.482 176.501 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.64 -61.28 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 105.451 -3.06 . . . . 0.0 105.451 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -168.94 -55.82 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -178.656 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -62.95 109.84 1.59 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 117.959 2.577 . . . . 0.0 117.959 -177.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -129.41 153.87 47.49 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.764 0.825 . . . . 0.0 112.056 178.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.9 m -120.6 143.31 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 176.429 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 89' ' ' ILE . 83.8 t -137.05 136.24 47.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -175.659 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.3 pt -121.69 -177.71 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.376 0 C-N-CA 124.537 1.135 . . . . 0.0 113.606 -177.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -80.93 -175.2 5.25 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.133 2.173 . . . . 0.0 109.375 179.338 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.281 8.3 t -85.41 27.68 0.8 Allowed 'General case' 0 C--N 1.342 0.24 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 -178.328 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -150.62 -67.3 0.19 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.109 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.25 -14.61 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -176.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -78.91 128.65 33.59 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -175.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.489 ' CE2' ' CG1' ' A' ' 16' ' ' VAL . 16.3 t80 -60.11 136.41 58.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.631 1.173 . . . . 0.0 111.093 -179.186 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.24 -61.84 1.5 Allowed 'General case' 0 C--N 1.345 0.397 0 C-N-CA 124.422 1.089 . . . . 0.0 111.972 -178.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.14 170.05 42.82 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.115 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.67 145.89 46.98 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 125.039 1.336 . . . . 0.0 110.021 178.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.412 HD11 HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -144.28 162.63 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.352 1.061 . . . . 0.0 108.895 179.426 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 t -159.34 143.29 14.96 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -178.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -82.11 40.63 0.63 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.733 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -55.49 -31.32 61.92 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.946 -1.096 . . . . 0.0 113.224 -178.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.09 -69.61 0.02 OUTLIER Glycine 0 C--N 1.337 0.591 0 N-CA-C 106.614 -2.594 . . . . 0.0 106.614 178.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 50.67 -111.48 0.53 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.537 1.535 . . . . 0.0 111.546 178.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.1 m -157.13 77.3 0.87 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.456 1.502 . . . . 0.0 107.162 179.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.63 -105.34 2.39 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -101.61 22.93 11.95 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.333 1.053 . . . . 0.0 111.506 -179.351 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -89.86 177.46 6.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.502 0.721 . . . . 0.0 109.979 179.527 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -121.76 158.87 27.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.961 1.705 . . . . 0.0 110.899 -179.137 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.3 m -141.59 158.14 21.48 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.79 146.98 36.07 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.747 -178.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.2 t -89.5 -167.32 1.83 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.587 1.555 . . . . 0.0 107.274 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 75.8 m -63.66 121.27 13.52 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.749 0.419 . . . . 0.0 110.804 178.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.99 9.01 85.88 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.379 0.99 . . . . 0.0 113.917 179.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 18.5 m -91.93 137.57 32.26 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.434 1.117 . . . . 0.0 108.983 179.179 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 t30 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 116.458 -1.734 . . . . 0.0 110.915 179.333 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.4 t -149.68 72.02 1.12 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.447 1.099 . . . . 0.0 108.581 -179.463 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.56 141.71 0.05 Allowed 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 127.155 2.182 . . . . 0.0 111.163 -179.356 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -129.15 96.06 4.22 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.046 0.938 . . . . 0.0 111.48 -179.504 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -98.97 94.52 6.6 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 101.42 -3.548 . . . . 0.0 101.42 177.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 59.7 m -90.98 73.67 6.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.241 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.34 -99.67 1.73 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 -178.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.6 m -101.54 -39.43 7.52 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.29 1.436 . . . . 0.0 109.249 178.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.71 105.54 4.34 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.047 1.339 . . . . 0.0 108.555 -179.344 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -111.36 134.37 52.99 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.152 0.981 . . . . 0.0 112.481 -178.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.49 149.87 44.61 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.718 1.607 . . . . 0.0 107.186 178.514 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.0 m -72.72 155.24 40.18 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 124.317 1.047 . . . . 0.0 110.507 -179.018 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.1 -19.3 43.25 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 176.71 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.6 t -72.54 -40.79 66.45 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 124.954 1.302 . . . . 0.0 109.461 178.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -70.93 -35.23 72.15 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 123.029 0.532 . . . . 0.0 111.153 179.299 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.1 t -59.6 -48.31 87.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.643 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -65.74 -38.03 88.01 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.203 1.401 . . . . 0.0 111.431 179.51 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 -55.19 15.34 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 118.489 0.586 . . . . 0.0 110.168 -179.285 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.45 -31.3 70.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.073 0.949 . . . . 0.0 110.852 179.451 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.98 -44.78 46.34 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 118.905 -0.569 . . . . 0.0 111.558 179.032 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -60.62 -24.53 65.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.479 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.37 -51.53 10.67 Favored 'General case' 0 C--N 1.346 0.418 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -178.451 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.81 -32.38 31.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.89 1.276 . . . . 0.0 110.886 177.125 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 64.3 m -70.8 -54.07 13.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.772 0.715 . . . . 0.0 110.536 178.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -58.56 -42.28 87.55 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.753 0.421 . . . . 0.0 111.162 -178.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -74.47 -44.2 52.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.485 1.114 . . . . 0.0 110.96 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 27' ' ' TYR . 2.1 t80 -55.23 -36.39 65.96 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.568 1.076 . . . . 0.0 108.789 179.034 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -71.33 -67.23 0.53 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 155.51 -6.34 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.904 2.481 . . . . 0.0 113.57 -179.068 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.01 56.02 1.9 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.738 1.153 . . . . 0.0 113.153 -178.469 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 138.36 115.77 0.0 OUTLIER 'General case' 0 C--N 1.344 0.349 1 C-N-CA 131.97 4.108 . . . . 0.0 108.525 178.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.3 p -95.95 63.9 2.36 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.687 0.795 . . . . 0.0 109.243 -179.462 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.39 -161.03 0.42 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.848 1.259 . . . . 0.0 110.53 -179.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 45.79 -120.47 4.43 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.394 1.949 . . . . 0.0 113.868 178.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.1 t -139.68 -92.01 0.17 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.04 0.936 . . . . 0.0 110.874 -179.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 m -161.93 -41.71 0.04 OUTLIER 'General case' 0 C--N 1.344 0.337 0 C-N-CA 124.174 0.99 . . . . 0.0 111.102 -178.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 64.2 p -79.78 37.33 0.35 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.511 1.124 . . . . 0.0 112.932 -178.703 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 163.4 117.62 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 131.237 3.815 . . . . 0.0 104.453 179.114 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.97 126.23 11.99 Favored 'Cis proline' 0 N--CA 1.447 -1.236 0 N-CA-C 110.273 -0.703 . . . . 0.0 110.273 0.046 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.91 147.29 27.02 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 125.342 1.457 . . . . 0.0 110.28 179.425 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.19 139.42 58.66 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.969 1.308 . . . . 0.0 112.082 179.256 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -140.2 158.48 43.98 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 123.362 0.414 . . . . 0.0 111.028 178.083 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -154.01 -179.71 8.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.724 1.21 . . . . 0.0 109.617 -178.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.2 m120 73.52 165.96 0.29 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 126.79 2.036 . . . . 0.0 112.476 178.832 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 61.71 72.23 0.52 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.51 1.524 . . . . 0.0 110.775 179.337 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -74.36 162.25 29.05 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.073 0.949 . . . . 0.0 110.897 -179.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -178.35 -65.58 0.07 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 179.414 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -104.6 164.53 11.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.165 1.786 . . . . 0.0 108.74 179.009 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -131.56 124.22 29.57 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.834 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.417 ' HB3' ' HB1' ' A' ' 86' ' ' ALA . 58.0 m-85 -89.95 154.49 47.54 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.711 1.204 . . . . 0.0 110.195 -178.799 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -45.8 -60.16 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 124.41 3.406 . . . . 0.0 114.125 179.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.1 m -76.81 152.92 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.663 0.785 . . . . 0.0 109.884 179.283 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -81.6 -80.1 0.16 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.756 0.822 . . . . 0.0 110.399 -179.179 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -175.12 171.26 44.43 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 118.853 -0.971 . . . . 0.0 111.147 179.545 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.11 157.95 27.13 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 119.799 1.8 . . . . 0.0 112.847 -1.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.637 ' CZ ' HG12 ' A' ' 78' ' ' VAL . 32.4 t80 -150.41 129.38 12.57 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.208 0.603 . . . . 0.0 109.698 -177.082 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -117.68 152.82 34.45 Favored 'General case' 0 C--N 1.347 0.485 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -176.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -90.53 144.87 25.36 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.763 2.825 . . . . 0.0 111.041 -177.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -147.75 109.69 3.82 Favored Pre-proline 0 C--N 1.346 0.447 0 C-N-CA 123.409 0.683 . . . . 0.0 109.157 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -78.14 142.82 19.63 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 122.189 1.926 . . . . 0.0 115.996 -175.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.512 HG12 ' H ' ' A' ' 62' ' ' LYS . 1.2 tt -122.04 -165.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-O 124.177 1.942 . . . . 0.0 111.943 179.206 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.512 ' H ' HG12 ' A' ' 61' ' ' ILE . 79.6 tttt -161.55 -179.73 7.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 109.233 -3.622 . . . . 0.0 109.191 -179.319 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.5 t -87.33 62.03 6.98 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.19 67.66 0.91 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.126 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.39 101.63 0.16 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.97 133.68 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.993 0.917 . . . . 0.0 109.174 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 p90 43.8 46.09 6.39 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.152 1.781 . . . . 0.0 113.402 -178.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.8 t -150.01 163.74 37.33 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.725 0.81 . . . . 0.0 110.451 -179.499 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.87 155.63 32.14 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -178.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -179.7 86.27 0.07 OUTLIER Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -179.322 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 m -148.39 -68.95 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.458 1.103 . . . . 0.0 109.178 179.304 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.06 -45.86 0.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.082 1.854 . . . . 0.0 110.925 173.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 61.47 58.5 12.97 Favored Glycine 0 C--N 1.342 0.892 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.432 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -129.77 -58.57 1.09 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.317 1.047 . . . . 0.0 112.058 -178.381 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -56.91 109.44 0.64 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.184 2.594 . . . . 0.0 117.154 -178.031 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -147.95 122.13 9.55 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -179.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.0 m -81.13 160.67 3.92 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.662 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.637 HG12 ' CZ ' ' A' ' 56' ' ' TYR . 45.4 t -141.04 126.87 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 120.789 -1.195 . . . . 0.0 108.688 -178.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.2 pt -117.28 173.93 4.06 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 C-N-CA 125.176 1.39 . . . . 0.0 113.233 -177.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -79.54 -164.94 0.71 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 124.464 1.106 . . . . 0.0 111.182 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.427 0.6 OUTLIER -96.62 37.89 1.25 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 117.193 2.294 . . . . 0.0 117.193 -178.145 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -160.52 -78.4 0.05 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 16.2 t -163.32 63.92 0.18 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 113.619 -1.628 . . . . 0.0 114.125 -177.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -147.07 120.17 8.83 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.394 1.452 . . . . 0.0 113.744 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -65.84 122.45 17.35 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 177.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 50' ' ' PHE . . . -103.77 -39.37 6.68 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.69 -172.89 39.47 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.019 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -144.33 139.0 28.26 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.936 0.894 . . . . 0.0 109.912 179.252 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.0 pt -132.45 166.57 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.728 1.211 . . . . 0.0 110.439 -178.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.3 t -160.46 150.06 17.57 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.974 0.91 . . . . 0.0 111.664 179.357 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.432 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 34.0 m170 -79.35 55.26 1.86 Allowed 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 118.453 0.57 . . . . 0.0 109.73 175.113 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.9 m -80.34 -85.39 0.09 Allowed 'General case' 0 C--N 1.342 0.259 0 O-C-N 120.766 -1.209 . . . . 0.0 109.318 179.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.412 ' H ' HG21 ' A' ' 100' ' ' VAL . . . -80.31 7.03 58.55 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.688 1.137 . . . . 0.0 112.006 179.011 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.92 162.87 23.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.17 1.388 . . . . 0.0 111.203 179.234 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.6 t -66.99 -48.8 67.35 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.567 0.747 . . . . 0.0 109.833 179.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.29 -51.08 0.2 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -179.298 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -87.52 -46.03 9.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.23 1.012 . . . . 0.0 110.597 -179.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -70.79 -171.23 0.5 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.626 0.77 . . . . 0.0 112.379 -179.109 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -137.07 172.05 13.59 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.014 1.325 . . . . 0.0 113.553 -177.724 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.412 HG21 ' H ' ' A' ' 93' ' ' GLY . 12.8 m -140.02 161.44 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 127.659 2.384 . . . . 0.0 106.019 176.725 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.4 164.91 38.56 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 116.515 1.366 . . . . 0.0 116.515 -177.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.8 m -113.56 -175.08 2.59 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.76 2.024 . . . . 0.0 107.442 177.78 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 94.9 p -69.56 110.99 5.08 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.713 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.67 36.1 2.12 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.648 1.594 . . . . 0.0 110.078 -178.73 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.0 m -153.54 100.02 2.38 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.129 1.771 . . . . 0.0 107.129 179.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 116.782 -1.58 . . . . 0.0 108.257 -179.298 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 t -148.92 174.67 12.01 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.866 1.266 . . . . 0.0 109.654 -179.775 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.18 149.56 6.9 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.718 1.207 . . . . 0.0 113.181 -178.661 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 t -148.92 156.41 42.25 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.812 0.845 . . . . 0.0 109.31 179.287 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.99 110.95 9.42 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.254 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 93.0 m -90.62 72.97 6.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.46 -93.06 0.89 Allowed Glycine 0 C--N 1.34 0.792 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.0 p -98.99 -36.38 9.75 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.884 1.274 . . . . 0.0 110.612 179.102 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -71.24 97.59 1.58 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.668 0.787 . . . . 0.0 110.116 -178.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -82.31 151.6 26.67 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.553 1.141 . . . . 0.0 110.617 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -144.53 129.89 18.81 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.899 0.88 . . . . 0.0 111.015 179.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.2 p -69.67 155.97 39.69 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 125.11 1.364 . . . . 0.0 108.047 177.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.63 -22.61 62.1 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 176.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.5 t -69.2 -40.85 77.79 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -68.83 -48.45 63.49 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.095 0.958 . . . . 0.0 112.915 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.2 t -61.25 -46.99 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -64.42 -39.16 93.3 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.775 0.83 . . . . 0.0 110.719 179.169 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.42 -52.03 56.18 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.63 0.65 . . . . 0.0 110.423 -179.052 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.573 ' HA ' HG13 ' A' ' 66' ' ' VAL . . . -61.14 -34.14 74.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.26 0.624 . . . . 0.0 111.554 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.81 -43.82 24.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -179.368 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -69.98 -14.81 62.88 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.72 -61.08 1.87 Allowed 'General case' 0 C--N 1.346 0.42 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -48.3 -36.35 14.01 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.687 1.195 . . . . 0.0 110.752 177.232 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -66.01 -63.47 1.08 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.958 1.303 . . . . 0.0 109.908 178.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -56.03 -28.88 59.25 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.537 0.735 . . . . 0.0 111.848 -178.789 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 20.1 m-30 -79.61 -40.89 28.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.061 0.945 . . . . 0.0 111.486 179.148 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.462 ' CD2' ' HG3' ' A' ' 57' ' ' GLN . 23.9 t80 -101.25 23.88 10.3 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.799 0.84 . . . . 0.0 112.425 -178.298 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -86.0 14.6 5.95 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.942 -1.099 . . . . 0.0 112.076 179.176 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.3 m120 60.07 46.17 11.06 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.282 1.433 . . . . 0.0 111.527 178.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -154.72 73.03 0.88 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 179.09 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 80.62 110.67 0.07 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 127.617 2.367 . . . . 0.0 107.272 -178.128 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.6 t -87.66 -42.34 12.74 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.306 1.442 . . . . 0.0 113.332 -177.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 61.56 -171.46 0.15 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.628 1.171 . . . . 0.0 110.811 -178.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.35 167.07 39.3 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 121.96 -0.463 . . . . 0.0 112.326 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.9 t -148.99 -60.32 0.22 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.399 1.48 . . . . 0.0 107.685 179.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.4 p -124.55 -79.87 0.62 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.481 1.113 . . . . 0.0 108.125 178.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.488 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -160.39 41.65 0.18 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.233 1.013 . . . . 0.0 109.74 -179.0 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.488 ' CD1' ' C ' ' A' ' 37' ' ' THR . 43.0 m-85 -151.0 147.58 21.0 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 126.053 1.741 . . . . 0.0 107.993 -178.822 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.88 125.39 11.79 Favored 'Cis proline' 0 CA--C 1.539 0.75 0 CA-C-N 119.083 0.708 . . . . 0.0 111.726 0.219 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -119.14 165.61 13.96 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 125.994 1.717 . . . . 0.0 111.066 -179.269 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.8 p -67.8 145.83 54.29 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.443 0.697 . . . . 0.0 110.935 178.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -87.03 50.67 2.06 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.309 178.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -58.71 120.58 9.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.935 1.694 . . . . 0.0 108.052 179.751 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.7 m120 78.43 129.06 0.05 OUTLIER 'General case' 0 C--N 1.341 0.216 0 C-N-CA 126.42 1.888 . . . . 0.0 107.516 -178.223 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -82.41 20.43 1.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.346 -0.835 . . . . 0.0 112.691 -179.036 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 33.04 -99.13 0.02 OUTLIER 'General case' 0 C--N 1.347 0.485 0 C-N-CA 127.156 2.183 . . . . 0.0 112.025 179.437 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.45 23.16 2.84 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.572 1.082 . . . . 0.0 110.49 178.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.66 149.55 25.37 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 118.188 0.994 . . . . 0.0 111.271 -179.301 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -153.03 179.9 8.28 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.628 0.771 . . . . 0.0 111.701 -178.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -139.94 165.19 32.62 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 127.425 2.29 . . . . 0.0 106.552 -179.262 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.3 -51.86 10.14 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.435 2.756 . . . . 0.0 111.843 178.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 52' ' ' VAL . 3.7 m -82.24 151.17 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.803 1.241 . . . . 0.0 109.338 178.842 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -172.36 127.22 0.54 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.742 0.817 . . . . 0.0 112.613 -178.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.99 114.84 0.02 OUTLIER Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.008 1.766 . . . . 0.0 115.798 177.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -62.8 149.72 64.31 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.084 1.942 . . . . 0.0 109.85 -2.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.13 150.18 28.82 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.538 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.542 ' O ' HG13 ' A' ' 78' ' ' VAL . 63.0 mm-40 -133.4 157.82 44.57 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -178.115 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -112.01 151.04 29.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.715 2.406 . . . . 0.0 109.741 179.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -160.54 112.14 1.35 Allowed Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 177.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.434 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 24.3 Cg_endo -81.06 135.72 9.95 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 121.063 1.175 . . . . 0.0 111.08 -176.924 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.549 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 4.2 tt -109.32 178.13 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-O 124.22 1.962 . . . . 0.0 113.119 -179.419 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.549 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 19.9 ptmt -161.59 151.9 17.38 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 108.486 -3.961 . . . . 0.0 111.255 178.411 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.6 p -86.22 59.05 5.4 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.501 1.12 . . . . 0.0 108.656 179.462 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.92 71.82 0.06 OUTLIER Glycine 0 C--N 1.338 0.644 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.123 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.48 -178.83 47.64 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 123.942 0.782 . . . . 0.0 112.184 178.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.573 HG13 ' HA ' ' A' ' 19' ' ' ALA . 67.5 t -86.71 62.48 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.622 1.169 . . . . 0.0 109.924 -179.024 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 62.35 158.97 0.06 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.053 1.341 . . . . 0.0 114.287 178.646 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.9 p -138.53 -62.09 0.57 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.378 1.471 . . . . 0.0 108.435 178.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.38 -137.6 3.53 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.121 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.38 168.72 44.57 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.056 0.836 . . . . 0.0 113.145 178.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 m -74.11 174.5 4.89 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 125.815 1.646 . . . . 0.0 110.177 179.385 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -58.31 170.43 2.35 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.541 2.828 . . . . 0.0 112.804 178.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 74' ' ' ALA . . . -152.62 -69.54 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 103.953 -3.659 . . . . 0.0 103.953 -179.331 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . 170.75 -50.03 0.01 OUTLIER 'General case' 0 C--N 1.346 0.434 0 O-C-N 124.981 1.048 . . . . 0.0 113.296 -179.294 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -74.44 113.63 11.9 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 119.842 3.275 . . . . 0.0 119.842 -176.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.5 ptt180 -143.02 133.05 24.26 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.009 0.924 . . . . 0.0 110.552 177.772 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -90.48 147.04 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 178.308 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 57' ' ' GLN 0.254 78.0 t -133.61 123.83 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -176.791 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pt -105.75 -175.48 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.586 0 C-N-CA 126.455 1.902 . . . . 0.0 114.973 -177.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -112.82 145.21 41.02 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 128.903 2.881 . . . . 0.0 105.084 177.39 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.277 1.4 t -59.67 -16.84 29.34 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 120.783 3.623 . . . . 0.0 120.783 -177.072 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -79.61 -77.5 0.18 Allowed 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 103.625 -2.732 . . . . 0.0 103.625 178.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.53 -3.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.678 1.591 . . . . 0.0 114.598 -178.883 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.11 156.36 28.33 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 119.049 0.84 . . . . 0.0 111.151 -176.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -109.26 133.57 52.87 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.124 0.97 . . . . 0.0 110.709 -179.213 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.48 -64.84 1.08 Allowed 'General case' 0 C--N 1.342 0.268 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.042 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.25 168.4 37.0 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 120.001 -1.095 . . . . 0.0 113.183 -179.436 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.54 127.4 46.92 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.377 1.471 . . . . 0.0 109.638 -179.305 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 35.0 pt -120.52 154.61 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.656 1.182 . . . . 0.0 108.024 179.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.1 t -158.73 135.53 9.6 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -178.373 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.401 ' N ' ' HB1' ' A' ' 74' ' ' ALA . 4.0 p80 -105.9 52.88 0.72 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.018 0.372 . . . . 0.0 110.685 174.851 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.7 t -60.12 -48.01 83.51 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -178.134 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.01 42.65 0.2 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.91 -40.23 11.27 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.533 1.133 . . . . 0.0 109.673 179.094 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.9 t -152.64 -51.8 0.11 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.193 1.397 . . . . 0.0 109.834 -179.512 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.82 -37.48 1.02 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -178.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -126.0 -40.9 1.98 Allowed 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.753 1.621 . . . . 0.0 110.031 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -64.45 124.01 20.7 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.053 0.541 . . . . 0.0 109.553 179.457 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -79.48 162.43 25.45 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.026 1.73 . . . . 0.0 112.06 -178.594 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.2 m -137.41 164.2 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 127.922 2.489 . . . . 0.0 105.979 176.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.74 137.88 15.19 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 123.134 0.397 . . . . 0.0 112.948 -177.751 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.4 m -81.58 -171.18 3.17 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.33 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.0 p -72.21 123.02 22.06 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.692 -0.63 . . . . 0.0 111.271 -177.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.77 38.15 28.22 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -178.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -148.75 127.78 12.76 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.054 1.342 . . . . 0.0 108.395 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.3 t30 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 116.524 -1.703 . . . . 0.0 109.041 179.336 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.519 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.5 m -136.98 172.94 12.26 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.322 1.849 . . . . 0.0 109.202 -179.46 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.15 160.03 31.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.509 0.724 . . . . 0.0 110.645 -179.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 t -152.21 139.51 19.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.08 103.96 11.08 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 179.204 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.5 m -90.3 82.14 6.0 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.453 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.25 -111.0 3.47 Favored Glycine 0 C--N 1.34 0.769 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.165 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.4 t -88.31 -43.24 11.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.129 0.972 . . . . 0.0 109.64 178.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 m -69.98 106.29 3.15 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.463 1.105 . . . . 0.0 109.741 -179.294 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -86.38 157.99 19.73 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.089 0.956 . . . . 0.0 111.979 -179.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -144.3 136.8 26.71 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.624 1.17 . . . . 0.0 110.582 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.5 t -79.91 154.27 28.43 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 125.215 1.406 . . . . 0.0 109.78 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.25 -18.93 64.09 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 176.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.6 m -78.78 -38.84 37.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.014 0.925 . . . . 0.0 108.731 178.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -71.48 -48.57 48.3 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.613 1.565 . . . . 0.0 110.811 -179.201 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.4 t -58.96 -46.71 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.948 1.699 . . . . 0.0 107.571 177.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -64.89 -39.49 93.61 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 124.204 1.002 . . . . 0.0 111.412 -179.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.26 -52.42 62.13 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.061 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.29 74.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.73 1.212 . . . . 0.0 110.921 179.564 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.22 -51.82 16.32 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.226 -179.205 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -60.68 -18.08 51.71 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.87 -64.71 1.12 Allowed 'General case' 0 C--N 1.347 0.5 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -178.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.478 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -43.93 -48.91 8.59 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.638 1.575 . . . . 0.0 110.495 177.494 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -55.51 -49.77 71.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 128.251 2.62 . . . . 0.0 111.268 178.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -68.11 -22.11 64.91 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.238 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -108.52 -19.47 13.43 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -179.117 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -71.87 -40.37 69.0 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -177.539 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -115.7 -28.18 6.83 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -178.04 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -67.57 -59.04 3.67 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.73 0.695 . . . . 0.0 110.228 -178.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 168.87 115.5 0.01 OUTLIER 'General case' 0 C--N 1.341 0.208 0 C-N-CA 128.192 2.597 . . . . 0.0 106.238 -178.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -54.85 127.25 27.7 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.341 1.057 . . . . 0.0 110.191 178.634 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.0 t -134.2 -51.4 0.82 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.684 0.794 . . . . 0.0 112.657 -178.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.56 172.82 8.91 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.917 0.487 . . . . 0.0 110.659 -179.426 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.87 82.27 0.52 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 107.908 -2.077 . . . . 0.0 107.908 179.056 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.4 p -168.14 101.35 0.45 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -176.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.5 p -128.63 -50.88 1.26 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.903 0.881 . . . . 0.0 109.678 -178.454 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 p -79.5 -6.34 56.75 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.572 0.749 . . . . 0.0 109.183 178.337 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -157.5 121.84 2.27 Favored Pre-proline 0 C--N 1.343 0.319 0 C-N-CA 128.147 2.579 . . . . 0.0 104.375 177.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.22 147.66 49.28 Favored 'Cis proline' 0 N--CA 1.453 -0.886 0 N-CA-C 117.468 2.065 . . . . 0.0 117.468 -0.091 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -137.98 136.7 37.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 128.162 2.585 . . . . 0.0 105.386 178.691 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.7 m -56.63 127.87 33.55 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.753 1.221 . . . . 0.0 110.067 179.078 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -79.85 78.24 6.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.561 1.144 . . . . 0.0 110.242 -178.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -80.66 -17.69 50.39 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.19 0.996 . . . . 0.0 112.535 179.46 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -79.33 149.89 31.61 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.683 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -168.43 89.68 0.25 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.681 1.992 . . . . 0.0 107.468 178.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -150.37 55.26 0.92 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.168 0.987 . . . . 0.0 108.689 179.818 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.07 -64.88 0.58 Allowed Glycine 0 C--N 1.338 0.651 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -179.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -99.92 132.92 44.98 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.401 1.08 . . . . 0.0 110.767 179.312 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -178.7 154.3 0.74 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 126.438 1.895 . . . . 0.0 109.428 178.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -123.26 105.37 34.05 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.503 1.121 . . . . 0.0 109.738 -178.087 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.23 84.83 1.93 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.519 2.812 . . . . 0.0 110.49 179.169 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.49 -72.64 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.226 0 C-N-CA 124.476 1.11 . . . . 0.0 110.908 179.191 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -133.71 -90.01 0.38 Allowed 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.516 0.598 . . . . 0.0 111.562 -179.114 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.81 131.97 4.28 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 -178.515 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -71.98 -177.89 18.8 Favored 'Cis proline' 0 N--CA 1.456 -0.7 0 CA-C-N 119.686 1.743 . . . . 0.0 111.699 1.238 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.05 173.25 11.66 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.182 1.793 . . . . 0.0 106.231 179.184 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.4 146.32 22.43 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -178.666 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -81.25 156.14 25.75 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 126.575 1.95 . . . . 0.0 112.397 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.478 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 14.5 t80 -160.87 102.1 1.29 Allowed Pre-proline 0 N--CA 1.452 -0.333 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.441 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -77.82 115.2 3.78 Favored 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 122.674 2.25 . . . . 0.0 111.802 -177.572 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.44 HG13 ' H ' ' A' ' 62' ' ' LYS . 6.4 tt -89.64 173.76 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-O 123.767 1.746 . . . . 0.0 111.747 -179.095 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.44 ' H ' HG13 ' A' ' 61' ' ' ILE . 63.2 pttt -160.45 151.86 19.44 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 109.849 -3.341 . . . . 0.0 112.213 179.114 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 t -88.68 58.95 4.88 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.932 1.293 . . . . 0.0 110.126 -179.348 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 169.05 34.37 0.02 OUTLIER Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.177 -0.791 . . . . 0.0 112.858 179.182 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.97 176.63 17.2 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 118.014 0.907 . . . . 0.0 112.807 179.111 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.6 t -95.35 144.9 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 126.345 1.858 . . . . 0.0 107.932 179.333 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.6 p90 56.92 -172.95 0.08 Allowed 'General case' 0 C--N 1.345 0.401 0 C-N-CA 126.76 2.024 . . . . 0.0 113.118 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.8 t -137.34 166.79 22.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.707 1.203 . . . . 0.0 110.696 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.89 133.71 8.93 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.048 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.2 -64.52 4.18 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.36 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 88.5 p -164.6 168.26 9.19 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.618 1.167 . . . . 0.0 109.489 -179.18 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -58.57 -170.52 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.131 3.221 . . . . 0.0 112.521 167.251 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.0 -55.37 0.07 OUTLIER Glycine 0 C--N 1.341 0.856 0 N-CA-C 105.276 -3.129 . . . . 0.0 105.276 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.447 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -165.03 -63.52 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.637 0.775 . . . . 0.0 110.472 179.348 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -70.72 126.01 28.42 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.038 1.735 . . . . 0.0 113.961 -178.593 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -145.28 126.35 14.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.18 0.992 . . . . 0.0 111.747 -179.714 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.9 m -91.69 147.69 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 176.672 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.3 t -136.08 115.9 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -177.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.5 pt -89.92 -178.89 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.652 0 C-N-CA 124.506 1.123 . . . . 0.0 112.892 -178.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -124.49 58.34 1.22 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 124.678 2.18 . . . . 0.0 112.549 -177.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.258 5.9 t 46.58 -21.31 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.245 1 C-N-CA 134.571 5.148 . . . . 0.0 121.707 177.499 . . . . . . . . 3 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -79.47 -74.16 0.31 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 178.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.47 -13.74 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.627 1.971 . . . . 0.0 114.078 -179.207 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -79.47 125.53 29.67 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.777 1.231 . . . . 0.0 113.795 -176.385 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -68.46 115.9 8.39 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.643 2.377 . . . . 0.0 109.453 178.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.26 -60.68 2.23 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 124.741 1.216 . . . . 0.0 111.239 -178.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.57 156.77 28.93 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.375 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.99 137.27 52.26 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.1 0.96 . . . . 0.0 109.273 -179.252 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.3 pt -125.43 156.77 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.3 1.44 . . . . 0.0 107.824 -179.455 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.8 t -158.85 150.05 20.41 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 33.2 m170 -79.03 -21.57 46.69 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 123.423 0.452 . . . . 0.0 111.251 176.093 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.3 m -59.65 109.03 0.82 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.032 1.333 . . . . 0.0 109.91 179.287 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.78 -29.49 8.9 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.762 1.172 . . . . 0.0 111.329 -179.236 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.4 -176.45 2.69 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.667 1.187 . . . . 0.0 111.95 -179.294 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -83.65 54.98 3.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.686 1.194 . . . . 0.0 111.614 -179.416 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.69 -74.47 1.55 Allowed Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.606 1.098 . . . . 0.0 113.055 178.634 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -80.05 -44.77 19.51 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.863 1.265 . . . . 0.0 111.03 -179.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -51.52 166.58 0.12 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.835 1.654 . . . . 0.0 113.459 -178.652 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -121.3 156.65 32.08 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.339 1.456 . . . . 0.0 112.308 -178.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.5 m -144.56 164.67 13.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 126.844 2.058 . . . . 0.0 107.139 177.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.75 138.76 14.54 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 123.679 0.657 . . . . 0.0 112.082 -178.261 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 34.0 m -82.24 -171.39 3.4 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.498 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.1 t -75.83 123.08 25.06 Favored 'General case' 0 C--N 1.341 0.197 0 O-C-N 121.833 -0.542 . . . . 0.0 109.611 -179.026 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.62 52.15 3.25 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -178.755 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.8 m -147.41 121.39 9.4 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.614 1.566 . . . . 0.0 106.833 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.7 t30 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 125.307 1.443 . . . . 0.0 110.685 -179.247 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 121.066 0.46 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -153.85 176.05 12.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.049 1.34 . . . . 0.0 109.057 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.81 148.17 25.99 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.228 1.011 . . . . 0.0 109.857 179.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.8 t -150.18 156.27 41.29 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.66 128.5 42.72 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.249 1.82 . . . . 0.0 106.186 178.754 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -116.72 90.08 3.25 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.46 -86.4 1.03 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -178.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.1 m -127.77 -16.05 4.79 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.642 1.577 . . . . 0.0 111.364 178.759 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -81.55 98.55 8.36 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.182 0.993 . . . . 0.0 109.627 -179.164 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -80.08 155.8 27.37 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.112 0.965 . . . . 0.0 110.685 179.449 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -147.06 141.45 26.37 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.924 1.29 . . . . 0.0 110.782 179.294 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 p -78.21 148.38 34.02 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 177.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.61 -23.37 16.75 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.182 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.0 t -67.63 -44.52 77.77 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.54 0.736 . . . . 0.0 109.603 179.451 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -69.6 -41.03 76.27 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -178.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.431 HG23 ' H ' ' A' ' 16' ' ' VAL . 2.2 t -61.75 -54.59 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -179.449 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.8 mtp85 -66.78 -34.92 78.88 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.795 1.238 . . . . 0.0 112.225 -178.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.79 -44.34 86.03 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 118.768 0.713 . . . . 0.0 109.737 179.366 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.19 80.48 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.08 0.552 . . . . 0.0 110.155 178.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.26 -40.46 62.33 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 119.109 -0.472 . . . . 0.0 112.252 178.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -66.01 -21.05 66.37 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.62 -62.39 1.68 Allowed 'General case' 0 C--N 1.344 0.363 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -46.4 -44.22 16.97 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 124.376 1.047 . . . . 0.0 110.83 176.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.7 t -55.02 -51.17 67.1 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 126.045 1.738 . . . . 0.0 111.361 179.243 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -63.99 -48.41 76.49 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.629 0.65 . . . . 0.0 112.012 -178.848 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -68.84 -32.58 72.37 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -63.75 -39.05 93.33 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.443 0.565 . . . . 0.0 111.626 -178.061 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -99.82 -49.18 4.44 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -178.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -75.46 -45.58 37.69 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -176.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -158.36 94.05 1.26 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.593 0.633 . . . . 0.0 110.609 -178.014 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.37 104.95 2.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.43 179.352 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.257 5.0 t 165.0 83.26 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.691 2.796 . . . . 0.0 110.812 -179.218 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -177.69 103.6 0.05 OUTLIER 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.493 1.517 . . . . 0.0 107.423 179.12 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 153.19 -179.24 29.75 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.1 m -50.41 -52.04 41.15 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.954 1.301 . . . . 0.0 112.117 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.3 t -165.22 -61.56 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.856 0.862 . . . . 0.0 108.742 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -126.94 75.97 1.61 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.024 1.33 . . . . 0.0 108.309 -179.514 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 86.3 m-85 -157.68 111.15 1.81 Allowed Pre-proline 0 C--O 1.23 0.053 0 N-CA-C 102.524 -3.139 . . . . 0.0 102.524 179.073 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.98 142.18 63.64 Favored 'Cis proline' 0 CA--C 1.536 0.611 0 N-CA-C 116.37 1.642 . . . . 0.0 116.37 2.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -157.77 152.92 25.73 Favored 'General case' 0 C--N 1.345 0.37 0 C-N-CA 127.238 2.215 . . . . 0.0 109.895 178.238 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.2 p -41.73 138.89 1.32 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 126.307 1.843 . . . . 0.0 114.233 -178.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -138.97 59.04 1.63 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.332 1.453 . . . . 0.0 108.399 179.308 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -154.62 2.02 0.21 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.919 0.888 . . . . 0.0 112.882 -179.158 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -63.99 -52.43 59.67 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.543 0.737 . . . . 0.0 110.188 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -109.83 127.55 54.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.041 1.337 . . . . 0.0 108.317 178.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -85.89 164.34 17.53 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.834 0.854 . . . . 0.0 109.704 179.408 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.38 -77.88 0.36 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 107.052 -2.419 . . . . 0.0 107.052 -179.231 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.99 89.46 8.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.751 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -147.39 143.08 27.7 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.482 1.513 . . . . 0.0 108.26 179.501 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -95.44 154.16 39.4 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 125.073 1.349 . . . . 0.0 109.989 -178.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.83 81.81 2.09 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 124.37 3.38 . . . . 0.0 111.425 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.4 169.7 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 125.927 1.691 . . . . 0.0 108.559 179.459 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -92.34 121.17 33.57 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.42 -177.45 51.91 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.651 0.643 . . . . 0.0 112.961 -179.041 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.99 161.35 87.03 Favored 'Cis proline' 0 CA--C 1.534 0.502 0 CA-C-N 117.536 0.668 . . . . 0.0 113.789 0.139 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.47 153.86 50.93 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 126.332 1.853 . . . . 0.0 106.746 178.788 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.74 153.35 47.16 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 123.703 0.627 . . . . 0.0 111.536 -178.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -84.48 163.81 19.2 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -160.4 110.1 1.36 Allowed Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 178.396 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 23.0 Cg_endo -80.35 125.95 5.96 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.906 1.737 . . . . 0.0 114.989 -175.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.425 HG13 ' H ' ' A' ' 62' ' ' LYS . 9.3 tt -87.79 159.1 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-O 124.45 2.071 . . . . 0.0 112.668 179.014 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.425 ' H ' HG13 ' A' ' 61' ' ' ILE . 3.1 mptp? -135.62 135.88 40.56 Favored 'General case' 0 C--N 1.316 -0.868 1 CA-C-N 107.974 -4.194 . . . . 0.0 109.486 -177.991 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.0 t -87.52 59.82 5.68 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.094 1.358 . . . . 0.0 109.993 -179.179 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.36 50.41 0.03 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.251 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.0 153.32 26.32 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.621 1.105 . . . . 0.0 110.378 -179.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.5 p -74.3 115.47 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.276 1.03 . . . . 0.0 110.868 -179.104 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.0 t80 53.15 76.95 0.18 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 125.535 1.534 . . . . 0.0 110.677 -179.26 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.0 p -138.73 64.02 1.5 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.468 1.107 . . . . 0.0 110.515 -178.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.11 -86.91 0.89 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.96 0.79 . . . . 0.0 111.97 178.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.83 -93.58 0.4 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.458 1.028 . . . . 0.0 110.613 -179.072 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.8 t 74.48 133.1 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 127.066 2.146 . . . . 0.0 111.593 179.343 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -67.72 -51.71 0.16 OUTLIER 'Cis proline' 0 C--N 1.348 0.532 0 CA-C-N 119.731 0.94 . . . . 0.0 112.042 -5.198 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.96 61.27 0.19 Allowed Glycine 0 C--N 1.341 0.856 0 C-N-CA 124.517 1.056 . . . . 0.0 111.594 179.379 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -79.06 -41.86 27.79 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.559 0.743 . . . . 0.0 109.05 178.441 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -70.3 111.49 5.93 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.085 1.754 . . . . 0.0 112.426 -178.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.05 128.88 46.99 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.959 0.903 . . . . 0.0 113.048 -178.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.0 m -100.34 148.36 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 102.595 -3.113 . . . . 0.0 102.595 176.04 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.5 t -140.13 135.96 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 O-C-N 121.873 -0.517 . . . . 0.0 109.651 -176.83 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.5 pt -126.46 165.55 24.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.308 0 C-N-CA 124.107 0.963 . . . . 0.0 111.865 -178.683 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -81.35 165.97 20.88 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 127.268 2.227 . . . . 0.0 108.186 178.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.356 12.2 t -64.77 -19.71 65.96 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 118.634 2.827 . . . . 0.0 118.634 -178.128 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -79.59 -85.54 0.08 Allowed 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 101.067 -3.679 . . . . 0.0 101.067 176.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 98.3 m -164.57 8.14 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 130.438 3.495 . . . . 0.0 112.832 -178.703 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -78.86 134.65 36.92 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 120.171 1.351 . . . . 0.0 111.798 -176.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.422 ' CE2' HG12 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -70.84 120.18 16.05 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.873 0.469 . . . . 0.0 110.09 -178.952 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.64 -48.95 7.86 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.178 0.991 . . . . 0.0 110.175 -179.082 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.12 -179.48 46.36 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-O 121.16 0.311 . . . . 0.0 112.686 179.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.0 135.24 45.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.842 2.057 . . . . 0.0 107.771 179.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.4 pt -146.61 171.67 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.785 1.234 . . . . 0.0 110.553 -178.392 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.5 t -160.06 151.77 20.03 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 179.349 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.445 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 9.0 m170 -79.28 -13.12 59.86 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 175.188 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.4 m -60.92 109.17 0.99 Allowed 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.003 1.321 . . . . 0.0 110.295 -179.333 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.5 59.46 5.27 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.407 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.52 -124.65 0.22 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.709 1.204 . . . . 0.0 108.558 179.467 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.5 m -149.16 73.17 1.19 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.793 1.237 . . . . 0.0 107.95 179.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.72 -104.86 1.61 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 179.587 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -79.8 -22.72 42.75 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.114 0.966 . . . . 0.0 111.18 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -56.16 159.07 3.62 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.577 1.151 . . . . 0.0 111.35 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -114.74 163.51 15.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.96 1.704 . . . . 0.0 111.854 -178.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.4 m -141.07 160.85 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 C-N-CA 126.228 1.811 . . . . 0.0 107.092 176.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.02 141.2 20.65 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 123.838 0.732 . . . . 0.0 114.158 -178.092 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -83.35 179.73 7.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 177.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.9 m -70.31 131.04 43.54 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.205 -0.935 . . . . 0.0 110.598 179.566 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.17 15.72 80.98 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.032 0.825 . . . . 0.0 113.712 179.322 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.3 m -80.01 131.71 35.85 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.323 1.061 . . . . 0.0 108.695 179.306 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 p30 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.816 -1.088 . . . . 0.0 110.558 -179.309 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.9 m -135.37 62.87 1.62 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.32 1.048 . . . . 0.0 109.446 -179.346 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.31 154.35 0.13 Allowed 'General case' 0 C--N 1.34 0.186 0 C-N-CA 126.831 2.052 . . . . 0.0 112.52 179.015 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.4 t -152.81 123.43 7.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.573 179.066 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -96.79 109.74 22.36 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 178.901 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.8 m -87.7 63.21 7.41 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.468 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.55 -91.54 0.4 Allowed Glycine 0 C--N 1.342 0.886 0 C-N-CA 126.03 1.776 . . . . 0.0 109.08 -178.761 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.3 p -92.82 -47.98 6.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.396 1.079 . . . . 0.0 109.817 179.13 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.2 m -66.83 100.01 0.67 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.488 1.515 . . . . 0.0 108.168 179.388 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -88.4 148.2 24.35 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.12 0.568 . . . . 0.0 111.978 -178.783 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -136.44 135.74 38.93 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 123.996 0.918 . . . . 0.0 111.249 178.606 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.7 m -82.46 150.34 27.1 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 126.571 1.948 . . . . 0.0 108.647 178.62 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.61 -21.86 29.95 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.137 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 84.2 p -72.96 -46.71 50.82 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.565 0.746 . . . . 0.0 109.529 179.455 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -69.08 -38.72 79.17 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.761 1.224 . . . . 0.0 111.418 -179.307 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.3 t -57.98 -53.19 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.836 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -33.37 75.72 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.67 1.588 . . . . 0.0 112.032 -179.336 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.11 -57.63 8.11 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.018 0.527 . . . . 0.0 109.725 -178.678 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.84 -26.75 67.8 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 123.538 0.523 . . . . 0.0 110.953 -179.295 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.01 -54.03 12.67 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.867 0.758 . . . . 0.0 111.035 179.248 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -61.2 -19.91 62.16 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.191 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.73 -67.95 0.62 Allowed 'General case' 0 C--N 1.349 0.574 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 -178.085 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.48 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -39.54 -46.07 1.68 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.625 1.17 . . . . 0.0 112.19 176.532 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 74.4 m -55.28 -68.49 0.19 Allowed 'General case' 0 C--N 1.346 0.417 0 C-N-CA 123.379 0.672 . . . . 0.0 110.342 179.366 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -53.81 -31.09 47.79 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.833 1.253 . . . . 0.0 112.928 -176.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -79.49 -48.0 14.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -179.066 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . 0.37 0.1 OUTLIER -91.85 -2.58 56.79 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 119.381 3.104 . . . . 0.0 119.381 -176.539 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -57.04 -52.48 65.12 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.011 1.278 . . . . 0.0 109.382 178.975 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 152.03 66.14 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 130.438 3.495 . . . . 0.0 105.561 179.553 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -165.32 98.38 0.71 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.551 1.14 . . . . 0.0 107.984 -178.915 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.266 4.4 p30 52.27 -165.92 0.06 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.236 1.815 . . . . 0.0 111.982 -179.203 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.1 t -152.57 -49.12 0.1 Allowed 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.646 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 55.82 84.07 0.08 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 125.063 1.345 . . . . 0.0 109.396 -178.238 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.23 162.48 6.03 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.24 1.4 . . . . 0.0 111.849 -178.856 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.1 p -176.98 102.84 0.05 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.979 1.311 . . . . 0.0 108.915 -179.231 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.8 m -68.64 -67.46 0.47 Allowed 'General case' 0 C--N 1.34 0.167 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.895 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.6 p -147.45 18.91 1.19 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.468 1.907 . . . . 0.0 108.502 178.008 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -144.34 154.95 57.73 Favored Pre-proline 0 C--N 1.348 0.528 0 C-N-CA 129.798 3.239 . . . . 0.0 105.95 -178.297 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -80.38 111.41 2.24 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 CA-C-N 120.932 1.369 . . . . 0.0 113.58 3.855 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -122.27 158.86 28.58 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.426 1.491 . . . . 0.0 108.441 179.114 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -63.26 154.84 30.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.701 1.6 . . . . 0.0 108.617 178.755 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -77.97 119.78 21.9 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.296 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.27 145.91 10.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.937 2.095 . . . . 0.0 114.2 -178.152 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -73.44 148.17 43.49 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.381 1.472 . . . . 0.0 110.1 179.495 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.7 t80 74.22 146.15 0.08 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.764 2.025 . . . . 0.0 110.972 179.411 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 58.35 53.0 6.7 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.568 1.147 . . . . 0.0 108.933 -178.599 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.23 106.84 2.03 Favored Glycine 0 C--N 1.339 0.729 0 C-N-CA 124.751 1.167 . . . . 0.0 112.324 -178.698 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -73.31 106.99 5.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 178.494 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -53.88 120.99 7.05 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.069 1.347 . . . . 0.0 113.109 -178.4 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -132.75 151.96 79.03 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.351 1.861 . . . . 0.0 108.217 179.081 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.57 166.98 28.3 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.505 2.803 . . . . 0.0 112.464 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.273 22.9 m 55.03 171.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 129.03 2.932 . . . . 0.0 115.445 179.321 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -81.2 153.59 27.11 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.971 1.308 . . . . 0.0 111.999 -178.847 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.77 -147.73 23.1 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.527 1.537 . . . . 0.0 110.251 179.202 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.39 133.21 17.27 Favored 'Cis proline' 0 N--CA 1.458 -0.605 0 CA-C-N 118.847 1.324 . . . . 0.0 110.031 -1.782 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -108.62 140.53 41.87 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.935 0.894 . . . . 0.0 111.847 179.343 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -122.91 159.17 28.79 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.051 1.741 . . . . 0.0 109.613 -179.027 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -87.7 159.59 18.44 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.561 1.544 . . . . 0.0 111.928 -178.553 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.48 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 18.4 t80 -160.41 109.74 1.36 Allowed Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.267 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -79.11 129.65 8.93 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 121.88 1.72 . . . . 0.0 111.151 -177.178 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.549 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.2 tt -87.71 -176.83 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-O 123.796 1.76 . . . . 0.0 110.237 179.096 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.549 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -152.52 141.24 20.94 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 110.07 -3.241 . . . . 0.0 111.623 -179.095 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 t -81.41 57.73 3.38 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.948 1.699 . . . . 0.0 109.942 179.647 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.21 45.54 0.08 OUTLIER Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.282 1.42 . . . . 0.0 112.008 179.059 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.76 176.36 26.08 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 117.884 0.842 . . . . 0.0 112.782 179.052 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 t -132.15 139.06 51.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.322 1.449 . . . . 0.0 108.278 178.961 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.263 26.4 p90 46.42 52.51 10.68 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.351 2.261 . . . . 0.0 114.487 179.473 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.9 p -80.49 -44.34 19.34 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.837 -0.539 . . . . 0.0 110.184 179.06 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.2 56.77 1.44 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.09 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -117.33 73.44 0.28 Allowed Glycine 0 C--N 1.34 0.793 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.485 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 92.0 p -71.17 152.16 94.6 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 124.082 0.953 . . . . 0.0 110.717 -179.938 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -75.98 -43.17 0.69 Allowed 'Cis proline' 0 N--CA 1.457 -0.672 0 CA-C-N 119.196 0.748 . . . . 0.0 110.904 -4.129 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.87 -54.61 3.7 Favored Glycine 0 C--N 1.34 0.764 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 179.187 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . 64.3 43.97 4.52 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.632 1.173 . . . . 0.0 110.312 -178.678 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.83 101.19 1.29 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.641 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.28 148.56 50.82 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.251 0.621 . . . . 0.0 111.398 -179.032 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.1 m -111.26 144.32 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 176.909 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.17 121.83 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 -177.673 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.478 HG22 ' HA ' ' A' ' 85' ' ' TYR . 3.2 pt -127.12 167.84 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.615 -176.517 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -94.31 166.99 11.82 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 123.996 0.918 . . . . 0.0 110.809 -179.641 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.432 1.9 t -73.29 8.51 1.67 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 121.396 3.851 . . . . 0.0 121.396 -177.07 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -91.05 -94.88 0.12 Allowed 'General case' 0 N--CA 1.437 -1.101 1 N-CA-C 93.486 -6.487 . . . . 0.0 93.486 174.859 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . 0.353 9.8 t -165.93 54.29 0.1 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 127.634 2.374 . . . . 0.0 111.44 176.955 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -136.06 127.64 28.82 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 120.186 1.357 . . . . 0.0 112.957 -178.063 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.478 ' HA ' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -69.2 121.61 17.14 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 127.264 2.226 . . . . 0.0 108.138 179.055 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.63 -54.55 2.6 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 123.552 0.741 . . . . 0.0 111.774 -178.605 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -119.15 155.32 16.11 Favored Glycine 0 C--N 1.341 0.853 0 C-N-CA 124.428 1.014 . . . . 0.0 113.907 -178.72 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.91 102.07 3.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 178.539 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.9 pt -112.75 157.05 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.903 0.881 . . . . 0.0 111.633 -178.293 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.2 t -155.89 155.32 32.67 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.083 1.353 . . . . 0.0 112.197 -178.368 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.501 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 38.6 m170 -80.34 3.78 20.01 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 119.156 -0.45 . . . . 0.0 110.954 177.208 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -43.64 -39.59 3.65 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -177.671 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.46 44.44 1.22 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.573 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -110.83 155.16 22.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.315 1.446 . . . . 0.0 110.924 -179.769 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.8 t -89.84 61.29 5.3 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.536 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.9 -86.93 0.96 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.659 1.123 . . . . 0.0 112.381 179.028 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -96.91 -6.17 36.35 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -178.073 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -69.26 -173.44 0.54 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.191 0.905 . . . . 0.0 110.592 -179.401 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -147.0 153.89 40.59 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.182 0.593 . . . . 0.0 111.379 -178.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.1 m -142.55 163.66 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 126.483 1.913 . . . . 0.0 107.57 178.129 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.85 152.35 28.54 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.701 0.667 . . . . 0.0 114.056 -177.928 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 51.8 m -87.71 -168.27 2.17 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.92 1.288 . . . . 0.0 108.331 178.191 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.2 t -68.35 112.92 5.51 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.036 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.58 50.21 4.31 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.258 0.932 . . . . 0.0 110.802 -179.201 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.4 m -147.9 97.75 2.85 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.06 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 116.585 -1.674 . . . . 0.0 108.833 -179.385 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.1 t -160.45 98.23 1.25 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.134 0.974 . . . . 0.0 109.705 -179.015 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 54.69 81.13 0.11 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 125.533 1.533 . . . . 0.0 109.29 -179.405 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.405 HG22 ' CG2' ' A' ' 16' ' ' VAL . 7.5 t -105.35 138.12 42.05 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.362 0.665 . . . . 0.0 111.977 -177.37 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.94 125.34 52.43 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.292 1.837 . . . . 0.0 109.773 179.405 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -105.87 71.27 0.89 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 178.841 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.17 -80.73 1.49 Allowed Glycine 0 C--N 1.342 0.889 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 -178.868 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.1 t -123.64 -30.49 3.6 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.975 1.71 . . . . 0.0 110.757 178.943 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 m -70.36 92.0 0.78 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.126 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -89.15 145.06 25.68 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.477 1.511 . . . . 0.0 114.074 -177.819 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -141.48 134.93 29.71 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.243 1.417 . . . . 0.0 111.682 178.376 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.6 m -72.32 156.57 38.96 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 126.057 1.743 . . . . 0.0 108.618 177.677 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.21 -22.88 44.01 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.029 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 98.3 p -76.45 -34.45 58.72 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.916 -179.143 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -75.55 -38.21 59.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.418 1.487 . . . . 0.0 111.617 -179.526 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.405 ' CG2' HG22 ' A' ' 4' ' ' THR . 43.1 t -63.42 -47.99 89.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.264 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -64.15 -32.1 73.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.7 1.6 . . . . 0.0 111.532 179.094 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.34 -56.65 7.8 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 123.078 0.551 . . . . 0.0 109.888 -179.081 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.5 -27.86 68.11 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 123.105 0.253 . . . . 0.0 110.551 179.656 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.34 -44.68 67.7 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.299 -0.876 . . . . 0.0 110.088 178.586 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -68.83 -17.51 64.02 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.338 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.32 -69.24 0.57 Allowed 'General case' 0 C--N 1.346 0.424 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 -178.387 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.511 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -38.1 -58.13 0.99 Allowed 'General case' 0 CA--C 1.537 0.463 0 O-C-N 124.527 1.142 . . . . 0.0 112.438 175.93 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.5 t -56.23 -40.9 74.81 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 123.835 0.854 . . . . 0.0 112.668 -178.952 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -87.24 -2.96 59.0 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 179.442 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -117.26 -63.15 1.48 Allowed 'General case' 0 C--N 1.347 0.5 0 CA-C-N 120.163 1.347 . . . . 0.0 114.097 -178.616 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -49.98 -42.2 48.41 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.894 1.278 . . . . 0.0 111.99 -177.036 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -103.85 14.11 31.51 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -177.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -154.51 62.95 0.68 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.176 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 63.24 91.03 0.07 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.174 1.79 . . . . 0.0 109.206 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -57.06 112.69 1.42 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.556 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.9 t -97.65 -34.63 10.87 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.348 1.459 . . . . 0.0 107.593 178.284 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.53 97.9 7.36 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.512 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -142.49 52.07 0.66 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.359 0.98 . . . . 0.0 111.155 -179.088 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.4 m -71.95 -53.06 14.24 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.501 0.72 . . . . 0.0 109.789 178.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.5 m -111.38 -162.07 0.78 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.037 1.335 . . . . 0.0 107.98 -179.063 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.4 t -83.08 49.9 1.63 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.98 0.912 . . . . 0.0 109.747 179.145 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -140.79 142.82 29.68 Favored Pre-proline 0 C--N 1.342 0.257 0 C-N-CA 126.311 1.845 . . . . 0.0 106.638 -179.026 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -69.6 145.68 79.73 Favored 'Cis proline' 0 CA--C 1.535 0.56 0 N-CA-C 115.053 1.136 . . . . 0.0 115.053 2.917 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.57 140.2 49.39 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -177.514 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.3 m -57.12 120.07 7.41 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 127.359 2.263 . . . . 0.0 110.564 178.983 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -79.43 99.56 7.25 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.656 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -140.53 61.83 1.5 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.215 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -105.63 -178.67 3.72 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.231 1.412 . . . . 0.0 109.183 -179.584 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -67.78 102.92 1.31 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.954 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.3 144.21 42.07 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.575 0.75 . . . . 0.0 111.501 -179.102 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.68 68.28 0.16 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 107.849 -2.101 . . . . 0.0 107.849 -178.938 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -162.65 173.01 14.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.51 1.124 . . . . 0.0 109.331 -179.627 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -59.93 162.85 5.11 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.591 1.156 . . . . 0.0 111.171 178.904 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 49.4 p90 44.65 53.7 11.63 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 126.239 1.816 . . . . 0.0 113.134 -179.345 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.75 -47.74 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.606 2.204 . . . . 0.0 110.834 -179.239 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.4 t 57.58 -100.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.768 1.627 . . . . 0.0 109.995 -179.577 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 p30 178.8 -45.61 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.437 1.895 . . . . 0.0 108.952 -179.382 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.89 -158.83 41.2 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.781 0.705 . . . . 0.0 112.362 179.199 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.01 130.35 1.67 Allowed 'Cis proline' 0 N--CA 1.46 -0.472 0 CA-C-N 118.372 1.086 . . . . 0.0 113.423 1.549 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -134.25 141.93 47.16 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.834 0.854 . . . . 0.0 109.412 179.391 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -132.07 164.94 25.13 Favored 'General case' 0 C--N 1.344 0.359 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -177.372 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -79.86 153.25 29.19 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.934 2.093 . . . . 0.0 112.059 -178.942 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.511 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 52.5 t80 -160.39 106.43 1.36 Allowed Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 178.731 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -67.71 141.96 56.46 Favored 'Trans proline' 0 N--CA 1.441 -1.584 0 CA-C-N 120.302 1.144 . . . . 0.0 110.676 -176.81 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.42 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -90.03 -145.21 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-O 122.972 1.368 . . . . 0.0 111.972 -177.607 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.42 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 36.0 ttpt -79.77 149.51 31.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.381 -179.022 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.0 t 170.09 48.28 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.455 1 C-N-CA 132.088 4.155 . . . . 0.0 103.641 178.482 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 133.58 -46.26 1.07 Allowed Glycine 0 CA--C 1.534 1.229 0 N-CA-C 105.984 -2.846 . . . . 0.0 105.984 -177.45 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.4 165.22 25.43 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.433 1.016 . . . . 0.0 111.742 178.68 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.59 131.31 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.514 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.9 t80 57.2 83.34 0.11 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.703 1.201 . . . . 0.0 110.845 -179.381 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.5 p -131.54 -48.61 0.98 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.465 1.106 . . . . 0.0 111.753 -179.076 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.56 51.78 3.18 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -178.782 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.16 47.69 0.07 OUTLIER Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.533 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.5 t -69.52 -59.58 4.68 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.376 1.07 . . . . 0.0 111.252 179.567 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -82.32 -26.18 9.15 Favored 'Cis proline' 0 C--N 1.347 0.483 0 CA-C-N 121.573 1.597 . . . . 0.0 112.246 -6.2 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.29 -160.49 22.56 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.562 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.758 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . 69.21 21.71 7.03 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 126.349 1.86 . . . . 0.0 112.331 -178.912 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -164.4 91.69 0.61 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.986 1.314 . . . . 0.0 107.926 179.099 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.8 mtt85 -138.3 134.05 33.83 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.334 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 m -93.74 153.05 3.43 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 177.065 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.96 120.11 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -178.867 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pt -110.48 174.04 2.05 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 C-N-CA 125.015 1.326 . . . . 0.0 114.073 -177.645 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -100.55 154.62 18.41 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 127.755 2.422 . . . . 0.0 108.544 179.054 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.283 3.3 t -71.92 0.93 8.0 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -178.599 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -86.0 -83.22 0.18 Allowed 'General case' 0 N--CA 1.441 -0.888 1 N-CA-C 100.115 -4.031 . . . . 0.0 100.115 177.07 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.7 t -165.08 -4.29 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.295 2.238 . . . . 0.0 114.157 177.619 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -79.35 130.59 35.59 Favored 'General case' 0 C--N 1.343 0.308 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -175.098 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -78.64 117.89 20.23 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.82 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.59 -59.73 2.63 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.344 0.658 . . . . 0.0 111.862 -177.557 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.45 156.83 17.82 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 179.61 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.49 155.27 18.38 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.588 1.155 . . . . 0.0 111.748 -179.249 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.5 pt -136.62 165.3 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 125.241 1.416 . . . . 0.0 110.802 179.28 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.1 t -159.32 144.84 16.0 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.666 0.786 . . . . 0.0 112.787 -178.774 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.758 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -82.42 -37.24 25.78 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.618 0.767 . . . . 0.0 111.073 177.892 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 m -49.97 -55.97 12.5 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.479 1.512 . . . . 0.0 112.367 -178.756 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -63.47 -27.0 70.15 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.108 0.861 . . . . 0.0 112.637 -179.58 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.39 178.76 6.91 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.288 1.035 . . . . 0.0 112.579 -178.925 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.9 m -65.59 -45.89 81.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.512 1.125 . . . . 0.0 110.54 179.07 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.05 -80.62 0.06 OUTLIER Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.466 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -79.53 -17.83 53.19 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.182 0.993 . . . . 0.0 112.039 -179.098 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -79.74 163.85 24.16 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.326 0.65 . . . . 0.0 110.263 179.298 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.05 113.35 19.42 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.63 1.572 . . . . 0.0 107.671 179.209 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.4 m -97.47 161.55 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.436 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -72.88 155.65 51.07 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.395 -179.063 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.25 -173.31 4.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.342 1.457 . . . . 0.0 109.008 178.924 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.2 t -68.02 133.67 49.41 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.825 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.66 23.2 73.42 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -178.775 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.3 m -144.05 93.87 2.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 179.065 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 116.747 -1.597 . . . . 0.0 109.688 -178.658 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.408 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -79.84 169.94 17.2 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.804 1.242 . . . . 0.0 111.858 -178.839 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -47.37 152.86 0.57 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 126.612 1.965 . . . . 0.0 113.028 179.296 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.66 94.37 3.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.076 1.35 . . . . 0.0 110.571 -178.517 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 5' ' ' THR . 1.1 m -99.58 94.53 6.44 Favored 'General case' 0 N--CA 1.437 -1.099 1 N-CA-C 100.179 -4.008 . . . . 0.0 100.179 177.808 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.0 m -96.19 75.48 3.0 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.246 -177.696 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.0 -97.42 1.64 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 -178.804 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.3 t -114.76 -31.71 6.06 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.442 1.497 . . . . 0.0 109.253 178.479 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.1 m -77.06 95.53 4.22 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 102.059 -3.312 . . . . 0.0 102.059 178.051 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -114.28 152.24 31.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.552 1.141 . . . . 0.0 113.098 -176.425 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -143.76 165.78 26.71 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 125.041 1.336 . . . . 0.0 111.229 -179.214 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.3 m -85.97 156.94 20.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.334 1.453 . . . . 0.0 110.652 178.88 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.95 -20.78 40.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 113.915 -1.493 . . . . 0.0 107.164 176.875 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -68.77 -46.01 69.88 Favored 'General case' 0 C--N 1.345 0.376 0 C-N-CA 124.538 1.135 . . . . 0.0 109.939 179.379 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -43.38 93.21 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 123.135 0.574 . . . . 0.0 111.4 179.195 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.0 t -61.25 -46.07 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 123.013 0.525 . . . . 0.0 109.754 178.776 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 ttp-105 -62.76 -43.8 97.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.587 0.755 . . . . 0.0 110.177 -179.217 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.55 -45.41 87.25 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.546 0.738 . . . . 0.0 110.772 179.122 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.98 -33.22 75.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.46 1.104 . . . . 0.0 110.753 179.329 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.84 -37.71 47.8 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.964 0.505 . . . . 0.0 110.456 178.881 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -68.22 -20.64 64.84 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.229 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.25 -61.38 1.97 Allowed 'General case' 0 C--N 1.346 0.449 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 -178.807 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -41.13 -52.05 3.33 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.336 1.054 . . . . 0.0 111.46 176.663 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 46.4 t -61.97 -39.77 93.31 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.693 1.597 . . . . 0.0 111.04 179.017 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -88.01 7.08 32.95 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.768 1.227 . . . . 0.0 113.527 179.015 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -129.73 -10.87 4.43 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.455 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -115.18 -27.28 7.34 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -179.059 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.95 -14.86 11.25 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -177.828 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -78.86 17.82 0.68 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.503 1.047 . . . . 0.0 113.616 -176.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.5 t70 86.51 40.22 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 127.941 2.496 . . . . 0.0 109.166 178.9 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -151.7 148.99 28.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.827 2.051 . . . . 0.0 106.232 179.269 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 t -166.24 77.99 0.24 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.127 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.19 96.04 0.1 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.182 0.993 . . . . 0.0 110.552 -179.228 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.94 58.87 4.58 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 125.226 1.393 . . . . 0.0 110.197 -179.265 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.4 t -72.78 -73.27 0.21 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.706 0.802 . . . . 0.0 110.147 -179.011 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 m -176.49 -49.63 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 127.441 2.297 . . . . 0.0 106.671 -178.584 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.0 t -79.95 25.04 0.38 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.485 1.914 . . . . 0.0 113.939 -178.844 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 74.49 163.69 0.14 Allowed Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 119.279 0.945 . . . . 0.0 109.839 178.414 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.25 117.94 3.5 Favored 'Cis proline' 0 N--CA 1.454 -0.838 0 N-CA-C 115.166 1.179 . . . . 0.0 115.166 2.65 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -125.71 150.86 47.32 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 127.223 2.209 . . . . 0.0 106.937 178.912 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 m -80.99 132.19 35.36 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 124.564 1.146 . . . . 0.0 109.777 -179.972 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -88.53 149.55 23.56 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.48 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -153.03 134.3 14.24 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.024 0.53 . . . . 0.0 110.494 -179.273 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 64.43 121.61 0.02 OUTLIER 'General case' 0 C--N 1.343 0.293 0 C-N-CA 127.378 2.271 . . . . 0.0 112.053 179.367 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -77.16 135.38 38.53 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.268 0.627 . . . . 0.0 109.699 179.433 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -126.91 75.3 1.56 Allowed 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.188 0.995 . . . . 0.0 109.407 -178.691 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.16 50.49 51.06 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.221 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -164.83 121.76 1.55 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.857 1.263 . . . . 0.0 108.69 -178.648 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -142.68 110.43 5.85 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.373 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -144.42 49.87 1.11 Allowed Pre-proline 0 N--CA 1.439 -1.014 0 C-N-CA 129.91 3.284 . . . . 0.0 108.879 177.635 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.56 150.3 27.87 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.006 2.471 . . . . 0.0 112.031 -178.998 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.7 t -142.03 -53.19 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.862 1.665 . . . . 0.0 106.892 178.757 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -160.19 126.38 4.19 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.136 1.375 . . . . 0.0 109.002 178.727 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.85 150.95 18.43 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.881 1.229 . . . . 0.0 112.238 -178.875 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.65 173.04 29.17 Favored 'Cis proline' 0 C--N 1.35 0.655 0 CA-C-N 119.375 1.588 . . . . 0.0 113.27 -2.251 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -126.17 174.71 8.3 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.292 1.437 . . . . 0.0 108.174 -179.256 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.63 154.01 37.96 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.879 0.371 . . . . 0.0 111.658 -179.491 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.18 153.17 19.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.594 1.558 . . . . 0.0 111.683 -178.889 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -157.33 117.17 1.99 Allowed Pre-proline 0 C--N 1.342 0.273 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.288 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.7 152.14 13.16 Favored 'Trans proline' 0 N--CA 1.438 -1.769 0 C-N-CA 121.187 1.258 . . . . 0.0 114.675 -176.382 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.52 178.32 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 127.77 2.428 . . . . 0.0 105.868 178.803 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -164.77 -168.92 1.58 Allowed 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 109.586 -3.461 . . . . 0.0 108.462 -178.879 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.2 m -84.65 60.71 6.28 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 177.136 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.54 71.53 1.16 Allowed Glycine 0 CA--C 1.53 0.999 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 -178.222 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.18 89.68 0.09 OUTLIER Glycine 0 CA--C 1.53 1.01 0 CA-C-N 117.295 0.547 . . . . 0.0 111.8 -179.329 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.1 t -94.68 97.49 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.317 1.447 . . . . 0.0 108.003 179.339 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 t80 48.82 66.21 1.15 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.394 1.478 . . . . 0.0 110.693 -179.586 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.2 p -104.53 -68.82 0.83 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.792 1.237 . . . . 0.0 109.43 179.853 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.33 177.23 47.3 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 179.47 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.54 -19.59 10.82 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 118.887 -0.952 . . . . 0.0 113.378 -179.787 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 92.0 p 50.35 71.69 1.48 Allowed Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 126.201 1.8 . . . . 0.0 111.6 -179.604 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.89 143.28 54.55 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.181 2.587 . . . . 0.0 109.403 -178.382 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.43 48.74 0.95 Allowed Glycine 0 C--N 1.338 0.691 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.252 -178.518 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.15 21.75 0.13 Allowed 'General case' 0 C--N 1.342 0.27 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 177.784 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.26 112.64 0.13 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 128.708 2.803 . . . . 0.0 105.85 176.18 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.91 134.31 9.58 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.387 1.875 . . . . 0.0 109.53 -176.298 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.9 m -90.8 152.8 3.29 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 177.615 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.1 t -135.62 119.21 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -178.694 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -102.54 176.54 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.4 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -99.28 168.42 10.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 127.258 2.223 . . . . 0.0 109.16 178.847 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.306 14.7 t -82.01 50.24 1.52 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -178.414 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -147.54 -90.1 0.09 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 102.545 -3.132 . . . . 0.0 102.545 177.477 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -163.16 0.44 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.657 1.983 . . . . 0.0 113.007 -178.939 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -82.7 133.68 35.16 Favored 'General case' 0 C--N 1.346 0.44 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -176.773 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -78.05 112.88 15.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.592 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.0 -49.65 11.52 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.322 1.049 . . . . 0.0 111.363 -178.171 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.07 151.29 7.95 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.108 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.56 158.18 17.12 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.855 0.862 . . . . 0.0 110.159 178.97 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.0 pt -138.71 151.84 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.602 -178.918 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.1 t -147.67 165.43 30.49 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 125.301 1.441 . . . . 0.0 112.749 -178.756 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -79.01 -50.86 10.42 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.457 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 m -39.9 107.8 0.08 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 127.026 2.13 . . . . 0.0 112.631 -178.763 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.8 -43.42 1.35 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.74 1.638 . . . . 0.0 109.259 -179.153 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.95 -175.89 0.62 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.799 1.639 . . . . 0.0 112.131 179.654 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.3 p -70.88 -50.76 31.53 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.171 0.988 . . . . 0.0 111.453 -179.894 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.54 -78.9 0.04 OUTLIER Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.372 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -79.35 -34.1 42.39 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.046 0.939 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -55.82 158.63 3.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.366 1.066 . . . . 0.0 111.046 179.205 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -118.5 157.98 26.24 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.67 1.188 . . . . 0.0 113.175 -178.298 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.6 160.94 41.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 C-N-CA 126.428 1.891 . . . . 0.0 107.192 177.712 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.52 161.11 46.21 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.068 0.842 . . . . 0.0 114.197 -177.928 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.6 t -143.06 163.75 31.98 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 126.002 1.721 . . . . 0.0 109.147 178.825 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.0 t 53.43 51.59 15.04 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.079 1.752 . . . . 0.0 111.468 -178.577 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.66 -10.79 70.73 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.087 -0.84 . . . . 0.0 113.285 179.2 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.9 m -79.55 143.95 34.36 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.604 1.202 . . . . 0.0 108.746 -179.351 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 p30 . . . . . 0 C--O 1.251 1.182 0 CA-C-O 117.528 -1.225 . . . . 0.0 110.045 -179.271 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 120.521 0.201 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t -160.08 102.77 1.45 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.292 0.637 . . . . 0.0 109.54 179.435 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.46 75.1 0.37 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.311 1.444 . . . . 0.0 109.393 179.72 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.5 m -79.35 101.06 7.89 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.104 1.762 . . . . 0.0 109.668 -178.001 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -115.96 115.85 26.9 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.553 1.541 . . . . 0.0 106.863 -179.154 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.4 m -113.39 93.82 4.58 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.58 0.752 . . . . 0.0 109.797 -179.223 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.07 -93.8 0.43 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.438 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.3 m -133.77 41.58 3.02 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.607 1.163 . . . . 0.0 109.233 179.184 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.4 m -141.16 89.2 2.22 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 179.075 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -85.67 141.57 29.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.656 1.182 . . . . 0.0 113.657 -177.594 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -141.81 136.72 30.91 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.69 1.596 . . . . 0.0 109.816 178.74 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.5 m -65.94 158.2 28.72 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.979 1.312 . . . . 0.0 110.266 178.231 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.05 -23.17 66.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.1 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.2 t -76.73 -33.25 58.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.145 1.378 . . . . 0.0 109.966 179.259 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -74.74 -39.55 61.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.867 0.867 . . . . 0.0 109.841 -179.028 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.47 -44.6 94.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.499 0.72 . . . . 0.0 110.43 178.342 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.48 -38.55 90.1 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 123.304 0.642 . . . . 0.0 110.46 179.47 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.08 -46.33 74.63 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.868 0.867 . . . . 0.0 109.259 179.029 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.58 -42.14 82.55 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 123.961 0.904 . . . . 0.0 108.953 178.775 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.91 -20.03 50.38 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 179.324 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -74.52 -26.21 59.84 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.315 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.74 -49.81 10.68 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -179.445 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.14 -48.83 23.19 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 124.612 1.195 . . . . 0.0 109.661 176.233 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.5 t -68.73 -29.79 68.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.82 2.048 . . . . 0.0 113.189 -179.922 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -73.35 -63.78 1.12 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.45 1.023 . . . . 0.0 112.206 -178.611 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.351 0.1 OUTLIER -66.79 -47.01 73.45 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 -176.035 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -60.02 -28.2 67.54 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.552 1.141 . . . . 0.0 112.32 -178.722 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -82.7 -71.5 0.49 Allowed 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -178.435 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -171.19 23.28 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -178.718 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -121.28 76.72 1.26 Allowed 'General case' 0 C--N 1.339 0.128 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.803 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 111.19 133.79 0.0 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 131.355 3.862 . . . . 0.0 108.294 -178.713 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 t -90.96 81.58 5.66 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.004 1.321 . . . . 0.0 108.845 179.688 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.44 162.43 12.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.879 0.872 . . . . 0.0 112.387 -179.263 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -42.37 96.67 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.592 1.091 . . . . 0.0 114.947 -178.706 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.4 m 61.08 75.81 0.39 Allowed 'General case' 0 C--N 1.344 0.353 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -178.288 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 p 175.39 -43.85 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 103.471 -2.789 . . . . 0.0 103.471 -176.361 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.7 p -115.69 51.25 0.95 Allowed 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.856 2.062 . . . . 0.0 110.437 178.432 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 23.4 m-85 64.08 133.21 0.03 OUTLIER Pre-proline 0 C--N 1.355 0.83 0 C-N-CA 126.093 1.757 . . . . 0.0 110.76 176.504 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -76.39 161.58 93.57 Favored 'Cis proline' 0 N--CA 1.45 -1.035 0 CA-C-N 120.18 1.1 . . . . 0.0 109.931 3.555 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.74 147.25 37.08 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.026 1.331 . . . . 0.0 109.919 -177.788 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 t -76.31 132.1 39.6 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 103.46 -2.793 . . . . 0.0 103.46 177.12 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -95.6 106.1 18.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 -178.115 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -162.31 -58.07 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.567 1.147 . . . . 0.0 108.771 -179.241 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -81.39 70.65 8.3 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.559 1.144 . . . . 0.0 109.618 -179.367 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.55 -72.9 0.09 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.11 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -176.39 147.82 0.71 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.493 1.117 . . . . 0.0 109.275 179.18 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.75 150.82 49.83 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 178.93 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.17 170.56 18.16 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.104 0.562 . . . . 0.0 110.415 -179.209 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -71.6 -163.94 0.11 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.293 0.637 . . . . 0.0 111.63 -179.352 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 38.0 p90 54.28 58.73 12.11 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 125.889 1.676 . . . . 0.0 111.088 -178.178 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.28 66.83 8.74 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 124.016 3.144 . . . . 0.0 110.445 -179.429 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.37 -65.31 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.135 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -166.32 -165.09 0.74 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.048 1.339 . . . . 0.0 107.987 179.294 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 172.99 -174.88 45.98 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 121.91 -0.494 . . . . 0.0 112.879 179.103 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.2 128.37 6.42 Favored 'Cis proline' 0 N--CA 1.458 -0.568 0 O-C-N 122.526 0.75 . . . . 0.0 112.364 -0.292 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.72 150.57 25.01 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.114 0.966 . . . . 0.0 110.536 179.343 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -103.22 162.95 12.55 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.547 1.539 . . . . 0.0 112.82 -178.709 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.278 14.9 tp10 -101.3 151.82 21.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.646 2.379 . . . . 0.0 110.496 -178.783 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -160.16 107.43 1.39 Allowed Pre-proline 0 C--N 1.342 0.244 0 C-N-CA 124.567 1.147 . . . . 0.0 108.494 177.546 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -83.3 132.43 6.02 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 121.653 1.569 . . . . 0.0 112.607 -177.532 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.501 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 5.7 tt -107.81 172.41 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-O 124.466 2.079 . . . . 0.0 113.234 -179.289 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.501 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 16.5 ptpt -161.65 164.51 29.2 Favored 'General case' 0 C--N 1.316 -0.871 1 CA-C-N 108.191 -4.095 . . . . 0.0 112.379 179.974 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 42.1 m -92.33 60.33 3.63 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.536 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.5 -62.75 0.03 OUTLIER Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -179.271 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.31 -172.27 13.13 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.647 0.642 . . . . 0.0 113.939 -178.663 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.3 t -124.33 103.99 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 127.889 2.476 . . . . 0.0 105.678 -179.418 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 46.9 t80 60.56 92.78 0.04 OUTLIER 'General case' 0 C--N 1.345 0.38 0 C-N-CA 126.09 1.756 . . . . 0.0 110.871 -178.519 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.3 p -142.85 39.68 1.5 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.844 0.858 . . . . 0.0 110.336 179.302 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.11 98.38 0.06 OUTLIER Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.979 0.8 . . . . 0.0 112.25 179.178 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.92 -178.54 48.96 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 123.718 0.675 . . . . 0.0 111.512 179.13 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.0 t 63.12 91.81 0.07 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 125.684 1.593 . . . . 0.0 110.5 -179.124 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -59.87 132.31 8.07 Favored 'Cis proline' 0 C--N 1.348 0.534 0 CA-C-N 119.355 0.805 . . . . 0.0 113.338 1.901 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.79 71.57 0.03 OUTLIER Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.507 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.495 ' HB1' ' CB ' ' A' ' 91' ' ' HIS . . . -62.93 -20.64 65.4 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.861 178.863 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.72 137.4 33.86 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.289 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -157.66 147.28 20.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.522 -179.069 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.9 m -110.04 145.98 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 177.237 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.5 t -127.66 121.24 56.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -177.328 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -107.84 173.17 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.38 0 C-N-CA 125.189 1.396 . . . . 0.0 112.45 -177.58 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -91.56 161.89 14.75 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.248 1.419 . . . . 0.0 109.293 179.363 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.32 15.3 t -79.16 54.08 1.58 Allowed 'General case' 0 C--N 1.341 0.223 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -179.076 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -151.81 -88.45 0.06 Allowed 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 101.982 -3.34 . . . . 0.0 101.982 177.209 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.24 5.51 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.181 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -91.3 129.75 37.25 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 -175.48 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.56 124.14 20.61 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 177.447 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.8 -51.73 5.08 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.166 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 177.24 153.45 10.93 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.075 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.84 141.28 31.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.569 1.148 . . . . 0.0 110.062 179.3 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.0 pt -135.14 156.76 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 125.267 1.427 . . . . 0.0 108.081 179.157 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.58 159.67 37.33 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 119.113 -0.47 . . . . 0.0 111.308 -178.731 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.495 ' CB ' ' HB1' ' A' ' 74' ' ' ALA . 21.4 m170 -78.88 -58.76 3.08 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.015 177.412 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.288 4.8 t 48.06 9.35 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 129.228 3.011 . . . . 0.0 117.168 -178.053 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.68 44.98 0.21 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.142 1.353 . . . . 0.0 110.505 179.399 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.88 -168.6 2.29 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.985 0.914 . . . . 0.0 109.073 179.086 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.8 m -59.84 -46.57 88.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.321 0.648 . . . . 0.0 110.426 179.167 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.28 -91.48 0.08 OUTLIER Glycine 0 C--N 1.337 0.619 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 179.157 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -85.37 -2.5 58.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.022 0.929 . . . . 0.0 110.234 178.458 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -63.51 168.21 4.86 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.629 1.172 . . . . 0.0 110.708 179.114 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -138.85 156.21 47.49 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -177.608 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.4 m -132.61 165.54 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 127.331 2.253 . . . . 0.0 106.692 177.093 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -75.2 162.07 53.42 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 114.668 0.627 . . . . 0.0 114.668 -178.185 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 6.6 t -148.26 159.15 44.27 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 126.096 1.758 . . . . 0.0 108.953 178.289 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t 61.38 38.11 16.4 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.726 2.01 . . . . 0.0 111.819 -178.328 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.72 42.98 99.59 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.154 1.359 . . . . 0.0 112.239 179.041 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.6 t -88.21 26.03 1.49 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 179.871 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 116.618 -1.658 . . . . 0.0 110.615 -179.31 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.488 0.185 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.5 p -125.85 177.09 6.5 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.936 1.294 . . . . 0.0 110.843 -178.98 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.13 152.66 39.96 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.791 1.236 . . . . 0.0 110.777 179.359 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.4 t -140.4 134.21 30.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.155 0.582 . . . . 0.0 110.508 179.043 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -109.92 103.33 12.09 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 178.854 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 20.6 m -88.24 70.21 9.19 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.184 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.08 -82.24 0.88 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.416 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.5 p -106.1 -48.14 3.67 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.161 1.384 . . . . 0.0 112.058 -178.887 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.5 m -72.79 105.59 4.41 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 122.984 0.513 . . . . 0.0 111.694 -178.436 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -81.8 148.51 28.84 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 125.219 1.408 . . . . 0.0 110.531 179.869 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -148.08 127.68 13.29 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.383 1.073 . . . . 0.0 109.495 179.156 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.9 p -71.15 160.12 33.45 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 125.133 1.373 . . . . 0.0 110.504 178.323 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.36 -19.73 37.96 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.164 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.4 t -77.74 -36.72 50.45 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 123.604 0.762 . . . . 0.0 109.385 -179.986 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -42.5 64.86 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.67 1.188 . . . . 0.0 111.069 179.205 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.477 HG11 ' CE2' ' A' ' 85' ' ' TYR . 22.3 t -61.87 -45.93 97.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.297 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -66.91 -41.48 87.04 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 124.883 1.273 . . . . 0.0 112.967 179.821 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.88 -53.61 53.42 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.749 0.42 . . . . 0.0 110.294 -178.122 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.16 -32.38 72.1 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.086 179.439 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.36 -49.32 43.39 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 179.874 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -61.87 -22.94 65.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.693 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.23 -71.98 0.28 Allowed 'General case' 0 C--N 1.348 0.52 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 -177.698 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.631 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -38.53 -44.44 0.95 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.912 0.885 . . . . 0.0 112.261 178.096 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 69.3 m -55.82 -52.71 63.05 Favored 'General case' 0 C--N 1.346 0.447 0 O-C-N 123.288 0.367 . . . . 0.0 111.784 179.184 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -56.16 -40.15 73.42 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.755 0.822 . . . . 0.0 112.421 -178.124 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -89.38 -16.48 30.88 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -178.875 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -80.45 -24.04 39.82 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.791 1.236 . . . . 0.0 113.826 179.367 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -60.64 -33.54 72.95 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.297 0.639 . . . . 0.0 112.692 -177.921 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -126.17 -86.27 0.61 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.147 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t0 168.13 59.05 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 128.354 2.662 . . . . 0.0 105.701 -178.379 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -81.66 -178.5 6.99 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.597 179.441 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.338 11.3 t -69.07 86.68 0.37 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -177.838 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.03 -161.66 1.07 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 127.242 2.217 . . . . 0.0 107.07 177.363 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -45.55 -49.21 11.82 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.478 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.1 m 47.62 50.04 15.57 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.181 1.792 . . . . 0.0 113.606 178.051 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.1 p -143.48 -54.3 0.38 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.776 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.456 HG23 ' CE1' ' A' ' 38' ' ' TYR . 1.1 t -154.3 19.44 0.49 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.387 1.475 . . . . 0.0 110.543 178.984 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.474 ' CD2' ' HD3' ' A' ' 60' ' ' PRO . 12.8 m-85 -166.03 129.39 1.58 Allowed Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 126.403 1.881 . . . . 0.0 106.32 178.879 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -80.64 135.8 34.03 Favored 'Cis proline' 0 N--CA 1.449 -1.118 0 CA-C-N 120.355 1.163 . . . . 0.0 110.402 -1.53 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.88 155.97 36.7 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.932 0.493 . . . . 0.0 110.214 178.762 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -64.02 157.73 24.42 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.845 1.258 . . . . 0.0 112.297 -179.332 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.92 45.14 1.13 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.956 0.903 . . . . 0.0 110.212 179.263 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 48.0 -121.56 1.38 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.84 2.056 . . . . 0.0 112.103 179.895 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -137.64 -179.27 5.65 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.858 1.663 . . . . 0.0 108.813 -179.367 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 66.91 -142.53 0.14 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.066 1.346 . . . . 0.0 110.965 178.933 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -126.29 106.53 9.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.188 1.395 . . . . 0.0 109.252 -178.571 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.98 93.0 0.31 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.295 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.4 t80 51.26 65.32 1.52 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.438 1.495 . . . . 0.0 109.666 -179.138 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.36 153.31 42.43 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.792 0.806 . . . . 0.0 112.684 -178.499 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -109.31 163.88 16.01 Favored Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 127.53 2.332 . . . . 0.0 108.522 -179.124 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.98 53.66 4.27 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.848 3.032 . . . . 0.0 111.837 178.865 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.2 m -155.04 171.09 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 127.842 2.457 . . . . 0.0 108.058 -179.333 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -92.46 -133.94 0.14 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.949 0.9 . . . . 0.0 109.52 179.983 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 166.32 -156.48 28.4 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.386 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.45 151.79 12.9 Favored 'Cis proline' 0 C--N 1.349 0.587 0 CA-C-N 119.205 1.503 . . . . 0.0 113.097 -1.5 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -134.26 148.38 50.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.205 1.002 . . . . 0.0 111.877 -178.635 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.57 152.31 22.57 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -177.659 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -104.81 146.59 28.77 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 127.471 2.308 . . . . 0.0 108.459 179.276 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.631 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 52.8 t80 -160.05 121.92 1.81 Allowed Pre-proline 0 C--O 1.224 -0.238 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 179.347 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.474 ' HD3' ' CD2' ' A' ' 38' ' ' TYR . 22.8 Cg_endo -75.97 145.28 28.07 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 CA-C-N 120.624 1.259 . . . . 0.0 112.753 -176.031 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.271 5.0 tp -78.99 159.83 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 124.483 2.087 . . . . 0.0 114.094 -178.07 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.94 118.74 37.4 Favored 'General case' 0 C--N 1.321 -0.672 1 CA-C-N 108.004 -4.18 . . . . 0.0 118.222 -176.372 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.1 m -105.86 43.99 1.08 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.743 1.617 . . . . 0.0 107.075 177.997 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 130.41 -6.28 5.94 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 118.279 -1.29 . . . . 0.0 115.366 -179.388 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.71 134.27 2.92 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 120.15 1.975 . . . . 0.0 113.064 179.462 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.94 141.83 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.194 1.398 . . . . 0.0 110.357 -179.005 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.8 p90 39.94 54.47 2.63 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.407 2.283 . . . . 0.0 114.527 179.311 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.2 p -134.09 34.32 3.34 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.833 1.253 . . . . 0.0 108.887 178.717 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.41 -154.6 11.45 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 124.294 0.95 . . . . 0.0 111.251 -179.257 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 47.71 74.93 0.21 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.856 1.217 . . . . 0.0 112.834 178.992 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.1 m -55.53 143.41 57.97 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.178 179.314 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -45.85 -50.72 9.28 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.554 2.836 . . . . 0.0 110.993 172.829 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.41 -39.85 0.22 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 178.526 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -171.11 29.21 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 116.429 -1.748 . . . . 0.0 113.629 -177.92 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -108.57 130.39 55.3 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 122.453 2.388 . . . . 0.0 113.749 -178.464 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -134.27 155.41 50.25 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 124.372 1.069 . . . . 0.0 113.112 179.884 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 m -124.97 142.04 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 103.404 -2.813 . . . . 0.0 103.404 176.115 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.9 t -136.45 127.9 43.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -176.955 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.63 172.5 5.21 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 C-N-CA 127.065 2.146 . . . . 0.0 110.71 -177.901 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -100.49 -178.24 3.74 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 126.066 1.746 . . . . 0.0 110.138 179.044 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.371 13.8 t -80.33 52.48 1.61 Allowed 'General case' 0 C--N 1.344 0.34 0 N-CA-C 118.524 2.787 . . . . 0.0 118.524 -178.068 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -160.5 -93.37 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 100.394 -3.928 . . . . 0.0 100.394 176.752 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 58.2 m -163.68 16.19 0.06 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 130.101 3.36 . . . . 0.0 112.353 179.398 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -79.21 97.65 6.31 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.778 1.172 . . . . 0.0 110.256 -177.69 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.477 ' CE2' HG11 ' A' ' 16' ' ' VAL . 9.1 t80 -55.64 112.72 1.21 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.667 1.587 . . . . 0.0 108.699 178.998 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.05 -51.52 9.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.449 0.7 . . . . 0.0 110.822 -178.641 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 166.66 162.27 17.8 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.275 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.84 147.06 24.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.059 0.944 . . . . 0.0 109.104 179.028 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.2 pt -134.52 160.59 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.966 1.306 . . . . 0.0 109.241 -178.969 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 74' ' ' ALA . 11.9 t -158.43 167.43 29.69 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.453 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.431 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 17.1 m170 -78.45 -65.3 1.0 Allowed 'General case' 0 C--N 1.348 0.511 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.343 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.1 t 42.78 14.28 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 129.249 3.02 . . . . 0.0 116.778 -179.364 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 170.99 -32.71 0.15 Allowed Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.466 1.507 . . . . 0.0 110.44 -179.038 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.18 127.57 17.27 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.829 1.652 . . . . 0.0 112.09 179.233 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.9 t -105.89 69.19 0.81 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.986 1.315 . . . . 0.0 109.114 179.718 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.67 -161.01 30.35 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.452 1.025 . . . . 0.0 110.921 179.373 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -79.5 8.55 6.14 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.071 0.948 . . . . 0.0 111.388 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -80.24 156.83 26.69 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.233 1.413 . . . . 0.0 110.286 178.852 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -137.78 159.96 40.56 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.279 1.432 . . . . 0.0 111.195 -178.192 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.9 m -128.38 176.15 8.46 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 C-N-CA 127.877 2.471 . . . . 0.0 106.969 178.05 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.31 171.07 43.6 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 117.054 1.581 . . . . 0.0 117.054 -177.647 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.3 m -129.26 -176.49 3.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.917 2.487 . . . . 0.0 107.206 177.963 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.6 t 28.5 38.84 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -177.099 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 53.32 48.94 58.49 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.324 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.6 t -79.23 150.54 31.58 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.596 0.759 . . . . 0.0 111.801 -178.615 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.1 t30 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.245 -1.36 . . . . 0.0 108.717 -179.386 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 m -78.25 150.84 33.33 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.75 1.62 . . . . 0.0 108.299 179.082 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 76.82 63.08 0.04 OUTLIER 'General case' 0 C--N 1.34 0.167 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 -177.433 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 t -106.02 156.43 18.41 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.893 0.877 . . . . 0.0 111.354 -177.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.08 112.28 12.2 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 178.723 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.6 m -96.55 74.93 2.82 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.242 1.017 . . . . 0.0 110.012 -178.825 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.3 -70.81 2.1 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 125.097 1.332 . . . . 0.0 111.524 179.121 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.2 t -126.49 -44.58 1.69 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.896 1.678 . . . . 0.0 109.919 -179.222 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 m -68.5 111.06 4.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.644 0.778 . . . . 0.0 109.514 -179.349 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -81.41 151.94 27.66 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.083 0.953 . . . . 0.0 110.532 179.911 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -143.27 110.14 5.58 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.427 1.091 . . . . 0.0 110.326 -179.551 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.8 m -63.1 154.15 31.88 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 125.275 1.43 . . . . 0.0 109.171 178.77 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -20.9 57.81 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.865 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.4 m -74.35 -43.22 57.53 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.042 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -67.82 -47.29 69.46 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.189 0.995 . . . . 0.0 112.343 -179.174 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -60.19 -52.65 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 124.194 0.998 . . . . 0.0 109.215 -179.342 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -66.38 -38.8 88.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.141 1.377 . . . . 0.0 113.002 -177.841 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.51 -52.6 60.54 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.355 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.488 ' HB1' ' HE2' ' A' ' 59' ' ' PHE . . . -61.96 -32.55 73.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.431 179.237 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.92 -32.29 61.75 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 178.896 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -69.74 -24.66 63.57 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 176.959 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.06 -63.67 1.26 Allowed 'General case' 0 C--N 1.349 0.57 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 -179.222 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.497 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -41.58 -40.1 1.79 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.273 1.429 . . . . 0.0 112.447 176.852 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -60.89 -63.54 1.26 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.282 1.433 . . . . 0.0 110.247 179.219 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -66.43 -24.17 66.41 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -179.065 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -82.25 -45.31 15.18 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.211 1.404 . . . . 0.0 113.531 -177.798 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -66.23 -28.26 68.6 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.374 1.069 . . . . 0.0 112.589 -178.525 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -74.84 -64.73 0.98 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.407 0.548 . . . . 0.0 110.904 -177.738 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -172.49 -29.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.546 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -75.49 39.02 0.15 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -177.502 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.05 169.7 0.06 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 127.224 2.21 . . . . 0.0 110.689 178.608 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.0 t -158.28 37.19 0.24 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.388 1.475 . . . . 0.0 110.337 179.322 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.04 158.98 27.78 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.754 0.822 . . . . 0.0 111.835 -179.149 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.64 -137.59 7.33 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.573 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.7 t -145.32 -68.53 0.29 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.625 1.17 . . . . 0.0 108.452 179.091 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.2 m -83.33 -94.1 0.06 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.908 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.3 p -140.63 40.57 1.86 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.389 0.675 . . . . 0.0 110.677 178.571 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -82.17 132.06 54.49 Favored Pre-proline 0 C--N 1.345 0.389 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 177.66 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.49 123.75 5.73 Favored 'Cis proline' 0 CA--C 1.544 1.015 0 N-CA-C 114.044 0.748 . . . . 0.0 114.044 3.005 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.85 148.4 22.52 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 128.452 2.701 . . . . 0.0 113.758 -177.319 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.97 113.76 2.99 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.933 0.893 . . . . 0.0 109.264 179.047 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -95.03 90.38 5.92 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 120.838 0.352 . . . . 0.0 110.072 -178.821 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -156.12 119.21 4.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.162 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -128.58 -79.82 0.57 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.295 1.038 . . . . 0.0 109.336 -179.089 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -143.61 11.26 1.66 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.904 1.281 . . . . 0.0 110.884 179.467 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 55.45 47.64 20.66 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.225 1.41 . . . . 0.0 110.682 -178.852 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.67 -31.53 6.67 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.292 1.425 . . . . 0.0 111.303 179.413 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -127.44 94.02 3.87 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.041 1.336 . . . . 0.0 108.391 -179.195 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -118.88 -177.95 3.44 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.582 1.153 . . . . 0.0 111.487 -178.837 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.21 175.53 3.21 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.989 1.716 . . . . 0.0 108.553 -178.714 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.63 68.07 7.11 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.352 2.701 . . . . 0.0 111.573 -179.403 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.5 m -143.18 157.28 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 125.668 1.587 . . . . 0.0 109.78 179.695 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -85.5 -44.97 12.24 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.797 1.239 . . . . 0.0 111.235 -179.326 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.79 177.82 43.81 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.72 1.152 . . . . 0.0 111.865 -179.423 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.29 152.96 85.19 Favored 'Cis proline' 0 N--CA 1.458 -0.594 0 CA-C-N 117.973 0.886 . . . . 0.0 112.409 0.763 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.1 154.96 47.74 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 127.185 2.194 . . . . 0.0 109.981 179.325 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -135.85 160.81 37.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.049 -178.743 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.98 162.26 26.08 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.719 1.608 . . . . 0.0 112.14 -177.552 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.497 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 70.9 t80 -160.61 104.38 1.32 Allowed Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 177.388 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -80.84 135.46 10.09 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 121.899 1.733 . . . . 0.0 112.774 -175.778 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.58 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 3.7 tt -105.35 -176.34 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-O 124.249 1.976 . . . . 0.0 112.401 -179.223 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.58 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.3 mmtm -160.51 142.84 12.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 108.945 -3.752 . . . . 0.0 110.229 179.72 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.7 t -85.83 60.83 6.47 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.71 1.204 . . . . 0.0 109.138 -179.134 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.51 49.81 0.1 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.93 1.729 . . . . 0.0 109.003 -179.214 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.6 154.39 7.57 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.328 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.8 t -135.61 150.94 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.168 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 16.6 p90 48.33 48.47 18.93 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.818 1.647 . . . . 0.0 111.963 -179.051 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.1 m -79.29 138.31 37.7 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 125.027 1.331 . . . . 0.0 108.964 -178.896 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.91 -84.15 0.23 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.871 0.748 . . . . 0.0 112.791 -178.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.56 76.56 1.32 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.165 0.888 . . . . 0.0 112.096 -178.825 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.3 m -98.65 157.78 33.65 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.229 1.412 . . . . 0.0 110.177 179.338 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.9 -44.28 49.74 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.731 2.954 . . . . 0.0 111.495 164.61 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.57 24.23 26.49 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.773 1.178 . . . . 0.0 112.11 179.18 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.539 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -94.16 -68.92 0.77 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 118.158 -0.925 . . . . 0.0 109.548 179.203 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -70.4 107.1 3.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.096 0.958 . . . . 0.0 112.622 -178.621 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -140.03 131.65 27.2 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.338 0.655 . . . . 0.0 111.719 -179.074 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -94.19 153.16 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 176.882 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.7 t -132.95 130.42 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -178.348 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.5 pt -116.79 176.22 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.6 1.16 . . . . 0.0 112.634 -177.997 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -90.49 177.34 6.4 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 126.442 1.897 . . . . 0.0 110.022 179.763 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.322 12.9 t -81.2 47.71 1.05 Allowed 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 118.58 2.807 . . . . 0.0 118.58 -178.651 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -160.41 -87.04 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 177.05 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 76.7 m -162.97 62.6 0.19 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.198 2.599 . . . . 0.0 110.082 -176.793 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -144.02 117.74 9.27 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.202 1.819 . . . . 0.0 114.391 -179.416 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -55.74 128.83 36.73 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 124.365 1.066 . . . . 0.0 108.449 178.622 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.61 -59.6 1.68 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.931 0.892 . . . . 0.0 108.833 178.805 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.91 173.57 41.51 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.369 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.47 115.95 22.42 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.681 1.593 . . . . 0.0 109.231 179.267 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.9 pt -108.83 158.01 8.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 125.06 1.344 . . . . 0.0 110.017 -179.235 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 t -159.61 137.11 9.84 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 -179.529 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.539 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 6.5 m170 -78.1 -11.22 59.9 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 117.881 -1.057 . . . . 0.0 112.034 174.997 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.7 m -26.53 -65.63 0.06 Allowed 'General case' 0 C--N 1.349 0.549 0 C-N-CA 126.447 1.899 . . . . 0.0 114.937 -178.469 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.04 -75.51 1.25 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -179.348 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 50.81 -150.23 0.26 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.064 1.346 . . . . 0.0 112.27 -179.306 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 60.1 p -153.97 -51.41 0.1 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.163 1.385 . . . . 0.0 108.651 179.118 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -121.55 -86.38 0.86 Allowed Glycine 0 C--N 1.34 0.791 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 178.817 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -134.13 28.13 3.8 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.547 1.539 . . . . 0.0 110.734 179.23 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -85.96 164.96 17.1 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.906 1.282 . . . . 0.0 111.628 -178.885 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.454 ' CE2' ' NE2' ' A' ' 91' ' ' HIS . 13.5 m-85 -118.65 116.05 25.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.122 1.769 . . . . 0.0 107.781 179.098 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.4 m -90.89 164.44 2.12 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.255 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -91.15 133.83 11.99 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.071 -178.32 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 26.2 m -81.32 -172.99 4.09 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.526 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.9 t -75.8 93.06 3.1 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.993 -0.442 . . . . 0.0 110.12 -179.03 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.49 51.27 0.24 Allowed Glycine 0 CA--C 1.527 0.834 0 C-N-CA 126.105 1.812 . . . . 0.0 109.397 -179.37 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.0 m -154.66 110.82 3.22 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 125.2 1.4 . . . . 0.0 108.853 -179.14 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.5 m120 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.217 -1.373 . . . . 0.0 109.414 179.111 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.2 m -145.36 139.18 26.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.964 0.905 . . . . 0.0 109.497 -179.287 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -50.29 136.55 19.8 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.541 1.536 . . . . 0.0 111.436 -179.784 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.3 p -104.0 150.13 24.53 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.976 1.31 . . . . 0.0 111.379 -179.034 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -133.46 97.03 3.84 Favored 'General case' 0 N--CA 1.424 -1.772 1 N-CA-C 97.38 -5.044 . . . . 0.0 97.38 176.591 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -97.31 85.57 3.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.471 0.653 . . . . 0.0 110.668 -177.185 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.12 -96.2 1.58 Allowed Glycine 0 C--N 1.34 0.762 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 -178.879 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.7 m -104.91 -36.61 7.29 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.353 1.061 . . . . 0.0 110.307 179.23 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.38 168.03 19.27 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.346 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -156.75 132.45 9.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.091 0.156 . . . . 0.0 110.86 179.323 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -123.74 158.35 31.89 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.876 1.27 . . . . 0.0 109.947 -179.683 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.1 m -78.05 156.26 30.17 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.224 1.41 . . . . 0.0 110.479 -179.667 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.38 -18.9 42.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.83 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 90.7 p -72.66 -38.05 67.75 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 123.637 0.775 . . . . 0.0 109.966 179.248 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.93 -47.93 67.34 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.807 0.731 . . . . 0.0 110.236 178.654 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.2 t -53.14 -49.89 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 125.077 1.351 . . . . 0.0 108.496 179.09 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -69.51 -38.32 77.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.372 1.469 . . . . 0.0 113.083 -178.819 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.59 -54.18 31.43 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.817 0.735 . . . . 0.0 110.79 -178.507 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.25 -34.1 75.88 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.584 0.754 . . . . 0.0 111.118 179.43 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.11 -36.89 61.63 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 119.477 -0.297 . . . . 0.0 111.506 178.957 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -69.32 -20.78 63.87 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.449 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.5 -57.41 3.36 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -178.224 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.8 -38.26 47.38 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.088 1.355 . . . . 0.0 109.822 177.269 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.2 t -60.69 -54.57 43.68 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.358 1.463 . . . . 0.0 109.158 178.506 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -56.79 -36.85 70.35 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.687 0.395 . . . . 0.0 110.837 179.532 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.25 -6.52 59.28 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.714 1.206 . . . . 0.0 114.098 -179.863 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.46 ' CD2' ' HG3' ' A' ' 57' ' ' GLN . 8.7 t80 -128.23 43.96 3.04 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.154 0.888 . . . . 0.0 111.402 178.926 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -130.78 -84.46 0.52 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 125.338 1.455 . . . . 0.0 107.598 177.483 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -162.93 -14.75 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.274 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -84.17 65.21 8.66 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 125.586 1.554 . . . . 0.0 107.576 179.89 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 78.04 111.35 0.07 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 128.138 2.575 . . . . 0.0 108.475 -178.971 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.4 p -87.49 77.63 8.78 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.544 1.138 . . . . 0.0 109.295 -178.68 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.59 91.93 2.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.516 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.48 108.34 2.77 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 126.113 1.816 . . . . 0.0 108.57 -179.519 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 m -71.18 -66.9 0.56 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.834 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.0 p 156.49 -47.87 0.0 OUTLIER 'General case' 0 C--N 1.34 0.184 0 N-CA-C 100.537 -3.875 . . . . 0.0 100.537 -177.664 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.442 ' C ' ' CG ' ' A' ' 38' ' ' TYR . 7.5 t -93.11 53.2 1.92 Allowed 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 125.838 1.655 . . . . 0.0 107.308 176.951 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 38' ' ' TYR . 0.2 OUTLIER 79.69 155.15 0.13 Allowed Pre-proline 0 C--N 1.348 0.53 0 C-N-CA 127.376 2.27 . . . . 0.0 115.086 175.737 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.93 127.66 13.1 Favored 'Cis proline' 0 C--N 1.349 0.582 0 N-CA-C 114.93 1.089 . . . . 0.0 114.93 1.899 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.04 169.56 20.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.748 1.219 . . . . 0.0 110.212 178.913 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 m -37.52 131.66 0.9 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 128.737 2.815 . . . . 0.0 115.828 -178.911 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -109.07 109.21 20.17 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.975 1.71 . . . . 0.0 106.708 178.418 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -70.91 -36.34 72.67 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.616 1.166 . . . . 0.0 113.636 -178.788 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 70.86 77.26 0.18 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.198 1.399 . . . . 0.0 108.134 -178.465 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -72.76 91.53 1.49 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.111 1.364 . . . . 0.0 111.747 -178.641 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 54.75 152.83 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 129.305 3.042 . . . . 0.0 115.821 179.191 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.61 -145.25 24.26 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.774 1.178 . . . . 0.0 112.583 179.236 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.04 172.27 0.09 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.05 1.74 . . . . 0.0 113.46 -179.36 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -158.45 121.93 3.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 179.395 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -132.81 105.34 12.78 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 178.448 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.64 80.86 1.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.699 2.933 . . . . 0.0 113.397 -178.223 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.04 160.5 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 126.472 1.909 . . . . 0.0 107.81 178.822 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.57 -50.51 8.71 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.726 0.81 . . . . 0.0 110.623 179.557 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.54 -159.76 35.3 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.059 0.837 . . . . 0.0 111.257 -179.389 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.82 153.67 13.38 Favored 'Cis proline' 0 C--N 1.347 0.478 0 CA-C-N 119.092 1.446 . . . . 0.0 113.802 -0.172 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.87 158.25 20.41 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 123.877 0.871 . . . . 0.0 110.933 -178.994 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.46 ' HG3' ' CD2' ' A' ' 27' ' ' TYR . 6.2 mm100 -130.98 150.89 51.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.51 1.124 . . . . 0.0 111.687 -178.601 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -88.04 156.28 19.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.556 1.142 . . . . 0.0 110.653 179.216 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -159.74 109.22 1.46 Allowed Pre-proline 0 N--CA 1.457 -0.121 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.24 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -81.28 136.63 10.15 Favored 'Trans proline' 0 N--CA 1.436 -1.897 0 C-N-CA 121.043 1.162 . . . . 0.0 113.088 -177.827 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.26 -173.78 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 128.868 2.867 . . . . 0.0 103.891 178.896 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.36 -179.38 6.52 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 112.308 -2.224 . . . . 0.0 113.022 -177.989 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.3 t -89.42 51.05 2.03 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.075 1.35 . . . . 0.0 107.647 178.013 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.33 -66.78 0.03 OUTLIER Glycine 0 C--N 1.344 0.975 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.097 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.22 -149.41 7.28 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 117.75 0.775 . . . . 0.0 113.14 -179.774 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 t -61.86 130.72 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 126.509 1.923 . . . . 0.0 108.941 -179.165 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.1 133.14 45.36 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.879 0.872 . . . . 0.0 112.752 -178.732 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 m -132.34 -33.85 1.26 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.544 1.938 . . . . 0.0 110.352 179.394 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.26 -141.21 0.36 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.307 1.432 . . . . 0.0 114.851 -178.636 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.77 -151.69 1.55 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.364 1.459 . . . . 0.0 113.957 -178.777 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 m 72.88 151.33 0.14 Allowed Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 126.545 1.938 . . . . 0.0 110.664 -179.246 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -57.95 -72.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.042 2.495 . . . . 0.0 110.537 179.146 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.24 64.69 1.45 Allowed Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 178.304 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' A' ' 91' ' ' HIS . . . -61.69 -49.0 78.24 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.434 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.01 132.48 48.68 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.742 1.617 . . . . 0.0 108.218 178.725 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -157.96 132.73 8.47 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -178.512 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.6 m -95.95 147.66 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 176.309 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -128.65 117.32 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -178.635 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 35.4 pt -99.96 174.1 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.412 0 C-N-CA 126.345 1.858 . . . . 0.0 112.684 -178.287 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -94.85 -175.36 3.54 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.135 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.295 13.8 t -84.51 42.85 0.92 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 -179.9 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.8 -72.49 0.1 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.054 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -162.68 -9.04 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 117.009 2.226 . . . . 0.0 117.009 -177.227 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -79.3 118.59 21.36 Favored 'General case' 0 N--CA 1.458 -0.061 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -175.921 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -71.29 115.03 9.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.249 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.76 -57.97 3.41 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.945 0.898 . . . . 0.0 112.126 -178.548 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.77 151.6 12.03 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.769 179.716 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.07 131.11 44.76 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.291 1.436 . . . . 0.0 110.847 -179.052 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.6 pt -130.99 162.56 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 125.45 1.5 . . . . 0.0 109.638 -179.019 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 t -156.56 146.83 21.34 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -179.606 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.459 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 19.8 m170 -79.26 -26.64 42.36 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.237 175.177 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.0 m -31.05 -59.94 0.21 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 127.946 2.498 . . . . 0.0 115.347 -178.13 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.39 34.06 4.57 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.297 0.951 . . . . 0.0 112.231 -178.908 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.81 -87.51 0.16 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 117.604 0.702 . . . . 0.0 110.981 179.511 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.2 t -162.29 -51.94 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.083 1.353 . . . . 0.0 108.723 -179.188 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.46 -88.96 0.07 OUTLIER Glycine 0 C--N 1.339 0.71 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 179.24 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -79.94 -28.61 39.65 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.115 0.966 . . . . 0.0 110.325 178.725 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -63.19 169.3 3.6 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.287 1.435 . . . . 0.0 111.538 -179.541 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -128.64 156.71 42.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.899 2.08 . . . . 0.0 109.743 -179.711 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.7 m -141.88 155.84 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 C-N-CA 124.432 1.093 . . . . 0.0 108.17 177.094 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.47 129.05 9.05 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.122 -177.775 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 37.4 m -79.93 179.75 7.41 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.298 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.2 p -61.19 124.7 21.3 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.872 -1.143 . . . . 0.0 109.683 179.152 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.04 37.61 5.65 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -178.752 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 60.5 m -152.52 145.68 24.64 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.759 1.624 . . . . 0.0 107.965 -179.732 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 125.948 1.699 . . . . 0.0 110.952 179.47 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 121.027 0.442 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.1 t -160.14 69.86 0.41 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.896 1.279 . . . . 0.0 107.966 -179.04 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.59 177.29 0.21 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.47 1.508 . . . . 0.0 110.274 -178.877 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.6 p -143.95 94.13 2.54 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.08 0.552 . . . . 0.0 110.273 178.869 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.0 m -87.76 89.61 8.06 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 102.51 -3.144 . . . . 0.0 102.51 177.792 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.3 m -86.92 63.76 8.12 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.308 1.843 . . . . 0.0 108.852 -178.952 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.13 -79.29 1.88 Allowed Glycine 0 C--N 1.34 0.779 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.085 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.7 p -115.07 -42.45 3.2 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.429 1.491 . . . . 0.0 109.68 179.256 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.35 114.3 3.11 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 124.514 1.125 . . . . 0.0 108.568 178.925 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.65 99.75 7.96 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.709 0.804 . . . . 0.0 110.368 -178.176 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -94.67 146.24 24.29 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.559 0.743 . . . . 0.0 109.08 179.048 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.4 m -72.15 153.12 41.84 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 124.094 0.958 . . . . 0.0 109.979 -179.555 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.44 -18.87 43.09 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 176.822 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 63.3 m -75.28 -39.75 59.37 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 125.002 1.321 . . . . 0.0 109.176 178.705 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -68.92 -40.84 78.83 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 123.946 0.899 . . . . 0.0 110.85 179.188 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.1 t -61.53 -48.32 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.888 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 ttt85 -65.83 -39.82 91.2 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.58 1.552 . . . . 0.0 112.125 -179.715 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.19 -51.83 66.23 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.178 0.591 . . . . 0.0 109.65 -179.074 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.51 -30.67 71.44 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.272 0.629 . . . . 0.0 111.477 179.256 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.65 -46.71 45.01 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.302 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -65.71 -20.24 66.2 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.76 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.96 -61.49 2.0 Allowed 'General case' 0 C--N 1.346 0.456 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -177.643 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -43.83 -51.64 7.27 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 124.849 1.343 . . . . 0.0 109.313 176.732 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 m -48.19 -54.25 14.09 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 126.479 1.912 . . . . 0.0 111.155 178.775 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -70.99 -25.92 62.91 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -178.729 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -106.08 -2.21 22.94 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 -176.93 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.416 ' CD2' ' HB2' ' A' ' 57' ' ' GLN . 0.1 OUTLIER -110.48 -5.66 15.09 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.076 1.307 . . . . 0.0 114.275 178.683 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -78.3 -62.95 1.52 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.062 0.846 . . . . 0.0 112.134 -178.102 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -159.68 -41.32 0.05 Allowed 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.124 0.57 . . . . 0.0 110.916 -178.785 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.68 60.71 5.4 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.222 1.409 . . . . 0.0 107.643 178.814 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -69.99 123.24 21.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.611 1.564 . . . . 0.0 111.408 -178.423 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.8 t -149.41 39.56 0.82 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.871 0.869 . . . . 0.0 110.906 179.032 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -174.69 105.01 0.1 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.47 1.908 . . . . 0.0 106.025 179.122 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.32 114.59 0.63 Allowed Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.242 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 78.8 p -70.59 -67.84 0.47 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.411 1.084 . . . . 0.0 111.038 -179.031 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.1 m -143.09 -69.44 0.33 Allowed 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.156 0.983 . . . . 0.0 108.69 179.421 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.0 p -104.62 -58.44 1.88 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.494 1.118 . . . . 0.0 108.091 179.338 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.95 123.62 82.5 Favored Pre-proline 0 N--CA 1.468 0.457 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 178.316 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.31 123.59 8.67 Favored 'Cis proline' 0 N--CA 1.456 -0.699 0 N-CA-C 116.662 1.755 . . . . 0.0 116.662 3.892 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.64 173.23 2.02 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 128.207 2.603 . . . . 0.0 108.031 178.051 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 52.4 p -72.15 160.14 32.95 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.68 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -117.86 119.47 34.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.131 2.172 . . . . 0.0 108.658 179.554 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -166.68 44.95 0.06 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.288 1.435 . . . . 0.0 108.703 179.138 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -95.2 77.47 3.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.257 1.023 . . . . 0.0 110.384 -179.013 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 63.28 -177.21 0.15 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.614 1.566 . . . . 0.0 113.685 178.505 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -74.25 -173.0 1.55 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.722 1.609 . . . . 0.0 111.295 179.127 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.09 -52.56 0.63 Allowed Glycine 0 C--N 1.34 0.782 0 C-N-CA 124.603 1.097 . . . . 0.0 110.46 179.452 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -138.36 131.52 30.09 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.103 0.961 . . . . 0.0 110.312 179.274 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -161.04 137.29 8.36 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.223 1.809 . . . . 0.0 107.278 179.302 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -94.47 151.71 39.52 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.943 0.897 . . . . 0.0 110.339 -178.86 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.88 67.29 6.67 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 124.244 3.296 . . . . 0.0 112.044 -179.368 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.0 m -147.65 163.94 6.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 125.866 1.666 . . . . 0.0 108.066 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -66.27 -44.42 83.65 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.749 0.819 . . . . 0.0 111.725 -179.652 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.3 -171.29 49.18 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.182 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.53 167.11 24.25 Favored 'Cis proline' 0 C--N 1.348 0.526 0 CA-C-N 119.529 1.665 . . . . 0.0 113.766 -1.5 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -128.69 146.97 50.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.178 1.391 . . . . 0.0 110.832 -179.338 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.416 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 2.5 tp60 -91.69 138.2 31.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 128.086 2.554 . . . . 0.0 113.43 -178.342 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.1 141.52 30.94 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.285 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -149.75 114.46 3.47 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.862 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -80.59 133.36 9.37 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.141 1.894 . . . . 0.0 112.516 -176.882 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.58 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 2.3 tt -106.05 -170.23 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-O 123.481 1.61 . . . . 0.0 111.984 -179.262 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.58 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.2 mmtp -160.76 -170.06 2.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 109.962 -3.29 . . . . 0.0 112.493 179.37 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.1 t -85.77 63.05 7.83 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 126.705 2.002 . . . . 0.0 108.108 -179.667 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.47 59.99 2.06 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -179.261 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.13 98.24 0.18 Allowed Glycine 0 C--N 1.338 0.668 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.076 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.3 t -64.42 147.26 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 178.207 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.5 t80 69.85 -167.43 0.17 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.093 0.957 . . . . 0.0 108.693 -179.041 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.2 p -78.73 114.91 18.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.256 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.56 -130.31 5.58 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.826 1.203 . . . . 0.0 110.816 -179.285 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.65 73.18 2.7 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.195 0.903 . . . . 0.0 112.981 -178.94 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.3 m 56.55 69.82 1.64 Allowed Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.153 1.381 . . . . 0.0 112.401 178.885 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.99 85.03 1.57 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.212 3.274 . . . . 0.0 111.463 179.39 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.77 31.54 8.56 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.01 -0.883 . . . . 0.0 113.717 -179.203 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.4 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -157.08 -71.5 0.1 Allowed 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.75 1.275 . . . . 0.0 111.251 178.932 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -68.93 108.63 3.57 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.356 1.862 . . . . 0.0 114.926 -178.728 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -128.35 126.2 40.23 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 125.253 1.421 . . . . 0.0 111.846 179.693 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 m -93.74 144.2 10.03 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 176.699 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.7 t -137.63 127.18 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.042 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.7 pt -113.81 171.36 4.07 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 C-N-CA 125.188 1.395 . . . . 0.0 111.655 -178.352 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -85.22 165.95 16.94 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.881 1.672 . . . . 0.0 107.897 178.833 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.389 5.9 t -80.04 48.16 0.96 Allowed 'General case' 0 C--N 1.343 0.309 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -178.204 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -143.64 -85.59 0.14 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 102.071 -3.307 . . . . 0.0 102.071 176.754 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.2 m -163.61 -3.57 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.579 1.951 . . . . 0.0 114.616 178.687 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -79.67 122.4 26.5 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -176.084 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -63.32 117.15 6.22 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.507 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.65 -53.41 4.65 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 123.515 0.726 . . . . 0.0 110.761 -177.647 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.66 150.94 9.97 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 179.356 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.97 130.37 54.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.648 1.179 . . . . 0.0 108.145 179.565 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.8 pt -122.27 157.43 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.938 1.295 . . . . 0.0 108.579 -179.27 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.3 t -156.97 146.08 20.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -178.661 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.4 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 24.7 m170 -84.33 65.0 8.64 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 174.571 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.5 m -51.07 -46.61 61.81 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.927 0.785 . . . . 0.0 110.387 179.236 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.57 -51.48 0.03 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 179.401 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 30.25 -99.35 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 128.071 2.548 . . . . 0.0 112.669 -179.13 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.4 m -159.58 79.46 0.72 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.854 1.662 . . . . 0.0 107.251 179.141 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.49 -108.05 2.31 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.462 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -79.77 -5.9 56.23 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.736 0.814 . . . . 0.0 113.0 -179.325 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -64.64 160.86 18.86 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.002 0.819 . . . . 0.0 110.339 179.288 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -121.82 167.55 12.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.572 1.549 . . . . 0.0 113.656 -177.832 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.8 m -146.19 165.99 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 128.953 2.901 . . . . 0.0 105.928 176.737 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.2 144.96 17.09 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.369 0.509 . . . . 0.0 113.946 -178.238 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 13.9 m -94.3 165.24 12.68 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 124.092 0.957 . . . . 0.0 109.049 178.43 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 88.1 p 21.81 43.47 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 129.11 2.964 . . . . 0.0 118.091 -177.887 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.77 59.38 9.8 Favored Glycine 0 C--N 1.337 0.632 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.587 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.3 t -78.99 151.31 31.64 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.983 0.42 . . . . 0.0 110.689 -179.397 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 . . . . . 0 C--O 1.251 1.132 0 CA-C-O 116.468 -1.73 . . . . 0.0 110.779 -178.956 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 121.05 0.452 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t -152.44 143.94 23.41 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.865 1.266 . . . . 0.0 108.231 179.937 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.51 132.61 45.14 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.14 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.4 t -132.93 143.34 49.42 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -177.76 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.82 117.34 29.93 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.952 1.701 . . . . 0.0 108.212 178.885 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.8 m -103.76 78.18 1.54 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.896 1.278 . . . . 0.0 108.506 -178.814 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.51 -57.75 4.89 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.415 1.007 . . . . 0.0 111.723 179.392 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.1 t -150.79 -42.1 0.12 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.963 1.305 . . . . 0.0 110.56 -179.369 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.71 113.31 5.39 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.382 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -82.29 155.11 25.0 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.564 1.546 . . . . 0.0 111.394 -178.876 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -149.74 139.96 22.2 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.077 1.351 . . . . 0.0 109.092 178.956 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 m -81.52 160.19 23.98 Favored 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 124.862 1.265 . . . . 0.0 108.502 177.7 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.33 -23.42 48.71 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.863 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.2 p -77.85 -31.12 51.3 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.678 0.611 . . . . 0.0 110.286 -178.955 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.63 -39.43 70.42 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.939 0.896 . . . . 0.0 111.525 179.162 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.03 -38.66 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -179.141 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -72.0 -24.71 61.62 Favored 'General case' 0 C--N 1.347 0.461 0 C-N-CA 124.576 1.15 . . . . 0.0 112.384 179.124 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.47 -58.32 4.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.381 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.18 -23.34 63.92 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.076 179.33 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.73 -43.48 54.78 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 120.693 1.588 . . . . 0.0 111.292 178.944 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -66.93 -21.62 65.98 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.982 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.18 -64.3 1.17 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 -178.733 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.553 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -34.7 -53.05 0.54 Allowed 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.35 1.86 . . . . 0.0 111.226 175.952 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.3 t -56.75 -53.63 55.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.316 1.446 . . . . 0.0 110.919 179.446 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -73.87 -12.51 60.69 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -179.169 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -108.88 -19.24 13.47 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -178.832 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -80.84 -59.32 2.72 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.516 1.507 . . . . 0.0 112.785 -177.735 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -143.81 51.9 1.32 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.927 0.785 . . . . 0.0 111.713 -178.784 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -134.99 -53.58 0.8 Allowed 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.665 1.186 . . . . 0.0 108.835 178.764 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -138.4 86.21 2.14 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -178.977 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 68.23 -167.92 0.19 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.81 1.244 . . . . 0.0 110.215 -179.507 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.5 p -107.41 -41.02 5.2 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.17 1.388 . . . . 0.0 110.024 178.748 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 52.08 95.63 0.01 OUTLIER 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.505 1.922 . . . . 0.0 113.329 178.888 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.72 -95.64 0.99 Allowed Glycine 0 C--N 1.336 0.563 0 C-N-CA 124.816 1.198 . . . . 0.0 110.363 179.936 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m 54.8 67.48 1.01 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.413 1.085 . . . . 0.0 110.095 -179.09 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.4 t -113.08 -56.03 2.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 102.311 -3.218 . . . . 0.0 102.311 179.436 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.49 ' O ' ' CD1' ' A' ' 38' ' ' TYR . 22.3 p -119.9 -31.54 4.46 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 127.645 2.378 . . . . 0.0 107.464 177.047 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.49 ' CD1' ' O ' ' A' ' 37' ' ' THR . 1.8 m-85 -149.19 154.51 39.18 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 127.377 2.271 . . . . 0.0 110.044 -178.786 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.17 119.71 6.59 Favored 'Cis proline' 0 CA--C 1.542 0.907 0 N-CA-C 114.082 0.762 . . . . 0.0 114.082 1.93 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -127.85 158.83 36.67 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 125.966 1.706 . . . . 0.0 110.71 -179.343 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.9 m -59.64 135.7 57.76 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.996 2.118 . . . . 0.0 110.104 178.708 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -135.94 60.58 1.67 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.019 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -161.79 58.31 0.26 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.874 1.27 . . . . 0.0 109.076 -179.033 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -70.98 -62.69 1.3 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.968 0.907 . . . . 0.0 110.196 179.802 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -141.14 -80.66 0.25 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.949 1.3 . . . . 0.0 108.152 179.458 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -166.04 121.7 1.26 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -179.373 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.69 -73.59 0.05 OUTLIER Glycine 0 C--N 1.336 0.565 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 178.941 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.21 171.71 8.43 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.012 0.925 . . . . 0.0 109.446 179.068 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -128.46 146.37 50.83 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.142 0.977 . . . . 0.0 111.168 -179.201 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -153.1 155.17 31.76 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 125.866 1.667 . . . . 0.0 108.201 -179.707 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.28 -32.63 61.58 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.945 2.43 . . . . 0.0 111.137 178.874 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.9 m -74.78 164.93 3.38 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 C-N-CA 123.576 0.75 . . . . 0.0 111.094 179.276 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -100.43 -61.3 1.39 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.024 1.33 . . . . 0.0 109.203 179.431 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 135.77 -165.72 24.75 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.71 1.148 . . . . 0.0 110.998 179.441 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.61 138.21 23.31 Favored 'Cis proline' 0 C--N 1.345 0.392 0 CA-C-N 118.247 1.024 . . . . 0.0 111.533 -0.632 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -135.25 138.95 44.04 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 179.989 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -125.3 157.81 35.73 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.626 1.57 . . . . 0.0 112.116 -178.748 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.33 157.26 25.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 127.631 2.373 . . . . 0.0 114.151 -177.934 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.553 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 60.7 t80 -160.8 113.36 1.32 Allowed Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.248 1.019 . . . . 0.0 110.157 177.915 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . 0.269 24.8 Cg_endo -70.52 138.64 35.86 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 CA-C-N 120.17 1.097 . . . . 0.0 112.731 -177.243 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.499 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -80.96 -149.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -176.969 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.499 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 27.0 mmmt -83.35 -171.04 3.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 131.156 3.783 . . . . 0.0 111.945 -178.15 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.3 t 91.56 54.97 0.0 OUTLIER 'General case' 0 C--N 1.343 0.295 0 C-N-CA 129.56 3.144 . . . . 0.0 105.383 -178.008 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.21 -46.02 0.84 Allowed Glycine 0 CA--C 1.53 0.997 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -178.377 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.29 172.09 24.09 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.364 1.459 . . . . 0.0 109.989 179.41 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.35 114.46 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 178.939 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 75.1 t80 61.63 75.81 0.39 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.163 1.385 . . . . 0.0 111.462 -179.181 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 t -160.26 -178.34 6.89 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.341 1.057 . . . . 0.0 110.128 178.724 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.16 -150.54 1.94 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.665 1.126 . . . . 0.0 112.316 179.508 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.4 -55.3 4.72 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -178.997 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.4 t -137.8 79.52 33.54 Favored Pre-proline 0 N--CA 1.451 -0.386 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.647 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -35.09 -54.63 0.63 Allowed 'Trans proline' 0 C--N 1.349 0.595 1 C-N-CA 126.242 4.628 . . . . 0.0 116.362 -175.824 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.72 99.26 0.16 Allowed Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.59 -0.815 . . . . 0.0 113.559 -179.231 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.442 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . -155.11 -76.52 0.1 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 177.244 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.59 110.53 1.15 Allowed 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.761 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -136.29 119.66 16.84 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.821 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.4 m -89.15 152.0 3.4 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 176.622 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -137.75 141.77 38.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -176.982 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.59 179.56 4.17 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 123.72 0.808 . . . . 0.0 112.531 -178.485 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -96.38 169.84 9.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.461 1.905 . . . . 0.0 110.015 -178.62 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.278 6.5 t -76.56 28.03 0.13 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 118.051 2.611 . . . . 0.0 118.051 -177.967 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -129.5 -78.0 0.55 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 102.648 -3.093 . . . . 0.0 102.648 177.167 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.09 -19.67 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -178.686 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -79.28 145.57 33.45 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -175.4 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . 0.267 31.7 m-85 -63.61 157.16 24.55 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 127.498 2.319 . . . . 0.0 115.497 -179.042 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -113.84 -44.53 3.16 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 175.556 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.01 -148.45 20.22 Favored Glycine 0 C--N 1.349 1.262 0 C-N-CA 126.222 1.867 . . . . 0.0 111.752 177.576 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.84 147.77 35.96 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-O 121.554 0.693 . . . . 0.0 112.283 -178.79 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 pt -147.0 167.39 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 127.017 2.127 . . . . 0.0 108.376 -179.108 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.6 t -158.88 148.13 18.82 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 179.548 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.442 ' HB2' ' CB ' ' A' ' 74' ' ' ALA . 24.7 m170 -83.67 36.1 0.53 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 175.196 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.3 t -58.72 -35.51 72.79 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.46 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -173.25 60.35 0.14 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.568 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -97.17 -71.06 0.69 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.279 1.032 . . . . 0.0 108.999 179.323 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.3 t -170.66 -62.86 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.758 1.623 . . . . 0.0 109.041 179.219 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -159.46 -87.11 0.06 OUTLIER Glycine 0 C--N 1.338 0.671 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 179.407 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -79.87 -18.25 51.16 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.531 0.732 . . . . 0.0 110.215 178.743 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -65.03 168.36 6.64 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.369 1.468 . . . . 0.0 110.727 179.327 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -136.27 169.79 17.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.914 1.285 . . . . 0.0 113.056 -177.972 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.3 m -141.38 164.82 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.94 2.096 . . . . 0.0 106.424 176.65 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -77.47 142.65 27.26 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 115.029 0.772 . . . . 0.0 115.029 -177.493 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 24.6 t -109.37 169.99 8.35 Favored 'General case' 0 C--N 1.341 0.202 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 177.671 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.36 -157.57 0.33 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.684 -0.635 . . . . 0.0 109.425 -178.3 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.53 -9.34 58.25 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 124.183 0.897 . . . . 0.0 111.396 177.346 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.7 m -79.41 143.42 35.06 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 125.17 1.388 . . . . 0.0 108.982 179.213 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 C--O 1.25 1.131 0 C-N-CA 125.189 1.396 . . . . 0.0 109.956 -179.217 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 121.215 0.531 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 81.6 p -85.93 176.86 7.83 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.419 1.087 . . . . 0.0 109.762 179.117 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.33 127.43 8.96 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.061 1.345 . . . . 0.0 111.084 179.104 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -111.61 123.48 50.32 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.814 1.246 . . . . 0.0 109.713 -178.802 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -129.71 93.66 3.57 Favored 'General case' 0 N--CA 1.428 -1.53 1 N-CA-C 98.558 -4.608 . . . . 0.0 98.558 176.839 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.5 m -102.91 88.3 3.15 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.195 0.598 . . . . 0.0 110.295 -177.655 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.07 -79.38 1.02 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -178.946 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.2 p -132.83 -31.69 1.3 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.304 1.842 . . . . 0.0 110.464 178.521 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 m -67.41 106.7 2.19 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.024 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -108.07 141.66 39.42 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.546 1.138 . . . . 0.0 111.738 -178.352 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -144.45 144.33 31.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.779 1.632 . . . . 0.0 108.155 179.356 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.8 t -70.11 155.43 40.63 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 124.448 1.099 . . . . 0.0 109.912 178.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.71 -21.94 56.23 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 176.388 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -73.2 -35.85 66.43 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 125.157 1.383 . . . . 0.0 109.959 179.215 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.2 tp-100 -73.75 -35.56 65.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.173 0.589 . . . . 0.0 112.384 179.185 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 t -69.02 -47.13 77.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.377 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.3 ptt85 -65.26 -43.26 91.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.02 0.528 . . . . 0.0 110.554 179.551 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.72 89.5 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.543 0.737 . . . . 0.0 109.398 179.023 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.81 -38.98 79.81 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.369 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.92 -29.73 62.2 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 178.506 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -70.81 -24.1 62.49 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.494 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HB1' ' CE2' ' A' ' 26' ' ' TYR . . . -77.36 -64.3 1.17 Allowed 'General case' 0 C--N 1.346 0.441 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 -178.76 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.535 ' HB2' ' CG ' ' A' ' 59' ' ' PHE . . . -39.25 -50.59 1.98 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.078 1.351 . . . . 0.0 112.211 176.445 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.5 t -51.99 -62.88 1.35 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 128.029 2.531 . . . . 0.0 111.586 179.324 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -66.03 -42.12 90.03 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.543 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.422 ' CE2' ' HB1' ' A' ' 22' ' ' ALA . 6.4 m-30 -67.54 -30.85 70.6 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.418 1.087 . . . . 0.0 113.149 -177.728 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -84.48 -44.64 13.43 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 118.957 0.799 . . . . 0.0 112.12 -179.739 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -69.56 -51.13 38.25 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.233 0.613 . . . . 0.0 111.648 -179.007 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -78.03 -20.61 52.11 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 119.263 -0.399 . . . . 0.0 111.789 -179.458 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 63.74 65.21 0.73 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 124.935 1.294 . . . . 0.0 110.362 179.815 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -150.55 167.38 27.38 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 126.032 1.733 . . . . 0.0 108.049 179.099 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.287 0.0 OUTLIER 49.53 71.58 0.38 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.263 1.025 . . . . 0.0 113.46 -179.459 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -150.63 144.91 25.54 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.06 1.344 . . . . 0.0 108.549 179.179 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.72 -165.85 23.0 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.804 -0.519 . . . . 0.0 111.804 -179.42 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.1 m -83.86 46.66 1.2 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.904 0.882 . . . . 0.0 111.139 -179.384 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 87.7 p -146.75 161.54 40.4 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 178.733 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.7 p -80.11 33.31 0.28 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.885 -179.556 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -92.65 127.23 48.99 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 119.922 1.237 . . . . 0.0 109.504 -178.462 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -60.95 120.67 1.21 Allowed 'Cis proline' 0 C--N 1.348 0.506 0 N-CA-C 116.144 1.556 . . . . 0.0 116.144 -1.426 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -103.65 157.3 17.16 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.488 1.115 . . . . 0.0 108.84 178.933 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.92 118.86 8.36 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 122.706 0.403 . . . . 0.0 110.956 179.871 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.92 105.4 13.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 178.771 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -153.59 143.16 21.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.93 0.892 . . . . 0.0 110.296 -178.664 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 56.0 -134.0 1.44 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.07 1.348 . . . . 0.0 110.999 178.998 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 73.92 -73.7 0.09 Allowed 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.139 1.776 . . . . 0.0 109.065 -179.302 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -127.82 -37.09 1.96 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.787 1.635 . . . . 0.0 109.176 178.949 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.09 70.65 1.3 Allowed Glycine 0 C--N 1.342 0.874 0 C-N-CA 124.243 0.925 . . . . 0.0 112.027 178.92 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.33 -169.05 2.42 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.689 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -154.64 156.94 37.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.487 0.715 . . . . 0.0 110.689 179.449 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -148.92 144.51 18.24 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 125.739 1.616 . . . . 0.0 107.616 178.681 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -45.19 -45.47 14.74 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.49 3.46 . . . . 0.0 113.371 178.649 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -83.31 149.11 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 124.158 0.983 . . . . 0.0 110.482 179.323 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -91.61 168.7 11.32 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.855 1.262 . . . . 0.0 111.162 -178.854 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.08 -158.16 27.3 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.386 0.993 . . . . 0.0 111.797 -179.244 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -57.91 128.09 2.94 Favored 'Cis proline' 0 N--CA 1.453 -0.856 0 CA-C-N 118.215 1.007 . . . . 0.0 112.202 -0.362 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.44 158.33 21.71 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.907 2.083 . . . . 0.0 109.025 178.793 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -137.08 164.28 28.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.558 -177.954 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.98 157.54 26.8 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 126.709 2.004 . . . . 0.0 110.698 -178.078 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.535 ' CG ' ' HB2' ' A' ' 23' ' ' ALA . 56.9 t80 -160.12 96.77 1.51 Allowed Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 176.246 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.58 145.76 47.78 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 C-N-CA 120.379 0.719 . . . . 0.0 110.935 -176.119 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.589 ' CG1' ' H ' ' A' ' 62' ' ' LYS . 2.9 tt -109.33 -172.77 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 124.253 1.978 . . . . 0.0 111.589 178.639 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.589 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 2.9 tttm -160.02 152.13 20.55 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 109.12 -3.673 . . . . 0.0 109.84 -179.397 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.1 t -76.58 52.27 0.79 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.628 1.571 . . . . 0.0 113.748 -178.165 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.0 43.05 0.24 Allowed Glycine 0 CA--C 1.526 0.759 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.402 178.016 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.58 76.48 0.03 OUTLIER Glycine 0 C--N 1.345 1.049 0 CA-C-N 119.53 1.665 . . . . 0.0 116.247 178.767 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 67' ' ' TYR 0.333 8.6 p 37.06 -139.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.43 0 C-N-CA 126.167 1.787 . . . . 0.0 113.385 177.683 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.422 ' H ' HG22 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -58.12 -175.9 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.604 2.362 . . . . 0.0 114.173 178.548 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 71.1 p -78.92 158.74 27.98 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.398 1.079 . . . . 0.0 113.854 -177.373 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 178.77 47.98 0.07 OUTLIER Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.247 1.88 . . . . 0.0 108.686 179.247 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 170.25 -160.19 32.91 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.139 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 76.9 p -158.84 156.71 27.36 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 124.752 1.221 . . . . 0.0 109.437 -179.329 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -79.74 166.07 78.22 Favored 'Cis proline' 0 N--CA 1.458 -0.56 0 CA-C-N 119.427 0.831 . . . . 0.0 111.36 -2.505 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.64 -109.45 1.1 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 124.224 0.916 . . . . 0.0 112.406 -178.935 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.484 ' CB ' ' HB2' ' A' ' 91' ' ' HIS . . . 58.68 35.39 24.41 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 125.362 1.465 . . . . 0.0 111.541 -178.753 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -152.51 107.77 3.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.324 1.05 . . . . 0.0 110.529 178.377 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.44 130.56 19.54 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.51 -179.314 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.4 m -98.52 157.29 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 176.361 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.6 t -135.44 133.15 52.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -178.479 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -116.61 -179.95 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.781 1.232 . . . . 0.0 112.444 -178.307 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -101.45 174.82 5.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.952 2.101 . . . . 0.0 109.548 179.128 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.31 13.7 t -82.19 49.08 1.34 Allowed 'General case' 0 C--N 1.345 0.386 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 -178.576 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -152.46 -87.99 0.06 Allowed 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 177.429 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 94.9 m -161.83 -0.22 0.05 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.874 2.469 . . . . 0.0 113.879 -176.898 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -80.06 138.85 37.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.364 0.984 . . . . 0.0 113.063 -176.866 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -80.0 128.39 33.42 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.405 1.482 . . . . 0.0 108.042 178.829 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.28 -47.89 6.42 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 123.556 0.743 . . . . 0.0 110.505 179.605 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.15 -174.24 46.25 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 179.339 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.97 141.88 44.48 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.39 1.476 . . . . 0.0 109.915 179.329 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.5 pt -141.07 157.26 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.795 1.238 . . . . 0.0 109.621 -179.079 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.0 t -150.81 149.81 30.19 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.126 0.97 . . . . 0.0 113.402 -178.48 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.484 ' HB2' ' CB ' ' A' ' 74' ' ' ALA 0.266 37.8 m170 -79.51 -24.1 42.49 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.972 0.805 . . . . 0.0 109.118 175.999 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.1 m -50.75 102.55 0.04 OUTLIER 'General case' 0 C--N 1.343 0.299 0 C-N-CA 126.339 1.855 . . . . 0.0 109.255 178.994 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.13 63.23 1.75 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -178.646 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.47 179.57 8.05 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.385 1.074 . . . . 0.0 110.609 179.571 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.7 t -86.18 62.07 7.21 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.507 1.523 . . . . 0.0 110.527 -179.353 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.21 -90.03 0.43 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.824 1.678 . . . . 0.0 113.199 178.418 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.35 -23.12 43.62 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.148 0.979 . . . . 0.0 111.344 -179.064 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -59.75 158.38 10.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.472 1.109 . . . . 0.0 112.129 -179.086 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -121.15 135.0 55.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.084 1.754 . . . . 0.0 108.991 -179.459 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 m -110.06 163.5 6.97 Favored 'Isoleucine or valine' 0 C--N 1.341 0.224 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.697 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.65 149.34 31.62 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.894 0.759 . . . . 0.0 112.935 -178.439 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.7 t -137.26 164.67 27.97 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 125.725 1.61 . . . . 0.0 108.849 178.76 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 96.4 p 46.47 50.65 12.47 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.366 2.267 . . . . 0.0 112.631 -179.649 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.12 64.04 2.28 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.241 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 99.4 m -146.01 132.99 20.22 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.863 1.265 . . . . 0.0 108.132 179.083 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 116.756 -1.592 . . . . 0.0 109.036 179.352 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 121.235 0.54 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t -159.88 71.86 0.49 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.272 1.029 . . . . 0.0 108.576 -179.338 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.84 97.52 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.416 1.886 . . . . 0.0 110.878 179.34 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.5 m -99.69 121.73 41.67 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.46 1.904 . . . . 0.0 107.504 -178.733 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -122.59 111.29 16.6 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -179.683 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.3 m -100.04 81.91 2.48 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.484 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.89 -95.36 0.72 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.317 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.6 p -104.23 -36.33 7.68 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.116 1.366 . . . . 0.0 110.977 179.375 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 m -73.83 103.77 4.48 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 123.113 0.565 . . . . 0.0 110.099 -178.876 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -83.06 152.91 25.16 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.43 1.092 . . . . 0.0 110.622 -179.243 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -148.11 137.71 22.33 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.964 0.906 . . . . 0.0 111.281 -179.815 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.5 m -78.17 150.44 33.56 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.475 1.51 . . . . 0.0 107.757 178.295 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.96 -17.5 25.3 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.087 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.2 t -74.55 -44.99 48.43 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 124.506 1.122 . . . . 0.0 109.513 178.956 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -68.7 -43.73 75.42 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.051 0.94 . . . . 0.0 110.917 -179.894 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.9 t -56.72 -54.4 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 C-N-CA 126.988 2.115 . . . . 0.0 109.135 178.954 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -67.93 -43.05 80.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.071 -178.128 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.8 -49.48 77.33 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.694 0.679 . . . . 0.0 109.674 179.297 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.82 -31.75 68.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.313 1.045 . . . . 0.0 110.478 178.837 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.47 -38.47 29.87 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 179.769 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -66.7 -22.12 66.08 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.419 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.09 -54.91 5.53 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -179.182 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.439 ' HB2' ' CD2' ' A' ' 59' ' ' PHE . . . -46.77 -43.71 18.43 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.431 1.492 . . . . 0.0 112.499 177.853 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.0 p -73.28 -43.42 61.04 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.996 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -60.99 -31.02 70.63 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.137 0.426 . . . . 0.0 110.685 178.737 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -97.14 -3.88 40.26 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.341 1.457 . . . . 0.0 113.135 -179.177 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -57.45 -24.82 57.92 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.358 -0.839 . . . . 0.0 111.663 178.722 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.467 0.0 OUTLIER 127.73 59.44 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.634 1 C-N-CA 135.15 5.38 . . . . 0.0 112.837 -178.221 . . . . . . . . 4 3 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -129.16 -35.11 1.83 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.696 1.198 . . . . 0.0 112.188 -179.109 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -153.96 64.72 0.71 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.22 0.918 . . . . 0.0 113.127 179.505 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 t70 57.89 -170.32 0.11 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.315 1.446 . . . . 0.0 113.285 178.154 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.3 p 47.68 43.67 16.79 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.924 1.69 . . . . 0.0 112.94 179.049 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.85 -175.59 3.54 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.279 1.431 . . . . 0.0 114.426 -178.532 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -32.35 138.02 0.1 Allowed Glycine 0 C--N 1.341 0.846 0 C-N-CA 128.118 2.771 . . . . 0.0 117.558 -178.217 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.9 m -101.88 -55.94 2.39 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.311 1.444 . . . . 0.0 110.629 -179.519 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.6 p -97.65 -63.57 1.12 Allowed 'General case' 0 C--N 1.346 0.454 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -179.256 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.8 p -146.41 -42.03 0.2 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.598 1.959 . . . . 0.0 110.376 -179.532 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -91.59 151.6 42.62 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 124.692 1.197 . . . . 0.0 109.746 -178.088 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -84.38 134.2 20.57 Favored 'Cis proline' 0 N--CA 1.45 -1.048 0 CA-C-N 119.655 0.913 . . . . 0.0 111.127 -1.72 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.05 172.9 15.15 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 126.033 1.733 . . . . 0.0 108.207 179.412 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 t -60.4 147.77 39.66 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.715 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -80.01 116.61 20.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.998 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -68.48 -52.75 28.9 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.654 1.181 . . . . 0.0 112.301 -179.345 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -88.38 -170.04 2.8 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.482 1.113 . . . . 0.0 111.173 -179.061 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -129.07 -50.78 1.21 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.635 1.974 . . . . 0.0 108.638 179.505 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 53.99 70.61 0.59 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.326 1.85 . . . . 0.0 113.763 178.455 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.45 -98.38 0.24 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.684 1.135 . . . . 0.0 113.217 178.579 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.05 154.15 16.27 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.689 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -121.21 -170.11 1.96 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 126.23 1.812 . . . . 0.0 109.062 179.788 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -131.25 158.38 75.41 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 125.328 1.451 . . . . 0.0 108.233 -178.63 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.409 ' O ' HG13 ' A' ' 52' ' ' VAL . 81.2 Cg_endo -73.5 66.57 4.58 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 124.006 3.137 . . . . 0.0 113.226 -178.766 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 51' ' ' PRO . 3.0 m -163.1 164.94 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 126.86 2.064 . . . . 0.0 108.873 179.315 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -84.77 -58.99 2.49 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.478 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.95 177.63 15.02 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.11 1.338 . . . . 0.0 110.516 -179.321 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.57 139.17 58.46 Favored 'Cis proline' 0 N--CA 1.457 -0.629 0 CA-C-N 117.916 0.858 . . . . 0.0 111.442 0.127 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -114.8 150.79 34.89 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.891 1.277 . . . . 0.0 109.511 178.698 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -113.7 159.32 19.84 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -177.002 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -98.7 152.48 19.61 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.133 1.773 . . . . 0.0 109.529 179.132 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 23' ' ' ALA . 58.6 t80 -160.84 119.83 1.53 Allowed Pre-proline 0 C--O 1.223 -0.301 0 C-N-CA 124.008 0.923 . . . . 0.0 108.707 177.272 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.91 122.97 3.09 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 121.229 1.286 . . . . 0.0 113.795 -177.572 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 62' ' ' LYS . 4.4 tp -86.17 168.25 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 CA-C-O 123.678 1.704 . . . . 0.0 111.998 179.293 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.408 ' N ' HG13 ' A' ' 61' ' ' ILE . 25.9 mmtt -158.64 158.11 33.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 109.233 -3.621 . . . . 0.0 111.604 -178.851 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.1 m -84.92 60.04 5.97 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.813 1.645 . . . . 0.0 110.36 -178.946 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.85 -61.69 0.01 OUTLIER Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 179.083 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.85 -104.47 0.19 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.207 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.3 t -80.24 163.97 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.429 1.092 . . . . 0.0 108.438 -179.455 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.93 152.63 12.52 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -178.37 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.8 p -139.21 -65.68 0.48 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.649 1.58 . . . . 0.0 108.575 179.378 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.02 105.11 0.27 Allowed Glycine 0 C--N 1.341 0.837 0 C-N-CA 124.417 1.008 . . . . 0.0 110.783 179.301 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -150.1 19.97 1.09 Allowed Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.808 -0.996 . . . . 0.0 113.069 179.313 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.1 m 67.42 119.97 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 126.375 1.87 . . . . 0.0 112.069 179.204 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.71 -176.24 17.91 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 CA-C-N 119.785 0.959 . . . . 0.0 112.499 0.131 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.07 66.99 0.32 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 108.19 -1.964 . . . . 0.0 108.19 179.287 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.95 -58.85 2.27 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.474 0.71 . . . . 0.0 112.097 -178.831 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -61.14 117.83 6.05 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.434 1.494 . . . . 0.0 113.398 -178.116 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -138.56 118.15 13.02 Favored 'General case' 0 C--N 1.344 0.368 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.159 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.5 m -81.64 148.39 5.46 Favored 'Isoleucine or valine' 0 C--N 1.343 0.301 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 176.879 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.27 53.6 t -130.97 111.51 20.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -178.071 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -101.12 -179.67 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 125.861 1.664 . . . . 0.0 113.936 -176.382 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -101.86 155.16 18.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 127.957 2.503 . . . . 0.0 108.62 179.875 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.282 11.4 t -64.11 -8.45 12.1 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -178.323 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -84.27 -80.74 0.19 Allowed 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 102.485 -3.154 . . . . 0.0 102.485 177.645 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 23.4 m -164.34 -7.39 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 129.589 3.155 . . . . 0.0 114.951 -179.17 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -79.68 132.76 36.29 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 116.501 2.038 . . . . 0.0 116.501 -175.314 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -75.34 123.16 24.87 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.152 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.51 -59.55 2.28 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.825 0.85 . . . . 0.0 111.258 -178.184 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.11 164.28 33.54 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -179.899 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.29 158.81 19.29 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.814 0.816 . . . . 0.0 112.25 -178.858 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.8 pt -140.46 160.3 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.329 2.252 . . . . 0.0 106.859 179.288 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.3 t -156.65 152.15 26.78 Favored 'General case' 0 C--N 1.343 0.326 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -179.046 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -83.57 38.34 0.62 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.337 0.655 . . . . 0.0 111.07 176.571 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 92.2 m -77.7 -73.3 0.31 Allowed 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.369 0.986 . . . . 0.0 109.624 -179.334 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.35 -9.21 60.63 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.489 1.043 . . . . 0.0 112.116 178.939 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.81 155.07 27.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.555 1.542 . . . . 0.0 111.748 178.993 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.8 m -68.89 -50.09 52.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.659 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.93 -84.29 0.05 OUTLIER Glycine 0 CA--C 1.527 0.787 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.193 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -89.01 0.32 56.77 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.127 0.971 . . . . 0.0 111.891 179.828 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -71.34 -170.57 0.51 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.863 0.865 . . . . 0.0 110.56 179.516 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -147.78 160.88 42.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -178.644 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.1 m -142.41 162.7 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 127.585 2.354 . . . . 0.0 106.334 177.012 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.98 121.53 5.55 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.074 0.845 . . . . 0.0 114.401 -178.808 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.44 159.6 15.03 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.65 1.18 . . . . 0.0 109.404 178.502 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.7 p 60.27 45.22 11.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.472 1.909 . . . . 0.0 111.042 -178.781 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.01 44.17 96.3 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.299 0.952 . . . . 0.0 111.928 179.448 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.9 m -104.84 149.53 25.59 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.625 1.17 . . . . 0.0 109.362 179.316 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.106 0 C-N-CA 124.445 1.098 . . . . 0.0 108.146 179.083 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 110.727 -0.101 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.9 m -146.33 163.2 36.31 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.607 1.163 . . . . 0.0 109.684 -179.312 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.03 124.58 19.18 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.427 1.091 . . . . 0.0 109.817 179.274 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 p -89.46 81.39 6.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -178.309 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.27 92.09 6.88 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 175.877 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -100.51 79.06 2.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.535 1.534 . . . . 0.0 109.324 -177.643 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.76 -70.62 1.98 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.345 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.2 p -137.98 -34.11 0.68 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.632 1.573 . . . . 0.0 111.877 179.453 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 m -72.67 93.55 1.65 Allowed 'General case' 0 C--N 1.345 0.389 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.148 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -96.6 113.74 25.33 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.777 1.631 . . . . 0.0 112.869 -178.43 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -109.78 144.75 37.77 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.885 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 16' ' ' VAL . 50.0 m -66.37 152.3 45.33 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 124.229 1.011 . . . . 0.0 109.527 179.148 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.94 -24.73 25.16 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.705 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.4 t -71.33 -43.79 66.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.146 1.378 . . . . 0.0 109.594 179.31 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -71.86 -29.47 64.41 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -179.263 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 12' ' ' SER . 1.9 t -72.29 -45.26 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.28 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 -67.86 -32.94 73.79 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.37 1.068 . . . . 0.0 111.857 179.393 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.04 -58.17 5.43 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.444 1.02 . . . . 0.0 110.135 -179.265 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.4 ' HB1' ' HE2' ' A' ' 59' ' ' PHE . . . -60.53 -37.09 80.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.787 -178.843 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.32 -35.78 58.63 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 179.413 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -68.78 -19.89 64.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.785 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.54 -60.86 2.17 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 179.525 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.463 ' HB2' ' CD1' ' A' ' 59' ' ' PHE . . . -48.71 -41.34 31.55 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.371 1.068 . . . . 0.0 112.4 177.219 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -55.74 30.86 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.002 1.321 . . . . 0.0 109.906 179.014 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -56.55 -31.47 64.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.675 1.19 . . . . 0.0 110.893 -178.379 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 -89.07 -32.05 17.74 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -178.832 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -63.94 -36.53 84.26 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.636 1.107 . . . . 0.0 113.927 -177.7 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -105.33 27.0 8.72 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.975 0.91 . . . . 0.0 111.98 -178.513 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.99 -36.83 8.46 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.076 0.95 . . . . 0.0 111.992 179.338 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.7 t70 83.49 96.19 0.04 OUTLIER 'General case' 0 C--N 1.344 0.345 0 C-N-CA 127.354 2.262 . . . . 0.0 108.789 -178.597 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 70.99 109.0 0.06 Allowed 'General case' 0 C--N 1.342 0.248 0 C-N-CA 127.192 2.197 . . . . 0.0 109.65 -178.755 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -175.97 -47.98 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.25 1.42 . . . . 0.0 111.422 -177.622 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.88 96.92 3.21 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.986 0.514 . . . . 0.0 109.845 -179.288 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.16 49.62 3.78 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.564 1.078 . . . . 0.0 110.461 179.705 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.0 m -89.14 -76.49 0.41 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.799 1.239 . . . . 0.0 108.374 -179.463 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.8 t -173.72 -64.98 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.114 1.765 . . . . 0.0 106.48 179.235 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.525 HG23 ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -150.08 8.67 0.65 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.388 1.475 . . . . 0.0 111.857 178.84 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -94.95 129.8 34.7 Favored Pre-proline 0 C--N 1.345 0.382 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.294 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -70.15 129.0 13.94 Favored 'Cis proline' 0 N--CA 1.456 -0.726 0 N-CA-C 115.444 1.286 . . . . 0.0 115.444 0.115 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.525 ' CE1' HG23 ' A' ' 37' ' ' THR 0.252 21.3 m-70 -96.87 143.65 27.57 Favored 'General case' 0 C--N 1.343 0.298 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 178.059 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 t -63.14 142.15 58.49 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.584 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -107.35 119.26 38.92 Favored 'General case' 0 C--O 1.23 0.048 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.04 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -149.64 -63.57 0.22 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.279 1.832 . . . . 0.0 107.085 178.921 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 47.4 t30 50.91 -115.56 0.88 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.03 1.732 . . . . 0.0 112.044 178.798 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -169.37 -174.96 2.08 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.02 2.128 . . . . 0.0 107.627 -179.165 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 76.93 157.42 0.18 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.801 1.641 . . . . 0.0 110.869 179.319 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.45 70.14 2.47 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.077 0.846 . . . . 0.0 111.292 179.19 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.5 111.74 6.55 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.167 1.387 . . . . 0.0 107.809 179.042 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -148.31 -175.49 4.93 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.847 1.259 . . . . 0.0 108.355 179.721 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -132.01 144.97 55.42 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.662 1.185 . . . . 0.0 108.647 -179.076 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.23 67.3 6.95 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 124.36 3.373 . . . . 0.0 112.293 -179.226 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.05 -170.65 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 127.496 2.318 . . . . 0.0 107.573 179.246 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -118.57 131.33 56.21 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.765 1.226 . . . . 0.0 109.606 179.18 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.02 -172.23 45.92 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.324 0.964 . . . . 0.0 112.341 -179.353 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.95 151.93 97.61 Favored 'Cis proline' 0 N--CA 1.458 -0.594 0 CA-C-N 118.041 0.92 . . . . 0.0 111.809 0.078 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -118.14 176.28 5.29 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.861 1.265 . . . . 0.0 109.942 179.324 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.12 153.51 31.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.972 178.992 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.274 8.0 tp10 -79.92 150.05 30.67 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.099 2.56 . . . . 0.0 111.579 -177.7 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 77.7 t80 -155.27 106.0 2.23 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.004 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.429 ' HG2' ' CD1' ' A' ' 67' ' ' TYR . 60.5 Cg_endo -72.71 135.06 23.11 Favored 'Trans proline' 0 N--CA 1.442 -1.542 0 N-CA-C 107.674 -1.702 . . . . 0.0 107.674 -177.311 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.466 ' CG1' ' H ' ' A' ' 62' ' ' LYS 0.266 0.1 OUTLIER -85.76 -147.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.34 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -176.1 . . . . . . . . 4 4 . 1 . 042 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.466 ' H ' ' CG1' ' A' ' 61' ' ' ILE . 3.9 mmmm -79.25 166.28 22.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 110.936 -2.847 . . . . 0.0 111.401 -178.287 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.2 m 132.31 51.73 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.493 1 C-N-CA 133.199 4.599 . . . . 0.0 104.723 -177.987 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.54 -52.09 0.59 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.665 1.602 . . . . 0.0 109.243 -178.545 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 177.53 -164.72 34.02 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.483 1.04 . . . . 0.0 110.562 179.728 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.6 p -75.25 71.33 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.92 1.288 . . . . 0.0 107.975 178.888 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.429 ' CD1' ' HG2' ' A' ' 60' ' ' PRO . 34.7 t80 65.81 80.07 0.23 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 128.484 2.713 . . . . 0.0 111.251 -178.269 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 t -157.78 105.59 2.01 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.782 1.233 . . . . 0.0 108.909 179.083 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 179.13 -118.71 0.61 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.4 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 174.29 -99.4 0.14 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.159 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.0 m -60.84 -58.2 21.0 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.241 1.016 . . . . 0.0 112.138 179.534 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.17 134.31 36.17 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.064 1.843 . . . . 0.0 110.497 177.788 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.99 -103.64 0.17 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 179.522 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.441 ' HB1' ' H ' ' A' ' 91' ' ' HIS . . . 72.66 -46.42 0.65 Allowed 'General case' 0 C--N 1.344 0.366 0 C-N-CA 127.257 2.223 . . . . 0.0 113.502 -179.645 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.24 125.17 28.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.848 1.659 . . . . 0.0 112.744 -178.488 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -146.28 124.18 12.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.686 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.5 m -86.76 156.17 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 103.317 -2.846 . . . . 0.0 103.317 177.098 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 73.3 t -134.89 115.49 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 -178.08 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 85' ' ' TYR . 1.8 pt -95.52 165.92 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.428 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -176.313 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -99.75 163.03 12.65 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 124.677 1.191 . . . . 0.0 108.185 178.949 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.327 5.2 t -74.11 27.84 0.08 Allowed 'General case' 0 C--N 1.339 0.144 0 N-CA-C 119.698 3.221 . . . . 0.0 119.698 -177.232 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -123.35 -79.32 0.61 Allowed 'General case' 0 N--CA 1.441 -0.917 1 N-CA-C 100.058 -4.053 . . . . 0.0 100.058 176.61 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 2.0 t -164.13 -24.03 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.14 1.776 . . . . 0.0 114.409 179.008 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -79.68 127.42 32.17 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -176.442 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 79' ' ' ILE 0.344 4.5 p90 -82.24 147.67 28.82 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 123.665 0.603 . . . . 0.0 111.343 -178.922 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.81 -46.26 19.13 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.655 1.182 . . . . 0.0 111.335 -177.338 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.79 -153.69 16.6 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.116 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.82 150.36 32.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.393 0.616 . . . . 0.0 111.402 -179.308 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 44.2 pt -138.47 157.86 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.031 1.733 . . . . 0.0 108.043 -179.337 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.8 t -157.7 154.89 29.01 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -179.063 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.441 ' H ' ' HB1' ' A' ' 74' ' ' ALA . 11.3 m170 -79.34 -14.89 58.69 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 123.344 0.403 . . . . 0.0 110.297 175.517 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.3 m -62.0 115.3 3.96 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 123.873 0.869 . . . . 0.0 109.832 -179.304 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.27 -15.3 63.52 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.959 0.79 . . . . 0.0 112.382 -179.11 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.97 -177.45 5.57 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.446 1.098 . . . . 0.0 111.4 -179.564 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.8 t -87.36 59.46 5.54 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.836 1.255 . . . . 0.0 111.141 -179.396 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.34 -89.31 1.01 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.971 1.272 . . . . 0.0 112.865 178.486 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -79.8 -31.6 40.74 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.405 1.082 . . . . 0.0 111.22 -179.35 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -55.21 165.65 0.69 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.685 1.594 . . . . 0.0 111.709 179.627 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -120.18 155.25 33.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.48 1.512 . . . . 0.0 111.956 -179.178 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.3 m -139.17 163.05 27.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 C-N-CA 125.949 1.7 . . . . 0.0 107.96 177.794 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -82.81 140.15 19.94 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.892 0.758 . . . . 0.0 112.183 -178.717 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 t -83.22 -177.41 6.74 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.658 1.183 . . . . 0.0 109.73 178.949 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.8 t -70.51 112.35 6.72 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.822 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.86 -41.24 2.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -178.95 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.1 m -86.49 94.19 9.35 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.988 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 t30 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.225 -1.369 . . . . 0.0 109.445 -178.918 . . . . . . . . 0 0 . 1 stop_ save_